Citrus Sinensis ID: 048243
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 303 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LDQ3 | 669 | Putative cysteine-rich re | yes | no | 1.0 | 0.452 | 0.509 | 8e-86 | |
| Q9ZR08 | 852 | G-type lectin S-receptor- | no | no | 0.976 | 0.347 | 0.531 | 3e-84 | |
| Q9LW83 | 850 | G-type lectin S-receptor- | no | no | 0.887 | 0.316 | 0.551 | 4e-84 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.993 | 0.357 | 0.536 | 1e-83 | |
| Q3E9X6 | 690 | Cysteine-rich receptor-li | no | no | 1.0 | 0.439 | 0.511 | 2e-83 | |
| O64793 | 818 | G-type lectin S-receptor- | no | no | 0.887 | 0.328 | 0.569 | 2e-83 | |
| Q8GYA4 | 669 | Cysteine-rich receptor-li | no | no | 0.996 | 0.451 | 0.506 | 3e-83 | |
| Q9LZU4 | 676 | Cysteine-rich receptor-li | no | no | 1.0 | 0.448 | 0.491 | 1e-82 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 1.0 | 0.359 | 0.522 | 3e-82 | |
| O65482 | 830 | Putative cysteine-rich re | no | no | 0.990 | 0.361 | 0.495 | 9e-82 |
| >sp|Q9LDQ3|CRK35_ARATH Putative cysteine-rich receptor-like protein kinase 35 OS=Arabidopsis thaliana GN=CRK35 PE=3 SV=3 | Back alignment and function desciption |
|---|
Score = 317 bits (811), Expect = 8e-86, Method: Compositional matrix adjust.
Identities = 157/308 (50%), Positives = 218/308 (70%), Gaps = 5/308 (1%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G L G +AVK+LSKTS QG EEFKNE +L +KLQH NL+R+LGFC++ EE++LVYE++
Sbjct: 362 GKLSSGPEVAVKRLSKTSGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEFV 421
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD +LFDP ++ LDW +R +II GI +G+LYL + SRLTIIHRDLKASNILL D
Sbjct: 422 PNKSLDYFLFDPAKQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDAD 481
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKI+DFG+ARIF + +ANT ++ GT GY+ PEYA +G +S KSDV+SFGVL+L+II
Sbjct: 482 MNPKIADFGMARIFGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEII 541
Query: 181 SGKRLSMLCGINENLS-ILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239
SGK+ S I+++ S ++ HA+ LW+ G +E VD ++ ++ + RC+ IALLCVQ
Sbjct: 542 SGKKNSSFYNIDDSGSNLVTHAWRLWRNGSPLELVDPTIGESYQSSEATRCIHIALLCVQ 601
Query: 240 ENPNDRPSMLQVSSMLKNETTNRNTPKKPAF---SKQVDEIGIELL-STTQLEKCSACDL 295
E+P DRP + + ML + TT + P+ P F + +++ G+E ST++ S D
Sbjct: 602 EDPADRPLLPAIIMMLTSSTTTLHVPRAPGFCLSGRDLEQDGVEYTESTSRSIPGSINDA 661
Query: 296 SFSEVVAR 303
S +E R
Sbjct: 662 SITEFYPR 669
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 311 bits (798), Expect = 3e-84, Method: Compositional matrix adjust.
Identities = 160/301 (53%), Positives = 215/301 (71%), Gaps = 5/301 (1%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G+ P + IAVK+LS+ S QG EEFKNEV+L AKLQH NL+R+LG+C+ EE++L+YEYM
Sbjct: 549 GMFPGDQEIAVKRLSRCSGQGLEEFKNEVVLIAKLQHRNLVRLLGYCVAGEEKLLLYEYM 608
Query: 61 PNKSLDCYLFDPIRRLI--LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
P+KSLD ++FD R+L LDWK R +II GI +GLLYL + SRL IIHRDLK SNILL
Sbjct: 609 PHKSLDFFIFD--RKLCQRLDWKMRCNIILGIARGLLYLHQDSRLRIIHRDLKTSNILLD 666
Query: 119 EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
E+M PKISDFGLARIF ANT +VVGT GY+ PEYA +G++S KSDVFSFGV++++
Sbjct: 667 EEMNPKISDFGLARIFGGSETSANTNRVVGTYGYMSPEYALEGLFSFKSDVFSFGVVVIE 726
Query: 179 IISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238
ISGKR + ++LS+L HA++LWK +G+E +D +L ++ ++CL + LLCV
Sbjct: 727 TISGKRNTGFHEPEKSLSLLGHAWDLWKAERGIELLDQALQESCETEGFLKCLNVGLLCV 786
Query: 239 QENPNDRPSMLQVSSML-KNETTNRNTPKKPAFSKQVDEIGIELLSTTQLEKCSACDLSF 297
QE+PNDRP+M V ML +E TPK+PAF + + S+T+ E CS +L+
Sbjct: 787 QEDPNDRPTMSNVVFMLGSSEAATLPTPKQPAFVLRRCPSSSKASSSTKPETCSENELTI 846
Query: 298 S 298
+
Sbjct: 847 T 847
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LW83|CE101_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase CES101 OS=Arabidopsis thaliana GN=CES101 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 311 bits (797), Expect = 4e-84, Method: Compositional matrix adjust.
Identities = 151/274 (55%), Positives = 208/274 (75%), Gaps = 5/274 (1%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G L G+ +A+K+LS S QG EFKNE ML AKLQH NL+++LG C++ +E+ML+YEYM
Sbjct: 544 GRLIDGEEVAIKRLSLASGQGLVEFKNEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYM 603
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD +LFDP+R+++LDWK R I+EGI QGLLYL +YSRL +IHRD+KA NILL ED
Sbjct: 604 PNKSLDYFLFDPLRKIVLDWKLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDED 663
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKISDFG+ARIF + +ANT++V GT GY+ PEY R+G++S KSDVFSFGVL+L+II
Sbjct: 664 MNPKISDFGMARIFGAQESKANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEII 723
Query: 181 SGKRLSMLCGINEN-LSILEHAYELWKGGKGVEFVDSSLDDT--NSPCKLMRCLEIALLC 237
G++ + +E L+++ H + L+K + E +D SL D+ +P +++RC+++ALLC
Sbjct: 724 CGRKNNSFHHDSEGPLNLIVHVWNLFKENRVREVIDPSLGDSAVENP-QVLRCVQVALLC 782
Query: 238 VQENPNDRPSMLQVSSMLKNETTNR-NTPKKPAF 270
VQ+N +DRPSML V SM+ + N + PK+PAF
Sbjct: 783 VQQNADDRPSMLDVVSMIYGDGNNALSLPKEPAF 816
|
Promotes the expression of genes involved in photosynthesis at least in dedifferentiated calli. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 310 bits (793), Expect = 1e-83, Method: Compositional matrix adjust.
Identities = 163/304 (53%), Positives = 208/304 (68%), Gaps = 3/304 (0%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G LP G+ IAVK+LS+ S QG EE NEV++ +KLQH NL+++LG CI+ EERMLVYEYM
Sbjct: 541 GKLPEGQEIAVKRLSRKSGQGLEELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYM 600
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
P KSLD YLFDP+++ ILDWK R +I+EGI +GLLYL SRL IIHRDLKASNILL E+
Sbjct: 601 PKKSLDAYLFDPMKQKILDWKTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDEN 660
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
+ PKISDFGLARIF EANT +VVGT GY+ PEYA +G +S KSDVFS GV+ L+II
Sbjct: 661 LNPKISDFGLARIFRANEDEANTRRVVGTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEII 720
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240
SG+R S NL++L +A++LW G+ D ++ D ++ +C+ I LLCVQE
Sbjct: 721 SGRRNSSSHKEENNLNLLAYAWKLWNDGEAASLADPAVFDKCFEKEIEKCVHIGLLCVQE 780
Query: 241 NPNDRPSMLQVSSMLKNETTNRNTPKKPAFSKQVDEIGIELLSTTQ-LEKCSACDLSFSE 299
NDRP++ V ML E + PK+PAF V E S+ Q +K S D+S +
Sbjct: 781 VANDRPNVSNVIWMLTTENMSLADPKQPAFI--VRRGASEAESSDQSSQKVSINDVSLTA 838
Query: 300 VVAR 303
V R
Sbjct: 839 VTGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3E9X6|CRK21_ARATH Cysteine-rich receptor-like protein kinase 21 OS=Arabidopsis thaliana GN=CRK21 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 309 bits (791), Expect = 2e-83, Method: Compositional matrix adjust.
Identities = 159/311 (51%), Positives = 212/311 (68%), Gaps = 8/311 (2%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G+ P G +A K+LSK S QG EFKNEV+L A+LQH NL+ +LGF ++ EE++LVYE++
Sbjct: 380 GMFPNGTEVAAKRLSKPSDQGEPEFKNEVLLVARLQHKNLVGLLGFSVEGEEKILVYEFV 439
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD +LFDPI+R+ LDW +R +IIEGIT+G+LYL + SRLTIIHRDLKASNILL +
Sbjct: 440 PNKSLDHFLFDPIKRVQLDWPRRHNIIEGITRGILYLHQDSRLTIIHRDLKASNILLDAE 499
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKI+DFGLAR F EANT +VVGT GY+PPEY G +STKSDV+SFGVL+L+II
Sbjct: 500 MNPKIADFGLARNFRVNQTEANTGRVVGTFGYMPPEYVANGQFSTKSDVYSFGVLILEII 559
Query: 181 SGKRLSMLCGINENLS-ILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239
GK+ S I+ ++S ++ H + L G +E VD ++ + +++RC+ I LLCVQ
Sbjct: 560 GGKKNSSFHQIDGSVSNLVTHVWRLRNNGSLLELVDPAIGENYDKDEVIRCIHIGLLCVQ 619
Query: 240 ENPNDRPSMLQVSSMLKNETTNRNTPKKPAF----SKQVDEIGIELL---STTQLEKCSA 292
ENP+DRPSM + ML N + P+ P F + + + LL ST+ CS
Sbjct: 620 ENPDDRPSMSTIFRMLTNVSITLPVPQPPGFFFRERSEPNPLAERLLPGPSTSMSFTCSV 679
Query: 293 CDLSFSEVVAR 303
D S + V R
Sbjct: 680 DDASITSVRPR 690
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O64793|Y1675_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520 OS=Arabidopsis thaliana GN=At1g67520 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 308 bits (790), Expect = 2e-83, Method: Compositional matrix adjust.
Identities = 156/274 (56%), Positives = 203/274 (74%), Gaps = 5/274 (1%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G L G+ +A+K+LS S QG EFKNE +L AKLQH NL++VLG CI+ +E+ML+YEYM
Sbjct: 513 GKLLNGEEVAIKRLSLASGQGLVEFKNEAILIAKLQHTNLVQVLGCCIEKDEKMLIYEYM 572
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
NKSLD +LFDP+R+ +LDW R I+EGI QGLLYL +YSRL +IHRD+KASNILL ED
Sbjct: 573 QNKSLDYFLFDPLRKNVLDWTLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKASNILLDED 632
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKISDFGLARIF E ANT++V GT GY+ PEY R+G++S KSDVFSFGVL+L+II
Sbjct: 633 MNPKISDFGLARIFGAEETRANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEII 692
Query: 181 SGKR-LSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDT--NSPCKLMRCLEIALLC 237
G++ S + L+++ H + L+K K E +D SL D+ + P +++RC+++ALLC
Sbjct: 693 CGRKNNSFHHDLEGPLNLIVHVWNLFKENKIREVIDLSLRDSALDYP-QVLRCVQVALLC 751
Query: 238 VQENPNDRPSMLQVSSMLKNETTNR-NTPKKPAF 270
VQEN DRPSML V SM+ E N + PK+PAF
Sbjct: 752 VQENAEDRPSMLDVVSMIYGEGNNALSLPKEPAF 785
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 308 bits (790), Expect = 3e-83, Method: Compositional matrix adjust.
Identities = 155/306 (50%), Positives = 208/306 (67%), Gaps = 4/306 (1%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G L G +AVK+LSK+S QG EFKNEV+L AKLQH NL+R+LGFC+D EER+LVYEY+
Sbjct: 365 GTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYV 424
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD +LFDP ++ LDW +R II G+ +G+LYL + SRLTIIHRDLKASNILL D
Sbjct: 425 PNKSLDYFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDAD 484
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKI+DFG+ARIF + E NT ++VGT GY+ PEYA G YS KSDV+SFGVL+L+II
Sbjct: 485 MNPKIADFGMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEII 544
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240
SGK+ S + ++ +A+ LW G+ +E VD ++ + +++RC+ I LLCVQE
Sbjct: 545 SGKKNSSFYQTDGAHDLVSYAWGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQE 604
Query: 241 NPNDRPSMLQVSSMLKNETTNRNTPKKPAFSKQVDEIGIELLSTTQLEKC---SACDLSF 297
+P +RP++ + ML + T P++P Q IG + L T K S D S
Sbjct: 605 DPAERPTLSTIVLMLTSNTVTLPVPRQPGLFFQ-SRIGKDPLDTDTTSKSLLGSVDDASI 663
Query: 298 SEVVAR 303
+++ R
Sbjct: 664 TDIHPR 669
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LZU4|CRK4_ARATH Cysteine-rich receptor-like protein kinase 4 OS=Arabidopsis thaliana GN=CRK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 306 bits (785), Expect = 1e-82, Method: Compositional matrix adjust.
Identities = 152/309 (49%), Positives = 209/309 (67%), Gaps = 6/309 (1%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G+ P G +AVK+LSKTS QG EF NEV++ AKLQH NL+R+LGFC++ +ER+LVYE++
Sbjct: 368 GIFPSGVQVAVKRLSKTSGQGEREFANEVIVVAKLQHRNLVRLLGFCLERDERILVYEFV 427
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD ++FD + +LDW +R II GI +G+LYL + SRLTIIHRDLKA NILLG+D
Sbjct: 428 PNKSLDYFIFDSTMQSLLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLGDD 487
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M KI+DFG+ARIF + EANT ++VGT GY+ PEYA G +S KSDV+SFGVL+L+II
Sbjct: 488 MNAKIADFGMARIFGMDQTEANTRRIVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEII 547
Query: 181 SGKRLSMLCGINENLS--ILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238
SGK+ S + ++ + ++ + + LW G +E VD S D ++ RC+ IALLCV
Sbjct: 548 SGKKNSNVYQMDGTSAGNLVTYTWRLWSNGSPLELVDPSFRDNYRINEVSRCIHIALLCV 607
Query: 239 QENPNDRPSMLQVSSMLKNETTNRNTPKKPAF---SKQVDEIG-IELLSTTQLEKCSACD 294
QE DRP+M + ML + P++P F S + +++G ++ LS CS D
Sbjct: 608 QEEAEDRPTMSAIVQMLTTSSIALAVPQRPGFFFRSSKHEQVGLVDRLSINTSALCSVDD 667
Query: 295 LSFSEVVAR 303
S + V R
Sbjct: 668 ASITNVTPR 676
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 305 bits (781), Expect = 3e-82, Method: Compositional matrix adjust.
Identities = 161/308 (52%), Positives = 207/308 (67%), Gaps = 5/308 (1%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G L GK IAVK+LSK S+QG +EF NEV L AKLQH+NL+R+LG C+D E+ML+YEY+
Sbjct: 536 GRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYL 595
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
N SLD +LFD R L+W+KR II GI +GLLYL + SR IIHRDLKASN+LL ++
Sbjct: 596 ENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKN 655
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKISDFG+ARIF +E EANT +VVGT GY+ PEYA G++S KSDVFSFGVLLL+II
Sbjct: 656 MTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEII 715
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGVEFVD----SSLDDTNSPCKLMRCLEIALL 236
SGKR N +L++L + WK G +E VD SL +++RC++I LL
Sbjct: 716 SGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLL 775
Query: 237 CVQENPNDRPSMLQVSSMLKNETTNRNTPKKPAFSKQVDEIGIELLSTTQL-EKCSACDL 295
CVQE DRP M V ML +ETT PK+P F + + S+TQ ++C+ +
Sbjct: 776 CVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQI 835
Query: 296 SFSEVVAR 303
+ S + AR
Sbjct: 836 TLSVIDAR 843
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65482|CRK23_ARATH Putative cysteine-rich receptor-like protein kinase 23 OS=Arabidopsis thaliana GN=CRK23 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 303 bits (777), Expect = 9e-82, Method: Compositional matrix adjust.
Identities = 153/309 (49%), Positives = 207/309 (66%), Gaps = 9/309 (2%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G P G +AVK+LSKTS QG EF+NEV++ AKLQH NL+R+LG+C++ EE++LVYE++
Sbjct: 525 GTFPSGVQVAVKRLSKTSGQGEREFENEVVVVAKLQHRNLVRLLGYCLEGEEKILVYEFV 584
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
NKSLD +LFD + LDW +R II GI +G+LYL + SRLTIIHRDLKA NILL D
Sbjct: 585 HNKSLDYFLFDTTMKRQLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDAD 644
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PK++DFG+ARIF + EANT +VVGT GY+ PEYA G +S KSDV+SFGVL+ +II
Sbjct: 645 MNPKVADFGMARIFGMDQTEANTRRVVGTYGYMAPEYAMYGQFSMKSDVYSFGVLVFEII 704
Query: 181 SGKRLSMLCGINENLS-ILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239
SG + S L +++++S ++ + + LW G ++ VD S D + RC+ IALLCVQ
Sbjct: 705 SGMKNSSLYQMDDSVSNLVTYTWRLWSNGSQLDLVDPSFGDNYQTHDITRCIHIALLCVQ 764
Query: 240 ENPNDRPSMLQVSSMLKNETTNRNTPKKPAF-----SKQVDEIGIELLSTTQLEKCSACD 294
E+ +DRP+M + ML + PK+P F +QV E+G S +L CS D
Sbjct: 765 EDVDDRPNMSAIVQMLTTSSIVLAVPKQPGFFFRGRHEQVGEVGS---SVDRLALCSIDD 821
Query: 295 LSFSEVVAR 303
S + V R
Sbjct: 822 ASITSVAPR 830
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 303 | ||||||
| 224142425 | 763 | predicted protein [Populus trichocarpa] | 1.0 | 0.397 | 0.702 | 1e-122 | |
| 356558668 | 909 | PREDICTED: uncharacterized protein LOC10 | 0.993 | 0.331 | 0.679 | 1e-118 | |
| 224142427 | 327 | predicted protein [Populus trichocarpa] | 0.910 | 0.844 | 0.702 | 1e-114 | |
| 296088199 | 1130 | unnamed protein product [Vitis vinifera] | 1.0 | 0.268 | 0.643 | 1e-111 | |
| 255565055 | 721 | conserved hypothetical protein [Ricinus | 1.0 | 0.420 | 0.641 | 1e-109 | |
| 224142431 | 332 | predicted protein [Populus trichocarpa] | 0.996 | 0.909 | 0.621 | 1e-108 | |
| 224082290 | 335 | predicted protein [Populus trichocarpa] | 0.996 | 0.901 | 0.621 | 1e-108 | |
| 296084604 | 580 | unnamed protein product [Vitis vinifera] | 0.983 | 0.513 | 0.631 | 1e-105 | |
| 359484771 | 781 | PREDICTED: G-type lectin S-receptor-like | 0.983 | 0.381 | 0.631 | 1e-105 | |
| 359497026 | 738 | PREDICTED: G-type lectin S-receptor-like | 0.910 | 0.373 | 0.673 | 1e-104 |
| >gi|224142425|ref|XP_002324558.1| predicted protein [Populus trichocarpa] gi|222865992|gb|EEF03123.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 445 bits (1144), Expect = e-122, Method: Compositional matrix adjust.
Identities = 213/303 (70%), Positives = 249/303 (82%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
GVLP G+ IAVKKLSK+STQGF+EFKNEVMLTAKLQHVNL++VLGFC++ EE++L+YEYM
Sbjct: 461 GVLPGGQEIAVKKLSKSSTQGFDEFKNEVMLTAKLQHVNLVKVLGFCVEREEKVLIYEYM 520
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
P KSLD YLFDPIRR +LDWK+R IIEGITQGLLYLQEYSRLTIIHRDLKASNILL D
Sbjct: 521 PKKSLDSYLFDPIRRYLLDWKRREEIIEGITQGLLYLQEYSRLTIIHRDLKASNILLDGD 580
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
MKPKISDFG+ARIF K+ EANT ++VGT GY+PPEY R GVYS KSDV+SFG++LL II
Sbjct: 581 MKPKISDFGMARIFTKDEQEANTSRLVGTYGYVPPEYVRNGVYSIKSDVYSFGIVLLHII 640
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240
SGK+ L G +E LS+LE+AYELWK GKG+E +D SLDDT S CKL++CL+IALLCVQE
Sbjct: 641 SGKKNGSLYGSDETLSLLEYAYELWKDGKGMEIMDPSLDDTLSSCKLIKCLQIALLCVQE 700
Query: 241 NPNDRPSMLQVSSMLKNETTNRNTPKKPAFSKQVDEIGIELLSTTQLEKCSACDLSFSEV 300
NP DRPSML+VSSMLKNET PK+PAFS + DE ++ CS D + S+V
Sbjct: 701 NPIDRPSMLEVSSMLKNETAIVTIPKRPAFSVKTDEDDKNRPDQLHIKICSVDDATISQV 760
Query: 301 VAR 303
V R
Sbjct: 761 VGR 763
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558668|ref|XP_003547625.1| PREDICTED: uncharacterized protein LOC100787480 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 431 bits (1107), Expect = e-118, Method: Compositional matrix adjust.
Identities = 206/303 (67%), Positives = 253/303 (83%), Gaps = 2/303 (0%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G+L + +AVKKLSK STQGFEEFKNEVMLTA+LQHVNL+R+LGF ID E++MLVYEYM
Sbjct: 450 GILSNRQEVAVKKLSKASTQGFEEFKNEVMLTARLQHVNLVRLLGFYIDGEQQMLVYEYM 509
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD YLFDPIRR +LDW+KR++IIEGITQGLLYLQEYSRLTIIHRD+KASNILL +
Sbjct: 510 PNKSLDSYLFDPIRRYLLDWRKRIYIIEGITQGLLYLQEYSRLTIIHRDIKASNILLDNE 569
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
MKPKISDFG+ARIF K+ LEANT ++VGT GY+ PEYA +G+YSTKSDV+SFGVLLLQI+
Sbjct: 570 MKPKISDFGMARIFRKDELEANTSKIVGTYGYVSPEYAMKGLYSTKSDVYSFGVLLLQIV 629
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240
SG+R + G +ENL+++E+AYELWK GKG+EF D SLDD++S CKL+RC++IALLCVQE
Sbjct: 630 SGRRTACFYGEHENLNLMEYAYELWKEGKGMEFADPSLDDSHSTCKLLRCMQIALLCVQE 689
Query: 241 NPNDRPSMLQVSSMLKNETTNRNTPKKPAFSKQVDEIGIELLSTTQLEKCSACDLSFSEV 300
+ NDRP++ ++SSMLK++T P+KPAFS DE + EKCS D + S+V
Sbjct: 690 DANDRPTVKEISSMLKSDTI-LIIPQKPAFSINRDEKKPNKFIMHE-EKCSINDATISQV 747
Query: 301 VAR 303
VAR
Sbjct: 748 VAR 750
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224142427|ref|XP_002324559.1| predicted protein [Populus trichocarpa] gi|222865993|gb|EEF03124.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 418 bits (1075), Expect = e-114, Method: Compositional matrix adjust.
Identities = 194/276 (70%), Positives = 233/276 (84%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G LP GK IAVK+LSKTSTQG EEFKNEV LT KLQHVN++ VLGFC + EE+ML+YEYM
Sbjct: 28 GKLPNGKEIAVKRLSKTSTQGEEEFKNEVTLTEKLQHVNIVTVLGFCAEREEKMLIYEYM 87
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD Y++DPIRR +LDW+KRV IIEG+TQGLLYLQEYS TIIHRD+K+SN+LL E+
Sbjct: 88 PNKSLDIYIYDPIRRYMLDWRKRVQIIEGLTQGLLYLQEYSNFTIIHRDIKSSNVLLDEE 147
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKISDFG+AR+F K+ LEANT ++VGT GY+PPEY R+G+YS K DV+SFGVLLLQII
Sbjct: 148 MNPKISDFGMARLFRKDELEANTSRIVGTYGYVPPEYVRKGIYSMKYDVYSFGVLLLQII 207
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240
SGK+ + G +EN ++LE+AYELWK G+GVEF D SLDD+ S CKL RCL++ALLCVQE
Sbjct: 208 SGKKSTCYYGADENWNLLEYAYELWKDGEGVEFFDPSLDDSFSSCKLTRCLQVALLCVQE 267
Query: 241 NPNDRPSMLQVSSMLKNETTNRNTPKKPAFSKQVDE 276
NP DRPSML++SSMLKNE TPK+P+FS + DE
Sbjct: 268 NPLDRPSMLKISSMLKNENAPIATPKRPSFSTKRDE 303
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296088199|emb|CBI35714.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 407 bits (1046), Expect = e-111, Method: Compositional matrix adjust.
Identities = 195/303 (64%), Positives = 241/303 (79%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G LP G+ IAVK+LSKTS QG EEFKNEV LTA LQHVNL+++LGFC EE+ML+YE M
Sbjct: 828 GKLPKGQEIAVKRLSKTSHQGLEEFKNEVTLTATLQHVNLVKLLGFCTQREEKMLIYECM 887
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD YLFDP +++LDW KR+HIIEGITQGLLYLQEYSRL IIHRDLKASNILL +
Sbjct: 888 PNKSLDFYLFDPEGQVLLDWGKRIHIIEGITQGLLYLQEYSRLRIIHRDLKASNILLDGE 947
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
MKPKI+DFG+ARIF K+ EANT ++VGT GY+ PEY ++G YS KSDV+SFGVLLLQII
Sbjct: 948 MKPKIADFGIARIFQKDENEANTGRIVGTYGYVSPEYVQKGTYSVKSDVYSFGVLLLQII 1007
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240
SGK+ + G+++NL +LE+AYELWK GK +EF+D SLDD S CKL RC+++ALLCVQE
Sbjct: 1008 SGKKNTCFYGLDQNLHLLEYAYELWKDGKSMEFMDPSLDDACSSCKLTRCMQVALLCVQE 1067
Query: 241 NPNDRPSMLQVSSMLKNETTNRNTPKKPAFSKQVDEIGIELLSTTQLEKCSACDLSFSEV 300
NP DRPS+L+V SM+KNET TP++PAF+ + DE+ + S + E S + S+V
Sbjct: 1068 NPADRPSVLEVDSMIKNETAAIATPRRPAFAAKRDEVEADGKSASGHEIGSVNVTTISQV 1127
Query: 301 VAR 303
+ R
Sbjct: 1128 LPR 1130
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255565055|ref|XP_002523520.1| conserved hypothetical protein [Ricinus communis] gi|223537227|gb|EEF38859.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 399 bits (1026), Expect = e-109, Method: Compositional matrix adjust.
Identities = 195/304 (64%), Positives = 242/304 (79%), Gaps = 1/304 (0%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G LP G+ IAVK+LSKTS QG +EFKNE+ LTAKLQHVNL+R+LG+C + +E+ML+YEYM
Sbjct: 418 GKLPRGQEIAVKRLSKTSNQGLKEFKNELKLTAKLQHVNLVRLLGYCTERKEKMLIYEYM 477
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD YLFD RRL L+W+KRVHIIEGI QGLLYLQEYS LTIIH+D+K+SNILL +
Sbjct: 478 PNKSLDFYLFDQKRRLELNWEKRVHIIEGIAQGLLYLQEYSNLTIIHKDIKSSNILLDSN 537
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
MKPKISDFG+ARIF KE+ EANT Q+VGT GY+PPEY ++GVYSTK DV+SFGVLLLQII
Sbjct: 538 MKPKISDFGMARIFQKENHEANTCQIVGTYGYVPPEYVKRGVYSTKYDVYSFGVLLLQII 597
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240
SGK+ + G + NL++LE+AYE W+ G G EF+D LDD++S CKL+RCL++ LLCVQE
Sbjct: 598 SGKKNTCYYGSHVNLNLLEYAYEFWETGNGKEFLDPVLDDSHSTCKLLRCLQVGLLCVQE 657
Query: 241 NPNDRPSMLQVSSMLKNETTNRNTPKKPAFS-KQVDEIGIELLSTTQLEKCSACDLSFSE 299
+P DRPS+LQ+ SMLKNE +PK+PAFS DEI + +T + S S SE
Sbjct: 658 SPIDRPSILQICSMLKNENDIIVSPKRPAFSVTSNDEIEKNVSKSTSQDVGSVNSASLSE 717
Query: 300 VVAR 303
++ R
Sbjct: 718 LLPR 721
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224142431|ref|XP_002324561.1| predicted protein [Populus trichocarpa] gi|222865995|gb|EEF03126.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 397 bits (1021), Expect = e-108, Method: Compositional matrix adjust.
Identities = 189/304 (62%), Positives = 243/304 (79%), Gaps = 2/304 (0%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G LP G IAVK+LS +STQG EEFKNEV LTA+LQHVNL+R+LGFC + E+ML+YEYM
Sbjct: 30 GKLPRGLEIAVKRLSASSTQGLEEFKNEVSLTARLQHVNLVRLLGFCSERGEKMLIYEYM 89
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD YLFDPIRR LDW KRV IIEG+TQGLLYLQEYS TIIHRDLK+SNILL ++
Sbjct: 90 PNKSLDLYLFDPIRRYSLDWSKRVRIIEGVTQGLLYLQEYSNFTIIHRDLKSSNILLDDE 149
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKISDFG+A++F K+ EANT ++VGT GYIPPEYAR+G+YS K DV+SFGV+LLQ+I
Sbjct: 150 MNPKISDFGMAKLFRKDVYEANTSRIVGTYGYIPPEYARKGIYSIKYDVYSFGVVLLQMI 209
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240
SGK + NE+L++LE+AY+LWK G+G+EF+D LDD++SPCKL+ C+++ALLCVQE
Sbjct: 210 SGKTNTRFYSENEDLNLLEYAYDLWKNGRGMEFIDPFLDDSSSPCKLLTCMQVALLCVQE 269
Query: 241 NPNDRPSMLQVSSMLKNETT-NRNTPKKPAFSKQVDEIGIELLSTTQLEKCSACDLSFSE 299
NP+ RP+ML+ SMLKN+ + TP++P FS++ + +E+ S++Q CS D S+
Sbjct: 270 NPDARPTMLEAFSMLKNDDSLAIATPERPGFSEK-KKGDMEIASSSQQVMCSFNDSQVSQ 328
Query: 300 VVAR 303
+ R
Sbjct: 329 LEPR 332
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224082290|ref|XP_002335492.1| predicted protein [Populus trichocarpa] gi|222834258|gb|EEE72735.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 396 bits (1018), Expect = e-108, Method: Compositional matrix adjust.
Identities = 189/304 (62%), Positives = 242/304 (79%), Gaps = 2/304 (0%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G LP G IAVK+LS +STQG EEFKNEV LTA+LQHVNL+R+LGFC + E+ML+YEYM
Sbjct: 33 GKLPRGLEIAVKRLSASSTQGLEEFKNEVSLTARLQHVNLVRLLGFCSERGEKMLIYEYM 92
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD YLFDPIRR LDW KRV IIEG+TQGLLYLQEYS TIIHRDLK+SNILL ++
Sbjct: 93 PNKSLDLYLFDPIRRYSLDWSKRVRIIEGVTQGLLYLQEYSNFTIIHRDLKSSNILLDDE 152
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKISDFG+A++F K+ EANT ++VGT GYIPPEYAR+G+YS K DV+SFGV+LLQ+I
Sbjct: 153 MNPKISDFGMAKLFRKDVYEANTSRIVGTYGYIPPEYARKGIYSIKYDVYSFGVVLLQMI 212
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240
SGK + NE+L++LE+AY+LWK G+G+EF+D LDD++SPCKL+ C+++ALLCVQE
Sbjct: 213 SGKTNTRFYSENEDLNLLEYAYDLWKNGRGMEFIDPFLDDSSSPCKLLTCMQVALLCVQE 272
Query: 241 NPNDRPSMLQVSSMLKNETT-NRNTPKKPAFSKQVDEIGIELLSTTQLEKCSACDLSFSE 299
NP+ RP+ML+ SMLKN+ + TP++P FS++ + +E S++Q CS D S+
Sbjct: 273 NPDARPTMLEAFSMLKNDDSLAIATPERPGFSEK-KKGDMETASSSQQVMCSFNDSQVSQ 331
Query: 300 VVAR 303
+ R
Sbjct: 332 LEPR 335
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296084604|emb|CBI25625.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 386 bits (991), Expect = e-105, Method: Compositional matrix adjust.
Identities = 190/301 (63%), Positives = 240/301 (79%), Gaps = 3/301 (0%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+ +AVK+LSKTS QG EEFKNEV LTAKLQHVNL+R+ GFC + EE+ML+YEYMPNKSL
Sbjct: 280 GEEMAVKRLSKTSNQGAEEFKNEVTLTAKLQHVNLVRLQGFCTEGEEKMLIYEYMPNKSL 339
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D YLFDP RR LDW KR+ IIEGITQGLLYLQEYS TIIHRDLKASNILL +MKPKI
Sbjct: 340 DFYLFDPTRRYFLDWTKRIAIIEGITQGLLYLQEYSNFTIIHRDLKASNILLDSEMKPKI 399
Query: 126 SDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRL 185
SDFG+AR F K+ EA+T ++VGT GY+PPEY R+G+YS K DV+SFGVLLLQIIS +R
Sbjct: 400 SDFGIARAFQKDEHEASTGRIVGTYGYVPPEYVRRGIYSMKYDVYSFGVLLLQIISSRRN 459
Query: 186 SMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDR 245
S G+++NL++LE+AYELWK G+G+ F+D SLDD++S CKLM C+++ALLC+QENP+ R
Sbjct: 460 SCTYGLSQNLNLLEYAYELWKEGEGMRFMDPSLDDSSSSCKLMACMQVALLCIQENPDHR 519
Query: 246 PSMLQVSSMLKNETTNRNTPKKPAFSKQVDEIGIEL---LSTTQLEKCSACDLSFSEVVA 302
P+ML+VSSMLK+ET P +PAFS + +E + + +++Q S D + S++V
Sbjct: 520 PTMLEVSSMLKSETAAMPAPLRPAFSIKSNEDKLSVNDATTSSQQNILSVNDATISDLVP 579
Query: 303 R 303
R
Sbjct: 580 R 580
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484771|ref|XP_003633158.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RKS1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 386 bits (991), Expect = e-105, Method: Compositional matrix adjust.
Identities = 190/301 (63%), Positives = 240/301 (79%), Gaps = 3/301 (0%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+ +AVK+LSKTS QG EEFKNEV LTAKLQHVNL+R+ GFC + EE+ML+YEYMPNKSL
Sbjct: 481 GEEMAVKRLSKTSNQGAEEFKNEVTLTAKLQHVNLVRLQGFCTEGEEKMLIYEYMPNKSL 540
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D YLFDP RR LDW KR+ IIEGITQGLLYLQEYS TIIHRDLKASNILL +MKPKI
Sbjct: 541 DFYLFDPTRRYFLDWTKRIAIIEGITQGLLYLQEYSNFTIIHRDLKASNILLDSEMKPKI 600
Query: 126 SDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRL 185
SDFG+AR F K+ EA+T ++VGT GY+PPEY R+G+YS K DV+SFGVLLLQIIS +R
Sbjct: 601 SDFGIARAFQKDEHEASTGRIVGTYGYVPPEYVRRGIYSMKYDVYSFGVLLLQIISSRRN 660
Query: 186 SMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDR 245
S G+++NL++LE+AYELWK G+G+ F+D SLDD++S CKLM C+++ALLC+QENP+ R
Sbjct: 661 SCTYGLSQNLNLLEYAYELWKEGEGMRFMDPSLDDSSSSCKLMACMQVALLCIQENPDHR 720
Query: 246 PSMLQVSSMLKNETTNRNTPKKPAFSKQVDEIGIEL---LSTTQLEKCSACDLSFSEVVA 302
P+ML+VSSMLK+ET P +PAFS + +E + + +++Q S D + S++V
Sbjct: 721 PTMLEVSSMLKSETAAMPAPLRPAFSIKSNEDKLSVNDATTSSQQNILSVNDATISDLVP 780
Query: 303 R 303
R
Sbjct: 781 R 781
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359497026|ref|XP_003635401.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 382 bits (982), Expect = e-104, Method: Compositional matrix adjust.
Identities = 186/276 (67%), Positives = 227/276 (82%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G LP G+ IAVK+LSKTS QG EEFKNEV LTA LQHVNL+++LGFC EE+ML+YE M
Sbjct: 450 GKLPKGQEIAVKRLSKTSHQGLEEFKNEVTLTATLQHVNLVKLLGFCTQREEKMLIYECM 509
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD YLFDP RR LDW KR+ IIEGITQGLLYLQEYS TIIHRDLKASNILL +
Sbjct: 510 PNKSLDFYLFDPTRRYFLDWTKRIAIIEGITQGLLYLQEYSNFTIIHRDLKASNILLDSE 569
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
MKPKISDFG+AR F K+ EA+T ++VGT GY+PPEY R+G+YS K DV+SFGVLLLQII
Sbjct: 570 MKPKISDFGIARAFQKDEHEASTGRIVGTYGYVPPEYVRRGIYSMKYDVYSFGVLLLQII 629
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240
S +R S G+++NL++LE+AYELWK G+G+ F+D SLDD++S CKLM C+++ALLC+QE
Sbjct: 630 SSRRNSCTYGLSQNLNLLEYAYELWKEGEGMRFMDPSLDDSSSSCKLMACMQVALLCIQE 689
Query: 241 NPNDRPSMLQVSSMLKNETTNRNTPKKPAFSKQVDE 276
NP+ RP+ML+VSSMLK+ET P +PAFS + +E
Sbjct: 690 NPDHRPTMLEVSSMLKSETAAMPAPLRPAFSIKSNE 725
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 303 | ||||||
| TAIR|locus:2093397 | 850 | CES101 "CALLUS EXPRESSION OF R | 0.996 | 0.355 | 0.509 | 8.7e-79 | |
| TAIR|locus:2123111 | 669 | CRK34 "cysteine-rich RLK (RECE | 1.0 | 0.452 | 0.509 | 1.4e-78 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 1.0 | 0.357 | 0.529 | 1e-77 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 1.0 | 0.359 | 0.525 | 1.9e-76 | |
| TAIR|locus:2121706 | 690 | CRK21 "cysteine-rich RLK (RECE | 1.0 | 0.439 | 0.511 | 3.9e-76 | |
| TAIR|locus:2121676 | 669 | CRK10 "cysteine-rich RLK (RECE | 0.996 | 0.451 | 0.506 | 1.7e-75 | |
| TAIR|locus:2077147 | 676 | CRK4 "cysteine-rich RLK (RECEP | 1.0 | 0.448 | 0.491 | 2.7e-75 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.996 | 0.355 | 0.508 | 4.5e-75 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.993 | 0.362 | 0.506 | 7.3e-75 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.910 | 0.325 | 0.528 | 1.2e-74 |
| TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 792 (283.9 bits), Expect = 8.7e-79, P = 8.7e-79
Identities = 157/308 (50%), Positives = 222/308 (72%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G L G+ +A+K+LS S QG EFKNE ML AKLQH NL+++LG C++ +E+ML+YEYM
Sbjct: 544 GRLIDGEEVAIKRLSLASGQGLVEFKNEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYM 603
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD +LFDP+R+++LDWK R I+EGI QGLLYL +YSRL +IHRD+KA NILL ED
Sbjct: 604 PNKSLDYFLFDPLRKIVLDWKLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDED 663
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKISDFG+ARIF + +ANT++V GT GY+ PEY R+G++S KSDVFSFGVL+L+II
Sbjct: 664 MNPKISDFGMARIFGAQESKANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEII 723
Query: 181 SGKRLSMLCGINEN-LSILEHAYELWKGGKGVEFVDSSLDDT--NSPCKLMRCLEIALLC 237
G++ + +E L+++ H + L+K + E +D SL D+ +P +++RC+++ALLC
Sbjct: 724 CGRKNNSFHHDSEGPLNLIVHVWNLFKENRVREVIDPSLGDSAVENP-QVLRCVQVALLC 782
Query: 238 VQENPNDRPSMLQVSSMLKNETTNR-NTPKKPAFSKQVDEIGIEL-LSTTQLEKCSACDL 295
VQ+N +DRPSML V SM+ + N + PK+PAF E+ + ++E SA +
Sbjct: 783 VQQNADDRPSMLDVVSMIYGDGNNALSLPKEPAFYDGPPRSSPEMEVEPPEMENVSANRV 842
Query: 296 SFSEVVAR 303
+ + + AR
Sbjct: 843 TITVMEAR 850
|
|
| TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 790 (283.2 bits), Expect = 1.4e-78, P = 1.4e-78
Identities = 157/308 (50%), Positives = 218/308 (70%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G L G +AVK+LSKTS QG EEFKNE +L +KLQH NL+R+LGFC++ EE++LVYE++
Sbjct: 362 GKLSSGPEVAVKRLSKTSGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEFV 421
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD +LFDP ++ LDW +R +II GI +G+LYL + SRLTIIHRDLKASNILL D
Sbjct: 422 PNKSLDYFLFDPAKQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDAD 481
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKI+DFG+ARIF + +ANT ++ GT GY+ PEYA +G +S KSDV+SFGVL+L+II
Sbjct: 482 MNPKIADFGMARIFGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEII 541
Query: 181 SGKRLSMLCGINENLS-ILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239
SGK+ S I+++ S ++ HA+ LW+ G +E VD ++ ++ + RC+ IALLCVQ
Sbjct: 542 SGKKNSSFYNIDDSGSNLVTHAWRLWRNGSPLELVDPTIGESYQSSEATRCIHIALLCVQ 601
Query: 240 ENPNDRPSMLQVSSMLKNETTNRNTPKKPAF---SKQVDEIGIELL-STTQLEKCSACDL 295
E+P DRP + + ML + TT + P+ P F + +++ G+E ST++ S D
Sbjct: 602 EDPADRPLLPAIIMMLTSSTTTLHVPRAPGFCLSGRDLEQDGVEYTESTSRSIPGSINDA 661
Query: 296 SFSEVVAR 303
S +E R
Sbjct: 662 SITEFYPR 669
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 782 (280.3 bits), Expect = 1.0e-77, P = 1.0e-77
Identities = 163/308 (52%), Positives = 214/308 (69%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G+L GK IAVK+LSK S+QG +EF NEV L AKLQH+NL+R+LG C+D E+ML+YEY+
Sbjct: 540 GMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYL 599
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
N SLD +LFD R L+W+KR II GI +GLLYL + SR IIHRDLKASN+LL ++
Sbjct: 600 ENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKN 659
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKISDFG+ARIF +E EANT +VVGT GY+ PEYA G++S KSDVFSFGVLLL+II
Sbjct: 660 MTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEII 719
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS-SLDDTNS--PC-KLMRCLEIALL 236
SGKR N +L++L + WK GK +E VD ++D +S P +++RC++I LL
Sbjct: 720 SGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLL 779
Query: 237 CVQENPNDRPSMLQVSSMLKNETTNRNTPKKPAFSKQVDEIGIELLSTTQLE-KCSACDL 295
CVQE DRP M V ML +ETT PK+P F + ++ S+TQ + +C+ +
Sbjct: 780 CVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQV 839
Query: 296 SFSEVVAR 303
+ S + AR
Sbjct: 840 TLSVIDAR 847
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 770 (276.1 bits), Expect = 1.9e-76, P = 1.9e-76
Identities = 162/308 (52%), Positives = 211/308 (68%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G L GK IAVK+LSK S+QG +EF NEV L AKLQH+NL+R+LG C+D E+ML+YEY+
Sbjct: 536 GRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYL 595
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
N SLD +LFD R L+W+KR II GI +GLLYL + SR IIHRDLKASN+LL ++
Sbjct: 596 ENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKN 655
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKISDFG+ARIF +E EANT +VVGT GY+ PEYA G++S KSDVFSFGVLLL+II
Sbjct: 656 MTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEII 715
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS-SLDDTNS--PC-KLMRCLEIALL 236
SGKR N +L++L + WK G +E VD ++D +S P +++RC++I LL
Sbjct: 716 SGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLL 775
Query: 237 CVQENPNDRPSMLQVSSMLKNETTNRNTPKKPAFSKQVDEIGIELLSTTQLE-KCSACDL 295
CVQE DRP M V ML +ETT PK+P F + + S+TQ + +C+ +
Sbjct: 776 CVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQI 835
Query: 296 SFSEVVAR 303
+ S + AR
Sbjct: 836 TLSVIDAR 843
|
|
| TAIR|locus:2121706 CRK21 "cysteine-rich RLK (RECEPTOR-like protein kinase) 21" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 767 (275.1 bits), Expect = 3.9e-76, P = 3.9e-76
Identities = 159/311 (51%), Positives = 212/311 (68%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G+ P G +A K+LSK S QG EFKNEV+L A+LQH NL+ +LGF ++ EE++LVYE++
Sbjct: 380 GMFPNGTEVAAKRLSKPSDQGEPEFKNEVLLVARLQHKNLVGLLGFSVEGEEKILVYEFV 439
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD +LFDPI+R+ LDW +R +IIEGIT+G+LYL + SRLTIIHRDLKASNILL +
Sbjct: 440 PNKSLDHFLFDPIKRVQLDWPRRHNIIEGITRGILYLHQDSRLTIIHRDLKASNILLDAE 499
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKI+DFGLAR F EANT +VVGT GY+PPEY G +STKSDV+SFGVL+L+II
Sbjct: 500 MNPKIADFGLARNFRVNQTEANTGRVVGTFGYMPPEYVANGQFSTKSDVYSFGVLILEII 559
Query: 181 SGKRLSMLCGINENLS-ILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239
GK+ S I+ ++S ++ H + L G +E VD ++ + +++RC+ I LLCVQ
Sbjct: 560 GGKKNSSFHQIDGSVSNLVTHVWRLRNNGSLLELVDPAIGENYDKDEVIRCIHIGLLCVQ 619
Query: 240 ENPNDRPSMLQVSSMLKNETTNRNTPKKPAF----SKQVDEIGIELL---STTQLEKCSA 292
ENP+DRPSM + ML N + P+ P F + + + LL ST+ CS
Sbjct: 620 ENPDDRPSMSTIFRMLTNVSITLPVPQPPGFFFRERSEPNPLAERLLPGPSTSMSFTCSV 679
Query: 293 CDLSFSEVVAR 303
D S + V R
Sbjct: 680 DDASITSVRPR 690
|
|
| TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 761 (272.9 bits), Expect = 1.7e-75, P = 1.7e-75
Identities = 155/306 (50%), Positives = 208/306 (67%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G L G +AVK+LSK+S QG EFKNEV+L AKLQH NL+R+LGFC+D EER+LVYEY+
Sbjct: 365 GTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYV 424
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD +LFDP ++ LDW +R II G+ +G+LYL + SRLTIIHRDLKASNILL D
Sbjct: 425 PNKSLDYFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDAD 484
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKI+DFG+ARIF + E NT ++VGT GY+ PEYA G YS KSDV+SFGVL+L+II
Sbjct: 485 MNPKIADFGMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEII 544
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240
SGK+ S + ++ +A+ LW G+ +E VD ++ + +++RC+ I LLCVQE
Sbjct: 545 SGKKNSSFYQTDGAHDLVSYAWGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQE 604
Query: 241 NPNDRPSMLQVSSMLKNETTNRNTPKKPAFSKQVDEIGIELLSTTQLEKC---SACDLSF 297
+P +RP++ + ML + T P++P Q IG + L T K S D S
Sbjct: 605 DPAERPTLSTIVLMLTSNTVTLPVPRQPGLFFQ-SRIGKDPLDTDTTSKSLLGSVDDASI 663
Query: 298 SEVVAR 303
+++ R
Sbjct: 664 TDIHPR 669
|
|
| TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 759 (272.2 bits), Expect = 2.7e-75, P = 2.7e-75
Identities = 152/309 (49%), Positives = 209/309 (67%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G+ P G +AVK+LSKTS QG EF NEV++ AKLQH NL+R+LGFC++ +ER+LVYE++
Sbjct: 368 GIFPSGVQVAVKRLSKTSGQGEREFANEVIVVAKLQHRNLVRLLGFCLERDERILVYEFV 427
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD ++FD + +LDW +R II GI +G+LYL + SRLTIIHRDLKA NILLG+D
Sbjct: 428 PNKSLDYFIFDSTMQSLLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLGDD 487
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M KI+DFG+ARIF + EANT ++VGT GY+ PEYA G +S KSDV+SFGVL+L+II
Sbjct: 488 MNAKIADFGMARIFGMDQTEANTRRIVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEII 547
Query: 181 SGKRLSMLCGINENLS--ILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238
SGK+ S + ++ + ++ + + LW G +E VD S D ++ RC+ IALLCV
Sbjct: 548 SGKKNSNVYQMDGTSAGNLVTYTWRLWSNGSPLELVDPSFRDNYRINEVSRCIHIALLCV 607
Query: 239 QENPNDRPSMLQVSSMLKNETTNRNTPKKPAF---SKQVDEIG-IELLSTTQLEKCSACD 294
QE DRP+M + ML + P++P F S + +++G ++ LS CS D
Sbjct: 608 QEEAEDRPTMSAIVQMLTTSSIALAVPQRPGFFFRSSKHEQVGLVDRLSINTSALCSVDD 667
Query: 295 LSFSEVVAR 303
S + V R
Sbjct: 668 ASITNVTPR 676
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 757 (271.5 bits), Expect = 4.5e-75, P = 4.5e-75
Identities = 155/305 (50%), Positives = 216/305 (70%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
GVL G+ IAVK+LS S QG +EFKNE++L AKLQH NL+R+LG C + EE+MLVYEYM
Sbjct: 546 GVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYM 605
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD +LFD ++ ++DWK R IIEGI +GLLYL SRL IIHRDLK SN+LL +
Sbjct: 606 PNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAE 665
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
M PKISDFG+ARIF EANT +VVGT GY+ PEYA +G++S KSDV+SFGVLLL+I+
Sbjct: 666 MNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIV 725
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240
SGKR + L +E+ S++ +A+ L+ G+ E VD + T S + +RC+ +A+LCVQ+
Sbjct: 726 SGKRNTSLRS-SEHGSLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQD 784
Query: 241 NPNDRPSMLQVSSMLKNETTNRNTPKKPAF-SKQVDEIGIEL-LSTTQLEKCSACDLSFS 298
+ +RP+M V ML+++T P++P F S + + I + L ++Q S+ +++ +
Sbjct: 785 SAAERPNMASVLLMLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITST 844
Query: 299 EVVAR 303
V+ R
Sbjct: 845 VVLGR 849
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 755 (270.8 bits), Expect = 7.3e-75, P = 7.3e-75
Identities = 154/304 (50%), Positives = 212/304 (69%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G L G IAVK+LS+TS QG EEF NEV++ +KLQH NL+R+LGFCI+ EERMLVYE+M
Sbjct: 529 GRLQEGLDIAVKRLSRTSGQGVEEFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFM 588
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
P LD YLFDP+++ +LDWK R +II+GI +GL+YL SRL IIHRDLKASNILL E+
Sbjct: 589 PENCLDAYLFDPVKQRLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDEN 648
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
+ PKISDFGLARIF E +T +VVGT GY+ PEYA G++S KSDVFS GV+LL+I+
Sbjct: 649 LNPKISDFGLARIFQGNEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIV 708
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240
SG+R S +N ++ +A++LW G+ + VD + + ++ RC+ + LLCVQ+
Sbjct: 709 SGRRNSSFYNDGQNPNLSAYAWKLWNTGEDIALVDPVIFEECFENEIRRCVHVGLLCVQD 768
Query: 241 NPNDRPSMLQVSSMLKNETTNRNTPKKPAFSKQVDEIGIELLSTTQLE-KCSACDLSFSE 299
+ NDRPS+ V ML +E +N PK+PAF + +E S+ Q + + S ++S ++
Sbjct: 769 HANDRPSVATVIWMLSSENSNLPEPKQPAFIPRRGTSEVE--SSGQSDPRASINNVSLTK 826
Query: 300 VVAR 303
+ R
Sbjct: 827 ITGR 830
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 753 (270.1 bits), Expect = 1.2e-74, P = 1.2e-74
Identities = 147/278 (52%), Positives = 201/278 (72%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G LP G+ +AVK+L + S QG EEFKNEV+L AKLQH NL+R+LG CI EE++LVYEYM
Sbjct: 547 GTLPGGEEVAVKRLCRNSGQGLEEFKNEVILIAKLQHRNLVRLLGCCIPREEKILVYEYM 606
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
PNKSLD +LF+P ++ +LDWKKR IIEGI +GLLYL SRL ++HRDLKASNILL D
Sbjct: 607 PNKSLDAFLFNPEKQRLLDWKKRFDIIEGIARGLLYLHRDSRLRVVHRDLKASNILLDAD 666
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
MKPKISDFG+AR+F + + NT +VVGT GY+ PEYA +G++S KSDV+ FGVL+L+II
Sbjct: 667 MKPKISDFGMARMFGGDQNQFNTNRVVGTFGYMSPEYAMEGIFSVKSDVYGFGVLILEII 726
Query: 181 SGKR-LSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239
+GKR +S C ++L+I +A+ W E +D + + S +++RC+ IALLCVQ
Sbjct: 727 TGKRAVSFHCH-EDSLNIAGYAWRQWNEDNAAELIDPVIRASCSVRQVLRCIHIALLCVQ 785
Query: 240 ENPNDRPSMLQVSSMLKNETTNRNTPKKPAFSKQVDEI 277
++ ++RP + V ML N++++ P+ P + EI
Sbjct: 786 DHADERPDIPTVILMLSNDSSSLPNPRPPTLMLRGREI 823
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 303 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-45 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-44 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-43 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-42 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-41 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-36 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-27 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-26 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-26 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-25 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-25 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-24 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-24 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-23 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-23 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-22 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-22 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-22 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-21 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-18 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-16 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-15 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-13 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-13 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-12 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-12 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-10 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-09 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-08 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-06 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 9e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 5e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 6e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 8e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.001 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.001 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 5e-45
Identities = 83/253 (32%), Positives = 120/253 (47%), Gaps = 33/253 (13%)
Query: 10 AVKKLSK-TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
AVK L + S Q EEF E + KL H N++++LG C + E M+V EYMP L Y
Sbjct: 32 AVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDY 91
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L R L + I +G+ YL IHRDL A N L+GE++ KISDF
Sbjct: 92 LRKN-RPKELSLSDLLSFALQIARGMEYL---ESKNFIHRDLAARNCLVGENLVVKISDF 147
Query: 129 GLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS-G 182
GL+R + + G +P PE ++G +++KSDV+SFGVLL +I + G
Sbjct: 148 GLSR------DLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLG 201
Query: 183 KRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242
+ +S E K G + N P +L + + L C E+P
Sbjct: 202 EEP------YPGMS-NAEVLEYLKKGYRLPKPP------NCPPELYK---LMLQCWAEDP 245
Query: 243 NDRPSMLQVSSML 255
DRP+ ++ +L
Sbjct: 246 EDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 7e-45
Identities = 81/254 (31%), Positives = 118/254 (46%), Gaps = 34/254 (13%)
Query: 9 IAVKKLSK-TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+AVK L + S Q EEF E + KL H N++++LG C + E +V EYM L
Sbjct: 31 VAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLS 90
Query: 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISD 127
YL + L + I +G+ YL IHRDL A N L+GE++ KISD
Sbjct: 91 YLRKNRPK--LSLSDLLSFALQIARGMEYL---ESKNFIHRDLAARNCLVGENLVVKISD 145
Query: 128 FGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIISG 182
FGL+R + + G +P PE ++G +++KSDV+SFGVLL +I +
Sbjct: 146 FGLSR------DLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT- 198
Query: 183 KRLSMLCGI-NENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241
L +S E E K G + N P +L + L C E+
Sbjct: 199 -----LGEQPYPGMS-NEEVLEYLKNGYRLPQPP------NCPPELYD---LMLQCWAED 243
Query: 242 PNDRPSMLQVSSML 255
P DRP+ ++ +L
Sbjct: 244 PEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 3e-44
Identities = 78/250 (31%), Positives = 118/250 (47%), Gaps = 23/250 (9%)
Query: 6 GKVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
GK++AVK L K S + + + E+ + +L H N++R++ D + LV EY
Sbjct: 24 GKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGG 83
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
L YL R L + I I +GL YL IIHRDLK NILL E+
Sbjct: 84 DLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHSNG---IIHRDLKPENILLDENGVV 137
Query: 124 KISDFGLARIFAKESLEANTEQVVGTIGYIPPE-YARQGVYSTKSDVFSFGVLLLQIISG 182
KI+DFGLA+ K S T VGT Y+ PE Y K DV+S GV+L ++++G
Sbjct: 138 KIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTG 195
Query: 183 KRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCK-LMRCLEIALLCVQEN 241
K I + L ++ G +EF + + K L++ C+ ++
Sbjct: 196 KPPFSGENILDQLQLIRR-----ILGPPLEFDEPKWSSGSEEAKDLIKK------CLNKD 244
Query: 242 PNDRPSMLQV 251
P+ RP+ ++
Sbjct: 245 PSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 1e-43
Identities = 67/187 (35%), Positives = 94/187 (50%), Gaps = 10/187 (5%)
Query: 6 GKVIAVKKLSK-TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
GK +A+K + K S+ EE E+ + KL H N++++ G D LV EY S
Sbjct: 18 GKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGS 77
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED-MKP 123
L L + +L D R I+ I +GL YL IIHRDLK NILL D K
Sbjct: 78 LKDLLKENEGKLSEDEILR--ILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKV 132
Query: 124 KISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV-YSTKSDVFSFGVLLLQIISG 182
K++DFGL+++ + T +VGT Y+ PE YS KSD++S GV+L ++
Sbjct: 133 KLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYELPEL 190
Query: 183 KRLSMLC 189
K L
Sbjct: 191 KDLIRKM 197
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 6e-43
Identities = 78/252 (30%), Positives = 118/252 (46%), Gaps = 31/252 (12%)
Query: 10 AVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
AVK L + ++ + EEF E + KL H N++R+LG C E +V EYMP L +
Sbjct: 32 AVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDF 91
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L L K + + I +G+ YL +HRDL A N L+ E++ KISDF
Sbjct: 92 L--RKHGEKLTLKDLLQMALQIAKGMEYL---ESKNFVHRDLAARNCLVTENLVVKISDF 146
Query: 129 GLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIISGK 183
GL+R + + G +P PE + G +++KSDV+SFGVLL +I +
Sbjct: 147 GLSR-----DIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLG 201
Query: 184 RLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPN 243
G++ E EL + G + + N P +L E+ L C +P
Sbjct: 202 EQP-YPGMS-----NEEVLELLEDGYRLPRPE------NCPDELY---ELMLQCWAYDPE 246
Query: 244 DRPSMLQVSSML 255
DRP+ ++ L
Sbjct: 247 DRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 3e-42
Identities = 83/267 (31%), Positives = 120/267 (44%), Gaps = 51/267 (19%)
Query: 10 AVKKLSK-TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
AVK L + S + ++F E + KL H N++R+LG C + E LV EYM L Y
Sbjct: 27 AVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDY 86
Query: 69 L------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
L F + L K + I +G+ YL + +HRDL A N L+GED+
Sbjct: 87 LRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL---ASKKFVHRDLAARNCLVGEDLV 143
Query: 123 PKISDFGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLL 177
KISDFGL+R + + T G +P PE + G++++KSDV+SFGVLL
Sbjct: 144 VKISDFGLSR-----DVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLW 198
Query: 178 QIISGKRLSMLCGI-NENLS---ILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL-- 231
+I + L LS +LE+ L K C
Sbjct: 199 EIFT------LGATPYPGLSNEEVLEY-----------------LRKGYRLPKPEYCPDE 235
Query: 232 --EIALLCVQENPNDRPSMLQVSSMLK 256
E+ L C Q +P DRP+ ++ L+
Sbjct: 236 LYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 3e-41
Identities = 68/249 (27%), Positives = 105/249 (42%), Gaps = 27/249 (10%)
Query: 6 GKVIAVKKLSKTSTQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
GK++A+K + K + E E+ + KL+H N++R+ D ++ LV EY
Sbjct: 24 GKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGD 83
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
L L +R L + + I L YL I+HRDLK NILL ED K
Sbjct: 84 LFDLL---KKRGRLSEDEARFYLRQILSALEYLHS---KGIVHRDLKPENILLDEDGHVK 137
Query: 125 ISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKR 184
++DFGLAR VGT Y+ PE Y D++S GV+L ++++GK
Sbjct: 138 LADFGLARQLDPGEK---LTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKP 194
Query: 185 LSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCK--LMRCLEIALLCVQENP 242
G ++ L + + K GK D + K + + L +P
Sbjct: 195 P--FPGDDQLLELFK------KIGKPKPPFPPPEWDISPEAKDLIRKLLVK-------DP 239
Query: 243 NDRPSMLQV 251
R + +
Sbjct: 240 EKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 6e-36
Identities = 73/257 (28%), Positives = 112/257 (43%), Gaps = 46/257 (17%)
Query: 6 GKVIAVKK--LSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML-VY-EYMP 61
G+++AVK LS S + E + E+ + + LQH N++R G D E+ L ++ EY+
Sbjct: 25 GELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS 84
Query: 62 NKSLDCYL--FDP-----IRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
SL L F IR+ I +GL YL I+HRD+K +N
Sbjct: 85 GGSLSSLLKKFGKLPEPVIRKYTRQ----------ILEGLAYLHSNG---IVHRDIKGAN 131
Query: 115 ILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGV 174
IL+ D K++DFG A+ T V GT ++ PE R Y +D++S G
Sbjct: 132 ILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGC 191
Query: 175 LLLQIISGKR-LSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSP-CK--LMRC 230
++++ +GK S L N L+K G E + + S K L +C
Sbjct: 192 TVIEMATGKPPWSEL----GNPMAA-----LYKIGSSGE--PPEIPEHLSEEAKDFLRKC 240
Query: 231 LEIALLCVQENPNDRPS 247
L +P RP+
Sbjct: 241 LRR-------DPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 6e-29
Identities = 76/240 (31%), Positives = 116/240 (48%), Gaps = 23/240 (9%)
Query: 9 IAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
+AVK L K T ++F E + KL+H LI++ C E +V E M SL Y
Sbjct: 33 VAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEY 91
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L R L + + + + G+ YL+ + IHRDL A N+L+GE+ K++DF
Sbjct: 92 LQGGAGR-ALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADF 147
Query: 129 GLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSML 188
GLAR+ ++ EA I + PE A +S KSDV+SFG+LL +I++ R+
Sbjct: 148 GLARVIKEDIYEAREGAKF-PIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYP 206
Query: 189 CGIN-ENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPS 247
N E L ++ Y + P +L +I L C +E+P+DRP+
Sbjct: 207 GMTNAEVLQQVDQGYRMPC-------------PPGCPKELY---DIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 9e-29
Identities = 66/184 (35%), Positives = 100/184 (54%), Gaps = 20/184 (10%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+ +AVK L ST + F E + L+H NL+++LG + +V EYM SL
Sbjct: 29 GQKVAVKCLKDDSTAA-QAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSL 87
Query: 66 DCYLFDPIR---RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
YL R R ++ +++ + +G+ YL+E + +HRDL A N+L+ ED+
Sbjct: 88 VDYL----RSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLV 140
Query: 123 PKISDFGLARIFAKESLEANTEQVVGT--IGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
K+SDFGLA+ EA+ Q G + + PE R+ +STKSDV+SFG+LL +I
Sbjct: 141 AKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 193
Query: 181 SGKR 184
S R
Sbjct: 194 SFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-28
Identities = 59/173 (34%), Positives = 98/173 (56%), Gaps = 6/173 (3%)
Query: 9 IAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
+A+K L ++F+ EV +L+H +LI + C E ++ E M SL +
Sbjct: 33 VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAF 92
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L P + +L + + + +G+ YL+E + IHRDL A NIL+GED+ K++DF
Sbjct: 93 LRSPEGQ-VLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADF 148
Query: 129 GLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
GLAR+ KE + ++++ + + PE A G +STKSDV+SFG+LL ++ +
Sbjct: 149 GLARLI-KEDVYLSSDKKI-PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 9e-28
Identities = 51/184 (27%), Positives = 90/184 (48%), Gaps = 20/184 (10%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
GK +A+K + S + E+ NE+ + K +H N+++ G + +E +V E+ SL
Sbjct: 25 GKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL 84
Query: 66 DCYLFDPIRRLILDWKKRV------HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
+ L+ + + ++ + + +GL YL IIHRD+KA+NILL
Sbjct: 85 --------KDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTS 133
Query: 120 DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQI 179
D + K+ DFGL+ + VGT ++ PE Y K+D++S G+ +++
Sbjct: 134 DGEVKLIDFGLSAQLSDTKARNTM---VGTPYWMAPEVINGKPYDYKADIWSLGITAIEL 190
Query: 180 ISGK 183
GK
Sbjct: 191 AEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-27
Identities = 78/243 (32%), Positives = 118/243 (48%), Gaps = 29/243 (11%)
Query: 9 IAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
+AVK L K T E F E + KL+H L+++ C + E +V EYM SL +
Sbjct: 33 VAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDF 91
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L + L + V + I +G+ YL+ IHRDL A NIL+GE++ KI+DF
Sbjct: 92 LKSGEGKK-LRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADF 147
Query: 129 GLARIFAKESLEANTEQVVGT---IGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRL 185
GLAR+ + A G I + PE A G ++ KSDV+SFG+LL +I++ R+
Sbjct: 148 GLARLIEDDEYTARE----GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRV 203
Query: 186 SMLCGIN-ENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPND 244
N E L +E Y + + N P +L ++ L C ++P +
Sbjct: 204 PYPGMTNREVLEQVERGYRMPR-------------PPNCPEELY---DLMLQCWDKDPEE 247
Query: 245 RPS 247
RP+
Sbjct: 248 RPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 8e-27
Identities = 76/252 (30%), Positives = 124/252 (49%), Gaps = 21/252 (8%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
+AVK L K T EEF E + +++H NL+++LG C ++ E+M +L
Sbjct: 31 SLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 89
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
YL + R+ ++ +++ I+ + YL+ + IHRDL A N L+GE+ K+
Sbjct: 90 LDYLRECNRQE-VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKV 145
Query: 126 SDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRL 185
+DFGL+R+ ++ A+ I + PE +S KSDV++FGVLL +I + +
Sbjct: 146 ADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT-YGM 203
Query: 186 SMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDR 245
S GI+ L YEL + G +E + +LMR C Q NP+DR
Sbjct: 204 SPYPGID-----LSQVYELLEKGYRMERPEGCPPKVY---ELMRA------CWQWNPSDR 249
Query: 246 PSMLQVSSMLKN 257
PS ++ +
Sbjct: 250 PSFAEIHQAFET 261
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-26
Identities = 72/250 (28%), Positives = 113/250 (45%), Gaps = 28/250 (11%)
Query: 9 IAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
+A+K + + ++F E + KL H NL+++ G C +V EYM N L Y
Sbjct: 31 VAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNY 89
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L + R+ L + + + + + + YL+ IHRDL A N L+GED K+SDF
Sbjct: 90 LRE--RKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDF 144
Query: 129 GLARIFAKESLEANTEQVVGT---IGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRL 185
GLAR + ++ GT + + PPE +S+KSDV+SFGVL+ ++ S ++
Sbjct: 145 GLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKM 200
Query: 186 SMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDR 245
YE + + VE V + I C E P DR
Sbjct: 201 P---------------YERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDR 245
Query: 246 PSMLQVSSML 255
P+ ++ S L
Sbjct: 246 PAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-26
Identities = 80/250 (32%), Positives = 124/250 (49%), Gaps = 24/250 (9%)
Query: 9 IAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
+A+K L K + E F E L +LQH L+R L + E ++ EYM N SL +
Sbjct: 33 VAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVR-LYAVVTQEPIYIITEYMENGSLVDF 90
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L P + L K + + I +G+ +++ R IHRDL+A+NIL+ E + KI+DF
Sbjct: 91 LKTP-EGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADF 146
Query: 129 GLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSML 188
GLAR+ A E I + PE G ++ KSDV+SFG+LL +I++ R+
Sbjct: 147 GLARLIEDNEYTAR-EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYP 205
Query: 189 CGIN-ENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPS 247
N E + LE Y + + N P +L E+ LC +E P +RP+
Sbjct: 206 GMTNPEVIQNLERGYRMPR-------------PDNCPEELY---ELMRLCWKEKPEERPT 249
Query: 248 MLQVSSMLKN 257
+ S+L++
Sbjct: 250 FEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-26
Identities = 60/188 (31%), Positives = 101/188 (53%), Gaps = 19/188 (10%)
Query: 9 IAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+A+K L + + +EF+ E L + LQH N++ +LG C + +++EY+ + L
Sbjct: 38 VAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHE 97
Query: 68 YLF-------------DPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
+L D + LD +HI I G+ YL S +HRDL A N
Sbjct: 98 FLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARN 154
Query: 115 ILLGEDMKPKISDFGLAR-IFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFG 173
L+GE + KISDFGL+R I++ + ++ ++ + ++PPE G ++T+SD++SFG
Sbjct: 155 CLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL-PVRWMPPEAILYGKFTTESDIWSFG 213
Query: 174 VLLLQIIS 181
V+L +I S
Sbjct: 214 VVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 104 bits (258), Expect = 2e-25
Identities = 70/260 (26%), Positives = 111/260 (42%), Gaps = 21/260 (8%)
Query: 7 KVIAVKKLSK--TSTQGFEE-FKNEVMLTAKLQH-VNLIRVLGFCIDSEERMLVYEYMPN 62
K++A+K L+K S E F E+ + A L H N++++ F D LV EY+
Sbjct: 23 KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG 82
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED-M 121
SL+ L R+ L + + I+ I L YL IIHRD+K NILL D
Sbjct: 83 GSLEDLLKKIGRKGPLSESEALFILAQILSALEYL---HSKGIIHRDIKPENILLDRDGR 139
Query: 122 KPKISDFGLARIFAKESLEANTEQ----VVGTIGYIPPEYARQGV---YSTKSDVFSFGV 174
K+ DFGLA++ ++ VGT GY+ PE S+ SD++S G+
Sbjct: 140 VVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGI 199
Query: 175 LLLQIISGKRLSMLC-GINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEI 233
L ++++G + L+ EL + S L +N ++
Sbjct: 200 TLYELLTGLPPFEGEKNSSATSQTLKIILEL-----PTPSLASPLSPSNPELISKAASDL 254
Query: 234 ALLCVQENPNDRPSMLQVSS 253
+ ++P +R S S
Sbjct: 255 LKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 53/182 (29%), Positives = 99/182 (54%), Gaps = 16/182 (8%)
Query: 9 IAVKKL-SKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+A+K L +TS + +E +E + A + H +++R+LG C+ S + L+ + MP L
Sbjct: 39 VAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLD 97
Query: 68 YLFDPIRRL----ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
Y+ + + +L+W + I +G+ YL+E ++HRDL A N+L+
Sbjct: 98 YVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEEKR---LVHRDLAARNVLVKTPQHV 148
Query: 124 KISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-G 182
KI+DFGLA++ + E + E I ++ E +Y+ KSDV+S+GV + ++++ G
Sbjct: 149 KITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFG 208
Query: 183 KR 184
+
Sbjct: 209 AK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 3e-25
Identities = 55/188 (29%), Positives = 92/188 (48%), Gaps = 26/188 (13%)
Query: 6 GKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
G +A+K++S + + E+ L L+H N+++ +G S+ ++ EY N
Sbjct: 25 GDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENG 84
Query: 64 SLDCYLFDPIRRLILDWKKRVHI--------IEGITQGLLYLQEYSRLTIIHRDLKASNI 115
SL R++I KK + + QGL YL E +IHRD+KA+NI
Sbjct: 85 SL--------RQII---KKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANI 130
Query: 116 LLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVL 175
L +D K++DFG+A S + VVGT ++ PE ST SD++S G
Sbjct: 131 LTTKDGVVKLADFGVATKLNDVSK--DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCT 188
Query: 176 LLQIISGK 183
++++++G
Sbjct: 189 VIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-25
Identities = 76/260 (29%), Positives = 120/260 (46%), Gaps = 41/260 (15%)
Query: 7 KVIAVKKLSKTSTQGFE-EFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
+A+K L S+ +F E + + H N+IR+ G S M++ EYM N SL
Sbjct: 33 IDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSL 92
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D +L + + V ++ GI G+ YL S + +HRDL A NIL+ ++ K+
Sbjct: 93 DKFLRE--NDGKFTVGQLVGMLRGIASGMKYL---SEMNYVHRDLAARNILVNSNLVCKV 147
Query: 126 SDFGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQII 180
SDFGL+R E EA T G G IP PE +++ SDV+SFG+++ +++
Sbjct: 148 SDFGLSRR--LEDSEA-TYTTKG--GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM 202
Query: 181 S-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRC----LEIAL 235
S G+R Y V +++D M C ++ L
Sbjct: 203 SYGER----------------PYWDMSNQD----VIKAVEDGYRLPPPMDCPSALYQLML 242
Query: 236 LCVQENPNDRPSMLQVSSML 255
C Q++ N+RP+ Q+ S L
Sbjct: 243 DCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-25
Identities = 73/255 (28%), Positives = 114/255 (44%), Gaps = 28/255 (10%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER--MLVYEYMPNK 63
G+V+AVKKL ++ + +F+ E+ + LQH N+++ G C + R LV EY+P
Sbjct: 33 GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
SL YL RL D +K + I +G+ YL +HRDL NIL+ + +
Sbjct: 93 SLRDYLQKHRERL--DHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRV 147
Query: 124 KISDFGLARIFA--KESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII- 180
KI DFGL ++ KE + E I + PE + +S SDV+SFGV+L ++
Sbjct: 148 KIGDFGLTKVLPQDKEYYKV-REPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
Query: 181 --------SGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLE 232
+ + M+ + I+ H EL K + +
Sbjct: 207 YSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIY---------A 257
Query: 233 IALLCVQENPNDRPS 247
I C +P+ RPS
Sbjct: 258 IMKECWNNDPSQRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 6e-25
Identities = 64/207 (30%), Positives = 107/207 (51%), Gaps = 33/207 (15%)
Query: 1 GVLPCGK--VIAVKKLSK-TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVY 57
G+LP ++AVK L + S +F+ E L A+ H N++++LG C + L++
Sbjct: 28 GLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLF 87
Query: 58 EYMPNKSLDCYLFD-------------------PIRRLILDWKKRVHIIEGITQGLLYLQ 98
EYM L+ +L + L L +++ I + + G+ YL
Sbjct: 88 EYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS 147
Query: 99 EYSRLTIIHRDLKASNILLGEDMKPKISDFGLAR-IFAKESLEANTEQVVGTIGYIPPE- 156
E +HRDL N L+GE+M KI+DFGL+R I++ + +A+ + I ++PPE
Sbjct: 148 ERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAI-PIRWMPPES 203
Query: 157 --YARQGVYSTKSDVFSFGVLLLQIIS 181
Y R Y+T+SDV+++GV+L +I S
Sbjct: 204 IFYNR---YTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 7e-25
Identities = 81/259 (31%), Positives = 117/259 (45%), Gaps = 36/259 (13%)
Query: 6 GKVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER--MLVYEYMP 61
G+ +AVK L S Q +F+ E+ + L H N+++ G C R L+ EY+P
Sbjct: 33 GEQVAVKSL-NHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLP 91
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
+ SL YL R ++ K+ + I +G+ YL IHRDL A NIL+ +
Sbjct: 92 SGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESED 146
Query: 122 KPKISDFGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLL 176
KISDFGLA+ E + V G P PE R +S+ SDV+SFGV L
Sbjct: 147 LVKISDFGLAK-VLPEDKDYYY---VKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTL 202
Query: 177 LQIISGKRLS--------MLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLM 228
++ + S + GI + I+ EL K G+ + S D+ LM
Sbjct: 203 YELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVY---DLM 259
Query: 229 RCLEIALLCVQENPNDRPS 247
+ LC + P DRPS
Sbjct: 260 K------LCWEAEPQDRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 8e-25
Identities = 59/182 (32%), Positives = 87/182 (47%), Gaps = 13/182 (7%)
Query: 6 GKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMP 61
GK+ A+K L K + E E + +++ H +++ L + +EE++ LV EY P
Sbjct: 18 GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK-LHYAFQTEEKLYLVLEYAP 76
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
L +L R + + I L YL L II+RDLK NILL D
Sbjct: 77 GGELFSHL-SKEGRFSEERARF--YAAEIVLALEYLH---SLGIIYRDLKPENILLDADG 130
Query: 122 KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
K++DFGLA+ + E NT GT Y+ PE Y D +S GVLL ++++
Sbjct: 131 HIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLT 188
Query: 182 GK 183
GK
Sbjct: 189 GK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 1e-24
Identities = 78/275 (28%), Positives = 115/275 (41%), Gaps = 58/275 (21%)
Query: 3 LPCGKVI--AVKKLSK-TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEY 59
+ GK + AVK L + G +EF E + A+L H ++R++G C E MLV E
Sbjct: 18 MKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMEL 76
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQ---GLLYLQEYSRLTIIHRDLKASNIL 116
P L YL RR I + E Q G+ YL+ +HRDL A N+L
Sbjct: 77 APLGPLLKYLKK--RREI----PVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVL 127
Query: 117 LGEDMKPKISDFGLARIFAKESLEANTEQVVGTIG------YIPPEYARQGVYSTKSDVF 170
L + KISDFG++R +L A ++ T + PE G +S+KSDV+
Sbjct: 128 LVNRHQAKISDFGMSR-----ALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVW 182
Query: 171 SFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRC 230
S+GV L E S Y KG + + ++S + +
Sbjct: 183 SYGVTLW---------------EAFSYGAKPYGEMKGAEVIAMLES--------GERLPR 219
Query: 231 LE--------IALLCVQENPNDRPSMLQVSSMLKN 257
E I L C + P DRP+ ++ S +
Sbjct: 220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 5e-24
Identities = 71/247 (28%), Positives = 113/247 (45%), Gaps = 26/247 (10%)
Query: 9 IAVKKLSKTSTQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+AVK L ++ ++ E F E ++ +K H N++R++G + R ++ E M L
Sbjct: 39 VAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKS 98
Query: 68 YLFD----PIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GED 120
+L + P R L K + + +G YL+E IHRD+ A N LL G
Sbjct: 99 FLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPG 155
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
KI+DFG+AR + S + + I ++PPE G++++K+DV+SFGVLL +I
Sbjct: 156 RVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIF 215
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240
S + N+ E GG ++ P + R I C Q
Sbjct: 216 SLGYMPYPGRTNQE------VMEFVTGGGRLDP------PKGCPGPVYR---IMTDCWQH 260
Query: 241 NPNDRPS 247
P DRP+
Sbjct: 261 TPEDRPN 267
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 8e-24
Identities = 76/251 (30%), Positives = 121/251 (48%), Gaps = 25/251 (9%)
Query: 9 IAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL-DC 67
+AVK L K T + F E L LQH L+R+ E ++ EYM SL D
Sbjct: 33 VAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDF 91
Query: 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISD 127
D +++L K + I +G+ Y++ R IHRDL+A+N+L+ E + KI+D
Sbjct: 92 LKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIAD 146
Query: 128 FGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSM 187
FGLAR+ A E I + PE G ++ KSDV+SFG+LL +I++ ++
Sbjct: 147 FGLARVIEDNEYTAR-EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPY 205
Query: 188 LCGINEN-LSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRP 246
N + +S L+ Y + + +E N P +L +I C +E +RP
Sbjct: 206 PGMSNSDVMSALQRGYRMPR----ME---------NCPDELY---DIMKTCWKEKAEERP 249
Query: 247 SMLQVSSMLKN 257
+ + S+L +
Sbjct: 250 TFDYLQSVLDD 260
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 1e-23
Identities = 68/238 (28%), Positives = 109/238 (45%), Gaps = 30/238 (12%)
Query: 16 KTSTQGF---EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDP 72
KT +G E+F E + KL H L+++ G C + LV+E+M + L YL
Sbjct: 34 KTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYL--R 91
Query: 73 IRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLAR 132
+R + + + + +G+ YL+ + +IHRDL A N L+GE+ K+SDFG+ R
Sbjct: 92 AQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTR 148
Query: 133 IFAKESLEANTEQVVGT---IGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLC 189
+ ++T GT + + PE YS+KSDV+SFGVL+ ++ S +
Sbjct: 149 FVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKT---- 200
Query: 190 GINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPS 247
YE + VE +++ E+ C +E P DRPS
Sbjct: 201 -----------PYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 2e-23
Identities = 78/261 (29%), Positives = 132/261 (50%), Gaps = 32/261 (12%)
Query: 9 IAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+AVK L K +T Q +EF E L + H N++++LG C+ +E + ++ E M L
Sbjct: 29 VAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLS 88
Query: 68 YLFDP----IRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE---- 119
YL D +L K+ + I + +G +YL+ ++ IHRDL A N L+ E
Sbjct: 89 YLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYD 145
Query: 120 -DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
D KI DFGLAR K + + + ++ PE G ++T+SDV+SFGVL+ +
Sbjct: 146 ADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWE 205
Query: 179 IIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDD-TNSPCKLMRCLEIALL 236
I++ G++ +N N +L+H GG+ L N P K+ + +
Sbjct: 206 ILTLGQQ--PYPALN-NQEVLQHVTA---GGR--------LQKPENCPDKIYQLM---TN 248
Query: 237 CVQENPNDRPSMLQVSSMLKN 257
C ++P++RP+ ++ +L+N
Sbjct: 249 CWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 3e-23
Identities = 58/185 (31%), Positives = 94/185 (50%), Gaps = 10/185 (5%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGF-EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEY 59
GVL +AVK T +F E + + H N+++++G C+ + +V E
Sbjct: 14 GVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMEL 73
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
+P SL +L RL + KK + + G+ YL+ S+ IHRDL A N L+GE
Sbjct: 74 VPGGSLLTFLRKKKNRLTV--KKLLQMSLDAAAGMEYLE--SK-NCIHRDLAARNCLVGE 128
Query: 120 DMKPKISDFGLARIFAKE--SLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
+ KISDFG++R ++ +Q+ I + PE G Y+++SDV+S+G+LL
Sbjct: 129 NNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALNYGRYTSESDVWSYGILLW 186
Query: 178 QIISG 182
+ S
Sbjct: 187 ETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 5e-23
Identities = 79/252 (31%), Positives = 128/252 (50%), Gaps = 28/252 (11%)
Query: 9 IAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMPNKSLDC 67
+AVK L K T E F E + KL+H L+++ + + SEE + +V EYM SL
Sbjct: 33 VAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQL--YAVVSEEPIYIVTEYMSKGSLLD 89
Query: 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISD 127
+L D R L V + + G+ Y++ R+ IHRDL+++NIL+G+ + KI+D
Sbjct: 90 FLKDGEGR-ALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIAD 145
Query: 128 FGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSM 187
FGLAR+ A + I + PE A G ++ KSDV+SFG+LL ++++ R+
Sbjct: 146 FGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204
Query: 188 LCGIN--ENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDR 245
G+N E L +E Y + + P L E+ L C +++P +R
Sbjct: 205 -PGMNNREVLEQVERGYRMPCPQ-------------DCPISLH---ELMLQCWKKDPEER 247
Query: 246 PSMLQVSSMLKN 257
P+ + S L++
Sbjct: 248 PTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 5e-23
Identities = 59/194 (30%), Positives = 100/194 (51%), Gaps = 24/194 (12%)
Query: 8 VIAVKKLSKTSTQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLD 66
++AVK L +T++ + F+ E L QH N+++ G C + + ++V+EYM + L+
Sbjct: 37 LVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLN 96
Query: 67 CYL--FDP-IRRLI--------LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
+L P L L + + I I G++YL + +HRDL N
Sbjct: 97 KFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNC 153
Query: 116 LLGEDMKPKISDFGLARIFAKESLEANTEQVVGT----IGYIPPEYARQGVYSTKSDVFS 171
L+G D+ KI DFG++R + + +V G I ++PPE ++T+SDV+S
Sbjct: 154 LVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 209
Query: 172 FGVLLLQIIS-GKR 184
FGV+L +I + GK+
Sbjct: 210 FGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 9e-23
Identities = 81/272 (29%), Positives = 104/272 (38%), Gaps = 55/272 (20%)
Query: 4 PCGKVI--AVKKLSKTSTQG-FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
GKVI AVK L ++F E + L H NLIR+ G + M+V E
Sbjct: 19 SGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHP-LMMVTELA 77
Query: 61 PNKSL------DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
P SL D I L D+ I G+ YL E R IHRDL A N
Sbjct: 78 PLGSLLDRLRKDALGHFLISTL-CDYA------VQIANGMRYL-ESKRF--IHRDLAARN 127
Query: 115 ILLGEDMKPKISDFGLARIFAKESLEANTEQVVGT------IGYIPPEYARQGVYSTKSD 168
ILL D K KI DFGL R +L N + V + PE R +S SD
Sbjct: 128 ILLASDDKVKIGDFGLMR-----ALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASD 182
Query: 169 VFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF---VDSSLDDTNSP- 224
V+ FGV L ++ + + E W G G + +D + P
Sbjct: 183 VWMFGVTLWEMFT------------------YGEEPWAGLSGSQILKKIDKEGERLERPE 224
Query: 225 -CKLMRCLEIALLCVQENPNDRPSMLQVSSML 255
C + L C NP DRP+ + L
Sbjct: 225 ACPQ-DIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-22
Identities = 57/191 (29%), Positives = 103/191 (53%), Gaps = 18/191 (9%)
Query: 8 VIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
++AVK L + S ++F+ E L LQH +++R G C + ++V+EYM + L+
Sbjct: 37 LVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNR 96
Query: 68 YL--FDPIRRLI----------LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
+L P +++ L + + I I G++YL + L +HRDL N
Sbjct: 97 FLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNC 153
Query: 116 LLGEDMKPKISDFGLAR-IFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGV 174
L+G+ + KI DFG++R I++ + ++ I ++PPE ++T+SD++SFGV
Sbjct: 154 LVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML-PIRWMPPESILYRKFTTESDIWSFGV 212
Query: 175 LLLQIIS-GKR 184
+L +I + GK+
Sbjct: 213 VLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-22
Identities = 67/259 (25%), Positives = 119/259 (45%), Gaps = 27/259 (10%)
Query: 7 KVIAVKKLSKTSTQGFE-EFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
++ VK L KT + + EF+ E+ + KL H N++R+LG C ++E ++ EY L
Sbjct: 36 TLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDL 95
Query: 66 DCYL------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
+L + ++ L K++V + I G+ +L S +HRDL A N L+
Sbjct: 96 KQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSS 152
Query: 120 DMKPKISDFGLAR-IFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
+ K+S L++ ++ E + + + ++ PE ++ +STKSDV+SFGVL+ +
Sbjct: 153 QREVKVSLLSLSKDVYNSEYYKLR--NALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWE 210
Query: 179 IISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238
+ + L +E +L +E P +L + + C
Sbjct: 211 VFTQGELPFYGLSDE--EVLNRL-----QAGKLELPVPE----GCPSRLYK---LMTRCW 256
Query: 239 QENPNDRPSMLQVSSMLKN 257
NP DRPS ++ S L
Sbjct: 257 AVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-22
Identities = 70/278 (25%), Positives = 122/278 (43%), Gaps = 44/278 (15%)
Query: 9 IAVKKLSKTSTQG-FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+AVK L + ++ + +E L ++ H ++I++ G C +L+ EY SL
Sbjct: 33 VAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRS 92
Query: 68 YL----------------------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTI 105
+L +P R L + I++G+ YL E + +
Sbjct: 93 FLRESRKVGPSYLGSDGNRNSSYLDNPDER-ALTMGDLISFAWQISRGMQYLAE---MKL 148
Query: 106 IHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYST 165
+HRDL A N+L+ E K KISDFGL+R +E + + ++ E +Y+T
Sbjct: 149 VHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTT 208
Query: 166 KSDVFSFGVLLLQIISGKRLSMLCGINENLSIL-EHAYELWKGGKGVEFVDSSLDDTNSP 224
+SDV+SFGVLL +I++ G N I E + L K G +E ++ ++ +
Sbjct: 209 QSDVWSFGVLLWEIVT-------LGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYN- 260
Query: 225 CKLMRCLEIALLCVQENPNDRPSMLQVSSMLKNETTNR 262
+ L C ++ P+ RP+ +S L+
Sbjct: 261 --------LMLTCWKQEPDKRPTFADISKELEKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 3e-22
Identities = 61/183 (33%), Positives = 98/183 (53%), Gaps = 16/183 (8%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMPNKS 64
G +AVK + +T + F E + +L+H NL+++LG ++ + + +V EYM S
Sbjct: 29 GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 86
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
L YL R +L + + + + YL+ + +HRDL A N+L+ ED K
Sbjct: 87 LVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAK 142
Query: 125 ISDFGLARIFAKESLEANTEQVVGT--IGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
+SDFGL + EA++ Q G + + PE R+ +STKSDV+SFG+LL +I S
Sbjct: 143 VSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF 195
Query: 183 KRL 185
R+
Sbjct: 196 GRV 198
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 3e-22
Identities = 69/267 (25%), Positives = 123/267 (46%), Gaps = 37/267 (13%)
Query: 9 IAVKKLSKTSTQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+AVK L ++ E+F EV + ++L N+ R+LG C ++ EYM N L+
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 68 YL--------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
+L L + +++ I G+ YL+ L +HRDL N L+G+
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGK 165
Query: 120 DMKPKISDFGLARIFAKESLEANTEQVVGT----IGYIPPEYARQGVYSTKSDVFSFGVL 175
+ KI+DFG++R ++ +V G I ++ E G ++TKSDV++FGV
Sbjct: 166 NYTIKIADFGMSR----NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVT 221
Query: 176 LLQIISGKRLSMLCGIN--ENLS---ILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRC 230
L +I++ LC E+L+ ++E+A ++ ++ N P
Sbjct: 222 LWEILT------LCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRP---PNCP---KDI 269
Query: 231 LEIALLCVQENPNDRPSMLQVSSMLKN 257
E+ L C + + DRP+ ++ L+
Sbjct: 270 YELMLECWRRDEEDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 6e-22
Identities = 57/192 (29%), Positives = 103/192 (53%), Gaps = 19/192 (9%)
Query: 8 VIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
++AVK L + ++F+ E L LQH ++++ G C D + ++V+EYM + L+
Sbjct: 37 LVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNK 96
Query: 68 YL--FDPIRRLILDWKKR-----------VHIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
+L P +++D + R +HI I G++YL +HRDL N
Sbjct: 97 FLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRN 153
Query: 115 ILLGEDMKPKISDFGLAR-IFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFG 173
L+G ++ KI DFG++R +++ + ++ I ++PPE ++T+SDV+SFG
Sbjct: 154 CLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML-PIRWMPPESIMYRKFTTESDVWSFG 212
Query: 174 VLLLQIIS-GKR 184
V+L +I + GK+
Sbjct: 213 VILWEIFTYGKQ 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 7e-22
Identities = 67/266 (25%), Positives = 110/266 (41%), Gaps = 56/266 (21%)
Query: 4 PCGKVIAVKKLSKTSTQGFE-EFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
P GK+ A+KK+ + F + E+ + +++ G E +V EYM
Sbjct: 24 PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG 83
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGIT--------QGLLYLQEYSRLTIIHRDLKASN 114
SL L+ KK I E + +GL YL +++ IIHRD+K SN
Sbjct: 84 GSLA--------DLL---KKVGKIPEPVLAYIARQILKGLDYL--HTKRHIIHRDIKPSN 130
Query: 115 ILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGV 174
+L+ + KI+DFG++++ + NT VGT+ Y+ PE + YS +D++S G+
Sbjct: 131 LLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYMSPERIQGESYSYAADIWSLGL 188
Query: 175 LLLQIISGKR----------LSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSP 224
LL+ GK ++ I + L EF D
Sbjct: 189 TLLECALGKFPFLPPGQPSFFELMQAICD-----GPPPSLPAEEFSPEFRD--------- 234
Query: 225 CKLMRCLEIALLCVQENPNDRPSMLQ 250
+ C+Q++P RPS +
Sbjct: 235 --FISA------CLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 7e-22
Identities = 58/192 (30%), Positives = 90/192 (46%), Gaps = 28/192 (14%)
Query: 6 GKVIAVKK--LSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERML--VYEY 59
GK+ +K+ LS S + E+ NEV + KL H N+I+ +S E+ L V EY
Sbjct: 25 GKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK----YYESFEEKGKLCIVMEY 80
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVH------IIEGITQGLLYLQEYSRLTIIHRDLKAS 113
L + I KK I++ Q L L+ I+HRD+K
Sbjct: 81 ADGGDLS--------QKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQ 132
Query: 114 NILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE-YARQGVYSTKSDVFSF 172
NI L + K+ DFG++++ + A T VVGT Y+ PE + Y+ KSD++S
Sbjct: 133 NIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPELCQNKP-YNYKSDIWSL 189
Query: 173 GVLLLQIISGKR 184
G +L ++ + K
Sbjct: 190 GCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 2e-21
Identities = 69/262 (26%), Positives = 128/262 (48%), Gaps = 32/262 (12%)
Query: 8 VIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
++AVK L S ++F E L LQH ++++ G C++ + ++V+EYM + L+
Sbjct: 37 LVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNK 96
Query: 68 YL--FDPIRRLI--------LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
+L P L+ L + +HI + I G++YL +HRDL N L+
Sbjct: 97 FLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLV 153
Query: 118 GEDMKPKISDFGLAR-IFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
GE++ KI DFG++R +++ + ++ I ++PPE ++T+SDV+S GV+L
Sbjct: 154 GENLLVKIGDFGMSRDVYSTDYYRVGGHTML-PIRWMPPESIMYRKFTTESDVWSLGVVL 212
Query: 177 LQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235
+I + GK+ NE + + L + P ++ ++ L
Sbjct: 213 WEIFTYGKQPWYQLSNNEVIECITQGRVLQR-------------PRTCPKEVY---DLML 256
Query: 236 LCVQENPNDRPSMLQVSSMLKN 257
C Q P+ R ++ ++ S+L+N
Sbjct: 257 GCWQREPHMRLNIKEIHSLLQN 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 2e-21
Identities = 77/255 (30%), Positives = 129/255 (50%), Gaps = 34/255 (13%)
Query: 9 IAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMPNKSLDC 67
+A+K L K T E F E + KL+H L+ + + + SEE + +V E+M SL
Sbjct: 33 VAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPL--YAVVSEEPIYIVTEFMGKGSLLD 89
Query: 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISD 127
+L + + L + V + I G+ Y++ R+ IHRDL+A+NIL+G+++ KI+D
Sbjct: 90 FLKEGDGKY-LKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIAD 145
Query: 128 FGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSM 187
FGLAR+ A + I + PE A G ++ KSDV+SFG+LL ++++ R+
Sbjct: 146 FGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204
Query: 188 LCGIN-ENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRC----LEIALLCVQENP 242
+N E L +E Y + PC C E+ LC +++P
Sbjct: 205 PGMVNREVLEQVERGYRM-------------------PCP-QGCPESLHELMKLCWKKDP 244
Query: 243 NDRPSMLQVSSMLKN 257
++RP+ + S L++
Sbjct: 245 DERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 2e-21
Identities = 72/266 (27%), Positives = 118/266 (44%), Gaps = 44/266 (16%)
Query: 9 IAVKKLSKTSTQGFE-EFKNE--VMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
+A+K +++ ++ EF NE VM HV +R+LG + ++V E M L
Sbjct: 39 VAIKTVNENASMRERIEFLNEASVMKEFNCHHV--VRLLGVVSTGQPTLVVMELMAKGDL 96
Query: 66 DCYL------------FDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKA 112
YL P + + E I G+ YL +HRDL A
Sbjct: 97 KSYLRSRRPEAENNPGLGPPTLQKFIQM-----AAE-IADGMAYLAA---KKFVHRDLAA 147
Query: 113 SNILLGEDMKPKISDFGLAR-IFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFS 171
N ++ ED+ KI DFG+ R I+ + + ++ + ++ PE + GV++TKSDV+S
Sbjct: 148 RNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRWMAPESLKDGVFTTKSDVWS 206
Query: 172 FGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL 231
FGV+L ++ + N E + G ++ + N P K L
Sbjct: 207 FGVVLWEMATLAEQPYQGLSN------EEVLKFVIDGGHLDLPE------NCPDK---LL 251
Query: 232 EIALLCVQENPNDRPSMLQVSSMLKN 257
E+ +C Q NP RP+ L++ S LK+
Sbjct: 252 ELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 3e-21
Identities = 75/255 (29%), Positives = 126/255 (49%), Gaps = 34/255 (13%)
Query: 9 IAVKKLSKTSTQG-FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+A+K L T+ +F +E + + H N+I + G S+ M+V EYM N SLD
Sbjct: 35 VAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDA 94
Query: 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISD 127
+L + + + V ++ GI G+ YL S + +HRDL A NIL+ ++ K+SD
Sbjct: 95 FLRKHDGQFTV--IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSD 149
Query: 128 FGLARIFAKESLEANTEQVVGTI-GYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS 181
FGL+R+ LE + E T G IP PE +++ SDV+S+G+++ +++S
Sbjct: 150 FGLSRV-----LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
Query: 182 -GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240
G+R + + +E Y L + +D + +LM L C Q+
Sbjct: 205 YGERPYWEMSNQDVIKAIEEGYRL----------PAPMDCPAALHQLM------LDCWQK 248
Query: 241 NPNDRPSMLQVSSML 255
+ N+RP Q+ S+L
Sbjct: 249 DRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 4e-21
Identities = 59/192 (30%), Positives = 99/192 (51%), Gaps = 20/192 (10%)
Query: 6 GKVIAVKKLSK-TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
+++A+K L + Q + EF+ E L A+L H N++ +LG + +++EY+
Sbjct: 34 AQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGD 93
Query: 65 LDCYLF--------------DPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 110
L +L D + LD +HI I G+ YL + +H+DL
Sbjct: 94 LHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDL 150
Query: 111 KASNILLGEDMKPKISDFGLAR-IFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDV 169
A NIL+GE + KISD GL+R I++ + + ++ I ++PPE G +S+ SD+
Sbjct: 151 AARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL-PIRWMPPEAIMYGKFSSDSDI 209
Query: 170 FSFGVLLLQIIS 181
+SFGV+L +I S
Sbjct: 210 WSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 5e-21
Identities = 72/251 (28%), Positives = 118/251 (47%), Gaps = 26/251 (10%)
Query: 9 IAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL-DC 67
+AVK + K + E F E + LQH L++ L + E ++ E+M SL D
Sbjct: 33 VAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGSLLDF 90
Query: 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISD 127
D + L K + I +G+ ++++ + IHRDL+A+NIL+ + KI+D
Sbjct: 91 LKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIAD 145
Query: 128 FGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSM 187
FGLAR+ A E I + PE G ++ KSDV+SFG+LL++I++ R+
Sbjct: 146 FGLARVIEDNEYTAR-EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 204
Query: 188 LCGIN-ENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRP 246
N E + LE Y + + N P +L I + C + P +RP
Sbjct: 205 PGMSNPEVIRALERGYRMPR-------------PENCPEELY---NIMMRCWKNRPEERP 248
Query: 247 SMLQVSSMLKN 257
+ + S+L +
Sbjct: 249 TFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 5e-21
Identities = 75/258 (29%), Positives = 127/258 (49%), Gaps = 34/258 (13%)
Query: 9 IAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMPNKSLDC 67
+A+K L K T E F E + KL+H L+++ + + SEE + +V EYM SL
Sbjct: 33 VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVTEYMSKGSLLD 89
Query: 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISD 127
+L + + L + V + I G+ Y++ R+ +HRDL+A+NIL+GE++ K++D
Sbjct: 90 FLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVAD 145
Query: 128 FGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSM 187
FGLAR+ A + I + PE A G ++ KSDV+SFG+LL ++ + R+
Sbjct: 146 FGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 204
Query: 188 LCGIN-ENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRC----LEIALLCVQENP 242
+N E L +E Y + PC C ++ C ++ P
Sbjct: 205 PGMVNREVLDQVERGYRM-------------------PCP-PECPESLHDLMCQCWRKEP 244
Query: 243 NDRPSMLQVSSMLKNETT 260
+RP+ + + L++ T
Sbjct: 245 EERPTFEYLQAFLEDYFT 262
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 8e-21
Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 21/207 (10%)
Query: 6 GKVIAVKKLS-KTSTQGFE-EFKNEVMLTAKLQHVNLIRVLGFCIDSEER---MLVYEYM 60
G+++A+KK+ + +GF E+ L KL+H N++R+ S+ + +V+EYM
Sbjct: 24 GELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVT-SKGKGSIYMVFEYM 82
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
+ L L P + K ++ + +GL YL I+HRD+K SNIL+ D
Sbjct: 83 DH-DLTGLLDSPEVKFTESQIK--CYMKQLLEGLQYLHSNG---ILHRDIKGSNILINND 136
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGVLLL 177
K++DFGLAR + K + T +V+ T+ Y PPE A + Y + D++S G +L
Sbjct: 137 GVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGATR--YGPEVDMWSVGCILA 193
Query: 178 QIISGKRLSMLCGINENLSILEHAYEL 204
++ GK + G E L LE +EL
Sbjct: 194 ELFLGK--PIFQGSTE-LEQLEKIFEL 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 1e-20
Identities = 61/179 (34%), Positives = 91/179 (50%), Gaps = 11/179 (6%)
Query: 7 KVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLD 66
K I V++++K + NE + L H N+I ++ + M+V EY P +L
Sbjct: 31 KQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLA 87
Query: 67 CYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-DMKPKI 125
Y+ +LD I+ Q LL L I+HRDLK NILL + M KI
Sbjct: 88 EYIQKR-CNSLLDEDT---ILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKI 143
Query: 126 SDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKR 184
DFG+++I + +S +A T VVGT YI PE Y+ KSD+++ G +L ++ S KR
Sbjct: 144 GDFGISKILSSKS-KAYT--VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-20
Identities = 66/267 (24%), Positives = 118/267 (44%), Gaps = 43/267 (16%)
Query: 9 IAVK--KLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER------MLVYEYM 60
+AVK KL + EEF +E H N+++++G C ++ M++ +M
Sbjct: 30 VAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFM 89
Query: 61 PNKSLDCYLFD----------PIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 110
+ L +L P++ L+ + I G+ YL S IHRDL
Sbjct: 90 KHGDLHSFLLYSRLGGLPEKLPLQTLLK-------FMVDIALGMEYL---SNRNFIHRDL 139
Query: 111 KASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVF 170
A N +L EDM ++DFGL++ + +I E VY++KSDV+
Sbjct: 140 AARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVW 199
Query: 171 SFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRC 230
+FGV + +I + + + G+ EN I Y+ + G ++ + LD+
Sbjct: 200 AFGVTMWEIAT-RGQTPYPGV-ENHEI----YDYLRHGNRLKQPEDCLDEL--------- 244
Query: 231 LEIALLCVQENPNDRPSMLQVSSMLKN 257
++ C + +P DRP+ ++ +L+N
Sbjct: 245 YDLMYSCWRADPKDRPTFTKLREVLEN 271
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-20
Identities = 70/255 (27%), Positives = 122/255 (47%), Gaps = 37/255 (14%)
Query: 6 GKVIAVKKLS----KTSTQG--FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEY 59
G ++AVK+++ +S Q E + E+ L A+L H ++IR+LG + L E+
Sbjct: 25 GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84
Query: 60 MPNKSLDCYL--FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
M S+ L + + ++ ++ E + +GL YL E IIHRD+K +N+L+
Sbjct: 85 MAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHENQ---IIHRDVKGANLLI 136
Query: 118 ---GEDMKPKISDFGLARIFAKESLEAN--TEQVVGTIGYIPPEYARQGVYSTKSDVFSF 172
G+ ++ I+DFG A A + A Q++GTI ++ PE R Y DV+S
Sbjct: 137 DSTGQRLR--IADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSV 194
Query: 173 GVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL- 231
G +++++ + K E S H ++K + S+ + P L L
Sbjct: 195 GCVIIEMATAK----PPWNAEKHS--NHLALIFK-------IASATTAPSIPEHLSPGLR 241
Query: 232 EIALLCVQENPNDRP 246
++ L C++ P DRP
Sbjct: 242 DVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 6e-20
Identities = 71/260 (27%), Positives = 122/260 (46%), Gaps = 42/260 (16%)
Query: 9 IAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+A+K L T + +F +E + + H N+I + G S M++ E+M N +LD
Sbjct: 35 VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDS 94
Query: 68 YL------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
+L F I + V ++ GI G+ YL E + +HRDL A NIL+ ++
Sbjct: 95 FLRQNDGQFTVI--------QLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNL 143
Query: 122 KPKISDFGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLL 176
K+SDFGL+R ++ + +G G IP PE +++ SDV+S+G+++
Sbjct: 144 VCKVSDFGLSRFLEDDTSDPTYTSSLG--GKIPIRWTAPEAIAYRKFTSASDVWSYGIVM 201
Query: 177 LQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235
+++S G+R + ++ +E Y L +D + +LM L
Sbjct: 202 WEVMSYGERPYWDMSNQDVINAIEQDYRL----------PPPMDCPTALHQLM------L 245
Query: 236 LCVQENPNDRPSMLQVSSML 255
C Q++ N RP Q+ S L
Sbjct: 246 DCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-19
Identities = 72/261 (27%), Positives = 126/261 (48%), Gaps = 46/261 (17%)
Query: 9 IAVKKLSKTSTQG-FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+A+K L T+ ++F +E + + H N+IR+ G + M++ EYM N +LD
Sbjct: 36 VAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDK 95
Query: 68 YL------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
YL F + V ++ GI G+ YL S + +HRDL A NIL+ ++
Sbjct: 96 YLRDHDGEFSSY--------QLVGMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNL 144
Query: 122 KPKISDFGLARIFAKESLEANTEQVVGTI-GYIP-----PEYARQGVYSTKSDVFSFGVL 175
+ K+SDFGL+R+ LE + E T G IP PE +++ SDV+SFG++
Sbjct: 145 ECKVSDFGLSRV-----LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIV 199
Query: 176 LLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIA 234
+ +++S G+R +E + + + L + +D ++ +LM
Sbjct: 200 MWEVMSFGERPYWDMSNHEVMKAINDGFRL----------PAPMDCPSAVYQLM------ 243
Query: 235 LLCVQENPNDRPSMLQVSSML 255
L C Q++ RP + + ++L
Sbjct: 244 LQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-19
Identities = 57/186 (30%), Positives = 91/186 (48%), Gaps = 26/186 (13%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
GK +A+KK+ Q E NE+++ +H N++ + +E +V EYM SL
Sbjct: 44 GKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL 102
Query: 66 -DCYLFDPIRRLILDWKKRVHIIEG--------ITQGLLYLQEYSRLTIIHRDLKASNIL 116
D I+ V + E + QGL YL +IHRD+K+ NIL
Sbjct: 103 TD----------IITQNF-VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNIL 148
Query: 117 LGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
L +D K++DFG A KE + N+ VVGT ++ PE ++ Y K D++S G++
Sbjct: 149 LSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMC 206
Query: 177 LQIISG 182
+++ G
Sbjct: 207 IEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-19
Identities = 73/254 (28%), Positives = 117/254 (46%), Gaps = 29/254 (11%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+ +AVK + T + F E + KL H NL+R+LG I +V E M +L
Sbjct: 29 GQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLG-VILHNGLYIVMELMSKGNL 85
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
+L R L+ + + + +G+ YL+ ++HRDL A NIL+ ED K+
Sbjct: 86 VNFLRTRGRALV-SVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKV 141
Query: 126 SDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKR 184
SDFGLAR+ S+ + ++ + + PE + +S+KSDV+S+GVLL ++ S G+
Sbjct: 142 SDFGLARV---GSMGVDNSKL--PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRA 196
Query: 185 LSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPND 244
+ E +E Y + E + D LM C + P
Sbjct: 197 PYPKMSLKEVKECVEKGYRM-------EPPEGCPADVYV---LMTS------CWETEPKK 240
Query: 245 RPSMLQVSSMLKNE 258
RPS ++ L+ E
Sbjct: 241 RPSFHKLREKLEKE 254
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-19
Identities = 70/262 (26%), Positives = 117/262 (44%), Gaps = 36/262 (13%)
Query: 9 IAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+A+K +++ S + EF NE + + +++R+LG + +++ E M L
Sbjct: 39 VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 98
Query: 68 YLFDPIRRLILD-----------WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNIL 116
YL R L + KK + + I G+ YL +HRDL A N +
Sbjct: 99 YL----RSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCM 151
Query: 117 LGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
+ ED KI DFG+ R + + + + ++ PE + GV++T SDV+SFGV+L
Sbjct: 152 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 211
Query: 177 LQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV-DSSLDDTNSPCKLMRCLEIAL 235
+I ++ E Y+ + + FV + L D C M E+
Sbjct: 212 WEIA---------------TLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDM-LFELMR 255
Query: 236 LCVQENPNDRPSMLQVSSMLKN 257
+C Q NP RPS L++ S +K
Sbjct: 256 MCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 9e-19
Identities = 73/271 (26%), Positives = 127/271 (46%), Gaps = 39/271 (14%)
Query: 8 VIAVKKLSKTSTQGFE-EFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLD 66
++AVK L + + +F EV + ++L+ N+IR+LG C+D + ++ EYM N L+
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 67 CYL--------------FDPIRR--LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 110
+L P + + +H+ I G+ YL S L +HRDL
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDL 164
Query: 111 KASNILLGEDMKPKISDFGLAR-IFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDV 169
N L+GE++ KI+DFG++R ++A + V+ I ++ E G ++T SDV
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVL-PIRWMAWECILMGKFTTASDV 223
Query: 170 FSFGVLLLQIISGKRLSMLC-----GINENLSILEHAYELWKGGKGVEFVDSSLDDTNSP 224
++FGV L +I+ MLC G + ++E+A E ++ ++ P
Sbjct: 224 WAFGVTLWEIL------MLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRP-----PP 272
Query: 225 CKLMRCLEIALLCVQENPNDRPSMLQVSSML 255
C E+ L C + +RPS + + L
Sbjct: 273 CP-QGLYELMLQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-18
Identities = 57/196 (29%), Positives = 98/196 (50%), Gaps = 28/196 (14%)
Query: 6 GKVIAVKK--LSKTSTQGFEE--------FKNEVMLTAKLQHVNLIRVLGFCIDSEERML 55
G+++AVK+ L T + ++E+ L H+N+++ LGF E +
Sbjct: 26 GEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI 85
Query: 56 VYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
EY+P S+ L R + + E + +GL YL I+HRDLKA N+
Sbjct: 86 FLEYVPGGSIGSCLRTYGR---FEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNL 139
Query: 116 LLGEDMKPKISDFGLAR----IFAKESLEANTEQVVGTIGYIPPEY---ARQGVYSTKSD 168
L+ D KISDFG+++ I+ + + + Q G++ ++ PE QG YS K D
Sbjct: 140 LVDADGICKISDFGISKKSDDIYD--NDQNMSMQ--GSVFWMAPEVIHSYSQG-YSAKVD 194
Query: 169 VFSFGVLLLQIISGKR 184
++S G ++L++ +G+R
Sbjct: 195 IWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-18
Identities = 61/181 (33%), Positives = 89/181 (49%), Gaps = 10/181 (5%)
Query: 6 GKVIAVKK--LSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
+V A+K+ LSK + + EE +E + AKL +IR +D + +V EY N
Sbjct: 25 KRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENG 84
Query: 64 SLDCYLFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
L L R L D R I Q LL L I+HRD+K+ N+ L
Sbjct: 85 DLHKLLKMQRGRPLPEDQVWRFFI-----QILLGLAHLHSKKILHRDIKSLNLFLDAYDN 139
Query: 123 PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
KI D G+A++ + + ANT +VGT Y+ PE Y+ KSDV++ GV+L + +G
Sbjct: 140 VKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTG 197
Query: 183 K 183
K
Sbjct: 198 K 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 57/193 (29%), Positives = 92/193 (47%), Gaps = 25/193 (12%)
Query: 6 GKVIAVKKLS--KTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
GK++ K++ + + ++ +EV + +L+H N++R ID + +Y M
Sbjct: 25 GKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ-TLYIVME-- 81
Query: 64 SLDCY-----LFDPIRRLILDWKKRV--HIIEGI-TQGLLYLQE-----YSRLTIIHRDL 110
Y L I++ + +K + I I TQ LL L E T++HRDL
Sbjct: 82 ----YCEGGDLAQLIQKCKKE-RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDL 136
Query: 111 KASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVF 170
K +NI L + K+ DFGLA+I +S A T VGT Y+ PE Y KSD++
Sbjct: 137 KPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPEQLNHMSYDEKSDIW 194
Query: 171 SFGVLLLQIISGK 183
S G L+ ++ +
Sbjct: 195 SLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-18
Identities = 70/261 (26%), Positives = 120/261 (45%), Gaps = 32/261 (12%)
Query: 9 IAVKKLSKT-STQGFEEFKNE--VMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
+AVK ++++ S + EF NE VM HV +R+LG + ++V E M + L
Sbjct: 39 VAVKTVNESASLRERIEFLNEASVMKGFTCHHV--VRLLGVVSKGQPTLVVMELMAHGDL 96
Query: 66 DCYLF-------DPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
YL + R ++ + + I G+ YL +HRDL A N ++
Sbjct: 97 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVA 153
Query: 119 EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
D KI DFG+ R + + + + ++ PE + GV++T SD++SFGV+L +
Sbjct: 154 HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE 213
Query: 179 IISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV-DSSLDDTNSPCKLMRCLEIALLC 237
I S+ E Y+ + ++FV D D C R ++ +C
Sbjct: 214 IT---------------SLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCP-ERVTDLMRMC 257
Query: 238 VQENPNDRPSMLQVSSMLKNE 258
Q NP RP+ L++ ++LK++
Sbjct: 258 WQFNPKMRPTFLEIVNLLKDD 278
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-18
Identities = 58/197 (29%), Positives = 103/197 (52%), Gaps = 31/197 (15%)
Query: 6 GKVIAVKK--LSKTSTQG-------FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLV 56
G+++AVK+ L S + E+ L +LQH N+++ LG +D++ +
Sbjct: 25 GELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIF 84
Query: 57 YEYMPNKS----LDCY--LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 110
EY+P S L+ Y + + R + + I +GL YL ++R IIHRD+
Sbjct: 85 LEYVPGGSVAALLNNYGAFEETLVR---------NFVRQILKGLNYL--HNR-GIIHRDI 132
Query: 111 KASNILLGEDMKPKISDFGLARIFAKESLEANTEQ----VVGTIGYIPPEYARQGVYSTK 166
K +NIL+ KISDFG+++ SL T + G++ ++ PE +Q Y+ K
Sbjct: 133 KGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRK 192
Query: 167 SDVFSFGVLLLQIISGK 183
+D++S G L++++++GK
Sbjct: 193 ADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-18
Identities = 63/243 (25%), Positives = 111/243 (45%), Gaps = 22/243 (9%)
Query: 9 IAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
+A+K +++ + E+F E + KL H L+++ G C + +V E+M N L Y
Sbjct: 31 VAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNY 89
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L R+ L + + + + +G+ YL+ R + IHRDL A N L+ K+SDF
Sbjct: 90 LRQ--RQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDF 144
Query: 129 GLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSML 188
G+ R + + ++ + + PPE YS+KSDV+SFGVL+ ++ + ++
Sbjct: 145 GMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPF- 202
Query: 189 CGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSM 248
E S E + +G + L + E+ C E P RP+
Sbjct: 203 ----EKKSNYEVVEMISRGFR--------LYRPKLASMTV--YEVMYSCWHEKPEGRPTF 248
Query: 249 LQV 251
++
Sbjct: 249 AEL 251
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 5e-18
Identities = 67/244 (27%), Positives = 108/244 (44%), Gaps = 27/244 (11%)
Query: 13 KLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDP 72
K+ K + +EF E + KL H L+++ G C +V EYM N L YL +
Sbjct: 34 KMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREH 93
Query: 73 IRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLAR 132
+R + + + + + +G+ YL+ IHRDL A N L+ + K+SDFGL+R
Sbjct: 94 GKRF--QPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSR 148
Query: 133 IFAKESLEANTEQVVGT---IGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLC 189
L+ VG+ + + PPE +S+KSDV++FGVL+ ++ S ++
Sbjct: 149 YV----LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKM---- 200
Query: 190 GINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSML 249
YE + + VE V L + I C E +RP+
Sbjct: 201 -----------PYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQ 249
Query: 250 QVSS 253
Q+ S
Sbjct: 250 QLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 5e-18
Identities = 58/188 (30%), Positives = 93/188 (49%), Gaps = 13/188 (6%)
Query: 3 LPCGKVIAVKK--LSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
LP + +A+K+ L K T +E + EV ++ H N+++ + +E LV Y+
Sbjct: 23 LPNNEKVAIKRIDLEKCQTS-VDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL 81
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
SL + R LD +++ + +GL YL + IHRD+KA NILLGED
Sbjct: 82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGED 138
Query: 121 MKPKISDFGLARIFAK----ESLEANTEQVVGTIGYIPPEYARQGV-YSTKSDVFSFGVL 175
KI+DFG++ A T VGT ++ PE Q Y K+D++SFG+
Sbjct: 139 GSVKIADFGVSASLADGGDRTRKVRKT--FVGTPCWMAPEVMEQVHGYDFKADIWSFGIT 196
Query: 176 LLQIISGK 183
+++ +G
Sbjct: 197 AIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 6e-18
Identities = 66/270 (24%), Positives = 122/270 (45%), Gaps = 48/270 (17%)
Query: 1 GVLPCGKVIAVKKLS------KTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM 54
G+ G++IAVK++ + + +E+ + EV L L+HVN+++ LG C+D
Sbjct: 19 GLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTIS 78
Query: 55 LVYEYMPNKSLDCYL--FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKA 112
+ E++P S+ L F P+ + + I G+ YL ++HRD+K
Sbjct: 79 IFMEFVPGGSISSILNRFGPLPEPVF-----CKYTKQILDGVAYLHNNC---VVHRDIKG 130
Query: 113 SNILLGEDMKPKISDFGLARIFAKESLEANTEQVV----GTIGYIPPEYARQGVYSTKSD 168
+N++L + K+ DFG AR A L ++ GT ++ PE + Y KSD
Sbjct: 131 NNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSD 190
Query: 169 VFSFGVLLLQIISGK-------RLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDT 221
++S G + ++ +GK RL+ + I + ++ + + ++FV S
Sbjct: 191 IWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAA-AIDFVTS----- 244
Query: 222 NSPCKLMRCLEIALLCVQENPNDRPSMLQV 251
C+ + ++RPS LQ+
Sbjct: 245 ---------------CLTRDQHERPSALQL 259
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-18
Identities = 54/193 (27%), Positives = 96/193 (49%), Gaps = 25/193 (12%)
Query: 7 KVIAVKKLS-KTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
+ +A+K L K EEFK+E M+ ++LQH N++ +LG + +++ Y + L
Sbjct: 36 QAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL 95
Query: 66 DCYLF-------------DPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKA 112
+L D + L+ VHI+ I G+ +L + ++H+DL
Sbjct: 96 HEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLAT 152
Query: 113 SNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGT----IGYIPPEYARQGVYSTKSD 168
N+L+ + + KISD GL R E A+ +++G I ++ PE G +S SD
Sbjct: 153 RNVLVFDKLNVKISDLGLFR----EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSD 208
Query: 169 VFSFGVLLLQIIS 181
++S+GV+L ++ S
Sbjct: 209 IWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 7e-18
Identities = 58/186 (31%), Positives = 90/186 (48%), Gaps = 19/186 (10%)
Query: 4 PCGKVIAVKKLSKTSTQGFEEFKNEVM---LTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
P GK++AVK + + K + + K ++ G ++ + + EYM
Sbjct: 24 PTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81
Query: 61 PNKSLDCYL---FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
SLD L I IL K I + +GL YL + + IIHRD+K SNIL+
Sbjct: 82 DGGSLDKILKEVQGRIPERIL--GK---IAVAVLKGLTYL--HEKHKIIHRDVKPSNILV 134
Query: 118 GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
+ K+ DFG++ SL A T VGT Y+ PE + YS KSD++S G+ L+
Sbjct: 135 NSRGQIKLCDFGVSGQLV-NSL-AKTF--VGTSSYMAPERIQGNDYSVKSDIWSLGLSLI 190
Query: 178 QIISGK 183
++ +G+
Sbjct: 191 ELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 8e-18
Identities = 57/188 (30%), Positives = 91/188 (48%), Gaps = 29/188 (15%)
Query: 3 LPCGKVIAVKKLSKTSTQGFEEFK--------NEVMLTAKLQHVNLIRVLGFCIDSEERM 54
L G+V+A+KK+ Q FE E+ L +L H N+I+ L I++ E
Sbjct: 24 LLDGRVVALKKV-----QIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELN 78
Query: 55 LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLT------IIHR 108
+V E L R+I +KK+ +I T ++Q S L I+HR
Sbjct: 79 IVLELADAGDL--------SRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHR 130
Query: 109 DLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSD 168
D+K +N+ + K+ D GL R F+ ++ A++ +VGT Y+ PE + Y+ KSD
Sbjct: 131 DIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSD 188
Query: 169 VFSFGVLL 176
++S G LL
Sbjct: 189 IWSLGCLL 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 9e-18
Identities = 83/278 (29%), Positives = 130/278 (46%), Gaps = 48/278 (17%)
Query: 10 AVKKLSKTSTQG-FEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
A+K++ + +++ +F E+ + KL H N+I +LG C L EY P+ +L
Sbjct: 38 AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 97
Query: 68 YL-------FDPIRRL------ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
+L DP + L ++ +H + +G+ YL S+ IHRDL A N
Sbjct: 98 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARN 154
Query: 115 ILLGEDMKPKISDFGLARIFAKESLEANTEQVVG--TIGYIPPEYARQGVYSTKSDVFSF 172
IL+GE+ KI+DFGL+R E ++ +G + ++ E VY+T SDV+S+
Sbjct: 155 ILVGENYVAKIADFGLSR-----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 209
Query: 173 GVLLLQIISGKRLSMLCGIN--ENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRC 230
GVLL +I+S + CG+ E L Y L K L+ + LMR
Sbjct: 210 GVLLWEIVSLGG-TPYCGMTCAELYEKLPQGYRLEK----------PLNCDDEVYDLMR- 257
Query: 231 LEIALLCVQENPNDRPSMLQV----SSMLKNETTNRNT 264
C +E P +RPS Q+ + ML+ T NT
Sbjct: 258 -----QCWREKPYERPSFAQILVSLNRMLEERKTYVNT 290
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-17
Identities = 45/128 (35%), Positives = 68/128 (53%), Gaps = 13/128 (10%)
Query: 58 EYMPNKSLDCYL--FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
E+M SLD PI IL I + +GL YL Y+ I+HRD+K SNI
Sbjct: 83 EFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYL--YNVHRIMHRDIKPSNI 135
Query: 116 LLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVL 175
L+ + K+ DFG++ E + + + VGT Y+ PE + G Y+ KSDV+S G+
Sbjct: 136 LVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGIS 191
Query: 176 LLQIISGK 183
++++ GK
Sbjct: 192 IIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 2e-17
Identities = 64/213 (30%), Positives = 88/213 (41%), Gaps = 32/213 (15%)
Query: 6 GKVIAVKKLSK---TSTQGFEEFKNE-VMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMP 61
K A+K L K + + K E +LT H +I++ D E V EY P
Sbjct: 26 NKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP 85
Query: 62 NKSLDCYLFDPIRRL-ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
N L IR+ LD K I L YL IIHRDLK NILL +D
Sbjct: 86 NGEL----LQYIRKYGSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKD 138
Query: 121 MKPKISDFGLARIFAKESLEANTEQV------------------VGTIGYIPPEYARQGV 162
M KI+DFG A++ S + + VGT Y+ PE +
Sbjct: 139 MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP 198
Query: 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENL 195
SD+++ G ++ Q+++GK G NE L
Sbjct: 199 AGKSSDLWALGCIIYQMLTGK--PPFRGSNEYL 229
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-17
Identities = 56/178 (31%), Positives = 101/178 (56%), Gaps = 15/178 (8%)
Query: 9 IAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+A+K L++T+ + EF +E ++ A + H +L+R+LG C+ S LV + MP+ L
Sbjct: 39 VAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCL-SPTIQLVTQLMPHGCLLD 97
Query: 68 YLF---DPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
Y+ D I +L+L+W + I +G++YL+E ++HRDL A N+L+
Sbjct: 98 YVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEERR---LVHRDLAARNVLVKSPNHV 148
Query: 124 KISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
KI+DFGLAR+ + E N + I ++ E ++ +SDV+S+GV + ++++
Sbjct: 149 KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-17
Identities = 59/251 (23%), Positives = 109/251 (43%), Gaps = 40/251 (15%)
Query: 14 LSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI 73
L++ S + + NE+++ + LQH N+I +D ++ EY +L +D I
Sbjct: 35 LTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTL----YDKI 90
Query: 74 RR---LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGL 130
R + + + + + I + Y+ + I+HRD+K NI L + K+ DFG+
Sbjct: 91 VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGI 147
Query: 131 ARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKR------ 184
++I E A T VVGT Y+ PE + Y+ KSD+++ G +L ++++ KR
Sbjct: 148 SKILGSEYSMAET--VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN 205
Query: 185 LSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPND 244
L + I++ Y E + L+ +Q++P
Sbjct: 206 PLNLV-----VKIVQGNYTPVVSVYSSELI-----------SLVHS------LLQQDPEK 243
Query: 245 RPSMLQVSSML 255
RP+ +V
Sbjct: 244 RPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 6e-17
Identities = 60/187 (32%), Positives = 91/187 (48%), Gaps = 24/187 (12%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKN-----EVMLTAKLQHVNLIRVLG-FCIDSEERMLVYEY 59
G+++A+KK+ + ++ N E+ L +L+H N+I +L F S LV+E+
Sbjct: 25 GRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNIN-LVFEF 83
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
M L+ + D L K + +GL YL I+HRDLK +N+L+
Sbjct: 84 MET-DLEKVIKDKSIVLTPADIKS--YMLMTLRGLEYLHSNW---ILHRDLKPNNLLIAS 137
Query: 120 DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGV-- 174
D K++DFGLAR F + + T QVV T Y PE AR Y D++S G
Sbjct: 138 DGVLKLADFGLARSFGSPNRKM-THQVV-TRWYRAPELLFGARH--YGVGVDMWSVGCIF 193
Query: 175 --LLLQI 179
LLL++
Sbjct: 194 AELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-17
Identities = 49/178 (27%), Positives = 94/178 (52%), Gaps = 9/178 (5%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+ +AVK + Q E NEV++ QH N++ + + EE ++ E++ +L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D + + L+ ++ + E + Q L YL +IHRD+K+ +ILL D + K+
Sbjct: 106 T----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKL 158
Query: 126 SDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
SDFG +K+ + +VGT ++ PE + Y T+ D++S G+++++++ G+
Sbjct: 159 SDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 7e-17
Identities = 51/188 (27%), Positives = 83/188 (44%), Gaps = 19/188 (10%)
Query: 6 GKVIAVKKLSKTSTQG---FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMP 61
G + A+K + K ++ E + ++ Q +++ L + ++ + LV EY+P
Sbjct: 18 GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK-LYYSFQGKKNLYLVMEYLP 76
Query: 62 NKSLDCY-LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
D L + + L D + I I L YL IIHRDLK NIL+ +
Sbjct: 77 GG--DLASLLENVGSLDEDVAR--IYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSN 129
Query: 121 MKPKISDFGLA------RIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGV 174
K++DFGL+ R E +++VGT YI PE +S D +S G
Sbjct: 130 GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGC 189
Query: 175 LLLQIISG 182
+L + + G
Sbjct: 190 ILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 54/183 (29%), Positives = 89/183 (48%), Gaps = 11/183 (6%)
Query: 6 GKVIAVKKLS-KTSTQGFEEFK-NEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
G+++A+KK+ + ++G + E+ L +L H N+I++L + LV+E+M
Sbjct: 24 GEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM--- 80
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
D Y R+ L + + QGL + + I+HRDLK N+L+ +
Sbjct: 81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVL 137
Query: 124 KISDFGLARIFAKESLEANTEQVVGTIGYIPPE-YARQGVYSTKSDVFSFGVLLLQIISG 182
K++DFGLAR F T VV T Y PE YST D++S G + +++S
Sbjct: 138 KLADFGLARSFGSPV-RPYTHYVV-TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSR 195
Query: 183 KRL 185
+ L
Sbjct: 196 RPL 198
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-16
Identities = 50/184 (27%), Positives = 90/184 (48%), Gaps = 13/184 (7%)
Query: 8 VIAVKKL-SKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLD 66
++AVK L + + +F E+ + ++L++ N+IR+LG C+ + ++ EYM N L+
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 67 CYLFD-PIRRLI--------LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
+L I + +++ I G+ YL + L +HRDL N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162
Query: 118 GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
G KI+DFG++R + V I ++ E G ++T SDV++FGV L
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLW 222
Query: 178 QIIS 181
++ +
Sbjct: 223 EMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-16
Identities = 69/266 (25%), Positives = 115/266 (43%), Gaps = 58/266 (21%)
Query: 10 AVKKLSKTSTQGFEEFKNEV-MLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
A K + + + +EV ++ +L+H N++R ++++ +V + +
Sbjct: 40 AFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGA----- 94
Query: 69 LFDPIRRLILDWKKRVH---------IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
P+ K++ I + L YL + R I+HRDL +NI+LGE
Sbjct: 95 ---PLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGE 149
Query: 120 DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQI 179
D K I+DFGLA+ ++ E+ VVGTI Y PE + Y K+DV++FG +L Q+
Sbjct: 150 DDKVTITDFGLAK---QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQM 206
Query: 180 I-------SGKRLSMLCGINENLSILEHAYELWKGG---KGVEFVDSSLDDTNSPCKLMR 229
S LS+ I+E YE G + V V +S
Sbjct: 207 CTLQPPFYSTNMLSLA------TKIVEAVYEPLPEGMYSEDVTDVITS------------ 248
Query: 230 CLEIALLCVQENPNDRPSMLQVSSML 255
C+ + RP ++QVS+M+
Sbjct: 249 -------CLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 76/274 (27%), Positives = 122/274 (44%), Gaps = 50/274 (18%)
Query: 7 KVIAVKKLSKTSTQGFEEFKN---EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
+V+AVKK+S + Q E++++ EV +L+H N I G + LV EY
Sbjct: 47 EVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGS 106
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
+ D + + L + I G QGL YL ++ +IHRD+KA NILL E +
Sbjct: 107 ASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQV 160
Query: 124 KISDFGLARIFAKESLEANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGVLLLQII 180
K++DFG A S + VGT ++ PE +G Y K DV+S G+ +++
Sbjct: 161 KLADFGSA------SKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 214
Query: 181 SGK-------RLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEI 233
K +S L I +N S + E +G FVD
Sbjct: 215 ERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRG--FVD------------------ 254
Query: 234 ALLCVQENPNDRPSMLQVSSMLKNETTNRNTPKK 267
C+Q+ P +RP+ + +L+++ R+ P +
Sbjct: 255 --YCLQKIPQERPASAE---LLRHDFVRRDRPAR 283
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-16
Identities = 54/176 (30%), Positives = 90/176 (51%), Gaps = 9/176 (5%)
Query: 10 AVKKLSK-TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE-ERMLVYEYMPNKSLDC 67
AVK L++ T + E+F E ++ H N++ +LG C+ SE ++V YM + L
Sbjct: 27 AVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRN 86
Query: 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISD 127
++ + K + + +G+ YL +HRDL A N +L E K++D
Sbjct: 87 FIRSETHNPTV--KDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVAD 141
Query: 128 FGLAR-IFAKESLEA-NTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
FGLAR I+ KE N + ++ E + ++TKSDV+SFGVLL ++++
Sbjct: 142 FGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-16
Identities = 64/259 (24%), Positives = 107/259 (41%), Gaps = 37/259 (14%)
Query: 6 GKVIAVKK--LSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
+ A+K+ L S + E+ NE+ + A + H N+I +D + +V EY P
Sbjct: 25 NQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFG 84
Query: 64 SLDCYL--FDPIRRLI---LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
L + R+LI W+ + ++ G LQ I+HRDLK++NILL
Sbjct: 85 DLSKAISKRKKKRKLIPEQEIWRIFIQLLRG-------LQALHEQKILHRDLKSANILLV 137
Query: 119 EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
+ KI D G++++ K A T +GT Y+ PE + YS KSD++S G LL +
Sbjct: 138 ANDLVKIGDLGISKVLKKNM--AKT--QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYE 193
Query: 179 IISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238
+ + ++ + GK D + + M +
Sbjct: 194 MATFA-------PPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSM---------L 237
Query: 239 QENPNDRPSM---LQVSSM 254
Q P RP+ L ++
Sbjct: 238 QVKPKLRPNCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 3e-16
Identities = 62/254 (24%), Positives = 112/254 (44%), Gaps = 45/254 (17%)
Query: 5 CGKVIAVKK--LSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
+V+A+K L + + E+ + E+ ++ + + + G + + ++ EY
Sbjct: 25 TNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGG 83
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
S D ++ LD I+ + GL YL E + IHRD+KA+NILL E+
Sbjct: 84 GSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEEGK---IHRDIKAANILLSEEGD 136
Query: 123 PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
K++DFG++ + NT VGT ++ PE +Q Y K+D++S G+ +++ G
Sbjct: 137 VKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194
Query: 183 K---------RLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEI 233
+ R+ L N S+ + + K K +FV
Sbjct: 195 EPPLSDLHPMRVLFLIPKNNPPSLEGNKFS--KPFK--DFVS------------------ 232
Query: 234 ALLCVQENPNDRPS 247
LC+ ++P +RPS
Sbjct: 233 --LCLNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-16
Identities = 77/263 (29%), Positives = 122/263 (46%), Gaps = 40/263 (15%)
Query: 10 AVKKLSKTSTQG-FEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
A+K L + +++ +F E+ + KL H N+I +LG C + + EY P +L
Sbjct: 33 AIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLD 92
Query: 68 YL-------FDPI------RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
+L DP L ++ + + G+ YL E IHRDL A N
Sbjct: 93 FLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARN 149
Query: 115 ILLGEDMKPKISDFGLARIFAKESLEANTEQVVG--TIGYIPPEYARQGVYSTKSDVFSF 172
+L+GE++ KI+DFGL+R E ++ +G + ++ E VY+TKSDV+SF
Sbjct: 150 VLVGENLASKIADFGLSR-----GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSF 204
Query: 173 GVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLE 232
GVLL +I+S + CG+ YE G +E + D+ +LMR
Sbjct: 205 GVLLWEIVSLGG-TPYCGMT-----CAELYEKLPQGYRMEKPRNCDDEVY---ELMR--- 252
Query: 233 IALLCVQENPNDRPSMLQVSSML 255
C ++ P +RP Q+S L
Sbjct: 253 ---QCWRDRPYERPPFAQISVQL 272
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 4e-16
Identities = 77/263 (29%), Positives = 122/263 (46%), Gaps = 40/263 (15%)
Query: 10 AVKKLSKTSTQG-FEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
A+K++ + +++ +F E+ + KL H N+I +LG C L EY P+ +L
Sbjct: 26 AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 85
Query: 68 YL-------FDPI------RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
+L DP L ++ +H + +G+ YL + IHRDL A N
Sbjct: 86 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARN 142
Query: 115 ILLGEDMKPKISDFGLARIFAKESLEANTEQVVG--TIGYIPPEYARQGVYSTKSDVFSF 172
IL+GE+ KI+DFGL+R E ++ +G + ++ E VY+T SDV+S+
Sbjct: 143 ILVGENYVAKIADFGLSR-----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 197
Query: 173 GVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLE 232
GVLL +I+S + CG+ YE G +E + D+ LMR
Sbjct: 198 GVLLWEIVSLGG-TPYCGMT-----CAELYEKLPQGYRLEKPLNCDDEVY---DLMR--- 245
Query: 233 IALLCVQENPNDRPSMLQVSSML 255
C +E P +RPS Q+ L
Sbjct: 246 ---QCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-16
Identities = 69/268 (25%), Positives = 117/268 (43%), Gaps = 45/268 (16%)
Query: 9 IAVK--KLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER------MLVYEYM 60
+AVK K++ + E+F +E + + H N++R++G C+ + E +++ +M
Sbjct: 29 VAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFM 88
Query: 61 PNKSL----------DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 110
+ L DC + P + L V + I G+ YL S + IHRDL
Sbjct: 89 KHGDLHSFLLYSRLGDCPQYLPTQML-------VKFMTDIASGMEYL---SSKSFIHRDL 138
Query: 111 KASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVF 170
A N +L E+M ++DFGL++ + +I E VY+TKSDV+
Sbjct: 139 AARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVW 198
Query: 171 SFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRC 230
SFGV + +I + + + G+ EN I ++ L +G + P +
Sbjct: 199 SFGVTMWEIAT-RGQTPYPGV-ENSEIYDY---LRQGNR-----------LKQPPDCLDG 242
Query: 231 L-EIALLCVQENPNDRPSMLQVSSMLKN 257
L + C NP DRPS + L+
Sbjct: 243 LYSLMSSCWLLNPKDRPSFETLRCELEK 270
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-16
Identities = 49/178 (27%), Positives = 90/178 (50%), Gaps = 8/178 (4%)
Query: 9 IAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
IA+K++ + ++ + E+ L + L+H N+++ LG ++ + E +P SL
Sbjct: 36 IAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSAL 95
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-DMKPKISD 127
L L + + + + I +GL YL + I+HRD+K N+L+ KISD
Sbjct: 96 LRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISD 152
Query: 128 FGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV--YSTKSDVFSFGVLLLQIISGK 183
FG ++ A + TE GT+ Y+ PE +G Y +D++S G ++++ +GK
Sbjct: 153 FGTSKRLA--GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 5e-16
Identities = 80/278 (28%), Positives = 119/278 (42%), Gaps = 60/278 (21%)
Query: 6 GKVIAVKKLS---KTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
+V+A+KK+S K S + +++ EV +L+H N I G + LV EY
Sbjct: 40 NEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG 99
Query: 63 KSLDCYLFDPIRRLILD-WKKRVH------IIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
+ D IL+ KK + I G QGL YL + R IHRD+KA NI
Sbjct: 100 SASD----------ILEVHKKPLQEVEIAAICHGALQGLAYLHSHER---IHRDIKAGNI 146
Query: 116 LLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSF 172
LL E K++DFG A + + AN+ VGT ++ PE +G Y K DV+S
Sbjct: 147 LLTEPGTVKLADFGSASLVSP----ANS--FVGTPYWMAPEVILAMDEGQYDGKVDVWSL 200
Query: 173 GVLLLQIISGKRLSMLCGINENLSILEHAYE-----LWKGGKGVEFVDSSLDDTNSPCKL 227
G+ +++ +R L +N +S L H + L F +
Sbjct: 201 GITCIEL--AERKPPLFNMNA-MSALYHIAQNDSPTLSSNDWSDYFRN------------ 245
Query: 228 MRCLEIALLCVQENPNDRPSMLQVSSMLKNETTNRNTP 265
C+Q+ P DRPS + +LK+ R P
Sbjct: 246 -----FVDSCLQKIPQDRPSSEE---LLKHRFVLRERP 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 5e-16
Identities = 50/180 (27%), Positives = 95/180 (52%), Gaps = 19/180 (10%)
Query: 9 IAVKKL-SKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+A+K + ++ Q F+E + ++ L H ++R+LG C + + LV + P SL
Sbjct: 39 VAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLD 97
Query: 68 YL------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
++ DP + +L+W + I +G+ YL+E+ ++HR+L A NILL D
Sbjct: 98 HVRQHRDSLDP--QRLLNWCVQ------IAKGMYYLEEHR---MVHRNLAARNILLKSDS 146
Query: 122 KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
+I+DFG+A + + + + I ++ E G Y+ +SDV+S+GV + +++S
Sbjct: 147 IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 5e-16
Identities = 69/253 (27%), Positives = 124/253 (49%), Gaps = 40/253 (15%)
Query: 6 GKVIAVKKLS-----KTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVY-EY 59
G AVK++S +T + ++ + E+ L +KLQH N+++ LG E+ + ++ E
Sbjct: 25 GDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLG-TEREEDNLYIFLEL 83
Query: 60 MPNKSLDCYL--FDPIRR-LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNIL 116
+P SL L + +I + ++ I GL YL + R +HRD+K +NIL
Sbjct: 84 VPGGSLAKLLKKYGSFPEPVIRLYTRQ------ILLGLEYL--HDR-NTVHRDIKGANIL 134
Query: 117 LGEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPPEY-ARQGVYSTKSDVFSFGV 174
+ + K++DFG+ AK+ +E + + G+ ++ PE A+QG Y +D++S G
Sbjct: 135 VDTNGVVKLADFGM----AKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGC 190
Query: 175 LLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIA 234
+L++ +GK S LE ++K G+ E + D S +
Sbjct: 191 TVLEMATGK---------PPWSQLEGVAAVFKIGRSKEL--PPIPDHLSD----EAKDFI 235
Query: 235 LLCVQENPNDRPS 247
L C+Q +P+ RP+
Sbjct: 236 LKCLQRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 6e-16
Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 13/183 (7%)
Query: 6 GKVIAVKKLSKTSTQGFE-EFKNEVMLTAKLQHVNLIRVLGFCIDSEERML--VYEYMPN 62
G + A+K ++ + + E+ + + +++ G +D + EY
Sbjct: 26 GMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEG 85
Query: 63 KSLDCYLFDPIRRLILDWKKRV--HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
SLD ++ +++ ++V I E + +GL YL IIHRD+K SNILL
Sbjct: 86 GSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRK 141
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
+ K+ DFG+ + E + + GT Y+ PE + YS SDV+S G+ LL++
Sbjct: 142 GQVKLCDFGV----SGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVA 197
Query: 181 SGK 183
+
Sbjct: 198 QNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 6e-16
Identities = 81/268 (30%), Positives = 116/268 (43%), Gaps = 51/268 (19%)
Query: 8 VIAVKKLSKTSTQGFEEFKNEV--MLTAKL--QHVNLIRVLGFCIDSEERMLVYEYMPNK 63
+AVK L +T+ ++ + V M K+ +H N+I +LG C +V EY +
Sbjct: 44 TVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHG 101
Query: 64 SLDCYL-----------FDPIRRLI--LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 110
+L +L D R L K V + +G+ +L IHRDL
Sbjct: 102 NLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDL 158
Query: 111 KASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYST 165
A N+L+ ED KI+DFGLAR T T G +P PE VY+
Sbjct: 159 AARNVLVTEDHVMKIADFGLARDIHHIDYYRKT-----TNGRLPVKWMAPEALFDRVYTH 213
Query: 166 KSDVFSFGVLLLQIIS--GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNS 223
+SDV+SFGVLL +I + G S GI +E ++L K G +E + T
Sbjct: 214 QSDVWSFGVLLWEIFTLGG---SPYPGIP-----VEELFKLLKEGYRME---KPQNCTQE 262
Query: 224 PCKLMRCLEIALLCVQENPNDRPSMLQV 251
LMR C E P+ RP+ Q+
Sbjct: 263 LYHLMRD------CWHEVPSQRPTFKQL 284
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 7e-16
Identities = 77/273 (28%), Positives = 118/273 (43%), Gaps = 50/273 (18%)
Query: 7 KVIAVKKLS---KTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
+V+A+KK+S K S + +++ EV +++H N I G + LV EY
Sbjct: 51 EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGS 110
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
+ D + + L + I G QGL YL + +IHRD+KA NILL E +
Sbjct: 111 ASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQV 164
Query: 124 KISDFGLARIFAKESLEANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGVLLLQII 180
K++DFG A S+ + VGT ++ PE +G Y K DV+S G+ +++
Sbjct: 165 KLADFGSA------SIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 218
Query: 181 SGK-------RLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEI 233
K +S L I +N S + E W FVDS
Sbjct: 219 ERKPPLFNMNAMSALYHIAQNESPTLQSNE-WS-DYFRNFVDS----------------- 259
Query: 234 ALLCVQENPNDRPSMLQVSSMLKNETTNRNTPK 266
C+Q+ P DRP+ +LK+ R P+
Sbjct: 260 ---CLQKIPQDRPTS---EELLKHMFVLRERPE 286
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 8e-16
Identities = 56/183 (30%), Positives = 89/183 (48%), Gaps = 22/183 (12%)
Query: 9 IAVKKLSKTSTQGFEE-FKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLD 66
+AVK L T+ E +E+ + + L H N++ +LG C +++ EY
Sbjct: 68 VAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYC------ 121
Query: 67 CY--LFDPIRR---LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
CY L + +RR L + + + +G+ +L + IHRDL A N+LL
Sbjct: 122 CYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGK 178
Query: 122 KPKISDFGLARIFAKES---LEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
KI DFGLAR +S ++ N V ++ PE VY+ +SDV+S+G+LL +
Sbjct: 179 IVKICDFGLARDIMNDSNYVVKGNARLPV---KWMAPESIFNCVYTFESDVWSYGILLWE 235
Query: 179 IIS 181
I S
Sbjct: 236 IFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 8e-16
Identities = 35/95 (36%), Positives = 45/95 (47%), Gaps = 6/95 (6%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGT 149
I L YL IIHRD+K NILL E I+DF +A ++ T GT
Sbjct: 109 IVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGT 162
Query: 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKR 184
GY+ PE + YS D +S GV + + GKR
Sbjct: 163 PGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 8e-16
Identities = 73/247 (29%), Positives = 113/247 (45%), Gaps = 33/247 (13%)
Query: 7 KVIAVKKLSKTSTQGFEEFKN---EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
+V+A+KK+S + Q E++++ EV KL+H N I+ G + LV EY
Sbjct: 41 EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGS 100
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
+ D + + L + + G QGL YL ++ +IHRD+KA NILL E
Sbjct: 101 ASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLV 154
Query: 124 KISDFGLARIFAKESLEANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGVLLLQII 180
K+ DFG A I A AN VGT ++ PE +G Y K DV+S G+ +++
Sbjct: 155 KLGDFGSASIMAP----ANX--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL- 207
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240
+R L +N +S L H + +S + + R C+Q+
Sbjct: 208 -AERKPPLFNMNA-MSALYHIAQ----------NESPALQSGHWSEYFR--NFVDSCLQK 253
Query: 241 NPNDRPS 247
P DRP+
Sbjct: 254 IPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 9e-16
Identities = 47/178 (26%), Positives = 93/178 (52%), Gaps = 9/178 (5%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+ +AVKK+ Q E NEV++ QH N++ + + +E +V E++ +L
Sbjct: 44 GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D + ++ ++ + + + L +L +IHRD+K+ +ILL D + K+
Sbjct: 104 T----DIVTHTRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKL 156
Query: 126 SDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
SDFG +KE + +VGT ++ PE + Y T+ D++S G+++++++ G+
Sbjct: 157 SDFGFCAQVSKEV--PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-15
Identities = 65/259 (25%), Positives = 114/259 (44%), Gaps = 35/259 (13%)
Query: 7 KVIAVKKLSKTSTQGFEEFKNEVMLTAK-LQHVN---LIRVLGFCIDSEERMLVYEYMPN 62
K +AVK L + K+E++ A +Q ++ ++R++G C ++E MLV E
Sbjct: 23 KTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAEL 79
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
L+ +L + + + K ++ ++ G+ YL+E + +HRDL A N+LL
Sbjct: 80 GPLNKFLQK--NKHVTE-KNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHY 133
Query: 123 PKISDFGLARIFAKESLEANTEQVVGT----IGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
KISDFGL++ + N + + + PE +S+KSDV+SFGVL+
Sbjct: 134 AKISDFGLSKALGADE---NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMW- 189
Query: 179 IISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238
E S + Y+ KG + + ++S ++ LC
Sbjct: 190 --------------EAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCW 235
Query: 239 QENPNDRPSMLQVSSMLKN 257
++RP V L+N
Sbjct: 236 TYGVDERPGFAVVELRLRN 254
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 2e-15
Identities = 56/161 (34%), Positives = 85/161 (52%), Gaps = 13/161 (8%)
Query: 28 EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHII 87
E+ L +L+H N++++L + LV+EY + L YL L + K I+
Sbjct: 48 EISLLKELKHPNIVKLLDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIK--SIM 104
Query: 88 EGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVV 147
+ +GL Y +S I+HRDLK NIL+ D K++DFGLAR F L T +VV
Sbjct: 105 YQLLRGLAYC--HSHR-ILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV 160
Query: 148 GTIGYIPPEY---ARQGVYSTKSDVFSFGVLLLQIISGKRL 185
T+ Y PE ++ YST D++S G + ++I+GK L
Sbjct: 161 -TLWYRAPEILLGSKH--YSTAVDIWSVGCIFAEMITGKPL 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 4e-15
Identities = 48/178 (26%), Positives = 90/178 (50%), Gaps = 9/178 (5%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+ +A+K+++ E NE+++ + +H N++ L + +E +V EY+ SL
Sbjct: 44 GQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSL 103
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D + +D + + Q L +L +IHRD+K+ NILLG D K+
Sbjct: 104 T----DVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 156
Query: 126 SDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
+DFG E + +T +VGT ++ PE + Y K D++S G++ ++++ G+
Sbjct: 157 TDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 5e-15
Identities = 47/178 (26%), Positives = 89/178 (50%), Gaps = 9/178 (5%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+V+A+K + + +E E+ + + +++ G + + +V EY S+
Sbjct: 28 GQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSV 85
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
+ I L ++ I+ +GL YL IHRD+KA NILL E+ + K+
Sbjct: 86 -SDIMK-ITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKL 140
Query: 126 SDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
+DFG++ + NT V+GT ++ PE ++ Y+ K+D++S G+ +++ GK
Sbjct: 141 ADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 7e-15
Identities = 54/184 (29%), Positives = 90/184 (48%), Gaps = 18/184 (9%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAK----LQHVNLIRVLGFCIDSEERMLVYEYMP 61
G+ +A+KK+ + N+ + K QH ++++L +LV EYMP
Sbjct: 25 GETVALKKV--ALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP 82
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
+ L L D R L K + + +G+ Y+ I+HRDLK +N+L+ D
Sbjct: 83 S-DLSEVLRDEERPLPEAQVKS--YMRMLLKGVAYMHA---NGIMHRDLKPANLLISADG 136
Query: 122 KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGVLLLQ 178
KI+DFGLAR+F++E + Q V T Y PE AR+ Y D+++ G + +
Sbjct: 137 VLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPELLYGARK--YDPGVDLWAVGCIFAE 193
Query: 179 IISG 182
+++G
Sbjct: 194 LLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 8e-15
Identities = 56/181 (30%), Positives = 93/181 (51%), Gaps = 24/181 (13%)
Query: 6 GKVIAVKKLS-KTSTQGFEEFK-NEVMLTAKLQ---HVNLIRVLGFC--IDSEERM---L 55
G+ +A+KK+ S +G E+ L +L+ H N++R+L C ++ + L
Sbjct: 24 GRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL 83
Query: 56 VYEYMPNKSLDCYLFDPIRRLI---LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKA 112
V+E++ D L + + L + ++ + +G+ +L + I+HRDLK
Sbjct: 84 VFEHV-----DQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKP 135
Query: 113 SNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSF 172
NIL+ D + KI+DFGLARI++ E A T VV T+ Y PE Q Y+T D++S
Sbjct: 136 QNILVTSDGQVKIADFGLARIYSFEM--ALTSVVV-TLWYRAPEVLLQSSYATPVDMWSV 192
Query: 173 G 173
G
Sbjct: 193 G 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 8e-15
Identities = 58/182 (31%), Positives = 91/182 (50%), Gaps = 15/182 (8%)
Query: 6 GKVIAVKKLSKTSTQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEER--MLVYEYMPN 62
G+++AVK L + Q +K E+ + L H N+++ G C + + L+ EY+P
Sbjct: 33 GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPL 92
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYL--QEYSRLTIIHRDLKASNILLGED 120
SL YL P +L L + + + I +G+ YL Q Y IHRDL A N+LL D
Sbjct: 93 GSLRDYL--PKHKLNL--AQLLLFAQQICEGMAYLHSQHY-----IHRDLAARNVLLDND 143
Query: 121 MKPKISDFGLAR-IFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQI 179
KI DFGLA+ + E + + E ++ +S SDV+SFGV L ++
Sbjct: 144 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYEL 203
Query: 180 IS 181
++
Sbjct: 204 LT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 9e-15
Identities = 65/257 (25%), Positives = 122/257 (47%), Gaps = 19/257 (7%)
Query: 8 VIAVKKL-SKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLD 66
++AVK L + +F E+ + ++L+ N+IR+L CI S+ ++ EYM N L+
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 67 CYLF------DPIR--RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
+L + + + + + + I G+ YL S L +HRDL N L+G
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVG 164
Query: 119 EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
++ KI+DFG++R + V I ++ E G ++T SDV++FGV L +
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224
Query: 179 IISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238
I++ + +++ ++E+ E ++ ++ +S KLM L C
Sbjct: 225 ILTLCKEQPYSQLSDE-QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLM------LSCW 277
Query: 239 QENPNDRPSMLQVSSML 255
+ N +RPS ++ + L
Sbjct: 278 RRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 9e-15
Identities = 49/178 (27%), Positives = 92/178 (51%), Gaps = 9/178 (5%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
GK +AVKK+ Q E NEV++ H N++ + + +E +V E++ +L
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D + ++ ++ + + + L YL +IHRD+K+ +ILL D + K+
Sbjct: 107 T----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKL 159
Query: 126 SDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
SDFG +KE + +VGT ++ PE + Y T+ D++S G++++++I G+
Sbjct: 160 SDFGFCAQVSKEV--PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 50/178 (28%), Positives = 97/178 (54%), Gaps = 15/178 (8%)
Query: 9 IAVKKLSK-TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+A+K+L + TS + +E +E + A + + ++ R+LG C+ S + L+ + MP L
Sbjct: 39 VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD 97
Query: 68 YLFDPIRRL----ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
Y+ + + +L+W + I +G+ YL+E ++HRDL A N+L+
Sbjct: 98 YVREHKDNIGSQYLLNWCVQ------IAKGMNYLEERR---LVHRDLAARNVLVKTPQHV 148
Query: 124 KISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
KI+DFGLA++ + E + E I ++ E +Y+ +SDV+S+GV + ++++
Sbjct: 149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 47/178 (26%), Positives = 92/178 (51%), Gaps = 9/178 (5%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
GK++AVKK+ Q E NEV++ QH N++ + + +E +V E++ +L
Sbjct: 45 GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D + ++ ++ + + + L L +IHRD+K+ +ILL D + K+
Sbjct: 105 T----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKL 157
Query: 126 SDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
SDFG +KE + +VGT ++ PE + Y + D++S G+++++++ G+
Sbjct: 158 SDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-14
Identities = 54/179 (30%), Positives = 91/179 (50%), Gaps = 17/179 (9%)
Query: 9 IAVKKLSKTSTQGFE-EFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+AVK + Q + +F +E + + H N+++++G C + +V E +P
Sbjct: 22 VAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81
Query: 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISD 127
+L ++ L K+ V G+ YL+ + IHRDL A N L+GE+ KISD
Sbjct: 82 FLRK--KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISD 136
Query: 128 FGLAR-----IFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
FG++R I++ L +Q+ I + PE G YS++SDV+S+G+LL + S
Sbjct: 137 FGMSRQEDDGIYSSSGL----KQI--PIKWTAPEALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 72.1 bits (176), Expect = 1e-14
Identities = 47/178 (26%), Positives = 91/178 (51%), Gaps = 9/178 (5%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+ +A+K+++ E NE+++ +L++ N++ L + +E +V EY+ SL
Sbjct: 44 GQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL 103
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D + +D + + Q L +L +IHRD+K+ N+LLG D K+
Sbjct: 104 T----DVVTETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKL 156
Query: 126 SDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
+DFG E + +T +VGT ++ PE + Y K D++S G++ ++++ G+
Sbjct: 157 TDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-14
Identities = 55/164 (33%), Positives = 90/164 (54%), Gaps = 17/164 (10%)
Query: 28 EVMLTAKLQHVNLIRVLGFCIDSEER-MLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86
E+ L +L+H N++R L I +E + MLV+EYM +K L Y+ R LD
Sbjct: 48 EISLMKELKHENIVR-LHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSF 105
Query: 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANT--E 144
+ +G+ + E ++HRDLK N+L+ + + K++DFGLAR F + NT
Sbjct: 106 TYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSN 159
Query: 145 QVVGTIGYIPPEY---ARQGVYSTKSDVFSFGVLLLQIISGKRL 185
+VV T+ Y P+ +R YST D++S G ++ ++I+G+ L
Sbjct: 160 EVV-TLWYRAPDVLLGSR--TYSTSIDIWSVGCIMAEMITGRPL 200
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 3e-14
Identities = 46/178 (25%), Positives = 89/178 (50%), Gaps = 9/178 (5%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+ +A+++++ E NE+++ + ++ N++ L + +E +V EY+ SL
Sbjct: 45 GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D + +D + + Q L +L +IHRD+K+ NILLG D K+
Sbjct: 105 T----DVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 157
Query: 126 SDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
+DFG E ++ +VGT ++ PE + Y K D++S G++ +++I G+
Sbjct: 158 TDFGFCAQITPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-14
Identities = 51/188 (27%), Positives = 94/188 (50%), Gaps = 22/188 (11%)
Query: 4 PCGKVIAVKKLS-KTSTQGFEEFKNEVMLTAKLQHV---NLIRVLGFCIDSEERMLVYEY 59
P G+V+A+K ++ T + + EV L ++L+ N+ + G + ++ EY
Sbjct: 24 PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEY 83
Query: 60 MPNKSLDCYLFDPIRRLI----LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
S +R L+ + K II + L Y+ ++ +IHRD+KA+NI
Sbjct: 84 AEGGS--------VRTLMKAGPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANI 132
Query: 116 LLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV-YSTKSDVFSFGV 174
L+ K+ DFG+A + + S + +T VGT ++ PE +G Y TK+D++S G+
Sbjct: 133 LVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITEGKYYDTKADIWSLGI 190
Query: 175 LLLQIISG 182
+ ++ +G
Sbjct: 191 TIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 4e-14
Identities = 47/178 (26%), Positives = 90/178 (50%), Gaps = 9/178 (5%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+ +A+K+++ E NE+++ + ++ N++ L + +E +V EY+ SL
Sbjct: 44 GQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 103
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D + +D + + Q L +L +IHRD+K+ NILLG D K+
Sbjct: 104 T----DVVTETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKL 156
Query: 126 SDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
+DFG E + +T +VGT ++ PE + Y K D++S G++ ++++ G+
Sbjct: 157 TDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-14
Identities = 58/238 (24%), Positives = 106/238 (44%), Gaps = 35/238 (14%)
Query: 25 FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84
F E + + H N++R+ G M+V EYM N +LD +L +L+ + +
Sbjct: 53 FLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVA--GQLM 110
Query: 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTE 144
++ G+ G+ YL E + +H+ L A +L+ D+ KIS F + E +E
Sbjct: 111 GMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQ-------EDKSE 160
Query: 145 QVVGTIG------YIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSI 197
+ T+ + PE + +S+ SDV+SFG+++ +++S G+R + +
Sbjct: 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKA 220
Query: 198 LEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSML 255
+E + L N P L + + L C Q+ +RP Q+ S+L
Sbjct: 221 VEDGFRLPA-------------PRNCPNLLHQLM---LDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-14
Identities = 49/182 (26%), Positives = 83/182 (45%), Gaps = 12/182 (6%)
Query: 6 GKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMP 61
GK+ A KKL K +G + NE + K+ I L + ++++ + LV M
Sbjct: 18 GKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAFETKDDLCLVMTLMN 76
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
L ++++ + + + + I GL +L + I++RDLK N+LL +
Sbjct: 77 GGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLH---QRRIVYRDLKPENVLLDDHG 132
Query: 122 KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
+ISD GLA + GT GY+ PE + VY D F+ G L ++I+
Sbjct: 133 NVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIA 189
Query: 182 GK 183
G+
Sbjct: 190 GR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-14
Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 6/174 (3%)
Query: 9 IAVKKLSKTSTQGFE-EFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+AVK +T + +F E + + H N++R++G C + +V E +
Sbjct: 23 VAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT 82
Query: 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISD 127
+L RL + K+ + ++E G+ YL+ IHRDL A N L+ E KISD
Sbjct: 83 FLRTEGPRLKV--KELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISD 137
Query: 128 FGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
FG++R + + + PE G YS++SDV+SFG+LL + S
Sbjct: 138 FGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 8e-14
Identities = 47/179 (26%), Positives = 86/179 (48%), Gaps = 16/179 (8%)
Query: 2 VLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMP 61
+ G+++A+K + FE + E+ + + +H N++ G + ++ +V EY
Sbjct: 24 DIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83
Query: 62 NKSLD---CYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
SL P+ L + ++ +GL YL E + IHRD+K +NILL
Sbjct: 84 GGSLQDIYQVTRGPLSELQI-----AYVCRETLKGLAYLHETGK---IHRDIKGANILLT 135
Query: 119 EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA---RQGVYSTKSDVFSFGV 174
ED K++DFG++ + + +GT ++ PE A R+G Y K D+++ G+
Sbjct: 136 EDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWMAPEVAAVERKGGYDGKCDIWALGI 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 17/161 (10%)
Query: 28 EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHII 87
E+ + + H N+++ + E ++ E+M SL+ I D + +
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE-------GTHIADEQFLADVA 174
Query: 88 EGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVV 147
I G+ YL R I+HRD+K SN+L+ KI+DFG++RI A+ N+ V
Sbjct: 175 RQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--V 229
Query: 148 GTIGYIPPEYA----RQGVYSTKS-DVFSFGVLLLQIISGK 183
GTI Y+ PE G Y + D++S GV +L+ G+
Sbjct: 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 1e-13
Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 35/203 (17%)
Query: 5 CGKVIAVKKLSKTSTQGFEEFKN--EVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMP 61
G+++A+KK+ K +EE N EV KL H N++++ +++E V+EYM
Sbjct: 23 TGELVAIKKM-KKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80
Query: 62 NKSLDCYLFDPIRRLILDWKKRV-------HIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
+ L+ L+ D K + II I QGL ++ + HRDLK N
Sbjct: 81 ----EGNLYQ----LMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPEN 129
Query: 115 ILLGEDMKPKISDFGLARIFAKESLEAN---TEQVVGTIGYIPPE-YARQGVYSTKSDVF 170
+L+ KI+DFGLAR + + T+ V T Y PE R YS+ D++
Sbjct: 130 LLVSGPEVVKIADFGLAR-----EIRSRPPYTD-YVSTRWYRAPEILLRSTSYSSPVDIW 183
Query: 171 SFGVLLLQIISGKRLSMLCGINE 193
+ G ++ ++ + + L G +E
Sbjct: 184 ALGCIMAELYTLRPL--FPGSSE 204
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 48/179 (26%), Positives = 90/179 (50%), Gaps = 12/179 (6%)
Query: 7 KVIAVKKLS-KTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS- 64
+V+A+K + + + E+ + E+ + ++ + R G + + ++ EY+ S
Sbjct: 30 EVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSA 89
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
LD P+ + I+ I +GL YL + IHRD+KA+N+LL E K
Sbjct: 90 LDLLKPGPLEETYI-----ATILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVK 141
Query: 125 ISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
++DFG+A ++ NT VGT ++ PE +Q Y K+D++S G+ +++ G+
Sbjct: 142 LADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-13
Identities = 55/185 (29%), Positives = 100/185 (54%), Gaps = 14/185 (7%)
Query: 6 GKVIAVKKLS-KTSTQGFEEFK-NEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMPN 62
G+V+A+KK+ T T+G E+ L +L H N++++L I +E ++ LV+E++ +
Sbjct: 25 GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD-VIHTENKLYLVFEFL-H 82
Query: 63 KSLDCYL-FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
+ L ++ P+ + L K + + QGL + + ++HRDLK N+L+ +
Sbjct: 83 QDLKKFMDASPLSGIPLPLIKSY--LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEG 137
Query: 122 KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE-YARQGVYSTKSDVFSFGVLLLQII 180
K++DFGLAR F + T +VV T+ Y PE YST D++S G + +++
Sbjct: 138 AIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 195
Query: 181 SGKRL 185
+ + L
Sbjct: 196 TRRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 59/188 (31%), Positives = 89/188 (47%), Gaps = 18/188 (9%)
Query: 9 IAVKKLSKTST-QGFEEFKNEV-MLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLD 66
+AVK L +T + + +E+ M+ +H N+I +LG C ++ EY +L
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLR 106
Query: 67 CYL-----------FDPIR--RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKAS 113
YL FD + L +K V + +G+ YL + IHRDL A
Sbjct: 107 EYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAAR 163
Query: 114 NILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFG 173
N+L+ ED KI+DFGLAR T + ++ PE VY+ +SDV+SFG
Sbjct: 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223
Query: 174 VLLLQIIS 181
VLL +I +
Sbjct: 224 VLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 2e-13
Identities = 47/178 (26%), Positives = 91/178 (51%), Gaps = 10/178 (5%)
Query: 7 KVIAVKKLS-KTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
KV+A+K + + + E+ + E+ + ++ + + G + + ++ EY+ S
Sbjct: 30 KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA 89
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D + LD + I+ I +GL YL + IHRD+KA+N+LL E + K+
Sbjct: 90 ----LDLLEPGPLDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKL 142
Query: 126 SDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
+DFG+A ++ N VGT ++ PE +Q Y +K+D++S G+ +++ G+
Sbjct: 143 ADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-13
Identities = 52/180 (28%), Positives = 92/180 (51%), Gaps = 9/180 (5%)
Query: 6 GKVIAVKKLS-KTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER--MLVYEYMPN 62
G+ +AVK L ++ + K E+ + L H N+++ G C + L+ E++P+
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
SL YL P + ++ K+++ I +G+ YL SR +HRDL A N+L+ + +
Sbjct: 93 GSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLG--SR-QYVHRDLAARNVLVESEHQ 147
Query: 123 PKISDFGLAR-IFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
KI DFGL + I + + + + + PE Q + SDV+SFGV L ++++
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-13
Identities = 46/178 (25%), Positives = 92/178 (51%), Gaps = 10/178 (5%)
Query: 7 KVIAVKKLS-KTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
+V+A+K + + + E+ + E+ + ++ + + G + + ++ EY+ S
Sbjct: 30 QVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSA 89
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D +R D + +++ I +GL YL + IHRD+KA+N+LL E K+
Sbjct: 90 ----LDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKL 142
Query: 126 SDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
+DFG+A ++ NT VGT ++ PE +Q Y +K+D++S G+ +++ G+
Sbjct: 143 ADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 3e-13
Identities = 58/188 (30%), Positives = 91/188 (48%), Gaps = 18/188 (9%)
Query: 9 IAVKKLSKTST-QGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLD 66
+AVK L +T + + +E+ L + +H N+I +LG C ++ EY +L
Sbjct: 47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLR 106
Query: 67 CYL-----------FDPIR--RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKAS 113
+L FD + L +K V + +G+ YL+ SR IHRDL A
Sbjct: 107 EFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE--SR-RCIHRDLAAR 163
Query: 114 NILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFG 173
N+L+ ED KI+DFGLAR T + ++ PE VY+ +SDV+SFG
Sbjct: 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223
Query: 174 VLLLQIIS 181
+L+ +I +
Sbjct: 224 ILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 56/175 (32%), Positives = 91/175 (52%), Gaps = 20/175 (11%)
Query: 28 EVMLTAKLQ---HVNLIRVLGFC----IDSEERM-LVYEYMPNKSLDCYLFD-PIRRLIL 78
EV L +L+ H N++R++ C D E ++ LV+E++ ++ L YL P L
Sbjct: 49 EVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPA 107
Query: 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKES 138
+ K ++ +GL +L I+HRDLK NIL+ + K++DFGLARI+ S
Sbjct: 108 ETIK--DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY---S 159
Query: 139 LEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINE 193
+ VV T+ Y PE Q Y+T D++S G + ++ +R + CG +E
Sbjct: 160 CQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF--RRKPLFCGNSE 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 72/258 (27%), Positives = 112/258 (43%), Gaps = 33/258 (12%)
Query: 9 IAVKKL-SKTSTQGFEEFKNEV-MLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLD 66
+AVK L S + + + +E+ M+ +H N+I +LG C ++ EY +L
Sbjct: 53 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 112
Query: 67 -------------CYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKAS 113
CY + L +K V + +G+ YL + IHRDL A
Sbjct: 113 EYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAAR 169
Query: 114 NILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFG 173
N+L+ ED KI+DFGLAR T + ++ PE +Y+ +SDV+SFG
Sbjct: 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 229
Query: 174 VLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEI 233
VLL +I + L G +E ++L K G +D + TN +MR
Sbjct: 230 VLLWEIFT------LGGSPYPGVPVEELFKLLKEG---HRMDKPSNCTNELYMMMRD--- 277
Query: 234 ALLCVQENPNDRPSMLQV 251
C P+ RP+ Q+
Sbjct: 278 ---CWHAVPSQRPTFKQL 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-13
Identities = 51/181 (28%), Positives = 91/181 (50%), Gaps = 10/181 (5%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN--LIRVLGFCIDSEERM-LVYEYMPN 62
GK+ A KKL K + K ++ L+ VN I L + +S+ + LV M
Sbjct: 18 GKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNG 77
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
L ++++ + L+ ++ +H IT G+L+L + I++RD+K N+LL +
Sbjct: 78 GDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGN 133
Query: 123 PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
++SD GLA + K+ Q GT GY+ PE ++ YS D F+ G + ++++G
Sbjct: 134 CRLSDLGLA-VELKDG--KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAG 190
Query: 183 K 183
+
Sbjct: 191 R 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 4e-13
Identities = 52/189 (27%), Positives = 92/189 (48%), Gaps = 19/189 (10%)
Query: 6 GKVIAVK--KLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
G+++AVK ++ + +E +E+ + L+H NL++ G + E+ + EY
Sbjct: 25 GELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGG 84
Query: 64 SLDCYLFDPIRRL--ILDWK-KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
+L+ L ILD RV+ ++ + +GL YL + I+HRD+K +NI L +
Sbjct: 85 TLEELL-----EHGRILDEHVIRVYTLQ-LLEGLAYLHSHG---IVHRDIKPANIFLDHN 135
Query: 121 MKPKISDFGLARIFAKESLEANTEQ--VVGTIGYIPPEYARQGVYSTK---SDVFSFGVL 175
K+ DFG A + E + GT Y+ PE G +D++S G +
Sbjct: 136 GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCV 195
Query: 176 LLQIISGKR 184
+L++ +GKR
Sbjct: 196 VLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 5e-13
Identities = 68/261 (26%), Positives = 110/261 (42%), Gaps = 49/261 (18%)
Query: 8 VIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
VI +SK S + EE + EV + + ++H N+++ ++ +V +Y L
Sbjct: 29 VIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDL-- 86
Query: 68 YLFDPI---------RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
+ I ILDW Q L L+ I+HRD+K+ NI L
Sbjct: 87 --YKKINAQRGVLFPEDQILDW---------FVQICLALKHVHDRKILHRDIKSQNIFLT 135
Query: 119 EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
+D K+ DFG+AR+ A T +GT Y+ PE Y+ KSD+++ G +L +
Sbjct: 136 KDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSPEICENRPYNNKSDIWALGCVLYE 193
Query: 179 IISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238
+ + L+HA+E G V + + P ++ L
Sbjct: 194 MCT----------------LKHAFE---AGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVS 234
Query: 239 Q---ENPNDRPSMLQVSSMLK 256
Q NP DRPS V+S+L+
Sbjct: 235 QLFKRNPRDRPS---VNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 6e-13
Identities = 48/172 (27%), Positives = 75/172 (43%), Gaps = 34/172 (19%)
Query: 6 GKVIAVKKL--SKTSTQGFEEFK-NEVMLTAKLQHVNLIRVLGFCIDSEERM--LVYEYM 60
GK A+KK K G + E+ L +L+H N++ ++ ++ ++ L+++Y
Sbjct: 27 GKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYA 86
Query: 61 PNKSLDCYLFDPIRRLILDW---KKRVHIIEG--------ITQGLLYLQEYSRLTIIHRD 109
+ I+ + KRV I I G+ YL ++HRD
Sbjct: 87 EHDLWQ----------IIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRD 133
Query: 110 LKASNILL----GEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPPE 156
LK +NIL+ E KI D GLAR+F A+ + VV TI Y PE
Sbjct: 134 LKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 8e-13
Identities = 56/234 (23%), Positives = 112/234 (47%), Gaps = 20/234 (8%)
Query: 34 KLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQG 93
KLQH N+++++G C + L++EY+ K+L L + L W++R I GI +
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKA 792
Query: 94 LLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYI 153
L +L ++ +L I++ +P + R+ L +T+ + + Y+
Sbjct: 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISS-AYV 845
Query: 154 PPEYARQGVYSTKSDVFSFGVLLLQIISGKRLS-MLCGINENLSILEHAYELWKGGKGVE 212
PE + KSD++ FG++L+++++GK + G++ SI+E A +
Sbjct: 846 APETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG--SIVEWARYCYSDCHLDM 903
Query: 213 FVDSSLDDTNSPCK--LMRCLEIALLCVQENPNDRPSMLQVSSMLKNETTNRNT 264
++D S+ S + ++ + +AL C +P RP V L E+ +R++
Sbjct: 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL--ESASRSS 955
|
Length = 968 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 8e-13
Identities = 36/76 (47%), Positives = 45/76 (59%)
Query: 106 IHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYST 165
IHRDL A NILL E+ KI DFGLAR K+ + ++ PE VY+T
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254
Query: 166 KSDVFSFGVLLLQIIS 181
+SDV+SFGVLL +I S
Sbjct: 255 QSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-13
Identities = 59/235 (25%), Positives = 104/235 (44%), Gaps = 27/235 (11%)
Query: 28 EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYL--FDPIRRLILD---WKK 82
E+ L +L H N+I+ I+ E +V E L + F +RLI + WK
Sbjct: 52 EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKY 111
Query: 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEAN 142
V + L+ ++HRD+K +N+ + K+ D GL R F+ ++ A+
Sbjct: 112 FVQLCSA-------LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 164
Query: 143 TEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY 202
+ +VGT Y+ PE + Y+ KSD++S G LL ++ + + S G NL Y
Sbjct: 165 S--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDKMNL------Y 214
Query: 203 ELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSMLKN 257
L K + ++ D + + ++ +C+ +P RP + V + K
Sbjct: 215 SLCKKIEQCDYPPLPSDHYSEELR-----QLVNMCINPDPEKRPDITYVYDVAKR 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 9e-13
Identities = 56/188 (29%), Positives = 89/188 (47%), Gaps = 18/188 (9%)
Query: 9 IAVKKLSKTSTQ-GFEEFKNEV-MLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLD 66
+AVK L +T+ + +E+ M+ +H N+I +LG C ++ EY +L
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109
Query: 67 CYL-----------FDPIR--RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKAS 113
YL +D R + +K V + +G+ YL + IHRDL A
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAAR 166
Query: 114 NILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFG 173
N+L+ E+ KI+DFGLAR T + ++ PE VY+ +SDV+SFG
Sbjct: 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 226
Query: 174 VLLLQIIS 181
VL+ +I +
Sbjct: 227 VLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 1e-12
Identities = 67/202 (33%), Positives = 99/202 (49%), Gaps = 43/202 (21%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKN---------EVMLTAKL-QHVNLIRVLGFCIDSEERM- 54
+V+A+KK+ F+ F+N E+M +L H N++++L I +E
Sbjct: 32 KEVVALKKI-------FDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNV-IKAENDKD 83
Query: 55 --LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEY--SRLTIIHRDL 110
LV+EYM + L IR IL + VH + Q LL +Y S +IHRDL
Sbjct: 84 IYLVFEYM-----ETDLHAVIRANIL---EDVHKRYIMYQ-LLKALKYIHSG-NVIHRDL 133
Query: 111 KASNILLGEDMKPKISDFGLARIFAKESLEANTEQV----VGTIGYIPPEY---ARQGVY 163
K SNILL D + K++DFGLAR + E E V V T Y PE + + Y
Sbjct: 134 KPSNILLNSDCRVKLADFGLARSLS-ELEENPENPVLTDYVATRWYRAPEILLGSTR--Y 190
Query: 164 STKSDVFSFGVLLLQIISGKRL 185
+ D++S G +L +++ GK L
Sbjct: 191 TKGVDMWSVGCILGEMLLGKPL 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 55/190 (28%), Positives = 98/190 (51%), Gaps = 18/190 (9%)
Query: 6 GKVIAVKKLS-KTSTQGFE-EFKNEVMLTAKLQ---HVNLIRVLGFCI----DSEERM-L 55
G+ +A+K++ +T +G EV + L+ H N++R+ C D E ++ L
Sbjct: 27 GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 86
Query: 56 VYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
V+E++ ++ L YL D + + + ++ + +GL +L + ++HRDLK NI
Sbjct: 87 VFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNI 141
Query: 116 LLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVL 175
L+ + K++DFGLARI+ S + VV T+ Y PE Q Y+T D++S G +
Sbjct: 142 LVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCI 198
Query: 176 LLQIISGKRL 185
++ K L
Sbjct: 199 FAEMFRRKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 50/171 (29%), Positives = 78/171 (45%), Gaps = 16/171 (9%)
Query: 18 STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRL- 76
S+ E+ + E +L AK++H N++ +V EY L + +L
Sbjct: 38 SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLF 97
Query: 77 ----ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLAR 132
IL W Q L +Q ++HRD+K+ NI L ++ K K+ DFG AR
Sbjct: 98 PEDTILQW---------FVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148
Query: 133 IFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
+ A T VGT Y+PPE Y+ KSD++S G +L ++ + K
Sbjct: 149 LLTSPGAYACT--YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 47/157 (29%), Positives = 79/157 (50%), Gaps = 14/157 (8%)
Query: 28 EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYL--FDPIRRLILD---WKK 82
E+ L +L H N+I+ L I+ E +V E L + F +RLI + WK
Sbjct: 52 EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111
Query: 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEAN 142
V + + +SR ++HRD+K +N+ + K+ D GL R F+ ++ A+
Sbjct: 112 FVQLCSAVEH------MHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 164
Query: 143 TEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQI 179
+ +VGT Y+ PE + Y+ KSD++S G LL ++
Sbjct: 165 S--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-12
Identities = 50/184 (27%), Positives = 80/184 (43%), Gaps = 19/184 (10%)
Query: 9 IAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+ VK+L ++T F EV +L H N+++ LG CI+S +LV E+ P L
Sbjct: 25 VVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKN 84
Query: 68 YLFDPIRRLILDWKKRV--HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
YL + +K V + + GLL+L + IH DL N L D+ KI
Sbjct: 85 YLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKI 141
Query: 126 SDFGLARIFAKESLEANTEQVVGTIGYIPPEY----------ARQGVYSTKSDVFSFGVL 175
D+GLA E + + ++ PE Q + KS+++S GV
Sbjct: 142 GDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQ---TKKSNIWSLGVT 198
Query: 176 LLQI 179
+ ++
Sbjct: 199 MWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-12
Identities = 51/184 (27%), Positives = 89/184 (48%), Gaps = 14/184 (7%)
Query: 6 GKVIAVKKLSKTS----TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYM 60
GK+ A+K L K + + E + E + ++ + L + ++ ++ L+ +Y+
Sbjct: 28 GKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYV 87
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
L +L+ R + + RV+I E + L L +L II+RD+K NILL +
Sbjct: 88 NGGELFTHLYQ--REHFTESEVRVYIAEIV----LALDHLHQLGIIYRDIKLENILLDSE 141
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV--YSTKSDVFSFGVLLLQ 178
++DFGL++ F E E GTI Y+ PE R G + D +S GVL +
Sbjct: 142 GHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFE 200
Query: 179 IISG 182
+++G
Sbjct: 201 LLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 37/99 (37%), Positives = 60/99 (60%), Gaps = 8/99 (8%)
Query: 93 GLLYLQ-------EYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQ 145
GLL++Q +S+ +IHRD+K++NILL + K+ DFG ++++A +
Sbjct: 146 GLLFIQVLLAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT 204
Query: 146 VVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKR 184
GT Y+ PE R+ YS K+D+FS GVLL ++++ KR
Sbjct: 205 FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 55/189 (29%), Positives = 86/189 (45%), Gaps = 31/189 (16%)
Query: 8 VIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
VI L+K + E K EV+L AK++H N++ ++ +V EY C
Sbjct: 29 VIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY-------C 81
Query: 68 YLFDPIRRL------------ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
D ++R+ IL W Q L L+ I+HRD+K+ NI
Sbjct: 82 DGGDLMKRINRQRGVLFSEDQILSW---------FVQISLGLKHIHDRKILHRDIKSQNI 132
Query: 116 LLGED-MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGV 174
L ++ M K+ DFG+AR A T VGT Y+ PE + Y+ K+D++S G
Sbjct: 133 FLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPYYLSPEICQNRPYNNKTDIWSLGC 190
Query: 175 LLLQIISGK 183
+L ++ + K
Sbjct: 191 VLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 69/240 (28%), Positives = 106/240 (44%), Gaps = 25/240 (10%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE--RMLVYE 58
G C ++IA K K ++ + +NE++ +L H N++++ EE R
Sbjct: 188 GKPKCERLIA--KRVKAGSRAAIQLENEILALGRLNHENILKI-------EEILRSEANT 238
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRVHIIE--GITQGLLYLQEY--SRLTIIHRDLKASN 114
YM + D L+ + DWK R + + I + LL EY + +IHRD+K N
Sbjct: 239 YMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK-LIHRDIKLEN 297
Query: 115 ILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGV 174
I L D K + DFG A F KE EA VGT+ PE Y +D++S G+
Sbjct: 298 IFLNCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGL 356
Query: 175 LLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIA 234
+LL ++S C I + + +L K + D D PCKL ++ A
Sbjct: 357 ILLDMLSHD----FCPIGDGGG--KPGKQLLKIIDSLSVCDEEFPD--PPCKLFDYIDSA 408
|
Length = 501 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 36/76 (47%), Positives = 45/76 (59%)
Query: 106 IHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYST 165
IHRDL A NILL E+ KI DFGLAR K+ + ++ PE VY+T
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255
Query: 166 KSDVFSFGVLLLQIIS 181
+SDV+SFGVLL +I S
Sbjct: 256 QSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-12
Identities = 34/79 (43%), Positives = 51/79 (64%), Gaps = 5/79 (6%)
Query: 105 IIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV-Y 163
+++RDLK +NILL E +ISD GLA F+K+ A+ VGT GY+ PE ++GV Y
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGVAY 173
Query: 164 STKSDVFSFGVLLLQIISG 182
+ +D FS G +L +++ G
Sbjct: 174 DSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 4e-12
Identities = 35/90 (38%), Positives = 53/90 (58%), Gaps = 6/90 (6%)
Query: 95 LYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL--EANTEQVVGTIGY 152
L L L II+RDLK NILL E+ K++DFGL +KES+ E GT+ Y
Sbjct: 109 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGL----SKESIDHEKKAYSFCGTVEY 164
Query: 153 IPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
+ PE + ++ +D +SFGVL+ ++++G
Sbjct: 165 MAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 4e-12
Identities = 41/154 (26%), Positives = 74/154 (48%), Gaps = 9/154 (5%)
Query: 28 EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHII 87
E ML + H ++IR+ + +V +P+ S D Y + R L + + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 88 EGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVV 147
+ I +GL YL IIHRD+K NI + + + I D G A+ + +
Sbjct: 164 KQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLA 217
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
GT+ PE + Y++K+D++S G++L ++++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 5e-12
Identities = 42/126 (33%), Positives = 72/126 (57%), Gaps = 9/126 (7%)
Query: 58 EYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
E+M SLD L R+ + ++ I + +GL YL+E + I+HRD+K SNIL+
Sbjct: 79 EHMDGGSLDQVL-KKAGRIPENILGKISI--AVLRGLTYLRE--KHKIMHRDVKPSNILV 133
Query: 118 GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
+ K+ DFG++ +S+ AN+ VGT Y+ PE + Y+ +SD++S G+ L+
Sbjct: 134 NSRGEIKLCDFGVSGQLI-DSM-ANS--FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLV 189
Query: 178 QIISGK 183
++ G+
Sbjct: 190 EMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 7e-12
Identities = 52/178 (29%), Positives = 80/178 (44%), Gaps = 25/178 (14%)
Query: 28 EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK--RVH 85
E L +KL H +++ ++ + ++ EY + LDC + L K
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDC----KLEELKHTGKTLSENQ 107
Query: 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQ 145
+ E Q LL + + I+HRDLKA NI L ++ KI DFG++R+ A T
Sbjct: 108 VCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATT-- 164
Query: 146 VVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE 203
GT Y+ PE + Y +KSD++S G +L + M C L HA+E
Sbjct: 165 FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYE--------MCC--------LAHAFE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 8e-12
Identities = 51/178 (28%), Positives = 95/178 (53%), Gaps = 15/178 (8%)
Query: 9 IAVKKLSK-TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+A+K L + TS + +E +E + A + + R+LG C+ S + LV + MP L
Sbjct: 39 VAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLD 97
Query: 68 YLFDPIRRL----ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
Y+ + R+ +L+W + I +G+ YL+E + ++HRDL A N+L+
Sbjct: 98 YVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE---VRLVHRDLAARNVLVKSPNHV 148
Query: 124 KISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
KI+DFGLAR+ + E + + I ++ E ++ +SDV+S+GV + ++++
Sbjct: 149 KITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 8e-12
Identities = 67/267 (25%), Positives = 115/267 (43%), Gaps = 37/267 (13%)
Query: 6 GKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER------MLVY 57
+ +AVK L S+ EEF E + H N+I+++G + S + M++
Sbjct: 27 FQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVIL 86
Query: 58 EYMPNKSLDCYLF------DPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLK 111
+M + L +L +P L + V + I G+ YL S IHRDL
Sbjct: 87 PFMKHGDLHTFLLMSRIGEEPFT---LPLQTLVRFMIDIASGMEYL---SSKNFIHRDLA 140
Query: 112 ASNILLGEDMKPKISDFGLAR-IFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVF 170
A N +L E+M ++DFGL++ I++ + + + ++ E VY+T SDV+
Sbjct: 141 ARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL-PVKWLALESLADNVYTTHSDVW 199
Query: 171 SFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRC 230
+FGV + +I++ + + G+ EN I Y G ++ L+D
Sbjct: 200 AFGVTMWEIMT-RGQTPYAGV-ENSEI----YNYLIKGNRLKQPPDCLEDV--------- 244
Query: 231 LEIALLCVQENPNDRPSMLQVSSMLKN 257
E+ C P RPS + L+
Sbjct: 245 YELMCQCWSPEPKCRPSFQHLRDQLEL 271
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-11
Identities = 50/186 (26%), Positives = 84/186 (45%), Gaps = 16/186 (8%)
Query: 6 GKVIAVKK-----LSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G+ +AVK+ S + + + E+ L LQH +++ G D E + EYM
Sbjct: 27 GRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86
Query: 61 PNKSLDCYL--FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
P S+ L + + + R I +G+ YL I+HRD+K +NIL
Sbjct: 87 PGGSVKDQLKAYGALTETVTRKYTR-----QILEGVEYLH---SNMIVHRDIKGANILRD 138
Query: 119 EDMKPKISDFGLA-RIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
K+ DFG + R+ S + V GT ++ PE Y K+DV+S G ++
Sbjct: 139 SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVV 198
Query: 178 QIISGK 183
++++ K
Sbjct: 199 EMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-11
Identities = 52/191 (27%), Positives = 84/191 (43%), Gaps = 21/191 (10%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
V P +V V K+ + + F L ++L H +L+++ G C+ E M V EY+
Sbjct: 24 IVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENIM-VEEYV 82
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL--- 117
LD +L + L WK + + + + L YL++ ++H ++ NIL+
Sbjct: 83 KFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLED---KKLVHGNVCGKNILVARY 137
Query: 118 GEDMKP----KISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKS--DVFS 171
G + K+SD G+ E+ V I +I PE R G S D +S
Sbjct: 138 GLNEGYVPFIKLSDPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWS 191
Query: 172 FGVLLLQIISG 182
FG LL+I S
Sbjct: 192 FGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 53/166 (31%), Positives = 89/166 (53%), Gaps = 22/166 (13%)
Query: 28 EVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMP---NKSLD-CYLFDPIRRLILDWKK 82
E+ L +L H N++R+L + SE ++ LV+E++ K +D L LI K
Sbjct: 48 EISLLKELNHPNIVRLLDV-VHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLI---KS 103
Query: 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEAN 142
++ + QG+ Y +S ++HRDLK N+L+ + K++DFGLAR F +
Sbjct: 104 YLY---QLLQGIAYC--HSH-RVLHRDLKPQNLLIDREGALKLADFGLARAFGV-PVRTY 156
Query: 143 TEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGVLLLQIISGKRL 185
T +VV T+ Y PE +RQ YST D++S G + ++++ + L
Sbjct: 157 THEVV-TLWYRAPEILLGSRQ--YSTPVDIWSIGCIFAEMVNRRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 48/169 (28%), Positives = 82/169 (48%), Gaps = 18/169 (10%)
Query: 28 EVMLTAKLQHVNLIRVLGFCIDSEERM----------LVYEYMPNKSLDCYLFDPIRRLI 77
E+ + +L H N++ + D ++ + LV+EYM D L + +
Sbjct: 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGL 110
Query: 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKE 137
+ + + HI + Q L L + +HRD+K SNILL + K++DFGLAR++ E
Sbjct: 111 VHFSED-HIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169
Query: 138 SLEANTEQVVGTIGYIPPEYAR-QGVYSTKSDVFSFGVLLLQIISGKRL 185
T +V+ T+ Y PPE + Y DV+S G +L ++ + K +
Sbjct: 170 ESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 36/93 (38%), Positives = 56/93 (60%), Gaps = 5/93 (5%)
Query: 91 TQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTI 150
T+ +L L+ +++RDLK +NILL E +ISD GLA F+K+ A+ VGT
Sbjct: 104 TEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTH 159
Query: 151 GYIPPEYARQGV-YSTKSDVFSFGVLLLQIISG 182
GY+ PE ++G Y + +D FS G +L +++ G
Sbjct: 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 54/202 (26%), Positives = 86/202 (42%), Gaps = 35/202 (17%)
Query: 2 VLPC-----GKVIAVKKLSKTSTQGFEEFKN----EVMLTAKLQHVNLIRVLGFCIDSEE 52
VL C G+++A+KK ++ E+ K EV + +L+H N++ +
Sbjct: 17 VLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGR 74
Query: 53 RMLVYEYMPNKSLDCYL--------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLT 104
LV+EY+ L+ L D +R I W+ + Q + Y
Sbjct: 75 LYLVFEYVERTLLE-LLEASPGGLPPDAVRSYI--WQ--------LLQAIAYCH---SHN 120
Query: 105 IIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV-Y 163
IIHRD+K NIL+ E K+ DFG AR T+ V T Y PE Y
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELLVGDTNY 179
Query: 164 STKSDVFSFGVLLLQIISGKRL 185
DV++ G ++ +++ G+ L
Sbjct: 180 GKPVDVWAIGCIMAELLDGEPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 53/184 (28%), Positives = 87/184 (47%), Gaps = 24/184 (13%)
Query: 14 LSKTSTQGFEE-----FKNEVMLTAKLQHVNLIRVLGFCI-DSEERMLVYEYMPNKSLDC 67
KT E E L L H N++ +L CI D E ++Y YM +L
Sbjct: 39 FVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKL 98
Query: 68 YLFDPIRRLI-------LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
+L RL L ++ VH+ I G+ YL + +IH+D+ A N ++ E+
Sbjct: 99 FLQQC--RLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEE 153
Query: 121 MKPKISDFGLAR-IFAKE--SLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
++ KI+D L+R +F + L N + + ++ E YS+ SDV+SFGVLL
Sbjct: 154 LQVKITDNALSRDLFPMDYHCLGDNENR---PVKWMALESLVNKEYSSASDVWSFGVLLW 210
Query: 178 QIIS 181
++++
Sbjct: 211 ELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 46/179 (25%), Positives = 88/179 (49%), Gaps = 16/179 (8%)
Query: 9 IAVKKL-SKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+A+K L ++ +E E + +L + ++R++G C ++E MLV E L+
Sbjct: 25 VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLNK 83
Query: 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISD 127
+L ++ + V ++ ++ G+ YL+ + +HRDL A N+LL KISD
Sbjct: 84 FLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISD 138
Query: 128 FGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS 181
FGL++ + ++ + G P PE +S++SDV+S+G+ + + S
Sbjct: 139 FGLSKALGAD----DSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 35/76 (46%), Positives = 44/76 (57%)
Query: 106 IHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYST 165
IHRDL A NILL E+ KI DFGLAR K+ + ++ PE VY+
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260
Query: 166 KSDVFSFGVLLLQIIS 181
+SDV+SFGVLL +I S
Sbjct: 261 QSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (153), Expect = 4e-11
Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 48/206 (23%)
Query: 5 CGKVIAVKKLSKTSTQGFEEFKN---------EVMLTAKLQHVNLIRVLG-FCIDSEERM 54
G+ +A+KK+S F + E+ L L+H N+I +L S E
Sbjct: 24 TGRKVAIKKISNV-------FDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDF 76
Query: 55 ----LVYEYMPNKSLDCYLFDPIRRLI-----LDWKKRVHIIEGITQGLLYLQEYSRLTI 105
+V E M D + ++I L + + I +GL YL + +
Sbjct: 77 NDVYIVTELME---TDLH------KVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---V 124
Query: 106 IHRDLKASNILLGEDMKPKISDFGLARIFAKESLEAN--TEQVVGTIGYIPPE----YAR 159
IHRDLK SNIL+ + KI DFGLAR + E TE VV T Y PE +R
Sbjct: 125 IHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-TRWYRAPELLLSSSR 183
Query: 160 QGVYSTKSDVFSFGVLLLQIISGKRL 185
Y+ D++S G + ++++ K L
Sbjct: 184 ---YTKAIDIWSVGCIFAELLTRKPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 6e-11
Identities = 48/178 (26%), Positives = 84/178 (47%), Gaps = 27/178 (15%)
Query: 22 FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML-VYEYMPNKSLDCYLFDPIRRLILDW 80
F+ E L A+L H N++ +L + V+EY+P ++L L D
Sbjct: 22 RARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLR-------EVLAAD- 73
Query: 81 KKRVHIIEGITQGLLYLQEYSRLT------IIHRDLKASNILLGE-DMKP--KISDFGLA 131
+ G L LQ L I+HRDLK NI++ + ++P K+ DFG+
Sbjct: 74 ----GALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIG 129
Query: 132 RIF--AKESLEAN---TEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKR 184
+ +++ A T +V+GT Y PE R + SD++++G++ L+ ++G+R
Sbjct: 130 TLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 8e-11
Identities = 52/160 (32%), Positives = 75/160 (46%), Gaps = 18/160 (11%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL--EANTEQVV 147
I GL +L E II+RDLK N+LL + KI+DFG+ KE + T
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGM----CKEGILGGVTTSTFC 157
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL---SILEH--AY 202
GT YI PE Y D ++ GVLL ++++G+ S G +E+ SILE Y
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ--SPFEGDDEDELFQSILEDEVRY 215
Query: 203 ELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242
W + + S L T +P K + CL ++ +P
Sbjct: 216 PRWLSKEAKSILKSFL--TKNPEKRLGCLPTGEQDIKGHP 253
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 52/213 (24%), Positives = 87/213 (40%), Gaps = 55/213 (25%)
Query: 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM---------- 54
C K +AVKK+ T Q + E+ + +L H N+++V S +
Sbjct: 29 CDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTEL 88
Query: 55 ----LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRL------- 103
+V EYM + ++ QG L +E++RL
Sbjct: 89 NSVYIVQEYMETD---------LANVL-------------EQGPL-SEEHARLFMYQLLR 125
Query: 104 --------TIIHRDLKASNILLG-EDMKPKISDFGLARIFAKE-SLEANTEQVVGTIGYI 153
++HRDLK +N+ + ED+ KI DFGLARI S + + + T Y
Sbjct: 126 GLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYR 185
Query: 154 PPEYARQGVYSTKS-DVFSFGVLLLQIISGKRL 185
P TK+ D+++ G + ++++GK L
Sbjct: 186 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPL 218
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 52/196 (26%), Positives = 87/196 (44%), Gaps = 29/196 (14%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGF------CIDSEERMLVYE 58
G+++A+K + + EE K E + K H N+ G + ++ LV E
Sbjct: 31 GQLVAIKIMDIIEDEE-EEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVME 89
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRV------HIIEGITQGLLYLQEYSRLTIIHRDLKA 112
S+ D ++ L KR+ +I+ +GL YL E +IHRD+K
Sbjct: 90 LCGGGSVT----DLVKGL-RKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKG 141
Query: 113 SNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE-----YARQGVYSTKS 167
NILL ++ + K+ DFG++ NT +GT ++ PE Y +S
Sbjct: 142 QNILLTKNAEVKLVDFGVSAQLDSTLGRRNT--FIGTPYWMAPEVIACDEQPDASYDARS 199
Query: 168 DVFSFGVLLLQIISGK 183
DV+S G+ +++ GK
Sbjct: 200 DVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 50/159 (31%), Positives = 78/159 (49%), Gaps = 9/159 (5%)
Query: 28 EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHII 87
EV L L+H N++ + + LV+EY+ +K L Y+ D I+ +
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGN--IMSMHNVKIFL 110
Query: 88 EGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVV 147
I +GL Y R ++HRDLK N+L+ E + K++DFGLAR AK V
Sbjct: 111 YQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEV 165
Query: 148 GTIGYIPPEYAR-QGVYSTKSDVFSFGVLLLQIISGKRL 185
T+ Y PP+ YST+ D++ G + ++ SG+ L
Sbjct: 166 VTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 46/187 (24%), Positives = 77/187 (41%), Gaps = 16/187 (8%)
Query: 2 VLPCGKVIAVKKLSKTS--TQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYE 58
V + A+K + K G +E +E + + H ++++ D + ++ E
Sbjct: 14 VKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLME 73
Query: 59 YMPNKSLDCYLFDPIRRL-ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
Y L + +R + D I + YL II+RDLK N+LL
Sbjct: 74 YCLGGEL----WTILRDRGLFDEYTARFYIACVVLAFEYL---HNRGIIYRDLKPENLLL 126
Query: 118 GEDMKPKISDFGLARIFAKE-SLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
+ K+ DFG FAK+ T GT Y+ PE Y D +S G+LL
Sbjct: 127 DSNGYVKLVDFG----FAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILL 182
Query: 177 LQIISGK 183
++++G+
Sbjct: 183 YELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 51/184 (27%), Positives = 92/184 (50%), Gaps = 17/184 (9%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G L KVI K S + E++ E+ + A H ++++LG + ++ E+
Sbjct: 37 GALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
P ++D + + R L + ++ +I Q L LQ + IIHRDLKA N+LL D
Sbjct: 92 PGGAVDAIMLELDRGLT---EPQIQVI--CRQMLEALQYLHSMKIIHRDLKAGNVLLTLD 146
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA-----RQGVYSTKSDVFSFGVL 175
K++DFG++ K +L+ + +GT ++ PE + Y K+D++S G+
Sbjct: 147 GDIKLADFGVSAKNVK-TLQ-RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGIT 204
Query: 176 LLQI 179
L+++
Sbjct: 205 LIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 41/126 (32%), Positives = 72/126 (57%), Gaps = 9/126 (7%)
Query: 58 EYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
E+M SLD L + +R+ + +V I + +GL YL+E + I+HRD+K SNIL+
Sbjct: 83 EHMDGGSLDQVLKEA-KRIPEEILGKVSI--AVLRGLAYLRE--KHQIMHRDVKPSNILV 137
Query: 118 GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
+ K+ DFG++ + +++ VGT Y+ PE + YS +SD++S G+ L+
Sbjct: 138 NSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 193
Query: 178 QIISGK 183
++ G+
Sbjct: 194 ELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-10
Identities = 49/159 (30%), Positives = 80/159 (50%), Gaps = 9/159 (5%)
Query: 28 EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHII 87
EV L L+H N++ + + LV+EY+ +K L YL D I ++ +
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYL-DDCGNSINMHNVKLFLF 111
Query: 88 EGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVV 147
+ + +GL Y R ++HRDLK N+L+ E + K++DFGLAR AK V
Sbjct: 112 Q-LLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEV 165
Query: 148 GTIGYIPPEYARQGV-YSTKSDVFSFGVLLLQIISGKRL 185
T+ Y PP+ YST+ D++ G + ++ +G+ L
Sbjct: 166 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 2e-10
Identities = 48/187 (25%), Positives = 82/187 (43%), Gaps = 23/187 (12%)
Query: 2 VLPCGKVIAVKKLSKTSTQGFE-EFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
L +++AVK + T + + +E+ + K +I G + E+M
Sbjct: 22 HLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGIT----QGLLYLQEYSRLTIIHRDLKASNIL 116
SLD Y K H++ I +GL YL L I+HRD+K SN+L
Sbjct: 82 DGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNML 127
Query: 117 LGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
+ + K+ DFG++ + + + + VGT Y+ PE Y SDV+S G+
Sbjct: 128 VNTRGQVKLCDFGVST----QLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISF 183
Query: 177 LQIISGK 183
+++ G+
Sbjct: 184 MELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 35/176 (19%)
Query: 89 GITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVG 148
I + L YL +L++IHRD+K SN+L+ + + K+ DFG++ +S+ A T G
Sbjct: 111 SIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV-DSV-AKTID-AG 165
Query: 149 TIGYIPPEY----ARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL 204
Y+ PE Q Y KSDV+S G+ ++++ +G+ Y+
Sbjct: 166 CKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR----------------FPYDS 209
Query: 205 WKG-----GKGVEFVDSSL-DDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254
WK + VE L + SP + C+++N +RP+ ++
Sbjct: 210 WKTPFQQLKQVVEEPSPQLPAEKFSP----EFQDFVNKCLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-10
Identities = 46/180 (25%), Positives = 91/180 (50%), Gaps = 17/180 (9%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G++ A+K + + F + E+++ +H N++ G + ++ + E+ SL
Sbjct: 34 GELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSL 93
Query: 66 -DCY-LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
D Y + P+ + + R + QGL YL + +HRD+K +NILL ++
Sbjct: 94 QDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGK---MHRDIKGANILLTDNGHV 145
Query: 124 KISDFGL-ARIFAKESLEANTEQVVGTIGYIPPEYA---RQGVYSTKSDVFSFGVLLLQI 179
K++DFG+ A+I A A + +GT ++ PE A R+G Y+ D+++ G+ +++
Sbjct: 146 KLADFGVSAQITAT---IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-10
Identities = 49/180 (27%), Positives = 90/180 (50%), Gaps = 17/180 (9%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G++ AVK + F + E+ + + +H N++ G + E+ + EY SL
Sbjct: 34 GELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSL 93
Query: 66 -DCY-LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
D Y + P+ L + + R + QGL YL ++ HRD+K +NILL ++
Sbjct: 94 QDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGKM---HRDIKGANILLTDNGDV 145
Query: 124 KISDFGLARIFAK-ESLEANTEQVVGTIGYIPPEYA---RQGVYSTKSDVFSFGVLLLQI 179
K++DFG+A AK + A + +GT ++ PE A + G Y+ D+++ G+ +++
Sbjct: 146 KLADFGVA---AKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 51/210 (24%), Positives = 86/210 (40%), Gaps = 42/210 (20%)
Query: 5 CGKVIAVKKLSKTSTQGFEEFKN----EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
C + +A+KK+ + K E + A L H ++ V C D + VY M
Sbjct: 26 CSRRVALKKIRE-DLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD---PVYYTM 81
Query: 61 P---NKSLDCYLFDPIRRLILDWKKRVH----------IIEGITQGLLYLQEYSRLTIIH 107
P +L L ++ L K + I I + Y+ +S+ ++H
Sbjct: 82 PYIEGYTLKSLLKSVWQKESL--SKELAEKTSVGAFLSIFHKICATIEYV--HSK-GVLH 136
Query: 108 RDLKASNILLGEDMKPKISDFGLARIFAKE-----SLEANTE-----------QVVGTIG 151
RDLK NILLG + I D+G A E ++ + ++VGT
Sbjct: 137 RDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPD 196
Query: 152 YIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
Y+ PE S +D+++ GV+L Q+++
Sbjct: 197 YMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-10
Identities = 52/185 (28%), Positives = 92/185 (49%), Gaps = 19/185 (10%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
GVL KVI K S + E++ E+ + A H N++++L ++ E+
Sbjct: 30 GVLAAAKVIDTK-----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
++D + + + R + + + RV + + + L YL E IIHRDLKA NIL D
Sbjct: 85 AGGAVDAVMLE-LERPLTEPQIRV-VCKQTLEALNYLHENK---IIHRDLKAGNILFTLD 139
Query: 121 MKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPPEY-----ARQGVYSTKSDVFSFGV 174
K++DFG++ AK + + +GT ++ PE ++ Y K+DV+S G+
Sbjct: 140 GDIKLADFGVS---AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGI 196
Query: 175 LLLQI 179
L+++
Sbjct: 197 TLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 45/153 (29%), Positives = 71/153 (46%), Gaps = 16/153 (10%)
Query: 106 IHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYST 165
+HRDL A N+LL + KI DFGLAR +S + + ++ PE +Y+T
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT 318
Query: 166 KSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA-YELWKGGKGVEFVDSSLDDTNSP 224
SDV+S+G+LL +I S L G I++ Y K G + D + +
Sbjct: 319 LSDVWSYGILLWEIFS------LGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEV--- 369
Query: 225 CKLMRCLEIALLCVQENPNDRPSMLQVSSMLKN 257
+I + C P RPS L +S ++++
Sbjct: 370 ------YDIMVKCWNSEPEKRPSFLHLSDIVES 396
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 42/106 (39%), Positives = 57/106 (53%), Gaps = 11/106 (10%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL--EANTEQVV 147
I GL +L I++RDLK NILL D KI+DFG+ KE++ +A T
Sbjct: 105 IICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGM----CKENMLGDAKTCTFC 157
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINE 193
GT YI PE Y+T D +SFGVLL +++ G+ S G +E
Sbjct: 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ--SPFHGHDE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-10
Identities = 44/185 (23%), Positives = 94/185 (50%), Gaps = 19/185 (10%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVL-GFCIDSEERMLVYEY 59
G+ K+I ++ S + E+F E+ + ++ +H N++ + + +++ +L+ E+
Sbjct: 30 GLFAAAKIIQIE-----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI-EF 83
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
+LD + + R + + + R + + + L +L + +IHRDLKA NILL
Sbjct: 84 CDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLHSHK---VIHRDLKAGNILLTL 138
Query: 120 DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA-----RQGVYSTKSDVFSFGV 174
D K++DFG++ + +T +GT ++ PE + Y K+D++S G+
Sbjct: 139 DGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGI 196
Query: 175 LLLQI 179
L+++
Sbjct: 197 TLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 4e-10
Identities = 65/261 (24%), Positives = 106/261 (40%), Gaps = 64/261 (24%)
Query: 6 GKVIAVKK-LSKTSTQGFE-EFKNEVMLTAKLQHVNLIRVLGFCID-----SEERMLVYE 58
G+V+A+KK L GF E+ + KL+H N++ ++ ++ +R VY
Sbjct: 33 GRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYM 92
Query: 59 YMP--NKSLDCYLFDPIRRLILDWKKRVH--------IIEGITQGLLYLQEYSRLTIIHR 108
P + L L +P V + + +G+ YL E I+HR
Sbjct: 93 VTPYMDHDLSGLLENP----------SVKLTESQIKCYMLQLLEGINYLHENH---ILHR 139
Query: 109 DLKASNILLGEDMKPKISDFGLARIF----------AKESLEANTEQVVGTIGYIPPEY- 157
D+KA+NIL+ KI+DFGLAR + T VV T Y PPE
Sbjct: 140 DIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVV-TRWYRPPELL 198
Query: 158 --ARQGVYSTKSDVFSFGVLLLQIISGK----------RLSM---LCGINENLSILEHAY 202
R+ Y+T D++ G + ++ + + +L + LCG + E +
Sbjct: 199 LGERR--YTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG-----TPTEETW 251
Query: 203 ELWKGGKGVEFVDSSLDDTNS 223
W+ G E V S + +
Sbjct: 252 PGWRSLPGCEGVHSFTNYPRT 272
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-10
Identities = 49/183 (26%), Positives = 91/183 (49%), Gaps = 13/183 (7%)
Query: 6 GKVIAVKKLSKTS----TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYM 60
GK+ A+K L K + + E + E + ++ + L + +E ++ L+ +Y+
Sbjct: 28 GKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYV 87
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
+ +L+ R + + R + E I L L+ +L I++RD+K NILL +
Sbjct: 88 SGGEMFTHLYQ--RDNFSEDEVRFYSGEII----LALEHLHKLGIVYRDIKLENILLDSE 141
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR-QGVYSTKSDVFSFGVLLLQI 179
++DFGL++ F E E T GTI Y+ PE R +G + D +S G+L+ ++
Sbjct: 142 GHVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFEL 200
Query: 180 ISG 182
++G
Sbjct: 201 LTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 4e-10
Identities = 56/188 (29%), Positives = 87/188 (46%), Gaps = 21/188 (11%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKN----EVMLTAKLQHVNLIRVLGFCIDS---EERMLVYE 58
G+ +A+KKLS+ E F E+ L +QH N+I +L + +E Y
Sbjct: 40 GEKVAIKKLSRPFQS--EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYL 97
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
MP D I L K +++ + GL Y+ IIHRDLK N+ +
Sbjct: 98 VMPYMQTD---LQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVN 151
Query: 119 EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKS-DVFSFGVLLL 177
ED + KI DFGLAR +A V T Y PE ++ ++ D++S G ++
Sbjct: 152 EDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMA 206
Query: 178 QIISGKRL 185
++++GK L
Sbjct: 207 EMLTGKTL 214
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 5e-10
Identities = 61/195 (31%), Positives = 89/195 (45%), Gaps = 24/195 (12%)
Query: 3 LPCGKVIAVKKLSKTSTQGF-EEFKNEVMLTAKLQHVNLIRVLGF-CIDSEERM----LV 56
P G +A+KK+S Q F + E+ + + +H N+I +L S E +V
Sbjct: 27 KPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIV 86
Query: 57 YEYMPNKSLDCYLFDPIRRLILDWKKRVHI---IEGITQGLLYLQEYSRLTIIHRDLKAS 113
E M D Y + L D HI + I +GL Y+ + ++HRDLK S
Sbjct: 87 QELMET---DLYKLIKTQHLSND-----HIQYFLYQILRGLKYIHSAN---VLHRDLKPS 135
Query: 114 NILLGEDMKPKISDFGLARIFAKESLEAN--TEQVVGTIGYIPPEYA-RQGVYSTKSDVF 170
N+LL + KI DFGLARI E TE V T Y PE Y+ D++
Sbjct: 136 NLLLNTNCDLKICDFGLARIADPEHDHTGFLTE-YVATRWYRAPEIMLNSKGYTKAIDIW 194
Query: 171 SFGVLLLQIISGKRL 185
S G +L +++S + L
Sbjct: 195 SVGCILAEMLSNRPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 5e-10
Identities = 34/82 (41%), Positives = 47/82 (57%), Gaps = 3/82 (3%)
Query: 105 IIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE-YARQGVY 163
I+HRDLK SN+LL KI DFGLAR + L+ T+ VV T+ Y PE Y
Sbjct: 127 ILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQLVV-TLWYRAPELLLGAKEY 184
Query: 164 STKSDVFSFGVLLLQIISGKRL 185
ST D++S G + ++++ K L
Sbjct: 185 STAIDMWSVGCIFAELLTKKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 6e-10
Identities = 54/167 (32%), Positives = 89/167 (53%), Gaps = 23/167 (13%)
Query: 28 EVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMP---NKSLD-CYLFDPIRRLILDWKK 82
E+ L ++QH N++R L + SE+R+ LV+EY+ K +D F RLI
Sbjct: 51 EISLLKEMQHGNIVR-LQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLI----- 104
Query: 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP-KISDFGLARIFAKESLEA 141
+ ++ + I +G+ Y + ++HRDLK N+L+ K++DFGLAR F +
Sbjct: 105 KTYLYQ-ILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRT 159
Query: 142 NTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGVLLLQIISGKRL 185
T +VV T+ Y PE +R YST D++S G + ++++ K L
Sbjct: 160 FTHEVV-TLWYRAPEILLGSRH--YSTPVDIWSVGCIFAEMVNQKPL 203
|
Length = 294 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 6e-10
Identities = 46/156 (29%), Positives = 63/156 (40%), Gaps = 35/156 (22%)
Query: 55 LVYEYMPNKSLDCYLFDPIRRLILDWK-KRVHIIEGITQGLLYLQEYSRLTIIHRDLKAS 113
LV EYMP L L IR+ + + R +I E + L L +L IHRD+K
Sbjct: 78 LVMEYMPGGDLMNLL---IRKDVFPEETARFYIAELV----LALDSVHKLGFIHRDIKPD 130
Query: 114 NILLGEDMKPKISDFGLA---------------------------RIFAKESLEANTEQV 146
NIL+ D K++DFGL R +
Sbjct: 131 NILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANST 190
Query: 147 VGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
VGT YI PE R Y + D +S GV+L +++ G
Sbjct: 191 VGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 6e-10
Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 20/183 (10%)
Query: 6 GKVIAVKKLSKTSTQGFEEFK---NE--VMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G+++A+K++ K+ E + E ++ T K L+++L D E L EY+
Sbjct: 26 GEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK--SEWLVKLLYAFQDDEYLYLAMEYV 83
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
P L + ++ + R ++ E + L IHRDLK N L+
Sbjct: 84 PGGDFRTLLNN--LGVLSEDHARFYMAEMF----EAVDALHELGYIHRDLKPENFLIDAS 137
Query: 121 MKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQI 179
K++DFGL +K + AN+ VVG+ Y+ PE R Y D +S G +L +
Sbjct: 138 GHIKLTDFGL----SKGIVTYANS--VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEF 191
Query: 180 ISG 182
+ G
Sbjct: 192 LCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 6e-10
Identities = 54/187 (28%), Positives = 87/187 (46%), Gaps = 19/187 (10%)
Query: 6 GKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMP 61
GK+ A KKL+K +G+E E + AK+ H I L + ++ + LV M
Sbjct: 18 GKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTKTDLCLVMTIMN 76
Query: 62 NKSLDCYLFD-----PIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNIL 116
L ++++ P + I GL +L + II+RDLK N+L
Sbjct: 77 GGDLRYHIYNVDEENPG----FPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVL 129
Query: 117 LGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
L D +ISD GLA + K+ ++ T+ GT G++ PE + Y D F+ GV L
Sbjct: 130 LDNDGNVRISDLGLA-VELKDG-QSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTL 187
Query: 177 LQIISGK 183
++I+ +
Sbjct: 188 YEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 9e-10
Identities = 60/185 (32%), Positives = 92/185 (49%), Gaps = 18/185 (9%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVM-LTAK--LQHVNLIRV--LGFCIDSEERM-LVYEY 59
GK+ A KKL K + ++ K E M L K L+ VN V L + ++++ + LV
Sbjct: 25 GKMYACKKLEK---KRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
M L ++++ + D ++ V IT GL L R I++RDLK NILL +
Sbjct: 82 MNGGDLKFHIYN-MGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDD 137
Query: 120 DMKPKISDFGLA-RIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
+ISD GLA I E++ VGT+GY+ PE + Y+ D + G L+ +
Sbjct: 138 YGHIRISDLGLAVEIPEGETIRGR----VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYE 193
Query: 179 IISGK 183
+I GK
Sbjct: 194 MIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 9e-10
Identities = 54/194 (27%), Positives = 85/194 (43%), Gaps = 37/194 (19%)
Query: 6 GKVIAVKKLSK------TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCID-SEERMLVYE 58
G+ +A+KK+ K + + + E K L L+H N+I + I E+ V E
Sbjct: 35 GQNVAIKKIMKPFSTPVLAKRTYRELK----LLKHLRHENIISLSDIFISPLEDIYFVTE 90
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
+ D + R L + + + + I +GL Y+ ++HRDLK SNIL+
Sbjct: 91 LL---GTDLHRLLTSRPLEKQFIQ--YFLYQILRGLKYVHSAG---VVHRDLKPSNILIN 142
Query: 119 EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ-------GVYSTKSDVFS 171
E+ KI DFGLARI Q GY+ Y R Y + D++S
Sbjct: 143 ENCDLKICDFGLARI-----------QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWS 191
Query: 172 FGVLLLQIISGKRL 185
G + +++ GK L
Sbjct: 192 AGCIFAEMLEGKPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 31/79 (39%), Positives = 45/79 (56%), Gaps = 2/79 (2%)
Query: 105 IIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYS 164
II+RDLK N+LL +D KI+DFG+ + + E GT YI PE + Y+
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCK--ENMNGEGKASTFCGTPDYIAPEILKGQKYN 174
Query: 165 TKSDVFSFGVLLLQIISGK 183
D +SFGVLL +++ G+
Sbjct: 175 ESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 57/186 (30%), Positives = 86/186 (46%), Gaps = 22/186 (11%)
Query: 9 IAVKKLSK------TSTQGFEEFKNEVMLTAKLQHVNLIRVLG-FCIDS--EERMLVYEY 59
+A+KKLS+ + + + E +M H N+I +L F EE VY
Sbjct: 44 VAIKKLSRPFQNVTHAKRAYRELV--LMKLVN--HKNIIGLLNVFTPQKSLEEFQDVYLV 99
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
M + +D L I+ LD ++ +++ + G+ +L IIHRDLK SNI++
Sbjct: 100 M--ELMDANLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKS 153
Query: 120 DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQI 179
D KI DFGLAR + T VV T Y PE Y D++S G ++ ++
Sbjct: 154 DCTLKILDFGLARTAGTSFMM--TPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 210
Query: 180 ISGKRL 185
I G L
Sbjct: 211 IRGTVL 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 54/180 (30%), Positives = 81/180 (45%), Gaps = 14/180 (7%)
Query: 6 GKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
GK A+K LSK + E NE + ++H L+ + G D LV EY+P
Sbjct: 26 GKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPG 85
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
L R R + + + L YL L I++RDLK N+LL D
Sbjct: 86 GEL-FSHLRKSGRFPEPVA-RFYAAQ-VVLALEYLH---SLDIVYRDLKPENLLLDSDGY 139
Query: 123 PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
KI+DFG FAK ++ T + GT Y+ PE Y D ++ G+L+ ++++G
Sbjct: 140 IKITDFG----FAKR-VKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 32/95 (33%), Positives = 57/95 (60%), Gaps = 6/95 (6%)
Query: 89 GITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVG 148
+ +GL YL+E + I+HRD+K SNIL+ + K+ DFG++ + +++ VG
Sbjct: 111 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVG 164
Query: 149 TIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
T Y+ PE + YS +SD++S G+ L+++ G+
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-09
Identities = 48/187 (25%), Positives = 84/187 (44%), Gaps = 16/187 (8%)
Query: 6 GKVIAVKKL-----SKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML--VYE 58
G+ +AVK++ S +++ + E+ L L H +++ G D ER L E
Sbjct: 27 GRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86
Query: 59 YMPNKSLDCYLFDPIRRL-ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
+MP S+ D ++ L I +G+ YL I+HRD+K +NIL
Sbjct: 87 HMPGGSIK----DQLKSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILR 139
Query: 118 GEDMKPKISDFGLARIFAKESLEAN-TEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
K+ DFG ++ L + V GT ++ PE Y K+D++S G +
Sbjct: 140 DSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTV 199
Query: 177 LQIISGK 183
+++++ K
Sbjct: 200 VEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 40/116 (34%), Positives = 59/116 (50%), Gaps = 14/116 (12%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL--EANTEQVV 147
I GL +L II+RDLK N++L + KI+DFG+ KE++ T
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGM----CKENIFGGKTTRTFC 162
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINEN---LSILEH 200
GT YI PE Y D ++FGVLL ++++G+ G +E+ SI+EH
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ--PPFDGEDEDELFQSIMEH 216
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 15/163 (9%)
Query: 23 EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML--VYEYMPNKSLDCYLFDPIRRLILDW 80
+ NE + ++ H +IR+ F + ++R L + EY+P L YL + +
Sbjct: 46 QHVHNEKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRN--SGRFSNS 101
Query: 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE 140
+ E I L YL I++RDLK NILL ++ K++DFG FAK+ L
Sbjct: 102 TGLFYASE-IVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFG----FAKK-LR 152
Query: 141 ANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
T + GT Y+ PE + ++ D ++ G+L+ +++ G
Sbjct: 153 DRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 30/76 (39%), Positives = 45/76 (59%)
Query: 106 IHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYST 165
+HRDL A N+L+ E KI DFGLAR ++S + + ++ PE +Y+T
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320
Query: 166 KSDVFSFGVLLLQIIS 181
SDV+SFG+LL +I +
Sbjct: 321 LSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 50/172 (29%), Positives = 84/172 (48%), Gaps = 9/172 (5%)
Query: 28 EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHII 87
EV L L+H N++ + LV+EY+ + L YL D L+ ++ +
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKIFMF 110
Query: 88 EGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVV 147
+ + +GL Y + I+HRDLK N+L+ E + K++DFGLAR AK V
Sbjct: 111 Q-LLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEV 164
Query: 148 GTIGYIPPEYARQGV-YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSIL 198
T+ Y PP+ YST D++ G +L ++ +G+ + + E L ++
Sbjct: 165 VTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 48/184 (26%), Positives = 91/184 (49%), Gaps = 14/184 (7%)
Query: 6 GKVIAVKKLSKTS----TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYM 60
GK+ A+K L K + + E + E + ++ + L + ++ ++ L+ +Y+
Sbjct: 28 GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYI 87
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
L +L R ++ V I G + +L L+ +L II+RD+K NILL +
Sbjct: 88 NGGELFTHLSQRERFK----EQEVQIYSG--EIVLALEHLHKLGIIYRDIKLENILLDSN 141
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV--YSTKSDVFSFGVLLLQ 178
++DFGL++ F ++ +E GTI Y+ P+ R G + D +S GVL+ +
Sbjct: 142 GHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYE 200
Query: 179 IISG 182
+++G
Sbjct: 201 LLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-09
Identities = 30/88 (34%), Positives = 52/88 (59%), Gaps = 5/88 (5%)
Query: 97 LQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLA-RIFAKESLEANTEQVVGTIGYIPP 155
L++ + I++RDLK NILL + +ISD GLA + ++++ VGT+GY+ P
Sbjct: 115 LEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAP 170
Query: 156 EYARQGVYSTKSDVFSFGVLLLQIISGK 183
E + Y+ D ++ G LL ++I+G+
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 9/95 (9%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKES---LEANTEQV 146
+ QG+ +L + IHRD+ A N+LL + KI DFGLAR +S ++ N
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 147 VGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
V ++ PE VY+ +SDV+S+G+LL +I S
Sbjct: 278 V---KWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-09
Identities = 55/184 (29%), Positives = 95/184 (51%), Gaps = 11/184 (5%)
Query: 6 GKVIAVKKLSKTST-QGFEEFK-NEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
G+++A+KK+ S +G E+ L +LQH N++ + + L++E++ +
Sbjct: 25 GQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL-SM 83
Query: 64 SLDCYLFDPIRRL-ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
L YL D + + +D + + I QG+L+ +SR ++HRDLK N+L+
Sbjct: 84 DLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFC--HSR-RVLHRDLKPQNLLIDNKGV 139
Query: 123 PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV-YSTKSDVFSFGVLLLQIIS 181
K++DFGLAR F + T +VV T+ Y PE YST D++S G + ++ +
Sbjct: 140 IKLADFGLARAFGI-PVRVYTHEVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197
Query: 182 GKRL 185
K L
Sbjct: 198 KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 53/182 (29%), Positives = 84/182 (46%), Gaps = 14/182 (7%)
Query: 9 IAVKKLSKTSTQGFEEFKN---EVMLTAKLQHVNLIRVLG-FCIDSEERMLVYEYMPNKS 64
+A+KKLS+ Q K E+ L + H N+I +L F S Y+
Sbjct: 43 VAIKKLSR-PFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHL 101
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
+ L + ++ L ++ I +GL Y+ IIHRDLK SNI + ED + K
Sbjct: 102 MGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELK 158
Query: 125 ISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKS-DVFSFGVLLLQIISGK 183
I DFGLAR + V T Y PE ++ ++ D++S G ++ ++++GK
Sbjct: 159 ILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
Query: 184 RL 185
L
Sbjct: 214 TL 215
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 52/192 (27%), Positives = 87/192 (45%), Gaps = 26/192 (13%)
Query: 6 GKVIAVKKL-----SKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLV--YE 58
G+ +A K++ S +++ + E+ L LQH +++ G D E+ L E
Sbjct: 27 GRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME 86
Query: 59 YMPNKS----LDCY--LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKA 112
YMP S L Y L + + R K I+EG++ YL I+HRD+K
Sbjct: 87 YMPGGSVKDQLKAYGALTESVTR-----KYTRQILEGMS----YLHSN---MIVHRDIKG 134
Query: 113 SNILLGEDMKPKISDFGLARIFAKESLEAN-TEQVVGTIGYIPPEYARQGVYSTKSDVFS 171
+NIL K+ DFG ++ + V GT ++ PE Y K+DV+S
Sbjct: 135 ANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWS 194
Query: 172 FGVLLLQIISGK 183
G ++++++ K
Sbjct: 195 LGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 34/79 (43%), Positives = 45/79 (56%), Gaps = 6/79 (7%)
Query: 106 IHRDLKASNILLGEDMKPKISDFGLARIFAKES---LEANTEQVVGTIGYIPPEYARQGV 162
IHRDL A NILL KI DFGLAR +S ++ N V ++ PE V
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV---KWMAPESIFNCV 292
Query: 163 YSTKSDVFSFGVLLLQIIS 181
Y+ +SDV+S+G+LL +I S
Sbjct: 293 YTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-09
Identities = 37/132 (28%), Positives = 64/132 (48%), Gaps = 12/132 (9%)
Query: 58 EYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
EYM SLD + + I + +GL +L+E IIHRD+K +N+L+
Sbjct: 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLV 136
Query: 118 GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG------VYSTKSDVFS 171
+ + K+ DFG++ + N +G Y+ PE + G Y+ +SDV+S
Sbjct: 137 NGNGQVKLCDFGVSGNLVASLAKTN----IGCQSYMAPERIKSGGPNQNPTYTVQSDVWS 192
Query: 172 FGVLLLQIISGK 183
G+ +L++ G+
Sbjct: 193 LGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 4e-09
Identities = 40/116 (34%), Positives = 61/116 (52%), Gaps = 14/116 (12%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL--EANTEQVV 147
I GL +L II+RDLK N++L + KI+DFG+ KE++ T+
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC----KENMWDGVTTKTFC 162
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINEN---LSILEH 200
GT YI PE Y D ++FGVLL ++++G+ + G +E+ SI+EH
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ--APFEGEDEDELFQSIMEH 216
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-09
Identities = 48/157 (30%), Positives = 80/157 (50%), Gaps = 19/157 (12%)
Query: 31 LTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGI 90
L +++ H++L V G C+ E ++V E++ + LD L R+ + WK + + + +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWK--ITVAQQL 126
Query: 91 TQGLLYLQEYSRLTIIHRDLKASNIL-----LGEDMKP--KISDFGLARIFAKESLEANT 143
L YL++ + ++H ++ A NIL L E P K+SD G++ F S E
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTALSREERV 181
Query: 144 EQVVGTIGYIPPEYARQGV-YSTKSDVFSFGVLLLQI 179
E+ I +I PE G ST +D +SFG LL+I
Sbjct: 182 ER----IPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 34/96 (35%), Positives = 49/96 (51%), Gaps = 4/96 (4%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGT 149
+ +GL Y+ + ++HRDLK SN+LL + KI DFGLAR E + TE VV
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVVTR 172
Query: 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRL 185
P Y+T DV+S G + +++ K L
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-09
Identities = 32/88 (36%), Positives = 48/88 (54%), Gaps = 5/88 (5%)
Query: 97 LQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLA-RIFAKESLEANTEQVVGTIGYIPP 155
L++ R ++RDLK NILL + +ISD GLA +I ES+ VGT+GY+ P
Sbjct: 115 LEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAP 170
Query: 156 EYARQGVYSTKSDVFSFGVLLLQIISGK 183
E Y+ D + G L+ ++I G+
Sbjct: 171 EVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 5e-09
Identities = 54/191 (28%), Positives = 88/191 (46%), Gaps = 28/191 (14%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHV-------NLIRVLGFCIDSEERMLVYE 58
G V+AVK++ +T + EE K +M L V +++ G+ I + + E
Sbjct: 40 GHVMAVKQMRRTGNK--EENKRILM---DLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94
Query: 59 YMPN--KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNIL 116
M L + PI IL + I + L YL+E + +IHRD+K SNIL
Sbjct: 95 LMSTCLDKLLKRIQGPIPEDILG-----KMTVAIVKALHYLKE--KHGVIHRDVKPSNIL 147
Query: 117 LGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY----ARQGVYSTKSDVFSF 172
L K+ DFG++ +S +A T G Y+ PE Y ++DV+S
Sbjct: 148 LDASGNVKLCDFGISG-RLVDS-KAKTRS-AGCAAYMAPERIDPPDPNPKYDIRADVWSL 204
Query: 173 GVLLLQIISGK 183
G+ L+++ +G+
Sbjct: 205 GISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-09
Identities = 64/252 (25%), Positives = 111/252 (44%), Gaps = 45/252 (17%)
Query: 9 IAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
+ +K L K+ E F + ++L H +L+ G C+ +E ++V EY+ SLD Y
Sbjct: 30 VLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTY 89
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG--EDMKP--- 123
L + + WK + + + + L +L++ + H ++ A N+LL ED K
Sbjct: 90 LKKNKNLINISWK--LEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNP 144
Query: 124 ---KISDFGLA-RIFAKESLEANTEQVVGTIGYIPPEYARQG-VYSTKSDVFSFGVLLLQ 178
K+SD G++ + KE L + I ++PPE S +D +SFG L +
Sbjct: 145 PFIKLSDPGISITVLPKEIL-------LERIPWVPPECIENPQNLSLAADKWSFGTTLWE 197
Query: 179 IISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL-- 236
I G ++ LS L+ K ++F + +P + E+A L
Sbjct: 198 I--------FSGGDKPLSALDSQ-------KKLQFYEDRH-QLPAP----KWTELANLIN 237
Query: 237 -CVQENPNDRPS 247
C+ P+ RPS
Sbjct: 238 QCMDYEPDFRPS 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 6e-09
Identities = 45/184 (24%), Positives = 81/184 (44%), Gaps = 21/184 (11%)
Query: 4 PCGKVIAVKK--LSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMP 61
P ++AVKK L S + + + E++ + +LQH N++ + I E +V M
Sbjct: 23 PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82
Query: 62 NKS----LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
S L + + + L + I++ + L Y+ IHR +KAS+ILL
Sbjct: 83 YGSCEDLLKTHFPEGLPELAI-----AFILKDVLNALDYIH---SKGFIHRSVKASHILL 134
Query: 118 GEDMKPKISDFGLARIFAKES-----LEANTEQVVGTIGYIPPEYARQGV--YSTKSDVF 170
D K +S + K + + V + ++ PE +Q + Y+ KSD++
Sbjct: 135 SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIY 194
Query: 171 SFGV 174
S G+
Sbjct: 195 SVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 7e-09
Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANT--EQVV 147
+ +GL Y+ + +IHRDLK SN+L+ ED + +I DFG+AR + E + V
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 148 GTIGYIPPEYA-RQGVYSTKSDVFSFGVLLLQIISGKRL 185
T Y PE Y+T D++S G + +++ ++L
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 7e-09
Identities = 53/182 (29%), Positives = 81/182 (44%), Gaps = 15/182 (8%)
Query: 9 IAVKKL-SKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+ VK+L S Q +F E LQH NL++ LG C + +LV E+ P L
Sbjct: 25 VVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKG 84
Query: 68 YLFD--PIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
YL + D + I GLL+L + IH DL N LL D+ KI
Sbjct: 85 YLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKI 141
Query: 126 SDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY--------STKSDVFSFGVLLL 177
D+GL+ KE +Q+ + +I PE + V+ + +S+V+S GV +
Sbjct: 142 GDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE-VHGNLLVVDQTKESNVWSLGVTIW 200
Query: 178 QI 179
++
Sbjct: 201 EL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 50/188 (26%), Positives = 94/188 (50%), Gaps = 23/188 (12%)
Query: 6 GKVIAVKKLS-KTSTQGFEEFK-NEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
+++A+K++ +G E+ L +L+H N++R+ ++ LV+EY ++
Sbjct: 25 HEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC-DQ 83
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGIT----QGLLYLQEYSRLTIIHRDLKASNILLGE 119
L Y FD I I++ +GL + ++ ++HRDLK N+L+ +
Sbjct: 84 DLKKY-FDSCNGDI-----DPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINK 134
Query: 120 DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGVLL 176
+ + K++DFGLAR F + E V T+ Y PP+ A+ +YST D++S G +
Sbjct: 135 NGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAK--LYSTSIDMWSAGCIF 190
Query: 177 LQIISGKR 184
++ + R
Sbjct: 191 AELANAGR 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 49/187 (26%), Positives = 86/187 (45%), Gaps = 16/187 (8%)
Query: 6 GKVIAVKKL-----SKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML--VYE 58
G+ +AVK++ S+ +++ + E+ L L+H +++ G D EE+ L E
Sbjct: 27 GRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE 86
Query: 59 YMPNKSLDCYLFDPIRRL-ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
YMP S+ D ++ L I QG+ YL I+HRD+K +NIL
Sbjct: 87 YMPGGSIK----DQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILR 139
Query: 118 GEDMKPKISDFGLARIFAKESLEAN-TEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
K+ DFG ++ + + V GT ++ PE Y K+DV+S +
Sbjct: 140 DSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTV 199
Query: 177 LQIISGK 183
+++++ K
Sbjct: 200 VEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 1e-08
Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 15/152 (9%)
Query: 47 CIDSEERML-VYEYMPNKSLDCYLFDPIR-RLILDWKKRVHIIEGITQGLLYLQEYSRLT 104
C +E R+ V EY+ L +F R R + + R + E I+ L YL E
Sbjct: 64 CFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALNYLHERG--- 116
Query: 105 IIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEA--NTEQVVGTIGYIPPEYARQGV 162
II+RDLK N+LL + K++D+G+ KE L T GT YI PE R
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMC----KEGLRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINEN 194
Y D ++ GVL+ ++++G+ + G ++N
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-08
Identities = 52/181 (28%), Positives = 89/181 (49%), Gaps = 14/181 (7%)
Query: 6 GKVIAVKKLSKTSTQG--FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
GK++A+K + +G F + E L L+H N++ + E LV+EY+
Sbjct: 30 GKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTD 88
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYL-QEYSRLTIIHRDLKASNILLGEDMK 122
C D + ++ + + + +GL Y+ Q Y I+HRDLK N+L+ + +
Sbjct: 89 L--CQYMDKHPGGLHPENVKLFLFQ-LLRGLSYIHQRY----ILHRDLKPQNLLISDTGE 141
Query: 123 PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV-YSTKSDVFSFGVLLLQIIS 181
K++DFGLAR + S + E V T+ Y PP+ YST D++ G + +++I
Sbjct: 142 LKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQ 199
Query: 182 G 182
G
Sbjct: 200 G 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 33/99 (33%), Positives = 54/99 (54%), Gaps = 9/99 (9%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGT 149
I +GL YL I+HRD+K N+L+ + KI DFGLAR+ + + T++VV T
Sbjct: 112 ILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-T 167
Query: 150 IGYIPPEY---ARQGVYSTKSDVFSFGVLLLQIISGKRL 185
Y PE +R Y++ D++S G + +++ + L
Sbjct: 168 QYYRAPEILMGSRH--YTSAVDIWSVGCIFAELLGRRIL 204
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 56/185 (30%), Positives = 92/185 (49%), Gaps = 18/185 (9%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVM-LTAK--LQHVN--LIRVLGFCIDSEERM-LVYEY 59
GK+ A KKL K + ++ K E M L K L+ VN + L + ++++ + LV
Sbjct: 25 GKMYACKKLEK---KRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
M L ++++ + D ++ + + GL LQ R I++RDLK NILL +
Sbjct: 82 MNGGDLKFHIYN-MGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDD 137
Query: 120 DMKPKISDFGLA-RIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
+ISD GLA +I E++ VGT+GY+ PE Y+ D + G L+ +
Sbjct: 138 RGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYE 193
Query: 179 IISGK 183
+I G+
Sbjct: 194 MIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 50/194 (25%), Positives = 85/194 (43%), Gaps = 35/194 (18%)
Query: 6 GKVIAVKKLS--KTSTQGFEEFKNEVMLTAKLQHVNLIR--------------VLGFCID 49
GK +KKL+ S + + + E L ++L+H N++ V+GFC
Sbjct: 25 GKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFC-- 82
Query: 50 SEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRD 109
E +Y + + +++W + I L YL E I+HRD
Sbjct: 83 --EGGDLYHKLKEQKGKLLP----ENQVVEWFVQ------IAMALQYLHEKH---ILHRD 127
Query: 110 LKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDV 169
LK N+ L K+ D G+AR+ + A+T ++GT Y+ PE Y+ KSDV
Sbjct: 128 LKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPYNYKSDV 185
Query: 170 FSFGVLLLQIISGK 183
++ G + ++ + K
Sbjct: 186 WALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE--ANTEQVV 147
IT L++L + II+RDLK N+LL + K++DFG+ KE + T
Sbjct: 105 ITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGM----CKEGIFNGKTTSTFC 157
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
GT YI PE ++ +Y D ++ GVLL +++ G
Sbjct: 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 57/195 (29%), Positives = 88/195 (45%), Gaps = 40/195 (20%)
Query: 9 IAVKKLSK--TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL- 65
+AVKKLS+ S + E+ L ++H N+I +L + P +SL
Sbjct: 45 VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV------------FTPARSLE 92
Query: 66 ---DCYLFDPI-----------RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLK 111
D YL + ++L D + +I I +GL Y+ IIHRDLK
Sbjct: 93 EFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ--FLIYQILRGLKYIHSAD---IIHRDLK 147
Query: 112 ASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV-YSTKSDVF 170
SN+ + ED + KI DFGLAR E V T Y PE + Y+ D++
Sbjct: 148 PSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIW 202
Query: 171 SFGVLLLQIISGKRL 185
S G ++ ++++G+ L
Sbjct: 203 SVGCIMAELLTGRTL 217
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 50/165 (30%), Positives = 87/165 (52%), Gaps = 22/165 (13%)
Query: 6 GKVIAVKK-LSKTSTQGFEEFK-NEVMLTAKLQHVNLIRVLGFCIDSEERM--------- 54
+++A+KK L + +GF E+ + L+H N++ ++ C ++
Sbjct: 37 KQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEIC-RTKATPYNRYKGSFY 95
Query: 55 LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
LV+E+ + L L + + L K+V ++ + GL Y+ R I+HRD+KA+N
Sbjct: 96 LVFEFCEH-DLAGLLSNKNVKFTLSEIKKV--MKMLLNGLYYIH---RNKILHRDMKAAN 149
Query: 115 ILLGEDMKPKISDFGLARIF-AKESLEAN--TEQVVGTIGYIPPE 156
IL+ +D K++DFGLAR F ++ + N T +VV T+ Y PPE
Sbjct: 150 ILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 36/103 (34%), Positives = 52/103 (50%), Gaps = 18/103 (17%)
Query: 94 LLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARI-------------FAKESLE 140
L YL Y I+HRDLK N+L+ K++DFGL++I K++ E
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 141 ANTEQVVGTIGYIPPEYA-RQGVYSTKSDVFSFGVLLLQIISG 182
+QV GT YI PE RQG Y D ++ G++L + + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 67/275 (24%), Positives = 121/275 (44%), Gaps = 45/275 (16%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKN----EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMP 61
G+++A+KK ++ + K E+ + +L+H NL+ ++ + LV+E++
Sbjct: 26 GQIVAIKKFLESEDD--KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVD 83
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
+ LD P LD + + I +G+ + ++ IIHRD+K NIL+ +
Sbjct: 84 HTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSG 137
Query: 122 KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV-YSTKSDVFSFGVLLLQII 180
K+ DFG AR A E T+ V T Y PE Y D+++ G L+ +++
Sbjct: 138 VVKLCDFGFARTLAAPG-EVYTD-YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEML 195
Query: 181 SGKRL------------SMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLM 228
+G+ L + C N ++ E+++ K F L + L
Sbjct: 196 TGEPLFPGDSDIDQLYHIIKCLGN----LIPRHQEIFQ--KNPLFAGMRLPEVKEIEPLE 249
Query: 229 R--------CLEIALLCVQENPNDRPSMLQVSSML 255
+ L++A C++ +P+DRPS SS L
Sbjct: 250 KRFPKLSGLVLDLAKQCLRIDPDDRPS----SSQL 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-08
Identities = 53/203 (26%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 6 GKVIAVKKLSKTSTQG--FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
G+++A+K +S + +G F + E L L+H N++ + E V+EYM +
Sbjct: 30 GQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-HT 87
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
L Y+ L + R+ + + + +GL Y+ I+HRDLK N+L+ +
Sbjct: 88 DLAQYMIQHPGGL-HPYNVRLFMFQ-LLRGLAYIH---GQHILHRDLKPQNLLISYLGEL 142
Query: 124 KISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV-YSTKSDVFSFGVLLLQIISG 182
K++DFGLAR + S ++E V T+ Y PP+ YS+ D++ G + ++++ G
Sbjct: 143 KLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQG 200
Query: 183 KRLSMLCGINENLSILEHAYELW 205
+ G++ + E ++W
Sbjct: 201 QPA--FPGVS---DVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 40/107 (37%), Positives = 53/107 (49%), Gaps = 18/107 (16%)
Query: 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFG----LARIFAKESLE 140
I + L YL+E L IIHRD+K SNILL + K+ DFG L AK
Sbjct: 111 KIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---- 164
Query: 141 ANTEQVVGTIGYIPPE----YARQGVYSTKSDVFSFGVLLLQIISGK 183
+ G Y+ PE AR G Y +SDV+S G+ L ++ +GK
Sbjct: 165 ---TRDAGCRPYMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 15/162 (9%)
Query: 47 CIDSEERM-LVYEYMPNKSLDCYLFDPIR-RLILDWKKRVHIIEGITQGLLYLQEYSRLT 104
C + R+ LV EY+ L +F R R + + R + E I L +L E
Sbjct: 64 CFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAE-ICIALNFLHERG--- 116
Query: 105 IIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEA--NTEQVVGTIGYIPPEYARQGV 162
II+RDLK N+LL D K++D+G+ KE L T GT YI PE R
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGM----CKEGLGPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL 204
Y D ++ GVL+ ++++G+ + N +++ ++ +++
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV 214
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-08
Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 15/152 (9%)
Query: 47 CIDSEERM-LVYEYMPNKSLDCYLFDPIR-RLILDWKKRVHIIEGITQGLLYLQEYSRLT 104
C +E R+ V E++ L +F R R + + R + E I+ L +L E
Sbjct: 64 CFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALNFLHERG--- 116
Query: 105 IIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEAN--TEQVVGTIGYIPPEYARQGV 162
II+RDLK N+LL + K++D+G+ KE + T GT YI PE R
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGM----CKEGIRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINEN 194
Y D ++ GVL+ ++++G+ + G+++N
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-08
Identities = 45/180 (25%), Positives = 82/180 (45%), Gaps = 20/180 (11%)
Query: 9 IAVKKLSKTSTQGF-EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+AVK ++ E+F E + + H ++++++G + +V E P L
Sbjct: 37 VAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRS 95
Query: 68 YLFD-----PIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
YL + LIL ++ L YL+ +HRD+ A N+L+
Sbjct: 96 YLQVNKYSLDLASLIL-------YSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDC 145
Query: 123 PKISDFGLARIFAKESL-EANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
K+ DFGL+R ES +A+ ++ I ++ PE +++ SDV+ FGV + +I+
Sbjct: 146 VKLGDFGLSRYLEDESYYKASKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 4e-08
Identities = 31/81 (38%), Positives = 46/81 (56%), Gaps = 6/81 (7%)
Query: 105 IIHRDLKASNILLGEDMKPKISDFGLARIFAKESL--EANTEQVVGTIGYIPPEYARQGV 162
II+RDLK N++L D KI+DFG+ KE++ + GT YI PE +
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGM----CKENVFGDNRASTFCGTPDYIAPEILQGLK 172
Query: 163 YSTKSDVFSFGVLLLQIISGK 183
Y+ D +SFGVLL +++ G+
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 57/183 (31%), Positives = 86/183 (46%), Gaps = 16/183 (8%)
Query: 6 GKVIAVKKLSK---TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS---EERMLVYEY 59
G +AVKKLS+ T ++ V+L + H N+I +L EE VY
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKC-VNHKNIISLLNVFTPQKSLEEFQDVYLV 104
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
M + +D L I + LD ++ +++ + G+ +L IIHRDLK SNI++
Sbjct: 105 M--ELMDANLCQVIH-MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKS 158
Query: 120 DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQI 179
D KI DFGLAR + T VV T Y PE Y D++S G ++ ++
Sbjct: 159 DCTLKILDFGLARTACTNFMM--TPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215
Query: 180 ISG 182
+ G
Sbjct: 216 VKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 5/94 (5%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGT 149
I+ GL +L II+RDLK N++L + KI+DFG+ + + + T GT
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGT 164
Query: 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
YI PE Y D +++GVLL ++++G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 5e-08
Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 94 LLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEAN--TEQVVGTIG 151
L L+ + II+RDLK NILL K++DFGL KES+ T GTI
Sbjct: 110 SLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGL----CKESIHEGTVTHTFCGTIE 165
Query: 152 YIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
Y+ PE + + D +S G L+ +++G
Sbjct: 166 YMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-08
Identities = 52/186 (27%), Positives = 86/186 (46%), Gaps = 22/186 (11%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN----LIRVLGFCIDSEERM-LVYEYM 60
G A+K L K+ + N V + + + L + S++ + LV EY+
Sbjct: 21 GDYFAIKVLKKSDMIAKNQVTN-VKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL 79
Query: 61 PNKSLDC-YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
DC L + L DW K+ I + +L +++ + IIHRD+K N+L+ +
Sbjct: 80 NGG--DCASLIKTLGGLPEDWAKQY-----IAEVVLGVEDLHQRGIIHRDIKPENLLIDQ 132
Query: 120 DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTK-SDVFSFGVLLLQ 178
K++DFGL+R LE ++ VGT Y+ PE GV K SD +S G ++ +
Sbjct: 133 TGHLKLTDFGLSRN----GLE--NKKFVGTPDYLAPE-TILGVGDDKMSDWWSLGCVIFE 185
Query: 179 IISGKR 184
+ G
Sbjct: 186 FLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 40/96 (41%), Positives = 55/96 (57%), Gaps = 10/96 (10%)
Query: 93 GLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEAN--TEQVVGTI 150
GL YL E IIHRDLK SN+LL + KI+DFGLAR + L A T +VV T+
Sbjct: 120 GLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY---GLPAKPMTPKVV-TL 172
Query: 151 GYIPPEYA-RQGVYSTKSDVFSFGVLLLQIISGKRL 185
Y PE Y+T D+++ G +L ++++ K L
Sbjct: 173 WYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-08
Identities = 55/185 (29%), Positives = 85/185 (45%), Gaps = 20/185 (10%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVM-----LTAKLQHVNLIRVLGFCIDSEERM-LVYEY 59
GK AVK L K + +E K+ +M L ++H L+ L + + +++ V +Y
Sbjct: 20 GKFYAVKVLQKKAILKKKEQKH-IMAERNVLLKNVKHPFLVG-LHYSFQTADKLYFVLDY 77
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
+ L +L R + + R + E I L YL L II+RDLK NILL
Sbjct: 78 VNGGELFFHL--QRERSFPEPRARFYAAE-IASALGYLHS---LNIIYRDLKPENILLDS 131
Query: 120 DMKPKISDFGLARIFAKESLEAN--TEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
++DFGL KE +E + T GT Y+ PE R+ Y D + G +L
Sbjct: 132 QGHVVLTDFGL----CKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLY 187
Query: 178 QIISG 182
+++ G
Sbjct: 188 EMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 5e-08
Identities = 31/86 (36%), Positives = 46/86 (53%), Gaps = 11/86 (12%)
Query: 105 IIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQV---VGTIGYIPPE----Y 157
++HRDLK N+L+ D + KI DFGLAR F+ E+ N + V T Y PE +
Sbjct: 126 VLHRDLKPGNLLVNADCELKICDFGLARGFS-ENPGENAGFMTEYVATRWYRAPEIMLSF 184
Query: 158 ARQGVYSTKSDVFSFGVLLLQIISGK 183
Y+ DV+S G +L +++ K
Sbjct: 185 QS---YTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 5e-08
Identities = 51/189 (26%), Positives = 87/189 (46%), Gaps = 19/189 (10%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEV-MLTAKLQHVNLIRVLGFCIDS------EERMLVYE 58
G++ A+K + T + EE K E+ ML H N+ G I ++ LV E
Sbjct: 31 GQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME 89
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
+ S+ L + L + +I I +GL +L ++ +IHRD+K N+LL
Sbjct: 90 FCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLT 145
Query: 119 EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR-----QGVYSTKSDVFSFG 173
E+ + K+ DFG++ + NT +GT ++ PE Y KSD++S G
Sbjct: 146 ENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 203
Query: 174 VLLLQIISG 182
+ +++ G
Sbjct: 204 ITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 6e-08
Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 9/96 (9%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEAN--TEQVV 147
+T L++L + +I+RDLK NILL + K++DFG+ KE + T
Sbjct: 105 VTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGM----CKEGILNGVTTTTFC 157
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
GT YI PE ++ Y D ++ GVL+ ++++G+
Sbjct: 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 8e-08
Identities = 46/166 (27%), Positives = 74/166 (44%), Gaps = 28/166 (16%)
Query: 92 QGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKE-SLEANTEQVVGTI 150
Q +L L E ++HRDLK++NI L K+ DFG ++ ++ SL+ + GT
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS-SFCGTP 235
Query: 151 GYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG 210
Y+ PE + YS K+D++S GV+L ++++ R +KG
Sbjct: 236 YYLAPELWERKRYSKKADMWSLGVILYELLTLHR-------------------PFKGPSQ 276
Query: 211 VEFVDSSLDDTNSPCKL-----MRCLEIALLCVQENPNDRPSMLQV 251
E + L P M+ L LL +NP RP+ Q+
Sbjct: 277 REIMQQVLYGKYDPFPCPVSSGMKALLDPLL--SKNPALRPTTQQL 320
|
Length = 478 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 8e-08
Identities = 50/162 (30%), Positives = 84/162 (51%), Gaps = 15/162 (9%)
Query: 28 EVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86
E L L+H N++ L I +++ + LV+EY+ + L Y+ D L
Sbjct: 53 EASLLKDLKHANIV-TLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGG--GLSMHNVRLF 108
Query: 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANT--E 144
+ + +GL Y + ++HRDLK N+L+ E + K++DFGLAR AK S+ + T
Sbjct: 109 LFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR--AK-SVPSKTYSN 162
Query: 145 QVVGTIGYIPPEYARQGV-YSTKSDVFSFGVLLLQIISGKRL 185
+VV T+ Y PP+ YST D++ G + ++ +G+ L
Sbjct: 163 EVV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPL 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 8e-08
Identities = 55/183 (30%), Positives = 86/183 (46%), Gaps = 16/183 (8%)
Query: 9 IAVKKLSK---TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS---EERMLVYEYMPN 62
+A+KKLS+ T ++ E++L + H N+I +L EE VY M
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM-- 108
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
+ +D L I+ + LD ++ +++ + G+ +L IIHRDLK SNI++ D
Sbjct: 109 ELMDANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCT 164
Query: 123 PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
KI DFGLAR + V T Y PE Y D++S G ++ ++I G
Sbjct: 165 LKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
Query: 183 KRL 185
L
Sbjct: 222 GVL 224
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 51/186 (27%), Positives = 81/186 (43%), Gaps = 21/186 (11%)
Query: 6 GKVIAVKKLSK---TSTQGFEEFKNE--VMLTA-KLQHVNLIRVLGFCIDSEERM-LVYE 58
G++ A+K L K + E E + TA +H L+ + C +E+ + V E
Sbjct: 24 GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFA-CFQTEDHVCFVME 82
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
Y L + I + + V + GL YL E I++RDLK N+LL
Sbjct: 83 YAAGGDLMMH----IHTDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLD 135
Query: 119 EDMKPKISDFGLARIFAKESL--EANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
+ KI+DFGL KE + T GT ++ PE + Y+ D + GVL+
Sbjct: 136 TEGFVKIADFGL----CKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLI 191
Query: 177 LQIISG 182
+++ G
Sbjct: 192 YEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 2/93 (2%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGT 149
+ L L+ + +I+RDLK NILL + DFGL ++ K+ + NT GT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156
Query: 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
Y+ PE Y+ D ++ GVLL ++++G
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 96 YLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155
YLQ L I++RDLK N+LL +D K++DFG A++ ++ T + GT YI P
Sbjct: 146 YLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYIAP 197
Query: 156 EYARQGVYSTKSDVFSFGVLLLQIISG 182
E + +D ++ G+ + +I+ G
Sbjct: 198 EILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGT 149
I + +L L+ + I++RDLK NILL + DFGL++ A + T GT
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGT 159
Query: 150 IGYIPPE-YARQGVYSTKSDVFSFGVLLLQIISG 182
Y+ PE + Y+ D +S GVL+ ++ G
Sbjct: 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 42/178 (23%), Positives = 80/178 (44%), Gaps = 16/178 (8%)
Query: 12 KKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM----LVYEYMPNKSLDC 67
KK K + +NE+ ++ N++++ GF ID + + L+ EY L
Sbjct: 52 KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLRE 111
Query: 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISD 127
L + L +K ++ + +GL L +Y+ +++L + + L+ E+ K KI
Sbjct: 112 VLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIIC 166
Query: 128 FGLARIFAKESLEANTEQVVGTIGYIPPEYARQ--GVYSTKSDVFSFGVLLLQIISGK 183
GL +I + + V + Y + Y+ K D++S GV+L +I +GK
Sbjct: 167 HGLEKILSSPPFKN-----VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 55/189 (29%), Positives = 90/189 (47%), Gaps = 22/189 (11%)
Query: 6 GKVIAVKKLSK--TSTQGFEEFKNEVMLTAKLQHVNLIRVLG-FCIDS--EERMLVYEYM 60
G +A+KKL + S + E+ L ++H N+I +L F D + Y M
Sbjct: 40 GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVH-IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
P D +L D R+ ++ + +GL Y+ IIHRDLK N+ + E
Sbjct: 100 PFMGTDLGKLMKHEKLSED---RIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNE 153
Query: 120 DMKPKISDFGLARIFAKESLEANTEQV--VGTIGYIPPEYARQGVYSTKS-DVFSFGVLL 176
D + KI DFGLAR + ++E V T Y PE ++ T++ D++S G ++
Sbjct: 154 DCELKILDFGLAR-------QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIM 206
Query: 177 LQIISGKRL 185
++++GK L
Sbjct: 207 AEMLTGKPL 215
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 52/190 (27%), Positives = 86/190 (45%), Gaps = 21/190 (11%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEV-MLTAKLQHVNLIRVLGFCI------DSEERMLVYE 58
G++ A+K + T + EE K E+ ML H N+ G I ++ LV E
Sbjct: 41 GQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVME 99
Query: 59 YMPNKSL-DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
+ S+ D L DW +I I +GL +L + +IHRD+K N+LL
Sbjct: 100 FCGAGSVTDLVKNTKGNALKEDWI--AYICREILRGLAHLHAHK---VIHRDIKGQNVLL 154
Query: 118 GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR-----QGVYSTKSDVFSF 172
E+ + K+ DFG++ + NT +GT ++ PE Y +SD++S
Sbjct: 155 TENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDYRSDIWSL 212
Query: 173 GVLLLQIISG 182
G+ +++ G
Sbjct: 213 GITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 31/87 (35%), Positives = 45/87 (51%), Gaps = 8/87 (9%)
Query: 96 YLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155
YL II+RDLK N+LL K++DFG FAK+ + T + GT Y+ P
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFG----FAKKVPD-RTFTLCGTPEYLAP 184
Query: 156 EYARQGVYSTKSDVFSFGVLLLQIISG 182
E + + D ++ GVLL + I+G
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-07
Identities = 33/104 (31%), Positives = 56/104 (53%), Gaps = 11/104 (10%)
Query: 105 IIHRDLKASNILLGED-MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY---ARQ 160
++HRDLK N+L+ + KI+D GL R F+ +++ T ++V T+ Y PE +
Sbjct: 131 VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-PVKSYTHEIV-TLWYRAPEVLLGSTH 188
Query: 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL 204
YST D++S G + ++ + L G +E L L H ++L
Sbjct: 189 --YSTPVDIWSVGCIFAEMSRKQPL--FPGDSE-LQQLLHIFKL 227
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 31/84 (36%), Positives = 41/84 (48%), Gaps = 3/84 (3%)
Query: 105 IIHRDLKASNILLGEDMKPKISDFGLARI-FAKESLEANTEQVVGTIGYIPPEYARQ--G 161
+ HRDLK NIL D K KI DFGLAR+ F V T Y PE
Sbjct: 124 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFS 183
Query: 162 VYSTKSDVFSFGVLLLQIISGKRL 185
Y+ D++S G + ++++GK L
Sbjct: 184 KYTPAIDIWSIGCIFAEVLTGKPL 207
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 36/103 (34%), Positives = 55/103 (53%), Gaps = 13/103 (12%)
Query: 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQ 145
+I + +GL Y+ IIHRDLK SN+ + ED + +I DFGLAR +A+ E
Sbjct: 123 LIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-------QADDEM 172
Query: 146 V--VGTIGYIPPEYARQGV-YSTKSDVFSFGVLLLQIISGKRL 185
V T Y PE + Y+ D++S G ++ +++ GK L
Sbjct: 173 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKAL 215
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 4e-07
Identities = 56/183 (30%), Positives = 88/183 (48%), Gaps = 16/183 (8%)
Query: 9 IAVKKLSK---TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS---EERMLVYEYMPN 62
+A+KKLS+ T ++ E++L + H N+I +L EE VY M
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM-- 101
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
+ +D L I+ + LD ++ +++ + G+ +L IIHRDLK SNI++ D
Sbjct: 102 ELMDANLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCT 157
Query: 123 PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
KI DFGLAR + T VV T Y PE Y D++S G ++ +++
Sbjct: 158 LKILDFGLARTAGTSFMM--TPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 214
Query: 183 KRL 185
K L
Sbjct: 215 KIL 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-07
Identities = 55/185 (29%), Positives = 84/185 (45%), Gaps = 20/185 (10%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVM-----LTAKLQHVNLIRVLGFCIDSEERM-LVYEY 59
G AVK L K + +E +N +M L L+H L+ L + + E++ V +Y
Sbjct: 20 GSFYAVKVLQKKTILKKKE-QNHIMAERNVLLKNLKHPFLVG-LHYSFQTAEKLYFVLDY 77
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
+ L +L R L+ + R + E + + YL L II+RDLK NILL
Sbjct: 78 VNGGELFFHL--QRERCFLEPRARFYAAE-VASAIGYLHS---LNIIYRDLKPENILLDS 131
Query: 120 DMKPKISDFGLARIFAKESL--EANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
++DFGL KE + E T GT Y+ PE R+ Y D + G +L
Sbjct: 132 QGHVVLTDFGL----CKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLY 187
Query: 178 QIISG 182
+++ G
Sbjct: 188 EMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 5e-07
Identities = 54/189 (28%), Positives = 82/189 (43%), Gaps = 27/189 (14%)
Query: 7 KVIAVKKLSK-----TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML--VYEY 59
KV A+K LSK S F + ++M A V V FC +++ L V EY
Sbjct: 69 KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV----VQLFCAFQDDKYLYMVMEY 124
Query: 60 MPNKSLDCYL--FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
MP L + +D + W K + +L L + +IHRD+K N+LL
Sbjct: 125 MPGGDLVNLMSNYDVPEK----WAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLL 175
Query: 118 GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ----GVYSTKSDVFSFG 173
+ K++DFG + + + VGT YI PE + G Y + D +S G
Sbjct: 176 DKHGHLKLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234
Query: 174 VLLLQIISG 182
V L +++ G
Sbjct: 235 VFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 51/192 (26%), Positives = 86/192 (44%), Gaps = 21/192 (10%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAK-----------LQHVN--LIRVLGFCIDSEE 52
GKVI VK+ + + K EV++ LQ+ + L + + +
Sbjct: 9 GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD 68
Query: 53 RM-LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLK 111
R+ V EY L +L R+ + + R + E I L YL +S +++RDLK
Sbjct: 69 RLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSALDYL--HSEKNVVYRDLK 123
Query: 112 ASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFS 171
N++L +D KI+DFGL + K+ A + GT Y+ PE Y D +
Sbjct: 124 LENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 181
Query: 172 FGVLLLQIISGK 183
GV++ +++ G+
Sbjct: 182 LGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 6e-07
Identities = 50/183 (27%), Positives = 85/183 (46%), Gaps = 15/183 (8%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN--LIRVLGFCIDSEERM-LVYEYMPN 62
G+ A+K L K +E + V + LQ+ + L + + +R+ V EY
Sbjct: 20 GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
L +L R+ + + R + E I L YL +SR +++RD+K N++L +D
Sbjct: 80 GELFFHL--SRERVFTEERARFYGAE-IVSALEYL--HSR-DVVYRDIKLENLMLDKDGH 133
Query: 123 PKISDFGLARIFAKESL--EANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
KI+DFGL KE + A + GT Y+ PE Y D + GV++ +++
Sbjct: 134 IKITDFGL----CKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189
Query: 181 SGK 183
G+
Sbjct: 190 CGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 7e-07
Identities = 37/110 (33%), Positives = 53/110 (48%), Gaps = 10/110 (9%)
Query: 75 RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIF 134
R L+ + R + E I L YL L I++RDLK NILL ++DFGL
Sbjct: 91 RCFLEPRARFYAAE-IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGL---- 142
Query: 135 AKESLEAN--TEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
KE++E N T GT Y+ PE + Y D + G +L +++ G
Sbjct: 143 CKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 8e-07
Identities = 47/183 (25%), Positives = 84/183 (45%), Gaps = 13/183 (7%)
Query: 7 KVIAVKKLSKTSTQGFEEFKN----EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
+++A+KK ++ EE K E+ + L+ N++ + + LV+EY+
Sbjct: 27 EIVAIKKFK--DSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEK 84
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
L+ L + + + K R +I + I + + I+HRD+K N+L+ +
Sbjct: 85 NMLE--LLEEMPNGVPPEKVRSYIYQLIKA----IHWCHKNDIVHRDIKPENLLISHNDV 138
Query: 123 PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
K+ DFG AR + E AN + V T Y PE Y D++S G +L ++ G
Sbjct: 139 LKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDG 197
Query: 183 KRL 185
+ L
Sbjct: 198 QPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 9e-07
Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 38/216 (17%)
Query: 6 GKVIAVKK--LSKTSTQGFEEFKN------------EVMLTAKLQHVNLIRVLGFCIDSE 51
GK++A+KK + + S ++ + E+ + +++H N++ ++ ++ +
Sbjct: 34 GKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93
Query: 52 ERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLK 111
LV + M S + D RL K I+ I GL L ++ +HRDL
Sbjct: 94 FINLVMDIM--ASDLKKVVDRKIRLTESQVK--CILLQILNGLNVLHKWY---FMHRDLS 146
Query: 112 ASNILLGEDMKPKISDFGLARIFAKESL-------------EANTEQVVGTIGYIPPEYA 158
+NI + KI+DFGLAR + E T +VV T+ Y PE
Sbjct: 147 PANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVV-TLWYRAPELL 205
Query: 159 RQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINE 193
Y D++S G + ++++GK L G NE
Sbjct: 206 MGAEKYHFAVDMWSVGCIFAELLTGKPL--FPGENE 239
|
Length = 335 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 31/93 (33%), Positives = 46/93 (49%), Gaps = 5/93 (5%)
Query: 94 LLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYI 153
+L L + IHRD+K N+LL + K++DFG KE + + VGT YI
Sbjct: 152 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYI 210
Query: 154 PPEYARQ----GVYSTKSDVFSFGVLLLQIISG 182
PE + G Y + D +S GV L +++ G
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 46/170 (27%), Positives = 83/170 (48%), Gaps = 18/170 (10%)
Query: 28 EVMLTAKLQHVNLIRVLGFCIDSEERM--LVYEYMPNKSLDCYLFDPIRRLILDWKKRVH 85
E+ L +L+H N+I + + +R L+++Y + D + R KK V
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH---DLWHIIKFHRASKANKKPVQ 104
Query: 86 IIEGITQGLLY-----LQEYSRLTIIHRDLKASNILL----GEDMKPKISDFGLARIFAK 136
+ G+ + LLY + ++HRDLK +NIL+ E + KI+D G AR+F
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF-N 163
Query: 137 ESLE--ANTEQVVGTIGYIPPEYARQGVYSTKS-DVFSFGVLLLQIISGK 183
L+ A+ + VV T Y PE + TK+ D+++ G + ++++ +
Sbjct: 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 47/181 (25%), Positives = 84/181 (46%), Gaps = 11/181 (6%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN--LIRVLGFCIDSEERM-LVYEYMPN 62
GK A+K L K +E + + + L++ + L + +++R+ V EY+
Sbjct: 20 GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
L +L R+ + + R + E I L YL I++RDLK N++L +D
Sbjct: 80 GELFFHL--SRERVFSEDRTRFYGAE-IVSALDYLHSGK---IVYRDLKLENLMLDKDGH 133
Query: 123 PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
KI+DFGL + ++ A + GT Y+ PE Y D + GV++ +++ G
Sbjct: 134 IKITDFGLCKEGITDA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191
Query: 183 K 183
+
Sbjct: 192 R 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 32/95 (33%), Positives = 46/95 (48%), Gaps = 7/95 (7%)
Query: 93 GLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGY 152
LL LQ IIHRD+K +NILL + K+ DFG++ L NT VGT +
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFW 194
Query: 153 IPPEY-----ARQGVYSTKSDVFSFGVLLLQIISG 182
+ PE Y + DV+S G+ +++ G
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 9/96 (9%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE--ANTEQVV 147
I L YL +++RDLK N++L +D KI+DFGL KE + A +
Sbjct: 104 IVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGL----CKEGISDGATMKTFC 156
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
GT Y+ PE Y D + GV++ +++ G+
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 40/157 (25%), Positives = 67/157 (42%), Gaps = 10/157 (6%)
Query: 28 EVMLTAKLQHVNLIRVLG-FCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86
E + + H ++I++ G F + +++ Y + L CYL I D + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD--LYCYLAAKRNIAICDI---LAI 187
Query: 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQV 146
+ + + YL E IIHRD+KA NI + + DFG A F +
Sbjct: 188 ERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGW 243
Query: 147 VGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
GTI PE + Y D++S G++L ++ +
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 52/186 (27%), Positives = 81/186 (43%), Gaps = 24/186 (12%)
Query: 7 KVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-EERMLVYEYMPNKSL 65
KVI VK ++ T G E+ + + H +I + I + + V MP
Sbjct: 121 KVI-VKAVTGGKTPG-----REIDILKTISHRAIINL----IHAYRWKSTVCMVMPKYKC 170
Query: 66 DCYLFDPIRRL-ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
D LF + R L ++ + I + + L YL IIHRD+K NI L E
Sbjct: 171 D--LFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAV 225
Query: 125 ISDFGLARIFAKESLEANTEQV---VGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
+ DFG A K +T Q GT+ PE Y K+D++S G++L + +S
Sbjct: 226 LGDFGAA---CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFE-MS 281
Query: 182 GKRLSM 187
K +++
Sbjct: 282 VKNVTL 287
|
Length = 392 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 8e-06
Identities = 29/100 (29%), Positives = 56/100 (56%), Gaps = 8/100 (8%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFG-LARIFAKESLEANTEQVVG 148
+ + +L + +L +HRD+K N+LL ++ +++DFG R+ A ++++N VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV--AVG 165
Query: 149 TIGYIPPEYAR-----QGVYSTKSDVFSFGVLLLQIISGK 183
T YI PE + +G Y + D +S GV + +++ G+
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 9e-06
Identities = 54/185 (29%), Positives = 90/185 (48%), Gaps = 23/185 (12%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKN--EVMLTAKLQ-HVNLIRVLGFCIDSEER--MLVYEYM 60
GK A+K + K + E+ N E+ +L H N++R++ D + LV+E M
Sbjct: 24 GKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM 82
Query: 61 PNKSLDCYLFDPI--RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
D L++ I R+ L K+ + + + L ++ R I HRD+K NIL+
Sbjct: 83 -----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIK 134
Query: 119 EDMKPKISDFGLAR-IFAKESLEANTEQVVGTIGYIPPE-YARQGVYSTKSDVFSFGVLL 176
+D+ K++DFG R I++K TE + T Y PE G Y K D+++ G +
Sbjct: 135 DDIL-KLADFGSCRGIYSKPPY---TE-YISTRWYRAPECLLTDGYYGPKMDIWAVGCVF 189
Query: 177 LQIIS 181
+I+S
Sbjct: 190 FEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (110), Expect = 1e-05
Identities = 54/214 (25%), Positives = 86/214 (40%), Gaps = 50/214 (23%)
Query: 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML--VYEYMPN 62
C K I+ + L + + EV + +L+H N++R + ++ + L + E+
Sbjct: 42 CWKAISYRGLKEREKS---QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDA 98
Query: 63 KSLD-----CY-LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSR--------LTIIHR 108
L CY +F I H I IT+ LL+ Y ++HR
Sbjct: 99 GDLSRNIQKCYKMFGKIEE---------HAIVDITRQLLHALAYCHNLKDGPNGERVLHR 149
Query: 109 DLKASNILLGEDMK-----------------PKISDFGLARIFAKESLEANTEQVVGTIG 151
DLK NI L ++ KI DFGL++ ES+ VGT
Sbjct: 150 DLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPY 206
Query: 152 YIPPEYARQGV--YSTKSDVFSFGVLLLQIISGK 183
Y PE Y KSD+++ G ++ ++ SGK
Sbjct: 207 YWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 42/171 (24%), Positives = 66/171 (38%), Gaps = 44/171 (25%)
Query: 49 DSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK-RVHIIEGITQGLLYLQEYSRLTIIH 107
D L+ EY+P + L +++ ++ R +I E I L + +L IH
Sbjct: 72 DENYLYLIMEYLPGGDMMTLL---MKKDTFTEEETRFYIAETI----LAIDSIHKLGYIH 124
Query: 108 RDLKASNILLGEDMKPKISDFGL------------ARIFAKESLEANTE----------- 144
RD+K N+LL K+SDFGL RI + +
Sbjct: 125 RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184
Query: 145 -------------QVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
VGT YI PE Q Y+ + D +S GV++ +++ G
Sbjct: 185 AETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 27/81 (33%), Positives = 40/81 (49%), Gaps = 5/81 (6%)
Query: 106 IHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR----QG 161
IHRD+K N+LL + K++DFG + + VGT YI PE + G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 162 VYSTKSDVFSFGVLLLQIISG 182
Y + D +S GV L +++ G
Sbjct: 223 YYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 35/126 (27%), Positives = 52/126 (41%), Gaps = 33/126 (26%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAK------------- 136
I + +L + +L IHRD+K N+LL K+SDFGL K
Sbjct: 107 IAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166
Query: 137 ----------------ESLEANTEQV----VGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
E+ + N Q+ VGT YI PE Q Y+ D +S GV++
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 177 LQIISG 182
+++ G
Sbjct: 227 YEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 33/104 (31%), Positives = 48/104 (46%), Gaps = 10/104 (9%)
Query: 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKE--S 138
+ R + E I L YL + I++RDLK NILL ++DFGL KE +
Sbjct: 97 RARFYAAE-IASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGL----CKEGIA 148
Query: 139 LEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
T GT Y+ PE R+ Y D + G +L +++ G
Sbjct: 149 QSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 3e-05
Identities = 44/170 (25%), Positives = 82/170 (48%), Gaps = 18/170 (10%)
Query: 28 EVMLTAKLQHVNLIRVLGFCIDSEERM--LVYEYMPNKSLDCYLFDPIRRLILDWKKRVH 85
E+ L +L+H N+I + + +R L+++Y + D + R KK +
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH---DLWHIIKFHRASKANKKPMQ 104
Query: 86 IIEGITQGLLY-----LQEYSRLTIIHRDLKASNILL----GEDMKPKISDFGLARIFAK 136
+ + + LLY + ++HRDLK +NIL+ E + KI+D G AR+F
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF-N 163
Query: 137 ESLE--ANTEQVVGTIGYIPPEYARQGVYSTKS-DVFSFGVLLLQIISGK 183
L+ A+ + VV T Y PE + TK+ D+++ G + ++++ +
Sbjct: 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-05
Identities = 30/96 (31%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 92 QGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIG 151
+ L+ LQ IHRD+K +NILL + K+ DFG++ L NT VGT
Sbjct: 132 EALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPF 189
Query: 152 YIPPEYAR-----QGVYSTKSDVFSFGVLLLQIISG 182
++ PE Y + DV+S G+ +++ G
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 4e-05
Identities = 35/126 (27%), Positives = 52/126 (41%), Gaps = 33/126 (26%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAK------------- 136
I + +L + +L IHRD+K N+LL K+SDFGL K
Sbjct: 107 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166
Query: 137 ----------------ESLEANTEQV----VGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
E+ + N Q+ VGT YI PE Q Y+ D +S GV++
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 177 LQIISG 182
+++ G
Sbjct: 227 YEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 4e-05
Identities = 39/159 (24%), Positives = 68/159 (42%), Gaps = 23/159 (14%)
Query: 35 LQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR-VHIIE----- 88
LQH N+++ LG C+++ +LV+EY L YL W +R ++
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQE------QWHRRNSQLLLLQRMA 105
Query: 89 -GITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVV 147
I G+ ++ + +H DL N L D+ K+ D+G+ KE +
Sbjct: 106 CEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKC 162
Query: 148 GTIGYIPPEY--ARQG----VYSTK-SDVFSFGVLLLQI 179
+ ++ PE G TK S+V++ GV L ++
Sbjct: 163 VPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 5e-05
Identities = 25/130 (19%), Positives = 47/130 (36%), Gaps = 14/130 (10%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLI--RVLGFCIDSEERMLVYEYMPNK 63
+ +K + + EV + L L +VL L+ E++ +
Sbjct: 21 DEDYVLKINPSREKG--ADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
+LD + +++ I E + + L L + L + H DL NIL+ +
Sbjct: 79 TLD----------EVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKIL 128
Query: 124 KISDFGLARI 133
I D+ A
Sbjct: 129 GIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 6e-05
Identities = 48/192 (25%), Positives = 85/192 (44%), Gaps = 29/192 (15%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKN-------EVMLTAKLQHVNLIRVLGFCIDSEERMLVYE 58
G+++A+KK ++ E+ E+ + +L+H NL+ ++ + LV+E
Sbjct: 26 GQIVAIKKFVES-----EDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKR---VHIIEGIT-QGLLYLQEYSRLTIIHRDLKASN 114
Y + L+ L+ R H+I+ I Q L + + IHRD+K N
Sbjct: 81 YCDHTVLN----------ELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPEN 130
Query: 115 ILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY-ARQGVYSTKSDVFSFG 173
IL+ + + K+ DFG ARI + V T Y PE Y DV++ G
Sbjct: 131 ILITKQGQIKLCDFGFARILTGP--GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIG 188
Query: 174 VLLLQIISGKRL 185
+ ++++G+ L
Sbjct: 189 CVFAELLTGQPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 6e-05
Identities = 48/189 (25%), Positives = 78/189 (41%), Gaps = 53/189 (28%)
Query: 81 KKRVHIIEGIT-QGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL 139
K+ +++I+G+ Q L L++ R+ I+HRD+K N+L+ D + KI DFG A
Sbjct: 305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA---VDMCT 361
Query: 140 EANTEQVVGTIG--YIPPE--------------------------YARQGVYSTKSDVFS 171
N + G + Y PPE Y R ++ D ++
Sbjct: 362 GINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLF----DSYT 417
Query: 172 FGVLLLQI-------ISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNS- 223
GVLL+Q+ ++ RL N L ++ W+ KG ++ S LD
Sbjct: 418 AGVLLMQMCVPELRPVANIRL-----FNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEA 472
Query: 224 ----PCKLM 228
CKL+
Sbjct: 473 GWDLACKLI 481
|
Length = 507 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 8e-05
Identities = 55/234 (23%), Positives = 89/234 (38%), Gaps = 72/234 (30%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
GK+ A+K L K+ E FK + +L HV R + DS + +Y Y +
Sbjct: 26 GKIYAMKTLLKS-----EMFKKD-----QLAHVKAERDVLAESDSPWVVSLY-YSFQDAQ 74
Query: 66 DCYL---FDP---IRRLILDWK------KRVHIIEGITQGLLYLQEYSRLTIIHRDLKAS 113
YL F P + +++ + R ++ E + L ++ +L IHRD+K
Sbjct: 75 YLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECV----LAIEAVHKLGFIHRDIKPD 130
Query: 114 NILLGEDMKPKISDFGLARIFAKES--------LEANTEQ-------------------- 145
NIL+ K+SDFGL+ F K+ L+ + +
Sbjct: 131 NILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSS 190
Query: 146 -----------------VVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
VGT YI PE Q Y + D +S G ++ + + G
Sbjct: 191 KDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 27/99 (27%), Positives = 49/99 (49%), Gaps = 6/99 (6%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGT 149
I + +L + +L +HRD+K N+LL + +++DFG ++ + VGT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-TVQSSVAVGT 166
Query: 150 IGYIPPEYAR-----QGVYSTKSDVFSFGVLLLQIISGK 183
YI PE + G Y + D +S GV + +++ G+
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 1e-04
Identities = 50/195 (25%), Positives = 83/195 (42%), Gaps = 31/195 (15%)
Query: 6 GKVIAVKKLSKTSTQGFEE---FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
G + A+K + K+ E F+ E + + + ++ D + LV EY P
Sbjct: 26 GDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPG 85
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYS-------RLTIIHRDLKASNI 115
L L L + E + Q YL E ++ +HRD+K N+
Sbjct: 86 GDL----------LSLLNRYEDQFDEDMAQ--FYLAELVLAIHSVHQMGYVHRDIKPENV 133
Query: 116 LLGEDMKPKISDFG-LARIFAKESLEANTEQVVGTIGYIPPEY------ARQGVYSTKSD 168
L+ K++DFG AR+ A + + N++ VGT YI PE +G Y + D
Sbjct: 134 LIDRTGHIKLADFGSAARLTANKMV--NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECD 191
Query: 169 VFSFGVLLLQIISGK 183
+S GV+ ++I G+
Sbjct: 192 WWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 2e-04
Identities = 26/99 (26%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGT 149
+ + ++ + +L +HRD+K NIL+ + +++DFG + + E + VGT
Sbjct: 108 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGT 166
Query: 150 IGYIPPEYAR-----QGVYSTKSDVFSFGVLLLQIISGK 183
YI PE + +G Y + D +S GV + +++ G+
Sbjct: 167 PDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 46/198 (23%), Positives = 91/198 (45%), Gaps = 31/198 (15%)
Query: 4 PCGKVIAVK--KLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMP 61
P G ++ V+ L + + + +NEV+L+ +H N++ ++ +M
Sbjct: 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 62 ----NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
N L Y + + ++ +I+ G +GL YL + IHR++KAS+IL+
Sbjct: 83 YGSANSLLKTYFPEGMSEALIG-----NILFGALRGLNYLHQNG---YIHRNIKASHILI 134
Query: 118 GEDMKPKISDFGLARIFAKESLEANTEQV----------VGTIGYIPPEYARQGV--YST 165
D +S GL+ ++ SL N ++ + ++ PE RQ + Y+
Sbjct: 135 SGDGLVSLS--GLSHLY---SLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNV 189
Query: 166 KSDVFSFGVLLLQIISGK 183
KSD++S G+ ++ +G+
Sbjct: 190 KSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 19/51 (37%), Positives = 29/51 (56%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE 140
I++ L L R IIHRDLK N+L+ + K++DFGL+++ L
Sbjct: 110 ISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELN 160
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 34/124 (27%), Positives = 52/124 (41%), Gaps = 43/124 (34%)
Query: 102 RLTIIHRDLKASNILLGEDMKPKISDFGLARIF---------------AKESLEANTE-- 144
++ IHRD+K NIL+ D K++DFGL F ++S+E + E
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 145 ------------------------QVVGTIGYIPPE-YARQGVYSTKSDVFSFGVLLLQI 179
+VGT YI PE R G Y+ D +S GV+L ++
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEM 237
Query: 180 ISGK 183
+ G+
Sbjct: 238 LVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 5e-04
Identities = 32/118 (27%), Positives = 53/118 (44%), Gaps = 13/118 (11%)
Query: 69 LFDPIRR-LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP-KIS 126
LFD +++ L + II + + L L ++ IIH D+K N+L +
Sbjct: 96 LFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLC 152
Query: 127 DFGLARIFAKESLEANTEQVV-GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
D+GL +I T GT+ Y PE + Y D ++ GVL ++++GK
Sbjct: 153 DYGLCKI-------IGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 7e-04
Identities = 35/139 (25%), Positives = 57/139 (41%), Gaps = 45/139 (32%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIF--------------- 134
I + L ++ ++ IHRD+K NIL+ D K++DFGL F
Sbjct: 107 IAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHI 166
Query: 135 AKESLEANT-----------------EQ-------------VVGTIGYIPPEYARQGVYS 164
++S+E + EQ +VGT YI PE + Y+
Sbjct: 167 RQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT 226
Query: 165 TKSDVFSFGVLLLQIISGK 183
D +S GV+L +++ G+
Sbjct: 227 QLCDWWSVGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 8e-04
Identities = 45/194 (23%), Positives = 86/194 (44%), Gaps = 25/194 (12%)
Query: 4 PCGKVIAVKK--LSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM- 60
P G+ + V++ L + + + E+ ++ H N++ I E +V +M
Sbjct: 23 PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82
Query: 61 --PNKSLDCYLF-DPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
K L C F D + L + +I++G+ + L Y+ + +HR +KAS+IL+
Sbjct: 83 YGSAKDLICTHFMDGMSELAI-----AYILQGVLKALDYIHH---MGYVHRSVKASHILI 134
Query: 118 GEDMKPKISDFGLARIFAKESLEANTEQV-------VGTIGYIPPEYARQGV--YSTKSD 168
D K +S GL + + V V + ++ PE +Q + Y KSD
Sbjct: 135 SVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSD 192
Query: 169 VFSFGVLLLQIISG 182
++S G+ ++ +G
Sbjct: 193 IYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 31/127 (24%), Positives = 51/127 (40%), Gaps = 45/127 (35%)
Query: 102 RLTIIHRDLKASNILLGEDMKPKISDFGLARIF---------------AKESLEANTE-- 144
++ IHRD+K NIL+ D K++DFGL F ++S++ + E
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 145 ----------------------------QVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
+VGT YI PE + Y+ D +S GV+L
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 177 LQIISGK 183
+++ G+
Sbjct: 239 YEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.001
Identities = 31/120 (25%), Positives = 45/120 (37%), Gaps = 30/120 (25%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLA------------------ 131
+ L YL L I++RDLK NILL E +SDF L+
Sbjct: 112 VLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGS 168
Query: 132 ---------RIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
E + VGT YI PE + + D ++ G+LL +++ G
Sbjct: 169 RRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 303 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.65 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.63 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.63 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.63 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.61 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.57 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.55 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.52 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.45 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.36 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.34 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.31 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.28 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.21 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.2 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.19 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.15 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.15 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.14 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.12 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.07 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.01 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.99 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.91 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.91 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.83 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.66 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.51 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.44 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.38 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.38 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.38 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.37 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.25 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.19 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.12 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.99 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.95 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.89 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.83 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.71 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.63 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.61 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.56 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.46 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.38 | |
| PLN02236 | 344 | choline kinase | 97.38 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.38 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.3 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.23 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.23 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.2 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.15 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.99 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.91 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.86 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.83 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.77 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.74 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.64 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.43 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.36 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.87 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.66 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.59 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 95.54 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 95.23 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 95.03 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.92 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.77 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.6 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.52 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 93.63 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=329.59 Aligned_cols=231 Identities=27% Similarity=0.349 Sum_probs=191.9
Q ss_pred CCCcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCC-eeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE-ERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
++++.+|+|.+... +....+++.+|++++++++||+||++|+.|..+. ..+++||||++|+|++++.. .+.+++.
T Consensus 102 ~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~---~g~i~E~ 178 (364)
T KOG0581|consen 102 PTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKR---VGRIPEP 178 (364)
T ss_pred CCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhh---cCCCCHH
Confidence 57899999999655 4556678999999999999999999999999998 59999999999999999843 4679999
Q ss_pred HHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 82 KRVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..-+++.++++||.|||+ .+ |+||||||+|+|++..|.|||+|||.+..+.+. ....++||..|||||.+.+
T Consensus 179 ~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g 251 (364)
T KOG0581|consen 179 VLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISG 251 (364)
T ss_pred HHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh----hcccccccccccChhhhcC
Confidence 999999999999999996 66 999999999999999999999999999876654 4455789999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..|+.++||||||++++|+++|+.|+..... .....+........ +..+.+.. ...+.++++|+..||++
T Consensus 252 ~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-~~~~~~~Ll~~Iv~-~ppP~lP~--------~~fS~ef~~FV~~CL~K 321 (364)
T KOG0581|consen 252 ESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-PYLDIFELLCAIVD-EPPPRLPE--------GEFSPEFRSFVSCCLRK 321 (364)
T ss_pred CcCCcccceecccHHHHHHhhCCCCCCCcCC-CCCCHHHHHHHHhc-CCCCCCCc--------ccCCHHHHHHHHHHhcC
Confidence 9999999999999999999999999876511 11222222222221 11111111 13566899999999999
Q ss_pred CCCCCCCHHHHHHH
Q 048243 241 NPNDRPSMLQVSSM 254 (303)
Q Consensus 241 dp~~Rpt~~el~~~ 254 (303)
||.+|||+.|+++.
T Consensus 322 dp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 322 DPSERPSAKQLLQH 335 (364)
T ss_pred CcccCCCHHHHhcC
Confidence 99999999999874
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-49 Score=327.64 Aligned_cols=231 Identities=25% Similarity=0.346 Sum_probs=186.2
Q ss_pred cCCCcEEEEEEecCCCcc-------cHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcccc
Q 048243 3 LPCGKVIAVKKLSKTSTQ-------GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 75 (303)
..+|+.||||++++.... ......+|+++|++|+|||||+++++|+.....||||||++||.|.+++ ..+
T Consensus 194 ~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~v---v~n 270 (475)
T KOG0615|consen 194 KKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKV---VAN 270 (475)
T ss_pred cccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHH---Hhc
Confidence 368999999999754211 2234679999999999999999999999999999999999999999999 456
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCC---CceEEcccccccccccCCccccccccccccCC
Q 048243 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED---MKPKISDFGLARIFAKESLEANTEQVVGTIGY 152 (303)
Q Consensus 76 ~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~---~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y 152 (303)
+.+.+..-+.++.|++.|+.|||+.| |+||||||+|||++.+ -.+||+|||+|+..+.. ......+||+.|
T Consensus 271 k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~---sfm~TlCGTpsY 344 (475)
T KOG0615|consen 271 KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEG---SFMKTLCGTPSY 344 (475)
T ss_pred cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhhccccc---eehhhhcCCccc
Confidence 77888899999999999999999999 9999999999999877 56999999999887633 445568999999
Q ss_pred CChhhhccCCC---CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHH
Q 048243 153 IPPEYARQGVY---STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMR 229 (303)
Q Consensus 153 ~aPE~~~~~~~---~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (303)
.|||++.+... ..++|+||+||++|-+++|.+||......... .+....+... .....-...+++
T Consensus 345 vAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl------~eQI~~G~y~------f~p~~w~~Isee 412 (475)
T KOG0615|consen 345 VAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSL------KEQILKGRYA------FGPLQWDRISEE 412 (475)
T ss_pred cChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccH------HHHHhcCccc------ccChhhhhhhHH
Confidence 99999987653 44889999999999999999999654433211 1111111110 111122345678
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 230 CLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 230 l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
..+||.+||.+||++|||+.|+++.
T Consensus 413 a~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 413 ALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred HHHHHHHhhEeCcccCcCHHHHhcC
Confidence 9999999999999999999999864
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=333.48 Aligned_cols=227 Identities=29% Similarity=0.418 Sum_probs=194.3
Q ss_pred cCCCcEEEEEEecCC---CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 3 LPCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 3 ~~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
+.+|+.||+|++.+. .....+.+.+||++-++|+|||||+++++|++++..|+|.|+|..++|..++. +++.++
T Consensus 40 ~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~K---rrk~lt 116 (592)
T KOG0575|consen 40 LDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLK---RRKPLT 116 (592)
T ss_pred cCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHH---hcCCCC
Confidence 478999999999654 45667889999999999999999999999999999999999999999999983 678899
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+.+++.+++||+.||.|||+.+ |+|||||..|+|++++.+|||+|||+|..+.... ......+||+.|.|||++.
T Consensus 117 EpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~--Erk~TlCGTPNYIAPEVl~ 191 (592)
T KOG0575|consen 117 EPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG--ERKKTLCGTPNYIAPEVLN 191 (592)
T ss_pred cHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCcc--cccceecCCCcccChhHhc
Confidence 9999999999999999999999 9999999999999999999999999998876543 2334478999999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
....+..+||||+||++|.|+.|++||..-...+.+..+... + ...+...+.+..+||.++|+
T Consensus 192 k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~-------------~----Y~~P~~ls~~A~dLI~~lL~ 254 (592)
T KOG0575|consen 192 KSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN-------------E----YSMPSHLSAEAKDLIRKLLR 254 (592)
T ss_pred cCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc-------------C----cccccccCHHHHHHHHHHhc
Confidence 999999999999999999999999999755444433322211 0 11112334478899999999
Q ss_pred CCCCCCCCHHHHHHH
Q 048243 240 ENPNDRPSMLQVSSM 254 (303)
Q Consensus 240 ~dp~~Rpt~~el~~~ 254 (303)
.||.+|||+++++..
T Consensus 255 ~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 255 PNPSERPSLDEVLDH 269 (592)
T ss_pred CCcccCCCHHHHhcC
Confidence 999999999999863
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=318.84 Aligned_cols=256 Identities=43% Similarity=0.713 Sum_probs=216.6
Q ss_pred CccCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCC-eeEEEEeecCCCChhhhhcCccccccCC
Q 048243 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE-ERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 1 ~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
|.+++|+.||||++.........+|.+|+.++.+++|||+++++|+|.+.+ +.+||+|||.+|+|.+.|...... .++
T Consensus 94 G~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~ 172 (361)
T KOG1187|consen 94 GVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLD 172 (361)
T ss_pred EEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCC
Confidence 678899999999887654331456999999999999999999999999988 599999999999999999764333 899
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcccccccc-ccccCCCChhhh
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQV-VGTIGYIPPEYA 158 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~-~g~~~y~aPE~~ 158 (303)
|..+++|+.++|.||+|||+....+|+||||||+|||+|++...||+|||+++..... ....... .||..|+|||++
T Consensus 173 W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~ 250 (361)
T KOG1187|consen 173 WETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYA 250 (361)
T ss_pred HHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc--ccceeeecCCCCccCChhhh
Confidence 9999999999999999999987778999999999999999999999999999543321 1111112 789999999999
Q ss_pred ccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCC-CCCCH-HHHHHHHHHHHH
Q 048243 159 RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLD-DTNSP-CKLMRCLEIALL 236 (303)
Q Consensus 159 ~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~ 236 (303)
.....+.|+||||||++++|+++|+.+..............+....+......+++|+.+. ..... .....+..+..+
T Consensus 251 ~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~ 330 (361)
T KOG1187|consen 251 STGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALR 330 (361)
T ss_pred ccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHH
Confidence 9888999999999999999999999887765544445567777788888888999999987 44443 567779999999
Q ss_pred cccCCCCCCCCHHHHHHHhcccc
Q 048243 237 CVQENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 237 ~l~~dp~~Rpt~~el~~~L~~~~ 259 (303)
|++.+|.+||++.|+++.|+...
T Consensus 331 C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 331 CLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HcCcCCCcCcCHHHHHHHHHhhc
Confidence 99999999999999999995554
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=315.95 Aligned_cols=241 Identities=31% Similarity=0.447 Sum_probs=194.5
Q ss_pred ccCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCccccEEEEEEeCC-eeEEEEeecCCCChhhhhcCccccccC
Q 048243 2 VLPCGKVIAVKKLSKTSTQ--GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE-ERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 2 ~~~~~~~valK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
.+.+...||+|++...... ..+.|.+|+.+|.+++||||++++|++.... ..++||||+++|+|..++... ....+
T Consensus 61 ~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~-~~~~l 139 (362)
T KOG0192|consen 61 KWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKK-RKRKL 139 (362)
T ss_pred EeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhc-ccCCC
Confidence 3443344999999765422 2568999999999999999999999999887 799999999999999999653 46779
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCC-ceEEcccccccccccCCccccccccccccCCCChhh
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM-KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~-~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 157 (303)
++..++.++.||+.||.|||+++. |+||||||+|+|++.++ ++||+|||+++...... .......||+.|||||+
T Consensus 140 ~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv 215 (362)
T KOG0192|consen 140 PLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEV 215 (362)
T ss_pred CHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhh
Confidence 999999999999999999999864 89999999999999997 99999999998765432 22222678999999999
Q ss_pred hc--cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHH
Q 048243 158 AR--QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235 (303)
Q Consensus 158 ~~--~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
+. ...++.|+||||||+++|||++|..||..... ...............+.. .....+..++.
T Consensus 216 ~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~Rp~~p~---------~~~~~l~~l~~ 280 (362)
T KOG0192|consen 216 LRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLRPPIPK---------ECPPHLSSLME 280 (362)
T ss_pred hcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCCCCCCc---------cCCHHHHHHHH
Confidence 99 56899999999999999999999999975543 122222222222222222 23447889999
Q ss_pred HcccCCCCCCCCHHHHHHHhccccCCC
Q 048243 236 LCVQENPNDRPSMLQVSSMLKNETTNR 262 (303)
Q Consensus 236 ~~l~~dp~~Rpt~~el~~~L~~~~~~~ 262 (303)
+||..||..||++.+++..|+......
T Consensus 281 ~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 281 RCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred HhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 999999999999999999998665433
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=304.84 Aligned_cols=240 Identities=22% Similarity=0.318 Sum_probs=193.3
Q ss_pred ccCCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEE-EEEeCC-eeEEEEeecCCCChhhhhcCc-cccc
Q 048243 2 VLPCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLG-FCIDSE-ERMLVYEYMPNKSLDCYLFDP-IRRL 76 (303)
Q Consensus 2 ~~~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~-~~~lv~e~~~~~~L~~~l~~~-~~~~ 76 (303)
++.+|+.+|.|.++-. +...++.+..|+.+|++|+||||+++++ .+..++ .+++|||+|++|+|...+..- ..+.
T Consensus 40 ~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr 119 (375)
T KOG0591|consen 40 CLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKR 119 (375)
T ss_pred eccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccc
Confidence 4678999999998633 4556678999999999999999999999 455444 489999999999999988652 2356
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCC-CCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCCh
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSR-LTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~-~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aP 155 (303)
.+++..+|+++.|++.||..+|.+-. +.|.||||||.|||++.+|.+||+|||+++.+.+.... ....+|||.||+|
T Consensus 120 ~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tf--A~S~VGTPyYMSP 197 (375)
T KOG0591|consen 120 LIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTF--AHSLVGTPYYMSP 197 (375)
T ss_pred cCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHH--HHhhcCCCcccCH
Confidence 79999999999999999999998322 34999999999999999999999999999988765433 3347899999999
Q ss_pred hhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHH
Q 048243 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
|.+.+.+|+.++||||+||++|||+..++||.+- +..... .....+ ....-...-++..+..+|.
T Consensus 198 E~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~-~KI~qg--------d~~~~p~~~YS~~l~~li~ 262 (375)
T KOG0591|consen 198 ERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLC-KKIEQG--------DYPPLPDEHYSTDLRELIN 262 (375)
T ss_pred HHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHH-HHHHcC--------CCCCCcHHHhhhHHHHHHH
Confidence 9999999999999999999999999999999644 222222 222211 1112222567789999999
Q ss_pred HcccCCCCCCCCHHHHHHHhccc
Q 048243 236 LCVQENPNDRPSMLQVSSMLKNE 258 (303)
Q Consensus 236 ~~l~~dp~~Rpt~~el~~~L~~~ 258 (303)
.|+.+||+.||+...+++.+...
T Consensus 263 ~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 263 MCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred HHccCCcccCCCcchHHHHHHHH
Confidence 99999999999976666665543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=304.93 Aligned_cols=181 Identities=32% Similarity=0.464 Sum_probs=162.5
Q ss_pred CCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
+++..||||.+.+. .....+.+..||.+|+.++|||||.+++++.+++.+|+|||||+||+|..|+. ..+.+++.
T Consensus 33 ~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~---~~~~l~e~ 109 (429)
T KOG0595|consen 33 KSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIR---RRGRLPEA 109 (429)
T ss_pred cCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHH---HcCCCCHH
Confidence 56799999999776 55667788999999999999999999999999999999999999999999994 55679999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCC------CceEEcccccccccccCCccccccccccccCCCCh
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED------MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~------~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aP 155 (303)
.++.++.||+.||++||+++ |+||||||+|||++.. -.+||+|||+++.+... .......|++.||||
T Consensus 110 t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~---~~a~tlcGSplYMAP 183 (429)
T KOG0595|consen 110 TARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG---SMAETLCGSPLYMAP 183 (429)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch---hHHHHhhCCccccCH
Confidence 99999999999999999999 9999999999999865 45899999999987743 334557899999999
Q ss_pred hhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCc
Q 048243 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINE 193 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~ 193 (303)
|++....|+.|+|+||+|+++|++++|..||.-....+
T Consensus 184 EV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 184 EVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred HHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 99999999999999999999999999999997554433
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-45 Score=305.82 Aligned_cols=242 Identities=22% Similarity=0.314 Sum_probs=194.3
Q ss_pred ccCCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 2 VLPCGKVIAVKKLSKTSTQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 2 ~~~~~~~valK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
+.+.++.||||+++..... ..+.+.+|+..|+.++||||++++..|..+..+|+||+||.+|++.+.+..... ..+++
T Consensus 47 c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~-~Gl~E 125 (516)
T KOG0582|consen 47 CIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYP-DGLEE 125 (516)
T ss_pred ecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHcc-ccccH
Confidence 3577899999999866433 368899999999999999999999999999999999999999999999976443 34999
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-ccc-cccccccCCCChhhh
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-ANT-EQVVGTIGYIPPEYA 158 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-~~~-~~~~g~~~y~aPE~~ 158 (303)
..+..+++++++||.|||.+| .+|||||+.|||++.+|.|+|+|||.+..+...+.. ... ..+.|+++|+|||++
T Consensus 126 ~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl 202 (516)
T KOG0582|consen 126 ASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVL 202 (516)
T ss_pred HHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHh
Confidence 999999999999999999999 999999999999999999999999988766544322 112 557899999999996
Q ss_pred ccC--CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 159 RQG--VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 159 ~~~--~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
.+. .|+.|+||||||++..||++|..||....+... ....+.+.... ..-..++..........+++++..
T Consensus 203 ~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv------Ll~tLqn~pp~-~~t~~~~~d~~k~~~ksf~e~i~~ 275 (516)
T KOG0582|consen 203 MQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV------LLLTLQNDPPT-LLTSGLDKDEDKKFSKSFREMIAL 275 (516)
T ss_pred hhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH------HHHHhcCCCCC-cccccCChHHhhhhcHHHHHHHHH
Confidence 443 699999999999999999999999965443221 11222221111 112223333344555689999999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 048243 237 CVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 237 ~l~~dp~~Rpt~~el~~~ 254 (303)
||+.||++||||++++..
T Consensus 276 CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 276 CLVKDPSKRPTASKLLKH 293 (516)
T ss_pred HhhcCcccCCCHHHHhcc
Confidence 999999999999999863
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=315.15 Aligned_cols=238 Identities=33% Similarity=0.483 Sum_probs=196.9
Q ss_pred CccCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 1 ~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
|.+++...||+|.++.... ..+.|.+|+++|++|+|++||++++++..+..+|||||||..|+|.+||.. ..+..+..
T Consensus 225 g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~-~~~~~l~~ 302 (468)
T KOG0197|consen 225 GKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRT-REGGLLNL 302 (468)
T ss_pred EEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhh-cCCCccch
Confidence 5677778999999987644 336788999999999999999999999998899999999999999999976 34667899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
...+.++.||++|++||++++ +|||||.+.||||+++..+||+|||+++....... .......-+..|.|||.+..
T Consensus 303 ~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y-~~~~~~kfPIkWtAPEa~~~ 378 (468)
T KOG0197|consen 303 PQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY-TASEGGKFPIKWTAPEALNY 378 (468)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCce-eecCCCCCCceecCHHHHhh
Confidence 999999999999999999999 99999999999999999999999999995554432 22222333678999999999
Q ss_pred CCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 161 GVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
..++.|+||||||+++|||+| |+.|+......+....++ ...+-..+...+.++++++..||+
T Consensus 379 ~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le----------------~GyRlp~P~~CP~~vY~lM~~CW~ 442 (468)
T KOG0197|consen 379 GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE----------------RGYRLPRPEGCPDEVYELMKSCWH 442 (468)
T ss_pred CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh----------------ccCcCCCCCCCCHHHHHHHHHHhh
Confidence 999999999999999999998 777765544333332222 222223333445589999999999
Q ss_pred CCCCCCCCHHHHHHHhccccC
Q 048243 240 ENPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 240 ~dp~~Rpt~~el~~~L~~~~~ 260 (303)
.+|++|||++.+...|+....
T Consensus 443 ~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 443 EDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCcccCCCHHHHHHHHHHhhh
Confidence 999999999999999988764
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=316.76 Aligned_cols=229 Identities=24% Similarity=0.350 Sum_probs=194.0
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
..+++.||||.+........+-+.+|+.+|+..+|+|||.+++.|.....+|+|||||+||+|.+.+ ....+++.+
T Consensus 295 ~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvV----t~~~~~E~q 370 (550)
T KOG0578|consen 295 ISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVV----TKTRMTEGQ 370 (550)
T ss_pred ccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhh----hcccccHHH
Confidence 4578889999997766556678999999999999999999999999999999999999999998888 455699999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
+..++++++.||+|||.+| |+|||||.+|||++.+|.+||+|||++..+..... .....+||+.|||||+.....
T Consensus 371 IA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~ 445 (550)
T KOG0578|consen 371 IAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKP 445 (550)
T ss_pred HHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccccccCCCCccchhhhhhcc
Confidence 9999999999999999999 99999999999999999999999999987665432 344578999999999999999
Q ss_pred CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC
Q 048243 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 242 (303)
|..+.||||||++++||+-|++||-...+.. ..+.... ............+..+.+|+.+||+.|+
T Consensus 446 YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr------AlyLIa~--------ng~P~lk~~~klS~~~kdFL~~cL~~dv 511 (550)
T KOG0578|consen 446 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIAT--------NGTPKLKNPEKLSPELKDFLDRCLVVDV 511 (550)
T ss_pred cCccccchhhhhHHHHHhcCCCCccCCChHH------HHHHHhh--------cCCCCcCCccccCHHHHHHHHHHhhcch
Confidence 9999999999999999999999985422211 1111111 1122333445566789999999999999
Q ss_pred CCCCCHHHHHHH
Q 048243 243 NDRPSMLQVSSM 254 (303)
Q Consensus 243 ~~Rpt~~el~~~ 254 (303)
.+|++|.|||+.
T Consensus 512 ~~RasA~eLL~H 523 (550)
T KOG0578|consen 512 EQRASAKELLEH 523 (550)
T ss_pred hcCCCHHHHhcC
Confidence 999999999974
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=293.32 Aligned_cols=242 Identities=21% Similarity=0.287 Sum_probs=191.1
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
++|+.||||++.... +.-.+..++||.+|++++|+|+|.++++|......++|+|||+..-|.++-. ....++..
T Consensus 25 ~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~eLe~---~p~G~~~~ 101 (396)
T KOG0593|consen 25 DTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLHELER---YPNGVPSE 101 (396)
T ss_pred CcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHHHHHHh---ccCCCCHH
Confidence 689999999996543 4455678999999999999999999999999999999999998766655542 23458899
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc-
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ- 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~- 160 (303)
.+.++++|++.|+.|+|+++ ++||||||+|||++.+|.+||+|||.|+..... ...-...+.|.+|+|||++.+
T Consensus 102 ~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--gd~YTDYVATRWYRaPELLvGD 176 (396)
T KOG0593|consen 102 LVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP--GDNYTDYVATRWYRAPELLVGD 176 (396)
T ss_pred HHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC--cchhhhhhhhhhccChhhhccc
Confidence 99999999999999999999 999999999999999999999999999887642 233344567999999999987
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHH--------HHHH------hCCCcceeccccCCCCCCHHH
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA--------YELW------KGGKGVEFVDSSLDDTNSPCK 226 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~------~~~~~~~~~~~~~~~~~~~~~ 226 (303)
..|...+||||+||++.||++|.+.|.+.+..+..-.+... ...+ .+...++.-....-....+..
T Consensus 177 tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~ 256 (396)
T KOG0593|consen 177 TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKI 256 (396)
T ss_pred CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccc
Confidence 67999999999999999999999999776654433322221 1111 122222222222222333455
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 227 LMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 227 ~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
+..+.+|+++||+.||.+|++.++++.
T Consensus 257 s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 257 SNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred hHHHHHHHHHHhcCCccccccHHHHhc
Confidence 567899999999999999999999875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=309.21 Aligned_cols=229 Identities=26% Similarity=0.320 Sum_probs=190.2
Q ss_pred cCCCcEEEEEEecCC---CcccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccC
Q 048243 3 LPCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 3 ~~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
..+++.+|||++.+. .....+.+..|-+.|.+| .||.|+++|..|.+...+|+|+||+++|.|.++|. +-+.+
T Consensus 95 ~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~---K~Gsf 171 (604)
T KOG0592|consen 95 KATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIK---KYGSF 171 (604)
T ss_pred cCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHH---HhCcc
Confidence 358999999998654 223345677899999999 89999999999999999999999999999999994 45779
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc---------cc--ccccc
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE---------AN--TEQVV 147 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~---------~~--~~~~~ 147 (303)
++.-.+.++.+|+.||+|||++| ||||||||+|||++++++++|.|||.++.+...... .. ...++
T Consensus 172 de~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFV 248 (604)
T KOG0592|consen 172 DETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFV 248 (604)
T ss_pred hHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCccccee
Confidence 99999999999999999999999 999999999999999999999999999887543221 11 24479
Q ss_pred cccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHH
Q 048243 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKL 227 (303)
Q Consensus 148 g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
||..|++||++.....+..+|+|+|||++|+|+.|.+||...+.......+... ....++..+
T Consensus 249 GTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l-----------------~y~fp~~fp 311 (604)
T KOG0592|consen 249 GTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL-----------------DYEFPEGFP 311 (604)
T ss_pred eeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh-----------------cccCCCCCC
Confidence 999999999999999999999999999999999999999766543322222111 112222333
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 228 MRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 228 ~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
+...+|++++|..||.+|+|+.+|.+.
T Consensus 312 ~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 312 EDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHHHHHHHHccCccccccHHHHhhC
Confidence 578899999999999999999999885
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=298.54 Aligned_cols=232 Identities=25% Similarity=0.357 Sum_probs=183.5
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCC--eeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE--ERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
++|+.+|||.+...+....+.+.+|+.+|.+++|||||++++...... .++++|||+++|+|.+++... +..+++.
T Consensus 40 ~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~--g~~l~E~ 117 (313)
T KOG0198|consen 40 KTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRY--GGKLPEP 117 (313)
T ss_pred CCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHc--CCCCCHH
Confidence 358899999987664333677999999999999999999999855554 689999999999999999542 2269999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC-CCceEEcccccccccccC-CccccccccccccCCCChhhhc
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-DMKPKISDFGLARIFAKE-SLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-~~~v~l~Df~~~~~~~~~-~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
.+..++.||++||+|||++| ++|+||||+|||++. ++.+||+|||++...... ..........||+.|||||++.
T Consensus 118 ~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~ 194 (313)
T KOG0198|consen 118 LVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIR 194 (313)
T ss_pred HHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhc
Confidence 99999999999999999999 999999999999999 799999999998876641 1223334578999999999998
Q ss_pred cC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcc
Q 048243 160 QG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238 (303)
Q Consensus 160 ~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 238 (303)
+. ....++|||||||++.||+||.+||... ................+ ..+...+.+..+|+.+|+
T Consensus 195 ~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P---------~ip~~ls~~a~~Fl~~C~ 260 (313)
T KOG0198|consen 195 NGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLP---------EIPDSLSDEAKDFLRKCF 260 (313)
T ss_pred CCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCC---------CCCcccCHHHHHHHHHHh
Confidence 63 3345999999999999999999998653 11112222222222111 122224457889999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 048243 239 QENPNDRPSMLQVSSM 254 (303)
Q Consensus 239 ~~dp~~Rpt~~el~~~ 254 (303)
..||++||||+++++.
T Consensus 261 ~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 261 KRDPEKRPTAEELLEH 276 (313)
T ss_pred hcCcccCcCHHHHhhC
Confidence 9999999999999986
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=295.75 Aligned_cols=226 Identities=25% Similarity=0.321 Sum_probs=187.1
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
++++.+|+|++++.. ....+....|..+|.+++||+||+++..|.+...+|+|++|+.||.|...| .+.+.+++
T Consensus 48 dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL---~~eg~F~E 124 (357)
T KOG0598|consen 48 DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHL---QREGRFSE 124 (357)
T ss_pred ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHH---HhcCCcch
Confidence 689999999997663 345678889999999999999999999999999999999999999999988 35677999
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..+..++++|+.||.|||++| |+||||||+|||++..|+++|+|||+++..-..+ .....++||+.|||||++.+
T Consensus 125 ~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~--~~t~tfcGT~eYmAPEil~~ 199 (357)
T KOG0598|consen 125 DRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG--DATRTFCGTPEYMAPEILLG 199 (357)
T ss_pred hHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccCC--CccccccCCccccChHHHhc
Confidence 999999999999999999999 9999999999999999999999999998543332 23344799999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
.+++.++|.||||+++|+|++|.+||...+.....+.+. ... ....+...+.+.+++++++|..
T Consensus 200 ~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~------~~k----------~~~~p~~ls~~ardll~~LL~r 263 (357)
T KOG0598|consen 200 KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKIL------KGK----------LPLPPGYLSEEARDLLKKLLKR 263 (357)
T ss_pred CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHh------cCc----------CCCCCccCCHHHHHHHHHHhcc
Confidence 999999999999999999999999996554333222111 110 0111122445788999999999
Q ss_pred CCCCCC----CHHHHHH
Q 048243 241 NPNDRP----SMLQVSS 253 (303)
Q Consensus 241 dp~~Rp----t~~el~~ 253 (303)
||++|. ++.+|.+
T Consensus 264 dp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 264 DPRQRLGGPGDAEEIKR 280 (357)
T ss_pred CHHHhcCCCCChHHhhc
Confidence 999996 4555543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=311.03 Aligned_cols=225 Identities=26% Similarity=0.359 Sum_probs=188.9
Q ss_pred CCCcEEEEEEecCC---CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.+|||++.+. .......+.+||-+|+.+.||||+.+|++|++++++|+|.||+++|-|++++ ...+++++
T Consensus 35 ~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdyl---v~kG~l~e 111 (786)
T KOG0588|consen 35 ETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYL---VRKGPLPE 111 (786)
T ss_pred cccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHH---HhhCCCCC
Confidence 58999999999655 2334457889999999999999999999999999999999999999999999 56788999
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
.+..+++.||+.|+.|+|..+ |||||+||+|+|++..+.+||+|||+|..- ......+.-+|.++|.|||++.+
T Consensus 112 ~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe---~~gklLeTSCGSPHYA~PEIV~G 185 (786)
T KOG0588|consen 112 REAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLE---VPGKLLETSCGSPHYAAPEIVSG 185 (786)
T ss_pred HHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecc---cCCccccccCCCcccCCchhhcC
Confidence 999999999999999999999 999999999999999999999999999653 23355566789999999999999
Q ss_pred CCC-CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 161 GVY-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 161 ~~~-~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
.+| ..++||||.|+|+|.|++|..||...+...-+ .....+.. ..+...+.++++||.+||.
T Consensus 186 ~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LL-------lKV~~G~f----------~MPs~Is~eaQdLLr~ml~ 248 (786)
T KOG0588|consen 186 RPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLL-------LKVQRGVF----------EMPSNISSEAQDLLRRMLD 248 (786)
T ss_pred CCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHH-------HHHHcCcc----------cCCCcCCHHHHHHHHHHhc
Confidence 988 56899999999999999999999744332211 12221111 1112334488899999999
Q ss_pred CCCCCCCCHHHHHHH
Q 048243 240 ENPNDRPSMLQVSSM 254 (303)
Q Consensus 240 ~dp~~Rpt~~el~~~ 254 (303)
+||.+|.|++||++.
T Consensus 249 VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 249 VDPSTRITTEEILKH 263 (786)
T ss_pred cCccccccHHHHhhC
Confidence 999999999999885
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=275.64 Aligned_cols=244 Identities=25% Similarity=0.298 Sum_probs=189.7
Q ss_pred cCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 3 LPCGKVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.++|+.||||+++.... .--....+||..|++++|+||+.++++|.......+|+||++ .+|...+.+ ....+..
T Consensus 24 ~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~-tdLe~vIkd--~~i~l~p 100 (318)
T KOG0659|consen 24 TETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP-TDLEVVIKD--KNIILSP 100 (318)
T ss_pred cCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc-ccHHHHhcc--cccccCH
Confidence 47899999999976532 223467899999999999999999999999999999999996 588888865 4567889
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..+..|+.++++|++|||++. |+||||||.|+|++.+|.+||+|||+++.++....... ..+-|..|+|||++.+
T Consensus 101 a~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~--~~V~TRWYRAPELLfG 175 (318)
T KOG0659|consen 101 ADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT--HQVVTRWYRAPELLFG 175 (318)
T ss_pred HHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcccc--cceeeeeccChHHhcc
Confidence 999999999999999999999 99999999999999999999999999998876543222 2366999999998877
Q ss_pred C-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCccee---cc--------ccCCCCCCHHHHH
Q 048243 161 G-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF---VD--------SSLDDTNSPCKLM 228 (303)
Q Consensus 161 ~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~--------~~~~~~~~~~~~~ 228 (303)
. .|+...||||.||++.||+.|.+.|.+.+.-+....+...........+.++ .+ ........+..+.
T Consensus 176 sr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~ 255 (318)
T KOG0659|consen 176 SRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASS 255 (318)
T ss_pred chhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccH
Confidence 6 5999999999999999999998877655443333333222211111111111 00 0011113344556
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 229 RCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 229 ~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
...+|+.+||..||.+|+|+.|+++.
T Consensus 256 d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 256 DALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHHHHhhhccCchhcccHHHHhcc
Confidence 77999999999999999999999865
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=295.19 Aligned_cols=244 Identities=23% Similarity=0.281 Sum_probs=188.6
Q ss_pred cCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeC--CeeEEEEeecCCCChhhhhcCccccccC
Q 048243 3 LPCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 3 ~~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
+.+|+.||+|++.... .....-..+||.+|++|+||||+++.+..... ..+|||+|||+. +|.-++.. ....+
T Consensus 139 ~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~--p~vkf 215 (560)
T KOG0600|consen 139 LETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSS--PGVKF 215 (560)
T ss_pred cccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcC--CCccc
Confidence 5789999999997554 44455677899999999999999999999876 689999999975 67777643 35579
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
++.++..++.||+.||+|||..| |+|||||.+|||++.+|.+||+|||+|+++....... ...++.|.+|+|||++
T Consensus 216 t~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~-~T~rVvTLWYRpPELL 291 (560)
T KOG0600|consen 216 TEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP-YTSRVVTLWYRPPELL 291 (560)
T ss_pred ChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCCCcc-cccceEEeeccChHHh
Confidence 99999999999999999999999 9999999999999999999999999999877665443 3335669999999999
Q ss_pred ccC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcc--ee-----ccccCCCCC-----CHH
Q 048243 159 RQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV--EF-----VDSSLDDTN-----SPC 225 (303)
Q Consensus 159 ~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-----~~~~~~~~~-----~~~ 225 (303)
.+. .|+.+.|+||.|||+.||+.|++.|.+....+....+...........+. .+ +.+...... ...
T Consensus 292 LG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~ 371 (560)
T KOG0600|consen 292 LGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKD 371 (560)
T ss_pred cCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhcc
Confidence 887 49999999999999999999999887655444443333222211111111 00 010000000 112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 226 KLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 226 ~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
.+....+|+..+|..||.+|.||.++++
T Consensus 372 ~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 372 FPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCHHHHHHHHHHhccCccccccHHHHhc
Confidence 2346789999999999999999998875
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=299.81 Aligned_cols=225 Identities=24% Similarity=0.345 Sum_probs=184.1
Q ss_pred CCCcEEEEEEecCC----Cc-ccHHHHHHHHHHHhcCC-CCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcccccc
Q 048243 4 PCGKVIAVKKLSKT----ST-QGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~~~~valK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
.+|+.||+|++... .. ...+.+.+|+.+++.++ ||||+++++++......++||||+.||.|.+++. ..+.
T Consensus 40 ~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~---~~g~ 116 (370)
T KOG0583|consen 40 LTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIV---NKGR 116 (370)
T ss_pred cCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHH---HcCC
Confidence 46799999987654 11 23456778999999998 9999999999999999999999999999999994 3567
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCC-CceEEcccccccccccCCccccccccccccCCCChh
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED-MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE 156 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~-~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE 156 (303)
+.+..+..+++|++.|++|||+.| |+||||||+|++++.+ +.+||+|||++.... ..........|++.|+|||
T Consensus 117 l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPE 191 (370)
T KOG0583|consen 117 LKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPE 191 (370)
T ss_pred CChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHH
Confidence 889999999999999999999999 9999999999999999 999999999998764 2223445578999999999
Q ss_pred hhccCC-CC-CccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHH-HHHHHHH
Q 048243 157 YARQGV-YS-TKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCK-LMRCLEI 233 (303)
Q Consensus 157 ~~~~~~-~~-~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~l 233 (303)
++.+.. |+ .++||||+|+++|.|++|..||....... .......+.. ..+... +.++.++
T Consensus 192 vl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~------l~~ki~~~~~-----------~~p~~~~S~~~~~L 254 (370)
T KOG0583|consen 192 VLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN------LYRKIRKGEF-----------KIPSYLLSPEARSL 254 (370)
T ss_pred HhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH------HHHHHhcCCc-----------cCCCCcCCHHHHHH
Confidence 999987 75 68999999999999999999997622211 1111111110 001111 5588899
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 048243 234 ALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 234 i~~~l~~dp~~Rpt~~el~~ 253 (303)
+.+||..||.+|+|+.+++.
T Consensus 255 i~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 255 IEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred HHHHcCCCcccCCCHHHHhh
Confidence 99999999999999999984
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=290.90 Aligned_cols=229 Identities=21% Similarity=0.282 Sum_probs=183.2
Q ss_pred CCcEEEEEEecCCCccc---HHHHHHHHHHHhcCCCCccccEEEEEEe----CCeeEEEEeecCCCChhhhhcCcccccc
Q 048243 5 CGKVIAVKKLSKTSTQG---FEEFKNEVMLTAKLQHVNLIRVLGFCID----SEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
+|+.||+|.++...... .+.+.+|+.++.+++||||+++++++.+ ....++||||+++|+|.+++.. ...
T Consensus 42 ~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~---~~~ 118 (283)
T PHA02988 42 NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK---EKD 118 (283)
T ss_pred CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhh---CCC
Confidence 68899999997654333 4677899999999999999999999877 3467999999999999999843 456
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChh
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEY-SRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE 156 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~-~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE 156 (303)
+++.....++.+++.||+|||+. + ++||||||+||+++.++.++|+|||++....... ....|+..|+|||
T Consensus 119 ~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE 190 (283)
T PHA02988 119 LSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYK 190 (283)
T ss_pred CChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----ccccCcccccCHH
Confidence 88999999999999999999984 6 8899999999999999999999999987654322 1245788999999
Q ss_pred hhcc--CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHH
Q 048243 157 YARQ--GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIA 234 (303)
Q Consensus 157 ~~~~--~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
++.+ ..++.++|||||||++|+|++|..||........ .. ......... ..+...+..+.+++
T Consensus 191 ~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~---~~---~i~~~~~~~---------~~~~~~~~~l~~li 255 (283)
T PHA02988 191 MLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI---YD---LIINKNNSL---------KLPLDCPLEIKCIV 255 (283)
T ss_pred HhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH---HH---HHHhcCCCC---------CCCCcCcHHHHHHH
Confidence 9976 5789999999999999999999999964432111 11 111111111 11112345788999
Q ss_pred HHcccCCCCCCCCHHHHHHHhcccc
Q 048243 235 LLCVQENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 235 ~~~l~~dp~~Rpt~~el~~~L~~~~ 259 (303)
.+||+.||++|||+.|+++.|+...
T Consensus 256 ~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 256 EACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HHHhcCCcccCcCHHHHHHHHHHHH
Confidence 9999999999999999999998764
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=298.43 Aligned_cols=242 Identities=25% Similarity=0.302 Sum_probs=187.9
Q ss_pred cCCCcEEEEEEecCCCcccHHH--HHHHHHHHhcCC-CCccccEEEEEEeCC-eeEEEEeecCCCChhhhhcCccccccC
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEE--FKNEVMLTAKLQ-HVNLIRVLGFCIDSE-ERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~--~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
..+|+.||||+++.+-.. +++ =.+|+..|++++ ||||+++.+++.+.. .+++|||||+. +|.+++.+ ++..+
T Consensus 32 ~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~--R~r~f 107 (538)
T KOG0661|consen 32 KETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKD--RNRLF 107 (538)
T ss_pred cCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhh--cCCcC
Confidence 467889999999876543 333 347999999997 999999999999887 89999999975 78888865 37889
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
++..++.|+.||+.||+|+|.+| +.|||+||+|||+..+..+||+|||+|+...+.... ...+.|.+|+|||++
T Consensus 108 se~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY---TeYVSTRWYRAPEvL 181 (538)
T KOG0661|consen 108 SESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY---TEYVSTRWYRAPEVL 181 (538)
T ss_pred CHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccCCCc---chhhhcccccchHHh
Confidence 99999999999999999999999 999999999999999899999999999987665332 335679999999987
Q ss_pred cc-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcce---------eccccCCC----CCCH
Q 048243 159 RQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVE---------FVDSSLDD----TNSP 224 (303)
Q Consensus 159 ~~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~----~~~~ 224 (303)
.. ..|+.+.||||+||+++|+++.++.|.+.+..+....+.............+ +..+...+ ...+
T Consensus 182 Lrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p 261 (538)
T KOG0661|consen 182 LRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLP 261 (538)
T ss_pred hhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCc
Confidence 65 4689999999999999999999999987665443322222111111100000 00001111 1112
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 225 CKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 225 ~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
..+.++.++|.+||.+||.+||||.|.++.
T Consensus 262 ~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 262 NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 356688999999999999999999999985
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=293.92 Aligned_cols=227 Identities=26% Similarity=0.339 Sum_probs=192.2
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+++.||+|++.... ....+.+++|+.+|.+++++||.++|+.+..+..++++||||.||++.+++. .+..+++..
T Consensus 36 ~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~---~~~~~~E~~ 112 (467)
T KOG0201|consen 36 KTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLK---SGNILDEFE 112 (467)
T ss_pred cccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhc---cCCCCccce
Confidence 578999999998663 5567889999999999999999999999999999999999999999999983 344558888
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
+.-++++++.|+.|||..+ .+|||||+.||++..+|.++|+|||.+........ ....++||+.|||||++.+..
T Consensus 113 i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--rr~tfvGTPfwMAPEVI~~~~ 187 (467)
T KOG0201|consen 113 IAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--RRKTFVGTPFWMAPEVIKQSG 187 (467)
T ss_pred eeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh--ccccccccccccchhhhcccc
Confidence 9999999999999999999 99999999999999999999999999876654432 236689999999999999999
Q ss_pred CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC
Q 048243 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 242 (303)
|+.|+||||||++.+||++|.+|+....+..... ++............+..+.+|+..||..||
T Consensus 188 Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf----------------lIpk~~PP~L~~~~S~~~kEFV~~CL~k~P 251 (467)
T KOG0201|consen 188 YDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF----------------LIPKSAPPRLDGDFSPPFKEFVEACLDKNP 251 (467)
T ss_pred ccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE----------------eccCCCCCccccccCHHHHHHHHHHhhcCc
Confidence 9999999999999999999999987655533222 112222222222455678999999999999
Q ss_pred CCCCCHHHHHHH
Q 048243 243 NDRPSMLQVSSM 254 (303)
Q Consensus 243 ~~Rpt~~el~~~ 254 (303)
+.||+|.+++..
T Consensus 252 ~~RpsA~~LLKh 263 (467)
T KOG0201|consen 252 EFRPSAKELLKH 263 (467)
T ss_pred ccCcCHHHHhhh
Confidence 999999999764
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=312.58 Aligned_cols=238 Identities=32% Similarity=0.481 Sum_probs=202.0
Q ss_pred CCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc-------c-
Q 048243 4 PCGKVIAVKKLSKTSTQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-------R- 74 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~- 74 (303)
+....||||.++..... .+.+|++|++++..++|||||+++|+|..++..|||+|||..|+|.+||.... .
T Consensus 514 ~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g 593 (774)
T KOG1026|consen 514 QDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASG 593 (774)
T ss_pred ccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCC
Confidence 45678999999887655 77899999999999999999999999999999999999999999999997411 1
Q ss_pred ---cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccC
Q 048243 75 ---RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIG 151 (303)
Q Consensus 75 ---~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~ 151 (303)
...++..+.+.++.||+.|+.||-+++ +|||||-..|+||.++..|||+|||+++.....+.++..+...-+.+
T Consensus 594 ~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIR 670 (774)
T KOG1026|consen 594 QDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIR 670 (774)
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeee
Confidence 233888999999999999999999999 99999999999999999999999999999888888777766666889
Q ss_pred CCChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHH
Q 048243 152 YIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRC 230 (303)
Q Consensus 152 y~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 230 (303)
|||||.+....+|+++||||+|+++||+++ |..|+......+.. +....+.. ...+...+.++
T Consensus 671 WMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI-------e~i~~g~l---------L~~Pe~CP~~v 734 (774)
T KOG1026|consen 671 WMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI-------ECIRAGQL---------LSCPENCPTEV 734 (774)
T ss_pred cCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH-------HHHHcCCc---------ccCCCCCCHHH
Confidence 999999999999999999999999999998 88887655443322 22222222 22233345589
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHhccccC
Q 048243 231 LEIALLCVQENPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 231 ~~li~~~l~~dp~~Rpt~~el~~~L~~~~~ 260 (303)
++|+..||+.+|.+||+++||-..|+.-..
T Consensus 735 Y~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 735 YSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 999999999999999999999999876543
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=294.14 Aligned_cols=228 Identities=26% Similarity=0.347 Sum_probs=192.4
Q ss_pred CCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCe-eEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 5 CGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE-RMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 5 ~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
+++.+++|++.... ........+|+.++++++||||+.+.+.|..++. .++||+||+||++.+.+.... +..+++.
T Consensus 28 ~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k-~~~f~E~ 106 (426)
T KOG0589|consen 28 DDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQK-GVLFPEE 106 (426)
T ss_pred CCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHh-hccccHH
Confidence 56789999987654 3445578899999999999999999999999988 999999999999999997643 6779999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
.+..|+.|++.|+.|||+++ |+|||||+.|||++.++.|+|+|||+++.+.... .......||+.|++||++.+.
T Consensus 107 ~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~ 181 (426)
T KOG0589|consen 107 RILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED--SLASTVVGTPYYMCPEILSDI 181 (426)
T ss_pred HHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch--hhhheecCCCcccCHHHhCCC
Confidence 99999999999999999988 9999999999999999999999999999877653 234457899999999999999
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
+|..|+|||||||++|||++.+++|...+... ...+.... .....+..++.++..+++.||+.+
T Consensus 182 pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~------Li~ki~~~----------~~~Plp~~ys~el~~lv~~~l~~~ 245 (426)
T KOG0589|consen 182 PYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE------LILKINRG----------LYSPLPSMYSSELRSLVKSMLRKN 245 (426)
T ss_pred CCCccCcchhhcchHHHHHhcccccCccchHH------HHHHHhhc----------cCCCCCccccHHHHHHHHHHhhcC
Confidence 99999999999999999999999986443222 11122111 122333456678999999999999
Q ss_pred CCCCCCHHHHHHH
Q 048243 242 PNDRPSMLQVSSM 254 (303)
Q Consensus 242 p~~Rpt~~el~~~ 254 (303)
|+.||++.+++..
T Consensus 246 P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 246 PEHRPSALELLRR 258 (426)
T ss_pred CccCCCHHHHhhC
Confidence 9999999999875
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=292.68 Aligned_cols=238 Identities=28% Similarity=0.414 Sum_probs=183.4
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCccccEEEEEEeC-CeeEEEEeecCCCChhhhhcCccc------
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS-EERMLVYEYMPNKSLDCYLFDPIR------ 74 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~------ 74 (303)
.+++.||+|+++... ....+.+.+|+.++..+ +||||+++++++... ...++||||+++|+|.+++.....
T Consensus 35 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~ 114 (338)
T cd05102 35 SSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYR 114 (338)
T ss_pred ccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhccccc
Confidence 345789999997543 23446788999999999 899999999988764 457899999999999998854211
Q ss_pred -----------------------------------------------------cccCCHHHHHHHHHHHHHHHHHHHhCC
Q 048243 75 -----------------------------------------------------RLILDWKKRVHIIEGITQGLLYLQEYS 101 (303)
Q Consensus 75 -----------------------------------------------------~~~l~~~~~~~~~~~i~~~l~~Lh~~~ 101 (303)
...+++..+..++.||+.||+|||+.|
T Consensus 115 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ 194 (338)
T cd05102 115 EKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK 194 (338)
T ss_pred ccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 134778889999999999999999998
Q ss_pred CCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHh
Q 048243 102 RLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181 (303)
Q Consensus 102 ~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~ 181 (303)
|+||||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++
T Consensus 195 ---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~ 271 (338)
T cd05102 195 ---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271 (338)
T ss_pred ---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHh
Confidence 99999999999999999999999999876543222222223345678999999998889999999999999999997
Q ss_pred -CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcccc
Q 048243 182 -GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 182 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~ 259 (303)
|..||........ .......+.... .+...+..+.+++.+||+.||.+|||+.|+++.|++..
T Consensus 272 ~g~~pf~~~~~~~~------~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 272 LGASPYPGVQINEE------FCQRLKDGTRMR---------APENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred CCCCCCCCCCccHH------HHHHHhcCCCCC---------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999865332211 111111111110 11123447889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=266.58 Aligned_cols=241 Identities=24% Similarity=0.275 Sum_probs=191.6
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeC-----CeeEEEEeecCCCChhhhhcCccc-cc
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-----EERMLVYEYMPNKSLDCYLFDPIR-RL 76 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~-~~ 76 (303)
+.+++.+|+|++......+.+..++|++..++++|||+++++++...+ ...|++++|...|+|.+.+..... +.
T Consensus 43 ~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~ 122 (302)
T KOG2345|consen 43 LSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGN 122 (302)
T ss_pred cCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCC
Confidence 357889999999877777888999999999999999999999887654 358999999999999999876444 44
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-------ccccccccc
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-------ANTEQVVGT 149 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-------~~~~~~~g~ 149 (303)
.+++.+++.|+.+|.+||++||+.. .++.||||||.||++++.+.++++|||.+....-.-.. ........|
T Consensus 123 ~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct 201 (302)
T KOG2345|consen 123 FVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCT 201 (302)
T ss_pred ccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCC
Confidence 7899999999999999999999985 47999999999999999999999999998654321110 112234568
Q ss_pred cCCCChhhhccC---CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCc-ceeccccCCCCCCHH
Q 048243 150 IGYIPPEYARQG---VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG-VEFVDSSLDDTNSPC 225 (303)
Q Consensus 150 ~~y~aPE~~~~~---~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 225 (303)
..|+|||++.-. ..+.++|||||||++|.|+.|..||...- . .++.. .............+.
T Consensus 202 ~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~------------~--~GgSlaLAv~n~q~s~P~~~~ 267 (302)
T KOG2345|consen 202 IPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY------------Q--QGGSLALAVQNAQISIPNSSR 267 (302)
T ss_pred CcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh------------h--cCCeEEEeeeccccccCCCCC
Confidence 999999998644 57899999999999999999999985211 1 11111 112222333333344
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhccc
Q 048243 226 KLMRCLEIALLCVQENPNDRPSMLQVSSMLKNE 258 (303)
Q Consensus 226 ~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~ 258 (303)
.++.+.+++++||++||.+||++.+++..+++.
T Consensus 268 yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 268 YSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 778999999999999999999999999988764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=271.37 Aligned_cols=214 Identities=25% Similarity=0.317 Sum_probs=182.8
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|..+|+|+++... ..+.+...+|..+|+.+.||+++++++.+.+...++|||||.+||.|..+++ +.+++++
T Consensus 67 ~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lr---k~~rF~e 143 (355)
T KOG0616|consen 67 HSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLR---KSGRFSE 143 (355)
T ss_pred cCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHH---hcCCCCc
Confidence 578999999997653 4456678899999999999999999999999999999999999999999994 4567999
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.||+.||+|||+.+ |++||+||+|||+|.+|.+||.|||.++..... .-..+||+.|+|||++..
T Consensus 144 ~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-----T~TlCGTPeYLAPEii~s 215 (355)
T KOG0616|consen 144 PHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQS 215 (355)
T ss_pred hhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc-----EEEecCCccccChHHhhc
Confidence 999999999999999999999 999999999999999999999999999876543 334689999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
.++..++|-||||+++|||+.|.+||...+....+ .+...+. ...++..+..+.+|++++|++
T Consensus 216 k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY------~KI~~~~-----------v~fP~~fs~~~kdLl~~LL~v 278 (355)
T KOG0616|consen 216 KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIY------EKILEGK-----------VKFPSYFSSDAKDLLKKLLQV 278 (355)
T ss_pred CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHH------HHHHhCc-----------ccCCcccCHHHHHHHHHHHhh
Confidence 99999999999999999999999999765542221 1222211 122334455788999999999
Q ss_pred CCCCC
Q 048243 241 NPNDR 245 (303)
Q Consensus 241 dp~~R 245 (303)
|-.+|
T Consensus 279 D~t~R 283 (355)
T KOG0616|consen 279 DLTKR 283 (355)
T ss_pred hhHhh
Confidence 99999
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=281.00 Aligned_cols=255 Identities=24% Similarity=0.310 Sum_probs=192.9
Q ss_pred CCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEe-----CCeeEEEEeecCCCChhhhhcCccccc
Q 048243 4 PCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCID-----SEERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~ 76 (303)
.+|+.||||++... .....++..+|+.+|+.++|+||+.+.+++.. -+..|+|+|+| +.+|...+ ..+.
T Consensus 45 ~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~ii---k~~~ 120 (359)
T KOG0660|consen 45 RTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQII---KSQQ 120 (359)
T ss_pred CCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHH---HcCc
Confidence 57899999999733 44556788899999999999999999999875 35789999999 56888888 3455
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChh
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE 156 (303)
.++...+..+++||++||+|+|+.+ ++|||+||+|++++.+..+||+|||+|+...........+..+.|.+|+|||
T Consensus 121 ~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPE 197 (359)
T KOG0660|consen 121 DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPE 197 (359)
T ss_pred cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHH
Confidence 5999999999999999999999999 9999999999999999999999999999876543334445567799999999
Q ss_pred hhcc-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHH--------HHhCCCcceeccccCCC------C
Q 048243 157 YARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE--------LWKGGKGVEFVDSSLDD------T 221 (303)
Q Consensus 157 ~~~~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~------~ 221 (303)
++.. ..|+.+.||||+||++.||++|++.|.+.........+..... ...+......+.+.... .
T Consensus 198 lll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~ 277 (359)
T KOG0660|consen 198 LLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSS 277 (359)
T ss_pred HHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHH
Confidence 8754 4699999999999999999999999976554333322221110 01100011111111100 0
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccccCCCCCC
Q 048243 222 NSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM--LKNETTNRNTP 265 (303)
Q Consensus 222 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~--L~~~~~~~~~~ 265 (303)
..+.......+|+.+||..||.+|+|++|.++. |+........|
T Consensus 278 ~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 278 IFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred HcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 112233467899999999999999999999885 66555544444
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=282.64 Aligned_cols=241 Identities=27% Similarity=0.411 Sum_probs=182.9
Q ss_pred CCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc----------
Q 048243 5 CGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI---------- 73 (303)
Q Consensus 5 ~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------- 73 (303)
++..||+|.+.... ......+.+|+.++.+++||||+++++++.+....++||||+.+++|.+++....
T Consensus 45 ~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 124 (304)
T cd05096 45 RPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124 (304)
T ss_pred cceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhcccccccccccc
Confidence 34579999997653 3345678999999999999999999999999999999999999999999885421
Q ss_pred ------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccc
Q 048243 74 ------RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVV 147 (303)
Q Consensus 74 ------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~ 147 (303)
....+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||++................
T Consensus 125 ~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~ 201 (304)
T cd05096 125 AVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAV 201 (304)
T ss_pred ccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCC
Confidence 1134677889999999999999999999 9999999999999999999999999987654433222333345
Q ss_pred cccCCCChhhhccCCCCCccchhhHHHHHHHHHhC--CCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHH
Q 048243 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG--KRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPC 225 (303)
Q Consensus 148 g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g--~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (303)
++..|+|||.+.+..++.++||||||+++|+|+++ ..||...... ................. ....++.
T Consensus 202 ~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~------~~~~~~~ 272 (304)
T cd05096 202 LPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE---QVIENAGEFFRDQGRQV------YLFRPPP 272 (304)
T ss_pred CCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHH---HHHHHHHHHhhhccccc------cccCCCC
Confidence 67889999999888899999999999999999874 4555433221 11111111111111000 0111122
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 048243 226 KLMRCLEIALLCVQENPNDRPSMLQVSSMLKN 257 (303)
Q Consensus 226 ~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~ 257 (303)
.+..+.+++.+||..||.+|||+.+|.+.|++
T Consensus 273 ~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 273 CPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 33578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=287.84 Aligned_cols=226 Identities=20% Similarity=0.223 Sum_probs=181.7
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|+++... ......+.+|+.+++.++||||+++++.+......|+||||+.+++|.+++. ....+++
T Consensus 18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~ 94 (323)
T cd05571 18 ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS---RERVFSE 94 (323)
T ss_pred CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHH---HcCCCCH
Confidence 578999999997542 2334567889999999999999999999999999999999999999988884 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..+..++.||+.||+|||+.| |+||||||+||+++.++.++|+|||+++...... .......|++.|+|||.+.+
T Consensus 95 ~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~ 169 (323)
T cd05571 95 DRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLED 169 (323)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--CcccceecCccccChhhhcC
Confidence 999999999999999999999 9999999999999999999999999986532211 12233568999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|||||||++|+|++|..||....... ......... ...+...+..+.+++.+||+.
T Consensus 170 ~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~------~~~~~~~~~-----------~~~p~~~~~~~~~li~~~L~~ 232 (323)
T cd05571 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILMEE-----------IRFPRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred CCCCccccCcccchhhhhhhcCCCCCCCCCHHH------HHHHHHcCC-----------CCCCCCCCHHHHHHHHHHccC
Confidence 999999999999999999999999985432111 111111110 011122345788999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 048243 241 NPNDRP-----SMLQVSSM 254 (303)
Q Consensus 241 dp~~Rp-----t~~el~~~ 254 (303)
||++|| ++.++++.
T Consensus 233 dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 233 DPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CHHHcCCCCCCCHHHHHcC
Confidence 999999 79998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=281.40 Aligned_cols=229 Identities=25% Similarity=0.368 Sum_probs=179.6
Q ss_pred CCCcEEEEEEecCCC--------------cccHHHHHHHHHHHhcCCCCccccEEEEEEeC--CeeEEEEeecCCCChhh
Q 048243 4 PCGKVIAVKKLSKTS--------------TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDC 67 (303)
Q Consensus 4 ~~~~~valK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~ 67 (303)
.+|+.||||++.+.. -...+...+||.+|++++|||||+++.+..+. ..+|||+|||..|.+..
T Consensus 120 ~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w 199 (576)
T KOG0585|consen 120 VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKW 199 (576)
T ss_pred CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCcccc
Confidence 578999999986541 12236788999999999999999999999875 57899999999987743
Q ss_pred hhcCcccccc-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCC---ccccc
Q 048243 68 YLFDPIRRLI-LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKES---LEANT 143 (303)
Q Consensus 68 ~l~~~~~~~~-l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~---~~~~~ 143 (303)
-= ..+. +.+.++++++++++.||+|||.+| |+||||||+|+|++.+|++||+|||.+..+.... .....
T Consensus 200 ~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L 272 (576)
T KOG0585|consen 200 CP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQL 272 (576)
T ss_pred CC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHH
Confidence 22 3344 899999999999999999999999 9999999999999999999999999987653221 11223
Q ss_pred cccccccCCCChhhhccCC----CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCC
Q 048243 144 EQVVGTIGYIPPEYARQGV----YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLD 219 (303)
Q Consensus 144 ~~~~g~~~y~aPE~~~~~~----~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (303)
...+||+.|+|||...+.. .+.+.||||+|+++|-|+.|+.||....... .+.. +....+.
T Consensus 273 ~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~-------l~~K--------Ivn~pL~ 337 (576)
T KOG0585|consen 273 SRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE-------LFDK--------IVNDPLE 337 (576)
T ss_pred hhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH-------HHHH--------HhcCccc
Confidence 3468999999999987632 3668999999999999999999995332111 1111 1222233
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 220 DTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 220 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
....+...+.+.+||.+||++||..|.+..+|...
T Consensus 338 fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 338 FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred CCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 33334556788999999999999999999999765
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=283.92 Aligned_cols=228 Identities=20% Similarity=0.237 Sum_probs=180.1
Q ss_pred CCCcEEEEEEecCC---CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+++.||+|.++.. .......+..|+.++.+++||||+++++.+......++||||+++|+|.+++. ....+++
T Consensus 16 ~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~---~~~~~~~ 92 (312)
T cd05585 16 DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQ---REGRFDL 92 (312)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHH---hcCCCCH
Confidence 46889999999653 23344567889999999999999999999999999999999999999999884 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....... .......|++.|+|||.+.+
T Consensus 93 ~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~ 167 (312)
T cd05585 93 SRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCGTPEYLAPELLLG 167 (312)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--CccccccCCcccCCHHHHcC
Confidence 999999999999999999999 9999999999999999999999999987532221 12233568999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|||||||++|+|++|..||....... ......... ...+...+..+.+++.+||..
T Consensus 168 ~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~~~~~~~~-----------~~~~~~~~~~~~~li~~~L~~ 230 (312)
T cd05585 168 HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MYRKILQEP-----------LRFPDGFDRDAKDLLIGLLSR 230 (312)
T ss_pred CCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HHHHHHcCC-----------CCCCCcCCHHHHHHHHHHcCC
Confidence 999999999999999999999999996432111 111111110 011122345788999999999
Q ss_pred CCCCCCCHHHHHHHhc
Q 048243 241 NPNDRPSMLQVSSMLK 256 (303)
Q Consensus 241 dp~~Rpt~~el~~~L~ 256 (303)
||.+||++..+.+.|.
T Consensus 231 dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 231 DPTRRLGYNGAQEIKN 246 (312)
T ss_pred CHHHcCCCCCHHHHHc
Confidence 9999986544444433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=292.86 Aligned_cols=238 Identities=28% Similarity=0.409 Sum_probs=184.7
Q ss_pred cCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc-------
Q 048243 3 LPCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI------- 73 (303)
Q Consensus 3 ~~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------- 73 (303)
..+++.||+|.++... ....+.+.+|+.+++.+ +|+||+++++.+......++||||+.+|+|.+++....
T Consensus 65 ~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~ 144 (374)
T cd05106 65 EDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFV 144 (374)
T ss_pred ccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhcccc
Confidence 3456789999997543 33456788999999999 89999999999999999999999999999998874311
Q ss_pred ------------------------------------------------------------ccccCCHHHHHHHHHHHHHH
Q 048243 74 ------------------------------------------------------------RRLILDWKKRVHIIEGITQG 93 (303)
Q Consensus 74 ------------------------------------------------------------~~~~l~~~~~~~~~~~i~~~ 93 (303)
....+++..++.++.||+.|
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 224 (374)
T cd05106 145 MALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQG 224 (374)
T ss_pred ccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHH
Confidence 11347788899999999999
Q ss_pred HHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCCCccchhhHH
Q 048243 94 LLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFG 173 (303)
Q Consensus 94 l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG 173 (303)
|+|||+++ ++||||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||
T Consensus 225 L~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG 301 (374)
T cd05106 225 MDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 301 (374)
T ss_pred HHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHH
Confidence 99999998 999999999999999999999999998765433222222223356789999999888899999999999
Q ss_pred HHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 048243 174 VLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVS 252 (303)
Q Consensus 174 ~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~ 252 (303)
|++|+|++ |..||........ ........... ..+...+.++.+++.+||+.||.+|||+.+++
T Consensus 302 vil~ellt~G~~Pf~~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~ 366 (374)
T cd05106 302 ILLWEIFSLGKSPYPGILVNSK------FYKMVKRGYQM---------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQIS 366 (374)
T ss_pred HHHHHHHhCCCCCCccccccHH------HHHHHHcccCc---------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 99999997 9999864322110 11111111100 00111235788999999999999999999999
Q ss_pred HHhccc
Q 048243 253 SMLKNE 258 (303)
Q Consensus 253 ~~L~~~ 258 (303)
+.|++.
T Consensus 367 ~~l~~~ 372 (374)
T cd05106 367 QLIQRQ 372 (374)
T ss_pred HHHHHH
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=298.22 Aligned_cols=234 Identities=24% Similarity=0.299 Sum_probs=190.6
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCccccEEEE-EEeC------CeeEEEEeecCCCChhhhhcCccccc
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGF-CIDS------EERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~-~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~ 76 (303)
.|..||+|++-..++...+.+.+||++|++|+ |+|||.+++. .... -++.|+||||.||.|-+++.......
T Consensus 61 ~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~ 140 (738)
T KOG1989|consen 61 GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR 140 (738)
T ss_pred CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhcc
Confidence 34899999998778888899999999999995 9999999993 3221 36789999999999999997655444
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCc-ccc----cc--ccccc
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL-EAN----TE--QVVGT 149 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~-~~~----~~--~~~g~ 149 (303)
|.+.++++|++++++|+++||.. ..+|+|||||-+|||++.+|..||||||.+.-...... ... .. ...-|
T Consensus 141 -lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TT 218 (738)
T KOG1989|consen 141 -LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTT 218 (738)
T ss_pred -CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCC
Confidence 99999999999999999999998 57899999999999999999999999999854322211 000 00 12458
Q ss_pred cCCCChhhh---ccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHH
Q 048243 150 IGYIPPEYA---RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCK 226 (303)
Q Consensus 150 ~~y~aPE~~---~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
+.|+|||.+ .+.++++|+|||+|||++|-|+....||+..+.. .++...+.....+.+
T Consensus 219 p~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-------------------aIlng~Y~~P~~p~y 279 (738)
T KOG1989|consen 219 PQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-------------------AILNGNYSFPPFPNY 279 (738)
T ss_pred ccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-------------------eEEeccccCCCCccH
Confidence 999999976 5678999999999999999999999999754332 234444444455678
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhcccc
Q 048243 227 LMRCLEIALLCVQENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 227 ~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~ 259 (303)
+..+.+||..||+.||.+||++-+++..+-...
T Consensus 280 s~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 280 SDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred HHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 889999999999999999999999988865544
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=294.34 Aligned_cols=245 Identities=27% Similarity=0.368 Sum_probs=191.7
Q ss_pred CcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHH
Q 048243 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVH 85 (303)
Q Consensus 6 ~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~ 85 (303)
++.||||+++.- -..+|..|++|+|+||+.+.++|.....+|+|||||..|.|...|. .+..+.......
T Consensus 147 netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLk---a~~~itp~llv~ 216 (904)
T KOG4721|consen 147 NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLK---AGRPITPSLLVD 216 (904)
T ss_pred CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHh---ccCccCHHHHHH
Confidence 678999988632 2357899999999999999999999999999999999999999984 566788899999
Q ss_pred HHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCCC
Q 048243 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYST 165 (303)
Q Consensus 86 ~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 165 (303)
|..+|+.|+.|||.+. |+|||||.-||||+.+..|||+|||.++....... .-.+.||..|||||++.+.+.+.
T Consensus 217 Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST---kMSFaGTVaWMAPEvIrnePcsE 290 (904)
T KOG4721|consen 217 WSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKST---KMSFAGTVAWMAPEVIRNEPCSE 290 (904)
T ss_pred HHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhh---hhhhhhhHhhhCHHHhhcCCccc
Confidence 9999999999999998 99999999999999999999999999877554422 12368999999999999999999
Q ss_pred ccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 048243 166 KSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDR 245 (303)
Q Consensus 166 ~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 245 (303)
|+||||||+|+|||+||..|+....... -.|. ... ..+....+...+.-+.-|+++||+-.|++|
T Consensus 291 KVDIwSfGVVLWEmLT~EiPYkdVdssA---------IIwG--VGs----NsL~LpvPstcP~GfklL~Kqcw~sKpRNR 355 (904)
T KOG4721|consen 291 KVDIWSFGVVLWEMLTGEIPYKDVDSSA---------IIWG--VGS----NSLHLPVPSTCPDGFKLLLKQCWNSKPRNR 355 (904)
T ss_pred ccceehhHHHHHHHHhcCCCccccchhe---------eEEe--ccC----CcccccCcccCchHHHHHHHHHHhcCCCCC
Confidence 9999999999999999999985332111 1111 111 111122222233456779999999999999
Q ss_pred CCHHHHHHHhccccCCCCCCCCCCCccccccccccc
Q 048243 246 PSMLQVSSMLKNETTNRNTPKKPAFSKQVDEIGIEL 281 (303)
Q Consensus 246 pt~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (303)
|++++++..|+-....+-......+.+...++-+++
T Consensus 356 PSFrqil~HldIa~pell~~tee~yf~sq~swrEev 391 (904)
T KOG4721|consen 356 PSFRQILLHLDIASPELLSTTEETYFKSQASWREEV 391 (904)
T ss_pred ccHHHHHHHHhhcCHHHhcccHHHHHHHHHHHHHHH
Confidence 999999999876554443333344444444444443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=267.45 Aligned_cols=272 Identities=21% Similarity=0.249 Sum_probs=202.6
Q ss_pred CCCcEEEEEEecCCCcc-c-HHHHHHHHHHHhcCCCCccccEEEEEEeC--CeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTSTQ-G-FEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~-~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+++.||+|+++..... . --...+||.+|.+++|||||.+-.+.... +..|+|||||+ -+|..++... ..++.
T Consensus 99 ~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E-hDLksl~d~m--~q~F~ 175 (419)
T KOG0663|consen 99 KTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE-HDLKSLMETM--KQPFL 175 (419)
T ss_pred CcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH-hhHHHHHHhc--cCCCc
Confidence 57899999999876421 1 12457899999999999999999998754 47999999996 4788887542 35788
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
..++.-++.|+++|++|||.+. |+|||||++|+|++..|.+||+|||+|+.++.... .....+-|.+|+|||++.
T Consensus 176 ~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k--~~T~lVVTLWYRaPELLL 250 (419)
T KOG0663|consen 176 PGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK--PYTPLVVTLWYRAPELLL 250 (419)
T ss_pred hHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCCcc--cCcceEEEeeecCHHHhc
Confidence 9999999999999999999999 99999999999999999999999999999887632 223356699999999988
Q ss_pred cCC-CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHH-----HhCCCcceecc---------ccCCCCCCH
Q 048243 160 QGV-YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL-----WKGGKGVEFVD---------SSLDDTNSP 224 (303)
Q Consensus 160 ~~~-~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~---------~~~~~~~~~ 224 (303)
+.. |+++.|+||+|||+.|++++.+.|.+-+..+..+.+...... |.+-....... ..+...+..
T Consensus 251 G~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~ 330 (419)
T KOG0663|consen 251 GAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGA 330 (419)
T ss_pred CCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccc
Confidence 764 899999999999999999999999876665554444332222 22111111110 111111111
Q ss_pred H-HHHHHHHHHHHcccCCCCCCCCHHHHHHHhccccCCCCCCCCCCCccccccccccccccc
Q 048243 225 C-KLMRCLEIALLCVQENPNDRPSMLQVSSMLKNETTNRNTPKKPAFSKQVDEIGIELLSTT 285 (303)
Q Consensus 225 ~-~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (303)
. .+..-.+|+..+|..||.+|.||+|.++. ..+.....|.+|...-..+.....++...
T Consensus 331 ~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e~P~p~~P~~~Pt~P~k~~~~~~~~ 390 (419)
T KOG0663|consen 331 LSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRETPLPIDPSMFPTWPAKSEQQRVKR 390 (419)
T ss_pred cccchhHHHHHHHHhccCccccccHHHhhcc--cccccCCCCCChhhcCCCccccccccCCC
Confidence 1 33567899999999999999999998764 34444456666666655555555555433
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=284.14 Aligned_cols=232 Identities=21% Similarity=0.271 Sum_probs=187.2
Q ss_pred cCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 3 LPCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 3 ~~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
..+|+.+|+|++++.. ..+.+.++.|-.+|...++|.||++|..|.+...+||||||++||++-.+| .....++
T Consensus 163 k~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL---~~~~~L~ 239 (550)
T KOG0605|consen 163 KDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLL---MRKDTLT 239 (550)
T ss_pred ccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHH---HhcCcCc
Confidence 4689999999998764 445667888999999999999999999999999999999999999999999 4677899
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccC----------------------
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKE---------------------- 137 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~---------------------- 137 (303)
+..+..++.+++.|+..+|+.| ++||||||+|+||+..|++||+|||++......
T Consensus 240 e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (550)
T KOG0605|consen 240 EDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPS 316 (550)
T ss_pred hHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCc
Confidence 9999999999999999999999 999999999999999999999999998543210
Q ss_pred Cccc----cc-------------------cccccccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCcc
Q 048243 138 SLEA----NT-------------------EQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINEN 194 (303)
Q Consensus 138 ~~~~----~~-------------------~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~ 194 (303)
.... .. ...+|||-|+|||++.+..|+..+|.||||||+|||+.|.+||....+...
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T 396 (550)
T KOG0605|consen 317 DFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQET 396 (550)
T ss_pred cccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 0000 00 014699999999999999999999999999999999999999976665544
Q ss_pred ccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 048243 195 LSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPS---MLQVSSM 254 (303)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt---~~el~~~ 254 (303)
...+..-...+. .......+.+..|||.+||. ||.+|.- +.||.+.
T Consensus 397 ~rkI~nwr~~l~-------------fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 397 YRKIVNWRETLK-------------FPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH 445 (550)
T ss_pred HHHHHHHhhhcc-------------CCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence 333322111111 11111122588899999999 9999986 6666553
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=291.90 Aligned_cols=237 Identities=27% Similarity=0.418 Sum_probs=184.6
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc--------
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-------- 73 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------- 73 (303)
++++.||||+++... ....+.+.+|+.++..+ +||||+++++++......++||||+++|+|.+++....
T Consensus 63 ~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~ 142 (375)
T cd05104 63 DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKH 142 (375)
T ss_pred ccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccc
Confidence 456789999997543 33456788999999999 89999999999999999999999999999998885321
Q ss_pred ----------------------------------------------------------------ccccCCHHHHHHHHHH
Q 048243 74 ----------------------------------------------------------------RRLILDWKKRVHIIEG 89 (303)
Q Consensus 74 ----------------------------------------------------------------~~~~l~~~~~~~~~~~ 89 (303)
....+++..++.++.|
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 222 (375)
T cd05104 143 EDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQ 222 (375)
T ss_pred cchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHH
Confidence 0124788899999999
Q ss_pred HHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCCCccch
Q 048243 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDV 169 (303)
Q Consensus 90 i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di 169 (303)
|+.||+|||+.+ ++||||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++||
T Consensus 223 i~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi 299 (375)
T cd05104 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV 299 (375)
T ss_pred HHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCH
Confidence 999999999998 99999999999999999999999999876544332222222344667999999999899999999
Q ss_pred hhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCH
Q 048243 170 FSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSM 248 (303)
Q Consensus 170 wslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~ 248 (303)
|||||++|+|++ |..||....... ............ ..+...+.++.+++.+||+.||++|||+
T Consensus 300 ~slG~~l~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~ 364 (375)
T cd05104 300 WSYGILLWEIFSLGSSPYPGMPVDS------KFYKMIKEGYRM---------LSPECAPSEMYDIMKSCWDADPLKRPTF 364 (375)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCchH------HHHHHHHhCccC---------CCCCCCCHHHHHHHHHHccCChhHCcCH
Confidence 999999999998 788875432211 111112111110 0111123478899999999999999999
Q ss_pred HHHHHHhccc
Q 048243 249 LQVSSMLKNE 258 (303)
Q Consensus 249 ~el~~~L~~~ 258 (303)
.|+++.|++.
T Consensus 365 ~eil~~l~~~ 374 (375)
T cd05104 365 KQIVQLIEQQ 374 (375)
T ss_pred HHHHHHHHhh
Confidence 9999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=275.22 Aligned_cols=224 Identities=24% Similarity=0.364 Sum_probs=189.2
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||||.+++.. ..+.-.+.+||++|..|+||||+.+|.+|+++....+||||..+|.|.+|+ ...+.+++
T Consensus 76 ~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYi---Ser~~LsE 152 (668)
T KOG0611|consen 76 KSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYI---SERGSLSE 152 (668)
T ss_pred cCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHH---HHhccccH
Confidence 689999999997663 344557889999999999999999999999999999999999999999999 45677999
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
...+.+++||..|+-|+|.++ ++|||||.+|||++.|+++||+|||++..+... .....++|.+-|.+||++.+
T Consensus 153 rEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~---kfLqTFCGSPLYASPEIvNG 226 (668)
T KOG0611|consen 153 REARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK---KFLQTFCGSPLYASPEIVNG 226 (668)
T ss_pred HHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc---cHHHHhcCCcccCCccccCC
Confidence 999999999999999999999 999999999999999999999999999877544 44556789999999999999
Q ss_pred CCC-CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 161 GVY-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 161 ~~~-~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
.+| .+.+|.||||+++|-|+.|..||.+....... .....+...+. ..+....-||+|||.
T Consensus 227 ~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lv-------rQIs~GaYrEP-----------~~PSdA~gLIRwmLm 288 (668)
T KOG0611|consen 227 TPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLV-------RQISRGAYREP-----------ETPSDASGLIRWMLM 288 (668)
T ss_pred CCCCCCccchhhHHHHHHHHhhcccccCCchHHHHH-------HHhhcccccCC-----------CCCchHHHHHHHHHh
Confidence 987 56899999999999999999999765433321 22222222211 111245579999999
Q ss_pred CCCCCCCCHHHHHHH
Q 048243 240 ENPNDRPSMLQVSSM 254 (303)
Q Consensus 240 ~dp~~Rpt~~el~~~ 254 (303)
+||++|.|+.++...
T Consensus 289 VNP~RRATieDiAsH 303 (668)
T KOG0611|consen 289 VNPERRATIEDIASH 303 (668)
T ss_pred cCcccchhHHHHhhh
Confidence 999999999999875
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=277.45 Aligned_cols=234 Identities=29% Similarity=0.479 Sum_probs=186.7
Q ss_pred CCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccc---------
Q 048243 5 CGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR--------- 74 (303)
Q Consensus 5 ~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------- 74 (303)
.++.||+|.++... ......+.+|+..+..++||||+++++++......+++|||+++++|.+++.....
T Consensus 34 ~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~ 113 (283)
T cd05048 34 SATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113 (283)
T ss_pred ceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccc
Confidence 34679999997543 33446788999999999999999999999998999999999999999999864211
Q ss_pred ----cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcccccccccccc
Q 048243 75 ----RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTI 150 (303)
Q Consensus 75 ----~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~ 150 (303)
...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++................++.
T Consensus 114 ~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~ 190 (283)
T cd05048 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPV 190 (283)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccc
Confidence 145788999999999999999999999 9999999999999999999999999987654333222333445678
Q ss_pred CCCChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHH
Q 048243 151 GYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMR 229 (303)
Q Consensus 151 ~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (303)
.|+|||.+.+..++.++|||||||++|+|++ |..||......+ ....+...... ..+...+.+
T Consensus 191 ~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-------~~~~i~~~~~~---------~~~~~~~~~ 254 (283)
T cd05048 191 RWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-------VIEMIRSRQLL---------PCPEDCPAR 254 (283)
T ss_pred cccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHcCCcC---------CCcccCCHH
Confidence 8999999988889999999999999999998 988886433221 11122211111 112233468
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 048243 230 CLEIALLCVQENPNDRPSMLQVSSMLKN 257 (303)
Q Consensus 230 l~~li~~~l~~dp~~Rpt~~el~~~L~~ 257 (303)
+.+|+.+||+.||.+||++.|+++.|++
T Consensus 255 ~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 255 VYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 8999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=296.79 Aligned_cols=229 Identities=19% Similarity=0.215 Sum_probs=184.0
Q ss_pred CcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc-ccccCCHHHHH
Q 048243 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-RRLILDWKKRV 84 (303)
Q Consensus 6 ~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~ 84 (303)
++.||+|.+..........+..|+.+++.++||||+++++++......++||||+++|+|.+++.... ....+++..+.
T Consensus 93 ~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~ 172 (478)
T PTZ00267 93 KEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172 (478)
T ss_pred CeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHH
Confidence 67899998866555555678889999999999999999999999999999999999999998875422 24568899999
Q ss_pred HHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCC
Q 048243 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYS 164 (303)
Q Consensus 85 ~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 164 (303)
.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++................||+.|+|||++.+..++
T Consensus 173 ~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 249 (478)
T PTZ00267 173 LLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249 (478)
T ss_pred HHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCC
Confidence 99999999999999998 999999999999999999999999999876543322223345689999999999998999
Q ss_pred CccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCC
Q 048243 165 TKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPND 244 (303)
Q Consensus 165 ~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 244 (303)
.++|||||||++|+|++|..||...... ........+.. . ..+...+..+.++|.+||..||++
T Consensus 250 ~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~~~~~~~~~-~---------~~~~~~s~~~~~li~~~L~~dP~~ 313 (478)
T PTZ00267 250 KKADMWSLGVILYELLTLHRPFKGPSQR------EIMQQVLYGKY-D---------PFPCPVSSGMKALLDPLLSKNPAL 313 (478)
T ss_pred cHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC-C---------CCCccCCHHHHHHHHHHhccChhh
Confidence 9999999999999999999998543211 11111111110 0 011123347889999999999999
Q ss_pred CCCHHHHHH
Q 048243 245 RPSMLQVSS 253 (303)
Q Consensus 245 Rpt~~el~~ 253 (303)
||++.+++.
T Consensus 314 Rps~~~~l~ 322 (478)
T PTZ00267 314 RPTTQQLLH 322 (478)
T ss_pred CcCHHHHHh
Confidence 999999864
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=276.60 Aligned_cols=230 Identities=24% Similarity=0.288 Sum_probs=181.5
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|.+.... ......+.+|+.+++.++|++|+++++++.+.+..++||||+.+|+|..++... ....+++
T Consensus 23 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~ 101 (285)
T cd05631 23 ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM-GNPGFDE 101 (285)
T ss_pred cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhh-CCCCCCH
Confidence 578999999986542 223346788999999999999999999999999999999999999998877432 2345889
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....... ......|+..|+|||.+.+
T Consensus 102 ~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~ 175 (285)
T cd05631 102 QRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVINN 175 (285)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC---eecCCCCCCCccCHhhhcC
Confidence 999999999999999999999 9999999999999999999999999987653221 1223468999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|||||||++|+|++|..||............. ...... ........+..+.+|+.+||..
T Consensus 176 ~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~~~~~----------~~~~~~~~s~~~~~li~~~l~~ 242 (285)
T cd05631 176 EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD---RRVKED----------QEEYSEKFSEDAKSICRMLLTK 242 (285)
T ss_pred CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH---HHhhcc----------cccCCccCCHHHHHHHHHHhhc
Confidence 999999999999999999999999996543322111111 111100 0011122345788999999999
Q ss_pred CCCCCCC-----HHHHHH
Q 048243 241 NPNDRPS-----MLQVSS 253 (303)
Q Consensus 241 dp~~Rpt-----~~el~~ 253 (303)
||.+||+ ++++++
T Consensus 243 ~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 243 NPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CHHHhcCCCCCCHHHHhc
Confidence 9999997 778776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=277.82 Aligned_cols=234 Identities=27% Similarity=0.444 Sum_probs=186.0
Q ss_pred CCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc----------
Q 048243 5 CGKVIAVKKLSKTSTQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI---------- 73 (303)
Q Consensus 5 ~~~~valK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------- 73 (303)
+++.||+|.++..... ..+.+.+|+++++.++|+||+++++++......++||||+++++|.+++....
T Consensus 34 ~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~ 113 (280)
T cd05049 34 DKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPD 113 (280)
T ss_pred CcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccc
Confidence 4678999999765433 45689999999999999999999999999999999999999999999985421
Q ss_pred -ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCC
Q 048243 74 -RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGY 152 (303)
Q Consensus 74 -~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y 152 (303)
....+++..+..++.|++.|+++||+++ ++||||||+||+++.++.++|+|||.+................++..|
T Consensus 114 ~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y 190 (280)
T cd05049 114 SPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRW 190 (280)
T ss_pred cccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCccccee
Confidence 2345788899999999999999999998 999999999999999999999999998765333222222334457889
Q ss_pred CChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHH
Q 048243 153 IPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL 231 (303)
Q Consensus 153 ~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
+|||.+.+..++.++||||||+++|+|++ |..||........ ......+... ..+...+..+.
T Consensus 191 ~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~-------~~~~~~~~~~---------~~~~~~~~~~~ 254 (280)
T cd05049 191 MPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV-------IECITQGRLL---------QRPRTCPSEVY 254 (280)
T ss_pred cChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCCcC---------CCCCCCCHHHH
Confidence 99999999999999999999999999998 9998854332111 1111111111 01112345788
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhcc
Q 048243 232 EIALLCVQENPNDRPSMLQVSSMLKN 257 (303)
Q Consensus 232 ~li~~~l~~dp~~Rpt~~el~~~L~~ 257 (303)
+++.+||..||.+||++.|+++.|++
T Consensus 255 ~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 255 DIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 99999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=279.30 Aligned_cols=238 Identities=28% Similarity=0.448 Sum_probs=190.3
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc----------
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI---------- 73 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------- 73 (303)
.++..+++|.+........+.+.+|+..++.++|+||+++++++......++||||+++++|.+++....
T Consensus 33 ~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~ 112 (291)
T cd05094 33 KDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 112 (291)
T ss_pred CcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccc
Confidence 4566799999977665556788999999999999999999999999999999999999999999985421
Q ss_pred ---ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcccccccccccc
Q 048243 74 ---RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTI 150 (303)
Q Consensus 74 ---~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~ 150 (303)
....+++..++.++.||+.|++|||+++ ++||||||+||+++.++.++|+|||++................++.
T Consensus 113 ~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~ 189 (291)
T cd05094 113 PRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189 (291)
T ss_pred cccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcce
Confidence 1234789999999999999999999999 9999999999999999999999999987654433222233345678
Q ss_pred CCCChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHH
Q 048243 151 GYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMR 229 (303)
Q Consensus 151 ~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (303)
.|+|||.+.+..++.++||||||+++|+|++ |..||....... ............ .....+..
T Consensus 190 ~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~ 253 (291)
T cd05094 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------VIECITQGRVLE---------RPRVCPKE 253 (291)
T ss_pred eecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhCCCCCC---------CCccCCHH
Confidence 8999999998889999999999999999998 888875432211 111111111111 11122447
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHhccccC
Q 048243 230 CLEIALLCVQENPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 230 l~~li~~~l~~dp~~Rpt~~el~~~L~~~~~ 260 (303)
+.+++.+||+.||.+|||+.++++.|++...
T Consensus 254 ~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 254 VYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 8899999999999999999999999988854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=281.96 Aligned_cols=240 Identities=23% Similarity=0.299 Sum_probs=182.5
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.||+|.+.... ....+.+.+|++++++++||||+++++++..+...++||||+++++|.+++. ....+++..
T Consensus 28 ~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~ 104 (331)
T cd06649 28 PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---EAKRIPEEI 104 (331)
T ss_pred CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHH---HcCCCCHHH
Confidence 468899999997553 3345679999999999999999999999999999999999999999999984 344688999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
+..++.|++.||+|||+.+ +++||||||+||+++.++.++|+|||++...... ......|+..|+|||.+.+..
T Consensus 105 ~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~ 178 (331)
T cd06649 105 LGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTH 178 (331)
T ss_pred HHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc----ccccCCCCcCcCCHhHhcCCC
Confidence 9999999999999999853 2999999999999999999999999998754322 122346899999999999988
Q ss_pred CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCC-cc----------------------------e-
Q 048243 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK-GV----------------------------E- 212 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~----------------------------~- 212 (303)
++.++|||||||++|+|++|+.||.............. ....... .. .
T Consensus 179 ~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T cd06649 179 YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGR--PVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFEL 256 (331)
T ss_pred CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc--cccccccCCccccCcccccccccccccccccccchhHHHH
Confidence 99999999999999999999999854322110000000 0000000 00 0
Q ss_pred ---eccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 213 ---FVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 213 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
+.............+.++.+|+.+||+.||++|||+.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 257 LDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred HHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000001112345678999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=270.83 Aligned_cols=237 Identities=22% Similarity=0.257 Sum_probs=192.3
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+++.+|+|++.+.. .....+++.|-++|+.++||++..+|+.|+.+...|++||||+||+|..+++. ..+..+++
T Consensus 100 ~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~Lrqk-Qp~~~fse 178 (459)
T KOG0610|consen 100 GTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQK-QPGKRFSE 178 (459)
T ss_pred CCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhh-CCCCccch
Confidence 345899999997653 23345678899999999999999999999999999999999999999998866 35677999
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccC-----------------------
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKE----------------------- 137 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~----------------------- 137 (303)
..++.++.+++-||+|||-.| ||+|||||+||||-++|+|.|+||+++..+...
T Consensus 179 ~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~ 255 (459)
T KOG0610|consen 179 SAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQP 255 (459)
T ss_pred hhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccc
Confidence 999999999999999999999 999999999999999999999999987553110
Q ss_pred ---------Ccc----------------------ccccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCC
Q 048243 138 ---------SLE----------------------ANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLS 186 (303)
Q Consensus 138 ---------~~~----------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~ 186 (303)
... .....++||-.|+|||++.+..-+.++|.|+||+++|||+.|..||
T Consensus 256 s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPF 335 (459)
T KOG0610|consen 256 SCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPF 335 (459)
T ss_pred cccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 000 0012357899999999999999999999999999999999999999
Q ss_pred ccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCC----HHHHHHH--hcccc
Q 048243 187 MLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPS----MLQVSSM--LKNET 259 (303)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt----~~el~~~--L~~~~ 259 (303)
.+.+....... ++...+.....+..+..+.|||+++|.+||++|.. |+||.+. +++..
T Consensus 336 KG~~~~~Tl~N---------------Iv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVn 399 (459)
T KOG0610|consen 336 KGSNNKETLRN---------------IVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVN 399 (459)
T ss_pred CCCCchhhHHH---------------HhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCC
Confidence 87765543221 12222223333356678899999999999999998 9999763 44443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=284.80 Aligned_cols=225 Identities=24% Similarity=0.323 Sum_probs=189.4
Q ss_pred CCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+.+.||+|.+.+. ...+.+.+.+|+++++.++||||+.+++.|+.+.+.|+|+|||.| +|..++. ..+.++++
T Consensus 25 ~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~---~d~~lpEe 100 (808)
T KOG0597|consen 25 YTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILE---QDGKLPEE 100 (808)
T ss_pred cceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHH---hccCCCHH
Confidence 46789999999654 344567899999999999999999999999999999999999976 9999994 56779999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
.+..++.+++.||.|||+.+ |.|||+||.||++..+|.+|++|||+++.++.+. .......||+-|||||+..+.
T Consensus 101 ~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t--~vltsikGtPlYmAPElv~e~ 175 (808)
T KOG0597|consen 101 QVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT--SVLTSIKGTPLYMAPELVEEQ 175 (808)
T ss_pred HHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc--eeeeeccCcccccCHHHHcCC
Confidence 99999999999999999999 9999999999999999999999999999887653 445557899999999999999
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
+|+..+|+|||||++||+++|++||-..+ +.+.......+ +...+...+..+..|+..+|..|
T Consensus 176 pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~d-----------~v~~p~~~S~~f~nfl~gLL~kd 238 (808)
T KOG0597|consen 176 PYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILKD-----------PVKPPSTASSSFVNFLQGLLIKD 238 (808)
T ss_pred CccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhcC-----------CCCCcccccHHHHHHHHHHhhcC
Confidence 99999999999999999999999984221 11111111111 11222355668899999999999
Q ss_pred CCCCCCHHHHHHH
Q 048243 242 PNDRPSMLQVSSM 254 (303)
Q Consensus 242 p~~Rpt~~el~~~ 254 (303)
|.+|.|..+++..
T Consensus 239 P~~RltW~~Ll~H 251 (808)
T KOG0597|consen 239 PAQRLTWTDLLGH 251 (808)
T ss_pred hhhcccHHHHhcC
Confidence 9999999999764
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=279.45 Aligned_cols=235 Identities=23% Similarity=0.331 Sum_probs=196.1
Q ss_pred CCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 5 CGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 5 ~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
+|+.||||++.+.. ......+.+|+..|+.++|||||++|.++.....+|||+|.-++|+|.+||.+ ....+.+..
T Consensus 42 TGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImK--He~Gl~E~L 119 (864)
T KOG4717|consen 42 TGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMK--HEEGLNEDL 119 (864)
T ss_pred ccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHh--hhccccHHH
Confidence 68999999996553 34456899999999999999999999999999999999999999999999975 455689999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEEC-CCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG-EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~-~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
..++++||+.|+.|+|+.+ +|||||||+|+.+. .-|-|||.|||++..+... ...+..+|...|-|||++.+.
T Consensus 120 a~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG---~kL~TsCGSLAYSAPEILLGD 193 (864)
T KOG4717|consen 120 AKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG---KKLTTSCGSLAYSAPEILLGD 193 (864)
T ss_pred HHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc---chhhcccchhhccCchhhhcC
Confidence 9999999999999999999 99999999999775 4688999999999876544 234456899999999999998
Q ss_pred CCC-CccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 162 VYS-TKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~-~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
.|+ +++||||||+++|.|+.|+.||...+..+.+..+. +. ....+.-.+.++.+||..||..
T Consensus 194 sYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm---------------DC--KYtvPshvS~eCrdLI~sMLvR 256 (864)
T KOG4717|consen 194 SYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM---------------DC--KYTVPSHVSKECRDLIQSMLVR 256 (864)
T ss_pred ccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh---------------cc--cccCchhhhHHHHHHHHHHHhc
Confidence 875 58999999999999999999998666554443322 21 1233456678999999999999
Q ss_pred CCCCCCCHHHHHH--HhccccCCCCC
Q 048243 241 NPNDRPSMLQVSS--MLKNETTNRNT 264 (303)
Q Consensus 241 dp~~Rpt~~el~~--~L~~~~~~~~~ 264 (303)
||.+|.+.+||.. +|+.....+++
T Consensus 257 dPkkRAslEeI~s~~Wlq~~D~~~sT 282 (864)
T KOG4717|consen 257 DPKKRASLEEIVSTSWLQAGDRGLST 282 (864)
T ss_pred CchhhccHHHHhccccccCCCCCccc
Confidence 9999999999965 46655554444
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=280.83 Aligned_cols=226 Identities=24% Similarity=0.306 Sum_probs=180.4
Q ss_pred CCCcEEEEEEecCCC----cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTS----TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+|+.||+|.++... ......+..|+.+++.++||||+++++.+..+...|+||||+.+++|.+++. ....+.
T Consensus 22 ~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~ 98 (323)
T cd05584 22 DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLE---REGIFM 98 (323)
T ss_pred CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHH---HcCCCC
Confidence 478999999997532 2233567789999999999999999999999999999999999999998884 345678
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..+..++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++....... .......|++.|+|||.+.
T Consensus 99 ~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~ 173 (323)
T cd05584 99 EDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--TVTHTFCGTIEYMAPEILM 173 (323)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--CcccccCCCccccChhhcc
Confidence 8899999999999999999999 9999999999999999999999999986533222 1122356899999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++|||||||++|+|++|..||....... .......... ..++..+..+.+++.+||+
T Consensus 174 ~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------~~~~~~~~~~-----------~~~~~~~~~~~~li~~~l~ 236 (323)
T cd05584 174 RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------TIDKILKGKL-----------NLPPYLTPEARDLLKKLLK 236 (323)
T ss_pred CCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------HHHHHHcCCC-----------CCCCCCCHHHHHHHHHHcc
Confidence 8889999999999999999999999986433211 1111111110 0111223478899999999
Q ss_pred CCCCCCC-----CHHHHHHH
Q 048243 240 ENPNDRP-----SMLQVSSM 254 (303)
Q Consensus 240 ~dp~~Rp-----t~~el~~~ 254 (303)
.||++|| ++.++++.
T Consensus 237 ~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 237 RNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred cCHhHcCCCCCCCHHHHhcC
Confidence 9999999 78888763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=284.21 Aligned_cols=223 Identities=21% Similarity=0.249 Sum_probs=179.9
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|.++... ....+.+.+|+.++++++||||+++++++.++...++||||+.+++|.+++. ....+++
T Consensus 41 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~ 117 (329)
T PTZ00263 41 GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR---KAGRFPN 117 (329)
T ss_pred CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHH---HcCCCCH
Confidence 468999999996542 2344678899999999999999999999999999999999999999999884 3456889
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..+..++.||+.||+|||+.| ++||||||+||+++.++.++|+|||++....... ....|++.|+|||.+.+
T Consensus 118 ~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~ 189 (329)
T PTZ00263 118 DVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQS 189 (329)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-----ceecCChhhcCHHHHcC
Confidence 999999999999999999999 9999999999999999999999999987653321 22468999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|||||||++|+|++|..||...... . ......... .. .+...+..+.+|+.+||+.
T Consensus 190 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~-~~~~i~~~~-~~---------~p~~~~~~~~~li~~~L~~ 252 (329)
T PTZ00263 190 KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------R-IYEKILAGR-LK---------FPNWFDGRARDLVKGLLQT 252 (329)
T ss_pred CCCCCcceeechHHHHHHHHcCCCCCCCCCHH------H-HHHHHhcCC-cC---------CCCCCCHHHHHHHHHHhhc
Confidence 98999999999999999999999998543211 1 111111111 00 0111234688999999999
Q ss_pred CCCCCCC-----HHHHHHH
Q 048243 241 NPNDRPS-----MLQVSSM 254 (303)
Q Consensus 241 dp~~Rpt-----~~el~~~ 254 (303)
||.+||+ +.+++..
T Consensus 253 dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 253 DHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CHHHcCCCCCCCHHHHhcC
Confidence 9999997 5777643
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=280.86 Aligned_cols=223 Identities=21% Similarity=0.240 Sum_probs=180.1
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++.++...++||||+.+++|.+++. ....+++
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~ 100 (291)
T cd05612 24 ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLR---NSGRFSN 100 (291)
T ss_pred CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHH---HcCCCCH
Confidence 468999999986432 2334568899999999999999999999999999999999999999999984 3456889
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..+..++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++...... .....|++.|+|||.+.+
T Consensus 101 ~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~ 172 (291)
T cd05612 101 STGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQS 172 (291)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC-----cccccCChhhcCHHHHcC
Confidence 999999999999999999999 999999999999999999999999998765332 122468999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|||||||++|+|++|..||........ .. ...... . ..+...+..+.+++.+||+.
T Consensus 173 ~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~---~~---~i~~~~--~---------~~~~~~~~~~~~li~~~l~~ 235 (291)
T cd05612 173 KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI---YE---KILAGK--L---------EFPRHLDLYAKDLIKKLLVV 235 (291)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH---HHHhCC--c---------CCCccCCHHHHHHHHHHcCC
Confidence 8899999999999999999999999864332111 11 111110 0 01112244788999999999
Q ss_pred CCCCCCC-----HHHHHHH
Q 048243 241 NPNDRPS-----MLQVSSM 254 (303)
Q Consensus 241 dp~~Rpt-----~~el~~~ 254 (303)
||.+||+ +.++++.
T Consensus 236 dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 236 DRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CHHHccCCccCCHHHHhcC
Confidence 9999995 8888754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=285.19 Aligned_cols=231 Identities=22% Similarity=0.295 Sum_probs=183.6
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|+++... ......+.+|+.++..++||||+++++++......|+||||+++++|.+++. ....+++
T Consensus 24 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~---~~~~l~~ 100 (333)
T cd05600 24 DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN---NLGVLSE 100 (333)
T ss_pred CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHH---HcCCCCH
Confidence 468999999997542 2344578889999999999999999999999999999999999999999984 3456889
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++..... ......|++.|+|||++.+
T Consensus 101 ~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~ 172 (333)
T cd05600 101 DHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRG 172 (333)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcC
Confidence 999999999999999999999 99999999999999999999999999875433 2233568999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|||||||++|+|++|..||...........+ ..+... .. .+. ........+.++.+++.+||..
T Consensus 173 ~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i----~~~~~~--~~--~~~-~~~~~~~~s~~~~~li~~~l~~ 243 (333)
T cd05600 173 KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL----KYWKET--LQ--RPV-YDDPRFNLSDEAWDLITKLIND 243 (333)
T ss_pred CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH----Hhcccc--cc--CCC-CCccccccCHHHHHHHHHHhhC
Confidence 89999999999999999999999998644322211111 111100 00 000 0000112345788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 048243 241 NPNDRPSMLQVSSM 254 (303)
Q Consensus 241 dp~~Rpt~~el~~~ 254 (303)
+|.+||++.++++.
T Consensus 244 ~~~rr~s~~~ll~h 257 (333)
T cd05600 244 PSRRFGSLEDIKNH 257 (333)
T ss_pred hhhhcCCHHHHHhC
Confidence 99999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=278.74 Aligned_cols=237 Identities=29% Similarity=0.470 Sum_probs=188.2
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc----------c
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI----------R 74 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~ 74 (303)
++..+|+|.+........+.+.+|++++++++||||+++++++......++||||+++++|.+++.... .
T Consensus 34 ~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~ 113 (288)
T cd05093 34 DKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNR 113 (288)
T ss_pred cceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCC
Confidence 456799999976655556789999999999999999999999999999999999999999999885321 1
Q ss_pred cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCC
Q 048243 75 RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIP 154 (303)
Q Consensus 75 ~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~a 154 (303)
...+++..++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||.+................++..|+|
T Consensus 114 ~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 190 (288)
T cd05093 114 PAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP 190 (288)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccC
Confidence 235899999999999999999999999 99999999999999999999999999876543332222233445778999
Q ss_pred hhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHH
Q 048243 155 PEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEI 233 (303)
Q Consensus 155 PE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 233 (303)
||.+.+..++.++||||||+++|+|++ |..||....... . ........... .. ...+..+.++
T Consensus 191 PE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~----~~~i~~~~~~~-----~~----~~~~~~l~~l 254 (288)
T cd05093 191 PESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---V----IECITQGRVLQ-----RP----RTCPKEVYDL 254 (288)
T ss_pred HHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcCCcCC-----CC----CCCCHHHHHH
Confidence 999998889999999999999999998 888875433211 1 11111111111 01 1123468899
Q ss_pred HHHcccCCCCCCCCHHHHHHHhccccC
Q 048243 234 ALLCVQENPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 234 i~~~l~~dp~~Rpt~~el~~~L~~~~~ 260 (303)
+.+||+.||.+|||+.++.+.|++...
T Consensus 255 i~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 255 MLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=277.03 Aligned_cols=243 Identities=21% Similarity=0.232 Sum_probs=181.5
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+++.||+|+++... ....+.+.+|+.+++.++||||+++++++..+...++||||+.++.+..+.. ....+++.
T Consensus 24 ~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~ 100 (287)
T cd07848 24 ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEE---MPNGVPPE 100 (287)
T ss_pred CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHh---cCCCCCHH
Confidence 468899999997542 3345678899999999999999999999999999999999999887765542 23468899
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
.++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++........ .......|+..|+|||.+.+.
T Consensus 101 ~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 176 (287)
T cd07848 101 KVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-ANYTEYVATRWYRSPELLLGA 176 (287)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccc-ccccccccccccCCcHHHcCC
Confidence 99999999999999999999 99999999999999999999999999876543221 122235689999999999988
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHH--------HHHHh-CCCcceeccccCCC------CCCHHH
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA--------YELWK-GGKGVEFVDSSLDD------TNSPCK 226 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~-~~~~~~~~~~~~~~------~~~~~~ 226 (303)
.++.++|||||||++|+|++|..||............... ...+. .........+.... ......
T Consensus 177 ~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (287)
T cd07848 177 PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGIL 256 (287)
T ss_pred CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhccc
Confidence 8999999999999999999999999654322211111100 00000 00000000000000 001123
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 227 LMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 227 ~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
+..+.+|+.+||+.||++|||++|+++
T Consensus 257 s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 257 SGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 457899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=282.65 Aligned_cols=226 Identities=21% Similarity=0.228 Sum_probs=181.1
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|++.... ......+.+|+.+++.++||||+++++.+......++||||+++|+|..++. ....+++
T Consensus 18 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~---~~~~l~~ 94 (328)
T cd05593 18 ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLS---RERVFSE 94 (328)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHH---hcCCCCH
Confidence 578999999997542 2344677889999999999999999999999999999999999999988874 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++....... .......|++.|+|||.+.+
T Consensus 95 ~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~ 169 (328)
T cd05593 95 DRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKTFCGTPEYLAPEVLED 169 (328)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccccccCCcCccChhhhcC
Confidence 999999999999999999999 9999999999999999999999999986532211 11223568999999999998
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|||||||++|+|++|..||....... ......... .. .+...+..+.+++.+||..
T Consensus 170 ~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~------~~~~~~~~~-------~~----~p~~~~~~~~~li~~~L~~ 232 (328)
T cd05593 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILMED-------IK----FPRTLSADAKSLLSGLLIK 232 (328)
T ss_pred CCCCccCCccccchHHHHHhhCCCCCCCCCHHH------HHHHhccCC-------cc----CCCCCCHHHHHHHHHHcCC
Confidence 889999999999999999999999985432211 101111100 01 1112345788999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 048243 241 NPNDRP-----SMLQVSSM 254 (303)
Q Consensus 241 dp~~Rp-----t~~el~~~ 254 (303)
||++|| ++.++++.
T Consensus 233 dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 233 DPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CHHHcCCCCCCCHHHHhcC
Confidence 999997 89998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=278.15 Aligned_cols=242 Identities=22% Similarity=0.320 Sum_probs=179.0
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+++.||+|.++... ......+.+|+.+++.++||||+++++++......++||||+.+ +|.+++.. ....+++..
T Consensus 28 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~ 104 (288)
T cd07871 28 LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDN--CGNLMSMHN 104 (288)
T ss_pred CCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHh--cCCCCCHHH
Confidence 478999999997543 22345678999999999999999999999999999999999975 88887743 234578899
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc-C
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ-G 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~ 161 (303)
+..++.||+.||+|||+.| |+||||||+||+++.++.++|+|||++....... .......++..|+|||.+.+ .
T Consensus 105 ~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~ 179 (288)
T cd07871 105 VKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGST 179 (288)
T ss_pred HHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC--ccccCceecccccChHHhcCCc
Confidence 9999999999999999999 9999999999999999999999999987543221 11223467899999998865 4
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHH-----HHHhCCCcc----eeccccCCCC----CCHHHHH
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY-----ELWKGGKGV----EFVDSSLDDT----NSPCKLM 228 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~----~~~~~~~~~~----~~~~~~~ 228 (303)
.++.++||||+||++|+|++|..||................ ..|...... ....+..... ..+..+.
T Consensus 180 ~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (288)
T cd07871 180 EYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDT 259 (288)
T ss_pred ccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCH
Confidence 68899999999999999999999996543322211111100 011110000 0000000000 0012235
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 229 RCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 229 ~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
++.+|+.+||+.||.+|||+.|+++
T Consensus 260 ~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 260 DGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred HHHHHHHHhcCcCcccCCCHHHHhc
Confidence 6789999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=282.69 Aligned_cols=226 Identities=19% Similarity=0.236 Sum_probs=180.3
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|.++... ......+.+|+.+++.++||||+++++++......|+||||+++++|..++. ....+++
T Consensus 18 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~---~~~~~~~ 94 (323)
T cd05595 18 ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTE 94 (323)
T ss_pred CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHH---HcCCCCH
Confidence 578999999997542 2334567789999999999999999999999999999999999999988874 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.||+.||+|||+.| ++||||||+||+++.++.++|+|||++....... .......|++.|+|||.+.+
T Consensus 95 ~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~ 169 (323)
T cd05595 95 ERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLED 169 (323)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--CccccccCCcCcCCcccccC
Confidence 999999999999999999999 9999999999999999999999999886532221 11223568999999999998
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|||||||++|+|++|..||......... ........ .+ +...+..+.+++.+||+.
T Consensus 170 ~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~------~~~~~~~~-------~~----p~~~~~~~~~li~~~L~~ 232 (323)
T cd05595 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF------ELILMEEI-------RF----PRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHH------HHHhcCCC-------CC----CCCCCHHHHHHHHHHccC
Confidence 88999999999999999999999998643321111 11111100 01 112345788999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 048243 241 NPNDRP-----SMLQVSSM 254 (303)
Q Consensus 241 dp~~Rp-----t~~el~~~ 254 (303)
||.+|| ++.++++.
T Consensus 233 dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 233 DPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CHHHhCCCCCCCHHHHHcC
Confidence 999998 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=273.24 Aligned_cols=233 Identities=30% Similarity=0.452 Sum_probs=188.0
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
..+++.+|+|.+..........+..|+.+++.++|+||+++++++......++||||+++++|.+++... ....+++..
T Consensus 27 ~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~ 105 (261)
T cd05148 27 WKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSP-EGQVLPVAS 105 (261)
T ss_pred ecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcC-CCCCCCHHH
Confidence 4568899999998776656678999999999999999999999999999999999999999999999653 345689999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
++.++.|++.|++|||+.| ++|+||+|+||+++.++.++|+|||.+.......... ....++..|+|||.+.+..
T Consensus 106 ~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~--~~~~~~~~~~~PE~~~~~~ 180 (261)
T cd05148 106 LIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS--SDKKIPYKWTAPEAASHGT 180 (261)
T ss_pred HHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccccc--cCCCCceEecCHHHHccCC
Confidence 9999999999999999998 9999999999999999999999999987654322111 1233567899999998888
Q ss_pred CCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
++.++||||||+++|+|++ |..||....... .. ....... ....+...+..+.+++.+||+.|
T Consensus 181 ~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~----~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~~ 244 (261)
T cd05148 181 FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VY----DQITAGY---------RMPCPAKCPQEIYKIMLECWAAE 244 (261)
T ss_pred CCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HH----HHHHhCC---------cCCCCCCCCHHHHHHHHHHcCCC
Confidence 9999999999999999998 788885433111 11 1111110 01111223457889999999999
Q ss_pred CCCCCCHHHHHHHhcc
Q 048243 242 PNDRPSMLQVSSMLKN 257 (303)
Q Consensus 242 p~~Rpt~~el~~~L~~ 257 (303)
|.+|||+.++++.|++
T Consensus 245 p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 245 PEDRPSFKALREELDN 260 (261)
T ss_pred chhCcCHHHHHHHHhc
Confidence 9999999999999976
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=271.51 Aligned_cols=232 Identities=26% Similarity=0.346 Sum_probs=181.2
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.||+|.+.... ......+.+|+++++.++||||+++++++......++||||+.+++|.+++.. ....+++..
T Consensus 18 ~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~ 95 (252)
T cd05084 18 ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGPRLKVKE 95 (252)
T ss_pred cCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHh--CCCCCCHHH
Confidence 478899999986543 33446789999999999999999999999999999999999999999998843 234588999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
++.++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||.+................++..|+|||.+.+..
T Consensus 96 ~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 172 (252)
T cd05084 96 LIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR 172 (252)
T ss_pred HHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCC
Confidence 9999999999999999998 9999999999999999999999999987544321111111122345799999998888
Q ss_pred CCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
++.++||||||+++|++++ |..||....... .......... ...+...+..+.+++.+||+.|
T Consensus 173 ~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~ 236 (252)
T cd05084 173 YSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQGVR---------LPCPELCPDAVYRLMERCWEYD 236 (252)
T ss_pred CChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHHcCCC---------CCCcccCCHHHHHHHHHHcCCC
Confidence 9999999999999999998 777774322111 1111111100 1111223457889999999999
Q ss_pred CCCCCCHHHHHHHhc
Q 048243 242 PNDRPSMLQVSSMLK 256 (303)
Q Consensus 242 p~~Rpt~~el~~~L~ 256 (303)
|++|||+.++.+.|+
T Consensus 237 p~~Rps~~~~~~~l~ 251 (252)
T cd05084 237 PGQRPSFSTVHQELQ 251 (252)
T ss_pred hhhCcCHHHHHHHHh
Confidence 999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=271.28 Aligned_cols=233 Identities=29% Similarity=0.441 Sum_probs=185.0
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
++++.||+|.+... ......+.+|+..++.++|+||+++++++......+++|||+++++|.+++... ....+++..+
T Consensus 29 ~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~l~~~~~ 106 (263)
T cd05052 29 KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVL 106 (263)
T ss_pred cCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhC-CCCCCCHHHH
Confidence 45889999998654 334567889999999999999999999999999999999999999999988542 2345889999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
+.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||.+......... ......++..|+|||.+.+..+
T Consensus 107 ~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 182 (263)
T cd05052 107 LYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKF 182 (263)
T ss_pred HHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee-ccCCCCCccccCCHHHhccCCC
Confidence 999999999999999998 999999999999999999999999998765543221 1122234567999999998889
Q ss_pred CCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC
Q 048243 164 STKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 242 (303)
+.++||||||+++|+|++ |..||....... .......... ...+...+..+.+++.+||..||
T Consensus 183 ~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p 246 (263)
T cd05052 183 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKGYR---------MERPEGCPPKVYELMRACWQWNP 246 (263)
T ss_pred CchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCC---------CCCCCCCCHHHHHHHHHHccCCc
Confidence 999999999999999998 888875332111 1111111110 11112234578899999999999
Q ss_pred CCCCCHHHHHHHhccc
Q 048243 243 NDRPSMLQVSSMLKNE 258 (303)
Q Consensus 243 ~~Rpt~~el~~~L~~~ 258 (303)
++|||+.++++.|++.
T Consensus 247 ~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 247 SDRPSFAEIHQAFETM 262 (263)
T ss_pred ccCCCHHHHHHHHHhh
Confidence 9999999999999764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=270.48 Aligned_cols=234 Identities=30% Similarity=0.422 Sum_probs=185.2
Q ss_pred ccCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 2 VLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 2 ~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
..++++.||+|.++... ...+.+.+|+.++++++|+||+++++++...+..+++|||+.+++|.+++.... ...+++.
T Consensus 26 ~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~ 103 (261)
T cd05068 26 LWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGA-GRALKLP 103 (261)
T ss_pred EecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccC-CCCCCHH
Confidence 34567889999997544 345678899999999999999999999999999999999999999999985422 3468999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
.+..++.|++.|+.+||+.| ++||||||+||+++.++.++|+|||++......... .......+..|+|||.+.+.
T Consensus 104 ~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~ 179 (261)
T cd05068 104 QLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPEAALYN 179 (261)
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-ccCCCcCceeccCccccccC
Confidence 99999999999999999999 999999999999999999999999998876532211 11112234579999999988
Q ss_pred CCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 162 VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
.++.++||||||+++|+|++ |..||....... .......... .......+..+.+++.+||+.
T Consensus 180 ~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~ 243 (261)
T cd05068 180 RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-------VLQQVDQGYR---------MPCPPGCPKELYDIMLDCWKE 243 (261)
T ss_pred CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC---------CCCCCcCCHHHHHHHHHHhhc
Confidence 89999999999999999999 888885332111 1111111110 011112345788999999999
Q ss_pred CCCCCCCHHHHHHHhcc
Q 048243 241 NPNDRPSMLQVSSMLKN 257 (303)
Q Consensus 241 dp~~Rpt~~el~~~L~~ 257 (303)
+|.+||++.++++.|++
T Consensus 244 ~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 244 DPDDRPTFETLQWKLED 260 (261)
T ss_pred CcccCCCHHHHHHHHhc
Confidence 99999999999999976
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=275.32 Aligned_cols=225 Identities=23% Similarity=0.283 Sum_probs=176.2
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+++.||+|.++... ....+.+..|..++... +||||+++++++......++||||+++|+|..++. ....++
T Consensus 18 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~---~~~~~~ 94 (316)
T cd05592 18 GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQ---SSGRFD 94 (316)
T ss_pred CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHH---HcCCCC
Confidence 468899999997542 23344556677777655 89999999999999999999999999999988884 344689
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++....... .......|++.|+|||.+.
T Consensus 95 ~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~ 169 (316)
T cd05592 95 EARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTPDYIAPEILK 169 (316)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccCCccccCHHHHc
Confidence 9999999999999999999998 9999999999999999999999999987543222 2223456899999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++|||||||++|+|++|..||....... . ........ ...+...+..+.+++.+||+
T Consensus 170 ~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~----~~~i~~~~----------~~~~~~~~~~~~~ll~~~l~ 232 (316)
T cd05592 170 GQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---L----FDSILNDR----------PHFPRWISKEAKDCLSKLFE 232 (316)
T ss_pred CCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---H----HHHHHcCC----------CCCCCCCCHHHHHHHHHHcc
Confidence 8889999999999999999999999996433211 1 11111110 01111234477899999999
Q ss_pred CCCCCCCCHH-HHHH
Q 048243 240 ENPNDRPSML-QVSS 253 (303)
Q Consensus 240 ~dp~~Rpt~~-el~~ 253 (303)
.||.+||++. ++++
T Consensus 233 ~~P~~R~~~~~~l~~ 247 (316)
T cd05592 233 RDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCHHHcCCChHHHHc
Confidence 9999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=283.39 Aligned_cols=222 Identities=21% Similarity=0.269 Sum_probs=178.1
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+|+.||+|++.... ......+..|++++++++||||+++++++......|+||||+.+++|.+++. ....+++.
T Consensus 22 ~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~l~~~ 98 (318)
T cd05582 22 DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS---KEVMFTEE 98 (318)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHH---HcCCCCHH
Confidence 478999999997542 2234567789999999999999999999999999999999999999998884 34568999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
.++.++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||++....... .......|+..|+|||.+.+.
T Consensus 99 ~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~ 173 (318)
T cd05582 99 DVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRR 173 (318)
T ss_pred HHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--CceecccCChhhcCHHHHcCC
Confidence 99999999999999999999 9999999999999999999999999987643321 112235689999999999988
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
.++.++|||||||++|+|++|..||....... .......... ..+...+..+.+++.+||+.|
T Consensus 174 ~~~~~~DiwslG~il~el~tg~~p~~~~~~~~------~~~~i~~~~~-----------~~p~~~~~~~~~li~~~l~~~ 236 (318)
T cd05582 174 GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE------TMTMILKAKL-----------GMPQFLSPEAQSLLRALFKRN 236 (318)
T ss_pred CCCCccceeccceEeeeeccCCCCCCCCCHHH------HHHHHHcCCC-----------CCCCCCCHHHHHHHHHHhhcC
Confidence 89999999999999999999999986432111 1111111110 011123447889999999999
Q ss_pred CCCCCCHHH
Q 048243 242 PNDRPSMLQ 250 (303)
Q Consensus 242 p~~Rpt~~e 250 (303)
|.+||++.+
T Consensus 237 P~~R~~a~~ 245 (318)
T cd05582 237 PANRLGAGP 245 (318)
T ss_pred HhHcCCCCC
Confidence 999999665
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=278.96 Aligned_cols=221 Identities=20% Similarity=0.227 Sum_probs=179.1
Q ss_pred CcEEEEEEecCC---CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 6 GKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 6 ~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+....++||||+.+|+|.+++. ....+++..
T Consensus 56 ~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~---~~~~~~~~~ 132 (340)
T PTZ00426 56 FPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR---RNKRFPNDV 132 (340)
T ss_pred CeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH---HcCCCCHHH
Confidence 468999998643 22344678899999999999999999999999999999999999999999984 345689999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
+..++.|++.||+|||+.| ++||||||+|||++.++.++|+|||++...... .....|++.|+|||++.+..
T Consensus 133 ~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~ 204 (340)
T PTZ00426 133 GCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVG 204 (340)
T ss_pred HHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC-----cceecCChhhcCHHHHhCCC
Confidence 9999999999999999999 999999999999999999999999998765332 12356899999999999888
Q ss_pred CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC
Q 048243 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 242 (303)
++.++|||||||++|+|++|..||....... .......... ..+...+..+.+++.+||+.||
T Consensus 205 ~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~------~~~~i~~~~~-----------~~p~~~~~~~~~li~~~l~~dp 267 (340)
T PTZ00426 205 HGKAADWWTLGIFIYEILVGCPPFYANEPLL------IYQKILEGII-----------YFPKFLDNNCKHLMKKLLSHDL 267 (340)
T ss_pred CCccccccchhhHHHHHhcCCCCCCCCCHHH------HHHHHhcCCC-----------CCCCCCCHHHHHHHHHHcccCH
Confidence 9999999999999999999999996432211 1111111110 0111123467899999999999
Q ss_pred CCCC-----CHHHHHHH
Q 048243 243 NDRP-----SMLQVSSM 254 (303)
Q Consensus 243 ~~Rp-----t~~el~~~ 254 (303)
.+|+ ++.++++.
T Consensus 268 ~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 268 TKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHcCCCCCCCHHHHHcC
Confidence 9995 89998774
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=280.12 Aligned_cols=226 Identities=24% Similarity=0.361 Sum_probs=175.2
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.||||++.... ....+.+.+|+.+++.++|+||+++++++......++||||+++++|.... ...+..
T Consensus 97 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~-------~~~~~~ 169 (353)
T PLN00034 97 PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH-------IADEQF 169 (353)
T ss_pred CCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc-------cCCHHH
Confidence 478999999996543 334467889999999999999999999999999999999999999885432 355678
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc--
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ-- 160 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-- 160 (303)
+..++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||++....... .......|+..|+|||.+..
T Consensus 170 ~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~ 244 (353)
T PLN00034 170 LADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--DPCNSSVGTIAYMSPERINTDL 244 (353)
T ss_pred HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc--ccccccccCccccCcccccccc
Confidence 8899999999999999999 9999999999999999999999999987654321 11223568999999998743
Q ss_pred ---CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHc
Q 048243 161 ---GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237 (303)
Q Consensus 161 ---~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 237 (303)
...+.++|||||||++|+|++|..||............. .... .. ........+.++.+||.+|
T Consensus 245 ~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~~~-~~---------~~~~~~~~~~~l~~li~~~ 311 (353)
T PLN00034 245 NHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC---AICM-SQ---------PPEAPATASREFRHFISCC 311 (353)
T ss_pred ccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH---HHhc-cC---------CCCCCCccCHHHHHHHHHH
Confidence 234568999999999999999999997333222111111 0000 00 0111123345789999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 048243 238 VQENPNDRPSMLQVSSM 254 (303)
Q Consensus 238 l~~dp~~Rpt~~el~~~ 254 (303)
|..||++|||+.|+++.
T Consensus 312 l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 312 LQREPAKRWSAMQLLQH 328 (353)
T ss_pred ccCChhhCcCHHHHhcC
Confidence 99999999999999875
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=278.50 Aligned_cols=226 Identities=22% Similarity=0.268 Sum_probs=179.5
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+|+.||+|+++... ....+.+..|..++..+ +||||+++++++......|+||||+++++|..++. ....++
T Consensus 18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~---~~~~~~ 94 (321)
T cd05591 18 GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQ---RSRKFD 94 (321)
T ss_pred CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHH---HcCCCC
Confidence 468899999997542 33445677888888876 89999999999999999999999999999988884 345688
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..+..++.||+.||+|||+.| ++||||||+||+++.++.++|+|||++....... .......|+..|+|||++.
T Consensus 95 ~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~ 169 (321)
T cd05591 95 EPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPDYIAPEILQ 169 (321)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--ccccccccCccccCHHHHc
Confidence 9999999999999999999999 9999999999999999999999999986533221 1223356899999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++|||||||++|+|++|..||........ . ........ ..+...+.++.+++.+||+
T Consensus 170 ~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~---~---~~i~~~~~-----------~~p~~~~~~~~~ll~~~L~ 232 (321)
T cd05591 170 ELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL---F---ESILHDDV-----------LYPVWLSKEAVSILKAFMT 232 (321)
T ss_pred CCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH---H---HHHHcCCC-----------CCCCCCCHHHHHHHHHHhc
Confidence 98999999999999999999999999964432111 1 11111110 0111123478899999999
Q ss_pred CCCCCCC-------CHHHHHHH
Q 048243 240 ENPNDRP-------SMLQVSSM 254 (303)
Q Consensus 240 ~dp~~Rp-------t~~el~~~ 254 (303)
.||.+|| ++.++++.
T Consensus 233 ~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 233 KNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred cCHHHcCCCCCCCCCHHHHhcC
Confidence 9999999 78888754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=275.66 Aligned_cols=232 Identities=35% Similarity=0.514 Sum_probs=177.5
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
..+..|+||.++... ....+.+.+|++.+++++||||+++++++......++|+||+++|+|.+++... ....+++..
T Consensus 26 ~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~-~~~~~~~~~ 104 (259)
T PF07714_consen 26 DKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSK-NKEPLSEQQ 104 (259)
T ss_dssp SSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHT-CTTTSBHHH
T ss_pred CCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 356789999996543 334678999999999999999999999999888899999999999999999652 245689999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
++.++.||+.||+|||+.+ ++|+||+++||+++.++.+||+|||++................+...|+|||.+.+..
T Consensus 105 ~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 181 (259)
T PF07714_consen 105 RLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGE 181 (259)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSE
T ss_pred ccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999999998 9999999999999999999999999997763333333333345678899999999888
Q ss_pred CCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
++.++||||||+++||+++ |..|+..... ... ........... .+...+..+.+++.+||..|
T Consensus 182 ~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~----~~~~~~~~~~~---------~~~~~~~~~~~li~~C~~~~ 245 (259)
T PF07714_consen 182 YTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEI----IEKLKQGQRLP---------IPDNCPKDIYSLIQQCWSHD 245 (259)
T ss_dssp ESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHH----HHHHHTTEETT---------SBTTSBHHHHHHHHHHT-SS
T ss_pred cccccccccccccccccccccccccccccc---ccc----cccccccccce---------eccchhHHHHHHHHHHcCCC
Confidence 9999999999999999999 6677643311 111 11222221111 11112347889999999999
Q ss_pred CCCCCCHHHHHHHh
Q 048243 242 PNDRPSMLQVSSML 255 (303)
Q Consensus 242 p~~Rpt~~el~~~L 255 (303)
|.+|||+.++++.|
T Consensus 246 p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 246 PEKRPSFQEILQEL 259 (259)
T ss_dssp GGGS--HHHHHHHH
T ss_pred hhhCcCHHHHHhcC
Confidence 99999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=272.58 Aligned_cols=248 Identities=24% Similarity=0.339 Sum_probs=183.5
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeC--CeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+++.||+|.++... ......+.+|+++++.++||||+++++++... ...+++|||+.+++|.+++. ...+++
T Consensus 31 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~l~~ 106 (283)
T cd05080 31 GTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLP----KHKLNL 106 (283)
T ss_pred CCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHH----HcCCCH
Confidence 468899999997553 23456788999999999999999999987653 46899999999999999884 235899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-ccccccccccCCCChhhhc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~ 159 (303)
..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++......... .......++..|+|||.+.
T Consensus 107 ~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~ 183 (283)
T cd05080 107 AQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183 (283)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhc
Confidence 999999999999999999999 999999999999999999999999998765433221 1112234566799999998
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++||||||+++|+|++|..|+........ ...........................+...+..+.+++.+||+
T Consensus 184 ~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 262 (283)
T cd05080 184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWE 262 (283)
T ss_pred ccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhc
Confidence 88899999999999999999999998754321100 00000000000000000000011111112234578899999999
Q ss_pred CCCCCCCCHHHHHHHhcccc
Q 048243 240 ENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 240 ~dp~~Rpt~~el~~~L~~~~ 259 (303)
.||++|||+.++++.|+...
T Consensus 263 ~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 263 TEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cChhhCCCHHHHHHHHHHhh
Confidence 99999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=273.18 Aligned_cols=234 Identities=27% Similarity=0.437 Sum_probs=184.7
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccc----------
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR---------- 74 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------- 74 (303)
++..+|+|.+........+.+.+|++.++.++|+||+++++++......+++|||+.+++|.+++.....
T Consensus 34 ~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~ 113 (280)
T cd05092 34 DKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGED 113 (280)
T ss_pred CceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhccccc
Confidence 4668999998776666667899999999999999999999999999999999999999999999854211
Q ss_pred --cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCC
Q 048243 75 --RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGY 152 (303)
Q Consensus 75 --~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y 152 (303)
...+++..++.++.|++.|++|||+.| ++||||||+||++++++.++|+|||++................++..|
T Consensus 114 ~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y 190 (280)
T cd05092 114 VAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 190 (280)
T ss_pred CCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccc
Confidence 135788999999999999999999999 999999999999999999999999998765433222222333456789
Q ss_pred CChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHH
Q 048243 153 IPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL 231 (303)
Q Consensus 153 ~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
+|||.+.+..++.++|||||||++|+|++ |..||........ . ......... ..+...+..+.
T Consensus 191 ~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~----~~~~~~~~~---------~~~~~~~~~~~ 254 (280)
T cd05092 191 MPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA---I----ECITQGREL---------ERPRTCPPEVY 254 (280)
T ss_pred cCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---H----HHHHcCccC---------CCCCCCCHHHH
Confidence 99999998889999999999999999998 8888753322111 1 111111000 00112234688
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhcc
Q 048243 232 EIALLCVQENPNDRPSMLQVSSMLKN 257 (303)
Q Consensus 232 ~li~~~l~~dp~~Rpt~~el~~~L~~ 257 (303)
+++.+||+.||.+||++.|+++.|+.
T Consensus 255 ~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 255 AIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHHHccCChhhCCCHHHHHHHHhC
Confidence 99999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=275.18 Aligned_cols=224 Identities=24% Similarity=0.285 Sum_probs=176.2
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+|+.||+|.++... ....+.+..|..++... +||||+++++++.+....|+||||+.+++|..++. ....++
T Consensus 18 ~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~---~~~~~~ 94 (316)
T cd05620 18 GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQ---DKGRFD 94 (316)
T ss_pred CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHH---HcCCCC
Confidence 468899999997542 23345567788888765 89999999999999999999999999999988884 345688
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..+..++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++....... .......|+..|+|||++.
T Consensus 95 ~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~ 169 (316)
T cd05620 95 LYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRASTFCGTPDYIAPEILQ 169 (316)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--CceeccCCCcCccCHHHHc
Confidence 9999999999999999999999 9999999999999999999999999986432111 1223356899999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++|||||||++|+|++|..||....... . ....... .... +...+.++.+++.+||+
T Consensus 170 ~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~----~~~~~~~------~~~~----~~~~~~~~~~li~~~l~ 232 (316)
T cd05620 170 GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---L----FESIRVD------TPHY----PRWITKESKDILEKLFE 232 (316)
T ss_pred CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---H----HHHHHhC------CCCC----CCCCCHHHHHHHHHHcc
Confidence 9999999999999999999999999996432111 1 1111110 0011 11134478899999999
Q ss_pred CCCCCCCCHH-HHH
Q 048243 240 ENPNDRPSML-QVS 252 (303)
Q Consensus 240 ~dp~~Rpt~~-el~ 252 (303)
.||++||++. +++
T Consensus 233 ~dP~~R~~~~~~~~ 246 (316)
T cd05620 233 RDPTRRLGVVGNIR 246 (316)
T ss_pred CCHHHcCCChHHHH
Confidence 9999999985 665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=298.50 Aligned_cols=234 Identities=30% Similarity=0.492 Sum_probs=191.4
Q ss_pred cEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc----ccccCCHH
Q 048243 7 KVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI----RRLILDWK 81 (303)
Q Consensus 7 ~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~l~~~ 81 (303)
-.||+|.+++.. .....+|.+|..+|++++||||++++|++.+....++++|||.+|+|..||++.+ ....+...
T Consensus 723 ~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~ 802 (1025)
T KOG1095|consen 723 IQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMR 802 (1025)
T ss_pred eEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHH
Confidence 359999997764 4566789999999999999999999999999999999999999999999998632 24568899
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
..+.++.||++|+.||++++ +|||||...|+|++....+||+|||+|+.+.............-...|||||.+...
T Consensus 803 dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~ 879 (1025)
T KOG1095|consen 803 DLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG 879 (1025)
T ss_pred HHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhc
Confidence 99999999999999999999 999999999999999999999999999976665555544443446799999999999
Q ss_pred CCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 162 VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
.++.|+||||||+++||+++ |..|+......+.. .....++ . ...+...+..++++|..||+.
T Consensus 880 iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~------~~~~~gg-R---------L~~P~~CP~~ly~lM~~CW~~ 943 (1025)
T KOG1095|consen 880 IFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL------LDVLEGG-R---------LDPPSYCPEKLYQLMLQCWKH 943 (1025)
T ss_pred ccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH------HHHHhCC-c---------cCCCCCCChHHHHHHHHHccC
Confidence 99999999999999999998 66776533322211 1122222 1 112223344788999999999
Q ss_pred CCCCCCCHHHHHHHhcccc
Q 048243 241 NPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 241 dp~~Rpt~~el~~~L~~~~ 259 (303)
+|++||++..|++.+....
T Consensus 944 ~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 944 DPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred ChhhCccHHHHHhhhhhhh
Confidence 9999999999999876544
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=261.14 Aligned_cols=229 Identities=26% Similarity=0.367 Sum_probs=181.1
Q ss_pred CCCcEEEEEEecCCC----cc----cHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccc
Q 048243 4 PCGKVIAVKKLSKTS----TQ----GFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR 74 (303)
Q Consensus 4 ~~~~~valK~~~~~~----~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 74 (303)
++|+..|+|++.... .. -.+.-.+|+.+|+++ .||+|+++.++|+.+...++|++.|+.|.|.+++ ..
T Consensus 40 ~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyL---ts 116 (411)
T KOG0599|consen 40 ETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYL---TS 116 (411)
T ss_pred ccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHh---hh
Confidence 578889999985331 11 123455799999999 7999999999999999999999999999999999 45
Q ss_pred cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCC
Q 048243 75 RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIP 154 (303)
Q Consensus 75 ~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~a 154 (303)
...+++...+++++|+++|++|||..+ |||||+||+|||+++|-+++|+|||.+..+..+ ......+||+.|+|
T Consensus 117 ~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~~G---ekLrelCGTPgYLA 190 (411)
T KOG0599|consen 117 KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLEPG---EKLRELCGTPGYLA 190 (411)
T ss_pred heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccCCc---hhHHHhcCCCcccC
Confidence 667999999999999999999999998 999999999999999999999999999765443 34455789999999
Q ss_pred hhhhccC------CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHH
Q 048243 155 PEYARQG------VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLM 228 (303)
Q Consensus 155 PE~~~~~------~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
||.+... .|+...|+|++|+++|.|+.|.+||-.-.....+..+. .+. ..+....-.+.+.
T Consensus 191 PEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Im-------eGk------yqF~speWadis~ 257 (411)
T KOG0599|consen 191 PETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIM-------EGK------YQFRSPEWADISA 257 (411)
T ss_pred hhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHH-------hcc------cccCCcchhhccc
Confidence 9998753 47788999999999999999999983111111111111 110 0111111123455
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 229 RCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 229 ~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
...+||.+||++||.+|.|++|.++.
T Consensus 258 ~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 258 TVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred cHHHHHHHHHeeCchhcccHHHHhcC
Confidence 78899999999999999999999763
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=259.65 Aligned_cols=228 Identities=23% Similarity=0.326 Sum_probs=186.5
Q ss_pred CCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
++|+.+|+|+++.+ +..+.+.+.+|+.+-+.|+||||+++.+.+......|+|+|+++|+.|..-+. .+-..++.
T Consensus 34 ~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV---~R~~ySEa 110 (355)
T KOG0033|consen 34 TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV---AREFYSEA 110 (355)
T ss_pred cchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHH---HHHHHHHH
Confidence 67889999988644 45577899999999999999999999999999999999999999999976663 34567888
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCC---CceEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED---MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~---~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
.+-.+++||+++|.|+|.++ |+|||+||+|+++... --+||+|||++...+. ......+.||+.|+|||++
T Consensus 111 ~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~---g~~~~G~~GtP~fmaPEvv 184 (355)
T KOG0033|consen 111 DASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND---GEAWHGFAGTPGYLSPEVL 184 (355)
T ss_pred HHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeCC---ccccccccCCCcccCHHHh
Confidence 99999999999999999999 9999999999999643 3499999999988762 3455668899999999999
Q ss_pred ccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcc
Q 048243 159 RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238 (303)
Q Consensus 159 ~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 238 (303)
...+++..+|||+.|+++|-|+.|.+||-.......+..+. .+ +..+++..-+..+++..+|+++||
T Consensus 185 rkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~-------~g------~yd~~~~~w~~is~~Ak~LvrrML 251 (355)
T KOG0033|consen 185 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIK-------AG------AYDYPSPEWDTVTPEAKSLIRRML 251 (355)
T ss_pred hcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHh-------cc------ccCCCCcccCcCCHHHHHHHHHHh
Confidence 99999999999999999999999999996533222222111 11 111222222344567889999999
Q ss_pred cCCCCCCCCHHHHHH
Q 048243 239 QENPNDRPSMLQVSS 253 (303)
Q Consensus 239 ~~dp~~Rpt~~el~~ 253 (303)
..||.+|.|+.|.+.
T Consensus 252 ~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 252 TVNPKKRITADEALK 266 (355)
T ss_pred ccChhhhccHHHHhC
Confidence 999999999988765
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=264.77 Aligned_cols=243 Identities=23% Similarity=0.278 Sum_probs=185.7
Q ss_pred cCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCc-cccEEEEEEeCC------eeEEEEeecCCCChhhhhcCcc
Q 048243 3 LPCGKVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVN-LIRVLGFCIDSE------ERMLVYEYMPNKSLDCYLFDPI 73 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~ 73 (303)
..+|+.||+|+++.... ..-....+|+.+|++++|+| |+.+++++...+ ..++|+||++ .+|..++....
T Consensus 33 ~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d-~DL~~ymd~~~ 111 (323)
T KOG0594|consen 33 KRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLD-RDLKKYMDSLP 111 (323)
T ss_pred ecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeec-ccHHHHHHhcc
Confidence 35789999999976643 23356789999999999999 999999999887 8899999995 58989886533
Q ss_pred cc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCC
Q 048243 74 RR-LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGY 152 (303)
Q Consensus 74 ~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y 152 (303)
.. ..++...++.++.||+.||+|||+++ |+||||||.|++++.+|.+||+|||+++..+-... .....++|..|
T Consensus 112 ~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~--~yt~evvTlWY 186 (323)
T KOG0594|consen 112 KKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMR--TYTPEVVTLWY 186 (323)
T ss_pred ccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHHHhcCCcc--cccccEEEeec
Confidence 21 46777899999999999999999999 99999999999999999999999999986553322 12335679999
Q ss_pred CChhhhccC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCC---Ccce-----eccccCCCCC-
Q 048243 153 IPPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG---KGVE-----FVDSSLDDTN- 222 (303)
Q Consensus 153 ~aPE~~~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~-----~~~~~~~~~~- 222 (303)
+|||++.+. .|+...||||+||++.||++++..|......+ +........... .++. -.+.......
T Consensus 187 RaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~---ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~ 263 (323)
T KOG0594|consen 187 RAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID---QLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPG 263 (323)
T ss_pred cCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH---HHHHHHHHcCCCCccCCCCccccccccccCcCCCC
Confidence 999998887 68999999999999999999999987665533 223333322211 1111 1111111111
Q ss_pred C-------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 223 S-------PCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 223 ~-------~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
+ +.......+++.+||+.+|.+|.|+...++.
T Consensus 264 ~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 264 PKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1 1111367899999999999999999999875
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=282.65 Aligned_cols=244 Identities=22% Similarity=0.323 Sum_probs=176.7
Q ss_pred CCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEeC-----CeeEEEEeecCCCChhhhhcCccccc
Q 048243 4 PCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-----EERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~ 76 (303)
.+|+.||+|+++.. .......+.+|+.+++.++||||+++++++... ...|+||||+. ++|.+++. ...
T Consensus 23 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~---~~~ 98 (338)
T cd07859 23 HTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIK---AND 98 (338)
T ss_pred CCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHH---hcc
Confidence 57899999998643 223345688999999999999999999988643 24799999995 68888873 345
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCc-cccccccccccCCCCh
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL-EANTEQVVGTIGYIPP 155 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~-~~~~~~~~g~~~y~aP 155 (303)
.+++..+..++.||+.||+|||+.| ++||||||+||+++.++.++|+|||+++....... ........|+..|+||
T Consensus 99 ~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aP 175 (338)
T cd07859 99 DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175 (338)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCH
Confidence 6899999999999999999999999 99999999999999999999999999875433221 1122345689999999
Q ss_pred hhhcc--CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHH--------HHHHhCCCcceeccc---cCCC--
Q 048243 156 EYARQ--GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA--------YELWKGGKGVEFVDS---SLDD-- 220 (303)
Q Consensus 156 E~~~~--~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~---~~~~-- 220 (303)
|++.+ ..++.++|||||||++|+|++|..||............... ...+........... ....
T Consensus 176 E~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 255 (338)
T cd07859 176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPF 255 (338)
T ss_pred HHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCch
Confidence 99876 56889999999999999999999998654321111100000 000000000000000 0000
Q ss_pred -CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 221 -TNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 221 -~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
...+..+..+.+++.+||+.||++|||++|+++.
T Consensus 256 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 256 SQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0001123467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=270.70 Aligned_cols=232 Identities=24% Similarity=0.354 Sum_probs=181.9
Q ss_pred CCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 5 CGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+..||+|.++... ......+.+|+..+.+++||||+++++++..+...++||||+++|+|.+++.. ....+++..+
T Consensus 32 ~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~l~~~~~ 109 (266)
T cd05064 32 RELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK--HEGQLVAGQL 109 (266)
T ss_pred ceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHh--CCCCCCHHHH
Confidence 46789999997653 23345788999999999999999999999999999999999999999998853 2346889999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
+.++.|++.||+|||+.+ ++||||||+||+++.++.++++|||.+......... ......++..|+|||.+.+..+
T Consensus 110 ~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 185 (266)
T cd05064 110 MGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHF 185 (266)
T ss_pred HHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccccchh-cccCCCCceeecCHHHHhhCCc
Confidence 999999999999999999 999999999999999999999999986543222111 1112234578999999998899
Q ss_pred CCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC
Q 048243 164 STKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 242 (303)
+.++|||||||++|++++ |..||....... . .......... ..+...+..+.+++.+||+.+|
T Consensus 186 ~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~----~~~~~~~~~~---------~~~~~~~~~~~~li~~c~~~~p 249 (266)
T cd05064 186 SSASDVWSFGIVMWEVMSYGERPYWDMSGQD---V----IKAVEDGFRL---------PAPRNCPNLLHQLMLDCWQKER 249 (266)
T ss_pred cchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---H----HHHHHCCCCC---------CCCCCCCHHHHHHHHHHcCCCc
Confidence 999999999999999775 999985432211 1 1111111111 1112234578899999999999
Q ss_pred CCCCCHHHHHHHhccc
Q 048243 243 NDRPSMLQVSSMLKNE 258 (303)
Q Consensus 243 ~~Rpt~~el~~~L~~~ 258 (303)
.+||++.+|.+.|++.
T Consensus 250 ~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 250 GERPRFSQIHSILSKM 265 (266)
T ss_pred hhCCCHHHHHHHHHhh
Confidence 9999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=276.74 Aligned_cols=232 Identities=19% Similarity=0.296 Sum_probs=180.5
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+|+.||+|+++... ....+.+..|+.++..+ +||||+++++++.+....++||||+++|+|..++. ....++
T Consensus 18 ~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~---~~~~l~ 94 (329)
T cd05588 18 KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQ---RQRKLP 94 (329)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHH---HcCCCC
Confidence 478999999997542 23345678899999998 79999999999999999999999999999988874 345699
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..++.++.|++.||+|||++| ++||||||+||+++.++.++|+|||++...... ........|+..|+|||++.
T Consensus 95 ~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~ 169 (329)
T cd05588 95 EEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTTSTFCGTPNYIAPEILR 169 (329)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCccccccCCccccCHHHHc
Confidence 9999999999999999999999 999999999999999999999999998642211 11223356899999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCc--cccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINE--NLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 237 (303)
+..++.++|+|||||++|+|++|..||....... ................. ..+...+..+.+++.+|
T Consensus 170 ~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~p~~~~~~~~~li~~~ 239 (329)
T cd05588 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI----------RIPRSLSVKASSVLKGF 239 (329)
T ss_pred CCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------CCCCCCCHHHHHHHHHH
Confidence 9899999999999999999999999996543322 11111111111111100 01112234788999999
Q ss_pred ccCCCCCCCC------HHHHHH
Q 048243 238 VQENPNDRPS------MLQVSS 253 (303)
Q Consensus 238 l~~dp~~Rpt------~~el~~ 253 (303)
|+.||.+||+ +.++++
T Consensus 240 L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 240 LNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred hccCHHHcCCCCCCCCHHHHhc
Confidence 9999999998 566664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=280.69 Aligned_cols=226 Identities=21% Similarity=0.254 Sum_probs=179.8
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|+++... ......+..|+.++..++||||+++++.+......|+||||+++|+|..++. ....+++
T Consensus 18 ~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~---~~~~l~~ 94 (325)
T cd05594 18 ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS---RERVFSE 94 (325)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHH---hcCCCCH
Confidence 578999999997542 2334567789999999999999999999999999999999999999988874 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 81 KKRVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
..++.++.||+.||+|||+ .| ++||||||+||+++.++.++|+|||++....... .......|+..|+|||.+.
T Consensus 95 ~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~ 169 (325)
T cd05594 95 DRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLE 169 (325)
T ss_pred HHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cccccccCCcccCCHHHHc
Confidence 9999999999999999997 67 9999999999999999999999999986532221 1122346899999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++|||||||++|+|++|..||....... ......... ..+ +...+..+.+++.+||+
T Consensus 170 ~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~-------~~~~i~~~~------~~~----p~~~~~~~~~li~~~L~ 232 (325)
T cd05594 170 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEE------IRF----PRTLSPEAKSLLSGLLK 232 (325)
T ss_pred cCCCCCccccccccceeeeeccCCCCCCCCCHHH-------HHHHHhcCC------CCC----CCCCCHHHHHHHHHHhh
Confidence 8899999999999999999999999985432211 011111000 001 11224478899999999
Q ss_pred CCCCCCC-----CHHHHHHH
Q 048243 240 ENPNDRP-----SMLQVSSM 254 (303)
Q Consensus 240 ~dp~~Rp-----t~~el~~~ 254 (303)
.||++|+ ++.++++.
T Consensus 233 ~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 233 KDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred cCHHHhCCCCCCCHHHHhcC
Confidence 9999997 89998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=271.87 Aligned_cols=240 Identities=23% Similarity=0.263 Sum_probs=176.5
Q ss_pred CCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.||+|+++.... .....+.+|+.+++.++||||+++++++.+....++||||+. ++|.+++.. ....+++..
T Consensus 28 ~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~ 104 (303)
T cd07869 28 VNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDK--HPGGLHPEN 104 (303)
T ss_pred CCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHh--CCCCCCHHH
Confidence 3689999999975432 233467889999999999999999999999999999999996 577777643 235588899
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC-
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG- 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~- 161 (303)
+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....... .......|++.|+|||++.+.
T Consensus 105 ~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~ 179 (303)
T cd07869 105 VKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--HTYSNEVVTLWYRPPDVLLGST 179 (303)
T ss_pred HHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC--ccCCCCcccCCCCChHHHcCCC
Confidence 9999999999999999999 9999999999999999999999999986543221 112234678999999998754
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCC--------cceecc-ccCCCCCC---H-----
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK--------GVEFVD-SSLDDTNS---P----- 224 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~-~~~~~~~~---~----- 224 (303)
.++.++|||||||++|+|++|..||..... ................ ...... .......+ .
T Consensus 180 ~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (303)
T cd07869 180 EYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNK 257 (303)
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhc
Confidence 578899999999999999999999964321 1111111111111000 000000 00000000 0
Q ss_pred -HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 225 -CKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 225 -~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
..+..+.+|+.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 258 LSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 01246789999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=277.15 Aligned_cols=176 Identities=26% Similarity=0.342 Sum_probs=152.6
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.+|+|.+.... ....+.+.+|+++++.++|+||+++++++..++..++||||+.+++|.+++. ....+++..
T Consensus 28 ~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~ 104 (333)
T cd06650 28 PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQI 104 (333)
T ss_pred CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHH---HcCCCCHHH
Confidence 468889999987542 3344678899999999999999999999999999999999999999999984 345688999
Q ss_pred HHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 83 RVHIIEGITQGLLYLQEY-SRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~-~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
+..++.|++.||+|||+. + ++|+||||+||+++.++.++|+|||++...... ......|+..|+|||.+.+.
T Consensus 105 ~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~ 177 (333)
T cd06650 105 LGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGT 177 (333)
T ss_pred HHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh----ccccCCCCccccCHHHhcCC
Confidence 999999999999999974 6 999999999999999999999999998654322 12234688999999999988
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccC
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLC 189 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~ 189 (303)
.++.++|||||||++|+|++|..||...
T Consensus 178 ~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 178 HYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 8999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=267.20 Aligned_cols=232 Identities=27% Similarity=0.428 Sum_probs=181.8
Q ss_pred ccCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 2 VLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 2 ~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+.++..+|+|.+.... .....+.+|+.+++.++||||+++++++......++||||+++|+|.+++... ...+++.
T Consensus 24 ~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~ 100 (256)
T cd05114 24 KWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQR--QGKLSKD 100 (256)
T ss_pred EeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhC--ccCCCHH
Confidence 34566789999986443 33467889999999999999999999999999999999999999999988532 2358899
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
.++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+......... ......++..|+|||.+.+.
T Consensus 101 ~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~ 176 (256)
T cd05114 101 MLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFS 176 (256)
T ss_pred HHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-ccCCCCCchhhCChhhcccC
Confidence 99999999999999999999 999999999999999999999999998765432211 11222345689999999888
Q ss_pred CCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 162 VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
.++.++||||||+++|+|++ |..||....... .. ......... ..+...+..+.+++.+||..
T Consensus 177 ~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~----~~i~~~~~~---------~~~~~~~~~~~~li~~c~~~ 240 (256)
T cd05114 177 KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VV----EMISRGFRL---------YRPKLASMTVYEVMYSCWHE 240 (256)
T ss_pred ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHCCCCC---------CCCCCCCHHHHHHHHHHccC
Confidence 89999999999999999999 888885332111 11 111111110 00111234788999999999
Q ss_pred CCCCCCCHHHHHHHhc
Q 048243 241 NPNDRPSMLQVSSMLK 256 (303)
Q Consensus 241 dp~~Rpt~~el~~~L~ 256 (303)
||++||++.++++.|.
T Consensus 241 ~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 241 KPEGRPTFAELLRAIT 256 (256)
T ss_pred CcccCcCHHHHHHhhC
Confidence 9999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=268.12 Aligned_cols=233 Identities=27% Similarity=0.383 Sum_probs=182.9
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
++++.+|+|+++... ....+.+.+|+.+++.++|+||+++++++. ....++||||+.+++|.+++. ....+++.
T Consensus 20 ~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~ 95 (257)
T cd05116 20 KSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQ---KNKHVTEK 95 (257)
T ss_pred CCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHH---hcCCCCHH
Confidence 468899999986543 234567889999999999999999999885 456789999999999999984 33468899
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccc-cccccccccCCCChhhhcc
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEA-NTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~ 160 (303)
.+..++.|++.||+|||+.| ++||||||+||+++.++.++|+|||.+.......... ......++..|+|||.+..
T Consensus 96 ~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 172 (257)
T cd05116 96 NITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172 (257)
T ss_pred HHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhcc
Confidence 99999999999999999999 9999999999999999999999999987664432211 1112233578999999988
Q ss_pred CCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 161 GVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
..++.++|+||||+++|+|++ |..||........ ........... .+...+.++.++|.+||+
T Consensus 173 ~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-------~~~i~~~~~~~---------~~~~~~~~l~~li~~~~~ 236 (257)
T cd05116 173 YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV-------TQMIESGERME---------CPQRCPPEMYDLMKLCWT 236 (257)
T ss_pred CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHCCCCCC---------CCCCCCHHHHHHHHHHhc
Confidence 888999999999999999998 8999864332211 11111111111 111234578899999999
Q ss_pred CCCCCCCCHHHHHHHhcccc
Q 048243 240 ENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 240 ~dp~~Rpt~~el~~~L~~~~ 259 (303)
.||++||++.+|.+.|++.+
T Consensus 237 ~~p~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05116 237 YGVDERPGFAVVELRLRNYY 256 (257)
T ss_pred cCchhCcCHHHHHHHHhccc
Confidence 99999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=277.60 Aligned_cols=220 Identities=23% Similarity=0.302 Sum_probs=175.8
Q ss_pred CCCcEEEEEEecCC---CcccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+|+.||+|+++.. .....+.+..|..++..+ +||||+++++++......|+||||+++|+|..++. ....++
T Consensus 18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~---~~~~l~ 94 (320)
T cd05590 18 ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQ---KSRRFD 94 (320)
T ss_pred CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHH---HcCCCC
Confidence 46899999999753 233445677888888877 79999999999999999999999999999998884 345689
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....... .......|++.|+|||.+.
T Consensus 95 ~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~ 169 (320)
T cd05590 95 EARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGTPDYIAPEILQ 169 (320)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--CcccccccCccccCHHHHc
Confidence 9999999999999999999999 9999999999999999999999999986532221 1223356899999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++|||||||++|+|++|..||........ ......... ..+...+..+.+++.+||+
T Consensus 170 ~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-------~~~i~~~~~----------~~~~~~~~~~~~li~~~L~ 232 (320)
T cd05590 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL-------FEAILNDEV----------VYPTWLSQDAVDILKAFMT 232 (320)
T ss_pred CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-------HHHHhcCCC----------CCCCCCCHHHHHHHHHHcc
Confidence 88899999999999999999999999964332111 111111100 0111234578899999999
Q ss_pred CCCCCCCCH
Q 048243 240 ENPNDRPSM 248 (303)
Q Consensus 240 ~dp~~Rpt~ 248 (303)
.||.+||++
T Consensus 233 ~dP~~R~~~ 241 (320)
T cd05590 233 KNPTMRLGS 241 (320)
T ss_pred cCHHHCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=270.89 Aligned_cols=234 Identities=26% Similarity=0.402 Sum_probs=180.5
Q ss_pred CCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccc-------cc
Q 048243 5 CGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR-------RL 76 (303)
Q Consensus 5 ~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~ 76 (303)
+++.||+|+++... ......+.+|+.+++.++|+||+++++++......++||||+++++|.+++..... ..
T Consensus 35 ~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 114 (277)
T cd05062 35 PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114 (277)
T ss_pred ceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCcccccccccc
Confidence 45789999986432 23345688999999999999999999999988999999999999999998854211 12
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChh
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE 156 (303)
.+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++................++..|+|||
T Consensus 115 ~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 191 (277)
T cd05062 115 PPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 191 (277)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChh
Confidence 3567888999999999999999998 9999999999999999999999999987654332222222234577899999
Q ss_pred hhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHH
Q 048243 157 YARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
.+.+..++.++||||||+++|+|++ |..||....... ............ . +...+..+.+++.
T Consensus 192 ~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~-------~~~~~~~~~~~~-----~----~~~~~~~~~~li~ 255 (277)
T cd05062 192 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-------VLRFVMEGGLLD-----K----PDNCPDMLFELMR 255 (277)
T ss_pred HhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHcCCcCC-----C----CCCCCHHHHHHHH
Confidence 9998889999999999999999998 677875432211 111111111111 0 1112346889999
Q ss_pred HcccCCCCCCCCHHHHHHHhcc
Q 048243 236 LCVQENPNDRPSMLQVSSMLKN 257 (303)
Q Consensus 236 ~~l~~dp~~Rpt~~el~~~L~~ 257 (303)
+||+.||++|||+.|+++.|++
T Consensus 256 ~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 256 MCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCChhhCcCHHHHHHHhhC
Confidence 9999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=283.40 Aligned_cols=236 Identities=27% Similarity=0.387 Sum_probs=183.9
Q ss_pred CcEEEEEEecCCC-cccHHHHHHHHHHHhcCC-CCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc----------
Q 048243 6 GKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI---------- 73 (303)
Q Consensus 6 ~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------- 73 (303)
+..||||+++... ....+.+.+|+.+++.+. ||||+++++++......++|||||++|+|.+++....
T Consensus 67 ~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~ 146 (400)
T cd05105 67 VMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEK 146 (400)
T ss_pred ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhcccccc
Confidence 4579999997543 334567899999999995 9999999999999999999999999999998875321
Q ss_pred --------------------------------------------------------------------------------
Q 048243 74 -------------------------------------------------------------------------------- 73 (303)
Q Consensus 74 -------------------------------------------------------------------------------- 73 (303)
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 226 (400)
T cd05105 147 PKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLL 226 (400)
T ss_pred ccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHH
Confidence
Q ss_pred ---ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcccccccccccc
Q 048243 74 ---RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTI 150 (303)
Q Consensus 74 ---~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~ 150 (303)
....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++................++.
T Consensus 227 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~ 303 (400)
T cd05105 227 SDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303 (400)
T ss_pred HhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCc
Confidence 0124778888999999999999999998 9999999999999999999999999987654332222223345678
Q ss_pred CCCChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHH
Q 048243 151 GYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMR 229 (303)
Q Consensus 151 ~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (303)
.|+|||.+.+..++.++||||||+++|+|++ |..||....... ........... .......+..
T Consensus 304 ~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~~ 368 (400)
T cd05105 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS------TFYNKIKSGYR---------MAKPDHATQE 368 (400)
T ss_pred ceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH------HHHHHHhcCCC---------CCCCccCCHH
Confidence 8999999998889999999999999999997 888875432111 01111111111 1111223457
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHhcccc
Q 048243 230 CLEIALLCVQENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 230 l~~li~~~l~~dp~~Rpt~~el~~~L~~~~ 259 (303)
+.+++.+||..||++|||+.+|.+.|+...
T Consensus 369 l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 369 VYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=266.97 Aligned_cols=233 Identities=32% Similarity=0.474 Sum_probs=188.2
Q ss_pred CCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccc------ccc
Q 048243 5 CGKVIAVKKLSKTSTQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR------RLI 77 (303)
Q Consensus 5 ~~~~valK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~ 77 (303)
++..|++|.++..... ..+.+.+|+..+..++|+||+++++++......++||||+++++|.+++..... ...
T Consensus 22 ~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 101 (262)
T cd00192 22 KTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKST 101 (262)
T ss_pred CCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhcccccccccccc
Confidence 3888999999766433 367899999999999999999999999999999999999999999999865311 367
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhh
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 157 (303)
+++..++.++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||.+................++..|+|||.
T Consensus 102 ~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 178 (262)
T cd00192 102 LSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178 (262)
T ss_pred CCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHH
Confidence 899999999999999999999998 99999999999999999999999999987655432223334556889999999
Q ss_pred hccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 158 ARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 158 ~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
+.+..++.++||||||+++|+|++ |..||....... .......... ...+...+..+.+++.+
T Consensus 179 ~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~---------~~~~~~~~~~~~~li~~ 242 (262)
T cd00192 179 LKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------VLEYLRKGYR---------LPKPEYCPDELYELMLS 242 (262)
T ss_pred hccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC---------CCCCccCChHHHHHHHH
Confidence 988889999999999999999999 588886542111 1111111111 11112225588899999
Q ss_pred cccCCCCCCCCHHHHHHHhc
Q 048243 237 CVQENPNDRPSMLQVSSMLK 256 (303)
Q Consensus 237 ~l~~dp~~Rpt~~el~~~L~ 256 (303)
||..||++|||+.++++.|+
T Consensus 243 ~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 243 CWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HccCCcccCcCHHHHHHhhC
Confidence 99999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=268.71 Aligned_cols=233 Identities=28% Similarity=0.413 Sum_probs=184.8
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.++++.||+|.+..... ..+.+.+|+.+++.++|+||+++++.+......+++|||+.+++|.+++... ....+++..
T Consensus 27 ~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~ 104 (261)
T cd05072 27 YNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSD-EGGKVLLPK 104 (261)
T ss_pred ecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHh-cCCCCCHHH
Confidence 46678899999865433 3578899999999999999999999999999999999999999999988542 345688889
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
++.++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||.+......... ......++..|+|||.+.+..
T Consensus 105 ~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~ 180 (261)
T cd05072 105 LIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGS 180 (261)
T ss_pred HHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee-ccCCCccceecCCHHHhccCC
Confidence 9999999999999999998 999999999999999999999999999765433211 122234567899999998888
Q ss_pred CCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
++.++||||||+++|+|++ |..||....... . .......... ......+..+.+++.+||..+
T Consensus 181 ~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~----~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~ 244 (261)
T cd05072 181 FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---V----MSALQRGYRM---------PRMENCPDELYDIMKTCWKEK 244 (261)
T ss_pred CChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---H----HHHHHcCCCC---------CCCCCCCHHHHHHHHHHccCC
Confidence 9999999999999999998 888885332111 1 1111111110 011123347889999999999
Q ss_pred CCCCCCHHHHHHHhcc
Q 048243 242 PNDRPSMLQVSSMLKN 257 (303)
Q Consensus 242 p~~Rpt~~el~~~L~~ 257 (303)
|++||++.++.+.|++
T Consensus 245 p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 245 AEERPTFDYLQSVLDD 260 (261)
T ss_pred cccCcCHHHHHHHHhc
Confidence 9999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=268.74 Aligned_cols=233 Identities=24% Similarity=0.255 Sum_probs=181.6
Q ss_pred CCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCc-cccccCC
Q 048243 4 PCGKVIAVKKLSKTST---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDP-IRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~l~ 79 (303)
.+|+.||+|.+..... ...+.+..|+.+++.++|+||+++.+++......++||||+++|+|..++... .....++
T Consensus 16 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~ 95 (280)
T cd05608 16 ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFP 95 (280)
T ss_pred cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCC
Confidence 4789999999865422 23356778999999999999999999999999999999999999998877432 2345689
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..+..++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||.+........ ......|++.|+|||.+.
T Consensus 96 ~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~ 170 (280)
T cd05608 96 EPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAGTPGFMAPELLQ 170 (280)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--cccccCCCcCccCHHHhc
Confidence 9999999999999999999999 99999999999999999999999999876543321 122346899999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++||||||+++|+|++|..||............ ....... . ...+...+..+.+++.+||+
T Consensus 171 ~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~---~~~~~~~--------~--~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 171 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL---KQRILND--------S--VTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH---HHhhccc--------C--CCCcccCCHHHHHHHHHHhc
Confidence 999999999999999999999999999643322111100 0000000 0 01112244578899999999
Q ss_pred CCCCCCC-----CHHHHHHH
Q 048243 240 ENPNDRP-----SMLQVSSM 254 (303)
Q Consensus 240 ~dp~~Rp-----t~~el~~~ 254 (303)
.||++|| +++++++.
T Consensus 238 ~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCHHHhcCCCCCCHHHHhcC
Confidence 9999999 66777653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=275.64 Aligned_cols=231 Identities=23% Similarity=0.300 Sum_probs=180.1
Q ss_pred CCCcEEEEEEecCC----CcccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccC
Q 048243 4 PCGKVIAVKKLSKT----STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 4 ~~~~~valK~~~~~----~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
.+|+.||+|++... .....+.+..|+.++..+ +|++|+++++++......++||||+.+|+|.+++. .+..+
T Consensus 26 ~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~---~~~~~ 102 (332)
T cd05614 26 DTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY---QRDNF 102 (332)
T ss_pred CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHH---HcCCC
Confidence 57899999998643 223345678899999999 59999999999999999999999999999999884 34568
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
++..+..++.||+.||+|||+.| ++||||||+|||++.++.++|+|||++......... ......|+..|+|||.+
T Consensus 103 ~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~ 178 (332)
T cd05614 103 SEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYMAPEII 178 (332)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccccCCC-ccccccCCccccCHHHh
Confidence 99999999999999999999999 999999999999999999999999998765332211 12235689999999998
Q ss_pred ccC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHc
Q 048243 159 RQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237 (303)
Q Consensus 159 ~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 237 (303)
.+. .++.++|||||||++|+|++|..||.............. ..... .. ..+...+..+.+++.+|
T Consensus 179 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~--~~~~~-------~~----~~~~~~~~~~~~li~~~ 245 (332)
T cd05614 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR--RILKC-------DP----PFPSFIGPEAQDLLHKL 245 (332)
T ss_pred cCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH--HHhcC-------CC----CCCCCCCHHHHHHHHHH
Confidence 865 478899999999999999999999965433222211111 11110 01 11112344788999999
Q ss_pred ccCCCCCCC-----CHHHHHHH
Q 048243 238 VQENPNDRP-----SMLQVSSM 254 (303)
Q Consensus 238 l~~dp~~Rp-----t~~el~~~ 254 (303)
|..||++|| ++.++++.
T Consensus 246 l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 246 LRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred cCCCHHHcCCCCCCCHHHHHcC
Confidence 999999999 66677653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=276.22 Aligned_cols=225 Identities=22% Similarity=0.283 Sum_probs=175.3
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHH---hcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcccccc
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLT---AKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
.+|+.||||+++... ....+.+..|+.++ +.++||||+++++++......|+||||+.+++|..++. ...
T Consensus 22 ~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~----~~~ 97 (324)
T cd05589 22 KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH----TDV 97 (324)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhh----cCC
Confidence 478999999997542 22345666676655 45689999999999999999999999999999988773 346
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhh
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 157 (303)
+++..++.++.||+.||+|||+.| ++||||||+||+++.++.++|+|||++....... .......|++.|+|||.
T Consensus 98 l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~ 172 (324)
T cd05589 98 FSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG--DRTSTFCGTPEFLAPEV 172 (324)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCC--CcccccccCccccCHhH
Confidence 899999999999999999999999 9999999999999999999999999886432211 12233568999999999
Q ss_pred hccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHc
Q 048243 158 ARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237 (303)
Q Consensus 158 ~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 237 (303)
+.+..++.++|||||||++|+|++|..||........ . ........ . .+...+..+.+++.+|
T Consensus 173 ~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~---~---~~i~~~~~-------~----~p~~~~~~~~~li~~~ 235 (324)
T cd05589 173 LTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV---F---DSIVNDEV-------R----YPRFLSREAISIMRRL 235 (324)
T ss_pred hcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH---H---HHHHhCCC-------C----CCCCCCHHHHHHHHHH
Confidence 9998899999999999999999999999864332111 1 11111110 0 1112244778999999
Q ss_pred ccCCCCCCC-----CHHHHHHH
Q 048243 238 VQENPNDRP-----SMLQVSSM 254 (303)
Q Consensus 238 l~~dp~~Rp-----t~~el~~~ 254 (303)
|+.||.+|| ++.++++.
T Consensus 236 L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 236 LRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred hhcCHhHcCCCCCCCHHHHhhC
Confidence 999999999 56676653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=273.69 Aligned_cols=226 Identities=24% Similarity=0.268 Sum_probs=179.3
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+++.||+|.++... ......+..|+.++..+ +||||+++++++......|+||||+.+++|..++. ....++
T Consensus 18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~l~ 94 (318)
T cd05570 18 GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ---RSGRFD 94 (318)
T ss_pred CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHH---HcCCCC
Confidence 468899999997542 23445677888999888 79999999999999999999999999999988874 344689
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....... .......|+..|+|||.+.
T Consensus 95 ~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~ 169 (318)
T cd05570 95 EPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTSTFCGTPDYIAPEILS 169 (318)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--CcccceecCccccCHHHhc
Confidence 9999999999999999999999 9999999999999999999999999886432211 1122346899999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++|||||||++|+|++|..||....... ......... ...+...+..+.++|.+||+
T Consensus 170 ~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~-------~~~~i~~~~----------~~~~~~~~~~~~~li~~~l~ 232 (318)
T cd05570 170 YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE-------LFQSILEDE----------VRYPRWLSKEAKSILKSFLT 232 (318)
T ss_pred CCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCC----------CCCCCcCCHHHHHHHHHHcc
Confidence 9999999999999999999999999986433111 111111110 00111234578899999999
Q ss_pred CCCCCCCCH-----HHHHHH
Q 048243 240 ENPNDRPSM-----LQVSSM 254 (303)
Q Consensus 240 ~dp~~Rpt~-----~el~~~ 254 (303)
.||.+||++ .++++.
T Consensus 233 ~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 233 KNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCHHHcCCCCCCCHHHHhcC
Confidence 999999999 888753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=275.28 Aligned_cols=221 Identities=24% Similarity=0.274 Sum_probs=172.9
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHH-HHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVM-LTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+|+.||+|++.... ......+..|.. +++.++||||+++++.+......++||||+.+|+|..++. ....++
T Consensus 18 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~---~~~~~~ 94 (323)
T cd05575 18 ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQ---RERSFP 94 (323)
T ss_pred CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHH---hcCCCC
Confidence 478999999996542 222334555554 5677899999999999999999999999999999998884 345688
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..+..++.||+.||+|||++| ++||||||+||+++.++.++|+|||++....... .......|++.|+|||.+.
T Consensus 95 ~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~ 169 (323)
T cd05575 95 EPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTSTFCGTPEYLAPEVLR 169 (323)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--CccccccCChhhcChhhhc
Confidence 9999999999999999999999 9999999999999999999999999986532211 1223356899999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++|||||||++|+|++|..||....... .. ....... ... .+..+..+.+++.+||+
T Consensus 170 ~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~---~~i~~~~-------~~~----~~~~~~~~~~li~~~l~ 232 (323)
T cd05575 170 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE---MY---DNILNKP-------LRL----KPNISVSARHLLEGLLQ 232 (323)
T ss_pred CCCCCccccccccchhhhhhhcCCCCCCCCCHHH---HH---HHHHcCC-------CCC----CCCCCHHHHHHHHHHhh
Confidence 9899999999999999999999999986432211 11 1111110 001 11224578899999999
Q ss_pred CCCCCCCCHH
Q 048243 240 ENPNDRPSML 249 (303)
Q Consensus 240 ~dp~~Rpt~~ 249 (303)
.||.+||++.
T Consensus 233 ~~p~~R~~~~ 242 (323)
T cd05575 233 KDRTKRLGAK 242 (323)
T ss_pred cCHHhCCCCC
Confidence 9999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=267.03 Aligned_cols=231 Identities=27% Similarity=0.401 Sum_probs=181.2
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
..++..+|+|.++... ...+.+.+|+.++++++||||+++++++......+++|||+.+++|.+++... ...+++..
T Consensus 25 ~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~--~~~~~~~~ 101 (256)
T cd05113 25 WRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREH--GKRFQPSQ 101 (256)
T ss_pred ecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhc--CCCCCHHH
Confidence 3455679999987543 23467899999999999999999999999888899999999999999988542 23689999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
++.++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||.++........ ......++..|+|||.+.+..
T Consensus 102 ~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~ 177 (256)
T cd05113 102 LLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSK 177 (256)
T ss_pred HHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-ecCCCccChhhCCHHHHhcCc
Confidence 9999999999999999999 999999999999999999999999998765433211 111223567899999998888
Q ss_pred CCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
++.++||||||+++|+|++ |..||....... . .......... ......+..+.+++.+||+.|
T Consensus 178 ~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~----~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~ 241 (256)
T cd05113 178 FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---T----VEKVSQGLRL---------YRPHLASEKVYAIMYSCWHEK 241 (256)
T ss_pred ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---H----HHHHhcCCCC---------CCCCCCCHHHHHHHHHHcCCC
Confidence 9999999999999999998 888875433211 1 1111111110 011112457889999999999
Q ss_pred CCCCCCHHHHHHHhc
Q 048243 242 PNDRPSMLQVSSMLK 256 (303)
Q Consensus 242 p~~Rpt~~el~~~L~ 256 (303)
|.+|||+.++++.|+
T Consensus 242 p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 242 AEERPTFQQLLSSIE 256 (256)
T ss_pred cccCCCHHHHHHhhC
Confidence 999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=269.22 Aligned_cols=234 Identities=25% Similarity=0.399 Sum_probs=183.1
Q ss_pred CCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc----------
Q 048243 5 CGKVIAVKKLSKTSTQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI---------- 73 (303)
Q Consensus 5 ~~~~valK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------- 73 (303)
.++.||+|+++..... ..+.+.+|+.++..++||||+++++++......+++++|+.+++|.+++....
T Consensus 34 ~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~ 113 (283)
T cd05091 34 QTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113 (283)
T ss_pred ceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCcccccccc
Confidence 4678999999755432 34568899999999999999999999999999999999999999999885311
Q ss_pred ---ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcccccccccccc
Q 048243 74 ---RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTI 150 (303)
Q Consensus 74 ---~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~ 150 (303)
....+++..++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||+++...............+++
T Consensus 114 ~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 190 (283)
T cd05091 114 DKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI 190 (283)
T ss_pred ccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCceEecccccccccccchheeeccCccCCc
Confidence 1235788889999999999999999999 9999999999999999999999999987654333222233345678
Q ss_pred CCCChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHH
Q 048243 151 GYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMR 229 (303)
Q Consensus 151 ~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (303)
.|+|||.+.+..++.++|||||||++|+|++ |..||....... ............ .+...+..
T Consensus 191 ~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~i~~~~~~~---------~~~~~~~~ 254 (283)
T cd05091 191 RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-------VIEMIRNRQVLP---------CPDDCPAW 254 (283)
T ss_pred cccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHcCCcCC---------CCCCCCHH
Confidence 8999999988889999999999999999998 777775432211 111111111110 11123446
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 048243 230 CLEIALLCVQENPNDRPSMLQVSSMLKN 257 (303)
Q Consensus 230 l~~li~~~l~~dp~~Rpt~~el~~~L~~ 257 (303)
+.+++.+||+.+|.+||++.++++.|+.
T Consensus 255 ~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 255 VYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 8899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=268.27 Aligned_cols=232 Identities=22% Similarity=0.272 Sum_probs=180.0
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|.+.... ......+..|++++++++||||+++++.+..+...++||||+.+++|.+++... ....+++
T Consensus 16 ~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~-~~~~~~~ 94 (277)
T cd05607 16 NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNV-GERGLEM 94 (277)
T ss_pred cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhc-cccCCCH
Confidence 468999999986432 122345667999999999999999999999999999999999999998887432 3345888
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....... ......|+..|+|||.+.+
T Consensus 95 ~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~ 168 (277)
T cd05607 95 ERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKE 168 (277)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeeccCCCCCccCHHHHcc
Confidence 999999999999999999999 9999999999999999999999999987654322 1223467899999999998
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++||||+||++|+|++|..||......... ........... ... .....+.++.+++.+||+.
T Consensus 169 ~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~---------~~~-~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 169 EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRRTLEDE---------VKF-EHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHHhhccc---------ccc-ccccCCHHHHHHHHHHhcc
Confidence 88999999999999999999999998643321111 11111111100 000 0112345788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 048243 241 NPNDRPSMLQVSSM 254 (303)
Q Consensus 241 dp~~Rpt~~el~~~ 254 (303)
||.+||++.|+++.
T Consensus 237 ~P~~R~~~~~~~~~ 250 (277)
T cd05607 237 KPEDRLGSREKNDD 250 (277)
T ss_pred CHhhCCCCccchhh
Confidence 99999999876643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=275.01 Aligned_cols=227 Identities=21% Similarity=0.302 Sum_probs=177.1
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+++.||+|+++... ....+.+..|+.++.++ +||||+++++++......++||||+++++|..++. ....++
T Consensus 18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~---~~~~l~ 94 (329)
T cd05618 18 KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLP 94 (329)
T ss_pred CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHH---HcCCCC
Confidence 568899999997542 23345677898888877 89999999999999999999999999999988873 345689
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..++.++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++....... .......|+..|+|||++.
T Consensus 95 ~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~ 169 (329)
T cd05618 95 EEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILR 169 (329)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--CccccccCCccccCHHHHc
Confidence 9999999999999999999999 9999999999999999999999999986532211 1223356899999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCcc--ccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINEN--LSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 237 (303)
+..++.++|||||||++|+|++|..||........ ................ ..+...+..+.+++.+|
T Consensus 170 ~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~~p~~~~~~~~~ll~~~ 239 (329)
T cd05618 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------RIPRSLSVKAASVLKSF 239 (329)
T ss_pred CCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------CCCCCCCHHHHHHHHHH
Confidence 99999999999999999999999999964332211 1111111111111110 11122344778999999
Q ss_pred ccCCCCCCCCH
Q 048243 238 VQENPNDRPSM 248 (303)
Q Consensus 238 l~~dp~~Rpt~ 248 (303)
|..||.+||++
T Consensus 240 L~~dP~~R~~~ 250 (329)
T cd05618 240 LNKDPKERLGC 250 (329)
T ss_pred hcCCHHHcCCC
Confidence 99999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=279.96 Aligned_cols=232 Identities=20% Similarity=0.253 Sum_probs=178.0
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+++.||+|++.... ......+.+|+.+++.++|+||+++++++.+....++||||+++|+|.+++. ....+++
T Consensus 24 ~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~~~e 100 (381)
T cd05626 24 DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI---RMEVFPE 100 (381)
T ss_pred CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHH---hcCCCCH
Confidence 578999999996542 2334578899999999999999999999999999999999999999999884 3456889
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCc---------------------
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL--------------------- 139 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~--------------------- 139 (303)
..+..++.||+.||+|||+.| |+||||||+||+++.++.++|+|||++..+.....
T Consensus 101 ~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (381)
T cd05626 101 VLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177 (381)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCccccc
Confidence 999999999999999999999 99999999999999999999999998754311000
Q ss_pred ------------------------cccccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccc
Q 048243 140 ------------------------EANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL 195 (303)
Q Consensus 140 ------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~ 195 (303)
........||..|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~ 257 (381)
T cd05626 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQ 257 (381)
T ss_pred ccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHH
Confidence 00011246899999999999888999999999999999999999999654322111
Q ss_pred cHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcc--cCCCCCCCCHHHHHHH
Q 048243 196 SILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV--QENPNDRPSMLQVSSM 254 (303)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l--~~dp~~Rpt~~el~~~ 254 (303)
........... .......+.++.++|.+|+ ..+|..||++.+++..
T Consensus 258 ------~~i~~~~~~~~-------~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 258 ------LKVINWENTLH-------IPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred ------HHHHccccccC-------CCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 11111000000 0011112347788998844 5666679999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=270.81 Aligned_cols=235 Identities=29% Similarity=0.458 Sum_probs=183.7
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc---------
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI--------- 73 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------- 73 (303)
.+++.||+|.++... ......+.+|+.+++.++||||+++++++......|++|||+.+++|.+++....
T Consensus 32 ~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 111 (283)
T cd05090 32 DHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSS 111 (283)
T ss_pred CCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCcccccc
Confidence 356889999997543 2334578899999999999999999999999999999999999999999885321
Q ss_pred -----ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcccccccccc
Q 048243 74 -----RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVG 148 (303)
Q Consensus 74 -----~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g 148 (303)
....+++..+..++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++................+
T Consensus 112 ~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 188 (283)
T cd05090 112 DEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188 (283)
T ss_pred ccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCc
Confidence 1234788899999999999999999999 99999999999999999999999999976644332222333445
Q ss_pred ccCCCChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHH
Q 048243 149 TIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKL 227 (303)
Q Consensus 149 ~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
+..|+|||.+.+..++.++||||||+++|+|++ |..||....... ............ .+...+
T Consensus 189 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~---------~~~~~~ 252 (283)
T cd05090 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE-------VIEMVRKRQLLP---------CSEDCP 252 (283)
T ss_pred cceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHcCCcCC---------CCCCCC
Confidence 678999999988889999999999999999998 888875432111 111111111111 111123
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 048243 228 MRCLEIALLCVQENPNDRPSMLQVSSMLKN 257 (303)
Q Consensus 228 ~~l~~li~~~l~~dp~~Rpt~~el~~~L~~ 257 (303)
..+.+++.+||+.||.+||++.++++.|..
T Consensus 253 ~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 253 PRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 478899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=267.11 Aligned_cols=230 Identities=30% Similarity=0.453 Sum_probs=180.8
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.++++.+|+|++..... ....+.+|+.+++.++|+||+++++++......++||||+++++|.+++.. ....+++..
T Consensus 25 ~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~ 101 (256)
T cd05059 25 WRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRE--RKGKLGTEW 101 (256)
T ss_pred ecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHh--cccCCCHHH
Confidence 45667899999865432 345788899999999999999999999999999999999999999999853 234688999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
++.++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||.++........ ......++..|+|||.+.+..
T Consensus 102 ~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~ 177 (256)
T cd05059 102 LLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSR 177 (256)
T ss_pred HHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-ccCCCCCCccccCHHHhccCC
Confidence 9999999999999999999 999999999999999999999999998765432211 111122345799999999888
Q ss_pred CCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
++.++||||||+++|++++ |..||....... .. ....... ....+...+..+.+++.+||..+
T Consensus 178 ~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~----~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~ 241 (256)
T cd05059 178 FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VV----ESVSAGY---------RLYRPKLAPTEVYTIMYSCWHEK 241 (256)
T ss_pred CCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HH----HHHHcCC---------cCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999999999999999998 788885432211 11 1111110 01111223457889999999999
Q ss_pred CCCCCCHHHHHHHh
Q 048243 242 PNDRPSMLQVSSML 255 (303)
Q Consensus 242 p~~Rpt~~el~~~L 255 (303)
|++|||+.|+++.|
T Consensus 242 p~~Rpt~~~~l~~l 255 (256)
T cd05059 242 PEDRPAFKKLLSQL 255 (256)
T ss_pred hhhCcCHHHHHHHh
Confidence 99999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=270.05 Aligned_cols=238 Identities=23% Similarity=0.269 Sum_probs=179.3
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCC-----eeEEEEeecCCCChhhhhcC-ccccc
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE-----ERMLVYEYMPNKSLDCYLFD-PIRRL 76 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~-~~~~~ 76 (303)
..+++.||||+.-.... .-..|+++|+.++||||+++..+|.... ...+||||++ .+|.+++.. ...+.
T Consensus 46 ~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP-~tL~~~~r~~~~~~~ 120 (364)
T KOG0658|consen 46 RETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP-ETLYRVIRHYTRANQ 120 (364)
T ss_pred cCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch-HHHHHHHHHHhhcCC
Confidence 35689999999865542 2246999999999999999999987542 3358999997 478887753 12356
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCC-CceEEcccccccccccCCccccccccccccCCCCh
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED-MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~-~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aP 155 (303)
.++...++-+++||++||+|||+.| ||||||||.|+|+|.+ |.+||+|||.|+....+... .....+..|+||
T Consensus 121 ~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn---iSYicSRyYRaP 194 (364)
T KOG0658|consen 121 RMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN---ISYICSRYYRAP 194 (364)
T ss_pred CCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc---eeEEEeccccCH
Confidence 7888999999999999999999998 9999999999999976 89999999999887654322 224568999999
Q ss_pred hhhccC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCc---------------ceeccccCC
Q 048243 156 EYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG---------------VEFVDSSLD 219 (303)
Q Consensus 156 E~~~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~ 219 (303)
|++.+. .|+.+.||||.||++.||+.|++.|.+.+..+....+- +.+..... .++....+.
T Consensus 195 ELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIi---k~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~ 271 (364)
T KOG0658|consen 195 ELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEII---KVLGTPTREDIKSMNPNYTEFKFPQIKAHPWH 271 (364)
T ss_pred HHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHH---HHhCCCCHHHHhhcCcccccccCcccccccce
Confidence 998876 59999999999999999999999998755444333222 22221111 111111111
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 220 DTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 220 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
.......+.+..+|+.++|+.+|.+|.++.|++..
T Consensus 272 ~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 272 KVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred eecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 11223344578899999999999999999999764
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=270.17 Aligned_cols=241 Identities=25% Similarity=0.411 Sum_probs=184.6
Q ss_pred CCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc--------cc
Q 048243 5 CGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI--------RR 75 (303)
Q Consensus 5 ~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~ 75 (303)
.+..||+|.+.... ....+.+.+|+.++++++||||+++++++..+...+++||++.+++|.+++.... ..
T Consensus 45 ~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 124 (296)
T cd05051 45 APVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS 124 (296)
T ss_pred CceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccC
Confidence 45679999997553 3445678899999999999999999999999999999999999999999985422 11
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCCh
Q 048243 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aP 155 (303)
..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||.+................++..|+||
T Consensus 125 ~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 201 (296)
T cd05051 125 KSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAW 201 (296)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCH
Confidence 25899999999999999999999998 999999999999999999999999998765433322223334567789999
Q ss_pred hhhccCCCCCccchhhHHHHHHHHHh--CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHH
Q 048243 156 EYARQGVYSTKSDVFSFGVLLLQIIS--GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEI 233 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~~~~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 233 (303)
|.+.+..++.++||||||+++|+|++ +..||...... .........+....... ....+...+.++.++
T Consensus 202 E~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~l 272 (296)
T cd05051 202 ESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ---QVIENAGHFFRDDGRQI------YLPRPPNCPKDIYEL 272 (296)
T ss_pred HHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH---HHHHHHHhccccccccc------cCCCccCCCHHHHHH
Confidence 99988889999999999999999998 55666432211 11111111111111000 011112234578999
Q ss_pred HHHcccCCCCCCCCHHHHHHHhcc
Q 048243 234 ALLCVQENPNDRPSMLQVSSMLKN 257 (303)
Q Consensus 234 i~~~l~~dp~~Rpt~~el~~~L~~ 257 (303)
+.+||+.||.+|||+.||++.|++
T Consensus 273 i~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 273 MLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHhccChhcCCCHHHHHHHhcC
Confidence 999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=272.70 Aligned_cols=234 Identities=27% Similarity=0.393 Sum_probs=184.3
Q ss_pred CCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 5 CGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 5 ~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
++..||+|.++... ....+.+.+|+.+++++ +|+||+++++++......+++|||+.+++|.+++... ....+++..
T Consensus 64 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~ 142 (302)
T cd05055 64 AVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK-RESFLTLED 142 (302)
T ss_pred ceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhC-CCCCCCHHH
Confidence 45679999987553 33446788999999999 7999999999999999999999999999999998542 223489999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
++.++.|++.||+|||+.+ ++|+||||+||+++.++.++++|||.+................++..|+|||.+.+..
T Consensus 143 ~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 219 (302)
T cd05055 143 LLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV 219 (302)
T ss_pred HHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCC
Confidence 9999999999999999998 9999999999999999999999999987654432222222334577899999999888
Q ss_pred CCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
++.++||||+|+++|+|++ |..||....... ........... ...+...+..+.+++.+||..+
T Consensus 220 ~~~~~DiwslGvil~el~t~g~~p~~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~ 284 (302)
T cd05055 220 YTFESDVWSYGILLWEIFSLGSNPYPGMPVDS------KFYKLIKEGYR---------MAQPEHAPAEIYDIMKTCWDAD 284 (302)
T ss_pred CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH------HHHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcCCC
Confidence 9999999999999999998 888875433221 11111111110 0111122457889999999999
Q ss_pred CCCCCCHHHHHHHhcc
Q 048243 242 PNDRPSMLQVSSMLKN 257 (303)
Q Consensus 242 p~~Rpt~~el~~~L~~ 257 (303)
|++|||+.|+++.|++
T Consensus 285 p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 285 PLKRPTFKQIVQLIGK 300 (302)
T ss_pred chhCcCHHHHHHHHHh
Confidence 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=272.78 Aligned_cols=235 Identities=28% Similarity=0.398 Sum_probs=184.1
Q ss_pred CCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCc----------
Q 048243 5 CGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDP---------- 72 (303)
Q Consensus 5 ~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------- 72 (303)
+.+.+|+|.+.... ......+.+|+++++.+ +|+||+++++++..+...+++|||+.+++|..++...
T Consensus 41 ~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~ 120 (293)
T cd05053 41 ETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPD 120 (293)
T ss_pred CceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccc
Confidence 45789999987542 23345688999999999 8999999999999999999999999999999998532
Q ss_pred ---cccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccc
Q 048243 73 ---IRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGT 149 (303)
Q Consensus 73 ---~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~ 149 (303)
.....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||.+................++
T Consensus 121 ~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~ 197 (293)
T cd05053 121 DPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLP 197 (293)
T ss_pred cccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCC
Confidence 12456889999999999999999999998 999999999999999999999999998765543322222223346
Q ss_pred cCCCChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHH
Q 048243 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLM 228 (303)
Q Consensus 150 ~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
..|+|||.+.+..++.++|||||||++|++++ |..||....... ........... ..+...+.
T Consensus 198 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~ 261 (293)
T cd05053 198 VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-------LFKLLKEGYRM---------EKPQNCTQ 261 (293)
T ss_pred ccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-------HHHHHHcCCcC---------CCCCCCCH
Confidence 67999999988889999999999999999997 888875332111 11111111111 11112244
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHhccc
Q 048243 229 RCLEIALLCVQENPNDRPSMLQVSSMLKNE 258 (303)
Q Consensus 229 ~l~~li~~~l~~dp~~Rpt~~el~~~L~~~ 258 (303)
.+.+|+.+||..||.+|||+.|+++.|++.
T Consensus 262 ~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 262 ELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 788999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=267.39 Aligned_cols=241 Identities=24% Similarity=0.420 Sum_probs=182.6
Q ss_pred CCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccc--------c
Q 048243 5 CGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR--------R 75 (303)
Q Consensus 5 ~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~ 75 (303)
++..||+|.++... ....+.+.+|+.+++.++|+||+++++++......+++|||+.+++|.+++..... .
T Consensus 45 ~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 124 (296)
T cd05095 45 QPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124 (296)
T ss_pred ceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccc
Confidence 45579999997553 33456889999999999999999999999999999999999999999998864221 1
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCCh
Q 048243 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aP 155 (303)
..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..+.............++..|++|
T Consensus 125 ~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p 201 (296)
T cd05095 125 VTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSW 201 (296)
T ss_pred cccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCH
Confidence 34677889999999999999999999 999999999999999999999999998765443222222233446789999
Q ss_pred hhhccCCCCCccchhhHHHHHHHHHh--CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHH
Q 048243 156 EYARQGVYSTKSDVFSFGVLLLQIIS--GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEI 233 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~~~~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 233 (303)
|...+..++.++|||||||++|+|++ |..||........ ................. ..+...+..+.++
T Consensus 202 e~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l 272 (296)
T cd05095 202 ESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV---IENTGEFFRDQGRQVYL------PKPALCPDSLYKL 272 (296)
T ss_pred HHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH---HHHHHHHHhhccccccC------CCCCCCCHHHHHH
Confidence 99888889999999999999999998 6677753322211 11111111111000000 0111223578899
Q ss_pred HHHcccCCCCCCCCHHHHHHHhcc
Q 048243 234 ALLCVQENPNDRPSMLQVSSMLKN 257 (303)
Q Consensus 234 i~~~l~~dp~~Rpt~~el~~~L~~ 257 (303)
+.+||+.||.+||++.+|++.|++
T Consensus 273 i~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 273 MLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHcCCCcccCCCHHHHHHHHhC
Confidence 999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=273.50 Aligned_cols=227 Identities=20% Similarity=0.270 Sum_probs=178.8
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+++.||+|+++... ....+.+.+|+.++.++ +||+|+++++++......++||||+++++|..++. ....++
T Consensus 18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~l~ 94 (327)
T cd05617 18 KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQ---RQRKLP 94 (327)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHH---HcCCCC
Confidence 578999999997542 23445688899999888 69999999999999999999999999999988874 345699
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..++.++.||+.||+|||+.| ++||||||+||+++.++.++|+|||++....... .......|++.|+|||.+.
T Consensus 95 ~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~ 169 (327)
T cd05617 95 EEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILR 169 (327)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--CceecccCCcccCCHHHHC
Confidence 9999999999999999999999 9999999999999999999999999986432211 1223356899999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++|||||||++|+|++|..||....................... ...+...+..+.+++.+||.
T Consensus 170 ~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------~~~p~~~~~~~~~li~~~L~ 239 (327)
T cd05617 170 GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP----------IRIPRFLSVKASHVLKGFLN 239 (327)
T ss_pred CCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC----------CCCCCCCCHHHHHHHHHHhc
Confidence 99999999999999999999999999965443322222222222221110 00111223467899999999
Q ss_pred CCCCCCCCH
Q 048243 240 ENPNDRPSM 248 (303)
Q Consensus 240 ~dp~~Rpt~ 248 (303)
.||.+|+++
T Consensus 240 ~dP~~R~~~ 248 (327)
T cd05617 240 KDPKERLGC 248 (327)
T ss_pred cCHHHcCCC
Confidence 999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=274.92 Aligned_cols=222 Identities=23% Similarity=0.272 Sum_probs=173.4
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHH-HHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVM-LTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+|+.||+|++.... ......+..|.. +++.++||||+++++.+..+...++||||+.+++|..++. ....++
T Consensus 18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~ 94 (325)
T cd05604 18 LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQ---RERSFP 94 (325)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHH---HcCCCC
Confidence 578999999996542 223344555554 4677899999999999999999999999999999988874 445689
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..+..++.||+.||+|||+.| ++||||||+||+++.++.++|+|||++...... ........|+..|+|||.+.
T Consensus 95 ~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~ 169 (325)
T cd05604 95 EPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTTTTFCGTPEYLAPEVIR 169 (325)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCcccccCChhhCCHHHHc
Confidence 9999999999999999999999 999999999999999999999999998643221 11223356899999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++|||||||++|+|++|..||....... .. ........ ... +..+..+.+++.+||+
T Consensus 170 ~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~---~~~~~~~~-------~~~----~~~~~~~~~ll~~ll~ 232 (325)
T cd05604 170 KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---MY---DNILHKPL-------VLR----PGASLTAWSILEELLE 232 (325)
T ss_pred CCCCCCcCccccccceehhhhcCCCCCCCCCHHH---HH---HHHHcCCc-------cCC----CCCCHHHHHHHHHHhc
Confidence 9999999999999999999999999986432211 11 11111100 011 1233477899999999
Q ss_pred CCCCCCCCHHH
Q 048243 240 ENPNDRPSMLQ 250 (303)
Q Consensus 240 ~dp~~Rpt~~e 250 (303)
.||.+||++.+
T Consensus 233 ~~p~~R~~~~~ 243 (325)
T cd05604 233 KDRQRRLGAKE 243 (325)
T ss_pred cCHHhcCCCCC
Confidence 99999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=264.26 Aligned_cols=237 Identities=21% Similarity=0.293 Sum_probs=186.4
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc-ccccCC
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-RRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~l~ 79 (303)
.+|+.||+|.++... ......+.+|+.+++.++||||+++++++......++++||+++++|.+++.... ....++
T Consensus 25 ~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~ 104 (267)
T cd08228 25 LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIP 104 (267)
T ss_pred CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCC
Confidence 478999999886432 2334568889999999999999999999999999999999999999988875322 234578
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||.+........ ......|+..|+|||.+.
T Consensus 105 ~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~ 179 (267)
T cd08228 105 ERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIH 179 (267)
T ss_pred HHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccchhH--HHhcCCCCccccChhhhc
Confidence 8999999999999999999998 99999999999999999999999999876543321 122345788999999998
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++|+||+|+++|+|++|..||....... .. .......... ........+..+.+++.+||.
T Consensus 180 ~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~-~~~~~~~~~~--------~~~~~~~~~~~~~~li~~cl~ 246 (267)
T cd08228 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FS-LCQKIEQCDY--------PPLPTEHYSEKLRELVSMCIY 246 (267)
T ss_pred cCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HH-HHHHHhcCCC--------CCCChhhcCHHHHHHHHHHCC
Confidence 8888999999999999999999999985332111 11 1111111110 111122344678999999999
Q ss_pred CCCCCCCCHHHHHHHhccc
Q 048243 240 ENPNDRPSMLQVSSMLKNE 258 (303)
Q Consensus 240 ~dp~~Rpt~~el~~~L~~~ 258 (303)
.+|++||++.++++.|++.
T Consensus 247 ~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 247 PDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCcccCcCHHHHHHHHHHh
Confidence 9999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=264.37 Aligned_cols=232 Identities=27% Similarity=0.381 Sum_probs=182.5
Q ss_pred CCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTSTQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
++|+.||+|.+...... ....+.+|++++++++|+||+++++++......++||||+.+++|.+++.. ....+++..
T Consensus 17 ~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~--~~~~~~~~~ 94 (251)
T cd05041 17 KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRK--KKNRLTVKK 94 (251)
T ss_pred eCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHh--cCCCCCHHH
Confidence 44899999998765433 456789999999999999999999999999999999999999999998854 234578899
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
+..++.+++.+++|||+++ ++||||+|+||+++.++.++|+|||.+................++..|+|||.+.+..
T Consensus 95 ~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 171 (251)
T cd05041 95 LLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171 (251)
T ss_pred HHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCC
Confidence 9999999999999999998 9999999999999999999999999987654322111111223356799999998888
Q ss_pred CCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
++.++|+||||+++|+|++ |..||....... .......... ...+...+..+.+++.+||..+
T Consensus 172 ~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-------~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~ 235 (251)
T cd05041 172 YTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-------TRERIESGYR---------MPAPQLCPEEIYRLMLQCWAYD 235 (251)
T ss_pred CCcchhHHHHHHHHHHHHhccCCCCccCCHHH-------HHHHHhcCCC---------CCCCccCCHHHHHHHHHHhccC
Confidence 9999999999999999999 777775433211 1111111110 0111123457889999999999
Q ss_pred CCCCCCHHHHHHHhc
Q 048243 242 PNDRPSMLQVSSMLK 256 (303)
Q Consensus 242 p~~Rpt~~el~~~L~ 256 (303)
|.+|||+.|+++.|+
T Consensus 236 p~~Rp~~~ell~~l~ 250 (251)
T cd05041 236 PENRPSFSEIYNELQ 250 (251)
T ss_pred hhhCcCHHHHHHHhh
Confidence 999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=273.06 Aligned_cols=225 Identities=24% Similarity=0.288 Sum_probs=177.0
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+++.||+|.++... .........|..++... +||||+++++++.+....++||||+++|+|..++. ....++
T Consensus 18 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~---~~~~~~ 94 (316)
T cd05619 18 GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQ---SCHKFD 94 (316)
T ss_pred CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH---HcCCCC
Confidence 468899999997542 23345566778888765 99999999999999999999999999999998884 335688
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....... .......|+..|+|||.+.
T Consensus 95 ~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~ 169 (316)
T cd05619 95 LPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTCTFCGTPDYIAPEILL 169 (316)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--CceeeecCCccccCHHHHc
Confidence 9999999999999999999999 9999999999999999999999999986432211 1223356899999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++||||+||++|+|++|..||....... .. ...... ... .+...+..+.+++.+||+
T Consensus 170 ~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~----~~i~~~------~~~----~~~~~~~~~~~li~~~l~ 232 (316)
T cd05619 170 GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LF----QSIRMD------NPC----YPRWLTREAKDILVKLFV 232 (316)
T ss_pred CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HH----HHHHhC------CCC----CCccCCHHHHHHHHHHhc
Confidence 8889999999999999999999999986433211 11 111110 000 111234478899999999
Q ss_pred CCCCCCCCHH-HHHH
Q 048243 240 ENPNDRPSML-QVSS 253 (303)
Q Consensus 240 ~dp~~Rpt~~-el~~ 253 (303)
.||.+||++. ++++
T Consensus 233 ~~P~~R~~~~~~l~~ 247 (316)
T cd05619 233 REPERRLGVKGDIRQ 247 (316)
T ss_pred cCHhhcCCChHHHHc
Confidence 9999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=274.55 Aligned_cols=238 Identities=29% Similarity=0.432 Sum_probs=183.6
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCccccEEEEEEeC-CeeEEEEeecCCCChhhhhcCccc------
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS-EERMLVYEYMPNKSLDCYLFDPIR------ 74 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~------ 74 (303)
.+++.||+|+++... ....+.+.+|+.++.++ +|+||+++++++... ...+++|||+++++|.+++.....
T Consensus 35 ~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~ 114 (337)
T cd05054 35 ASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYR 114 (337)
T ss_pred cccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccc
Confidence 456899999997543 23345678899999999 899999999988654 567899999999999988853211
Q ss_pred ----------------------------------------------------cccCCHHHHHHHHHHHHHHHHHHHhCCC
Q 048243 75 ----------------------------------------------------RLILDWKKRVHIIEGITQGLLYLQEYSR 102 (303)
Q Consensus 75 ----------------------------------------------------~~~l~~~~~~~~~~~i~~~l~~Lh~~~~ 102 (303)
...+++..+..++.||+.||+|||+.+
T Consensus 115 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~- 193 (337)
T cd05054 115 NKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK- 193 (337)
T ss_pred cccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 136788999999999999999999998
Q ss_pred CCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHh-
Q 048243 103 LTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS- 181 (303)
Q Consensus 103 ~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~- 181 (303)
|+||||||+||+++.++.++|+|||++..+.............++..|+|||.+.+..++.++|||||||++|+|++
T Consensus 194 --ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~ 271 (337)
T cd05054 194 --CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSL 271 (337)
T ss_pred --eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHc
Confidence 99999999999999999999999999976543322222233455678999999999999999999999999999998
Q ss_pred CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcccc
Q 048243 182 GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 182 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~ 259 (303)
|..||........ ........... ..+...+.++.+++.+||+.+|++||++.|+++.|+...
T Consensus 272 g~~p~~~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 272 GASPYPGVQIDEE------FCRRLKEGTRM---------RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred CCCCCCCCCccHH------HHHHHhccCCC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9888854322111 11111111111 111123457889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=281.11 Aligned_cols=231 Identities=24% Similarity=0.339 Sum_probs=183.7
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|+++... ......+..|+.++..++|+||+++++++.++...++||||+.+++|.+++.. ...+++
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~ 100 (350)
T cd05573 24 DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR---KDVFPE 100 (350)
T ss_pred CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHH---cCCCCH
Confidence 368999999997542 23456788999999999999999999999999999999999999999999853 356899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCC----------------------
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKES---------------------- 138 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~---------------------- 138 (303)
..++.++.||+.||+|||+.| ++||||||+||+++.++.++|+|||++.......
T Consensus 101 ~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (350)
T cd05573 101 ETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177 (350)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccc
Confidence 999999999999999999998 9999999999999999999999999987654332
Q ss_pred -----ccccccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCccee
Q 048243 139 -----LEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF 213 (303)
Q Consensus 139 -----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (303)
.........|++.|+|||.+.+..++.++|||||||++|+|++|..||........ ............
T Consensus 178 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~------~~~i~~~~~~~~- 250 (350)
T cd05573 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET------YNKIINWKESLR- 250 (350)
T ss_pred cccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH------HHHHhccCCccc-
Confidence 00112335689999999999999999999999999999999999999965442111 111111000000
Q ss_pred ccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 048243 214 VDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPS-MLQVSSM 254 (303)
Q Consensus 214 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt-~~el~~~ 254 (303)
.......+..+.++|.+||. ||.+||+ +.++++.
T Consensus 251 ------~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 251 ------FPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred ------CCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 00011134578899999998 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=267.90 Aligned_cols=228 Identities=22% Similarity=0.345 Sum_probs=183.5
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+|+.||+|.+........+.+.+|+.+++.++|+||+++++.+......++||||+++++|.+++. ...+++..+
T Consensus 43 ~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~ 118 (296)
T cd06654 43 ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQI 118 (296)
T ss_pred CCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHH----hcCCCHHHH
Confidence 5789999999977665556788999999999999999999999999999999999999999999883 335788999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
..++.|++.||+|||+.| ++||||+|+||+++.++.++|+|||.+....... .......|+..|+|||.+.+..+
T Consensus 119 ~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~ 193 (296)
T cd06654 119 AAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAY 193 (296)
T ss_pred HHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc--cccCcccCCccccCHHHHcCCCC
Confidence 999999999999999999 9999999999999999999999999886543221 11122467889999999998888
Q ss_pred CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCC
Q 048243 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 243 (303)
+.++|||||||++|+|++|..||....... .......... . ....+......+.+++.+||..||.
T Consensus 194 ~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~------~~~~~~~~~~-~-------~~~~~~~~~~~l~~li~~~l~~~p~ 259 (296)
T cd06654 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGT-P-------ELQNPEKLSAIFRDFLNRCLDMDVE 259 (296)
T ss_pred CccchHHHHHHHHHHHHhCCCCCCCCCHHH------hHHHHhcCCC-C-------CCCCccccCHHHHHHHHHHCcCCcc
Confidence 999999999999999999999985433211 0111111110 0 0011223445788999999999999
Q ss_pred CCCCHHHHHHH
Q 048243 244 DRPSMLQVSSM 254 (303)
Q Consensus 244 ~Rpt~~el~~~ 254 (303)
+|||+.++++.
T Consensus 260 ~Rpt~~eil~~ 270 (296)
T cd06654 260 KRGSAKELLQH 270 (296)
T ss_pred cCcCHHHHhhC
Confidence 99999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=270.58 Aligned_cols=241 Identities=29% Similarity=0.435 Sum_probs=182.1
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEe--CCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCID--SEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+++.||+|.+........+.+.+|+.+++.++||||+++++++.. ....++||||+++++|.+++.. ....+++.
T Consensus 31 ~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~l~~~ 108 (284)
T cd05081 31 NTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK--HRERLDHR 108 (284)
T ss_pred CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHh--cCcCCCHH
Confidence 4688999999987666666788999999999999999999998754 3467999999999999999853 23458899
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccc-cccccccccCCCChhhhcc
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEA-NTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~ 160 (303)
.++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++.......... ......++..|+|||.+.+
T Consensus 109 ~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 185 (284)
T cd05081 109 KLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE 185 (284)
T ss_pred HHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhcc
Confidence 99999999999999999999 9999999999999999999999999988654332211 1111223456999999988
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCc---------cccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHH
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINE---------NLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL 231 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
..++.++||||||+++|+|++|..++....... ............... .........+..+.
T Consensus 186 ~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~ 256 (284)
T cd05081 186 SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN---------GRLPAPPGCPAEIY 256 (284)
T ss_pred CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcC---------CcCCCCCCCCHHHH
Confidence 889999999999999999999876653221100 000000111111111 00111122344788
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhccc
Q 048243 232 EIALLCVQENPNDRPSMLQVSSMLKNE 258 (303)
Q Consensus 232 ~li~~~l~~dp~~Rpt~~el~~~L~~~ 258 (303)
+++.+||..+|++|||+.|+++.|+..
T Consensus 257 ~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 257 AIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=266.42 Aligned_cols=232 Identities=28% Similarity=0.423 Sum_probs=182.8
Q ss_pred CcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHH
Q 048243 6 GKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 6 ~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~ 84 (303)
...||+|.++... ......+..|+..+++++||||+++++++......+++|||+++++|.+++.. ....+++..++
T Consensus 32 ~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~ 109 (266)
T cd05033 32 EIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRE--NDGKFTVGQLV 109 (266)
T ss_pred cceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHh--ccCCCCHHHHH
Confidence 4579999987543 33446788999999999999999999999999999999999999999999854 23468899999
Q ss_pred HHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCC
Q 048243 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYS 164 (303)
Q Consensus 85 ~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 164 (303)
.++.|++.|++|||+.+ ++||||+|+||+++.++.++|+|||++................++..|+|||.+.+..++
T Consensus 110 ~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~ 186 (266)
T cd05033 110 GMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFT 186 (266)
T ss_pred HHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCc
Confidence 99999999999999998 999999999999999999999999999876522211112223346789999999988899
Q ss_pred CccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCC
Q 048243 165 TKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 165 ~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 243 (303)
.++||||||+++|++++ |..||....... ........... ..+...+..+.+++.+||+.+|+
T Consensus 187 ~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~ 250 (266)
T cd05033 187 SASDVWSFGIVMWEVMSYGERPYWDMSNQD-------VIKAVEDGYRL---------PPPMDCPSALYQLMLDCWQKDRN 250 (266)
T ss_pred cccchHHHHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcc
Confidence 99999999999999997 888874322111 11111111110 01112345788999999999999
Q ss_pred CCCCHHHHHHHhccc
Q 048243 244 DRPSMLQVSSMLKNE 258 (303)
Q Consensus 244 ~Rpt~~el~~~L~~~ 258 (303)
+||++.|+++.|++.
T Consensus 251 ~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 251 ERPTFSQIVSTLDKM 265 (266)
T ss_pred cCcCHHHHHHHHHhh
Confidence 999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=277.56 Aligned_cols=237 Identities=18% Similarity=0.177 Sum_probs=174.9
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+++.||+|.... ..+.+|++++++++||||+++++++......++|+|++. ++|..++. ....+++..+
T Consensus 115 ~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~---~~~~l~~~~~ 184 (391)
T PHA03212 115 KTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLA---AKRNIAICDI 184 (391)
T ss_pred CCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHH---hcCCCCHHHH
Confidence 5788999997532 356789999999999999999999999999999999985 67877774 3346889999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
+.++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++....... ........||+.|+|||++.+..+
T Consensus 185 ~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~ 260 (391)
T PHA03212 185 LAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKYYGWAGTIATNAPELLARDPY 260 (391)
T ss_pred HHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-ccccccccCccCCCChhhhcCCCC
Confidence 999999999999999998 9999999999999999999999999986533221 111223568999999999999899
Q ss_pred CCccchhhHHHHHHHHHhCCCCCccCCCCcc----ccHHHHHHHHHhCCCc-------------------ceeccccCC-
Q 048243 164 STKSDVFSFGVLLLQIISGKRLSMLCGINEN----LSILEHAYELWKGGKG-------------------VEFVDSSLD- 219 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~-------------------~~~~~~~~~- 219 (303)
+.++|||||||++|+|++|..||........ ...+............ .....+...
T Consensus 261 ~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (391)
T PHA03212 261 GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRP 340 (391)
T ss_pred CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCC
Confidence 9999999999999999999987643221110 0111111110000000 000000000
Q ss_pred -CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 220 -DTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 220 -~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
.......+.++.+||.+||+.||.+|||+.|+++.
T Consensus 341 ~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 341 LWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred CHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00011234578899999999999999999999853
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=269.93 Aligned_cols=242 Identities=24% Similarity=0.301 Sum_probs=174.7
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcC---CCCccccEEEEEEe-----CCeeEEEEeecCCCChhhhhcCcc
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKL---QHVNLIRVLGFCID-----SEERMLVYEYMPNKSLDCYLFDPI 73 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~ 73 (303)
.+|+.||+|.++... ......+.+|+.+++.+ +||||+++++++.. ....++||||+. ++|.+++...
T Consensus 25 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~- 102 (290)
T cd07862 25 NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKV- 102 (290)
T ss_pred CCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhC-
Confidence 357889999986542 22234566777777665 69999999999853 346899999996 5888888542
Q ss_pred ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCC
Q 048243 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYI 153 (303)
Q Consensus 74 ~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~ 153 (303)
....+++..++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++...... .......|+..|+
T Consensus 103 ~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~ 176 (290)
T cd07862 103 PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYR 176 (290)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccceEeccCC---ccccccccccccc
Confidence 2345889999999999999999999999 999999999999999999999999998765433 2223356899999
Q ss_pred ChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcc---eeccccCC--CC-----CC
Q 048243 154 PPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV---EFVDSSLD--DT-----NS 223 (303)
Q Consensus 154 aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~--~~-----~~ 223 (303)
|||.+.+..++.++|||||||++|+|++|.+||...........+............. ......+. .. ..
T Consensus 177 aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (290)
T cd07862 177 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFV 256 (290)
T ss_pred ChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHc
Confidence 9999988889999999999999999999999987543322111111000000000000 00000000 00 01
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 224 PCKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 224 ~~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
+..+..+.+++.+||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 257 TDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred cCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=272.98 Aligned_cols=227 Identities=21% Similarity=0.243 Sum_probs=174.3
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHH-HHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVM-LTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+|+.||+|++.... ......+..|.. +++.++||||+++++.+.+.+..++||||+++++|...+. ....++
T Consensus 18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~ 94 (321)
T cd05603 18 SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQ---RERCFL 94 (321)
T ss_pred CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHH---HcCCCC
Confidence 468999999996542 222334555554 5788899999999999999999999999999999988773 345688
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..+..++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||++....... .......|++.|+|||.+.
T Consensus 95 ~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~ 169 (321)
T cd05603 95 EPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTSTFCGTPEYLAPEVLR 169 (321)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--CccccccCCcccCCHHHhc
Confidence 8999999999999999999998 9999999999999999999999999986532211 1223356899999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++|||||||++|+|++|..||....... ......... ...++..+..+.+++.+||+
T Consensus 170 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~~~-----------~~~~~~~~~~~~~li~~~l~ 232 (321)
T cd05603 170 KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ------MYDNILHKP-----------LQLPGGKTVAACDLLVGLLH 232 (321)
T ss_pred CCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH------HHHHHhcCC-----------CCCCCCCCHHHHHHHHHHcc
Confidence 8889999999999999999999999986432111 111111110 01112234478899999999
Q ss_pred CCCCCCCCHH-HHHHHh
Q 048243 240 ENPNDRPSML-QVSSML 255 (303)
Q Consensus 240 ~dp~~Rpt~~-el~~~L 255 (303)
.||.+||++. ++.+.+
T Consensus 233 ~~p~~R~~~~~~~~~~~ 249 (321)
T cd05603 233 KDQRRRLGAKADFLEIK 249 (321)
T ss_pred CCHhhcCCCCCCHHHHh
Confidence 9999999864 333433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=278.57 Aligned_cols=235 Identities=29% Similarity=0.438 Sum_probs=184.4
Q ss_pred EEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHH
Q 048243 8 VIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVH 85 (303)
Q Consensus 8 ~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~ 85 (303)
.||||+++... +...+.|++|+..+++-+|.||+-+.|++..... .+|+-+|+|.+|..++.- .+..++....+.
T Consensus 416 dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv--~etkfdm~~~id 492 (678)
T KOG0193|consen 416 DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHV--QETKFDMNTTID 492 (678)
T ss_pred ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccc--hhhhhhHHHHHH
Confidence 59999998774 4567789999999999999999999999988776 999999999999999864 456799999999
Q ss_pred HHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc---cCC
Q 048243 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR---QGV 162 (303)
Q Consensus 86 ~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~ 162 (303)
|+.||+.|+.|||.++ |+|+|||..|||+.++++|+|+|||++..-..-....-.....|...|+|||++. ..+
T Consensus 493 IAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nP 569 (678)
T KOG0193|consen 493 IAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNP 569 (678)
T ss_pred HHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCC
Confidence 9999999999999999 9999999999999999999999999985422111111123345788999999986 446
Q ss_pred CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC
Q 048243 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 242 (303)
|+.++||||||+|+|||++|..|+......... |..+...-..+..... .....++.+|+..||..++
T Consensus 570 fS~qSDVYaFGiV~YELltg~lPysi~~~dqIi---------fmVGrG~l~pd~s~~~---s~~pk~mk~Ll~~C~~~~~ 637 (678)
T KOG0193|consen 570 FSFQSDVYAFGIVWYELLTGELPYSIQNRDQII---------FMVGRGYLMPDLSKIR---SNCPKAMKRLLSDCWKFDR 637 (678)
T ss_pred CCcccchhhhhHHHHHHHhCcCCcCCCChhheE---------EEecccccCccchhhh---ccCHHHHHHHHHHHHhcCc
Confidence 899999999999999999999999733222211 1111111111111111 1223478899999999999
Q ss_pred CCCCCHHHHHHHhccccC
Q 048243 243 NDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 243 ~~Rpt~~el~~~L~~~~~ 260 (303)
++||.+.+|+..|+....
T Consensus 638 ~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 638 EERPLFPQLLSKLEELLP 655 (678)
T ss_pred ccCccHHHHHHHHHHhhh
Confidence 999999999997766543
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=277.54 Aligned_cols=231 Identities=19% Similarity=0.252 Sum_probs=181.1
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|+++... ....+.+.+|+.+++.++|+||+++++++.+....++||||+++++|.+++.. ....+++
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~l~~ 101 (330)
T cd05601 24 ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNR--YEDQFDE 101 (330)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHH--hcCCCCH
Confidence 478999999997542 23445688899999999999999999999999999999999999999999854 2356899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc-
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR- 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~- 159 (303)
..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......... ......|++.|+|||++.
T Consensus 102 ~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~ 177 (330)
T cd05601 102 DMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTT 177 (330)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCce-eeecccCCccccCHHHhcc
Confidence 999999999999999999999 999999999999999999999999998765433221 222346899999999986
Q ss_pred -----cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHH
Q 048243 160 -----QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIA 234 (303)
Q Consensus 160 -----~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
...++.++|||||||++|+|++|..||....... ............. ....+..+..+.+|+
T Consensus 178 ~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~~-------~~~~~~~~~~~~~li 244 (330)
T cd05601 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNFQRFLK-------FPEDPKVSSDFLDLI 244 (330)
T ss_pred ccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcCCCccC-------CCCCCCCCHHHHHHH
Confidence 4457889999999999999999999986433211 1111111111111 111112345788999
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 048243 235 LLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 235 ~~~l~~dp~~Rpt~~el~~~ 254 (303)
.+||. ||.+|||+.+++..
T Consensus 245 ~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 245 QSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHHcc-ChhhCCCHHHHhCC
Confidence 99998 99999999999863
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=264.25 Aligned_cols=232 Identities=22% Similarity=0.330 Sum_probs=181.4
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+|+.||+|++..........+.+|+.++++++||||+++++.+......++||||+++++|.+++. ....+++..+
T Consensus 32 ~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~---~~~~~~~~~~ 108 (267)
T cd06646 32 HTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYH---VTGPLSELQI 108 (267)
T ss_pred CCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHH---hcCCCCHHHH
Confidence 5788999999976654555678899999999999999999999999999999999999999998884 3456889999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc---c
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR---Q 160 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~ 160 (303)
..++.|++.|++|||+.+ ++||||+|+||+++.++.++|+|||++........ ......|+..|+|||.+. .
T Consensus 109 ~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~ 183 (267)
T cd06646 109 AYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--KRKSFIGTPYWMAPEVAAVEKN 183 (267)
T ss_pred HHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc--ccCccccCccccCHhHcccccC
Confidence 999999999999999998 99999999999999999999999999876543211 122345788999999874 3
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|+||+|+++|+|++|..||.......... ..... ....+.. ......+..+.+++.+||..
T Consensus 184 ~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~---~~~~~~~--~~~~~~~~~~~~li~~~l~~ 251 (267)
T cd06646 184 GGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKS---NFQPPKL--KDKTKWSSTFHNFVKISLTK 251 (267)
T ss_pred CCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecC---CCCCCCC--ccccccCHHHHHHHHHHhhC
Confidence 447789999999999999999999985332111000 00000 0000000 01122345788999999999
Q ss_pred CCCCCCCHHHHHHHh
Q 048243 241 NPNDRPSMLQVSSML 255 (303)
Q Consensus 241 dp~~Rpt~~el~~~L 255 (303)
+|++|||++++++.|
T Consensus 252 ~P~~Rp~~~~il~~l 266 (267)
T cd06646 252 NPKKRPTAERLLTHL 266 (267)
T ss_pred ChhhCcCHHHHhcCC
Confidence 999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=280.51 Aligned_cols=231 Identities=21% Similarity=0.269 Sum_probs=177.7
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|++.... ......+.+|+.++++++|+||+++++.+.+++..++||||+++|+|.+++. ....+++
T Consensus 24 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~---~~~~~~~ 100 (376)
T cd05598 24 DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI---RLGIFEE 100 (376)
T ss_pred CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHH---hcCCCCH
Confidence 568999999986432 2334568899999999999999999999999999999999999999999984 3456889
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCc---------------------
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL--------------------- 139 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~--------------------- 139 (303)
..+..++.||+.||+|||+.| |+||||||+||+++.++.++|+|||++..+.....
T Consensus 101 ~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (376)
T cd05598 101 DLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW 177 (376)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccc
Confidence 999999999999999999999 99999999999999999999999998753210000
Q ss_pred --------------------cccccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHH
Q 048243 140 --------------------EANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILE 199 (303)
Q Consensus 140 --------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~ 199 (303)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~---- 253 (376)
T cd05598 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQ---- 253 (376)
T ss_pred cccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHH----
Confidence 00011246899999999999999999999999999999999999999654322111
Q ss_pred HHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCC---CHHHHHHH
Q 048243 200 HAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRP---SMLQVSSM 254 (303)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---t~~el~~~ 254 (303)
........... .......+..+.++|.+|+ .+|.+|+ ++.|+++.
T Consensus 254 --~~i~~~~~~~~-------~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 254 --LKVINWETTLH-------IPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred --HHHhccCcccc-------CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 11111100000 0011122346778888876 5999999 88998765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=267.11 Aligned_cols=231 Identities=25% Similarity=0.265 Sum_probs=181.6
Q ss_pred CCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTST---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|++..... .....+.+|+.+++.++||||+++++.+..+...++||||+.+++|.+++... ....+++
T Consensus 23 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~ 101 (285)
T cd05605 23 ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNM-GNPGFDE 101 (285)
T ss_pred CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhc-CcCCCCH
Confidence 4689999999965422 22345778999999999999999999999999999999999999998877432 2346899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++........ .....|+..|+|||.+.+
T Consensus 102 ~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~ 175 (285)
T cd05605 102 ERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGYMAPEVVKN 175 (285)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---cccccCCCCccCcHHhcC
Confidence 999999999999999999999 99999999999999999999999999876533221 123467899999999998
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++||||+|+++|++++|..||............ ....... ....+...+..+.+|+.+||..
T Consensus 176 ~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~---~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~ 242 (285)
T cd05605 176 ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV---ERRVKED----------QEEYSEKFSEAARSICRQLLTK 242 (285)
T ss_pred CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH---HHHhhhc----------ccccCcccCHHHHHHHHHHccC
Confidence 88999999999999999999999999643322111111 1111100 0111223455788999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 048243 241 NPNDRP-----SMLQVSSM 254 (303)
Q Consensus 241 dp~~Rp-----t~~el~~~ 254 (303)
||.+|| ++.++++.
T Consensus 243 ~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 243 DPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred CHHHhcCCCCCCHHHHhcC
Confidence 999999 88888664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=268.38 Aligned_cols=234 Identities=26% Similarity=0.426 Sum_probs=183.6
Q ss_pred CCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccc-------cc
Q 048243 5 CGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR-------RL 76 (303)
Q Consensus 5 ~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~ 76 (303)
.++.||+|.+.... ......+.+|+.++..++|+||+++++++......++||||+++++|.+++..... ..
T Consensus 35 ~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~ 114 (277)
T cd05032 35 PETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLG 114 (277)
T ss_pred cceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCC
Confidence 45789999986543 23345788999999999999999999999999999999999999999999854221 23
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChh
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE 156 (303)
.+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||+++...............++..|+|||
T Consensus 115 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 191 (277)
T cd05032 115 PPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE 191 (277)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHH
Confidence 4678899999999999999999998 9999999999999999999999999987654433222223345678899999
Q ss_pred hhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHH
Q 048243 157 YARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
.+.+..++.++|||||||++|++++ |..||....... . ............ +...+..+.+++.
T Consensus 192 ~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~----~~~~~~~~~~~~---------~~~~~~~~~~li~ 255 (277)
T cd05032 192 SLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---V----LKFVIDGGHLDL---------PENCPDKLLELMR 255 (277)
T ss_pred HHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---H----HHHHhcCCCCCC---------CCCCCHHHHHHHH
Confidence 9988889999999999999999998 888875332211 1 111111111111 1112457889999
Q ss_pred HcccCCCCCCCCHHHHHHHhcc
Q 048243 236 LCVQENPNDRPSMLQVSSMLKN 257 (303)
Q Consensus 236 ~~l~~dp~~Rpt~~el~~~L~~ 257 (303)
+||+.+|++|||+.++++.|++
T Consensus 256 ~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 256 MCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HHcCCChhhCCCHHHHHHHhcC
Confidence 9999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=261.89 Aligned_cols=228 Identities=23% Similarity=0.358 Sum_probs=194.1
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
++|+.+|||.+.... +.+++.+||.++++++.|++|++|+.|.....+|+|||||..|++.+.+.. +++++.+..+
T Consensus 56 EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~--R~K~L~E~EI 131 (502)
T KOG0574|consen 56 ESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRA--RRKPLSEQEI 131 (502)
T ss_pred ccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHH--hcCCccHHHH
Confidence 689999999986543 567889999999999999999999999999999999999999999998854 6788999999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
..++...++||+|||... -+|||||..|||++.+|..||+|||.+..+... -...+...||+.|||||++..-.|
T Consensus 132 s~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAKRNTVIGTPFWMAPEVI~EIGY 206 (502)
T KOG0574|consen 132 SAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAKRNTVIGTPFWMAPEVIEEIGY 206 (502)
T ss_pred HHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh--HHhhCccccCcccccHHHHHHhcc
Confidence 999999999999999988 899999999999999999999999998654432 233456789999999999999999
Q ss_pred CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCC
Q 048243 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 243 (303)
..++||||||++..||..|++|+....+....-.+ ...+......+..++.++-+|+++||..+|+
T Consensus 207 ~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI--------------PT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE 272 (502)
T KOG0574|consen 207 DTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI--------------PTKPPPTFKKPEEWSSEFNDFIRSCLIKKPE 272 (502)
T ss_pred chhhhHhhhcchhhhhhcCCCCcccccccceeEec--------------cCCCCCCCCChHhhhhHHHHHHHHHhcCCHH
Confidence 99999999999999999999998654433311100 0112223445567788999999999999999
Q ss_pred CCCCHHHHHHH
Q 048243 244 DRPSMLQVSSM 254 (303)
Q Consensus 244 ~Rpt~~el~~~ 254 (303)
+|.|+.++++.
T Consensus 273 ~R~TA~~L~~H 283 (502)
T KOG0574|consen 273 ERKTALRLCEH 283 (502)
T ss_pred HHHHHHHHhhh
Confidence 99999999875
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=266.52 Aligned_cols=234 Identities=26% Similarity=0.438 Sum_probs=181.9
Q ss_pred CcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCe------eEEEEeecCCCChhhhhcCcc---c
Q 048243 6 GKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE------RMLVYEYMPNKSLDCYLFDPI---R 74 (303)
Q Consensus 6 ~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~---~ 74 (303)
++.||+|.++... ......+.+|+..++.++|+||+++++++..... .++++||+.+++|..++.... .
T Consensus 27 ~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~ 106 (273)
T cd05035 27 QLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGL 106 (273)
T ss_pred cceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCC
Confidence 4789999997543 3344678899999999999999999998876544 799999999999998885422 2
Q ss_pred cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCC
Q 048243 75 RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIP 154 (303)
Q Consensus 75 ~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~a 154 (303)
...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||.++...............++..|+|
T Consensus 107 ~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (273)
T cd05035 107 PEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183 (273)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccC
Confidence 346889999999999999999999998 99999999999999999999999999876544332222222334678999
Q ss_pred hhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHH
Q 048243 155 PEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEI 233 (303)
Q Consensus 155 PE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 233 (303)
||.+.+..++.++|||||||++|+|++ |..||....... . ........... .+...+..+.++
T Consensus 184 pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~----~~~~~~~~~~~---------~~~~~~~~~~~l 247 (273)
T cd05035 184 IESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---I----YDYLRHGNRLK---------QPEDCLDELYDL 247 (273)
T ss_pred HhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcCCCCC---------CCcCCCHHHHHH
Confidence 999988889999999999999999999 778875432111 1 11111111111 112234578899
Q ss_pred HHHcccCCCCCCCCHHHHHHHhccc
Q 048243 234 ALLCVQENPNDRPSMLQVSSMLKNE 258 (303)
Q Consensus 234 i~~~l~~dp~~Rpt~~el~~~L~~~ 258 (303)
+.+||+.||.+|||+.|+++.|++.
T Consensus 248 i~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 248 MYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHHHcCCChhhCcCHHHHHHHHHhh
Confidence 9999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=280.48 Aligned_cols=231 Identities=21% Similarity=0.271 Sum_probs=179.7
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||||++.... ......+.+|+.++..++||||+++++.+.++...++||||+.+|+|.+++. ....+++
T Consensus 24 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~---~~~~l~~ 100 (364)
T cd05599 24 DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLM---KKDTFTE 100 (364)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHH---HcCCCCH
Confidence 478999999997532 2334567889999999999999999999999999999999999999999984 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccc-------------------
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEA------------------- 141 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~------------------- 141 (303)
..+..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++..+.......
T Consensus 101 ~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (364)
T cd05599 101 EETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISK 177 (364)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccc
Confidence 999999999999999999999 9999999999999999999999999986543211000
Q ss_pred -----------------cccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHH
Q 048243 142 -----------------NTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL 204 (303)
Q Consensus 142 -----------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 204 (303)
......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~------~~~~i 251 (364)
T cd05599 178 PMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQE------TYRKI 251 (364)
T ss_pred cccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHH------HHHHH
Confidence 0012358999999999999899999999999999999999999996443211 11111
Q ss_pred HhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 048243 205 WKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPS---MLQVSSM 254 (303)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt---~~el~~~ 254 (303)
......... ......+..+.++|.+||. +|.+|++ +.|+++.
T Consensus 252 ~~~~~~~~~-------~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 252 INWKETLQF-------PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred HcCCCccCC-------CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 111111110 0011224477899999997 9999998 8888763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=263.88 Aligned_cols=233 Identities=23% Similarity=0.342 Sum_probs=181.4
Q ss_pred CCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 5 CGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+..||+|.+.... ....+.+.+|+.++++++|+||+++++++. ....++||||+++++|.+++.. ....+++..+
T Consensus 21 ~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~ 97 (257)
T cd05115 21 KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSG--KKDEITVSNV 97 (257)
T ss_pred CceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHh--CCCCCCHHHH
Confidence 45679999997553 233467889999999999999999999885 4578999999999999998853 2446899999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-ccccccccccCCCChhhhccCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
+.++.|++.||+|||++| ++||||||+||+++.++.++|+|||.+......... .......++..|+|||.+....
T Consensus 98 ~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 174 (257)
T cd05115 98 VELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174 (257)
T ss_pred HHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCC
Confidence 999999999999999998 999999999999999999999999998755433221 1111122356899999998888
Q ss_pred CCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
++.++||||||+++|++++ |..||....... ........... ..+...+.++.+++.+||..|
T Consensus 175 ~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~l~~li~~c~~~~ 238 (257)
T cd05115 175 FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-------VMSFIEQGKRL---------DCPAECPPEMYALMKDCWIYK 238 (257)
T ss_pred CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCCC---------CCCCCCCHHHHHHHHHHcCCC
Confidence 9999999999999999996 999986443211 11111111111 111223457889999999999
Q ss_pred CCCCCCHHHHHHHhcccc
Q 048243 242 PNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 242 p~~Rpt~~el~~~L~~~~ 259 (303)
|++||++.++.+.|+...
T Consensus 239 ~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 239 WEDRPNFAKVEERMRTYY 256 (257)
T ss_pred hhhCcCHHHHHHHHhhhc
Confidence 999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=277.49 Aligned_cols=241 Identities=21% Similarity=0.296 Sum_probs=182.6
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-C-----CccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccc
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-H-----VNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 76 (303)
.++++.||||+++... .-..+...|+.+|..++ | -|+|+++++|...++.|||+|.+ +.+|.+++... .-.
T Consensus 208 ~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n-~f~ 284 (586)
T KOG0667|consen 208 HKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNN-KFR 284 (586)
T ss_pred cCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh-hhhHHHHHHhc-CCC
Confidence 4689999999997654 33456778999999996 3 38999999999999999999998 57999999764 344
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCC--ceEEcccccccccccCCccccccccccccCCCC
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM--KPKISDFGLARIFAKESLEANTEQVVGTIGYIP 154 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~--~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~a 154 (303)
.++...++.++.||+.||.+||+.+ |+|+||||+|||+..-+ .|||+|||.+........ ....+..|+|
T Consensus 285 Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy-----tYiQSRfYRA 356 (586)
T KOG0667|consen 285 GLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY-----TYIQSRFYRA 356 (586)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccccCCcce-----eeeecccccc
Confidence 5999999999999999999999999 99999999999997543 599999999876544322 2345789999
Q ss_pred hhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHH---------------HHhC-CCccee-----
Q 048243 155 PEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE---------------LWKG-GKGVEF----- 213 (303)
Q Consensus 155 PE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------~~~~-~~~~~~----- 213 (303)
||++.+.+|+.+.||||||||+.||++|.+.|.+.+..+....+..... .+.. ......
T Consensus 357 PEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~ 436 (586)
T KOG0667|consen 357 PEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETS 436 (586)
T ss_pred chhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeec
Confidence 9999999999999999999999999999988876554443322221110 0111 000000
Q ss_pred ------------------cc---c----cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 214 ------------------VD---S----SLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 214 ------------------~~---~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
.. + .+...........+.+|+++||.+||.+|+|+.+.+..
T Consensus 437 ~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 437 APRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNH 502 (586)
T ss_pred ccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00 0 00000111344578999999999999999999999874
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=272.70 Aligned_cols=228 Identities=24% Similarity=0.321 Sum_probs=190.3
Q ss_pred CCCcEEEEEEecCCCcc---cHHHHHHHHHHHhcCC-CCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTSTQ---GFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~---~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+|+.+|+|.+.+.... ..+.+.+|+.+|+++. ||||+.+++.|++....++|||+|.||.|.+.+... .++
T Consensus 58 ~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~----~~s 133 (382)
T KOG0032|consen 58 STGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK----HYS 133 (382)
T ss_pred CCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc----cCC
Confidence 45999999999766433 4468999999999997 999999999999999999999999999999999654 399
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCC----CceEEcccccccccccCCccccccccccccCCCCh
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED----MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~----~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aP 155 (303)
+..+..++.|++.+++|||+.| ++|||+||+|+|+... +.++++|||++..... .......+||+.|+||
T Consensus 134 E~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~AP 207 (382)
T KOG0032|consen 134 ERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAP 207 (382)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC---CceEeeecCCccccCc
Confidence 9999999999999999999999 9999999999999643 4799999999987665 3445668899999999
Q ss_pred hhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHH
Q 048243 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
|++...+++..+||||+|+++|.|+.|.+||.......... ....+. ..+....-+..+..+.+++.
T Consensus 208 Evl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~~-------~~f~~~~w~~is~~akd~i~ 274 (382)
T KOG0032|consen 208 EVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRGD-------FDFTSEPWDDISESAKDFIR 274 (382)
T ss_pred hhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcCC-------CCCCCCCccccCHHHHHHHH
Confidence 99999999999999999999999999999996544322111 111111 12223333445678899999
Q ss_pred HcccCCCCCCCCHHHHHHH
Q 048243 236 LCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 236 ~~l~~dp~~Rpt~~el~~~ 254 (303)
+||..||.+|+|+.++++.
T Consensus 275 ~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 275 KLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HhcccCcccCCCHHHHhcC
Confidence 9999999999999999984
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=261.54 Aligned_cols=229 Identities=30% Similarity=0.395 Sum_probs=182.5
Q ss_pred EEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHH
Q 048243 8 VIAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86 (303)
Q Consensus 8 ~valK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~ 86 (303)
.||+|.+..... ...+.+.+|+..+++++|+||+++++.+.. ...++||||+++++|.+++..... ..+++..++.+
T Consensus 25 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~ 102 (257)
T cd05040 25 PVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDAL-GHFLISTLCDY 102 (257)
T ss_pred EEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhccc-ccCcHHHHHHH
Confidence 699999977655 556789999999999999999999999988 889999999999999999865322 46899999999
Q ss_pred HHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-ccccccccccCCCChhhhccCCCCC
Q 048243 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPPEYARQGVYST 165 (303)
Q Consensus 87 ~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~ 165 (303)
+.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++......... .......++..|+|||.+.+..++.
T Consensus 103 ~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~ 179 (257)
T cd05040 103 AVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSH 179 (257)
T ss_pred HHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCc
Confidence 999999999999998 999999999999999999999999998876543221 1112244677899999999888999
Q ss_pred ccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCC
Q 048243 166 KSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPND 244 (303)
Q Consensus 166 ~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 244 (303)
++||||||+++|+|++ |..||....... ..... ....... ..+...+..+.+++.+||..+|++
T Consensus 180 ~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~---~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~ 244 (257)
T cd05040 180 ASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKKI---DKEGERL---------ERPEACPQDIYNVMLQCWAHNPAD 244 (257)
T ss_pred hhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---HhcCCcC---------CCCccCCHHHHHHHHHHCCCCccc
Confidence 9999999999999998 999985332211 11111 1100000 011123457889999999999999
Q ss_pred CCCHHHHHHHhc
Q 048243 245 RPSMLQVSSMLK 256 (303)
Q Consensus 245 Rpt~~el~~~L~ 256 (303)
|||+.++++.|.
T Consensus 245 Rps~~~~~~~l~ 256 (257)
T cd05040 245 RPTFAALREFLP 256 (257)
T ss_pred CCCHHHHHHHhc
Confidence 999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=280.65 Aligned_cols=231 Identities=21% Similarity=0.267 Sum_probs=177.3
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+....|+||||+++|+|.+++. ....+++
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~~~~ 100 (377)
T cd05629 24 DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI---KYDTFSE 100 (377)
T ss_pred CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHH---hcCCCCH
Confidence 578999999986432 2334578889999999999999999999999999999999999999999884 3456889
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc------------c-------
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE------------A------- 141 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~------------~------- 141 (303)
..+..++.|++.||+|||+.| |+||||||+||+++.++.++|+|||+++.+...... .
T Consensus 101 ~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (377)
T cd05629 101 DVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177 (377)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccccccccccccccccccccccccccc
Confidence 999999999999999999999 999999999999999999999999998643211000 0
Q ss_pred --------------------------cccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccc
Q 048243 142 --------------------------NTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL 195 (303)
Q Consensus 142 --------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~ 195 (303)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-- 255 (377)
T cd05629 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHE-- 255 (377)
T ss_pred ccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHH--
Confidence 0001358999999999998899999999999999999999999995433211
Q ss_pred cHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCC---CCHHHHHHH
Q 048243 196 SILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDR---PSMLQVSSM 254 (303)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R---pt~~el~~~ 254 (303)
... ..........+. .....+.++.++|.+||. +|.+| +++.|+++.
T Consensus 256 -~~~---~i~~~~~~~~~p-------~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 256 -TYR---KIINWRETLYFP-------DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred -HHH---HHHccCCccCCC-------CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 111 111111111110 011123478899999998 77765 599998774
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=277.63 Aligned_cols=237 Identities=21% Similarity=0.206 Sum_probs=180.3
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHH
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~ 84 (303)
.++.||+|.+... ....+|+.+++.++||||+++++++......|++||++. ++|.+++ .....+++..++
T Consensus 118 ~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l---~~~~~l~~~~~~ 188 (392)
T PHA03207 118 QRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYV---DRSGPLPLEQAI 188 (392)
T ss_pred cceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHH---HhcCCCCHHHHH
Confidence 4678999988643 234679999999999999999999999999999999985 5787777 234568999999
Q ss_pred HHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCC
Q 048243 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYS 164 (303)
Q Consensus 85 ~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 164 (303)
.++.||+.||+|||+.| |+||||||+|||++.++.++|+|||++................|+..|+|||++.+..++
T Consensus 189 ~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 265 (392)
T PHA03207 189 TIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYC 265 (392)
T ss_pred HHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCC
Confidence 99999999999999999 999999999999999999999999998766544333333345789999999999998999
Q ss_pred CccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceec--------------cccCCC--CCC-----
Q 048243 165 TKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV--------------DSSLDD--TNS----- 223 (303)
Q Consensus 165 ~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~--~~~----- 223 (303)
.++|||||||++|+|++|..||...........+............ .+. ...... ..+
T Consensus 266 ~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (392)
T PHA03207 266 AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPL-EFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRK 344 (392)
T ss_pred chhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcc-ccCCccchhHHHHHHhhcccccCCccccchhhc
Confidence 9999999999999999999998665443322222221111110000 000 000000 000
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 224 PCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 224 ~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
......+.++|.+||..||++|||+.|++..
T Consensus 345 ~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 345 YGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0123467899999999999999999999875
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=278.16 Aligned_cols=230 Identities=20% Similarity=0.240 Sum_probs=179.8
Q ss_pred CCCcEEEEEEecCC---CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|.+... .......+.+|+.+++.++||||+++++++.+....++||||+++|+|.+++. ...+++
T Consensus 66 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~----~~~l~~ 141 (370)
T cd05596 66 SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMS----NYDIPE 141 (370)
T ss_pred CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHH----hcCCCH
Confidence 47889999999643 22334557789999999999999999999999999999999999999999883 335888
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..+..++.||+.||+|||+.| |+||||||+|||++.++.++|+|||.+........ .......|++.|+|||++.+
T Consensus 142 ~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~ 217 (370)
T cd05596 142 KWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKS 217 (370)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc-ccCCCCCCCcCeECHHHhcc
Confidence 899999999999999999999 99999999999999999999999999876543221 11233568999999999865
Q ss_pred C----CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 161 G----VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 161 ~----~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
. .++.++|||||||++|+|++|..||....... ............. .......+..+.++|.+
T Consensus 218 ~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~~~~~-------~~~~~~~s~~~~~li~~ 284 (370)
T cd05596 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMDHKNSLT-------FPDDIEISKQAKDLICA 284 (370)
T ss_pred CCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH------HHHHHHcCCCcCC-------CCCcCCCCHHHHHHHHH
Confidence 4 37889999999999999999999996433211 1111111111111 11111234578899999
Q ss_pred cccCCCCC--CCCHHHHHHH
Q 048243 237 CVQENPND--RPSMLQVSSM 254 (303)
Q Consensus 237 ~l~~dp~~--Rpt~~el~~~ 254 (303)
||..+|.+ |+|+.|+++.
T Consensus 285 ~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 285 FLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HccChhhccCCCCHHHHhcC
Confidence 99999988 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=270.93 Aligned_cols=236 Identities=27% Similarity=0.386 Sum_probs=184.5
Q ss_pred CCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccc--------
Q 048243 5 CGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR-------- 74 (303)
Q Consensus 5 ~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------- 74 (303)
.+..||+|.+.... ......+.+|+.+++.+ +||||+++++++......+++|||+.+++|.+++.....
T Consensus 46 ~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 125 (304)
T cd05101 46 EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125 (304)
T ss_pred cceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccc
Confidence 34579999987542 34456788999999999 899999999999999999999999999999999864211
Q ss_pred -----cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccc
Q 048243 75 -----RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGT 149 (303)
Q Consensus 75 -----~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~ 149 (303)
...+++..++.++.||+.||+|||+.| ++||||||+||+++.++.++|+|||.+................++
T Consensus 126 ~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~ 202 (304)
T cd05101 126 IARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLP 202 (304)
T ss_pred cccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCC
Confidence 235788889999999999999999999 999999999999999999999999998776543322222223456
Q ss_pred cCCCChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHH
Q 048243 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLM 228 (303)
Q Consensus 150 ~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
..|+|||.+.+..++.++||||||+++|++++ |..||....... ........... ..+...+.
T Consensus 203 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~ 266 (304)
T cd05101 203 VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-------LFKLLKEGHRM---------DKPANCTN 266 (304)
T ss_pred ceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHcCCcC---------CCCCCCCH
Confidence 78999999988889999999999999999998 677764332111 11111111111 01112345
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHhcccc
Q 048243 229 RCLEIALLCVQENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 229 ~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~ 259 (303)
.+.+++.+||+.+|.+|||+.|+++.|++..
T Consensus 267 ~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 267 ELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred HHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 7889999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=262.84 Aligned_cols=230 Identities=23% Similarity=0.293 Sum_probs=181.0
Q ss_pred CCCcEEEEEEecCCCc-----ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccC
Q 048243 4 PCGKVIAVKKLSKTST-----QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 4 ~~~~~valK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
.+|+.||+|.+..... ...+.+.+|+.++++++||||+++++++......++|+||+++++|.+++. ....+
T Consensus 25 ~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~---~~~~~ 101 (263)
T cd06625 25 DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLK---AYGAL 101 (263)
T ss_pred CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHH---HhCCC
Confidence 5789999999864421 123568889999999999999999999999999999999999999998884 34568
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcccc-ccccccccCCCChhh
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEAN-TEQVVGTIGYIPPEY 157 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~-~~~~~g~~~y~aPE~ 157 (303)
++..+..++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||.+........... .....|+..|+|||.
T Consensus 102 ~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 178 (263)
T cd06625 102 TETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEV 178 (263)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcce
Confidence 88999999999999999999999 99999999999999999999999999875533211111 123457789999999
Q ss_pred hccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHc
Q 048243 158 ARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237 (303)
Q Consensus 158 ~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 237 (303)
+.+..++.++||||||+++|++++|..||...... ........... ....+...+..+.+++.+|
T Consensus 179 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~ 243 (263)
T cd06625 179 ISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQPT---------NPQLPSHVSPDARNFLRRT 243 (263)
T ss_pred eccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------HHHHHHhccCC---------CCCCCccCCHHHHHHHHHH
Confidence 99888999999999999999999999998533211 11111111110 0111122344788999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 048243 238 VQENPNDRPSMLQVSSM 254 (303)
Q Consensus 238 l~~dp~~Rpt~~el~~~ 254 (303)
|..+|.+|||+.++++.
T Consensus 244 l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 244 FVENAKKRPSAEELLRH 260 (263)
T ss_pred hhcCcccCCCHHHHhhC
Confidence 99999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=279.62 Aligned_cols=234 Identities=29% Similarity=0.391 Sum_probs=186.9
Q ss_pred EEEEEecCC---CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHH
Q 048243 9 IAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVH 85 (303)
Q Consensus 9 valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~ 85 (303)
||+|..+.. ......++++|+++|++++||||+++||+....+.+++|||+|.||+|.++|.. ....++..+...
T Consensus 189 VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k--~~~~v~~~ek~~ 266 (474)
T KOG0194|consen 189 VAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKK--NKKSLPTLEKLR 266 (474)
T ss_pred eEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHh--CCCCCCHHHHHH
Confidence 899999853 356678899999999999999999999999999999999999999999999964 223699999999
Q ss_pred HHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCCC
Q 048243 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYST 165 (303)
Q Consensus 86 ~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 165 (303)
++.+.+.||+|||+++ ++||||-..|+|++.++.+||+|||+++.-.. .........-+.+|+|||.+....++.
T Consensus 267 ~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~ 341 (474)
T KOG0194|consen 267 FCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSF 341 (474)
T ss_pred HHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCcc--eeeccccccCcceecChhhhccCcccc
Confidence 9999999999999999 99999999999999999999999999865331 111111123467999999999999999
Q ss_pred ccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCC
Q 048243 166 KSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPND 244 (303)
Q Consensus 166 ~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 244 (303)
++|||||||++||+++ |..|+......... ......+ .+...+...+..+..++.+||..||++
T Consensus 342 kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~------~kI~~~~---------~r~~~~~~~p~~~~~~~~~c~~~~p~~ 406 (474)
T KOG0194|consen 342 KTDVWSFGVLLWEIFENGAEPYPGMKNYEVK------AKIVKNG---------YRMPIPSKTPKELAKVMKQCWKKDPED 406 (474)
T ss_pred ccchhheeeeEEeeeccCCCCCCCCCHHHHH------HHHHhcC---------ccCCCCCCCHHHHHHHHHHhccCChhh
Confidence 9999999999999998 77787544432111 1111111 111222234457778999999999999
Q ss_pred CCCHHHHHHHhccccCCCCC
Q 048243 245 RPSMLQVSSMLKNETTNRNT 264 (303)
Q Consensus 245 Rpt~~el~~~L~~~~~~~~~ 264 (303)
|||+.++.+.|+........
T Consensus 407 R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 407 RPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ccCHHHHHHHHHHHHhcccc
Confidence 99999999998877655443
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=260.41 Aligned_cols=238 Identities=22% Similarity=0.306 Sum_probs=188.1
Q ss_pred CCCcEEEEEEecCC---CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc-ccccCC
Q 048243 4 PCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-RRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~l~ 79 (303)
.+|+.||+|.++.. .....+.+.+|++++++++|+||+++++.+..+...++||||+++++|..++.... ....++
T Consensus 25 ~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 104 (267)
T cd08224 25 LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIP 104 (267)
T ss_pred CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcC
Confidence 37899999988643 23345678899999999999999999999999999999999999999998885422 245588
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..++.++.+++.||+|||+.| ++||||+|+||+++.++.++|+|||.+......... .....++..|.|||.+.
T Consensus 105 ~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~ 179 (267)
T cd08224 105 ERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIH 179 (267)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCCCcc--cceecCCccccCHHHhc
Confidence 9999999999999999999999 999999999999999999999999998765433211 22245788899999998
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++|+||||+++|+|++|..||...... .............. .......+..+.+++.+||.
T Consensus 180 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~i~~cl~ 246 (267)
T cd08224 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYSLCKKIEKCDYP--------PLPADHYSEELRDLVSRCIN 246 (267)
T ss_pred cCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-----HHHHHhhhhcCCCC--------CCChhhcCHHHHHHHHHHcC
Confidence 888999999999999999999999998543311 01111111111110 11112344578899999999
Q ss_pred CCCCCCCCHHHHHHHhcccc
Q 048243 240 ENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 240 ~dp~~Rpt~~el~~~L~~~~ 259 (303)
.+|++|||+.+|++.|++..
T Consensus 247 ~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 247 PDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCcccCCCHHHHHHHHHHhc
Confidence 99999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=263.26 Aligned_cols=231 Identities=29% Similarity=0.429 Sum_probs=181.1
Q ss_pred CcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHH
Q 048243 6 GKVIAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 6 ~~~valK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~ 84 (303)
+..+|+|.+..... ...+.+.+|+.+++.++|+||+++++++. ....++||||+.+++|.+++.. ...+++..++
T Consensus 23 ~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~ 98 (257)
T cd05060 23 EVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKK---RREIPVSDLK 98 (257)
T ss_pred cceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHh---CCCCCHHHHH
Confidence 47899999975543 34567889999999999999999999876 4567999999999999999853 3468999999
Q ss_pred HHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccc-cccccccccCCCChhhhccCCC
Q 048243 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEA-NTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 85 ~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
.++.|++.||+|||..+ ++|+||||+||+++.++.++|+|||.+.......... ......++..|+|||.+.+..+
T Consensus 99 ~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 175 (257)
T cd05060 99 ELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175 (257)
T ss_pred HHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCC
Confidence 99999999999999998 9999999999999999999999999987664332211 1111223467999999988889
Q ss_pred CCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC
Q 048243 164 STKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 242 (303)
+.++||||||+++|++++ |..||....... ........... ..+...+..+.+++.+||..+|
T Consensus 176 ~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p 239 (257)
T cd05060 176 SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE-------VIAMLESGERL---------PRPEECPQEIYSIMLSCWKYRP 239 (257)
T ss_pred CccchHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHhcCCh
Confidence 999999999999999998 899885432211 11111111111 1111223478899999999999
Q ss_pred CCCCCHHHHHHHhcccc
Q 048243 243 NDRPSMLQVSSMLKNET 259 (303)
Q Consensus 243 ~~Rpt~~el~~~L~~~~ 259 (303)
.+||++.++++.|++..
T Consensus 240 ~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 240 EDRPTFSELESTFRRDP 256 (257)
T ss_pred hhCcCHHHHHHHHHhcc
Confidence 99999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=268.75 Aligned_cols=236 Identities=27% Similarity=0.413 Sum_probs=184.2
Q ss_pred CCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc----------
Q 048243 5 CGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI---------- 73 (303)
Q Consensus 5 ~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------- 73 (303)
+...+++|.+.... ......+.+|+.+++.++||||+++++.+......++++||+.+++|.+++....
T Consensus 29 ~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 108 (290)
T cd05045 29 GYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSD 108 (290)
T ss_pred cceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccc
Confidence 44679999886543 2334678899999999999999999999999999999999999999999875321
Q ss_pred -----------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcccc
Q 048243 74 -----------RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEAN 142 (303)
Q Consensus 74 -----------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~ 142 (303)
....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||.+...........
T Consensus 109 ~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~ 185 (290)
T cd05045 109 GNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK 185 (290)
T ss_pred cccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEEEcCCCcEEeccccccccccCccchhc
Confidence 1235788999999999999999999998 99999999999999999999999999876533322212
Q ss_pred ccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCC
Q 048243 143 TEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDT 221 (303)
Q Consensus 143 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (303)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .......... ..
T Consensus 186 ~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~---------~~ 249 (290)
T cd05045 186 RSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER-------LFNLLKTGYR---------ME 249 (290)
T ss_pred ccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhCCCC---------CC
Confidence 222345678999999988889999999999999999998 888885432111 1111111110 11
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcccc
Q 048243 222 NSPCKLMRCLEIALLCVQENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 222 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~ 259 (303)
.+...+..+.+++.+||+.+|.+||++.|+++.|++..
T Consensus 250 ~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 250 RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 11223357889999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=263.21 Aligned_cols=232 Identities=29% Similarity=0.446 Sum_probs=181.8
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||+.+++|.+++... ....+++..
T Consensus 27 ~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~ 103 (260)
T cd05070 27 WNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDG-EGRALKLPN 103 (260)
T ss_pred ecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhc-CCCCCCHHH
Confidence 46678899999976443 3467899999999999999999999885 45689999999999999988542 234588999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+......... ......++..|+|||.+.+..
T Consensus 104 ~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~ 179 (260)
T cd05070 104 LVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR 179 (260)
T ss_pred HHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-cccCCCCCccccChHHHhcCC
Confidence 9999999999999999999 999999999999999999999999998765433211 111223456799999998888
Q ss_pred CCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
++.++||||||+++|+|++ |..||....... ........... ..+...+..+.+++.+||..+
T Consensus 180 ~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~ 243 (260)
T cd05070 180 FTIKSDVWSFGILLTELVTKGRVPYPGMNNRE-------VLEQVERGYRM---------PCPQDCPISLHELMLQCWKKD 243 (260)
T ss_pred CcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCC---------CCCCcCCHHHHHHHHHHcccC
Confidence 9999999999999999999 888885432111 11111111111 111223457889999999999
Q ss_pred CCCCCCHHHHHHHhcc
Q 048243 242 PNDRPSMLQVSSMLKN 257 (303)
Q Consensus 242 p~~Rpt~~el~~~L~~ 257 (303)
|.+|||+.++.++|++
T Consensus 244 p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 244 PEERPTFEYLQSFLED 259 (260)
T ss_pred cccCcCHHHHHHHHhc
Confidence 9999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=268.25 Aligned_cols=234 Identities=29% Similarity=0.473 Sum_probs=182.4
Q ss_pred CCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc----------
Q 048243 5 CGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI---------- 73 (303)
Q Consensus 5 ~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------- 73 (303)
+++.||+|.+.... ......+.+|+.+++.++||||+++++++......+++|||+.+++|.+++....
T Consensus 34 ~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 113 (288)
T cd05050 34 PFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHS 113 (288)
T ss_pred cceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCcccccccccc
Confidence 57889999987553 3334678899999999999999999999999999999999999999999986321
Q ss_pred ---------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcccccc
Q 048243 74 ---------RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTE 144 (303)
Q Consensus 74 ---------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~ 144 (303)
....+++..++.++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||.+.............
T Consensus 114 ~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 190 (288)
T cd05050 114 TSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASE 190 (288)
T ss_pred ccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhheEecCCCceEECccccceecccCccccccC
Confidence 1134778889999999999999999998 9999999999999999999999999987654332222222
Q ss_pred ccccccCCCChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCC
Q 048243 145 QVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNS 223 (303)
Q Consensus 145 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
...++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ............ .+
T Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~-------~~~~~~~~~~~~---------~~ 254 (288)
T cd05050 191 NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE-------VIYYVRDGNVLS---------CP 254 (288)
T ss_pred CCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhcCCCCC---------CC
Confidence 2344667999999988889999999999999999997 777774322111 111111111110 01
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 048243 224 PCKLMRCLEIALLCVQENPNDRPSMLQVSSMLKN 257 (303)
Q Consensus 224 ~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~ 257 (303)
...+..+.+++.+||+.||.+|||+.|+++.|++
T Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 255 DNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1223578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=266.61 Aligned_cols=233 Identities=29% Similarity=0.437 Sum_probs=180.5
Q ss_pred CCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccc----cccCC
Q 048243 5 CGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR----RLILD 79 (303)
Q Consensus 5 ~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~l~ 79 (303)
++..||+|.+.... ......+.+|+.+++.++|+||+++++++......++||||+.+++|.+++..... ...++
T Consensus 35 ~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~ 114 (277)
T cd05036 35 VELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLT 114 (277)
T ss_pred CceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCC
Confidence 56789999886543 33345688999999999999999999999988899999999999999998854221 23588
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCC---ceEEcccccccccccCCccccccccccccCCCChh
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM---KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE 156 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~---~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE 156 (303)
+..++.++.||+.||+|||+.+ ++|+||||+||+++.++ .++|+|||+++...............++..|+|||
T Consensus 115 ~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 191 (277)
T cd05036 115 MKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPE 191 (277)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHH
Confidence 9999999999999999999998 99999999999998764 59999999987653332222122223456899999
Q ss_pred hhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHH
Q 048243 157 YARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
.+.+..++.++|||||||++|+|++ |..||....... ............ .+...+..+.+++.
T Consensus 192 ~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~~~~~i~ 255 (277)
T cd05036 192 AFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-------VMEFVTGGGRLD---------PPKGCPGPVYRIMT 255 (277)
T ss_pred HHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHcCCcCC---------CCCCCCHHHHHHHH
Confidence 9998889999999999999999997 888886432211 111111111111 11122357889999
Q ss_pred HcccCCCCCCCCHHHHHHHhc
Q 048243 236 LCVQENPNDRPSMLQVSSMLK 256 (303)
Q Consensus 236 ~~l~~dp~~Rpt~~el~~~L~ 256 (303)
+||+.+|++|||+.++++.|+
T Consensus 256 ~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 256 DCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHcCCCcccCcCHHHHHHHhh
Confidence 999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=265.62 Aligned_cols=239 Identities=24% Similarity=0.427 Sum_probs=180.6
Q ss_pred cEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc---------ccc
Q 048243 7 KVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI---------RRL 76 (303)
Q Consensus 7 ~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~ 76 (303)
..||+|.++.. .......+.+|++++++++|+||+++++++......++||||+.+++|.+++.... ...
T Consensus 45 ~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 124 (295)
T cd05097 45 VLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124 (295)
T ss_pred eEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCC
Confidence 35899999754 33345678899999999999999999999999999999999999999999885321 112
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChh
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE 156 (303)
.+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++................++..|+|||
T Consensus 125 ~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 201 (295)
T cd05097 125 SVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWE 201 (295)
T ss_pred cccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChh
Confidence 4678899999999999999999999 9999999999999999999999999987654332222223344567899999
Q ss_pred hhccCCCCCccchhhHHHHHHHHHh--CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHH
Q 048243 157 YARQGVYSTKSDVFSFGVLLLQIIS--GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIA 234 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~~~~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
.+.+..++.++||||||+++|+|++ +..||....... ........+........ ....+..+..+.+|+
T Consensus 202 ~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li 272 (295)
T cd05097 202 SILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ---VIENTGEFFRNQGRQIY------LSQTPLCPSPVFKLM 272 (295)
T ss_pred hhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH---HHHHHHHhhhhcccccc------CCCCCCCCHHHHHHH
Confidence 9988889999999999999999998 455654332211 11111111111100000 011112335788999
Q ss_pred HHcccCCCCCCCCHHHHHHHhcc
Q 048243 235 LLCVQENPNDRPSMLQVSSMLKN 257 (303)
Q Consensus 235 ~~~l~~dp~~Rpt~~el~~~L~~ 257 (303)
.+||..||.+|||+.++++.|+.
T Consensus 273 ~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 273 MRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHcCCCchhCcCHHHHHHHHhC
Confidence 99999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=276.70 Aligned_cols=232 Identities=21% Similarity=0.270 Sum_probs=176.6
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|+++... ......+..|+.++..++|+||+++++.+.+....|+||||+++|+|.+++. ....+++
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~l~~ 100 (363)
T cd05628 24 DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM---KKDTLTE 100 (363)
T ss_pred CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHH---hcCCCCH
Confidence 468999999996542 2234567889999999999999999999999999999999999999999984 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc--------------------
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-------------------- 140 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-------------------- 140 (303)
..+..++.|++.||+|||+.| |+||||||+|||++.++.++|+|||++.........
T Consensus 101 ~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (363)
T cd05628 101 EETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177 (363)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccc
Confidence 999999999999999999999 999999999999999999999999998754321100
Q ss_pred -------------ccccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhC
Q 048243 141 -------------ANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKG 207 (303)
Q Consensus 141 -------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 207 (303)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~------~~i~~~ 251 (363)
T cd05628 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETY------KKVMNW 251 (363)
T ss_pred cccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHH------HHHHcC
Confidence 0011346899999999999999999999999999999999999999643321111 111111
Q ss_pred CCcceeccccCCCCCCHHHHHHHHHHHHHccc--CCCCCCCCHHHHHHH
Q 048243 208 GKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ--ENPNDRPSMLQVSSM 254 (303)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~--~dp~~Rpt~~el~~~ 254 (303)
.....+ .+ ....+..+.+++.+++. .++..||+++|+++.
T Consensus 252 ~~~~~~-p~------~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 252 KETLIF-PP------EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred cCcccC-CC------cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 000000 00 01123467788888654 233456899999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=277.36 Aligned_cols=243 Identities=25% Similarity=0.400 Sum_probs=198.8
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
+++..||+|+++... +..+..|.+||.+|.+++||||+.++++|..++.+|+|+|||++|+|.+|+....... +....
T Consensus 560 eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt-~~t~~ 638 (807)
T KOG1094|consen 560 EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPT-AETAP 638 (807)
T ss_pred cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcc-cccch
Confidence 456899999998775 4456899999999999999999999999999999999999999999999996543222 44556
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
..+++.||+.|++||.+.+ +|||||.+.|+|+++++++||+|||+++-+..+.....+...+-+.+|+|+|.+....
T Consensus 639 ~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgk 715 (807)
T KOG1094|consen 639 GVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGK 715 (807)
T ss_pred hHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhcc
Confidence 6779999999999999998 9999999999999999999999999999888888888888888899999999999999
Q ss_pred CCCccchhhHHHHHHHHHh--CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 163 YSTKSDVFSFGVLLLQIIS--GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
+++++|+|+||+++||+++ ...||....... ..+.....+.+... ......++..+..+++++.+||..
T Consensus 716 FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~------~~~l~~P~~cp~~lyelml~Cw~~ 786 (807)
T KOG1094|consen 716 FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGR------QVVLSRPPACPQGLYELMLRCWRR 786 (807)
T ss_pred ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCc------ceeccCCCcCcHHHHHHHHHHhch
Confidence 9999999999999999876 566764332211 11222222222211 122334445566888999999999
Q ss_pred CCCCCCCHHHHHHHhcccc
Q 048243 241 NPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 241 dp~~Rpt~~el~~~L~~~~ 259 (303)
|-.+||+++++...|+...
T Consensus 787 es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 787 ESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred hhhcCCCHHHHHHHHHHhc
Confidence 9999999999998887654
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=262.32 Aligned_cols=229 Identities=21% Similarity=0.303 Sum_probs=179.2
Q ss_pred CCCcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+++.||+|.+... .....+.+.+|+.++++++||||+++++++......++||||+++++|..+. .+++..
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-------~~~~~~ 96 (279)
T cd06619 24 LTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR-------KIPEHV 96 (279)
T ss_pred CCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh-------cCCHHH
Confidence 57899999998654 2334457889999999999999999999999999999999999999986542 367888
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....... .....|+..|+|||.+.+..
T Consensus 97 ~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~ 169 (279)
T cd06619 97 LGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----AKTYVGTNAYMAPERISGEQ 169 (279)
T ss_pred HHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----ccCCCCChhhcCceeecCCC
Confidence 9999999999999999999 9999999999999999999999999987654321 22346889999999999888
Q ss_pred CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC
Q 048243 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 242 (303)
++.++|+||||+++|+|++|..||.......................... . .....+..+.+++.+||+.||
T Consensus 170 ~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~---~~~~~~~~~~~li~~~l~~~P 241 (279)
T cd06619 170 YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV-----L---PVGQFSEKFVHFITQCMRKQP 241 (279)
T ss_pred CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC-----C---CCCcCCHHHHHHHHHHhhCCh
Confidence 99999999999999999999999864332221111111111111111000 0 111233478899999999999
Q ss_pred CCCCCHHHHHHH
Q 048243 243 NDRPSMLQVSSM 254 (303)
Q Consensus 243 ~~Rpt~~el~~~ 254 (303)
++||+++|+++.
T Consensus 242 ~~Rp~~~eil~~ 253 (279)
T cd06619 242 KERPAPENLMDH 253 (279)
T ss_pred hhCCCHHHHhcC
Confidence 999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=272.15 Aligned_cols=225 Identities=22% Similarity=0.261 Sum_probs=176.4
Q ss_pred CCCcEEEEEEecCC---CcccHHHHHHHHHHHhcCCCC-ccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHV-NLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+++.||+|++... .....+.+..|+.++..++|+ +|+.+++++...+..|+||||+++|+|..++. ....++
T Consensus 23 ~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~---~~~~~~ 99 (324)
T cd05587 23 GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ---QVGKFK 99 (324)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHH---HcCCCC
Confidence 46789999999754 233456778899999999654 68889999999999999999999999998884 345688
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..+..++.||+.||+|||+.| ++||||||+|||++.++.++|+|||++....... .......|+..|+|||++.
T Consensus 100 ~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~ 174 (324)
T cd05587 100 EPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG--KTTRTFCGTPDYIAPEIIA 174 (324)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCC--CceeeecCCccccChhhhc
Confidence 9999999999999999999999 9999999999999999999999999986432221 1223356899999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++||||+||++|+|++|..||....... ... ...... ...+...+..+.+++.+||.
T Consensus 175 ~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~---~i~~~~-----------~~~~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQ---SIMEHN-----------VSYPKSLSKEAVSICKGLLT 237 (324)
T ss_pred CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHH---HHHcCC-----------CCCCCCCCHHHHHHHHHHhh
Confidence 9899999999999999999999999986432111 111 111110 01111234478899999999
Q ss_pred CCCCCCCCH-----HHHHH
Q 048243 240 ENPNDRPSM-----LQVSS 253 (303)
Q Consensus 240 ~dp~~Rpt~-----~el~~ 253 (303)
.||.+|+++ .++++
T Consensus 238 ~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 238 KHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred cCHHHcCCCCCCCHHHHhc
Confidence 999999986 56654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=273.80 Aligned_cols=223 Identities=21% Similarity=0.237 Sum_probs=172.8
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHH-HHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEV-MLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+++.||+|++.... ......+..|. .+++.++|+||+++++++......++||||+.+++|..++. ....+.
T Consensus 18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~ 94 (325)
T cd05602 18 AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ---RERCFL 94 (325)
T ss_pred CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHH---hcCCCC
Confidence 467899999996542 12223344444 45677899999999999999999999999999999998884 345578
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..+..++.||+.||+|||+.| ++||||||+||+++.++.++|+|||++....... .......|++.|+|||++.
T Consensus 95 ~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~ 169 (325)
T cd05602 95 EPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTSTFCGTPEYLAPEVLH 169 (325)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCcccccCCccccCHHHHc
Confidence 8899999999999999999999 9999999999999999999999999986532211 1223456899999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++|||||||++|+|++|..||........ .. ...... ....+..+..+.+++.+||+
T Consensus 170 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~---~i~~~~-----------~~~~~~~~~~~~~li~~~l~ 232 (325)
T cd05602 170 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YD---NILNKP-----------LQLKPNITNSARHLLEGLLQ 232 (325)
T ss_pred CCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH---HH---HHHhCC-----------cCCCCCCCHHHHHHHHHHcc
Confidence 99999999999999999999999999964332111 11 111110 00111234478899999999
Q ss_pred CCCCCCCCHHHH
Q 048243 240 ENPNDRPSMLQV 251 (303)
Q Consensus 240 ~dp~~Rpt~~el 251 (303)
.||.+||++.+.
T Consensus 233 ~~p~~R~~~~~~ 244 (325)
T cd05602 233 KDRTKRLGAKDD 244 (325)
T ss_pred cCHHHCCCCCCC
Confidence 999999998743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=265.84 Aligned_cols=233 Identities=30% Similarity=0.470 Sum_probs=182.7
Q ss_pred CcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc----ccccCCH
Q 048243 6 GKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI----RRLILDW 80 (303)
Q Consensus 6 ~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~l~~ 80 (303)
++.+|+|.+.... ......+.+|+.+++.++||||+++++++......++||||+++++|.+++.... ....+++
T Consensus 26 ~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 105 (269)
T cd05044 26 PIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTL 105 (269)
T ss_pred ceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccH
Confidence 4689999886543 2345678899999999999999999999999999999999999999999986422 2244788
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCC-----ceEEcccccccccccCCccccccccccccCCCCh
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM-----KPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~-----~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aP 155 (303)
..++.++.|++.||+|||+.+ ++|+||+|+||+++.++ .++|+|||++................++..|+||
T Consensus 106 ~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 182 (269)
T cd05044 106 KELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAP 182 (269)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCH
Confidence 999999999999999999998 99999999999999887 8999999998765433222222233457789999
Q ss_pred hhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHH
Q 048243 156 EYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIA 234 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
|.+.+..++.++||||||+++|+|++ |..||....... .. ........ .......+..+.+++
T Consensus 183 E~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~----~~~~~~~~---------~~~~~~~~~~~~~li 246 (269)
T cd05044 183 ESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VL----QHVTAGGR---------LQKPENCPDKIYQLM 246 (269)
T ss_pred HHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HH----HHHhcCCc---------cCCcccchHHHHHHH
Confidence 99998889999999999999999998 888885332111 11 11111100 011122345788999
Q ss_pred HHcccCCCCCCCCHHHHHHHhcc
Q 048243 235 LLCVQENPNDRPSMLQVSSMLKN 257 (303)
Q Consensus 235 ~~~l~~dp~~Rpt~~el~~~L~~ 257 (303)
.+||..+|.+||++.++++.|++
T Consensus 247 ~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 247 TNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred HHHcCCCcccCCCHHHHHHHHhC
Confidence 99999999999999999998864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=280.48 Aligned_cols=230 Identities=27% Similarity=0.427 Sum_probs=194.6
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccC--CH
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL--DW 80 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l--~~ 80 (303)
.++...+|||.+...+....+-+.+||.+-+.++|.|||+++|.+..++..-+.||-.+||+|.+++.. .++++ ++
T Consensus 597 ~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrs--kWGPlKDNE 674 (1226)
T KOG4279|consen 597 MDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRS--KWGPLKDNE 674 (1226)
T ss_pred ccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHh--ccCCCccch
Confidence 356677999999877766667889999999999999999999999999999999999999999999964 57777 88
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC-CCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
.++-.+..||++||.|||++. |||||||-+|++++. .|.+||+|||-++..... .+..+.+.||..|||||++.
T Consensus 675 stm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TETFTGTLQYMAPEvID 749 (1226)
T KOG4279|consen 675 STMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTETFTGTLQYMAPEVID 749 (1226)
T ss_pred hHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--CccccccccchhhhChHhhc
Confidence 899999999999999999999 999999999999985 688999999999877543 46667789999999999998
Q ss_pred cCC--CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHc
Q 048243 160 QGV--YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237 (303)
Q Consensus 160 ~~~--~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 237 (303)
..+ |..++|||||||++.||.||++||-..+... ...+..+. .......+...+.+...||.+|
T Consensus 750 qG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--------AAMFkVGm------yKvHP~iPeelsaeak~Filrc 815 (1226)
T KOG4279|consen 750 QGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--------AAMFKVGM------YKVHPPIPEELSAEAKNFILRC 815 (1226)
T ss_pred cCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--------Hhhhhhcc------eecCCCCcHHHHHHHHHHHHHH
Confidence 664 8889999999999999999999995433221 22222221 2234555667788999999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 048243 238 VQENPNDRPSMLQVSS 253 (303)
Q Consensus 238 l~~dp~~Rpt~~el~~ 253 (303)
+.+||.+||+|.++++
T Consensus 816 Fepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 816 FEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cCCCcccCccHHHhcc
Confidence 9999999999999986
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=285.15 Aligned_cols=233 Identities=22% Similarity=0.280 Sum_probs=182.9
Q ss_pred cCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCC--------eeEEEEeecCCCChhhhhcCc
Q 048243 3 LPCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE--------ERMLVYEYMPNKSLDCYLFDP 72 (303)
Q Consensus 3 ~~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~ 72 (303)
..+|+.||||.+.... ......+.+|+..+..++|+||+++++.+.... ..++||||+++|+|.+++...
T Consensus 54 ~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~ 133 (496)
T PTZ00283 54 VSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSR 133 (496)
T ss_pred cCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHh
Confidence 3578999999986543 334567889999999999999999988775432 368999999999999988643
Q ss_pred c-ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccC
Q 048243 73 I-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIG 151 (303)
Q Consensus 73 ~-~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~ 151 (303)
. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+++.+.............|++.
T Consensus 134 ~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~ 210 (496)
T PTZ00283 134 AKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210 (496)
T ss_pred hccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcc
Confidence 2 2456899999999999999999999999 99999999999999999999999999876654322223334578999
Q ss_pred CCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHH
Q 048243 152 YIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL 231 (303)
Q Consensus 152 y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
|+|||.+.+..++.++|||||||++|+|++|..||....... ....... .... ..++..+..+.
T Consensus 211 Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~------~~~~~~~-~~~~---------~~~~~~~~~l~ 274 (496)
T PTZ00283 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE------VMHKTLA-GRYD---------PLPPSISPEMQ 274 (496)
T ss_pred eeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHhc-CCCC---------CCCCCCCHHHH
Confidence 999999999999999999999999999999999986432111 1111111 1100 01122345788
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 048243 232 EIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 232 ~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
+++.+||..||.+||++.+++..
T Consensus 275 ~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 275 EIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHHcccChhhCcCHHHHHhC
Confidence 99999999999999999999763
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=261.05 Aligned_cols=237 Identities=21% Similarity=0.294 Sum_probs=186.9
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCc-cccccCC
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDP-IRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~l~ 79 (303)
.+|+.+|||.+.... ......+.+|+.+++.++|+||+++++++..+...+++|||+.+++|.+++... .....++
T Consensus 25 ~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~ 104 (267)
T cd08229 25 LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP 104 (267)
T ss_pred CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCC
Confidence 578999999886532 233457889999999999999999999999999999999999999999887532 2245689
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..++.++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||++........ ......|+..|+|||.+.
T Consensus 105 ~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~ape~~~ 179 (267)
T cd08229 105 EKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIH 179 (267)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccCCc--ccccccCCcCccCHHHhc
Confidence 9999999999999999999999 99999999999999999999999999876543321 112345788999999998
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++|+||||+++|+|++|..||....... . ......... ..........+..+.+++.+||.
T Consensus 180 ~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~----~~~~~~~~~--------~~~~~~~~~~~~~~~~li~~~l~ 246 (267)
T cd08229 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-Y----SLCKKIEQC--------DYPPLPSDHYSEELRQLVNMCIN 246 (267)
T ss_pred CCCccchhhHHHHHHHHHHHHhCCCCcccccchH-H----HHhhhhhcC--------CCCCCCcccccHHHHHHHHHhcC
Confidence 8889999999999999999999999985332110 0 001111110 01111112345578999999999
Q ss_pred CCCCCCCCHHHHHHHhccc
Q 048243 240 ENPNDRPSMLQVSSMLKNE 258 (303)
Q Consensus 240 ~dp~~Rpt~~el~~~L~~~ 258 (303)
.||.+|||+.+|++.+++.
T Consensus 247 ~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 247 PDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCcccCCCHHHHHHHHhhh
Confidence 9999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=259.54 Aligned_cols=229 Identities=25% Similarity=0.319 Sum_probs=184.2
Q ss_pred CCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+|+.|++|.+... .......+.+|+.+++.++||||+++++++......++||||+.+++|.+++... ....+++.
T Consensus 23 ~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~ 101 (256)
T cd08529 23 ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQ-RGRPLPED 101 (256)
T ss_pred CCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHh-cCCCCCHH
Confidence 47899999998643 3345567889999999999999999999999999999999999999999998642 24568899
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
.++.++.+++.||.|||+.| ++|+||+|+||+++.++.++|+|||.+......... .....|+..|+|||++.+.
T Consensus 102 ~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~ 176 (256)
T cd08529 102 QVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF--ANTIVGTPYYLSPELCEDK 176 (256)
T ss_pred HHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccch--hhccccCccccCHHHhcCC
Confidence 99999999999999999998 999999999999999999999999998765443221 2234578899999999998
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
.++.++|+||||+++|+|++|..||....... ....... .... ......+..+.+++.+||+.+
T Consensus 177 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~-~~~~---------~~~~~~~~~~~~~i~~~l~~~ 240 (256)
T cd08529 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQGA------LILKIIR-GVFP---------PVSQMYSQQLAQLIDQCLTKD 240 (256)
T ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHc-CCCC---------CCccccCHHHHHHHHHHccCC
Confidence 89999999999999999999999986443111 1111111 1110 111123457889999999999
Q ss_pred CCCCCCHHHHHHH
Q 048243 242 PNDRPSMLQVSSM 254 (303)
Q Consensus 242 p~~Rpt~~el~~~ 254 (303)
|++||++.++++.
T Consensus 241 p~~Rp~~~~ll~~ 253 (256)
T cd08529 241 YRQRPDTFQLLRN 253 (256)
T ss_pred cccCcCHHHHhhC
Confidence 9999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=260.52 Aligned_cols=233 Identities=31% Similarity=0.474 Sum_probs=184.1
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.++++.||+|.+.... ...+.+.+|+.++++++|+||+++++++......++||||+++++|.+++... ....+++..
T Consensus 27 ~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~-~~~~~~~~~ 104 (261)
T cd05034 27 WNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSG-EGKKLRLPQ 104 (261)
T ss_pred EcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhcc-ccCCCCHHH
Confidence 4567889999997543 34577899999999999999999999999888999999999999999998542 234689999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
+..++.+++.|++|||+++ ++|+||+|+||+++.++.++|+|||.+......... ......++..|+|||.+.+..
T Consensus 105 ~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~ 180 (261)
T cd05034 105 LVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT-AREGAKFPIKWTAPEAANYGR 180 (261)
T ss_pred HHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh-hhhccCCCccccCHHHhccCC
Confidence 9999999999999999999 999999999999999999999999998765432111 111223456899999999888
Q ss_pred CCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
++.++|+||+|+++|++++ |..||...... .... ....... ...+...+..+.+++.+||..+
T Consensus 181 ~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~----~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~~ 244 (261)
T cd05034 181 FTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLE----QVERGYR---------MPRPPNCPEELYDLMLQCWDKD 244 (261)
T ss_pred cCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCC---------CCCCCCCCHHHHHHHHHHcccC
Confidence 9999999999999999998 88888533211 1111 1111100 0001112457889999999999
Q ss_pred CCCCCCHHHHHHHhcc
Q 048243 242 PNDRPSMLQVSSMLKN 257 (303)
Q Consensus 242 p~~Rpt~~el~~~L~~ 257 (303)
|.+||++.++.+.|++
T Consensus 245 p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 245 PEERPTFEYLQSFLED 260 (261)
T ss_pred cccCCCHHHHHHHHhc
Confidence 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=259.34 Aligned_cols=231 Identities=22% Similarity=0.320 Sum_probs=184.7
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+++.+++|.+........+.+.+|+++++.++||||+++++.+.+....+++|||+.+++|.+++.. ....+++..+
T Consensus 26 ~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~--~~~~l~~~~~ 103 (262)
T cd06613 26 ATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQV--TRGPLSELQI 103 (262)
T ss_pred CCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHh--hccCCCHHHH
Confidence 46788999999876655678899999999999999999999999999999999999999999998853 2356889999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC--
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG-- 161 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-- 161 (303)
+.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+.
T Consensus 104 ~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~ 178 (262)
T cd06613 104 AYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEVAAVERK 178 (262)
T ss_pred HHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--hccccccCCccccCchhhccccc
Confidence 999999999999999998 9999999999999999999999999987654321 112234678899999998776
Q ss_pred -CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 162 -VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 -~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
.++.++|+||||+++|+|++|..||........ .......... . .........+..+.+++.+||..
T Consensus 179 ~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~------~~~~~~~~~~----~--~~~~~~~~~~~~~~~li~~~l~~ 246 (262)
T cd06613 179 GGYDGKCDIWALGITAIELAELQPPMFDLHPMRA------LFLISKSNFP----P--PKLKDKEKWSPVFHDFIKKCLTK 246 (262)
T ss_pred CCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhccCC----C--ccccchhhhhHHHHHHHHHHcCC
Confidence 788999999999999999999999864332111 1111111000 0 00112234456789999999999
Q ss_pred CCCCCCCHHHHHH
Q 048243 241 NPNDRPSMLQVSS 253 (303)
Q Consensus 241 dp~~Rpt~~el~~ 253 (303)
+|.+|||+.+++.
T Consensus 247 ~p~~Rpt~~~il~ 259 (262)
T cd06613 247 DPKKRPTATKLLQ 259 (262)
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=267.73 Aligned_cols=237 Identities=27% Similarity=0.399 Sum_probs=183.5
Q ss_pred CCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc---------
Q 048243 5 CGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI--------- 73 (303)
Q Consensus 5 ~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------- 73 (303)
++..+|+|.++... ......+.+|+.+++.+ +||||+++++++......+++|||+.+++|.+++....
T Consensus 43 ~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~ 122 (314)
T cd05099 43 QTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFD 122 (314)
T ss_pred cceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCccccccc
Confidence 35679999987543 33456788999999999 69999999999999889999999999999999985421
Q ss_pred ----ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccc
Q 048243 74 ----RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGT 149 (303)
Q Consensus 74 ----~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~ 149 (303)
....+++..+..++.|++.||+|||++| ++||||||+||+++.++.++|+|||.++...............++
T Consensus 123 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~ 199 (314)
T cd05099 123 ITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLP 199 (314)
T ss_pred ccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCC
Confidence 1245888999999999999999999998 999999999999999999999999999765433222112222345
Q ss_pred cCCCChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHH
Q 048243 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLM 228 (303)
Q Consensus 150 ~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
..|+|||.+.+..++.++||||||+++|+|++ |..||....... ........... ..+...+.
T Consensus 200 ~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~ 263 (314)
T cd05099 200 VKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE-------LFKLLREGHRM---------DKPSNCTH 263 (314)
T ss_pred ccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCC---------CCCCCCCH
Confidence 67999999988889999999999999999998 788874332111 11111111111 11112234
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHhccccC
Q 048243 229 RCLEIALLCVQENPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 229 ~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~~ 260 (303)
.+.+++.+||..||.+|||+.++++.|++...
T Consensus 264 ~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 264 ELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 78899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=267.79 Aligned_cols=244 Identities=20% Similarity=0.260 Sum_probs=177.8
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
++|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++... ....+++.
T Consensus 23 ~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~l~~~ 101 (327)
T cd08227 23 PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH-FMDGMSEL 101 (327)
T ss_pred ccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhh-ccCCCCHH
Confidence 678999999997543 223456778999999999999999999999999999999999999999998542 23458899
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-----ccccccccccCCCChh
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-----ANTEQVVGTIGYIPPE 156 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-----~~~~~~~g~~~y~aPE 156 (303)
.++.++.|++.||+|||+.+ ++||||||+||+++.++.++++||+........... .......++..|+|||
T Consensus 102 ~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 178 (327)
T cd08227 102 AIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPE 178 (327)
T ss_pred HHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChH
Confidence 99999999999999999999 999999999999999999999999865433211110 1112234677899999
Q ss_pred hhcc--CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHH--------------HHh-----CCCcceecc
Q 048243 157 YARQ--GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE--------------LWK-----GGKGVEFVD 215 (303)
Q Consensus 157 ~~~~--~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------~~~-----~~~~~~~~~ 215 (303)
.+.+ ..++.++|||||||++|+|++|..||......... ...... ... .........
T Consensus 179 ~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T cd08227 179 VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGE 256 (327)
T ss_pred HhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--HHHhcCCccccccccchhhhhcccCCcccCCcCCCCc
Confidence 9876 35889999999999999999999998643211100 000000 000 000000000
Q ss_pred ------------ccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 216 ------------SSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 216 ------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
...........+..+.+|+.+||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 257 STTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00000011223457889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=272.05 Aligned_cols=231 Identities=23% Similarity=0.397 Sum_probs=179.7
Q ss_pred EEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHH
Q 048243 8 VIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86 (303)
Q Consensus 8 ~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~ 86 (303)
.||+|.++... ....+.+.+|+.+++.++||||+++++++... ..+++++|+.+|+|.+++.. ....+++..++.+
T Consensus 38 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~--~~~~~~~~~~~~~ 114 (316)
T cd05108 38 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNW 114 (316)
T ss_pred eEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHh--ccccCCHHHHHHH
Confidence 48999997543 33456788999999999999999999998765 57899999999999999854 2345788899999
Q ss_pred HHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCCCc
Q 048243 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTK 166 (303)
Q Consensus 87 ~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 166 (303)
+.||+.||+|||+.+ ++||||||+||+++.++.++|+|||++................++..|+|||.+.+..++.+
T Consensus 115 ~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~ 191 (316)
T cd05108 115 CVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQ 191 (316)
T ss_pred HHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCch
Confidence 999999999999999 99999999999999999999999999987654322222222334668999999999899999
Q ss_pred cchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 048243 167 SDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDR 245 (303)
Q Consensus 167 ~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 245 (303)
+||||||+++|+|++ |..||....... ........... ..++..+..+.+++.+||..||.+|
T Consensus 192 ~Di~slGv~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~R 255 (316)
T cd05108 192 SDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERL---------PQPPICTIDVYMIMVKCWMIDADSR 255 (316)
T ss_pred hhhHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHhCCCCC---------CCCCCCCHHHHHHHHHHccCChhhC
Confidence 999999999999997 888885432111 11111111110 0011123467899999999999999
Q ss_pred CCHHHHHHHhccccC
Q 048243 246 PSMLQVSSMLKNETT 260 (303)
Q Consensus 246 pt~~el~~~L~~~~~ 260 (303)
|++.+++..|.....
T Consensus 256 ps~~~l~~~l~~~~~ 270 (316)
T cd05108 256 PKFRELIIEFSKMAR 270 (316)
T ss_pred cCHHHHHHHHHHHHc
Confidence 999999998876653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=259.97 Aligned_cols=229 Identities=23% Similarity=0.304 Sum_probs=183.1
Q ss_pred CCCcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+++.+|+|.++.. .....+.+.+|+.+++.++|+||+++++.+..+...+++|||+++++|.+++.. .....+++..
T Consensus 23 ~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~ 101 (255)
T cd08219 23 NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKL-QRGKLFPEDT 101 (255)
T ss_pred CCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHh-ccCCCCCHHH
Confidence 46889999998643 334556788999999999999999999999999999999999999999888753 2344578999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
++.++.|++.||.+||+.| ++|+||+|+||+++.++.++++|||.+........ ......|+..|+|||.+.+..
T Consensus 102 ~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~ 176 (255)
T cd08219 102 ILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--YACTYVGTPYYVPPEIWENMP 176 (255)
T ss_pred HHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc--ccccccCCccccCHHHHccCC
Confidence 9999999999999999999 99999999999999999999999999876543321 122346788999999999888
Q ss_pred CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC
Q 048243 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 242 (303)
++.++|+||||+++|+|++|..||....... ....... .... ..+...+..+.+++.+||..||
T Consensus 177 ~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~-~~~~---------~~~~~~~~~~~~li~~~l~~~P 240 (255)
T cd08219 177 YNNKSDIWSLGCILYELCTLKHPFQANSWKN------LILKVCQ-GSYK---------PLPSHYSYELRSLIKQMFKRNP 240 (255)
T ss_pred cCchhhhhhhchhheehhhccCCCCCCCHHH------HHHHHhc-CCCC---------CCCcccCHHHHHHHHHHHhCCc
Confidence 9999999999999999999999985432111 1111111 1111 0112234468899999999999
Q ss_pred CCCCCHHHHHHH
Q 048243 243 NDRPSMLQVSSM 254 (303)
Q Consensus 243 ~~Rpt~~el~~~ 254 (303)
.+|||+.+++..
T Consensus 241 ~~Rp~~~~il~~ 252 (255)
T cd08219 241 RSRPSATTILSR 252 (255)
T ss_pred ccCCCHHHHhhc
Confidence 999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=261.94 Aligned_cols=234 Identities=27% Similarity=0.415 Sum_probs=181.8
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+++..||+|+++.... ..+.+.+|+++++.++|+||+++++++.. ...++||||+.+++|.+++... ....+++..
T Consensus 27 ~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~ 103 (262)
T cd05071 27 WNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-MGKYLRLPQ 103 (262)
T ss_pred ecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhc-cccCCCHHH
Confidence 34556799999975433 34678999999999999999999998754 5579999999999999998542 234578899
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+......... ......++..|+|||...+..
T Consensus 104 ~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~ 179 (262)
T cd05071 104 LVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGR 179 (262)
T ss_pred HHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-cccCCcccceecCHhHhccCC
Confidence 9999999999999999998 999999999999999999999999998765433211 112234567899999998888
Q ss_pred CCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
++.++||||||+++|+|++ |..||....... .. ........ .......+..+.+++.+||+.|
T Consensus 180 ~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~~----~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~ 243 (262)
T cd05071 180 FTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VL----DQVERGYR---------MPCPPECPESLHDLMCQCWRKE 243 (262)
T ss_pred CCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---HH----HHHhcCCC---------CCCccccCHHHHHHHHHHccCC
Confidence 9999999999999999999 777775332111 11 11111100 0111233457889999999999
Q ss_pred CCCCCCHHHHHHHhcccc
Q 048243 242 PNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 242 p~~Rpt~~el~~~L~~~~ 259 (303)
|++||++.+++++|+...
T Consensus 244 p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 244 PEERPTFEYLQAFLEDYF 261 (262)
T ss_pred cccCCCHHHHHHHHHHhc
Confidence 999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=258.22 Aligned_cols=233 Identities=25% Similarity=0.352 Sum_probs=182.4
Q ss_pred ccCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 2 VLPCGKVIAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 2 ~~~~~~~valK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
...+++.+|+|.++.... .....+.+|+++++.++||||+++++++......++||||+++++|.+++.. ....+++
T Consensus 15 ~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~ 92 (250)
T cd05085 15 TLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRK--KKDELKT 92 (250)
T ss_pred EecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHh--cCCCCCH
Confidence 356788999999875532 2334688999999999999999999999999999999999999999998853 2345789
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.+++.+|.|||+.| ++||||+|+||+++.++.++|+|||++........ .......++..|+|||.+.+
T Consensus 93 ~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~ 168 (250)
T cd05085 93 KQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQIPIKWTAPEALNY 168 (250)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCCcccccCHHHhcc
Confidence 999999999999999999998 99999999999999999999999999865433211 11112234567999999988
Q ss_pred CCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 161 GVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
..++.++||||||+++|++++ |..||....... . .......... ......+..+.+++.+||.
T Consensus 169 ~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~------~-~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~ 232 (250)
T cd05085 169 GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ------A-REQVEKGYRM---------SCPQKCPDDVYKVMQRCWD 232 (250)
T ss_pred CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH------H-HHHHHcCCCC---------CCCCCCCHHHHHHHHHHcc
Confidence 889999999999999999998 888885432111 1 1111111110 1111234578899999999
Q ss_pred CCCCCCCCHHHHHHHhc
Q 048243 240 ENPNDRPSMLQVSSMLK 256 (303)
Q Consensus 240 ~dp~~Rpt~~el~~~L~ 256 (303)
.+|++||++.|+++.|.
T Consensus 233 ~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 233 YKPENRPKFSELQKELA 249 (250)
T ss_pred cCcccCCCHHHHHHHhc
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=260.92 Aligned_cols=231 Identities=20% Similarity=0.318 Sum_probs=180.9
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+++.||+|.++.........+.+|+.+++.++||||+++++.+......++||||+++++|.+++. ..+.+++..+
T Consensus 32 ~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~ 108 (267)
T cd06645 32 NTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYH---VTGPLSESQI 108 (267)
T ss_pred CCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHH---hcCCCCHHHH
Confidence 4789999999976655555678899999999999999999999999999999999999999999884 3456899999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc---c
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR---Q 160 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~ 160 (303)
+.++.|++.|++|||+.| ++|+||||+||+++.++.++|+|||.+....... .......|+..|+|||.+. .
T Consensus 109 ~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~ 183 (267)
T cd06645 109 AYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AKRKSFIGTPYWMAPEVAAVERK 183 (267)
T ss_pred HHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--cccccccCcccccChhhhccccC
Confidence 999999999999999999 9999999999999999999999999987654321 1223356889999999874 4
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|+|||||++|+|++|..||......... ......... .+.... ....+..+.+++.+||..
T Consensus 184 ~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~------~~~~~~~~~----~~~~~~--~~~~~~~~~~li~~~l~~ 251 (267)
T cd06645 184 GGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------FLMTKSNFQ----PPKLKD--KMKWSNSFHHFVKMALTK 251 (267)
T ss_pred CCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH------HhhhccCCC----CCcccc--cCCCCHHHHHHHHHHccC
Confidence 45788999999999999999999998543321110 000000000 000000 011234678999999999
Q ss_pred CCCCCCCHHHHHHH
Q 048243 241 NPNDRPSMLQVSSM 254 (303)
Q Consensus 241 dp~~Rpt~~el~~~ 254 (303)
||++|||+.++++.
T Consensus 252 ~P~~R~~~~~ll~~ 265 (267)
T cd06645 252 NPKKRPTAEKLLQH 265 (267)
T ss_pred CchhCcCHHHHhcC
Confidence 99999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=263.13 Aligned_cols=232 Identities=27% Similarity=0.447 Sum_probs=178.7
Q ss_pred EEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEeC------CeeEEEEeecCCCChhhhhcCcc---ccc
Q 048243 8 VIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------EERMLVYEYMPNKSLDCYLFDPI---RRL 76 (303)
Q Consensus 8 ~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~---~~~ 76 (303)
.||+|.++.. .....+.+..|+.+++.++|+||+++++++... ...+++|||+.+|+|.+++.... ...
T Consensus 28 ~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~ 107 (272)
T cd05075 28 KVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ 107 (272)
T ss_pred eEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcc
Confidence 6899988654 234456788999999999999999999987532 24689999999999988874321 234
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChh
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE 156 (303)
.+++..+..++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++..+.............++..|+|||
T Consensus 108 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe 184 (272)
T cd05075 108 YLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184 (272)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHH
Confidence 5789999999999999999999998 9999999999999999999999999988765433222222234567899999
Q ss_pred hhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHH
Q 048243 157 YARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
...+..++.++||||||+++|+|++ |..||....... ............ ..+..+..+.+++.
T Consensus 185 ~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~~~~li~ 248 (272)
T cd05075 185 SLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-------IYDYLRQGNRLK---------QPPDCLDGLYSLMS 248 (272)
T ss_pred HccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHcCCCCC---------CCCCCCHHHHHHHH
Confidence 9998889999999999999999999 788875422111 111222111111 11122346889999
Q ss_pred HcccCCCCCCCCHHHHHHHhccc
Q 048243 236 LCVQENPNDRPSMLQVSSMLKNE 258 (303)
Q Consensus 236 ~~l~~dp~~Rpt~~el~~~L~~~ 258 (303)
+||+.||++|||+.++++.|++.
T Consensus 249 ~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 249 SCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHcCCCcccCcCHHHHHHHHHhh
Confidence 99999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=278.13 Aligned_cols=219 Identities=23% Similarity=0.290 Sum_probs=181.6
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+++.+|||.+++.. .++.+..+.|..++... +||+++.++.+|..+.++|+||||+.||++.-. .....++
T Consensus 391 ~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~----~~~~~F~ 466 (694)
T KOG0694|consen 391 GTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHH----IHTDVFS 466 (694)
T ss_pred CCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEE----Eeccccc
Confidence 578899999998773 45677888898888888 699999999999999999999999999984222 3556799
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..+..++..|+.||+|||++| |+|||||.+|||+|..|.+||+|||+++.--.. ......+.||+.|+|||++.
T Consensus 467 e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~--g~~TsTfCGTpey~aPEil~ 541 (694)
T KOG0694|consen 467 EPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ--GDRTSTFCGTPEFLAPEVLT 541 (694)
T ss_pred HHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCC--CCccccccCChhhcChhhhc
Confidence 9999999999999999999999 999999999999999999999999999864322 23456689999999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..|+.++|.||||+++|||+.|..||...+..+..+.+ .... ...+...+.+..++++++|.
T Consensus 542 e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI------~~d~-----------~~yP~~ls~ea~~il~~ll~ 604 (694)
T KOG0694|consen 542 EQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI------VNDE-----------VRYPRFLSKEAIAIMRRLLR 604 (694)
T ss_pred cCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------hcCC-----------CCCCCcccHHHHHHHHHHhc
Confidence 999999999999999999999999999755433322111 1111 11222334578899999999
Q ss_pred CCCCCCCCH
Q 048243 240 ENPNDRPSM 248 (303)
Q Consensus 240 ~dp~~Rpt~ 248 (303)
.||++|.-+
T Consensus 605 k~p~kRLG~ 613 (694)
T KOG0694|consen 605 KNPEKRLGS 613 (694)
T ss_pred cCcccccCC
Confidence 999999865
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=265.47 Aligned_cols=228 Identities=23% Similarity=0.356 Sum_probs=183.1
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+|+.|++|.+........+.+.+|+..++.++|+||+++++++......++|+||+.+++|..++. ...+++..+
T Consensus 42 ~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~l~~~~~ 117 (296)
T cd06655 42 ATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVT----ETCMDEAQI 117 (296)
T ss_pred CCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHH----hcCCCHHHH
Confidence 5789999999976655556788999999999999999999999999999999999999999998883 345899999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
..++.|++.|++|||+.| ++||||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..+
T Consensus 118 ~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 192 (296)
T cd06655 118 AAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAY 192 (296)
T ss_pred HHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc--cCCCcCCCccccCcchhcCCCC
Confidence 999999999999999999 99999999999999999999999998875433221 1122457889999999998889
Q ss_pred CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCC
Q 048243 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 243 (303)
+.++||||||+++|++++|..||........ ......... .. ...+...+..+.++|.+||..||.
T Consensus 193 ~~~~Dv~slGvil~~lltg~~pf~~~~~~~~------~~~~~~~~~-~~-------~~~~~~~~~~~~~li~~~l~~dp~ 258 (296)
T cd06655 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNGT-PE-------LQNPEKLSPIFRDFLNRCLEMDVE 258 (296)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhcCC-cc-------cCCcccCCHHHHHHHHHHhhcChh
Confidence 9999999999999999999999854432111 111111110 00 011112344788999999999999
Q ss_pred CCCCHHHHHHH
Q 048243 244 DRPSMLQVSSM 254 (303)
Q Consensus 244 ~Rpt~~el~~~ 254 (303)
+|||+.+++..
T Consensus 259 ~Rpt~~~il~~ 269 (296)
T cd06655 259 KRGSAKELLQH 269 (296)
T ss_pred hCCCHHHHhhC
Confidence 99999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=278.63 Aligned_cols=230 Identities=22% Similarity=0.280 Sum_probs=176.5
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+++.||+|++.... ......+.+|+.++++++|+||+++++.+.++...++|||||++|+|.+++. ....+++
T Consensus 24 ~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~~~e 100 (382)
T cd05625 24 DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI---RMGIFPE 100 (382)
T ss_pred CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHH---hcCCCCH
Confidence 578999999996542 2334578889999999999999999999999999999999999999999884 3356889
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCc---------------------
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL--------------------- 139 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~--------------------- 139 (303)
..+..++.||+.||+|||+.+ |+||||||+|||++.+|.++|+|||++..+.....
T Consensus 101 ~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (382)
T cd05625 101 DLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177 (382)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccc
Confidence 999999999999999999999 99999999999999999999999999753211000
Q ss_pred ------------------------cccccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccc
Q 048243 140 ------------------------EANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL 195 (303)
Q Consensus 140 ------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~ 195 (303)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-- 255 (382)
T cd05625 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLE-- 255 (382)
T ss_pred cccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHH--
Confidence 000112468999999999999999999999999999999999999996433211
Q ss_pred cHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 048243 196 SILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPS---MLQVSS 253 (303)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt---~~el~~ 253 (303)
............ ........+.++.++|.+|+ .+|.+|++ +.|+++
T Consensus 256 ----~~~~i~~~~~~~-------~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 256 ----TQMKVINWQTSL-------HIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred ----HHHHHHccCCCc-------CCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 111111111100 01111123446778888876 49999997 777765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=261.87 Aligned_cols=228 Identities=30% Similarity=0.437 Sum_probs=183.0
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
..|+.||+|.++.... ..+.+.+|+.+++.++|+||+++++++.+....++||||+++++|.+++... ....+++..+
T Consensus 27 ~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~ 104 (256)
T cd05039 27 YRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSR-GRAVITLAQQ 104 (256)
T ss_pred ecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhc-CCCCCCHHHH
Confidence 3578999999976654 5678899999999999999999999999888999999999999999998542 2236899999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+........ ...++..|.|||.+....+
T Consensus 105 ~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~ 176 (256)
T cd05039 105 LGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTAPEALREKKF 176 (256)
T ss_pred HHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-----cCCCcccccCchhhcCCcC
Confidence 999999999999999999 99999999999999999999999999876532211 1234567999999988888
Q ss_pred CCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC
Q 048243 164 STKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 242 (303)
+.++||||||+++|++++ |..||....... ........... ..+...+..+.+++.+||..+|
T Consensus 177 ~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p 240 (256)
T cd05039 177 STKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPHVEKGYRM---------EAPEGCPPEVYKVMKDCWELDP 240 (256)
T ss_pred CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhcCCCC---------CCccCCCHHHHHHHHHHhccCh
Confidence 999999999999999997 888875332111 11111111110 1111224578899999999999
Q ss_pred CCCCCHHHHHHHhcc
Q 048243 243 NDRPSMLQVSSMLKN 257 (303)
Q Consensus 243 ~~Rpt~~el~~~L~~ 257 (303)
.+|||+.|+++.|++
T Consensus 241 ~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 241 AKRPTFKQLREQLAL 255 (256)
T ss_pred hhCcCHHHHHHHHhc
Confidence 999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=258.68 Aligned_cols=226 Identities=22% Similarity=0.340 Sum_probs=182.7
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHH
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~ 84 (303)
+++.+++|.+..... .+.+.+|+++++.++|+||+++++.+......|+++|++.+++|.+++.. ....+++..++
T Consensus 27 ~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~--~~~~l~~~~~~ 102 (256)
T cd06612 27 TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKI--TNKTLTEEEIA 102 (256)
T ss_pred CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHh--CccCCCHHHHH
Confidence 578999999975543 57899999999999999999999999999999999999999999998843 34568999999
Q ss_pred HHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCC
Q 048243 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYS 164 (303)
Q Consensus 85 ~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 164 (303)
.++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++
T Consensus 103 ~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~ 177 (256)
T cd06612 103 AILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYN 177 (256)
T ss_pred HHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccccccCCccccCHHHHhcCCCC
Confidence 99999999999999999 99999999999999999999999999876544321 22334578899999999988899
Q ss_pred CccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCC
Q 048243 165 TKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPND 244 (303)
Q Consensus 165 ~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 244 (303)
.++||||||+++|+|++|..||......... ...... ...........+..+.+++.+||+.||.+
T Consensus 178 ~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-------~~~~~~-------~~~~~~~~~~~~~~~~~~i~~~l~~~P~~ 243 (256)
T cd06612 178 NKADIWSLGITAIEMAEGKPPYSDIHPMRAI-------FMIPNK-------PPPTLSDPEKWSPEFNDFVKKCLVKDPEE 243 (256)
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCcchhhhh-------hhhccC-------CCCCCCchhhcCHHHHHHHHHHHhcChhh
Confidence 9999999999999999999998643221110 000000 00011112234457889999999999999
Q ss_pred CCCHHHHHH
Q 048243 245 RPSMLQVSS 253 (303)
Q Consensus 245 Rpt~~el~~ 253 (303)
|||+.|+++
T Consensus 244 Rps~~~il~ 252 (256)
T cd06612 244 RPSAIQLLQ 252 (256)
T ss_pred CcCHHHHhc
Confidence 999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=268.87 Aligned_cols=236 Identities=29% Similarity=0.403 Sum_probs=183.7
Q ss_pred cEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc-----------
Q 048243 7 KVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI----------- 73 (303)
Q Consensus 7 ~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------- 73 (303)
..||+|.++... ....+.+.+|+.+++++ +||||+++++++......++++||+.+++|.+++....
T Consensus 45 ~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 124 (334)
T cd05100 45 VTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC 124 (334)
T ss_pred eeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccc
Confidence 478999887543 33456788999999999 89999999999999999999999999999999985421
Q ss_pred --ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccC
Q 048243 74 --RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIG 151 (303)
Q Consensus 74 --~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~ 151 (303)
....+++..++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||.++...............++..
T Consensus 125 ~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~ 201 (334)
T cd05100 125 KLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVK 201 (334)
T ss_pred cCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCce
Confidence 2235788899999999999999999999 99999999999999999999999999876544322222222234567
Q ss_pred CCChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHH
Q 048243 152 YIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRC 230 (303)
Q Consensus 152 y~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 230 (303)
|+|||.+.+..++.++||||||+++|+|++ |..||....... ........... ..+...+..+
T Consensus 202 y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~l 265 (334)
T cd05100 202 WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-------LFKLLKEGHRM---------DKPANCTHEL 265 (334)
T ss_pred EcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCC---------CCCCCCCHHH
Confidence 999999998889999999999999999998 778875332111 11111111111 1111223478
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHhccccCC
Q 048243 231 LEIALLCVQENPNDRPSMLQVSSMLKNETTN 261 (303)
Q Consensus 231 ~~li~~~l~~dp~~Rpt~~el~~~L~~~~~~ 261 (303)
.+++.+||+.+|.+|||+.|+++.|++....
T Consensus 266 ~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 266 YMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred HHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 8999999999999999999999999887743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=259.38 Aligned_cols=233 Identities=30% Similarity=0.462 Sum_probs=183.2
Q ss_pred ccCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 2 VLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 2 ~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
..++++.||+|.+..... ....+.+|+.+++.++|+||+++++++. ....+++|||+.+++|.+++... .+..+++.
T Consensus 26 ~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~ 102 (260)
T cd05067 26 YYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTP-EGIKLTIN 102 (260)
T ss_pred ecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhc-CCCCCCHH
Confidence 356789999999975443 4467889999999999999999999874 45689999999999999988542 34568899
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
.++.++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||.+...
T Consensus 103 ~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~ 178 (260)
T cd05067 103 KLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYG 178 (260)
T ss_pred HHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc-ccccCCcccccccCHHHhccC
Confidence 99999999999999999998 99999999999999999999999999876543221 112223456789999999888
Q ss_pred CCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 162 VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
.++.++||||||+++|++++ |..||....... . ........... .....+..+.+++.+||..
T Consensus 179 ~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~----~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~ 242 (260)
T cd05067 179 TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---V----IQNLERGYRMP---------RPDNCPEELYELMRLCWKE 242 (260)
T ss_pred CcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---H----HHHHHcCCCCC---------CCCCCCHHHHHHHHHHccC
Confidence 89999999999999999998 999986433211 1 11111111110 1112234788999999999
Q ss_pred CCCCCCCHHHHHHHhcc
Q 048243 241 NPNDRPSMLQVSSMLKN 257 (303)
Q Consensus 241 dp~~Rpt~~el~~~L~~ 257 (303)
+|++|||++++++.|++
T Consensus 243 ~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 243 KPEERPTFEYLRSVLED 259 (260)
T ss_pred ChhhCCCHHHHHHHhhc
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=265.60 Aligned_cols=236 Identities=24% Similarity=0.349 Sum_probs=184.3
Q ss_pred CcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEe-CCeeEEEEeecCCCChhhhhcCcccc-----ccC
Q 048243 6 GKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCID-SEERMLVYEYMPNKSLDCYLFDPIRR-----LIL 78 (303)
Q Consensus 6 ~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~l 78 (303)
++.|++|.+.... ....+.+.+|+.+++.++|+||+++++++.. ....+++++|+.+++|.+++...... ..+
T Consensus 35 ~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l 114 (280)
T cd05043 35 EEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL 114 (280)
T ss_pred eeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCC
Confidence 7889999987543 3345678899999999999999999998776 46789999999999999998543222 568
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||+++.+.............++..|+|||.+
T Consensus 115 ~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~ 191 (280)
T cd05043 115 STQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESL 191 (280)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHH
Confidence 89999999999999999999998 999999999999999999999999998765433222222223456789999999
Q ss_pred ccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHc
Q 048243 159 RQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237 (303)
Q Consensus 159 ~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 237 (303)
.+..++.++||||||+++|++++ |..||....... ........... ......+..+.+++.+|
T Consensus 192 ~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~~~li~~~ 255 (280)
T cd05043 192 VNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-------MAAYLKDGYRL---------AQPINCPDELFAVMACC 255 (280)
T ss_pred hcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHcCCCC---------CCCCcCCHHHHHHHHHH
Confidence 98889999999999999999998 999885432211 11112211110 01111234788999999
Q ss_pred ccCCCCCCCCHHHHHHHhccccC
Q 048243 238 VQENPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 238 l~~dp~~Rpt~~el~~~L~~~~~ 260 (303)
|..||++|||+.++++.|+...+
T Consensus 256 l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 256 WALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred cCCChhhCCCHHHHHHHHHHHHh
Confidence 99999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=261.74 Aligned_cols=241 Identities=29% Similarity=0.431 Sum_probs=185.5
Q ss_pred CCCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCccccEEEEEEe--CCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTSTQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCID--SEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
++++.||+|.++..... ..+.+.+|+.+++.++|+||+++++++.. ....+++|||+++++|.+++.. ....+++
T Consensus 31 ~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~--~~~~~~~ 108 (284)
T cd05038 31 NTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR--HRDQINL 108 (284)
T ss_pred CCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHh--CccccCH
Confidence 45789999999766443 45789999999999999999999999887 5578999999999999999854 2235899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-ccccccccccCCCChhhhc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~ 159 (303)
..++.++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||.+......... .......++..|+|||.+.
T Consensus 109 ~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~ 185 (284)
T cd05038 109 KRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185 (284)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHc
Confidence 999999999999999999998 999999999999999999999999998776532211 1111223456799999998
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccc--------cHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHH
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL--------SILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL 231 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
+..++.++||||||+++|+|++|..|+......... .............. ....+...+.++.
T Consensus 186 ~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~ 256 (284)
T cd05038 186 TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE---------RLPRPPSCPDEVY 256 (284)
T ss_pred cCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCC---------cCCCCccCCHHHH
Confidence 888999999999999999999999887543221100 01111111111111 1111122235788
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhccc
Q 048243 232 EIALLCVQENPNDRPSMLQVSSMLKNE 258 (303)
Q Consensus 232 ~li~~~l~~dp~~Rpt~~el~~~L~~~ 258 (303)
+++.+||+.+|.+|||+.|+++.|++.
T Consensus 257 ~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 257 DLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=274.95 Aligned_cols=230 Identities=20% Similarity=0.241 Sum_probs=177.6
Q ss_pred CCCcEEEEEEecCC---CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+++.||+|.+... .......+.+|+.+++.++||||+++++++.++...|+||||+++|+|.+++. ...+++
T Consensus 66 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~----~~~~~~ 141 (370)
T cd05621 66 SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS----NYDVPE 141 (370)
T ss_pred CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHH----hcCCCH
Confidence 46889999998643 22234567889999999999999999999999999999999999999999883 335888
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++........ .......||+.|+|||++.+
T Consensus 142 ~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~ 217 (370)
T cd05621 142 KWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKS 217 (370)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCCc-eecccCCCCcccCCHHHHhc
Confidence 999999999999999999999 99999999999999999999999999876543221 12234568999999999876
Q ss_pred CC----CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 161 GV----YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 161 ~~----~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
.. ++.++||||+||++|+|++|..||....... ............. .......+..+.+++.+
T Consensus 218 ~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~------~~~~i~~~~~~~~-------~p~~~~~s~~~~~li~~ 284 (370)
T cd05621 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG------TYSKIMDHKNSLN-------FPEDVEISKHAKNLICA 284 (370)
T ss_pred cCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCcccC-------CCCcccCCHHHHHHHHH
Confidence 43 7789999999999999999999996433211 1111111111111 11111234577899999
Q ss_pred cccCCCCC--CCCHHHHHHH
Q 048243 237 CVQENPND--RPSMLQVSSM 254 (303)
Q Consensus 237 ~l~~dp~~--Rpt~~el~~~ 254 (303)
||..++.+ |+++.|+++.
T Consensus 285 ~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 285 FLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HccCchhccCCCCHHHHhcC
Confidence 99855543 8999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=257.37 Aligned_cols=237 Identities=27% Similarity=0.350 Sum_probs=177.3
Q ss_pred CCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccc--cccCCHH
Q 048243 5 CGKVIAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR--RLILDWK 81 (303)
Q Consensus 5 ~~~~valK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~l~~~ 81 (303)
++..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|+|.+++..... ....++.
T Consensus 21 ~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 100 (269)
T cd05087 21 TPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPT 100 (269)
T ss_pred CceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHH
Confidence 346799999876542 2335788899999999999999999999988889999999999999999854221 2345677
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
.+..++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||.+................++..|+|||++.+.
T Consensus 101 ~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 177 (269)
T cd05087 101 TLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177 (269)
T ss_pred HHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccc
Confidence 88899999999999999999 999999999999999999999999998654433322223334567889999988643
Q ss_pred -------CCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHH
Q 048243 162 -------VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEI 233 (303)
Q Consensus 162 -------~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 233 (303)
.++.++||||||+++|+|++ |..||........ . ..... ........+.... ..+..+.++
T Consensus 178 ~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~---~~~~~-~~~~~~~~~~~~~----~~~~~~~~l 246 (269)
T cd05087 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---L---TYTVR-EQQLKLPKPRLKL----PLSDRWYEV 246 (269)
T ss_pred cccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---H---HHHhh-cccCCCCCCccCC----CCChHHHHH
Confidence 35789999999999999996 9989854332211 0 01111 1111111111111 123367789
Q ss_pred HHHcccCCCCCCCCHHHHHHHhc
Q 048243 234 ALLCVQENPNDRPSMLQVSSMLK 256 (303)
Q Consensus 234 i~~~l~~dp~~Rpt~~el~~~L~ 256 (303)
+.+|| .+|++|||+.||...|+
T Consensus 247 ~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 247 MQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HHHHh-cCcccCCCHHHHHHHhc
Confidence 99999 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=263.79 Aligned_cols=228 Identities=22% Similarity=0.337 Sum_probs=183.4
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+|+.||+|.+........+.+.+|+.+++.++|+||+++++++......++||||+++++|.+++. ...+++..+
T Consensus 42 ~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~ 117 (297)
T cd06656 42 ATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQI 117 (297)
T ss_pred CCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHH----hCCCCHHHH
Confidence 5789999999976655556778899999999999999999999999999999999999999999883 345788999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||.+........ ......+++.|+|||.+.+..+
T Consensus 118 ~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 192 (297)
T cd06656 118 AAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAY 192 (297)
T ss_pred HHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc--CcCcccCCccccCHHHHcCCCC
Confidence 999999999999999998 99999999999999999999999999875433221 1223467889999999998889
Q ss_pred CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCC
Q 048243 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 243 (303)
+.++|+||||+++|++++|..||.......... ...... ......+...+..+.+++.+||..||+
T Consensus 193 ~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~~--------~~~~~~~~~~~~~~~~li~~~l~~~p~ 258 (297)
T cd06656 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG--------TPELQNPERLSAVFRDFLNRCLEMDVD 258 (297)
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccCC--------CCCCCCccccCHHHHHHHHHHccCChh
Confidence 999999999999999999999985433211110 000000 000111223345678999999999999
Q ss_pred CCCCHHHHHHH
Q 048243 244 DRPSMLQVSSM 254 (303)
Q Consensus 244 ~Rpt~~el~~~ 254 (303)
+||++.++++.
T Consensus 259 ~Rps~~~il~~ 269 (297)
T cd06656 259 RRGSAKELLQH 269 (297)
T ss_pred hCcCHHHHhcC
Confidence 99999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=260.26 Aligned_cols=232 Identities=28% Similarity=0.426 Sum_probs=180.5
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+++..+|+|.+.... ...+.+.+|+.+++.++|+|++++++++.. ...+++|||+.+++|.+++... ....+++..
T Consensus 27 ~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~ 103 (260)
T cd05069 27 WNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEG-DGKYLKLPQ 103 (260)
T ss_pred EcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCCCHHHHHhhC-CCCCCCHHH
Confidence 3455679999986543 234678899999999999999999998854 5679999999999999998542 234578999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
+..++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||...+..
T Consensus 104 ~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~ 179 (260)
T cd05069 104 LVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGR 179 (260)
T ss_pred HHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc-cccCCCccchhhCCHHHhccCC
Confidence 9999999999999999998 99999999999999999999999999876543321 1112234567899999998888
Q ss_pred CCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
++.++||||||+++|+|++ |..||....... . ......... ...+...+..+.+++.+||..|
T Consensus 180 ~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~----~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~ 243 (260)
T cd05069 180 FTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---V----LEQVERGYR---------MPCPQGCPESLHELMKLCWKKD 243 (260)
T ss_pred cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcCCC---------CCCCcccCHHHHHHHHHHccCC
Confidence 9999999999999999999 888875332111 1 111111110 0111223457889999999999
Q ss_pred CCCCCCHHHHHHHhcc
Q 048243 242 PNDRPSMLQVSSMLKN 257 (303)
Q Consensus 242 p~~Rpt~~el~~~L~~ 257 (303)
|.+||++.+++++|++
T Consensus 244 p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 244 PDERPTFEYIQSFLED 259 (260)
T ss_pred cccCcCHHHHHHHHhc
Confidence 9999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=260.65 Aligned_cols=222 Identities=20% Similarity=0.336 Sum_probs=173.5
Q ss_pred CcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHH
Q 048243 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVH 85 (303)
Q Consensus 6 ~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~ 85 (303)
...|++|.+..........+.+|+.++..++||||+++++++..+...++||||+++++|..++.. ....+++..++.
T Consensus 32 ~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~ 109 (262)
T cd05077 32 EIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR--KSDVLTTPWKFK 109 (262)
T ss_pred ceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHh--cCCCCCHHHHHH
Confidence 346899998766555556788899999999999999999999999899999999999999888743 234589999999
Q ss_pred HHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCc-------eEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK-------PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 86 ~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~-------v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
++.||+.||+|||+.+ ++||||||+||+++.++. ++++|||.+...... ....++..|+|||.+
T Consensus 110 i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~ 180 (262)
T cd05077 110 VAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECV 180 (262)
T ss_pred HHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc------ccccccccccChhhh
Confidence 9999999999999998 999999999999987664 899999987654321 224567889999988
Q ss_pred c-cCCCCCccchhhHHHHHHHHH-hCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 159 R-QGVYSTKSDVFSFGVLLLQII-SGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 159 ~-~~~~~~~~DiwslG~~~~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
. +..++.++||||||+++|+|+ .|..|+....... ......... . . .......+.+|+.+
T Consensus 181 ~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~~~~~--~-----~----~~~~~~~~~~li~~ 242 (262)
T cd05077 181 EDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-------KERFYEGQC--M-----L----VTPSCKELADLMTH 242 (262)
T ss_pred cCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-------HHHHHhcCc--c-----C----CCCChHHHHHHHHH
Confidence 6 456889999999999999998 4777764322111 011111100 0 0 01123468899999
Q ss_pred cccCCCCCCCCHHHHHHHhc
Q 048243 237 CVQENPNDRPSMLQVSSMLK 256 (303)
Q Consensus 237 ~l~~dp~~Rpt~~el~~~L~ 256 (303)
||+.||.+||++.+|++.|+
T Consensus 243 cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 243 CMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HcCCChhhCcCHHHHHHhcC
Confidence 99999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=268.73 Aligned_cols=236 Identities=28% Similarity=0.391 Sum_probs=182.7
Q ss_pred CCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccc--------
Q 048243 5 CGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR-------- 74 (303)
Q Consensus 5 ~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------- 74 (303)
+++.+|+|.++... ......+..|+.+++.+ +|+||+++++++......++||||+.+++|.+++.....
T Consensus 49 ~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~ 128 (307)
T cd05098 49 RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYN 128 (307)
T ss_pred ccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccc
Confidence 34579999997542 33456788899999999 899999999999999999999999999999999864221
Q ss_pred -----cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccc
Q 048243 75 -----RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGT 149 (303)
Q Consensus 75 -----~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~ 149 (303)
...+++..++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||.+................++
T Consensus 129 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~ 205 (307)
T cd05098 129 PTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 205 (307)
T ss_pred cccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCc
Confidence 235788999999999999999999998 999999999999999999999999998765432211111122345
Q ss_pred cCCCChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHH
Q 048243 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLM 228 (303)
Q Consensus 150 ~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
..|+|||.+.+..++.++||||||+++|+|++ |..||..... ............. ..+...+.
T Consensus 206 ~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~~~---------~~~~~~~~ 269 (307)
T cd05098 206 VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-------EELFKLLKEGHRM---------DKPSNCTN 269 (307)
T ss_pred cceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-------HHHHHHHHcCCCC---------CCCCcCCH
Confidence 68999999988889999999999999999998 7788743221 1111111111111 11112345
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHhcccc
Q 048243 229 RCLEIALLCVQENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 229 ~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~ 259 (303)
.+.+++.+||..+|.+|||+.++++.|+...
T Consensus 270 ~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 270 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred HHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 7889999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=261.25 Aligned_cols=230 Identities=21% Similarity=0.298 Sum_probs=180.6
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+++.+++|.+........+.+.+|+++++.++|+||+++++++......++|+||+.+++|..++.. ....+++..+
T Consensus 28 ~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~--~~~~l~~~~~ 105 (282)
T cd06643 28 ETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTEPQI 105 (282)
T ss_pred CCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHh--cCCCCCHHHH
Confidence 35788999999766655667788999999999999999999999999999999999999999887743 2356899999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc----
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR---- 159 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---- 159 (303)
+.++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++....... .......++..|+|||.+.
T Consensus 106 ~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~ 180 (282)
T cd06643 106 RVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETS 180 (282)
T ss_pred HHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--cccccccccccccCHhhccccCC
Confidence 999999999999999999 9999999999999999999999999986543221 1122346788999999874
Q ss_pred -cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcc
Q 048243 160 -QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238 (303)
Q Consensus 160 -~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 238 (303)
+..++.++||||+||++|+|++|..||....... ......... .... ..+...+..+.+++.+||
T Consensus 181 ~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~-~~~~-------~~~~~~~~~~~~li~~~l 246 (282)
T cd06643 181 KDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSE-PPTL-------AQPSRWSSEFKDFLKKCL 246 (282)
T ss_pred CCCCCCccchhhhHHHHHHHHccCCCCccccCHHH------HHHHHhhcC-CCCC-------CCccccCHHHHHHHHHHc
Confidence 3457789999999999999999999985432111 111111110 0000 011123457889999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 048243 239 QENPNDRPSMLQVSSM 254 (303)
Q Consensus 239 ~~dp~~Rpt~~el~~~ 254 (303)
..||.+||++.++++.
T Consensus 247 ~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 247 EKNVDARWTTTQLLQH 262 (282)
T ss_pred cCChhhCcCHHHHhcC
Confidence 9999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=267.85 Aligned_cols=220 Identities=22% Similarity=0.282 Sum_probs=173.7
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCC-CCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+|+.||+|++.... ....+.+..|+.++..+. |++|+++++++......++||||+++|+|..++. ....++
T Consensus 23 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~---~~~~l~ 99 (323)
T cd05615 23 GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ---QVGKFK 99 (323)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHH---HcCCCC
Confidence 578999999997542 233456778888888885 6778899999999999999999999999998884 345689
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++....... .......|+..|+|||.+.
T Consensus 100 ~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~ 174 (323)
T cd05615 100 EPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIAPEIIA 174 (323)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC--ccccCccCCccccCHHHHc
Confidence 9999999999999999999999 9999999999999999999999999987533221 1122346899999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++||||+||++|+|++|..||....... ... ....... ..+...+..+.+++.+||+
T Consensus 175 ~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~---~i~~~~~-----------~~p~~~~~~~~~li~~~l~ 237 (323)
T cd05615 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LFQ---SIMEHNV-----------SYPKSLSKEAVSICKGLMT 237 (323)
T ss_pred CCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HHH---HHHhCCC-----------CCCccCCHHHHHHHHHHcc
Confidence 8889999999999999999999999986432211 111 1111110 0111223477899999999
Q ss_pred CCCCCCCCH
Q 048243 240 ENPNDRPSM 248 (303)
Q Consensus 240 ~dp~~Rpt~ 248 (303)
.||.+|++.
T Consensus 238 ~~p~~R~~~ 246 (323)
T cd05615 238 KHPSKRLGC 246 (323)
T ss_pred cCHhhCCCC
Confidence 999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=259.53 Aligned_cols=228 Identities=25% Similarity=0.434 Sum_probs=180.7
Q ss_pred CCCcEEEEEEecCCCcc---------cHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccc
Q 048243 4 PCGKVIAVKKLSKTSTQ---------GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR 74 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 74 (303)
.+++.+|+|.+...... ..+.+.+|+.++++++||||+++++++......+++|||+++++|.+++. .
T Consensus 23 ~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~ 99 (267)
T cd06628 23 SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN---N 99 (267)
T ss_pred CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHH---h
Confidence 46789999988654322 12467889999999999999999999999999999999999999999984 3
Q ss_pred cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc----cccccccccc
Q 048243 75 RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE----ANTEQVVGTI 150 (303)
Q Consensus 75 ~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~----~~~~~~~g~~ 150 (303)
...+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||.++........ .......|+.
T Consensus 100 ~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (267)
T cd06628 100 YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176 (267)
T ss_pred ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCc
Confidence 456888999999999999999999998 999999999999999999999999998766532211 1112235788
Q ss_pred CCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHH
Q 048243 151 GYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRC 230 (303)
Q Consensus 151 ~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 230 (303)
.|+|||.+.+..++.++|+||||+++|+|++|..||...... ........ . .....+...+..+
T Consensus 177 ~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~---------~~~~~~~~~~~~~ 240 (267)
T cd06628 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------QAIFKIGE-N---------ASPEIPSNISSEA 240 (267)
T ss_pred CccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------HHHHHHhc-c---------CCCcCCcccCHHH
Confidence 999999999888899999999999999999999998643211 11111111 0 0111112234578
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 048243 231 LEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 231 ~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
.+++.+||+.||.+||++.|+++
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 241 IDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhh
Confidence 89999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=263.03 Aligned_cols=245 Identities=23% Similarity=0.291 Sum_probs=179.0
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+|+.||+|+++... ....+.+.+|+.+++.++||||+++++++..+...++||||+. ++|.+++.....+..+++.
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~ 101 (285)
T cd07861 23 KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAE 101 (285)
T ss_pred CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHH
Confidence 478999999986542 2334678899999999999999999999999999999999997 5888887553444678999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
.++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+.
T Consensus 102 ~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~ 176 (285)
T cd07861 102 LVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--RVYTHEVVTLWYRAPEVLLGS 176 (285)
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc--ccccCCcccccccChHHhcCC
Confidence 99999999999999999998 9999999999999999999999999987554321 112223568899999988654
Q ss_pred -CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHH-----HHHHhCCCcceeccccC-------CCCCCHHHHH
Q 048243 162 -VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA-----YELWKGGKGVEFVDSSL-------DDTNSPCKLM 228 (303)
Q Consensus 162 -~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~-------~~~~~~~~~~ 228 (303)
.++.++||||||+++|+|++|+.||............... ...|.......-..... ........+.
T Consensus 177 ~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (285)
T cd07861 177 PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDE 256 (285)
T ss_pred CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCH
Confidence 4788999999999999999999998643211100000000 00000000000000000 0000111345
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 229 RCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 229 ~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
++.++|.+||..||.+|||+.+++..
T Consensus 257 ~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 257 DGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 77899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=269.37 Aligned_cols=220 Identities=22% Similarity=0.273 Sum_probs=173.8
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+++.||+|+++... ....+.+..|..++..+ +|++|+++++++......++||||+++|+|..++. ....++
T Consensus 23 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~---~~~~~~ 99 (323)
T cd05616 23 GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQ---QVGRFK 99 (323)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHH---HcCCCC
Confidence 467899999997542 22334567788888877 68999999999999999999999999999988884 345688
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..+..++.||+.||+|||+.| ++||||||+||+++.++.++|+|||++....... .......|++.|+|||++.
T Consensus 100 ~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~ 174 (323)
T cd05616 100 EPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPDYIAPEIIA 174 (323)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC--CccccCCCChhhcCHHHhc
Confidence 9999999999999999999999 9999999999999999999999999986533221 1223356899999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++|||||||++|+|++|..||....... ... ...... ...+...+.++.+++.+||+
T Consensus 175 ~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~~---~i~~~~-----------~~~p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQ---SIMEHN-----------VAYPKSMSKEAVAICKGLMT 237 (323)
T ss_pred CCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---HHH---HHHhCC-----------CCCCCcCCHHHHHHHHHHcc
Confidence 9999999999999999999999999996433211 111 111110 01111234578899999999
Q ss_pred CCCCCCCCH
Q 048243 240 ENPNDRPSM 248 (303)
Q Consensus 240 ~dp~~Rpt~ 248 (303)
.||.+|++.
T Consensus 238 ~~p~~R~~~ 246 (323)
T cd05616 238 KHPGKRLGC 246 (323)
T ss_pred cCHHhcCCC
Confidence 999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=259.65 Aligned_cols=241 Identities=23% Similarity=0.362 Sum_probs=183.1
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeC--CeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+++.||+|.++... ......+.+|+.+++.++||||+++++++... ...++||||+++++|.+++.. ....+++
T Consensus 31 ~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--~~~~~~~ 108 (284)
T cd05079 31 NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR--NKNKINL 108 (284)
T ss_pred CccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHh--ccCCCCH
Confidence 468899999987553 33446789999999999999999999998875 568999999999999998843 2235889
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-ccccccccccCCCChhhhc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~ 159 (303)
..+..++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++......... .......++..|+|||.+.
T Consensus 109 ~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~ 185 (284)
T cd05079 109 KQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185 (284)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhc
Confidence 999999999999999999999 999999999999999999999999998765443221 1223345677899999998
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCC--------ccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHH
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGIN--------ENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL 231 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
+..++.++||||||+++|+|+++..|....... .................. .......+..+.
T Consensus 186 ~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~ 256 (284)
T cd05079 186 QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKR---------LPRPPNCPEEVY 256 (284)
T ss_pred cCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCcc---------CCCCCCCCHHHH
Confidence 888999999999999999999977654221100 000001111111111111 011112345789
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhccc
Q 048243 232 EIALLCVQENPNDRPSMLQVSSMLKNE 258 (303)
Q Consensus 232 ~li~~~l~~dp~~Rpt~~el~~~L~~~ 258 (303)
+|+.+||+.||.+|||+.++++.|+..
T Consensus 257 ~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 257 QLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=257.18 Aligned_cols=236 Identities=24% Similarity=0.338 Sum_probs=173.8
Q ss_pred CcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccc--cccCCHHH
Q 048243 6 GKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR--RLILDWKK 82 (303)
Q Consensus 6 ~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~l~~~~ 82 (303)
...+|+|.+.... ......+.+|+..++.++|+||+++++.+......++||||+++|+|.+++..... ....++..
T Consensus 22 ~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 101 (269)
T cd05042 22 KARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV 101 (269)
T ss_pred CeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHH
Confidence 4578888876443 23345688999999999999999999999999999999999999999999865322 23356778
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc--
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ-- 160 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-- 160 (303)
.+.++.||+.|++|||+.+ ++||||||+||+++.++.++|+|||++................++..|+|||++..
T Consensus 102 ~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 178 (269)
T cd05042 102 LQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178 (269)
T ss_pred HHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhcc
Confidence 8999999999999999998 99999999999999999999999999865433221111223345678999998743
Q ss_pred -----CCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHH
Q 048243 161 -----GVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIA 234 (303)
Q Consensus 161 -----~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
..++.++|||||||++|+|++ |..||....... ........ ....+..+... ...+..+.+++
T Consensus 179 ~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~~~ 247 (269)
T cd05042 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVRE-QDIKLPKPQLD----LKYSDRWYEVM 247 (269)
T ss_pred ccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhhc-cCccCCCCccc----ccCCHHHHHHH
Confidence 346789999999999999998 677775332111 11111111 11111111111 22334667788
Q ss_pred HHcccCCCCCCCCHHHHHHHhc
Q 048243 235 LLCVQENPNDRPSMLQVSSMLK 256 (303)
Q Consensus 235 ~~~l~~dp~~Rpt~~el~~~L~ 256 (303)
..|| .||++|||+.+|++.|.
T Consensus 248 ~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 248 QFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred HHHh-cCcccccCHHHHHHHhc
Confidence 9998 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=274.25 Aligned_cols=241 Identities=22% Similarity=0.280 Sum_probs=178.4
Q ss_pred CCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCC-----eeEEEEeecCCCChhhhhcCccccc
Q 048243 4 PCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE-----ERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~ 76 (303)
.+|+.||+|++... .....+.+.+|+.+++.++|+||+++++++.... ..|+||||+. ++|.+++. ...
T Consensus 23 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~ 98 (372)
T cd07853 23 RDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIV---SPQ 98 (372)
T ss_pred CCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHh---cCC
Confidence 57899999998653 2234467889999999999999999999998776 7899999996 57777763 345
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChh
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE 156 (303)
.+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||++........ .......++..|+|||
T Consensus 99 ~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE 174 (372)
T cd07853 99 PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-KHMTQEVVTQYYRAPE 174 (372)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecccCcc-ccCCCCCcCCCcCCHH
Confidence 6899999999999999999999999 99999999999999999999999999876433221 1122345788999999
Q ss_pred hhccC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHH----------------HHHHH-hCCCcceeccccC
Q 048243 157 YARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH----------------AYELW-KGGKGVEFVDSSL 218 (303)
Q Consensus 157 ~~~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~----------------~~~~~-~~~~~~~~~~~~~ 218 (303)
.+.+. .++.++||||+||++|+|++|..||...........+.. ....+ .............
T Consensus 175 ~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (372)
T cd07853 175 ILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLY 254 (372)
T ss_pred HHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhc
Confidence 98875 478899999999999999999999965433221111100 00000 0000000000000
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 219 DDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 219 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
......+.++.+|+.+||+.||++|||+.|+++.
T Consensus 255 --~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 255 --TLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred --ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0011124578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=267.90 Aligned_cols=242 Identities=24% Similarity=0.359 Sum_probs=178.3
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+++.||+|.++... ......+.+|+.++++++||||+++++++..+...++||||+.+ +|.+++.. .+..+++..
T Consensus 29 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~ 105 (309)
T cd07872 29 LTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDD--CGNIMSMHN 105 (309)
T ss_pred CCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHh--cCCCCCHHH
Confidence 467889999987543 23334677899999999999999999999999999999999975 77777643 234578899
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc-C
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ-G 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~ 161 (303)
++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||.+........ ......++..|+|||.+.+ .
T Consensus 106 ~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~ 180 (309)
T cd07872 106 VKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSS 180 (309)
T ss_pred HHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc--ccccccccccccCCHHHhCCC
Confidence 9999999999999999999 99999999999999999999999999875433221 1222457889999998865 4
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHH-----HHHhCCCcc-eecc---ccCC----CCCCHHHHH
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY-----ELWKGGKGV-EFVD---SSLD----DTNSPCKLM 228 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~-~~~~---~~~~----~~~~~~~~~ 228 (303)
.++.++||||||+++|+|++|..||......+......... ..|...... .... +... ....+..+.
T Consensus 181 ~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (309)
T cd07872 181 EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDT 260 (309)
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCH
Confidence 57889999999999999999999996554332221111100 001000000 0000 0000 000112345
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 229 RCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 229 ~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
++.+++.+||+.||.+|||+.|+++
T Consensus 261 ~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 261 EGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred HHHHHHHHhccCChhhCCCHHHHhc
Confidence 7789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=264.49 Aligned_cols=241 Identities=22% Similarity=0.292 Sum_probs=180.6
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.+|+|.++... ......+.+|++++++++||||+++++++..+...++||||+++++|.+++.. ...+++..
T Consensus 24 ~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~---~~~~~~~~ 100 (308)
T cd06615 24 PSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---AGRIPENI 100 (308)
T ss_pred CCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHh---cCCCCHHH
Confidence 468889999987553 23345688999999999999999999999999999999999999999999843 35688999
Q ss_pred HHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 83 RVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
+..++.|++.||+|||+ .+ ++|+||+|+||+++.++.++|+|||++...... ......|+..|+|||.+.+.
T Consensus 101 ~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~ 173 (308)
T cd06615 101 LGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGT 173 (308)
T ss_pred HHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc----ccccCCCCcCccChhHhcCC
Confidence 99999999999999997 46 999999999999999999999999988654322 12234678999999999888
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCc-----------------ce----eccccCCC
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG-----------------VE----FVDSSLDD 220 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~----~~~~~~~~ 220 (303)
.++.++|+||||+++|+|++|..||........................ .+ ........
T Consensus 174 ~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (308)
T cd06615 174 HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPK 253 (308)
T ss_pred CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCcc
Confidence 8899999999999999999999998533211111000000000000000 00 00000000
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 221 TNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 221 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
......+..+.+++.+||..||++|||+.++++.
T Consensus 254 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 254 LPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111234578899999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=262.86 Aligned_cols=232 Identities=23% Similarity=0.375 Sum_probs=180.2
Q ss_pred EEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHH
Q 048243 8 VIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86 (303)
Q Consensus 8 ~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~ 86 (303)
.||+|.++... ......+.+|+.++..++|+||+++++++.. ...+++++|+++|+|.+++.. ....+++..++.+
T Consensus 38 ~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~ 114 (279)
T cd05109 38 PVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRE--NKDRIGSQDLLNW 114 (279)
T ss_pred EEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhh--ccCCCCHHHHHHH
Confidence 58999987543 3345678899999999999999999999875 457899999999999998853 2346899999999
Q ss_pred HHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCCCc
Q 048243 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTK 166 (303)
Q Consensus 87 ~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 166 (303)
+.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++...............++..|+|||...+..++.+
T Consensus 115 ~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~ 191 (279)
T cd05109 115 CVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQ 191 (279)
T ss_pred HHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCch
Confidence 999999999999999 99999999999999999999999999876643322211222234678999999988889999
Q ss_pred cchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 048243 167 SDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDR 245 (303)
Q Consensus 167 ~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 245 (303)
+|||||||++|+|++ |..||....... ............ .....+..+.+++.+||..||++|
T Consensus 192 ~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~R 255 (279)
T cd05109 192 SDVWSYGVTVWELMTFGAKPYDGIPARE-------IPDLLEKGERLP---------QPPICTIDVYMIMVKCWMIDSECR 255 (279)
T ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCcCC---------CCccCCHHHHHHHHHHcCCChhhC
Confidence 999999999999998 888875332111 111122111111 111234478899999999999999
Q ss_pred CCHHHHHHHhccccCC
Q 048243 246 PSMLQVSSMLKNETTN 261 (303)
Q Consensus 246 pt~~el~~~L~~~~~~ 261 (303)
|++.++++.|+.....
T Consensus 256 p~~~~l~~~l~~~~~~ 271 (279)
T cd05109 256 PRFRELVDEFSRMARD 271 (279)
T ss_pred cCHHHHHHHHHHhhcC
Confidence 9999999998776543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=261.49 Aligned_cols=231 Identities=26% Similarity=0.419 Sum_probs=180.3
Q ss_pred cEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHH
Q 048243 7 KVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVH 85 (303)
Q Consensus 7 ~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~ 85 (303)
..||+|.++.. .......+..|+.+++.++||||+++++++..+...++||||+.+++|.+++.. ....+++..++.
T Consensus 33 ~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~ 110 (269)
T cd05065 33 IFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQ--NDGQFTVIQLVG 110 (269)
T ss_pred eeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhh--CCCCCCHHHHHH
Confidence 46999999755 344456899999999999999999999999999999999999999999998854 234688999999
Q ss_pred HHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccc---cccCCCChhhhccCC
Q 048243 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVV---GTIGYIPPEYARQGV 162 (303)
Q Consensus 86 ~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~---g~~~y~aPE~~~~~~ 162 (303)
++.|++.|++|||+.| ++|+||+|+||+++.++.++|+|||.+................ .+..|+|||.+.+..
T Consensus 111 i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 187 (269)
T cd05065 111 MLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK 187 (269)
T ss_pred HHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCc
Confidence 9999999999999998 9999999999999999999999999987654332211111111 245799999999888
Q ss_pred CCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
++.++||||+|+++|++++ |..||....... .. ........ .......+..+.+++.+||..+
T Consensus 188 ~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~----~~i~~~~~---------~~~~~~~~~~~~~li~~~l~~~ 251 (269)
T cd05065 188 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VI----NAIEQDYR---------LPPPMDCPTALHQLMLDCWQKD 251 (269)
T ss_pred ccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HH----HHHHcCCc---------CCCcccCCHHHHHHHHHHcCCC
Confidence 9999999999999999886 888885432211 11 11111100 0111122346789999999999
Q ss_pred CCCCCCHHHHHHHhccc
Q 048243 242 PNDRPSMLQVSSMLKNE 258 (303)
Q Consensus 242 p~~Rpt~~el~~~L~~~ 258 (303)
|.+||++.+++..|++.
T Consensus 252 p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 252 RNARPKFGQIVSTLDKM 268 (269)
T ss_pred hhhCcCHHHHHHHHHhh
Confidence 99999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=275.24 Aligned_cols=237 Identities=27% Similarity=0.390 Sum_probs=183.4
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCC-CCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc--------
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-------- 73 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------- 73 (303)
.+++.||+|+++... ....+.+.+|+.++..+. ||||+++++++......++||||+.+|+|.+++....
T Consensus 65 ~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~ 144 (401)
T cd05107 65 QSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYL 144 (401)
T ss_pred CCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhc
Confidence 456789999997653 233457889999999997 9999999999999889999999999999999885321
Q ss_pred --------------------------------------------------------------------------------
Q 048243 74 -------------------------------------------------------------------------------- 73 (303)
Q Consensus 74 -------------------------------------------------------------------------------- 73 (303)
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (401)
T cd05107 145 DKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERT 224 (401)
T ss_pred ccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCc
Confidence
Q ss_pred -------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcccccccc
Q 048243 74 -------RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQV 146 (303)
Q Consensus 74 -------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~ 146 (303)
....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++..............
T Consensus 225 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 301 (401)
T cd05107 225 RRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGST 301 (401)
T ss_pred chhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCc
Confidence 0123567788999999999999999998 999999999999999999999999998765332221122223
Q ss_pred ccccCCCChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHH
Q 048243 147 VGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPC 225 (303)
Q Consensus 147 ~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (303)
.++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ........+... ..+..
T Consensus 302 ~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~------~~~~~~~~~~~~---------~~p~~ 366 (401)
T cd05107 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE------QFYNAIKRGYRM---------AKPAH 366 (401)
T ss_pred CCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH------HHHHHHHcCCCC---------CCCCC
Confidence 56788999999998889999999999999999998 888875432111 111111111111 11112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhccc
Q 048243 226 KLMRCLEIALLCVQENPNDRPSMLQVSSMLKNE 258 (303)
Q Consensus 226 ~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~ 258 (303)
.+..+.+++.+||..+|.+||++.+|++.|++.
T Consensus 367 ~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 367 ASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 345788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=279.48 Aligned_cols=237 Identities=18% Similarity=0.231 Sum_probs=170.9
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeC--------CeeEEEEeecCCCChhhhhcCc-cc
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--------EERMLVYEYMPNKSLDCYLFDP-IR 74 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~-~~ 74 (303)
.+++.||||++.... ....+|+.+++.++||||+++++++... ...++||||+++ +|.+++... ..
T Consensus 89 ~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~ 163 (440)
T PTZ00036 89 DTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARN 163 (440)
T ss_pred CCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhc
Confidence 578999999885432 2345799999999999999999887532 246799999975 666665321 23
Q ss_pred cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCC-ceEEcccccccccccCCccccccccccccCCC
Q 048243 75 RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM-KPKISDFGLARIFAKESLEANTEQVVGTIGYI 153 (303)
Q Consensus 75 ~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~-~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~ 153 (303)
...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++ .+||+|||+++.+..... .....|++.|+
T Consensus 164 ~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~ 237 (440)
T PTZ00036 164 NHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR---SVSYICSRFYR 237 (440)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccchhccCCCC---cccCCCCcCcc
Confidence 567899999999999999999999999 99999999999999665 699999999976543221 12246789999
Q ss_pred ChhhhccC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCC----------cceeccc-----c
Q 048243 154 PPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK----------GVEFVDS-----S 217 (303)
Q Consensus 154 aPE~~~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~-----~ 217 (303)
|||++.+. .++.++|||||||++|+|++|.+||.......... .......... ...+..+ .
T Consensus 238 aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~---~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 314 (440)
T PTZ00036 238 APELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV---RIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKD 314 (440)
T ss_pred CHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCCHHHHHHhchhhhcccCCccCchh
Confidence 99998764 68999999999999999999999996543222111 1111110000 0000000 0
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 218 LDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 218 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
+....+...+.++.+||.+||+.||.+|||+.|+++.
T Consensus 315 l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 315 LKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0000111234578899999999999999999999853
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=264.47 Aligned_cols=228 Identities=22% Similarity=0.347 Sum_probs=182.3
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+|+.||+|.+........+.+.+|+..+..++||||+++++++......++++||+++++|..++ ....+++..+
T Consensus 44 ~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~----~~~~~~~~~~ 119 (297)
T cd06659 44 HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIV----SQTRLNEEQI 119 (297)
T ss_pred CCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHH----hhcCCCHHHH
Confidence 468999999997655555677889999999999999999999999999999999999999998877 3345889999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
+.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ ......|+..|+|||.+.+..+
T Consensus 120 ~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 194 (297)
T cd06659 120 ATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRTPY 194 (297)
T ss_pred HHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccceecCccccCHHHHccCCC
Confidence 999999999999999998 99999999999999999999999999865433221 1223567899999999998889
Q ss_pred CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCC
Q 048243 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 243 (303)
+.++||||||+++|+|++|..||....... ... ......... .......+..+.+++.+||+.+|.
T Consensus 195 ~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~----~~~~~~~~~-------~~~~~~~~~~l~~~i~~~l~~~P~ 260 (297)
T cd06659 195 GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AMK----RLRDSPPPK-------LKNAHKISPVLRDFLERMLTREPQ 260 (297)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH----HHhccCCCC-------ccccCCCCHHHHHHHHHHhcCCcc
Confidence 999999999999999999999986332111 111 111110000 001112234678999999999999
Q ss_pred CCCCHHHHHHH
Q 048243 244 DRPSMLQVSSM 254 (303)
Q Consensus 244 ~Rpt~~el~~~ 254 (303)
+||++.++++.
T Consensus 261 ~Rps~~~ll~~ 271 (297)
T cd06659 261 ERATAQELLDH 271 (297)
T ss_pred cCcCHHHHhhC
Confidence 99999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=264.71 Aligned_cols=228 Identities=23% Similarity=0.345 Sum_probs=182.0
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+++.||||.+........+.+.+|+..++.++|+||+++++.+......++||||+++++|.+++. ...+++..+
T Consensus 45 ~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~l~~~~~ 120 (292)
T cd06658 45 HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVT----HTRMNEEQI 120 (292)
T ss_pred CCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHh----cCCCCHHHH
Confidence 4688999999876555556678899999999999999999999999999999999999999988873 345889999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
+.++.||+.||+|||+.+ ++||||+|+||+++.++.++|+|||++....... .......|+..|+|||.+.+..+
T Consensus 121 ~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~ 195 (292)
T cd06658 121 ATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRKSLVGTPYWMAPEVISRLPY 195 (292)
T ss_pred HHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCceeecCccccCHHHHccCCC
Confidence 999999999999999998 9999999999999999999999999986543322 11223467899999999988889
Q ss_pred CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCC
Q 048243 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 243 (303)
+.++||||||+++|+|++|..||....... ... ..... ....+. .....+..+.+++.+||..||.
T Consensus 196 ~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~----~~~~~-----~~~~~~--~~~~~~~~~~~li~~~l~~~P~ 261 (292)
T cd06658 196 GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AMR----RIRDN-----LPPRVK--DSHKVSSVLRGFLDLMLVREPS 261 (292)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH----HHHhc-----CCCccc--cccccCHHHHHHHHHHccCChh
Confidence 999999999999999999999986432111 111 11100 001110 0112344688999999999999
Q ss_pred CCCCHHHHHHH
Q 048243 244 DRPSMLQVSSM 254 (303)
Q Consensus 244 ~Rpt~~el~~~ 254 (303)
+|||+.++++.
T Consensus 262 ~Rpt~~~il~~ 272 (292)
T cd06658 262 QRATAQELLQH 272 (292)
T ss_pred HCcCHHHHhhC
Confidence 99999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=260.72 Aligned_cols=231 Identities=25% Similarity=0.387 Sum_probs=177.6
Q ss_pred EEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHH
Q 048243 8 VIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86 (303)
Q Consensus 8 ~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~ 86 (303)
.+++|.+.... ......+..|+..+..++||||+++++++.. ...++++||+.+|+|.+++.. ....+++..+..+
T Consensus 38 ~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i 114 (279)
T cd05111 38 PVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQ--HRDSLDPQRLLNW 114 (279)
T ss_pred EEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHh--cccCCCHHHHHHH
Confidence 47788875432 2234567788889999999999999998754 457899999999999999853 2456899999999
Q ss_pred HHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCCCc
Q 048243 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTK 166 (303)
Q Consensus 87 ~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 166 (303)
+.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||.++...............++..|+|||.+.+..++.+
T Consensus 115 ~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~ 191 (279)
T cd05111 115 CVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQ 191 (279)
T ss_pred HHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCch
Confidence 999999999999998 99999999999999999999999999876543322222233456778999999988889999
Q ss_pred cchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 048243 167 SDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDR 245 (303)
Q Consensus 167 ~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 245 (303)
+||||||+++|++++ |..||....... ............ .+ ...+..+.+++.+||..||.+|
T Consensus 192 ~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~--~~-------~~~~~~~~~li~~c~~~~p~~R 255 (279)
T cd05111 192 SDVWSYGVTVWEMMSYGAEPYAGMRPHE-------VPDLLEKGERLA--QP-------QICTIDVYMVMVKCWMIDENVR 255 (279)
T ss_pred hhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCcCC--CC-------CCCCHHHHHHHHHHcCCCcccC
Confidence 999999999999998 888885432111 111222111111 00 0122367789999999999999
Q ss_pred CCHHHHHHHhccccC
Q 048243 246 PSMLQVSSMLKNETT 260 (303)
Q Consensus 246 pt~~el~~~L~~~~~ 260 (303)
||+.|+++.|.....
T Consensus 256 ps~~el~~~l~~~~~ 270 (279)
T cd05111 256 PTFKELANEFTRMAR 270 (279)
T ss_pred cCHHHHHHHHHHHHh
Confidence 999999999877653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=261.63 Aligned_cols=226 Identities=23% Similarity=0.327 Sum_probs=181.0
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.||+|.+.... ....+.+.+|+.+++.++||||+++++.+..+...++||||+++++|.+++. ...+++..
T Consensus 27 ~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~ 102 (277)
T cd06642 27 RTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK----PGPLEETY 102 (277)
T ss_pred CCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhh----cCCCCHHH
Confidence 467899999987543 3345678899999999999999999999999999999999999999998873 34588999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ......|+..|+|||.+.+..
T Consensus 103 ~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~ 177 (277)
T cd06642 103 IATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSA 177 (277)
T ss_pred HHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch--hhhcccCcccccCHHHhCcCC
Confidence 9999999999999999998 99999999999999999999999999876543221 122245788999999999888
Q ss_pred CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC
Q 048243 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 242 (303)
++.++|+||||+++|+|++|..|+......... ....... ........+..+.+++.+||+.+|
T Consensus 178 ~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p 241 (277)
T cd06642 178 YDFKADIWSLGITAIELAKGEPPNSDLHPMRVL-------FLIPKNS---------PPTLEGQYSKPFKEFVEACLNKDP 241 (277)
T ss_pred CchhhhHHHHHHHHHHHHhCCCCCcccchhhHH-------hhhhcCC---------CCCCCcccCHHHHHHHHHHccCCc
Confidence 999999999999999999999997533211100 0011000 011112234578899999999999
Q ss_pred CCCCCHHHHHHH
Q 048243 243 NDRPSMLQVSSM 254 (303)
Q Consensus 243 ~~Rpt~~el~~~ 254 (303)
.+||++.+++..
T Consensus 242 ~~Rp~~~~il~~ 253 (277)
T cd06642 242 RFRPTAKELLKH 253 (277)
T ss_pred ccCcCHHHHHHh
Confidence 999999999874
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=262.05 Aligned_cols=245 Identities=23% Similarity=0.280 Sum_probs=182.9
Q ss_pred CCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+|+.||+|+++.. .....+.+.+|+.+++.++|+||+++++++......+++|||+.+++|.+++... ....+++.
T Consensus 23 ~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~-~~~~~~~~ 101 (314)
T cd08216 23 PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTH-FPEGLPEL 101 (314)
T ss_pred CCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHh-cccCCCHH
Confidence 37899999999755 3345568999999999999999999999999999999999999999999988542 23458899
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-----ccccccccccCCCChh
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-----ANTEQVVGTIGYIPPE 156 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-----~~~~~~~g~~~y~aPE 156 (303)
.+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+||+.+......... .......++..|+|||
T Consensus 102 ~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 178 (314)
T cd08216 102 AIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE 178 (314)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHH
Confidence 99999999999999999999 999999999999999999999999988654322111 1112234677899999
Q ss_pred hhccC--CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHH-----------hCCCcc--------eecc
Q 048243 157 YARQG--VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELW-----------KGGKGV--------EFVD 215 (303)
Q Consensus 157 ~~~~~--~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~~--------~~~~ 215 (303)
++.+. .++.++|+||+||++|+|++|..||....... .......... ...... ....
T Consensus 179 ~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (314)
T cd08216 179 VLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNR 256 (314)
T ss_pred HhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhcCCcCcccccccccchh
Confidence 98764 57889999999999999999999986432211 0011000000 000000 0000
Q ss_pred ccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 216 SSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 216 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
...........+..+.+++.+||..||++|||+.++++.
T Consensus 257 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 257 DSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 011111223445678899999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=255.78 Aligned_cols=229 Identities=23% Similarity=0.335 Sum_probs=184.5
Q ss_pred CCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+|+.+++|.+... .......+.+|+.++++++|+||+++++++.+....+++|||+++++|.+++... ....+++.
T Consensus 23 ~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~-~~~~~~~~ 101 (256)
T cd08221 23 EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQ-KGQLFEEE 101 (256)
T ss_pred CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhc-cccCCCHH
Confidence 56889999998654 2444567889999999999999999999999999999999999999999988542 24568899
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
.+..++.|++.+++|||+.+ ++|+||+|+||+++.++.++|+|||.+........ ......|+..|.|||.+.+.
T Consensus 102 ~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~ 176 (256)
T cd08221 102 MVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGV 176 (256)
T ss_pred HHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCCC
Confidence 99999999999999999998 99999999999999999999999999876544331 22335678999999999888
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
.++.++|+||||+++|+|++|..||....... .......+. ... .....+..+.+++.+||..+
T Consensus 177 ~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~~~~-~~~---------~~~~~~~~~~~~i~~~l~~~ 240 (256)
T cd08221 177 KYNFKSDIWALGCVLYELLTLKRTFDATNPLN------LVVKIVQGN-YTP---------VVSVYSSELISLVHSLLQQD 240 (256)
T ss_pred CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHcCC-CCC---------CccccCHHHHHHHHHHcccC
Confidence 88999999999999999999999985432111 111111111 100 11233457889999999999
Q ss_pred CCCCCCHHHHHHH
Q 048243 242 PNDRPSMLQVSSM 254 (303)
Q Consensus 242 p~~Rpt~~el~~~ 254 (303)
|.+||++.++++.
T Consensus 241 p~~R~s~~~ll~~ 253 (256)
T cd08221 241 PEKRPTADEVLDQ 253 (256)
T ss_pred cccCCCHHHHhhC
Confidence 9999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=258.20 Aligned_cols=231 Identities=29% Similarity=0.448 Sum_probs=181.0
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
+.+++.+|+|.+..... ....+.+|++++++++||||+++++++......++||||+.+++|.+++.. ....+++..
T Consensus 25 ~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~ 101 (256)
T cd05112 25 WLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRA--QRGKFSQET 101 (256)
T ss_pred EeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHh--CccCCCHHH
Confidence 34578899999865433 346788999999999999999999999999999999999999999988853 234578899
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
++.++.|++.++++||+.+ ++|+||+|+||+++.++.++|+|||.+......... ......++..|+|||.+.+..
T Consensus 102 ~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~ 177 (256)
T cd05112 102 LLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SSTGTKFPVKWSSPEVFSFSK 177 (256)
T ss_pred HHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-ccCCCccchhhcCHhHhccCC
Confidence 9999999999999999999 999999999999999999999999998765432211 111223467899999998888
Q ss_pred CCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
++.++||||||+++|+|++ |..||....... ......... .... +...+..+.+|+.+||..+
T Consensus 178 ~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~--~~~~-------~~~~~~~~~~l~~~~l~~~ 241 (256)
T cd05112 178 YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-------VVETINAGF--RLYK-------PRLASQSVYELMQHCWKER 241 (256)
T ss_pred cChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-------HHHHHhCCC--CCCC-------CCCCCHHHHHHHHHHcccC
Confidence 9999999999999999998 888875322111 111111110 0000 1112357889999999999
Q ss_pred CCCCCCHHHHHHHhc
Q 048243 242 PNDRPSMLQVSSMLK 256 (303)
Q Consensus 242 p~~Rpt~~el~~~L~ 256 (303)
|.+|||+.|+++.|.
T Consensus 242 p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 242 PEDRPSFSLLLHQLA 256 (256)
T ss_pred hhhCCCHHHHHHhhC
Confidence 999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=260.09 Aligned_cols=230 Identities=24% Similarity=0.297 Sum_probs=179.6
Q ss_pred CCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTST---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+++.||+|.+..... .....+.+|+.+++.++|++|+++++.+......++||||+.+++|.+++.. .....+++
T Consensus 23 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~~~l~~ 101 (285)
T cd05630 23 ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYH-MGEAGFEE 101 (285)
T ss_pred CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHH-hcccCCCH
Confidence 4688999999865432 2234577899999999999999999999999999999999999999988843 22345889
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....... ......|+..|+|||.+.+
T Consensus 102 ~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~ 175 (285)
T cd05630 102 GRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKN 175 (285)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc---cccCCCCCccccChHHHcC
Confidence 999999999999999999998 9999999999999999999999999986543221 1123468999999999998
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++||||+|+++|+|++|..||............. ...... ... .....+..+.+|+.+||+.
T Consensus 176 ~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~---~~~~~~------~~~----~~~~~~~~~~~li~~~l~~ 242 (285)
T cd05630 176 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---RLVKEV------QEE----YSEKFSPDARSLCKMLLCK 242 (285)
T ss_pred CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---hhhhhh------hhh----cCccCCHHHHHHHHHHhhc
Confidence 889999999999999999999999996432211111111 110000 000 1112234688999999999
Q ss_pred CCCCCCC-----HHHHHH
Q 048243 241 NPNDRPS-----MLQVSS 253 (303)
Q Consensus 241 dp~~Rpt-----~~el~~ 253 (303)
||.+||| +.|+++
T Consensus 243 ~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 243 DPKERLGCQGGGAREVKE 260 (285)
T ss_pred CHHHccCCCCCchHHHHc
Confidence 9999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=259.44 Aligned_cols=232 Identities=29% Similarity=0.426 Sum_probs=181.9
Q ss_pred CCCcEEEEEEecCCCcccH--HHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTSTQGF--EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+++.||+|.+........ .....|+..+++++||||+++++++.+....++|||++.+++|.+++. ....+++.
T Consensus 22 ~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~---~~~~~~~~ 98 (260)
T PF00069_consen 22 KNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQ---KNKPLSEE 98 (260)
T ss_dssp TTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHH---HHSSBBHH
T ss_pred CCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccccccccccc---cccccccc
Confidence 4677899999987754332 234569999999999999999999999999999999999999999984 45678999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc-c
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR-Q 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~ 160 (303)
.+..++.|++.||++||+.+ ++|+||||+||+++.++.++|+|||.+.... ..........++..|.|||.+. +
T Consensus 99 ~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~ 173 (260)
T PF00069_consen 99 EILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNENFNPFVGTPEYMAPEVLQQG 173 (260)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STTSEBSSSSSSGGGSCHHHHTTT
T ss_pred cccccccccccccccccccc---ccccccccccccccccccccccccccccccc--cccccccccccccccccccccccc
Confidence 99999999999999999999 9999999999999999999999999987641 1122333456789999999998 7
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++||||||+++|+|++|..||................... ........ ......+.+++.+||+.
T Consensus 174 ~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~---~~~~~~l~~li~~~l~~ 243 (260)
T PF00069_consen 174 KKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRP-------LPSSSQQS---REKSEELRDLIKKMLSK 243 (260)
T ss_dssp SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTH-------HHHHTTSH---TTSHHHHHHHHHHHSSS
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhccccc-------cccccccc---chhHHHHHHHHHHHccC
Confidence 788999999999999999999999987552122221111111100 00000000 00115889999999999
Q ss_pred CCCCCCCHHHHHH
Q 048243 241 NPNDRPSMLQVSS 253 (303)
Q Consensus 241 dp~~Rpt~~el~~ 253 (303)
||++|||+.++++
T Consensus 244 ~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 244 DPEQRPSAEELLK 256 (260)
T ss_dssp SGGGSTTHHHHHT
T ss_pred ChhHCcCHHHHhc
Confidence 9999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=246.87 Aligned_cols=226 Identities=26% Similarity=0.365 Sum_probs=187.9
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
+++-.||+|++.+.. .....++.+|+++...|+||||+++|++|.++...|+++||...|.+...|... ....+++
T Consensus 45 ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~-~~~~f~e 123 (281)
T KOG0580|consen 45 KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEG-RMKRFDE 123 (281)
T ss_pred cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhc-ccccccc
Confidence 567789999986542 233467899999999999999999999999999999999999999999888642 4556889
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
.....+..|++.|+.|+|.++ ++||||||+|+|++..|.++++|||-+.... .......+||.-|.+||...+
T Consensus 124 ~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p----~~kR~tlcgt~dyl~pEmv~~ 196 (281)
T KOG0580|consen 124 QRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP----SNKRKTLCGTLDYLPPEMVEG 196 (281)
T ss_pred cchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC----CCCceeeecccccCCHhhcCC
Confidence 999999999999999999999 9999999999999999999999999886532 233444689999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
...+...|+|++|++.||++.|.+||......+.+..+... +...+...+....++|.+||..
T Consensus 197 ~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~-----------------~~~~p~~is~~a~dlI~~ll~~ 259 (281)
T KOG0580|consen 197 RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV-----------------DLKFPSTISGGAADLISRLLVK 259 (281)
T ss_pred CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc-----------------cccCCcccChhHHHHHHHHhcc
Confidence 99999999999999999999999999755533322222111 1112233455788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 048243 241 NPNDRPSMLQVSSM 254 (303)
Q Consensus 241 dp~~Rpt~~el~~~ 254 (303)
+|.+|.+..|+++.
T Consensus 260 ~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 260 NPIERLALTEVMDH 273 (281)
T ss_pred CccccccHHHHhhh
Confidence 99999999999864
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=262.99 Aligned_cols=181 Identities=24% Similarity=0.347 Sum_probs=145.5
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEe--CCeeEEEEeecCCCChhhhhcCcc------cc
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCID--SEERMLVYEYMPNKSLDCYLFDPI------RR 75 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~------~~ 75 (303)
.+++.||+|.+..... ...+.+|+.+++.++||||+++++++.. +...+++|||+. ++|..++.... ..
T Consensus 26 ~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~ 102 (317)
T cd07868 26 KDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKP 102 (317)
T ss_pred CCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCc
Confidence 3678899999965432 2457789999999999999999999864 456889999986 47766664211 12
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEE----CCCCceEEcccccccccccCCcc-cccccccccc
Q 048243 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL----GEDMKPKISDFGLARIFAKESLE-ANTEQVVGTI 150 (303)
Q Consensus 76 ~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~----~~~~~v~l~Df~~~~~~~~~~~~-~~~~~~~g~~ 150 (303)
..+++..++.++.||+.||+|||+.| ++||||||+||++ +.++.++|+|||++......... .......||+
T Consensus 103 ~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~ 179 (317)
T cd07868 103 VQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179 (317)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccc
Confidence 35889999999999999999999999 9999999999999 45678999999999776443221 2223457899
Q ss_pred CCCChhhhccC-CCCCccchhhHHHHHHHHHhCCCCCccCC
Q 048243 151 GYIPPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCG 190 (303)
Q Consensus 151 ~y~aPE~~~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~ 190 (303)
.|+|||++.+. .++.++||||+||++|+|++|.+||....
T Consensus 180 ~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 99999998774 58899999999999999999999996433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=262.53 Aligned_cols=235 Identities=25% Similarity=0.413 Sum_probs=181.3
Q ss_pred CcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccc-------ccc
Q 048243 6 GKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR-------RLI 77 (303)
Q Consensus 6 ~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~ 77 (303)
+..||+|.++... ......+.+|+..++.++|+||+++++++......++||||+.+|+|.+++..... ...
T Consensus 36 ~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 115 (288)
T cd05061 36 ETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 115 (288)
T ss_pred ceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCC
Confidence 5589999986543 22334678899999999999999999999998999999999999999999854211 233
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhh
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 157 (303)
.....+..++.|++.||+|||+++ ++||||||+||+++.++.++|+|||+++...............++..|+|||.
T Consensus 116 ~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~ 192 (288)
T cd05061 116 PTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPES 192 (288)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHH
Confidence 466788999999999999999999 99999999999999999999999999876543322222222345678999999
Q ss_pred hccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 158 ARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 158 ~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
+.+..++.++|||||||++|+|++ |..||....... ............. +...+..+.+++.+
T Consensus 193 ~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~~~~~~~~~---------~~~~~~~~~~li~~ 256 (288)
T cd05061 193 LKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-------VLKFVMDGGYLDQ---------PDNCPERVTDLMRM 256 (288)
T ss_pred hccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCCC---------CCCCCHHHHHHHHH
Confidence 998889999999999999999998 677875322111 1111111111110 01123478899999
Q ss_pred cccCCCCCCCCHHHHHHHhcccc
Q 048243 237 CVQENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 237 ~l~~dp~~Rpt~~el~~~L~~~~ 259 (303)
||+.||++|||+.++++.|++..
T Consensus 257 ~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 257 CWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HcCCChhHCcCHHHHHHHHHhhc
Confidence 99999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=260.11 Aligned_cols=230 Identities=20% Similarity=0.290 Sum_probs=182.3
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+++.||+|.+........+.+..|+.++++++|+||+++++.+..+...++||||+++++|.+++.. ....+++..+
T Consensus 28 ~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~l~~~~~ 105 (280)
T cd06611 28 ETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLE--LERGLTEPQI 105 (280)
T ss_pred CCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHH--hcCCCCHHHH
Confidence 46899999999876666667888999999999999999999999999999999999999999998853 2346899999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc----
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR---- 159 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---- 159 (303)
+.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.
T Consensus 106 ~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~ 180 (280)
T cd06611 106 RYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--QKRDTFIGTPYWMAPEVVACETF 180 (280)
T ss_pred HHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc--cccceeecchhhcCHHHHhhccc
Confidence 999999999999999999 9999999999999999999999999876543321 1223346788999999875
Q ss_pred -cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcc
Q 048243 160 -QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238 (303)
Q Consensus 160 -~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 238 (303)
...++.++|+||||+++|+|++|..||....... .... +...... ....+...+..+.+++.+||
T Consensus 181 ~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~-------~~~~~~~~~~~~~~li~~~l 246 (280)
T cd06611 181 KDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR------VLLK-ILKSEPP-------TLDQPSKWSSSFNDFLKSCL 246 (280)
T ss_pred CCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH------HHHH-HhcCCCC-------CcCCcccCCHHHHHHHHHHh
Confidence 3446789999999999999999999986432111 1111 1111100 00111223457889999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 048243 239 QENPNDRPSMLQVSSM 254 (303)
Q Consensus 239 ~~dp~~Rpt~~el~~~ 254 (303)
+.+|.+||++.++++.
T Consensus 247 ~~~p~~Rps~~~il~~ 262 (280)
T cd06611 247 VKDPDDRPTAAELLKH 262 (280)
T ss_pred ccChhhCcCHHHHhcC
Confidence 9999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=260.88 Aligned_cols=230 Identities=23% Similarity=0.324 Sum_probs=180.8
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+|+.|++|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||+++++|..++.. ....+++..+
T Consensus 35 ~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~l~~~~~ 112 (292)
T cd06644 35 ETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLE--LDRGLTEPQI 112 (292)
T ss_pred CCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHh--hcCCCCHHHH
Confidence 46899999999877666667888999999999999999999999999999999999999999887743 2345899999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc----
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR---- 159 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---- 159 (303)
+.++.|++.+++|||+.+ ++||||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.
T Consensus 113 ~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~ 187 (292)
T cd06644 113 QVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QRRDSFIGTPYWMAPEVVMCETM 187 (292)
T ss_pred HHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--cccceecCCccccCceeeccccc
Confidence 999999999999999998 9999999999999999999999999876543221 1122345788999999874
Q ss_pred -cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcc
Q 048243 160 -QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238 (303)
Q Consensus 160 -~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 238 (303)
...++.++|||||||++|+|++|..||....... ....... ..... .......+..+.+++.+||
T Consensus 188 ~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~~~-~~~~~-------~~~~~~~~~~~~~li~~~l 253 (292)
T cd06644 188 KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAK-SEPPT-------LSQPSKWSMEFRDFLKTAL 253 (292)
T ss_pred cCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH------HHHHHhc-CCCcc-------CCCCcccCHHHHHHHHHHh
Confidence 3456889999999999999999999985433211 1111111 11000 0111223447889999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 048243 239 QENPNDRPSMLQVSSM 254 (303)
Q Consensus 239 ~~dp~~Rpt~~el~~~ 254 (303)
..||++||++.++++.
T Consensus 254 ~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 254 DKHPETRPSAAQLLEH 269 (292)
T ss_pred cCCcccCcCHHHHhcC
Confidence 9999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=258.46 Aligned_cols=226 Identities=23% Similarity=0.323 Sum_probs=182.7
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+++.||+|.+.... ......+.+|+.+++.++|+||+++++++.++...++||||+++++|.+++. ...+++..
T Consensus 27 ~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~----~~~l~~~~ 102 (277)
T cd06640 27 RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR----AGPFDEFQ 102 (277)
T ss_pred cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHh----cCCCCHHH
Confidence 468899999987543 3445678899999999999999999999999999999999999999999883 34588899
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
+..++.|++.|+++||+.+ ++|+||+|+||+++.++.++++|||++........ ......++..|+|||.+.+..
T Consensus 103 ~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~ 177 (277)
T cd06640 103 IATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSA 177 (277)
T ss_pred HHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--ccccccCcccccCHhHhccCC
Confidence 9999999999999999998 99999999999999999999999999876543321 122245788899999998888
Q ss_pred CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC
Q 048243 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 242 (303)
++.++|+||||+++|+|++|..||......... .... ...........+..+.+++.+||+.+|
T Consensus 178 ~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-------~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p 241 (277)
T cd06640 178 YDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-------FLIP---------KNNPPTLTGEFSKPFKEFIDACLNKDP 241 (277)
T ss_pred CccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-------hhhh---------cCCCCCCchhhhHHHHHHHHHHcccCc
Confidence 999999999999999999999998543221100 0000 001112233456678899999999999
Q ss_pred CCCCCHHHHHHH
Q 048243 243 NDRPSMLQVSSM 254 (303)
Q Consensus 243 ~~Rpt~~el~~~ 254 (303)
.+||++.+++..
T Consensus 242 ~~Rp~~~~il~~ 253 (277)
T cd06640 242 SFRPTAKELLKH 253 (277)
T ss_pred ccCcCHHHHHhC
Confidence 999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=275.27 Aligned_cols=224 Identities=29% Similarity=0.384 Sum_probs=183.8
Q ss_pred CCCcEEEEEEecCC---CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.|.+.||||++.-. ....++++.+|+..|++++|||++.+-++|.....+|||||||- |+-.+++. ...+++.+
T Consensus 49 ~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-GSAsDlle--VhkKplqE 125 (948)
T KOG0577|consen 49 RNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDLLE--VHKKPLQE 125 (948)
T ss_pred CccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-ccHHHHHH--HHhccchH
Confidence 47889999998644 23456789999999999999999999999999999999999995 56777763 35678999
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..+..++.+.+.||+|||+.+ .+|||||..|||+++.|.|||+|||.+..+. ..+.++||+.|||||++.-
T Consensus 126 vEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------PAnsFvGTPywMAPEVILA 196 (948)
T KOG0577|consen 126 VEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA------PANSFVGTPYWMAPEVILA 196 (948)
T ss_pred HHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC------chhcccCCccccchhHhee
Confidence 999999999999999999999 9999999999999999999999999986543 2345899999999999864
Q ss_pred ---CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHc
Q 048243 161 ---GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237 (303)
Q Consensus 161 ---~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 237 (303)
..|+-++||||||++..+|...++|....+....+ +..-. . ..+.-..+.++..+..|+..|
T Consensus 197 MDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL------YHIAQ-N--------esPtLqs~eWS~~F~~Fvd~C 261 (948)
T KOG0577|consen 197 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQ-N--------ESPTLQSNEWSDYFRNFVDSC 261 (948)
T ss_pred ccccccCCccceeeccchhhhhhhcCCCccCchHHHHH------HHHHh-c--------CCCCCCCchhHHHHHHHHHHH
Confidence 45899999999999999999999986543322211 11111 1 111222567888999999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 048243 238 VQENPNDRPSMLQVSSM 254 (303)
Q Consensus 238 l~~dp~~Rpt~~el~~~ 254 (303)
|+.-|.+|||.++++..
T Consensus 262 LqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 262 LQKIPQERPTSEELLKH 278 (948)
T ss_pred HhhCcccCCcHHHHhhc
Confidence 99999999999988763
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=256.40 Aligned_cols=226 Identities=28% Similarity=0.410 Sum_probs=177.3
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEE-eCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCI-DSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.|+.||+|.++... ..+.+.+|+.+++.++|+|++++++++. .+...+++|||+++++|.+++... ....+++..+
T Consensus 28 ~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~ 104 (256)
T cd05082 28 RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCL 104 (256)
T ss_pred cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhc-CCCCCCHHHH
Confidence 47789999986443 3467889999999999999999999765 456789999999999999998542 2345889999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
+.++.|++.||+|||++| ++||||||+||+++.++.++|+|||.+....... ....++..|+|||.+.+..+
T Consensus 105 ~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~ 176 (256)
T cd05082 105 LKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKF 176 (256)
T ss_pred HHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC-----CCCccceeecCHHHHccCCC
Confidence 999999999999999998 9999999999999999999999999987543221 11233567999999988889
Q ss_pred CCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC
Q 048243 164 STKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 242 (303)
+.++|||||||++|+|++ |..||....... .......... .......+..+.+++.+||+.+|
T Consensus 177 ~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p 240 (256)
T cd05082 177 STKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYK---------MDAPDGCPPVVYDVMKQCWHLDA 240 (256)
T ss_pred CchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhcCCC---------CCCCCCCCHHHHHHHHHHhcCCh
Confidence 999999999999999997 888875332111 1111111110 01111234578899999999999
Q ss_pred CCCCCHHHHHHHhcc
Q 048243 243 NDRPSMLQVSSMLKN 257 (303)
Q Consensus 243 ~~Rpt~~el~~~L~~ 257 (303)
++|||+.++++.|++
T Consensus 241 ~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 241 ATRPSFLQLREQLEH 255 (256)
T ss_pred hhCcCHHHHHHHHhc
Confidence 999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=264.02 Aligned_cols=242 Identities=24% Similarity=0.329 Sum_probs=177.7
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+++.||+|.++... ......+.+|+.+++.++||||+++++++......++||||+. ++|..++.. ....+++..
T Consensus 29 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~ 105 (301)
T cd07873 29 LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDD--CGNSINMHN 105 (301)
T ss_pred CCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHh--cCCCCCHHH
Confidence 468899999986543 3334567889999999999999999999999999999999997 588887743 234588999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC-
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG- 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~- 161 (303)
++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....... .......++..|+|||.+.+.
T Consensus 106 ~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~ 180 (301)
T cd07873 106 VKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTYSNEVVTLWYRPPDILLGST 180 (301)
T ss_pred HHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--CcccccceeecccCcHHHhCCC
Confidence 9999999999999999999 9999999999999999999999999986543221 111223568899999988654
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHH-----HHHhCCCcc-eeccccCCC-------CCCHHHHH
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY-----ELWKGGKGV-EFVDSSLDD-------TNSPCKLM 228 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~-~~~~~~~~~-------~~~~~~~~ 228 (303)
.++.++||||||+++|+|++|..||................ ..|...... ......... ......+.
T Consensus 181 ~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (301)
T cd07873 181 DYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDS 260 (301)
T ss_pred CCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCH
Confidence 47889999999999999999999986543221111111000 000000000 000000000 00112244
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 229 RCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 229 ~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
.+.+||.+||+.||.+|||+.|+++
T Consensus 261 ~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 261 DGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhc
Confidence 6789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=274.12 Aligned_cols=238 Identities=16% Similarity=0.151 Sum_probs=173.6
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHH
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~ 84 (303)
+++.||||.... ..+.+|+.++++++|+||+++++++......++||+++. ++|..++.. ....+++..++
T Consensus 193 ~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~~l~~~~~~ 263 (461)
T PHA03211 193 YPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGA--RLRPLGLAQVT 263 (461)
T ss_pred CCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHh--cCCCCCHHHHH
Confidence 567889986422 345689999999999999999999999999999999995 678777743 23468999999
Q ss_pred HHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCC
Q 048243 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYS 164 (303)
Q Consensus 85 ~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 164 (303)
.++.|++.||+|||+.| |+||||||+|||++.++.++|+|||+++...............||..|+|||++.+..++
T Consensus 264 ~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~ 340 (461)
T PHA03211 264 AVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYT 340 (461)
T ss_pred HHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCC
Confidence 99999999999999999 999999999999999999999999998765433222222335689999999999999999
Q ss_pred CccchhhHHHHHHHHHhCCCCCccCCCCcc----ccHHHHHHHHHhC--CCcceec----------------cccCCC--
Q 048243 165 TKSDVFSFGVLLLQIISGKRLSMLCGINEN----LSILEHAYELWKG--GKGVEFV----------------DSSLDD-- 220 (303)
Q Consensus 165 ~~~DiwslG~~~~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~--~~~~~~~----------------~~~~~~-- 220 (303)
.++|||||||++|||++|..++........ ...+......... ....... ......
T Consensus 341 ~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 420 (461)
T PHA03211 341 PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPA 420 (461)
T ss_pred chHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcc
Confidence 999999999999999998766533221111 0111111110000 0000000 000000
Q ss_pred -CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 221 -TNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 221 -~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
.........+.+||.+||+.||.+|||+.|+++.
T Consensus 421 ~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 421 WTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0001123467899999999999999999999875
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=259.34 Aligned_cols=234 Identities=24% Similarity=0.369 Sum_probs=176.7
Q ss_pred CCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEE-eCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 5 CGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCI-DSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 5 ~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
++..||+|.+.... ....+.+.+|+.+++.++||||+++++++. .+...+++|||+.+++|.+++... .....+..
T Consensus 22 ~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~ 99 (262)
T cd05058 22 QKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSE--THNPTVKD 99 (262)
T ss_pred ceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhc--CCCCCHHH
Confidence 34679999986432 334567889999999999999999999775 455689999999999999998532 23467778
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccc--cccccccccCCCChhhhcc
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEA--NTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~ 160 (303)
+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.......... ......++..|+|||.+.+
T Consensus 100 ~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 176 (262)
T cd05058 100 LIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176 (262)
T ss_pred HHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhcc
Confidence 8999999999999999998 9999999999999999999999999987554322111 1112345678999999988
Q ss_pred CCCCCccchhhHHHHHHHHHhCC-CCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGK-RLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
..++.++||||||+++|+|++|. +||..... ........... .. ..+...+..+.+++.+||.
T Consensus 177 ~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~~~~~~~~-~~---------~~~~~~~~~~~~li~~cl~ 240 (262)
T cd05058 177 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS------FDITVYLLQGR-RL---------LQPEYCPDPLYEVMLSCWH 240 (262)
T ss_pred CccchHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHhcCC-CC---------CCCCcCCHHHHHHHHHHcC
Confidence 88999999999999999999954 45532211 11111111111 00 0011123478899999999
Q ss_pred CCCCCCCCHHHHHHHhcccc
Q 048243 240 ENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 240 ~dp~~Rpt~~el~~~L~~~~ 259 (303)
.+|++||++.++++.|++..
T Consensus 241 ~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 241 PKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CChhhCCCHHHHHHHHHHHh
Confidence 99999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=256.89 Aligned_cols=230 Identities=24% Similarity=0.372 Sum_probs=179.7
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccC--CHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL--DWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l--~~~ 81 (303)
++++.||+|.+........+.+.+|+.+++.++|+||+++++++......++|+||+++++|.+++... ...+ ++.
T Consensus 31 ~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~ 108 (268)
T cd06624 31 STQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSK--WGPLKDNEQ 108 (268)
T ss_pred CCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHh--cccCCCcHH
Confidence 467889999998776666678999999999999999999999999999999999999999999998542 2334 788
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC-CCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
.+..++.|++.||+|||+.+ ++||||+|+||+++. ++.++|+|||.+........ ......|+..|+|||.+.+
T Consensus 109 ~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~ 183 (268)
T cd06624 109 TIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDK 183 (268)
T ss_pred HHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--ccccCCCCccccChhhhcc
Confidence 89999999999999999998 999999999999976 67899999999876543221 1222357889999999866
Q ss_pred CC--CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcc
Q 048243 161 GV--YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238 (303)
Q Consensus 161 ~~--~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 238 (303)
.. ++.++||||+|+++|+|++|..||......... ....... ......+......+.+++.+||
T Consensus 184 ~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~-----~~~~~~~---------~~~~~~~~~~~~~~~~li~~~l 249 (268)
T cd06624 184 GPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA-----MFKVGMF---------KIHPEIPESLSAEAKNFILRCF 249 (268)
T ss_pred ccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh-----Hhhhhhh---------ccCCCCCcccCHHHHHHHHHHc
Confidence 43 788999999999999999999998543211100 0000000 0011112233457889999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 048243 239 QENPNDRPSMLQVSSM 254 (303)
Q Consensus 239 ~~dp~~Rpt~~el~~~ 254 (303)
..+|.+|||+.|+++.
T Consensus 250 ~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 250 EPDPDKRASAHDLLQD 265 (268)
T ss_pred CCCchhCCCHHHHHhC
Confidence 9999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=273.62 Aligned_cols=230 Identities=20% Similarity=0.280 Sum_probs=176.4
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|+++... ......+..|+.++..++|++|+++++.+.+....++||||+++|+|.+++. ....+++
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~l~~ 100 (360)
T cd05627 24 DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM---KKDTLSE 100 (360)
T ss_pred CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHH---hcCCCCH
Confidence 478999999996432 2344678889999999999999999999999999999999999999999984 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc--------------------
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-------------------- 140 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-------------------- 140 (303)
..+..++.|++.||+|||+.| |+||||||+||+++.++.++|+|||++.........
T Consensus 101 ~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (360)
T cd05627 101 EATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177 (360)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccc
Confidence 999999999999999999999 999999999999999999999999998654221100
Q ss_pred -------------ccccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhC
Q 048243 141 -------------ANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKG 207 (303)
Q Consensus 141 -------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 207 (303)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~------~~i~~~ 251 (360)
T cd05627 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETY------RKVMNW 251 (360)
T ss_pred cccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHH------HHHHcC
Confidence 0011246899999999999999999999999999999999999999643322111 111111
Q ss_pred CCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 048243 208 GKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPS---MLQVSS 253 (303)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt---~~el~~ 253 (303)
.....+ . .....+.++.++|.+|+. ||.+|++ +.|+++
T Consensus 252 ~~~~~~-p------~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 252 KETLVF-P------PEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCceec-C------CCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 100100 0 001123477889998774 9999996 455544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=258.44 Aligned_cols=231 Identities=28% Similarity=0.425 Sum_probs=181.3
Q ss_pred cEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHH
Q 048243 7 KVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVH 85 (303)
Q Consensus 7 ~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~ 85 (303)
..+|+|.++... ....+.+.+|+.+++.++||||+++++++..+...++||||+++++|.+++.. ....+++..++.
T Consensus 33 ~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~ 110 (267)
T cd05066 33 IPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK--HDGQFTVIQLVG 110 (267)
T ss_pred eEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHh--cCCCCCHHHHHH
Confidence 479999986543 33456789999999999999999999999999999999999999999999853 234578999999
Q ss_pred HHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcccc-ccccccccCCCChhhhccCCCC
Q 048243 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEAN-TEQVVGTIGYIPPEYARQGVYS 164 (303)
Q Consensus 86 ~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~ 164 (303)
++.|++.|+++||+.+ ++|+||||+||+++.++.++|+|||++..+........ .....++..|+|||.+.+..++
T Consensus 111 i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~ 187 (267)
T cd05066 111 MLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 187 (267)
T ss_pred HHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccC
Confidence 9999999999999999 99999999999999999999999999887654322111 1112235679999999988899
Q ss_pred CccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCC
Q 048243 165 TKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 165 ~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 243 (303)
.++|+||||+++|++++ |..||........ . ........ .......+..+.+++.+||+.+|.
T Consensus 188 ~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~----~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~ 251 (267)
T cd05066 188 SASDVWSYGIVMWEVMSYGERPYWEMSNQDV---I----KAIEEGYR---------LPAPMDCPAALHQLMLDCWQKDRN 251 (267)
T ss_pred chhhhHHHHHHHHHHhcCCCCCcccCCHHHH---H----HHHhCCCc---------CCCCCCCCHHHHHHHHHHcccCch
Confidence 99999999999999886 9999854332211 1 11111110 011112244778999999999999
Q ss_pred CCCCHHHHHHHhccc
Q 048243 244 DRPSMLQVSSMLKNE 258 (303)
Q Consensus 244 ~Rpt~~el~~~L~~~ 258 (303)
+||++.++++.|++.
T Consensus 252 ~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 252 ERPKFEQIVSILDKL 266 (267)
T ss_pred hCCCHHHHHHHHHhh
Confidence 999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=257.48 Aligned_cols=232 Identities=27% Similarity=0.410 Sum_probs=181.8
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
..++..+|+|.+.... ...+.+.+|+.+++.++|+||+++++++.. ...+++|||+++++|.+++... ....+++..
T Consensus 27 ~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~ 103 (260)
T cd05073 27 YNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSD-EGSKQPLPK 103 (260)
T ss_pred ecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhC-CccccCHHH
Confidence 3566779999886543 234678899999999999999999999887 7789999999999999998542 234578889
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
++.++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||.+....
T Consensus 104 ~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~ 179 (260)
T cd05073 104 LIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGS 179 (260)
T ss_pred HHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc-ccccCCcccccccCHhHhccCC
Confidence 9999999999999999998 99999999999999999999999999876543221 1122234567799999998888
Q ss_pred CCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
++.++|+||||+++|++++ |..||....... ........... ......+..+.+++.+||+.+
T Consensus 180 ~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~~ 243 (260)
T cd05073 180 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALERGYRM---------PRPENCPEELYNIMMRCWKNR 243 (260)
T ss_pred cCccccchHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhCCCCC---------CCcccCCHHHHHHHHHHcccC
Confidence 9999999999999999998 888885332111 11111111111 111223457889999999999
Q ss_pred CCCCCCHHHHHHHhcc
Q 048243 242 PNDRPSMLQVSSMLKN 257 (303)
Q Consensus 242 p~~Rpt~~el~~~L~~ 257 (303)
|++||++.++.+.|++
T Consensus 244 p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 244 PEERPTFEYIQSVLDD 259 (260)
T ss_pred cccCcCHHHHHHHHhc
Confidence 9999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=256.72 Aligned_cols=229 Identities=33% Similarity=0.506 Sum_probs=181.1
Q ss_pred CcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHH
Q 048243 6 GKVIAVKKLSKTSTQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 6 ~~~valK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~ 84 (303)
++.||+|.++..... ..+.+.+|+..++.++|+||+++++++...+..+++|||+++++|.+++.... ...+++..++
T Consensus 28 ~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~-~~~~~~~~~~ 106 (258)
T smart00219 28 EVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNR-PKELSLSDLL 106 (258)
T ss_pred CceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhh-hccCCHHHHH
Confidence 588999999765433 56789999999999999999999999999999999999999999999985421 1228999999
Q ss_pred HHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCC
Q 048243 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYS 164 (303)
Q Consensus 85 ~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 164 (303)
.++.|++.||++||+.+ ++|+||+|+||+++.++.++|+|||.+............ ...++..|+|||.+.+..++
T Consensus 107 ~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~ 182 (258)
T smart00219 107 SFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFT 182 (258)
T ss_pred HHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccccccccc-cCCCcccccChHHhccCCCC
Confidence 99999999999999998 999999999999999999999999998776544222211 22367899999999888899
Q ss_pred CccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCC
Q 048243 165 TKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 165 ~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 243 (303)
.++||||||+++++|++ |..||...... ... ......... ......+..+.+++.+||..||+
T Consensus 183 ~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~----~~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~~p~ 246 (258)
T smart00219 183 SKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVL----EYLKKGYRL---------PKPENCPPEIYKLMLQCWAEDPE 246 (258)
T ss_pred cchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHhcCCCC---------CCCCcCCHHHHHHHHHHCcCChh
Confidence 99999999999999998 77776532111 111 111111110 11112445788999999999999
Q ss_pred CCCCHHHHHHHh
Q 048243 244 DRPSMLQVSSML 255 (303)
Q Consensus 244 ~Rpt~~el~~~L 255 (303)
+|||+.++++.|
T Consensus 247 ~Rpt~~~ll~~l 258 (258)
T smart00219 247 DRPTFSELVEIL 258 (258)
T ss_pred hCcCHHHHHhhC
Confidence 999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=258.85 Aligned_cols=227 Identities=24% Similarity=0.350 Sum_probs=182.7
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.||+|.+.... ......+.+|+.+++.++|+||+++++++.+....++|+||+.+++|.+++.. ..+++..
T Consensus 24 ~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~~~~~ 99 (274)
T cd06609 24 RTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP----GKLDETY 99 (274)
T ss_pred CCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhh----cCCCHHH
Confidence 478999999987543 33446788999999999999999999999999999999999999999998843 2689999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+..
T Consensus 100 ~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~ 174 (274)
T cd06609 100 IAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRNTFVGTPFWMAPEVIKQSG 174 (274)
T ss_pred HHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc--cccccccCCccccChhhhccCC
Confidence 9999999999999999998 9999999999999999999999999987765432 1223356788999999999888
Q ss_pred CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC
Q 048243 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 242 (303)
++.++||||||+++|+|++|..||....... ....... .... .+.. ...+..+.+++.+||..+|
T Consensus 175 ~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~~~~~~~-~~~~-----~~~~---~~~~~~~~~~l~~~l~~~p 239 (274)
T cd06609 175 YDEKADIWSLGITAIELAKGEPPLSDLHPMR------VLFLIPK-NNPP-----SLEG---NKFSKPFKDFVSLCLNKDP 239 (274)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcccCchHH------HHHHhhh-cCCC-----CCcc---cccCHHHHHHHHHHhhCCh
Confidence 9999999999999999999999986433111 1111111 1000 1111 1134478899999999999
Q ss_pred CCCCCHHHHHHH
Q 048243 243 NDRPSMLQVSSM 254 (303)
Q Consensus 243 ~~Rpt~~el~~~ 254 (303)
++|||++++++.
T Consensus 240 ~~Rpt~~~il~~ 251 (274)
T cd06609 240 KERPSAKELLKH 251 (274)
T ss_pred hhCcCHHHHhhC
Confidence 999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=265.29 Aligned_cols=233 Identities=30% Similarity=0.425 Sum_probs=178.8
Q ss_pred EEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc------------
Q 048243 8 VIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI------------ 73 (303)
Q Consensus 8 ~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 73 (303)
.+|+|.++... ......+.+|+.++.++ +|+||+++++++..+...++||||+++++|.+++....
T Consensus 36 ~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 115 (303)
T cd05088 36 DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 115 (303)
T ss_pred eEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccc
Confidence 45777776432 33445788999999999 89999999999999999999999999999999985421
Q ss_pred -ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCC
Q 048243 74 -RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGY 152 (303)
Q Consensus 74 -~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y 152 (303)
....+++..++.++.|++.|++|||+.| ++||||||+||+++.++.++|+|||++...... .......++..|
T Consensus 116 ~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y 189 (303)
T cd05088 116 STASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRW 189 (303)
T ss_pred cccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcEEeCccccCcccchh---hhcccCCCcccc
Confidence 1235789999999999999999999998 999999999999999999999999998532111 111112335679
Q ss_pred CChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHH
Q 048243 153 IPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL 231 (303)
Q Consensus 153 ~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
+|||.+.+..++.++||||||+++|+|++ |..||....... ........... ..+...+..+.
T Consensus 190 ~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~~ 253 (303)
T cd05088 190 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEKLPQGYRL---------EKPLNCDDEVY 253 (303)
T ss_pred cCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-------HHHHHhcCCcC---------CCCCCCCHHHH
Confidence 99999988889999999999999999998 998885332111 11111111000 01111234678
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhccccCCC
Q 048243 232 EIALLCVQENPNDRPSMLQVSSMLKNETTNR 262 (303)
Q Consensus 232 ~li~~~l~~dp~~Rpt~~el~~~L~~~~~~~ 262 (303)
+++.+||+.+|++||++.++++.|++....+
T Consensus 254 ~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 254 DLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 9999999999999999999999987665444
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=258.73 Aligned_cols=231 Identities=27% Similarity=0.440 Sum_probs=180.8
Q ss_pred cEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHH
Q 048243 7 KVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVH 85 (303)
Q Consensus 7 ~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~ 85 (303)
..+|+|.++... ....+.+.+|+.+++.++|+||+++++++......++||||+++++|.+++.. ....+++..+..
T Consensus 34 ~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~ 111 (268)
T cd05063 34 VAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVG 111 (268)
T ss_pred eEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHh--cCCCCCHHHHHH
Confidence 379999987552 33456788999999999999999999999999999999999999999998853 235688999999
Q ss_pred HHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccc-cccccccCCCChhhhccCCCC
Q 048243 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANT-EQVVGTIGYIPPEYARQGVYS 164 (303)
Q Consensus 86 ~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~ 164 (303)
++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||++............ .....+..|+|||.+.+..++
T Consensus 112 ~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~ 188 (268)
T cd05063 112 MLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188 (268)
T ss_pred HHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcC
Confidence 9999999999999999 999999999999999999999999998765433211111 112234579999999888889
Q ss_pred CccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCC
Q 048243 165 TKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 165 ~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 243 (303)
.++||||||+++|++++ |..||....... ............ .....+..+.+++.+||..+|+
T Consensus 189 ~~~Dv~slG~il~ell~~g~~p~~~~~~~~-------~~~~i~~~~~~~---------~~~~~~~~~~~li~~c~~~~p~ 252 (268)
T cd05063 189 SASDVWSFGIVMWEVMSFGERPYWDMSNHE-------VMKAINDGFRLP---------APMDCPSAVYQLMLQCWQQDRA 252 (268)
T ss_pred hHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-------HHHHHhcCCCCC---------CCCCCCHHHHHHHHHHcCCCcc
Confidence 99999999999999997 999985432111 111111111000 0112234788999999999999
Q ss_pred CCCCHHHHHHHhccc
Q 048243 244 DRPSMLQVSSMLKNE 258 (303)
Q Consensus 244 ~Rpt~~el~~~L~~~ 258 (303)
+||++.++++.|++.
T Consensus 253 ~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 253 RRPRFVDIVNLLDKL 267 (268)
T ss_pred cCcCHHHHHHHHHhh
Confidence 999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=259.53 Aligned_cols=231 Identities=23% Similarity=0.339 Sum_probs=180.5
Q ss_pred CCCcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.||+|.++.. .......+.+|++++++++|+||+++++.+......++||||+++++|..++........+++..
T Consensus 24 ~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~ 103 (286)
T cd06622 24 PTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDV 103 (286)
T ss_pred CCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHH
Confidence 36899999998654 33334678899999999999999999999999999999999999999988885433344789999
Q ss_pred HHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 83 RVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||.+....... .....++..|+|||.+.+.
T Consensus 104 ~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~ 176 (286)
T cd06622 104 LRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL----AKTNIGCQSYMAPERIKSG 176 (286)
T ss_pred HHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc----cccCCCccCccCcchhcCC
Confidence 99999999999999996 47 9999999999999999999999999986543221 2223578899999988554
Q ss_pred C------CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHH
Q 048243 162 V------YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235 (303)
Q Consensus 162 ~------~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
. ++.++|+|||||++|+|++|..||............ ....... ....++..+..+.+++.
T Consensus 177 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~----~~~~~~~---------~~~~~~~~~~~~~~li~ 243 (286)
T cd06622 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL----SAIVDGD---------PPTLPSGYSDDAQDFVA 243 (286)
T ss_pred CCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH----HHHhhcC---------CCCCCcccCHHHHHHHH
Confidence 3 478999999999999999999998543221111111 1111111 11122235567889999
Q ss_pred HcccCCCCCCCCHHHHHHH
Q 048243 236 LCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 236 ~~l~~dp~~Rpt~~el~~~ 254 (303)
+||..+|.+||++.+++..
T Consensus 244 ~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 244 KCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HHcccCcccCCCHHHHhcC
Confidence 9999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=271.13 Aligned_cols=230 Identities=21% Similarity=0.257 Sum_probs=176.5
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+++.||+|++.... ......+.+|+.+++.++||||+++++.+......++||||+++|+|.+++. ...+++
T Consensus 66 ~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~----~~~~~~ 141 (371)
T cd05622 66 STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS----NYDVPE 141 (371)
T ss_pred CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHH----hcCCCH
Confidence 478899999986432 2234567789999999999999999999999999999999999999999883 335888
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++........ .......||+.|+|||++.+
T Consensus 142 ~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~ 217 (371)
T cd05622 142 KWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKS 217 (371)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhc
Confidence 899999999999999999999 99999999999999999999999999876543221 11233568999999999875
Q ss_pred CC----CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 161 GV----YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 161 ~~----~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
.. ++.++|||||||++|+|++|..||...... ..............+ ......+..+.++|.+
T Consensus 218 ~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~~~-------~~~~~~s~~~~~li~~ 284 (371)
T cd05622 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNHKNSLTF-------PDDNDISKEAKNLICA 284 (371)
T ss_pred cCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCCcccC-------CCcCCCCHHHHHHHHH
Confidence 43 788999999999999999999999643321 111111111111111 1112234578899999
Q ss_pred cccCCCCC--CCCHHHHHHH
Q 048243 237 CVQENPND--RPSMLQVSSM 254 (303)
Q Consensus 237 ~l~~dp~~--Rpt~~el~~~ 254 (303)
||..++.+ |+++.|+++.
T Consensus 285 ~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 285 FLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HcCChhhhcCCCCHHHHhcC
Confidence 99844433 7899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=258.71 Aligned_cols=229 Identities=30% Similarity=0.428 Sum_probs=177.0
Q ss_pred EEEEEEecCC-CcccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc------------
Q 048243 8 VIAVKKLSKT-STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI------------ 73 (303)
Q Consensus 8 ~valK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 73 (303)
.+++|.++.. .....+.+.+|++++.++ +||||+++++++......+++|||+++++|.+++....
T Consensus 24 ~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~ 103 (270)
T cd05047 24 DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 103 (270)
T ss_pred EEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhcccccccccccccc
Confidence 4688888754 334456788999999999 89999999999999999999999999999999985421
Q ss_pred -ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCC
Q 048243 74 -RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGY 152 (303)
Q Consensus 74 -~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y 152 (303)
....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...... ........+..|
T Consensus 104 ~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~---~~~~~~~~~~~y 177 (270)
T cd05047 104 STASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRW 177 (270)
T ss_pred CCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCCccccchh---hhccCCCCcccc
Confidence 1234788999999999999999999998 999999999999999999999999987532211 111112235679
Q ss_pred CChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHH
Q 048243 153 IPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL 231 (303)
Q Consensus 153 ~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
+|||.+....++.++||||||+++|+|++ |..||....... ........... ......+..+.
T Consensus 178 ~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~~ 241 (270)
T cd05047 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEKLPQGYRL---------EKPLNCDDEVY 241 (270)
T ss_pred CChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-------HHHHHhCCCCC---------CCCCcCCHHHH
Confidence 99999988889999999999999999997 999985322111 11111111110 01112234688
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhccc
Q 048243 232 EIALLCVQENPNDRPSMLQVSSMLKNE 258 (303)
Q Consensus 232 ~li~~~l~~dp~~Rpt~~el~~~L~~~ 258 (303)
+++.+||..||.+|||+.++++.|++.
T Consensus 242 ~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 242 DLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred HHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=259.87 Aligned_cols=242 Identities=21% Similarity=0.278 Sum_probs=179.3
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+|+.||+|++.... ....+.+.+|+.+++.++|+||+++++++......++||||+++++|..++. ....+++.
T Consensus 24 ~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~---~~~~~~~~ 100 (286)
T cd07847 24 ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEK---NPRGVPEH 100 (286)
T ss_pred CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHh---CCCCCCHH
Confidence 368999999986442 2234567899999999999999999999999999999999999988877763 33458999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc-
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ- 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~- 160 (303)
.++.++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+
T Consensus 101 ~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~ 175 (286)
T cd07847 101 LIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAPELLVGD 175 (286)
T ss_pred HHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc--cccCcccccccCCHHHHhCC
Confidence 99999999999999999998 99999999999999999999999999876544321 1222456889999999876
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHH--------HHHhCCCc-ceeccccCCCCC-----CHHH
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY--------ELWKGGKG-VEFVDSSLDDTN-----SPCK 226 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~-~~~~~~~~~~~~-----~~~~ 226 (303)
..++.++||||||+++|+|++|..||......+......... ..+..... .....+...... .+..
T Consensus 176 ~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (286)
T cd07847 176 TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNI 255 (286)
T ss_pred CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccC
Confidence 457889999999999999999999986443222111111000 00000000 000000000000 0122
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 227 LMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 227 ~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
+..+.+|+.+||+.||++|||+.|++.
T Consensus 256 ~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 256 SSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=257.35 Aligned_cols=231 Identities=25% Similarity=0.380 Sum_probs=180.4
Q ss_pred cCCCcEEEEEEecCCCc------ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccc
Q 048243 3 LPCGKVIAVKKLSKTST------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 76 (303)
..+|+.+|+|.++.... .....+.+|++.++.++|+||+++++++.+....++++||+.+++|.+++.. ..
T Consensus 21 ~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~ 97 (265)
T cd06631 21 TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNR---FG 97 (265)
T ss_pred EcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHh---cC
Confidence 35788999999864421 2235688899999999999999999999999999999999999999999843 34
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCc----cccccccccccCC
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL----EANTEQVVGTIGY 152 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~----~~~~~~~~g~~~y 152 (303)
.+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+........ ........|+..|
T Consensus 98 ~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (265)
T cd06631 98 PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174 (265)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccc
Confidence 5889999999999999999999998 99999999999999999999999999876432111 1112234578899
Q ss_pred CChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHH
Q 048243 153 IPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLE 232 (303)
Q Consensus 153 ~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 232 (303)
+|||.+.+..++.++|+||||+++|+|++|..||........ .......... .+. .+...+..+.+
T Consensus 175 ~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~~~~~~~~~~----~~~----~~~~~~~~~~~ 240 (265)
T cd06631 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA------MFYIGAHRGL----MPR----LPDSFSAAAID 240 (265)
T ss_pred cChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH------HHHhhhccCC----CCC----CCCCCCHHHHH
Confidence 999999988889999999999999999999999854321110 0000000000 011 11223457889
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 048243 233 IALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 233 li~~~l~~dp~~Rpt~~el~~ 253 (303)
++.+||+.+|.+||++.++++
T Consensus 241 ~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 241 FVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHHhcCCcccCCCHHHHhc
Confidence 999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=271.02 Aligned_cols=210 Identities=26% Similarity=0.400 Sum_probs=172.8
Q ss_pred ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCe--eEEEEeecCCCChhhhhcCccccccCCHHHHHHHHHHHHHHHHHH
Q 048243 20 QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE--RMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYL 97 (303)
Q Consensus 20 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~L 97 (303)
...++|..|+.+|+.|+|+||+++|++|.+... ..+|+|.+.+|+|..|+. +.+.++...++.|++||++||.||
T Consensus 83 ~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yL 159 (632)
T KOG0584|consen 83 EELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYL 159 (632)
T ss_pred HHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhh
Confidence 344788999999999999999999999997654 789999999999999994 455688899999999999999999
Q ss_pred HhCCCCCeEecCCCCCceEECCC-CceEEcccccccccccCCccccccccccccCCCChhhhccCCCCCccchhhHHHHH
Q 048243 98 QEYSRLTIIHRDLKASNILLGED-MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176 (303)
Q Consensus 98 h~~~~~~i~H~dikp~nil~~~~-~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~ 176 (303)
|++ ..+|+|||||.+||||+.+ |.|||||+|+|....... .....|||.|||||++. ..|+..+||||||+++
T Consensus 160 Hs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCm 233 (632)
T KOG0584|consen 160 HSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCM 233 (632)
T ss_pred hcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHH
Confidence 998 5789999999999999976 889999999998765432 22268999999999887 7889999999999999
Q ss_pred HHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 177 LQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 177 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
+||+|+..|+..+.... .+++....+..+..+. . ...+++++||.+||.. .++|||+.||+.
T Consensus 234 LEMvT~eYPYsEC~n~A------QIYKKV~SGiKP~sl~----k----V~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 234 LEMVTSEYPYSECTNPA------QIYKKVTSGIKPAALS----K----VKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHHhccCChhhhCCHH------HHHHHHHcCCCHHHhh----c----cCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 99999999987665322 2334443333222211 1 1234788999999999 999999999986
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=258.31 Aligned_cols=221 Identities=24% Similarity=0.336 Sum_probs=171.9
Q ss_pred cEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHH
Q 048243 7 KVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86 (303)
Q Consensus 7 ~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~ 86 (303)
..|++|.+..........+.+|+.+++.++||||+++++++......++||||+++++|..++.. ....+++..+..+
T Consensus 45 ~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i 122 (274)
T cd05076 45 LRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITV 122 (274)
T ss_pred eeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHH
Confidence 45899998765444456788899999999999999999999999999999999999999888843 2456889999999
Q ss_pred HHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCC-------ceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM-------KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 87 ~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~-------~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+.|++.||+|||+.+ ++||||||+||+++..+ .++++|||.+...... ....++..|+|||.+.
T Consensus 123 ~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~ 193 (274)
T cd05076 123 AQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVP 193 (274)
T ss_pred HHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhc
Confidence 999999999999998 99999999999997643 4899999987543221 1235678899999886
Q ss_pred c-CCCCCccchhhHHHHHHHHH-hCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHc
Q 048243 160 Q-GVYSTKSDVFSFGVLLLQII-SGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237 (303)
Q Consensus 160 ~-~~~~~~~DiwslG~~~~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 237 (303)
+ ..++.++||||||+++|+++ +|..||.......... ...... ..... ....+.+++.+|
T Consensus 194 ~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-------~~~~~~-------~~~~~----~~~~~~~li~~c 255 (274)
T cd05076 194 GGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-------FYEKKH-------RLPEP----SCKELATLISQC 255 (274)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-------HHHhcc-------CCCCC----CChHHHHHHHHH
Confidence 5 45789999999999999995 6888875432211110 011000 00011 123688999999
Q ss_pred ccCCCCCCCCHHHHHHHhc
Q 048243 238 VQENPNDRPSMLQVSSMLK 256 (303)
Q Consensus 238 l~~dp~~Rpt~~el~~~L~ 256 (303)
|+.+|.+|||+.++++.|.
T Consensus 256 l~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 256 LTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred cccChhhCcCHHHHHHhhC
Confidence 9999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=259.89 Aligned_cols=239 Identities=26% Similarity=0.341 Sum_probs=173.5
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcC---CCCccccEEEEEEeC-----CeeEEEEeecCCCChhhhhcCcc
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKL---QHVNLIRVLGFCIDS-----EERMLVYEYMPNKSLDCYLFDPI 73 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~ 73 (303)
.+|+.||+|.++... ......+.+|+.+++.+ +||||+++++++... ...+++||++.+ +|..++...
T Consensus 23 ~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~- 100 (288)
T cd07863 23 HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKV- 100 (288)
T ss_pred CCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhc-
Confidence 578999999987542 22223556677777665 799999999998642 357999999974 787777432
Q ss_pred ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCC
Q 048243 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYI 153 (303)
Q Consensus 74 ~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~ 153 (303)
....+++..+..++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++....... ......|+..|+
T Consensus 101 ~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~ 174 (288)
T cd07863 101 PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQM---ALTPVVVTLWYR 174 (288)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccccccCcc---cCCCcccccccc
Confidence 2345899999999999999999999999 9999999999999999999999999987654322 122346788999
Q ss_pred ChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcc------eeccccCC-------C
Q 048243 154 PPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV------EFVDSSLD-------D 220 (303)
Q Consensus 154 aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~-------~ 220 (303)
|||.+.+..++.++||||+||++|+|++|.+||......... ............. ........ .
T Consensus 175 aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (288)
T cd07863 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL---GKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQ 251 (288)
T ss_pred CchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHH---HHHHHHhCCCChhhCcccccccccccCCCCCCchH
Confidence 999999888999999999999999999999998543322111 1111111000000 00000000 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 221 TNSPCKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 221 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
...+..+..+.+++.+||+.||++|||+.|++.
T Consensus 252 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 252 SVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 011223456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=257.94 Aligned_cols=227 Identities=22% Similarity=0.336 Sum_probs=181.3
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+++.+++|.+........+.+.+|+.+++.++|+||+++++++......++++||+.+++|.+++.. ..+++..+
T Consensus 42 ~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~~~~~~ 117 (285)
T cd06648 42 STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH----TRMNEEQI 117 (285)
T ss_pred CCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh----CCCCHHHH
Confidence 57889999998765544556788999999999999999999999999999999999999999998843 45889999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
+.++.|++.|+++||+.+ ++||||+|+||+++.++.++|+|||.+....... .......|+..|+|||.+.+..+
T Consensus 118 ~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~ 192 (285)
T cd06648 118 ATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPEVISRLPY 192 (285)
T ss_pred HHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC--cccccccCCccccCHHHhcCCCC
Confidence 999999999999999999 9999999999999999999999999876543321 11223457889999999988889
Q ss_pred CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCC
Q 048243 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 243 (303)
+.++||||||+++|+|++|..||...... ........ .... ... .....+..+.+++.+||..+|+
T Consensus 193 ~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~~~~-~~~~-----~~~--~~~~~~~~l~~li~~~l~~~p~ 258 (285)
T cd06648 193 GTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKRIRD-NLPP-----KLK--NLHKVSPRLRSFLDRMLVRDPA 258 (285)
T ss_pred CCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHh-cCCC-----CCc--ccccCCHHHHHHHHHHcccChh
Confidence 99999999999999999999998542211 11111111 1000 000 0111345788999999999999
Q ss_pred CCCCHHHHHH
Q 048243 244 DRPSMLQVSS 253 (303)
Q Consensus 244 ~Rpt~~el~~ 253 (303)
+|||+.++++
T Consensus 259 ~Rpt~~~il~ 268 (285)
T cd06648 259 QRATAAELLN 268 (285)
T ss_pred hCcCHHHHcc
Confidence 9999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=257.79 Aligned_cols=231 Identities=22% Similarity=0.252 Sum_probs=179.8
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|.+.... ......+.+|+.+++.++|+||+.+++.+..+...+++|||+.+++|.+++... ....+++
T Consensus 23 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~ 101 (285)
T cd05632 23 ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM-GNPGFEE 101 (285)
T ss_pred CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHh-cCCCCCH
Confidence 578999999996543 222345778999999999999999999999999999999999999998887532 2346899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....... ......|+..|+|||.+.+
T Consensus 102 ~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~~~aPE~~~~ 175 (285)
T cd05632 102 ERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIRGRVGTVGYMAPEVLNN 175 (285)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC---cccCCCCCcCccChHHhcC
Confidence 999999999999999999999 9999999999999999999999999886543221 1123468999999999988
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|+||+|+++|+|++|..||.......... .......... .......+..+.+|+.+||+.
T Consensus 176 ~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~---~~~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~ 242 (285)
T cd05632 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE---EVDRRVLETE----------EVYSAKFSEEAKSICKMLLTK 242 (285)
T ss_pred CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhhhccc----------cccCccCCHHHHHHHHHHccC
Confidence 889999999999999999999999986432211111 1111111000 001112334678999999999
Q ss_pred CCCCCCC-----HHHHHHH
Q 048243 241 NPNDRPS-----MLQVSSM 254 (303)
Q Consensus 241 dp~~Rpt-----~~el~~~ 254 (303)
||.+||+ +.+++..
T Consensus 243 ~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 243 DPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred CHhHcCCCcccChHHHHcC
Confidence 9999999 6677653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=257.23 Aligned_cols=234 Identities=28% Similarity=0.392 Sum_probs=181.5
Q ss_pred CCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcccc------cc
Q 048243 5 CGKVIAVKKLSKTSTQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRR------LI 77 (303)
Q Consensus 5 ~~~~valK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~ 77 (303)
+.+.|++|.+...... ..+.+.+|+.++++++|+||+++++++.+....++||||+++++|.+++...... ..
T Consensus 34 ~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~ 113 (275)
T cd05046 34 GETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP 113 (275)
T ss_pred CcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccC
Confidence 4577999988654433 4567899999999999999999999999888999999999999999998643321 25
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhh
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 157 (303)
+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++++|||.+....... ........++..|+|||.
T Consensus 114 l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~ 189 (275)
T cd05046 114 LSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE-YYKLRNALIPLRWLAPEA 189 (275)
T ss_pred CCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcccccccccCccc-ccccCCceeEEeecChhh
Confidence 899999999999999999999999 9999999999999999999999999886543221 112223355778999999
Q ss_pred hccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 158 ARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 158 ~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
+.+..++.++||||||+++|++++ |..||....... ... ........ .......+..+.+++.+
T Consensus 190 ~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~----~~~~~~~~--------~~~~~~~~~~l~~~i~~ 254 (275)
T cd05046 190 VQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLN----RLQAGKLE--------LPVPEGCPSRLYKLMTR 254 (275)
T ss_pred hccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHH----HHHcCCcC--------CCCCCCCCHHHHHHHHH
Confidence 988888999999999999999998 777875332111 111 11111000 00111223478899999
Q ss_pred cccCCCCCCCCHHHHHHHhcc
Q 048243 237 CVQENPNDRPSMLQVSSMLKN 257 (303)
Q Consensus 237 ~l~~dp~~Rpt~~el~~~L~~ 257 (303)
||+.||.+|||+.|+++.|.+
T Consensus 255 ~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 255 CWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred HcCCCcccCCCHHHHHHHhcC
Confidence 999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=255.42 Aligned_cols=232 Identities=25% Similarity=0.423 Sum_probs=183.0
Q ss_pred CCCcEEEEEEecCCCc------ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcccccc
Q 048243 4 PCGKVIAVKKLSKTST------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~~~~valK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
.+|+.||+|.+..... ...+.+.+|+..++.++|+||+++++++.+.+..++|+||+.+++|.+++. ....
T Consensus 23 ~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~---~~~~ 99 (268)
T cd06630 23 KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS---KYGA 99 (268)
T ss_pred CCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHH---HhCC
Confidence 5789999999864431 134678899999999999999999999999999999999999999999884 3446
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCC-ceEEcccccccccccCCcc--ccccccccccCCCC
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM-KPKISDFGLARIFAKESLE--ANTEQVVGTIGYIP 154 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~-~v~l~Df~~~~~~~~~~~~--~~~~~~~g~~~y~a 154 (303)
+++..+..++.|++.||+|||+.| ++|+||+|+||+++.++ .++|+|||.+......... .......|+..|+|
T Consensus 100 ~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (268)
T cd06630 100 FKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176 (268)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeC
Confidence 889999999999999999999999 99999999999998776 5999999998766543211 11223467889999
Q ss_pred hhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHH
Q 048243 155 PEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIA 234 (303)
Q Consensus 155 PE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
||.+.+..++.++|+||+|+++|++++|..||............ ..... .......+...+..+.+++
T Consensus 177 PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~---------~~~~~~~~~~~~~~~~~~i 244 (268)
T cd06630 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI---FKIAS---------ATTAPSIPEHLSPGLRDVT 244 (268)
T ss_pred HhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH---HHHhc---------cCCCCCCchhhCHHHHHHH
Confidence 99998888899999999999999999999998543322111111 11100 0111222334556888999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 048243 235 LLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 235 ~~~l~~dp~~Rpt~~el~~ 253 (303)
.+||..+|.+|||+.+++.
T Consensus 245 ~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 245 LRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHcCCCcccCcCHHHHhc
Confidence 9999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=258.72 Aligned_cols=222 Identities=23% Similarity=0.370 Sum_probs=172.6
Q ss_pred CcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHH
Q 048243 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVH 85 (303)
Q Consensus 6 ~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~ 85 (303)
...||+|.+........+.+.+|+.+++.++||||+++++++......++||||+.+|+|..++... ...+++..++.
T Consensus 27 ~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~ 104 (258)
T cd05078 27 KTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKN--KNLINISWKLE 104 (258)
T ss_pred cchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcC--CCCCCHHHHHH
Confidence 3458888886555455567889999999999999999999999989999999999999999998542 33588999999
Q ss_pred HHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCc--------eEEcccccccccccCCccccccccccccCCCChhh
Q 048243 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK--------PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 86 ~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~--------v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 157 (303)
++.||+.||+|||+.+ ++||||||+||+++.++. ++++|||.+...... ....++..|+|||.
T Consensus 105 ~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~ 175 (258)
T cd05078 105 VAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK------EILLERIPWVPPEC 175 (258)
T ss_pred HHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccccccCCc------hhccccCCccCchh
Confidence 9999999999999999 999999999999987765 699999987544321 22456888999999
Q ss_pred hccC-CCCCccchhhHHHHHHHHHhCC-CCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHH
Q 048243 158 ARQG-VYSTKSDVFSFGVLLLQIISGK-RLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235 (303)
Q Consensus 158 ~~~~-~~~~~~DiwslG~~~~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
+.+. .++.++||||||+++|+|++|. .|+....... . ....... . ..+...+.++.+++.
T Consensus 176 ~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~------~-~~~~~~~--~---------~~~~~~~~~~~~li~ 237 (258)
T cd05078 176 IENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK------K-LQFYEDR--H---------QLPAPKWTELANLIN 237 (258)
T ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH------H-HHHHHcc--c---------cCCCCCcHHHHHHHH
Confidence 8864 4788999999999999999985 4443221111 0 0011100 0 011112346889999
Q ss_pred HcccCCCCCCCCHHHHHHHhc
Q 048243 236 LCVQENPNDRPSMLQVSSMLK 256 (303)
Q Consensus 236 ~~l~~dp~~Rpt~~el~~~L~ 256 (303)
+||+.||++|||++++++.|+
T Consensus 238 ~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 238 QCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHhccChhhCCCHHHHHHhcC
Confidence 999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=253.68 Aligned_cols=229 Identities=24% Similarity=0.313 Sum_probs=181.0
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEe-CCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCID-SEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+++.||+|++.... ....+.+.+|++++++++|+|++++++.+.. +...+++|||+++++|.+++... ....+++
T Consensus 23 ~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~-~~~~l~~ 101 (257)
T cd08223 23 TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQ-KGKLLPE 101 (257)
T ss_pred CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHh-cCCCCCH
Confidence 467899999986543 2345678899999999999999999998764 44679999999999999888542 2445899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.+++.|+++||+.| ++||||+|+||+++.++.++|+|||++....... .......+++.|+|||.+.+
T Consensus 102 ~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~ 176 (257)
T cd08223 102 NQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--DMASTLIGTPYYMSPELFSN 176 (257)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC--CccccccCCcCccChhHhcC
Confidence 999999999999999999999 9999999999999999999999999987664332 12233567899999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|+||+|++++++++|..||...... ........+ .. ...+...+..+.+++.+||..
T Consensus 177 ~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~~~~~-~~---------~~~~~~~~~~~~~li~~~l~~ 240 (257)
T cd08223 177 KPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYRIIEG-KL---------PPMPKDYSPELGELIATMLSK 240 (257)
T ss_pred CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHhc-CC---------CCCccccCHHHHHHHHHHhcc
Confidence 88999999999999999999999998532211 111111111 11 011223445788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 048243 241 NPNDRPSMLQVSSM 254 (303)
Q Consensus 241 dp~~Rpt~~el~~~ 254 (303)
||.+|||+.+++..
T Consensus 241 ~p~~Rp~~~~~l~~ 254 (257)
T cd08223 241 RPEKRPSVKSILRQ 254 (257)
T ss_pred CcccCCCHHHHhcC
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=270.83 Aligned_cols=226 Identities=21% Similarity=0.261 Sum_probs=172.2
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcC---CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcccccc
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKL---QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
.+|+.||+|++.... .........|..++... +||||+++++.+......++||||+.+|+|..++. ....
T Consensus 16 ~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~---~~~~ 92 (330)
T cd05586 16 DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQ---KEGR 92 (330)
T ss_pred CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHH---hcCC
Confidence 468999999986432 12223445566666655 69999999999999999999999999999988884 3456
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhh
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 157 (303)
+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++....... .......|+..|+|||.
T Consensus 93 ~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~ 167 (330)
T cd05586 93 FSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTNTFCGTTEYLAPEV 167 (330)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCccCccCCccccCHHH
Confidence 899999999999999999999999 9999999999999999999999999986532221 12233568999999999
Q ss_pred hccC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 158 ARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 158 ~~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
+.+. .++.++|||||||++|+|++|..||....... .......... . +.. ...+..+.+++.+
T Consensus 168 ~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~-~-----~~~---~~~~~~~~~li~~ 231 (330)
T cd05586 168 LLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-------MYRNIAFGKV-R-----FPK---NVLSDEGRQFVKG 231 (330)
T ss_pred HcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-------HHHHHHcCCC-C-----CCC---ccCCHHHHHHHHH
Confidence 8754 47899999999999999999999985432111 1111111100 0 000 1124477899999
Q ss_pred cccCCCCCCC----CHHHHHH
Q 048243 237 CVQENPNDRP----SMLQVSS 253 (303)
Q Consensus 237 ~l~~dp~~Rp----t~~el~~ 253 (303)
||..||.+|| ++.++++
T Consensus 232 ~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 232 LLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HcCCCHHHCCCCCCCHHHHhc
Confidence 9999999998 5666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=269.78 Aligned_cols=239 Identities=23% Similarity=0.270 Sum_probs=174.0
Q ss_pred CCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCC------eeEEEEeecCCCChhhhhcCcccc
Q 048243 4 PCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE------ERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~ 75 (303)
.+|+.||+|++... .......+.+|+.+++.++||||+++++++.... ..|+||||+.+ +|...+.
T Consensus 44 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----- 117 (359)
T cd07876 44 VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH----- 117 (359)
T ss_pred CCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHh-----
Confidence 56899999999654 2334467789999999999999999999986543 47999999975 4555542
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCCh
Q 048243 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aP 155 (303)
..+++..+..++.|++.||+|||+.| |+||||||+||+++.++.++|+|||++...... .......|+..|+||
T Consensus 118 ~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aP 191 (359)
T cd07876 118 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYYRAP 191 (359)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCccccccC---ccCCCCcccCCCCCc
Confidence 23788889999999999999999999 999999999999999999999999998654322 112234678999999
Q ss_pred hhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHH------------HH----HHHHHhCC-Ccc-----ee
Q 048243 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSIL------------EH----AYELWKGG-KGV-----EF 213 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~------------~~----~~~~~~~~-~~~-----~~ 213 (303)
|.+.+..++.++|||||||++|+|++|..||............ .. ........ ... +.
T Consensus 192 E~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (359)
T cd07876 192 EVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEEL 271 (359)
T ss_pred hhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhh
Confidence 9999989999999999999999999999999754321110000 00 00000000 000 00
Q ss_pred cccc---CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 214 VDSS---LDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 214 ~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
.... .........+..+.+|+.+||..||++|||+.|+++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 272 FPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred ccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 0000111224568899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=257.84 Aligned_cols=230 Identities=23% Similarity=0.356 Sum_probs=180.2
Q ss_pred cEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHH
Q 048243 7 KVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVH 85 (303)
Q Consensus 7 ~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~ 85 (303)
..||+|...... ....+.+.+|+.+++.++||||+++++++.+ ...++||||+++++|.+++.. ....+++..++.
T Consensus 35 ~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~ 111 (270)
T cd05056 35 IAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQV--NKYSLDLASLIL 111 (270)
T ss_pred cceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHh--CCCCCCHHHHHH
Confidence 468999887654 4455689999999999999999999999875 457899999999999999853 233589999999
Q ss_pred HHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCCC
Q 048243 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYST 165 (303)
Q Consensus 86 ~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 165 (303)
++.+++.||+|||+.+ ++||||||+||+++.++.++|+|||.+.......... .....++..|+|||.+....++.
T Consensus 112 ~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~ 187 (270)
T cd05056 112 YSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK-ASKGKLPIKWMAPESINFRRFTS 187 (270)
T ss_pred HHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccccccee-cCCCCccccccChhhhccCCCCc
Confidence 9999999999999998 9999999999999999999999999987654432211 11223456799999998888999
Q ss_pred ccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCC
Q 048243 166 KSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPND 244 (303)
Q Consensus 166 ~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 244 (303)
++||||||+++|++++ |..||........ . .......... .+...+..+.+++.+||..+|.+
T Consensus 188 ~~Di~slG~il~el~~~g~~pf~~~~~~~~---~----~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~ 251 (270)
T cd05056 188 ASDVWMFGVCMWEILMLGVKPFQGVKNNDV---I----GRIENGERLP---------MPPNCPPTLYSLMTKCWAYDPSK 251 (270)
T ss_pred hhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---H----HHHHcCCcCC---------CCCCCCHHHHHHHHHHcCCChhh
Confidence 9999999999999986 9999854432211 1 1111111111 11122347889999999999999
Q ss_pred CCCHHHHHHHhcccc
Q 048243 245 RPSMLQVSSMLKNET 259 (303)
Q Consensus 245 Rpt~~el~~~L~~~~ 259 (303)
|||+.++++.|++..
T Consensus 252 Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 252 RPRFTELKAQLSDIL 266 (270)
T ss_pred CcCHHHHHHHHHHHH
Confidence 999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=254.56 Aligned_cols=227 Identities=29% Similarity=0.438 Sum_probs=178.8
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+++.||+|.++... ..+.+.+|+.+++.++||||+++++++..+ ..+++|||+.+++|.+++... ....+++..+
T Consensus 27 ~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~ 102 (254)
T cd05083 27 YTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTR-GRALVSVIQL 102 (254)
T ss_pred cCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhc-CcCCCCHHHH
Confidence 467889999986543 336788999999999999999999998764 579999999999999998542 2345789999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
+.++.|++.|++|||+.| ++||||+|+||+++.++.++|+|||.+....... .....+..|+|||.+.+..+
T Consensus 103 ~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~ 174 (254)
T cd05083 103 LQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-----DNSKLPVKWTAPEALKHKKF 174 (254)
T ss_pred HHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC-----CCCCCCceecCHHHhccCCc
Confidence 999999999999999998 9999999999999999999999999986533211 11233567999999988889
Q ss_pred CCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC
Q 048243 164 STKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 242 (303)
+.++|+||||+++|+|++ |..||........ .......... ......+..+.+++.+||+.+|
T Consensus 175 ~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p 238 (254)
T cd05083 175 SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV-------KECVEKGYRM---------EPPEGCPADVYVLMTSCWETEP 238 (254)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCccCCHHHH-------HHHHhCCCCC---------CCCCcCCHHHHHHHHHHcCCCh
Confidence 999999999999999997 8888854332111 1111111110 1112234578899999999999
Q ss_pred CCCCCHHHHHHHhccc
Q 048243 243 NDRPSMLQVSSMLKNE 258 (303)
Q Consensus 243 ~~Rpt~~el~~~L~~~ 258 (303)
.+||++.++++.|+++
T Consensus 239 ~~Rp~~~~l~~~l~~~ 254 (254)
T cd05083 239 KKRPSFHKLREKLEKE 254 (254)
T ss_pred hhCcCHHHHHHHHccC
Confidence 9999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=265.32 Aligned_cols=238 Identities=27% Similarity=0.398 Sum_probs=180.8
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCccccEEEEEEeC-CeeEEEEeecCCCChhhhhcCccc------
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS-EERMLVYEYMPNKSLDCYLFDPIR------ 74 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~------ 74 (303)
.+++.||||.++... ......+.+|+.++.++ +|+||+++++++... ...+++|||+++|+|.+++.....
T Consensus 35 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~ 114 (343)
T cd05103 35 ATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYK 114 (343)
T ss_pred ccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCcccccc
Confidence 568899999997543 23345788999999999 689999999988654 467899999999999998853210
Q ss_pred ----------------------------------------------------------cccCCHHHHHHHHHHHHHHHHH
Q 048243 75 ----------------------------------------------------------RLILDWKKRVHIIEGITQGLLY 96 (303)
Q Consensus 75 ----------------------------------------------------------~~~l~~~~~~~~~~~i~~~l~~ 96 (303)
...+++..+..++.|++.||+|
T Consensus 115 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~ 194 (343)
T cd05103 115 TKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEF 194 (343)
T ss_pred ccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHH
Confidence 1246778889999999999999
Q ss_pred HHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCCCccchhhHHHHH
Q 048243 97 LQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176 (303)
Q Consensus 97 Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~ 176 (303)
||+.+ ++||||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++
T Consensus 195 lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 271 (343)
T cd05103 195 LASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 271 (343)
T ss_pred HHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHH
Confidence 99998 999999999999999999999999998765332221222223456789999999888899999999999999
Q ss_pred HHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048243 177 LQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSML 255 (303)
Q Consensus 177 ~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~L 255 (303)
|+|++ |..||....... . ............. +...+..+.+++.+||+.||.+|||+.|+++.|
T Consensus 272 ~el~~~g~~p~~~~~~~~--~----~~~~~~~~~~~~~---------~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l 336 (343)
T cd05103 272 WEIFSLGASPYPGVKIDE--E----FCRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336 (343)
T ss_pred HHHHHCCCCCCCCccccH--H----HHHHHhccCCCCC---------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 99997 888875432211 0 1111111111110 111234688999999999999999999999999
Q ss_pred cccc
Q 048243 256 KNET 259 (303)
Q Consensus 256 ~~~~ 259 (303)
+...
T Consensus 337 ~~~~ 340 (343)
T cd05103 337 GNLL 340 (343)
T ss_pred HHHH
Confidence 8764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=251.43 Aligned_cols=234 Identities=22% Similarity=0.339 Sum_probs=172.1
Q ss_pred EEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccc-cccCCHHHHHH
Q 048243 8 VIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR-RLILDWKKRVH 85 (303)
Q Consensus 8 ~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~l~~~~~~~ 85 (303)
.+++|.++... ....+.+.+|+..++.++||||+++++.+......++||||+++|+|.+++..... ....+...++.
T Consensus 24 ~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 103 (268)
T cd05086 24 RVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR 103 (268)
T ss_pred eEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHH
Confidence 46677665443 23456889999999999999999999999999999999999999999999864221 23467778889
Q ss_pred HHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc-----
Q 048243 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ----- 160 (303)
Q Consensus 86 ~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----- 160 (303)
++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++................++..|+|||++..
T Consensus 104 ~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 180 (268)
T cd05086 104 MACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGL 180 (268)
T ss_pred HHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCcc
Confidence 9999999999999998 99999999999999999999999998754322211112223457889999998753
Q ss_pred --CCCCCccchhhHHHHHHHHHhC-CCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHc
Q 048243 161 --GVYSTKSDVFSFGVLLLQIISG-KRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237 (303)
Q Consensus 161 --~~~~~~~DiwslG~~~~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 237 (303)
..++.++||||||+++|+|+++ ..||....... .. ...... ......++.... .....+.+++..|
T Consensus 181 ~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~---~~~~~~-~~~~~~~~~~~~----~~~~~~~~l~~~c 249 (268)
T cd05086 181 ITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE---VL---NHVIKD-QQVKLFKPQLEL----PYSERWYEVLQFC 249 (268)
T ss_pred ccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH---HH---HHHHhh-cccccCCCccCC----CCcHHHHHHHHHH
Confidence 2357799999999999999974 55664332111 11 111111 111122222221 2345678899999
Q ss_pred ccCCCCCCCCHHHHHHHhc
Q 048243 238 VQENPNDRPSMLQVSSMLK 256 (303)
Q Consensus 238 l~~dp~~Rpt~~el~~~L~ 256 (303)
| .+|++||++.++++.|.
T Consensus 250 ~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 250 W-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred h-hCcccCCCHHHHHHHhc
Confidence 9 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=299.27 Aligned_cols=231 Identities=25% Similarity=0.344 Sum_probs=187.7
Q ss_pred cCCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 3 LPCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 3 ~~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
+++|+..|+|.++-. +....+.+.+|+.++..++|||++++||+-.+.+..++.||||++|+|.+++. .+...++
T Consensus 1257 ~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~---~gri~dE 1333 (1509)
T KOG4645|consen 1257 LDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLE---HGRIEDE 1333 (1509)
T ss_pred CCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHH---hcchhhh
Confidence 578999999988643 34455678899999999999999999999999999999999999999999993 4556788
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCC--ccccccccccccCCCChhhh
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKES--LEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~--~~~~~~~~~g~~~y~aPE~~ 158 (303)
.....+..|++.|++|||++| ||||||||.||+++.+|.+|++|||.|..+.+.. .........||+.|||||++
T Consensus 1334 ~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvi 1410 (1509)
T KOG4645|consen 1334 MVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVI 1410 (1509)
T ss_pred hHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhh
Confidence 888999999999999999999 9999999999999999999999999999877653 23444557899999999999
Q ss_pred ccCC---CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHH
Q 048243 159 RQGV---YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235 (303)
Q Consensus 159 ~~~~---~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
.+.. -..++||||||||+.||+||+.||...... . ...+. ...+..+ ..+...+.+-++||.
T Consensus 1411 t~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--~---aIMy~-V~~gh~P---------q~P~~ls~~g~dFle 1475 (1509)
T KOG4645|consen 1411 TGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--W---AIMYH-VAAGHKP---------QIPERLSSEGRDFLE 1475 (1509)
T ss_pred cccccCCCCcchhhhcccceEEEeecCCCchhhccch--h---HHHhH-HhccCCC---------CCchhhhHhHHHHHH
Confidence 8754 456899999999999999999998533211 1 11111 1111111 112225667889999
Q ss_pred HcccCCCCCCCCHHHHHHH
Q 048243 236 LCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 236 ~~l~~dp~~Rpt~~el~~~ 254 (303)
.||+.||.+|.++.||++.
T Consensus 1476 ~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1476 HCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHHhcCchhhhHHHHHHHh
Confidence 9999999999999988875
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=254.63 Aligned_cols=219 Identities=24% Similarity=0.391 Sum_probs=172.2
Q ss_pred cEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHH
Q 048243 7 KVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86 (303)
Q Consensus 7 ~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~ 86 (303)
..|++|.+...... ...+.+|+.+++.++||||+++++++.. ...++||||+.+++|.+++... ...+++..++.+
T Consensus 31 ~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~ 106 (259)
T cd05037 31 VSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHRE--KNNVSLHWKLDV 106 (259)
T ss_pred eeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhh--ccCCCHHHHHHH
Confidence 35788887655433 5788899999999999999999999988 7789999999999999998542 226889999999
Q ss_pred HHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCC-------ceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM-------KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 87 ~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~-------~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+.||+.||+|||+.+ ++|+||||+||+++.++ .++|+|||++..... .....++..|+|||.+.
T Consensus 107 ~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~ 177 (259)
T cd05037 107 AKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIR 177 (259)
T ss_pred HHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCccccccc------ccccccCCCccChhhhc
Confidence 999999999999998 99999999999999887 799999999876433 12234577899999988
Q ss_pred cC--CCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 160 QG--VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 160 ~~--~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
+. .++.++||||||+++|+|++ |..|+......... ..+..... .... ....+.+++.+
T Consensus 178 ~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~-------~~~~~~~~-------~~~~----~~~~~~~li~~ 239 (259)
T cd05037 178 NGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE-------RFYQDQHR-------LPMP----DCAELANLINQ 239 (259)
T ss_pred CCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH-------HHHhcCCC-------CCCC----CchHHHHHHHH
Confidence 76 68899999999999999999 46666443211110 11110000 0000 01578899999
Q ss_pred cccCCCCCCCCHHHHHHHhc
Q 048243 237 CVQENPNDRPSMLQVSSMLK 256 (303)
Q Consensus 237 ~l~~dp~~Rpt~~el~~~L~ 256 (303)
||..+|.+|||+.++++.|+
T Consensus 240 ~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 240 CWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HhccChhhCCCHHHHHHhcC
Confidence 99999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=257.86 Aligned_cols=230 Identities=24% Similarity=0.401 Sum_probs=180.4
Q ss_pred EEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHH
Q 048243 8 VIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86 (303)
Q Consensus 8 ~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~ 86 (303)
.+|+|.+.... ......+.+|+..++.++|+||+++++++.. ...++||||+.+|+|.+++.. ....+++..+..+
T Consensus 38 ~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~ 114 (279)
T cd05057 38 PVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRN--HKDNIGSQYLLNW 114 (279)
T ss_pred EEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHh--ccCCCCHHHHHHH
Confidence 68999886554 3344678899999999999999999999987 788999999999999999854 2345899999999
Q ss_pred HHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCCCc
Q 048243 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTK 166 (303)
Q Consensus 87 ~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 166 (303)
+.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||.+................++..|+|||.+....++.+
T Consensus 115 ~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~ 191 (279)
T cd05057 115 CVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHK 191 (279)
T ss_pred HHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCch
Confidence 999999999999998 99999999999999999999999999876543322111111223568999999988889999
Q ss_pred cchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 048243 167 SDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDR 245 (303)
Q Consensus 167 ~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 245 (303)
+|+||||+++|++++ |..||....... .......... ...+...+..+.+++.+||..||.+|
T Consensus 192 ~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~~p~~R 255 (279)
T cd05057 192 SDVWSYGVTVWELMTFGAKPYEGIPAVE-------IPDLLEKGER---------LPQPPICTIDVYMVLVKCWMIDAESR 255 (279)
T ss_pred hhHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHhCCCC---------CCCCCCCCHHHHHHHHHHcCCChhhC
Confidence 999999999999998 999985433211 1111111110 01111123467899999999999999
Q ss_pred CCHHHHHHHhcccc
Q 048243 246 PSMLQVSSMLKNET 259 (303)
Q Consensus 246 pt~~el~~~L~~~~ 259 (303)
|++.++++.|+...
T Consensus 256 p~~~~l~~~l~~~~ 269 (279)
T cd05057 256 PTFKELINEFSKMA 269 (279)
T ss_pred CCHHHHHHHHHHHH
Confidence 99999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=258.90 Aligned_cols=240 Identities=24% Similarity=0.288 Sum_probs=178.9
Q ss_pred CCCcEEEEEEecCCCcc-----cHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccC
Q 048243 4 PCGKVIAVKKLSKTSTQ-----GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
.+|+.||+|.++..... ....+.+|+.+++.++|+||+++++++.+....++||||+ +++|.+++... ...+
T Consensus 23 ~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~--~~~~ 99 (298)
T cd07841 23 ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDK--SIVL 99 (298)
T ss_pred CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhcc--CCCC
Confidence 46899999999765322 2345778999999999999999999999999999999999 89999998542 1368
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
++..++.++.||+.||+|||++| ++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+
T Consensus 100 ~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~ 174 (298)
T cd07841 100 TPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR--KMTHQVVTRWYRAPELL 174 (298)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCCc--cccccccceeeeCHHHH
Confidence 99999999999999999999999 99999999999999999999999999876544321 11223457789999988
Q ss_pred cc-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCC---------CcceeccccCCCC-----CC
Q 048243 159 RQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG---------KGVEFVDSSLDDT-----NS 223 (303)
Q Consensus 159 ~~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~-----~~ 223 (303)
.+ ..++.++|||||||++|+|++|.++|........ ........... ............. ..
T Consensus 175 ~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T cd07841 175 FGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ---LGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIF 251 (298)
T ss_pred hCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH---HHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhc
Confidence 65 4578899999999999999999777654332111 11111110000 0000000000000 01
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 224 PCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 224 ~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
...+..+.+++.+||..||++|||+.|+++.
T Consensus 252 ~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 252 PAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1234578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=260.10 Aligned_cols=233 Identities=30% Similarity=0.422 Sum_probs=178.9
Q ss_pred EEEEEEecCC-CcccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc------------
Q 048243 8 VIAVKKLSKT-STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI------------ 73 (303)
Q Consensus 8 ~valK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 73 (303)
.+++|.++.. .....+.+.+|+.++.++ +||||+++++++......++++||+++++|.+++....
T Consensus 31 ~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 110 (297)
T cd05089 31 NAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEH 110 (297)
T ss_pred eeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhcccccccccccccc
Confidence 4788888743 333456788999999999 79999999999999899999999999999999985421
Q ss_pred -ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCC
Q 048243 74 -RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGY 152 (303)
Q Consensus 74 -~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y 152 (303)
....+++..++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++...... ........+..|
T Consensus 111 ~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y 184 (297)
T cd05089 111 GTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEVY---VKKTMGRLPVRW 184 (297)
T ss_pred CccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEECCcCCCccccce---eccCCCCcCccc
Confidence 1235888999999999999999999998 999999999999999999999999987532211 011111224579
Q ss_pred CChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHH
Q 048243 153 IPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL 231 (303)
Q Consensus 153 ~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
+|||.+.+..++.++|||||||++|+|++ |..||....... ......... ....+...+..+.
T Consensus 185 ~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-------~~~~~~~~~---------~~~~~~~~~~~~~ 248 (297)
T cd05089 185 MAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-------LYEKLPQGY---------RMEKPRNCDDEVY 248 (297)
T ss_pred cCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHhcCC---------CCCCCCCCCHHHH
Confidence 99999988889999999999999999997 988985432211 111111110 0111112335788
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhccccCCC
Q 048243 232 EIALLCVQENPNDRPSMLQVSSMLKNETTNR 262 (303)
Q Consensus 232 ~li~~~l~~dp~~Rpt~~el~~~L~~~~~~~ 262 (303)
+|+.+||+.+|.+|||++++++.|++.....
T Consensus 249 ~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 249 ELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 9999999999999999999999987666433
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=255.65 Aligned_cols=232 Identities=24% Similarity=0.379 Sum_probs=182.5
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
++|+.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||+++++|.+++. ..+.+++..
T Consensus 28 ~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~ 104 (284)
T cd06620 28 PTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYK---KGGPIPVEI 104 (284)
T ss_pred CCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHH---hccCCCHHH
Confidence 568999999986543 3345688999999999999999999999999999999999999999988874 345689999
Q ss_pred HHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 83 RVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
+..++.+++.+|.|||+ .+ ++|+||+|+||+++.++.++|+|||++....... .....|+..|+|||.+.+.
T Consensus 105 ~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~ 177 (284)
T cd06620 105 LGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI----ADTFVGTSTYMSPERIQGG 177 (284)
T ss_pred HHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc----cCccccCcccCCHHHHccC
Confidence 99999999999999997 46 9999999999999999999999999876543221 1234689999999999888
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCcc-----ccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINEN-----LSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
.++.++|+|||||++|++++|..||........ .............. .........+..+.+++.+
T Consensus 178 ~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~li~~ 248 (284)
T cd06620 178 KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP---------PPRLPSSDFPEDLRDFVDA 248 (284)
T ss_pred CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc---------CCCCCchhcCHHHHHHHHH
Confidence 889999999999999999999999975443211 00111111111100 0000111234578899999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 048243 237 CVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 237 ~l~~dp~~Rpt~~el~~~ 254 (303)
||+.||.+|||+.|+++.
T Consensus 249 ~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 249 CLLKDPTERPTPQQLCAM 266 (284)
T ss_pred HhcCCcccCcCHHHHhcC
Confidence 999999999999999976
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=260.08 Aligned_cols=232 Identities=23% Similarity=0.249 Sum_probs=182.3
Q ss_pred CCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTST---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|.+..... ...+.+..|++.++.++|+||+++++.+......++||||+.+++|.+++.. .....+++
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~l~~ 102 (316)
T cd05574 24 GTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQR-QPGKCLSE 102 (316)
T ss_pred CCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHh-CCCCccCH
Confidence 3689999999975532 2445788999999999999999999999999999999999999999998853 23456899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc--------------------
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-------------------- 140 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-------------------- 140 (303)
..+..++.|++.||+|||+.| ++|+||||+||+++.++.++|+|||++.........
T Consensus 103 ~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (316)
T cd05574 103 EVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179 (316)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchh
Confidence 999999999999999999998 999999999999999999999999998654322110
Q ss_pred -------ccccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCccee
Q 048243 141 -------ANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF 213 (303)
Q Consensus 141 -------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (303)
.......|+..|+|||.+.+..++.++||||||+++|+|++|..||........ ........
T Consensus 180 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~------~~~~~~~~----- 248 (316)
T cd05574 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET------FSNILKKE----- 248 (316)
T ss_pred hhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH------HHHHhcCC-----
Confidence 011234678899999999988899999999999999999999999864432211 11111110
Q ss_pred ccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCC----HHHHHHH
Q 048243 214 VDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPS----MLQVSSM 254 (303)
Q Consensus 214 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt----~~el~~~ 254 (303)
.........+..+.+++.+||..||++||| +.|++..
T Consensus 249 ----~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 249 ----VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred ----ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 001111114568899999999999999999 7777763
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=284.97 Aligned_cols=238 Identities=21% Similarity=0.253 Sum_probs=180.5
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccc------
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR------ 74 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------ 74 (303)
.+|+.||+|++.... ....+++.+|+.++++++||||+++++++.+++..+++|||++|++|.+++.....
T Consensus 25 ~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e 104 (932)
T PRK13184 25 VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSK 104 (932)
T ss_pred CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccch
Confidence 468999999997542 22345788999999999999999999999999999999999999999998853111
Q ss_pred --cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCc-------------
Q 048243 75 --RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL------------- 139 (303)
Q Consensus 75 --~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~------------- 139 (303)
...++...++.++.||+.||+|||+.| ++||||||+||+++.++.++|+|||++........
T Consensus 105 ~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~ 181 (932)
T PRK13184 105 ELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181 (932)
T ss_pred hhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCcceeccccccccccccccccccc
Confidence 233556778999999999999999998 99999999999999999999999999976521110
Q ss_pred ---cccccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccc
Q 048243 140 ---EANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS 216 (303)
Q Consensus 140 ---~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (303)
........||+.|+|||.+.+..++.++|||||||++|+|++|..||........ ... .....
T Consensus 182 ~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki---~~~--~~i~~--------- 247 (932)
T PRK13184 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI---SYR--DVILS--------- 247 (932)
T ss_pred ccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh---hhh--hhccC---------
Confidence 0111234689999999999999999999999999999999999999864221110 000 00000
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHhccc
Q 048243 217 SLDDTNSPCKLMRCLEIALLCVQENPNDRP-SMLQVSSMLKNE 258 (303)
Q Consensus 217 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-t~~el~~~L~~~ 258 (303)
..........+..+.+++.+||..||++|| +++++++.|+..
T Consensus 248 P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 248 PIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred hhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000001112334678999999999999996 566667766654
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=253.28 Aligned_cols=232 Identities=26% Similarity=0.349 Sum_probs=182.5
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+++.+|+|.+.... ....+.+.+|++.+++++||||+++++.+......++++||+.+++|.+++... ...+++..
T Consensus 24 ~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~ 101 (265)
T cd06605 24 PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEV--QGRIPERI 101 (265)
T ss_pred CCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHc--cCCCCHHH
Confidence 468999999987653 334467889999999999999999999999999999999999999999998542 26688999
Q ss_pred HHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 83 RVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
+..++.|++.|++|||+ .+ ++|+||+|+||+++.++.++|+|||.+........ ....++..|+|||.+.+.
T Consensus 102 ~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~y~~PE~~~~~ 174 (265)
T cd06605 102 LGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA----KTFVGTSSYMAPERIQGN 174 (265)
T ss_pred HHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh----hcccCChhccCHHHHcCC
Confidence 99999999999999999 88 99999999999999999999999998865532211 115678899999999988
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
.++.++||||||+++|+|++|..||....... ....... .......... + .....+..+.++|.+||..|
T Consensus 175 ~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~-~~~~~~~~~~-----~---~~~~~~~~~~~li~~~l~~~ 244 (265)
T cd06605 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELL-QYIVNEPPPR-----L---PSGKFSPDFQDFVNLCLIKD 244 (265)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHH-HHHhcCCCCC-----C---ChhhcCHHHHHHHHHHcCCC
Confidence 89999999999999999999999986442211 1111111 1111111100 0 01114557889999999999
Q ss_pred CCCCCCHHHHHHH
Q 048243 242 PNDRPSMLQVSSM 254 (303)
Q Consensus 242 p~~Rpt~~el~~~ 254 (303)
|.+|||+.+++..
T Consensus 245 p~~Rpt~~~ll~~ 257 (265)
T cd06605 245 PRERPSYKELLEH 257 (265)
T ss_pred chhCcCHHHHhhC
Confidence 9999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=252.51 Aligned_cols=229 Identities=22% Similarity=0.336 Sum_probs=182.2
Q ss_pred CCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+|+.||+|.+... .....+.+.+|+.++++++|+||+++++++......++|+||+.+++|.+++... ....+++.
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~ 101 (256)
T cd08218 23 EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQ-RGVLFPED 101 (256)
T ss_pred CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhc-cCCCCCHH
Confidence 47899999998643 2334567899999999999999999999999999999999999999999888531 23357889
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
.++.++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||.+........ ......|+..|+|||.+.+.
T Consensus 102 ~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~ 176 (256)
T cd08218 102 QILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENR 176 (256)
T ss_pred HHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh--hhhhccCCccccCHHHhCCC
Confidence 99999999999999999998 99999999999999999999999999876543221 12234578889999999888
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
.++.++|+||||++++++++|..||....... .......+. .. ..+...+..+.++|.+||+.+
T Consensus 177 ~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~~~~-~~---------~~~~~~~~~~~~li~~~l~~~ 240 (256)
T cd08218 177 PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN------LVLKIIRGS-YP---------PVSSHYSYDLRNLVSQLFKRN 240 (256)
T ss_pred CCCCccchhHHHHHHHHHHcCCCCccCCCHHH------HHHHHhcCC-CC---------CCcccCCHHHHHHHHHHhhCC
Confidence 89999999999999999999999985332111 111111111 10 111223457889999999999
Q ss_pred CCCCCCHHHHHHH
Q 048243 242 PNDRPSMLQVSSM 254 (303)
Q Consensus 242 p~~Rpt~~el~~~ 254 (303)
|.+||++.++++.
T Consensus 241 p~~Rp~~~~vl~~ 253 (256)
T cd08218 241 PRDRPSVNSILEK 253 (256)
T ss_pred hhhCcCHHHHhhC
Confidence 9999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=251.54 Aligned_cols=236 Identities=26% Similarity=0.373 Sum_probs=185.7
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+++.+|+|++.... ......+.+|+..++.++|+||+++++.+......++|||++.+++|.+++........+++..
T Consensus 24 ~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~ 103 (267)
T cd06610 24 PNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAI 103 (267)
T ss_pred CCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHH
Confidence 478899999996543 2355678999999999999999999999999999999999999999999986533335689999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccc--cccccccccCCCChhhhcc
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEA--NTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~ 160 (303)
+..++.|++.|+++||+.| ++||||+|+||++++++.++|+|||++.......... ......|+..|+|||.+..
T Consensus 104 ~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~ 180 (267)
T cd06610 104 IATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180 (267)
T ss_pred HHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHcc
Confidence 9999999999999999999 9999999999999999999999999987665433221 2233467889999999877
Q ss_pred C-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCC-CCHHHHHHHHHHHHHcc
Q 048243 161 G-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDT-NSPCKLMRCLEIALLCV 238 (303)
Q Consensus 161 ~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l 238 (303)
. .++.++|+||||+++|+|++|..||....... ......... ....... .....+..+.+++.+||
T Consensus 181 ~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l 248 (267)
T cd06610 181 VHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQND------PPSLETGADYKKYSKSFRKMISLCL 248 (267)
T ss_pred ccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcCC------CCCcCCccccccccHHHHHHHHHHc
Confidence 6 78899999999999999999999985432211 111111110 0011111 11233457889999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 048243 239 QENPNDRPSMLQVSSM 254 (303)
Q Consensus 239 ~~dp~~Rpt~~el~~~ 254 (303)
..||++|||+.++++.
T Consensus 249 ~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 249 QKDPSKRPTAEELLKH 264 (267)
T ss_pred CCChhhCcCHHHHhhC
Confidence 9999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=266.96 Aligned_cols=239 Identities=23% Similarity=0.242 Sum_probs=174.4
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeC------CeeEEEEeecCCCChhhhhcCcccc
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------EERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~ 75 (303)
.+++.||||++.... ......+.+|+.+++.++||||+++++++... ...|+||||+.+ +|..++.
T Consensus 47 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----- 120 (364)
T cd07875 47 ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ----- 120 (364)
T ss_pred CCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHH-----
Confidence 468899999997542 33446788899999999999999999987643 357999999975 6666652
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCCh
Q 048243 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aP 155 (303)
..+++..+..++.|++.||+|||++| |+||||||+||+++.++.++|+|||+++...... ......|+..|+||
T Consensus 121 ~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aP 194 (364)
T cd07875 121 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAP 194 (364)
T ss_pred hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccccCCCC---cccCCcccCCcCCH
Confidence 23778889999999999999999998 9999999999999999999999999997654321 12234679999999
Q ss_pred hhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHH---------------H-HHHHhCCC-cc-----ee
Q 048243 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH---------------A-YELWKGGK-GV-----EF 213 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~---------------~-~~~~~~~~-~~-----~~ 213 (303)
|++.+..++.++|||||||++|+|++|..||.............. . ........ .. ..
T Consensus 195 E~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (364)
T cd07875 195 EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKL 274 (364)
T ss_pred HHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhh
Confidence 999999999999999999999999999999964432111100000 0 00000000 00 00
Q ss_pred ccc---cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 214 VDS---SLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 214 ~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
... .............+.+||.+||+.||.+|||+.|+++.
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 275 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred CccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 00001111223467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=253.37 Aligned_cols=228 Identities=23% Similarity=0.329 Sum_probs=176.3
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCccccEEEEEEeC------CeeEEEEeecCCCChhhhhcCccccc
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS------EERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~ 76 (303)
.+++.||+|.+.... .....+..|+.++.++ +|+||+++++++... ...+++|||+.+++|.+++... ...
T Consensus 29 ~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~-~~~ 106 (272)
T cd06637 29 KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGN 106 (272)
T ss_pred CCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhc-cCC
Confidence 468899999996543 3446788999999998 799999999998753 4579999999999999988542 234
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChh
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE 156 (303)
.+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......|+..|+|||
T Consensus 107 ~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE 181 (272)
T cd06637 107 TLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPE 181 (272)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCceeccccc--ccCCcccccccccCHh
Confidence 6889999999999999999999998 9999999999999999999999999987543221 1223356788999999
Q ss_pred hhc-----cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHH
Q 048243 157 YAR-----QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL 231 (303)
Q Consensus 157 ~~~-----~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
++. +..++.++||||+||++|+|++|..||....... ......... . ........+..+.
T Consensus 182 ~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~------~~~~~~~~~-~--------~~~~~~~~~~~~~ 246 (272)
T cd06637 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------ALFLIPRNP-A--------PRLKSKKWSKKFQ 246 (272)
T ss_pred HhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH------HHHHHhcCC-C--------CCCCCCCcCHHHH
Confidence 986 3357889999999999999999999985332111 111111110 0 0011112334788
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 048243 232 EIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 232 ~li~~~l~~dp~~Rpt~~el~~ 253 (303)
+|+.+||..||.+|||+.+++.
T Consensus 247 ~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 247 SFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHHHHHcCCChhhCCCHHHHhh
Confidence 9999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=253.61 Aligned_cols=234 Identities=25% Similarity=0.377 Sum_probs=180.0
Q ss_pred CCCcEEEEEEecCCCc----------ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc
Q 048243 4 PCGKVIAVKKLSKTST----------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI 73 (303)
Q Consensus 4 ~~~~~valK~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 73 (303)
.+|+.||+|.++.... ...+.+..|+..++.++|+||+++++++......++||||+.+++|.+++..
T Consensus 24 ~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-- 101 (272)
T cd06629 24 TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT-- 101 (272)
T ss_pred CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhh--
Confidence 4789999998854211 0124578899999999999999999999999999999999999999999843
Q ss_pred ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCC
Q 048243 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYI 153 (303)
Q Consensus 74 ~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~ 153 (303)
...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||.+................|+..|+
T Consensus 102 -~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~ 177 (272)
T cd06629 102 -YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177 (272)
T ss_pred -ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCcccc
Confidence 356889999999999999999999998 9999999999999999999999999987654322222223345788999
Q ss_pred ChhhhccCC--CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHH
Q 048243 154 PPEYARQGV--YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL 231 (303)
Q Consensus 154 aPE~~~~~~--~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
|||.+.... ++.++|+||||+++|++++|..||...... ............. ..........+..+.
T Consensus 178 ~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 246 (272)
T cd06629 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMFKLGNKRSAP-----PIPPDVSMNLSPVAL 246 (272)
T ss_pred CHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHHHhhccccCC-----cCCccccccCCHHHH
Confidence 999987654 788999999999999999999998532211 1111111111111 111111123356888
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 048243 232 EIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 232 ~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
+++.+||..+|.+|||+.++++.
T Consensus 247 ~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 247 DFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred HHHHHHhcCChhhCCCHHHHhhC
Confidence 99999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=250.92 Aligned_cols=230 Identities=26% Similarity=0.368 Sum_probs=185.8
Q ss_pred CCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.|++|++..... .....+.+|+..+..++|+||+++++++......++||||+++++|.+++.. ...+++..
T Consensus 24 ~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~ 100 (264)
T cd06623 24 PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKK---VGKIPEPV 100 (264)
T ss_pred CCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHH---cCCCCHHH
Confidence 3689999999976643 4457899999999999999999999999999999999999999999999843 36689999
Q ss_pred HHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 83 RVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
++.++.|++.|++|||+ .+ ++|+||+|+||+++.++.++|+|||.+......... .....++..|+|||.+...
T Consensus 101 ~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~ 175 (264)
T cd06623 101 LAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--CNTFVGTVTYMSPERIQGE 175 (264)
T ss_pred HHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc--ccceeecccccCHhhhCCC
Confidence 99999999999999999 88 999999999999999999999999998765433222 1234578899999999888
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHH-HHHHHHHHHHHcccC
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPC-KLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~ 240 (303)
.++.++|+||||+++|+|++|..||............. ... ...... .... .+..+.+++.+||..
T Consensus 176 ~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~---~~~-~~~~~~---------~~~~~~~~~l~~li~~~l~~ 242 (264)
T cd06623 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ---AIC-DGPPPS---------LPAEEFSPEFRDFISACLQK 242 (264)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH---HHh-cCCCCC---------CCcccCCHHHHHHHHHHccC
Confidence 88999999999999999999999986554312111111 111 111110 1111 345788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 048243 241 NPNDRPSMLQVSSM 254 (303)
Q Consensus 241 dp~~Rpt~~el~~~ 254 (303)
+|++||++.++++.
T Consensus 243 ~p~~R~~~~~ll~~ 256 (264)
T cd06623 243 DPKKRPSAAELLQH 256 (264)
T ss_pred ChhhCCCHHHHHhC
Confidence 99999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=256.18 Aligned_cols=235 Identities=26% Similarity=0.406 Sum_probs=179.5
Q ss_pred CCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCC------eeEEEEeecCCCChhhhhcCcc---
Q 048243 5 CGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE------ERMLVYEYMPNKSLDCYLFDPI--- 73 (303)
Q Consensus 5 ~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~--- 73 (303)
+|+.||||.+.... ....+.+.+|+.+++.++||||+++++++.... ..+++++|+.+|+|..++....
T Consensus 26 ~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 105 (273)
T cd05074 26 SFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGE 105 (273)
T ss_pred CceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccC
Confidence 57899999997543 334567889999999999999999999886542 2478899999999988774321
Q ss_pred ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCC
Q 048243 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYI 153 (303)
Q Consensus 74 ~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~ 153 (303)
....++...++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||.++...............++..|+
T Consensus 106 ~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 182 (273)
T cd05074 106 EPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182 (273)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhc
Confidence 1235788899999999999999999998 9999999999999999999999999987654332222222234567899
Q ss_pred ChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHH
Q 048243 154 PPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLE 232 (303)
Q Consensus 154 aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 232 (303)
+||.+.+..++.++||||||+++|+|++ |..||....... ........... ...+..+..+.+
T Consensus 183 ~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~~~ 246 (273)
T cd05074 183 ALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE-------IYNYLIKGNRL---------KQPPDCLEDVYE 246 (273)
T ss_pred CHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH-------HHHHHHcCCcC---------CCCCCCCHHHHH
Confidence 9999988889999999999999999999 777775322111 11111111100 011123357889
Q ss_pred HHHHcccCCCCCCCCHHHHHHHhccc
Q 048243 233 IALLCVQENPNDRPSMLQVSSMLKNE 258 (303)
Q Consensus 233 li~~~l~~dp~~Rpt~~el~~~L~~~ 258 (303)
++.+||..+|++|||+.++++.|++.
T Consensus 247 l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 247 LMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=267.74 Aligned_cols=239 Identities=24% Similarity=0.264 Sum_probs=174.5
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeC------CeeEEEEeecCCCChhhhhcCcccc
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------EERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~ 75 (303)
.+++.||+|++.... ......+.+|+.+++.++||||+++++++... ...++||||+++ ++...+.
T Consensus 40 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----- 113 (355)
T cd07874 40 VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ----- 113 (355)
T ss_pred CCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHh-----
Confidence 468899999997542 23345778899999999999999999998643 357999999975 5655552
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCCh
Q 048243 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aP 155 (303)
..+++..+..++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++....... ......|+..|+||
T Consensus 114 ~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aP 187 (355)
T cd07874 114 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAP 187 (355)
T ss_pred hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccCCCcc---ccCCccccCCccCH
Confidence 23788899999999999999999999 9999999999999999999999999987654321 12234679999999
Q ss_pred hhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHH----------------HHHHHhCCCc-c-----ee
Q 048243 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH----------------AYELWKGGKG-V-----EF 213 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~----------------~~~~~~~~~~-~-----~~ 213 (303)
|.+.+..++.++|||||||++|+|++|..||.............. .......... . ..
T Consensus 188 E~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (355)
T cd07874 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 267 (355)
T ss_pred HHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhh
Confidence 999998999999999999999999999999964332111100000 0000000000 0 00
Q ss_pred c-cccC--CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 214 V-DSSL--DDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 214 ~-~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
. +... ...........+.+||.+||+.||++|||+.|+++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 268 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred ccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0 0000 001111224567899999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=259.49 Aligned_cols=233 Identities=18% Similarity=0.221 Sum_probs=176.7
Q ss_pred CCCcEEEEEEecCC---CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+++.||+|++... .....+.+.+|+.++..++|+||+++++++..+...|+||||+.+|+|.+++.. ....+++
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--~~~~~~~ 101 (331)
T cd05597 24 NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSK--FEDRLPE 101 (331)
T ss_pred CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHH--hcCCCCH
Confidence 46899999999642 223345688899999999999999999999999999999999999999999843 2456889
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..+..++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||++........ .......|++.|+|||++..
T Consensus 102 ~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~ 177 (331)
T cd05597 102 DMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGTPDYISPEILQA 177 (331)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCC-ccccceeccccccCHHHHhh
Confidence 999999999999999999999 99999999999999999999999999866543221 11222468999999999873
Q ss_pred -----CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHH
Q 048243 161 -----GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235 (303)
Q Consensus 161 -----~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
..++.++||||+||++|+|++|..||....... .............+.. .....+..+.+++.
T Consensus 178 ~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~~~~~------~~~~~~~~~~~li~ 245 (331)
T cd05597 178 MEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKEHFQFPP------DVTDVSEEAKDLIR 245 (331)
T ss_pred ccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH------HHHHHHcCCCcccCCC------ccCCCCHHHHHHHH
Confidence 346889999999999999999999985432211 1111111111111100 01123457889999
Q ss_pred HcccCCCC--CCCCHHHHHHH
Q 048243 236 LCVQENPN--DRPSMLQVSSM 254 (303)
Q Consensus 236 ~~l~~dp~--~Rpt~~el~~~ 254 (303)
+||..+++ .|+++.++++.
T Consensus 246 ~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 246 RLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHccCcccccCCCCHHHHhcC
Confidence 98865333 37899888775
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=256.88 Aligned_cols=223 Identities=26% Similarity=0.300 Sum_probs=180.3
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+++.||+|.+.... ....+.+.+|++++++++||||+++++++......++||||+++++|.+++.. ...+++
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~l~~ 100 (290)
T cd05580 24 GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK---SGRFPE 100 (290)
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHH---cCCCCH
Confidence 468999999986542 23446788999999999999999999999999999999999999999999843 456899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..+..++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||++...... .....|+..|+|||.+.+
T Consensus 101 ~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~ 172 (290)
T cd05580 101 PVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILS 172 (290)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcC
Confidence 999999999999999999998 999999999999999999999999998765433 223457889999999988
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++||||||+++|+|++|..||...... . ......... . . .+...+..+.+++.+||..
T Consensus 173 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~-~~~~~~~~~-~-----~----~~~~~~~~l~~li~~~l~~ 235 (290)
T cd05580 173 KGYGKAVDWWALGILIYEMLAGYPPFFDDNPI------Q-IYEKILEGK-V-----R----FPSFFSPDAKDLIRNLLQV 235 (290)
T ss_pred CCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHhcCC-c-----c----CCccCCHHHHHHHHHHccC
Confidence 88899999999999999999999998644311 1 111111110 0 0 1111245788999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 048243 241 NPNDRP-----SMLQVSSM 254 (303)
Q Consensus 241 dp~~Rp-----t~~el~~~ 254 (303)
||.+|+ +++|+++.
T Consensus 236 ~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 236 DLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred CHHHccCcccCCHHHHHcC
Confidence 999999 77777643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=259.02 Aligned_cols=178 Identities=25% Similarity=0.366 Sum_probs=143.7
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEe--CCeeEEEEeecCCCChhhhhcCc------cccc
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCID--SEERMLVYEYMPNKSLDCYLFDP------IRRL 76 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~------~~~~ 76 (303)
+++.||+|.+..... ...+.+|+.++++++||||+++++++.. +...++||||+.+ +|.+++... ....
T Consensus 27 ~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~ 103 (317)
T cd07867 27 DEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPM 103 (317)
T ss_pred ccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCc
Confidence 567899999865432 2457789999999999999999999864 4578999999865 666665321 1233
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEE----CCCCceEEcccccccccccCCcc-ccccccccccC
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL----GEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIG 151 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~----~~~~~v~l~Df~~~~~~~~~~~~-~~~~~~~g~~~ 151 (303)
.+++..++.++.||+.||+|||+.+ ++||||||+||++ +.++.++|+|||+++........ .......|+..
T Consensus 104 ~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~ 180 (317)
T cd07867 104 QLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180 (317)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceeccc
Confidence 5788999999999999999999999 9999999999999 56678999999999876543221 22234567999
Q ss_pred CCChhhhccC-CCCCccchhhHHHHHHHHHhCCCCCcc
Q 048243 152 YIPPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSML 188 (303)
Q Consensus 152 y~aPE~~~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~ 188 (303)
|+|||.+.+. .++.++|||||||++|+|++|.+||..
T Consensus 181 y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred ccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 9999998764 578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=256.33 Aligned_cols=228 Identities=23% Similarity=0.352 Sum_probs=182.8
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+++.||+|.+........+.+.+|+.+++.++||||+++++.+......++|+||+++++|.+++. ...+++..+
T Consensus 42 ~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~l~~~~~ 117 (293)
T cd06647 42 ATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQI 117 (293)
T ss_pred CCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHh----hcCCCHHHH
Confidence 4688999999876555556778999999999999999999999999999999999999999999883 335788899
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
..++.|++.|++|||+.| ++|+||+|+||+++.++.++|+|||.+........ ......|+..|+|||.+.+..+
T Consensus 118 ~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~ 192 (293)
T cd06647 118 AAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAY 192 (293)
T ss_pred HHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc--ccccccCChhhcCchhhccCCC
Confidence 999999999999999999 99999999999999999999999998765443221 1223457889999999988888
Q ss_pred CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCC
Q 048243 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 243 (303)
+.++|+||||+++|++++|..||........... ..... ..........+..+.+++.+||..+|.
T Consensus 193 ~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~~p~ 258 (293)
T cd06647 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG--------TPELQNPEKLSAIFRDFLNRCLEMDVE 258 (293)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcCC--------CCCCCCccccCHHHHHHHHHHccCChh
Confidence 9999999999999999999999965433221110 00000 000111122345788999999999999
Q ss_pred CCCCHHHHHHH
Q 048243 244 DRPSMLQVSSM 254 (303)
Q Consensus 244 ~Rpt~~el~~~ 254 (303)
+||++.+++..
T Consensus 259 ~Rp~~~~il~h 269 (293)
T cd06647 259 KRGSAKELLQH 269 (293)
T ss_pred hCcCHHHHhcC
Confidence 99999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=258.46 Aligned_cols=243 Identities=23% Similarity=0.319 Sum_probs=180.9
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
++++.||+|+++... ....+.+.+|+++++.++|+||+++++++..+...+++|||+.++.+..+.. ....+++.
T Consensus 24 ~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~---~~~~~~~~ 100 (288)
T cd07833 24 ATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA---SPGGLPPD 100 (288)
T ss_pred CCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHh---cCCCCCHH
Confidence 468899999987542 3345688999999999999999999999999999999999999877766552 33458999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
.++.++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||.+.+.
T Consensus 101 ~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~ 176 (288)
T cd07833 101 AVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPLTDYVATRWYRAPELLVGD 176 (288)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccccCcccccCCcCCchhcCC
Confidence 99999999999999999998 99999999999999999999999999876554332 122234578889999999887
Q ss_pred -CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHH--------HHHhCCCcc---eecccc----CCCCCCHH
Q 048243 162 -VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY--------ELWKGGKGV---EFVDSS----LDDTNSPC 225 (303)
Q Consensus 162 -~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~---~~~~~~----~~~~~~~~ 225 (303)
.++.++||||||+++|+|++|..||......+......... ..+...... ...... ........
T Consensus 177 ~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (288)
T cd07833 177 TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGK 256 (288)
T ss_pred CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCc
Confidence 78999999999999999999999986443221111000000 000000000 000000 00001112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 226 KLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 226 ~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
.+.++.++|.+||..+|++|||+++++.
T Consensus 257 ~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 257 VSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cchHHHHHHHHHhccCchhcccHHHHhc
Confidence 2567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=258.99 Aligned_cols=236 Identities=19% Similarity=0.217 Sum_probs=181.4
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+++.||+|.+.... ....+.+.+|+.+++.++||||+++++.+..+...++||||+++++|.+++. ....+++
T Consensus 24 ~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~---~~~~~~~ 100 (305)
T cd05609 24 ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLK---NIGALPV 100 (305)
T ss_pred CCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHH---HcCCCCH
Confidence 467899999987553 2234577899999999999999999999999999999999999999999984 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCc-------------cccccccc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL-------------EANTEQVV 147 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~-------------~~~~~~~~ 147 (303)
..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||.++....... ........
T Consensus 101 ~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (305)
T cd05609 101 DMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177 (305)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCc
Confidence 999999999999999999998 99999999999999999999999998864211100 00111235
Q ss_pred cccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHH
Q 048243 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKL 227 (303)
Q Consensus 148 g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
++..|+|||.+.+..++.++|+||||+++|++++|..||....... ... ........ .+ ......+
T Consensus 178 ~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~---~~~---~~~~~~~~----~~----~~~~~~~ 243 (305)
T cd05609 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFG---QVISDDIE----WP----EGDEALP 243 (305)
T ss_pred cCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---HHHhcccC----CC----CccccCC
Confidence 6788999999988889999999999999999999999985322111 111 11111000 00 0011234
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhcccc
Q 048243 228 MRCLEIALLCVQENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 228 ~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~ 259 (303)
..+.+++.+||+.||++||++.++.+.|+...
T Consensus 244 ~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~ 275 (305)
T cd05609 244 ADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275 (305)
T ss_pred HHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence 46889999999999999999877777776654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=258.36 Aligned_cols=240 Identities=21% Similarity=0.264 Sum_probs=176.3
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+|+.||+|.++... ......+.+|+.++++++|+||+++++++.+....++++||+. ++|.+++.. ....+++.
T Consensus 23 ~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~ 99 (284)
T cd07839 23 ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDS--CNGDIDPE 99 (284)
T ss_pred CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHh--cCCCCCHH
Confidence 478999999986542 2223567789999999999999999999999999999999997 477776643 24568999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
.++.++.||+.||+|||+.+ ++||||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+.
T Consensus 100 ~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~ 174 (284)
T cd07839 100 IVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGA 174 (284)
T ss_pred HHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC--CCcCCCccccCCcChHHHhCC
Confidence 99999999999999999999 9999999999999999999999999987654321 111224568899999988764
Q ss_pred -CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCC---------ccee-ccccCCC-----CCCHH
Q 048243 162 -VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK---------GVEF-VDSSLDD-----TNSPC 225 (303)
Q Consensus 162 -~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~-~~~~~~~-----~~~~~ 225 (303)
.++.++|||||||++|+|++|..|+...... ............... .... ....... ...+.
T Consensus 175 ~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (284)
T cd07839 175 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPK 252 (284)
T ss_pred cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH--HHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhccc
Confidence 4788999999999999999999886432221 111111111110000 0000 0000000 01122
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 226 KLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 226 ~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
.+..+.+++.+||+.||.+|||+++++.
T Consensus 253 ~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 253 LNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred CCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 3457889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=257.22 Aligned_cols=241 Identities=23% Similarity=0.287 Sum_probs=180.9
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+|+.||+|++.... ....+.+.+|+.++++++||||+++++++......++|+||+ +++|.+++.. ....+++.
T Consensus 23 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~--~~~~~~~~ 99 (286)
T cd07832 23 ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRD--EERPLPEA 99 (286)
T ss_pred CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHh--cCCCCCHH
Confidence 478999999997654 334567889999999999999999999999999999999999 9999998854 23568999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
.++.++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+........ .......|+..|+|||.+.+.
T Consensus 100 ~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 175 (286)
T cd07832 100 QVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGA 175 (286)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-CccccccCcccccCceeeecc
Confidence 99999999999999999998 99999999999999999999999999876544321 112234678899999988654
Q ss_pred -CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCc---------ceeccccCCC-------CCCH
Q 048243 162 -VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG---------VEFVDSSLDD-------TNSP 224 (303)
Q Consensus 162 -~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~-------~~~~ 224 (303)
.++.++||||+|+++|+|++|.++|....... .............. .......... ...+
T Consensus 176 ~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (286)
T cd07832 176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFP 252 (286)
T ss_pred ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCC
Confidence 46889999999999999999977775332211 11111111100000 0000000000 0011
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 225 CKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 225 ~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
..+..+.+++.+||..||++|||+++++..
T Consensus 253 ~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 253 DASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 224688999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=267.90 Aligned_cols=234 Identities=25% Similarity=0.299 Sum_probs=173.1
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeC------CeeEEEEeecCCCChhhhhcCcccc
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------EERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~ 75 (303)
.+++.||+|++.... ......+.+|+.+++.++||||+++++++... ...|++++++ +++|..++. .
T Consensus 38 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~----~ 112 (343)
T cd07878 38 RLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK----C 112 (343)
T ss_pred CCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHh----c
Confidence 578899999997542 22345677899999999999999999987643 3568999988 678877763 3
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCCh
Q 048243 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aP 155 (303)
..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++...... .....|+..|+||
T Consensus 113 ~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aP 184 (343)
T cd07878 113 QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRAP 184 (343)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceecCCC-----cCCccccccccCc
Confidence 45899999999999999999999999 999999999999999999999999998764432 2234679999999
Q ss_pred hhhcc-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCC-----------cceeccccCCCCCC
Q 048243 156 EYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK-----------GVEFVDSSLDDTNS 223 (303)
Q Consensus 156 E~~~~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~ 223 (303)
|.+.+ ..++.++|||||||++|+|++|..||........ ............ ...... .+.....
T Consensus 185 E~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 260 (343)
T cd07878 185 EIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ---LKRIMEVVGTPSPEVLKKISSEHARKYIQ-SLPHMPQ 260 (343)
T ss_pred hHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHhCCCCHHHHHhcchhhHHHHhh-ccccccc
Confidence 99877 4688999999999999999999999864332111 111111000000 000000 0000000
Q ss_pred -------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 224 -------PCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 224 -------~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
......+.+|+.+||..||.+|||+.|+++.
T Consensus 261 ~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 261 QDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0112357799999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=249.76 Aligned_cols=228 Identities=22% Similarity=0.278 Sum_probs=181.8
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+++.||+|.+.... ....+.+.+|+.+++.++||||+++++.+.++...++++||+++++|.+++.. ...+++
T Consensus 16 ~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~ 92 (262)
T cd05572 16 SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRD---RGLFDE 92 (262)
T ss_pred CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhh---cCCCCH
Confidence 358999999996543 23446789999999999999999999999999999999999999999999843 345889
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+
T Consensus 93 ~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~ 166 (262)
T cd05572 93 YTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILN 166 (262)
T ss_pred HHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcCccChhHhcC
Confidence 999999999999999999998 9999999999999999999999999987654432 1223467889999999988
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|+||+|+++|++++|..||....... ............. ...+...+..+.+++.+||..
T Consensus 167 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~ 233 (262)
T cd05572 167 KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDILKGNGK---------LEFPNYIDKAAKDLIKQLLRR 233 (262)
T ss_pred CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHhccCCC---------CCCCcccCHHHHHHHHHHccC
Confidence 889999999999999999999999986544211 1111111110111 111111245889999999999
Q ss_pred CCCCCCC-----HHHHHH
Q 048243 241 NPNDRPS-----MLQVSS 253 (303)
Q Consensus 241 dp~~Rpt-----~~el~~ 253 (303)
||++||+ +.|+++
T Consensus 234 ~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 234 NPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ChhhCcCCcccCHHHHhc
Confidence 9999999 788776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=251.18 Aligned_cols=226 Identities=24% Similarity=0.339 Sum_probs=180.2
Q ss_pred CCCcEEEEEEecCCC-----cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccC
Q 048243 4 PCGKVIAVKKLSKTS-----TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 4 ~~~~~valK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
.+++.|++|.+.... ....+.+.+|+.+++.++|+||+++++++......++++||+++++|.+++.. ...+
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~ 99 (258)
T cd06632 23 DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKK---YGSF 99 (258)
T ss_pred CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHh---cCCC
Confidence 378999999986543 22346788999999999999999999999999999999999999999999843 3458
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
++..+..++.|++.|+++||+.| ++|+||+|+||+++.++.++|+|||.+....... ......|+..|+|||.+
T Consensus 100 ~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~ 173 (258)
T cd06632 100 PEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVI 173 (258)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc---cccccCCCcceeCHHHh
Confidence 89999999999999999999999 9999999999999999999999999987654332 22335678899999998
Q ss_pred ccCC-CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHc
Q 048243 159 RQGV-YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237 (303)
Q Consensus 159 ~~~~-~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 237 (303)
.... ++.++|+||||+++|+|++|..||...... ............ ...+...+..+.+++.+|
T Consensus 174 ~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~ 238 (258)
T cd06632 174 AQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVFKIGRSKEL---------PPIPDHLSDEAKDFILKC 238 (258)
T ss_pred cCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHHHHHhcccC---------CCcCCCcCHHHHHHHHHH
Confidence 7766 889999999999999999999998644311 111111110000 011122345788999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 048243 238 VQENPNDRPSMLQVSS 253 (303)
Q Consensus 238 l~~dp~~Rpt~~el~~ 253 (303)
|..+|.+||++.+++.
T Consensus 239 l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 239 LQRDPSLRPTAAELLE 254 (258)
T ss_pred hhcCcccCcCHHHHhc
Confidence 9999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=253.28 Aligned_cols=228 Identities=21% Similarity=0.315 Sum_probs=175.1
Q ss_pred CCCcEEEEEEecCCCc-----ccHHHHHHHHHHHhcCCCCccccEEEEEEeC--CeeEEEEeecCCCChhhhhcCccccc
Q 048243 4 PCGKVIAVKKLSKTST-----QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~~~~valK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~ 76 (303)
.+|+.||+|.+..... .....+.+|+.+++.++||||+++++++... ...++++||+++++|.+++. ...
T Consensus 25 ~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~---~~~ 101 (266)
T cd06651 25 DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLK---AYG 101 (266)
T ss_pred CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHH---HcC
Confidence 4688999999864321 2335688899999999999999999998763 57889999999999999884 334
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCc-cccccccccccCCCCh
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL-EANTEQVVGTIGYIPP 155 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~-~~~~~~~~g~~~y~aP 155 (303)
.+++...+.++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++........ ........++..|+||
T Consensus 102 ~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP 178 (266)
T cd06651 102 ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178 (266)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCH
Confidence 5888999999999999999999998 99999999999999999999999999876532211 1112234578899999
Q ss_pred hhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHH
Q 048243 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
|.+.+..++.++||||+||++|+|++|..||..... ........... .....+......+.+++
T Consensus 179 E~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~~~---------~~~~~~~~~~~~~~~li- 242 (266)
T cd06651 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIATQP---------TNPQLPSHISEHARDFL- 242 (266)
T ss_pred HHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhcCC---------CCCCCchhcCHHHHHHH-
Confidence 999988899999999999999999999999853311 11111111110 01112223345667787
Q ss_pred HcccCCCCCCCCHHHHHH
Q 048243 236 LCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 236 ~~l~~dp~~Rpt~~el~~ 253 (303)
+||..+|++||+++|++.
T Consensus 243 ~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 243 GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHhcCChhhCcCHHHHhc
Confidence 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=265.45 Aligned_cols=227 Identities=23% Similarity=0.388 Sum_probs=189.0
Q ss_pred EEEEEEecCC-CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHH
Q 048243 8 VIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86 (303)
Q Consensus 8 ~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~ 86 (303)
-||||.-+.+ +....+.|+.|..+|++++||||++++|+|.. +..|+|||.++.|.|..|+.. ....++......+
T Consensus 420 aVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly 496 (974)
T KOG4257|consen 420 AVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMELAPLGELREYLQQ--NKDSLPLRTLTLY 496 (974)
T ss_pred eeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEecccchhHHHHHHh--ccccchHHHHHHH
Confidence 3888988764 56678899999999999999999999999975 467999999999999999964 3456888899999
Q ss_pred HHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCCCc
Q 048243 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTK 166 (303)
Q Consensus 87 ~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 166 (303)
+.||..||+|||+.. +|||||...|||+.....|||+|||+++.+.....+... ...-+..|||||.+.-..++.+
T Consensus 497 ~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtA 572 (974)
T KOG4257|consen 497 CYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTA 572 (974)
T ss_pred HHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccchhhcc-ccccceeecCccccchhcccch
Confidence 999999999999998 999999999999999999999999999998877665544 2233678999999999999999
Q ss_pred cchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 048243 167 SDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDR 245 (303)
Q Consensus 167 ~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 245 (303)
+|||-||+++||+++ |..||.+....+..-. +...-+...++..++.++.|+.+||..+|.+|
T Consensus 573 SDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~----------------iEnGeRlP~P~nCPp~LYslmskcWayeP~kR 636 (974)
T KOG4257|consen 573 SDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH----------------IENGERLPCPPNCPPALYSLMSKCWAYEPSKR 636 (974)
T ss_pred hhHHHHHHHHHHHHHhcCCccccccccceEEE----------------ecCCCCCCCCCCCChHHHHHHHHHhccCcccC
Confidence 999999999999987 8899976655443321 12222223333445588899999999999999
Q ss_pred CCHHHHHHHhcc
Q 048243 246 PSMLQVSSMLKN 257 (303)
Q Consensus 246 pt~~el~~~L~~ 257 (303)
|++.|+...|+.
T Consensus 637 Prftei~~~lsd 648 (974)
T KOG4257|consen 637 PRFTEIKAILSD 648 (974)
T ss_pred CcHHHHHHHHHH
Confidence 999999877643
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=250.83 Aligned_cols=239 Identities=23% Similarity=0.300 Sum_probs=181.7
Q ss_pred CCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCccccEEEEEEeC--CeeEEEEeecCCCChhhhhcCcc-ccccCC
Q 048243 4 PCGKVIAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPI-RRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~-~~~~l~ 79 (303)
.+++.+|+|.+..... .....+.+|+++++.++||||+++++++... ...++||||+++++|.+++.... ....++
T Consensus 24 ~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~ 103 (287)
T cd06621 24 NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIG 103 (287)
T ss_pred CCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCC
Confidence 4688999999975432 3456788999999999999999999998653 46899999999999988764322 245578
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....++..|+|||.+.
T Consensus 104 ~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~~pE~~~ 176 (287)
T cd06621 104 EKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL----AGTFTGTSFYMAPERIQ 176 (287)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccccc----cccccCCccccCHHHhc
Confidence 8999999999999999999999 9999999999999999999999999986543221 12245688999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++||||||+++|+|++|..||........ ..... ...........+ ..... .....+..+.+++.+||+
T Consensus 177 ~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~-~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~li~~~l~ 251 (287)
T cd06621 177 GKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-GPIEL-LSYIVNMPNPEL-KDEPG--NGIKWSEEFKDFIKQCLE 251 (287)
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC-ChHHH-HHHHhcCCchhh-ccCCC--CCCchHHHHHHHHHHHcC
Confidence 88899999999999999999999999875533111 11111 111111111111 10100 001245678999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 048243 240 ENPNDRPSMLQVSSM 254 (303)
Q Consensus 240 ~dp~~Rpt~~el~~~ 254 (303)
.||.+|||+.|+++.
T Consensus 252 ~~p~~Rpt~~eil~~ 266 (287)
T cd06621 252 KDPTRRPTPWDMLEH 266 (287)
T ss_pred CCcccCCCHHHHHhC
Confidence 999999999999873
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=250.22 Aligned_cols=229 Identities=21% Similarity=0.292 Sum_probs=177.1
Q ss_pred CCCcEEEEEEecCCC-----cccHHHHHHHHHHHhcCCCCccccEEEEEEeC--CeeEEEEeecCCCChhhhhcCccccc
Q 048243 4 PCGKVIAVKKLSKTS-----TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~~~~valK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~ 76 (303)
.+|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+. ...+++|||+++++|.+++. ...
T Consensus 25 ~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~---~~~ 101 (265)
T cd06652 25 DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLK---SYG 101 (265)
T ss_pred CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHH---HcC
Confidence 568999999885332 12345788899999999999999999998764 46789999999999999884 334
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-ccccccccccCCCCh
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPP 155 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-~~~~~~~g~~~y~aP 155 (303)
.+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+......... .......|+..|+||
T Consensus 102 ~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP 178 (265)
T cd06652 102 ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178 (265)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccCh
Confidence 5788899999999999999999999 999999999999999999999999998765322111 112234578899999
Q ss_pred hhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHH
Q 048243 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
|.+.+..++.++||||||+++|+|++|..||...... ......... ......+...+..+.+++.
T Consensus 179 E~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~---------~~~~~~~~~~~~~~~~~i~ 243 (265)
T cd06652 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQ---------PTNPVLPPHVSDHCRDFLK 243 (265)
T ss_pred hhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH------HHHHHHhcC---------CCCCCCchhhCHHHHHHHH
Confidence 9998888999999999999999999999998532111 111111110 0112223445567889999
Q ss_pred HcccCCCCCCCCHHHHHHH
Q 048243 236 LCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 236 ~~l~~dp~~Rpt~~el~~~ 254 (303)
+||. +|.+||+++|+++.
T Consensus 244 ~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 244 RIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHhc-ChhhCCCHHHHhcC
Confidence 9995 99999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=252.39 Aligned_cols=230 Identities=23% Similarity=0.256 Sum_probs=179.4
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|.+.... ......+..|+++++.++||||+++++.+......|+||||+++++|.+++.... ...+++
T Consensus 16 ~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~ 94 (277)
T cd05577 16 ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVG-EPGFPE 94 (277)
T ss_pred CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcC-cCCCCH
Confidence 468999999986542 2234466789999999999999999999999999999999999999998885422 236899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+
T Consensus 95 ~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~~PE~~~~ 168 (277)
T cd05577 95 ARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQG 168 (277)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccccCCCCcCCHHHhcC
Confidence 999999999999999999999 9999999999999999999999999887654321 1223456789999999988
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++||||||+++|+|++|..||............. ..... .....+...+..+.++|.+||+.
T Consensus 169 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~----------~~~~~~~~~~~~~~~li~~~l~~ 235 (277)
T cd05577 169 EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK---RRTLE----------MAVEYPDKFSPEAKDLCEALLQK 235 (277)
T ss_pred CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH---hcccc----------ccccCCccCCHHHHHHHHHHccC
Confidence 889999999999999999999999986443321111111 00000 00111122355788999999999
Q ss_pred CCCCCC-----CHHHHHH
Q 048243 241 NPNDRP-----SMLQVSS 253 (303)
Q Consensus 241 dp~~Rp-----t~~el~~ 253 (303)
||.+|| ++.+++.
T Consensus 236 ~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 236 DPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ChhHccCCCcccHHHHHh
Confidence 999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=252.16 Aligned_cols=226 Identities=25% Similarity=0.394 Sum_probs=179.3
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCC---CCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQ---HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+|+.||+|.++... ....+.+.+|+.+++.++ |||++++++++..+...++||||+.+++|.+++.. ..++
T Consensus 24 ~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~l~ 99 (277)
T cd06917 24 PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA----GPIA 99 (277)
T ss_pred CCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc----cCCC
Confidence 578999999987543 344567889999999996 99999999999999999999999999999998843 3688
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..++.++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||.+....... .......|+..|+|||.+.
T Consensus 100 ~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~ 174 (277)
T cd06917 100 EKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEVIT 174 (277)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--cccccccCCcceeCHHHhc
Confidence 9999999999999999999999 9999999999999999999999999987665433 1122346788999999886
Q ss_pred c-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcc
Q 048243 160 Q-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238 (303)
Q Consensus 160 ~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 238 (303)
+ ..++.++|+||||+++|+|++|..||........ . ....... .+.+... ..+..+.+++.+||
T Consensus 175 ~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~-~~~~~~~-----~~~~~~~---~~~~~~~~~i~~~l 239 (277)
T cd06917 175 EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------M-MLIPKSK-----PPRLEDN---GYSKLLREFVAACL 239 (277)
T ss_pred cCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------h-hccccCC-----CCCCCcc---cCCHHHHHHHHHHc
Confidence 5 4568899999999999999999999854322110 0 0000000 0111111 13457889999999
Q ss_pred cCCCCCCCCHHHHHH
Q 048243 239 QENPNDRPSMLQVSS 253 (303)
Q Consensus 239 ~~dp~~Rpt~~el~~ 253 (303)
..||.+||++.+++.
T Consensus 240 ~~~p~~R~~~~~il~ 254 (277)
T cd06917 240 DEEPKERLSAEELLK 254 (277)
T ss_pred CCCcccCcCHHHHhh
Confidence 999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=258.54 Aligned_cols=245 Identities=22% Similarity=0.293 Sum_probs=178.7
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++......++|+||+.++++.+++... ....+++.
T Consensus 23 ~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~-~~~~~~~~ 101 (328)
T cd08226 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTY-FPEGMSEA 101 (328)
T ss_pred CCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhh-cccCCCHH
Confidence 579999999987543 233467889999999999999999999999999999999999999999988542 23358899
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccc-----cccccccccCCCChh
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEA-----NTEQVVGTIGYIPPE 156 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~-----~~~~~~g~~~y~aPE 156 (303)
.++.++.|++.||+|||+.+ ++||||||+||+++.++.++++||+.+.......... ......++..|+|||
T Consensus 102 ~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 178 (328)
T cd08226 102 LIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178 (328)
T ss_pred HHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChh
Confidence 99999999999999999998 9999999999999999999999997654322211110 011123456799999
Q ss_pred hhccC--CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHH----------------HHHHhC-----------
Q 048243 157 YARQG--VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA----------------YELWKG----------- 207 (303)
Q Consensus 157 ~~~~~--~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~----------------~~~~~~----------- 207 (303)
.+.+. .++.++||||+||++|+|++|..||......... .... ...+..
T Consensus 179 ~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (328)
T cd08226 179 LLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGE 256 (328)
T ss_pred hhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCCccccccchhhhhhccchhhhhccccc
Confidence 98764 4788999999999999999999998643211100 0000 000000
Q ss_pred -----CCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 208 -----GKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 208 -----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
..........+........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 257 SVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred chhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00000001111112223456678999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=254.50 Aligned_cols=228 Identities=22% Similarity=0.322 Sum_probs=180.5
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+|+.||+|++..........+.+|+.+++.++|+||+++++.+......+++|||+++++|.+++. ...+++..+
T Consensus 43 ~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~ 118 (292)
T cd06657 43 SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT----HTRMNEEQI 118 (292)
T ss_pred CCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHh----cCCCCHHHH
Confidence 5789999999865544455678899999999999999999999999999999999999999988773 335789999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
..++.|++.+++|||+.| ++||||+|+||+++.++.++|+|||.+........ ......|+..|+|||.+.+..+
T Consensus 119 ~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~ 193 (292)
T cd06657 119 AAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPY 193 (292)
T ss_pred HHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccccCccccCHHHhcCCCC
Confidence 999999999999999998 99999999999999999999999998765433221 1223457889999999988888
Q ss_pred CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCC
Q 048243 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 243 (303)
+.++|+||+|+++|+|++|..||........ ... ...... .... .....+..+.+++.+||+.||.
T Consensus 194 ~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~~~----~~~~~~-----~~~~--~~~~~~~~l~~li~~~l~~~P~ 259 (292)
T cd06657 194 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKM----IRDNLP-----PKLK--NLHKVSPSLKGFLDRLLVRDPA 259 (292)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH----HHhhCC-----cccC--CcccCCHHHHHHHHHHHhCCcc
Confidence 9999999999999999999999854322111 111 110000 0000 0111234678999999999999
Q ss_pred CCCCHHHHHHH
Q 048243 244 DRPSMLQVSSM 254 (303)
Q Consensus 244 ~Rpt~~el~~~ 254 (303)
+||++.++++.
T Consensus 260 ~R~~~~~ll~~ 270 (292)
T cd06657 260 QRATAAELLKH 270 (292)
T ss_pred cCcCHHHHhcC
Confidence 99999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=248.86 Aligned_cols=228 Identities=27% Similarity=0.381 Sum_probs=180.7
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+++.+|+|.+.... ....+.+.+|+++++.++||||+++++.+......++||||+++++|.+++... ....+++.
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~ 101 (256)
T cd08220 23 ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKR-CNSLLDED 101 (256)
T ss_pred CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHh-cccCCCHH
Confidence 478899999986542 334567889999999999999999999999999999999999999999998542 24458899
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCC-ceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM-KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~-~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
.++.++.+++.+++|||+++ ++|+||+|+||+++.++ .++|+|||.+........ .....|+..|+|||.+.+
T Consensus 102 ~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~ 175 (256)
T cd08220 102 TILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPELCEG 175 (256)
T ss_pred HHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc---ccccccCCcccCchhccC
Confidence 99999999999999999998 99999999999998654 589999999876544321 122457889999999998
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++||||||+++|+|++|..||....... ... ..... .... .....+..+.+++.+||..
T Consensus 176 ~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~---~~~~~-~~~~---------~~~~~~~~l~~li~~~l~~ 239 (256)
T cd08220 176 KPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVL---KIMSG-TFAP---------ISDRYSPDLRQLILSMLNL 239 (256)
T ss_pred CCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHH---HHHhc-CCCC---------CCCCcCHHHHHHHHHHccC
Confidence 888999999999999999999999985433211 111 11111 0000 1112344788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 048243 241 NPNDRPSMLQVSSM 254 (303)
Q Consensus 241 dp~~Rpt~~el~~~ 254 (303)
||.+|||+.|+++.
T Consensus 240 ~p~~Rpt~~~ll~~ 253 (256)
T cd08220 240 DPSKRPQLSQIMAQ 253 (256)
T ss_pred ChhhCCCHHHHhhC
Confidence 99999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=261.68 Aligned_cols=168 Identities=25% Similarity=0.328 Sum_probs=141.8
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+++.||+|+.... ....|+.++++++|+||+++++++......++|||++. ++|.+++.. ....+++..+
T Consensus 89 ~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~ 159 (357)
T PHA03209 89 GQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTK--RSRPLPIDQA 159 (357)
T ss_pred CCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHh--ccCCCCHHHH
Confidence 35678999975433 23468999999999999999999999999999999995 578777743 3456899999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
+.++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||.+...... .......|+..|+|||.+.+..+
T Consensus 160 ~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~ 233 (357)
T PHA03209 160 LIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---PAFLGLAGTVETNAPEVLARDKY 233 (357)
T ss_pred HHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC---cccccccccccccCCeecCCCCC
Confidence 999999999999999999 999999999999999999999999998653221 11223468999999999998899
Q ss_pred CCccchhhHHHHHHHHHhCCCCC
Q 048243 164 STKSDVFSFGVLLLQIISGKRLS 186 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~g~~p~ 186 (303)
+.++|||||||++|+|+++..++
T Consensus 234 ~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 234 NSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred CchhhHHHHHHHHHHHHHcCCcc
Confidence 99999999999999999866554
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=256.77 Aligned_cols=246 Identities=21% Similarity=0.266 Sum_probs=178.2
Q ss_pred CCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeC--CeeEEEEeecCCCChhhhhcCccc--ccc
Q 048243 5 CGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIR--RLI 77 (303)
Q Consensus 5 ~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~--~~~ 77 (303)
+|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+. ...++||||+.+ ++.+++..... ...
T Consensus 26 ~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~ 104 (316)
T cd07842 26 DGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVS 104 (316)
T ss_pred CCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcC
Confidence 68999999997643 33446778899999999999999999999988 789999999975 66666543222 236
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC----CCceEEcccccccccccCCc-cccccccccccCC
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE----DMKPKISDFGLARIFAKESL-EANTEQVVGTIGY 152 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~----~~~v~l~Df~~~~~~~~~~~-~~~~~~~~g~~~y 152 (303)
+++..++.++.|++.||+|||+.+ ++||||||+||+++. ++.++|+|||++........ ........++..|
T Consensus 105 ~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y 181 (316)
T cd07842 105 IPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWY 181 (316)
T ss_pred cCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccc
Confidence 889999999999999999999999 999999999999999 89999999999876544322 1122334678899
Q ss_pred CChhhhccC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccc------cHHHHHHHHHhCCC---------cceecc-
Q 048243 153 IPPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL------SILEHAYELWKGGK---------GVEFVD- 215 (303)
Q Consensus 153 ~aPE~~~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~------~~~~~~~~~~~~~~---------~~~~~~- 215 (303)
+|||.+.+. .++.++||||||+++|+|++|..||......... .........+.... ..+...
T Consensus 182 ~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (316)
T cd07842 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTL 261 (316)
T ss_pred cCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhh
Confidence 999987664 5788999999999999999999998654432200 00111111110000 000000
Q ss_pred --c----cCCCCCCH-------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 216 --S----SLDDTNSP-------CKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 216 --~----~~~~~~~~-------~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
. ........ ..+..+.+++.+||+.||++|||+.|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 262 MKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred hhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 00000000 223468899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=250.90 Aligned_cols=231 Identities=25% Similarity=0.379 Sum_probs=179.6
Q ss_pred CCcEEEEEEecCCC----------cccHHHHHHHHHHHhc-CCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCc-
Q 048243 5 CGKVIAVKKLSKTS----------TQGFEEFKNEVMLTAK-LQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDP- 72 (303)
Q Consensus 5 ~~~~valK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~- 72 (303)
+++.+|+|.+.... ......+..|+.++.+ ++|+||+++++++..+...+++|||+.+++|.+++...
T Consensus 25 ~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~ 104 (269)
T cd08528 25 GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLK 104 (269)
T ss_pred CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHH
Confidence 57889999885331 2233456778888875 69999999999999999999999999999998887431
Q ss_pred cccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccC
Q 048243 73 IRRLILDWKKRVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIG 151 (303)
Q Consensus 73 ~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~ 151 (303)
.....+++..++.++.|++.+|.|||+ .+ ++|+||+|+||+++.++.++|+|||.+....... ......|+..
T Consensus 105 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~ 178 (269)
T cd08528 105 EKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTIL 178 (269)
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecccceeeccccc---ccccccCccc
Confidence 234568899999999999999999996 66 9999999999999999999999999987654432 2234567889
Q ss_pred CCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHH
Q 048243 152 YIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL 231 (303)
Q Consensus 152 y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
|+|||.+.+..++.++|+||||+++|+|++|..||....... . ............ .....+..+.
T Consensus 179 ~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~---~----~~~~~~~~~~~~--------~~~~~~~~l~ 243 (269)
T cd08528 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS---L----ATKIVEAVYEPL--------PEGMYSEDVT 243 (269)
T ss_pred CcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH---H----HHHHhhccCCcC--------CcccCCHHHH
Confidence 999999998889999999999999999999999985332111 0 111111111100 0112335788
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhc
Q 048243 232 EIALLCVQENPNDRPSMLQVSSMLK 256 (303)
Q Consensus 232 ~li~~~l~~dp~~Rpt~~el~~~L~ 256 (303)
+++.+||+.||++||++.|+.++++
T Consensus 244 ~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 244 DVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHHHCCCCCccCCCHHHHHHHhc
Confidence 9999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=259.21 Aligned_cols=230 Identities=25% Similarity=0.443 Sum_probs=177.4
Q ss_pred EEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHH
Q 048243 8 VIAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86 (303)
Q Consensus 8 ~valK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~ 86 (303)
.||+|.+..... .....+.+|+.+++.++||||+++++++... ..+++++|+++|+|.+++.. ....+++..++.+
T Consensus 38 ~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~ 114 (303)
T cd05110 38 PVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHE--HKDNIGSQLLLNW 114 (303)
T ss_pred eEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHh--cccCCCHHHHHHH
Confidence 578898865432 2334688999999999999999999998754 46799999999999998853 2335788999999
Q ss_pred HHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCCCc
Q 048243 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTK 166 (303)
Q Consensus 87 ~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 166 (303)
+.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.+
T Consensus 115 ~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~ 191 (303)
T cd05110 115 CVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ 191 (303)
T ss_pred HHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChH
Confidence 999999999999998 99999999999999999999999999976543322222222345678999999998889999
Q ss_pred cchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 048243 167 SDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDR 245 (303)
Q Consensus 167 ~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 245 (303)
+||||||+++|++++ |..||....... ............ ..+..+..+.+++.+||..+|++|
T Consensus 192 ~DiwslG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~~~~li~~c~~~~p~~R 255 (303)
T cd05110 192 SDVWSYGVTIWELMTFGGKPYDGIPTRE-------IPDLLEKGERLP---------QPPICTIDVYMVMVKCWMIDADSR 255 (303)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHCCCCCC---------CCCCCCHHHHHHHHHHcCCChhhC
Confidence 999999999999997 888875332111 111111111110 011123467899999999999999
Q ss_pred CCHHHHHHHhcccc
Q 048243 246 PSMLQVSSMLKNET 259 (303)
Q Consensus 246 pt~~el~~~L~~~~ 259 (303)
|++.++++.|+...
T Consensus 256 p~~~~l~~~l~~~~ 269 (303)
T cd05110 256 PKFKELAAEFSRMA 269 (303)
T ss_pred cCHHHHHHHHHHHH
Confidence 99999999988654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=270.09 Aligned_cols=226 Identities=21% Similarity=0.305 Sum_probs=182.5
Q ss_pred EEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHHH
Q 048243 8 VIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHII 87 (303)
Q Consensus 8 ~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~ 87 (303)
..|-|++.-......+.++-||++|..++||+|+++++.|...+.++++.|||.||-+...+.. -+..+.+.++..++
T Consensus 59 lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlE--L~r~LtE~QIqvvc 136 (1187)
T KOG0579|consen 59 LAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLE--LGRVLTEDQIQVVC 136 (1187)
T ss_pred hhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHH--hccccchHHHHHHH
Confidence 3456666655666678899999999999999999999999999999999999999999877643 35679999999999
Q ss_pred HHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc-----cCC
Q 048243 88 EGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR-----QGV 162 (303)
Q Consensus 88 ~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~ 162 (303)
+|++.||.|||++. |+|||||..|||++-+|.++|+|||.+..... .......+.||+.|||||+.. ..+
T Consensus 137 ~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~P 211 (1187)
T KOG0579|consen 137 YQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQP 211 (1187)
T ss_pred HHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--HHhhhccccCCcccccchheeeccccCCC
Confidence 99999999999999 99999999999999999999999999764332 223344588999999999764 457
Q ss_pred CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC
Q 048243 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 242 (303)
|+.++||||||+++.+|..+.+|....++..... +.-.. ..+ ....+..++..+.||+++||..||
T Consensus 212 YDykaDiWSlGITLIEMAqiEPPHhelnpMRVll------KiaKS-ePP-------TLlqPS~Ws~~F~DfLk~cL~Knp 277 (1187)
T KOG0579|consen 212 YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL------KIAKS-EPP-------TLLQPSHWSRSFSDFLKRCLVKNP 277 (1187)
T ss_pred chhhhhHHhhhhHHHHHhccCCCccccchHHHHH------HHhhc-CCC-------cccCcchhhhHHHHHHHHHHhcCC
Confidence 8999999999999999999999865444333211 11111 111 112334566789999999999999
Q ss_pred CCCCCHHHHHHH
Q 048243 243 NDRPSMLQVSSM 254 (303)
Q Consensus 243 ~~Rpt~~el~~~ 254 (303)
+.||++.+|++.
T Consensus 278 ~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 278 RNRPPAAQLLKH 289 (1187)
T ss_pred ccCCCHHHHhhC
Confidence 999999999874
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=252.06 Aligned_cols=227 Identities=25% Similarity=0.362 Sum_probs=181.0
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHH
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~ 84 (303)
+++.|++|.+..... ..+.+.+|++.++.++|+||+++++.+......++++||+++++|.+++... ...+++..+.
T Consensus 43 ~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~ 119 (286)
T cd06614 43 TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN--FVRMNEPQIA 119 (286)
T ss_pred CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHh--ccCCCHHHHH
Confidence 588999999976544 4567889999999999999999999999999999999999999999998542 1378999999
Q ss_pred HHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCC
Q 048243 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYS 164 (303)
Q Consensus 85 ~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 164 (303)
.++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+..++
T Consensus 120 ~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~ 194 (286)
T cd06614 120 YVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYG 194 (286)
T ss_pred HHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchh--hhccccCCcccCCHhHhcCCCCC
Confidence 99999999999999998 99999999999999999999999998765433211 12234568899999999888899
Q ss_pred CccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCC
Q 048243 165 TKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPND 244 (303)
Q Consensus 165 ~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 244 (303)
.++|+||||+++|+|++|..||........ ... ........ .......+..+.+++.+||+.+|.+
T Consensus 195 ~~~Dv~slGvil~~l~~g~~p~~~~~~~~~------~~~-~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~ 260 (286)
T cd06614 195 PKVDIWSLGIMCIEMAEGEPPYLREPPLRA------LFL-ITTKGIPP-------LKNPEKWSPEFKDFLNKCLVKDPEK 260 (286)
T ss_pred CccccHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-HHhcCCCC-------CcchhhCCHHHHHHHHHHhccChhh
Confidence 999999999999999999999853322110 001 11100000 0111123457889999999999999
Q ss_pred CCCHHHHHH
Q 048243 245 RPSMLQVSS 253 (303)
Q Consensus 245 Rpt~~el~~ 253 (303)
|||+.++++
T Consensus 261 Rpt~~~il~ 269 (286)
T cd06614 261 RPSAEELLQ 269 (286)
T ss_pred CcCHHHHhh
Confidence 999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=251.10 Aligned_cols=230 Identities=23% Similarity=0.309 Sum_probs=178.1
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCccccEEEEEEeCC------eeEEEEeecCCCChhhhhcCcc-cc
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSE------ERMLVYEYMPNKSLDCYLFDPI-RR 75 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~-~~ 75 (303)
.+++.+++|.+..... ..+.+.+|+.+++++ +|+||+++++++.... ..++||||+++++|.+++.... ..
T Consensus 29 ~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~ 107 (275)
T cd06608 29 KTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG 107 (275)
T ss_pred CCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcC
Confidence 4678999999875543 346789999999999 7999999999997654 4899999999999998885422 24
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCCh
Q 048243 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aP 155 (303)
..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .......|+..|+||
T Consensus 108 ~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aP 182 (275)
T cd06608 108 KRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAP 182 (275)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccceecccch--hhhcCccccccccCH
Confidence 57899999999999999999999998 9999999999999999999999999987654322 222335678899999
Q ss_pred hhhcc-----CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHH
Q 048243 156 EYARQ-----GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRC 230 (303)
Q Consensus 156 E~~~~-----~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 230 (303)
|.+.. ..++.++||||||+++|++++|..||....... ......... .. ........+..+
T Consensus 183 E~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~-~~-------~~~~~~~~~~~~ 248 (275)
T cd06608 183 EVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR------ALFKIPRNP-PP-------TLKSPENWSKKF 248 (275)
T ss_pred hHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH------HHHHhhccC-CC-------CCCchhhcCHHH
Confidence 98754 246788999999999999999999985332111 111111110 00 111112245678
Q ss_pred HHHHHHcccCCCCCCCCHHHHHH
Q 048243 231 LEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 231 ~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
.+++.+||..||++|||+.++++
T Consensus 249 ~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 249 NDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HHHHHHHhhcChhhCcCHHHHhc
Confidence 89999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=254.77 Aligned_cols=243 Identities=23% Similarity=0.281 Sum_probs=177.8
Q ss_pred CCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCccccEEEEEEeC--CeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+++.+|+|.++.... .....+.+|+.++++++||||+++++++... ...++||||+. ++|.+++.. ....++
T Consensus 28 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~l~ 104 (293)
T cd07843 28 KTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMET--MKQPFL 104 (293)
T ss_pred CCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHh--ccCCCC
Confidence 3688999999975432 2234567899999999999999999999877 88999999997 488887743 233689
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.
T Consensus 105 ~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~ 179 (293)
T cd07843 105 QSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL--KPYTQLVVTLWYRAPELLL 179 (293)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc--cccccccccccccCchhhc
Confidence 9999999999999999999999 9999999999999999999999999987655432 1122345688999999987
Q ss_pred cCC-CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHH-----HHHh---C------CCcceeccccCCCCCCH
Q 048243 160 QGV-YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY-----ELWK---G------GKGVEFVDSSLDDTNSP 224 (303)
Q Consensus 160 ~~~-~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~---~------~~~~~~~~~~~~~~~~~ 224 (303)
+.. ++.++|+||||+++|+|++|..||................ ..|. . ..........+....+.
T Consensus 180 ~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (293)
T cd07843 180 GAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPA 259 (293)
T ss_pred CCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccc
Confidence 654 6889999999999999999999986443221111110000 0000 0 00000000011111111
Q ss_pred H-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 225 C-KLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 225 ~-~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
. .+..+.++|.+||+.||++|||+.|++..
T Consensus 260 ~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 260 LSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1 35578899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=268.39 Aligned_cols=232 Identities=28% Similarity=0.426 Sum_probs=190.3
Q ss_pred cEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHH
Q 048243 7 KVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86 (303)
Q Consensus 7 ~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~ 86 (303)
-.||||.++... ...++|+.|+.+|+.++|||+|+++++|.....+|+|+|||..|+|.+||... .+..++....+.+
T Consensus 293 lTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRec-nr~ev~avvLlyM 370 (1157)
T KOG4278|consen 293 LTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLREC-NRSEVPAVVLLYM 370 (1157)
T ss_pred eeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHh-chhhcchhHHHHH
Confidence 358999996554 46689999999999999999999999999999999999999999999999753 3455777788999
Q ss_pred HHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCCCc
Q 048243 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTK 166 (303)
Q Consensus 87 ~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 166 (303)
+.||..|++||..++ ++||||...|+|+.++..||++|||+++.+.......... ..-...|.|||.+.-+.++.|
T Consensus 371 AtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAG-AKFPIKWTAPEsLAyNtFSiK 446 (1157)
T KOG4278|consen 371 ATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNTFSIK 446 (1157)
T ss_pred HHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceecccC-ccCcccccCcccccccccccc
Confidence 999999999999999 9999999999999999999999999999987765443322 222568999999999999999
Q ss_pred cchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 048243 167 SDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDR 245 (303)
Q Consensus 167 ~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 245 (303)
+|||+||+++||+.| |..|+.+...... +.++..+.. -..+...++.+++|+..||+++|.+|
T Consensus 447 SDVWAFGVLLWEIATYGMsPYPGidlSqV-------Y~LLEkgyR---------M~~PeGCPpkVYeLMraCW~WsPsDR 510 (1157)
T KOG4278|consen 447 SDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YGLLEKGYR---------MDGPEGCPPKVYELMRACWNWSPSDR 510 (1157)
T ss_pred hhhHHHHHHHHHHHhcCCCCCCCccHHHH-------HHHHhcccc---------ccCCCCCCHHHHHHHHHHhcCCcccC
Confidence 999999999999998 7778765443222 333332222 22222334488999999999999999
Q ss_pred CCHHHHHHHhccccC
Q 048243 246 PSMLQVSSMLKNETT 260 (303)
Q Consensus 246 pt~~el~~~L~~~~~ 260 (303)
|+++|+-+.++..+.
T Consensus 511 PsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 511 PSFAEIHQAFETMFS 525 (1157)
T ss_pred ccHHHHHHHHHHHhc
Confidence 999999998876653
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=245.93 Aligned_cols=230 Identities=25% Similarity=0.384 Sum_probs=185.3
Q ss_pred CCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCccccEEEEEEeC--CeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 5 CGKVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 5 ~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
+|+.|++|.+..... ...+.+.+|+..+++++|+||+++++.+... ...++++|++++++|.+++.. ...+++
T Consensus 24 ~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~ 100 (260)
T cd06606 24 TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK---FGKLPE 100 (260)
T ss_pred CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHH---cCCCCH
Confidence 689999999876542 4567889999999999999999999999988 889999999999999999853 337899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.|++.+++|||+.+ ++|+||+|+||+++.++.++|+|||.+................++..|.|||.+.+
T Consensus 101 ~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~ 177 (260)
T cd06606 101 PVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177 (260)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcC
Confidence 999999999999999999998 99999999999999999999999999877655432112233567889999999988
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
...+.++||||||+++++|++|..||.... .............. ....+...+..+.+++.+||..
T Consensus 178 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~---------~~~~~~~~~~~l~~~i~~~l~~ 243 (260)
T cd06606 178 EEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGE---------PPEIPEHLSEEAKDFLRKCLRR 243 (260)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCC---------CcCCCcccCHHHHHHHHHhCcC
Confidence 889999999999999999999999986544 11111111111001 1111122256889999999999
Q ss_pred CCCCCCCHHHHHHH
Q 048243 241 NPNDRPSMLQVSSM 254 (303)
Q Consensus 241 dp~~Rpt~~el~~~ 254 (303)
||++||++.+++..
T Consensus 244 ~p~~Rp~~~~ll~~ 257 (260)
T cd06606 244 DPKKRPTADELLQH 257 (260)
T ss_pred ChhhCCCHHHHhhC
Confidence 99999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=257.22 Aligned_cols=240 Identities=24% Similarity=0.316 Sum_probs=178.0
Q ss_pred CCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
++|+.||+|.+..... ...+.+.+|+++++.++||||+++++++..+...++|+||+++++|..+.. ....+++.
T Consensus 24 ~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~ 100 (286)
T cd07846 24 ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEK---YPNGLDES 100 (286)
T ss_pred CCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHh---ccCCCCHH
Confidence 3689999999865432 234568889999999999999999999999999999999999988877663 23458999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
.++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+.
T Consensus 101 ~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~ 175 (286)
T cd07846 101 RVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYTDYVATRWYRAPELLVGD 175 (286)
T ss_pred HHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--cccCcccceeeccCcHHhccc
Confidence 99999999999999999998 9999999999999999999999999987654332 122234578899999988754
Q ss_pred -CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhC-----------CCc-ceeccccCCC-----CCC
Q 048243 162 -VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKG-----------GKG-VEFVDSSLDD-----TNS 223 (303)
Q Consensus 162 -~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~-~~~~~~~~~~-----~~~ 223 (303)
.++.++||||||+++|+|++|..||....... ........... ... .....+.... ...
T Consensus 176 ~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (286)
T cd07846 176 TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID---QLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRF 252 (286)
T ss_pred cccCchHhHHHHHHHHHHHHcCCCCCCCCchHH---HHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhC
Confidence 46789999999999999999998885332111 11111100000 000 0000000000 001
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 224 PCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 224 ~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
+..+..+.+++.+||..+|++||++.++++.
T Consensus 253 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 253 PKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred CCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 1234578899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=279.80 Aligned_cols=236 Identities=23% Similarity=0.293 Sum_probs=178.6
Q ss_pred CCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEeC--CeeEEEEeecCCCChhhhhcCcc-ccccC
Q 048243 4 PCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPI-RRLIL 78 (303)
Q Consensus 4 ~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~-~~~~l 78 (303)
.+++.||+|.+... .......+..|+.++..++||||++++++|... ..+|+||||+.+++|.++|.... ....+
T Consensus 36 ~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L 115 (1021)
T PTZ00266 36 RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKI 115 (1021)
T ss_pred CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCC
Confidence 46788999998654 233456788999999999999999999988653 57899999999999999885422 23569
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCC----CCeEecCCCCCceEECC-----------------CCceEEcccccccccccC
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSR----LTIIHRDLKASNILLGE-----------------DMKPKISDFGLARIFAKE 137 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~----~~i~H~dikp~nil~~~-----------------~~~v~l~Df~~~~~~~~~ 137 (303)
++..++.++.||+.||+|||+.+. .+|+|+||||+|||++. .+.++|+|||++..+...
T Consensus 116 ~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~ 195 (1021)
T PTZ00266 116 EEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE 195 (1021)
T ss_pred CHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccc
Confidence 999999999999999999998532 34999999999999964 345899999998765433
Q ss_pred CccccccccccccCCCChhhhcc--CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceecc
Q 048243 138 SLEANTEQVVGTIGYIPPEYARQ--GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 215 (303)
Q Consensus 138 ~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (303)
. ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||....... ...........
T Consensus 196 s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~------qli~~lk~~p~----- 261 (1021)
T PTZ00266 196 S---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS------QLISELKRGPD----- 261 (1021)
T ss_pred c---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH------HHHHHHhcCCC-----
Confidence 2 1233568999999999864 357889999999999999999999996432111 11111111110
Q ss_pred ccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--Hhccc
Q 048243 216 SSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSS--MLKNE 258 (303)
Q Consensus 216 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~--~L~~~ 258 (303)
+ .....+..+.+||.+||..+|.+||++.+++. ++...
T Consensus 262 --l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 262 --L---PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred --C---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 0 01112457889999999999999999999984 45433
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=245.91 Aligned_cols=229 Identities=26% Similarity=0.378 Sum_probs=184.5
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+|+.+++|++........+.+.+|+..++.++|++|+++++++..+...++++||+++++|.+++... ...+++..+
T Consensus 23 ~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~--~~~~~~~~~ 100 (253)
T cd05122 23 RTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKST--NQTLTESQI 100 (253)
T ss_pred CCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhc--CCCCCHHHH
Confidence 368999999997765556678999999999999999999999999999999999999999999988542 256899999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
..++.|++.++++||+.| ++||||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+..+
T Consensus 101 ~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~ 174 (253)
T cd05122 101 AYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPY 174 (253)
T ss_pred HHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccCHHHHcCCCC
Confidence 999999999999999998 99999999999999999999999999876554321 234567889999999988888
Q ss_pred CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCC
Q 048243 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 243 (303)
+.++|+||||+++|+|++|..||......... .. ........... ....+..+.+++.+||+.||+
T Consensus 175 ~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~~-~~~~~~~~~~~-------~~~~~~~~~~~i~~~l~~~p~ 240 (253)
T cd05122 175 DYKADIWSLGITAIELAEGKPPYSELPPMKAL------FK-IATNGPPGLRN-------PEKWSDEFKDFLKKCLQKNPE 240 (253)
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCCchHHHH------HH-HHhcCCCCcCc-------ccccCHHHHHHHHHHccCChh
Confidence 99999999999999999999998643311111 01 11010111000 111245788999999999999
Q ss_pred CCCCHHHHHHH
Q 048243 244 DRPSMLQVSSM 254 (303)
Q Consensus 244 ~Rpt~~el~~~ 254 (303)
+|||+.++++.
T Consensus 241 ~R~t~~~~l~~ 251 (253)
T cd05122 241 KRPTAEQLLKH 251 (253)
T ss_pred hCCCHHHHhcC
Confidence 99999999853
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=258.31 Aligned_cols=233 Identities=17% Similarity=0.203 Sum_probs=177.1
Q ss_pred CCCcEEEEEEecCC---CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+++.||+|.+... .......+.+|+.++..++|++|+++++++.+.+..|+||||+.+|+|.+++.. ....+++
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~--~~~~l~~ 101 (331)
T cd05624 24 HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSK--FEDRLPE 101 (331)
T ss_pred CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH--hcCCCCH
Confidence 47889999998643 222345578899999999999999999999999999999999999999999853 2346889
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++......... ......|++.|+|||++.+
T Consensus 102 ~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~ 177 (331)
T cd05624 102 DMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-QSSVAVGTPDYISPEILQA 177 (331)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCce-eeccccCCcccCCHHHHhc
Confidence 999999999999999999999 999999999999999999999999998765433211 1223468999999999875
Q ss_pred -----CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHH
Q 048243 161 -----GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235 (303)
Q Consensus 161 -----~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
..++.++||||||+++|+|++|..||...... ..............+ . ......+..+.+++.
T Consensus 178 ~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~~~-----p-~~~~~~~~~~~~li~ 245 (331)
T cd05624 178 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHEERFQF-----P-SHITDVSEEAKDLIQ 245 (331)
T ss_pred cccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcCCCcccC-----C-CccccCCHHHHHHHH
Confidence 45788999999999999999999998643221 111111111111110 0 011123457889999
Q ss_pred HcccCCCCC--CCCHHHHHHH
Q 048243 236 LCVQENPND--RPSMLQVSSM 254 (303)
Q Consensus 236 ~~l~~dp~~--Rpt~~el~~~ 254 (303)
+||..++++ |++++++++.
T Consensus 246 ~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 246 RLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHccCchhhcCCCCHHHHhcC
Confidence 999876544 4678888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=252.38 Aligned_cols=233 Identities=24% Similarity=0.294 Sum_probs=183.3
Q ss_pred CCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 5 CGKVIAVKKLSKTST---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 5 ~~~~valK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
+|+.+++|.+..... ...+.+.+|+++++.++|+||+++++.+......++++||+.+++|.+++.. ...+++.
T Consensus 17 ~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~ 93 (265)
T cd05579 17 TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLEN---VGSLDED 93 (265)
T ss_pred CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHH---cCCCCHH
Confidence 589999999965533 4456788999999999999999999999999999999999999999998843 3368999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCc------cccccccccccCCCCh
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL------EANTEQVVGTIGYIPP 155 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~------~~~~~~~~g~~~y~aP 155 (303)
.++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ ........++..|+||
T Consensus 94 ~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P 170 (265)
T cd05579 94 VARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170 (265)
T ss_pred HHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCH
Confidence 99999999999999999999 99999999999999999999999999875433211 1122334578899999
Q ss_pred hhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHH
Q 048243 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
|...+...+.++|+||||+++|++++|..||....... .......... . .......+..+.+++.
T Consensus 171 e~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~-~-------~~~~~~~~~~~~~~i~ 235 (265)
T cd05579 171 EVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-------IFQNILNGKI-E-------WPEDVEVSDEAIDLIS 235 (265)
T ss_pred HHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCc-C-------CCccccCCHHHHHHHH
Confidence 99988888999999999999999999999985433111 0111111100 0 0000012457889999
Q ss_pred HcccCCCCCCCCHHHHHHHhccc
Q 048243 236 LCVQENPNDRPSMLQVSSMLKNE 258 (303)
Q Consensus 236 ~~l~~dp~~Rpt~~el~~~L~~~ 258 (303)
+||+.+|.+|||+.++.+.|+..
T Consensus 236 ~~l~~~p~~Rpt~~~~~~~l~~~ 258 (265)
T cd05579 236 KLLVPDPEKRLGAKSIEEIKNHP 258 (265)
T ss_pred HHhcCCHhhcCCCccHHHHhcCc
Confidence 99999999999997777666544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=248.57 Aligned_cols=231 Identities=24% Similarity=0.378 Sum_probs=181.8
Q ss_pred CCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTSTQ--GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+++.|++|.++..... ..+.+..|+++++.++|+||+++++++......++|+||+.+++|.+++.. +..+++.
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~ 99 (264)
T cd06626 23 DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH---GRILDEH 99 (264)
T ss_pred CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhh---cCCCChH
Confidence 47899999999766443 567899999999999999999999999999999999999999999998843 3457889
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcccc--ccccccccCCCChhhhc
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEAN--TEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~--~~~~~g~~~y~aPE~~~ 159 (303)
.++.++.+++.|++|||+.+ ++|+||+|+||+++.++.++|+|||.+........... .....++..|+|||.+.
T Consensus 100 ~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~ 176 (264)
T cd06626 100 VIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176 (264)
T ss_pred HHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhcc
Confidence 99999999999999999999 99999999999999999999999999877544322111 12345788999999988
Q ss_pred cCC---CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 160 QGV---YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 160 ~~~---~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
+.. .+.++||||||+++|++++|..||....... ........ ..... .. .....+..+.+++.+
T Consensus 177 ~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-----~~~~~~~~-~~~~~-----~~--~~~~~~~~~~~li~~ 243 (264)
T cd06626 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-----QIMFHVGA-GHKPP-----IP--DSLQLSPEGKDFLDR 243 (264)
T ss_pred CCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-----HHHHHHhc-CCCCC-----CC--cccccCHHHHHHHHH
Confidence 766 7889999999999999999999986432111 11111111 10000 00 011124567899999
Q ss_pred cccCCCCCCCCHHHHHH
Q 048243 237 CVQENPNDRPSMLQVSS 253 (303)
Q Consensus 237 ~l~~dp~~Rpt~~el~~ 253 (303)
||+.+|.+|||+.+++.
T Consensus 244 ~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 244 CLESDPKKRPTASELLQ 260 (264)
T ss_pred HccCCcccCCCHHHHhc
Confidence 99999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=253.85 Aligned_cols=228 Identities=24% Similarity=0.328 Sum_probs=175.4
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCccccEEEEEEe------CCeeEEEEeecCCCChhhhhcCccccc
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCID------SEERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~ 76 (303)
++++.+|+|.+.... .....+..|+.+++++ +|+||+++++++.. ....+++|||+.+++|.+++... ...
T Consensus 39 ~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~ 116 (282)
T cd06636 39 KTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGN 116 (282)
T ss_pred CCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHc-cCC
Confidence 578899999986543 2345688899999998 79999999999853 45789999999999999988542 234
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChh
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE 156 (303)
.+++..++.++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .......|+..|+|||
T Consensus 117 ~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE 191 (282)
T cd06636 117 ALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPE 191 (282)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhhhhccc--cCCCcccccccccCHh
Confidence 5788889999999999999999998 9999999999999999999999999987543221 1122356788999999
Q ss_pred hhc-----cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHH
Q 048243 157 YAR-----QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL 231 (303)
Q Consensus 157 ~~~-----~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
.+. +..++.++|+||||+++|+|++|..||......... ...... ..........+..+.
T Consensus 192 ~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~------~~~~~~---------~~~~~~~~~~~~~~~ 256 (282)
T cd06636 192 VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL------FLIPRN---------PPPKLKSKKWSKKFI 256 (282)
T ss_pred hcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh------hhHhhC---------CCCCCcccccCHHHH
Confidence 875 345788999999999999999999998543221110 011000 001111112345788
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 048243 232 EIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 232 ~li~~~l~~dp~~Rpt~~el~~ 253 (303)
++|.+||..||.+|||+.|+++
T Consensus 257 ~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 257 DFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred HHHHHHhCCChhhCcCHHHHhc
Confidence 9999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=259.31 Aligned_cols=230 Identities=23% Similarity=0.331 Sum_probs=176.0
Q ss_pred CCcEEEEEEecC--CCcccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 5 CGKVIAVKKLSK--TSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 5 ~~~~valK~~~~--~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
+.+.+|+|++.. .+......+.+||..|.+| .|.+|+.++++-..++.+|||||+- ..+|...|.. ....++..
T Consensus 384 ~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k--~~~~~~~~ 460 (677)
T KOG0596|consen 384 DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKK--KKSIDPDW 460 (677)
T ss_pred CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHh--ccCCCchH
Confidence 345677776643 3555677899999999999 5999999999999999999999976 4678888753 23334444
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
.++.+..|++.++.++|+.| |||.||||.|+++.. |.+||+|||+|.-+...+..-.....+||+.||+||.+...
T Consensus 461 ~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~ 536 (677)
T KOG0596|consen 461 FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDM 536 (677)
T ss_pred HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhc
Confidence 88999999999999999999 999999999999976 68999999999988777766666678999999999988644
Q ss_pred C-----------CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHH
Q 048243 162 V-----------YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRC 230 (303)
Q Consensus 162 ~-----------~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 230 (303)
. .+.++|||||||++|+|+.|+.||... ...+.............++. ... .. .++
T Consensus 537 ~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-----~n~~aKl~aI~~P~~~Iefp--~~~---~~---~~l 603 (677)
T KOG0596|consen 537 SSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-----INQIAKLHAITDPNHEIEFP--DIP---EN---DEL 603 (677)
T ss_pred cccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-----HHHHHHHHhhcCCCcccccc--CCC---Cc---hHH
Confidence 3 457899999999999999999998522 11122211111111111111 110 11 138
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHH
Q 048243 231 LEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 231 ~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
.++++.||..||.+|||+.||++.
T Consensus 604 i~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 604 IDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHHHHHHhcCcccCCCcHHHhcC
Confidence 899999999999999999999874
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=252.71 Aligned_cols=231 Identities=21% Similarity=0.261 Sum_probs=175.4
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCccccEEEEEE-----eCCeeEEEEeecCCCChhhhhcCcc-ccc
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCI-----DSEERMLVYEYMPNKSLDCYLFDPI-RRL 76 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~-~~~ 76 (303)
.+|+.+|+|++..... ....+..|+.+++.+ +|+||+++++++. .+...++||||+++++|.+++.... ...
T Consensus 41 ~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 119 (286)
T cd06638 41 KNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE 119 (286)
T ss_pred CCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCc
Confidence 4688999999865332 235678899999999 7999999999874 3456899999999999998875322 345
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChh
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE 156 (303)
.+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||.+........ ......|+..|+|||
T Consensus 120 ~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE 194 (286)
T cd06638 120 RMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPE 194 (286)
T ss_pred cccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCceeecccCCC--ccccccCCCcccChh
Confidence 6889999999999999999999998 99999999999999999999999999876543221 122345889999999
Q ss_pred hhcc-----CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHH
Q 048243 157 YARQ-----GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL 231 (303)
Q Consensus 157 ~~~~-----~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
.+.. ..++.++||||+||++|+|++|..||....... .... .......... .+...+..+.
T Consensus 195 ~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~------~~~~-~~~~~~~~~~-------~~~~~~~~~~ 260 (286)
T cd06638 195 VIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR------ALFK-IPRNPPPTLH-------QPELWSNEFN 260 (286)
T ss_pred hhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH------HHhh-ccccCCCccc-------CCCCcCHHHH
Confidence 8753 347889999999999999999999985432211 0001 0000000000 0111234688
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 048243 232 EIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 232 ~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
+++.+||+.||++|||+.|+++.
T Consensus 261 ~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 261 DFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred HHHHHHccCCcccCCCHHHHhhc
Confidence 99999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=251.21 Aligned_cols=240 Identities=24% Similarity=0.307 Sum_probs=174.8
Q ss_pred CCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.||+|.+..... .....+.+|++++++++|+||+++++++..+...++||||+.+ +|.+++.. ....+++..
T Consensus 28 ~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~--~~~~~~~~~ 104 (291)
T cd07844 28 LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDD--CGGGLSMHN 104 (291)
T ss_pred CCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHh--CCCCCCHHH
Confidence 4689999999865432 2234567899999999999999999999999999999999975 88887753 234688999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc-C
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ-G 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~ 161 (303)
++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+ .
T Consensus 105 ~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~ 179 (291)
T cd07844 105 VRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--TYSNEVVTLWYRPPDVLLGST 179 (291)
T ss_pred HHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc--cccccccccccCCcHHhhcCc
Confidence 9999999999999999998 99999999999999999999999999865432211 1112345788999998875 4
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcce---------eccccCCCC-------CCHH
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVE---------FVDSSLDDT-------NSPC 225 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~-------~~~~ 225 (303)
.++.++||||+|+++|+|++|..||...... .................. ......... ....
T Consensus 180 ~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (291)
T cd07844 180 EYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPR 257 (291)
T ss_pred ccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcC
Confidence 5788999999999999999999998544311 111111111111000000 000000000 0000
Q ss_pred H--HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 226 K--LMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 226 ~--~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
. ...+.+++.+||..||++|||+.|+++
T Consensus 258 ~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 258 LDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred CCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 1 146789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=251.26 Aligned_cols=226 Identities=24% Similarity=0.347 Sum_probs=180.7
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+++.||+|.+.... ......+.+|+..+..++||||+++++++..+...++||||+++++|.+++. ...+++..
T Consensus 27 ~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~----~~~~~~~~ 102 (277)
T cd06641 27 RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE----PGPLDETQ 102 (277)
T ss_pred CCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHh----cCCCCHHH
Confidence 468899999986443 3344678899999999999999999999999999999999999999998883 34588999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
+..++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..
T Consensus 103 ~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~ 177 (277)
T cd06641 103 IATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSA 177 (277)
T ss_pred HHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh--hhccccCCccccChhhhccCC
Confidence 9999999999999999998 99999999999999999999999999876543221 122245788999999998888
Q ss_pred CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC
Q 048243 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 242 (303)
++.++|+||||+++|+|++|..||....... .. ........ .......+..+.+++.+||+.+|
T Consensus 178 ~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~----~~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~~p 241 (277)
T cd06641 178 YDSKADIWSLGITAIELAKGEPPHSELHPMK---VL----FLIPKNNP---------PTLEGNYSKPLKEFVEACLNKEP 241 (277)
T ss_pred CCchhhHHHHHHHHHHHHcCCCCCCccchHH---HH----HHHhcCCC---------CCCCcccCHHHHHHHHHHccCCh
Confidence 8999999999999999999999985432111 00 11111100 01112234578899999999999
Q ss_pred CCCCCHHHHHHH
Q 048243 243 NDRPSMLQVSSM 254 (303)
Q Consensus 243 ~~Rpt~~el~~~ 254 (303)
.+||++.+++..
T Consensus 242 ~~Rp~~~~~l~~ 253 (277)
T cd06641 242 SFRPTAKELLKH 253 (277)
T ss_pred hhCcCHHHHHhC
Confidence 999999999884
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=252.28 Aligned_cols=242 Identities=24% Similarity=0.320 Sum_probs=180.0
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.||+|.++... ....+.+.+|+.+++.++|+||+++++++...+..++||||+.+ +|.+++........+++..
T Consensus 23 ~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~ 101 (284)
T cd07836 23 TTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNT 101 (284)
T ss_pred CCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHH
Confidence 468999999997553 23346778899999999999999999999999999999999975 7888875533345689999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC-
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG- 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~- 161 (303)
+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++........ ......++..|++||.+.+.
T Consensus 102 ~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~ 176 (284)
T cd07836 102 VKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSR 176 (284)
T ss_pred HHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--ccccccccccccChHHhcCCC
Confidence 9999999999999999998 99999999999999999999999999875543211 11223467889999988654
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCC--------CcceeccccCCC-------CCCHHH
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG--------KGVEFVDSSLDD-------TNSPCK 226 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~-------~~~~~~ 226 (303)
.++.++||||||+++|++++|..||.......... ......... ............ ...+..
T Consensus 177 ~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (284)
T cd07836 177 TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL---KIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHA 253 (284)
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH---HHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhc
Confidence 46889999999999999999999986543221111 111111000 000000000000 001123
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 227 LMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 227 ~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
+..+.+++.+||+.||.+||++.++++.
T Consensus 254 ~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 254 DPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred CcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 4578899999999999999999999853
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=250.50 Aligned_cols=226 Identities=24% Similarity=0.266 Sum_probs=181.3
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|.+.... ....+.+.+|++.+++++||||+++++++......++|+||+.+++|.+++.. ...+++
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~ 99 (258)
T cd05578 23 DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQ---KVKFSE 99 (258)
T ss_pred cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHh---cCCcCH
Confidence 368999999997543 23456889999999999999999999999999999999999999999999843 357899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......|+..|+|||.+.+
T Consensus 100 ~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~ 173 (258)
T cd05578 100 EQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCR 173 (258)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc---cccccCCChhhcCHHHHcc
Confidence 999999999999999999998 9999999999999999999999999987654332 1223457889999999998
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|+||||+++|+|++|..||.......... ....... .....+...+..+.+++.+||..
T Consensus 174 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~ 239 (258)
T cd05578 174 QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ----IRAKQET----------ADVLYPATWSTEAIDAINKLLER 239 (258)
T ss_pred cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHH----HHHHhcc----------ccccCcccCcHHHHHHHHHHccC
Confidence 889999999999999999999999986544321111 1111110 00111122346888999999999
Q ss_pred CCCCCCCH--HHHH
Q 048243 241 NPNDRPSM--LQVS 252 (303)
Q Consensus 241 dp~~Rpt~--~el~ 252 (303)
||.+||++ .|++
T Consensus 240 ~p~~R~~~~~~~l~ 253 (258)
T cd05578 240 DPQKRLGDNLKDLK 253 (258)
T ss_pred ChhHcCCccHHHHh
Confidence 99999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=271.51 Aligned_cols=237 Identities=18% Similarity=0.231 Sum_probs=168.4
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCC------CccccEEEEEEeC-CeeEEEEeecCCCChhhhhcCccccc
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQH------VNLIRVLGFCIDS-EERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~ 76 (303)
.+++.||||+++.... .......|+.+++.++| .+++++++++... ...|+||+++ +++|.+++. ...
T Consensus 152 ~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~---~~~ 226 (467)
T PTZ00284 152 KRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIM---KHG 226 (467)
T ss_pred CCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHH---HcC
Confidence 4688999999964322 22445667777777654 4588888888765 5789999988 678888874 345
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceEECCCC----------------ceEEcccccccccccCCc
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDM----------------KPKISDFGLARIFAKESL 139 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~~~~----------------~v~l~Df~~~~~~~~~~~ 139 (303)
.+++..+..++.||+.||+|||. .| |+||||||+|||++.++ .+||+|||.+.....
T Consensus 227 ~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~--- 300 (467)
T PTZ00284 227 PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH--- 300 (467)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc---
Confidence 68999999999999999999997 58 99999999999998765 499999998753221
Q ss_pred cccccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHH----HHhCC----Ccc
Q 048243 140 EANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE----LWKGG----KGV 211 (303)
Q Consensus 140 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~----~~~ 211 (303)
......||..|+|||++.+..++.++|||||||++|+|++|+.||...........+..... .|... ...
T Consensus 301 --~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~ 378 (467)
T PTZ00284 301 --SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEAR 378 (467)
T ss_pred --ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHH
Confidence 12335789999999999999999999999999999999999999965443221111111000 00000 000
Q ss_pred eec------cccCC-----------CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 212 EFV------DSSLD-----------DTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 212 ~~~------~~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
.+. .+... ..........+.+||.+||+.||.+|||++|+++
T Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 379 LLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 000 00000 0000112346789999999999999999999997
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=249.40 Aligned_cols=230 Identities=18% Similarity=0.206 Sum_probs=175.0
Q ss_pred CCCcEEEEEEecCCCcc---cHHHHHHHHHHH-hcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTSTQ---GFEEFKNEVMLT-AKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~---~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+|+.||+|.+...... ....+..|...+ ...+|+|++++++++..+...++|+||+++++|.+++. ....++
T Consensus 19 ~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~ 95 (260)
T cd05611 19 STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIK---TLGGLP 95 (260)
T ss_pred CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHH---HcCCCC
Confidence 46889999998654321 122334454444 44589999999999999999999999999999999884 345689
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||.+..... .....++..|+|||.+.
T Consensus 96 ~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~ 166 (260)
T cd05611 96 EDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETIL 166 (260)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCCCcCccChhhhc
Confidence 9999999999999999999998 99999999999999999999999998865332 22345788999999998
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++||||||+++|+|++|..||....... ... ....... ..........+..+.+++.+||.
T Consensus 167 ~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~---~~~~~~~-------~~~~~~~~~~~~~~~~~i~~~l~ 233 (260)
T cd05611 167 GVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA---VFD---NILSRRI-------NWPEEVKEFCSPEAVDLINRLLC 233 (260)
T ss_pred CCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHH---HHHhccc-------CCCCcccccCCHHHHHHHHHHcc
Confidence 8888999999999999999999999986433211 111 1101000 00111111234578899999999
Q ss_pred CCCCCCCCHHHHHHHhccc
Q 048243 240 ENPNDRPSMLQVSSMLKNE 258 (303)
Q Consensus 240 ~dp~~Rpt~~el~~~L~~~ 258 (303)
.||++||++.++.+.|...
T Consensus 234 ~~p~~R~~~~~~~~~l~~~ 252 (260)
T cd05611 234 MDPAKRLGANGYQEIKSHP 252 (260)
T ss_pred CCHHHccCCCcHHHHHcCh
Confidence 9999999887776666543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=243.59 Aligned_cols=231 Identities=21% Similarity=0.330 Sum_probs=181.6
Q ss_pred cCCCcEEEEEEecCC-CcccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 3 LPCGKVIAVKKLSKT-STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 3 ~~~~~~valK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
..+|..+|||-+... ...+.++++..+.++... ++|+||+.+|+|..+...++.||.| +.++..++.. ..+++++
T Consensus 114 rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkr--ik~piPE 190 (391)
T KOG0983|consen 114 RSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKR--IKGPIPE 190 (391)
T ss_pred cccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHH--hcCCchH
Confidence 457899999998665 344556777788777776 5999999999999999999999998 4567776643 4566999
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..+-++...+++||.||.+++ +|+|||+||+|||+++.|.+||+|||++.++... .......|-+.|||||.+..
T Consensus 191 ~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS---kAhtrsAGC~~YMaPERidp 265 (391)
T KOG0983|consen 191 RILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS---KAHTRSAGCAAYMAPERIDP 265 (391)
T ss_pred HhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc---cccccccCCccccCccccCC
Confidence 999999999999999998876 4999999999999999999999999998766443 23344578899999999875
Q ss_pred C---CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHc
Q 048243 161 G---VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237 (303)
Q Consensus 161 ~---~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 237 (303)
. .|+-.+||||||++++||+||+.||..+...-.. .......+. +.++... .+++.+.+|+..|
T Consensus 266 ~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~-----ltkvln~eP------P~L~~~~--gFSp~F~~fv~~C 332 (391)
T KOG0983|consen 266 PDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV-----LTKVLNEEP------PLLPGHM--GFSPDFQSFVKDC 332 (391)
T ss_pred CCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH-----HHHHHhcCC------CCCCccc--CcCHHHHHHHHHH
Confidence 4 4788999999999999999999999876644211 112222111 1222211 1556889999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 048243 238 VQENPNDRPSMLQVSSM 254 (303)
Q Consensus 238 l~~dp~~Rpt~~el~~~ 254 (303)
|..|+++||...++++.
T Consensus 333 L~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 333 LTKDHRKRPKYNKLLEH 349 (391)
T ss_pred hhcCcccCcchHHHhcC
Confidence 99999999999999875
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=277.20 Aligned_cols=236 Identities=27% Similarity=0.419 Sum_probs=194.6
Q ss_pred CcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHH
Q 048243 6 GKVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 6 ~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~ 84 (303)
...||||-++.. ...++.+|+.|+.+|.+++||||+++.|+........+|+|||++|+|+.||+.. .+.+...+..
T Consensus 657 e~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~--DGqftviQLV 734 (996)
T KOG0196|consen 657 EITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQN--DGQFTVIQLV 734 (996)
T ss_pred ceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhc--CCceEeehHH
Confidence 456999999876 4566778999999999999999999999999999999999999999999999763 3458888999
Q ss_pred HHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-ccccccccccCCCChhhhccCCC
Q 048243 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 85 ~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
-+++.|+.|++||-+.+ +|||||...|||++.+-.+|++|||+++...+.... .......-+.+|.|||.+....+
T Consensus 735 gMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKF 811 (996)
T KOG0196|consen 735 GMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKF 811 (996)
T ss_pred HHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhccc
Confidence 99999999999999999 999999999999999999999999999977554311 11111222579999999999999
Q ss_pred CCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC
Q 048243 164 STKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 242 (303)
|.++||||+|+++||.++ |..|+=..+..+..+.+ ...++...+.+.+..+++|+..||++|.
T Consensus 812 TsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI----------------e~gyRLPpPmDCP~aL~qLMldCWqkdR 875 (996)
T KOG0196|consen 812 TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI----------------EQGYRLPPPMDCPAALYQLMLDCWQKDR 875 (996)
T ss_pred CchhhccccceEEEEecccCCCcccccchHHHHHHH----------------HhccCCCCCCCCcHHHHHHHHHHHHHHh
Confidence 999999999999999886 88887444333322222 2233334444556689999999999999
Q ss_pred CCCCCHHHHHHHhccccCCC
Q 048243 243 NDRPSMLQVSSMLKNETTNR 262 (303)
Q Consensus 243 ~~Rpt~~el~~~L~~~~~~~ 262 (303)
.+||.+.+|+..|.+.-.++
T Consensus 876 ~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 876 NRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred hcCCCHHHHHHHHHHHhcCc
Confidence 99999999999998876544
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=249.43 Aligned_cols=230 Identities=24% Similarity=0.312 Sum_probs=181.6
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEe--CCeeEEEEeecCCCChhhhhcCcc-ccccC
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCID--SEERMLVYEYMPNKSLDCYLFDPI-RRLIL 78 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~l 78 (303)
.+|+.||+|.+.... ....+.+.+|+++++.++|+||+++++++.. ....+++|||+++++|.+++.... ....+
T Consensus 23 ~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l 102 (265)
T cd08217 23 SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYI 102 (265)
T ss_pred CCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCC
Confidence 477899999986543 3345678889999999999999999998764 456799999999999999885422 24568
Q ss_pred CHHHHHHHHHHHHHHHHHHH-----hCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCC
Q 048243 79 DWKKRVHIIEGITQGLLYLQ-----EYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYI 153 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh-----~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~ 153 (303)
++..++.++.|++.||++|| +.+ ++|+||+|+||+++.++.++|+|||.+......... .....++..|+
T Consensus 103 ~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~ 177 (265)
T cd08217 103 EEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF--AKTYVGTPYYM 177 (265)
T ss_pred CHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccccccccCCccc--ccccccCCCcc
Confidence 99999999999999999999 666 999999999999999999999999998876543321 22346789999
Q ss_pred ChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHH
Q 048243 154 PPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEI 233 (303)
Q Consensus 154 aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 233 (303)
|||.+.+..++.++|+||||+++|+|++|..||...... ........... ...+...+..+.++
T Consensus 178 ~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~~~~l 241 (265)
T cd08217 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL-------QLASKIKEGKF---------RRIPYRYSSELNEV 241 (265)
T ss_pred ChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH-------HHHHHHhcCCC---------CCCccccCHHHHHH
Confidence 999998888999999999999999999999998643311 11111111111 11122334578899
Q ss_pred HHHcccCCCCCCCCHHHHHHH
Q 048243 234 ALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 234 i~~~l~~dp~~Rpt~~el~~~ 254 (303)
+.+||..+|++||++.++++.
T Consensus 242 ~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 242 IKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHccCCcccCCCHHHHhhC
Confidence 999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=257.78 Aligned_cols=233 Identities=18% Similarity=0.209 Sum_probs=176.2
Q ss_pred CCCcEEEEEEecCC---CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+++.+|+|++... .......+.+|+.++..++|++|+++++.+.+....++||||+.+|+|.+++.. ....+++
T Consensus 24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~l~~ 101 (332)
T cd05623 24 NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSK--FEDRLPE 101 (332)
T ss_pred CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHH--hcCCCCH
Confidence 46788999998642 122334578899999999999999999999999999999999999999999853 2346889
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..+..++.||+.||+|||+.+ ++||||||+||+++.++.++|+|||++........ .......|++.|+|||++.+
T Consensus 102 ~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~ 177 (332)
T cd05623 102 DMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQA 177 (332)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCc-ceecccccCccccCHHHHhc
Confidence 999999999999999999999 99999999999999999999999999865432221 11223568999999999863
Q ss_pred -----CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHH
Q 048243 161 -----GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235 (303)
Q Consensus 161 -----~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
..++.++|||||||++|+|++|..||...... ..............+. ......+..+.+++.
T Consensus 178 ~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~~~p------~~~~~~s~~~~~li~ 245 (332)
T cd05623 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKERFQFP------AQVTDVSEDAKDLIR 245 (332)
T ss_pred cccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH------HHHHHHhCCCccccCC------CccccCCHHHHHHHH
Confidence 45788999999999999999999999643211 1111111111111100 011123457889999
Q ss_pred HcccCCCCC--CCCHHHHHHH
Q 048243 236 LCVQENPND--RPSMLQVSSM 254 (303)
Q Consensus 236 ~~l~~dp~~--Rpt~~el~~~ 254 (303)
+||..++.. |+++.|+++.
T Consensus 246 ~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 246 RLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHccChhhhcCCCCHHHHhCC
Confidence 998654444 7899998775
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=250.40 Aligned_cols=231 Identities=23% Similarity=0.281 Sum_probs=176.4
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCccccEEEEEEeC-----CeeEEEEeecCCCChhhhhcCcc-ccc
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS-----EERMLVYEYMPNKSLDCYLFDPI-RRL 76 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~-~~~ 76 (303)
++|+.+|+|.+..... ....+.+|+.+++++ +|||++++++++... ...++||||+++++|.+++.... ...
T Consensus 45 ~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~ 123 (291)
T cd06639 45 KDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ 123 (291)
T ss_pred CCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCC
Confidence 5789999999865432 235677899999999 899999999998753 35899999999999998875322 345
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChh
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE 156 (303)
.+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........ ......|+..|+|||
T Consensus 124 ~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE 198 (291)
T cd06639 124 RLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPE 198 (291)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccchhcccccc--cccCccCCccccChh
Confidence 6889999999999999999999998 99999999999999999999999999876543221 112345788999999
Q ss_pred hhccC-----CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHH
Q 048243 157 YARQG-----VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL 231 (303)
Q Consensus 157 ~~~~~-----~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
.+... .++.++||||||+++|+|++|..||...... ......... ..... .........+.
T Consensus 199 ~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~------~~~~~~~~~-~~~~~-------~~~~~~~~~l~ 264 (291)
T cd06639 199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV------KTLFKIPRN-PPPTL-------LHPEKWCRSFN 264 (291)
T ss_pred hhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH------HHHHHHhcC-CCCCC-------CcccccCHHHH
Confidence 87643 3678999999999999999999998543211 111111111 11110 11122334788
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 048243 232 EIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 232 ~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
+++.+||+.+|++||++.|+++.
T Consensus 265 ~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 265 HFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHHHHhhcChhhCcCHHHHhcC
Confidence 99999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=253.30 Aligned_cols=240 Identities=21% Similarity=0.276 Sum_probs=177.1
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+|+.||||+++... ......+.+|++++++++||||+++++++.+....++||||+. ++|..++... ....+++.
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~-~~~~l~~~ 100 (284)
T cd07860 23 LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDAS-PLSGIPLP 100 (284)
T ss_pred CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhC-CCCCCCHH
Confidence 478999999986543 2234578899999999999999999999999999999999996 5788877442 34568999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
.++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+.
T Consensus 101 ~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~ 175 (284)
T cd07860 101 LIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGC 175 (284)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc--cccccccccccccCCeEEecC
Confidence 99999999999999999998 9999999999999999999999999987554321 111223467889999988765
Q ss_pred C-CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCC----------------cceeccccCCCCCCH
Q 048243 162 V-YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK----------------GVEFVDSSLDDTNSP 224 (303)
Q Consensus 162 ~-~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~ 224 (303)
. ++.++||||||+++|+|++|..||........ ............ ........+. ...+
T Consensus 176 ~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 251 (284)
T cd07860 176 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ---LFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFS-KVVP 251 (284)
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHH-HHcc
Confidence 4 58899999999999999999999864332111 111111000000 0000000000 0011
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 225 CKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 225 ~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
..+..+.++|.+||+.||.+|||+++++..
T Consensus 252 ~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 252 PLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred cCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 233467899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=248.91 Aligned_cols=227 Identities=22% Similarity=0.267 Sum_probs=172.9
Q ss_pred CCCcEEEEEEecCCCc---ccHHHHHHHHHHHhc---CCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcccccc
Q 048243 4 PCGKVIAVKKLSKTST---QGFEEFKNEVMLTAK---LQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~~~~valK~~~~~~~---~~~~~~~~e~~~l~~---l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
.+|+.+|+|.+..... .....+.+|..+++. .+||||+.+++.+...+..++||||+.+++|.+++. ....
T Consensus 17 ~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~---~~~~ 93 (279)
T cd05633 17 DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS---QHGV 93 (279)
T ss_pred CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHH---hcCC
Confidence 5689999999865421 112233444443333 479999999999999999999999999999998884 3456
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhh
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 157 (303)
+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....... .....|+..|+|||.
T Consensus 94 l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~ 166 (279)
T cd05633 94 FSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEV 166 (279)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC----ccCcCCCcCccCHHH
Confidence 899999999999999999999999 9999999999999999999999999986543321 122458999999998
Q ss_pred hc-cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 158 AR-QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 158 ~~-~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
+. +..++.++||||+||++|+|++|..||.......... .. .... ......+...+..+.+++.+
T Consensus 167 ~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~---~~~~----------~~~~~~~~~~~~~~~~li~~ 232 (279)
T cd05633 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-ID---RMTL----------TVNVELPDSFSPELKSLLEG 232 (279)
T ss_pred hcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HH---HHhh----------cCCcCCccccCHHHHHHHHH
Confidence 86 4567899999999999999999999996443222111 11 1000 01111222345578899999
Q ss_pred cccCCCCCCC-----CHHHHHHH
Q 048243 237 CVQENPNDRP-----SMLQVSSM 254 (303)
Q Consensus 237 ~l~~dp~~Rp-----t~~el~~~ 254 (303)
||+.||.+|| |+.|+++.
T Consensus 233 ~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 233 LLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HhcCCHHHhcCCCCCCHHHHHhC
Confidence 9999999999 59988874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=257.42 Aligned_cols=239 Identities=24% Similarity=0.264 Sum_probs=174.9
Q ss_pred CCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEeC------CeeEEEEeecCCCChhhhhcCcccc
Q 048243 4 PCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------EERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~ 75 (303)
.+|+.||+|.+... .......+.+|+.+++.++|+||+++++++... ...|+||||+. ++|.+.+..
T Consensus 39 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---- 113 (353)
T cd07850 39 VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM---- 113 (353)
T ss_pred CCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhh----
Confidence 47899999998643 223345677899999999999999999998644 35799999996 477777632
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCCh
Q 048243 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aP 155 (303)
.++...+..++.|++.||+|||+.| ++||||||+||+++.++.++|+|||.+........ .....++..|+||
T Consensus 114 -~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aP 186 (353)
T cd07850 114 -DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAP 186 (353)
T ss_pred -cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC---CCCCcccccccCH
Confidence 1788899999999999999999998 99999999999999999999999999976543221 2224578899999
Q ss_pred hhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHH------------H---HHH-HHhCCC------ccee
Q 048243 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILE------------H---AYE-LWKGGK------GVEF 213 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~------------~---~~~-~~~~~~------~~~~ 213 (303)
|.+.+..++.++|||||||++|+|++|..||...........+. . ... ...... ....
T Consensus 187 E~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (353)
T cd07850 187 EVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEEL 266 (353)
T ss_pred HHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhh
Confidence 99999999999999999999999999999986433211100000 0 000 000000 0000
Q ss_pred cccc----CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 214 VDSS----LDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 214 ~~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
.... .........+..+.+++.+||+.||++|||+.|+++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 267 FPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred CcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 0000012335568899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=253.54 Aligned_cols=240 Identities=24% Similarity=0.311 Sum_probs=175.2
Q ss_pred CCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCccccEEEEEEeC--CeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+|+.||+|.++.... .....+.+|+.++++++|+||+++++++... ...++||||+.+ +|.+++.. ....++
T Consensus 30 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~l~ 106 (309)
T cd07845 30 TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDN--MPTPFS 106 (309)
T ss_pred CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHh--cccCCC
Confidence 4689999999865432 2233566899999999999999999998765 468999999964 78777743 235689
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..++.++.|++.||+|||+.| ++||||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.
T Consensus 107 ~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~ 181 (309)
T cd07845 107 ESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK--PMTPKVVTLWYRAPELLL 181 (309)
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCccC--CCCcccccccccChhhhc
Confidence 9999999999999999999999 99999999999999999999999999876644321 112234577899999886
Q ss_pred c-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCc--------------ceeccccCCC--CC
Q 048243 160 Q-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG--------------VEFVDSSLDD--TN 222 (303)
Q Consensus 160 ~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~--~~ 222 (303)
+ ..++.++||||||+++|+|++|..||......... ............ .......... ..
T Consensus 182 ~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (309)
T cd07845 182 GCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQL---DLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHK 258 (309)
T ss_pred CCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHh
Confidence 5 45789999999999999999999998643322211 111111100000 0000000000 00
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 223 SPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 223 ~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
....+..+.++|.+||+.||++|||+.+++..
T Consensus 259 ~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 259 FPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 01135577899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=251.47 Aligned_cols=239 Identities=24% Similarity=0.287 Sum_probs=180.6
Q ss_pred CCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+|+.+++|.+..... .....+.+|+.+++.++|+||+++++++......++|+||+.+ ++..++.. ....+++.
T Consensus 22 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~--~~~~~~~~ 98 (283)
T cd05118 22 LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKD--RQRGLPES 98 (283)
T ss_pred CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHh--hcccCCHH
Confidence 4789999999875532 2456788899999999999999999999999999999999975 77777743 23568999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
.++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+.
T Consensus 99 ~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~ 173 (283)
T cd05118 99 LIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYTHYVVTRWYRAPELLLGD 173 (283)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccccCccCcccccCcHHHhcC
Confidence 99999999999999999999 9999999999999999999999999987665432 112224578889999998776
Q ss_pred -CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCc---ce-----------eccc--cCCCCCCH
Q 048243 162 -VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG---VE-----------FVDS--SLDDTNSP 224 (303)
Q Consensus 162 -~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~-----------~~~~--~~~~~~~~ 224 (303)
.++.++|+||||+++|+|++|..||...+..+. ............. .. .... .......+
T Consensus 174 ~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (283)
T cd05118 174 KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFP 250 (283)
T ss_pred CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhh
Confidence 688999999999999999999998854332111 1111111100000 00 0000 00001112
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 225 CKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 225 ~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
..+..+.++|.+||..||.+||++.+++.
T Consensus 251 ~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 251 NASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 34668899999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=250.86 Aligned_cols=224 Identities=29% Similarity=0.368 Sum_probs=174.7
Q ss_pred CCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTST---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++.++...++|+||+. |++.+++.. ....+++
T Consensus 38 ~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~--~~~~l~~ 114 (307)
T cd06607 38 RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEV--HKKPLQE 114 (307)
T ss_pred CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHH--cccCCCH
Confidence 4689999999864432 233568899999999999999999999999999999999997 566666532 2346899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc-
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR- 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~- 159 (303)
..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++...... ....++..|+|||.+.
T Consensus 115 ~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~ 185 (307)
T cd06607 115 VEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILA 185 (307)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC------CCccCCccccCceeeec
Confidence 999999999999999999998 999999999999999999999999988654322 2245788999999874
Q ss_pred --cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHc
Q 048243 160 --QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237 (303)
Q Consensus 160 --~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 237 (303)
...++.++||||||+++|+|++|..||....... ....... ... ........+..+.+++.+|
T Consensus 186 ~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~~~~~~~-~~~--------~~~~~~~~~~~~~~li~~~ 250 (307)
T cd06607 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQ-NDS--------PTLSSNDWSDYFRNFVDSC 250 (307)
T ss_pred cCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------HHHHHhc-CCC--------CCCCchhhCHHHHHHHHHH
Confidence 3457889999999999999999999985332111 1111111 000 0111123455789999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 048243 238 VQENPNDRPSMLQVSSM 254 (303)
Q Consensus 238 l~~dp~~Rpt~~el~~~ 254 (303)
|..||.+||++.+++..
T Consensus 251 l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 251 LQKIPQDRPSSEELLKH 267 (307)
T ss_pred hcCChhhCcCHHHHhcC
Confidence 99999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=245.86 Aligned_cols=229 Identities=24% Similarity=0.338 Sum_probs=180.2
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+|+.||+|.+.... ....+.+.+|+++++.++|+||+++++.+......++|+||+.+++|.+++... ....+++.
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~ 101 (257)
T cd08225 23 SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQ-RGVLFSED 101 (257)
T ss_pred CCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhc-cCCCCCHH
Confidence 367889999986542 234567889999999999999999999999999999999999999999988542 23357899
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCc-eEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK-PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~-v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
.+..++.|++.||+|||+.+ ++|+||+|+||+++.++. ++|+|||.+........ ......|+..|+|||.+.+
T Consensus 102 ~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~ 176 (257)
T cd08225 102 QILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--LAYTCVGTPYYLSPEICQN 176 (257)
T ss_pred HHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc--cccccCCCccccCHHHHcC
Confidence 99999999999999999998 999999999999998864 69999998876543321 1222457889999999988
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|+||||+++|++++|..||....... ........ ... ...+..+..+.+++.+||..
T Consensus 177 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~-~~~---------~~~~~~~~~~~~~i~~~l~~ 240 (257)
T cd08225 177 RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKICQG-YFA---------PISPNFSRDLRSLISQLFKV 240 (257)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHhcc-cCC---------CCCCCCCHHHHHHHHHHhcc
Confidence 889999999999999999999999985332111 11111111 100 01122345788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 048243 241 NPNDRPSMLQVSSM 254 (303)
Q Consensus 241 dp~~Rpt~~el~~~ 254 (303)
+|++|||+.|++..
T Consensus 241 ~p~~Rpt~~~ll~~ 254 (257)
T cd08225 241 SPRDRPSITSILKR 254 (257)
T ss_pred ChhhCcCHHHHhhC
Confidence 99999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=240.64 Aligned_cols=230 Identities=23% Similarity=0.306 Sum_probs=185.1
Q ss_pred CCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc-ccccCCH
Q 048243 4 PCGKVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-RRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~l~~ 80 (303)
++++.+++|.+..... .....+.+|++.++.++|+|++++++.+......++|+|++++++|.+++.... ....+++
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 102 (258)
T cd08215 23 SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPE 102 (258)
T ss_pred CCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCH
Confidence 3689999999975533 456678899999999999999999999999999999999999999999885422 1367899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..+..++.+++.||++||+.| ++|+||+|+||+++.++.++|+|||.+....... .......|++.|+|||.+.+
T Consensus 103 ~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~ 177 (258)
T cd08215 103 EQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQN 177 (258)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc--ceecceeeeecccChhHhcc
Confidence 999999999999999999998 9999999999999999999999999987655443 12233467889999999988
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|+||+|+++++|++|..||....... ............ .+...+..+.+++.+||..
T Consensus 178 ~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~ 241 (258)
T cd08215 178 KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE-------LALKILKGQYPP---------IPSQYSSELRNLVSSLLQK 241 (258)
T ss_pred CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH-------HHHHHhcCCCCC---------CCCCCCHHHHHHHHHHcCC
Confidence 889999999999999999999999985433111 111111111111 1112345788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 048243 241 NPNDRPSMLQVSSM 254 (303)
Q Consensus 241 dp~~Rpt~~el~~~ 254 (303)
+|++|||+.++++.
T Consensus 242 ~p~~Rp~~~~ll~~ 255 (258)
T cd08215 242 DPEERPSIAQILQS 255 (258)
T ss_pred ChhhCcCHHHHhcC
Confidence 99999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=244.87 Aligned_cols=226 Identities=26% Similarity=0.364 Sum_probs=182.7
Q ss_pred CCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+++.|++|.+..... ...+.+.+|++++.+++|+|++++++++.+.+..+++|+++++++|.+++.. ...+++.
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~l~~~ 99 (254)
T cd06627 23 ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKK---FGPFPES 99 (254)
T ss_pred CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHh---ccCCCHH
Confidence 4678999999976643 4556889999999999999999999999999999999999999999998843 3568999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
.++.++.|++.++.+||+.| ++||||+|+||+++.++.++|+|||.+......... .....++..|+|||...+.
T Consensus 100 ~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~ 174 (254)
T cd06627 100 LVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMS 174 (254)
T ss_pred HHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccccccchhhcCHhhhcCC
Confidence 99999999999999999998 999999999999999999999999998776543321 2234578899999998887
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
.++.++||||+|+++|+|++|..||...... .......... . ...+...+..+.+++.+||..+
T Consensus 175 ~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~-~---------~~~~~~~~~~~~~~i~~~l~~~ 238 (254)
T cd06627 175 GASTASDIWSLGCTVIELLTGNPPYYDLNPM------AALFRIVQDD-H---------PPLPEGISPELKDFLMQCFQKD 238 (254)
T ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHhccC-C---------CCCCCCCCHHHHHHHHHHHhCC
Confidence 7889999999999999999999998543311 1111111110 0 1111223457889999999999
Q ss_pred CCCCCCHHHHHH
Q 048243 242 PNDRPSMLQVSS 253 (303)
Q Consensus 242 p~~Rpt~~el~~ 253 (303)
|++|||+.+++.
T Consensus 239 p~~R~~~~~~l~ 250 (254)
T cd06627 239 PNLRPTAKQLLK 250 (254)
T ss_pred hhhCcCHHHHhc
Confidence 999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=250.35 Aligned_cols=242 Identities=22% Similarity=0.245 Sum_probs=174.9
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCe-----eEEEEeecCCCChhhhhcCccc-
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEE-----RMLVYEYMPNKSLDCYLFDPIR- 74 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~- 74 (303)
.+|+.||+|.+.... ......+.+|+.+++.+ +|+||+++++++..... .++||||+++ +|.+++.....
T Consensus 24 ~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~ 102 (295)
T cd07837 24 NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRG 102 (295)
T ss_pred CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhccc
Confidence 478999999986542 22345788899999999 46999999999987665 8999999985 78887754222
Q ss_pred -cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC-CCceEEcccccccccccCCccccccccccccCC
Q 048243 75 -RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-DMKPKISDFGLARIFAKESLEANTEQVVGTIGY 152 (303)
Q Consensus 75 -~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y 152 (303)
...+++..++.++.||+.||+|||+.+ ++||||+|+||+++. ++.++|+|||.+......... .....+++.|
T Consensus 103 ~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~ 177 (295)
T cd07837 103 PGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIVTLWY 177 (295)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecccceecCCCccc--cCCcccccCC
Confidence 346899999999999999999999998 999999999999998 889999999998765332111 1122457889
Q ss_pred CChhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCccee------cc----cc----
Q 048243 153 IPPEYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF------VD----SS---- 217 (303)
Q Consensus 153 ~aPE~~~~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~----~~---- 217 (303)
+|||.+.+ ..++.++||||||+++|+|++|..||........ ...............+ .. +.
T Consensus 178 ~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (295)
T cd07837 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ---LLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQ 254 (295)
T ss_pred CChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHhCCCChhhCcchhhccchhhcCcccch
Confidence 99998865 4578999999999999999999999864322111 1111111110000000 00 00
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 218 LDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 218 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
......+..+..+.++|.+||..||.+||++.|++..
T Consensus 255 ~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 255 DLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000011234578899999999999999999998753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=246.80 Aligned_cols=240 Identities=23% Similarity=0.260 Sum_probs=173.6
Q ss_pred CCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.||+|.+..... .....+.+|+.+++.++|+||+++++++......++||||+. +++.+++.. ....+.+..
T Consensus 28 ~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~ 104 (291)
T cd07870 28 INGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQ--HPGGLHPYN 104 (291)
T ss_pred CCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHh--CCCCCCHHH
Confidence 4688999999865432 233467789999999999999999999999999999999996 667666533 234577888
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC-
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG- 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~- 161 (303)
+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++........ ......++..|+|||.+.+.
T Consensus 105 ~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~ 179 (291)
T cd07870 105 VRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ--TYSSEVVTLWYRPPDVLLGAT 179 (291)
T ss_pred HHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCC--CCCCccccccccCCceeecCC
Confidence 8999999999999999998 99999999999999999999999999865433211 11223568899999988754
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCC------------C-cceeccccCCCCC-----C
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG------------K-GVEFVDSSLDDTN-----S 223 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------~-~~~~~~~~~~~~~-----~ 223 (303)
.++.++||||||+++|+|++|..||...... ..........+... . ............. .
T Consensus 180 ~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (291)
T cd07870 180 DYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKR 257 (291)
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccc
Confidence 5788999999999999999999998643321 11111111100000 0 0000000000000 0
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 224 PCKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 224 ~~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
......+.+++.+||..||.+|||+.|++.
T Consensus 258 ~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 258 LSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 011346789999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=283.55 Aligned_cols=239 Identities=23% Similarity=0.415 Sum_probs=181.5
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+|+.||+|+++...... ..|+..+++++||||+++++++.+....++||||+++|+|.+++. .+++..+
T Consensus 713 ~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~------~l~~~~~ 782 (968)
T PLN00113 713 KNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR------NLSWERR 782 (968)
T ss_pred CCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh------cCCHHHH
Confidence 578999999986543222 346889999999999999999999999999999999999999983 2789999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
..++.|++.|++|||.....+++||||||+||+++.++..++. |+....... .....|+..|+|||++.+..+
T Consensus 783 ~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~ 855 (968)
T PLN00113 783 RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDI 855 (968)
T ss_pred HHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCC
Confidence 9999999999999995544459999999999999998887765 554332211 112357899999999999899
Q ss_pred CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCC--CCCHHHHHHHHHHHHHcccCC
Q 048243 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDD--TNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~d 241 (303)
+.++|||||||++|||++|+.||..... .......+............+.++.... ........++.+++.+||+.|
T Consensus 856 ~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~ 934 (968)
T PLN00113 856 TEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATD 934 (968)
T ss_pred CcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCC
Confidence 9999999999999999999999843221 1112222222222222222333333322 223455667889999999999
Q ss_pred CCCCCCHHHHHHHhccccC
Q 048243 242 PNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 242 p~~Rpt~~el~~~L~~~~~ 260 (303)
|++|||++|+++.|++...
T Consensus 935 P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 935 PTARPCANDVLKTLESASR 953 (968)
T ss_pred chhCcCHHHHHHHHHHhhc
Confidence 9999999999999988754
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=246.44 Aligned_cols=236 Identities=22% Similarity=0.285 Sum_probs=182.4
Q ss_pred CCCcEEEEEEecCCC----cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccC
Q 048243 4 PCGKVIAVKKLSKTS----TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 4 ~~~~~valK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
.+++.||+|.++... ....+.+.+|+.++.++ +||||+++++.+..+...++||||+.+++|.+++. ....+
T Consensus 26 ~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~ 102 (288)
T cd05583 26 DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY---QREHF 102 (288)
T ss_pred cCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHh---hcCCc
Confidence 467899999986432 22345678899999999 69999999999999999999999999999998884 33468
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
++..+..++.|++.+|+|||+.+ ++||||+|+||+++.++.++|+|||++........ .......|+..|+|||.+
T Consensus 103 ~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~ 178 (288)
T cd05583 103 TESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE-ERAYSFCGTIEYMAPEVI 178 (288)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccccccc-cccccccCCccccCHHHh
Confidence 89999999999999999999998 99999999999999999999999999876543321 111224578899999998
Q ss_pred ccCC--CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 159 RQGV--YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 159 ~~~~--~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
.+.. .+.++||||||+++|+|++|..||............ ........ ...+...+..+.+++.+
T Consensus 179 ~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~--~~~~~~~~-----------~~~~~~~~~~l~~li~~ 245 (288)
T cd05583 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI--SRRILKSK-----------PPFPKTMSAEARDFIQK 245 (288)
T ss_pred cCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHH--HHHHHccC-----------CCCCcccCHHHHHHHHH
Confidence 7654 688999999999999999999998643322111111 11111110 01111233478899999
Q ss_pred cccCCCCCCCCHHHHHHHhcccc
Q 048243 237 CVQENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 237 ~l~~dp~~Rpt~~el~~~L~~~~ 259 (303)
||+.||++|||+.++.+.|+...
T Consensus 246 ~l~~~p~~R~t~~~~~~~l~~~~ 268 (288)
T cd05583 246 LLEKDPKKRLGANGADEIKNHPF 268 (288)
T ss_pred HhcCCHhhccCcchHHHHhcCcc
Confidence 99999999999999988877654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=241.44 Aligned_cols=239 Identities=25% Similarity=0.342 Sum_probs=185.2
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
+.+|+.+|||++.+..-..+.++.+|++++.++ .|+||+.++++|+++...|||||.|.||+|...|. .+..+++.
T Consensus 100 i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~---~~~~F~E~ 176 (463)
T KOG0607|consen 100 IQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQ---KRKHFNER 176 (463)
T ss_pred eccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHH---HhhhccHH
Confidence 578999999999887777888999999999999 59999999999999999999999999999999884 45669999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCc---eEEcccccccccccCC-----ccccccccccccCCC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK---PKISDFGLARIFAKES-----LEANTEQVVGTIGYI 153 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~---v~l~Df~~~~~~~~~~-----~~~~~~~~~g~~~y~ 153 (303)
++..+..+|+.||.|||.+| |.|||+||+|||...-+. |||+||++..-+.... ..+..-..+|+..||
T Consensus 177 EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfM 253 (463)
T KOG0607|consen 177 EASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFM 253 (463)
T ss_pred HHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhc
Confidence 99999999999999999999 999999999999986654 8999998865432221 122233467899999
Q ss_pred Chhhhc---c--CCCCCccchhhHHHHHHHHHhCCCCCcc-CCCCccccH------H-HHHHHHHhCCCcceeccccCCC
Q 048243 154 PPEYAR---Q--GVYSTKSDVFSFGVLLLQIISGKRLSML-CGINENLSI------L-EHAYELWKGGKGVEFVDSSLDD 220 (303)
Q Consensus 154 aPE~~~---~--~~~~~~~DiwslG~~~~~l~~g~~p~~~-~~~~~~~~~------~-~~~~~~~~~~~~~~~~~~~~~~ 220 (303)
|||+.. + ..|+.++|.||||+++|-|+.|.+||.+ ++...+.+. . +...+-...+. .++.+
T Consensus 254 APEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGk-YeFPd----- 327 (463)
T KOG0607|consen 254 APEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK-YEFPD----- 327 (463)
T ss_pred chhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccC-CcCCh-----
Confidence 999753 2 3588999999999999999999999964 232222211 0 11111111111 11111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 221 TNSPCKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 221 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
..=...+.+..+++..+|..|+.+|.++.+++.
T Consensus 328 kdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 328 KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 111234567789999999999999999988875
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=251.05 Aligned_cols=241 Identities=22% Similarity=0.272 Sum_probs=177.0
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+|+.||+|++.... ......+.+|+..++.++|||++++++++.+....+++|||+. ++|.+++... ....+++.
T Consensus 22 ~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~-~~~~~~~~ 99 (283)
T cd07835 22 LTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSS-PLTGLDPP 99 (283)
T ss_pred CCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhC-CCCCCCHH
Confidence 478999999987543 2234568889999999999999999999999999999999995 6888887432 22368999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
.++.++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+.
T Consensus 100 ~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~ 174 (283)
T cd07835 100 LIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGS 174 (283)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--ccCccccccCCCCCceeecC
Confidence 99999999999999999998 99999999999999999999999999875543211 11223457889999987664
Q ss_pred -CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCC---------cceecccc------CCCCCCHH
Q 048243 162 -VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK---------GVEFVDSS------LDDTNSPC 225 (303)
Q Consensus 162 -~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~------~~~~~~~~ 225 (303)
.++.++|+||||+++|+|++|..||........ ............ ........ ......+.
T Consensus 175 ~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (283)
T cd07835 175 RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ---LFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPN 251 (283)
T ss_pred cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCC
Confidence 468899999999999999999999854322110 000001000000 00000000 00001112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 226 KLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 226 ~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
.+..+.+++.+||+.||.+|||++|+++.
T Consensus 252 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 252 LDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 33578899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=256.96 Aligned_cols=246 Identities=24% Similarity=0.309 Sum_probs=178.1
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeC-----CeeEEEEeecCCCChhhhhcCcccccc
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-----EERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
.+|+.||+|.++... ......+.+|+.++++++|+||+++++++... ...++++||+. ++|..++ ....
T Consensus 28 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~----~~~~ 102 (336)
T cd07849 28 PTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLI----KTQH 102 (336)
T ss_pred CCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHH----hcCC
Confidence 578999999996432 33445678899999999999999999987654 35799999996 4777666 3346
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-ccccccccccCCCChh
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPPE 156 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-~~~~~~~g~~~y~aPE 156 (303)
+++..++.++.|++.||++||+.+ ++||||||+||+++.++.++|+|||++......... .......|+..|+|||
T Consensus 103 l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE 179 (336)
T cd07849 103 LSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPE 179 (336)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChH
Confidence 899999999999999999999999 999999999999999999999999998765433211 1122346789999999
Q ss_pred hhcc-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCC-----------CcceeccccC-CCC--
Q 048243 157 YARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG-----------KGVEFVDSSL-DDT-- 221 (303)
Q Consensus 157 ~~~~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~-~~~-- 221 (303)
.+.+ ..++.++||||+|+++|+|++|..||........ ........... .......... ...
T Consensus 180 ~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (336)
T cd07849 180 IMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVP 256 (336)
T ss_pred HhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCccc
Confidence 8754 4688999999999999999999999854322110 00000000000 0000000000 000
Q ss_pred ---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccccC
Q 048243 222 ---NSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM--LKNETT 260 (303)
Q Consensus 222 ---~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~--L~~~~~ 260 (303)
..+..+..+.+++.+||+.||.+|||+.|+++. ++....
T Consensus 257 ~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 257 WNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 011224578899999999999999999999886 665554
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=248.46 Aligned_cols=241 Identities=27% Similarity=0.351 Sum_probs=178.6
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeC--CeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+|+.+|+|.+.... ......+.+|+.+++.++|+|++++++++... ...++|+||+++ +|..++... ...++
T Consensus 22 ~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--~~~~~ 98 (287)
T cd07840 22 KTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSP--EVKFT 98 (287)
T ss_pred CCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhcc--CCCCC
Confidence 468999999997653 33445688899999999999999999999988 789999999974 788777432 24689
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..++.++.|++.||++||+.+ ++|+||+|+||++++++.++|+|||.+........ .......++..|+|||.+.
T Consensus 99 ~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~ 174 (287)
T cd07840 99 ESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-ADYTNRVITLWYRPPELLL 174 (287)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-ccccccccccccCCceeeE
Confidence 9999999999999999999998 99999999999999999999999999876654321 1122345678899999776
Q ss_pred c-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcc---eecc--------------ccCCCC
Q 048243 160 Q-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV---EFVD--------------SSLDDT 221 (303)
Q Consensus 160 ~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~--------------~~~~~~ 221 (303)
+ ..++.++||||||+++|+|++|..||......... ............. .... ..+...
T Consensus 175 ~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T cd07840 175 GATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL---EKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREF 251 (287)
T ss_pred ccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCchhhccccccchhhhhccccccchhHHHHH
Confidence 5 45788999999999999999999998644322111 1111111100000 0000 000000
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 222 NSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 222 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
.....+..+.+++.+||..||.+||++.++++.
T Consensus 252 ~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 252 FKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000124578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=241.22 Aligned_cols=229 Identities=21% Similarity=0.265 Sum_probs=173.5
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCccccEEEEEEeC----CeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS----EERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
+|+.+|+|++.. ....++|+++--.. .|||||.++++|++. ..+.+|||+|+||.|...+.+ .....++
T Consensus 86 T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~-~g~~afT 159 (400)
T KOG0604|consen 86 TQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQD-RGDQAFT 159 (400)
T ss_pred chhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHH-cccccch
Confidence 455666666632 24567788776666 699999999998753 356789999999999999866 3456799
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCC---CceEEcccccccccccCCccccccccccccCCCChh
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED---MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE 156 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~---~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE 156 (303)
+.++-.++.||..|+.|||+.+ |.||||||+|+|.+.. -.+||+|||.++..... ........|+.|.|||
T Consensus 160 Erea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~---~~L~TPc~TPyYvaPe 233 (400)
T KOG0604|consen 160 EREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP---GDLMTPCFTPYYVAPE 233 (400)
T ss_pred HHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccccccCCC---ccccCCcccccccCHH
Confidence 9999999999999999999999 9999999999999754 45999999999875432 2223345699999999
Q ss_pred hhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 157 YARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
++....|+..+|+||+|+++|-|+.|.+||-.........-.. .....+ ..++ ....=...++...++|+.
T Consensus 234 vlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk---~rI~~g-qy~F-----P~pEWs~VSe~aKdlIR~ 304 (400)
T KOG0604|consen 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---RRIRTG-QYEF-----PEPEWSCVSEAAKDLIRK 304 (400)
T ss_pred HhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHH---hHhhcc-CccC-----CChhHhHHHHHHHHHHHH
Confidence 9999999999999999999999999999985433222111000 001100 0111 111113567788999999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 048243 237 CVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 237 ~l~~dp~~Rpt~~el~~~ 254 (303)
+|+.+|.+|.|++++++.
T Consensus 305 LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 305 LLKTEPTERLTIEEVMDH 322 (400)
T ss_pred HhcCCchhheeHHHhhcC
Confidence 999999999999999864
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=255.16 Aligned_cols=244 Identities=21% Similarity=0.292 Sum_probs=177.2
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEe----CCeeEEEEeecCCCChhhhhcCcccccc
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCID----SEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
++|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.. ....++||||+. ++|.+++. ....
T Consensus 28 ~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~ 103 (334)
T cd07855 28 RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIH---SDQP 103 (334)
T ss_pred CCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhc---cCCC
Confidence 578999999987542 2345677889999999999999999988763 346899999995 58888873 3455
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc--ccccccccccCCCCh
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE--ANTEQVVGTIGYIPP 155 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~--~~~~~~~g~~~y~aP 155 (303)
+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||.+......... .......|+..|+||
T Consensus 104 ~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~P 180 (334)
T cd07855 104 LTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180 (334)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccCh
Confidence 899999999999999999999998 999999999999999999999999998765433211 111234678899999
Q ss_pred hhhcc-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHH--------HHHHhCCCcceeccccC-CCC----
Q 048243 156 EYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA--------YELWKGGKGVEFVDSSL-DDT---- 221 (303)
Q Consensus 156 E~~~~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~-~~~---- 221 (303)
|.+.+ ..++.++||||||+++|+|++|..||............... ................. ...
T Consensus 181 E~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (334)
T cd07855 181 ELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWS 260 (334)
T ss_pred HHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHH
Confidence 98865 45789999999999999999999999654322111100000 00000000000000000 000
Q ss_pred -CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 222 -NSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 222 -~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
..+..+..+.+++.+||+.+|++|||+.+++..
T Consensus 261 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 261 KIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 012235678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=246.63 Aligned_cols=233 Identities=23% Similarity=0.351 Sum_probs=175.7
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCC-CCccccEEEEEEeCCeeEEEEeecCCCChhhhhcC--ccccccCC
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFD--PIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~l~ 79 (303)
.+|+.||+|.+.... ......+.+|+.++.++. |+||+++++++......+++|||+.. ++.++... ......++
T Consensus 27 ~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~ 105 (288)
T cd06616 27 PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIP 105 (288)
T ss_pred CCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCC
Confidence 468999999987543 334557889999999995 99999999999999999999999864 55443321 11235689
Q ss_pred HHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 80 WKKRVHIIEGITQGLLYLQEY-SRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~-~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
+..+..++.+++.||+|||+. + ++||||||+||+++.++.++|+|||++........ .....|+..|+|||.+
T Consensus 106 ~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~ 179 (288)
T cd06616 106 EEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERI 179 (288)
T ss_pred HHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCCc---cccccCccCccCHHHh
Confidence 999999999999999999974 7 99999999999999999999999999876543211 1223578899999998
Q ss_pred ccC---CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHH
Q 048243 159 RQG---VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235 (303)
Q Consensus 159 ~~~---~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
.+. .++.++||||+|+++|+|++|..||.... ............. . +.+........+..+.+|+.
T Consensus 180 ~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~l~~li~ 248 (288)
T cd06616 180 DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKGD-P-----PILSNSEEREFSPSFVNFIN 248 (288)
T ss_pred ccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCCC-C-----CcCCCcCCCccCHHHHHHHH
Confidence 776 68899999999999999999999986433 1111111111110 0 11111111234557889999
Q ss_pred HcccCCCCCCCCHHHHHHH
Q 048243 236 LCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 236 ~~l~~dp~~Rpt~~el~~~ 254 (303)
+||..||.+|||+.+++..
T Consensus 249 ~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 249 LCLIKDESKRPKYKELLEH 267 (288)
T ss_pred HHccCChhhCcCHHHHhcC
Confidence 9999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=248.34 Aligned_cols=227 Identities=28% Similarity=0.369 Sum_probs=176.4
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|.+.... ....+.+.+|+.+++.++|+|++++++++..+...++||||+.+ ++.+.+.. ....+++
T Consensus 48 ~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~--~~~~l~~ 124 (317)
T cd06635 48 RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEV--HKKPLQE 124 (317)
T ss_pred CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHH--hcCCCCH
Confidence 478899999986432 22345788899999999999999999999999999999999975 67666632 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc-
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR- 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~- 159 (303)
..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++..... .....|+..|+|||.+.
T Consensus 125 ~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~ 195 (317)
T cd06635 125 VEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILA 195 (317)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC------cccccCCccccChhhhhc
Confidence 999999999999999999999 99999999999999999999999998764332 12345788999999874
Q ss_pred --cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHc
Q 048243 160 --QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237 (303)
Q Consensus 160 --~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 237 (303)
...++.++||||||+++|+|++|..||....... .......... ........+..+.+++.+|
T Consensus 196 ~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~ 260 (317)
T cd06635 196 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNES---------PTLQSNEWSDYFRNFVDSC 260 (317)
T ss_pred CCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHHhccC---------CCCCCccccHHHHHHHHHH
Confidence 3457889999999999999999999985432111 1111111110 0111123345788999999
Q ss_pred ccCCCCCCCCHHHHHHHhcc
Q 048243 238 VQENPNDRPSMLQVSSMLKN 257 (303)
Q Consensus 238 l~~dp~~Rpt~~el~~~L~~ 257 (303)
|+.+|.+||++.++++.+--
T Consensus 261 l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 261 LQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred ccCCcccCcCHHHHHhChhh
Confidence 99999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=250.48 Aligned_cols=245 Identities=21% Similarity=0.304 Sum_probs=173.6
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCC--------eeEEEEeecCCCChhhhhcCcc
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE--------ERMLVYEYMPNKSLDCYLFDPI 73 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~~ 73 (303)
.+|+.||+|.+.... ......+.+|+.++++++||||+++++++.... ..++||||+. ++|.+++..
T Consensus 35 ~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-- 111 (310)
T cd07865 35 KTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSN-- 111 (310)
T ss_pred CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHh--
Confidence 478999999986442 222345678999999999999999999987653 4599999996 477777643
Q ss_pred ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc--ccccccccccC
Q 048243 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE--ANTEQVVGTIG 151 (303)
Q Consensus 74 ~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~--~~~~~~~g~~~ 151 (303)
....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+......... .......++..
T Consensus 112 ~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 188 (310)
T cd07865 112 KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188 (310)
T ss_pred cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCcc
Confidence 2346899999999999999999999998 999999999999999999999999998765433221 11223456788
Q ss_pred CCChhhhccC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHH-----hCCCcceeccc-cCCCC---
Q 048243 152 YIPPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELW-----KGGKGVEFVDS-SLDDT--- 221 (303)
Q Consensus 152 y~aPE~~~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~-~~~~~--- 221 (303)
|+|||.+.+. .++.++||||||+++|+|++|..||................... ........... .....
T Consensus 189 y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (310)
T cd07865 189 YRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKR 268 (310)
T ss_pred ccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccch
Confidence 9999988664 36889999999999999999999886443221111111110000 00000000000 00000
Q ss_pred ------CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 222 ------NSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 222 ------~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
.....+..+.++|.+||..||.+|||++|+++.
T Consensus 269 ~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 269 KVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000113456799999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=243.77 Aligned_cols=228 Identities=25% Similarity=0.321 Sum_probs=183.6
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc-ccccCCH
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-RRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~l~~ 80 (303)
.+|+.+|+|.+.... ......+.+|+.+++.++|+||+++++++......++|+||+++++|.+++.... ....+++
T Consensus 23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~ 102 (256)
T cd08530 23 SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPE 102 (256)
T ss_pred CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCH
Confidence 478899999987543 3344577889999999999999999999999999999999999999998885422 2356889
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.|++.||++||+.| ++|+||+|+||+++.++.++|+|||.+...... ......++..|+|||.+.+
T Consensus 103 ~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~ 175 (256)
T cd08530 103 QEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGTPHYMAPEVWKG 175 (256)
T ss_pred HHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC----CcccccCCccccCHHHHCC
Confidence 999999999999999999999 999999999999999999999999998765543 1222457889999999998
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|+||||+++|+|++|..||....... .......... .......+..+.+++.+||..
T Consensus 176 ~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~ 239 (256)
T cd08530 176 RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-------LRYKVQRGKY---------PPIPPIYSQDLQNFIRSMLQV 239 (256)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCC---------CCCchhhCHHHHHHHHHHcCC
Confidence 889999999999999999999999986443211 0111111111 111224456789999999999
Q ss_pred CCCCCCCHHHHHHH
Q 048243 241 NPNDRPSMLQVSSM 254 (303)
Q Consensus 241 dp~~Rpt~~el~~~ 254 (303)
+|.+||++.++++.
T Consensus 240 ~p~~Rp~~~~~l~~ 253 (256)
T cd08530 240 KPKLRPNCDKILAS 253 (256)
T ss_pred CcccCCCHHHHhcC
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=247.18 Aligned_cols=241 Identities=21% Similarity=0.265 Sum_probs=173.9
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCccccEEEEEEeC--CeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+++.||+|.++... ........+|+..+.++ +|+||+++++++.+. +..++||||+. +++.+++.. ....++
T Consensus 22 ~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~ 98 (282)
T cd07831 22 KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKG--RKRPLP 98 (282)
T ss_pred CCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHh--ccCCCC
Confidence 478899999987542 22223445788899988 599999999999987 88999999997 577777743 235689
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..++.++.|++.||+|||+.+ ++||||+|+||+++. +.++|+|||.+......... ....++..|+|||.+.
T Consensus 99 ~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~ 171 (282)
T cd07831 99 EKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY---TEYISTRWYRAPECLL 171 (282)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCCc---CCCCCCcccCChhHhh
Confidence 9999999999999999999999 999999999999999 99999999998765433211 2245788999999765
Q ss_pred c-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHH--------HHHHhCCCcceeccccCCC----CCCHHH
Q 048243 160 Q-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA--------YELWKGGKGVEFVDSSLDD----TNSPCK 226 (303)
Q Consensus 160 ~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~----~~~~~~ 226 (303)
. ..++.++|||||||++|+|++|..||...+..+........ ..............+.... ...+..
T Consensus 172 ~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (282)
T cd07831 172 TDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNA 251 (282)
T ss_pred cCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccc
Confidence 4 45688999999999999999999998654322111100000 0000000000000000000 001133
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 227 LMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 227 ~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
+..+.++|.+||..||++|||+.++++.
T Consensus 252 ~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 252 SAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 5689999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=252.52 Aligned_cols=226 Identities=24% Similarity=0.271 Sum_probs=184.8
Q ss_pred cCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 3 LPCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 3 ~~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
-.+|+.+|+|++.+++ .......++|-++|.+++.++||.+-..|+.+..+|+|+..|+||+|.-.|.+ ..+..++
T Consensus 207 raTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn-~g~~gF~ 285 (591)
T KOG0986|consen 207 RATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYN-HGNPGFD 285 (591)
T ss_pred ecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeec-cCCCCCc
Confidence 3578888999886553 23445678899999999999999999999999999999999999999888865 3456799
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..+..++.+|+.||++||..+ ||+||+||+|||+|+.|+++|+|+|+|..+... .....++||..|||||++.
T Consensus 286 e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g---~~~~~rvGT~GYMAPEvl~ 359 (591)
T KOG0986|consen 286 EQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG---KPIRGRVGTVGYMAPEVLQ 359 (591)
T ss_pred hHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC---CccccccCcccccCHHHHc
Confidence 9999999999999999999999 999999999999999999999999999876544 2233458999999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..|+...|.|||||++|+|+.|+.||...........+.+... . .....+...+++..++....|.
T Consensus 360 ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~--~-----------~~~ey~~kFS~eakslc~~LL~ 426 (591)
T KOG0986|consen 360 NEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL--E-----------DPEEYSDKFSEEAKSLCEGLLT 426 (591)
T ss_pred CCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh--c-----------chhhcccccCHHHHHHHHHHHc
Confidence 99999999999999999999999999976554443322221100 0 0111223455688899999999
Q ss_pred CCCCCCCCH
Q 048243 240 ENPNDRPSM 248 (303)
Q Consensus 240 ~dp~~Rpt~ 248 (303)
.||.+|.-.
T Consensus 427 Kdp~~RLGc 435 (591)
T KOG0986|consen 427 KDPEKRLGC 435 (591)
T ss_pred cCHHHhccC
Confidence 999999643
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=247.22 Aligned_cols=229 Identities=21% Similarity=0.327 Sum_probs=172.2
Q ss_pred CCCcEEEEEEecCCCc-ccHHHHHHHHHH-HhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc-ccccCCH
Q 048243 4 PCGKVIAVKKLSKTST-QGFEEFKNEVML-TAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-RRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~~-~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~l~~ 80 (303)
.+|+.||+|.++.... .....+..|+.. ++.++||||+++++++..+...+++|||++ ++|.+++.... ....+++
T Consensus 24 ~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~ 102 (283)
T cd06617 24 PTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPE 102 (283)
T ss_pred CCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCH
Confidence 4689999999975532 223455556665 555689999999999999999999999996 67877765422 2356899
Q ss_pred HHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 81 KKRVHIIEGITQGLLYLQEY-SRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~-~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
..++.++.|++.||+|||++ + ++||||||+||+++.++.++|+|||.+....... ......|+..|+|||.+.
T Consensus 103 ~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~ 176 (283)
T cd06617 103 DILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV---AKTIDAGCKPYMAPERIN 176 (283)
T ss_pred HHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccccc---ccccccCCccccChhhcC
Confidence 99999999999999999986 7 9999999999999999999999999987653221 112245788999999886
Q ss_pred c----CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHH
Q 048243 160 Q----GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235 (303)
Q Consensus 160 ~----~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
+ ..++.++|+||||+++|+|++|..||...... .......... ..... .....+..+.+++.
T Consensus 177 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~-~~~~~--------~~~~~~~~l~~li~ 242 (283)
T cd06617 177 PELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLKQVVEE-PSPQL--------PAEKFSPEFQDFVN 242 (283)
T ss_pred CcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHHHHHHHhc-CCCCC--------CccccCHHHHHHHH
Confidence 5 34688999999999999999999998532211 1111111111 00100 01123457889999
Q ss_pred HcccCCCCCCCCHHHHHH
Q 048243 236 LCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 236 ~~l~~dp~~Rpt~~el~~ 253 (303)
+||..+|.+||++.++++
T Consensus 243 ~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 243 KCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHccCChhhCcCHHHHhc
Confidence 999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=243.51 Aligned_cols=226 Identities=24% Similarity=0.264 Sum_probs=172.1
Q ss_pred CCCcEEEEEEecCCCc---ccHHHHHHHHH---HHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcccccc
Q 048243 4 PCGKVIAVKKLSKTST---QGFEEFKNEVM---LTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~~~~valK~~~~~~~---~~~~~~~~e~~---~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
.+|+.||+|.+..... .....+..|.. .++...||+|+++++.+......++||||+.+++|..++. ....
T Consensus 17 ~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~---~~~~ 93 (278)
T cd05606 17 DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGV 93 (278)
T ss_pred cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHH---hcCC
Confidence 4689999999865421 11122333433 3444579999999999999999999999999999998884 3456
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhh
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 157 (303)
+++..+..++.|++.|++|||+.+ ++||||+|+||+++.++.++|+|||++....... .....|+..|+|||.
T Consensus 94 l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~ 166 (278)
T cd05606 94 FSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEV 166 (278)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC----CcCcCCCcCCcCcHH
Confidence 899999999999999999999998 9999999999999999999999999986543221 223468999999999
Q ss_pred hccC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 158 ARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 158 ~~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
+.+. .++.++||||+|+++|+|++|..||............ ...... . ...+...+..+.+++.+
T Consensus 167 ~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~~------~----~~~~~~~s~~~~~li~~ 232 (278)
T cd05606 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLTM------A----VELPDSFSPELRSLLEG 232 (278)
T ss_pred hcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH----HHhhcc------C----CCCCCcCCHHHHHHHHH
Confidence 8754 5889999999999999999999998654322211110 111000 0 11111224578899999
Q ss_pred cccCCCCCCC-----CHHHHHH
Q 048243 237 CVQENPNDRP-----SMLQVSS 253 (303)
Q Consensus 237 ~l~~dp~~Rp-----t~~el~~ 253 (303)
||..+|.+|| ++.++++
T Consensus 233 ~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 233 LLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred HhhcCHHhccCCCCCCHHHHHh
Confidence 9999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=256.05 Aligned_cols=225 Identities=25% Similarity=0.336 Sum_probs=185.6
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+|..||||++.+.. ......+.+|+++|+.++||||++++.+......+|+||||+.+|.+.+|+. ..+.+.+.
T Consensus 79 ~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~---~~gr~~e~ 155 (596)
T KOG0586|consen 79 LTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLV---KHGRMKEK 155 (596)
T ss_pred CCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHH---hcccchhh
Confidence 468899999997653 3344568899999999999999999999999999999999999999999995 45557778
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
....++.|+..|++|||+++ |+|||||++|++++.+-.++|+|||++..+... ......+|++.|.|||++.+.
T Consensus 156 ~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~---~~lqt~cgsppyAaPEl~~g~ 229 (596)
T KOG0586|consen 156 EARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG---LMLQTFCGSPPYAAPELFNGK 229 (596)
T ss_pred hhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc---ccccccCCCCCccChHhhcCc
Confidence 99999999999999999999 999999999999999999999999999877633 334457899999999999998
Q ss_pred CC-CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 162 VY-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~-~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
.+ ++.+|+||+|+++|.|+.|..||.+.....-... ... .. ...+...+.++.++|+++|..
T Consensus 230 ~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r------vl~---------gk--~rIp~~ms~dce~lLrk~lvl 292 (596)
T KOG0586|consen 230 KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR------VLR---------GK--YRIPFYMSCDCEDLLRKFLVL 292 (596)
T ss_pred ccCCcceehhhhhhhheeeeecccccCCcccccccch------hee---------ee--ecccceeechhHHHHHHhhcc
Confidence 76 6799999999999999999999975543321110 000 00 011122334778999999999
Q ss_pred CCCCCCCHHHHHHH
Q 048243 241 NPNDRPSMLQVSSM 254 (303)
Q Consensus 241 dp~~Rpt~~el~~~ 254 (303)
+|.+|++..++.+.
T Consensus 293 ~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 293 NPSKRGPCDQIMKD 306 (596)
T ss_pred CccccCCHHHhhhh
Confidence 99999999999764
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=241.24 Aligned_cols=229 Identities=21% Similarity=0.285 Sum_probs=177.4
Q ss_pred CCCcEEEEEEecCC-----CcccHHHHHHHHHHHhcCCCCccccEEEEEEeC--CeeEEEEeecCCCChhhhhcCccccc
Q 048243 4 PCGKVIAVKKLSKT-----STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~~~~valK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~ 76 (303)
.+|+.||+|.+... .......+.+|+.++++++|+||+++++++.+. ...++++||+++++|.+++. ...
T Consensus 25 ~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~---~~~ 101 (264)
T cd06653 25 DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLK---AYG 101 (264)
T ss_pred CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHH---HcC
Confidence 57899999987532 122345788999999999999999999998764 46889999999999999884 334
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-ccccccccccCCCCh
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPP 155 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-~~~~~~~g~~~y~aP 155 (303)
.+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+......... .......++..|+||
T Consensus 102 ~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP 178 (264)
T cd06653 102 ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178 (264)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCH
Confidence 5889999999999999999999999 999999999999999999999999998765332111 111234578899999
Q ss_pred hhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHH
Q 048243 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
|.+.+..++.++|+||||+++|++++|..||...... .......... .....+...+..+.+++.
T Consensus 179 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~---------~~~~~p~~~~~~~~~~i~ 243 (264)
T cd06653 179 EVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------AAIFKIATQP---------TKPMLPDGVSDACRDFLK 243 (264)
T ss_pred hhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH------HHHHHHHcCC---------CCCCCCcccCHHHHHHHH
Confidence 9998888899999999999999999999998533211 1111111110 111223334567889999
Q ss_pred HcccCCCCCCCCHHHHHHH
Q 048243 236 LCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 236 ~~l~~dp~~Rpt~~el~~~ 254 (303)
+||. +|..||++.+++..
T Consensus 244 ~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 244 QIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHhc-CcccCccHHHHhcC
Confidence 9999 57999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=254.94 Aligned_cols=239 Identities=23% Similarity=0.304 Sum_probs=175.7
Q ss_pred CCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEeC-----CeeEEEEeecCCCChhhhhcCccccc
Q 048243 4 PCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-----EERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~ 76 (303)
.+|+.||+|.+... .......+.+|+.+++.++|+||+++++++... ...++|+||+. ++|.+++. ...
T Consensus 28 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~ 103 (337)
T cd07858 28 ETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIR---SSQ 103 (337)
T ss_pred CCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHh---cCC
Confidence 57899999998653 233445677899999999999999999987654 34799999996 67887774 345
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChh
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE 156 (303)
.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||
T Consensus 104 ~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE 178 (337)
T cd07858 104 TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPE 178 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccCCCc--ccccccccccCccChH
Confidence 6899999999999999999999998 9999999999999999999999999987654332 1122345788999999
Q ss_pred hhcc-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhC-----------CCcceeccc---cCC--
Q 048243 157 YARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKG-----------GKGVEFVDS---SLD-- 219 (303)
Q Consensus 157 ~~~~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~---~~~-- 219 (303)
.+.+ ..++.++||||||+++|+|++|..||.......... ........ ......... ...
T Consensus 179 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (337)
T cd07858 179 LLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLK---LITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQS 255 (337)
T ss_pred HHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHH---HHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccC
Confidence 8765 458899999999999999999999986432211111 00000000 000000000 000
Q ss_pred -CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 220 -DTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 220 -~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
....+..+..+.+++.+||+.||++|||+.++++.
T Consensus 256 ~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 256 FARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00011234578899999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=253.96 Aligned_cols=243 Identities=27% Similarity=0.335 Sum_probs=175.6
Q ss_pred CCCcEEEEEEecCC--CcccHHHHHHHHHHHhcC-CCCccccEEEEEEeC--CeeEEEEeecCCCChhhhhcCccccccC
Q 048243 4 PCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 4 ~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
.+|+.+|+|++... .......+.+|+.+++++ +|+||+++++++... ...++||||+. ++|..++.. ..+
T Consensus 30 ~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~ 104 (337)
T cd07852 30 RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRA----NIL 104 (337)
T ss_pred CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhc----CCC
Confidence 46889999988543 233445677899999999 999999999998643 46899999997 588888733 267
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc---ccccccccccCCCCh
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE---ANTEQVVGTIGYIPP 155 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~---~~~~~~~g~~~y~aP 155 (303)
++..++.++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||.+......... .......|+..|+||
T Consensus 105 ~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 181 (337)
T cd07852 105 EDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181 (337)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCc
Confidence 88999999999999999999998 999999999999999999999999998765443221 222334678899999
Q ss_pred hhhcc-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHH--------HHHhCCCcceeccccC------CC
Q 048243 156 EYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY--------ELWKGGKGVEFVDSSL------DD 220 (303)
Q Consensus 156 E~~~~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~------~~ 220 (303)
|.+.+ ..++.++||||||+++|+|++|..||................ ..+............. ..
T Consensus 182 E~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (337)
T cd07852 182 EILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLD 261 (337)
T ss_pred eeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchh
Confidence 98765 457889999999999999999999986433221111000000 0000000000000000 00
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 221 TNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 221 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
...+..+..+.+++.+||+.||++|||+.++++.
T Consensus 262 ~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 262 ELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0011134578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=261.41 Aligned_cols=228 Identities=29% Similarity=0.401 Sum_probs=188.1
Q ss_pred CCcE--EEEEEecCCCcc-cHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 5 CGKV--IAVKKLSKTSTQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 5 ~~~~--valK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
+|+. ||||.++..... ....|.+|+.+|.+|+|+|++++||+..+ +...||||++++|+|.+.|.+ -....+-..
T Consensus 135 sgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrk-a~~~~llv~ 212 (1039)
T KOG0199|consen 135 SGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRK-AKKAILLVS 212 (1039)
T ss_pred CCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhh-ccccceeHH
Confidence 4443 899999876544 67899999999999999999999999987 678899999999999999976 345567788
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCc-cccccccccccCCCChhhhcc
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL-EANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..-.++.||+.|++||..++ +|||||-..|+++.....|||+|||+.+-++.... +.......-...|+|||.+..
T Consensus 213 ~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh 289 (1039)
T KOG0199|consen 213 RLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRH 289 (1039)
T ss_pred HHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcc
Confidence 88999999999999999999 99999999999999999999999999988765533 333333445778999999999
Q ss_pred CCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 161 GVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
..++.++|||++|+++|||++ |..||.+......+..+ +..-....+...++.++++++.||.
T Consensus 290 ~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~i----------------D~~erLpRPk~csedIY~imk~cWa 353 (1039)
T KOG0199|consen 290 RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNI----------------DAGERLPRPKYCSEDIYQIMKNCWA 353 (1039)
T ss_pred ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhc----------------cccccCCCCCCChHHHHHHHHHhcc
Confidence 999999999999999999998 77888766543322211 1122223344556789999999999
Q ss_pred CCCCCCCCHHHHHH
Q 048243 240 ENPNDRPSMLQVSS 253 (303)
Q Consensus 240 ~dp~~Rpt~~el~~ 253 (303)
.+|.+|||+..|.+
T Consensus 354 h~paDRptFsair~ 367 (1039)
T KOG0199|consen 354 HNPADRPTFSAIRE 367 (1039)
T ss_pred CCccccccHHHHHH
Confidence 99999999999974
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=246.37 Aligned_cols=224 Identities=29% Similarity=0.382 Sum_probs=174.2
Q ss_pred CCCcEEEEEEecCC---CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+++.+|+|.+... .......+.+|+.+++.++|+|++++++++......++||||+. +++.+++.. ....+++
T Consensus 38 ~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~l~~ 114 (308)
T cd06634 38 RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV--HKKPLQE 114 (308)
T ss_pred CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHH--cCCCCCH
Confidence 46889999998643 22334567889999999999999999999999999999999996 577766632 2445889
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc-
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR- 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~- 159 (303)
..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++...... ....++..|+|||.+.
T Consensus 115 ~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~ 185 (308)
T cd06634 115 VEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILA 185 (308)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc------ccccCCccccCHHHHhh
Confidence 999999999999999999998 999999999999999999999999988654322 2245788999999875
Q ss_pred --cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHc
Q 048243 160 --QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237 (303)
Q Consensus 160 --~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 237 (303)
...++.++||||||+++|+|++|..||....... ........ .. ........+..+.++|.+|
T Consensus 186 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~-~~--------~~~~~~~~~~~~~~li~~c 250 (308)
T cd06634 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQN-ES--------PALQSGHWSEYFRNFVDSC 250 (308)
T ss_pred cccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH------HHHHHhhc-CC--------CCcCcccccHHHHHHHHHH
Confidence 3457889999999999999999999975332111 11111111 00 1111223445788999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 048243 238 VQENPNDRPSMLQVSSM 254 (303)
Q Consensus 238 l~~dp~~Rpt~~el~~~ 254 (303)
|..+|.+||++.+++..
T Consensus 251 l~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 251 LQKIPQDRPTSEVLLKH 267 (308)
T ss_pred hhCCcccCCCHHHHhhC
Confidence 99999999999999876
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=259.40 Aligned_cols=238 Identities=29% Similarity=0.349 Sum_probs=184.3
Q ss_pred cCCCcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCC------eeEEEEeecCCCChhhhhcCcccc
Q 048243 3 LPCGKVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE------ERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 3 ~~~~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~ 75 (303)
-++|+.||||.++.. .....+...+|+++|++++|+|||+++++-+... ...+|||||.||+|...+..+...
T Consensus 35 ketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~ 114 (732)
T KOG4250|consen 35 KETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENA 114 (732)
T ss_pred cccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccc
Confidence 468999999999764 3556678899999999999999999999966543 568999999999999999998888
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC--CC--ceEEcccccccccccCCccccccccccccC
Q 048243 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE--DM--KPKISDFGLARIFAKESLEANTEQVVGTIG 151 (303)
Q Consensus 76 ~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~--~~--~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~ 151 (303)
..+++.+++.++.++..||.|||++| |+||||||.||++-. +| ..||+|||+|+....+. .....+||..
T Consensus 115 ~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s---~~~S~vGT~~ 188 (732)
T KOG4250|consen 115 YGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS---LFTSLVGTEE 188 (732)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC---eeeeecCchh
Confidence 89999999999999999999999999 999999999999853 23 37999999999877654 4455789999
Q ss_pred CCChhhhc-cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCcc-ccHHHHHHHHHhCCCcc-ee--------ccccC--
Q 048243 152 YIPPEYAR-QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINEN-LSILEHAYELWKGGKGV-EF--------VDSSL-- 218 (303)
Q Consensus 152 y~aPE~~~-~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~--------~~~~~-- 218 (303)
|.+||++. +..|+..+|.|||||++|+++||..||........ ..........-..+... .. ....+
T Consensus 189 YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~ 268 (732)
T KOG4250|consen 189 YLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQ 268 (732)
T ss_pred hcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCC
Confidence 99999999 47889999999999999999999999976654422 11111111110110000 00 00011
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 048243 219 DDTNSPCKLMRCLEIALLCVQENPNDRP 246 (303)
Q Consensus 219 ~~~~~~~~~~~l~~li~~~l~~dp~~Rp 246 (303)
.....+.....+-..+..+|..||++|-
T Consensus 269 p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 269 PNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred cccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1222344455667788889999999998
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=241.18 Aligned_cols=220 Identities=21% Similarity=0.253 Sum_probs=169.3
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.+|+|.+........ |+.....+ +|+||+++++.+...+..++||||+++++|.+++.. ...+++..
T Consensus 39 ~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~---~~~l~~~~ 110 (267)
T PHA03390 39 PTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK---EGKLSEAE 110 (267)
T ss_pred CCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHh---cCCCCHHH
Confidence 5688899999865432211 22222223 799999999999999999999999999999999843 34789999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCC-ceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM-KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~-~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
+..++.|++.||+|||+.+ ++||||+|+||+++.++ .++|+|||.+....... ...++..|+|||.+.+.
T Consensus 111 ~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~ 181 (267)
T PHA03390 111 VKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS------CYDGTLDYFSPEKIKGH 181 (267)
T ss_pred HHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc------cCCCCCcccChhhhcCC
Confidence 9999999999999999999 99999999999999998 99999999987654321 23578899999999988
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
.++.++||||+|+++|+|++|..||....... ....... .... . ........+..+.++|.+||+.|
T Consensus 182 ~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~-~~~~--~---------~~~~~~~~~~~~~~li~~~l~~~ 248 (267)
T PHA03390 182 NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLL-KRQQ--K---------KLPFIKNVSKNANDFVQSMLKYN 248 (267)
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHH-Hhhc--c---------cCCcccccCHHHHHHHHHHhccC
Confidence 89999999999999999999999997332221 1111100 0000 0 00111234557899999999999
Q ss_pred CCCCCC-HHHHHH
Q 048243 242 PNDRPS-MLQVSS 253 (303)
Q Consensus 242 p~~Rpt-~~el~~ 253 (303)
|.+||+ ++++++
T Consensus 249 p~~R~~~~~~~l~ 261 (267)
T PHA03390 249 INYRLTNYNEIIK 261 (267)
T ss_pred hhhCCchHHHHhc
Confidence 999996 588874
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=255.62 Aligned_cols=249 Identities=24% Similarity=0.285 Sum_probs=183.8
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCC-----eeEEEEeecCCCChhhhhcCccccc
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE-----ERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~ 76 (303)
.+|+.||+|++.... ....+.+.+|+..++.++|+||+++++++.... ..|++|+|+. ++|.+++. .+.
T Consensus 23 ~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~---~~~ 98 (330)
T cd07834 23 RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIK---SPQ 98 (330)
T ss_pred CCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHh---CCC
Confidence 458999999997653 344567889999999999999999999988765 7899999997 47888774 334
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-ccccccccccCCCCh
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPP 155 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-~~~~~~~g~~~y~aP 155 (303)
.+++..++.++.|++.||++||+.| ++||||||+||+++.++.++|+|||.+......... .......++..|+||
T Consensus 99 ~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP 175 (330)
T cd07834 99 PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAP 175 (330)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCc
Confidence 7899999999999999999999999 999999999999999999999999999876544211 122334678899999
Q ss_pred hhhccC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHH--------HhCCCcceeccccCC------C
Q 048243 156 EYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL--------WKGGKGVEFVDSSLD------D 220 (303)
Q Consensus 156 E~~~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~------~ 220 (303)
|.+.+. .++.++|+||||+++|+|++|..||.................. ............... .
T Consensus 176 E~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (330)
T cd07834 176 ELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLS 255 (330)
T ss_pred eeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhH
Confidence 999887 7899999999999999999999998654422111111000000 000000000000000 0
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hcccc
Q 048243 221 TNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM--LKNET 259 (303)
Q Consensus 221 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~--L~~~~ 259 (303)
...+..+..+.+++.+||+.+|.+|||+.+++.. +++..
T Consensus 256 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 256 KLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred HhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 0011234578899999999999999999999874 55443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=241.23 Aligned_cols=209 Identities=17% Similarity=0.149 Sum_probs=164.7
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+|+.||+|.+.... ....|...+....||||+++++++......+++|||+++++|.+++.. ...+++..+
T Consensus 16 ~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~ 87 (237)
T cd05576 16 RTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK---FLNIPEECV 87 (237)
T ss_pred cCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH---hcCCCHHHH
Confidence 578999999996543 223445555556799999999999999999999999999999998843 345899999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
..++.|++.||+|||+.+ ++||||||+||+++.++.++++|||.+....... ....++..|+|||.+....+
T Consensus 88 ~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~ 159 (237)
T cd05576 88 KRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYCAPEVGGISEE 159 (237)
T ss_pred HHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccccCCcccCCCCC
Confidence 999999999999999998 9999999999999999999999999876554321 11234677999999988888
Q ss_pred CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCC
Q 048243 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 243 (303)
+.++|+||+|+++|+|++|..|+....... ... .....+...+..+.+++.+||+.||+
T Consensus 160 ~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~---------~~~~~~~~~~~~~~~li~~~l~~dp~ 218 (237)
T cd05576 160 TEACDWWSLGAILFELLTGKTLVECHPSGI------------NTH---------TTLNIPEWVSEEARSLLQQLLQFNPT 218 (237)
T ss_pred CchhhHHHHHHHHHHHHHCcchhhcCchhc------------ccc---------cccCCcccCCHHHHHHHHHHccCCHH
Confidence 999999999999999999998764221100 000 00011122345788999999999999
Q ss_pred CCCCHH
Q 048243 244 DRPSML 249 (303)
Q Consensus 244 ~Rpt~~ 249 (303)
+||++.
T Consensus 219 ~R~~~~ 224 (237)
T cd05576 219 ERLGAG 224 (237)
T ss_pred HhcCCC
Confidence 999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=255.12 Aligned_cols=243 Identities=23% Similarity=0.288 Sum_probs=173.4
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeC--------------CeeEEEEeecCCCChhhhh
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--------------EERMLVYEYMPNKSLDCYL 69 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------------~~~~lv~e~~~~~~L~~~l 69 (303)
.+|+.||+|++........+.+.+|+++++.++||||+++++++... ...++||||+. ++|.+++
T Consensus 28 ~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~ 106 (342)
T cd07854 28 DCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVL 106 (342)
T ss_pred CCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHH
Confidence 57899999999776666667889999999999999999999876654 35789999997 5887776
Q ss_pred cCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC-CCceEEcccccccccccCCcc-ccccccc
Q 048243 70 FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-DMKPKISDFGLARIFAKESLE-ANTEQVV 147 (303)
Q Consensus 70 ~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-~~~v~l~Df~~~~~~~~~~~~-~~~~~~~ 147 (303)
. ...+++..++.++.||+.||.|||+.| ++||||||+||+++. ++.++|+|||.+......... .......
T Consensus 107 ~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 179 (342)
T cd07854 107 E----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGL 179 (342)
T ss_pred H----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCcccceecCCcccccccccccc
Confidence 3 345889999999999999999999999 999999999999974 557899999998764322111 1112235
Q ss_pred cccCCCChhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHH--------HHHHhCCCcceeccccC
Q 048243 148 GTIGYIPPEYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA--------YELWKGGKGVEFVDSSL 218 (303)
Q Consensus 148 g~~~y~aPE~~~~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~ 218 (303)
++..|+|||.+.+ ..++.++|||||||++|+|++|..||............... .................
T Consensus 180 ~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (342)
T cd07854 180 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGG 259 (342)
T ss_pred ccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhccc
Confidence 6889999998654 45788999999999999999999999644321111000000 00000000000000000
Q ss_pred CCCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 219 DDTN-----SPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 219 ~~~~-----~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
.... .+..+.++.+++.+||..||.+|||+.|++..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 260 EPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred ccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000 11233578899999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=247.53 Aligned_cols=241 Identities=23% Similarity=0.290 Sum_probs=174.9
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCC----------eeEEEEeecCCCChhhhhcC
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE----------ERMLVYEYMPNKSLDCYLFD 71 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----------~~~lv~e~~~~~~L~~~l~~ 71 (303)
.+|+.||+|.++... ......+.+|+++++.++||||+++++++.... ..++|+||+++ ++..++..
T Consensus 30 ~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~ 108 (302)
T cd07864 30 DTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLES 108 (302)
T ss_pred CCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhc
Confidence 468899999997543 233456788999999999999999999987654 78999999976 66666643
Q ss_pred ccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccC
Q 048243 72 PIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIG 151 (303)
Q Consensus 72 ~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~ 151 (303)
....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+........ .......++..
T Consensus 109 --~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~ 182 (302)
T cd07864 109 --GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES-RPYTNKVITLW 182 (302)
T ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcccccccccCCcc-cccccceeccC
Confidence 2346899999999999999999999998 99999999999999999999999999876543321 11122345778
Q ss_pred CCChhhhccC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCc---ceecc--------ccCC
Q 048243 152 YIPPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG---VEFVD--------SSLD 219 (303)
Q Consensus 152 y~aPE~~~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~--------~~~~ 219 (303)
|+|||.+.+. .++.++|||||||++|+|++|.+||........ ............. ..+.. ....
T Consensus 183 y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (302)
T cd07864 183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ---LELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQ 259 (302)
T ss_pred ccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhhcccccccccccccccccc
Confidence 9999987654 478899999999999999999999864332211 1111111111000 00000 0000
Q ss_pred -----CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 220 -----DTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 220 -----~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
.......+..+.+++.+||+.||.+|||+.++++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 260 YRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred cccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00001124578899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=246.66 Aligned_cols=241 Identities=21% Similarity=0.262 Sum_probs=174.0
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+|+.||+|++.... ....+.+.+|+.+++.++|+||+++++++......++||||++ ++|.+++... ....+++.
T Consensus 25 ~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~ 102 (294)
T PLN00009 25 VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSS-PDFAKNPR 102 (294)
T ss_pred CCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhC-CCCCcCHH
Confidence 478899999986543 2234568889999999999999999999999999999999996 5777776431 23346788
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC-CCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
.++.++.||+.||+|||+++ ++|+||+|+||+++. ++.++|+|||++........ ......++..|+|||.+.+
T Consensus 103 ~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~ 177 (294)
T PLN00009 103 LIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR--TFTHEVVTLWYRAPEILLG 177 (294)
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCcc--ccccCceeecccCHHHHhC
Confidence 88999999999999999998 999999999999985 55799999999875543211 1122356789999998866
Q ss_pred C-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCC--------cc-eec--cccCCCC----CCH
Q 048243 161 G-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK--------GV-EFV--DSSLDDT----NSP 224 (303)
Q Consensus 161 ~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~~-~~~--~~~~~~~----~~~ 224 (303)
. .++.++||||+|+++|+|++|..||....... ............. .. ... .+..... ..+
T Consensus 178 ~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (294)
T PLN00009 178 SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID---ELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVP 254 (294)
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCc
Confidence 4 57889999999999999999999986432211 1111111100000 00 000 0000000 012
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 225 CKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 225 ~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
..+..+.+++.+||+.+|++||++.++++.
T Consensus 255 ~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 255 TLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred CCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 234568899999999999999999999863
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=245.48 Aligned_cols=224 Identities=29% Similarity=0.380 Sum_probs=173.7
Q ss_pred CCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTST---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.|++|.+..... .....+.+|+++++.++|||++++++++.+....++||||+. +++.+++.. ....+++
T Consensus 44 ~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~l~~ 120 (313)
T cd06633 44 HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEV--HKKPLQE 120 (313)
T ss_pred CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHh--cCCCCCH
Confidence 4688999999864422 234568889999999999999999999999999999999996 567666632 3456889
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc-
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR- 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~- 159 (303)
..++.++.|++.+++|||+.| ++|+||+|+||+++.++.++|+|||.+.... ......|+..|+|||.+.
T Consensus 121 ~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~------~~~~~~~~~~y~aPE~~~~ 191 (313)
T cd06633 121 VEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS------PANSFVGTPYWMAPEVILA 191 (313)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC------CCCCccccccccChhhccc
Confidence 999999999999999999999 9999999999999999999999999875422 122346788999999974
Q ss_pred --cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHc
Q 048243 160 --QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237 (303)
Q Consensus 160 --~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 237 (303)
...++.++||||||+++|+|++|..||......... ...... ... .......+..+.+++.+|
T Consensus 192 ~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~~-~~~--------~~~~~~~~~~l~~li~~~ 256 (313)
T cd06633 192 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQN-DSP--------TLQSNEWTDSFRGFVDYC 256 (313)
T ss_pred cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHhc-CCC--------CCCccccCHHHHHHHHHH
Confidence 345788999999999999999999998543221111 111111 000 011112234688999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 048243 238 VQENPNDRPSMLQVSSM 254 (303)
Q Consensus 238 l~~dp~~Rpt~~el~~~ 254 (303)
|+.+|.+||++.+++..
T Consensus 257 l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 257 LQKIPQERPASAELLRH 273 (313)
T ss_pred ccCChhhCcCHHHHhcC
Confidence 99999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=250.15 Aligned_cols=241 Identities=22% Similarity=0.296 Sum_probs=177.1
Q ss_pred CCCcEEEEEEecCCCccc--------------HHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhh
Q 048243 4 PCGKVIAVKKLSKTSTQG--------------FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYL 69 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 69 (303)
.+|+.||+|+++...... ...+.+|+.+++.++|+||+++++++......++||||+. ++|.+++
T Consensus 32 ~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l 110 (335)
T PTZ00024 32 LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVV 110 (335)
T ss_pred CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHH
Confidence 478999999986543211 1247789999999999999999999999999999999997 5888887
Q ss_pred cCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCc----------
Q 048243 70 FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL---------- 139 (303)
Q Consensus 70 ~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~---------- 139 (303)
. ....+++.....++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||.+........
T Consensus 111 ~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 184 (335)
T PTZ00024 111 D---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184 (335)
T ss_pred H---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCccceeecccccccccccccccc
Confidence 4 3456889999999999999999999999 99999999999999999999999999876652211
Q ss_pred --cccccccccccCCCChhhhccC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceec--
Q 048243 140 --EANTEQVVGTIGYIPPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV-- 214 (303)
Q Consensus 140 --~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 214 (303)
........++..|+|||.+.+. .++.++|+||||+++|+|++|..||....... ................+.
T Consensus 185 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~---~~~~i~~~~~~~~~~~~~~~ 261 (335)
T PTZ00024 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID---QLGRIFELLGTPNEDNWPQA 261 (335)
T ss_pred cccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCchhhCcch
Confidence 0111123457789999988764 46889999999999999999999986443221 111111111111000000
Q ss_pred ------c---ccCCC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 215 ------D---SSLDD---TNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 215 ------~---~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
. ..... ......+..+.+++.+||+.+|++|||++|++..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 262 KKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred hhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 0 00000 0001224568899999999999999999999863
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=247.11 Aligned_cols=227 Identities=28% Similarity=0.350 Sum_probs=181.3
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCC-CCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+|+.||+|++.... ....+.+..|+.++.+++ |+||+++++++..+...++|||++.+++|.+++.. ...++
T Consensus 24 ~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~l~ 100 (280)
T cd05581 24 ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK---YGSLD 100 (280)
T ss_pred CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHH---cCCCC
Confidence 478999999986532 233467888999999998 99999999999999999999999999999998843 34699
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc------------------c
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE------------------A 141 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~------------------~ 141 (303)
+..++.++.|++.||++||+.| ++|+||+|+||+++.++.++|+|||++......... .
T Consensus 101 ~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (280)
T cd05581 101 EKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177 (280)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCcccccccccccc
Confidence 9999999999999999999999 999999999999999999999999998765443221 2
Q ss_pred cccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCC
Q 048243 142 NTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDT 221 (303)
Q Consensus 142 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (303)
......++..|+|||...+..++.++|+||||++++++++|..||....... ... ..... ...
T Consensus 178 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~---~~~~~-----------~~~ 240 (280)
T cd05581 178 RFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---TFQ---KILKL-----------EYS 240 (280)
T ss_pred ccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH---HHH---HHHhc-----------CCC
Confidence 2233457889999999988888999999999999999999999986543111 111 11110 011
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 048243 222 NSPCKLMRCLEIALLCVQENPNDRPSM----LQVSS 253 (303)
Q Consensus 222 ~~~~~~~~l~~li~~~l~~dp~~Rpt~----~el~~ 253 (303)
.+...+..+.+++.+||..||.+|||+ ++++.
T Consensus 241 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 241 FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111224578899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=241.90 Aligned_cols=231 Identities=22% Similarity=0.291 Sum_probs=177.1
Q ss_pred CCCcEEEEEEecCCC----cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccC
Q 048243 4 PCGKVIAVKKLSKTS----TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 4 ~~~~~valK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
++|+.||+|.++... ....+.+.+|+.++..+ +|+||+++++.+..+...++||||+++++|.+++. ....+
T Consensus 26 ~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~l 102 (290)
T cd05613 26 DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLS---QRERF 102 (290)
T ss_pred CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHH---HcCCC
Confidence 578999999997542 22346678899999999 69999999999999999999999999999999984 34568
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++........ .......|+..|+|||.+
T Consensus 103 ~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~ 178 (290)
T cd05613 103 KEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV-ERAYSFCGTIEYMAPDIV 178 (290)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceecccccc-cccccccCCcccCChhhc
Confidence 89999999999999999999998 99999999999999999999999999876543221 112234578899999998
Q ss_pred ccC--CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 159 RQG--VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 159 ~~~--~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
.+. .++.++||||||+++|+|++|..||...+...... ........... ..+...+..+.+++.+
T Consensus 179 ~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~--~~~~~~~~~~~-----------~~~~~~~~~~~~ll~~ 245 (290)
T cd05613 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQA--EISRRILKSEP-----------PYPQEMSALAKDIIQR 245 (290)
T ss_pred cCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHH--HHHHHhhccCC-----------CCCccCCHHHHHHHHH
Confidence 753 46789999999999999999999986432221111 11111111100 0111233477899999
Q ss_pred cccCCCCCCC-----CHHHHHHH
Q 048243 237 CVQENPNDRP-----SMLQVSSM 254 (303)
Q Consensus 237 ~l~~dp~~Rp-----t~~el~~~ 254 (303)
||..||.+|| ++.+++..
T Consensus 246 ~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 246 LLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HhcCCHHHhcCCCCCCHHHHHcC
Confidence 9999999997 66777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=239.80 Aligned_cols=222 Identities=27% Similarity=0.321 Sum_probs=177.7
Q ss_pred CCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTST---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.+|+|.+..... .....+..|+.+++.++|+||+++++.+..+...+++||++.+++|.+++.. ...+++
T Consensus 16 ~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~---~~~l~~ 92 (250)
T cd05123 16 DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSK---EGRFSE 92 (250)
T ss_pred CCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHh---cCCCCH
Confidence 3589999999876532 2456788999999999999999999999999999999999999999999843 346899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||...+
T Consensus 93 ~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~ 167 (250)
T cd05123 93 ERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPEYLAPEVLLG 167 (250)
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCccccChHHhCC
Confidence 999999999999999999998 9999999999999999999999999987654332 11233457889999999988
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|+||||+++|++++|..||..... ..... .... . . ...+...+..+.+++.+||..
T Consensus 168 ~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~---~~~~-~------~----~~~~~~~~~~l~~~i~~~l~~ 230 (250)
T cd05123 168 KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYE---KILK-D------P----LRFPEFLSPEARDLISGLLQK 230 (250)
T ss_pred CCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHH---HHhc-C------C----CCCCCCCCHHHHHHHHHHhcC
Confidence 8889999999999999999999999854322 11111 1111 0 0 011111245788999999999
Q ss_pred CCCCCCCHHH
Q 048243 241 NPNDRPSMLQ 250 (303)
Q Consensus 241 dp~~Rpt~~e 250 (303)
||++||++.+
T Consensus 231 ~p~~R~~~~~ 240 (250)
T cd05123 231 DPTKRLGSGG 240 (250)
T ss_pred CHhhCCCccc
Confidence 9999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=243.93 Aligned_cols=242 Identities=27% Similarity=0.319 Sum_probs=179.1
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+++.||+|.+.... ....+.+..|+.+++.++|+||+++++++......++|+||+. ++|.+++... ...+++.
T Consensus 22 ~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~--~~~~~~~ 98 (282)
T cd07829 22 KTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKR--PGPLSPN 98 (282)
T ss_pred CCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhh--ccCCCHH
Confidence 468999999997653 3344677889999999999999999999999999999999997 5898888542 2468999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
.++.++.|++.||++||+.+ ++||||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+.
T Consensus 99 ~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~ 173 (282)
T cd07829 99 LIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TYTHEVVTLWYRAPEILLGS 173 (282)
T ss_pred HHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc--ccCccccCcCcCChHHhcCC
Confidence 99999999999999999998 99999999999999999999999999876543321 11123456789999998776
Q ss_pred -CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHH-----HHHHhCCCcceecc---ccC----CCCCCHHHHH
Q 048243 162 -VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA-----YELWKGGKGVEFVD---SSL----DDTNSPCKLM 228 (303)
Q Consensus 162 -~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~---~~~----~~~~~~~~~~ 228 (303)
.++.++||||||+++|++++|..||............... ...|.......... +.. .....+..+.
T Consensus 174 ~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (282)
T cd07829 174 KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDP 253 (282)
T ss_pred cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccH
Confidence 7889999999999999999999888543321111110000 00000000000000 000 0011112255
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 229 RCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 229 ~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
.+.+++.+||..||++||++.+++.
T Consensus 254 ~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 254 EGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHHHHHHHhhccCcccCCCHHHHhh
Confidence 7899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=241.29 Aligned_cols=238 Identities=26% Similarity=0.351 Sum_probs=175.0
Q ss_pred CCcEEEEEEecCCCc--ccHHHHHHHHHHHhcC---CCCccccEEEEEEeCCe-----eEEEEeecCCCChhhhhcCccc
Q 048243 5 CGKVIAVKKLSKTST--QGFEEFKNEVMLTAKL---QHVNLIRVLGFCIDSEE-----RMLVYEYMPNKSLDCYLFDPIR 74 (303)
Q Consensus 5 ~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~ 74 (303)
+|+.||+|+++.... .....+.+|+.+++++ +|+||+++++++..... .+++||++.+ +|.+++... .
T Consensus 23 ~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~-~ 100 (287)
T cd07838 23 TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKC-P 100 (287)
T ss_pred CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHc-c
Confidence 589999999975432 2234566777777666 69999999999988766 8999999974 788877432 2
Q ss_pred cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCC
Q 048243 75 RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIP 154 (303)
Q Consensus 75 ~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~a 154 (303)
...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+........ .....++..|+|
T Consensus 101 ~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~ 174 (287)
T cd07838 101 KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---LTSVVVTLWYRA 174 (287)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceeccCCcc---cccccccccccC
Confidence 235899999999999999999999998 99999999999999999999999999876543321 122346888999
Q ss_pred hhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcce----------eccccCC---CC
Q 048243 155 PEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVE----------FVDSSLD---DT 221 (303)
Q Consensus 155 PE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~---~~ 221 (303)
||.+.+..++.++|+|||||++|+|++|..||........ ............... ....... ..
T Consensus 175 PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T cd07838 175 PEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ---LDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKS 251 (287)
T ss_pred hHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH---HHHHHHHcCCCChHhcCCCcccchhhcccccccchhh
Confidence 9999988899999999999999999999988864332221 111111110000000 0000000 11
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 222 NSPCKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 222 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
..+.....+.+++.+||..||.+||++.+++.
T Consensus 252 ~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 252 FVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 11234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=250.67 Aligned_cols=242 Identities=23% Similarity=0.258 Sum_probs=171.4
Q ss_pred CcEEEEEEecCCC--cccHHHHHHHHHHHhcC-CCCccccEEEEEEeC----CeeEEEEeecCCCChhhhhcCccccccC
Q 048243 6 GKVIAVKKLSKTS--TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS----EERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 6 ~~~valK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
++.||+|.+.... ....+.+.+|+.+++++ +||||+++++.+... ...+++++++. ++|.+++. ....+
T Consensus 27 ~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~---~~~~~ 102 (332)
T cd07857 27 EETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIR---SGQPL 102 (332)
T ss_pred CceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHh---cCCCC
Confidence 7899999986432 22345678899999999 599999999875432 45788999885 68888773 34568
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc--ccccccccccCCCChh
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE--ANTEQVVGTIGYIPPE 156 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~--~~~~~~~g~~~y~aPE 156 (303)
++..++.++.||+.||+|||+.| ++||||||+||+++.++.++|+|||.+......... .......|+..|+|||
T Consensus 103 ~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE 179 (332)
T cd07857 103 TDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179 (332)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcH
Confidence 99999999999999999999999 999999999999999999999999998765432211 1122346889999999
Q ss_pred hhcc-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHH--------HHHHHhCCCcceec---cccCC---CC
Q 048243 157 YARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH--------AYELWKGGKGVEFV---DSSLD---DT 221 (303)
Q Consensus 157 ~~~~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~---~~~~~---~~ 221 (303)
.+.+ ..++.++||||+|+++|++++|.+||.............. ....+......... ..... ..
T Consensus 180 ~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (332)
T cd07857 180 IMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFES 259 (332)
T ss_pred HHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHh
Confidence 8765 4688999999999999999999999865332110000000 00000000000000 00000 00
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 222 NSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 222 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
..+..+..+.+++.+||+.||.+|||+.+++..
T Consensus 260 ~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 260 IFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred hCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 001123578899999999999999999999753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=242.19 Aligned_cols=247 Identities=25% Similarity=0.340 Sum_probs=184.8
Q ss_pred CcEEEEEEecCCCcccHHHHHHHHHHHhcC--CCCccccEEEEEEeCC----eeEEEEeecCCCChhhhhcCccccccCC
Q 048243 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKL--QHVNLIRVLGFCIDSE----ERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 6 ~~~valK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
++.||||++.... .+.+++|-+++... +|+||+++++.-.... .++||++|.+.|+|.+|| ....++
T Consensus 233 ~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL----~~ntis 305 (534)
T KOG3653|consen 233 NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYL----KANTIS 305 (534)
T ss_pred CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHH----Hhcccc
Confidence 5999999997553 35677888887775 8999999999876544 889999999999999999 455699
Q ss_pred HHHHHHHHHHHHHHHHHHHhCC------CCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCC
Q 048243 80 WKKRVHIIEGITQGLLYLQEYS------RLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYI 153 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~------~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~ 153 (303)
|....+++..+++||+|||+.. ..+|+|||||..|||+.++++..|+|||++.++............+||.+||
T Consensus 306 w~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYM 385 (534)
T KOG3653|consen 306 WNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYM 385 (534)
T ss_pred HHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhc
Confidence 9999999999999999999732 4679999999999999999999999999998887555455555578999999
Q ss_pred ChhhhccCC-CC-----CccchhhHHHHHHHHHhCCCCCccCCCCccccHHH----------HHHHHH-hCCCcceeccc
Q 048243 154 PPEYARQGV-YS-----TKSDVFSFGVLLLQIISGKRLSMLCGINENLSILE----------HAYELW-KGGKGVEFVDS 216 (303)
Q Consensus 154 aPE~~~~~~-~~-----~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~----------~~~~~~-~~~~~~~~~~~ 216 (303)
|||++.+.- +. .+.||||+|.++|||+++-..+......+....++ ...... .....+.+.+
T Consensus 386 APEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~- 464 (534)
T KOG3653|consen 386 APEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPD- 464 (534)
T ss_pred CHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChh-
Confidence 999998763 22 36899999999999999765543222112111111 111111 1111111111
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccccCCCC
Q 048243 217 SLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSMLKNETTNRN 263 (303)
Q Consensus 217 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~~~~~ 263 (303)
.+.. ......+.+.+..||..||+.|.|+.-+-+++.+......
T Consensus 465 ~W~~---h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 465 AWRK---HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred hhhc---CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 1111 1334468899999999999999999999888877765443
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=259.68 Aligned_cols=231 Identities=22% Similarity=0.292 Sum_probs=190.9
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCccccEEEEEEe-----CCeeEEEEeecCCCChhhhhcCccccc
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCID-----SEERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~ 76 (303)
.++|+..|+|++....+.+ +++..|.++|+.. .|||++.+++++.. +..+|||||||.+|+..+++.... +.
T Consensus 41 ~~~~~~aa~kI~~~~~d~d-eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~ 118 (953)
T KOG0587|consen 41 VKTGQLAAIKIMDPTEDEE-EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GN 118 (953)
T ss_pred eecCceeeeEeecCCcccc-HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc-cc
Confidence 4688999999997765544 6788899999998 79999999999875 358899999999999999997755 77
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChh
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE 156 (303)
.+.|..+..+++.++.|+.+||.+. ++|||||-.|||++.++.|||.|||.+...... ....+...||+.|||||
T Consensus 119 rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT--~grRnT~iGtP~WMAPE 193 (953)
T KOG0587|consen 119 RLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST--VGRRNTFIGTPYWMAPE 193 (953)
T ss_pred chhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeeecc--cccccCcCCCcccccce
Confidence 8999999999999999999999998 999999999999999999999999998765433 34456689999999999
Q ss_pred hhccC-----CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHH
Q 048243 157 YARQG-----VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL 231 (303)
Q Consensus 157 ~~~~~-----~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
++... .|+..+|+||||++..||.-|.+|+-...+.. .++.- ...+......+..+++++.
T Consensus 194 Viac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr---------aLF~I-----pRNPPPkLkrp~kWs~~Fn 259 (953)
T KOG0587|consen 194 VIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR---------ALFLI-----PRNPPPKLKRPKKWSKKFN 259 (953)
T ss_pred eeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---------hhccC-----CCCCCccccchhhHHHHHH
Confidence 99754 36789999999999999999999975433222 11110 0122233344567888999
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 048243 232 EIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 232 ~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
+||..||..|..+||+..++++.
T Consensus 260 dFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 260 DFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred HHHHHHHhhccccCcchhhhccC
Confidence 99999999999999999998764
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=259.90 Aligned_cols=228 Identities=21% Similarity=0.256 Sum_probs=161.0
Q ss_pred HHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc-c-cccCCHHHHHHHHHHHHHHHHHHHh
Q 048243 22 FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-R-RLILDWKKRVHIIEGITQGLLYLQE 99 (303)
Q Consensus 22 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~-~~~l~~~~~~~~~~~i~~~l~~Lh~ 99 (303)
...+.+|+.+++.++|+||+++++++......++|++++. ++|..++.... . ........+..++.||+.||+|||+
T Consensus 207 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~ 285 (501)
T PHA03210 207 AIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD 285 (501)
T ss_pred HHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence 3467899999999999999999999999999999999985 56666664321 1 1223356678899999999999999
Q ss_pred CCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCCCccchhhHHHHHHHH
Q 048243 100 YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQI 179 (303)
Q Consensus 100 ~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l 179 (303)
++ |+||||||+|||++.++.++|+|||++..+..... .......|+..|+|||++.+..++.++|||||||++|+|
T Consensus 286 ~g---IiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el 361 (501)
T PHA03210 286 KK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361 (501)
T ss_pred CC---eecCCCCHHHEEECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHH
Confidence 98 99999999999999999999999999976643321 112235689999999999999999999999999999999
Q ss_pred HhCCCCCccCCCCccccHHHHHHHHHhCC--Ccc-------eecccc----CCCCCCH-----HHHHHHHHHHHHcccCC
Q 048243 180 ISGKRLSMLCGINENLSILEHAYELWKGG--KGV-------EFVDSS----LDDTNSP-----CKLMRCLEIALLCVQEN 241 (303)
Q Consensus 180 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~-------~~~~~~----~~~~~~~-----~~~~~l~~li~~~l~~d 241 (303)
++|..++...........+.......... ... .++... ....... .....+.++|.+||+.|
T Consensus 362 l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~D 441 (501)
T PHA03210 362 LSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFD 441 (501)
T ss_pred HHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccC
Confidence 99875433222111111111111100000 000 000000 0000000 01235678899999999
Q ss_pred CCCCCCHHHHHHH
Q 048243 242 PNDRPSMLQVSSM 254 (303)
Q Consensus 242 p~~Rpt~~el~~~ 254 (303)
|.+|||+.|+++.
T Consensus 442 P~~Rpsa~elL~h 454 (501)
T PHA03210 442 WHLRPGAAELLAL 454 (501)
T ss_pred cccCcCHHHHhhC
Confidence 9999999999874
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=250.67 Aligned_cols=254 Identities=22% Similarity=0.271 Sum_probs=179.8
Q ss_pred cCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCC------eeEEEEeecCCCChhhhhcCccc
Q 048243 3 LPCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE------ERMLVYEYMPNKSLDCYLFDPIR 74 (303)
Q Consensus 3 ~~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~ 74 (303)
..+|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++.... ..++||+|+ +++|.+++.
T Consensus 37 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~---- 111 (343)
T cd07880 37 RRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMK---- 111 (343)
T ss_pred CCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHh----
Confidence 3578999999986432 223456889999999999999999999987653 458999998 678887773
Q ss_pred cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCC
Q 048243 75 RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIP 154 (303)
Q Consensus 75 ~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~a 154 (303)
...+++..++.++.|++.||+|||+.| ++||||+|+||+++.++.++|+|||++...... .....++..|+|
T Consensus 112 ~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~a 183 (343)
T cd07880 112 HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRA 183 (343)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccccccC-----ccccccCCcccC
Confidence 346899999999999999999999999 999999999999999999999999998754332 122356889999
Q ss_pred hhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHH--------HHHHHhCCCcceecccc--CCC---
Q 048243 155 PEYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH--------AYELWKGGKGVEFVDSS--LDD--- 220 (303)
Q Consensus 155 PE~~~~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~--~~~--- 220 (303)
||.+.+ ..++.++|+||||+++|++++|..||.............. ....+............ ...
T Consensus 184 PE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (343)
T cd07880 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDF 263 (343)
T ss_pred HHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchH
Confidence 998876 3578899999999999999999999864332111000000 00000000000000000 000
Q ss_pred -CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccccCCCCCCCCCC
Q 048243 221 -TNSPCKLMRCLEIALLCVQENPNDRPSMLQVSS--MLKNETTNRNTPKKPA 269 (303)
Q Consensus 221 -~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~--~L~~~~~~~~~~~~~~ 269 (303)
...+..+..+.+++.+||..||.+|||+.+++. +++........+..++
T Consensus 264 ~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~~ 315 (343)
T cd07880 264 RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPP 315 (343)
T ss_pred HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCCC
Confidence 001122346889999999999999999999984 4555544433334443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=255.81 Aligned_cols=218 Identities=22% Similarity=0.299 Sum_probs=171.8
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
..+++..++|++..... +..+|+.++... +||||+++.+.+.+..+.|+|||.+.|+-+.+.+.. ......
T Consensus 344 ~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~----~~~~~~ 415 (612)
T KOG0603|consen 344 SPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRS----KPEFCS 415 (612)
T ss_pred cccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHh----cchhHH
Confidence 35677888998865522 234577677776 799999999999999999999999999988777733 223336
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEE-CCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL-GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~-~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
.+..|+++|+.|+.|||++| ++|||+||+|||+ +..|+++|+|||.+...... .....-|..|.|||++..
T Consensus 416 e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~ 487 (612)
T KOG0603|consen 416 EASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAI 487 (612)
T ss_pred HHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhcc
Confidence 77789999999999999999 9999999999999 58899999999998765433 111234788999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|+||||+++|+|++|..||...... .+.. .. ...+......+....+|+.+||+.
T Consensus 488 ~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~ei~-~~------------i~~~~~s~~vS~~AKdLl~~LL~~ 549 (612)
T KOG0603|consen 488 QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----IEIH-TR------------IQMPKFSECVSDEAKDLLQQLLQV 549 (612)
T ss_pred CCCCcchhhHHHHHHHHHHHhCCCccccCCch-----HHHH-Hh------------hcCCccccccCHHHHHHHHHhccC
Confidence 99999999999999999999999998644433 1111 11 111222245566889999999999
Q ss_pred CCCCCCCHHHHHHH
Q 048243 241 NPNDRPSMLQVSSM 254 (303)
Q Consensus 241 dp~~Rpt~~el~~~ 254 (303)
||.+||++.++...
T Consensus 550 dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 550 DPALRLGADEIGAH 563 (612)
T ss_pred ChhhCcChhhhccC
Confidence 99999999999754
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=244.05 Aligned_cols=238 Identities=26% Similarity=0.311 Sum_probs=173.3
Q ss_pred CCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEe-CCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCID-SEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|++... .....+.+..|+.+++.++||||+++++++.. ....++++||+ +++|..++. ...+++
T Consensus 33 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~----~~~~~~ 107 (328)
T cd07856 33 LTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLT----SRPLEK 107 (328)
T ss_pred CCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHh----cCCCCH
Confidence 47899999988543 23344678899999999999999999999875 46789999998 568877773 345788
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||.+...... .....++..|+|||.+.+
T Consensus 108 ~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~ 179 (328)
T cd07856 108 QFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLT 179 (328)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCC-----cCCCcccccccCceeeec
Confidence 889999999999999999999 999999999999999999999999998654321 122356788999998765
Q ss_pred -CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHH--------HHHHhCCCcceeccccCCCCC-C-----HH
Q 048243 161 -GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA--------YELWKGGKGVEFVDSSLDDTN-S-----PC 225 (303)
Q Consensus 161 -~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~-~-----~~ 225 (303)
..++.++||||||+++|+|++|..||............... ...........+......... + +.
T Consensus 180 ~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (328)
T cd07856 180 WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKN 259 (328)
T ss_pred cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCC
Confidence 56889999999999999999999998644321111100000 000000000000000000000 0 11
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 226 KLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 226 ~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
.+..+.++|.+||+.+|++|||+.+++..
T Consensus 260 ~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 260 ADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 23578899999999999999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=243.24 Aligned_cols=238 Identities=19% Similarity=0.257 Sum_probs=180.0
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcC--CCCc----cccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccC
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKL--QHVN----LIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l--~h~~----i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
++..||||+++.... -.+..+-|++.|+++ +.|+ ++.+.++|...++.|+|+|.+ |-++.+++.. ..-.++
T Consensus 113 ~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~-N~y~~f 189 (415)
T KOG0671|consen 113 TKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKE-NNYIPF 189 (415)
T ss_pred CCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhcc-CCcccc
Confidence 478899999976543 345677899999999 2332 678888899999999999998 5689999965 345678
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEEC--------------------CCCceEEcccccccccccCC
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG--------------------EDMKPKISDFGLARIFAKES 138 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~--------------------~~~~v~l~Df~~~~~~~~~~ 138 (303)
+...++.+.+|+++++++||+.+ ++|.||||+||++. .+..|+++|||.++.-...
T Consensus 190 pi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~- 265 (415)
T KOG0671|consen 190 PIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH- 265 (415)
T ss_pred chHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC-
Confidence 99999999999999999999999 99999999999993 1345899999998753322
Q ss_pred ccccccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHH--------------
Q 048243 139 LEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL-------------- 204 (303)
Q Consensus 139 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 204 (303)
....+.|.+|+|||++.+-+|+..+||||+||+++|+++|...|......+.+...+.....
T Consensus 266 ----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Ky 341 (415)
T KOG0671|consen 266 ----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKY 341 (415)
T ss_pred ----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhh
Confidence 24467799999999999999999999999999999999999999877744444333322211
Q ss_pred HhCCCcceeccccCCC----------------CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 205 WKGGKGVEFVDSSLDD----------------TNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 205 ~~~~~~~~~~~~~~~~----------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
+..+ ...+......+ ........++.+|+.+||..||.+|+|+.|+++.
T Consensus 342 f~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 342 FRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred hhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence 1111 11111111101 0112333468999999999999999999998763
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=241.94 Aligned_cols=241 Identities=22% Similarity=0.281 Sum_probs=171.9
Q ss_pred CCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCCCCccccEEEEEEeCC--------eeEEEEeecCCCChhhhhcCcc
Q 048243 4 PCGKVIAVKKLSKTSTQ--GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE--------ERMLVYEYMPNKSLDCYLFDPI 73 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~~ 73 (303)
.+|+.||+|.+...... ....+.+|+++++.++|+||+++++++.... ..++|++|+.+ ++...+..
T Consensus 31 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~-- 107 (311)
T cd07866 31 KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLEN-- 107 (311)
T ss_pred CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhc--
Confidence 46889999998654322 2345778999999999999999999875433 46999999865 56666533
Q ss_pred ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcccc---------cc
Q 048243 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEAN---------TE 144 (303)
Q Consensus 74 ~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~---------~~ 144 (303)
....+++..++.++.|+++||+|||+.| ++|+||+|+||+++.++.++|+|||++........... ..
T Consensus 108 ~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 184 (311)
T cd07866 108 PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184 (311)
T ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccc
Confidence 2456899999999999999999999999 99999999999999999999999999876543221111 12
Q ss_pred ccccccCCCChhhhccC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCc---------ceec
Q 048243 145 QVVGTIGYIPPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG---------VEFV 214 (303)
Q Consensus 145 ~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~ 214 (303)
...++..|+|||.+.+. .++.++||||||+++|+|++|.+||.......... ........... ....
T Consensus 185 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 261 (311)
T cd07866 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH---LIFKLCGTPTEETWPGWRSLPGCE 261 (311)
T ss_pred cceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCChhhchhhhhccccc
Confidence 23567889999987654 57889999999999999999999986443322111 11111100000 0000
Q ss_pred ----cccCCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 215 ----DSSLDDT---NSPCKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 215 ----~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
....... ........+.+++.+||..||.+|||+.|++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 262 GVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred ccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000000 00112246889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=241.17 Aligned_cols=243 Identities=23% Similarity=0.258 Sum_probs=176.5
Q ss_pred CCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCC-CCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTST-QGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+++.|++|.+..... .......+|+..+++++ |+||+++++++..+...++||||+ +++|.+++.... ...+++.
T Consensus 22 ~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~ 99 (283)
T cd07830 22 ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRK-GKPFSES 99 (283)
T ss_pred CCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcc-cccCCHH
Confidence 3688999999865532 22234567999999998 999999999999999999999999 788888774422 3468999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc-
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ- 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~- 160 (303)
.+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+
T Consensus 100 ~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~ 173 (283)
T cd07830 100 VIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP---YTDYVSTRWYRAPEILLRS 173 (283)
T ss_pred HHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC---cCCCCCcccccCceeeecC
Confidence 99999999999999999998 99999999999999999999999999876543221 122457889999998754
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHH-----HHHHhC-----CCcceeccccCC---CCCCHHHH
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA-----YELWKG-----GKGVEFVDSSLD---DTNSPCKL 227 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~-----~~~~~~~~~~~~---~~~~~~~~ 227 (303)
..++.++|+||||+++|+|++|..||............... ...|.. ............ ....+...
T Consensus 174 ~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (283)
T cd07830 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNAS 253 (283)
T ss_pred cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCC
Confidence 45788999999999999999999998654432211100000 000000 000000000000 00001113
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 228 MRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 228 ~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
..+.+++.+||+.||++|||+.|++..
T Consensus 254 ~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 254 PEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred HHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 578899999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=238.77 Aligned_cols=228 Identities=22% Similarity=0.353 Sum_probs=171.2
Q ss_pred CCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 5 CGKVIAVKKLSKTST-QGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 5 ~~~~valK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
+|+.||||.++.... .....+..|+..+.+. .|+||+++++++......+++|||+. +++..++.. ....+++..
T Consensus 39 ~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~--~~~~l~~~~ 115 (296)
T cd06618 39 TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKR--IQGPIPEDI 115 (296)
T ss_pred CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHH--hcCCCCHHH
Confidence 489999999975532 2344566777777776 59999999999999999999999985 467666633 234688999
Q ss_pred HHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 83 RVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
+..++.|++.|++|||+ .+ ++||||+|+||+++.++.++|+|||++..+...... ....++..|+|||.+.+.
T Consensus 116 ~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~ 189 (296)
T cd06618 116 LGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCAAYMAPERIDPP 189 (296)
T ss_pred HHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCCcc---cCCCCCccccCHhhcCCC
Confidence 99999999999999997 47 999999999999999999999999998765432211 223467889999998755
Q ss_pred C----CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHc
Q 048243 162 V----YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237 (303)
Q Consensus 162 ~----~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 237 (303)
. ++.++||||||+++|+|++|..||...... . .......... ... ... ....+.++.+++.+|
T Consensus 190 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~---~~~~~~~~~~-~~~-----~~~--~~~~~~~l~~li~~~ 256 (296)
T cd06618 190 DPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--F---EVLTKILQEE-PPS-----LPP--NEGFSPDFCSFVDLC 256 (296)
T ss_pred CCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--H---HHHHHHhcCC-CCC-----CCC--CCCCCHHHHHHHHHH
Confidence 3 788999999999999999999998542211 1 1111111111 100 000 012334788999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 048243 238 VQENPNDRPSMLQVSSM 254 (303)
Q Consensus 238 l~~dp~~Rpt~~el~~~ 254 (303)
|..||.+||++.++++.
T Consensus 257 l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 257 LTKDHRKRPKYRELLQH 273 (296)
T ss_pred ccCChhhCCCHHHHhcC
Confidence 99999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=247.11 Aligned_cols=235 Identities=26% Similarity=0.317 Sum_probs=173.6
Q ss_pred CCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCe------eEEEEeecCCCChhhhhcCcccc
Q 048243 4 PCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE------RMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~~ 75 (303)
.+++.||+|++... .....+.+.+|+.+++.++|+||+++++++..... .++|+||+ +++|.+++. .
T Consensus 38 ~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~----~ 112 (343)
T cd07851 38 KTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVK----C 112 (343)
T ss_pred CCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHh----c
Confidence 36889999998653 22334567789999999999999999988766544 89999998 568988873 3
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCCh
Q 048243 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aP 155 (303)
..+++..++.++.|++.||+|||+.| ++||||+|+||+++.++.++|+|||.+...... .....++..|+||
T Consensus 113 ~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aP 184 (343)
T cd07851 113 QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 184 (343)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccccccccc-----ccCCcccccccCH
Confidence 46899999999999999999999998 999999999999999999999999998765332 2223568889999
Q ss_pred hhhccC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhC-----------CCcceeccccCCC--C
Q 048243 156 EYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKG-----------GKGVEFVDSSLDD--T 221 (303)
Q Consensus 156 E~~~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~--~ 221 (303)
|.+.+. .++.++||||||+++|++++|..||........ .......... .....+....... .
T Consensus 185 E~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (343)
T cd07851 185 EIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ---LKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKK 261 (343)
T ss_pred HHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCC
Confidence 988653 578899999999999999999999864332111 1111110000 0000000000000 0
Q ss_pred C----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 222 N----SPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 222 ~----~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
. ....+..+.+++.+||..||.+|||+.|+++.
T Consensus 262 ~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 262 DFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0 01124578899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=246.58 Aligned_cols=238 Identities=24% Similarity=0.277 Sum_probs=171.5
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeC------CeeEEEEeecCCCChhhhhcCcccc
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------EERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~ 75 (303)
.+|+.||+|+++... ....+.+.+|+.++++++|+||+++++++... ...+++++++ +++|.+++. .
T Consensus 40 ~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~----~ 114 (345)
T cd07877 40 KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK----C 114 (345)
T ss_pred CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHh----c
Confidence 578999999997542 22345678899999999999999999988643 3467888877 678877763 3
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCCh
Q 048243 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aP 155 (303)
..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++...... .....++..|+||
T Consensus 115 ~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aP 186 (345)
T cd07877 115 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 186 (345)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEeccccccccccc-----ccccccCCCccCH
Confidence 35889999999999999999999999 999999999999999999999999998654321 2234578899999
Q ss_pred hhhcc-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHH--------HHHHhCCCcceec---cccCCC---
Q 048243 156 EYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA--------YELWKGGKGVEFV---DSSLDD--- 220 (303)
Q Consensus 156 E~~~~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~---~~~~~~--- 220 (303)
|.+.+ ..++.++|||||||++|+|++|..||............... ............. ......
T Consensus 187 E~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (345)
T cd07877 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA 266 (345)
T ss_pred HHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchh
Confidence 98866 46788999999999999999999998543221111100000 0000000000000 000000
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 221 TNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 221 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
......+..+.++|.+||+.||.+||++.+++..
T Consensus 267 ~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 267 NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000124467899999999999999999999764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=231.18 Aligned_cols=227 Identities=28% Similarity=0.330 Sum_probs=182.2
Q ss_pred CCCcEEEEEEecCCCccc-HHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTSTQG-FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.+|+|++....... .+.+.+|++.+++++|+||+++++++......++++|++.+++|..++.. ...++...
T Consensus 12 ~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~---~~~~~~~~ 88 (244)
T smart00220 12 KTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK---RGRLSEDE 88 (244)
T ss_pred CCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh---ccCCCHHH
Confidence 368999999997665444 67899999999999999999999999999999999999999999998843 22388999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
++.++.+++.++++||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..|++||.+.+..
T Consensus 89 ~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~ 162 (244)
T smart00220 89 ARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLGKG 162 (244)
T ss_pred HHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHHHccCC
Confidence 9999999999999999998 9999999999999999999999999987755432 223345788999999998888
Q ss_pred CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHH-HHHHHHHHHHHcccCC
Q 048243 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPC-KLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~d 241 (303)
++.++||||||++++++++|..||...... ............. ...... .+..+.+++.+||..+
T Consensus 163 ~~~~~Di~slG~~l~~l~~~~~p~~~~~~~------~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~~ 228 (244)
T smart00220 163 YGKAVDVWSLGVILYELLTGKPPFPGDDQL------LELFKKIGKPKPP--------FPPPEWKISPEAKDLIRKLLVKD 228 (244)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCcH------HHHHHHHhccCCC--------CccccccCCHHHHHHHHHHccCC
Confidence 899999999999999999999998542111 1111111111100 000000 3357889999999999
Q ss_pred CCCCCCHHHHHH
Q 048243 242 PNDRPSMLQVSS 253 (303)
Q Consensus 242 p~~Rpt~~el~~ 253 (303)
|++||++.++++
T Consensus 229 p~~Rp~~~~~~~ 240 (244)
T smart00220 229 PEKRLTAEEALQ 240 (244)
T ss_pred chhccCHHHHhh
Confidence 999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=231.66 Aligned_cols=244 Identities=23% Similarity=0.264 Sum_probs=180.9
Q ss_pred cEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCccccEEEEEEe-CCeeEEEEeecCCCChhhhhcCcc--ccccCCHH
Q 048243 7 KVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCID-SEERMLVYEYMPNKSLDCYLFDPI--RRLILDWK 81 (303)
Q Consensus 7 ~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~--~~~~l~~~ 81 (303)
+.+|||+++...+ .-....-+|+.++++++||||+.+..++.. +...+++++|.+. +|-..+.... ....++..
T Consensus 54 k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~ 132 (438)
T KOG0666|consen 54 KEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRS 132 (438)
T ss_pred hhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHH
Confidence 4689999976532 222456789999999999999999999987 7889999999864 5655554322 24578889
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCC----CceEEcccccccccccCCccc-cccccccccCCCChh
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED----MKPKISDFGLARIFAKESLEA-NTEQVVGTIGYIPPE 156 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~----~~v~l~Df~~~~~~~~~~~~~-~~~~~~g~~~y~aPE 156 (303)
.+..++.||+.|+.|||++= |+||||||.|||+..+ |+|||+|||+++.+.+.-... .....+-|..|+|||
T Consensus 133 mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPE 209 (438)
T KOG0666|consen 133 MVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPE 209 (438)
T ss_pred HHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChH
Confidence 99999999999999999998 9999999999999888 999999999999887664332 334456799999999
Q ss_pred hhccCC-CCCccchhhHHHHHHHHHhCCCCCccCCCCc------cccHHHHHHHHHhCCCcceeccc--c----------
Q 048243 157 YARQGV-YSTKSDVFSFGVLLLQIISGKRLSMLCGINE------NLSILEHAYELWKGGKGVEFVDS--S---------- 217 (303)
Q Consensus 157 ~~~~~~-~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~--~---------- 217 (303)
++.+.. ||.+.|||++||++.||++..+.|....... ..+.+.+..+.+.......+.+- .
T Consensus 210 LLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f 289 (438)
T KOG0666|consen 210 LLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDF 289 (438)
T ss_pred HhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHh
Confidence 998875 8999999999999999999999887543321 22334444443322211111110 0
Q ss_pred ---CCCCC-CHH-------HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 218 ---LDDTN-SPC-------KLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 218 ---~~~~~-~~~-------~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
..... ... .+....+|+.++|..||-+|.|+++.++.
T Consensus 290 ~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 290 RRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 00000 000 11236799999999999999999998875
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=244.56 Aligned_cols=239 Identities=24% Similarity=0.298 Sum_probs=172.3
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCC------eeEEEEeecCCCChhhhhcCcccc
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE------ERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~ 75 (303)
.+|+.||+|++.... ......+.+|+.+++.++|+||+++++++.... ..++|+||+. .+|..++ .
T Consensus 38 ~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~-----~ 111 (342)
T cd07879 38 RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIM-----G 111 (342)
T ss_pred CCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHH-----c
Confidence 578999999986542 223356789999999999999999999987542 4689999986 3665544 2
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCCh
Q 048243 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aP 155 (303)
..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++...... .....++..|+||
T Consensus 112 ~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aP 183 (342)
T cd07879 112 HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAP 183 (342)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-----CCCceeeecccCh
Confidence 35888999999999999999999998 999999999999999999999999998654321 1224568889999
Q ss_pred hhhcc-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHH-----------hCCCcceeccc--cC-CC
Q 048243 156 EYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELW-----------KGGKGVEFVDS--SL-DD 220 (303)
Q Consensus 156 E~~~~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~--~~-~~ 220 (303)
|.+.+ ..++.++||||||+++|+|++|..||....... ......... ........... .. ..
T Consensus 184 E~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (342)
T cd07879 184 EVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRK 260 (342)
T ss_pred hhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccc
Confidence 99876 457889999999999999999999996432211 111110000 00000000000 00 00
Q ss_pred C---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hcccc
Q 048243 221 T---NSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM--LKNET 259 (303)
Q Consensus 221 ~---~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~--L~~~~ 259 (303)
. ..+..+..+.+++.+||+.||.+||++.+++.. ++...
T Consensus 261 ~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 261 DFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred hHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0 001223467899999999999999999999854 55443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=257.05 Aligned_cols=235 Identities=25% Similarity=0.386 Sum_probs=187.9
Q ss_pred CcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc-----cc---
Q 048243 6 GKVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-----RR--- 75 (303)
Q Consensus 6 ~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~--- 75 (303)
...||||.++... ..+.+.+..|+++|+.+ +|+||+.+++.+..++..++|+||+..|+|..++.... ..
T Consensus 328 ~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~ 407 (609)
T KOG0200|consen 328 YVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGV 407 (609)
T ss_pred eEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCC
Confidence 5679999998664 35667899999999999 79999999999999999999999999999999997533 00
Q ss_pred -----ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcccccccc-ccc
Q 048243 76 -----LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQV-VGT 149 (303)
Q Consensus 76 -----~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~-~g~ 149 (303)
..+.......++.||+.|++||++.. ++||||-..|||+..+..+||+|||+++.............. .-.
T Consensus 408 ~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP 484 (609)
T KOG0200|consen 408 FPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLP 484 (609)
T ss_pred CccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccc
Confidence 23888999999999999999999998 999999999999999999999999999876555443322111 125
Q ss_pred cCCCChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHH
Q 048243 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLM 228 (303)
Q Consensus 150 ~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
..|||||.+....++.++||||+|+++||+++ |..|+....... ...+....+... ..+.....
T Consensus 485 ~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~------~l~~~l~~G~r~---------~~P~~c~~ 549 (609)
T KOG0200|consen 485 VKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE------ELLEFLKEGNRM---------EQPEHCSD 549 (609)
T ss_pred eeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH------HHHHHHhcCCCC---------CCCCCCCH
Confidence 56999999999999999999999999999998 777775421111 112233333222 22222255
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHhccc
Q 048243 229 RCLEIALLCVQENPNDRPSMLQVSSMLKNE 258 (303)
Q Consensus 229 ~l~~li~~~l~~dp~~Rpt~~el~~~L~~~ 258 (303)
+++++++.||+.+|++||++.++.++|+..
T Consensus 550 eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 550 EIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 888999999999999999999999999884
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=233.42 Aligned_cols=225 Identities=23% Similarity=0.250 Sum_probs=180.5
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
-+|+.+|+|++++.. ......-..|-..|+..+||++..+-..|....++|+||||..||.|.-.| .+...+++
T Consensus 191 at~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HL---srer~FsE 267 (516)
T KOG0690|consen 191 ATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHL---SRERVFSE 267 (516)
T ss_pred ccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeeh---hhhhcccc
Confidence 478999999998763 333445667889999999999999999999999999999999999998777 35667899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
...+.+-..|+.||.|||+.+ ||+||+|.+|+|++.+|++||.|||+++.-.. .......++||+.|+|||++..
T Consensus 268 ~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~--~g~t~kTFCGTPEYLAPEVleD 342 (516)
T KOG0690|consen 268 DRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK--YGDTTKTFCGTPEYLAPEVLED 342 (516)
T ss_pred hhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc--ccceeccccCChhhcCchhhcc
Confidence 999999999999999999998 99999999999999999999999999975322 2344556899999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..|..++|.|.+|+++|||+.|+.||.......-. ++.-.+ ....+...+.+...|+..+|..
T Consensus 343 nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLF-------eLIl~e----------d~kFPr~ls~eAktLLsGLL~k 405 (516)
T KOG0690|consen 343 NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLF-------ELILME----------DLKFPRTLSPEAKTLLSGLLKK 405 (516)
T ss_pred ccccceeehhhhhHHHHHHHhccCcccccchhHHH-------HHHHhh----------hccCCccCCHHHHHHHHHHhhc
Confidence 99999999999999999999999998533222111 111000 0111222334677899999999
Q ss_pred CCCCCCC-----HHHHHH
Q 048243 241 NPNDRPS-----MLQVSS 253 (303)
Q Consensus 241 dp~~Rpt-----~~el~~ 253 (303)
||.+|.. +.|+.+
T Consensus 406 dP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 406 DPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred ChHhhcCCCchhHHHHHh
Confidence 9999963 555544
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=229.86 Aligned_cols=236 Identities=23% Similarity=0.310 Sum_probs=179.8
Q ss_pred cCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcC--ccccccC
Q 048243 3 LPCGKVIAVKKLSKTST-QGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFD--PIRRLIL 78 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~l 78 (303)
-++|+.+|||.++.... .+.++++.|.+...+- ++||||++||.+...+.+|+.||.|+ .+|..+... ......+
T Consensus 86 k~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~i 164 (361)
T KOG1006|consen 86 KPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRI 164 (361)
T ss_pred CccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccC
Confidence 36899999999986643 5667888888777666 79999999999999999999999995 567655432 1235668
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
++...-++......||.||.+.. .|+|||+||+|||++..|.+||+|||++..+... -......|-..|+|||.+
T Consensus 165 pE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S---iAkT~daGCrpYmAPERi 239 (361)
T KOG1006|consen 165 PENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS---IAKTVDAGCRPYMAPERI 239 (361)
T ss_pred cHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH---HHhhhccCCccccChhcc
Confidence 89999999999999999997643 4999999999999999999999999998654332 112234678899999998
Q ss_pred ccC--CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 159 RQG--VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 159 ~~~--~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
... .|+-++||||||++++|+.||..|+..... ..+.. .....+..+.+.. .......+..+..+|.-
T Consensus 240 ~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql-~~Vv~gdpp~l~~----~~~~~~~s~~~~~fint 309 (361)
T KOG1006|consen 240 DPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQL-CQVVIGDPPILLF----DKECVHYSFSMVRFINT 309 (361)
T ss_pred CCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHH-HHHHcCCCCeecC----cccccccCHHHHHHHHH
Confidence 754 488899999999999999999999854332 22222 2222222222211 11122355688899999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 048243 237 CVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 237 ~l~~dp~~Rpt~~el~~~ 254 (303)
||.+|-+.||...+++.+
T Consensus 310 Cl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 310 CLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HhhcccccCcchhhhhcC
Confidence 999999999999999865
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=235.29 Aligned_cols=242 Identities=23% Similarity=0.326 Sum_probs=180.8
Q ss_pred CcEEEEEEecCCCcccHHHHHHHHHHHhcC--CCCccccEEEEEEeCC----eeEEEEeecCCCChhhhhcCccccccCC
Q 048243 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKL--QHVNLIRVLGFCIDSE----ERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 6 ~~~valK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
|+.||||++...+. ..+.+|.++++.. +|+||+.+++.-..++ .+|||++|.+.|||.+|| .+..++
T Consensus 234 Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL----~r~tv~ 306 (513)
T KOG2052|consen 234 GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYL----NRNTVT 306 (513)
T ss_pred CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHH----hhccCC
Confidence 88999999976543 4566777777764 9999999999976654 578999999999999999 446799
Q ss_pred HHHHHHHHHHHHHHHHHHHh-----CCCCCeEecCCCCCceEECCCCceEEcccccccccccCC--ccccccccccccCC
Q 048243 80 WKKRVHIIEGITQGLLYLQE-----YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKES--LEANTEQVVGTIGY 152 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~-----~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~--~~~~~~~~~g~~~y 152 (303)
....++++..++.||++||- +|..+|.|||||..||||..+|.+.|+|+|+|....... .....+..+||.+|
T Consensus 307 ~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRY 386 (513)
T KOG2052|consen 307 TEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRY 386 (513)
T ss_pred HHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeec
Confidence 99999999999999999994 566779999999999999999999999999997765442 23445668999999
Q ss_pred CChhhhccCC----C-C-CccchhhHHHHHHHHHhCC----------CCCccCCCCccccHHHHHHHHHhCCCcceeccc
Q 048243 153 IPPEYARQGV----Y-S-TKSDVFSFGVLLLQIISGK----------RLSMLCGINENLSILEHAYELWKGGKGVEFVDS 216 (303)
Q Consensus 153 ~aPE~~~~~~----~-~-~~~DiwslG~~~~~l~~g~----------~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (303)
||||++...- + + ..+||||||.++||++-+- .||...-+.+.. .+......-.+-..+
T Consensus 387 MAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs------~eeMrkVVCv~~~RP 460 (513)
T KOG2052|consen 387 MAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS------FEEMRKVVCVQKLRP 460 (513)
T ss_pred cChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC------HHHHhcceeecccCC
Confidence 9999987642 1 1 2589999999999997532 333222221111 112222222222222
Q ss_pred cCCCC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccccC
Q 048243 217 SLDDT-NSPCKLMRCLEIALLCVQENPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 217 ~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~~ 260 (303)
..+.. ........+.++++.||..||..|.||--+...|.+...
T Consensus 461 ~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 461 NIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 22211 123456678899999999999999999999888877653
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=211.41 Aligned_cols=244 Identities=21% Similarity=0.253 Sum_probs=184.8
Q ss_pred cCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 3 LPCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 3 ~~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
+++++.||+|.++..+ ..--....+||-+++.++|.||+++++....++.+.+|+|||. ..|..|... -++.++.
T Consensus 24 ~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-qdlkkyfds--lng~~d~ 100 (292)
T KOG0662|consen 24 RETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDS--LNGDLDP 100 (292)
T ss_pred CCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-HHHHHHHHh--cCCcCCH
Confidence 5788999999987653 3334678899999999999999999999999999999999996 467777632 3667999
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
...+.++.|+++||.++|+++ +.|||+||.|++++.||.+|++|||+++-++-... .....+-|..|++|+++.+
T Consensus 101 ~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr--cysaevvtlwyrppdvlfg 175 (292)
T KOG0662|consen 101 EIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFG 175 (292)
T ss_pred HHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE--eeeceeeeeeccCcceeee
Confidence 999999999999999999999 99999999999999999999999999987765432 2222356899999999887
Q ss_pred CC-CCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcc---eeccccCCCCCC---------HHH
Q 048243 161 GV-YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGV---EFVDSSLDDTNS---------PCK 226 (303)
Q Consensus 161 ~~-~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~---------~~~ 226 (303)
.. |++..|+||.||++.|+.. |++.|.+....+....+.+.........++ .+.+.......+ +..
T Consensus 176 akly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~l 255 (292)
T KOG0662|consen 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKL 255 (292)
T ss_pred eehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhh
Confidence 65 8999999999999999997 666665554444443333322222221111 112221111111 111
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 227 LMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 227 ~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
...-++++.+.|.-+|..|.++++.++.
T Consensus 256 ns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 256 NSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cchhHHHHHHHhccCcccccCHHHHhcC
Confidence 2245799999999999999999998764
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=232.97 Aligned_cols=227 Identities=22% Similarity=0.315 Sum_probs=173.8
Q ss_pred CcEEEEEEecCC-----CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCc-cccccCC
Q 048243 6 GKVIAVKKLSKT-----STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDP-IRRLILD 79 (303)
Q Consensus 6 ~~~valK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~l~ 79 (303)
+..+++|.++.. .......+..|+.+++.++||||+++++++.+....++|+||+.+++|.+++... .....++
T Consensus 25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~ 104 (260)
T cd08222 25 VAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLS 104 (260)
T ss_pred CCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccC
Confidence 344556665432 1223345677999999999999999999999999999999999999998887532 2345689
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..++.++.|++.|+.|||+.| ++|+||+|+||+++. +.++|+|||.+....... .......|+..|+|||.+.
T Consensus 105 ~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~~ 178 (260)
T cd08222 105 ENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC--DLATTFTGTPYYMSPEALK 178 (260)
T ss_pred HHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCCCc--ccccCCCCCcCccCHHHHc
Confidence 9999999999999999999998 999999999999975 579999999987654332 1222345788999999998
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++|+||||+++|+|++|..||..... ......... .. ....+...+..+.+++.+||.
T Consensus 179 ~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~~-~~---------~~~~~~~~~~~~~~li~~~l~ 242 (260)
T cd08222 179 HQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRIVE-GP---------TPSLPETYSRQLNSIMQSMLN 242 (260)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHc-CC---------CCCCcchhcHHHHHHHHHHhc
Confidence 88889999999999999999999999853221 111111111 10 111223445688899999999
Q ss_pred CCCCCCCCHHHHHHH
Q 048243 240 ENPNDRPSMLQVSSM 254 (303)
Q Consensus 240 ~dp~~Rpt~~el~~~ 254 (303)
.||++||++.|+++.
T Consensus 243 ~~p~~Rp~~~~il~~ 257 (260)
T cd08222 243 KDPSLRPSAAEILRN 257 (260)
T ss_pred CChhhCcCHHHHhhC
Confidence 999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=249.25 Aligned_cols=221 Identities=20% Similarity=0.226 Sum_probs=188.6
Q ss_pred EEEEEecCC---CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHH
Q 048243 9 IAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVH 85 (303)
Q Consensus 9 valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~ 85 (303)
+|+|++++. +..+.+.+..|-.+|..++.|+|+++|..|.++...|++||-|-||.|-..+ ..++.++......
T Consensus 448 fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiL---rdRg~Fdd~tarF 524 (732)
T KOG0614|consen 448 FALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTIL---RDRGSFDDYTARF 524 (732)
T ss_pred HHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhh---hhcCCcccchhhh
Confidence 688888765 3455677889999999999999999999999999999999999999987777 4567799999999
Q ss_pred HHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCCC
Q 048243 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYST 165 (303)
Q Consensus 86 ~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 165 (303)
++..+++|++|||.+| |++|||||+|++++.+|-+||.|||.++.+++.. ....++||+.|.|||++.+...+.
T Consensus 525 ~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~---KTwTFcGTpEYVAPEIILnKGHD~ 598 (732)
T KOG0614|consen 525 YVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR---KTWTFCGTPEYVAPEIILNKGHDR 598 (732)
T ss_pred hHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC---ceeeecCCcccccchhhhccCcch
Confidence 9999999999999999 9999999999999999999999999999887653 344578999999999999999999
Q ss_pred ccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 048243 166 KSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDR 245 (303)
Q Consensus 166 ~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 245 (303)
++|.||||+++|||++|.+||........++.+....+.+.-. ........++|+++.+.+|.+|
T Consensus 599 avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P---------------r~I~k~a~~Lik~LCr~~P~ER 663 (732)
T KOG0614|consen 599 AVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP---------------RRITKTATDLIKKLCRDNPTER 663 (732)
T ss_pred hhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc---------------cccchhHHHHHHHHHhcCcHhh
Confidence 9999999999999999999998887776666665554444311 1122356689999999999999
Q ss_pred CC-----HHHHHH
Q 048243 246 PS-----MLQVSS 253 (303)
Q Consensus 246 pt-----~~el~~ 253 (303)
.. +.+|..
T Consensus 664 LG~~~~gI~DIkk 676 (732)
T KOG0614|consen 664 LGYQKGGINDIKK 676 (732)
T ss_pred hccccCChHHHHh
Confidence 86 566654
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-32 Score=230.19 Aligned_cols=213 Identities=16% Similarity=0.163 Sum_probs=153.3
Q ss_pred HHHHHhcCCCCccccEEEEEEeCC----eeEEEEeecCCCChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 048243 28 EVMLTAKLQHVNLIRVLGFCIDSE----ERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRL 103 (303)
Q Consensus 28 e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~ 103 (303)
++..+..++|++++++++++.... ..+++++++. .++.+.+.. ....++..+..++.|++.||+|||+.+
T Consensus 73 ~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~-- 146 (294)
T PHA02882 73 LWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG-- 146 (294)
T ss_pred HHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 334456678999999999766543 3467777764 355555522 233577888999999999999999998
Q ss_pred CeEecCCCCCceEECCCCceEEcccccccccccCCcc-----ccccccccccCCCChhhhccCCCCCccchhhHHHHHHH
Q 048243 104 TIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-----ANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178 (303)
Q Consensus 104 ~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~ 178 (303)
++||||||+||+++.++.++|+|||+++.+...... .......||+.|+|||.+.+..++.++|||||||++|+
T Consensus 147 -iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~e 225 (294)
T PHA02882 147 -ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225 (294)
T ss_pred -eecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHH
Confidence 999999999999999999999999999766432211 11223468999999999999999999999999999999
Q ss_pred HHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048243 179 IISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSMLK 256 (303)
Q Consensus 179 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~ 256 (303)
|++|..||...+.......... ...... +....... +..+..+.+++..||..+|++||++.++++.|+
T Consensus 226 l~~g~~P~~~~~~~~~~~~~~~-~~~~~~-----~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 226 WAGIKLPWKGFGHNGNLIHAAK-CDFIKR-----LHEGKIKI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHhCCCCCCccccchHHHHHhH-HHHHHH-----hhhhhhcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 9999999975532221110000 011100 00000001 111357889999999999999999999998763
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=255.80 Aligned_cols=123 Identities=26% Similarity=0.326 Sum_probs=109.5
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+++.||||+++... ......+..|+.++..++|+||+++++++......|+||||+.+++|.+++.. ...+++
T Consensus 27 ~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~---~~~l~~ 103 (669)
T cd05610 27 NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHI---YGYFDE 103 (669)
T ss_pred CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHh---cCCCCH
Confidence 468999999997543 22346788899999999999999999999999999999999999999998843 345888
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEccccccc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~ 132 (303)
..++.++.||+.||+|||..+ |+||||||+|||++.++.++|+|||+++
T Consensus 104 ~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 104 EMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred HHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999999999998 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=217.65 Aligned_cols=235 Identities=18% Similarity=0.235 Sum_probs=179.4
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCccccEEEEEEeC--CeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
..+++.|+||++++... +.+.+|+.+|+.++ ||||++++++..+. ..+.+|+||.++.+...+. ..++
T Consensus 60 ~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly------~tl~ 130 (338)
T KOG0668|consen 60 ITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY------PTLT 130 (338)
T ss_pred cCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHh------hhhc
Confidence 46889999999987643 67889999999996 99999999999875 5678999999887776555 2477
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCC-CceEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED-MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~-~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
...+..++.++++||.|+|+.| |.|||+||.|++++.. ..++|+|||++.++...... +-++.+..|..||++
T Consensus 131 d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY---nVRVASRyfKGPELL 204 (338)
T KOG0668|consen 131 DYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELL 204 (338)
T ss_pred hhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCcee---eeeeehhhcCCchhe
Confidence 8899999999999999999999 9999999999999964 56999999999887654332 234567789999998
Q ss_pred ccCC-CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhC-----------------------CCcceec
Q 048243 159 RQGV-YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKG-----------------------GKGVEFV 214 (303)
Q Consensus 159 ~~~~-~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~ 214 (303)
..-. ++..-|+|||||++..|+..+.||.....+.. ++....+.+.. .......
T Consensus 205 Vdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D--QLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w 282 (338)
T KOG0668|consen 205 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPW 282 (338)
T ss_pred eechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH--HHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccH
Confidence 7654 78899999999999999999999865443322 11111111111 0011111
Q ss_pred cccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 215 DSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 215 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
............+++..+|+.++|..|..+|+||.|.+..
T Consensus 283 ~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 283 SRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 1122223334455688999999999999999999998764
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=242.69 Aligned_cols=228 Identities=24% Similarity=0.296 Sum_probs=183.3
Q ss_pred cCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 3 LPCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 3 ~~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.++|+.||||++.+.+ ..+..++++|+.+|+++.||.|+.+.-.|+.....++|||.+.| ++.+.+.. ...+.+++
T Consensus 586 RktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-DMLEMILS-sEkgRL~e 663 (888)
T KOG4236|consen 586 RKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-DMLEMILS-SEKGRLPE 663 (888)
T ss_pred cccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-hHHHHHHH-hhcccchH
Confidence 4689999999997653 44557899999999999999999999999999999999999965 55555533 24567999
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCC---CceEEcccccccccccCCccccccccccccCCCChhh
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED---MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~---~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 157 (303)
.....++.||+.||.|||.++ |+|+||||+|+|+... ..+||+|||.++.++.... ....+||+.|+|||+
T Consensus 664 r~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF---RrsVVGTPAYLaPEV 737 (888)
T KOG4236|consen 664 RITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF---RRSVVGTPAYLAPEV 737 (888)
T ss_pred HHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh---hhhhcCCccccCHHH
Confidence 999999999999999999999 9999999999999754 4699999999999876543 334689999999999
Q ss_pred hccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHc
Q 048243 158 ARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237 (303)
Q Consensus 158 ~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 237 (303)
+.+..|...-|+||.|+++|.-++|..||.... +..++++.. ........-...+....+||..+
T Consensus 738 LrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNA-------------aFMyPp~PW~eis~~AidlIn~L 802 (888)
T KOG4236|consen 738 LRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNA-------------AFMYPPNPWSEISPEAIDLINNL 802 (888)
T ss_pred HhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhcc-------------ccccCCCchhhcCHHHHHHHHHH
Confidence 999999999999999999999999999985322 111111111 01111122234455788999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 048243 238 VQENPNDRPSMLQVSS 253 (303)
Q Consensus 238 l~~dp~~Rpt~~el~~ 253 (303)
|++.-++|.|...-+.
T Consensus 803 LqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 803 LQVKMRKRYSVDKSLS 818 (888)
T ss_pred HHHHHHHhcchHhhcc
Confidence 9999999999877654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=253.19 Aligned_cols=225 Identities=25% Similarity=0.346 Sum_probs=174.9
Q ss_pred CcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCc-cccccCCHHHH
Q 048243 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDP-IRRLILDWKKR 83 (303)
Q Consensus 6 ~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~l~~~~~ 83 (303)
|+.||||.+-... ...+.+|+..|+.- +||||+++|+.-.+.+..|+..|.|. -+|.+++... ...........
T Consensus 533 ~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL~dlie~~~~d~~~~~~i~~ 608 (903)
T KOG1027|consen 533 GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSLQDLIESSGLDVEMQSDIDP 608 (903)
T ss_pred CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhHHHHHhccccchhhcccccH
Confidence 7889999886543 24678999999999 69999999999999999999999996 5899999653 11111111456
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC---C--CceEEcccccccccccCCc-cccccccccccCCCChhh
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE---D--MKPKISDFGLARIFAKESL-EANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~---~--~~v~l~Df~~~~~~~~~~~-~~~~~~~~g~~~y~aPE~ 157 (303)
+..+.|+++||++||+.+ |+||||||.||||+. + .+++|+|||+++....... ........||..|+|||.
T Consensus 609 ~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~ 685 (903)
T KOG1027|consen 609 ISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQ 685 (903)
T ss_pred HHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHH
Confidence 788999999999999999 999999999999976 3 4689999999998865533 344566789999999999
Q ss_pred hccCCCCCccchhhHHHHHHHHHhC-CCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 158 ARQGVYSTKSDVFSFGVLLLQIISG-KRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 158 ~~~~~~~~~~DiwslG~~~~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
+....-+.++||+||||++|+.++| .+||...- .+......+......+.+..+ . +..+||.+
T Consensus 686 L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~--------~R~~NIl~~~~~L~~L~~~~d------~--eA~dLI~~ 749 (903)
T KOG1027|consen 686 LREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL--------ERQANILTGNYTLVHLEPLPD------C--EAKDLISR 749 (903)
T ss_pred HhccccCcccchhhcCceEEEEecCCccCCCchH--------HhhhhhhcCccceeeeccCch------H--HHHHHHHH
Confidence 9998888899999999999999985 79986332 222233333332222222111 1 67799999
Q ss_pred cccCCCCCCCCHHHHHH
Q 048243 237 CVQENPNDRPSMLQVSS 253 (303)
Q Consensus 237 ~l~~dp~~Rpt~~el~~ 253 (303)
|+.++|..||+|.+++.
T Consensus 750 ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 750 MLNPDPQLRPSATDVLN 766 (903)
T ss_pred hcCCCcccCCCHHHHhC
Confidence 99999999999999875
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=254.30 Aligned_cols=181 Identities=23% Similarity=0.327 Sum_probs=129.4
Q ss_pred eEEEEeecCCCChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEccccccc
Q 048243 53 RMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 53 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~ 132 (303)
+|+=||||+..++.+++....... .....|+++++|++||+|+|+.| ++||||||.|||++.++.|||+|||++.
T Consensus 671 LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt 745 (1351)
T KOG1035|consen 671 LYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLAT 745 (1351)
T ss_pred EEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccch
Confidence 367788998877777774322111 46788999999999999999999 9999999999999999999999999997
Q ss_pred ccc------c----------CCccccccccccccCCCChhhhccCC---CCCccchhhHHHHHHHHHhCCCCCccCCCCc
Q 048243 133 IFA------K----------ESLEANTEQVVGTIGYIPPEYARQGV---YSTKSDVFSFGVLLLQIISGKRLSMLCGINE 193 (303)
Q Consensus 133 ~~~------~----------~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~ 193 (303)
... . .......+..+||.-|+|||++.+.. |+.|+|+||||++++||+. ||...
T Consensus 746 ~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts---- 818 (1351)
T KOG1035|consen 746 DLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS---- 818 (1351)
T ss_pred hhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCch----
Confidence 621 0 01112344578999999999998765 9999999999999999985 34211
Q ss_pred cccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 194 NLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
...+..... ++.+..+.. ..+. ......-..+|.+||+.||.+||||.|++.
T Consensus 819 -MERa~iL~~-LR~g~iP~~--~~f~----~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 819 -MERASILTN-LRKGSIPEP--ADFF----DPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred -HHHHHHHHh-cccCCCCCC--cccc----cccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 111111111 222222211 1111 112224457999999999999999999985
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-33 Score=249.48 Aligned_cols=230 Identities=27% Similarity=0.400 Sum_probs=191.0
Q ss_pred EEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHH
Q 048243 8 VIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86 (303)
Q Consensus 8 ~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~ 86 (303)
+||+|++.... .....++.+|+..|.+++|||++++++++..+. .-||++|++.|+|.+|++. .+..+.....+.|
T Consensus 727 pVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~--hr~~igsq~lLnw 803 (1177)
T KOG1025|consen 727 PVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVRE--HRDNIGSQDLLNW 803 (1177)
T ss_pred eeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHH--hhccccHHHHHHH
Confidence 58999886553 444578999999999999999999999998765 7899999999999999975 5667888999999
Q ss_pred HHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCCCc
Q 048243 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTK 166 (303)
Q Consensus 87 ~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 166 (303)
+.||++||.|||++. ++||||-..|+||..-..+|+.|||+++...............-.+.|+|-|.+....++.+
T Consensus 804 ~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thq 880 (1177)
T KOG1025|consen 804 CYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQ 880 (1177)
T ss_pred HHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCch
Confidence 999999999999998 99999999999999999999999999988776655444444445778999999999999999
Q ss_pred cchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 048243 167 SDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDR 245 (303)
Q Consensus 167 ~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 245 (303)
+||||||+++||++| |..|+......+..+.++. .-+.+.++.-+.+++-++.+||..|+..|
T Consensus 881 SDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~----------------geRLsqPpiCtiDVy~~mvkCwmid~~~r 944 (1177)
T KOG1025|consen 881 SDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK----------------GERLSQPPICTIDVYMVMVKCWMIDADSR 944 (1177)
T ss_pred hhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc----------------cccCCCCCCccHHHHHHHHHHhccCcccC
Confidence 999999999999998 8888766554443333221 12234455556688999999999999999
Q ss_pred CCHHHHHHHhcccc
Q 048243 246 PSMLQVSSMLKNET 259 (303)
Q Consensus 246 pt~~el~~~L~~~~ 259 (303)
|+++++...+.+..
T Consensus 945 p~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 945 PTFKELAEEFSRMA 958 (1177)
T ss_pred ccHHHHHHHHHHHh
Confidence 99999988765544
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-33 Score=219.99 Aligned_cols=245 Identities=22% Similarity=0.361 Sum_probs=177.6
Q ss_pred CCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEeC--------CeeEEEEeecCCCChhhhhcCcc
Q 048243 4 PCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--------EERMLVYEYMPNKSLDCYLFDPI 73 (303)
Q Consensus 4 ~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~ 73 (303)
++|+.||+|++-.. ...--....+|+.+|..++|+|++.++++|... ...|+||.+|+ .+|.-++.+
T Consensus 40 n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn-- 116 (376)
T KOG0669|consen 40 NTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCE-HDLAGLLSN-- 116 (376)
T ss_pred CccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhh-hhHHHHhcC--
Confidence 57888999976442 222234567899999999999999998887642 35799999996 477777743
Q ss_pred ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCc--cccccccccccC
Q 048243 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL--EANTEQVVGTIG 151 (303)
Q Consensus 74 ~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~--~~~~~~~~g~~~ 151 (303)
....++...+.+++.++..||.|+|... |+|||+||.|++++.+|.++|+|||+++.+..... ...-..++.|..
T Consensus 117 ~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLw 193 (376)
T KOG0669|consen 117 RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLW 193 (376)
T ss_pred ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeee
Confidence 3456899999999999999999999998 99999999999999999999999999976644322 222334566999
Q ss_pred CCChhhhccC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHH-----HHhCCCcceecccc----CCCC
Q 048243 152 YIPPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE-----LWKGGKGVEFVDSS----LDDT 221 (303)
Q Consensus 152 y~aPE~~~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~----~~~~ 221 (303)
|++||.+.+. .++++.|||..||++.+|+++.+.+...........+..... .|.+....++.... +...
T Consensus 194 YrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~ 273 (376)
T KOG0669|consen 194 YRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKG 273 (376)
T ss_pred cCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcc
Confidence 9999988765 589999999999999999999988765443333332222221 12211111111111 1111
Q ss_pred CC---H------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 222 NS---P------CKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 222 ~~---~------~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
.. . ....+..+|+.++|..||.+|+++.+++..
T Consensus 274 ~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 274 QKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred hhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 00 0 112367899999999999999999998753
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=251.07 Aligned_cols=230 Identities=21% Similarity=0.226 Sum_probs=182.2
Q ss_pred CCCcEEEEEEecCC---CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+++.||+|++++- ......-|..|-.+|..-+.+=|+.++..|.+...+|+||+||+||+|-.++.+ -..+++
T Consensus 98 ~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk---~~~~pE 174 (1317)
T KOG0612|consen 98 STEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSK---FDRLPE 174 (1317)
T ss_pred ccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhh---cCCChH
Confidence 56889999998762 233446788899999998999999999999999999999999999999988833 236999
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++..|.-||..||+.| +|||||||+|||++.+|++||+|||.+-.+...+.. .....+|||-|.+||++..
T Consensus 175 ~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V-~s~~aVGTPDYISPEvLqs 250 (1317)
T KOG0612|consen 175 DWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV-RSSVAVGTPDYISPEVLQS 250 (1317)
T ss_pred HHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCCcE-EeccccCCCCccCHHHHHh
Confidence 999999999999999999999 999999999999999999999999999888755432 2344689999999999863
Q ss_pred -----CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHH
Q 048243 161 -----GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235 (303)
Q Consensus 161 -----~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
..|+..+|.||+|+++|||+.|..||---+.. ....+...... .+........+.+..+||.
T Consensus 251 ~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv------eTY~KIm~hk~-------~l~FP~~~~VSeeakdLI~ 317 (1317)
T KOG0612|consen 251 QGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV------ETYGKIMNHKE-------SLSFPDETDVSEEAKDLIE 317 (1317)
T ss_pred hcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH------HHHHHHhchhh-------hcCCCcccccCHHHHHHHH
Confidence 35889999999999999999999999422221 11122222211 1112222346778889999
Q ss_pred HcccCCCCCCCC---HHHHHHH
Q 048243 236 LCVQENPNDRPS---MLQVSSM 254 (303)
Q Consensus 236 ~~l~~dp~~Rpt---~~el~~~ 254 (303)
+.+. +|+.|.. ++++...
T Consensus 318 ~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 318 ALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred HHhc-ChhhhcccccHHHHHhC
Confidence 8775 7888887 8888764
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=227.45 Aligned_cols=234 Identities=27% Similarity=0.358 Sum_probs=179.9
Q ss_pred CCCcEEEEEEecCCC-------cccHHHHHHHHHHHhcCCCCccccEEEEEEe-CCeeEEEEeecCCCChhhhhcCcccc
Q 048243 4 PCGKVIAVKKLSKTS-------TQGFEEFKNEVMLTAKLQHVNLIRVLGFCID-SEERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~~~~valK~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~ 75 (303)
...++||+|+-..+. ..-.+...+|..+-+.|+||.||++|++|.- ...+|-|+|||+|.+|.-||. ..
T Consensus 486 ~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLK---Qh 562 (775)
T KOG1151|consen 486 TEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLK---QH 562 (775)
T ss_pred chhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHH---hh
Confidence 457899999864332 1122456789999999999999999999874 467899999999999999984 56
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC---CCceEEcccccccccccCCccc-----cccccc
Q 048243 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE---DMKPKISDFGLARIFAKESLEA-----NTEQVV 147 (303)
Q Consensus 76 ~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~---~~~v~l~Df~~~~~~~~~~~~~-----~~~~~~ 147 (303)
..+++..++.|+.||+.||.||.+. ..+|+|.||||.|||+.+ .|.+||.|||+++.+....... ......
T Consensus 563 klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgA 641 (775)
T KOG1151|consen 563 KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGA 641 (775)
T ss_pred hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccC
Confidence 6799999999999999999999987 578999999999999954 4789999999999987765442 244578
Q ss_pred cccCCCChhhhc-c---CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCC
Q 048243 148 GTIGYIPPEYAR-Q---GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNS 223 (303)
Q Consensus 148 g~~~y~aPE~~~-~---~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
||.+|++||.+. + ..++.++||||+|+++|+++.|+.||...... .++++.. ..+. ...+....-
T Consensus 642 GTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdILqeN-TIlk--------AtEVqFP~K 710 (775)
T KOG1151|consen 642 GTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDILQEN-TILK--------ATEVQFPPK 710 (775)
T ss_pred ceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHHHhhh-chhc--------ceeccCCCC
Confidence 999999999764 2 23688999999999999999999999643222 1111111 1111 111222233
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 048243 224 PCKLMRCLEIALLCVQENPNDRPSMLQVS 252 (303)
Q Consensus 224 ~~~~~~l~~li~~~l~~dp~~Rpt~~el~ 252 (303)
|.++.+..+||++||.+--++|....++.
T Consensus 711 PvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 711 PVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred CccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 45566888999999999999999888875
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=235.52 Aligned_cols=241 Identities=20% Similarity=0.216 Sum_probs=183.1
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCC------CCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccC
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ------HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
-|+.||||+|..+.... +.=+.|+++|++|. --|+++++.+|...+++|||+|.+ ..+|.+.|..-..+..+
T Consensus 456 r~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL 533 (752)
T KOG0670|consen 456 RGQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGL 533 (752)
T ss_pred CCCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccce
Confidence 36789999997664332 34467999999994 238999999999999999999987 57898888765566778
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCC-CceEEcccccccccccCCccccccccccccCCCChhh
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED-MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~-~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 157 (303)
....+..++.|++-||..|..+| |+|.||||+|||++++ ..+||||||.|-..+.+...+ ......|.|||+
T Consensus 534 ~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneitP----YLVSRFYRaPEI 606 (752)
T KOG0670|consen 534 HIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSASFASENEITP----YLVSRFYRAPEI 606 (752)
T ss_pred eehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccccccccccccH----HHHHHhccCcce
Confidence 88999999999999999999999 9999999999999976 568999999987665543322 223668999999
Q ss_pred hccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHH-----Hh-CCCcceeccccC-------------
Q 048243 158 ARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL-----WK-GGKGVEFVDSSL------------- 218 (303)
Q Consensus 158 ~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~-~~~~~~~~~~~~------------- 218 (303)
+.+.+|+...|+||+||++|||+||+..|++...+..+.+....... +. +....+.++..+
T Consensus 607 iLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r 686 (752)
T KOG0670|consen 607 ILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTER 686 (752)
T ss_pred eecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccc
Confidence 99999999999999999999999999999876655444433322111 11 000011111100
Q ss_pred ------------------------CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 219 ------------------------DDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 219 ------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
.....+.....+.+|+.+||..||++|.|..+.+..
T Consensus 687 ~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 687 EKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred eeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence 011123445678999999999999999999988753
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=204.46 Aligned_cols=181 Identities=23% Similarity=0.327 Sum_probs=150.3
Q ss_pred cCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc-ccccCC
Q 048243 3 LPCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-RRLILD 79 (303)
Q Consensus 3 ~~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~l~ 79 (303)
.++|+.+|+|.+...- ....+++.+|+.+..+. .+|+++.+|+.+......++.||.|+ .+|..+..... .++.++
T Consensus 68 ~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-tSldkfy~~v~~~g~~ip 146 (282)
T KOG0984|consen 68 IQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-TSLDKFYRKVLKKGGTIP 146 (282)
T ss_pred ccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-hhHHHHHHHHHhcCCcCc
Confidence 4789999999997553 33456778888887776 79999999999999999999999995 57877665433 467899
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..+-+++..++.||.|||++- .++|||+||+|||++..|++|++|||++..+.+.-. .....|-..|+|||.+.
T Consensus 147 E~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA---kt~daGCkpYmaPEri~ 221 (282)
T KOG0984|consen 147 EDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA---KTMDAGCKPYMAPERIN 221 (282)
T ss_pred hHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhH---HHHhcCCCccCChhhcC
Confidence 9999999999999999999964 599999999999999999999999999876544321 12245778899999886
Q ss_pred c----CCCCCccchhhHHHHHHHHHhCCCCCccC
Q 048243 160 Q----GVYSTKSDVFSFGVLLLQIISGKRLSMLC 189 (303)
Q Consensus 160 ~----~~~~~~~DiwslG~~~~~l~~g~~p~~~~ 189 (303)
. ..|+-++||||||+++.||.+++.|+...
T Consensus 222 ~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 222 PELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred cccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 4 36889999999999999999999998533
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=219.25 Aligned_cols=238 Identities=26% Similarity=0.269 Sum_probs=175.3
Q ss_pred CCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeC------CeeEEEEeecCCCChhhhhcCccccc
Q 048243 5 CGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------EERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 5 ~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~ 76 (303)
.+++||+|++.... ....++..+|+.++..+.|+||++++.+|.-. ...|+|||+|+ .+|...+. -
T Consensus 40 ~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~-----~ 113 (369)
T KOG0665|consen 40 LGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVIL-----M 113 (369)
T ss_pred ccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHH-----H
Confidence 47889999886542 23446788999999999999999999999754 36799999996 57777764 2
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChh
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE 156 (303)
.++-..+..++.|++.|++|||+.| |+||||||+||++..+..+|+.|||+++.-+.. -.....+.+..|+|||
T Consensus 114 elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrape 187 (369)
T KOG0665|consen 114 ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPE 187 (369)
T ss_pred hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc---cccCchhheeeccCch
Confidence 3677889999999999999999999 999999999999999999999999999764332 2334456788999999
Q ss_pred hhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCcccc---------------HHHHHHH-HHhCCC-------ccee
Q 048243 157 YARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLS---------------ILEHAYE-LWKGGK-------GVEF 213 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~---------------~~~~~~~-~~~~~~-------~~~~ 213 (303)
++.+..+...+||||+||++.||++|...|.+...-+... .+..... ...... ...+
T Consensus 188 vil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~f 267 (369)
T KOG0665|consen 188 VILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELF 267 (369)
T ss_pred heeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhC
Confidence 9999999999999999999999999998886422111110 0000000 000000 0000
Q ss_pred ccccCCC--CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 214 VDSSLDD--TNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 214 ~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
.+..+.. ...+.....+.+++.+||..||++|.++++++..
T Consensus 268 pD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 268 PDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred CcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 1111110 1112333457899999999999999999999875
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=223.23 Aligned_cols=218 Identities=23% Similarity=0.270 Sum_probs=173.8
Q ss_pred CCcEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 5 CGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 5 ~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
+.+.+|||++++.. +.+.+--+.|-.+|... +-|+++.++.+|..-.++|+||||+.||+|--.++ .-+.+.+
T Consensus 373 tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQ---Q~GkFKE 449 (683)
T KOG0696|consen 373 TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ---QVGKFKE 449 (683)
T ss_pred cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHH---HhcccCC
Confidence 56789999998763 33334445677777776 67889999999999999999999999999976663 4456888
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..+..++.+|+-||-+||++| |++||||.+|+|++..|.+||.|||+++.--.. ......+.||+.|+|||++..
T Consensus 450 p~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~--~~TTkTFCGTPdYiAPEIi~Y 524 (683)
T KOG0696|consen 450 PVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD--GVTTKTFCGTPDYIAPEIIAY 524 (683)
T ss_pred chhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccccC--CcceeeecCCCcccccceEEe
Confidence 899999999999999999999 999999999999999999999999999753322 233445789999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
.+|..++|.||+|+++|||+.|++||.+....+....+. +. ..+.+...+.+..++++..|..
T Consensus 525 qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~---eh--------------nvsyPKslSkEAv~ickg~ltK 587 (683)
T KOG0696|consen 525 QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM---EH--------------NVSYPKSLSKEAVAICKGLLTK 587 (683)
T ss_pred cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH---Hc--------------cCcCcccccHHHHHHHHHHhhc
Confidence 999999999999999999999999997554332111111 10 1223334455788999999999
Q ss_pred CCCCCCC
Q 048243 241 NPNDRPS 247 (303)
Q Consensus 241 dp~~Rpt 247 (303)
+|.+|..
T Consensus 588 ~P~kRLG 594 (683)
T KOG0696|consen 588 HPGKRLG 594 (683)
T ss_pred CCccccC
Confidence 9999954
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=217.68 Aligned_cols=244 Identities=23% Similarity=0.313 Sum_probs=179.5
Q ss_pred CCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEeC-----CeeEEEEeecCCCChhhhhcCcccccc
Q 048243 5 CGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-----EERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 5 ~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
+|+.||+|++... .-...+.+.+|+.+|..++|.|++..+++..-. ++.|+++|.|. .+|+..+. +...
T Consensus 77 dgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ-SDLHKIIV---SPQ~ 152 (449)
T KOG0664|consen 77 SGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQ-SDLHKIIV---SPQA 152 (449)
T ss_pred CccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHH-hhhhheec---cCCC
Confidence 6899999998543 234567889999999999999999999887543 36688999885 57877774 5567
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhh
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 157 (303)
++...+.-+++||++||+|||+.+ |.||||||.|++++.|-.+||+|||+++....... ......+-|..|+|||+
T Consensus 153 Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~-~hMTqEVVTQYYRAPEi 228 (449)
T KOG0664|consen 153 LTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR-LNMTHEVVTQYYRAPEL 228 (449)
T ss_pred CCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhhh-hhhHHHHHHHHhccHHH
Confidence 888999999999999999999999 99999999999999999999999999987544332 22333456899999999
Q ss_pred hccCC-CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHH------------HH-----HHhCCCcceeccccCC
Q 048243 158 ARQGV-YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA------------YE-----LWKGGKGVEFVDSSLD 219 (303)
Q Consensus 158 ~~~~~-~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~------------~~-----~~~~~~~~~~~~~~~~ 219 (303)
+.+.. |+.+.||||.||++.|++.++..|.-.++....+.+-.. .+ .++......-..-...
T Consensus 229 LMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYt 308 (449)
T KOG0664|consen 229 LMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYK 308 (449)
T ss_pred hhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceee
Confidence 98875 899999999999999999999888765544433322111 00 0111100000000000
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048243 220 DTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSMLK 256 (303)
Q Consensus 220 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~ 256 (303)
.+.+.....+..+++.++|..||++|.+.++.+..+-
T Consensus 309 lsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 309 IASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred ecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 0111122234567899999999999999999887653
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=211.05 Aligned_cols=226 Identities=19% Similarity=0.300 Sum_probs=175.2
Q ss_pred CCCcEEEEEEecCC---CcccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
++.+.+|+|++++. ++.+.+-.+.|-....+- +||+++.++.+|.....+++|.||.+||+|--.+ .+...++
T Consensus 273 ~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhm---qrqrklp 349 (593)
T KOG0695|consen 273 KTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM---QRQRKLP 349 (593)
T ss_pred ccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeeh---hhhhcCc
Confidence 56788999999765 334444566777777776 7999999999999999999999999999985554 3445699
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
++.++.+..+|+-||.|||+.| |++||+|.+|++++..|.+||.|+|+++.-... ......+.||+.|.|||++.
T Consensus 350 eeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~--gd~tstfcgtpnyiapeilr 424 (593)
T KOG0695|consen 350 EEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP--GDTTSTFCGTPNYIAPEILR 424 (593)
T ss_pred HHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCC--CcccccccCCCcccchhhhc
Confidence 9999999999999999999999 999999999999999999999999999753322 34455689999999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCcc-ccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINEN-LSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 238 (303)
+..|....|.|+||++++||+.|+.||...+.... .+.-.......-. ... ..+...+.....+++.-|
T Consensus 425 geeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile--------kqi--riprslsvkas~vlkgfl 494 (593)
T KOG0695|consen 425 GEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE--------KQI--RIPRSLSVKASHVLKGFL 494 (593)
T ss_pred ccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh--------hcc--cccceeehhhHHHHHHhh
Confidence 99999999999999999999999999987664321 1111111111110 000 011122234557889999
Q ss_pred cCCCCCCCC
Q 048243 239 QENPNDRPS 247 (303)
Q Consensus 239 ~~dp~~Rpt 247 (303)
..||.+|..
T Consensus 495 nkdp~erlg 503 (593)
T KOG0695|consen 495 NKDPKERLG 503 (593)
T ss_pred cCCcHHhcC
Confidence 999999953
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-29 Score=200.69 Aligned_cols=196 Identities=34% Similarity=0.522 Sum_probs=168.8
Q ss_pred CCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 5 CGKVIAVKKLSKTSTQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~~~~valK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
+|+.+++|++...... ..+.+.+|+..++.++|++|+++++++......++++|++.+++|.+++... ...++...+
T Consensus 17 ~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~--~~~~~~~~~ 94 (215)
T cd00180 17 TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKEN--EGKLSEDEI 94 (215)
T ss_pred CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhc--cCCCCHHHH
Confidence 4899999999766432 3567899999999999999999999999989999999999999999998432 146889999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC-CCceEEcccccccccccCCccccccccccccCCCChhhhccC-
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG- 161 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~- 161 (303)
+.++.+++.++++||+.+ ++|+||+|.||+++. ++.++|+||+.+........ ......+...|.+||.+...
T Consensus 95 ~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~ 169 (215)
T cd00180 95 LRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKG 169 (215)
T ss_pred HHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhcccC
Confidence 999999999999999998 999999999999999 89999999999876544321 12224568889999998877
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
..+.++|+|++|++++++ ..+.+++.+|+..|
T Consensus 170 ~~~~~~D~~~lg~~~~~l------------------------------------------------~~~~~~l~~~l~~~ 201 (215)
T cd00180 170 YYSEKSDIWSLGVILYEL------------------------------------------------PELKDLIRKMLQKD 201 (215)
T ss_pred CCCchhhhHHHHHHHHHH------------------------------------------------HHHHHHHHHHhhCC
Confidence 778899999999999998 36778999999999
Q ss_pred CCCCCCHHHHHHHh
Q 048243 242 PNDRPSMLQVSSML 255 (303)
Q Consensus 242 p~~Rpt~~el~~~L 255 (303)
|.+||++.+++..+
T Consensus 202 p~~R~~~~~l~~~~ 215 (215)
T cd00180 202 PEKRPSAKEILEHL 215 (215)
T ss_pred cccCcCHHHHhhCC
Confidence 99999999998653
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=224.17 Aligned_cols=183 Identities=26% Similarity=0.368 Sum_probs=151.6
Q ss_pred CCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTST---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
++...+|.|.+.+.+. .+....+.|-.+|..-+.+-||++|..|.++..+|+||+|++||++-.+| .+.+.+++
T Consensus 652 DT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLL---IrmgIFeE 728 (1034)
T KOG0608|consen 652 DTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLL---IRMGIFEE 728 (1034)
T ss_pred chhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHH---HHhccCHH
Confidence 3445566676655432 23345677899999999999999999999999999999999999998888 45677999
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccc---------cCC--------ccc--
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFA---------KES--------LEA-- 141 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~---------~~~--------~~~-- 141 (303)
..++.++.++..|+++.|..| ++||||||+|||||.+|.+||.|||++.-+. .+. ...
T Consensus 729 ~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~ 805 (1034)
T KOG0608|consen 729 DLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEW 805 (1034)
T ss_pred HHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhh
Confidence 999999999999999999999 9999999999999999999999999985431 000 000
Q ss_pred --------c-------------ccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCC
Q 048243 142 --------N-------------TEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGIN 192 (303)
Q Consensus 142 --------~-------------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~ 192 (303)
. ....+||+.|+|||++....++..+|.||.|+++|+|+.|+.||-.....
T Consensus 806 ~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 806 ADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPG 877 (1034)
T ss_pred ccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCC
Confidence 0 01246999999999999999999999999999999999999999655544
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=227.80 Aligned_cols=235 Identities=19% Similarity=0.113 Sum_probs=144.1
Q ss_pred CcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEE------EEeCCeeEEEEeecCCCChhhhhcCccc-----
Q 048243 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGF------CIDSEERMLVYEYMPNKSLDCYLFDPIR----- 74 (303)
Q Consensus 6 ~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~------~~~~~~~~lv~e~~~~~~L~~~l~~~~~----- 74 (303)
++.||+|++...... +....+ .+....+.++..++.. .......++|++|+.+++|.+++.....
T Consensus 161 ~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~ 236 (566)
T PLN03225 161 EGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVE 236 (566)
T ss_pred CcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHH
Confidence 789999998643221 111111 1222222222222211 2345678999999999999988854211
Q ss_pred ------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC-CCceEEcccccccccccCCccc
Q 048243 75 ------------RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-DMKPKISDFGLARIFAKESLEA 141 (303)
Q Consensus 75 ------------~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-~~~v~l~Df~~~~~~~~~~~~~ 141 (303)
+.......+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||++..+.... ..
T Consensus 237 ~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~-~~ 312 (566)
T PLN03225 237 PYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGI-NY 312 (566)
T ss_pred HHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHEEEeCCCCcEEEEeCCCcccccccc-cc
Confidence 011123456789999999999999998 999999999999986 5789999999997653322 12
Q ss_pred cccccccccCCCChhhhccC----------------------CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHH
Q 048243 142 NTEQVVGTIGYIPPEYARQG----------------------VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILE 199 (303)
Q Consensus 142 ~~~~~~g~~~y~aPE~~~~~----------------------~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~ 199 (303)
......+++.|+|||.+... .++.++|||||||++|+|+++..++... .....
T Consensus 313 ~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~-----~~~~~ 387 (566)
T PLN03225 313 IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSN-----LIQFN 387 (566)
T ss_pred CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCchH-----HHHHH
Confidence 22345789999999966422 2344679999999999999866553210 00000
Q ss_pred HHH-------HHHhCCCcceeccccCC--CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 200 HAY-------ELWKGGKGVEFVDSSLD--DTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 200 ~~~-------~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
... ..|....... ...... ...........++|+.+||+.||++|||+.++++.
T Consensus 388 ~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 388 RQLKRNDYDLVAWRKLVEPR-ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHHHhcCCcHHHHHHhhccc-cchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCC
Confidence 000 0111000000 000000 00000112245689999999999999999999874
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=221.51 Aligned_cols=242 Identities=20% Similarity=0.204 Sum_probs=160.9
Q ss_pred CCCcEEEEEEecCCCcccHHH--------------HHHHHHHHhcCCCCcc-----ccEEEEEEe--------CCeeEEE
Q 048243 4 PCGKVIAVKKLSKTSTQGFEE--------------FKNEVMLTAKLQHVNL-----IRVLGFCID--------SEERMLV 56 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~--------------~~~e~~~l~~l~h~~i-----~~~~~~~~~--------~~~~~lv 56 (303)
.+++.||||+++.......+. ...|+..+.+++|.++ +++++++.. ....++|
T Consensus 184 ~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV 263 (507)
T PLN03224 184 QKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLV 263 (507)
T ss_pred ccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEE
Confidence 456789999987543322222 3346677777766543 667777653 3467999
Q ss_pred EeecCCCChhhhhcCcc---------------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCce
Q 048243 57 YEYMPNKSLDCYLFDPI---------------------RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115 (303)
Q Consensus 57 ~e~~~~~~L~~~l~~~~---------------------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~ni 115 (303)
|||+.+++|.+++.... ....+++..++.++.|++.+|.|||+.+ ++||||||+||
T Consensus 264 ~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NI 340 (507)
T PLN03224 264 WKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENL 340 (507)
T ss_pred EEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhE
Confidence 99999999998885311 1123456788999999999999999998 99999999999
Q ss_pred EECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC----------------------CCCccchhhHH
Q 048243 116 LLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV----------------------YSTKSDVFSFG 173 (303)
Q Consensus 116 l~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----------------------~~~~~DiwslG 173 (303)
+++.++.++|+|||++........ .......+++.|+|||.+.... ...+.||||+|
T Consensus 341 Ll~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlG 419 (507)
T PLN03224 341 LVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAG 419 (507)
T ss_pred EECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHH
Confidence 999999999999999865433211 1111233478999999875322 12347999999
Q ss_pred HHHHHHHhCCC-CCccCCC-CccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC---CCCCCH
Q 048243 174 VLLLQIISGKR-LSMLCGI-NENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP---NDRPSM 248 (303)
Q Consensus 174 ~~~~~l~~g~~-p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp---~~Rpt~ 248 (303)
|++++|+++.. |+..... .............|.... ............+...++|+.+||..+| .+|+|+
T Consensus 420 vil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~-----~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa 494 (507)
T PLN03224 420 VLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK-----GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSV 494 (507)
T ss_pred HHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc-----ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCH
Confidence 99999999874 5532211 111111111111121111 1111122223345678899999999766 789999
Q ss_pred HHHHHH
Q 048243 249 LQVSSM 254 (303)
Q Consensus 249 ~el~~~ 254 (303)
.|+++.
T Consensus 495 ~eaL~H 500 (507)
T PLN03224 495 GQALSH 500 (507)
T ss_pred HHHhCC
Confidence 999864
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=208.78 Aligned_cols=109 Identities=22% Similarity=0.270 Sum_probs=90.1
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-----CC---ccccEEEEEEe----CCeeEEEEeecCCCChhhhhcC
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-----HV---NLIRVLGFCID----SEERMLVYEYMPNKSLDCYLFD 71 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-----h~---~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~ 71 (303)
++.+.||+|+.+... .-.+..+.||.+|++++ |+ +||++++.|.. ..++|||+|++ |.+|..+|..
T Consensus 101 q~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~ 178 (590)
T KOG1290|consen 101 QNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKY 178 (590)
T ss_pred cCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHH
Confidence 578899999996543 34467889999999983 32 69999999985 46899999998 6678788765
Q ss_pred ccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEE
Q 048243 72 PIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117 (303)
Q Consensus 72 ~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~ 117 (303)
. .-..++...++.|++||+.||.|||... +|+|.||||+|||+
T Consensus 179 s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 179 S-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred h-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 3 3456899999999999999999999854 49999999999999
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=210.39 Aligned_cols=237 Identities=23% Similarity=0.293 Sum_probs=182.4
Q ss_pred CCcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCccccEEEEEEeC-CeeEEEEeecCCCChhhhhc-----Ccccccc
Q 048243 5 CGKVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-EERMLVYEYMPNKSLDCYLF-----DPIRRLI 77 (303)
Q Consensus 5 ~~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~-----~~~~~~~ 77 (303)
+.+.|-+|.++.. ...+...+..|...+..+.|||++.+.++...+ ..++++++++.-|+|..|+. ++.....
T Consensus 313 ~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqt 392 (563)
T KOG1024|consen 313 DCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQT 392 (563)
T ss_pred hHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccc
Confidence 3344555555444 233455788899999999999999999987654 57889999999999999998 5555667
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhh
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 157 (303)
+...+...++.|++.|++|||..+ ++|.||...|+++++.-++||+|=.+++..-.......-...-.+..||+||.
T Consensus 393 vtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEa 469 (563)
T KOG1024|consen 393 VTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEA 469 (563)
T ss_pred hhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHH
Confidence 788888999999999999999999 99999999999999999999999998876544433322222334678999999
Q ss_pred hccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 158 ARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 158 ~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
+.+..++.++|+||||+++|||++ |+.|+....+.+. ...+.++... .++...+.++..++.-
T Consensus 470 l~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm-------~~ylkdGyRl---------aQP~NCPDeLf~vMac 533 (563)
T KOG1024|consen 470 LQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM-------EHYLKDGYRL---------AQPFNCPDELFTVMAC 533 (563)
T ss_pred HhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH-------HHHHhcccee---------cCCCCCcHHHHHHHHH
Confidence 999999999999999999999998 7777643332221 1222222222 2222233488899999
Q ss_pred cccCCCCCCCCHHHHHHHhccccC
Q 048243 237 CVQENPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 237 ~l~~dp~~Rpt~~el~~~L~~~~~ 260 (303)
||..+|++||+++++..-|.+...
T Consensus 534 CWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 534 CWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred HHhcCcccCCCHHHHHHHHHHHHH
Confidence 999999999999999988876543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=241.21 Aligned_cols=197 Identities=17% Similarity=0.167 Sum_probs=136.5
Q ss_pred cCCC-CccccEEEEEE-------eCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 048243 34 KLQH-VNLIRVLGFCI-------DSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTI 105 (303)
Q Consensus 34 ~l~h-~~i~~~~~~~~-------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i 105 (303)
.++| +||+.+++.+. .....++++|++ +++|.+++.. ....+++..++.++.||+.||+|||++| |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4455 57888888772 234567788877 6699999854 2355899999999999999999999999 9
Q ss_pred EecCCCCCceEECCCCc-------------------eEEcccccccccccCCc--------------cccccccccccCC
Q 048243 106 IHRDLKASNILLGEDMK-------------------PKISDFGLARIFAKESL--------------EANTEQVVGTIGY 152 (303)
Q Consensus 106 ~H~dikp~nil~~~~~~-------------------v~l~Df~~~~~~~~~~~--------------~~~~~~~~g~~~y 152 (303)
+||||||+|||++..|. ++++|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999965444 55555555543211000 0001113578889
Q ss_pred CChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHH
Q 048243 153 IPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLE 232 (303)
Q Consensus 153 ~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 232 (303)
+|||++.+..++.++|||||||++|||++|..|+.... .... ..... ...+. .........+
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~----~~~~~----~~~~~-----~~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMS----SLRHR----VLPPQ-----ILLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHH----HHHHh----hcChh-----hhhcCHHHHH
Confidence 99999999999999999999999999999887753211 0000 00000 00000 0111234568
Q ss_pred HHHHcccCCCCCCCCHHHHHHH
Q 048243 233 IALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 233 li~~~l~~dp~~Rpt~~el~~~ 254 (303)
++.+||++||.+||++.|+++.
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhc
Confidence 8999999999999999999763
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-29 Score=222.27 Aligned_cols=230 Identities=22% Similarity=0.295 Sum_probs=182.8
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+|+..|+|+++.......+-+++|+-+++..+||||+.+++.+......++.||||.+|+|.+..+ ..+++.+.++
T Consensus 38 ~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~---~Tgplselqi 114 (829)
T KOG0576|consen 38 RSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYH---VTGPLSELQI 114 (829)
T ss_pred ccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceee---ecccchhHHH
Confidence 4788999999998877777888999999999999999999999999999999999999999988762 4667999999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhh---cc
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA---RQ 160 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~---~~ 160 (303)
...++..+.|++|||+.| -+|||||-.||++++.|.+++.|||.+..++.. -.....+.||+.|||||+- ..
T Consensus 115 ayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat--i~KrksfiGtpywmapEvaaverk 189 (829)
T KOG0576|consen 115 AYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVAAVERK 189 (829)
T ss_pred HHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh--hhhhhcccCCccccchhHHHHHhc
Confidence 999999999999999999 999999999999999999999999998665432 2233457899999999965 34
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..|...+|||++|++.-|+-..++|-....... ...+.. ....+ .........+++.+.+|++.+|..
T Consensus 190 ggynqlcdiwa~gitAiel~eLqpplfdlhpmr-------~l~LmT-kS~~q----pp~lkDk~kws~~fh~fvK~altk 257 (829)
T KOG0576|consen 190 GGYNQLCDIWALGITAIELGELQPPLFDLHPMR-------ALFLMT-KSGFQ----PPTLKDKTKWSEFFHNFVKGALTK 257 (829)
T ss_pred ccccccccccccccchhhhhhcCCcccccchHH-------HHHHhh-ccCCC----CCcccCCccchHHHHHHHHHHhcC
Confidence 568899999999999999988776632211111 111111 11100 011112234556788999999999
Q ss_pred CCCCCCCHHHHHH
Q 048243 241 NPNDRPSMLQVSS 253 (303)
Q Consensus 241 dp~~Rpt~~el~~ 253 (303)
+|.+|||++.+++
T Consensus 258 npKkRptaeklL~ 270 (829)
T KOG0576|consen 258 NPKKRPTAEKLLQ 270 (829)
T ss_pred CCccCCChhhhee
Confidence 9999999987765
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-28 Score=190.17 Aligned_cols=167 Identities=20% Similarity=0.137 Sum_probs=123.7
Q ss_pred CChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcccc
Q 048243 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEAN 142 (303)
Q Consensus 63 ~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~ 142 (303)
|+|.+++.. .+..+++..++.++.|++.||+|||+.+ ||+||+++.++.+++ ||.+.......
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 678888843 2456999999999999999999999875 999999999999999 99887654321
Q ss_pred ccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCC
Q 048243 143 TEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTN 222 (303)
Q Consensus 143 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (303)
..|++.|+|||++.+..++.++|||||||++|+|++|..||....... ............. .. .....
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~------~~-~~~~~ 131 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPAD------DP-RDRSN 131 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccC------Cc-ccccc
Confidence 257899999999999999999999999999999999999985432211 1111111111100 00 00011
Q ss_pred CHHHHH--HHHHHHHHcccCCCCCCCCHHHHHHHhccc
Q 048243 223 SPCKLM--RCLEIALLCVQENPNDRPSMLQVSSMLKNE 258 (303)
Q Consensus 223 ~~~~~~--~l~~li~~~l~~dp~~Rpt~~el~~~L~~~ 258 (303)
...... .+.+++.+||..||.+||++.|+++.+...
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 122222 689999999999999999999999886543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=214.05 Aligned_cols=172 Identities=23% Similarity=0.346 Sum_probs=147.0
Q ss_pred CCcEEEEEEecCCCc---cc-----HHHHHHHHHHHhcCC---CCccccEEEEEEeCCeeEEEEee-cCCCChhhhhcCc
Q 048243 5 CGKVIAVKKLSKTST---QG-----FEEFKNEVMLTAKLQ---HVNLIRVLGFCIDSEERMLVYEY-MPNKSLDCYLFDP 72 (303)
Q Consensus 5 ~~~~valK~~~~~~~---~~-----~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~ 72 (303)
+...|+||.+.+.+- .+ .-.+-.||++|..++ |+||++++++|+++..+|++||. -++.+|.+++.
T Consensus 585 n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE-- 662 (772)
T KOG1152|consen 585 NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIE-- 662 (772)
T ss_pred cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhh--
Confidence 467799999876531 11 112446999999996 99999999999999999999995 46788999994
Q ss_pred cccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCC
Q 048243 73 IRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGY 152 (303)
Q Consensus 73 ~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y 152 (303)
....+++.....++.|++-|+++||+.| |+|||||-+|+.++.+|.+||+|||.+....++. ...++||..|
T Consensus 663 -~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa~~ksgp----fd~f~gtv~~ 734 (772)
T KOG1152|consen 663 -FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGP----FDVFVGTVDY 734 (772)
T ss_pred -ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchhhhcCCC----cceeeeeccc
Confidence 5667999999999999999999999999 9999999999999999999999999987765543 3347899999
Q ss_pred CChhhhccCCC-CCccchhhHHHHHHHHHhCCCCC
Q 048243 153 IPPEYARQGVY-STKSDVFSFGVLLLQIISGKRLS 186 (303)
Q Consensus 153 ~aPE~~~~~~~-~~~~DiwslG~~~~~l~~g~~p~ 186 (303)
.|||++.+..| ....|||+||+++|.++....||
T Consensus 735 aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 735 AAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred cchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 99999999887 55689999999999999888876
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-26 Score=189.16 Aligned_cols=176 Identities=36% Similarity=0.503 Sum_probs=151.9
Q ss_pred CCcEEEEEEecCCCcc-cHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcccccc-CCHHH
Q 048243 5 CGKVIAVKKLSKTSTQ-GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI-LDWKK 82 (303)
Q Consensus 5 ~~~~valK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-l~~~~ 82 (303)
+++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++......++++|++.+++|.+++.. ... +++..
T Consensus 23 ~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~ 99 (225)
T smart00221 23 TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRK---KGGKLSEEE 99 (225)
T ss_pred CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHh---cccCCCHHH
Confidence 4789999999866544 567899999999999999999999999998999999999999999998843 222 78899
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhh-ccC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA-RQG 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~-~~~ 161 (303)
++.++.+++.++.+||+.+ ++|+||+|.|++++.++.++|+|||.+........ .......++..|++||.+ ...
T Consensus 100 ~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~ 175 (225)
T smart00221 100 ARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLKTVKGTPFYLAPEVLLGGK 175 (225)
T ss_pred HHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccccceeccCCcCCHhHhcCCC
Confidence 9999999999999999998 99999999999999999999999999877654321 122234567889999998 666
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCc
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSM 187 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~ 187 (303)
.++.++|+|+||+++++|++|+.||.
T Consensus 176 ~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 176 GYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 77889999999999999999999984
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=185.21 Aligned_cols=229 Identities=20% Similarity=0.288 Sum_probs=169.4
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCccccEEEE-EEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGF-CIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
++++.+++|-+..... ...+|.+|...--.| -|.||+..|+. |......++++||++.|+|..-+ ....+.+.
T Consensus 47 ~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv----~~~GigE~ 121 (378)
T KOG1345|consen 47 QSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNV----EAAGIGEA 121 (378)
T ss_pred CCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhc----CcccccHH
Confidence 5778899998865533 347888998877777 58899987776 45556778999999999998777 33558889
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC--CCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE--DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~--~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
...+++.|+++|+.|+|+++ +||||||.+|||+-. ..+|||+|||..+..+..- ...-....|.+||...
T Consensus 122 ~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV-----~~~~~~~~y~~pe~~~ 193 (378)
T KOG1345|consen 122 NTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV-----KYLEYVNNYHAPELCD 193 (378)
T ss_pred HHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCcee-----hhhhhhcccCCcHHHh
Confidence 99999999999999999999 999999999999953 3479999999987654332 2223366799999765
Q ss_pred cC-----CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHH
Q 048243 160 QG-----VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIA 234 (303)
Q Consensus 160 ~~-----~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
.. ...+.+|||.||+++|.+++|..||.-....+ .....+..|..+......+ .....++.++.+.
T Consensus 194 ~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d---~~Y~~~~~w~~rk~~~~P~------~F~~fs~~a~r~F 264 (378)
T KOG1345|consen 194 TVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD---KPYWEWEQWLKRKNPALPK------KFNPFSEKALRLF 264 (378)
T ss_pred hccccceEecccccchheeeeeeeeecCCCcchhhhccC---chHHHHHHHhcccCccCch------hhcccCHHHHHHH
Confidence 32 24678999999999999999999997443333 1222344555444332221 1223455788899
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 048243 235 LLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 235 ~~~l~~dp~~Rpt~~el~~~ 254 (303)
++-|..++++|--+.+....
T Consensus 265 kk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 265 KKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred HHhcCCcccccchhHHHHHH
Confidence 99999999999555554443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-26 Score=190.83 Aligned_cols=238 Identities=21% Similarity=0.300 Sum_probs=173.1
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
..+.||+|.+..... ...+..|+++|..+ -+.||+++.+++..+...++|+||++.....+++.. ++...+
T Consensus 63 ~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~------l~~~~i 134 (418)
T KOG1167|consen 63 KRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS------LSLAEI 134 (418)
T ss_pred ccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHhc------CCHHHH
Confidence 578899999865532 35789999999999 589999999999999999999999998888888743 668899
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCC-CceEEcccccccccccC-------C-----------------
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED-MKPKISDFGLARIFAKE-------S----------------- 138 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~-~~v~l~Df~~~~~~~~~-------~----------------- 138 (303)
..+++.++.||+++|.+| |+||||||+|++.+.. +.-.|.|||++...... .
T Consensus 135 ~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~ 211 (418)
T KOG1167|consen 135 RWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQ 211 (418)
T ss_pred HHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCccccc
Confidence 999999999999999999 9999999999999864 66899999998721100 0
Q ss_pred ----------c--------cccccccccccCCCChhhhccC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCcc-cc--
Q 048243 139 ----------L--------EANTEQVVGTIGYIPPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINEN-LS-- 196 (303)
Q Consensus 139 ----------~--------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~-~~-- 196 (303)
. ......+.||+.|+|||++... ..+++.||||.|+++..++++++||........ ..
T Consensus 212 ~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei 291 (418)
T KOG1167|consen 212 SVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEI 291 (418)
T ss_pred ccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHH
Confidence 0 0001124699999999987654 478899999999999999999999864332211 00
Q ss_pred -------HHHHHHHHHhCC-------Ccce---------ec--cccCC--------CCCCHHHHHHHHHHHHHcccCCCC
Q 048243 197 -------ILEHAYELWKGG-------KGVE---------FV--DSSLD--------DTNSPCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 197 -------~~~~~~~~~~~~-------~~~~---------~~--~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~ 243 (303)
.+... ....+. .... .+ ..... .......+..+++++.+||..||.
T Consensus 292 ~tifG~~~mrk~-A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~ 370 (418)
T KOG1167|consen 292 ATIFGSAEMRKC-AALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQ 370 (418)
T ss_pred HHHhChHHHHHH-hhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChh
Confidence 00000 011111 0000 00 00001 011122334789999999999999
Q ss_pred CCCCHHHHHHH
Q 048243 244 DRPSMLQVSSM 254 (303)
Q Consensus 244 ~Rpt~~el~~~ 254 (303)
+|.|+++.+..
T Consensus 371 kRitAEeALkH 381 (418)
T KOG1167|consen 371 KRITAEDALKH 381 (418)
T ss_pred hcccHHHHhcC
Confidence 99999998864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-24 Score=199.01 Aligned_cols=214 Identities=22% Similarity=0.273 Sum_probs=163.6
Q ss_pred HHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 048243 25 FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLT 104 (303)
Q Consensus 25 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~ 104 (303)
+..|+.+-..++|+|++..+..+.+.....-.||||++ +|..++. ....+....+-.++.|++.|++|+|+.|
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--- 440 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSMG--- 440 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhcC---
Confidence 44566666778999998877776665555555999998 9988883 4456888899999999999999999999
Q ss_pred eEecCCCCCceEECCCCceEEcccccccccccCCcc--ccccccccccCCCChhhhccCCCCC-ccchhhHHHHHHHHHh
Q 048243 105 IIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE--ANTEQVVGTIGYIPPEYARQGVYST-KSDVFSFGVLLLQIIS 181 (303)
Q Consensus 105 i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~-~~DiwslG~~~~~l~~ 181 (303)
+.|||+|++|++++.+|.+||+|||.+..+...... .......|...|+|||.+.+..|.+ ..||||.|+++..|++
T Consensus 441 iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~ 520 (601)
T KOG0590|consen 441 LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMIL 520 (601)
T ss_pred ceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEec
Confidence 999999999999999999999999998776544433 4455678999999999999998866 6899999999999999
Q ss_pred CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 182 GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 182 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
|+.||......+............. ...-........+...+.+|.+||++||.+|.|+.+|++
T Consensus 521 ~~~~Wk~a~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 521 GRFPWKVAKKSDNSFKTNNYSDQRN--------IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred CCCccccccccccchhhhccccccc--------cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 9999987665543210000000000 000001111233456789999999999999999999975
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.4e-24 Score=170.35 Aligned_cols=233 Identities=20% Similarity=0.313 Sum_probs=174.0
Q ss_pred CccCCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccC
Q 048243 1 GVLPCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 1 ~~~~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
|.|+ |..++.|+++.. +......|..|.-.|+-+.||||+.+++.|.....+.++..||+.|+|...+... .+...
T Consensus 209 grwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~-t~vvv 286 (448)
T KOG0195|consen 209 GRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQ-TSVVV 286 (448)
T ss_pred cccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcC-ccEEE
Confidence 4555 345667777543 2333357889999999999999999999999999999999999999999998653 34567
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
+..+..+++.++++|++|||+.. .-|----+....++++++-+.+|+--+ .+ +..+ .......+.|++||.+
T Consensus 287 d~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad-~k-fsfq-----e~gr~y~pawmspeal 358 (448)
T KOG0195|consen 287 DHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMAD-TK-FSFQ-----EVGRAYSPAWMSPEAL 358 (448)
T ss_pred ecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheeccc-ce-eeee-----ccccccCcccCCHHHH
Confidence 77889999999999999999975 223344688999999998776664211 11 1111 1123447899999999
Q ss_pred ccCCCC---CccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHH
Q 048243 159 RQGVYS---TKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235 (303)
Q Consensus 159 ~~~~~~---~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
+..+-+ .++|+|||++++||+.|...||...++.+-- ..+.-..++...++..+..+.+++.
T Consensus 359 qrkped~n~raadmwsfaillwel~trevpfadlspmecg---------------mkialeglrv~ippgis~hm~klm~ 423 (448)
T KOG0195|consen 359 QRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---------------MKIALEGLRVHIPPGISRHMNKLMN 423 (448)
T ss_pred hcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---------------hhhhhccccccCCCCccHHHHHHHH
Confidence 877643 3799999999999999999999765544311 0111223344455566678889999
Q ss_pred HcccCCCCCCCCHHHHHHHhccc
Q 048243 236 LCVQENPNDRPSMLQVSSMLKNE 258 (303)
Q Consensus 236 ~~l~~dp~~Rpt~~el~~~L~~~ 258 (303)
-|+..||.+||.+..++-.|++.
T Consensus 424 icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 424 ICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred HHhcCCCCcCCCcceehhhHHHh
Confidence 99999999999999998888764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.7e-23 Score=191.39 Aligned_cols=228 Identities=19% Similarity=0.211 Sum_probs=162.3
Q ss_pred cCCCcEEEEEEecCCC-cccHHHHHHHHHHHh--cCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 3 LPCGKVIAVKKLSKTS-TQGFEEFKNEVMLTA--KLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 3 ~~~~~~valK~~~~~~-~~~~~~~~~e~~~l~--~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
...|. |++|++-+.. ......+.++++-.+ .+++||++++.-....+...|||-+|.. .+|.+.+ ..+..+.
T Consensus 44 ~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvk-hnLyDRl---STRPFL~ 118 (1431)
T KOG1240|consen 44 DREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVK-HNLYDRL---STRPFLV 118 (1431)
T ss_pred CCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHh-hhhhhhh---ccchHHH
Confidence 34566 9999986554 444555555554444 3489999999988888888899999985 4787877 3566678
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCC-ccccccccc----cccCCCC
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKES-LEANTEQVV----GTIGYIP 154 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~-~~~~~~~~~----g~~~y~a 154 (303)
..+.+-++.|++.|+.-+|..| |+|||||.+|||++.=+-+.|+||...+...-.. .......+. .-.+|.|
T Consensus 119 ~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiA 195 (1431)
T KOG1240|consen 119 LIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIA 195 (1431)
T ss_pred HHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecC
Confidence 8889999999999999999999 9999999999999999999999998765432221 111122222 2347999
Q ss_pred hhhhccC----------C-CCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCC-C-cceeccccCCC
Q 048243 155 PEYARQG----------V-YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGG-K-GVEFVDSSLDD 220 (303)
Q Consensus 155 PE~~~~~----------~-~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~ 220 (303)
||.+... + .+++=||||+||+++||++ |+++|.... ......++ . ...++. .
T Consensus 196 PERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ----------L~aYr~~~~~~~e~~Le----~ 261 (1431)
T KOG1240|consen 196 PERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ----------LLAYRSGNADDPEQLLE----K 261 (1431)
T ss_pred hHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----------HHhHhccCccCHHHHHH----h
Confidence 9988642 2 5678899999999999987 678775321 11111110 0 000111 1
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048243 221 TNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSMLK 256 (303)
Q Consensus 221 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~ 256 (303)
. ....++.++..|++.||.+|.+|++.++.-.
T Consensus 262 I----ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 262 I----EDVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred C----cCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 0 1125779999999999999999999998733
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.9e-22 Score=174.39 Aligned_cols=219 Identities=26% Similarity=0.391 Sum_probs=165.0
Q ss_pred HhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCe-EecCC
Q 048243 32 TAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTI-IHRDL 110 (303)
Q Consensus 32 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i-~H~di 110 (303)
|+.+.|.|+.++++.+.++...+.|.+||..|+|.+.+.. ....+++.....++++|+.||+|||... | +||.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeee
Confidence 4578999999999999999999999999999999999965 4566899999999999999999999876 4 99999
Q ss_pred CCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC-------CCCccchhhHHHHHHHHHhCC
Q 048243 111 KASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV-------YSTKSDVFSFGVLLLQIISGK 183 (303)
Q Consensus 111 kp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-------~~~~~DiwslG~~~~~l~~g~ 183 (303)
++.|++++.+..+||.|||+.................-...|.|||.+.... .+.++||||+|++++|+++..
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999976543211111111122356799999987642 366799999999999999999
Q ss_pred CCCccCCCCccc-cHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccccCCC
Q 048243 184 RLSMLCGINENL-SILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSMLKNETTNR 262 (303)
Q Consensus 184 ~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~~~~ 262 (303)
.||......... ..+..... .....+.+...... .....+..++..||..+|.+||++..+...++......
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred CccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 999765444332 22222111 11111111111111 22336889999999999999999999999988776544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-20 Score=161.38 Aligned_cols=241 Identities=28% Similarity=0.350 Sum_probs=177.1
Q ss_pred cEEEEEEecCCCcc---cHHHHHHHHHHHhcCCCC-ccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 7 KVIAVKKLSKTSTQ---GFEEFKNEVMLTAKLQHV-NLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 7 ~~valK~~~~~~~~---~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
+.+++|.+...... ....+.+|+..+..+.|+ +++++++.+......+++++++.++++.+++........+....
T Consensus 23 ~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 102 (384)
T COG0515 23 KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESE 102 (384)
T ss_pred cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHH
Confidence 46788988655432 367889999999999888 79999999977777899999999999986663311113688999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCC-ceEEcccccccccccCCccc----cccccccccCCCChhh
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM-KPKISDFGLARIFAKESLEA----NTEQVVGTIGYIPPEY 157 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~-~v~l~Df~~~~~~~~~~~~~----~~~~~~g~~~y~aPE~ 157 (303)
...++.|++.+++++|+.+ ++|||+||+|++++..+ .++++|||.+.......... ......|+..|++||.
T Consensus 103 ~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~ 179 (384)
T COG0515 103 ALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179 (384)
T ss_pred HHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHH
Confidence 9999999999999999999 99999999999999988 79999999987554433221 2355678999999999
Q ss_pred hcc---CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHH
Q 048243 158 ARQ---GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIA 234 (303)
Q Consensus 158 ~~~---~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
+.+ .......|+||+|+++++++.|..||...... ................ .................+.+++
T Consensus 180 ~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 255 (384)
T COG0515 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP-SLASPLSPSNPELISKAASDLL 255 (384)
T ss_pred hcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc-ccccccCccccchhhHHHHHHH
Confidence 987 57788999999999999999999996544321 0011111111111100 0000000000022234677999
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 048243 235 LLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 235 ~~~l~~dp~~Rpt~~el~~~ 254 (303)
..++..+|..|.+..+....
T Consensus 256 ~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 256 KKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHhcCchhcCCHHHHhhc
Confidence 99999999999999887654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-20 Score=162.15 Aligned_cols=239 Identities=19% Similarity=0.158 Sum_probs=175.0
Q ss_pred cEEEEEEecCCCcccHHHHHHHHHHHhcCC----CCccccEEEEE-EeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 7 KVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ----HVNLIRVLGFC-IDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 7 ~~valK~~~~~~~~~~~~~~~e~~~l~~l~----h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
+.+|+|............+..|..++..+. .+++..+++.. ......++||+.+ |.+|.++..... ...++..
T Consensus 45 ~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~ 122 (322)
T KOG1164|consen 45 KEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNP-PGRFSRK 122 (322)
T ss_pred eeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCC-CCCcCHh
Confidence 578888876543332236778888888886 35899999999 4777889999987 789988774433 5779999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCC-----CceEEccccccc--ccccCCc----ccc--cccccc
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED-----MKPKISDFGLAR--IFAKESL----EAN--TEQVVG 148 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~-----~~v~l~Df~~~~--~~~~~~~----~~~--~~~~~g 148 (303)
+...++.|++.+|+++|+.| ++||||||+|+++... ..+.|.|||+++ .+..... ... .....|
T Consensus 123 T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rG 199 (322)
T KOG1164|consen 123 TVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRG 199 (322)
T ss_pred HHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCC
Confidence 99999999999999999999 9999999999999865 359999999998 4322211 111 234569
Q ss_pred ccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHH
Q 048243 149 TIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLM 228 (303)
Q Consensus 149 ~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
|.+|.++....+...+.+.|+||++.++.++..|..||...................... . .....+.
T Consensus 200 T~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~-------~-----~~~~~~~ 267 (322)
T KOG1164|consen 200 TLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTD-------R-----FGDLKPE 267 (322)
T ss_pred ccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccc-------c-----ccCCChH
Confidence 999999999999999999999999999999999999986555433221111111111000 0 1111223
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHhccccCCC
Q 048243 229 RCLEIALLCVQENPNDRPSMLQVSSMLKNETTNR 262 (303)
Q Consensus 229 ~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~~~~ 262 (303)
++.++...+-..+...+|....+...|+......
T Consensus 268 ~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 268 EFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 5556666666689999999999998876665443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=163.28 Aligned_cols=141 Identities=18% Similarity=0.187 Sum_probs=107.5
Q ss_pred CCcEEEEEEecCC-----CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 5 CGKVIAVKKLSKT-----STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 5 ~~~~valK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
+|+.||||++... .....+.+.+|+++|++++|+|+++.+.. ....++||||++|++|.. +. . ..
T Consensus 43 ~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE~~~G~~L~~-~~---~---~~ 112 (365)
T PRK09188 43 PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRGWTEGVPLHL-AR---P---HG 112 (365)
T ss_pred CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEEccCCCCHHH-hC---c---cc
Confidence 6788899987533 12235678999999999999999853322 245799999999999862 21 1 11
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCceEECCCCceEEcccccccccccCCccc------cccccccccCC
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDL-KASNILLGEDMKPKISDFGLARIFAKESLEA------NTEQVVGTIGY 152 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di-kp~nil~~~~~~v~l~Df~~~~~~~~~~~~~------~~~~~~g~~~y 152 (303)
...++.+++.+|+|||+.| |+|||| ||+||+++.++.++|+|||+++.+....... ......++..|
T Consensus 113 ---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~ 186 (365)
T PRK09188 113 ---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRT 186 (365)
T ss_pred ---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCcc
Confidence 1467899999999999999 999999 9999999999999999999998765543211 12345678889
Q ss_pred CChhhhccC
Q 048243 153 IPPEYARQG 161 (303)
Q Consensus 153 ~aPE~~~~~ 161 (303)
.|||.+...
T Consensus 187 ~~pe~~~~~ 195 (365)
T PRK09188 187 YAPDALTPR 195 (365)
T ss_pred CCcccCChh
Confidence 999988654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.5e-21 Score=158.16 Aligned_cols=212 Identities=18% Similarity=0.230 Sum_probs=133.9
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCC----------CccccEEEEEEeC------------C-----ee
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQH----------VNLIRVLGFCIDS------------E-----ER 53 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~~i~~~~~~~~~~------------~-----~~ 53 (303)
.+|+.+|+|++.... ....+.+++|......+.+ -.++..++..... . ..
T Consensus 35 ~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~ 114 (288)
T PF14531_consen 35 ETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFFERGPGQSIYWVLNR 114 (288)
T ss_dssp TTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEEEECETTEEEEEESE
T ss_pred cCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcceecCCCCccceeehh
Confidence 468999999875332 3356677777766666432 2333333333211 1 22
Q ss_pred EEEEeecCCCChhhhhcC----ccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccc
Q 048243 54 MLVYEYMPNKSLDCYLFD----PIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFG 129 (303)
Q Consensus 54 ~lv~e~~~~~~L~~~l~~----~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~ 129 (303)
+++|+-+ .++|.+++.. ......+.....+.+..|+++.+++||..| ++|+||+|+|++++.+|.+.|+||+
T Consensus 115 ~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nfll~~~G~v~Lg~F~ 190 (288)
T PF14531_consen 115 FLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIKPENFLLDQDGGVFLGDFS 190 (288)
T ss_dssp EEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE-TTS-EEE--GG
T ss_pred hhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccceeeEEEcCCCCEEEcChH
Confidence 5678877 4678776532 111233455667788899999999999999 9999999999999999999999998
Q ss_pred cccccccCCccccccccccccCCCChhhhccC--------CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHH
Q 048243 130 LARIFAKESLEANTEQVVGTIGYIPPEYARQG--------VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA 201 (303)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--------~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~ 201 (303)
.....+..... ...+..|.+||..... .++.+.|.|+||+++|.|+++..||...........
T Consensus 191 ~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~---- 261 (288)
T PF14531_consen 191 SLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW---- 261 (288)
T ss_dssp GEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG----
T ss_pred HHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc----
Confidence 87665443211 2335779999977542 468899999999999999999999975543321111
Q ss_pred HHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 048243 202 YELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDR 245 (303)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 245 (303)
....+...++.+..||..+|+.||++|
T Consensus 262 -----------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 -----------------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -----------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred -----------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 111222556688899999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.8e-20 Score=154.96 Aligned_cols=195 Identities=21% Similarity=0.245 Sum_probs=136.7
Q ss_pred CCCccccEEEEEEe---------------------------CCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHHHH
Q 048243 36 QHVNLIRVLGFCID---------------------------SEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIE 88 (303)
Q Consensus 36 ~h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~ 88 (303)
+||||+.++++|.+ ....|+||..++ -+|..|+.. ...+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc----CCCchHHHHHHHH
Confidence 69999999998764 236789999875 488888843 2244556677899
Q ss_pred HHHHHHHHHHhCCCCCeEecCCCCCceEEC--CC--CceEEcccccccccccCCcc----ccccccccccCCCChhhhcc
Q 048243 89 GITQGLLYLQEYSRLTIIHRDLKASNILLG--ED--MKPKISDFGLARIFAKESLE----ANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 89 ~i~~~l~~Lh~~~~~~i~H~dikp~nil~~--~~--~~v~l~Df~~~~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~ 160 (303)
|+++|+.|||.+| +.|||+|.+||++. ++ ..+.++|||++--....+.. .......|+..-||||+..-
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 99999999999994 23 35899999998544332221 12223567889999999875
Q ss_pred CCC------CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHH
Q 048243 161 GVY------STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIA 234 (303)
Q Consensus 161 ~~~------~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
.+- -.|+|.|+.|.+.||++....||-..+...-.. -. ..+---+.+.... +..+++++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~-r~----------Yqe~qLPalp~~v----pp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT-RT----------YQESQLPALPSRV----PPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech-hh----------hhhhhCCCCcccC----ChHHHHHH
Confidence 431 248999999999999999999986533221000 00 0011111222222 33678899
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 048243 235 LLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 235 ~~~l~~dp~~Rpt~~el~~ 253 (303)
...|+.||++|+++.=...
T Consensus 491 ~~lL~r~pskRvsp~iAAN 509 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAAN 509 (598)
T ss_pred HHHhcCCccccCCccHHHh
Confidence 9999999999999754433
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=143.20 Aligned_cols=245 Identities=17% Similarity=0.173 Sum_probs=182.7
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
+.+|+.||||.-...... .++.-|..+++.++ ...|..+..+......-.+||+.. |-+|.++... ....++..
T Consensus 37 i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnf--C~R~ftmk 111 (341)
T KOG1163|consen 37 ITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNF--CSRRFTMK 111 (341)
T ss_pred ccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHH--HhhhhhHH
Confidence 468999999998665443 35677899999996 456777777877778889999988 7899888753 45568888
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCC---CceEEcccccccccccCCccc-----cccccccccCCC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED---MKPKISDFGLARIFAKESLEA-----NTEQVVGTIGYI 153 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~---~~v~l~Df~~~~~~~~~~~~~-----~~~~~~g~~~y~ 153 (303)
+++-++.|++.-++|+|.++ ++||||||+|+|..-+ .++.++|||+++.+.+..... ......||.+|.
T Consensus 112 TvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYA 188 (341)
T KOG1163|consen 112 TVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYA 188 (341)
T ss_pred hHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeeh
Confidence 99999999999999999999 9999999999999644 569999999998876543322 223457899999
Q ss_pred ChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHH
Q 048243 154 PPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEI 233 (303)
Q Consensus 154 aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 233 (303)
+-....+...+..-|+-|+|.++.++--|..||............+...+.--+.....+.. ..+.++.-.
T Consensus 189 SinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~---------G~P~EF~my 259 (341)
T KOG1163|consen 189 SINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCK---------GFPAEFAMY 259 (341)
T ss_pred hhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhC---------CCcHHHHHH
Confidence 88877777778889999999999999999999988777666555555544433222222111 122355566
Q ss_pred HHHcccCCCCCCCCHHHHHHHhccccCCCCC
Q 048243 234 ALLCVQENPNDRPSMLQVSSMLKNETTNRNT 264 (303)
Q Consensus 234 i~~~l~~dp~~Rpt~~el~~~L~~~~~~~~~ 264 (303)
+.-|-..--++-|...-+.+.+.-...+++.
T Consensus 260 l~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~ 290 (341)
T KOG1163|consen 260 LNYCRGLGFEEKPDYMYLRQLFRILFRTLNH 290 (341)
T ss_pred HHHHhhcCCCCCCcHHHHHHHHHHHHhhccc
Confidence 7777777777777777776665544444433
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2e-19 Score=147.92 Aligned_cols=234 Identities=16% Similarity=0.163 Sum_probs=175.7
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
=++++||||.-..+.. .-++..|...++.| ..++|..+|.+.....+-.||++.+ |-+|.++.. ..+..++..+
T Consensus 51 ~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD--~CgR~FSvKT 125 (449)
T KOG1165|consen 51 YNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFD--LCGRRFSVKT 125 (449)
T ss_pred ccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHH--HhcCcccHHh
Confidence 3789999998755543 24788899999999 6889999998888877888999988 778988874 2566799999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCC-----CceEEcccccccccccCCccc-----cccccccccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED-----MKPKISDFGLARIFAKESLEA-----NTEQVVGTIGY 152 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~-----~~v~l~Df~~~~~~~~~~~~~-----~~~~~~g~~~y 152 (303)
+..++.|++.-++++|+++ +|+|||||+|+||..- ..+.++|||+++.+....... ......||.+|
T Consensus 126 V~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARY 202 (449)
T KOG1165|consen 126 VAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARY 202 (449)
T ss_pred HHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceee
Confidence 9999999999999999999 9999999999999643 459999999999886654432 23446799999
Q ss_pred CChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHH
Q 048243 153 IPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLE 232 (303)
Q Consensus 153 ~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 232 (303)
|+-....+...+..-|+=|||-++++.+-|..||.+..........+.+-+.-.......+.. ..+.++..
T Consensus 203 MSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~---------g~P~efa~ 273 (449)
T KOG1165|consen 203 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCE---------GFPEEFAT 273 (449)
T ss_pred eEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHh---------cCHHHHHH
Confidence 999988888889999999999999999999999987765554444433322222211111111 12334445
Q ss_pred HHHHcccCCCCCCCCHHHHHHH
Q 048243 233 IALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 233 li~~~l~~dp~~Rpt~~el~~~ 254 (303)
.+.-.-..+-.+-|..+-+...
T Consensus 274 Yl~yvR~L~F~E~PDYdylr~L 295 (449)
T KOG1165|consen 274 YLRYVRRLDFFETPDYDYLRKL 295 (449)
T ss_pred HHHHHHhcCcccCCCHHHHHHH
Confidence 5555555666777776555443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.8e-20 Score=149.56 Aligned_cols=147 Identities=14% Similarity=0.185 Sum_probs=110.8
Q ss_pred CCcEEEEEEecCCCcccHHH---------HHHHHHHHhcCCCCccccEEEEEEeC--------CeeEEEEeecCCCChhh
Q 048243 5 CGKVIAVKKLSKTSTQGFEE---------FKNEVMLTAKLQHVNLIRVLGFCIDS--------EERMLVYEYMPNKSLDC 67 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~---------~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~ 67 (303)
+++.+|+|.+.......... +.+|+..+.++.|++|..+.+++... ...+++|||++|.+|.+
T Consensus 53 ~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~ 132 (232)
T PRK10359 53 DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELND 132 (232)
T ss_pred CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHH
Confidence 46689999997654333222 67899999999999999999886643 35789999999999977
Q ss_pred hhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccc
Q 048243 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVV 147 (303)
Q Consensus 68 ~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~ 147 (303)
+.. ++. ....+++.++..+|..| ++|||++|+||+++.+| ++|+|||...........
T Consensus 133 ~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~------- 190 (232)
T PRK10359 133 MPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK------- 190 (232)
T ss_pred hhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECCCcccccchhhH-------
Confidence 631 222 24569999999999999 99999999999999988 999999987543211100
Q ss_pred cccCCCChhhhccCCCCCccchhhHHHHHHHHH
Q 048243 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180 (303)
Q Consensus 148 g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~ 180 (303)
..+.....+..++|+||||+++..+.
T Consensus 191 -------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 191 -------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -------HHHHHHhHhcccccccceeEeehHHH
Confidence 00233444567899999999887654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.5e-20 Score=165.04 Aligned_cols=218 Identities=21% Similarity=0.255 Sum_probs=171.3
Q ss_pred cCCCcEEEEEEecCCCcc--cHHHHHHHHHHHhcCC-CCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 3 LPCGKVIAVKKLSKTSTQ--GFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+.|+.+|+|.+++.+.. .......|-.++..++ ||+++++...+..+...++++++..+|.|...+ .....+.
T Consensus 19 ~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l---~~~~~f~ 95 (612)
T KOG0603|consen 19 ADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRL---SKEVMFD 95 (612)
T ss_pred ccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhcc---ccCCchH
Confidence 456788899988766422 1124556778888885 999999999999999999999999999887776 3455677
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+.....+...++-+++++|+.+ ++|+|+|++||+++.+|.+++.|||.++..-..... .||..|||||++.
T Consensus 96 ~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~------cgt~eymApEI~~ 166 (612)
T KOG0603|consen 96 ELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA------CGTYEYRAPEIIN 166 (612)
T ss_pred HHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc------ccchhhhhhHhhh
Confidence 8888899999999999999999 999999999999999999999999998765433221 7899999999998
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
....++|.||+|+++++|++|..||.. .... .... .....+...+....+++..++.
T Consensus 167 --gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~---~Il~-----------~~~~~p~~l~~~a~~~~~~l~~ 223 (612)
T KOG0603|consen 167 --GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMK---RILK-----------AELEMPRELSAEARSLFRQLFK 223 (612)
T ss_pred --ccCCcccchhhhhhHHHHhhCCCCCch-------HHHH---HHhh-----------hccCCchhhhHHHHHHHHHHHh
Confidence 567789999999999999999999865 1111 1111 0122234555678899999999
Q ss_pred CCCCCCCCH--HHHHHHh
Q 048243 240 ENPNDRPSM--LQVSSML 255 (303)
Q Consensus 240 ~dp~~Rpt~--~el~~~L 255 (303)
.+|.+|.-. ..+.+..
T Consensus 224 r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 224 RNPENRLGAGPDGVDEIK 241 (612)
T ss_pred hCHHHHhccCcchhHHHh
Confidence 999999865 3444443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.9e-19 Score=143.58 Aligned_cols=125 Identities=18% Similarity=0.137 Sum_probs=94.5
Q ss_pred ccCCCcEEEEEEecCCCcc--c------------------------HHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEE
Q 048243 2 VLPCGKVIAVKKLSKTSTQ--G------------------------FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML 55 (303)
Q Consensus 2 ~~~~~~~valK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 55 (303)
..++|+.||||+++..... . ......|+..+.++.++++.....+... ..++
T Consensus 17 ~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~p~~~~~~--~~~i 94 (190)
T cd05147 17 TTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPCPEPILLK--SHVL 94 (190)
T ss_pred ECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCcEEEec--CCEE
Confidence 3458999999999754211 1 0123459999999988776443333222 2389
Q ss_pred EEeecCCCChhhhhcCccccccCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCCCCceEECCCCceEEccccccccc
Q 048243 56 VYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYL-QEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIF 134 (303)
Q Consensus 56 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~L-h~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~ 134 (303)
||||++++++..... ....++...+..++.|++.+|.++ |+.| ++||||||+||+++ ++.++|+|||++...
T Consensus 95 VmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 95 VMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred EEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 999999877654431 335688899999999999999999 7888 99999999999998 478999999998654
Q ss_pred c
Q 048243 135 A 135 (303)
Q Consensus 135 ~ 135 (303)
.
T Consensus 168 ~ 168 (190)
T cd05147 168 D 168 (190)
T ss_pred C
Confidence 3
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.1e-20 Score=160.11 Aligned_cols=175 Identities=25% Similarity=0.320 Sum_probs=131.2
Q ss_pred eeEEEEeecCCCChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccc
Q 048243 52 ERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLA 131 (303)
Q Consensus 52 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~ 131 (303)
..|+.|++|...+|.+++.........++.....++.|++.+++| ++ .+|+|+||.||++..+..++|+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 568999999999999999765566677888999999999999999 66 999999999999999999999999998
Q ss_pred cccccCC----ccccccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHh
Q 048243 132 RIFAKES----LEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWK 206 (303)
Q Consensus 132 ~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 206 (303)
....... .........||..|++||.+.+..|+.++||||||++++|++. -...+.... ....++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~----------t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA----------TLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----------hhhhhh
Confidence 7765554 1223445679999999999999999999999999999999987 221211000 011111
Q ss_pred CCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 048243 207 GGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQV 251 (303)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el 251 (303)
.+...+... ...+.-+.|+.++|...|.+||++.+.
T Consensus 474 ~g~ip~~~~---------~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 474 DGIIPPEFL---------QDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred cCCCChHHh---------hcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 111110000 111234589999999999999955443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=163.85 Aligned_cols=226 Identities=16% Similarity=0.145 Sum_probs=165.1
Q ss_pred ccCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC---CCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccC
Q 048243 2 VLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ---HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 2 ~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
+..+|+.||||+-+....-+..... +++.+|+ -+.|..+...+...+..++|++|.+.|+|.+++. ..+.+
T Consensus 718 ~~~~~~~~alK~e~P~~~WEfYI~~---q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N---~~~~m 791 (974)
T KOG1166|consen 718 THSNGKLVALKVEKPPNPWEFYICL---QVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLIN---TNKVM 791 (974)
T ss_pred ecCCCcEEEEEeecCCCceeeeehH---HHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhc---cCCCC
Confidence 4456999999998877544322211 2333333 3456777777777888999999999999999994 67789
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEEC-------CCCceEEcccccccccccCCccccccccccccC
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG-------EDMKPKISDFGLARIFAKESLEANTEQVVGTIG 151 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~-------~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~ 151 (303)
++...+.+++|++..++.||..+ ||||||||+|+|+. .+-.++|+|||.+..+..-..........+|-.
T Consensus 792 ~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~ 868 (974)
T KOG1166|consen 792 DEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDL 868 (974)
T ss_pred CchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeecccc
Confidence 99999999999999999999999 99999999999994 234599999999977654433334445677889
Q ss_pred CCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHH-HH
Q 048243 152 YIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLM-RC 230 (303)
Q Consensus 152 y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~l 230 (303)
+-++|...+.+|+.++|-|.|+.+++-|+.|++. ..+. +..... ...+ ...... -.
T Consensus 869 f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~-----------------q~~~-g~~~~~-~~~~----~Ry~~~~~W 925 (974)
T KOG1166|consen 869 FDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM-----------------EVKN-GSSWMV-KTNF----PRYWKRDMW 925 (974)
T ss_pred chhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH-----------------HhcC-Ccceec-cccc----hhhhhHHHH
Confidence 9999999999999999999999999999998743 1111 111111 1111 111111 23
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHhcccc
Q 048243 231 LEIALLCVQENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 231 ~~li~~~l~~dp~~Rpt~~el~~~L~~~~ 259 (303)
.+|+..+|..|-..=|...+|...|++..
T Consensus 926 ~~~F~~lLN~~~~~~p~l~~lr~~~~~~~ 954 (974)
T KOG1166|consen 926 NKFFDLLLNPDCDTLPNLQELRTELEEVL 954 (974)
T ss_pred HHHHHHHhCcCcccchhHHHHHHHHHHHH
Confidence 46778888866666677888877776554
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.7e-18 Score=136.57 Aligned_cols=125 Identities=20% Similarity=0.232 Sum_probs=96.0
Q ss_pred cCCCcEEEEEEecCCCcc--c------------------------HHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEE
Q 048243 3 LPCGKVIAVKKLSKTSTQ--G------------------------FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLV 56 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 56 (303)
..+|+.||||+++..... . ...+..|+..+.++.|+++.....+... ..++|
T Consensus 18 ~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~lV 95 (190)
T cd05145 18 TGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPVPEPILLK--KNVLV 95 (190)
T ss_pred cCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCCceEEEec--CCEEE
Confidence 457999999999765311 0 1224578999999999987554444332 24899
Q ss_pred EeecCCCChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceEECCCCceEEcccccccccc
Q 048243 57 YEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFA 135 (303)
Q Consensus 57 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~ 135 (303)
|||++++++..... ....++......++.|++.++.++|. .| ++||||||+||+++ ++.++|+|||++....
T Consensus 96 mE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 96 MEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred EEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 99999875543321 23457788899999999999999999 88 99999999999999 7899999999987654
Q ss_pred c
Q 048243 136 K 136 (303)
Q Consensus 136 ~ 136 (303)
.
T Consensus 169 ~ 169 (190)
T cd05145 169 H 169 (190)
T ss_pred C
Confidence 3
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.8e-17 Score=130.24 Aligned_cols=166 Identities=19% Similarity=0.174 Sum_probs=118.8
Q ss_pred CCcEEEEEEecCCCc----ccHHHHHHHHHHHhcCC-CCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 5 CGKVIAVKKLSKTST----QGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 5 ~~~~valK~~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+.+++.+.+....- .....+.+|+++|+++. |+++.+++++ ...+++|+|+.|.+|...+. .
T Consensus 24 ~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~----~---- 91 (218)
T PRK12274 24 GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPP----R---- 91 (218)
T ss_pred CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhh----h----
Confidence 466777777654421 11225789999999995 5789999886 35799999999988854331 1
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCceEECCCCceEEcccccccccccCCcc------cc-----ccccc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDL-KASNILLGEDMKPKISDFGLARIFAKESLE------AN-----TEQVV 147 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~di-kp~nil~~~~~~v~l~Df~~~~~~~~~~~~------~~-----~~~~~ 147 (303)
....++.|++.+|+++|+.| |+|||| ||+||+++.++.++|+|||++......... .. .....
T Consensus 92 --~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~ 166 (218)
T PRK12274 92 --GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRM 166 (218)
T ss_pred --hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHh
Confidence 11357889999999999999 999999 799999999999999999999865443311 00 00123
Q ss_pred cccCCCChhhhccC-CCC-CccchhhHHHHHHHHHhCCCCCc
Q 048243 148 GTIGYIPPEYARQG-VYS-TKSDVFSFGVLLLQIISGKRLSM 187 (303)
Q Consensus 148 g~~~y~aPE~~~~~-~~~-~~~DiwslG~~~~~l~~g~~p~~ 187 (303)
.++.|+.|+...-- ..+ ...+.++-|+-+|.++|++.++-
T Consensus 167 y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 167 YCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred cCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 56677777643321 122 35677799999999999987753
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.7e-17 Score=131.65 Aligned_cols=113 Identities=19% Similarity=0.239 Sum_probs=90.0
Q ss_pred EEEEecCCCcccHHHHHHHHHHHhcC-----CCCccccEEEEEEeCC---e-eEEEEee--cCCCChhhhhcCccccccC
Q 048243 10 AVKKLSKTSTQGFEEFKNEVMLTAKL-----QHVNLIRVLGFCIDSE---E-RMLVYEY--MPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 10 alK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~-~~lv~e~--~~~~~L~~~l~~~~~~~~l 78 (303)
+||++........+.+.+|+.+++.+ +||||+++++++.++. . ..+|+|| +.+++|.+++.. ..+
T Consensus 28 ~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~----~~~ 103 (210)
T PRK10345 28 CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ----CRY 103 (210)
T ss_pred EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc----ccc
Confidence 68888765444567899999999999 5799999999999874 3 3378999 557999999943 235
Q ss_pred CHHHHHHHHHHHHHHH-HHHHhCCCCCeEecCCCCCceEECC----CCceEEcccccc
Q 048243 79 DWKKRVHIIEGITQGL-LYLQEYSRLTIIHRDLKASNILLGE----DMKPKISDFGLA 131 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l-~~Lh~~~~~~i~H~dikp~nil~~~----~~~v~l~Df~~~ 131 (303)
++. ..++.+++.++ +|||+++ |+||||||+||+++. ++.++|+||+.+
T Consensus 104 ~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 104 EED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred cHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 555 35688888887 9999999 999999999999974 347999995433
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-17 Score=137.08 Aligned_cols=206 Identities=20% Similarity=0.217 Sum_probs=143.9
Q ss_pred HHHHHhcCCCCccccEEEEEEeCC-----eeEEEEeecCCCChhhhhcCccc-cccCCHHHHHHHHHHHHHHHHHHHhCC
Q 048243 28 EVMLTAKLQHVNLIRVLGFCIDSE-----ERMLVYEYMPNKSLDCYLFDPIR-RLILDWKKRVHIIEGITQGLLYLQEYS 101 (303)
Q Consensus 28 e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~-~~~l~~~~~~~~~~~i~~~l~~Lh~~~ 101 (303)
-+..|.++.|.||++++.++.+.+ +..+++|||..|++..+|+.... ...+....+.+|+.||+.||.|||+.
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~- 195 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC- 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence 345666678999999999988654 46899999999999999976433 56788899999999999999999998
Q ss_pred CCCeEecCCCCCceEECCCCceEEccccc--ccccccCCccccccccccccCCCChhhhccCCCCCccchhhHHHHHHHH
Q 048243 102 RLTIIHRDLKASNILLGEDMKPKISDFGL--ARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQI 179 (303)
Q Consensus 102 ~~~i~H~dikp~nil~~~~~~v~l~Df~~--~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l 179 (303)
..+++|+++..+.+++..+|-++++--.- .+...............+.+.|.+||.-.-...+.++|||++|+...+|
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 57899999999999999999888853211 1111111111112234567889999977666677899999999999999
Q ss_pred HhCCCCCcc-CCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 180 ISGKRLSML-CGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 180 ~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
..+..-... .+.......+. .. ...+-+. .-++++.+|++..|..||+|++++..
T Consensus 276 ailEiq~tnseS~~~~ee~ia---~~-----i~~len~------------lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIA---NV-----IIGLENG------------LQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHheeccCCCcceeehhhhhh---hh-----eeeccCc------------cccCcCcccccCCCCCCcchhhhhcC
Confidence 887633111 11111000000 00 0000010 12368999999999999999998754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.4e-16 Score=148.52 Aligned_cols=141 Identities=25% Similarity=0.325 Sum_probs=105.4
Q ss_pred HHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCc------------ccc-ccccccccCCCChhh
Q 048243 91 TQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL------------EAN-TEQVVGTIGYIPPEY 157 (303)
Q Consensus 91 ~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~------------~~~-~~~~~g~~~y~aPE~ 157 (303)
+.+++|||..| |+|||+||+|.+|+.-|++|+.|||+.+....... ... ....+||+.|.|||+
T Consensus 153 vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 153 VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 77899999999 99999999999999999999999999865321100 001 123579999999999
Q ss_pred hccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHc
Q 048243 158 ARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237 (303)
Q Consensus 158 ~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 237 (303)
+....|...+|.|++|+++|+.+.|..||..-.+.+-...+-.....|.+. . .....+.+++|.++
T Consensus 230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~----------d----ea~p~Ea~dli~~L 295 (1205)
T KOG0606|consen 230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE----------D----EALPPEAQDLIEQL 295 (1205)
T ss_pred hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc----------C----cCCCHHHHHHHHHH
Confidence 999999999999999999999999999987554433222222111222211 1 12233788999999
Q ss_pred ccCCCCCCCCH
Q 048243 238 VQENPNDRPSM 248 (303)
Q Consensus 238 l~~dp~~Rpt~ 248 (303)
|+.+|.+|.-.
T Consensus 296 L~qnp~~Rlgt 306 (1205)
T KOG0606|consen 296 LRQNPLCRLGT 306 (1205)
T ss_pred HHhChHhhccc
Confidence 99999999643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=5.3e-17 Score=149.73 Aligned_cols=233 Identities=23% Similarity=0.297 Sum_probs=173.2
Q ss_pred CCcEEEEEEecCCC--cccHHHHHHHHHHHhcCC-CCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 5 CGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 5 ~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
....+|.|.+.... ....+.+..|..+-..+. |+|++.+++...+.+..++++++..++++.+.+.. ......+..
T Consensus 45 ~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~-~~~~~~~~~ 123 (601)
T KOG0590|consen 45 PESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISH-PDSTGTSSS 123 (601)
T ss_pred CcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCccccccccccccc-CCccCCCCc
Confidence 34456666664432 233445666877777885 99999999999999999999999999999877732 122246667
Q ss_pred HHHHHHHHHHHHHHHHH-hCCCCCeEecCCCCCceEECCCC-ceEEccccccccccc-CCcccccccccc-ccCCCChhh
Q 048243 82 KRVHIIEGITQGLLYLQ-EYSRLTIIHRDLKASNILLGEDM-KPKISDFGLARIFAK-ESLEANTEQVVG-TIGYIPPEY 157 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh-~~~~~~i~H~dikp~nil~~~~~-~v~l~Df~~~~~~~~-~~~~~~~~~~~g-~~~y~aPE~ 157 (303)
....++.|+..++.|+| ..+ +.|+|++|+|.+++.++ .+++.|||++..+.. .+.........| ++.|.|||.
T Consensus 124 ~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~ 200 (601)
T KOG0590|consen 124 SASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEH 200 (601)
T ss_pred chhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCccc
Confidence 78889999999999999 888 99999999999999999 999999999988776 555555566778 999999999
Q ss_pred hccC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 158 ARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 158 ~~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
..+. ......|+||.|+++..+++|..|+.......... ..|..... ...............+++.+
T Consensus 201 ~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~------~~~~~~~~------~~~~~~~~~~~~~~~~~l~k 268 (601)
T KOG0590|consen 201 LSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY------SSWKSNKG------RFTQLPWNSISDQAHDLLHK 268 (601)
T ss_pred ccchhhcCCCcccccccccccccccCCCCccccccccccc------eeeccccc------ccccCccccCChhhhhcccc
Confidence 8885 45678999999999999999999986554433111 11111100 00011111222356689999
Q ss_pred cccCCCCCCCCHHHHHH
Q 048243 237 CVQENPNDRPSMLQVSS 253 (303)
Q Consensus 237 ~l~~dp~~Rpt~~el~~ 253 (303)
++..+|..|.+.+++..
T Consensus 269 ~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 269 ILKENPSNRLSIEELKL 285 (601)
T ss_pred cccCCchhccccccccc
Confidence 99999999999998853
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.3e-15 Score=121.61 Aligned_cols=118 Identities=22% Similarity=0.284 Sum_probs=97.5
Q ss_pred CCcEEEEEEecCCCcc--------cHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccc
Q 048243 5 CGKVIAVKKLSKTSTQ--------GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 5 ~~~~valK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 76 (303)
+|..|++|+....... ....+.+|+.++..+.|+++.....++.+....+++|||++|++|.+++...
T Consensus 18 ~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~---- 93 (211)
T PRK14879 18 LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSN---- 93 (211)
T ss_pred CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhc----
Confidence 5778999987644221 1235778999999999999887777777778889999999999999887421
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccc
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARI 133 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~ 133 (303)
.. ....++.+++.+|.++|+.+ ++|||++|.||+++ ++.++++|||.+..
T Consensus 94 --~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 94 --GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred --cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 11 77889999999999999999 99999999999999 78899999998754
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.6e-15 Score=123.80 Aligned_cols=123 Identities=19% Similarity=0.184 Sum_probs=92.3
Q ss_pred cCCCcEEEEEEecCCCcc------------------------cHHHHHHHHHHHhcCCCC--ccccEEEEEEeCCeeEEE
Q 048243 3 LPCGKVIAVKKLSKTSTQ------------------------GFEEFKNEVMLTAKLQHV--NLIRVLGFCIDSEERMLV 56 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~------------------------~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv 56 (303)
..+|+.||+|.++..... ....+..|+..+.++.+. .+.++++. . ..++|
T Consensus 51 ~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~~p~~~~~---~-~~~lV 126 (237)
T smart00090 51 DGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVPVPKPIAW---R-RNVLV 126 (237)
T ss_pred CCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeEe---c-CceEE
Confidence 468999999998754210 012356899999999653 34444443 2 35899
Q ss_pred EeecCCCChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccc
Q 048243 57 YEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFA 135 (303)
Q Consensus 57 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~ 135 (303)
|||+.+++|..... ............++.|++.++++||..| .++||||||+||+++ ++.++|+|||.+...+
T Consensus 127 ~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 127 MEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 99999988866542 2334566677899999999999999876 399999999999999 7899999999886543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.61 E-value=5e-15 Score=119.43 Aligned_cols=115 Identities=24% Similarity=0.334 Sum_probs=91.9
Q ss_pred CCcEEEEEEecCCCc-c-------cHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccc
Q 048243 5 CGKVIAVKKLSKTST-Q-------GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 5 ~~~~valK~~~~~~~-~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 76 (303)
+|+.|++|....... . ....+.+|+.++..++|+++.....++......++||||++|++|.+++... .
T Consensus 16 ~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~---~ 92 (199)
T TIGR03724 16 LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEG---N 92 (199)
T ss_pred CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhc---H
Confidence 578899998654321 1 1255778999999998887665555555666789999999999998877321 1
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccc
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARI 133 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~ 133 (303)
. .++.+++.+|++||+.+ ++|||++|.||+++ ++.++++|||.+..
T Consensus 93 ~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 93 D-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred H-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 0 78999999999999999 99999999999999 78999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.3e-14 Score=116.96 Aligned_cols=118 Identities=20% Similarity=0.207 Sum_probs=90.5
Q ss_pred ccCCCcEEEEEEecCCCcc----------------------cHHHHHHHHHHHhcCCCC--ccccEEEEEEeCCeeEEEE
Q 048243 2 VLPCGKVIAVKKLSKTSTQ----------------------GFEEFKNEVMLTAKLQHV--NLIRVLGFCIDSEERMLVY 57 (303)
Q Consensus 2 ~~~~~~~valK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~ 57 (303)
..++|+.||||++...... .......|+..+..+.|+ .+...++. ...++||
T Consensus 35 ~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~~~~----~~~~lv~ 110 (198)
T cd05144 35 LDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPIDW----NRHAVVM 110 (198)
T ss_pred EcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCceeec----CCceEEE
Confidence 3568999999987643210 112356788899998776 44555442 3568999
Q ss_pred eecCCCChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccc
Q 048243 58 EYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFA 135 (303)
Q Consensus 58 e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~ 135 (303)
||+++++|..... ......++.+++.++.++|+.| ++||||+|+||+++.++.++|+|||++....
T Consensus 111 e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 111 EYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred EEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 9999998865542 0245678899999999999998 9999999999999999999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.4e-14 Score=118.31 Aligned_cols=118 Identities=21% Similarity=0.197 Sum_probs=90.1
Q ss_pred CCcEEEEEEecCCC-------------cccHHHHHHHHHHHhcCCCCcc--ccEEEEEEeCC----eeEEEEeecCC-CC
Q 048243 5 CGKVIAVKKLSKTS-------------TQGFEEFKNEVMLTAKLQHVNL--IRVLGFCIDSE----ERMLVYEYMPN-KS 64 (303)
Q Consensus 5 ~~~~valK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~~----~~~lv~e~~~~-~~ 64 (303)
+|..++||.+.... ......+.+|+.++..++|++| ...+++..... ..++|||+++| .+
T Consensus 54 ~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~ 133 (239)
T PRK01723 54 PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARD 133 (239)
T ss_pred CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCC
Confidence 46788999885321 1223567889999999988775 66776644322 23599999997 68
Q ss_pred hhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccc
Q 048243 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARI 133 (303)
Q Consensus 65 L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~ 133 (303)
|.+++.. ..++.. .+.+++.++.+||+.| |+|+||||.|||++.++.++|+|||.+..
T Consensus 134 L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 134 LVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred HHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 8888732 234443 3578999999999999 99999999999999989999999998765
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1e-13 Score=124.54 Aligned_cols=166 Identities=17% Similarity=0.193 Sum_probs=128.4
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
..++.+|.|..++...........+-+..|+.++||+|+++++.++.+...|+|+|.+ ..|..++.. +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH------hHHHH
Confidence 4578899999997765544567888899999999999999999999999999999987 467767633 33566
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
.-.-+.||+.||.|||+.+ .++|+||.-+.|+|+..|..+|++|.++........ ......-...|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence 6778999999999998543 399999999999999999999999988754332221 112222233566676655433
Q ss_pred CCCccchhhHHHHHHHHHhC
Q 048243 163 YSTKSDVFSFGVLLLQIISG 182 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~g 182 (303)
-..|.|-|||++++++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 246999999999999998
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.8e-14 Score=130.91 Aligned_cols=96 Identities=25% Similarity=0.396 Sum_probs=85.7
Q ss_pred HHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCC
Q 048243 23 EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSR 102 (303)
Q Consensus 23 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~ 102 (303)
+.+.+|++++..++|++++....++......++||||+++++|.+++. ....++.+++.+|++||+.+
T Consensus 381 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g- 448 (535)
T PRK09605 381 ERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG- 448 (535)
T ss_pred HHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC-
Confidence 467899999999999999888777777777899999999999988873 34678999999999999999
Q ss_pred CCeEecCCCCCceEECCCCceEEcccccccc
Q 048243 103 LTIIHRDLKASNILLGEDMKPKISDFGLARI 133 (303)
Q Consensus 103 ~~i~H~dikp~nil~~~~~~v~l~Df~~~~~ 133 (303)
++||||||+||++ .++.++|+|||+++.
T Consensus 449 --iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 449 --IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred --CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999999999 678999999999864
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.4e-13 Score=105.45 Aligned_cols=116 Identities=21% Similarity=0.221 Sum_probs=96.3
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCCC--CccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQH--VNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
+++.+++|....... ...+..|+..++.+++ .++.+++.+....+..+++|||+.++.+..+ +...
T Consensus 20 ~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~----------~~~~ 87 (155)
T cd05120 20 KDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV----------SEEE 87 (155)
T ss_pred cCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC----------CHHH
Confidence 346889999865433 4678899999999976 5899999988877889999999988777433 4556
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEccccccc
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~ 132 (303)
...++.+++.+++++|.....+++|+|++|.|++++..+.++++||+.+.
T Consensus 88 ~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 88 KEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred HHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 77889999999999998644459999999999999998999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.45 E-value=5e-13 Score=106.64 Aligned_cols=122 Identities=20% Similarity=0.186 Sum_probs=84.3
Q ss_pred cCCCcEEEEEEecCCCcc--cHHH----------------------HHHHHHHHhcCCCC--ccccEEEEEEeCCeeEEE
Q 048243 3 LPCGKVIAVKKLSKTSTQ--GFEE----------------------FKNEVMLTAKLQHV--NLIRVLGFCIDSEERMLV 56 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv 56 (303)
..+|+.||||+++..... .... ...|...+..+.+. .+.+++++. ..++|
T Consensus 18 ~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~----~~~lv 93 (187)
T cd05119 18 DGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPKPIDLN----RHVLV 93 (187)
T ss_pred CCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCceEecC----CCEEE
Confidence 457999999998754211 1111 13566666666433 345555442 46899
Q ss_pred EeecCCCChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceEECCCCceEEcccccccccc
Q 048243 57 YEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFA 135 (303)
Q Consensus 57 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~ 135 (303)
|||++++.+...... ..... ..+..++.+++.++.++|. .+ ++|+||+|+||+++ ++.++++|||.+....
T Consensus 94 ~e~~~g~~~~~~~l~---~~~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 94 MEFIGGDGIPAPRLK---DVRLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred EEEeCCCCccChhhh---hhhhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCcEEEEECccccccc
Confidence 999998554321111 10011 5678899999999999999 88 99999999999999 8899999999986544
Q ss_pred c
Q 048243 136 K 136 (303)
Q Consensus 136 ~ 136 (303)
.
T Consensus 166 ~ 166 (187)
T cd05119 166 H 166 (187)
T ss_pred C
Confidence 3
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1e-12 Score=116.82 Aligned_cols=228 Identities=20% Similarity=0.181 Sum_probs=163.3
Q ss_pred cCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 3 LPCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 3 ~~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
-.++..+|+|+-+... ......-.+|+..-..+ .|++.++.+..++..+..++-+|.|. .+|..+... ....++
T Consensus 140 ~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~--~~~~~p 216 (524)
T KOG0601|consen 140 SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHT--PCNFLP 216 (524)
T ss_pred ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeecccc-chhHHhhhc--ccccCC
Confidence 3567788888843332 22223344567777777 59999999999999999999999995 677777643 233477
Q ss_pred HHHHHHHHHHHHH----HHHHHHhCCCCCeEecCCCCCceEECCC-CceEEcccccccccccCCccccc---cccccccC
Q 048243 80 WKKRVHIIEGITQ----GLLYLQEYSRLTIIHRDLKASNILLGED-MKPKISDFGLARIFAKESLEANT---EQVVGTIG 151 (303)
Q Consensus 80 ~~~~~~~~~~i~~----~l~~Lh~~~~~~i~H~dikp~nil~~~~-~~v~l~Df~~~~~~~~~~~~~~~---~~~~g~~~ 151 (303)
....+..+.+... |+.++|..+ ++|-|++|.|++...+ ..++++|||+...++........ ....|...
T Consensus 217 ~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~ 293 (524)
T KOG0601|consen 217 DNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCI 293 (524)
T ss_pred chhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCce
Confidence 7888888888888 999999999 9999999999999999 88999999999888776543322 22367889
Q ss_pred CCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHH
Q 048243 152 YIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL 231 (303)
Q Consensus 152 y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
|++||...+ .++.+.|++++|.++.+...+.++.......... ..+.. .........-+.++.
T Consensus 294 Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~--------~~r~~--------~ip~e~~~~~s~~l~ 356 (524)
T KOG0601|consen 294 YAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWS--------QLRQG--------YIPLEFCEGGSSSLR 356 (524)
T ss_pred EeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcc--------ccccc--------cCchhhhcCcchhhh
Confidence 999997664 4588999999999999998887665322111100 00000 000111111122455
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 048243 232 EIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 232 ~li~~~l~~dp~~Rpt~~el~~ 253 (303)
..+.+|++.+|..|++++.+..
T Consensus 357 ~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 357 SVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred hHHHHhcCcchhhhhHHHHHhc
Confidence 5899999999999999988864
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.34 E-value=4.3e-12 Score=113.76 Aligned_cols=79 Identities=25% Similarity=0.295 Sum_probs=59.9
Q ss_pred CCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHHHHHHHH-HHHHHHhCCCCCeEecCCCCCceEECCCCceEEccc
Q 048243 50 SEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQ-GLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128 (303)
Q Consensus 50 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~-~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df 128 (303)
....++||||++|++|.++.... ....+ ...++..++. .+..+|..| ++|+|++|.||+++.++.++++||
T Consensus 230 ~~~~vLvmE~i~G~~L~~~~~~~--~~~~~---~~~ia~~~~~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDf 301 (437)
T TIGR01982 230 TSERVLTMEWIDGIPLSDIAALD--EAGLD---RKALAENLARSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDF 301 (437)
T ss_pred cCCceEEEEeECCcccccHHHHH--hcCCC---HHHHHHHHHHHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeC
Confidence 34579999999999998776321 11122 2345555555 467889888 999999999999999999999999
Q ss_pred cccccccc
Q 048243 129 GLARIFAK 136 (303)
Q Consensus 129 ~~~~~~~~ 136 (303)
|++..+..
T Consensus 302 G~~~~l~~ 309 (437)
T TIGR01982 302 GIVGRLSE 309 (437)
T ss_pred CCeeECCH
Confidence 99876643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.31 E-value=3.8e-11 Score=95.23 Aligned_cols=98 Identities=17% Similarity=0.198 Sum_probs=74.7
Q ss_pred HHHHHHhcCC--CCccccEEEEEEeCCeeEEEEeecCCCChhh-hhcCccccccCCHHHHHHHHHHHHHHHHHH-HhCCC
Q 048243 27 NEVMLTAKLQ--HVNLIRVLGFCIDSEERMLVYEYMPNKSLDC-YLFDPIRRLILDWKKRVHIIEGITQGLLYL-QEYSR 102 (303)
Q Consensus 27 ~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~l~~~~~~~~~~~i~~~l~~L-h~~~~ 102 (303)
+|+..|+++. .-++.+++++ ..-++||||+.+..+.. .+ ....++......++.+++.+|..+ |..|
T Consensus 75 kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L----kd~~~~~~~~~~i~~~i~~~l~~l~H~~g- 145 (197)
T cd05146 75 KEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL----KDAKLNDEEMKNAYYQVLSMMKQLYKECN- 145 (197)
T ss_pred HHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh----hccccCHHHHHHHHHHHHHHHHHHHHhCC-
Confidence 7999999994 3456677765 45789999997653321 22 222345556677889999999998 8888
Q ss_pred CCeEecCCCCCceEECCCCceEEccccccccccc
Q 048243 103 LTIIHRDLKASNILLGEDMKPKISDFGLARIFAK 136 (303)
Q Consensus 103 ~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~ 136 (303)
++|||+++.||++. ++.++|+|||.+.....
T Consensus 146 --lVHGDLs~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 146 --LVHADLSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred --eecCCCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 99999999999997 46899999998876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.7e-11 Score=96.14 Aligned_cols=113 Identities=20% Similarity=0.166 Sum_probs=81.9
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCcc-ccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL-IRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
+|+.|++|....... ....+..|+..++.+.+.++ .+++.+. ....++|||+++|.++...- ...
T Consensus 20 ~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~~~-----------~~~ 85 (170)
T cd05151 20 ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLTED-----------FSD 85 (170)
T ss_pred CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccccc-----------ccC
Confidence 467899999865432 12346789999999865554 4455443 33458999999998774320 111
Q ss_pred HHHHHHHHHHHHHHHhCC--CCCeEecCCCCCceEECCCCceEEccccccc
Q 048243 84 VHIIEGITQGLLYLQEYS--RLTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~--~~~i~H~dikp~nil~~~~~~v~l~Df~~~~ 132 (303)
...+.+++.+++.||..+ ...++|||++|.||+++ ++.++++||+.+.
T Consensus 86 ~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 86 PENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred HHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 345678999999999987 22359999999999999 6689999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.1e-10 Score=99.63 Aligned_cols=205 Identities=19% Similarity=0.223 Sum_probs=143.6
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEE----eCCeeEEEEeecCC-CChhhhhcCc-------
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCI----DSEERMLVYEYMPN-KSLDCYLFDP------- 72 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~~-~~L~~~l~~~------- 72 (303)
+|..|++|++...+.........-.++++++.|.||+++.+++. .+..+++|++|.++ ++|.++....
T Consensus 300 DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~ 379 (655)
T KOG3741|consen 300 DGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRT 379 (655)
T ss_pred CCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCcccccc
Confidence 68899999996554444444456789999999999999999887 34578999999874 5666655431
Q ss_pred -----cccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccc
Q 048243 73 -----IRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVV 147 (303)
Q Consensus 73 -----~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~ 147 (303)
..+...++..+|.++.|+..||.++|+.| +.-+-|.|.+|+++.+.+++|+.+|..........
T Consensus 380 n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~-------- 448 (655)
T KOG3741|consen 380 NSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT-------- 448 (655)
T ss_pred ccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCCCC--------
Confidence 23445778999999999999999999999 88899999999999999999998887654433220
Q ss_pred cccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHH
Q 048243 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKL 227 (303)
Q Consensus 148 g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
|.+.+ -.+-|.-.||.+++.|.+|..... ..+..... .. ......++
T Consensus 449 --------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~---~~d~~~~s--~~-----------------~~I~~~yS 495 (655)
T KOG3741|consen 449 --------EPLES---QQQNDLRDLGLLLLALATGTENSN---RTDSTQSS--HL-----------------TRITTTYS 495 (655)
T ss_pred --------cchhH---HhhhhHHHHHHHHHHHhhcccccc---cccchHHH--HH-----------------HHhhhhhh
Confidence 00111 225688899999999999863310 00000000 00 01113345
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 228 MRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 228 ~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
.++++++.-....++++ -++.+++.+
T Consensus 496 ~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 496 TDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 56777887777788876 677777665
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=6.1e-10 Score=95.67 Aligned_cols=202 Identities=14% Similarity=0.118 Sum_probs=130.8
Q ss_pred eeEEEEeecCCC-ChhhhhcCccc---cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcc
Q 048243 52 ERMLVYEYMPNK-SLDCYLFDPIR---RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISD 127 (303)
Q Consensus 52 ~~~lv~e~~~~~-~L~~~l~~~~~---~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~D 127 (303)
...++|+.+.+. ....++.-..+ -...+|....+..+.++.+.+.||+.| .+-||++++|+|+++++.|.|.|
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVd 160 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVD 160 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEc
Confidence 467899988764 22333322222 234678899999999999999999999 99999999999999999999998
Q ss_pred cccccccccCCccccccccccccCCCChhhhc-----cCCCCCccchhhHHHHHHHHHhC-CCCCccCCCC-ccccHHHH
Q 048243 128 FGLARIFAKESLEANTEQVVGTIGYIPPEYAR-----QGVYSTKSDVFSFGVLLLQIISG-KRLSMLCGIN-ENLSILEH 200 (303)
Q Consensus 128 f~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DiwslG~~~~~l~~g-~~p~~~~~~~-~~~~~~~~ 200 (303)
-+.-....+. ......+|...|.+||.-. +..-+...|.|.||+++++++.| ++||.+..-. ......+.
T Consensus 161 sDsfqi~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~ 237 (637)
T COG4248 161 SDSFQINANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET 237 (637)
T ss_pred ccceeeccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence 7654443322 2233457899999999755 33457789999999999999986 8998653321 11111110
Q ss_pred H--HHHHhC-CCcceeccccCCCCCCHHHHHHHHHHHHHcccC--CCCCCCCHHHHHHHhcccc
Q 048243 201 A--YELWKG-GKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE--NPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 201 ~--~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~--dp~~Rpt~~el~~~L~~~~ 259 (303)
. ...+.. .....-..+.............+..++.+|+.. ++.-|||++.++..|....
T Consensus 238 ~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 238 DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 0 000000 000000011111111122334677899999974 4678999999988775444
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.6e-11 Score=109.33 Aligned_cols=223 Identities=20% Similarity=0.176 Sum_probs=157.7
Q ss_pred CCCcEEEEEEecCCCcccH--HHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTSTQGF--EEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~--~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.++..+++|.+.+...... ..-..|..+...+ .|.+++.++..|......++=.|||+++++...+ .....+++
T Consensus 289 ~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~---~~~~~~d~ 365 (524)
T KOG0601|consen 289 EGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRS---VTSQMLDE 365 (524)
T ss_pred CCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhh---HHHHhcCc
Confidence 5677888887765533222 2334566666666 6899999988888888888889999999887666 34456788
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCC-CceEEcccccccccccCCccccccccccccCCC--Chhh
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED-MKPKISDFGLARIFAKESLEANTEQVVGTIGYI--PPEY 157 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~-~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~--aPE~ 157 (303)
...+++..|++.++-++|+.. ++|+|++|+||++..+ +..+++||+....+..... ...+.-++. ++..
T Consensus 366 ~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~-----~~~~~~r~~p~~~~~ 437 (524)
T KOG0601|consen 366 DPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG-----VFHHIDRLYPIAEIL 437 (524)
T ss_pred chhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccceecc-----cccccccccccchhh
Confidence 899999999999999999998 9999999999999986 7789999998764322211 112233333 5556
Q ss_pred hccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHc
Q 048243 158 ARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237 (303)
Q Consensus 158 ~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 237 (303)
.....+..++|++|||..+.+.+++....... .....+..... ...+.....+..+.+.+
T Consensus 438 ~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~------------------~~~~~i~~~~~--p~~~~~~~~~q~~~kv~ 497 (524)
T KOG0601|consen 438 LEDYPHLSKADIFSLGLSVDEAITGSPLSESG------------------VQSLTIRSGDT--PNLPGLKLQLQVLLKVM 497 (524)
T ss_pred ccccccccccccccccccccccccCcccCccc------------------ccceeeecccc--cCCCchHHhhhhhhhhh
Confidence 66677889999999999999999887543211 00111111111 11122225677889999
Q ss_pred ccCCCCCCCCHHHHHHHhcc
Q 048243 238 VQENPNDRPSMLQVSSMLKN 257 (303)
Q Consensus 238 l~~dp~~Rpt~~el~~~L~~ 257 (303)
+..++..||.+.++....+-
T Consensus 498 ~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 498 INPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred cCCccccchhhhhhcccchh
Confidence 99999999999998765443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.2e-10 Score=87.30 Aligned_cols=97 Identities=25% Similarity=0.376 Sum_probs=79.0
Q ss_pred HHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCC
Q 048243 23 EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSR 102 (303)
Q Consensus 23 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~ 102 (303)
++-.+|+.++.+++--.|...+=+..+.....++|||.+|..|.+++... ...++..+-.-+.-||..|
T Consensus 44 ~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g- 112 (204)
T COG3642 44 ERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG- 112 (204)
T ss_pred HHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC-
Confidence 34667999999987666655555555666778999999999998888432 2567888889999999999
Q ss_pred CCeEecCCCCCceEECCCCceEEcccccccc
Q 048243 103 LTIIHRDLKASNILLGEDMKPKISDFGLARI 133 (303)
Q Consensus 103 ~~i~H~dikp~nil~~~~~~v~l~Df~~~~~ 133 (303)
|+|||+.++|+++...+ +.++|||++..
T Consensus 113 --ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 113 --IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred --eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999999998765 99999999753
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=8.3e-10 Score=92.39 Aligned_cols=124 Identities=20% Similarity=0.161 Sum_probs=91.5
Q ss_pred CCcEEEEEEecCCCcc-----------cHHHHHHHHHHHhcCCCCc--cccEEEEEEe-----CCeeEEEEeecCCC-Ch
Q 048243 5 CGKVIAVKKLSKTSTQ-----------GFEEFKNEVMLTAKLQHVN--LIRVLGFCID-----SEERMLVYEYMPNK-SL 65 (303)
Q Consensus 5 ~~~~valK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~-----~~~~~lv~e~~~~~-~L 65 (303)
+|+.+.||......-. ....+.+|...+..+...+ ...++++... ....++|||++++. +|
T Consensus 44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL 123 (268)
T PRK15123 44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISL 123 (268)
T ss_pred CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccH
Confidence 5778999977443211 1124778999999884333 3455666543 23578999999875 78
Q ss_pred hhhhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC-------CCceEEccccccc
Q 048243 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-------DMKPKISDFGLAR 132 (303)
Q Consensus 66 ~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-------~~~v~l~Df~~~~ 132 (303)
.+++.... ....+......++.+++..+..||..| ++|||++++|||++. ++.+.++||+.+.
T Consensus 124 ~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 124 EDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 88874321 234556677899999999999999999 999999999999975 4679999999774
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.4e-10 Score=86.22 Aligned_cols=125 Identities=22% Similarity=0.299 Sum_probs=93.1
Q ss_pred CCcEEEEEEecCC--------CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCC-CChhhhhcCcccc
Q 048243 5 CGKVIAVKKLSKT--------STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN-KSLDCYLFDPIRR 75 (303)
Q Consensus 5 ~~~~valK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~ 75 (303)
+|+.+.||.=..+ ..-...+.++|+..|.+++--.|.-..-++.+...-.++|||.+| .++.+++......
T Consensus 29 ~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~ 108 (229)
T KOG3087|consen 29 SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMED 108 (229)
T ss_pred CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccC
Confidence 5777788854322 122345778899999999766666666666677777899999987 4778888654433
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCc---eEEcccccccc
Q 048243 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK---PKISDFGLARI 133 (303)
Q Consensus 76 ~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~---v~l~Df~~~~~ 133 (303)
.. .......++..|-..+.-||..+ ++||||..+||++..++. +.++|||++..
T Consensus 109 ~~-~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 109 ES-EDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred cc-cchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 32 22334788999999999999999 999999999999976543 58999998743
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.3e-11 Score=108.84 Aligned_cols=90 Identities=18% Similarity=0.196 Sum_probs=60.0
Q ss_pred CCccccEEEEEEe-CCeeEEEEeecCCCChhhhhc--C-ccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 048243 37 HVNLIRVLGFCID-SEERMLVYEYMPNKSLDCYLF--D-PIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKA 112 (303)
Q Consensus 37 h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~--~-~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp 112 (303)
+...+.+-.++.+ ....++||||++|+.+.+.-. . ......+....+..++.|++ ..| ++|+|++|
T Consensus 219 ~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~G---ffHaDpHP 288 (537)
T PRK04750 219 DSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDG---FFHADMHP 288 (537)
T ss_pred CCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCC---eeeCCCCh
Confidence 3333444444432 456789999999999976421 1 01111233444455555554 467 99999999
Q ss_pred CceEECCCC----ceEEccccccccccc
Q 048243 113 SNILLGEDM----KPKISDFGLARIFAK 136 (303)
Q Consensus 113 ~nil~~~~~----~v~l~Df~~~~~~~~ 136 (303)
.||+++.+| +++++|||+...+..
T Consensus 289 GNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 289 GNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHeEEecCCCCCCeEEEEecceEEECCH
Confidence 999999888 999999999876643
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.3e-09 Score=86.18 Aligned_cols=121 Identities=26% Similarity=0.264 Sum_probs=77.7
Q ss_pred ccCCCcEEEEEEecCCCc----------------------c----cHHHHHHHHHHHhcCCCC--ccccEEEEEEeCCee
Q 048243 2 VLPCGKVIAVKKLSKTST----------------------Q----GFEEFKNEVMLTAKLQHV--NLIRVLGFCIDSEER 53 (303)
Q Consensus 2 ~~~~~~~valK~~~~~~~----------------------~----~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~ 53 (303)
.-++|+.+|||+.+.... . ......+|+..|.++..- ++.+++++. .-
T Consensus 6 ~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~ 81 (188)
T PF01163_consen 6 IDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN----RN 81 (188)
T ss_dssp EECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE----TT
T ss_pred ECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe----CC
Confidence 346789999998754210 0 123466899999999655 466676553 35
Q ss_pred EEEEeecC--CCChhhhhcCccccccCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEecCCCCCceEECCCCceEEccccc
Q 048243 54 MLVYEYMP--NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLY-LQEYSRLTIIHRDLKASNILLGEDMKPKISDFGL 130 (303)
Q Consensus 54 ~lv~e~~~--~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~-Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~ 130 (303)
++||||++ |..+..+... .++......++.+++..+.. +|..| ++|||+.+.||+++++ .+.++|||.
T Consensus 82 ~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 82 VIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp EEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--GTT
T ss_pred EEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEecCc
Confidence 79999998 6555443321 11133456677788885554 57888 9999999999999987 999999998
Q ss_pred ccccc
Q 048243 131 ARIFA 135 (303)
Q Consensus 131 ~~~~~ 135 (303)
+....
T Consensus 153 av~~~ 157 (188)
T PF01163_consen 153 AVDSS 157 (188)
T ss_dssp EEETT
T ss_pred ceecC
Confidence 86543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.3e-10 Score=105.29 Aligned_cols=157 Identities=18% Similarity=0.214 Sum_probs=105.2
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcccccc-------ccccccCCCCh
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTE-------QVVGTIGYIPP 155 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~-------~~~g~~~y~aP 155 (303)
...=+.+++.|+.|+|... .+||++|.|++|+++.++..||+.|+.+............. ...-...|.||
T Consensus 101 ~f~nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~ap 178 (700)
T KOG2137|consen 101 GFANLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAP 178 (700)
T ss_pred hhhhhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccc
Confidence 3344556679999999865 49999999999999999999999999876544322211111 11235579999
Q ss_pred hhhccCCCCCccchhhHHHHHHHHHhCCCC-CccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHH
Q 048243 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRL-SMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIA 234 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~~~~~l~~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
|++.+...+.++|++|+|+.+|.+..|+.+ +...+....+...... +..-........+.++.+=+
T Consensus 179 E~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~-------------~~~~~~~~s~~~p~el~~~l 245 (700)
T KOG2137|consen 179 EYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNL-------------LNAGAFGYSNNLPSELRESL 245 (700)
T ss_pred hhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcc-------------cccccccccccCcHHHHHHH
Confidence 999998889999999999999999955444 3322222211111100 00000011123345788889
Q ss_pred HHcccCCCCCCCCHHHHHHH
Q 048243 235 LLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 235 ~~~l~~dp~~Rpt~~el~~~ 254 (303)
.+++..+...||++.++...
T Consensus 246 ~k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 246 KKLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred HHHhcCCcccCcchhhhhcc
Confidence 99999999999977776543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.99 E-value=5.3e-09 Score=85.55 Aligned_cols=124 Identities=19% Similarity=0.289 Sum_probs=92.1
Q ss_pred CCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCC--ccccEEEEEEeCC---eeEEEEeecCCCChhhhhcCccccccC
Q 048243 5 CGKVIAVKKLSKTST-QGFEEFKNEVMLTAKLQHV--NLIRVLGFCIDSE---ERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 5 ~~~~valK~~~~~~~-~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
+|+.+++|....... .....+..|+.+++.+.+. .+.+++.+..... ..++||||++|.++...+. ...+
T Consensus 21 ~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~----~~~~ 96 (223)
T cd05154 21 GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLL----RPEL 96 (223)
T ss_pred CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCC----CCCC
Confidence 468899999865432 1345788999999999653 4677777766542 5689999999988866542 1246
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------------------CCCe
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYS-----------------------------------------------------RLTI 105 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~-----------------------------------------------------~~~i 105 (303)
+......++.+++.+|+.||+.. ...+
T Consensus 97 ~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 176 (223)
T cd05154 97 SPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGL 176 (223)
T ss_pred CHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEE
Confidence 66677777888888888887521 2447
Q ss_pred EecCCCCCceEECC--CCceEEccccccc
Q 048243 106 IHRDLKASNILLGE--DMKPKISDFGLAR 132 (303)
Q Consensus 106 ~H~dikp~nil~~~--~~~v~l~Df~~~~ 132 (303)
+|||+.|.||+++. ++.+.|+||+.+.
T Consensus 177 ~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 177 VHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred EECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 99999999999998 5678999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.6e-08 Score=81.75 Aligned_cols=106 Identities=22% Similarity=0.233 Sum_probs=84.2
Q ss_pred HHHHHHHHHHHhcCCCC--ccccEEEEEEeCC----eeEEEEeecCCC-ChhhhhcCccccccCCHHHHHHHHHHHHHHH
Q 048243 22 FEEFKNEVMLTAKLQHV--NLIRVLGFCIDSE----ERMLVYEYMPNK-SLDCYLFDPIRRLILDWKKRVHIIEGITQGL 94 (303)
Q Consensus 22 ~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~----~~~lv~e~~~~~-~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l 94 (303)
.....+|...+..+... .+.+.+++..... ..++|+|++++. +|.+++... ...+......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHHH
Confidence 44678899988888433 4566777766532 458999999874 788888431 2256677889999999999
Q ss_pred HHHHhCCCCCeEecCCCCCceEECCCC---ceEEcccccccc
Q 048243 95 LYLQEYSRLTIIHRDLKASNILLGEDM---KPKISDFGLARI 133 (303)
Q Consensus 95 ~~Lh~~~~~~i~H~dikp~nil~~~~~---~v~l~Df~~~~~ 133 (303)
+-||..| ++|+|+++.|||++.++ .+.++||+-+..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999 99999999999999887 899999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.1e-10 Score=108.10 Aligned_cols=194 Identities=19% Similarity=0.160 Sum_probs=136.4
Q ss_pred CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCce
Q 048243 36 QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115 (303)
Q Consensus 36 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~ni 115 (303)
++|.++.....+......+|++++..+++|...+.. -+..+..........+..++++||... +.|+|++|.|.
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~---~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~ 935 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHN---SGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSL 935 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhhc---CCCcccccccchhHHHHhhhhccccch---hhcccccccch
Confidence 345555544444445677899999999999887743 234666667778888889999999987 89999999999
Q ss_pred EECCCCceEEcccccccccccC---------------------Cc----c----ccccccccccCCCChhhhccCCCCCc
Q 048243 116 LLGEDMKPKISDFGLARIFAKE---------------------SL----E----ANTEQVVGTIGYIPPEYARQGVYSTK 166 (303)
Q Consensus 116 l~~~~~~v~l~Df~~~~~~~~~---------------------~~----~----~~~~~~~g~~~y~aPE~~~~~~~~~~ 166 (303)
+...+|...+.||+.....+.. .. . .......||+.|.+||...+..-...
T Consensus 936 l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ 1015 (1205)
T KOG0606|consen 936 LIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA 1015 (1205)
T ss_pred hhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc
Confidence 9999999999999843221110 00 0 01123468999999999999999999
Q ss_pred cchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 048243 167 SDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRP 246 (303)
Q Consensus 167 ~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 246 (303)
+|.|++|+++++.++|.+||..........-+. ...+..+ .-+...+.+..+++...+..+|.+|.
T Consensus 1016 ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~----------~~~~~~p----~g~~~~s~~aq~~~~~ll~~~~~qr~ 1081 (1205)
T KOG0606|consen 1016 ADWWSSGVCLFEVLTGIPPFNAETPQQIFENIL----------NRDIPWP----EGPEEGSYEAQDLINRLLTEEPTQRL 1081 (1205)
T ss_pred chhhhhhhhhhhhhcCCCCCCCcchhhhhhccc----------cCCCCCC----CCccccChhhhhhhhhhhccCchhcc
Confidence 999999999999999999986443332211000 0000000 00112233677899999999999998
Q ss_pred CHH
Q 048243 247 SML 249 (303)
Q Consensus 247 t~~ 249 (303)
.+.
T Consensus 1082 ~a~ 1084 (1205)
T KOG0606|consen 1082 GAK 1084 (1205)
T ss_pred Ccc
Confidence 876
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.83 E-value=2e-08 Score=82.09 Aligned_cols=120 Identities=22% Similarity=0.218 Sum_probs=86.4
Q ss_pred ccCCCcEEEEEEecCC----------C------------cccHHHHHHHHHHHhcCCCC--ccccEEEEEEeCCeeEEEE
Q 048243 2 VLPCGKVIAVKKLSKT----------S------------TQGFEEFKNEVMLTAKLQHV--NLIRVLGFCIDSEERMLVY 57 (303)
Q Consensus 2 ~~~~~~~valK~~~~~----------~------------~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~ 57 (303)
..++|.++|||.=+.. . .-++...++|.++|..|... .|.+.++. +.-++||
T Consensus 111 ~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvM 186 (304)
T COG0478 111 IDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKPIAW----NRHAVVM 186 (304)
T ss_pred ECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCcccc----ccceeee
Confidence 4678999999952211 0 01234577899999999544 66677655 4668999
Q ss_pred eecCCCChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEccccccccccc
Q 048243 58 EYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAK 136 (303)
Q Consensus 58 e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~ 136 (303)
|+.+|..|... +++....-.++..|+.-+.-+-..| ++|||+++-||+++++|.+.++||-.+...+.
T Consensus 187 e~ieG~eL~~~--------r~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~~~vIDwPQ~v~~~h 254 (304)
T COG0478 187 EYIEGVELYRL--------RLDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGDIVVIDWPQAVPISH 254 (304)
T ss_pred ehcccceeecc--------cCcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCCEEEEeCcccccCCC
Confidence 99998666322 2234445566667777777676778 99999999999999999999999987755443
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.6e-07 Score=74.05 Aligned_cols=113 Identities=19% Similarity=0.187 Sum_probs=73.7
Q ss_pred CCcEEEEEEecCCCcccHHHH---------HHHHHHHhcCCCC---ccccEEEEEEe-----CCeeEEEEeecCCCChhh
Q 048243 5 CGKVIAVKKLSKTSTQGFEEF---------KNEVMLTAKLQHV---NLIRVLGFCID-----SEERMLVYEYMPNKSLDC 67 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~---------~~e~~~l~~l~h~---~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~ 67 (303)
+|+.+++|..+.......+.+ .+.+..+..++.. ....++.+... ....+++|||++|..|.+
T Consensus 53 ~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d 132 (229)
T PF06176_consen 53 DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELND 132 (229)
T ss_pred CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEecCeeccc
Confidence 467788888766543333322 2344444444332 23333333332 234568999999988865
Q ss_pred hhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEccccccc
Q 048243 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 68 ~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~ 132 (303)
... +++ .+...+..++.-+|+.| ++|||.+|.|++++++ .++++||+.-+
T Consensus 133 ~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 133 IED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred chh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cEEEEECcccc
Confidence 531 222 24456777899999999 9999999999999965 59999997643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.51 E-value=3e-06 Score=67.72 Aligned_cols=124 Identities=16% Similarity=0.117 Sum_probs=90.1
Q ss_pred CcEEEEEEecCC------CcccHHHHHHHHHHHhcCC--CCccccEEEEEEeC----CeeEEEEeecCC-CChhhhhcCc
Q 048243 6 GKVIAVKKLSKT------STQGFEEFKNEVMLTAKLQ--HVNLIRVLGFCIDS----EERMLVYEYMPN-KSLDCYLFDP 72 (303)
Q Consensus 6 ~~~valK~~~~~------~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~----~~~~lv~e~~~~-~~L~~~l~~~ 72 (303)
|+.+-+|.-... .+.....+.+|+..+..+. .-.+.++...-... ....||+|-+.+ .+|.+++...
T Consensus 41 g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~ 120 (216)
T PRK09902 41 GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQH 120 (216)
T ss_pred CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcC
Confidence 456888876422 1446678999999999994 33355555222221 246799996653 5777777432
Q ss_pred cccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCc--eEEcccccccc
Q 048243 73 IRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK--PKISDFGLARI 133 (303)
Q Consensus 73 ~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~--v~l~Df~~~~~ 133 (303)
.....+......++.+++.+++-||..| +.|+|+.+.||+++..|. +.++||--++.
T Consensus 121 -~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 121 -AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred -CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 2234567778899999999999999999 999999999999987777 99999976643
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.44 E-value=3e-06 Score=68.85 Aligned_cols=122 Identities=21% Similarity=0.281 Sum_probs=83.6
Q ss_pred CCCcEEEEEEecCCCccc-------------------HHH-----HHHHHHHHhcCC--CCccccEEEEEEeCCeeEEEE
Q 048243 4 PCGKVIAVKKLSKTSTQG-------------------FEE-----FKNEVMLTAKLQ--HVNLIRVLGFCIDSEERMLVY 57 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~-------------------~~~-----~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~ 57 (303)
.++..+|+|+++...... ..+ ..+|+..|+++. +=.+.+.+++. .-.|||
T Consensus 70 ~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvM 145 (268)
T COG1718 70 GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVM 145 (268)
T ss_pred CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEE
Confidence 468899999987542111 111 235777777773 34456666665 347999
Q ss_pred eecCCCCh-hhhhcCccccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceEECCCCceEEcccccccccc
Q 048243 58 EYMPNKSL-DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFA 135 (303)
Q Consensus 58 e~~~~~~L-~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~ 135 (303)
||+..... .-.| ....+.......+..+++..+.-|-. .+ +||+||+.-|||+. ++.+.++||+.+....
T Consensus 146 EfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 146 EFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred EeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 99854311 1112 22333444677788888899888876 77 99999999999999 7899999999987655
Q ss_pred cC
Q 048243 136 KE 137 (303)
Q Consensus 136 ~~ 137 (303)
++
T Consensus 218 hp 219 (268)
T COG1718 218 HP 219 (268)
T ss_pred CC
Confidence 43
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.38 E-value=9.3e-06 Score=66.61 Aligned_cols=124 Identities=15% Similarity=0.144 Sum_probs=73.0
Q ss_pred CcEEEEEEecCCCcccHHHHHHHHHHHhcCCCC--ccccEEEEEEeCCeeEEEEeecCCCC-hhhhhcC-----------
Q 048243 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHV--NLIRVLGFCIDSEERMLVYEYMPNKS-LDCYLFD----------- 71 (303)
Q Consensus 6 ~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~-L~~~l~~----------- 71 (303)
|..+++|...... ......+|.+.++.+..- .+.+.+++....+..++||++++|.+ +...+..
T Consensus 22 ~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~ 99 (226)
T TIGR02172 22 TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKI 99 (226)
T ss_pred CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHH
Confidence 4467788886533 335678899999998533 35778888888888899999999863 2111110
Q ss_pred ------cccc---ccCCHHHHHH-HHH----------HHHH-HHHHHHh-CCCCCeEecCCCCCceEECCCCceEEcccc
Q 048243 72 ------PIRR---LILDWKKRVH-IIE----------GITQ-GLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFG 129 (303)
Q Consensus 72 ------~~~~---~~l~~~~~~~-~~~----------~i~~-~l~~Lh~-~~~~~i~H~dikp~nil~~~~~~v~l~Df~ 129 (303)
.... ...+...... +.. .+.. ...+|.. .....++|||+.|.|+++++++ +.++||+
T Consensus 100 la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe 178 (226)
T TIGR02172 100 FAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLG 178 (226)
T ss_pred HHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEech
Confidence 0000 0111111000 000 0001 1111211 1234579999999999999888 9999998
Q ss_pred ccc
Q 048243 130 LAR 132 (303)
Q Consensus 130 ~~~ 132 (303)
.+.
T Consensus 179 ~a~ 181 (226)
T TIGR02172 179 DFG 181 (226)
T ss_pred hcC
Confidence 763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.38 E-value=4.1e-06 Score=80.86 Aligned_cols=197 Identities=20% Similarity=0.210 Sum_probs=135.7
Q ss_pred HHHHHHHHHhcCCCCccccEEEEEEeCCeeE----EEEeecCCCChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHh
Q 048243 24 EFKNEVMLTAKLQHVNLIRVLGFCIDSEERM----LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQE 99 (303)
Q Consensus 24 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~----lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~ 99 (303)
....|++.+.++.|+|++.++.+........ +..++|...++...+. .-..++....+.+..++.+|++++|+
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHHH
Confidence 3445777788889999999999987654433 4566788878777773 34567888999999999999999999
Q ss_pred CCCCCeEecCCCCC---ceEECCCCceEEc--ccccccccccCCccccccccccccCCCChhhhccCCCCCc--cchhhH
Q 048243 100 YSRLTIIHRDLKAS---NILLGEDMKPKIS--DFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTK--SDVFSF 172 (303)
Q Consensus 100 ~~~~~i~H~dikp~---nil~~~~~~v~l~--Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~--~Diwsl 172 (303)
.. ..|.-+..+ +.-.+..+.+.++ ||+............. ...+..+.++|.......+.+ .|+|.+
T Consensus 305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred hc---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHHHH
Confidence 86 666555554 4445566667777 8888766544432211 123556778887777665554 799999
Q ss_pred HHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 048243 173 GVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVS 252 (303)
Q Consensus 173 G~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~ 252 (303)
|.....+..|..+....... ...+.... . ....+...+|+..++++|+++.+++
T Consensus 379 gll~~~~~~~~~i~~~~~~~----------------------~~~l~~~~-~---~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSAVP----------------------VSLLDVLS-T---SELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHHhhhhhcCcccccccch----------------------hhhhcccc-c---hhhhhhhhhhcchhhhhccchhhhh
Confidence 99999998877553211100 00000000 0 0466889999999999999999998
Q ss_pred HHh
Q 048243 253 SML 255 (303)
Q Consensus 253 ~~L 255 (303)
...
T Consensus 433 ~~~ 435 (1351)
T KOG1035|consen 433 THP 435 (1351)
T ss_pred hch
Confidence 763
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.5e-06 Score=77.61 Aligned_cols=82 Identities=20% Similarity=0.241 Sum_probs=55.5
Q ss_pred eCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEccc
Q 048243 49 DSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128 (303)
Q Consensus 49 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df 128 (303)
......|+|||++|..+.+.... .....+...+.....++. +..+-..| ++|.|.+|.||++..+|++.+.||
T Consensus 237 ~t~~~VLtmE~i~Gi~i~d~~~l--~~~g~d~k~ia~~~~~~f--~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDf 309 (517)
T COG0661 237 YTTRRVLTMEWIDGIKISDIAAL--KSAGIDRKELAELLVRAF--LRQLLRDG---FFHADPHPGNILVRSDGRIVLLDF 309 (517)
T ss_pred ccCCcEEEEEeeCCEecccHHHH--HhcCCCHHHHHHHHHHHH--HHHHHhcC---ccccCCCccceEEecCCcEEEEcC
Confidence 35667899999999988877422 123344333222222211 22223356 999999999999999999999999
Q ss_pred ccccccccC
Q 048243 129 GLARIFAKE 137 (303)
Q Consensus 129 ~~~~~~~~~ 137 (303)
|+.......
T Consensus 310 Gi~g~l~~~ 318 (517)
T COG0661 310 GIVGRLDPK 318 (517)
T ss_pred cceecCCHH
Confidence 998766543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.37 E-value=3.3e-06 Score=67.06 Aligned_cols=104 Identities=24% Similarity=0.235 Sum_probs=81.3
Q ss_pred HHHHHHHhcCCC-CccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 048243 26 KNEVMLTAKLQH-VNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLT 104 (303)
Q Consensus 26 ~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~ 104 (303)
.+|..+++.+.+ +++.+++|+| ...++.|+...+++......-......+|..+.+++.++++.+.+|+......
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888888865 6999999999 55789999986655311000012234789999999999999999998865555
Q ss_pred eEecCCCCCceEECCCCceEEcccccccc
Q 048243 105 IIHRDLKASNILLGEDMKPKISDFGLARI 133 (303)
Q Consensus 105 i~H~dikp~nil~~~~~~v~l~Df~~~~~ 133 (303)
+.-.|++|+|+-++++|+++++|.+.+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88899999999999999999999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.4e-05 Score=66.38 Aligned_cols=60 Identities=13% Similarity=0.108 Sum_probs=43.6
Q ss_pred CcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhh
Q 048243 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68 (303)
Q Consensus 6 ~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 68 (303)
+..+.+|+..... ...+..|+.+++.+ ++--+.+++++.......++||++++|.++...
T Consensus 22 ~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 22 NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 4577888875443 24567799998888 344466788877766678999999998877643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.19 E-value=7.6e-07 Score=80.75 Aligned_cols=151 Identities=19% Similarity=0.188 Sum_probs=113.8
Q ss_pred HHHHHHHHHHhcCCCCc-cccEEEEEEeCCeeEEEEeecCCC-ChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHhC
Q 048243 23 EEFKNEVMLTAKLQHVN-LIRVLGFCIDSEERMLVYEYMPNK-SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEY 100 (303)
Q Consensus 23 ~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~ 100 (303)
....-++++|.+++||| .+..++-+..+...++.++++.++ +..... ......+...++...++.-.++++++|+.
T Consensus 278 l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~ 355 (829)
T KOG0576|consen 278 LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSS 355 (829)
T ss_pred hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccC--ChhhHhhhhhhhhhhhhhhcccccccccc
Confidence 45567899999999999 677777776677889999999877 222221 12334455667777888888999999987
Q ss_pred CCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCCCccchhhHHHHHHHHH
Q 048243 101 SRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180 (303)
Q Consensus 101 ~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~ 180 (303)
. =+|+| ||+..+ +..+.+||+....+.... ..+...+++.++|||+.....+..+.|+|++|.-..++.
T Consensus 356 ~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~a 424 (829)
T KOG0576|consen 356 Y---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMA 424 (829)
T ss_pred c---ccCcc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcC
Confidence 5 58888 666555 678999999876544332 234467899999999999999999999999998877777
Q ss_pred hCCCCC
Q 048243 181 SGKRLS 186 (303)
Q Consensus 181 ~g~~p~ 186 (303)
-|.+|-
T Consensus 425 p~~pPr 430 (829)
T KOG0576|consen 425 PGLPPR 430 (829)
T ss_pred CCCCCC
Confidence 777663
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.12 E-value=5.4e-05 Score=60.48 Aligned_cols=114 Identities=20% Similarity=0.258 Sum_probs=78.9
Q ss_pred cCCCcEEEEEEecCCC----------------cccHHHHHHHHHHHhcCC------CCccccEEEEEEeCCeeEEEEeec
Q 048243 3 LPCGKVIAVKKLSKTS----------------TQGFEEFKNEVMLTAKLQ------HVNLIRVLGFCIDSEERMLVYEYM 60 (303)
Q Consensus 3 ~~~~~~valK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~~ 60 (303)
.+++....||+..... .....+..+|+.....+. +.+|.+++|+.+.+....+|+|.+
T Consensus 20 HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I 99 (199)
T PF10707_consen 20 HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELI 99 (199)
T ss_pred CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEE
Confidence 4566777888886655 122345666766666665 789999999999999999999976
Q ss_pred C------CCChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCC----ceEEcc
Q 048243 61 P------NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM----KPKISD 127 (303)
Q Consensus 61 ~------~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~----~v~l~D 127 (303)
. .-+|.+++ ....++. .... .+-+-..+|-+.+ |+.+|++|.||++..+. .+.|+|
T Consensus 100 ~d~dG~~s~TL~~~l----~~~~~~~-~~~~---~L~~f~~~l~~~~---Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 100 RDADGNISPTLEDYL----KEGGLTE-ELRQ---ALDEFKRYLLDHH---IVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred ECCCCCcCccHHHHH----HcCCccH-HHHH---HHHHHHHHHHHcC---CeecCCCcccEEEEecCCCceEEEEEe
Confidence 3 23566666 3334554 3333 3444566777777 99999999999996432 466776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.99 E-value=2.5e-05 Score=71.01 Aligned_cols=81 Identities=19% Similarity=0.213 Sum_probs=54.2
Q ss_pred CCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC----CCceEE
Q 048243 50 SEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE----DMKPKI 125 (303)
Q Consensus 50 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~----~~~v~l 125 (303)
.....|+||||+|..+.+.-. .....++...+..-+.+... .-+-..| ++|+|-+|.||++.. ++.+.+
T Consensus 274 st~RVLtME~~~G~~i~Dl~~--i~~~gi~~~~i~~~l~~~~~--~qIf~~G---ffHaDPHPGNilv~~~~~~~~~ivl 346 (538)
T KOG1235|consen 274 STKRVLTMEYVDGIKINDLDA--IDKRGISPHDILNKLVEAYL--EQIFKTG---FFHADPHPGNILVRPNPEGDEEIVL 346 (538)
T ss_pred CcceEEEEEecCCccCCCHHH--HHHcCCCHHHHHHHHHHHHH--HHHHhcC---CccCCCCCCcEEEecCCCCCccEEE
Confidence 346789999999988876532 13334555544333333222 1223345 999999999999983 667999
Q ss_pred cccccccccccC
Q 048243 126 SDFGLARIFAKE 137 (303)
Q Consensus 126 ~Df~~~~~~~~~ 137 (303)
-|||+.......
T Consensus 347 lDhGl~~~is~~ 358 (538)
T KOG1235|consen 347 LDHGLYAVISHK 358 (538)
T ss_pred EcccccccccHH
Confidence 999998765443
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.95 E-value=8.1e-05 Score=61.10 Aligned_cols=125 Identities=24% Similarity=0.236 Sum_probs=67.5
Q ss_pred CcEEEEEEecCCCcccHHHHHHHHHHHhcCCCC--ccccEEEEEEe---CCeeEEEEeecCCCChhh-------------
Q 048243 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHV--NLIRVLGFCID---SEERMLVYEYMPNKSLDC------------- 67 (303)
Q Consensus 6 ~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~---~~~~~lv~e~~~~~~L~~------------- 67 (303)
+..+++|..... .....+..|..+++.+... .+.+++..... ....+++|++++|..+..
T Consensus 20 ~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~ 97 (239)
T PF01636_consen 20 DGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDDELSPEQRPELLRQ 97 (239)
T ss_dssp TSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHHTSTHHHHHHHHHH
T ss_pred CcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecccccccccccccccccccc
Confidence 358899987654 3456788899998888432 35667764433 335689999999887766
Q ss_pred ---hhcC--cc--ccccCCHHH---------HHHH------------HHHHHH-HHHHHHh----CCCCCeEecCCCCCc
Q 048243 68 ---YLFD--PI--RRLILDWKK---------RVHI------------IEGITQ-GLLYLQE----YSRLTIIHRDLKASN 114 (303)
Q Consensus 68 ---~l~~--~~--~~~~l~~~~---------~~~~------------~~~i~~-~l~~Lh~----~~~~~i~H~dikp~n 114 (303)
.+.. .. ......... .... ...+.. .++.++. .....++|||+.|.|
T Consensus 98 ~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~N 177 (239)
T PF01636_consen 98 LGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALLPKPLPPVLIHGDLHPGN 177 (239)
T ss_dssp HHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGG
T ss_pred chhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhhccCCCcEEEEecccccc
Confidence 1100 00 000011000 0000 111222 2333332 134559999999999
Q ss_pred eEEC-CCCceEEccccccc
Q 048243 115 ILLG-EDMKPKISDFGLAR 132 (303)
Q Consensus 115 il~~-~~~~v~l~Df~~~~ 132 (303)
|+++ .++.+.|+||+.+.
T Consensus 178 il~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 178 ILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp EEEESSTTEEEE--GTT-E
T ss_pred ceeeeccceeEEEecccce
Confidence 9999 66667899998653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.89 E-value=9.6e-05 Score=61.92 Aligned_cols=123 Identities=17% Similarity=0.136 Sum_probs=67.3
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCcc-ccEEEEEEeCCeeEEEEeecCCCChhhh-------hc------
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL-IRVLGFCIDSEERMLVYEYMPNKSLDCY-------LF------ 70 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~~~-------l~------ 70 (303)
+|+.+++|........-.-...+|..+++.+....+ .+++.... -++|++|++|..+... +.
T Consensus 18 ~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~~~~~~~~~~~la~~l 93 (256)
T TIGR02721 18 PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLDQFVALDLLLELAALL 93 (256)
T ss_pred CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccccccCchhHHHHHHHH
Confidence 466788887654322110135678899998854333 34454432 3799999998765421 00
Q ss_pred ----C-ccccccCCHH-HHHHHHHHH---------HHHHHHHHhC-----CCCCeEecCCCCCceEECCCCceEEccccc
Q 048243 71 ----D-PIRRLILDWK-KRVHIIEGI---------TQGLLYLQEY-----SRLTIIHRDLKASNILLGEDMKPKISDFGL 130 (303)
Q Consensus 71 ----~-~~~~~~l~~~-~~~~~~~~i---------~~~l~~Lh~~-----~~~~i~H~dikp~nil~~~~~~v~l~Df~~ 130 (303)
. ......++.. .+..+..++ ...+..+-.. ....++|+|+.|.||++++++ +.++||..
T Consensus 94 ~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~~-~~lIDwE~ 172 (256)
T TIGR02721 94 HQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTPQG-LKLIDWEY 172 (256)
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEeCCC-CEEEeccc
Confidence 0 0011112211 111211111 1112222111 123489999999999999876 78999987
Q ss_pred cc
Q 048243 131 AR 132 (303)
Q Consensus 131 ~~ 132 (303)
+.
T Consensus 173 a~ 174 (256)
T TIGR02721 173 AS 174 (256)
T ss_pred cC
Confidence 74
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00021 Score=59.02 Aligned_cols=31 Identities=26% Similarity=0.392 Sum_probs=25.7
Q ss_pred CCCeEecCCCCCceEECCCCceEEccccccc
Q 048243 102 RLTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 102 ~~~i~H~dikp~nil~~~~~~v~l~Df~~~~ 132 (303)
...++|||+.+.|+++++++..-|+||+.+.
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 3448999999999999877656799999763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.0006 Score=66.71 Aligned_cols=59 Identities=19% Similarity=0.344 Sum_probs=41.5
Q ss_pred cEEEEEEecCCC-cccHHHHHHHHHHHhcCC-CCcc--ccEEEEEEeC---CeeEEEEeecCCCCh
Q 048243 7 KVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQ-HVNL--IRVLGFCIDS---EERMLVYEYMPNKSL 65 (303)
Q Consensus 7 ~~valK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~---~~~~lv~e~~~~~~L 65 (303)
+.+++|+..... ......+.+|+.+++.+. |.++ .+++.++.+. ...++||||++|..+
T Consensus 66 ~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~ 131 (822)
T PLN02876 66 KRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIF 131 (822)
T ss_pred eeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCccc
Confidence 357777764432 223356889999999995 6664 7788877664 467899999988654
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00063 Score=56.12 Aligned_cols=30 Identities=30% Similarity=0.458 Sum_probs=26.2
Q ss_pred CCeEecCCCCCceEECC-CCceEEccccccc
Q 048243 103 LTIIHRDLKASNILLGE-DMKPKISDFGLAR 132 (303)
Q Consensus 103 ~~i~H~dikp~nil~~~-~~~v~l~Df~~~~ 132 (303)
..++|+|+.+.||+++. ++.+.++||..+.
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 45999999999999998 5789999998763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00055 Score=58.63 Aligned_cols=124 Identities=17% Similarity=0.125 Sum_probs=69.5
Q ss_pred CcEEEEEEecCCCcccHHHHHHHHHHHhcCCCC--ccccEEEE------EEeCCeeEEEEeecCCCChhh----hhcC--
Q 048243 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHV--NLIRVLGF------CIDSEERMLVYEYMPNKSLDC----YLFD-- 71 (303)
Q Consensus 6 ~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~------~~~~~~~~lv~e~~~~~~L~~----~l~~-- 71 (303)
+..+++|+... .....+..|+.++..+.+. .+.+++.. ....+..++|+++++|..+.. ....
T Consensus 37 ~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg 113 (296)
T cd05153 37 SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIG 113 (296)
T ss_pred CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHH
Confidence 45688888764 2335677788888887432 24444432 123446689999999876532 0000
Q ss_pred -----------cccc-----ccCCHHHH----------HHHHHHHHHHHHHHHh----CCCCCeEecCCCCCceEECCCC
Q 048243 72 -----------PIRR-----LILDWKKR----------VHIIEGITQGLLYLQE----YSRLTIIHRDLKASNILLGEDM 121 (303)
Q Consensus 72 -----------~~~~-----~~l~~~~~----------~~~~~~i~~~l~~Lh~----~~~~~i~H~dikp~nil~~~~~ 121 (303)
.... ....+... ......+..++.++.. .-...++|||+.|.|+++++++
T Consensus 114 ~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~ 193 (296)
T cd05153 114 EALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDE 193 (296)
T ss_pred HHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCc
Confidence 0000 00011100 0011112233444432 1124599999999999999987
Q ss_pred ceEEccccccc
Q 048243 122 KPKISDFGLAR 132 (303)
Q Consensus 122 ~v~l~Df~~~~ 132 (303)
.+.|+||+.+.
T Consensus 194 ~~~iIDfe~a~ 204 (296)
T cd05153 194 LSGVIDFYFAC 204 (296)
T ss_pred eEEEeehhhhc
Confidence 77899998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00055 Score=58.80 Aligned_cols=58 Identities=14% Similarity=0.240 Sum_probs=37.8
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCc-cccEEEEEEeCCeeEEEEeecCCCChhh
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN-LIRVLGFCIDSEERMLVYEYMPNKSLDC 67 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 67 (303)
.++.+++|+...... .......|..++..+...+ ..++++++. -.+|++|++|..+..
T Consensus 28 ~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~i~G~~l~~ 86 (302)
T cd05156 28 EPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEFIPSRTLTT 86 (302)
T ss_pred CCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhheeCCCcCCH
Confidence 368899999865432 2235577888888884333 345665553 246899998877643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0029 Score=54.22 Aligned_cols=56 Identities=16% Similarity=0.049 Sum_probs=39.9
Q ss_pred EEEEEEecCCCcccHHHHHHHHHHHhcCC-C--CccccEEEEEEeC---CeeEEEEeecCCCCh
Q 048243 8 VIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-H--VNLIRVLGFCIDS---EERMLVYEYMPNKSL 65 (303)
Q Consensus 8 ~valK~~~~~~~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~---~~~~lv~e~~~~~~L 65 (303)
.+.+|..+... ....+..|...|+.+. + -.+.++++++.+. +..++|||++++.++
T Consensus 39 ~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 39 NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence 46667754311 2257889999999984 3 3678888887643 568999999998765
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0019 Score=55.64 Aligned_cols=30 Identities=33% Similarity=0.445 Sum_probs=26.5
Q ss_pred CCCeEecCCCCCceEECCCCceEEcccccc
Q 048243 102 RLTIIHRDLKASNILLGEDMKPKISDFGLA 131 (303)
Q Consensus 102 ~~~i~H~dikp~nil~~~~~~v~l~Df~~~ 131 (303)
..+++|+|+.+.|++++.++.+.++||+.+
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFA 215 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeecccc
Confidence 355999999999999998877789999876
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0019 Score=56.52 Aligned_cols=122 Identities=20% Similarity=0.278 Sum_probs=70.1
Q ss_pred CcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCcc-ccEEEEEEeCCeeEEEEeecCCCChhhh-hcC------------
Q 048243 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL-IRVLGFCIDSEERMLVYEYMPNKSLDCY-LFD------------ 71 (303)
Q Consensus 6 ~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~------------ 71 (303)
++.|++|+.........+ ..+|+.+++.+...++ .++++.+.. ..|.+|+++.++... +.+
T Consensus 65 ~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~----g~v~efi~g~~l~~~~l~~~~~~~~ia~~L~ 139 (344)
T PLN02236 65 GRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN----GRVEEFIHARTLSAADLRDPEISALIAAKLR 139 (344)
T ss_pred CCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECC----ceEEEeeCCCCCCHHHcCChHHHHHHHHHHH
Confidence 478999988665433323 3678999998854444 456666633 258999987666421 100
Q ss_pred -----cccc-c-cCCHHHHHHHHHHHH-----------------HHHHH----HHh-CCCCCeEecCCCCCceEECC-CC
Q 048243 72 -----PIRR-L-ILDWKKRVHIIEGIT-----------------QGLLY----LQE-YSRLTIIHRDLKASNILLGE-DM 121 (303)
Q Consensus 72 -----~~~~-~-~l~~~~~~~~~~~i~-----------------~~l~~----Lh~-~~~~~i~H~dikp~nil~~~-~~ 121 (303)
.... . ...+..+..++.++. ..+.. +.. .....++|+|+++.||++++ ++
T Consensus 140 ~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~ 219 (344)
T PLN02236 140 EFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETR 219 (344)
T ss_pred HHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCC
Confidence 0000 0 111233333332211 11111 121 22345899999999999986 46
Q ss_pred ceEEccccccc
Q 048243 122 KPKISDFGLAR 132 (303)
Q Consensus 122 ~v~l~Df~~~~ 132 (303)
.+.++||..+.
T Consensus 220 ~~~lID~Eya~ 230 (344)
T PLN02236 220 AITIIDYEYAS 230 (344)
T ss_pred cEEEEeehhcc
Confidence 79999998774
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0029 Score=54.77 Aligned_cols=30 Identities=33% Similarity=0.391 Sum_probs=25.5
Q ss_pred CCeEecCCCCCceEECCCCceEEccccccc
Q 048243 103 LTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 103 ~~i~H~dikp~nil~~~~~~v~l~Df~~~~ 132 (303)
.++||||+.|.||+++.+...-++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 459999999999999976656899998763
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.00099 Score=54.04 Aligned_cols=122 Identities=22% Similarity=0.281 Sum_probs=61.2
Q ss_pred CcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCc-cccEEEEEEeCCeeEEEEeecCCCChhhh-hcC------------
Q 048243 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN-LIRVLGFCIDSEERMLVYEYMPNKSLDCY-LFD------------ 71 (303)
Q Consensus 6 ~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~------------ 71 (303)
++.|++|+....+. ..-....|..+++.+...+ -.++++++.. ..|.+|+++..|..- +.+
T Consensus 2 ~~~~~~Ri~g~~t~-~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEGTE-NFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESCGC-SHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCcc-cccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence 57899999977643 3355677999999885444 4566666532 357788876654321 110
Q ss_pred -----cc---ccccCCHHHHHHH----------------------HHHHHHHHHHHH----hCC-CCCeEecCCCCCceE
Q 048243 72 -----PI---RRLILDWKKRVHI----------------------IEGITQGLLYLQ----EYS-RLTIIHRDLKASNIL 116 (303)
Q Consensus 72 -----~~---~~~~l~~~~~~~~----------------------~~~i~~~l~~Lh----~~~-~~~i~H~dikp~nil 116 (303)
.. .....-+..+..| +..+..-+..+. ..+ ...++|+|+.|.||+
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 00 0000011122222 011111122221 111 245899999999999
Q ss_pred E-CCCCceEEccccccc
Q 048243 117 L-GEDMKPKISDFGLAR 132 (303)
Q Consensus 117 ~-~~~~~v~l~Df~~~~ 132 (303)
+ +.++.++++||..+.
T Consensus 157 ~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAG 173 (211)
T ss_dssp ETSSSSCEEE--GTT-E
T ss_pred eccCCCeEEEecHHHHh
Confidence 9 888999999998874
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0029 Score=49.04 Aligned_cols=110 Identities=20% Similarity=0.189 Sum_probs=74.4
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHH
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~ 84 (303)
.|..+|+|+-+..+ ....+..|+++|..+.-.++.+=+.++. .-.+.|||..|-.|.+.... .+.
T Consensus 44 ~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg---~~~i~me~i~G~~L~~~~~~------~~r---- 108 (201)
T COG2112 44 RGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG---EDFIRMEYIDGRPLGKLEIG------GDR---- 108 (201)
T ss_pred cCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec---hhhhhhhhhcCcchhhhhhc------ccH----
Confidence 46688999886554 4578999999999998777655333332 22345999998888655421 022
Q ss_pred HHHHHHHHHHHHHHhCCCCCeEecCCC-CCceEECCCCceEEccccccc
Q 048243 85 HIIEGITQGLLYLQEYSRLTIIHRDLK-ASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 85 ~~~~~i~~~l~~Lh~~~~~~i~H~dik-p~nil~~~~~~v~l~Df~~~~ 132 (303)
+-+..+++..--|-..| |-|+.|+ |...++.+++.+.|+||..|.
T Consensus 109 k~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 109 KHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred HHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchh
Confidence 23334455544555667 9999987 566666666699999999876
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0033 Score=53.91 Aligned_cols=119 Identities=18% Similarity=0.276 Sum_probs=75.5
Q ss_pred CcEEEEEEecC--CCcccHHHHHHHHHHHhcCC--CCccccEEEEEEeCC--eeEEEEeecCCCChhhhhcCccccccCC
Q 048243 6 GKVIAVKKLSK--TSTQGFEEFKNEVMLTAKLQ--HVNLIRVLGFCIDSE--ERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 6 ~~~valK~~~~--~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
++.++|. ... ..........+|+..++.+. .--+...++.|..+. ..+.||+|++|..+.+.+.. ....
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~----~~~~ 122 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPP----ESLG 122 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCc----ccch
Confidence 5667777 221 12233456677888888873 234556677776665 77999999988544222210 0011
Q ss_pred HHHHHHHH-HHHHHHHHHHHhCC-------------------------------------------------------CC
Q 048243 80 WKKRVHII-EGITQGLLYLQEYS-------------------------------------------------------RL 103 (303)
Q Consensus 80 ~~~~~~~~-~~i~~~l~~Lh~~~-------------------------------------------------------~~ 103 (303)
..++ ..+++.|+.||+-. ..
T Consensus 123 ----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~ 198 (321)
T COG3173 123 ----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPP 198 (321)
T ss_pred ----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCc
Confidence 1122 25555555565321 25
Q ss_pred CeEecCCCCCceEECCCCceEEcccccccc
Q 048243 104 TIIHRDLKASNILLGEDMKPKISDFGLARI 133 (303)
Q Consensus 104 ~i~H~dikp~nil~~~~~~v~l~Df~~~~~ 133 (303)
.++|||+.+.|++++.++-+-+.||+.+..
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 699999999999999998899999998754
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.00017 Score=64.53 Aligned_cols=47 Identities=28% Similarity=0.268 Sum_probs=38.8
Q ss_pred HHHHHHHHHHhcCCCCccccEEEEEEeC-CeeEEEEeecCCCChhhhhc
Q 048243 23 EEFKNEVMLTAKLQHVNLIRVLGFCIDS-EERMLVYEYMPNKSLDCYLF 70 (303)
Q Consensus 23 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~ 70 (303)
.++...++.++.+.|+|...++++.... .+..+|+|++ +.+|.+.+.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~ 74 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILK 74 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHH
Confidence 5677889999999999999999998765 3567899998 578888874
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.00056 Score=58.07 Aligned_cols=94 Identities=17% Similarity=0.191 Sum_probs=68.4
Q ss_pred HHHHHHHHHhcC-CCCc-cccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHhCC
Q 048243 24 EFKNEVMLTAKL-QHVN-LIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYS 101 (303)
Q Consensus 24 ~~~~e~~~l~~l-~h~~-i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~ 101 (303)
...+|+..|+.| .|.+ +.+.+++. ..|+||+++.+..|...- ...+ ...+...+...+--|..+|
T Consensus 156 aa~kEfafmkaL~e~gfpVPkpiD~~----RH~Vvmelv~g~Pl~~v~------~v~d---~~~ly~~lm~~Iv~la~~G 222 (465)
T KOG2268|consen 156 AATKEFAFMKALYERGFPVPKPIDHN----RHCVVMELVDGYPLRQVR------HVED---PPTLYDDLMGLIVRLANHG 222 (465)
T ss_pred HHHHHHHHHHHHHHcCCCCCCccccc----ceeeHHHhhcccceeeee------ecCC---hHHHHHHHHHHHHHHHHcC
Confidence 355788888888 3443 55666554 679999999988874322 1122 2334555666677788888
Q ss_pred CCCeEecCCCCCceEECCCCceEEcccccccc
Q 048243 102 RLTIIHRDLKASNILLGEDMKPKISDFGLARI 133 (303)
Q Consensus 102 ~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~ 133 (303)
++|||..--||++.+++.++++||-....
T Consensus 223 ---lIHgDFNEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 223 ---LIHGDFNEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred ---ceecccchheeEEecCCCEEEeechHhhc
Confidence 99999999999999999999999976543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.99 E-value=5.2e-05 Score=75.57 Aligned_cols=157 Identities=13% Similarity=-0.011 Sum_probs=109.1
Q ss_pred HHHHHhcCCCCccccEEEEEEeC--CeeEEEEeecCCCChhhhhcCcccc-ccCCHHHHHHHHHHHHHHHHHHHhCC--C
Q 048243 28 EVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRR-LILDWKKRVHIIEGITQGLLYLQEYS--R 102 (303)
Q Consensus 28 e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~-~~l~~~~~~~~~~~i~~~l~~Lh~~~--~ 102 (303)
|..-++...|+++...+.=.... ...+..++++.+|.+...+.+.... ..++.........+......-+|... +
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence 33344445788877666555433 3568899999999999888664432 23333333333333244444444433 3
Q ss_pred CCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHhC
Q 048243 103 LTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182 (303)
Q Consensus 103 ~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g 182 (303)
..-+|+++|+-|.++..+-.++++++|+.+.-.+ .....+...+++.|+.|++...-.++.++|+|..|+.+|....|
T Consensus 1359 ~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred ccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcc
Confidence 4478999999999999999999999999873221 12233445678889999998888888889999999999999888
Q ss_pred CCCC
Q 048243 183 KRLS 186 (303)
Q Consensus 183 ~~p~ 186 (303)
..+|
T Consensus 1437 n~~f 1440 (2724)
T KOG1826|consen 1437 NAYF 1440 (2724)
T ss_pred cHHH
Confidence 7775
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0053 Score=52.15 Aligned_cols=57 Identities=19% Similarity=0.261 Sum_probs=36.6
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC---CCccccEEEEEEeCCeeEEEEeecCCC
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ---HVNLIRVLGFCIDSEERMLVYEYMPNK 63 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~ 63 (303)
.+++.+.||.-... ....+..|..-|+.|. .-.+.+++++...+...++||||++.+
T Consensus 38 ~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 38 TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 46788899988622 2246788888888883 445788999988887889999998765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.017 Score=51.31 Aligned_cols=58 Identities=17% Similarity=0.135 Sum_probs=37.9
Q ss_pred CCC-cEEEEEEecCC-----C--cccHHHHHHHHHHHhcCC---CCccccEEEEEEeCCeeEEEEeecCCC
Q 048243 4 PCG-KVIAVKKLSKT-----S--TQGFEEFKNEVMLTAKLQ---HVNLIRVLGFCIDSEERMLVYEYMPNK 63 (303)
Q Consensus 4 ~~~-~~valK~~~~~-----~--~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~ 63 (303)
.+| +.|+||.-... . +...++...|.+.|..+. ..++.+++.+ +....++|||++++.
T Consensus 48 ~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lVME~L~~~ 116 (401)
T PRK09550 48 TEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTVMEDLSDH 116 (401)
T ss_pred CCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEEEecCCCc
Confidence 344 58999974321 1 234567778888888872 2356667766 345578999999764
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.013 Score=50.86 Aligned_cols=104 Identities=13% Similarity=0.118 Sum_probs=69.1
Q ss_pred eeEEEEeecCCCChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccc
Q 048243 52 ERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLA 131 (303)
Q Consensus 52 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~ 131 (303)
..|++|++- |+++. ..+...+.++..++++.+..+.-+..+- ++-|||+.-.||+++ +|.|.|+||.++
T Consensus 300 y~yl~~kdh-gt~is-------~ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 300 YLYLHFKDH-GTPIS-------IIKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred EEEEEEecC-Cceee-------eeecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeee
Confidence 345666654 44441 2334567888999999888888887654 589999999999999 899999999999
Q ss_pred cccccCCccccccccccccCCCChhhhccCCCCCccchhhHHH
Q 048243 132 RIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGV 174 (303)
Q Consensus 132 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~ 174 (303)
+.-..+.. .-..+.--|-.+.|.. +.+-+||-+--
T Consensus 369 Rl~~~q~~-------isy~rldhp~lF~G~d-d~QFeIYrlMr 403 (488)
T COG5072 369 RLSYSQGI-------ISYNRLDHPDLFNGVD-DYQFEIYRLMR 403 (488)
T ss_pred ecccCCce-------eeccccCchhhhcCcc-ceeeeHHHHHH
Confidence 84333221 1112233455555443 56667765543
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.0096 Score=51.86 Aligned_cols=123 Identities=15% Similarity=0.206 Sum_probs=68.2
Q ss_pred CcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCcc-ccEEEEEEeCCeeEEEEeecCCCChhhh-------hc-------
Q 048243 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL-IRVLGFCIDSEERMLVYEYMPNKSLDCY-------LF------- 70 (303)
Q Consensus 6 ~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~~~-------l~------- 70 (303)
+..|++|+........ -.-.+|..+++.+..-++ .++++++. + .+|.+|+++..+..- +.
T Consensus 42 ~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~--~--G~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~ 116 (330)
T PLN02421 42 EVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFG--N--GMIQSFINARTLTPSDMRKPKVAAEIAKELR 116 (330)
T ss_pred CceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeC--C--cEeehhhcCCCCChHHCCCHHHHHHHHHHHH
Confidence 3478999886554322 233578888888855444 45666652 2 258899887665321 10
Q ss_pred ---C-ccc--cccCCHHHHHHHHHHH-------------------------HHHHHHHH-hCC-CCCeEecCCCCCceEE
Q 048243 71 ---D-PIR--RLILDWKKRVHIIEGI-------------------------TQGLLYLQ-EYS-RLTIIHRDLKASNILL 117 (303)
Q Consensus 71 ---~-~~~--~~~l~~~~~~~~~~~i-------------------------~~~l~~Lh-~~~-~~~i~H~dikp~nil~ 117 (303)
. ... ....-+..+..+..++ +..+..+. ..+ ...++|+|+.+.||++
T Consensus 117 ~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~ 196 (330)
T PLN02421 117 RLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITDSLKAPVVFAHNDLLSGNLML 196 (330)
T ss_pred HHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhccCCCCeEEEECCCCcccEEE
Confidence 0 000 0011122222222221 11111121 111 2348999999999999
Q ss_pred CC-CCceEEcccccccc
Q 048243 118 GE-DMKPKISDFGLARI 133 (303)
Q Consensus 118 ~~-~~~v~l~Df~~~~~ 133 (303)
++ ++.++++||..+..
T Consensus 197 ~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 197 NEDEGKLYFIDFEYGSY 213 (330)
T ss_pred eCCCCcEEEEcccccCC
Confidence 75 57899999988743
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.012 Score=51.07 Aligned_cols=104 Identities=16% Similarity=0.173 Sum_probs=69.0
Q ss_pred HHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHHHHHHHHHHHHH-HhCCCC
Q 048243 25 FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYL-QEYSRL 103 (303)
Q Consensus 25 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~L-h~~~~~ 103 (303)
..+|+..|.++....|.-.--+... .-.|||+|+....- -........+....+..+-.+++.-+.-| +.++
T Consensus 213 AEKE~RNLkRl~~aGIP~PePIlLk--~hVLVM~FlGrdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~-- 285 (520)
T KOG2270|consen 213 AEKEMRNLKRLNNAGIPCPEPILLK--NHVLVMEFLGRDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR-- 285 (520)
T ss_pred HHHHHHHHHHHHhcCCCCCCceeee--cceEeeeeccCCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHhc--
Confidence 3468888888865554222212211 24699999853221 11112445567777888888888888887 4555
Q ss_pred CeEecCCCCCceEECCCCceEEcccccccccccC
Q 048243 104 TIIHRDLKASNILLGEDMKPKISDFGLARIFAKE 137 (303)
Q Consensus 104 ~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~ 137 (303)
+||.||.--|+|+.+ |.++++|-+.+.....+
T Consensus 286 -LVHADLSEfN~Lyhd-G~lyiIDVSQSVE~DHP 317 (520)
T KOG2270|consen 286 -LVHADLSEFNLLYHD-GKLYIIDVSQSVEHDHP 317 (520)
T ss_pred -eeccchhhhhheEEC-CEEEEEEccccccCCCh
Confidence 999999999999875 68999999887655443
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.0084 Score=48.33 Aligned_cols=87 Identities=14% Similarity=0.103 Sum_probs=58.2
Q ss_pred HHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCC
Q 048243 23 EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSR 102 (303)
Q Consensus 23 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~ 102 (303)
..+.++..++.++. .|+++..= +.....++.|.|..... . ...++..-+.+|.-.|+. .
T Consensus 103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------~----~~N~i~agi~~L~~fH~~-~ 161 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------N----FSNFITAGIKDLMDFHSE-N 161 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------c----hhHHHHHhHHHHHHhhcc-C
Confidence 45667777777764 45555522 33456799998854321 0 111222235667778854 3
Q ss_pred CCeEecCCCCCceEECCCCceEEccccc
Q 048243 103 LTIIHRDLKASNILLGEDMKPKISDFGL 130 (303)
Q Consensus 103 ~~i~H~dikp~nil~~~~~~v~l~Df~~ 130 (303)
...+|||..|+|||-+..|.+||.|-+.
T Consensus 162 ~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 162 QHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred CCeecCCCChhheeecCCCCEEecChhh
Confidence 4699999999999999999999999764
|
The function of this family is unknown. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.026 Score=47.80 Aligned_cols=30 Identities=30% Similarity=0.573 Sum_probs=24.9
Q ss_pred CCeEecCCCCCceEECCCCc-eEEccccccc
Q 048243 103 LTIIHRDLKASNILLGEDMK-PKISDFGLAR 132 (303)
Q Consensus 103 ~~i~H~dikp~nil~~~~~~-v~l~Df~~~~ 132 (303)
..++|||++|.|++++.++. .-|+||+.+.
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 34899999999999997555 5699999774
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.04 Score=47.76 Aligned_cols=124 Identities=23% Similarity=0.277 Sum_probs=69.5
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCcc--ccE--------EEEEEeCCeeEEEEeecCCCChhh-hhc---
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL--IRV--------LGFCIDSEERMLVYEYMPNKSLDC-YLF--- 70 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~~--------~~~~~~~~~~~lv~e~~~~~~L~~-~l~--- 70 (303)
+|+. +||+.... ....++..|+..+..+....| ... +..........-+++|++|..+.. .-.
T Consensus 48 ~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~~~~~~~~~~~ 124 (331)
T COG2334 48 DGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRPLERDDNAEQL 124 (331)
T ss_pred CCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcCcCCCCcHHHH
Confidence 4444 99999776 344677788888888832221 111 111111126788999999888763 110
Q ss_pred ---------------C-c----cccccCCHH-------------HHHHHHHHHHHHHHHHHhC----C-CCC--eEecCC
Q 048243 71 ---------------D-P----IRRLILDWK-------------KRVHIIEGITQGLLYLQEY----S-RLT--IIHRDL 110 (303)
Q Consensus 71 ---------------~-~----~~~~~l~~~-------------~~~~~~~~i~~~l~~Lh~~----~-~~~--i~H~di 110 (303)
. . .......|. .-.....++...++.+.+. - ..+ +||+|+
T Consensus 125 ~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~~~~~iIH~D~ 204 (331)
T COG2334 125 EELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPALGDQIIHGDL 204 (331)
T ss_pred HHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCcccceeeecCC
Confidence 0 0 001111221 0011222333334443321 1 122 899999
Q ss_pred CCCceEECCCCc-eEEcccccc
Q 048243 111 KASNILLGEDMK-PKISDFGLA 131 (303)
Q Consensus 111 kp~nil~~~~~~-v~l~Df~~~ 131 (303)
.|.||+++.++. +-++||+-+
T Consensus 205 ~~~NVl~d~~~~~~g~iDFdDa 226 (331)
T COG2334 205 HPDNVLFDDDTDVSGFIDFDDA 226 (331)
T ss_pred CccceeEcCCCCeeeEEEcccc
Confidence 999999999875 899999865
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.22 Score=43.29 Aligned_cols=61 Identities=11% Similarity=0.126 Sum_probs=36.6
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCC--ccccEE---E--EEEeCCeeEEEEeecCCCCh
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHV--NLIRVL---G--FCIDSEERMLVYEYMPNKSL 65 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~---~--~~~~~~~~~lv~e~~~~~~L 65 (303)
++|+.+++|+.+... .....+..|...+..+... .++... + ....++..+.++++.+|...
T Consensus 47 ~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 47 EDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred CCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 457789999885432 3446677788888777321 122221 1 12234567889999887643
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.16 Score=41.45 Aligned_cols=59 Identities=22% Similarity=0.292 Sum_probs=42.4
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcC---CCCccccEEEEEEeCCeeEEEEeecCCCChh
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKL---QHVNLIRVLGFCIDSEERMLVYEYMPNKSLD 66 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 66 (303)
+..++.+|.-... ....|..|+.-|+.+ +.-.+.+++.+.....+.|+|++|.+-+.+.
T Consensus 38 g~~~~FvK~n~~~---~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 38 GTDPFFVKCNQRE---QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred CCcceEEEecchh---hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 3455666654322 335677788888877 3456888999988899999999999876654
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.59 E-value=0.13 Score=46.70 Aligned_cols=55 Identities=9% Similarity=0.115 Sum_probs=35.5
Q ss_pred CcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccc-cEEEEEEeCCeeEEEEeecCCCCh
Q 048243 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLI-RVLGFCIDSEERMLVYEYMPNKSL 65 (303)
Q Consensus 6 ~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~L 65 (303)
++.|.+++....+..-. .-..|..+++.+...+|. ++++.+. -+.|.+|++|.+|
T Consensus 138 ~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I~efi~g~~l 193 (442)
T PTZ00296 138 RRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS----GGRIEEWLYGDPL 193 (442)
T ss_pred CceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC----CCEEEEeeCCccC
Confidence 57899999866543322 345688888888544443 4666552 3568899987644
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.14 Score=40.91 Aligned_cols=84 Identities=25% Similarity=0.436 Sum_probs=57.3
Q ss_pred HHHHHHHHHhcCC---CCcc--ccEEEEEEeCC------------------eeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 24 EFKNEVMLTAKLQ---HVNL--IRVLGFCIDSE------------------ERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 24 ~~~~e~~~l~~l~---h~~i--~~~~~~~~~~~------------------~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.|..|.....+|+ +.++ ++++|+..-.. ...+|.||..... .+.
T Consensus 100 PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~- 166 (207)
T PF13095_consen 100 PFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ- 166 (207)
T ss_pred hHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc-
Confidence 4778888888884 4455 88998875321 1246666654432 122
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLA 131 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~ 131 (303)
..-+.+|.+-+..+|..| |+-+|+++.|.. .=+|+|||.+
T Consensus 167 ---~~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 167 ---IRDIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred ---hhHHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 233456677788899999 999999999996 3488999864
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.035 Score=46.75 Aligned_cols=46 Identities=22% Similarity=0.270 Sum_probs=33.4
Q ss_pred HHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEccccccc
Q 048243 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 86 ~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~ 132 (303)
.+..+-.++.-++.. ...+||+|+.|+|++.++.+.++|+||..|.
T Consensus 137 ~~~~l~~~l~~~~~~-~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg 182 (269)
T COG0510 137 KLKELRRALEEVPKD-DLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG 182 (269)
T ss_pred HHHHHHHHhhhcCCC-ceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence 333344444444332 1349999999999999999999999998774
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.03 E-value=0.019 Score=45.35 Aligned_cols=29 Identities=24% Similarity=0.383 Sum_probs=25.3
Q ss_pred CCeEecCCCCCceEECCCCceEEccccccc
Q 048243 103 LTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 103 ~~i~H~dikp~nil~~~~~~v~l~Df~~~~ 132 (303)
...+|+|+.|.|++++++| ++++||+.+.
T Consensus 77 ~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 77 LAPLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred eeeecCCCCCccEEEECCC-EEEEeCCccc
Confidence 3479999999999998877 9999999874
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.92 E-value=0.17 Score=45.20 Aligned_cols=56 Identities=11% Similarity=0.006 Sum_probs=35.6
Q ss_pred CCcEEEEEEecCC----C---cccHHHHHHHHHHHhcCC---CCccccEEEEEEeCCeeEEEEeecCC
Q 048243 5 CGKVIAVKKLSKT----S---TQGFEEFKNEVMLTAKLQ---HVNLIRVLGFCIDSEERMLVYEYMPN 62 (303)
Q Consensus 5 ~~~~valK~~~~~----~---~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~ 62 (303)
+++.++||.-... . +....+-..|...|+.+. ..++.+++.++. ...+++||++++
T Consensus 54 ~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvME~L~~ 119 (418)
T PLN02756 54 SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGMRYLEP 119 (418)
T ss_pred CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEEeecCC
Confidence 4556888865411 1 123445555677777663 246778888876 346788999976
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.77 E-value=0.14 Score=45.56 Aligned_cols=29 Identities=31% Similarity=0.259 Sum_probs=24.3
Q ss_pred CCeEecCCCCCceEECCCCceEEccccccc
Q 048243 103 LTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 103 ~~i~H~dikp~nil~~~~~~v~l~Df~~~~ 132 (303)
..++|.|+.+.||+.++ +.+.++||..+.
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence 45899999999999765 469999998764
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.60 E-value=0.53 Score=47.50 Aligned_cols=30 Identities=37% Similarity=0.508 Sum_probs=25.1
Q ss_pred CCeEecCCCCCceEECCCC--ceE-Eccccccc
Q 048243 103 LTIIHRDLKASNILLGEDM--KPK-ISDFGLAR 132 (303)
Q Consensus 103 ~~i~H~dikp~nil~~~~~--~v~-l~Df~~~~ 132 (303)
.+++|+|+.+.||+++.++ .+. |+|||-+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 4599999999999999875 554 99999764
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.52 E-value=0.087 Score=45.35 Aligned_cols=28 Identities=29% Similarity=0.383 Sum_probs=24.5
Q ss_pred CCeEecCCCCCceEECCCCceEEcccccc
Q 048243 103 LTIIHRDLKASNILLGEDMKPKISDFGLA 131 (303)
Q Consensus 103 ~~i~H~dikp~nil~~~~~~v~l~Df~~~ 131 (303)
.+++|||+.+.|++++. +.+.++||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 45999999999999988 67899999865
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=93.63 E-value=0.12 Score=44.54 Aligned_cols=31 Identities=26% Similarity=0.335 Sum_probs=27.4
Q ss_pred CCCeEecCCCCCceEECCCCceEEccccccc
Q 048243 102 RLTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 102 ~~~i~H~dikp~nil~~~~~~v~l~Df~~~~ 132 (303)
..++||||+.++|+++++++.+.++||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 3459999999999999999999999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 303 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-43 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-43 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-34 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-34 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-32 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-32 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-32 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-22 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-22 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-22 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-22 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-22 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-22 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-22 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-22 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-22 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-22 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-22 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-22 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-22 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-22 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-21 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-20 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-19 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-19 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-19 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-19 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-19 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-19 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-19 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-19 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-19 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-18 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-18 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-18 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-18 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-18 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-18 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-16 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-16 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-16 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 9e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-11 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 9e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 9e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 9e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 7e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 5e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 7e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 7e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 8e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 320 bits (823), Expect = e-110
Identities = 95/265 (35%), Positives = 140/265 (52%), Gaps = 13/265 (4%)
Query: 1 GVLPCGKVIAVKKLSK----TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLV 56
G + +AVKKL+ T+ + ++F E+ + AK QH NL+ +LGF D ++ LV
Sbjct: 50 GYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLV 108
Query: 57 YEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNIL 116
Y YMPN SL L L W R I +G G+ +L E IHRD+K++NIL
Sbjct: 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL 165
Query: 117 LGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
L E KISDFGLAR K + T ++VGT Y+ PE R G + KSD++SFGV+L
Sbjct: 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVL 224
Query: 177 LQIISGKRLSMLCGINENLSILEHAYELWKGGKGVE-FVDSSLDDTNSPCKLMRCLEIAL 235
L+II+G + L L+ E+ K +E ++D ++D +S + +A
Sbjct: 225 LEIITGLPAVDEHREPQLL--LDIKEEIEDEEKTIEDYIDKKMNDADST-SVEAMYSVAS 281
Query: 236 LCVQENPNDRPSMLQVSSMLKNETT 260
C+ E N RP + +V +L+ T
Sbjct: 282 QCLHEKKNKRPDIKKVQQLLQEMTA 306
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 318 bits (818), Expect = e-109
Identities = 102/262 (38%), Positives = 154/262 (58%), Gaps = 5/262 (1%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFE-EFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEY 59
G L G ++AVK+L + TQG E +F+ EV + + H NL+R+ GFC+ ER+LVY Y
Sbjct: 49 GRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 108
Query: 60 MPNKSLDCYLFDPIR-RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
M N S+ L + + LDW KR I G +GL YL ++ IIHRD+KA+NILL
Sbjct: 109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD 168
Query: 119 EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
E+ + + DFGLA++ + T V GTIG+I PEY G S K+DVF +GV+LL+
Sbjct: 169 EEFEAVVGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLE 227
Query: 179 IISGKRLSMLCGI--NENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236
+I+G+R L + ++++ +L+ L K K VD L ++ + +++ALL
Sbjct: 228 LITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALL 287
Query: 237 CVQENPNDRPSMLQVSSMLKNE 258
C Q +P +RP M +V ML+ +
Sbjct: 288 CTQSSPMERPKMSEVVRMLEGD 309
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 290 bits (745), Expect = 4e-98
Identities = 90/257 (35%), Positives = 148/257 (57%), Gaps = 4/257 (1%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
GVL G +A+K+ + S+QG EEF+ E+ + +H +L+ ++GFC + E +L+Y+YM
Sbjct: 58 GVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117
Query: 61 PNKSLDCYLFDPIR-RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
N +L +L+ + + W++R+ I G +GL YL + IIHRD+K+ NILL E
Sbjct: 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDE 174
Query: 120 DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQI 179
+ PKI+DFG+++ + + V GT+GYI PEY +G + KSDV+SFGV+L ++
Sbjct: 175 NFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEV 234
Query: 180 ISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239
+ + + E +++ E A E G+ + VD +L D P L + + A+ C+
Sbjct: 235 LCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLA 294
Query: 240 ENPNDRPSMLQVSSMLK 256
+ DRPSM V L+
Sbjct: 295 LSSEDRPSMGDVLWKLE 311
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 3e-75
Identities = 60/276 (21%), Positives = 105/276 (38%), Gaps = 27/276 (9%)
Query: 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE----ERMLVYEY 59
+ +AVK Q ++ + EV ++H N+++ +G + L+ +
Sbjct: 45 LLNEYVAVKIFPIQDKQSWQ-NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAF 103
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYL-------QEYSRLTIIHRDLKA 112
SL +L + ++ W + HI E + +GL YL ++ + I HRD+K+
Sbjct: 104 HEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKS 159
Query: 113 SNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV-----YSTKS 167
N+LL ++ I+DFGLA F +T VGT Y+ PE + +
Sbjct: 160 KNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRI 219
Query: 168 DVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS-----SLDDTN 222
D+++ G++L ++ S + L E + E V L D
Sbjct: 220 DMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYW 279
Query: 223 SPCKLMRCL-EIALLCVQENPNDRPSMLQVSSMLKN 257
M L E C + R S V +
Sbjct: 280 QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 4e-60
Identities = 63/304 (20%), Positives = 106/304 (34%), Gaps = 50/304 (16%)
Query: 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCI-----DSEERMLVYEY 59
+ +AVK S + Q F K + ++H N+ R + E +LV EY
Sbjct: 35 DERPVAVKVFSFANRQNFINEK-NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEY 93
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYL------QEYSRLTIIHRDLKAS 113
PN SL YL DW + +T+GL YL ++ + I HRDL +
Sbjct: 94 YPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSR 149
Query: 114 NILLGEDMKPKISDFGLARIFAKESLEANTEQ------VVGTIGYIPPEYARQGV----- 162
N+L+ D ISDFGL+ L E+ VGTI Y+ PE V
Sbjct: 150 NVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDX 209
Query: 163 --YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV--------- 211
+ D+++ G++ +I + A++ G
Sbjct: 210 ESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM---AFQTEVGNHPTFEDMQVLVS 266
Query: 212 ------EFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSMLKNETTNRNTP 265
+F ++ +++ + L E C ++ R + +
Sbjct: 267 REKQRPKFPEAWKENSLAVRSLK---ETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323
Query: 266 KKPA 269
K +
Sbjct: 324 KSVS 327
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 1e-55
Identities = 67/259 (25%), Positives = 115/259 (44%), Gaps = 28/259 (10%)
Query: 5 CGKVIAVKKL--SKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
G +AVK L + EF EV + +L+H N++ +G +V EY+
Sbjct: 59 HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR 118
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
SL L R LD ++R+ + + +G+ YL I+HR+LK+ N+L+ +
Sbjct: 119 GSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYT 177
Query: 123 PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
K+ DFGL+R+ K S +++ GT ++ PE R + KSDV+SFGV+L ++ +
Sbjct: 178 VKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATL 235
Query: 183 KRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLD---DTNSPCK-LMRCLEIALLCV 238
++ NL+ + V F L+ + N ++ C
Sbjct: 236 QQP------WGNLNPAQVVA-------AVGFKCKRLEIPRNLNPQVAAIIE------GCW 276
Query: 239 QENPNDRPSMLQVSSMLKN 257
P RPS + +L+
Sbjct: 277 TNEPWKRPSFATIMDLLRP 295
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 9e-54
Identities = 62/269 (23%), Positives = 108/269 (40%), Gaps = 39/269 (14%)
Query: 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
G+V+ +K+L + + F EV + L+H N+++ +G + + EY+ +
Sbjct: 34 TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGT 93
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
L + + W +RV + I G+ YL + IIHRDL + N L+ E+
Sbjct: 94 LRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYL---HSMNIIHRDLNSHNCLVRENKNVV 148
Query: 125 ISDFGLARIFAKESLEANTEQ------------VVGTIGYIPPEYARQGVYSTKSDVFSF 172
++DFGLAR+ E + + VVG ++ PE Y K DVFSF
Sbjct: 149 VADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSF 208
Query: 173 GVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRC-- 230
G++L +II + + + L ++ C
Sbjct: 209 GIVLCEIIGRVN------ADPDYLPRTMDFGL------------NVRGFLDRYCPPNCPP 250
Query: 231 --LEIALLCVQENPNDRPSMLQVSSMLKN 257
I + C +P RPS +++ L+
Sbjct: 251 SFFPITVRCCDLDPEKRPSFVKLEHWLET 279
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-52
Identities = 74/258 (28%), Positives = 130/258 (50%), Gaps = 23/258 (8%)
Query: 5 CGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
G V AVK L+ T + Q + FKNEV + K +HVN++ +G+ + +V ++
Sbjct: 46 HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEG 103
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
SL +L + + KK + I +G+ YL +IIHRDLK++NI L ED
Sbjct: 104 SSLYHHLHASETKF--EMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNT 158
Query: 123 PKISDFGLARIFAKESLEANTEQVVGTIGYIPPE---YARQGVYSTKSDVFSFGVLLLQI 179
KI DFGLA ++ S EQ+ G+I ++ PE YS +SDV++FG++L ++
Sbjct: 159 VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYEL 218
Query: 180 ISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239
++G+ N++ + G+G D S +N P ++ + C++
Sbjct: 219 MTGQLPY------SNINNRDQII--EMVGRGSLSPDLSKVRSNCPKRM---KRLMAECLK 267
Query: 240 ENPNDRPSMLQVSSMLKN 257
+ ++RPS ++ + ++
Sbjct: 268 KKRDERPSFPRILAEIEE 285
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 6e-51
Identities = 59/259 (22%), Positives = 107/259 (41%), Gaps = 34/259 (13%)
Query: 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
K +A+K++ S + + F E+ +++ H N++++ G C++ LV EY S
Sbjct: 30 RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGS 85
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK-P 123
L L + +QG+ YL +IHRDLK N+LL
Sbjct: 86 LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVL 145
Query: 124 KISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
KI DFG A ++ + G+ ++ PE YS K DVFS+G++L ++I+ +
Sbjct: 146 KICDFGTACD-----IQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR 200
Query: 184 RLSMLCGINENLSILEHAYELWKGGKGV-----EFVDSSLDDTNSPCKLMRCLEIALLCV 238
+ + + W G + + + LM C
Sbjct: 201 KPF------DEIGGPAFRIM-WAVHNGTRPPLIKNLPKPI------ESLMTR------CW 241
Query: 239 QENPNDRPSMLQVSSMLKN 257
++P+ RPSM ++ ++ +
Sbjct: 242 SKDPSQRPSMEEIVKIMTH 260
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 4e-50
Identities = 74/269 (27%), Positives = 117/269 (43%), Gaps = 43/269 (15%)
Query: 5 CGKVIAVKKL----SKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G +AVK + +Q E + E L A L+H N+I + G C+ LV E+
Sbjct: 29 IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFA 88
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
L+ L + V+ I +G+ YL + + + IIHRDLK+SNIL+ +
Sbjct: 89 RGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQK 144
Query: 121 MKP--------KISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSF 172
++ KI+DFGLAR + + + + G ++ PE R ++S SDV+S+
Sbjct: 145 VENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMAPEVIRASMFSKGSDVWSY 200
Query: 173 GVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSL---DDTNSP-CKLM 228
GVLL ++++G+ + L AY GV +L P KLM
Sbjct: 201 GVLLWELLTGEVPF------RGIDGLAVAY-------GVAMNKLALPIPSTCPEPFAKLM 247
Query: 229 RCLEIALLCVQENPNDRPSMLQVSSMLKN 257
C +P+ RPS + L
Sbjct: 248 E------DCWNPDPHSRPSFTNILDQLTT 270
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 9e-49
Identities = 60/271 (22%), Positives = 113/271 (41%), Gaps = 47/271 (17%)
Query: 6 GKVIAVKKLSKTSTQG-------FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYE 58
V+A+K L ++G F+EF+ EV + + L H N++++ G +V E
Sbjct: 44 KSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH--NPPRMVME 101
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
++P L L D + + W ++ ++ I G+ Y+Q I+HRDL++ NI L
Sbjct: 102 FVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQ 158
Query: 119 E-----DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE--YARQGVYSTKSDVFS 171
+ K++DFGL++ ++G ++ PE A + Y+ K+D +S
Sbjct: 159 SLDENAPVCAKVADFGLSQQSVHSV-----SGLLGNFQWMAPETIGAEEESYTEKADTYS 213
Query: 172 FGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV-----EFVDSSLDDTNSPCK 226
F ++L I++G+ + S + + +G+ E L
Sbjct: 214 FAMILYTILTGEGPF------DEYSYGKIKFINMIREEGLRPTIPEDCPPRL------RN 261
Query: 227 LMRCLEIALLCVQENPNDRPSMLQVSSMLKN 257
++ LC +P RP + L
Sbjct: 262 VIE------LCWSGDPKKRPHFSYIVKELSE 286
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 9e-48
Identities = 57/262 (21%), Positives = 103/262 (39%), Gaps = 35/262 (13%)
Query: 5 CGKVIAVKKL--SKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER--MLVYEYM 60
G I VK L ST+ +F E H N++ VLG C L+ +M
Sbjct: 32 QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWM 91
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
P SL L + ++D + V + +G+ +L L I L + ++++ ED
Sbjct: 92 PYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLEPL-IPRHALNSRSVMIDED 149
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ---GVYSTKSDVFSFGVLLL 177
M +IS + F + ++ PE ++ +D++SF VLL
Sbjct: 150 MTARISMADVKFSFQSPG-------RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLW 202
Query: 178 QIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSP--CKLMRCLEIAL 235
++++ + +LS +E ++ G + SP KLM+
Sbjct: 203 ELVTREVPF------ADLSNMEIGMKVALEGLRPT-----IPPGISPHVSKLMK------ 245
Query: 236 LCVQENPNDRPSMLQVSSMLKN 257
+C+ E+P RP + +L+
Sbjct: 246 ICMNEDPAKRPKFDMIVPILEK 267
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-47
Identities = 56/266 (21%), Positives = 115/266 (43%), Gaps = 36/266 (13%)
Query: 6 GKVIAVKKL--SKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
G+V A++ + + + + FK EVM + +H N++ +G C+ ++ +
Sbjct: 56 GEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGR 114
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
+L + D +++LD K I + I +G+ YL +++ I+H+DLK+ N+ ++ K
Sbjct: 115 TLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYL--HAK-GILHKDLKSKNVFY-DNGKV 168
Query: 124 KISDFGLARIFAKESLEANTEQ---VVGTIGYIPPEYARQGV---------YSTKSDVFS 171
I+DFGL I ++ G + ++ PE RQ +S SDVF+
Sbjct: 169 VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFA 228
Query: 172 FGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL 231
G + ++ + + + +++ G K +L ++
Sbjct: 229 LGTIWYELHAREWPF------KTQPAEAIIWQMGTGMK------PNLSQIGMGKEIS--- 273
Query: 232 EIALLCVQENPNDRPSMLQVSSMLKN 257
+I L C +RP+ ++ ML+
Sbjct: 274 DILLFCWAFEQEERPTFTKLMDMLEK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-43
Identities = 63/277 (22%), Positives = 113/277 (40%), Gaps = 31/277 (11%)
Query: 5 CGKVIAVKKLSKTSTQGFEEFKNE--VMLTAKLQHVNLIRVLGFCIDSEER----MLVYE 58
G+ +AVK T + E + T ++H N++ + I L+ +
Sbjct: 59 RGEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITD 115
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYL-----QEYSRLTIIHRDLKAS 113
Y N SL +D ++ LD K + + GL +L + I HRDLK+
Sbjct: 116 YHENGSL----YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSK 171
Query: 114 NILLGEDMKPKISDFGLARIFAKESLEANTEQ--VVGTIGYIPPE------YARQGVYST 165
NIL+ ++ I+D GLA F ++ E + VGT Y+PPE
Sbjct: 172 NILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYI 231
Query: 166 KSDVFSFGVLLLQIISGKRLSMLCGIN----ENLSILEHAYELWKGGKGVEFVDSSLDDT 221
+D++SFG++L ++ + +L + +YE + ++ + S +
Sbjct: 232 MADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNR 291
Query: 222 NSPCKLMRCL-EIALLCVQENPNDRPSMLQVSSMLKN 257
S + +R + ++ C NP R + L+V L
Sbjct: 292 WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 9e-43
Identities = 60/289 (20%), Positives = 112/289 (38%), Gaps = 55/289 (19%)
Query: 5 CGKVIAVKKLSKTSTQGFEEFKNE--VMLTAKLQHVNLIRVLGFCIDSE----ERMLVYE 58
G+ +AVK S ++ + + E + T L+H N++ + + S + L+
Sbjct: 30 QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH 86
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYL-----QEYSRLTIIHRDLKAS 113
Y SL +D ++ LD + I+ I GL +L + I HRDLK+
Sbjct: 87 YHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSK 142
Query: 114 NILLGEDMKPKISDFGLARIFAKESLEANTEQ--VVGTIGYIPPE------YARQGVYST 165
NIL+ ++ + I+D GLA + ++ + + + VGT Y+ PE
Sbjct: 143 NILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYK 202
Query: 166 KSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG--------KGV------ 211
+ D+++FG++L ++ N + + + K V
Sbjct: 203 RVDIWAFGLVLWEVARR------MVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQR 256
Query: 212 -EFVDSSLDDTNSP--CKLMRCLEIALLCVQENPNDRPSMLQVSSMLKN 257
+ D KLM+ C +NP+ R + L++ L
Sbjct: 257 PNIPNRWFSDPTLTSLAKLMK------ECWYQNPSARLTALRIKKTLTK 299
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-41
Identities = 67/286 (23%), Positives = 110/286 (38%), Gaps = 51/286 (17%)
Query: 10 AVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER--MLVYEYMPNKSLDC 67
AVK+L + +F+ E+ + L +++ G + LV EY+P+ L
Sbjct: 56 AVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD 115
Query: 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISD 127
+L R LD + + I +G+ YL +HRDL A NIL+ + KI+D
Sbjct: 116 FL--QRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIAD 170
Query: 128 FGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIISG 182
FGLA++ + VV G P PE ++S +SDV+SFGV+L ++ +
Sbjct: 171 FGLAKLLPLDK----DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT- 225
Query: 183 KRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLE---------- 232
C + + D + +L+ LE
Sbjct: 226 -----YCDKS------------CSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPA 268
Query: 233 -------IALLCVQENPNDRPSMLQVSSMLKNETTNRNTPKKPAFS 271
+ LC +P DRPS + L + + AF+
Sbjct: 269 CPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFT 314
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-41
Identities = 68/271 (25%), Positives = 103/271 (38%), Gaps = 46/271 (16%)
Query: 1 GVLPCGKV-IAVKKL-SKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYE 58
G L +AVK +F E + + H N++R++G C + +V E
Sbjct: 133 GRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
+ +L RL + K + ++ G+ YL IHRDL A N L+
Sbjct: 193 LVQGGDFLTFLRTEGARLRV--KTLLQMVGDAAAGMEYL---ESKCCIHRDLAARNCLVT 247
Query: 119 EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFG 173
E KISDFG++R A A+ G + +P PE G YS++SDV+SFG
Sbjct: 248 EKNVLKISDFGMSREEADGVYAAS-----GGLRQVPVKWTAPEALNYGRYSSESDVWSFG 302
Query: 174 VLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS-----SLDDTNSP-CK 226
+LL + S G Y + EFV+ + +
Sbjct: 303 ILLWETFSLGAS----------------PYPNLSNQQTREFVEKGGRLPCPELCPDAVFR 346
Query: 227 LMRCLEIALLCVQENPNDRPSMLQVSSMLKN 257
LM C P RPS + L++
Sbjct: 347 LM------EQCWAYEPGQRPSFSTIYQELQS 371
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-40
Identities = 56/281 (19%), Positives = 106/281 (37%), Gaps = 39/281 (13%)
Query: 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE----ERMLVYEYM 60
G+ +AVK S + + + E+ T L+H N++ + + LV +Y
Sbjct: 64 RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 122
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYL-----QEYSRLTIIHRDLKASNI 115
+ SL FD + R + + + + GL +L + I HRDLK+ NI
Sbjct: 123 EHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 178
Query: 116 LLGEDMKPKISDFGLARIFAKESLEANTEQ--VVGTIGYIPPE------YARQGVYSTKS 167
L+ ++ I+D GLA + + VGT Y+ PE + ++
Sbjct: 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA 238
Query: 168 DVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKG-----GKGVEFVDS-----S 217
D+++ G++ +I C I + Y + + V +
Sbjct: 239 DIYAMGLVFWEIARR------CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPN 292
Query: 218 LDDTNSPCKLMRCL-EIALLCVQENPNDRPSMLQVSSMLKN 257
+ + C+ +R + +I C N R + L++ L
Sbjct: 293 IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-40
Identities = 72/271 (26%), Positives = 113/271 (41%), Gaps = 40/271 (14%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER--MLVYEYMPNK 63
G+V+AVKKL ++ + +F+ E+ + LQH N+++ G C + R L+ EY+P
Sbjct: 39 GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
SL YL + +D K + I +G+ YL IHRDL NIL+ + +
Sbjct: 99 SLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 153
Query: 124 KISDFGLARIFAKESLEANTEQ-VVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLL 177
KI DFGL ++ L + E V G P PE + +S SDV+SFGV+L
Sbjct: 154 KIGDFGLTKV-----LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 208
Query: 178 QIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSS--LDDTNSPC---------K 226
++ + S I +E + ++ L P
Sbjct: 209 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL-----PRPDGCPDEIYM 263
Query: 227 LMRCLEIALLCVQENPNDRPSMLQVSSMLKN 257
+M C N N RPS ++ +
Sbjct: 264 IM------TECWNNNVNQRPSFRDLALRVDQ 288
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-39
Identities = 72/271 (26%), Positives = 113/271 (41%), Gaps = 40/271 (14%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER--MLVYEYMPNK 63
G+V+AVKKL ++ + +F+ E+ + LQH N+++ G C + R L+ EY+P
Sbjct: 70 GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 129
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
SL YL + +D K + I +G+ YL IHRDL NIL+ + +
Sbjct: 130 SLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 184
Query: 124 KISDFGLARIFAKESLEANTEQ-VVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLL 177
KI DFGL ++ L + E V G P PE + +S SDV+SFGV+L
Sbjct: 185 KIGDFGLTKV-----LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 239
Query: 178 QIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSS--LDDTNSPC---------K 226
++ + S I +E + ++ L P
Sbjct: 240 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL-----PRPDGCPDEIYM 294
Query: 227 LMRCLEIALLCVQENPNDRPSMLQVSSMLKN 257
+M C N N RPS ++ +
Sbjct: 295 IM------TECWNNNVNQRPSFRDLALRVDQ 319
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 5e-39
Identities = 71/275 (25%), Positives = 124/275 (45%), Gaps = 43/275 (15%)
Query: 10 AVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYL 69
AVK L + + + EEF E + +++H NL+++LG C ++ E+M +L YL
Sbjct: 249 AVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 307
Query: 70 FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFG 129
+ R + +++ I+ + YL + IHR+L A N L+GE+ K++DFG
Sbjct: 308 REC-NRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFG 363
Query: 130 LARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSML 188
L+R+ ++ A+ I + PE +S KSDV++FGVLL +I + G
Sbjct: 364 LSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 422
Query: 189 CGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSP--C-----KLMRCLEIALLCVQEN 241
+++ +LE Y + + P C +LM C Q N
Sbjct: 423 IDLSQVYELLEKDYRMER-----------------PEGCPEKVYELM------RACWQWN 459
Query: 242 PNDRPSMLQVSSMLKNETTNRNTPKKPAFSKQVDE 276
P+DRPS ++ + + S +V++
Sbjct: 460 PSDRPSFAEIHQAFETMFQE------SSISDEVEK 488
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-38
Identities = 69/269 (25%), Positives = 104/269 (38%), Gaps = 46/269 (17%)
Query: 10 AVKKL-SKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER--MLVYEYMPNKSLD 66
AVK L + Q +K E+ + L H ++I+ G C D+ LV EY+P SL
Sbjct: 64 AVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLR 123
Query: 67 CYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKIS 126
YL R + + + + I +G+ YL IHRDL A N+LL D KI
Sbjct: 124 DYL----PRHSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIG 176
Query: 127 DFGLARIFAKESLEANTEQ-VVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQII 180
DFGLA+ + E V G P PE ++ + SDV+SFGV L +++
Sbjct: 177 DFGLAKA-----VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL 231
Query: 181 S-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSS--LDDTNSPC---------KLM 228
+ L + + E ++ L P LM
Sbjct: 232 THCDSSQSPPTKFLELIGIA--QGQMTVLRLTELLERGERL-----PRPDKCPAEVYHLM 284
Query: 229 RCLEIALLCVQENPNDRPSMLQVSSMLKN 257
C + + RP+ + +LK
Sbjct: 285 ------KNCWETEASFRPTFENLIPILKT 307
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-38
Identities = 72/278 (25%), Positives = 120/278 (43%), Gaps = 54/278 (19%)
Query: 10 AVKKL-SKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
A+K L + + + +F +E + + H N+IR+ G M+V EYM N SLD +
Sbjct: 81 AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTF 140
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L + + + V ++ G+ G+ YL S L +HRDL A N+L+ ++ K+SDF
Sbjct: 141 LRTHDGQFTI--MQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDF 195
Query: 129 GLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS-G 182
GL+R+ + A T G IP PE +S+ SDV+SFGV++ ++++ G
Sbjct: 196 GLSRVLEDDPDAAYTTTG----GKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYG 251
Query: 183 KRLSMLCGINENLSILEHAYELWKGGKGVEFVDSS--LDDTNSPC---------KLMRCL 231
+R Y + V+ L P +LM
Sbjct: 252 ER----------------PYWNMTNRDVISSVEEGYRL-----PAPMGCPHALHQLM--- 287
Query: 232 EIALLCVQENPNDRPSMLQVSSMLKNETTNRNTPKKPA 269
L C ++ RP Q+ S+L + + + A
Sbjct: 288 ---LDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATA 322
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-38
Identities = 71/278 (25%), Positives = 118/278 (42%), Gaps = 66/278 (23%)
Query: 10 AVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYL 69
AVK L + S ++F+ E L LQH +++R G C + ++V+EYM + L+ +L
Sbjct: 75 AVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFL 134
Query: 70 ------------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
+ + L + + + + G++YL + L +HRDL N L+
Sbjct: 135 RSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLV 191
Query: 118 GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSF 172
G+ + KI DFG++R + + VG +P PE ++T+SDV+SF
Sbjct: 192 GQGLVVKIGDFGMSR-----DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSF 246
Query: 173 GVLLLQIIS-GKR----LSMLCGINEN-LSILEHAYELWKGGKGVEFVDSSLDDTNSP-- 224
GV+L +I + GK+ LS N + + EL + P
Sbjct: 247 GVVLWEIFTYGKQPWYQLS-----NTEAIDCITQGRELER-----------------PRA 284
Query: 225 C-----KLMRCLEIALLCVQENPNDRPSMLQVSSMLKN 257
C +MR C Q P R S+ V + L+
Sbjct: 285 CPPEVYAIMR------GCWQREPQQRHSIKDVHARLQA 316
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-38
Identities = 68/282 (24%), Positives = 115/282 (40%), Gaps = 72/282 (25%)
Query: 10 AVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
A+K L + EEF++E ML A+LQH N++ +LG + +++ Y + L +
Sbjct: 43 AIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEF 102
Query: 69 L-------------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
L D + L+ VH++ I G+ YL S ++H+DL N+
Sbjct: 103 LVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNV 159
Query: 116 LLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVF 170
L+ + + KISD GL R + A + +P PE G +S SD++
Sbjct: 160 LVYDKLNVKISDLGLFRE-----VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIW 214
Query: 171 SFGVLLLQIIS-GKR----LSMLCGINEN-LSILEHAYELWKGGKGVEFVDSSLDDTNSP 224
S+GV+L ++ S G + S N++ + ++ + L P
Sbjct: 215 SYGVVLWEVFSYGLQPYCGYS-----NQDVVEMIRNRQVL-------------------P 250
Query: 225 C---------KLMRCLEIALLCVQENPNDRPSMLQVSSMLKN 257
C LM + C E P+ RP + S L+
Sbjct: 251 CPDDCPAWVYALM------IECWNEFPSRRPRFKDIHSRLRA 286
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-38
Identities = 68/289 (23%), Positives = 115/289 (39%), Gaps = 73/289 (25%)
Query: 10 AVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYL 69
AVK L + ++F+ E L LQH ++++ G C D + ++V+EYM + L+ +L
Sbjct: 49 AVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFL 108
Query: 70 -------------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNIL 116
+ L + +HI I G++YL + +HRDL N L
Sbjct: 109 RAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCL 165
Query: 117 LGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFS 171
+G ++ KI DFG++R + + VG +P PE ++T+SDV+S
Sbjct: 166 VGANLLVKIGDFGMSR-----DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 220
Query: 172 FGVLLLQIIS-GKR----LSMLCGINEN-LSILEHAYELWKGGKGVEFVDSSLDDTNSPC 225
FGV+L +I + GK+ LS N + + L
Sbjct: 221 FGVILWEIFTYGKQPWFQLS-----NTEVIECITQGRVL-------------------ER 256
Query: 226 ---------KLMRCLEIALLCVQENPNDRPSMLQVSSMLKNETTNRNTP 265
+M C Q P R ++ ++ +L + TP
Sbjct: 257 PRVCPKEVYDVML------GCWQREPQQRLNIKEIYKIL--HALGKATP 297
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-38
Identities = 72/272 (26%), Positives = 114/272 (41%), Gaps = 57/272 (20%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER-MLVYEYMPNKS 64
G +AVK + +T + F E + +L+H NL+++LG ++ + +V EYM S
Sbjct: 216 GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 273
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
L YL R +L + + + + YL +HRDL A N+L+ ED K
Sbjct: 274 LVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAK 329
Query: 125 ISDFGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQI 179
+SDFGL + + +P PE R+ +STKSDV+SFG+LL +I
Sbjct: 330 VSDFGLTKEASSTQDTGK----------LPVKWTAPEALREKKFSTKSDVWSFGILLWEI 379
Query: 180 IS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSS--LDDTNSP--C-----KLMR 229
S G+ Y V V+ +D +P C +M
Sbjct: 380 YSFGRV----------------PYPRIPLKDVVPRVEKGYKMD---APDGCPPAVYDVM- 419
Query: 230 CLEIALLCVQENPNDRPSMLQVSSMLKNETTN 261
C + RP+ LQ+ L++ T+
Sbjct: 420 -----KNCWHLDAATRPTFLQLREQLEHIRTH 446
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-38
Identities = 56/177 (31%), Positives = 89/177 (50%), Gaps = 16/177 (9%)
Query: 10 AVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYL 69
AVK L K T EEF E + +++H NL+++LG C ++ E+M +L YL
Sbjct: 42 AVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 100
Query: 70 FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFG 129
+ R + +++ I+ + YL + IHRDL A N L+GE+ K++DFG
Sbjct: 101 REC-NRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFG 156
Query: 130 LARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS 181
L+R+ ++ A+ P PE +S KSDV++FGVLL +I +
Sbjct: 157 LSRLMTGDTYTAHAG------AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-38
Identities = 78/278 (28%), Positives = 122/278 (43%), Gaps = 54/278 (19%)
Query: 10 AVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
A+K L T + +F E + + H N+IR+ G S+ M+V EYM N SLD +
Sbjct: 77 AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L + + V ++ GI G+ YL S + +HRDL A NIL+ ++ K+SDF
Sbjct: 137 LRKHDAQF--TVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDF 191
Query: 129 GLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS-G 182
GL R+ + A T + G IP PE +++ SDV+S+G++L +++S G
Sbjct: 192 GLGRVLEDDPEAAYTTRG----GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 183 KRLSMLCGINENLSILEHAYELWKGGKGVEFVDSS--LDDTNSPC---------KLMRCL 231
+R Y ++ VD L P +LM
Sbjct: 248 ER----------------PYWEMSNQDVIKAVDEGYRL-----PPPMDCPAALYQLM--- 283
Query: 232 EIALLCVQENPNDRPSMLQVSSMLKNETTNRNTPKKPA 269
L C Q++ N+RP Q+ S+L N + K
Sbjct: 284 ---LDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIIT 318
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-38
Identities = 64/267 (23%), Positives = 110/267 (41%), Gaps = 44/267 (16%)
Query: 10 AVKKL-SKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER--MLVYEYMPNKSLD 66
AVK L ++ + K E+ + L H N+++ G C + L+ E++P+ SL
Sbjct: 54 AVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLK 113
Query: 67 CYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKIS 126
YL P + ++ K+++ I +G+ YL +HRDL A N+L+ + + KI
Sbjct: 114 EYL--PKNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIG 168
Query: 127 DFGLARIFAKESLEANTEQ-VVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQII 180
DFGL + +E + E V P PE Q + SDV+SFGV L +++
Sbjct: 169 DFGLTKA-----IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 223
Query: 181 S-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSS--LDDTNSPC---------KLM 228
+ S + L ++ + + V + L PC +LM
Sbjct: 224 TYCDSDSS--PMALFLKMIGPTHGQMTVTRLVNTLKEGKRL-----PCPPNCPDEVYQLM 276
Query: 229 RCLEIALLCVQENPNDRPSMLQVSSML 255
C + P++R S +
Sbjct: 277 ------RKCWEFQPSNRTSFQNLIEGF 297
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 9e-38
Identities = 66/278 (23%), Positives = 119/278 (42%), Gaps = 54/278 (19%)
Query: 10 AVKKLSK-TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
A+K L + + +F E + + H N+IR+ G + M++ EYM N +LD +
Sbjct: 77 AIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF 136
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L + + + V ++ GI G+ YL + + +HRDL A NIL+ ++ K+SDF
Sbjct: 137 LREKDGEFSV--LQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDF 191
Query: 129 GLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS-G 182
GL+R+ + T G IP PE +++ SDV+SFG+++ ++++ G
Sbjct: 192 GLSRVLEDDPEATYTTSG----GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG 247
Query: 183 KRLSMLCGINENLSILEHAYELWKGGKGVEFVDSS--LDDTNSPC---------KLMRCL 231
+R Y + ++ ++ L P +LM
Sbjct: 248 ER----------------PYWELSNHEVMKAINDGFRL-----PTPMDCPSAIYQLM--- 283
Query: 232 EIALLCVQENPNDRPSMLQVSSMLKNETTNRNTPKKPA 269
+ C Q+ RP + S+L ++ K A
Sbjct: 284 ---MQCWQQERARRPKFADIVSILDKLIRAPDSLKTLA 318
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-37
Identities = 67/265 (25%), Positives = 113/265 (42%), Gaps = 48/265 (18%)
Query: 10 AVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYL 69
A+K + + E+F E + KL H L+++ G C++ LV E+M + L YL
Sbjct: 36 AIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL 94
Query: 70 FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFG 129
+R + + + + + +G+ YL +IHRDL A N L+GE+ K+SDFG
Sbjct: 95 RT--QRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFG 149
Query: 130 LARIFAKESLEANTEQVVGT---IGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRL 185
+ R + ++T GT + + PE YS+KSDV+SFGVL+ ++ S GK
Sbjct: 150 MTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
Query: 186 SMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPC---------KLMRCLEIALL 236
+E + + + L ++M
Sbjct: 206 YENRSNSEVVEDISTGFRL-------------------YKPRLASTHVYQIM------NH 240
Query: 237 CVQENPNDRPSMLQVSSMLKNETTN 261
C +E P DRP+ ++ L +
Sbjct: 241 CWRERPEDRPAFSRLLRQLAEIAES 265
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 74/270 (27%), Positives = 118/270 (43%), Gaps = 42/270 (15%)
Query: 10 AVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYL 69
A+K L K T E F E + KL+H L+++ + E +V EYM SL +L
Sbjct: 212 AIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL 269
Query: 70 FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFG 129
L + V + I G+ Y+ R+ +HRDL+A+NIL+GE++ K++DFG
Sbjct: 270 KGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFG 325
Query: 130 LARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSML 188
LAR+ A I + PE A G ++ KSDV+SFG+LL ++ + G+
Sbjct: 326 LARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 384
Query: 189 CGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPC---------KLMRCLEIALLCVQ 239
E L +E Y + PC LM C +
Sbjct: 385 MVNREVLDQVERGYRM-------------------PCPPECPESLHDLM------CQCWR 419
Query: 240 ENPNDRPSMLQVSSMLKNETTNRNTPKKPA 269
+ P +RP+ + + L++ T+ +P
Sbjct: 420 KEPEERPTFEYLQAFLEDYFTSTEPQYQPG 449
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-37
Identities = 74/270 (27%), Positives = 118/270 (43%), Gaps = 42/270 (15%)
Query: 10 AVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYL 69
A+K L K T E F E + KL+H L+++ + E +V EYM SL +L
Sbjct: 295 AIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFL 352
Query: 70 FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFG 129
L + V + I G+ Y+ R+ +HRDL+A+NIL+GE++ K++DFG
Sbjct: 353 KGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFG 408
Query: 130 LARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSML 188
LAR+ A I + PE A G ++ KSDV+SFG+LL ++ + G+
Sbjct: 409 LARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 467
Query: 189 CGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPC---------KLMRCLEIALLCVQ 239
E L +E Y + PC LM C +
Sbjct: 468 MVNREVLDQVERGYRM-------------------PCPPECPESLHDLM------CQCWR 502
Query: 240 ENPNDRPSMLQVSSMLKNETTNRNTPKKPA 269
+ P +RP+ + + L++ T+ +P
Sbjct: 503 KEPEERPTFEYLQAFLEDYFTSTEPQYQPG 532
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 7e-37
Identities = 59/268 (22%), Positives = 107/268 (39%), Gaps = 48/268 (17%)
Query: 9 IAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
+A+K + K + +EF E + L H L+++ G C ++ EYM N L Y
Sbjct: 51 VAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 109
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L + R ++ + + + + + + YL +HRDL A N L+ + K+SDF
Sbjct: 110 LRE--MRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDF 164
Query: 129 GLARIFAKESLEANTEQVVGT---IGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKR 184
GL+R + ++ G+ + + PPE +S+KSD+++FGVL+ +I S GK
Sbjct: 165 GLSRYVLDDEYTSSV----GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 220
Query: 185 LSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPC---------KLMRCLEIAL 235
+E + L +M
Sbjct: 221 PYERFTNSETAEHIAQGLRL-------------------YRPHLASEKVYTIM------Y 255
Query: 236 LCVQENPNDRPSMLQVSSMLKNETTNRN 263
C E ++RP+ + S + + +
Sbjct: 256 SCWHEKADERPTFKILLSNILDVMDEES 283
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-36
Identities = 65/262 (24%), Positives = 107/262 (40%), Gaps = 48/262 (18%)
Query: 9 IAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
+AVK + K + +EF E KL H L++ G C +V EY+ N L Y
Sbjct: 35 VAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNY 93
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L L+ + + + + +G+ +L IHRDL A N L+ D+ K+SDF
Sbjct: 94 LRS--HGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHRDLAARNCLVDRDLCVKVSDF 148
Query: 129 GLARIFAKESLEANTEQVVGT---IGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKR 184
G+ R + ++ GT + + PE YS+KSDV++FG+L+ ++ S GK
Sbjct: 149 GMTRYVLDDQYVSSV----GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKM 204
Query: 185 LSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPC---------KLMRCLEIAL 235
L +E + + + L ++M
Sbjct: 205 PYDLYTNSEVVLKVSQGHRL-------------------YRPHLASDTIYQIM------Y 239
Query: 236 LCVQENPNDRPSMLQVSSMLKN 257
C E P RP+ Q+ S ++
Sbjct: 240 SCWHELPEKRPTFQQLLSSIEP 261
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-36
Identities = 70/285 (24%), Positives = 108/285 (37%), Gaps = 60/285 (21%)
Query: 10 AVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
AVK L + + Q +F E ++ +K H N++R +G + S R ++ E M L +
Sbjct: 105 AVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSF 164
Query: 69 L----FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GEDM 121
L P + L +H+ I G YL IHRD+ A N LL G
Sbjct: 165 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGR 221
Query: 122 KPKISDFGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLL 176
KI DFG+AR + G +P PE +G++++K+D +SFGVLL
Sbjct: 222 VAKIGDFGMAR-----DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 276
Query: 177 LQIIS-GKR----LSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSP--C---- 225
+I S G S E L + + P C
Sbjct: 277 WEIFSLGYMPYPSKSN----QEVLEFVTSGGRMDP-----------------PKNCPGPV 315
Query: 226 -KLMRCLEIALLCVQENPNDRPSMLQVSSMLKNETTNRNTPKKPA 269
++M C Q P DRP+ + ++ T + +
Sbjct: 316 YRIMT------QCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 354
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-36
Identities = 46/182 (25%), Positives = 94/182 (51%), Gaps = 18/182 (9%)
Query: 10 AVKKLSKTSTQG-FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
A+K+L + ++ +E +E + A + + ++ R+LG C+ L+ + MP L Y
Sbjct: 48 AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDY 106
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
+ + + + + ++ I +G+ YL++ ++HRDL A N+L+ KI+DF
Sbjct: 107 VRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDF 161
Query: 129 GLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS-G 182
GLA++ L A ++ G +P E +Y+ +SDV+S+GV + ++++ G
Sbjct: 162 GLAKL-----LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 216
Query: 183 KR 184
+
Sbjct: 217 SK 218
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-36
Identities = 70/285 (24%), Positives = 109/285 (38%), Gaps = 60/285 (21%)
Query: 10 AVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
AVK L + + Q +F E ++ +K H N++R +G + S R ++ E M L +
Sbjct: 64 AVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSF 123
Query: 69 L----FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GEDM 121
L P + L +H+ I G YL IHRD+ A N LL G
Sbjct: 124 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGR 180
Query: 122 KPKISDFGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLL 176
KI DFG+AR + + G +P PE +G++++K+D +SFGVLL
Sbjct: 181 VAKIGDFGMAR-----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 235
Query: 177 LQIIS-GKR----LSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSP--C---- 225
+I S G S E L + + P C
Sbjct: 236 WEIFSLGYMPYPSKSN----QEVLEFVTSGGRMDP-----------------PKNCPGPV 274
Query: 226 -KLMRCLEIALLCVQENPNDRPSMLQVSSMLKNETTNRNTPKKPA 269
++M C Q P DRP+ + ++ T + +
Sbjct: 275 YRIMT------QCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 313
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-36
Identities = 65/262 (24%), Positives = 106/262 (40%), Gaps = 47/262 (17%)
Query: 10 AVK--KLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
AVK K +E E + +L + ++R++G C ++E MLV E L+
Sbjct: 48 AVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNK 106
Query: 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISD 127
YL + + K + ++ ++ G+ YL +HRDL A N+LL KISD
Sbjct: 107 YL---QQNRHVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISD 160
Query: 128 FGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS- 181
FGL++ + + G P PE +S+KSDV+SFGVL+ + S
Sbjct: 161 FGLSKALRADENYYKAQT----HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSY 216
Query: 182 GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSS--LDDTNSPCKLMRCL----EIAL 235
G++ Y KG + ++ + P C ++
Sbjct: 217 GQK----------------PYRGMKGSEVTAMLEKGERMG---CP---AGCPREMYDLMN 254
Query: 236 LCVQENPNDRPSMLQVSSMLKN 257
LC + +RP V L+N
Sbjct: 255 LCWTYDVENRPGFAAVELRLRN 276
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-36
Identities = 62/261 (23%), Positives = 105/261 (40%), Gaps = 45/261 (17%)
Query: 10 AVKKLSK-TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
A+K L + T EE E + +L + ++R++G C +E MLV E L +
Sbjct: 41 AIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKF 99
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L +R + ++ ++ G+ YL +HRDL A N+LL KISDF
Sbjct: 100 LVG--KREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDF 154
Query: 129 GLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS-G 182
GL++ + G P PE +S++SDV+S+GV + + +S G
Sbjct: 155 GLSKALGADDSYYTARS----AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG 210
Query: 183 KRLSMLCGINENLSILEHAYELWKGGKGVEFVDSS--LDDTNSPCKLMRCL----EIALL 236
++ Y+ KG + + F++ ++ P C +
Sbjct: 211 QK----------------PYKKMKGPEVMAFIEQGKRME---CP---PECPPELYALMSD 248
Query: 237 CVQENPNDRPSMLQVSSMLKN 257
C DRP L V ++
Sbjct: 249 CWIYKWEDRPDFLTVEQRMRA 269
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-36
Identities = 57/182 (31%), Positives = 88/182 (48%), Gaps = 22/182 (12%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER-MLVYEYMPNKS 64
G +AVK + +T + F E + +L+H NL+++LG ++ + +V EYM S
Sbjct: 44 GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 101
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
L YL R +L + + + + YL +HRDL A N+L+ ED K
Sbjct: 102 LVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAK 157
Query: 125 ISDFGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQI 179
+SDFGL + + +P PE R+ +STKSDV+SFG+LL +I
Sbjct: 158 VSDFGLTKEASSTQDTGK----------LPVKWTAPEALREKKFSTKSDVWSFGILLWEI 207
Query: 180 IS 181
S
Sbjct: 208 YS 209
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-36
Identities = 56/270 (20%), Positives = 97/270 (35%), Gaps = 63/270 (23%)
Query: 10 AVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYL 69
+K L K E F + +KL H +L+ G C+ +E +LV E++ SLD YL
Sbjct: 44 LLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL 103
Query: 70 FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP------ 123
+ + WK + + + + + +L T+IH ++ A NILL +
Sbjct: 104 KKNKNCINILWK--LEVAKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPP 158
Query: 124 --KISDFGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQG-VYSTKSDVFSFGVL 175
K+SD G++ + I PE + +D +SFG
Sbjct: 159 FIKLSDPGISITVLPKD-----------ILQERIPWVPPECIENPKNLNLATDKWSFGTT 207
Query: 176 LLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSS--LDDTNSPC-----KL 227
L +I S G + + ++F + L +P L
Sbjct: 208 LWEICSGGDK----------------PLSALDSQRKLQFYEDRHQLP---APKAAELANL 248
Query: 228 MRCLEIALLCVQENPNDRPSMLQVSSMLKN 257
+ C+ P+ RPS + L +
Sbjct: 249 I------NNCMDYEPDHRPSFRAIIRDLNS 272
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-36
Identities = 70/276 (25%), Positives = 111/276 (40%), Gaps = 64/276 (23%)
Query: 10 AVKKLSKTSTQG-FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
A+K +++ ++ EF NE + + +++R+LG + +++ E M L Y
Sbjct: 59 AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 118
Query: 69 L-------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
L + K + + I G+ YL + +HRDL A N ++ ED
Sbjct: 119 LRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDF 175
Query: 122 KPKISDFGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLL 176
KI DFG+ R + G G +P PE + GV++T SDV+SFGV+L
Sbjct: 176 TVKIGDFGMTR-----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 230
Query: 177 LQIISGKRLSMLCGI-------NENLSILEHAYELWKGGKGVEFVDSSLDDTNSP--C-- 225
+I + L + L + L K P C
Sbjct: 231 WEIAT------LAEQPYQGLSNEQVLRFVMEGGLLDK-----------------PDNCPD 267
Query: 226 ---KLMRCLEIALLCVQENPNDRPSMLQVSSMLKNE 258
+LMR +C Q NP RPS L++ S +K E
Sbjct: 268 MLFELMR------MCWQYNPKMRPSFLEIISSIKEE 297
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-36
Identities = 44/178 (24%), Positives = 88/178 (49%), Gaps = 17/178 (9%)
Query: 10 AVKKL-SKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
+K + K+ Q F+ + ++ L H +++R+LG C LV +Y+P SL +
Sbjct: 46 CIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDH 104
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
+ L + ++ I +G+ YL ++HR+L A N+LL + +++DF
Sbjct: 105 VRQHRGALGP--QLLLNWGVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADF 159
Query: 129 GLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS 181
G+A + L + +Q++ + P E G Y+ +SDV+S+GV + ++++
Sbjct: 160 GVADL-----LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-35
Identities = 63/267 (23%), Positives = 107/267 (40%), Gaps = 46/267 (17%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
+AVK + K + E F E + LQH L+++ E ++ E+M
Sbjct: 207 ATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 264
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
SL +L K + I +G+ ++ + IHRDL+A+NIL+
Sbjct: 265 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSAS 320
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVL 175
+ KI+DFGLAR+ A P PE G ++ KSDV+SFG+L
Sbjct: 321 LVCKIADFGLARVIEDNEYTAREG------AKFPIKWTAPEAINFGSFTIKSDVWSFGIL 374
Query: 176 LLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSS--LDDTNSPCKLMRCLE 232
L++I++ G+ Y + + ++ + + C E
Sbjct: 375 LMEIVTYGRI----------------PYPGMSNPEVIRALERGYRMP------RPENCPE 412
Query: 233 ----IALLCVQENPNDRPSMLQVSSML 255
I + C + P +RP+ + S+L
Sbjct: 413 ELYNIMMRCWKNRPEERPTFEYIQSVL 439
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-35
Identities = 64/266 (24%), Positives = 111/266 (41%), Gaps = 50/266 (18%)
Query: 9 IAVKKLSKTSTQG-FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE-RMLVYEYMPNKSLD 66
AVK L++ + G +F E ++ H N++ +LG C+ SE ++V YM + L
Sbjct: 56 CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 115
Query: 67 CYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKIS 126
++ + + K + + +G+ YL +HRDL A N +L E K++
Sbjct: 116 NFIRNETHNPTV--KDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVA 170
Query: 127 DFGLAR-IFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQII 180
DFGLAR ++ KE + + T +P E + ++TKSDV+SFGVLL +++
Sbjct: 171 DFGLARDMYDKEYYSVHNK----TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 226
Query: 181 S-GKR----LSMLCGINEN-LSILEHAYELWKGGKGVEFVDSSLDDTNSP---CKLMRCL 231
+ G ++ + L L + P ++M
Sbjct: 227 TRGAPPYPDVN-----TFDITVYLLQGRRLLQ-------------PEYCPDPLYEVM--- 265
Query: 232 EIALLCVQENPNDRPSMLQVSSMLKN 257
L C RPS ++ S +
Sbjct: 266 ---LKCWHPKAEMRPSFSELVSRISA 288
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-35
Identities = 54/181 (29%), Positives = 87/181 (48%), Gaps = 17/181 (9%)
Query: 9 IAVKKLSK-TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER-MLVYEYMPNKSLD 66
A+K LS+ T Q E F E +L L H N++ ++G + E ++ YM + L
Sbjct: 52 CAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLL 111
Query: 67 CYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKIS 126
++ P R + K + + +G+ YL + +HRDL A N +L E K++
Sbjct: 112 QFIRSPQRNPTV--KDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVA 166
Query: 127 DFGLAR-IFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQII 180
DFGLAR I +E +P E + ++TKSDV+SFGVLL +++
Sbjct: 167 DFGLARDILDREY----YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELL 222
Query: 181 S 181
+
Sbjct: 223 T 223
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-35
Identities = 49/178 (27%), Positives = 72/178 (40%), Gaps = 14/178 (7%)
Query: 10 AVKKL---SKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLD 66
AVK L + + ++F EV L H NLIR+ G + + +V E P SL
Sbjct: 50 AVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLL 108
Query: 67 CYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKIS 126
L +L + +G+ YL IHRDL A N+LL KI
Sbjct: 109 DRLRKHQGHFLL--GTLSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIG 163
Query: 127 DFGLARIFAKESLEANTEQVVGT---IGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
DFGL R + ++ + PE + +S SD + FGV L ++ +
Sbjct: 164 DFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-34
Identities = 58/178 (32%), Positives = 88/178 (49%), Gaps = 17/178 (9%)
Query: 9 IAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
+AVK L K + + F E L +LQH L+R+ E ++ EYM N SL +
Sbjct: 40 VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDF 97
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L P + L K + + I +G+ ++ IHRDL+A+NIL+ + + KI+DF
Sbjct: 98 LKTP-SGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADF 153
Query: 129 GLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS 181
GLAR+ A P PE G ++ KSDV+SFG+LL +I++
Sbjct: 154 GLARLIEDNEYTAREG------AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 64/266 (24%), Positives = 110/266 (41%), Gaps = 50/266 (18%)
Query: 9 IAVKKLSKTSTQG-FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE-RMLVYEYMPNKSLD 66
AVK L++ + G +F E ++ H N++ +LG C+ SE ++V YM + L
Sbjct: 120 CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179
Query: 67 CYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKIS 126
++ + + K + + +G+ +L +HRDL A N +L E K++
Sbjct: 180 NFIRNETHNPTV--KDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVA 234
Query: 127 DFGLAR-IFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQII 180
DFGLAR ++ KE + T +P E + ++TKSDV+SFGVLL +++
Sbjct: 235 DFGLARDMYDKEFDSVHN----KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 290
Query: 181 S-GKR----LSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL---- 231
+ G ++ + L L + P C
Sbjct: 291 TRGAPPYPDVNT----FDITVYLLQGRRLLQ-----------------P---EYCPDPLY 326
Query: 232 EIALLCVQENPNDRPSMLQVSSMLKN 257
E+ L C RPS ++ S +
Sbjct: 327 EVMLKCWHPKAEMRPSFSELVSRISA 352
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-34
Identities = 47/178 (26%), Positives = 93/178 (52%), Gaps = 17/178 (9%)
Query: 10 AVKKL-SKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
A+K+L TS + +E +E + A + + ++ R+LG C+ + L+ + MP L Y
Sbjct: 48 AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDY 106
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
+ + + + + ++ I +G+ YL++ ++HRDL A N+L+ KI+DF
Sbjct: 107 VRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDF 161
Query: 129 GLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS 181
GLA++ L A ++ G +P E +Y+ +SDV+S+GV + ++++
Sbjct: 162 GLAKL-----LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-34
Identities = 80/282 (28%), Positives = 120/282 (42%), Gaps = 60/282 (21%)
Query: 10 AVKKLSKTSTQG-FEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
A+K++ + +++ +F E+ + KL H N+I +LG C L EY P+ +L
Sbjct: 56 AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 115
Query: 68 YL-------------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
+L L ++ +H + +G+ YL S+ IHRDL A N
Sbjct: 116 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARN 172
Query: 115 ILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDV 169
IL+GE+ KI+DFGL+R V T+G +P E VY+T SDV
Sbjct: 173 ILVGENYVAKIADFGLSR--------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDV 224
Query: 170 FSFGVLLLQIIS-GKRLSMLCGIN--ENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCK 226
+S+GVLL +I+S G CG+ E L Y L K P
Sbjct: 225 WSYGVLLWEIVSLGGTPY--CGMTCAELYEKLPQGYRLEK-----------------P-- 263
Query: 227 LMRCL----EIALLCVQENPNDRPSMLQVSSMLKNETTNRNT 264
+ C ++ C +E P +RPS Q+ L R T
Sbjct: 264 -LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-34
Identities = 58/264 (21%), Positives = 102/264 (38%), Gaps = 53/264 (20%)
Query: 10 AVKKLSK-TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
AVK K + E+F +E ++ L H ++++++G + E ++ E P L Y
Sbjct: 44 AVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHY 102
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L L + V I + + YL + +HRD+ NIL+ K+ DF
Sbjct: 103 LERNKNSLKV--LTLVLYSLQICKAMAYL---ESINCVHRDIAVRNILVASPECVKLGDF 157
Query: 129 GLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS-G 182
GL+R E + ++ +P PE ++T SDV+ F V + +I+S G
Sbjct: 158 GLSRYIEDE------DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFG 211
Query: 183 KRLSMLCGINENLSILEHAYELWKGGKGVEFVDSS--LDDTNSP--C-----KLMRCLEI 233
K+ + + + ++ L P C LM
Sbjct: 212 KQ----------------PFFWLENKDVIGVLEKGDRLP---KPDLCPPVLYTLM----- 247
Query: 234 ALLCVQENPNDRPSMLQVSSMLKN 257
C +P+DRP ++ L +
Sbjct: 248 -TRCWDYDPSDRPRFTELVCSLSD 270
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-34
Identities = 69/288 (23%), Positives = 113/288 (39%), Gaps = 76/288 (26%)
Query: 10 AVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
AVK L + ++ +F+ E L A+ + N++++LG C + L++EYM L+ +
Sbjct: 81 AVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEF 140
Query: 69 L---------------------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIH 107
L L +++ I + G+ YL S +H
Sbjct: 141 LRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVH 197
Query: 108 RDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGV 162
RDL N L+GE+M KI+DFGL+R ++ + IP PE
Sbjct: 198 RDLATRNCLVGENMVVKIADFGLSR-----NIYSADYYKADGNDAIPIRWMPPESIFYNR 252
Query: 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGI------NENLSILEHAYELWKGGKGVEFVDS 216
Y+T+SDV+++GV+L +I S +E + + G +
Sbjct: 253 YTTESDVWAYGVVLWEIFS------YGLQPYYGMAHEEV------IYYVRDGNILA---- 296
Query: 217 SLDDTNSP--C-----KLMRCLEIALLCVQENPNDRPSMLQVSSMLKN 257
P C LMR LC + P DRPS + +L+
Sbjct: 297 ------CPENCPLELYNLMR------LCWSKLPADRPSFCSIHRILQR 332
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-34
Identities = 55/187 (29%), Positives = 87/187 (46%), Gaps = 23/187 (12%)
Query: 10 AVK--KLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE-----ERMLVYEYMPN 62
AVK KL +S + EEF +E H N+IR+LG CI+ + M++ +M
Sbjct: 66 AVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKY 125
Query: 63 KSLDCYL---FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
L YL + + + + I G+ YL S +HRDL A N +L +
Sbjct: 126 GDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRD 182
Query: 120 DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGV 174
DM ++DFGL++ + + G I +P E VY++KSDV++FGV
Sbjct: 183 DMTVCVADFGLSK-----KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGV 237
Query: 175 LLLQIIS 181
+ +I +
Sbjct: 238 TMWEIAT 244
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-34
Identities = 49/265 (18%), Positives = 97/265 (36%), Gaps = 47/265 (17%)
Query: 10 AVKKLSK-TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
A+K TS E+F E + + H ++++++G + ++ E L +
Sbjct: 47 AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSF 105
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L L L + ++ L YL +HRD+ A N+L+ + K+ DF
Sbjct: 106 LQVRKYSLDL--ASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDF 160
Query: 129 GLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS-G 182
GL+R ++ + G +P PE +++ SDV+ FGV + +I+ G
Sbjct: 161 GLSRYM------EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 214
Query: 183 KRLSMLCGINENLSILEHAYELWKGGKGVEFVDSS--LDDTNSPCKLMRCL----EIALL 236
+ ++ K + +++ L C +
Sbjct: 215 VK----------------PFQGVKNNDVIGRIENGERLP------MPPNCPPTLYSLMTK 252
Query: 237 CVQENPNDRPSMLQVSSMLKNETTN 261
C +P+ RP ++ + L
Sbjct: 253 CWAYDPSRRPRFTELKAQLSTILEE 277
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-34
Identities = 62/278 (22%), Positives = 109/278 (39%), Gaps = 45/278 (16%)
Query: 10 AVKKL-SKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
A+K L T EE E + +L + ++R++G C +E MLV E L +
Sbjct: 367 AIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKF 425
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L +R + ++ ++ G+ YL +HR+L A N+LL KISDF
Sbjct: 426 LVG--KREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDF 480
Query: 129 GLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS-G 182
GL++ + G P PE +S++SDV+S+GV + + +S G
Sbjct: 481 GLSKALGADDSYYTARS----AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG 536
Query: 183 KRLSMLCGINENLSILEHAYELWKGGKGVEFVDSS--LDDTNSPCKLMRCL----EIALL 236
++ Y+ KG + + F++ + C C +
Sbjct: 537 QK----------------PYKKMKGPEVMAFIEQGKRM-----ECP-PECPPELYALMSD 574
Query: 237 CVQENPNDRPSMLQVSSMLKNETTNRNTPKKPAFSKQV 274
C DRP L V ++ + + + + +V
Sbjct: 575 CWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGSALEV 612
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-33
Identities = 67/278 (24%), Positives = 108/278 (38%), Gaps = 61/278 (21%)
Query: 10 AVKKL-SKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEE-RMLVYEYMPNKSLD 66
AVK L + +E+ + + H+N++ +LG C M++ E+ +L
Sbjct: 61 AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS 120
Query: 67 CYL-------------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKAS 113
YL + + + L + + + +G+ +L + IHRDL A
Sbjct: 121 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAAR 177
Query: 114 NILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSD 168
NILL E KI DFGLAR K+ + V +P PE VY+ +SD
Sbjct: 178 NILLSEKNVVKICDFGLARDIYKDP-----DYVRKGDARLPLKWMAPETIFDRVYTIQSD 232
Query: 169 VFSFGVLLLQIISGKRLSML--CGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSP-- 224
V+SFGVLL +I S L G+ + L +G + + +P
Sbjct: 233 VWSFGVLLWEIFS---LGASPYPGVKIDEEFCRR---LKEGTR--------MR---APDY 275
Query: 225 C-----KLMRCLEIALLCVQENPNDRPSMLQVSSMLKN 257
+ M C P+ RP+ ++ L N
Sbjct: 276 TTPEMYQTML------DCWHGEPSQRPTFSELVEHLGN 307
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-33
Identities = 70/279 (25%), Positives = 110/279 (39%), Gaps = 65/279 (23%)
Query: 10 AVKKL-SKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
AVK L + + + +E+ + + +H N+I +LG C ++ EY +L
Sbjct: 71 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 130
Query: 68 YL-------------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
YL + + + +K V + +G+ YL + IHRDL A N
Sbjct: 131 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARN 187
Query: 115 ILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDV 169
+L+ E+ KI+DFGLAR T G +P PE VY+ +SDV
Sbjct: 188 VLVTENNVMKIADFGLARDINNID-----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 242
Query: 170 FSFGVLLLQIISGKRLSML--CGIN--ENLSILEHAYELWKGGKGVEFVDSSLDDTNSP- 224
+SFGVL+ +I + L GI E +L+ + + K P
Sbjct: 243 WSFGVLMWEIFT---LGGSPYPGIPVEELFKLLKEGHRMDK-----------------PA 282
Query: 225 -C-----KLMRCLEIALLCVQENPNDRPSMLQVSSMLKN 257
C +MR C P+ RP+ Q+ L
Sbjct: 283 NCTNELYMMMR------DCWHAVPSQRPTFKQLVEDLDR 315
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-33
Identities = 55/190 (28%), Positives = 83/190 (43%), Gaps = 26/190 (13%)
Query: 10 AVKKL-SKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
AVK L S E +E+ + + L QH N++ +LG C +++ EY L
Sbjct: 80 AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139
Query: 68 YL-----------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNIL 116
+L I + +H + QG+ +L + IHRD+ A N+L
Sbjct: 140 FLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVL 196
Query: 117 LGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFS 171
L KI DFGLAR +S +V +P PE VY+ +SDV+S
Sbjct: 197 LTNGHVAKIGDFGLARDIMNDS-----NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS 251
Query: 172 FGVLLLQIIS 181
+G+LL +I S
Sbjct: 252 YGILLWEIFS 261
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-33
Identities = 49/189 (25%), Positives = 83/189 (43%), Gaps = 24/189 (12%)
Query: 9 IAVK--KLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER------MLVYEYM 60
+AVK K ++ EEF E + H ++ +++G + S + M++ +M
Sbjct: 54 VAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFM 113
Query: 61 PNKSLDCYLFD---PIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
+ L +L L + V + I G+ YL S IHRDL A N +L
Sbjct: 114 KHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCML 170
Query: 118 GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSF 172
EDM ++DFGL+R + + G +P E +Y+ SDV++F
Sbjct: 171 AEDMTVCVADFGLSR-----KIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAF 225
Query: 173 GVLLLQIIS 181
GV + +I++
Sbjct: 226 GVTMWEIMT 234
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 5e-33
Identities = 70/279 (25%), Positives = 110/279 (39%), Gaps = 65/279 (23%)
Query: 10 AVKKL-SKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
AVK L + + + +E+ + + +H N+I +LG C ++ EY +L
Sbjct: 117 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 176
Query: 68 YL-------------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
YL + + + +K V + +G+ YL + IHRDL A N
Sbjct: 177 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARN 233
Query: 115 ILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDV 169
+L+ E+ KI+DFGLAR T G +P PE VY+ +SDV
Sbjct: 234 VLVTENNVMKIADFGLARDINNID-----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 288
Query: 170 FSFGVLLLQIISGKRLSML--CGI--NENLSILEHAYELWKGGKGVEFVDSSLDDTNSP- 224
+SFGVL+ +I + L GI E +L+ + + K P
Sbjct: 289 WSFGVLMWEIFT---LGGSPYPGIPVEELFKLLKEGHRMDK-----------------PA 328
Query: 225 -C-----KLMRCLEIALLCVQENPNDRPSMLQVSSMLKN 257
C +MR C P+ RP+ Q+ L
Sbjct: 329 NCTNELYMMMRD------CWHAVPSQRPTFKQLVEDLDR 361
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-33
Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 35/199 (17%)
Query: 10 AVKKLSKTSTQG-FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
AVK L + ++ + +E + ++ H ++I++ G C +L+ EY SL +
Sbjct: 57 AVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGF 116
Query: 69 L---------------------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIH 107
L D L + I+QG+ YL + + ++H
Sbjct: 117 LRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVH 173
Query: 108 RDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGV 162
RDL A NIL+ E K KISDFGL+R +E V + G IP E +
Sbjct: 174 RDLAARNILVAEGRKMKISDFGLSRDVYEED-----SYVKRSQGRIPVKWMAIESLFDHI 228
Query: 163 YSTKSDVFSFGVLLLQIIS 181
Y+T+SDV+SFGVLL +I++
Sbjct: 229 YTTQSDVWSFGVLLWEIVT 247
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-32
Identities = 66/278 (23%), Positives = 109/278 (39%), Gaps = 60/278 (21%)
Query: 10 AVKKL-SKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
AVK L E +E+ + + L H+N++ +LG C +++ EY L
Sbjct: 57 AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN 116
Query: 68 YL---------------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKA 112
+L L LD + + + +G+ +L + IHRDL A
Sbjct: 117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAA 173
Query: 113 SNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKS 167
NILL KI DFGLAR +S VV +P PE VY+ +S
Sbjct: 174 RNILLTHGRITKICDFGLARDIKNDS-----NYVVKGNARLPVKWMAPESIFNCVYTFES 228
Query: 168 DVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSP-- 224
DV+S+G+ L ++ S G S G+ + + + +G + + SP
Sbjct: 229 DVWSYGIFLWELFSLGS--SPYPGMPVDSKFYKM---IKEGFR--------ML---SPEH 272
Query: 225 C-----KLMRCLEIALLCVQENPNDRPSMLQVSSMLKN 257
+M+ C +P RP+ Q+ +++
Sbjct: 273 APAEMYDIMK------TCWDADPLKRPTFKQIVQLIEK 304
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 72/279 (25%), Positives = 109/279 (39%), Gaps = 65/279 (23%)
Query: 10 AVKKL-SKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
AVK L S + + + +E+ + + +H N+I +LG C ++ EY +L
Sbjct: 105 AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 164
Query: 68 YL-------------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
YL L K V + +G+ YL + IHRDL A N
Sbjct: 165 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARN 221
Query: 115 ILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDV 169
+L+ ED KI+DFGLAR + T G +P PE +Y+ +SDV
Sbjct: 222 VLVTEDNVMKIADFGLARD-----IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 276
Query: 170 FSFGVLLLQIISGKRLSML--CGIN--ENLSILEHAYELWKGGKGVEFVDSSLDDTNSP- 224
+SFGVLL +I + L G+ E +L+ + + K P
Sbjct: 277 WSFGVLLWEIFT---LGGSPYPGVPVEELFKLLKEGHRMDK-----------------PS 316
Query: 225 -C-----KLMRCLEIALLCVQENPNDRPSMLQVSSMLKN 257
C +MR C P+ RP+ Q+ L
Sbjct: 317 NCTNELYMMMR------DCWHAVPSQRPTFKQLVEDLDR 349
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-32
Identities = 50/265 (18%), Positives = 100/265 (37%), Gaps = 47/265 (17%)
Query: 10 AVKKL-SKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY 68
A+K + TS E+F E + + H ++++++G + ++ E L +
Sbjct: 422 AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSF 480
Query: 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128
L R+ LD + ++ L YL +HRD+ A N+L+ + K+ DF
Sbjct: 481 LQV--RKFSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDF 535
Query: 129 GLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIIS-G 182
GL+R ++ + G +P PE +++ SDV+ FGV + +I+ G
Sbjct: 536 GLSRYM------EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 589
Query: 183 KRLSMLCGINENLSILEHAYELWKGGKGVEFVDS--SLDDTNSPCKLMRCL----EIALL 236
+ ++ K + +++ L C +
Sbjct: 590 VK----------------PFQGVKNNDVIGRIENGERLP------MPPNCPPTLYSLMTK 627
Query: 237 CVQENPNDRPSMLQVSSMLKNETTN 261
C +P+ RP ++ + L
Sbjct: 628 CWAYDPSRRPRFTELKAQLSTILEE 652
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 70/287 (24%), Positives = 116/287 (40%), Gaps = 65/287 (22%)
Query: 10 AVKKL-SKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
AVK L K + E +E+ + +L H N++ +LG C S L++EY L
Sbjct: 79 AVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN 138
Query: 68 YL--------------------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIH 107
YL + +L ++ + + +G+ +L + +H
Sbjct: 139 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVH 195
Query: 108 RDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIP-----PEYARQGV 162
RDL A N+L+ KI DFGLAR +S VV +P PE +G+
Sbjct: 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDS-----NYVVRGNARLPVKWMAPESLFEGI 250
Query: 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDT 221
Y+ KSDV+S+G+LL +I S G + GI + + Y+L + G ++
Sbjct: 251 YTIKSDVWSYGILLWEIFSLGV--NPYPGIPVD----ANFYKLIQNGFKMD--------- 295
Query: 222 NSP--C-----KLMRCLEIALLCVQENPNDRPSMLQVSSMLKNETTN 261
P +M+ C + RPS ++S L + +
Sbjct: 296 -QPFYATEEIYIIMQ------SCWAFDSRKRPSFPNLTSFLGCQLAD 335
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 46/183 (25%), Positives = 91/183 (49%), Gaps = 12/183 (6%)
Query: 6 GKVIAVK--KLSKTSTQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
+A+K + + + F+ EV +++L H N++ ++ + + LV EY+
Sbjct: 36 NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEG 95
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYS-RLTIIHRDLKASNILLGEDM 121
+L Y+ L ++ I G+ +++ + I+HRD+K NIL+ +
Sbjct: 96 PTLSEYI---ESHGPLSVDTAINFTNQILDGI----KHAHDMRIVHRDIKPQNILIDSNK 148
Query: 122 KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
KI DFG+A+ ++ SL T V+GT+ Y PE A+ +D++S G++L +++
Sbjct: 149 TLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLV 207
Query: 182 GKR 184
G+
Sbjct: 208 GEP 210
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-29
Identities = 52/292 (17%), Positives = 103/292 (35%), Gaps = 48/292 (16%)
Query: 6 GKVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM---------- 54
A+K++ E+ EV AKL+H ++R ++
Sbjct: 30 DCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVY 89
Query: 55 --LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKA 112
+ + ++L ++ + +HI I + + +L ++HRDLK
Sbjct: 90 LYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKP 146
Query: 113 SNILLGEDMKPKISDFGLARIFAKESLEANTEQV----------VGTIGYIPPEYARQGV 162
SNI D K+ DFGL ++ E VGT Y+ PE
Sbjct: 147 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS 206
Query: 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTN 222
YS K D+FS G++L + +L + + + ++ +F
Sbjct: 207 YSHKVDIFSLGLILFE--------LLYPFSTQMERVRTLTDVRNL----KFPPLFTQKYP 254
Query: 223 SPCKLMRCLEIALLCVQENPNDRPSMLQVSSMLKNET-TNRNTPKKPAFSKQ 273
+++ + +P +RP + + ++N + + P K ++
Sbjct: 255 CEYVMVQ------DMLSPSPMERPEAINI---IENAVFEDLDFPGKTVLRQR 297
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-29
Identities = 56/193 (29%), Positives = 87/193 (45%), Gaps = 23/193 (11%)
Query: 6 GKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML--VYEYMP 61
GK++ K+L + + +EV L +L+H N++R ID L V EY
Sbjct: 31 GKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 90
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEG--------ITQGLLYL--QEYSRLTIIHRDLK 111
L I + K+R ++ E +T L + T++HRDLK
Sbjct: 91 GGDL----ASVITKGT---KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143
Query: 112 ASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFS 171
+N+ L K+ DFGLARI ++ A T VGT Y+ PE + Y+ KSD++S
Sbjct: 144 PANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNRMSYNEKSDIWS 201
Query: 172 FGVLLLQIISGKR 184
G LL ++ +
Sbjct: 202 LGCLLYELCALMP 214
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-29
Identities = 47/186 (25%), Positives = 90/186 (48%), Gaps = 18/186 (9%)
Query: 6 GKVIAVKK--LSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
G+ +K+ +S+ S++ EE + EV + A ++H N+++ ++ +V +Y
Sbjct: 49 GRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGG 108
Query: 64 SLDCYL----FDPIR-RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
L + + ILDW ++ I L ++ + I+HRD+K+ NI L
Sbjct: 109 DLFKRINAQKGVLFQEDQILDW-----FVQ-ICLALKHVHD---RKILHRDIKSQNIFLT 159
Query: 119 EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
+D ++ DFG+AR+ A +GT Y+ PE Y+ KSD+++ G +L +
Sbjct: 160 KDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEICENKPYNNKSDIWALGCVLYE 217
Query: 179 IISGKR 184
+ + K
Sbjct: 218 LCTLKH 223
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-29
Identities = 61/285 (21%), Positives = 103/285 (36%), Gaps = 65/285 (22%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
GK +K++ + E+ + EV AKL HVN++ G + ++S
Sbjct: 36 GKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSK 91
Query: 66 DCYLF---------DPIRRLILDWKKR-------VHIIEGITQGLLYLQEYSRLTIIHRD 109
LF + + I + + + E IT+G+ Y+ +I+RD
Sbjct: 92 TKCLFIQMEFCDKGT-LEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRD 147
Query: 110 LKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDV 169
LK SNI L + + KI DFGL + + GT+ Y+ PE Y + D+
Sbjct: 148 LKPSNIFLVDTKQVKIGDFGLVTSLKNDG-KRTR--SKGTLRYMSPEQISSQDYGKEVDL 204
Query: 170 FSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKL-- 227
++ G++L EL F S +
Sbjct: 205 YALGLIL-------------------------AELLHVCD-TAFETSKFFTDLRDGIISD 238
Query: 228 -----MRCLEIALLCVQENPNDRPSMLQVSSMLKNETTNRNTPKK 267
+ L LL P DRP+ ++ L+ T + +P+K
Sbjct: 239 IFDKKEKTLLQKLLSK--KPEDRPNTSEI---LRTLTVWKKSPEK 278
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 61/273 (22%), Positives = 110/273 (40%), Gaps = 61/273 (22%)
Query: 6 GKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNL--IRVLGFCIDSEERMLVYEYMP 61
++ A+K ++ Q + ++NE+ KLQ + IR+ + I + +V E
Sbjct: 52 KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG- 110
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
N L+ +L ++ +D +R + + + + + ++ I+H DLK +N L+ + M
Sbjct: 111 NIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM 164
Query: 122 KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE-----------YARQGVYSTKSDVF 170
K+ DFG+A ++ + VGT+ Y+PPE + S KSDV+
Sbjct: 165 -LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 223
Query: 171 SFGVLLLQIISGKRLSMLCG------INENLSIL------EHAYELWKGGKGVEFVDSSL 218
S G +L M G I +S L H E + + L
Sbjct: 224 SLGCILYY--------MTYGKTPFQQIINQISKLHAIIDPNHEIEFP------DIPEKDL 269
Query: 219 DDTNSPCKLMRCLEIALLCVQENPNDRPSMLQV 251
D L CL + +P R S+ ++
Sbjct: 270 QDV-----LKCCL-------KRDPKQRISIPEL 290
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-28
Identities = 42/189 (22%), Positives = 85/189 (44%), Gaps = 21/189 (11%)
Query: 6 GKVIAVKKL---SKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
G +A+KK+ + + E+ L +L H N+I+ I+ E +V E
Sbjct: 57 GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA 116
Query: 63 KSLDCYLFDPIRR-------LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
L + ++ + + ++ + L ++ ++HRD+K +N+
Sbjct: 117 GDLSRMIKHFKKQKRLIPERTVWKY-----FVQ-LCSALEHMHS---RRVMHRDIKPANV 167
Query: 116 LLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVL 175
+ K+ D GL R F+ ++ A++ +VGT Y+ PE + Y+ KSD++S G L
Sbjct: 168 FITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCL 225
Query: 176 LLQIISGKR 184
L ++ + +
Sbjct: 226 LYEMAALQS 234
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-28
Identities = 63/249 (25%), Positives = 104/249 (41%), Gaps = 30/249 (12%)
Query: 6 GKVIAVK--KLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM----LVYEY 59
+A + K + + FK E + LQH N++R + + LV E
Sbjct: 51 TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL-G 118
M + +L YL R ++ K I +GL +L IIHRDLK NI + G
Sbjct: 111 MTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITG 166
Query: 119 EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
KI D GLA + + V+GT ++ PE + Y DV++FG+ +L+
Sbjct: 167 PTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLE 221
Query: 179 IISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238
+ + + C +N + + + GV+ +S D P EI C+
Sbjct: 222 MATSEYPYSEC---QNAAQIYR-----RVTSGVK--PASFDKVAIPE----VKEIIEGCI 267
Query: 239 QENPNDRPS 247
++N ++R S
Sbjct: 268 RQNKDERYS 276
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-28
Identities = 58/258 (22%), Positives = 98/258 (37%), Gaps = 36/258 (13%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEV-MLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
+ +AVK++ + F EV +L +H N+IR D + + + E
Sbjct: 48 NRDVAVKRILP---ECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA--- 101
Query: 65 LDCYLFDPI--RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE--- 119
L + + + + + +++ T GL +L L I+HRDLK NIL+
Sbjct: 102 --ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNA 156
Query: 120 --DMKPKISDFGLARIF-AKESLEANTEQVVGTIGYIPPEYARQGV---YSTKSDVFSFG 173
+K ISDFGL + + V GT G+I PE + + D+FS G
Sbjct: 157 HGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAG 216
Query: 174 VLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEI 233
+ +IS + +IL A L + + + +L+
Sbjct: 217 CVFYYVISEGSHPFGKSLQRQANILLGACSL-------DCLHPEKHEDVIARELIEK--- 266
Query: 234 ALLCVQENPNDRPSMLQV 251
+ +P RPS V
Sbjct: 267 ---MIAMDPQKRPSAKHV 281
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 60/273 (21%), Positives = 108/273 (39%), Gaps = 61/273 (22%)
Query: 6 GKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNL--IRVLGFCIDSEERMLVYEYMP 61
++ A+K ++ Q + ++NE+ KLQ + IR+ + I + +V E
Sbjct: 80 KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-G 138
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
N L+ +L ++ +D +R + + + + + ++ I+H DLK +N L+ D
Sbjct: 139 NIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI-VDG 191
Query: 122 KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE-----------YARQGVYSTKSDVF 170
K+ DFG+A ++ + VG + Y+PPE + S KSDV+
Sbjct: 192 MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 251
Query: 171 SFGVLLLQIISGKRLSMLCG------INENLSILE------HAYELWKGGKGVEFVDSSL 218
S G +L M G I +S L H E + + L
Sbjct: 252 SLGCILYY--------MTYGKTPFQQIINQISKLHAIIDPNHEIEFP------DIPEKDL 297
Query: 219 DDTNSPCKLMRCLEIALLCVQENPNDRPSMLQV 251
D L CL + +P R S+ ++
Sbjct: 298 QDV-----LKCCL-------KRDPKQRISIPEL 318
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 61/273 (22%), Positives = 110/273 (40%), Gaps = 61/273 (22%)
Query: 6 GKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNL--IRVLGFCIDSEERMLVYEYMP 61
++ A+K ++ Q + ++NE+ KLQ + IR+ + I + +V E
Sbjct: 33 KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-G 91
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
N L+ +L ++ +D +R + + + + + ++ I+H DLK +N L+ + M
Sbjct: 92 NIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM 145
Query: 122 KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE-----------YARQGVYSTKSDVF 170
K+ DFG+A ++ + VGT+ Y+PPE + S KSDV+
Sbjct: 146 -LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 204
Query: 171 SFGVLLLQIISGKRLSMLCG------INENLSIL------EHAYELWKGGKGVEFVDSSL 218
S G +L M G I +S L H E + + L
Sbjct: 205 SLGCILYY--------MTYGKTPFQQIINQISKLHAIIDPNHEIEFP------DIPEKDL 250
Query: 219 DDTNSPCKLMRCLEIALLCVQENPNDRPSMLQV 251
D L CL + +P R S+ ++
Sbjct: 251 QDV-----LKCCL-------KRDPKQRISIPEL 271
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-27
Identities = 61/277 (22%), Positives = 99/277 (35%), Gaps = 57/277 (20%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM----------- 54
+ A+KK+ T + +EVML A L H ++R ++ +
Sbjct: 31 SRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKST 89
Query: 55 --LVYEYMPNKSLDCYLFDPI--RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 110
+ EY N +L +D I L + + I + L Y+ IIHRDL
Sbjct: 90 LFIQMEYCENGTL----YDLIHSENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDL 142
Query: 111 KASNILLGEDMKPKISDFGLARIFAKESLEANTEQ------------VVGTIGYIPPE-Y 157
K NI + E KI DFGLA+ + + +GT Y+ E
Sbjct: 143 KPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVL 202
Query: 158 ARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV-DS 216
G Y+ K D++S G++ + M+ + + K + V
Sbjct: 203 DGTGHYNEKIDMYSLGIIFFE--------MIYPFSTG----MERVNILKKLRSVSIEFPP 250
Query: 217 SLDDTNSP--CKLMRCLEIALLCVQENPNDRPSMLQV 251
DD K++R L + +PN RP +
Sbjct: 251 DFDDNKMKVEKKIIR------LLIDHDPNKRPGARTL 281
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 51/188 (27%), Positives = 84/188 (44%), Gaps = 16/188 (8%)
Query: 6 GKVIAVK--KLSKTSTQGFEE-FKNEVMLTAKLQHVNLIRVL--GFCIDSEERM--LVYE 58
+ +AVK + F F+ E A L H ++ V G + +V E
Sbjct: 37 HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 96
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYS-RLTIIHRDLKASNILL 117
Y+ +L + + K+ + +I Q L +S + IIHRD+K +NI++
Sbjct: 97 YVDGVTLRDIV---HTEGPMTPKRAIEVIADACQAL----NFSHQNGIIHRDVKPANIMI 149
Query: 118 GEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
K+ DFG+AR A T V+GT Y+ PE AR +SDV+S G +L
Sbjct: 150 SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVL 209
Query: 177 LQIISGKR 184
++++G+
Sbjct: 210 YEVLTGEP 217
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 37/185 (20%), Positives = 75/185 (40%), Gaps = 22/185 (11%)
Query: 6 GKVIAVKKLSKTSTQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERM-----LVYEY 59
G+ + +K L + + E A++ H +++++ F ++ +V EY
Sbjct: 106 GRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEY 165
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
+ +SL L + + + I L YL + +++ DLK NI+L E
Sbjct: 166 VGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTE 217
Query: 120 DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQI 179
+ + K+ D G + + + GT G+ PE R G + +D+++ G L +
Sbjct: 218 E-QLKLIDLGAVS-----RINS-FGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAAL 269
Query: 180 ISGKR 184
Sbjct: 270 TLDLP 274
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 40/183 (21%), Positives = 78/183 (42%), Gaps = 12/183 (6%)
Query: 6 GKVIAVKKLSK--TSTQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
+++A+K +S+ +S F + E +LQ +++ + F + + +
Sbjct: 59 ERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLING 118
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYS-RLTIIHRDLKASNILLGEDM 121
L L R+ L + V I+ I L + + HRD+K NIL+ D
Sbjct: 119 VDLAAML---RRQGPLAPPRAVAIVRQIGSAL----DAAHAAGATHRDVKPENILVSADD 171
Query: 122 KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
+ DFG+A E L VGT+ Y+ PE + + ++D+++ +L + ++
Sbjct: 172 FAYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLT 230
Query: 182 GKR 184
G
Sbjct: 231 GSP 233
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-25
Identities = 55/280 (19%), Positives = 100/280 (35%), Gaps = 59/280 (21%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEV-MLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
G+ +AVK++ + E+ +LT H N+IR + E
Sbjct: 39 GRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC---- 91
Query: 65 LDCYLFDPI--------RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNIL 116
+ L D + + + ++ I G+ +L L IIHRDLK NIL
Sbjct: 92 -NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNIL 147
Query: 117 L-------------GEDMKPKISDFGLARIFA--KESLEANTEQVVGTIGYIPPE----- 156
+ E+++ ISDFGL + + S N GT G+ PE
Sbjct: 148 VSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEES 207
Query: 157 --YARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV 214
+ + D+FS G + I+S + + +I+ + L + +
Sbjct: 208 NNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSL-------DEM 260
Query: 215 DSSLDDTNSP-CK--LMRCLEIALLCVQENPNDRPSMLQV 251
D + + + ++ +P RP+ ++V
Sbjct: 261 KCLHDRSLIAEATDLISQMIDH-------DPLKRPTAMKV 293
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 57/249 (22%), Positives = 106/249 (42%), Gaps = 30/249 (12%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
IA+K++ + ++ + E+ L L+H N+++ LG ++ + E +P SL
Sbjct: 47 QVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL 106
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM-KPK 124
L L + + + I +GL YL + I+HRD+K N+L+ K
Sbjct: 107 SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLK 163
Query: 125 ISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV--YSTKSDVFSFGVLLLQIISG 182
ISDFG ++ A + T GT+ Y+ PE +G Y +D++S G ++++ +G
Sbjct: 164 ISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG 221
Query: 183 KRLSMLCGINENLSILEHAYE-LWKGGKGVEFVDSSLDDTNSP-CK--LMRCLEIALLCV 238
K L ++K G + ++ S K +++C E
Sbjct: 222 KP---------PFYELGEPQAAMFKVGMFKV--HPEIPESMSAEAKAFILKCFEP----- 265
Query: 239 QENPNDRPS 247
+P+ R
Sbjct: 266 --DPDKRAC 272
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-25
Identities = 50/188 (26%), Positives = 83/188 (44%), Gaps = 25/188 (13%)
Query: 6 GKVIAVKKLSKTS--TQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMP 61
+V A K + K+ E E+ + L H +++ G + + + +V E
Sbjct: 66 KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG-FFEDNDFVFVVLELCR 124
Query: 62 NKSLDCYLFDPIRRLILDWKKRV------HIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
+SL + +R +K + + + I G YL R +IHRDLK N+
Sbjct: 125 RRSL----LELHKR-----RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNL 172
Query: 116 LLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVL 175
L ED++ KI DFGLA + + GT YI PE + +S + DV+S G +
Sbjct: 173 FLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSFEVDVWSIGCI 230
Query: 176 LLQIISGK 183
+ ++ GK
Sbjct: 231 MYTLLVGK 238
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-25
Identities = 43/178 (24%), Positives = 72/178 (40%), Gaps = 17/178 (9%)
Query: 7 KVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLD 66
K++ V K + + E+ K E + L+H +++ +L +V+E+M
Sbjct: 55 KIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGAD-- 112
Query: 67 CYLFDPIRRLILDW-----KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---G 118
L I + H + I + L Y + IIHRD+K +LL
Sbjct: 113 --LCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKE 167
Query: 119 EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
K+ FG+A + L A VGT ++ PE ++ Y DV+ GV+L
Sbjct: 168 NSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-25
Identities = 50/191 (26%), Positives = 83/191 (43%), Gaps = 25/191 (13%)
Query: 3 LPCGKVIAVKKLSKTS--TQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYE 58
+V A K + K+ E E+ + L H +++ G + + + +V E
Sbjct: 37 ADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG-FFEDNDFVFVVLE 95
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRV------HIIEGITQGLLYLQEYSRLTIIHRDLKA 112
+SL + +R +K + + + I G YL R +IHRDLK
Sbjct: 96 LCRRRSL----LELHKR-----RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKL 143
Query: 113 SNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSF 172
N+ L ED++ KI DFGLA + + GT YI PE + +S + DV+S
Sbjct: 144 GNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSFEVDVWSI 201
Query: 173 GVLLLQIISGK 183
G ++ ++ GK
Sbjct: 202 GCIMYTLLVGK 212
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 61/270 (22%), Positives = 105/270 (38%), Gaps = 50/270 (18%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM----LVYEYMP 61
G A+K++ Q EE + E + H N++R++ +C+ L+ +
Sbjct: 54 GHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFK 113
Query: 62 NKSLDCYLFDPIRRLILDWKKR------VHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
+L ++ I RL D + ++ GI +GL + HRDLK +NI
Sbjct: 114 RGTL----WNEIERL-KDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNI 165
Query: 116 LLGEDMKPKISDFGLARIFAKE---SLEANTEQ----VVGTIGYIPPE---YARQGVYST 165
LLG++ +P + D G S +A T Q TI Y PE V
Sbjct: 166 LLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDE 225
Query: 166 KSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE--LWKGGKGVEFVDSSLDDTNS 223
++DV+S G +L ++ G+ Y+ KG V + L S
Sbjct: 226 RTDVWSLGCVLYAMMFGE----------------GPYDMVFQKGDSVALAVQNQLSIPQS 269
Query: 224 PC--KLMRCLEIALLCVQENPNDRPSMLQV 251
P + L +++ +P+ RP + +
Sbjct: 270 PRHSSALWQLLNSMM--TVDPHQRPHIPLL 297
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 65/281 (23%), Positives = 104/281 (37%), Gaps = 27/281 (9%)
Query: 6 GKVIAVKKLSKTSTQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERM-------LVY 57
G+ +A+K+ + + E + E+ + KL H N++ D +++ L
Sbjct: 39 GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS-AREVPDGLQKLAPNDLPLLAM 97
Query: 58 EYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
EY L YL L ++ I+ L YL E IIHRDLK NI+L
Sbjct: 98 EYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVL 154
Query: 118 ---GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGV 174
+ + KI D G A+ + L + VGT+ Y+ PE Q Y+ D +SFG
Sbjct: 155 QPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGT 211
Query: 175 LLLQIISGKR------LSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLM 228
L + I+G R + EH V+F S L N ++
Sbjct: 212 LAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFS-SVLPTPNHLSGIL 270
Query: 229 RCLEIALLCV--QENPNDRPSMLQVSSMLKNETTNRNTPKK 267
L + R + Q ++ + + K
Sbjct: 271 AGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 45/266 (16%), Positives = 95/266 (35%), Gaps = 36/266 (13%)
Query: 7 KVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVY---EYMPNK 63
++ + + + ++ + +G S ++ +Y + +
Sbjct: 87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKE 146
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
+L ++ + +HI I + + +L ++HRDLK SNI D
Sbjct: 147 NLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFL---HSKGLMHRDLKPSNIFFTMDDVV 203
Query: 124 KISDFGLARIFAKESLEANTEQV----------VGTIGYIPPEYARQGVYSTKSDVFSFG 173
K+ DFGL ++ E VGT Y+ PE YS K D+FS G
Sbjct: 204 KVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLG 263
Query: 174 VLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEI 233
++L +++ M E + I+ ++ +F +++
Sbjct: 264 LILFELLYSFSTQM-----ERVRIIT---DVRNL----KFPLLFTQKYPQEHMMVQ---- 307
Query: 234 ALLCVQENPNDRPSMLQV--SSMLKN 257
+ +P +RP + +++ +N
Sbjct: 308 --DMLSPSPTERPEATDIIENAIFEN 331
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-24
Identities = 56/181 (30%), Positives = 94/181 (51%), Gaps = 10/181 (5%)
Query: 6 GKVIAVKKLSKTS--TQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
G +A+K + K + G + +NEV + +L+H +++ + + DS LV E N
Sbjct: 36 GLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN 95
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
++ YL + ++ + + R H + I G+LYL + I+HRDL SN+LL +M
Sbjct: 96 GEMNRYLKNRVKPF-SENEAR-HFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMN 150
Query: 123 PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
KI+DFGLA + T + GT YI PE A + + +SDV+S G + ++ G
Sbjct: 151 IKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIG 208
Query: 183 K 183
+
Sbjct: 209 R 209
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-24
Identities = 44/193 (22%), Positives = 79/193 (40%), Gaps = 21/193 (10%)
Query: 6 GKVIAVKKLSKTSTQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERM--LVYEYMPN 62
G + A+K + S + E + KL H N++++ ++ R L+ E+ P
Sbjct: 34 GDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG---- 118
SL L +P L + + ++ + G+ +L+E I+HR++K NI+
Sbjct: 94 GSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGED 150
Query: 119 EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE--------YARQGVYSTKSDVF 170
K++DFG AR + + GT Y+ P+ Q Y D++
Sbjct: 151 GQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLW 207
Query: 171 SFGVLLLQIISGK 183
S GV +G
Sbjct: 208 SIGVTFYHAATGS 220
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 9e-24
Identities = 44/193 (22%), Positives = 79/193 (40%), Gaps = 21/193 (10%)
Query: 6 GKVIAVKKLSKTSTQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERM--LVYEYMPN 62
G + A+K + S + E + KL H N++++ ++ R L+ E+ P
Sbjct: 34 GDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG---- 118
SL L +P L + + ++ + G+ +L+E I+HR++K NI+
Sbjct: 94 GSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGED 150
Query: 119 EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE--------YARQGVYSTKSDVF 170
K++DFG AR + + GT Y+ P+ Q Y D++
Sbjct: 151 GQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLW 207
Query: 171 SFGVLLLQIISGK 183
S GV +G
Sbjct: 208 SIGVTFYHAATGS 220
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-23
Identities = 49/182 (26%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 6 GKVIAVKKLSKTSTQGF---EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
++A+K L K + + + EV + + L+H N++R+ G+ D+ L+ EY P
Sbjct: 34 KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 93
Query: 63 KSLDCYLFDPIRRL-ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
++ + +++L D ++ I + L Y +IHRD+K N+LLG
Sbjct: 94 GTV----YRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAG 146
Query: 122 KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
+ KI+DFG + + + + GT+ Y+PPE ++ K D++S GVL + +
Sbjct: 147 ELKIADFGW----SVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 202
Query: 182 GK 183
GK
Sbjct: 203 GK 204
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-23
Identities = 58/188 (30%), Positives = 87/188 (46%), Gaps = 23/188 (12%)
Query: 6 GKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
A+K + KT ST + EV + L H N++++ F D LV E
Sbjct: 62 HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC---- 117
Query: 64 SLDCY---LFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL-- 117
LFD I R+ + II+ + G+ YL + I+HRDLK N+LL
Sbjct: 118 ---YKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLES 171
Query: 118 -GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
+D KI DFGL+ +F + ++ +GT YI PE + Y K DV+S GV+L
Sbjct: 172 KEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVIL 227
Query: 177 LQIISGKR 184
+++G
Sbjct: 228 FILLAGYP 235
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 98.2 bits (244), Expect = 1e-23
Identities = 32/287 (11%), Positives = 67/287 (23%), Gaps = 64/287 (22%)
Query: 6 GKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFC--------------- 47
+ A+K + S E A+L +
Sbjct: 87 LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146
Query: 48 -----IDSEERMLVYEY---MPNKSLD-CYLFDPIRRLI-----LDWKKRVHIIEGITQG 93
++ V Y MP S+D LF + + + + +
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206
Query: 94 LLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYI 153
LQ ++H N+ + D + + D + + Y
Sbjct: 207 AANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW-----KVGTRGPASSVPVTYA 258
Query: 154 PPEY--ARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG-----INENLSILEHAYELWK 206
P E+ A ++ + + G+ + + + C + +
Sbjct: 259 PREFLNASTATFTHALNAWQLGLSIYR--------VWCLFLPFGLVTPGIKGSWKRPSLR 310
Query: 207 GGKGVEFVDSSLDDTNSPCK--LMRCLEIALLCVQENPNDRPSMLQV 251
S K + R L + R L+
Sbjct: 311 VPGTDSLAFGSCTPLPDFVKTLIGRFL-------NFDRRRRLLPLEA 350
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-23
Identities = 50/175 (28%), Positives = 81/175 (46%), Gaps = 15/175 (8%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
GK+ A+K + K+ +NE+ + K++H N++ + + LV + +
Sbjct: 34 GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVS---- 89
Query: 66 DCYLFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GEDM 121
LFD I R + K +I+ + + YL E I+HRDLK N+L E+
Sbjct: 90 GGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENS 146
Query: 122 KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
K I+DFGL+++ + GT GY+ PE Q YS D +S GV+
Sbjct: 147 KIMITDFGLSKMEQNGIMS----TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-23
Identities = 48/184 (26%), Positives = 77/184 (41%), Gaps = 21/184 (11%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
A KK+ K + + FK E+ + L H N+IR+ D+ + LV E
Sbjct: 34 RIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL------ 87
Query: 66 DCY---LFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---G 118
C LF+ + + + I++ + + Y + L + HRDLK N L
Sbjct: 88 -CTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDS 143
Query: 119 EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
D K+ DFGLA F + VGT Y+ P+ Y + D +S GV++
Sbjct: 144 PDSPLKLIDFGLAARFKPGKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYV 199
Query: 179 IISG 182
++ G
Sbjct: 200 LLCG 203
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 4e-23
Identities = 43/189 (22%), Positives = 80/189 (42%), Gaps = 26/189 (13%)
Query: 6 GKVIAVKKLSKTSTQG-FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
G +K ++K +Q E+ + E+ + L H N+I++ D +V E
Sbjct: 47 GLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGE 106
Query: 65 LDCYLFDPIRRLILDWKKRVH--------IIEGITQGLLYLQEYSRLTIIHRDLKASNIL 116
L + R++ + +++ + L Y ++H+DLK NIL
Sbjct: 107 L----LE---RIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENIL 156
Query: 117 L---GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFG 173
KI DFGLA +F + + GT Y+ PE ++ + K D++S G
Sbjct: 157 FQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPEVFKRD-VTFKCDIWSAG 212
Query: 174 VLLLQIISG 182
V++ +++G
Sbjct: 213 VVMYFLLTG 221
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-23
Identities = 47/178 (26%), Positives = 90/178 (50%), Gaps = 9/178 (5%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+ +A+++++ E NE+++ + ++ N++ L + +E +V EY+ SL
Sbjct: 45 GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D + +D + + Q L +L +IHRD+K+ NILLG D K+
Sbjct: 105 T----DVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 157
Query: 126 SDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
+DFG E + +T +VGT ++ PE + Y K D++S G++ +++I G+
Sbjct: 158 TDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 5e-23
Identities = 41/178 (23%), Positives = 72/178 (40%), Gaps = 20/178 (11%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+V K ++ KNE+ + +L H LI + D E +L+ E+
Sbjct: 76 GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF------ 129
Query: 66 DCY---LFDPI--RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG-- 118
LFD I + + ++ + +GL ++ E +I+H D+K NI+
Sbjct: 130 -LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETK 185
Query: 119 EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
+ KI DFGLA + + T + PE + +D+++ GVL
Sbjct: 186 KASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 5e-23
Identities = 69/262 (26%), Positives = 97/262 (37%), Gaps = 49/262 (18%)
Query: 6 GKVIAVKKLSK---TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
G+ AVK +SK E EV L +L H N++++ F D LV E
Sbjct: 51 GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEV--- 107
Query: 63 KSLDCY---LFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL- 117
LFD I R II + G+ Y+ + I+HRDLK N+LL
Sbjct: 108 ----YTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLE 160
Query: 118 --GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVL 175
+D +I DFGL+ F + +GT YI PE G Y K DV+S GV+
Sbjct: 161 SKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVI 216
Query: 176 LLQIISGKRLSMLCGI----NENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCK--LMR 229
L +L G N + + + GK F + K + +
Sbjct: 217 LYI--------LLSGCPPFNGANEYDI---LKKVEKGK-YTFELPQWKKVSESAKDLIRK 264
Query: 230 CLEIALLCVQENPNDRPSMLQV 251
L P+ R S
Sbjct: 265 MLTY-------VPSMRISARDA 279
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 6e-23
Identities = 49/178 (27%), Positives = 98/178 (55%), Gaps = 9/178 (5%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+ +AVK + Q E NEV++ QH N++ + + EE ++ E++ +L
Sbjct: 70 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGAL 129
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D + ++ L+ ++ + E + Q L YL +IHRD+K+ +ILL D + K+
Sbjct: 130 T----DIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKL 182
Query: 126 SDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
SDFG +K+ + + +VGT ++ PE + +Y+T+ D++S G+++++++ G+
Sbjct: 183 SDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 6e-23
Identities = 39/178 (21%), Positives = 70/178 (39%), Gaps = 20/178 (11%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G A K + E + E+ + L+H L+ + D E +++YE+
Sbjct: 182 GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF------ 235
Query: 66 DCY---LFDPI--RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG-- 118
LF+ + + + V + + +GL ++ E +H DLK NI+
Sbjct: 236 -MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTK 291
Query: 119 EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
+ K+ DFGL + + + GT + PE A +D++S GVL
Sbjct: 292 RSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 7e-23
Identities = 60/183 (32%), Positives = 86/183 (46%), Gaps = 17/183 (9%)
Query: 6 GKVIAVKKLSKTSTQG--FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
+ AVK ++K S + EV L KL H N++++ DS +V E
Sbjct: 47 QQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG 106
Query: 64 SLDCYLFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GE 119
LFD I +R II+ + G+ Y+ + I+HRDLK NILL +
Sbjct: 107 E----LFDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEK 159
Query: 120 DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQI 179
D KI DFGL+ F + + + +GT YI PE R Y K DV+S GV+L +
Sbjct: 160 DCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYIL 215
Query: 180 ISG 182
+SG
Sbjct: 216 LSG 218
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 7e-23
Identities = 58/250 (23%), Positives = 95/250 (38%), Gaps = 17/250 (6%)
Query: 4 PCGKVIAVKKLSKTSTQG-FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
P G V+A K + + E+ + + ++ G E + E+M
Sbjct: 56 PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 115
Query: 63 KSLDCYL--FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
SLD L I IL + + +GL YL + I+HRD+K SNIL+
Sbjct: 116 GSLDQVLKKAGRIPEQIL-----GKVSIAVIKGLTYL--REKHKIMHRDVKPSNILVNSR 168
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
+ K+ DFG++ +S+ AN+ VGT Y+ PE + YS +SD++S G+ L+++
Sbjct: 169 GEIKLCDFGVSGQLI-DSM-ANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 224
Query: 181 SGK---RLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237
G+ + + M E+
Sbjct: 225 VGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYI 284
Query: 238 VQENPNDRPS 247
V E P PS
Sbjct: 285 VNEPPPKLPS 294
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-22
Identities = 49/178 (27%), Positives = 79/178 (44%), Gaps = 20/178 (11%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G +A K + + EE KNE+ + +L H NLI++ + +LV EY
Sbjct: 114 GLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY------ 167
Query: 66 DCY---LFDPI--RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG-- 118
LFD I L + ++ I +G+ ++ + + I+H DLK NIL
Sbjct: 168 -VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNR 223
Query: 119 EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
+ + KI DFGLAR + + GT ++ PE S +D++S GV+
Sbjct: 224 DAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-22
Identities = 45/251 (17%), Positives = 80/251 (31%), Gaps = 39/251 (15%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G AVKK+ + E++ A L ++ + G + + E + SL
Sbjct: 83 GFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137
Query: 66 DCYL--FDPIR-RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED-M 121
+ + L + + +GL YL I+H D+KA N+LL D
Sbjct: 138 GQLIKQMGCLPEDRAL------YYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGS 188
Query: 122 KPKISDFGLARIFAKESLEANTEQ---VVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
+ + DFG A + L + + GT ++ PE K D++S ++L
Sbjct: 189 RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLH 248
Query: 179 IISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCK--LMRCLEIALL 236
+++G + K + + L
Sbjct: 249 MLNGCH---------PWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRK--- 296
Query: 237 CVQENPNDRPS 247
P R S
Sbjct: 297 ----EPVHRAS 303
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-22
Identities = 44/187 (23%), Positives = 71/187 (37%), Gaps = 21/187 (11%)
Query: 6 GKVIAVKKLSKT--STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPN 62
G++ AVK+ + EV K+ QH +R+ + L E
Sbjct: 82 GRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-G 140
Query: 63 KSLDCYLFDPIRRL----ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
SL + L + + + + L +L ++H D+K +NI LG
Sbjct: 141 PSLQQHCEAWGASLPEAQVWGY-----LRD-TLLALAHLHSQG---LVHLDVKPANIFLG 191
Query: 119 EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
+ K+ DFGL + G Y+ PE QG Y T +DVFS G+ +L+
Sbjct: 192 PRGRCKLGDFGLLVELGTAGA-GEVQ--EGDPRYMAPE-LLQGSYGTAADVFSLGLTILE 247
Query: 179 IISGKRL 185
+ L
Sbjct: 248 VACNMEL 254
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-22
Identities = 59/299 (19%), Positives = 101/299 (33%), Gaps = 51/299 (17%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERM-------LVY 57
G+ A+K+L + EV KL H N+++ +E L+
Sbjct: 53 GREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLL 112
Query: 58 EYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
+ L +L R L + I + + ++ + IIHRDLK N+LL
Sbjct: 113 TELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLL 171
Query: 118 GEDMKPKISDFGLARIFAKESLEANTEQ----------VVGTIGYIPPE---YARQGVYS 164
K+ DFG A + + + Q T Y PE
Sbjct: 172 SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIG 231
Query: 165 TKSDVFSFGVLLLQIISGKRLSMLCGI-----NENLSILEHAYELWKGGKGVEFVDSSLD 219
K D+++ G +L + L I+ Y S+
Sbjct: 232 EKQDIWALGCIL--------YLLCFRQHPFEDGAKLRIVNGKY--------------SIP 269
Query: 220 DTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSMLKNETTNRNTPKKPAFSKQVDEIG 278
++ + L A+L Q NP +R S+ +V L+ RN K ++ +++ G
Sbjct: 270 PHDTQYTVFHSLIRAML--QVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNG 326
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-22
Identities = 45/195 (23%), Positives = 84/195 (43%), Gaps = 30/195 (15%)
Query: 6 GKVIAVKKLSKT-----------------STQGFEEFKNEVMLTAKLQHVNLIRVLGFCI 48
K A+KK K+ +++FKNE+ + +++ + G
Sbjct: 54 NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIIT 113
Query: 49 DSEERMLVYEYMPNKSLDCYL-----FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRL 103
+ +E ++YEYM N S+ + D + + II+ + Y+ ++
Sbjct: 114 NYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYI--HNEK 171
Query: 104 TIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE--YARQG 161
I HRD+K SNIL+ ++ + K+SDFG + + ++ GT ++PPE
Sbjct: 172 NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK--G--SRGTYEFMPPEFFSNESS 227
Query: 162 VYSTKSDVFSFGVLL 176
K D++S G+ L
Sbjct: 228 YNGAKVDIWSLGICL 242
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-22
Identities = 59/186 (31%), Positives = 86/186 (46%), Gaps = 23/186 (12%)
Query: 6 GKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
+ AVK ++K + EV L KL H N++++ DS +V E
Sbjct: 47 QQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL---- 102
Query: 64 SLDCY---LFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL-- 117
LFD I +R II+ + G+ Y+ + I+HRDLK NILL
Sbjct: 103 ---YTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLES 156
Query: 118 -GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
+D KI DFGL+ F + + + +GT YI PE +G Y K DV+S GV+L
Sbjct: 157 KEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212
Query: 177 LQIISG 182
++SG
Sbjct: 213 YILLSG 218
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 3e-22
Identities = 61/297 (20%), Positives = 97/297 (32%), Gaps = 77/297 (25%)
Query: 7 KVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLD 66
K++ K+ + + + E K EV L KL H N+ R+ D + LV E L
Sbjct: 57 KIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHL- 115
Query: 67 CYLFDPIRRLILDWKKRV-----------------------------------------H 85
D + I D + +
Sbjct: 116 ---LDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISN 172
Query: 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLG--EDMKPKISDFGLARIFAKESLEANT 143
I+ I L YL I HRD+K N L + + K+ DFGL++ F K +
Sbjct: 173 IMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYY 229
Query: 144 E--QVVGTIGYIPPEYARQGV--YSTKSDVFSFGVLLLQIISGKRLSMLCGI----NENL 195
GT ++ PE Y K D +S GVLL +L G N
Sbjct: 230 GMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL--------HLLLMGAVPFPGVND 281
Query: 196 SILEHAYELWKGGKGVEFVDSSLDDTNSPCK-LMRCLEIALLCVQENPNDRPSMLQV 251
+ K + F + + + + + L+ LL N ++R ++
Sbjct: 282 ADT---ISQVLNKK-LCFENPNYNVLSPLARDLLSN----LLNR--NVDERFDAMRA 328
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-22
Identities = 42/176 (23%), Positives = 74/176 (42%), Gaps = 16/176 (9%)
Query: 7 KVIAVKKL-SKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
K I ++ + EE + EV + ++ H N+I + + + +L+ E + L
Sbjct: 43 KFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL 102
Query: 66 DCYLFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL----GED 120
FD + ++ L ++ I+ I G+ YL I H DLK NI+L
Sbjct: 103 ----FDFLAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPI 155
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
K+ DFGLA + + GT ++ PE ++D++S GV+
Sbjct: 156 PHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 4e-22
Identities = 50/174 (28%), Positives = 79/174 (45%), Gaps = 17/174 (9%)
Query: 7 KVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLD 66
K+I KKLS F++ + E + KLQH N++R+ + LV++ + L
Sbjct: 37 KIINTKKLSARD---FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL- 92
Query: 67 CYLFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GEDMK 122
F+ I R H I+ I + + Y I+HR+LK N+LL +
Sbjct: 93 ---FEDIVAREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAA 146
Query: 123 PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
K++DFGLA GT GY+ PE ++ YS D+++ GV+L
Sbjct: 147 VKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-22
Identities = 50/174 (28%), Positives = 79/174 (45%), Gaps = 17/174 (9%)
Query: 7 KVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLD 66
K+I KKLS F++ + E + KLQH N++R+ + LV++ + L
Sbjct: 60 KIINTKKLSARD---FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL- 115
Query: 67 CYLFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GEDMK 122
F+ I R H I+ I + + Y I+HR+LK N+LL +
Sbjct: 116 ---FEDIVAREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAA 169
Query: 123 PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
K++DFGLA GT GY+ PE ++ YS D+++ GV+L
Sbjct: 170 VKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 7e-22
Identities = 42/176 (23%), Positives = 73/176 (41%), Gaps = 16/176 (9%)
Query: 7 KVIAVKKLS-KTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
K I ++ EE + EV + ++ H N+I + + + +L+ E + L
Sbjct: 43 KFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGEL 102
Query: 66 DCYLFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL----GED 120
FD + ++ L ++ I+ I G+ YL I H DLK NI+L
Sbjct: 103 ----FDFLAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPI 155
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
K+ DFGLA + + GT ++ PE ++D++S GV+
Sbjct: 156 PHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-21
Identities = 48/187 (25%), Positives = 86/187 (45%), Gaps = 25/187 (13%)
Query: 6 GKVIAVKKLSKT--STQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
++A+K L K+ +G E + E+ + + L+H N++R+ + D + L+ E+ P
Sbjct: 39 KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR 98
Query: 63 KSLDCYLFDPIRRLILDWKKRV------HIIEGITQGLLYLQEYSRLTIIHRDLKASNIL 116
L + +++ R +E + L Y +IHRD+K N+L
Sbjct: 99 GEL----YKELQK-----HGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLL 146
Query: 117 LGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
+G + KI+DFG + SL T + GT+ Y+PPE + K D++ GVL
Sbjct: 147 MGYKGELKIADFGWSVH--APSLRRRT--MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLC 202
Query: 177 LQIISGK 183
+ + G
Sbjct: 203 YEFLVGM 209
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-21
Identities = 42/179 (23%), Positives = 77/179 (43%), Gaps = 22/179 (12%)
Query: 7 KVIAVKKLSKTSTQG-FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
K I ++LS + EE + EV + +++H N+I + + + +L+ E
Sbjct: 36 KFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILEL------ 89
Query: 66 DCY---LFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---- 117
LFD + + L + ++ I G+ YL I H DLK NI+L
Sbjct: 90 -VSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKN 145
Query: 118 GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
+ + K+ DFG+A + + + GT ++ PE ++D++S GV+
Sbjct: 146 VPNPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-21
Identities = 37/178 (20%), Positives = 68/178 (38%), Gaps = 21/178 (11%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
K K + K E+ + +H N++ + EE ++++E+
Sbjct: 30 KKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF------ 82
Query: 66 DCY---LFDPI--RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG-- 118
+F+ I L+ ++ V + + + L +L I H D++ NI+
Sbjct: 83 -ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTR 138
Query: 119 EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
KI +FG AR K + Y PE + V ST +D++S G L+
Sbjct: 139 RSSTIKIIEFGQARQL-KPGDNFRL--LFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-21
Identities = 48/179 (26%), Positives = 90/179 (50%), Gaps = 10/179 (5%)
Query: 6 GKVIAVKKLSKTSTQG-FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
KV+A+K + + E+ + E+ + ++ + + G + + ++ EY+ S
Sbjct: 47 QKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 106
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
D + LD + I+ I +GL YL IHRD+KA+N+LL E + K
Sbjct: 107 AL----DLLEPGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVK 159
Query: 125 ISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
++DFG+A ++ NT VGT ++ PE +Q Y +K+D++S G+ +++ G+
Sbjct: 160 LADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-21
Identities = 44/179 (24%), Positives = 76/179 (42%), Gaps = 22/179 (12%)
Query: 7 KVIAVKKL-SKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
K I ++ S E+ + EV + ++QH N+I + + + +L+ E
Sbjct: 42 KFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL------ 95
Query: 66 DCY---LFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---- 117
LFD + + L ++ ++ I G+ YL L I H DLK NI+L
Sbjct: 96 -VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRN 151
Query: 118 GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
+ KI DFGLA + + + GT ++ PE ++D++S GV+
Sbjct: 152 VPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 92.0 bits (228), Expect = 3e-21
Identities = 25/223 (11%), Positives = 63/223 (28%), Gaps = 50/223 (22%)
Query: 6 GKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHV----------------NLIRVLGF 46
G+ V T + ++ K EV+ L+ + +L++
Sbjct: 103 GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162
Query: 47 C------IDSEERMLVYEYMPNKSLDCYLFDPIRRLI--------LDWKKRVHIIEGITQ 92
+D + ++ + + L L+ L R+ + + +
Sbjct: 163 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 222
Query: 93 GLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGY 152
L L Y ++H L+ +I+L + ++ F S + +
Sbjct: 223 LLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR-DGASAVSPIGRGFAPPET 278
Query: 153 IPPEYAR-----QGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190
+ + D ++ G+ + + C
Sbjct: 279 TAERMLPFGQHHPTLMTFAFDTWTLGLAIYW--------IWCA 313
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-21
Identities = 45/174 (25%), Positives = 79/174 (45%), Gaps = 16/174 (9%)
Query: 7 KVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLD 66
+I KKLS ++ + E + L+H N++R+ + L+++ + L
Sbjct: 42 MIINTKKLSARD---HQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL- 97
Query: 67 CYLFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GEDMK 122
F+ I R H I+ I + +L+ + + ++HR+LK N+LL +
Sbjct: 98 ---FEDIVAREYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAA 151
Query: 123 PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
K++DFGLA E GT GY+ PE R+ Y D+++ GV+L
Sbjct: 152 VKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 5e-21
Identities = 57/199 (28%), Positives = 86/199 (43%), Gaps = 34/199 (17%)
Query: 6 GKVIAVKKLSK-------------TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE 52
A+K + K + EE NE+ L L H N+I++ D +
Sbjct: 61 HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120
Query: 53 RMLVYEYMPNKSLDCY---LFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHR 108
LV E+ LF+ I R D +I++ I G+ YL + I+HR
Sbjct: 121 FYLVTEF-------YEGGELFEQIINRHKFDECDAANIMKQILSGICYLHK---HNIVHR 170
Query: 109 DLKASNILL---GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYST 165
D+K NILL + KI DFGL+ F+K+ +GT YI PE + Y+
Sbjct: 171 DIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPE-VLKKKYNE 226
Query: 166 KSDVFSFGVLLLQIISGKR 184
K DV+S GV++ ++ G
Sbjct: 227 KCDVWSCGVIMYILLCGYP 245
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 90.8 bits (225), Expect = 5e-21
Identities = 40/296 (13%), Positives = 80/296 (27%), Gaps = 86/296 (29%)
Query: 6 GKVIAVKKLSKTSTQG---FEEFKNEVMLTAKLQ-------------------------H 37
G+ V T ++ K EV+ L+
Sbjct: 98 GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157
Query: 38 VNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI-----LDWKKRVHIIEGITQ 92
+IRV D + Y +S + + L R+ + + +
Sbjct: 158 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 217
Query: 93 GLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGY 152
L L Y ++H L+ +I+L + ++ F + + G+
Sbjct: 218 LLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVV------SSVSRGF 268
Query: 153 IPPEY-----------ARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGI----NENLSI 197
PPE R+ + + D ++ G+++ + C +
Sbjct: 269 EPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW--------IWCADLPITKDAALG 320
Query: 198 LEHAYELWKGGKGVEFVDSSLDDTNSPCK--LMRCLEIALLCVQENPNDRPSMLQV 251
E++ S + P + L L + DR LQ
Sbjct: 321 G------------SEWIFRSCKNIPQPVRALLEGFL-------RYPKEDRLLPLQA 357
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 7e-21
Identities = 46/194 (23%), Positives = 88/194 (45%), Gaps = 27/194 (13%)
Query: 4 PCGKVIAVKKLSKTSTQGFEEFKNEVM----LTAKLQHVNLIRVLGFCIDSEERMLVYEY 59
P G+++AVK++ T +E K +M + + G + + E
Sbjct: 30 PSGQIMAVKRIRATVNS--QEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMEL 87
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRV------HIIEGITQGLLYLQEYSRLTIIHRDLKAS 113
M + SLD + + ++D + + I I + L +L +S+L++IHRD+K S
Sbjct: 88 M-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVKALEHL--HSKLSVIHRDVKPS 139
Query: 114 NILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE----YARQGVYSTKSDV 169
N+L+ + K+ DFG++ + + G Y+ PE Q YS KSD+
Sbjct: 140 NVLINALGQVKMCDFGISGYLVD-DVAKDI--DAGCKPYMAPERINPELNQKGYSVKSDI 196
Query: 170 FSFGVLLLQIISGK 183
+S G+ ++++ +
Sbjct: 197 WSLGITMIELAILR 210
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 8e-21
Identities = 54/194 (27%), Positives = 83/194 (42%), Gaps = 29/194 (14%)
Query: 7 KVIAVKKLSKTSTQGFEE---FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
++I+ +K + S + + + E+ + KL H +I++ F D+E+ +V E M
Sbjct: 166 RIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG 224
Query: 64 SLDCYLFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GE 119
L FD + L + + YL E IIHRDLK N+LL E
Sbjct: 225 EL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEE 277
Query: 120 DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE---YARQGVYSTKSDVFSFGVLL 176
D KI+DFG ++I + SL + GT Y+ PE Y+ D +S GV+L
Sbjct: 278 DCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
Query: 177 LQIISGKRLSMLCG 190
L G
Sbjct: 335 --------FICLSG 340
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 9e-21
Identities = 51/188 (27%), Positives = 81/188 (43%), Gaps = 27/188 (14%)
Query: 6 GKVIAVKKLSKTSTQGF---------EEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERML 55
K AVK + T F E EV + K+ H N+I++ + L
Sbjct: 42 CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101
Query: 56 VYEYMPNKSLDCYLFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
V++ M L FD + ++ L K+ I+ + + + L + L I+HRDLK N
Sbjct: 102 VFDLMKKGEL----FDYLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPEN 154
Query: 115 ILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE------YARQGVYSTKSD 168
ILL +DM K++DFG + +V GT Y+ PE Y + D
Sbjct: 155 ILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVD 211
Query: 169 VFSFGVLL 176
++S GV++
Sbjct: 212 MWSTGVIM 219
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-20
Identities = 53/190 (27%), Positives = 81/190 (42%), Gaps = 25/190 (13%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
AVK + K+ EE E++L QH N+I + D + +V E M L
Sbjct: 47 NMEFAVKIIDKSKRDPTEE--IEILLRY-GQHPNIITLKDVYDDGKYVYVVTELMKGGEL 103
Query: 66 DCYLFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GEDM 121
D I R+ ++ ++ IT+ + YL ++HRDLK SNIL +
Sbjct: 104 ----LDKILRQKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNP 156
Query: 122 KP-KISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
+ +I DFG A+ E+ T T ++ PE + Y D++S GVLL
Sbjct: 157 ESIRICDFGFAKQLRAENGLLMT--PCYTANFVAPEVLERQGYDAACDIWSLGVLL---- 210
Query: 181 SGKRLSMLCG 190
+ML G
Sbjct: 211 ----YTMLTG 216
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 3e-20
Identities = 55/287 (19%), Positives = 101/287 (35%), Gaps = 50/287 (17%)
Query: 3 LPCGKVIAVKK--LSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
P G+ + V++ L S + + E+ ++ H N++ I E +V +M
Sbjct: 49 KPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 108
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHI---IEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
S D I +D + I ++G+ + L Y+ +HR +KAS+IL+
Sbjct: 109 AYGSA----KDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGY---VHRSVKASHILI 161
Query: 118 GEDMKPKISDFGLARIFAKESLEANT-----EQVVGTIGYIPPEYARQGV--YSTKSDVF 170
D K +S + V + ++ PE +Q + Y KSD++
Sbjct: 162 SVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIY 221
Query: 171 SFGV-------------------LLLQIISGK--RLSMLCGINENLSILEHAYELWKGGK 209
S G+ +LL+ ++G L I + + + G
Sbjct: 222 SVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGL 281
Query: 210 GVEFVDSSLDDTNSPCKLMRCLE---------IALLCVQENPNDRPS 247
S+ +N + C+Q NP+ RPS
Sbjct: 282 SDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVE-QCLQRNPDARPS 327
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-20
Identities = 52/178 (29%), Positives = 80/178 (44%), Gaps = 22/178 (12%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
K A+K L KT + + + E+ + +L H N+I++ E LV E
Sbjct: 78 QKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL------ 129
Query: 66 DCY---LFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---G 118
LFD I + + ++ I + + YL E I+HRDLK N+L
Sbjct: 130 -VTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPA 185
Query: 119 EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176
D KI+DFGL++I + L + V GT GY PE R Y + D++S G++
Sbjct: 186 PDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 4e-20
Identities = 45/179 (25%), Positives = 86/179 (48%), Gaps = 11/179 (6%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+++A+K++ +E E+ + + ++++ G + + +V EY S+
Sbjct: 54 GQIVAIKQVP--VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSV 111
Query: 66 -DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
D L + I++ +GL YL IHRD+KA NILL + K
Sbjct: 112 SDIIRLRNKT---LTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAK 165
Query: 125 ISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
++DFG+A + NT V+GT ++ PE ++ Y+ +D++S G+ +++ GK
Sbjct: 166 LADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-20
Identities = 40/186 (21%), Positives = 76/186 (40%), Gaps = 31/186 (16%)
Query: 6 GKVIAVK--KLSKTSTQGFEEFKNEVMLTAKLQHV-NLIRVLGFCIDSEERMLVYEYMPN 62
G+ A K K + E +E+ + + +I + ++ E +L+ EY
Sbjct: 54 GQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEY--- 110
Query: 63 KSLDCY---LFDPIRRLILDWKKR------VHIIEGITQGLLYLQEYSRLTIIHRDLKAS 113
+F + + + + +I+ I +G+ YL + I+H DLK
Sbjct: 111 ----AAGGEIFS---LCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQ 160
Query: 114 NILL---GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVF 170
NILL KI DFG++R +++GT Y+ PE +T +D++
Sbjct: 161 NILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMW 217
Query: 171 SFGVLL 176
+ G++
Sbjct: 218 NIGIIA 223
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-20
Identities = 54/186 (29%), Positives = 79/186 (42%), Gaps = 26/186 (13%)
Query: 6 GKVIAVKKLSKTSTQGFEE--------FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVY 57
K +A+K +SK + E+ + KL H +I++ F D+E+ +V
Sbjct: 35 CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVL 93
Query: 58 EYMPNKSLDCYLFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNIL 116
E M L FD + L + + YL E IIHRDLK N+L
Sbjct: 94 ELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVL 146
Query: 117 L---GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE---YARQGVYSTKSDVF 170
L ED KI+DFG ++I + SL + GT Y+ PE Y+ D +
Sbjct: 147 LSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCW 203
Query: 171 SFGVLL 176
S GV+L
Sbjct: 204 SLGVIL 209
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 6e-20
Identities = 44/181 (24%), Positives = 81/181 (44%), Gaps = 21/181 (11%)
Query: 7 KVIAVKKLSKTSTQG---FEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPN 62
K++ V + Q E + E + ++ H ++I ++ S LV++ M
Sbjct: 125 KIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRK 184
Query: 63 KSLDCYLFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
L FD + ++ L K+ I+ + + + +L I+HRDLK NILL ++M
Sbjct: 185 GEL----FDYLTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNM 237
Query: 122 KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE------YARQGVYSTKSDVFSFGVL 175
+ ++SDFG + ++ GT GY+ PE Y + D+++ GV+
Sbjct: 238 QIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294
Query: 176 L 176
L
Sbjct: 295 L 295
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-20
Identities = 45/190 (23%), Positives = 82/190 (43%), Gaps = 25/190 (13%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKS 64
+ AVK +SK + E+ + H N++++ D LV E +
Sbjct: 36 NQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92
Query: 65 LDCYLFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GED 120
L F+ I ++ + +I+ + + ++ + + ++HRDLK N+L ++
Sbjct: 93 L----FERIKKKKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDN 145
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
++ KI DFG AR+ ++ T T+ Y PE Q Y D++S GV+L
Sbjct: 146 LEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELLNQNGYDESCDLWSLGVIL---- 199
Query: 181 SGKRLSMLCG 190
+ML G
Sbjct: 200 ----YTMLSG 205
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 8e-20
Identities = 48/207 (23%), Positives = 75/207 (36%), Gaps = 44/207 (21%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKS 64
+ AVK + K EV + + Q H N++ ++ F + + LV+E M S
Sbjct: 38 SQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS 97
Query: 65 LDCYLFDPIRRLILDWKKRVH--------IIEGITQGLLYLQEYSRLTIIHRDLKASNIL 116
+ I KR H +++ + L +L I HRDLK NIL
Sbjct: 98 I----LSHIH-------KRRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENIL 143
Query: 117 L---GEDMKPKISDFGLARIFAKESLEANTEQ-----VVGTIGYIPPE-----YARQGVY 163
+ KI DF L + G+ Y+ PE +Y
Sbjct: 144 CEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY 203
Query: 164 STKSDVFSFGVLLLQIISGKRLSMLCG 190
+ D++S GV+L I +L G
Sbjct: 204 DKRCDLWSLGVILY-I-------LLSG 222
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 8e-20
Identities = 48/191 (25%), Positives = 83/191 (43%), Gaps = 23/191 (12%)
Query: 4 PCGKVIAVKKLSKTSTQGFEEFKNEVM----LTAKLQHVNLIRVLGFCIDSEERMLVYEY 59
G VIAVK++ ++ + EE K +M + +++ G I + + + E
Sbjct: 48 KTGHVIAVKQMRRSGNK--EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105
Query: 60 MPNKSLDCYL--FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
M + PI IL + I + L YL + +IHRD+K SNILL
Sbjct: 106 MGTCAEKLKKRMQGPIPERIL-----GKMTVAIVKALYYL--KEKHGVIHRDVKPSNILL 158
Query: 118 GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE-----YARQGVYSTKSDVFSF 172
E + K+ DFG++ + G Y+ PE + Y ++DV+S
Sbjct: 159 DERGQIKLCDFGISGRLVD-DKAKDRS--AGCAAYMAPERIDPPDPTKPDYDIRADVWSL 215
Query: 173 GVLLLQIISGK 183
G+ L+++ +G+
Sbjct: 216 GISLVELATGQ 226
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-19
Identities = 54/263 (20%), Positives = 98/263 (37%), Gaps = 48/263 (18%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEV-MLTAKLQHVNLIRVLGFCIDSEERM----LVYEYM 60
G+ A+K L + + + EV +++ +L + ++ E M
Sbjct: 54 GQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECM 108
Query: 61 PNKSLDCYLFDPIRRLILDW---KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
L F I+ ++ I+ I + +L I HRD+K N+L
Sbjct: 109 EGGEL----FSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLY 161
Query: 118 ---GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGV 174
+D K++DFG A+ + +L+ T Y+ PE Y D++S GV
Sbjct: 162 TSKEKDAVLKLTDFGFAKETTQNALQ----TPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 217
Query: 175 LLLQIISGKRLSMLCGI-----NENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCK-LM 228
++ I +LCG N +I + G+ F + + + K L+
Sbjct: 218 IMY-I-------LLCGFPPFYSNTGQAISPGMKRRIRLGQ-YGFPNPEWSEVSEDAKQLI 268
Query: 229 RCLEIALLCVQENPNDRPSMLQV 251
R LL +P +R ++ Q
Sbjct: 269 RL----LLKT--DPTERLTITQF 285
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-19
Identities = 41/184 (22%), Positives = 87/184 (47%), Gaps = 14/184 (7%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G + A K + S + E++ E+ + A H ++++LG + ++ E+ P ++
Sbjct: 44 GALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV 103
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D + + R L + + + + L +L IIHRDLKA N+L+ + ++
Sbjct: 104 DAIMLELDRGLTEPQIQ--VVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRL 158
Query: 126 SDFGLARIFAKESLEANTEQVVGTIGY------IPPEYARQGVYSTKSDVFSFGVLLLQI 179
+DFG++ K + ++ +GT Y + E + Y K+D++S G+ L+++
Sbjct: 159 ADFGVSAKNLKTLQKRDS--FIGT-PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215
Query: 180 ISGK 183
+
Sbjct: 216 AQIE 219
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 85.8 bits (212), Expect = 3e-19
Identities = 22/191 (11%), Positives = 51/191 (26%), Gaps = 16/191 (8%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
+ +K + F + ++ + +LV E +L
Sbjct: 95 KQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTL 154
Query: 66 DCYL--FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
+ + ++ + + + + + IIH D+K N +LG
Sbjct: 155 LNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLE 211
Query: 124 -----------KISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSF 172
+ D G + T G+ E ++ + D F
Sbjct: 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGV 271
Query: 173 GVLLLQIISGK 183
+ ++ G
Sbjct: 272 AATVYCMLFGT 282
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 85.0 bits (210), Expect = 5e-19
Identities = 49/180 (27%), Positives = 75/180 (41%), Gaps = 33/180 (18%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGT 149
+ +G+ +L + IHRDL A NILL E KI DFGLAR + + + V
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDPDYVRKG 253
Query: 150 IGYIP-----PEYARQGVYSTKSDVFSFGVLLLQIISGKRLSML--CGINENLSILEHAY 202
+P PE VY+ +SDV+SFGVLL +I S L G+ +
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---LGASPYPGVKIDEEFCRR-- 308
Query: 203 ELWKGGKGVEFVDSSLDD-TNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSMLKNETTN 261
L +G + + + ++ + L C P+ RP+ ++ L N
Sbjct: 309 -LKEGTR--------MRAPDYTTPEM---YQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 6e-06
Identities = 28/129 (21%), Positives = 49/129 (37%), Gaps = 13/129 (10%)
Query: 7 KVIAVKKLSKTSTQG-FEEFKNEV-MLTAKLQHVNLIRVLGFCID-SEERMLVYEYMPNK 63
+ +AVK L + +T +E+ +L H+N++ +LG C M++ E+
Sbjct: 53 RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 112
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
+L YL KR + T+G + Q + I DLK +
Sbjct: 113 NLSTYL----------RSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSS 162
Query: 124 KISDFGLAR 132
S F +
Sbjct: 163 ASSGFVEEK 171
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-18
Identities = 46/194 (23%), Positives = 80/194 (41%), Gaps = 26/194 (13%)
Query: 4 PCGKVIAVKKLSKTSTQGFEEFKNEVM----LTAKLQHVNLIRVLGFCIDSEERMLVYEY 59
P G+++AVK++ T + +E K +M + +++ G + + E
Sbjct: 45 PSGQIMAVKRIRSTVDE--KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL 102
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRV------HIIEGITQGLLYLQEYSRLTIIHRDLKAS 113
M + S D + + + I + L +L L IIHRD+K S
Sbjct: 103 M-STSFD----KFYKYVYSVLDDVIPEEILGKITLATVKALNHL--KENLKIIHRDIKPS 155
Query: 114 NILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE----YARQGVYSTKSDV 169
NILL K+ DFG++ + G Y+ PE A + Y +SDV
Sbjct: 156 NILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGCRPYMAPERIDPSASRQGYDVRSDV 212
Query: 170 FSFGVLLLQIISGK 183
+S G+ L ++ +G+
Sbjct: 213 WSLGITLYELATGR 226
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-18
Identities = 59/184 (32%), Positives = 89/184 (48%), Gaps = 18/184 (9%)
Query: 6 GKVIAVKKLSKTSTQG---FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
+V+A+KK+S + Q +++ EV KL+H N I+ G + LV EY
Sbjct: 79 SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG 138
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
+ D + + L + + G QGL YL ++ +IHRD+KA NILL E
Sbjct: 139 SASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGL 192
Query: 123 PKISDFGLARIFAKESLEANTEQVVGTIGYIPPE---YARQGVYSTKSDVFSFGVLLLQI 179
K+ DFG A I A AN+ VGT ++ PE +G Y K DV+S G+ +++
Sbjct: 193 VKLGDFGSASIMAP----ANS--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246
Query: 180 ISGK 183
K
Sbjct: 247 AERK 250
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-17
Identities = 49/193 (25%), Positives = 89/193 (46%), Gaps = 17/193 (8%)
Query: 3 LPCGKVIAVKKLS-KTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMP 61
P + +A+K+++ + +E E+ ++ H N++ + +E LV + +
Sbjct: 37 APKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLS 96
Query: 62 NKSL-----DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNIL 116
S+ + +LD I+ + +GL YL + IHRD+KA NIL
Sbjct: 97 GGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNIL 153
Query: 117 LGEDMKPKISDFGLA-----RIFAKESLEANTEQVVGTIGYIPPEYARQGV-YSTKSDVF 170
LGED +I+DFG++ + T VGT ++ PE Q Y K+D++
Sbjct: 154 LGEDGSVQIADFGVSAFLATGGDITRNKVRKT--FVGTPCWMAPEVMEQVRGYDFKADIW 211
Query: 171 SFGVLLLQIISGK 183
SFG+ +++ +G
Sbjct: 212 SFGITAIELATGA 224
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-17
Identities = 52/199 (26%), Positives = 96/199 (48%), Gaps = 29/199 (14%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKN--------EVMLTAKLQHVNLIRVLGFCIDSEERMLVY 57
G+++A+K++ + E+ L +L H N++ ++ LV+
Sbjct: 45 GRIVALKRIR------LDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98
Query: 58 EYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
E+M K L L + L K + + +G+ + ++ I+HRDLK N+L+
Sbjct: 99 EFME-KDLKKVLDENKTGLQDSQIK--IYLYQLLRGVAHCHQHR---ILHRDLKPQNLLI 152
Query: 118 GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGV 174
D K++DFGLAR F + + T +VV T+ Y P+ +++ YST D++S G
Sbjct: 153 NSDGALKLADFGLARAFGIP-VRSYTHEVV-TLWYRAPDVLMGSKK--YSTSVDIWSIGC 208
Query: 175 LLLQIISGKRLSMLCGINE 193
+ ++I+GK L G+ +
Sbjct: 209 IFAEMITGKPL--FPGVTD 225
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 3e-17
Identities = 49/199 (24%), Positives = 95/199 (47%), Gaps = 29/199 (14%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKN--------EVMLTAKLQHVNLIRVLGFCIDSEERMLVY 57
G+ A+KK+ E+ E+ + +L+H N++++ + +LV+
Sbjct: 26 GETFALKKIR------LEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79
Query: 58 EYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
E++ + L L L K + + G+ Y + ++HRDLK N+L+
Sbjct: 80 EHLD-QDLKKLLDVCEGGLESVTAK--SFLLQLLNGIAYCHDRR---VLHRDLKPQNLLI 133
Query: 118 GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGV 174
+ + KI+DFGLAR F + T ++V T+ Y P+ +++ YST D++S G
Sbjct: 134 NREGELKIADFGLARAFGIP-VRKYTHEIV-TLWYRAPDVLMGSKK--YSTTIDIWSVGC 189
Query: 175 LLLQIISGKRLSMLCGINE 193
+ ++++G L G++E
Sbjct: 190 IFAEMVNGTPL--FPGVSE 206
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 4e-17
Identities = 54/186 (29%), Positives = 87/186 (46%), Gaps = 18/186 (9%)
Query: 6 GKVIAVKKLSKTSTQGFEE-FKN----EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
+++A+KK+ ++ E+ L +L H N+I +L LV+++M
Sbjct: 35 NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 94
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
L+ + D L K + QGL YL ++ I+HRDLK +N+LL E+
Sbjct: 95 E-TDLEVIIKDNSLVLTPSHIK--AYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDEN 148
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGVLLL 177
K++DFGLA+ F A T QVV T Y PE AR Y D+++ G +L
Sbjct: 149 GVLKLADFGLAKSFGSP-NRAYTHQVV-TRWYRAPELLFGARM--YGVGVDMWAVGCILA 204
Query: 178 QIISGK 183
+++
Sbjct: 205 ELLLRV 210
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 5e-17
Identities = 44/179 (24%), Positives = 86/179 (48%), Gaps = 27/179 (15%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKN--------EVMLTAKLQHVNLIRVLGFCIDSEERMLVY 57
+++A+K++ ++ E+ L +L+H N++R+ ++ LV+
Sbjct: 27 HEIVALKRVR------LDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80
Query: 58 EYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
E+ + L Y L + K + + +GL + + ++HRDLK N+L+
Sbjct: 81 EFCD-QDLKKYFDSCNGDLDPEIVK--SFLFQLLKGLGFCHSRN---VLHRDLKPQNLLI 134
Query: 118 GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFG 173
+ + K+++FGLAR F + + +VV T+ Y PP+ A+ YST D++S G
Sbjct: 135 NRNGELKLANFGLARAFGIP-VRCYSAEVV-TLWYRPPDVLFGAKL--YSTSIDMWSAG 189
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 6e-17
Identities = 43/197 (21%), Positives = 77/197 (39%), Gaps = 36/197 (18%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERM----LVYEYM 60
+ A+K L + + EV L + +++R++ + +V E +
Sbjct: 87 QEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 141
Query: 61 PNKSLDCYLFDPIRRLILDW---KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
L F I+ ++ I++ I + + YL + I HRD+K N+L
Sbjct: 142 DGGEL----FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLY 194
Query: 118 ---GEDMKPKISDFGLARIF-AKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFG 173
+ K++DFG A+ + SL T Y+ PE Y D++S G
Sbjct: 195 TSKRPNAILKLTDFGFAKETTSHNSLT----TPCYTPYYVAPEVLGPEKYDKSCDMWSLG 250
Query: 174 VLLLQIISGKRLSMLCG 190
V++ I +LCG
Sbjct: 251 VIMY-I-------LLCG 259
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 9e-17
Identities = 50/198 (25%), Positives = 84/198 (42%), Gaps = 32/198 (16%)
Query: 6 GKVIAVKKLSKTSTQGFEEFK-NEVMLTAKLQHVNLIRVLGFCIDSEER--MLVYEYMPN 62
K A+K++ G E+ L +L+H N+I + + +R L+++Y
Sbjct: 48 DKDYALKQIEG---TGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-- 102
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEG--------ITQGLLYLQEYSRLTIIHRDLKASN 114
D + R KK V + G I G+ YL ++HRDLK +N
Sbjct: 103 -EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPAN 158
Query: 115 ILLGEDMKP----KISDFGLARIFAK--ESLEANTEQVVGTIGYIPPEY---ARQGVYST 165
IL+ + KI+D G AR+F + L VV T Y PE AR Y+
Sbjct: 159 ILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYRAPELLLGARH--YTK 215
Query: 166 KSDVFSFGVLLLQIISGK 183
D+++ G + ++++ +
Sbjct: 216 AIDIWAIGCIFAELLTSE 233
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-16
Identities = 50/191 (26%), Positives = 86/191 (45%), Gaps = 21/191 (10%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEV-MLTAKLQHVNLIRVLG------FCIDSEERMLVYE 58
G++ A+K + + EE K E+ ML H N+ G ++ LV E
Sbjct: 49 GQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME 107
Query: 59 YMPNKSL-DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
+ S+ D L + L + +I I +GL +L ++ +IHRD+K N+LL
Sbjct: 108 FCGAGSVTD--LIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLL 162
Query: 118 GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE-----YARQGVYSTKSDVFSF 172
E+ + K+ DFG++ + NT +GT ++ PE Y KSD++S
Sbjct: 163 TENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSL 220
Query: 173 GVLLLQIISGK 183
G+ +++ G
Sbjct: 221 GITAIEMAEGA 231
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-16
Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 42/198 (21%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKN-EVMLTAKLQHVNLIRVLGFCIDSEERM------LVYE 58
G+++A+KK+ + + FKN E+ + KL H N++R+ F S E+ LV +
Sbjct: 79 GELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRVHIIEG---------ITQGLLYLQEYSRLTIIHRD 109
Y+P Y R+ + + + + + L Y+ I HRD
Sbjct: 134 YVP---ETVY------RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRD 181
Query: 110 LKASNILLGEDMKP-KISDFGLARIFAKESLEANTEQVVGTIGYIPPEY---ARQGVYST 165
+K N+LL D K+ DFG A+ + E N + + Y PE A Y++
Sbjct: 182 IKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYIC-SRYYRAPELIFGATD--YTS 236
Query: 166 KSDVFSFGVLLLQIISGK 183
DV+S G +L +++ G+
Sbjct: 237 SIDVWSAGCVLAELLLGQ 254
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-16
Identities = 54/191 (28%), Positives = 83/191 (43%), Gaps = 23/191 (12%)
Query: 6 GKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMP 61
+ A+K L K E + ++L H ++ L F +E++ Y
Sbjct: 55 SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK-LYFTFQDDEKLYFGLSYAK 113
Query: 62 NKSLDCYLFDPIRRL--ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
N L IR++ + R + E I L YL IIHRDLK NILL E
Sbjct: 114 NGEL----LKYIRKIGSFDETCTRFYTAE-IVSALEYLHG---KGIIHRDLKPENILLNE 165
Query: 120 DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQI 179
DM +I+DFG A++ + ES +A VGT Y+ PE + SD+++ G ++ Q
Sbjct: 166 DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ- 224
Query: 180 ISGKRLSMLCG 190
++ G
Sbjct: 225 -------LVAG 228
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-16
Identities = 44/266 (16%), Positives = 90/266 (33%), Gaps = 52/266 (19%)
Query: 6 GKVIAVKK--LSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPN 62
G + A+K+ + + EV A L QH +++R + + ++ EY
Sbjct: 36 GCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNG 95
Query: 63 KSLDCYLFDPIRRL-ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
SL + + R + + ++ + +GL Y+ S ++H D+K SNI +
Sbjct: 96 GSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTS 152
Query: 122 KP-------------------KISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162
P KI D G + E G ++ E ++
Sbjct: 153 IPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS----PQVE--EGDSRFLANEVLQENY 206
Query: 163 -YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDT 221
+ K+D+F+ + ++ + L + W + + +
Sbjct: 207 THLPKADIFALALTVVCAAGAEPLP-------------RNGDQWH--EIRQGRLPRIPQV 251
Query: 222 NSPCKLMRCLEIALLCVQENPNDRPS 247
S E+ + + +P RPS
Sbjct: 252 LSQ----EFTELLKVMIHPDPERRPS 273
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 49/202 (24%), Positives = 87/202 (43%), Gaps = 40/202 (19%)
Query: 4 PCGKVIAVKKLSKTSTQGFEEFKN---------EVMLTAKLQHVNLIRVLG-FCIDSEER 53
+A+KK+S F++ E+ + + +H N+I + + E+
Sbjct: 50 LNKVRVAIKKISP--------FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101
Query: 54 M----LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRD 109
M +V + M + L+ ++ L + + I +GL Y+ + ++HRD
Sbjct: 102 MKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRD 153
Query: 110 LKASNILLGEDMKPKISDFGLARIFAKESLEAN--TEQVVGTIGYIPPE----YARQGVY 163
LK SN+LL KI DFGLAR+ + TE V T Y PE Y
Sbjct: 154 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIMLNSKG---Y 209
Query: 164 STKSDVFSFGVLLLQIISGKRL 185
+ D++S G +L +++S + +
Sbjct: 210 TKSIDIWSVGCILAEMLSNRPI 231
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-16
Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 27/200 (13%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKN-----EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G +A+K++ S +G E+ L +L+H N++R+ + LV+E+M
Sbjct: 30 GVYVALKEVKLDSEEGT----PSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGIT----QGLLYLQEYSRLTIIHRDLKASNIL 116
L Y+ D +++++ QGL + E I+HRDLK N+L
Sbjct: 86 D-NDLKKYM-DSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLL 140
Query: 117 LGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFG 173
+ + + K+ DFGLAR F + + +VV T+ Y P+ +R YST D++S G
Sbjct: 141 INKRGQLKLGDFGLARAFGIP-VNTFSSEVV-TLWYRAPDVLMGSRT--YSTSIDIWSCG 196
Query: 174 VLLLQIISGKRLSMLCGINE 193
+L ++I+GK L G N+
Sbjct: 197 CILAEMITGKPL--FPGTND 214
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 48/185 (25%), Positives = 87/185 (47%), Gaps = 19/185 (10%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKN----EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMP 61
G+++A+KK ++ + K E+ L +L+H NL+ +L C + LV+E++
Sbjct: 50 GRIVAIKKFLESDDD--KMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV- 106
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
+ ++ L L ++ + I G+ + ++ IIHRD+K NIL+ +
Sbjct: 107 DHTILDDLELFPNGLDYQVVQK--YLFQIINGIGFCHSHN---IIHRDIKPENILVSQSG 161
Query: 122 KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGVLLLQ 178
K+ DFG AR A E ++V T Y PE + Y DV++ G L+ +
Sbjct: 162 VVKLCDFGFARTLAAP-GEVYDDEVA-TRWYRAPELLVGDVK--YGKAVDVWAIGCLVTE 217
Query: 179 IISGK 183
+ G+
Sbjct: 218 MFMGE 222
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 3e-16
Identities = 54/195 (27%), Positives = 85/195 (43%), Gaps = 34/195 (17%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKN---------EVMLTAKLQHVNLIRVL------GFCIDS 50
+ +A+KKLS+ F+N E++L + H N+I +L +
Sbjct: 87 DRNVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139
Query: 51 EERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 110
++ LV E M D L I+ + + +++ + G+ +L IIHRDL
Sbjct: 140 QDVYLVMELM-----DANLCQVIQMELDHERMS-YLLYQMLCGIKHLHS---AGIIHRDL 190
Query: 111 KASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVF 170
K SNI++ D KI DFGLAR T VV T Y PE Y D++
Sbjct: 191 KPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVV-TRYYRAPEVILGMGYKENVDIW 247
Query: 171 SFGVLLLQIISGKRL 185
S G ++ +++ K L
Sbjct: 248 SVGCIMGEMVRHKIL 262
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-16
Identities = 55/197 (27%), Positives = 85/197 (43%), Gaps = 38/197 (19%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKN---------EVMLTAKLQHVNLIRVLGFCIDSEERM-- 54
G +A+KKL + F++ E+ L ++H N+I +L E
Sbjct: 50 GAKVAIKKLYRP-------FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102
Query: 55 ----LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 110
LV +M L ++ L + ++ + +GL Y+ IIHRDL
Sbjct: 103 TDFYLVMPFM-----GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDL 154
Query: 111 KASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE--YARQGVYSTKSD 168
K N+ + ED + KI DFGLAR E T VV T Y PE Y+ D
Sbjct: 155 KPGNLAVNEDCELKILDFGLARQADSEM----TGYVV-TRWYRAPEVILNWMR-YTQTVD 208
Query: 169 VFSFGVLLLQIISGKRL 185
++S G ++ ++I+GK L
Sbjct: 209 IWSVGCIMAEMITGKTL 225
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-16
Identities = 50/200 (25%), Positives = 87/200 (43%), Gaps = 37/200 (18%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTA--------KLQHVNLIRVLGFCIDSEERM--- 54
G+ +A+KK+ E K +TA L+H N++ ++ C
Sbjct: 42 GQKVALKKVL------MENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95
Query: 55 -----LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRD 109
LV+++ L L + + + L K +++ + GL Y+ I+HRD
Sbjct: 96 KGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIK--RVMQMLLNGLYYIHRNK---ILHRD 149
Query: 110 LKASNILLGEDMKPKISDFGLARIF---AKESLEANTEQVVGTIGYIPPEY---ARQGVY 163
+KA+N+L+ D K++DFGLAR F T +VV T+ Y PPE R Y
Sbjct: 150 MKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV-TLWYRPPELLLGERD--Y 206
Query: 164 STKSDVFSFGVLLLQIISGK 183
D++ G ++ ++ +
Sbjct: 207 GPPIDLWGAGCIMAEMWTRS 226
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-16
Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 24/196 (12%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKN-----EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
++A+K++ +G EV L L+H N++ + + LV+EY+
Sbjct: 27 DNLVALKEIRLEHEEGA----PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 82
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
+K L YL D + + K + + +GL Y ++HRDLK N+L+ E
Sbjct: 83 -DKDLKQYLDDCGNIINMHNVK--LFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINER 136
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGVLLL 177
+ K++DFGLAR + + +VV T+ Y PP+ + YST+ D++ G +
Sbjct: 137 GELKLADFGLARAKSIP-TKTYDNEVV-TLWYRPPDILLGSTD--YSTQIDMWGVGCIFY 192
Query: 178 QIISGKRLSMLCGINE 193
++ +G+ L G
Sbjct: 193 EMATGRPL--FPGSTV 206
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 5e-16
Identities = 51/204 (25%), Positives = 85/204 (41%), Gaps = 35/204 (17%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKN--------EVMLTAKLQHVNLIRVLGFCIDSEERMLVY 57
+ +A+K++ E + EV L +LQH N+I + + L++
Sbjct: 59 NETVAIKRIR------LEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112
Query: 58 EYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
EY L Y+ D + + K + + G+ + +HRDLK N+LL
Sbjct: 113 EYA-ENDLKKYM-DKNPDVSMRVIK--SFLYQLINGVNFCHSR---RCLHRDLKPQNLLL 165
Query: 118 GEDMKP-----KISDFGLARIFAKESLEANTEQVVGTIGYIPPEY---ARQGVYSTKSDV 169
KI DFGLAR F + T +++ T+ Y PPE +R YST D+
Sbjct: 166 SVSDASETPVLKIGDFGLARAFGIP-IRQFTHEII-TLWYRPPEILLGSRH--YSTSVDI 221
Query: 170 FSFGVLLLQIISGKRLSMLCGINE 193
+S + +++ L G +E
Sbjct: 222 WSIACIWAEMLMKTPL--FPGDSE 243
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-16
Identities = 46/185 (24%), Positives = 82/185 (44%), Gaps = 19/185 (10%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKN----EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMP 61
G+++A+KK ++ K E+ + +L+H NL+ +L LV+EY
Sbjct: 28 GQIVAIKKFLESEDD--PVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC- 84
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
+ ++ L R + K I Q + + +++ IHRD+K NIL+ +
Sbjct: 85 DHTVLHELDRYQRGVPEHLVKS--ITWQTLQAVNFCHKHN---CIHRDVKPENILITKHS 139
Query: 122 KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY---ARQGVYSTKSDVFSFGVLLLQ 178
K+ DFG AR+ + ++V T Y PE Q Y DV++ G + +
Sbjct: 140 VIKLCDFGFARLLTGP-SDYYDDEVA-TRWYRSPELLVGDTQ--YGPPVDVWAIGCVFAE 195
Query: 179 IISGK 183
++SG
Sbjct: 196 LLSGV 200
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 7e-16
Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 14/183 (7%)
Query: 6 GKVIAVKKLSK---TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMP 61
GK+ A KKL K +G NE + K+ ++ L + ++++ + LV M
Sbjct: 209 GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LAYAYETKDALCLVLTLMN 267
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
L +++ + + + + E I GL L I++RDLK NILL +
Sbjct: 268 GGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLHR---ERIVYRDLKPENILLDDHG 323
Query: 122 KPKISDFGLARIFAKESLEAN-TEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
+ISD GL A E + VGT+GY+ PE + Y+ D ++ G LL ++I
Sbjct: 324 HIRISDLGL----AVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 379
Query: 181 SGK 183
+G+
Sbjct: 380 AGQ 382
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 7e-16
Identities = 56/195 (28%), Positives = 84/195 (43%), Gaps = 34/195 (17%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKN---------EVMLTAKLQHVNLIRVLGFCI--DSEERM 54
+ +A+KKLS+ F+N E++L + H N+I +L S E
Sbjct: 50 ERNVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102
Query: 55 ----LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 110
+V E M D L I+ + + +++ + G+ +L IIHRDL
Sbjct: 103 QDVYIVMELM-----DANLCQVIQMELDHERMS-YLLYQMLCGIKHLHSAG---IIHRDL 153
Query: 111 KASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVF 170
K SNI++ D KI DFGLAR T VV T Y PE Y D++
Sbjct: 154 KPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVV-TRYYRAPEVILGMGYKENVDIW 210
Query: 171 SFGVLLLQIISGKRL 185
S G ++ ++I G L
Sbjct: 211 SVGCIMGEMIKGGVL 225
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 1e-15
Identities = 47/189 (24%), Positives = 80/189 (42%), Gaps = 25/189 (13%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAK----LQHVNLIRV-----LGFCIDSEERM-L 55
GK+ A+K L K + K L L V+ + + + +++
Sbjct: 214 GKMYAMKCLDKKRIKM----KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 269
Query: 56 VYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
+ + M L +L + + R + E I GL ++ +++RDLK +NI
Sbjct: 270 ILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAE-IILGLEHMHN---RFVVYRDLKPANI 323
Query: 116 LLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE-YARQGVYSTKSDVFSFGV 174
LL E +ISD GL A + + VGT GY+ PE + Y + +D FS G
Sbjct: 324 LLDEHGHVRISDLGL----ACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGC 379
Query: 175 LLLQIISGK 183
+L +++ G
Sbjct: 380 MLFKLLRGH 388
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-15
Identities = 45/194 (23%), Positives = 76/194 (39%), Gaps = 31/194 (15%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKN------EVMLTAKLQHV--NLIRVLGFCIDSEERMLVY 57
+A+K + K + E N EV+L K+ +IR+L + + +L+
Sbjct: 68 NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 127
Query: 58 EYMPNKSLDCYLFDPIRRLILDWKKRV------HIIEGITQGLLYLQEYSRLTIIHRDLK 111
E P D LFD I + + + + + + ++HRD+K
Sbjct: 128 ER-PEPVQD--LFDFITE-----RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIK 176
Query: 112 ASNILL-GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYS-TKSDV 169
NIL+ + K+ DFG + GT Y PPE+ R Y + V
Sbjct: 177 DENILIDLNRGELKLIDFGSGALLKDTVYTD----FDGTRVYSPPEWIRYHRYHGRSAAV 232
Query: 170 FSFGVLLLQIISGK 183
+S G+LL ++ G
Sbjct: 233 WSLGILLYDMVCGD 246
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 47/198 (23%), Positives = 85/198 (42%), Gaps = 43/198 (21%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKN-EVMLTAKLQHVNLIRVLGFCIDSEERM------LVYE 58
+V A+KK+ + + FKN E+ + ++H N++ + F + ++ LV E
Sbjct: 65 DEV-AIKKVLQ-----DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRVHIIEG---------ITQGLLYLQEYSRLTIIHRD 109
Y+P Y R + K + + + L Y+ + I HRD
Sbjct: 119 YVP---ETVY------RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRD 166
Query: 110 LKASNILLGEDMKP-KISDFGLARIFAKESLEANTEQVVGTIGYIPPEY---ARQGVYST 165
+K N+LL K+ DFG A+I + E N + + Y PE A Y+T
Sbjct: 167 IKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYIC-SRYYRAPELIFGATN--YTT 221
Query: 166 KSDVFSFGVLLLQIISGK 183
D++S G ++ +++ G+
Sbjct: 222 NIDIWSTGCVMAELMQGQ 239
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-15
Identities = 47/195 (24%), Positives = 75/195 (38%), Gaps = 33/195 (16%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKN------EV----MLTAKLQHVNLIRVLGFCIDSEERML 55
+A+K + + G+ + EV + A H +IR+L + E ML
Sbjct: 56 RLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFML 115
Query: 56 VYEYMPNKSLDCYLFDPIRRLILDWKKRV------HIIEGITQGLLYLQEYSRLTIIHRD 109
V E P + D LFD I K + + + + ++HRD
Sbjct: 116 VLER-PLPAQD--LFDYITE-----KGPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRD 164
Query: 110 LKASNILL-GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYS-TKS 167
+K NIL+ K+ DFG + E GT Y PPE+ + Y +
Sbjct: 165 IKDENILIDLRRGCAKLIDFGSGALLHDEPYTD----FDGTRVYSPPEWISRHQYHALPA 220
Query: 168 DVFSFGVLLLQIISG 182
V+S G+LL ++ G
Sbjct: 221 TVWSLGILLYDMVCG 235
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-15
Identities = 48/212 (22%), Positives = 88/212 (41%), Gaps = 51/212 (24%)
Query: 4 PCGKVIAVKKLSKTSTQGFEEFKN---------EVMLTAKLQHVNLIRVL---------- 44
C K +A+KK+ + E+ + +L H N+++V
Sbjct: 34 DCDKRVAIKKIV---------LTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84
Query: 45 GFCIDSEERM----LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEY 100
+ S + +V EYM + L + + + L + + + +GL Y+
Sbjct: 85 TDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSA 139
Query: 101 SRLTIIHRDLKASNILL-GEDMKPKISDFGLARIFAKESLEAN--TEQVVGTIGYIPPE- 156
+ ++HRDLK +N+ + ED+ KI DFGLARI +E +V T Y P
Sbjct: 140 N---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRSPRL 195
Query: 157 ---YARQGVYSTKSDVFSFGVLLLQIISGKRL 185
Y+ D+++ G + ++++GK L
Sbjct: 196 LLSPNN---YTKAIDMWAAGCIFAEMLTGKTL 224
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-15
Identities = 49/192 (25%), Positives = 81/192 (42%), Gaps = 25/192 (13%)
Query: 6 GKVIAVKKLSKTSTQGFEEF----KNEVMLTAKLQHVNLIRVLGFCIDSEERM--LVYEY 59
AVK L K + K E+ L +L+H N+I+++ + E++ +V EY
Sbjct: 30 LCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY 89
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEG------ITQGLLYLQEYSRLTIIHRDLKAS 113
+ + D + +KR + + + GL YL I+H+D+K
Sbjct: 90 CVCGMQE--MLDSVP------EKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPG 138
Query: 114 NILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR-QGVYS-TKSDVFS 171
N+LL KIS G+A + + G+ + PPE A +S K D++S
Sbjct: 139 NLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWS 198
Query: 172 FGVLLLQIISGK 183
GV L I +G
Sbjct: 199 AGVTLYNITTGL 210
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-15
Identities = 53/197 (26%), Positives = 90/197 (45%), Gaps = 39/197 (19%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKN---------EVMLTAKLQHVNLIRVLGFCIDSEERM-- 54
G+ +A+KKLS+ F++ E++L +QH N+I +L +
Sbjct: 49 GEKVAIKKLSRP-------FQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101
Query: 55 ----LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 110
LV +M L + + K + +++ + +GL Y+ ++HRDL
Sbjct: 102 YDFYLVMPFM-----QTDLQKIMGLKFSEEKIQ-YLVYQMLKGLKYIHSAG---VVHRDL 152
Query: 111 KASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE--YARQGVYSTKSD 168
K N+ + ED + KI DFGLAR E T VV T Y PE + Y+ D
Sbjct: 153 KPGNLAVNEDCELKILDFGLARHADAEM----TGYVV-TRWYRAPEVILSWMH-YNQTVD 206
Query: 169 VFSFGVLLLQIISGKRL 185
++S G ++ ++++GK L
Sbjct: 207 IWSVGCIMAEMLTGKTL 223
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-15
Identities = 51/191 (26%), Positives = 81/191 (42%), Gaps = 27/191 (14%)
Query: 6 GKVIAVKKLSK---TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMP 61
GK+ A KKL+K +G++ E + AK+ ++ L + +++ + LV M
Sbjct: 210 GKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS-LAYAFETKTDLCLVMTIMN 268
Query: 62 ---------NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKA 112
N D F R + + I GL +L + II+RDLK
Sbjct: 269 GGDIRYHIYNVDEDNPGFQEPR-------AIFYTAQ-IVSGLEHLHQ---RNIIYRDLKP 317
Query: 113 SNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSF 172
N+LL +D +ISD GLA + GT G++ PE Y D F+
Sbjct: 318 ENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGTPGFMAPELLLGEEYDFSVDYFAL 375
Query: 173 GVLLLQIISGK 183
GV L ++I+ +
Sbjct: 376 GVTLYEMIAAR 386
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-15
Identities = 49/200 (24%), Positives = 80/200 (40%), Gaps = 32/200 (16%)
Query: 6 GKVIAVKKLSKTSTQGFEE--FKN---------EVMLTAKLQHVNLIRVLG-FCIDSEER 53
G +A+K++ T + G + E+ L H N++ + F E
Sbjct: 46 GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPA 105
Query: 54 M----LVYEYMPNKSLDCYLFDPIR--RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIH 107
M LV E M L I R+++ + + + I GL L E ++H
Sbjct: 106 MHKLYLVTELM-----RTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVH 157
Query: 108 RDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE--YARQGVYST 165
RDL NILL ++ I DF LAR + T V Y PE +G ++
Sbjct: 158 RDLHPGNILLADNNDITICDFNLAREDTAD--ANKTHYVT-HRWYRAPELVMQFKG-FTK 213
Query: 166 KSDVFSFGVLLLQIISGKRL 185
D++S G ++ ++ + K L
Sbjct: 214 LVDMWSAGCVMAEMFNRKAL 233
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-15
Identities = 53/188 (28%), Positives = 85/188 (45%), Gaps = 26/188 (13%)
Query: 6 GKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMPN 62
G+ +A+K + KT + ++ EV + L H N+++ L I++E+ + L+ EY
Sbjct: 40 GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK-LFEVIETEKTLYLIMEYASG 98
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEG------ITQGLLYLQEYSRLTIIHRDLKASNIL 116
+ FD + R+ E I + Y + I+HRDLKA N+L
Sbjct: 99 GEV----FDYLVA-----HGRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLL 146
Query: 117 LGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYS-TKSDVFSFGVL 175
L DM KI+DFG + F + G Y PE + Y + DV+S GV+
Sbjct: 147 LDADMNIKIADFGFSNEFTVGGKL-DAF--CGAPPYAAPELFQGKKYDGPEVDVWSLGVI 203
Query: 176 LLQIISGK 183
L ++SG
Sbjct: 204 LYTLVSGS 211
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 7e-15
Identities = 51/188 (27%), Positives = 81/188 (43%), Gaps = 21/188 (11%)
Query: 6 GKVIAVKKLSKT--------STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LV 56
K + VK + K + E+ + ++++H N+I+VL +++ LV
Sbjct: 49 NKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDI-FENQGFFQLV 107
Query: 57 YEYMPNKSLDCYLFDPI-RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
E + LD LF I R LD +I + + YL+ IIHRD+K NI
Sbjct: 108 MEKHGS-GLD--LFAFIDRHPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENI 161
Query: 116 LLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYS-TKSDVFSFGV 174
++ ED K+ DFG A + L GTI Y PE Y + +++S GV
Sbjct: 162 VIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGV 218
Query: 175 LLLQIISG 182
L ++
Sbjct: 219 TLYTLVFE 226
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 8e-15
Identities = 53/194 (27%), Positives = 82/194 (42%), Gaps = 30/194 (15%)
Query: 6 GKVIAVKKLSKTSTQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMPNK 63
+ +AVK + E K E+ + L H N+++ G L EY
Sbjct: 32 EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGG 90
Query: 64 SLDCYLFDPI---RRLILDWKKRV--HIIEGITQGLLYLQEYS-RLTIIHRDLKASNILL 117
L FD I + +R ++ G+ Y + I HRD+K N+LL
Sbjct: 91 EL----FDRIEPDIGMPEPDAQRFFHQLMAGV--------VYLHGIGITHRDIKPENLLL 138
Query: 118 GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE-YARQGVYSTKSDVFSFGVLL 176
E KISDFGLA +F + E ++ GT+ Y+ PE R+ ++ DV+S G++L
Sbjct: 139 DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVL 198
Query: 177 LQIISGKRLSMLCG 190
+ML G
Sbjct: 199 --------TAMLAG 204
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 8e-15
Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 20/159 (12%)
Query: 26 KNEVMLTAKLQHVNLIR---VLGFCIDSEERML--VYEYMPNKSLDCYLFDPIRRLILDW 80
E+ + KL H N+++ VL D E L V+E + + + L
Sbjct: 84 YQEIAILKKLDHPNVVKLVEVLD---DPNEDHLYMVFELVNQGPV----MEVPTLKPLSE 136
Query: 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE 140
+ + + +G+ YL IIHRD+K SN+L+GED KI+DFG++ F
Sbjct: 137 DQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 141 ANTEQVVGTIGYIPPE--YARQGVYS-TKSDVFSFGVLL 176
+ VGT ++ PE + ++S DV++ GV L
Sbjct: 194 LSN--TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 49/205 (23%), Positives = 81/205 (39%), Gaps = 43/205 (20%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKN---------EVMLTAKLQHVNLIRVLG-FCIDSEERM- 54
G+++A+KK+ F E+ + +H N+I + DS E
Sbjct: 36 GEIVAIKKIEP--------FDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87
Query: 55 ---LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLK 111
++ E M L I +L + I + + L + +IHRDLK
Sbjct: 88 EVYIIQELM-----QTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLK 139
Query: 112 ASNILLGEDMKPKISDFGLARIFAKESLEAN---------TEQVVGTIGYIPPE--YARQ 160
SN+L+ + K+ DFGLARI + + + + E V T Y PE
Sbjct: 140 PSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA-TRWYRAPEVMLTSA 198
Query: 161 GVYSTKSDVFSFGVLLLQIISGKRL 185
YS DV+S G +L ++ + +
Sbjct: 199 K-YSRAMDVWSCGCILAELFLRRPI 222
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 57/197 (28%), Positives = 86/197 (43%), Gaps = 38/197 (19%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKN---------EVMLTAKLQHVNLIRVLGFCIDSEERM-- 54
G +AVKKLS+ F++ E+ L ++H N+I +L +
Sbjct: 54 GLRVAVKKLSRP-------FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106
Query: 55 ----LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 110
LV M L + ++ L +I I +GL Y+ IIHRDL
Sbjct: 107 NDVYLVTHLM-----GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDL 158
Query: 111 KASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE--YARQGVYSTKSD 168
K SN+ + ED + KI DFGLAR A E T V T Y PE Y+ D
Sbjct: 159 KPSNLAVNEDCELKILDFGLARHTADEM----TGYVA-TRWYRAPEIMLNWMH-YNQTVD 212
Query: 169 VFSFGVLLLQIISGKRL 185
++S G ++ ++++G+ L
Sbjct: 213 IWSVGCIMAELLTGRTL 229
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-14
Identities = 53/194 (27%), Positives = 82/194 (42%), Gaps = 30/194 (15%)
Query: 6 GKVIAVKKLSKTSTQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMPNK 63
+ +AVK + E K E+ + L H N+++ G L EY
Sbjct: 32 EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGG 90
Query: 64 SLDCYLFDPI---RRLILDWKKRV--HIIEGITQGLLYLQEYS-RLTIIHRDLKASNILL 117
L FD I + +R ++ G+ Y + I HRD+K N+LL
Sbjct: 91 EL----FDRIEPDIGMPEPDAQRFFHQLMAGV--------VYLHGIGITHRDIKPENLLL 138
Query: 118 GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE-YARQGVYSTKSDVFSFGVLL 176
E KISDFGLA +F + E ++ GT+ Y+ PE R+ ++ DV+S G++L
Sbjct: 139 DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVL 198
Query: 177 LQIISGKRLSMLCG 190
+ML G
Sbjct: 199 --------TAMLAG 204
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-14
Identities = 52/204 (25%), Positives = 99/204 (48%), Gaps = 32/204 (15%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTA-----------KLQHVNLIRVL----GFCIDS 50
G+ +A+K++ + + + L+ +H N++R+ D
Sbjct: 37 GRFVALKRVR------VQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90
Query: 51 EERM-LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRD 109
E ++ LV+E++ ++ L YL D + + + ++ + +GL +L + ++HRD
Sbjct: 91 ETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRD 145
Query: 110 LKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDV 169
LK NIL+ + K++DFGLARI++ + A T VV T+ Y PE Q Y+T D+
Sbjct: 146 LKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVV-TLWYRAPEVLLQSSYATPVDL 202
Query: 170 FSFGVLLLQIISGKRLSMLCGINE 193
+S G + ++ K L G ++
Sbjct: 203 WSVGCIFAEMFRRKPL--FRGSSD 224
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 4e-14
Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 29/204 (14%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTA-----------KLQHVNLIRVLGFCIDSEER- 53
G +A+K + + + ++ +H N++R++ C S
Sbjct: 34 GHFVALKSVRVPNG---GGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDR 90
Query: 54 ----MLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRD 109
LV+E++ ++ L YL D L + ++ +GL +L I+HRD
Sbjct: 91 EIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRD 145
Query: 110 LKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDV 169
LK NIL+ K++DFGLARI++ + A T VV T+ Y PE Q Y+T D+
Sbjct: 146 LKPENILVTSGGTVKLADFGLARIYSYQM--ALTPVVV-TLWYRAPEVLLQSTYATPVDM 202
Query: 170 FSFGVLLLQIISGKRLSMLCGINE 193
+S G + ++ K L CG +E
Sbjct: 203 WSVGCIFAEMFRRKPL--FCGNSE 224
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-14
Identities = 43/207 (20%), Positives = 83/207 (40%), Gaps = 48/207 (23%)
Query: 3 LPCGKVIAVKKLSKTSTQGFEE--FKN----EVMLTAKLQHVNLIRVLGFCIDSEER--- 53
G +A+KK+ ++ F+N + A L H N++++ + ER
Sbjct: 45 KSTGMSVAIKKV-------IQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97
Query: 54 ----MLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEG---------ITQGLLYLQEY 100
+V EY+P + R ++ +R + + + L
Sbjct: 98 DIYLNVVMEYVP---DTLH------RCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP 148
Query: 101 SRLTIIHRDLKASNILL-GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY-- 157
S + + HRD+K N+L+ D K+ DFG A+ + E N + + Y PE
Sbjct: 149 S-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS--EPNVAYIC-SRYYRAPELIF 204
Query: 158 -ARQGVYSTKSDVFSFGVLLLQIISGK 183
+ Y+T D++S G + +++ G+
Sbjct: 205 GNQH--YTTAVDIWSVGCIFAEMMLGE 229
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-13
Identities = 34/98 (34%), Positives = 51/98 (52%), Gaps = 9/98 (9%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGT 149
+ L YLQ IIHRD+K NILL E I+DF +A + +E+ T + GT
Sbjct: 124 LVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ-ITT--MAGT 177
Query: 150 IGYIPPE-YARQGV--YSTKSDVFSFGVLLLQIISGKR 184
Y+ PE ++ + YS D +S GV +++ G+R
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-12
Identities = 18/183 (9%), Positives = 49/183 (26%), Gaps = 42/183 (22%)
Query: 6 GKVIAVKKL--SKTSTQGF-EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
+ +A+ + +E + + +++ + RVL ++V E++
Sbjct: 56 DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRG 115
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYS-RLTIIHRDLKASNILLGEDM 121
SL + ++ + + + R + S + + D
Sbjct: 116 GSLQEVADTS-----PSPVGAIRAMQSLAAAA----DAAHRAGVALSIDHPSRVRVSID- 165
Query: 122 KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
G V+ +P + D+ G L ++
Sbjct: 166 -------GDV--------------VLAYPATMPDANPQ-------DDIRGIGASLYALLV 197
Query: 182 GKR 184
+
Sbjct: 198 NRW 200
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 38/171 (22%), Positives = 65/171 (38%), Gaps = 30/171 (17%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKN---------EVMLTAKLQHVNLIRVLG-FCIDSEERM- 54
K +A+KK+++ F++ E+ + +L+ +IR+ D +
Sbjct: 51 EKNVAIKKVNRM-------FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103
Query: 55 ---LVYEYMPNKSLDCYLFDPIR-RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 110
+V E D L + + L + I+ + G ++ E IIHRDL
Sbjct: 104 ELYIVLEIA-----DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDL 155
Query: 111 KASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161
K +N LL +D K+ DFGLAR E + P +
Sbjct: 156 KPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 3e-12
Identities = 54/199 (27%), Positives = 85/199 (42%), Gaps = 35/199 (17%)
Query: 3 LPCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYE 58
G +AVK L++ S + K E+ +H ++I+ L I + +V E
Sbjct: 33 QLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK-LYQVISTPTDFFMVME 91
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRVHIIEG------ITQGLLYLQEYSRLTIIHRDLKA 112
Y+ L FD I + RV +E I + Y R ++HRDLK
Sbjct: 92 YVSGGEL----FDYICK-----HGRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKP 139
Query: 113 SNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYS-TKSDVFS 171
N+LL M KI+DFGL+ + + T G+ Y PE +Y+ + D++S
Sbjct: 140 ENVLLDAHMNAKIADFGLSNMMSDGEF-LRT--SCGSPNYAAPEVISGRLYAGPEVDIWS 196
Query: 172 FGVLLLQIISGKRLSMLCG 190
GV+L ++LCG
Sbjct: 197 CGVIL--------YALLCG 207
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 6e-12
Identities = 40/189 (21%), Positives = 73/189 (38%), Gaps = 30/189 (15%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVY--EYMPN 62
+ + VK L + + K E+ + L+ N+I + D R E++ N
Sbjct: 61 NEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 117
Query: 63 KSLDCYLFDPIRRLILDWKKRVHI---IEGITQGLLYLQEYSRLTIIHRDLKASNILL-G 118
+ L I + I + L Y +S I+HRD+K N+++
Sbjct: 118 TDFKQL----YQTLTDY-----DIRFYMYEILKALDYC--HSM-GIMHRDVKPHNVMIDH 165
Query: 119 EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE---YARQGVYSTKSDVFSFGVL 175
E K ++ D+GLA + + +V + + PE + Y D++S G +
Sbjct: 166 EHRKLRLIDWGLAEFY--HPGQEYNVRVA-SRYFKGPELLVDYQM--YDYSLDMWSLGCM 220
Query: 176 LLQIISGKR 184
L +I K
Sbjct: 221 LASMIFRKE 229
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 7e-12
Identities = 35/178 (19%), Positives = 64/178 (35%), Gaps = 34/178 (19%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKN---------EVMLTAKLQHVNLIRVLG-FCIDSEERM- 54
+V+A+KK+ F++ E+ + +L H ++++VL E+
Sbjct: 78 KRVVAIKKI-------LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130
Query: 55 ---LVYEYMPNKSLDCYLFDPIR---RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHR 108
+V E D R L K ++ + G+ Y+ I+HR
Sbjct: 131 ELYVVLEIA-----DSDFKKLFRTPVYLTELHIK--TLLYNLLVGVKYVHSAG---ILHR 180
Query: 109 DLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTK 166
DLK +N L+ +D K+ DFGLAR + + + +
Sbjct: 181 DLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKR 238
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 8e-12
Identities = 32/103 (31%), Positives = 49/103 (47%), Gaps = 16/103 (15%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEAN--TEQVV 147
I L YL +S +++RDLK N++L +D KI+DFGL KE ++ +
Sbjct: 257 IVSALDYL--HSEKNVVYRDLKLENLMLDKDGHIKITDFGL----CKEGIKDGATMKTFC 310
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190
GT Y+ PE Y D + GV++ + M+CG
Sbjct: 311 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE--------MMCG 345
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 46/197 (23%), Positives = 76/197 (38%), Gaps = 28/197 (14%)
Query: 6 GKVIAVKKLSKTSTQGFEE---FKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMP 61
G+V A+K ++K E F+ E + + + L F E + LV EY
Sbjct: 86 GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ-LHFAFQDENYLYLVMEYYV 144
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
L L R+ + R ++ E I + + +HRD+K NILL
Sbjct: 145 GGDLLTLLSKFGERIPAEMA-RFYLAE-IVMAIDSVHRLG---YVHRDIKPDNILLDRCG 199
Query: 122 KPKISDFGLA-RIFAKESLEANTEQVVGTIGYIPPE-------YARQGVYSTKSDVFSFG 173
+++DFG ++ A ++ + VGT Y+ PE G Y + D ++ G
Sbjct: 200 HIRLADFGSCLKLRADGTVRSLV--AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALG 257
Query: 174 VLLLQIISGKRLSMLCG 190
V + M G
Sbjct: 258 VFAYE--------MFYG 266
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 46/195 (23%), Positives = 81/195 (41%), Gaps = 26/195 (13%)
Query: 6 GKVIAVKKLSKTSTQGFEE---FKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMP 61
KV A+K L+K E F+ E + + L + + + LV +Y
Sbjct: 99 DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT-LHYAFQDDNNLYLVMDYYV 157
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
L L RL + R ++ E + + + + L +HRD+K NIL+ +
Sbjct: 158 GGDLLTLLSKFEDRLPEEMA-RFYLAE-MVIAIDSVHQ---LHYVHRDIKPDNILMDMNG 212
Query: 122 KPKISDFGLA-RIFAKESLEANTEQVVGTIGYIPPE-----YARQGVYSTKSDVFSFGVL 175
+++DFG ++ +++++ VGT YI PE +G Y + D +S GV
Sbjct: 213 HIRLADFGSCLKLMEDGTVQSSV--AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVC 270
Query: 176 LLQIISGKRLSMLCG 190
+ + ML G
Sbjct: 271 MYE--------MLYG 277
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 51/200 (25%), Positives = 78/200 (39%), Gaps = 45/200 (22%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMPNKS 64
+++AVK + + + E + E++ L+H N++R I + + ++ EY
Sbjct: 45 KELVAVKYIERGAAID-ENVQREIINHRSLRHPNIVR-FKEVILTPTHLAIIMEYASGGE 102
Query: 65 LDCYLFDPIRRLILDWKKRVH----------IIEGITQGLLYLQEYS-RLTIIHRDLKAS 113
L ++ I R ++ G+ Y + I HRDLK
Sbjct: 103 L----YERICN-----AGRFSEDEARFFFQQLLSGV--------SYCHSMQICHRDLKLE 145
Query: 114 NILLGEDMKP--KISDFGLARIFAKESLEANTEQVVGTIGYIPPE-YARQGVYSTKSDVF 170
N LL P KI DFG ++ S + VGT YI PE RQ +DV+
Sbjct: 146 NTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS--TVGTPAYIAPEVLLRQEYDGKIADVW 202
Query: 171 SFGVLLLQIISGKRLSMLCG 190
S GV L ML G
Sbjct: 203 SCGVTL--------YVMLVG 214
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 35/199 (17%)
Query: 3 LPCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYE 58
G +AVK L++ S + + E+ +H ++I+ L I + + +V E
Sbjct: 38 ELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK-LYQVISTPSDIFMVME 96
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRVHIIEG------ITQGLLYLQEYSRLTIIHRDLKA 112
Y+ L FD I + R+ E I G+ Y R ++HRDLK
Sbjct: 97 YVSGGEL----FDYICK-----NGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKP 144
Query: 113 SNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYS-TKSDVFS 171
N+LL M KI+DFGL+ + + T G+ Y PE +Y+ + D++S
Sbjct: 145 ENVLLDAHMNAKIADFGLSNMMSDGEF-LRT--SCGSPNYAAPEVISGRLYAGPEVDIWS 201
Query: 172 FGVLLLQIISGKRLSMLCG 190
GV+L ++LCG
Sbjct: 202 SGVIL--------YALLCG 212
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 4e-11
Identities = 31/144 (21%), Positives = 61/144 (42%), Gaps = 30/144 (20%)
Query: 55 LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEG---------ITQGLLYLQEYSRLTI 105
++ EY+P + +++ + + I + + + ++ L I
Sbjct: 115 VIMEYVP---DTLH------KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGI 162
Query: 106 IHRDLKASNILL-GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY---ARQG 161
HRD+K N+L+ +D K+ DFG A+ E + + + Y PE A +
Sbjct: 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS--EPSVAYIC-SRFYRAPELMLGATE- 218
Query: 162 VYSTKSDVFSFGVLLLQIISGKRL 185
Y+ D++S G + ++I GK L
Sbjct: 219 -YTPSIDLWSIGCVFGELILGKPL 241
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 4e-11
Identities = 31/101 (30%), Positives = 47/101 (46%), Gaps = 13/101 (12%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGT 149
I+ L +L + II+RDLK NI+L K++DFGL + + +T GT
Sbjct: 130 ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGT 184
Query: 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190
I Y+ PE + ++ D +S G L+ ML G
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYD--------MLTG 217
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 4e-11
Identities = 39/199 (19%), Positives = 70/199 (35%), Gaps = 61/199 (30%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERM----LVYEYM 60
+ A+K L + + EV L + Q +++R++ + +V E
Sbjct: 43 QEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC- 96
Query: 61 PNKSLDCY---LFDPIRRLILDW---KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
LF I+ ++ I++ I + + YL + I HRD+K N
Sbjct: 97 ------LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPEN 147
Query: 115 ILL---GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFS 171
+L + K++DFG A E + Y D++S
Sbjct: 148 LLYTSKRPNAILKLTDFGFA-----------------------KETTGEK-YDKSCDMWS 183
Query: 172 FGVLLLQIISGKRLSMLCG 190
GV++ I +LCG
Sbjct: 184 LGVIMY-I-------LLCG 194
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 35/103 (33%), Positives = 46/103 (44%), Gaps = 17/103 (16%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEAN--TEQVV 147
I L YL L I++RDLK NILL ++DFGL KE++E N T
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGL----CKENIEHNSTTSTFC 200
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190
GT Y+ PE + Y D + G +L + ML G
Sbjct: 201 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYE--------MLYG 235
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 5e-11
Identities = 50/212 (23%), Positives = 91/212 (42%), Gaps = 47/212 (22%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKN---------EVMLTAKLQ-HVNLIRVLGFCI--DSEER 53
G+V+AVKK+ F+N E+M+ +L H N++ +L + +
Sbjct: 34 GEVVAVKKIFDA-------FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86
Query: 54 MLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKAS 113
LV++YM + L IR IL+ + +++ + + + YL ++HRD+K S
Sbjct: 87 YLVFDYM-----ETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPS 138
Query: 114 NILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV----------- 162
NILL + K++DFGL+R F N + + + +
Sbjct: 139 NILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRA 198
Query: 163 ---------YSTKSDVFSFGVLLLQIISGKRL 185
Y+ D++S G +L +I+ GK +
Sbjct: 199 PEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 5e-11
Identities = 34/101 (33%), Positives = 53/101 (52%), Gaps = 13/101 (12%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGT 149
+ L +L L II+RDLK NILL E+ K++DFGL++ +A + GT
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 189
Query: 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190
+ Y+ PE + ++ +D +SFGVL+ + ML G
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFE--------MLTG 222
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 6e-11
Identities = 55/193 (28%), Positives = 89/193 (46%), Gaps = 30/193 (15%)
Query: 6 GKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMP 61
+ +A+K +S+ + + E+ L+H ++I+ L I + + +V EY
Sbjct: 34 QQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK-LYDVITTPTDIVMVIEYAG 92
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEGIT--QGLLYLQEYS-RLTIIHRDLKASNILLG 118
+ LFD I KKR+ EG Q ++ EY R I+HRDLK N+LL
Sbjct: 93 GE-----LFDYIVE-----KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD 142
Query: 119 EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYS-TKSDVFSFGVLLL 177
+++ KI+DFGL+ I + T G+ Y PE +Y+ + DV+S G++L
Sbjct: 143 DNLNVKIADFGLSNIMTDGNF-LKT--SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVL- 198
Query: 178 QIISGKRLSMLCG 190
ML G
Sbjct: 199 -------YVMLVG 204
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 6e-11
Identities = 37/103 (35%), Positives = 50/103 (48%), Gaps = 17/103 (16%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEAN--TEQVV 147
I GL +LQ II+RDLK N++L + KI+DFG+ KE++ T+
Sbjct: 130 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGM----CKENIWDGVTTKTFC 182
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190
GT YI PE Y D ++FGVLL + ML G
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE--------MLAG 217
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 6e-11
Identities = 35/103 (33%), Positives = 48/103 (46%), Gaps = 17/103 (16%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEAN--TEQVV 147
I+ L YL E II+RDLK N+LL + K++D+G+ KE L T
Sbjct: 119 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGM----CKEGLRPGDTTSTFC 171
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190
GT YI PE R Y D ++ GVL+ + M+ G
Sbjct: 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFE--------MMAG 206
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 7e-11
Identities = 30/103 (29%), Positives = 46/103 (44%), Gaps = 17/103 (16%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEAN--TEQVV 147
I L YL +++RD+K N++L +D KI+DFGL KE + +
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGL----CKEGISDGATMKTFC 166
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190
GT Y+ PE Y D + GV++ + M+CG
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE--------MMCG 201
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 8e-11
Identities = 35/103 (33%), Positives = 51/103 (49%), Gaps = 17/103 (16%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEAN--TEQVV 147
I L++L + II+RDLK N+LL + K++DFG+ KE + T
Sbjct: 133 IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGM----CKEGICNGVTTATFC 185
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190
GT YI PE ++ +Y D ++ GVLL + MLCG
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYE--------MLCG 220
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 61.6 bits (149), Expect = 9e-11
Identities = 37/103 (35%), Positives = 50/103 (48%), Gaps = 17/103 (16%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEAN--TEQVV 147
I GL +LQ II+RDLK N++L + KI+DFG+ KE++ T+
Sbjct: 451 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGM----CKENIWDGVTTKTFC 503
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190
GT YI PE Y D ++FGVLL + ML G
Sbjct: 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE--------MLAG 538
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 35/103 (33%), Positives = 48/103 (46%), Gaps = 17/103 (16%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEAN--TEQVV 147
I+ L YL E II+RDLK N+LL + K++D+G+ KE L T
Sbjct: 162 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGM----CKEGLRPGDTTSTFC 214
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190
GT YI PE R Y D ++ GVL+ + M+ G
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFE--------MMAG 249
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 39/103 (37%), Positives = 51/103 (49%), Gaps = 17/103 (16%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEAN--TEQVV 147
I GL +L I++RDLK NILL +D KI+DFG+ KE++ + T
Sbjct: 127 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGM----CKENMLGDAKTNTFC 179
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190
GT YI PE Y+ D +SFGVLL + ML G
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYE--------MLIG 214
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-10
Identities = 32/107 (29%), Positives = 48/107 (44%), Gaps = 22/107 (20%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEAN---TEQV 146
I L +L + L II+RD+K NILL + ++DFGL +KE +
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL----SKEFVADETERAYDF 220
Query: 147 VGTIGYIPPE---YARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190
GTI Y+ P+ G + D +S GVL+ + +L G
Sbjct: 221 CGTIEYMAPDIVRGGDSG-HDKAVDWWSLGVLMYE--------LLTG 258
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 6e-10
Identities = 51/194 (26%), Positives = 81/194 (41%), Gaps = 27/194 (13%)
Query: 6 GKVIAVKKLSKTSTQGFEE---FKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMP 61
KV A+K LSK + F E + A +++ L + + + +V EYMP
Sbjct: 94 RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ-LFYAFQDDRYLYMVMEYMP 152
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
L + + + W R + E + L + + IHRD+K N+LL +
Sbjct: 153 GGDLVNLMSN--YDVPEKWA-RFYTAE-VVLALDAIHS---MGFIHRDVKPDNMLLDKSG 205
Query: 122 KPKISDFGLA-RIFAKESLEANTEQVVGTIGYIPPE----YARQGVYSTKSDVFSFGVLL 176
K++DFG ++ + + +T VGT YI PE G Y + D +S GV L
Sbjct: 206 HLKLADFGTCMKMNKEGMVRCDT--AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 263
Query: 177 LQIISGKRLSMLCG 190
+ ML G
Sbjct: 264 YE--------MLVG 269
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 7e-10
Identities = 46/188 (24%), Positives = 77/188 (40%), Gaps = 22/188 (11%)
Query: 6 GKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
G A+K L K + E NE + + L+++ D+ +V EY+
Sbjct: 66 GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
+ +L I R R + + I YL L +I+RDLK N+L+ +
Sbjct: 126 GEMFSHLRR-IGRFSEPHA-RFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 123 PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
+++DFG FAK ++ T + GT + PE Y+ D ++ GVL+ +
Sbjct: 180 IQVTDFG----FAKR-VKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE---- 230
Query: 183 KRLSMLCG 190
M G
Sbjct: 231 ----MAAG 234
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 3e-09
Identities = 37/101 (36%), Positives = 49/101 (48%), Gaps = 16/101 (15%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGT 149
+ L YL II+RDLK NILL ++ KI+DFG FAK + T + GT
Sbjct: 115 VCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFG----FAKY-VPDVTYTLCGT 166
Query: 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190
YI PE Y+ D +SFG+L+ + ML G
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYE--------MLAG 199
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 9e-08
Identities = 50/323 (15%), Positives = 101/323 (31%), Gaps = 71/323 (21%)
Query: 1 GVLPCGK-VIAVKKLSKTSTQGFEEFKNEVM-LTAKLQHVNLIRVLGFCIDSEERM---- 54
GVL GK +A+ Q + ++ L L C E +
Sbjct: 157 GVLGSGKTWVALDVCLSYKVQ--CKMDFKIFWLN-----------LKNCNSPETVLEMLQ 203
Query: 55 -LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKAS 113
L+Y+ PN + I+ I + + + LL + Y ++ +++ +
Sbjct: 204 KLLYQIDPNWTSRSDHSSNIKLRIHSIQAEL-------RRLLKSKPYENCLLVLLNVQNA 256
Query: 114 NILLGEDMKPKISDFGLARIFAKESLEANTEQVVG-TIGYIPPEYARQGVYSTKSDVFSF 172
+ +I + T+ + T +I ++ + T +V S
Sbjct: 257 KAW-------NAFNLS-CKILLTTRFKQVTDFLSAATTTHISLDHHSMTL--TPDEVKS- 305
Query: 173 GVLLLQIISGKRLSML----CGIN--------ENLSILEHAYELWK---GGKGVEFVDSS 217
LLL+ + R L N E++ ++ WK K ++SS
Sbjct: 306 --LLLKYL-DCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESS 362
Query: 218 LDDTNSPCKLMRCLE-IALLCVQENPNDRPSMLQVSSMLKNETTNRNTP-------KKPA 269
L+ P + + + +++ P + S++ + + K
Sbjct: 363 LNVLE-PAEYRKMFDRLSVF-----PPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSL 416
Query: 270 FSKQVDEIGIELLSTTQLEKCSA 292
KQ E I + S K
Sbjct: 417 VEKQPKESTISIPSIYLELKVKL 439
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 40.6 bits (94), Expect = 6e-04
Identities = 52/330 (15%), Positives = 102/330 (30%), Gaps = 79/330 (23%)
Query: 14 LSKTSTQGFEEFKNEVM------LTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
L + ++F EV+ L + ++ +Y ++
Sbjct: 71 LLSKQEEMVQKFVEEVLRINYKFLMSPIKTE--------QRQPSMMTRMYIEQRDR---- 118
Query: 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL---K---ASNILLGEDM 121
L++ + R+ + Q LL L+ + +I L K A ++ L +
Sbjct: 119 -LYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNV-LIDGVLGSGKTWVALDVCLSYKV 176
Query: 122 KPKISDFGLARIF-----AKESLEANTEQVVGTIGYIPPEYARQ--GVYSTKSDVFSFGV 174
+ K+ DF IF S E E + + I P + + + K + S
Sbjct: 177 QCKM-DFK---IFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQA 232
Query: 175 LLLQIISGKRLSMLCGINENLSILEHAY--ELWKG------------GKGV-EFVDS--- 216
L +++ K L +L + + W K V +F+ +
Sbjct: 233 ELRRLLKSKPY------ENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATT 286
Query: 217 ---SLDDTNSPCKLMRCLEIALLCVQENPNDRPS-MLQVS----SMLKNETTNRNTPKKP 268
SLD + + L + P D P +L + S++ R+
Sbjct: 287 THISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESI--RDGLATW 344
Query: 269 AFSKQVD--------EIGIELLSTTQLEKC 290
K V+ E + +L + K
Sbjct: 345 DNWKHVNCDKLTTIIESSLNVLEPAEYRKM 374
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 4e-07
Identities = 38/179 (21%), Positives = 59/179 (32%), Gaps = 67/179 (37%)
Query: 67 CYLFDPIRRLILDWKKR-----------VHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
C +F+ + +L W + II+ + QGL YL ++ IIH D+K NI
Sbjct: 121 CMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENI 178
Query: 116 LLG-------------------------------------------------EDMKPKIS 126
LL E +K KI+
Sbjct: 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238
Query: 127 DFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRL 185
D G A K E + T Y E Y+T +D++S + ++ +G L
Sbjct: 239 DLGNACWVHKHFTE-----DIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYL 292
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 9e-06
Identities = 29/107 (27%), Positives = 47/107 (43%), Gaps = 13/107 (12%)
Query: 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP------KISDFGLARIFAKES 138
I + + GL Y+ + R IIH D+K N+L+ P KI+D G A + E
Sbjct: 135 QISKQLLLGLDYM--HRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDEH 191
Query: 139 LEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRL 185
+ T Y PE + +D++S L+ ++I+G L
Sbjct: 192 Y----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 234
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 3e-05
Identities = 15/80 (18%), Positives = 27/80 (33%), Gaps = 6/80 (7%)
Query: 55 LVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASN 114
+V E+ + +R + I+ +T L + L HRDL N
Sbjct: 139 IVLEFEFGGID----LEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGN 192
Query: 115 ILLGEDMKPKISDFGLARIF 134
+LL + K+ +
Sbjct: 193 VLLKKTSLKKLHYTLNGKSS 212
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 28/98 (28%), Positives = 45/98 (45%), Gaps = 10/98 (10%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP--KISDFGLARIFAKESLEANTEQVV 147
I Q L L + IIH DLK NILL + + K+ DFG + + + + +
Sbjct: 209 ILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYEHQRV----YTYI 260
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRL 185
+ Y PE Y D++S G +L ++++G L
Sbjct: 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPL 298
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 23/136 (16%), Positives = 51/136 (37%), Gaps = 19/136 (13%)
Query: 13 KLSKTSTQGFEEFK-----------NEVMLTAKLQHVNLIRVLGFCIDSEE-RMLVYEYM 60
KL + F E N+ + + +GF + ++ R LV +
Sbjct: 81 KLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL 140
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
+SL D + +L + + + + L +L E +H ++ A NI + +
Sbjct: 141 -GRSLQ-SALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPE 195
Query: 121 MKPKI--SDFGLARIF 134
+ ++ + +G A +
Sbjct: 196 DQSQVTLAGYGFAFRY 211
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 40/146 (27%), Positives = 62/146 (42%), Gaps = 16/146 (10%)
Query: 90 ITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP--KISDFGLARIFAKESLEANTEQVV 147
+ LL+L L+IIH DLK NILL + KI DFG + + + Q +
Sbjct: 166 MCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRI----YQYI 219
Query: 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRL-------SMLCGINENLSILEH 200
+ Y PE Y D++S G +L+++ +G+ L + I E L I
Sbjct: 220 QSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA 279
Query: 201 AYELWKGGKGVEFVDSSLDDTNSPCK 226
L + K +F + D T + K
Sbjct: 280 HI-LDQAPKARKFFEKLPDGTWNLKK 304
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 3e-04
Identities = 11/32 (34%), Positives = 21/32 (65%), Gaps = 2/32 (6%)
Query: 105 IIHRDLKASNILLGEDMKPKI--SDFGLARIF 134
+H D+KA+N+LLG ++ +D+GL+ +
Sbjct: 172 YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 4e-04
Identities = 12/32 (37%), Positives = 19/32 (59%), Gaps = 2/32 (6%)
Query: 105 IIHRDLKASNILLGEDMKPKI--SDFGLARIF 134
+H D+KASN+LL ++ D+GLA +
Sbjct: 173 YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 303 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.66 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.48 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.07 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.95 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.82 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.49 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.49 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.36 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.14 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.13 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.96 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.73 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.73 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.63 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.42 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.38 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.37 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.3 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.23 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.06 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.0 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.98 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.97 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.84 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.68 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.39 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.95 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.48 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 92.52 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.68 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 90.11 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=369.52 Aligned_cols=238 Identities=28% Similarity=0.474 Sum_probs=196.4
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCc----------c
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDP----------I 73 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------~ 73 (303)
.+|+.||||+++.......+.|.+|+.+|++++||||+++++++.+++..++|||||++|+|.+++... .
T Consensus 41 ~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~ 120 (299)
T 4asz_A 41 QDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGN 120 (299)
T ss_dssp --CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----
T ss_pred CCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccC
Confidence 358899999998777667788999999999999999999999999999999999999999999999642 1
Q ss_pred ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCC
Q 048243 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYI 153 (303)
Q Consensus 74 ~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~ 153 (303)
....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...............||+.|+
T Consensus 121 ~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ym 197 (299)
T 4asz_A 121 PPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197 (299)
T ss_dssp CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGC
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhc
Confidence 2356999999999999999999999999 9999999999999999999999999998765544334444467899999
Q ss_pred ChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHH
Q 048243 154 PPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLE 232 (303)
Q Consensus 154 aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 232 (303)
|||++.+..++.++|||||||++|||+| |+.||...+... ... .... +.... .+...+.++.+
T Consensus 198 APE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~---~i~~-~~~~~---------~p~~~~~~~~~ 261 (299)
T 4asz_A 198 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIE---CITQ-GRVLQ---------RPRTCPQEVYE 261 (299)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHH---HHHH-TCCCC---------CCTTCCHHHHH
T ss_pred CHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH---HHHc-CCCCC---------CCccchHHHHH
Confidence 9999999999999999999999999998 899986543221 111 1111 11111 11223457889
Q ss_pred HHHHcccCCCCCCCCHHHHHHHhccccC
Q 048243 233 IALLCVQENPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 233 li~~~l~~dp~~Rpt~~el~~~L~~~~~ 260 (303)
|+.+||+.||++|||+.||.+.|++...
T Consensus 262 li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 262 LMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999987653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-54 Score=370.17 Aligned_cols=238 Identities=27% Similarity=0.436 Sum_probs=187.5
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc----------
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI---------- 73 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------- 73 (303)
.+|+.||||+++.......+.|.+|+.+|++++||||+++++++.+....++|||||++|+|.+++....
T Consensus 69 ~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~ 148 (329)
T 4aoj_A 69 QDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGE 148 (329)
T ss_dssp --CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC--------
T ss_pred CCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccc
Confidence 3688999999987776677889999999999999999999999999999999999999999999986532
Q ss_pred --ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccC
Q 048243 74 --RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIG 151 (303)
Q Consensus 74 --~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~ 151 (303)
....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...............||+.
T Consensus 149 ~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ 225 (329)
T 4aoj_A 149 DVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225 (329)
T ss_dssp ---CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGG
T ss_pred cccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEEEcccccceeccCCCcceecCccccccc
Confidence 2346899999999999999999999998 99999999999999999999999999987655444444445678999
Q ss_pred CCChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHH
Q 048243 152 YIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRC 230 (303)
Q Consensus 152 y~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 230 (303)
|+|||++.+..++.++|||||||++|||+| |+.||....... ... ....+ ...+ .+...+.++
T Consensus 226 ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~---~i~~g-~~~~---------~p~~~~~~~ 289 (329)
T 4aoj_A 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---AID---CITQG-RELE---------RPRACPPEV 289 (329)
T ss_dssp GCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---HHH---HHHHT-CCCC---------CCTTCCHHH
T ss_pred ccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---HHH---HHHcC-CCCC---------CcccccHHH
Confidence 999999999999999999999999999998 899986543221 111 11111 1111 112234578
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHhccccC
Q 048243 231 LEIALLCVQENPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 231 ~~li~~~l~~dp~~Rpt~~el~~~L~~~~~ 260 (303)
.+|+.+||+.||++|||+.||++.|+....
T Consensus 290 ~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 290 YAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 899999999999999999999999988754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=368.00 Aligned_cols=227 Identities=22% Similarity=0.315 Sum_probs=188.6
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+|+.||||++........+.+.+|+.+|++++||||+++++++.+++.+|+|||||+||+|.+++. ...+++..+
T Consensus 97 ~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~----~~~l~e~~~ 172 (346)
T 4fih_A 97 SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT----HTRMNEEQI 172 (346)
T ss_dssp TTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHH----HSCCCHHHH
T ss_pred CCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHH----cCCCCHHHH
Confidence 5799999999976655556778999999999999999999999999999999999999999999883 356999999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+++.+.... ......+||+.|+|||++.+..|
T Consensus 173 ~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y 247 (346)
T 4fih_A 173 AAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPY 247 (346)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCB
T ss_pred HHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--CcccccccCcCcCCHHHHCCCCC
Confidence 999999999999999999 9999999999999999999999999998765432 22344689999999999999999
Q ss_pred CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCC
Q 048243 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 243 (303)
+.++|||||||++|+|++|..||...+... .... ... .... ........+.++.+||.+||+.||+
T Consensus 248 ~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~---i~~-~~~~-------~~~~~~~~s~~~~dli~~~L~~dP~ 313 (346)
T 4fih_A 248 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKM---IRD-NLPP-------RLKNLHKVSPSLKGFLDRLLVRDPA 313 (346)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHH---HHH-SSCC-------CCSCGGGSCHHHHHHHHHHSCSSTT
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHH---HHc-CCCC-------CCCccccCCHHHHHHHHHHcCCChh
Confidence 999999999999999999999996432211 1111 111 1100 0111123345889999999999999
Q ss_pred CCCCHHHHHH
Q 048243 244 DRPSMLQVSS 253 (303)
Q Consensus 244 ~Rpt~~el~~ 253 (303)
+|||+.|+++
T Consensus 314 ~R~ta~e~l~ 323 (346)
T 4fih_A 314 QRATAAELLK 323 (346)
T ss_dssp TSCCHHHHTT
T ss_pred HCcCHHHHhc
Confidence 9999999976
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-53 Score=362.49 Aligned_cols=236 Identities=25% Similarity=0.388 Sum_probs=193.0
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc---------
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI--------- 73 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------- 73 (303)
.+++.||||+++... ....+.|.+|+.++++++||||+++++++.+++..++|||||++|+|.++|....
T Consensus 54 ~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~ 133 (308)
T 4gt4_A 54 EQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTD 133 (308)
T ss_dssp --CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC---
T ss_pred CCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccc
Confidence 467899999997553 3456789999999999999999999999999999999999999999999996421
Q ss_pred ----ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccc
Q 048243 74 ----RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGT 149 (303)
Q Consensus 74 ----~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~ 149 (303)
....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...............||
T Consensus 134 ~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt 210 (308)
T 4gt4_A 134 DDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 210 (308)
T ss_dssp --CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBC
T ss_pred cccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccC
Confidence 1356899999999999999999999999 999999999999999999999999999876554444444556789
Q ss_pred cCCCChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHH
Q 048243 150 IGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLM 228 (303)
Q Consensus 150 ~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
+.|+|||++.+..++.++|||||||++|||+| |..||....... .......+...+ .+...+.
T Consensus 211 ~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~-------~~~~i~~~~~~~---------~p~~~~~ 274 (308)
T 4gt4_A 211 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-------VVEMIRNRQVLP---------CPDDCPA 274 (308)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH-------HHHHHHTTCCCC---------CCTTCCH
T ss_pred CcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCC---------CcccchH
Confidence 99999999999999999999999999999998 889986543211 112222222111 1122345
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHhccc
Q 048243 229 RCLEIALLCVQENPNDRPSMLQVSSMLKNE 258 (303)
Q Consensus 229 ~l~~li~~~l~~dp~~Rpt~~el~~~L~~~ 258 (303)
.+.+|+.+||+.||++|||+.||++.|+..
T Consensus 275 ~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 275 WVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 788999999999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-53 Score=363.70 Aligned_cols=243 Identities=19% Similarity=0.202 Sum_probs=191.4
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+|+.||||+++.... ..+|+.+++.++||||+++++++.+++..|+|||||+||+|.+++. ..+.+++..+
T Consensus 81 ~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~---~~~~l~e~~~ 152 (336)
T 4g3f_A 81 QTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK---QMGCLPEDRA 152 (336)
T ss_dssp TTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHH---HHSSCCHHHH
T ss_pred CCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHH---HcCCCCHHHH
Confidence 5799999999976532 2469999999999999999999999999999999999999999994 4567999999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCC-ceEEcccccccccccCCccc---cccccccccCCCChhhhc
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM-KPKISDFGLARIFAKESLEA---NTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~-~v~l~Df~~~~~~~~~~~~~---~~~~~~g~~~y~aPE~~~ 159 (303)
..++.||+.||+|||+++ |+||||||+|||++.+| .+||+|||+++......... ......||+.|+|||++.
T Consensus 153 ~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~ 229 (336)
T 4g3f_A 153 LYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229 (336)
T ss_dssp HHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHC
Confidence 999999999999999999 99999999999999987 69999999998765432211 123457999999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++|||||||++|+|++|.+||...........+ ....... ... ++..+..+.+||.+||+
T Consensus 230 ~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~~~~~~~----~~~----~~~~s~~~~~li~~~L~ 295 (336)
T 4g3f_A 230 GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI------ASEPPPI----REI----PPSCAPLTAQAIQEGLR 295 (336)
T ss_dssp TCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH------HHSCCGG----GGS----CTTSCHHHHHHHHHHTC
T ss_pred CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH------HcCCCCc----hhc----CccCCHHHHHHHHHHcc
Confidence 999999999999999999999999999754443322111 1111100 011 12234578899999999
Q ss_pred CCCCCCCCHHHHHHHhccccCCCCCCCCCCCc
Q 048243 240 ENPNDRPSMLQVSSMLKNETTNRNTPKKPAFS 271 (303)
Q Consensus 240 ~dp~~Rpt~~el~~~L~~~~~~~~~~~~~~~~ 271 (303)
.||.+|||+.|+++.|.........-..||..
T Consensus 296 ~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~ 327 (336)
T 4g3f_A 296 KEPVHRASAMELRRKVGKALQEVGGLKSPWKG 327 (336)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSS
T ss_pred CCHhHCcCHHHHHHHHHHHHhhhhhccCCCcC
Confidence 99999999999998876655444433444443
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-53 Score=361.41 Aligned_cols=227 Identities=24% Similarity=0.309 Sum_probs=190.0
Q ss_pred cCCCcEEEEEEecCC---CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 3 LPCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 3 ~~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
..+|+.||||++.+. .....+.+.+|+++|++++||||+++++++.+++..|+|||||+||+|.+++. ..+.++
T Consensus 54 ~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~---~~~~l~ 130 (311)
T 4aw0_A 54 LATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFD 130 (311)
T ss_dssp TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH---HHSSCC
T ss_pred CCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHH---HcCCCC
Confidence 367999999999653 23456789999999999999999999999999999999999999999999994 456799
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+++.+............+||+.|+|||++.
T Consensus 131 e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~ 207 (311)
T 4aw0_A 131 ETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 207 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHc
Confidence 9999999999999999999999 9999999999999999999999999998876554444455678999999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++|||||||++|+|++|..||...+... .. ........ .+. ...+.++.+||.+||+
T Consensus 208 ~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~---~~i~~~~~-------~~p----~~~s~~~~dli~~lL~ 270 (311)
T 4aw0_A 208 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL---IF---AKIIKLEY-------DFP----EKFFPKARDLVEKLLV 270 (311)
T ss_dssp HSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHHTCC-------CCC----TTCCHHHHHHHHHHSC
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HH---HHHHcCCC-------CCC----cccCHHHHHHHHHHcc
Confidence 9999999999999999999999999996433211 11 11122111 111 1234578899999999
Q ss_pred CCCCCCCCHHHHH
Q 048243 240 ENPNDRPSMLQVS 252 (303)
Q Consensus 240 ~dp~~Rpt~~el~ 252 (303)
.||++|||++|++
T Consensus 271 ~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 271 LDATKRLGCEEME 283 (311)
T ss_dssp SSGGGSTTSGGGT
T ss_pred CCHhHCcChHHHc
Confidence 9999999999863
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-53 Score=364.53 Aligned_cols=229 Identities=21% Similarity=0.322 Sum_probs=188.7
Q ss_pred cCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 3 LPCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 3 ~~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
..+|+.||||+++... ....+.+.+|+.+|++++||||+++++++.+++..|+|||||+||+|.+++.. ..+..+++
T Consensus 46 ~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~-~~~~~~~e 124 (350)
T 4b9d_A 46 TEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINA-QKGVLFQE 124 (350)
T ss_dssp TTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-TTTCCCCH
T ss_pred CCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHH-cCCCCCCH
Confidence 3579999999997553 34467899999999999999999999999999999999999999999999954 23456789
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+++...... .......||+.|+|||++.+
T Consensus 125 ~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~l~~ 199 (350)
T 4b9d_A 125 DQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV--ELARACIGTPYYLSPEICEN 199 (350)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH--HHHHHHHSCCTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc--ccccccCCCccccCHHHHCC
Confidence 999999999999999999999 9999999999999999999999999998754321 12234679999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|||||||++|+|++|..||...+... .......... .. .....+.++.+||.+||+.
T Consensus 200 ~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~~~~~-~~---------~~~~~s~~~~~li~~~L~~ 263 (350)
T 4b9d_A 200 KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN------LVLKIISGSF-PP---------VSLHYSYDLRSLVSQLFKR 263 (350)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHTCC-CC---------CCTTSCHHHHHHHHHHTCS
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHcCCC-CC---------CCccCCHHHHHHHHHHccC
Confidence 999999999999999999999999996443211 1112222111 10 1112345788999999999
Q ss_pred CCCCCCCHHHHHH
Q 048243 241 NPNDRPSMLQVSS 253 (303)
Q Consensus 241 dp~~Rpt~~el~~ 253 (303)
||++|||+.|+++
T Consensus 264 dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 264 NPRDRPSVNSILE 276 (350)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhHCcCHHHHhc
Confidence 9999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=369.45 Aligned_cols=227 Identities=22% Similarity=0.315 Sum_probs=189.0
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+|+.||||++........+.+.+|+.+|+.++||||+++++++.+.+.+|+|||||+||+|.+++. ...+++..+
T Consensus 174 ~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~----~~~l~e~~~ 249 (423)
T 4fie_A 174 SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT----HTRMNEEQI 249 (423)
T ss_dssp TTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHH----HSCCCHHHH
T ss_pred CCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHh----ccCCCHHHH
Confidence 5799999999987666666789999999999999999999999999999999999999999999883 346999999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+++.+.... ......+||+.|+|||++.+..|
T Consensus 250 ~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y 324 (423)
T 4fie_A 250 AAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPY 324 (423)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--CCBCCCEECTTTCCHHHHTTCCB
T ss_pred HHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC--ccccccccCcCcCCHHHHCCCCC
Confidence 999999999999999999 9999999999999999999999999998765432 22344689999999999999999
Q ss_pred CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCC
Q 048243 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 243 (303)
+.++|||||||++|+|++|..||....... ... ..... .... .......+.++.+||.+||..||+
T Consensus 325 ~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~---~i~~~-~~~~-------~~~~~~~s~~~~dli~~~L~~dP~ 390 (423)
T 4fie_A 325 GPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMK---MIRDN-LPPR-------LKNLHKVSPSLKGFLDRLLVRDPA 390 (423)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHH---HHHHS-CCCC-------CSCTTSSCHHHHHHHHHHSCSSTT
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHH---HHHcC-CCCC-------CcccccCCHHHHHHHHHHcCCChh
Confidence 999999999999999999999996432211 111 11111 1000 111122345788999999999999
Q ss_pred CCCCHHHHHH
Q 048243 244 DRPSMLQVSS 253 (303)
Q Consensus 244 ~Rpt~~el~~ 253 (303)
+|||+.|+++
T Consensus 391 ~R~ta~ell~ 400 (423)
T 4fie_A 391 QRATAAELLK 400 (423)
T ss_dssp TSCCHHHHTT
T ss_pred HCcCHHHHhc
Confidence 9999999986
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=351.03 Aligned_cols=237 Identities=27% Similarity=0.389 Sum_probs=182.0
Q ss_pred cEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHH
Q 048243 7 KVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 7 ~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~ 84 (303)
..||||+++... ....+.|.+|+.++++++||||+++++++.. +..++|||||++|+|.+++.. ....+++..+.
T Consensus 59 ~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~--~~~~l~~~~~~ 135 (307)
T 3omv_A 59 GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHV--QETKFQMFQLI 135 (307)
T ss_dssp SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHT--SCCCCCHHHHH
T ss_pred CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhh--cCCCCCHHHHH
Confidence 369999997543 3455789999999999999999999998754 568999999999999999854 34569999999
Q ss_pred HHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc---C
Q 048243 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ---G 161 (303)
Q Consensus 85 ~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~ 161 (303)
.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+ .
T Consensus 136 ~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~ 212 (307)
T 3omv_A 136 DIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNN 212 (307)
T ss_dssp HHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSC
T ss_pred HHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCC
Confidence 99999999999999998 99999999999999999999999999987654333333445689999999999864 3
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
.++.++|||||||++|||++|+.||....... ............. .+ .......+..+.+|+.+||+.|
T Consensus 213 ~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~~~~p----~~-~~~~~~~~~~l~~li~~cl~~d 281 (307)
T 3omv_A 213 PFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRGYASP----DL-SKLYKNCPKAMKRLVADCVKKV 281 (307)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTTCCCC----CS-TTSCTTSCHHHHHHHHHHTCSS
T ss_pred CCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCCCC----Cc-ccccccchHHHHHHHHHHcCCC
Confidence 58999999999999999999999996443221 1111111111111 00 0111223457889999999999
Q ss_pred CCCCCCHHHHHHHhccccC
Q 048243 242 PNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 242 p~~Rpt~~el~~~L~~~~~ 260 (303)
|++|||+.||++.|+....
T Consensus 282 P~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 282 KEERPLFPQILSSIELLQH 300 (307)
T ss_dssp STTSCCHHHHHHHHHHHHT
T ss_pred HhHCcCHHHHHHHHHHHhc
Confidence 9999999999999876653
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=344.96 Aligned_cols=223 Identities=23% Similarity=0.353 Sum_probs=174.4
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||||+++... ....+.+.+|+.++++++||||+++++++.+++..|+||||| +|+|.+++. ....+++
T Consensus 36 ~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~---~~~~l~e 111 (275)
T 3hyh_A 36 TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIV---QRDKMSE 111 (275)
T ss_dssp TTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHH---HSCSCCH
T ss_pred CCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHH---HcCCCCH
Confidence 579999999997542 344568999999999999999999999999999999999999 678988884 4567999
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...... ......||+.|+|||++.+
T Consensus 112 ~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~ 185 (275)
T 3hyh_A 112 QEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISG 185 (275)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------------------CTTSCHHHHSS
T ss_pred HHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCC---ccCCeeECcccCChhhhcC
Confidence 999999999999999999999 9999999999999999999999999997654332 2234679999999999998
Q ss_pred CCC-CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 161 GVY-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 161 ~~~-~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
..+ +.++||||+||++|+|++|..||...+... ... ....... .+ +...+.++.+||.+||+
T Consensus 186 ~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~---~~~---~i~~~~~-------~~----p~~~s~~~~~li~~~L~ 248 (275)
T 3hyh_A 186 KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV---LFK---NISNGVY-------TL----PKFLSPGAAGLIKRMLI 248 (275)
T ss_dssp SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHHTCC-------CC----CTTSCHHHHHHHHHHSC
T ss_pred CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHH---HHHcCCC-------CC----CCCCCHHHHHHHHHHcc
Confidence 876 579999999999999999999996432111 111 1111110 01 11234578899999999
Q ss_pred CCCCCCCCHHHHHH
Q 048243 240 ENPNDRPSMLQVSS 253 (303)
Q Consensus 240 ~dp~~Rpt~~el~~ 253 (303)
.||++|||++|+++
T Consensus 249 ~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 249 VNPLNRISIHEIMQ 262 (275)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhHCcCHHHHHc
Confidence 99999999999987
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=341.55 Aligned_cols=227 Identities=26% Similarity=0.369 Sum_probs=180.3
Q ss_pred CCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEe----CCeeEEEEeecCCCChhhhhcCcccccc
Q 048243 4 PCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCID----SEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
.+|+.||+|++... .....+.+.+|+.++++++||||+++++++.+ +...|+|||||++|+|.+++. ....
T Consensus 49 ~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~---~~~~ 125 (290)
T 3fpq_A 49 ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKV 125 (290)
T ss_dssp TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHH---HHSS
T ss_pred CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHH---hcCC
Confidence 57899999999644 34456789999999999999999999999875 345799999999999999994 4567
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC-CCceEEcccccccccccCCccccccccccccCCCChh
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE 156 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE 156 (303)
+++..+..++.||+.||+|||+++ .+|+||||||+|||++. +|.+||+|||+|+..... ......||+.|+|||
T Consensus 126 l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~----~~~~~~GTp~YmAPE 200 (290)
T 3fpq_A 126 MKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPE 200 (290)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC----ccCCcccCccccCHH
Confidence 999999999999999999999874 35999999999999984 789999999999754322 223467999999999
Q ss_pred hhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 157 YARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
++.+ .++.++|||||||++|+|++|..||....... ................ .. .+.++.+||.+
T Consensus 201 ~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~------~~~~~i~~~~~~~~~~----~~----~~~~~~~li~~ 265 (290)
T 3fpq_A 201 MYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVKPASFD----KV----AIPEVKEIIEG 265 (290)
T ss_dssp GGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCCCGGGG----GC----CCHHHHHHHHH
T ss_pred HcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH------HHHHHHHcCCCCCCCC----cc----CCHHHHHHHHH
Confidence 9875 58999999999999999999999996432211 1112222221111111 11 22368899999
Q ss_pred cccCCCCCCCCHHHHHH
Q 048243 237 CVQENPNDRPSMLQVSS 253 (303)
Q Consensus 237 ~l~~dp~~Rpt~~el~~ 253 (303)
||+.||++|||+.|+++
T Consensus 266 ~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 266 CIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HSCSSGGGSCCHHHHHT
T ss_pred HccCChhHCcCHHHHhc
Confidence 99999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=350.20 Aligned_cols=225 Identities=20% Similarity=0.267 Sum_probs=176.8
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
++++.||||+++... ......+.+|+.++++++||||+++++++.+++..|+|||||+||+|.+++. ..+.+++.
T Consensus 50 ~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~---~~~~l~e~ 126 (304)
T 3ubd_A 50 DARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS---KEVMFTEE 126 (304)
T ss_dssp TTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHH---HHCCCCHH
T ss_pred CCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHH---hcCCCCHH
Confidence 468899999997542 2233468889999999999999999999999999999999999999999994 45679999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
.+..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+++...... .......||+.|+|||++.+.
T Consensus 127 ~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~~~~~ 201 (304)
T 3ubd_A 127 DVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRR 201 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-------CCCCSCCCCGGGCCHHHHHTS
T ss_pred HHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCCC--ccccccccCcccCCHHHhccC
Confidence 99999999999999999999 9999999999999999999999999998654332 222346799999999999999
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
.++.++|||||||++|+|++|..||...+... .......... ..+...+.++.+||.+||+.|
T Consensus 202 ~y~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~~~~~-----------~~p~~~s~~~~~li~~~L~~d 264 (304)
T 3ubd_A 202 GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE------TMTMILKAKL-----------GMPQFLSPEAQSLLRMLFKRN 264 (304)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCC-----------CCCTTSCHHHHHHHHHHTCSS
T ss_pred CCCCCCcccchHHHHHHHHhCCCCCCCcCHHH------HHHHHHcCCC-----------CCCCcCCHHHHHHHHHHcccC
Confidence 99999999999999999999999996433221 1111111110 011123457889999999999
Q ss_pred CCCCCCH-----HHHHH
Q 048243 242 PNDRPSM-----LQVSS 253 (303)
Q Consensus 242 p~~Rpt~-----~el~~ 253 (303)
|++|||+ +|+++
T Consensus 265 P~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 265 PANRLGAGPDGVEEIKR 281 (304)
T ss_dssp GGGSTTCSTTTHHHHHT
T ss_pred HHHCCCCCcCCHHHHHc
Confidence 9999995 56654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=355.28 Aligned_cols=238 Identities=27% Similarity=0.401 Sum_probs=191.8
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCC-CccccEEEEEEeC-CeeEEEEeecCCCChhhhhcCccc------
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQH-VNLIRVLGFCIDS-EERMLVYEYMPNKSLDCYLFDPIR------ 74 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~------ 74 (303)
.+++.||||.++... ....+.+.+|+.+|.+++| |||++++++|... ...++|||||++|+|.++|.....
T Consensus 92 ~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~ 171 (353)
T 4ase_A 92 ATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 171 (353)
T ss_dssp TCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-
T ss_pred cCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhccccccccc
Confidence 356789999997654 3345679999999999965 8999999998764 568999999999999999964221
Q ss_pred -------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccc
Q 048243 75 -------RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVV 147 (303)
Q Consensus 75 -------~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~ 147 (303)
...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...............
T Consensus 172 ~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~ 248 (353)
T 4ase_A 172 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248 (353)
T ss_dssp ------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEE
T ss_pred ccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeecccc
Confidence 345899999999999999999999999 9999999999999999999999999998765544444445567
Q ss_pred cccCCCChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHH
Q 048243 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCK 226 (303)
Q Consensus 148 g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
||+.|+|||++.+..++.++|||||||++|||+| |..||......... ......+.... .+...
T Consensus 249 gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~------~~~i~~g~~~~---------~p~~~ 313 (353)
T 4ase_A 249 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------CRRLKEGTRMR---------APDYT 313 (353)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH------HHHHHHTCCCC---------CCTTC
T ss_pred ccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH------HHHHHcCCCCC---------CCccC
Confidence 8999999999999999999999999999999998 89999654433211 11122111111 11223
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhcccc
Q 048243 227 LMRCLEIALLCVQENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 227 ~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~ 259 (303)
+.++.+++.+||+.||++|||+.||++.|++..
T Consensus 314 ~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 314 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 457889999999999999999999999987653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=334.92 Aligned_cols=229 Identities=22% Similarity=0.279 Sum_probs=172.2
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCC------------eeEEEEeecCCCChhhhhc
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE------------ERMLVYEYMPNKSLDCYLF 70 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------------~~~lv~e~~~~~~L~~~l~ 70 (303)
.+|+.||||+++... ....+.+.+|+.+|++++||||+++++++.+.+ ..|+|||||++|+|.+++.
T Consensus 28 ~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~ 107 (299)
T 4g31_A 28 VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN 107 (299)
T ss_dssp TTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHH
T ss_pred CCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHH
Confidence 579999999996543 344567899999999999999999999987644 3699999999999999997
Q ss_pred CccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc----------
Q 048243 71 DPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE---------- 140 (303)
Q Consensus 71 ~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~---------- 140 (303)
........++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+++........
T Consensus 108 ~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~ 184 (299)
T 4g31_A 108 GRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184 (299)
T ss_dssp TCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCCCC-------------------
T ss_pred hcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccc
Confidence 5444445667788999999999999999999 999999999999999999999999999876543211
Q ss_pred ccccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCC
Q 048243 141 ANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDD 220 (303)
Q Consensus 141 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (303)
......+||+.|+|||++.+..++.++|||||||++|||++ ||... ......... ........
T Consensus 185 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~~~~~~~~-~~~~~~p~-------- 247 (299)
T 4g31_A 185 ARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----MERVRTLTD-VRNLKFPP-------- 247 (299)
T ss_dssp -------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHHHHHHHH-HHTTCCCH--------
T ss_pred cccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cHHHHHHHH-HhcCCCCC--------
Confidence 11233579999999999999999999999999999999996 55311 111111111 11111100
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 221 TNSPCKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 221 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
.....+..+.+||.+||+.||.+|||+.|+++
T Consensus 248 -~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 248 -LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01223345778999999999999999999987
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=338.47 Aligned_cols=247 Identities=22% Similarity=0.237 Sum_probs=179.7
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCC----eeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE----ERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
+|+.||||+++..... ......|+..+.+++||||+++++++..++ ..|+|||||++|+|.+++. ...+++
T Consensus 25 ~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~----~~~l~~ 99 (303)
T 3hmm_A 25 RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTV 99 (303)
T ss_dssp TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHH----HCCBCH
T ss_pred CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHH----hCCCCH
Confidence 5899999999654321 122344666667889999999999998654 5799999999999999994 446899
Q ss_pred HHHHHHHHHHHHHHHHHHhC-----CCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc--ccccccccccCCC
Q 048243 81 KKRVHIIEGITQGLLYLQEY-----SRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE--ANTEQVVGTIGYI 153 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~-----~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~--~~~~~~~g~~~y~ 153 (303)
..+.+++.|++.||+|||++ +..+|+||||||+|||++.++.+||+|||+++........ .......||+.|+
T Consensus 100 ~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ym 179 (303)
T 3hmm_A 100 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179 (303)
T ss_dssp HHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGC
T ss_pred HHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeeccccccccccc
Confidence 99999999999999999987 1223999999999999999999999999999876543322 1223457999999
Q ss_pred ChhhhccC------CCCCccchhhHHHHHHHHHhCCCCCccCCCCc--------cccHHHHHHHHHhCCCcceeccccCC
Q 048243 154 PPEYARQG------VYSTKSDVFSFGVLLLQIISGKRLSMLCGINE--------NLSILEHAYELWKGGKGVEFVDSSLD 219 (303)
Q Consensus 154 aPE~~~~~------~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (303)
|||++.+. .++.++|||||||++|||++|..||....... ................. .+.+.
T Consensus 180 APE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~----rp~~p 255 (303)
T 3hmm_A 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL----RPNIP 255 (303)
T ss_dssp CHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC----CCCCC
T ss_pred CHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccC----CCCCC
Confidence 99999764 35679999999999999999988775432211 00111111122111111 11111
Q ss_pred -CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccccC
Q 048243 220 -DTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 220 -~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~~ 260 (303)
.......+..+.+|+.+||+.||++|||+.||++.|++...
T Consensus 256 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 256 NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp GGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 11123455678899999999999999999999999987643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=339.10 Aligned_cols=245 Identities=20% Similarity=0.256 Sum_probs=183.6
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEe------CCeeEEEEeecCCCChhhhhcCcccc
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCID------SEERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~ 75 (303)
.+|+.||||+++... ....+.+.+|+.+|+.++||||+++++++.. .+..|+|||||+ |+|.+++. ..
T Consensus 77 ~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~---~~ 152 (398)
T 4b99_A 77 LTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIH---SS 152 (398)
T ss_dssp TTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHT---SS
T ss_pred CCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHH---hc
Confidence 579999999997543 3345678899999999999999999999764 357899999996 67988884 45
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCc--cccccccccccCCC
Q 048243 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL--EANTEQVVGTIGYI 153 (303)
Q Consensus 76 ~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~--~~~~~~~~g~~~y~ 153 (303)
+.+++..+..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+++.+..... .......+||+.|+
T Consensus 153 ~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~ 229 (398)
T 4b99_A 153 QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYR 229 (398)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTC
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhc
Confidence 67999999999999999999999999 99999999999999999999999999987644321 22234568999999
Q ss_pred ChhhhccC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcce-----------eccccCCCC
Q 048243 154 PPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVE-----------FVDSSLDDT 221 (303)
Q Consensus 154 aPE~~~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~ 221 (303)
|||++.+. .++.++||||+||++|+|++|.+||...+..... .............. .........
T Consensus 230 APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l---~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 306 (398)
T 4b99_A 230 APELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQL---QLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQ 306 (398)
T ss_dssp CHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH---HHHHHHHCCCCGGGTC-----CHHHHHHSSCCCC
T ss_pred CHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHH---HHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcC
Confidence 99998875 5699999999999999999999999654332222 11111111100000 000000000
Q ss_pred -C-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--Hhccc
Q 048243 222 -N-----SPCKLMRCLEIALLCVQENPNDRPSMLQVSS--MLKNE 258 (303)
Q Consensus 222 -~-----~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~--~L~~~ 258 (303)
. .+..+.++.+||.+||..||.+|||+.|+++ +|.+.
T Consensus 307 ~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 307 PVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp CCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred CCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 0 0112457889999999999999999999987 35544
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=319.61 Aligned_cols=255 Identities=35% Similarity=0.572 Sum_probs=215.3
Q ss_pred ccCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc-ccccCCH
Q 048243 2 VLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-RRLILDW 80 (303)
Q Consensus 2 ~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~l~~ 80 (303)
...+|+.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||+++++|.+++.... ....+++
T Consensus 59 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 138 (321)
T 2qkw_B 59 VLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSW 138 (321)
T ss_dssp ECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCH
T ss_pred EECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCH
Confidence 456799999999987766667889999999999999999999999999999999999999999999986532 2346899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++................|++.|+|||.+.+
T Consensus 139 ~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 215 (321)
T 2qkw_B 139 EQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK 215 (321)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcC
Confidence 999999999999999999999 99999999999999999999999999976544333333344568999999999988
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++||||||+++|+|++|..||............................++.......+..+..+.+++.+||+.
T Consensus 216 ~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 295 (321)
T 2qkw_B 216 GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLAL 295 (321)
T ss_dssp CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCS
T ss_pred CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCC
Confidence 88999999999999999999999999766655555555444444444545555566666667788889999999999999
Q ss_pred CCCCCCCHHHHHHHhcccc
Q 048243 241 NPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 241 dp~~Rpt~~el~~~L~~~~ 259 (303)
||++|||+.|+++.|+...
T Consensus 296 dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 296 SSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp SGGGSCCHHHHHHHHHHHH
T ss_pred CcccCcCHHHHHHHHHHHh
Confidence 9999999999999998664
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=347.66 Aligned_cols=229 Identities=21% Similarity=0.264 Sum_probs=188.8
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+|+.||+|++........+.+.+|+.+|+.++||||+++++++.+....|+|||||+||+|.+++.. ....+++..+
T Consensus 180 ~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~--~~~~l~e~~~ 257 (573)
T 3uto_A 180 ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEA 257 (573)
T ss_dssp TTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTC--TTSCEEHHHH
T ss_pred CCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHH--hCCCCCHHHH
Confidence 57999999999877666677899999999999999999999999999999999999999999998853 3456899999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCC--CceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED--MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~--~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++.+.... ......||+.|+|||++.+.
T Consensus 258 ~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~---~~~~~~GT~~y~APEv~~~~ 331 (573)
T 3uto_A 258 VEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGK 331 (573)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS---EEEEECSSGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC---ceeeeEECccccCHHHhCCC
Confidence 999999999999999999 9999999999999854 899999999998765432 22345799999999999999
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
.++.++|||||||++|+|++|..||....... ........... +........+..+.+||.+||+.|
T Consensus 332 ~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~------~~~~i~~~~~~-------~~~~~~~~~s~~~~dli~~~L~~d 398 (573)
T 3uto_A 332 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TLRNVKSCDWN-------MDDSAFSGISEDGKDFIRKLLLAD 398 (573)
T ss_dssp CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHTTCCC-------CCSGGGTTSCHHHHHHHHTTSCSS
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHhCCCC-------CCcccccCCCHHHHHHHHHHccCC
Confidence 99999999999999999999999996443221 11111111110 001111123457889999999999
Q ss_pred CCCCCCHHHHHH
Q 048243 242 PNDRPSMLQVSS 253 (303)
Q Consensus 242 p~~Rpt~~el~~ 253 (303)
|.+|||+.|+++
T Consensus 399 p~~R~t~~e~l~ 410 (573)
T 3uto_A 399 PNTRMTIHQALE 410 (573)
T ss_dssp GGGSCCHHHHHH
T ss_pred hhHCcCHHHHhc
Confidence 999999999987
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=323.53 Aligned_cols=175 Identities=24% Similarity=0.305 Sum_probs=149.1
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+++.||+|++.... ...++.+|+++|+.+ +||||+++++++.+.+..|+|||||++|+|.+++. .+++..
T Consensus 47 ~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~------~l~~~~ 118 (361)
T 4f9c_A 47 GPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN------SLSFQE 118 (361)
T ss_dssp SCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT------TCCHHH
T ss_pred CCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc------CCCHHH
Confidence 467899999986543 345788999999998 69999999999999999999999999999999882 388999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCC-CceEEcccccccccccCCcc---------------------
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED-MKPKISDFGLARIFAKESLE--------------------- 140 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~-~~v~l~Df~~~~~~~~~~~~--------------------- 140 (303)
++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+|+........
T Consensus 119 ~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (361)
T 4f9c_A 119 VREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSI 195 (361)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC----------------
T ss_pred HHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccc
Confidence 9999999999999999999 9999999999999876 79999999999765432110
Q ss_pred -----ccccccccccCCCChhhhccC-CCCCccchhhHHHHHHHHHhCCCCCccC
Q 048243 141 -----ANTEQVVGTIGYIPPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLC 189 (303)
Q Consensus 141 -----~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~ 189 (303)
......+||+.|+|||++.+. .++.++||||+||++|+|++|..||...
T Consensus 196 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 196 CLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp ----------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred cccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 111234799999999999875 4899999999999999999999999543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=337.10 Aligned_cols=226 Identities=23% Similarity=0.244 Sum_probs=180.7
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHH---HHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcccccc
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKN---EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
.+|+.||||++++.. ......+.+ ++.+++.++||||++++++|.+...+|+|||||+||+|..++. ..+.
T Consensus 212 ~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~---~~~~ 288 (689)
T 3v5w_A 212 DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGV 288 (689)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---HHCC
T ss_pred CCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHH---hcCC
Confidence 589999999996432 122233333 4667778899999999999999999999999999999999994 4567
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhh
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 157 (303)
+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+++.+.... ....+||+.|+|||+
T Consensus 289 l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPEv 361 (689)
T 3v5w_A 289 FSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEV 361 (689)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCC----CCSCCSCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCCCC----CCCccCCcCccCHHH
Confidence 999999999999999999999999 9999999999999999999999999998765432 234689999999999
Q ss_pred hcc-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 158 ARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 158 ~~~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
+.+ ..++.++|+|||||++|+|++|.+||.............. ..... ...+...+.++.+||.+
T Consensus 362 l~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~---i~~~~-----------~~~p~~~S~~a~dLI~~ 427 (689)
T 3v5w_A 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLTMA-----------VELPDSFSPELRSLLEG 427 (689)
T ss_dssp HSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH---HHHCC-----------CCCCTTSCHHHHHHHHH
T ss_pred HhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh---hcCCC-----------CCCCccCCHHHHHHHHH
Confidence 964 5799999999999999999999999975544332222111 11111 01112234578999999
Q ss_pred cccCCCCCCCC-----HHHHHH
Q 048243 237 CVQENPNDRPS-----MLQVSS 253 (303)
Q Consensus 237 ~l~~dp~~Rpt-----~~el~~ 253 (303)
||+.||.+|++ ++|+++
T Consensus 428 lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 428 LLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HTCSCGGGCTTCSSSTHHHHTT
T ss_pred HccCCHhHCCCCCCCCHHHHhc
Confidence 99999999998 678765
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=305.54 Aligned_cols=229 Identities=22% Similarity=0.342 Sum_probs=187.9
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
..+|+.||+|++........+.+.+|+.+++.++||||+++++++......++||||+.+++|.+++. ...+++..
T Consensus 42 ~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~ 117 (297)
T 3fxz_A 42 VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQ 117 (297)
T ss_dssp TTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHH----HSCCCHHH
T ss_pred CCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHh----hcCCCHHH
Confidence 36799999999976666667889999999999999999999999999999999999999999999984 34589999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++........ ......|++.|+|||.+.+..
T Consensus 118 ~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~ 192 (297)
T 3fxz_A 118 IAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKA 192 (297)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHHCSC
T ss_pred HHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--ccCCccCCcCccChhhhcCCC
Confidence 9999999999999999999 99999999999999999999999999876554322 233457899999999999999
Q ss_pred CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC
Q 048243 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 242 (303)
++.++|||||||++|+|++|..||....... .......... .....+...+..+.+++.+||+.||
T Consensus 193 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~dp 258 (297)
T 3fxz_A 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGT--------PELQNPEKLSAIFRDFLNRCLEMDV 258 (297)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCS--------CCCSCGGGSCHHHHHHHHHHSCSST
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC--------CCCCCccccCHHHHHHHHHHccCCh
Confidence 9999999999999999999999995432211 1111111110 0011112234578899999999999
Q ss_pred CCCCCHHHHHHH
Q 048243 243 NDRPSMLQVSSM 254 (303)
Q Consensus 243 ~~Rpt~~el~~~ 254 (303)
.+|||+.|+++.
T Consensus 259 ~~Rps~~ell~h 270 (297)
T 3fxz_A 259 EKRGSAKELLQH 270 (297)
T ss_dssp TTSCCHHHHTTC
T ss_pred hHCcCHHHHhhC
Confidence 999999999863
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=309.11 Aligned_cols=255 Identities=39% Similarity=0.639 Sum_probs=206.2
Q ss_pred ccCCCcEEEEEEecCCCc-ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc-ccccCC
Q 048243 2 VLPCGKVIAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-RRLILD 79 (303)
Q Consensus 2 ~~~~~~~valK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~l~ 79 (303)
...+|+.||||++..... .....+.+|+.+++.++||||+++++++......++||||+.+++|.+++.... ....++
T Consensus 50 ~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 129 (326)
T 3uim_A 50 RLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLD 129 (326)
T ss_dssp CCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCC
T ss_pred EecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCC
Confidence 356799999999976532 223468899999999999999999999999999999999999999999996533 244589
Q ss_pred HHHHHHHHHHHHHHHHHHHhC---CCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChh
Q 048243 80 WKKRVHIIEGITQGLLYLQEY---SRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE 156 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~---~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE 156 (303)
+..++.++.|++.||+|||+. | ++||||||+||+++.++.++|+|||++........ .......|++.|+|||
T Consensus 130 ~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE 205 (326)
T 3uim_A 130 WPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPE 205 (326)
T ss_dssp HHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHH
T ss_pred HHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHH
Confidence 999999999999999999999 7 99999999999999999999999999987654322 2233345899999999
Q ss_pred hhccCCCCCccchhhHHHHHHHHHhCCCCCccCCC--CccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHH
Q 048243 157 YARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGI--NENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIA 234 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
.+.+..++.++||||||+++|+|++|..||..... .......................+...........+..+.+++
T Consensus 206 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 285 (326)
T 3uim_A 206 YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVA 285 (326)
T ss_dssp HHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHH
T ss_pred HhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHH
Confidence 99888899999999999999999999999963221 1222222333333334444455555666677788889999999
Q ss_pred HHcccCCCCCCCCHHHHHHHhccccC
Q 048243 235 LLCVQENPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 235 ~~~l~~dp~~Rpt~~el~~~L~~~~~ 260 (303)
.+||+.||.+|||+.|+++.|++...
T Consensus 286 ~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 286 LLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp HHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred HHHhCcCCccCCCHHHHHHHhcCcch
Confidence 99999999999999999999987653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=305.58 Aligned_cols=238 Identities=26% Similarity=0.418 Sum_probs=192.3
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+|+.||+|++........+.+.+|+.++++++||||+++++++.++...++||||+++++|.+++.. ....+++..+
T Consensus 33 ~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~ 110 (310)
T 3s95_A 33 ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQR 110 (310)
T ss_dssp TTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--CCTTSCHHHH
T ss_pred CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHh--ccCCCCHHHH
Confidence 57899999999777666778899999999999999999999999999999999999999999999854 2456899999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcccc------------ccccccccC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEAN------------TEQVVGTIG 151 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~------------~~~~~g~~~ 151 (303)
+.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++........... .....||+.
T Consensus 111 ~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 187 (310)
T 3s95_A 111 VSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187 (310)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGG
T ss_pred HHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcc
Confidence 999999999999999999 99999999999999999999999999987644322111 113568999
Q ss_pred CCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccc--cHHHHHHHHHhCCCcceeccccCCCCCCHHHHHH
Q 048243 152 YIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL--SILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMR 229 (303)
Q Consensus 152 y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (303)
|+|||.+.+..++.++||||||+++|+|++|..|+......... .......... .. +..+..
T Consensus 188 y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~------------~~----~~~~~~ 251 (310)
T 3s95_A 188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY------------CP----PNCPPS 251 (310)
T ss_dssp GCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT------------CC----TTCCTT
T ss_pred eeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc------------CC----CCCCHH
Confidence 99999999999999999999999999999999998654332211 1111111100 00 111236
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHhccccCCC
Q 048243 230 CLEIALLCVQENPNDRPSMLQVSSMLKNETTNR 262 (303)
Q Consensus 230 l~~li~~~l~~dp~~Rpt~~el~~~L~~~~~~~ 262 (303)
+.+++.+||+.||++|||+.++++.|+......
T Consensus 252 l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 252 FFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 789999999999999999999999998776443
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=305.77 Aligned_cols=240 Identities=26% Similarity=0.360 Sum_probs=183.3
Q ss_pred CCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 5 CGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 5 ~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||||+++++|.+++........+++..
T Consensus 59 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 138 (309)
T 3p86_A 59 HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR 138 (309)
T ss_dssp TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHH
T ss_pred CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHH
Confidence 68899999997653 3344678899999999999999999999999999999999999999999996543344599999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
++.++.|++.||+|||+.| .+++||||||+||+++.++.++|+|||++....... .......|++.|+|||.+.+..
T Consensus 139 ~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~ 215 (309)
T 3p86_A 139 RLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEP 215 (309)
T ss_dssp HHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-------------------CCTTSCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccc--cccccCCCCccccChhhhcCCC
Confidence 9999999999999999874 349999999999999999999999999987543321 1223457899999999999999
Q ss_pred CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC
Q 048243 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 242 (303)
++.++||||||+++|+|++|..||....... ........... ...+...+..+.++|.+||+.||
T Consensus 216 ~~~~~DiwslG~il~elltg~~Pf~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP 280 (309)
T 3p86_A 216 SNEKSDVYSFGVILWELATLQQPWGNLNPAQ------VVAAVGFKCKR---------LEIPRNLNPQVAAIIEGCWTNEP 280 (309)
T ss_dssp CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHHHHSCCC---------CCCCTTSCHHHHHHHHHHTCSSG
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcCCC---------CCCCccCCHHHHHHHHHHccCCh
Confidence 9999999999999999999999996433211 11111111111 11112233478899999999999
Q ss_pred CCCCCHHHHHHHhccccCCC
Q 048243 243 NDRPSMLQVSSMLKNETTNR 262 (303)
Q Consensus 243 ~~Rpt~~el~~~L~~~~~~~ 262 (303)
.+|||+.++++.|+......
T Consensus 281 ~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 281 WKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp GGSCCHHHHHHHHHHHHC--
T ss_pred hhCcCHHHHHHHHHHHHHhC
Confidence 99999999999998877544
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=297.46 Aligned_cols=255 Identities=19% Similarity=0.232 Sum_probs=196.9
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCC--eeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE--ERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||||+++... ....+.+.+|+.++++++||||+++++++.... ..++||||+++++|.+++........+++
T Consensus 32 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 111 (319)
T 4euu_A 32 KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPE 111 (319)
T ss_dssp TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCH
T ss_pred CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCH
Confidence 468999999997543 345677889999999999999999999998765 77999999999999999976544455999
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEE----CCCCceEEcccccccccccCCccccccccccccCCCChh
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL----GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE 156 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~----~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE 156 (303)
..++.++.||+.||+|||+.| |+||||||+||++ +.++.++|+|||++........ .....|++.|+|||
T Consensus 112 ~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE 185 (319)
T 4euu_A 112 SEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPD 185 (319)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC---BCCCCSCGGGCCHH
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCc---eeecccCCCccCHH
Confidence 999999999999999999999 9999999999999 7888899999999987654322 22356899999999
Q ss_pred hhc--------cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCcccc-HHHHHHHHHhCCCccee----------c-cc
Q 048243 157 YAR--------QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLS-ILEHAYELWKGGKGVEF----------V-DS 216 (303)
Q Consensus 157 ~~~--------~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~----------~-~~ 216 (303)
++. +..++.++|||||||++|+|++|..||.......... ................. . ..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 265 (319)
T 4euu_A 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDM 265 (319)
T ss_dssp HHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSC
T ss_pred HhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccC
Confidence 986 4678899999999999999999999997554433222 22221111111100000 0 11
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccccCCCCC
Q 048243 217 SLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSMLKNETTNRNT 264 (303)
Q Consensus 217 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~~~~~~ 264 (303)
.............+.+++.+||+.||++|||+.|+++...+.....++
T Consensus 266 ~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~~~ 313 (319)
T 4euu_A 266 PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRGNS 313 (319)
T ss_dssp CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC----
T ss_pred CcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcCCc
Confidence 112244567788899999999999999999999999998887765544
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=310.73 Aligned_cols=237 Identities=27% Similarity=0.374 Sum_probs=191.8
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc--------
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-------- 73 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------- 73 (303)
.++..||||+++... ....+.+.+|+.+++.+ +||||+++++++.+....++||||+++|+|.+++....
T Consensus 111 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 190 (370)
T 2psq_A 111 KEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 190 (370)
T ss_dssp TCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC------
T ss_pred CcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccc
Confidence 456789999997653 33456789999999999 89999999999999999999999999999999986422
Q ss_pred -----ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcccccccccc
Q 048243 74 -----RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVG 148 (303)
Q Consensus 74 -----~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g 148 (303)
....+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||++................+
T Consensus 191 ~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~ 267 (370)
T 2psq_A 191 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 267 (370)
T ss_dssp -----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTS
T ss_pred cccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCc
Confidence 1245889999999999999999999999 99999999999999999999999999987655433333344567
Q ss_pred ccCCCChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHH
Q 048243 149 TIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKL 227 (303)
Q Consensus 149 ~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
++.|+|||++.+..++.++|||||||++|+|++ |..||........ . ........ ...+...+
T Consensus 268 t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~---~----~~~~~~~~---------~~~~~~~~ 331 (370)
T 2psq_A 268 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL---F----KLLKEGHR---------MDKPANCT 331 (370)
T ss_dssp CGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---H----HHHHTTCC---------CCCCTTSC
T ss_pred ccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH---H----HHHhcCCC---------CCCCCCCC
Confidence 889999999999999999999999999999999 9999865432221 1 11111111 11112234
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhcccc
Q 048243 228 MRCLEIALLCVQENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 228 ~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~ 259 (303)
..+.+++.+||+.||.+|||+.|+++.|++..
T Consensus 332 ~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 332 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 57889999999999999999999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=305.69 Aligned_cols=225 Identities=25% Similarity=0.360 Sum_probs=185.0
Q ss_pred CCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+|+.||||++... .....+.+.+|+.+++.++||||+++++++...+..++||||+++++|.+++. ....+++.
T Consensus 38 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~l~~~ 114 (328)
T 3fe3_A 38 LTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLV---AHGRMKEK 114 (328)
T ss_dssp TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHH---HHCCCCHH
T ss_pred CCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHH---HcCCCCHH
Confidence 68999999999654 33445678899999999999999999999999999999999999999999984 34569999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
.++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++....... ......||+.|+|||++.+.
T Consensus 115 ~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~ 188 (328)
T 3fe3_A 115 EARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQGK 188 (328)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC---GGGTTSSSGGGCCHHHHHTC
T ss_pred HHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC---ccccccCCcceeCcccccCC
Confidence 99999999999999999999 9999999999999999999999999997654332 23345789999999999888
Q ss_pred CCC-CccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 162 VYS-TKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~-~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
.+. .++|||||||++|+|++|..||....... .......+... .+...+..+.+|+.+||..
T Consensus 189 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~~~~-----------~p~~~s~~~~~li~~~L~~ 251 (328)
T 3fe3_A 189 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE------LRERVLRGKYR-----------IPFYMSTDCENLLKRFLVL 251 (328)
T ss_dssp CCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCC-----------CCTTSCHHHHHHHHHHCCS
T ss_pred CcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCC-----------CCCCCCHHHHHHHHHHCCC
Confidence 765 78999999999999999999996543211 11111111110 1112344788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 048243 241 NPNDRPSMLQVSSM 254 (303)
Q Consensus 241 dp~~Rpt~~el~~~ 254 (303)
||.+|||++|+++.
T Consensus 252 dP~~R~t~~eil~h 265 (328)
T 3fe3_A 252 NPIKRGTLEQIMKD 265 (328)
T ss_dssp STTTSCCHHHHTTC
T ss_pred ChhHCcCHHHHhcC
Confidence 99999999999864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=295.58 Aligned_cols=250 Identities=35% Similarity=0.507 Sum_probs=199.1
Q ss_pred CCCcEEEEEEecCCC----cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTS----TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++........++
T Consensus 52 ~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 131 (307)
T 2nru_A 52 VNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131 (307)
T ss_dssp SSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCC
T ss_pred ECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCC
Confidence 368899999986532 2345688999999999999999999999999999999999999999999986544456799
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++................|++.|+|||.+.
T Consensus 132 ~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 208 (307)
T 2nru_A 132 WHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR 208 (307)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhc
Confidence 9999999999999999999999 9999999999999999999999999987765443333334457899999999887
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+ .++.++||||||+++|+|++|..||.................. ........++... .......+..+.+++.+||+
T Consensus 209 ~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~ 285 (307)
T 2nru_A 209 G-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIED-EEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLH 285 (307)
T ss_dssp T-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHT-TSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTC
T ss_pred C-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhh-hhhhhhhhccccc-cccchHHHHHHHHHHHHHcC
Confidence 5 4788999999999999999999999765544333222211111 0111111222222 23456677889999999999
Q ss_pred CCCCCCCCHHHHHHHhcccc
Q 048243 240 ENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 240 ~dp~~Rpt~~el~~~L~~~~ 259 (303)
.||.+|||+.++++.|++..
T Consensus 286 ~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 286 EKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp SSTTTSCCHHHHHHHHHHHC
T ss_pred CCcccCcCHHHHHHHHHHHh
Confidence 99999999999999998764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=302.48 Aligned_cols=231 Identities=24% Similarity=0.333 Sum_probs=184.0
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++. ....+++..
T Consensus 30 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~ 106 (323)
T 3tki_A 30 VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPD 106 (323)
T ss_dssp TTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSB---TTTBCCHHH
T ss_pred CCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHh---hcCCCCHHH
Confidence 478999999996553 2334678899999999999999999999999999999999999999999984 445699999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
++.++.||+.||+|||+.| |+||||||+||+++.++.++|+|||++..+.............|++.|+|||++.+..
T Consensus 107 ~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 183 (323)
T 3tki_A 107 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183 (323)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSS
T ss_pred HHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCC
Confidence 9999999999999999999 9999999999999999999999999998765443333344567899999999998776
Q ss_pred C-CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 163 Y-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~-~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
+ +.++|||||||++|+|++|..||......... ...+...... .......+..+.+|+.+||+.|
T Consensus 184 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~~~~~~~~~--------~~~~~~~~~~~~~li~~~L~~d 249 (323)
T 3tki_A 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEKKTY--------LNPWKKIDSAPLALLHKILVEN 249 (323)
T ss_dssp BCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH------HHHHHTTCTT--------STTGGGSCHHHHHHHHHHSCSS
T ss_pred CCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH------HHHHhccccc--------CCccccCCHHHHHHHHHHccCC
Confidence 5 77899999999999999999999654432211 1111111100 0011123447789999999999
Q ss_pred CCCCCCHHHHHHH
Q 048243 242 PNDRPSMLQVSSM 254 (303)
Q Consensus 242 p~~Rpt~~el~~~ 254 (303)
|.+|||+.|+++.
T Consensus 250 P~~R~t~~eil~h 262 (323)
T 3tki_A 250 PSARITIPDIKKD 262 (323)
T ss_dssp TTTSCCHHHHTTC
T ss_pred hhhCcCHHHHhhC
Confidence 9999999999764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=299.92 Aligned_cols=228 Identities=23% Similarity=0.365 Sum_probs=187.4
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+|+.||||++........+.+.+|+.++++++||||+++++++......++||||+++++|.+++. ...+++..+
T Consensus 68 ~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~ 143 (321)
T 2c30_A 68 HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQI 143 (321)
T ss_dssp TTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHH
T ss_pred CCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHH
Confidence 4799999999987766677889999999999999999999999999999999999999999999883 346899999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
..++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++........ ......||+.|+|||.+.+..+
T Consensus 144 ~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~ 218 (321)
T 2c30_A 144 ATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLY 218 (321)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCB
T ss_pred HHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCC
Confidence 999999999999999999 99999999999999999999999999876544321 2234578999999999999899
Q ss_pred CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCC
Q 048243 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 243 (303)
+.++||||||+++|+|++|..||....... ... ..... .... .......+..+.+++.+||+.||+
T Consensus 219 ~~~~Dv~slG~il~el~~g~~pf~~~~~~~---~~~---~~~~~-~~~~-------~~~~~~~~~~l~~li~~~l~~dp~ 284 (321)
T 2c30_A 219 ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AMK---RLRDS-PPPK-------LKNSHKVSPVLRDFLERMLVRDPQ 284 (321)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHH---HHHHS-SCCC-------CTTGGGSCHHHHHHHHHHSCSSTT
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---HHhcC-CCCC-------cCccccCCHHHHHHHHHHccCChh
Confidence 999999999999999999999986432211 111 11111 1000 011112345788999999999999
Q ss_pred CCCCHHHHHHH
Q 048243 244 DRPSMLQVSSM 254 (303)
Q Consensus 244 ~Rpt~~el~~~ 254 (303)
+|||+.|+++.
T Consensus 285 ~Rps~~ell~h 295 (321)
T 2c30_A 285 ERATAQELLDH 295 (321)
T ss_dssp TSCCHHHHHTS
T ss_pred hCcCHHHHhcC
Confidence 99999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=304.33 Aligned_cols=244 Identities=23% Similarity=0.288 Sum_probs=186.5
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCC----eeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE----ERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.|+.||||++..... .......|+.++++++||||+++++++.... ..++||||+++|+|.+++. ...+++
T Consensus 46 ~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~----~~~~~~ 120 (322)
T 3soc_A 46 LNEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK----ANVVSW 120 (322)
T ss_dssp TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHH----HCCBCH
T ss_pred CCCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHH----hcCCCH
Confidence 478999999965432 3345667899999999999999999998754 4699999999999999984 345899
Q ss_pred HHHHHHHHHHHHHHHHHHhC----------CCCCeEecCCCCCceEECCCCceEEcccccccccccCCcccccccccccc
Q 048243 81 KKRVHIIEGITQGLLYLQEY----------SRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTI 150 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~----------~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~ 150 (303)
..++.++.|++.||+|||+. + ++||||||+||+++.++.+||+|||++................||+
T Consensus 121 ~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~ 197 (322)
T 3soc_A 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTR 197 (322)
T ss_dssp HHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCG
T ss_pred HHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCc
Confidence 99999999999999999998 8 9999999999999999999999999998766544333344467899
Q ss_pred CCCChhhhccC-----CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHH---------HHHHHHHhCCCcceeccc
Q 048243 151 GYIPPEYARQG-----VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSIL---------EHAYELWKGGKGVEFVDS 216 (303)
Q Consensus 151 ~y~aPE~~~~~-----~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~ 216 (303)
.|+|||++.+. .++.++|||||||++|+|++|..||............ ..................
T Consensus 198 ~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (322)
T 3soc_A 198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRD 277 (322)
T ss_dssp GGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCG
T ss_pred cccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccc
Confidence 99999999873 3456889999999999999999999754432221111 111111111111111111
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcccc
Q 048243 217 SLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 217 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~ 259 (303)
.. .....+..+.+||.+||+.||.+|||+.|+++.|++..
T Consensus 278 ~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 278 YW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp GG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 11234567899999999999999999999999998764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=292.40 Aligned_cols=241 Identities=21% Similarity=0.336 Sum_probs=187.0
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|.+.... ....+.+.+|+.++++++||||+++++++......++||||+++++|.+++. ....+++
T Consensus 34 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~---~~~~~~~ 110 (294)
T 4eqm_A 34 ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSV 110 (294)
T ss_dssp TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH---HHCSCCH
T ss_pred CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHH---hcCCCCH
Confidence 578999999985442 3345678899999999999999999999999999999999999999999984 3456999
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++........ .......|++.|+|||.+.+
T Consensus 111 ~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~ 186 (294)
T 4eqm_A 111 DTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKG 186 (294)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--------------CCSSCCHHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccccc-cccCccccCccccCHhHhcC
Confidence 999999999999999999999 99999999999999999999999999976543321 22233568999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++||||||+++|+|++|..||...... ........... .. ....... ..+..+.+++.+||..
T Consensus 187 ~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~-~~-~~~~~~~----~~~~~l~~li~~~l~~ 254 (294)
T 4eqm_A 187 EATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQDSV-PN-VTTDVRK----DIPQSLSNVILRATEK 254 (294)
T ss_dssp CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSSCC-CC-HHHHSCT----TSCHHHHHHHHHHSCS
T ss_pred CCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhccC-CC-cchhccc----CCCHHHHHHHHHHhcC
Confidence 99999999999999999999999999643311 11112221111 00 0111111 1234788999999999
Q ss_pred CCCCCC-CHHHHHHHhccccCCCC
Q 048243 241 NPNDRP-SMLQVSSMLKNETTNRN 263 (303)
Q Consensus 241 dp~~Rp-t~~el~~~L~~~~~~~~ 263 (303)
||.+|| ++.++.+.|+.......
T Consensus 255 dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 255 DKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp SGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred CHhHccccHHHHHHHHHHHHhhcc
Confidence 999999 89999999987765443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=302.58 Aligned_cols=236 Identities=26% Similarity=0.390 Sum_probs=187.4
Q ss_pred CCcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 5 CGKVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+..||||+++.. .....+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++.. ....+++..+
T Consensus 76 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~ 153 (325)
T 3kul_A 76 RDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT--HDGQFTIMQL 153 (325)
T ss_dssp CCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHT--TTTCSCHHHH
T ss_pred CCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHh--cccCCCHHHH
Confidence 4556999999765 344556799999999999999999999999999999999999999999999854 3456899999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-ccccccccccCCCChhhhccCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
+.++.|++.||+|||+.| |+||||||+||+++.++.++|+|||++......... .......++..|+|||.+.+..
T Consensus 154 ~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 230 (325)
T 3kul_A 154 VGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230 (325)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCC
Confidence 999999999999999999 999999999999999999999999999876543221 1222334577899999999888
Q ss_pred CCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
++.++||||||+++|+|++ |..||....... .......... ...+...+..+.+++.+||..|
T Consensus 231 ~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~d 294 (325)
T 3kul_A 231 FSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-------VISSVEEGYR---------LPAPMGCPHALHQLMLDCWHKD 294 (325)
T ss_dssp ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSS
T ss_pred CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHcCCC---------CCCCCCcCHHHHHHHHHHccCC
Confidence 9999999999999999999 999985433211 1111111111 1111223457889999999999
Q ss_pred CCCCCCHHHHHHHhccccCC
Q 048243 242 PNDRPSMLQVSSMLKNETTN 261 (303)
Q Consensus 242 p~~Rpt~~el~~~L~~~~~~ 261 (303)
|.+|||+.++++.|+.....
T Consensus 295 p~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 295 RAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp GGGSCCHHHHHHHHHHHHHS
T ss_pred hhhCcCHHHHHHHHHHHHhC
Confidence 99999999999999887643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=304.55 Aligned_cols=228 Identities=21% Similarity=0.266 Sum_probs=183.8
Q ss_pred CCCcEEEEEEecCCCc------ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcccccc
Q 048243 4 PCGKVIAVKKLSKTST------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~~~~valK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
.+|+.||+|+++.... ...+.+.+|+.++++++||||+++++++.+....++||||+++|+|.+++. ....
T Consensus 35 ~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~---~~~~ 111 (361)
T 2yab_A 35 STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLA---QKES 111 (361)
T ss_dssp TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHT---TCSC
T ss_pred CCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHH---hcCC
Confidence 4799999999975532 135789999999999999999999999999999999999999999999994 3456
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCC----ceEEcccccccccccCCccccccccccccCCC
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM----KPKISDFGLARIFAKESLEANTEQVVGTIGYI 153 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~----~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~ 153 (303)
+++..+..++.||+.||+|||+.| |+||||||+||+++.++ .++|+|||++....... ......||+.|+
T Consensus 112 l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~ 185 (361)
T 2yab_A 112 LSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFV 185 (361)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC---CCCCCCSCGGGC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC---ccccCCCCccEE
Confidence 999999999999999999999999 99999999999998877 79999999998765432 223356899999
Q ss_pred ChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHH
Q 048243 154 PPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEI 233 (303)
Q Consensus 154 aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 233 (303)
|||++.+..++.++|||||||++|+|++|..||....... ........... +.. .. ....+..+.+|
T Consensus 186 aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~------~~~~i~~~~~~--~~~-~~----~~~~s~~~~~l 252 (361)
T 2yab_A 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANITAVSYD--FDE-EF----FSQTSELAKDF 252 (361)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHTTCCC--CCH-HH----HTTSCHHHHHH
T ss_pred CchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcCCC--CCc-hh----ccCCCHHHHHH
Confidence 9999999899999999999999999999999996432111 11111111000 000 00 01123478899
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 048243 234 ALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 234 i~~~l~~dp~~Rpt~~el~~ 253 (303)
|.+||..||.+|||+.|+++
T Consensus 253 i~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 253 IRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHCCCChhHCcCHHHHhc
Confidence 99999999999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=292.06 Aligned_cols=236 Identities=27% Similarity=0.360 Sum_probs=190.3
Q ss_pred ccCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 2 VLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 2 ~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
...+++.||+|+++.... ..+.+.+|+.++++++||||+++++++.+....++||||+++++|.+++.. .+..+++.
T Consensus 28 ~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~ 104 (268)
T 3sxs_A 28 KWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS--HGKGLEPS 104 (268)
T ss_dssp EETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHH--HGGGCCHH
T ss_pred EecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHH--cCCCCCHH
Confidence 346778899999975543 447789999999999999999999999999999999999999999999853 34568999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
.++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||.+......... ......++..|+|||.+.+.
T Consensus 105 ~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~ 180 (268)
T 3sxs_A 105 QLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-SSVGTKFPVKWSAPEVFHYF 180 (268)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE-ECCSCCCCGGGCCHHHHHHS
T ss_pred HHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh-cccCCCcCcccCCHHHHhcc
Confidence 99999999999999999999 999999999999999999999999999766543322 22234467789999999988
Q ss_pred CCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 162 VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
.++.++||||||+++|+|++ |..||....... ......... . ...+...+..+.+++.+||+.
T Consensus 181 ~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~~-~---------~~~~~~~~~~l~~li~~~l~~ 244 (268)
T 3sxs_A 181 KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE------VVLKVSQGH-R---------LYRPHLASDTIYQIMYSCWHE 244 (268)
T ss_dssp EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHHHTTC-C---------CCCCTTSCHHHHHHHHHTTCS
T ss_pred CCchhhhhHHHHHHHHHHHcCCCCCccccChHH------HHHHHHcCC-C---------CCCCCcChHHHHHHHHHHcCC
Confidence 89999999999999999999 999985433221 111111111 0 011111234788999999999
Q ss_pred CCCCCCCHHHHHHHhccccC
Q 048243 241 NPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 241 dp~~Rpt~~el~~~L~~~~~ 260 (303)
||.+|||+.|+++.|+....
T Consensus 245 ~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 245 LPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp SGGGSCCHHHHHHHHGGGCC
T ss_pred ChhhCcCHHHHHHHHHHhhh
Confidence 99999999999999988764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=296.67 Aligned_cols=244 Identities=29% Similarity=0.415 Sum_probs=187.3
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeC--CeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+|+.||||++........+.+.+|+.++++++||||+++++++... ...++||||+++++|.+++.. ....+++.
T Consensus 37 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~ 114 (295)
T 3ugc_A 37 NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHI 114 (295)
T ss_dssp SCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHH--CGGGCCHH
T ss_pred CCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHh--cccccCHH
Confidence 47899999999877666677899999999999999999999998653 568999999999999999854 23458999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-ccccccccccCCCChhhhcc
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~ 160 (303)
.++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++......... .......++..|+|||.+.+
T Consensus 115 ~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 191 (295)
T 3ugc_A 115 KLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE 191 (295)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcC
Confidence 99999999999999999999 999999999999999999999999999876443221 22223456778999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCC---------CccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHH
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGI---------NENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL 231 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
..++.++||||||+++|+|++|..|+..... ................... ...+...+..+.
T Consensus 192 ~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~l~ 262 (295)
T 3ugc_A 192 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR---------LPRPDGCPDEIY 262 (295)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCC---------CCCCTTCCHHHH
T ss_pred CCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCc---------CCCCcCcCHHHH
Confidence 9999999999999999999999988753211 0000111111111211111 111222345788
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhccccCC
Q 048243 232 EIALLCVQENPNDRPSMLQVSSMLKNETTN 261 (303)
Q Consensus 232 ~li~~~l~~dp~~Rpt~~el~~~L~~~~~~ 261 (303)
+++.+||+.||.+|||+.|+++.|+....+
T Consensus 263 ~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 263 MIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 999999999999999999999999876543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=303.37 Aligned_cols=238 Identities=28% Similarity=0.405 Sum_probs=192.0
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccc--------
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR-------- 74 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------- 74 (303)
.+++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++.....
T Consensus 51 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 130 (314)
T 2ivs_A 51 AGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS 130 (314)
T ss_dssp SSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC--
T ss_pred cCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccc
Confidence 456899999997553 34557889999999999999999999999999999999999999999999864321
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccc
Q 048243 75 -------------RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEA 141 (303)
Q Consensus 75 -------------~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~ 141 (303)
...+++..++.++.||+.||+|||++| ++||||||+||+++.++.++|+|||++..........
T Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~ 207 (314)
T 2ivs_A 131 GGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207 (314)
T ss_dssp --------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEE
T ss_pred cccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---CcccccchheEEEcCCCCEEEccccccccccccccce
Confidence 234889999999999999999999999 9999999999999999999999999998765443333
Q ss_pred cccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCC
Q 048243 142 NTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDD 220 (303)
Q Consensus 142 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (303)
......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......... .........
T Consensus 208 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-------~~~~~~~~~--------- 271 (314)
T 2ivs_A 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF-------NLLKTGHRM--------- 271 (314)
T ss_dssp CSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-------HHHHTTCCC---------
T ss_pred eccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHhhcCCcC---------
Confidence 3344567888999999998889999999999999999999 99998654332211 111111111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccccC
Q 048243 221 TNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 221 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~~ 260 (303)
..+...+..+.+++.+||+.||.+|||+.|+++.|++...
T Consensus 272 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 272 ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1112234578899999999999999999999999987653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=299.92 Aligned_cols=226 Identities=19% Similarity=0.240 Sum_probs=184.9
Q ss_pred CCCcEEEEEEecCC---CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|+++.. .......+.+|+.+++.++||||+++++++.+....++||||+++|+|..++. ....+++
T Consensus 28 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~~~~ 104 (337)
T 1o6l_A 28 ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTE 104 (337)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHSCCCH
T ss_pred CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH---hcCCCCH
Confidence 57999999999654 23456778899999999999999999999999999999999999999998884 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.||+.||+|||++| |+||||||+||+++.+|.++|+|||++....... .......||+.|+|||++.+
T Consensus 105 ~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~ 179 (337)
T 1o6l_A 105 ERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLED 179 (337)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSS
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCC--CcccccccChhhCChhhhcC
Confidence 999999999999999999999 9999999999999999999999999987543222 22334678999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|||||||++|+|++|..||....... .. ........ . .+...+..+.++|.+||+.
T Consensus 180 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~---~~i~~~~~-------~----~p~~~s~~~~~li~~lL~~ 242 (337)
T 1o6l_A 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LF---ELILMEEI-------R----FPRTLSPEAKSLLAGLLKK 242 (337)
T ss_dssp SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHHCCC-------C----CCTTSCHHHHHHHHHHTCS
T ss_pred CCCCchhhcccchhHHHHHhcCCCCCCCCCHHH---HH---HHHHcCCC-------C----CCCCCCHHHHHHHHHHhhc
Confidence 999999999999999999999999996432111 11 11111110 0 1112345788999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 048243 241 NPNDRP-----SMLQVSSM 254 (303)
Q Consensus 241 dp~~Rp-----t~~el~~~ 254 (303)
||.+|| ++.|+++.
T Consensus 243 dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 243 DPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp STTTSTTCSTTTHHHHHTS
T ss_pred CHHHhcCCCCCCHHHHHcC
Confidence 999999 89999764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=313.29 Aligned_cols=235 Identities=26% Similarity=0.349 Sum_probs=187.7
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.||||.++... ....+.+.+|+.++++++||||+++++++......++||||+++|+|.+++.. .+..+++..
T Consensus 137 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~ 214 (377)
T 3cbl_A 137 ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKT 214 (377)
T ss_dssp TTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH--HGGGCCHHH
T ss_pred cCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHh--cCCCCCHHH
Confidence 378999999997543 23345688999999999999999999999998999999999999999999853 344689999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..
T Consensus 215 ~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 291 (377)
T 3cbl_A 215 LLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR 291 (377)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCC
Confidence 9999999999999999999 9999999999999999999999999987654332222222234577899999999888
Q ss_pred CCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
++.++|||||||++|+|++ |..||....... ............ .+...+..+.+++.+||+.|
T Consensus 292 ~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~d 355 (377)
T 3cbl_A 292 YSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------TREFVEKGGRLP---------CPELCPDAVFRLMEQCWAYE 355 (377)
T ss_dssp EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-------HHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSS
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCC---------CCCCCCHHHHHHHHHHcCCC
Confidence 9999999999999999998 888986443211 111111111111 11122347889999999999
Q ss_pred CCCCCCHHHHHHHhcccc
Q 048243 242 PNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 242 p~~Rpt~~el~~~L~~~~ 259 (303)
|.+|||+.++++.|+...
T Consensus 356 P~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 356 PGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp GGGSCCHHHHHHHHHHHH
T ss_pred chhCcCHHHHHHHHHHHH
Confidence 999999999999998764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=302.91 Aligned_cols=239 Identities=27% Similarity=0.384 Sum_probs=190.1
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccc-------
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR------- 74 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------- 74 (303)
.+++.||+|+++... ....+.+.+|+.++.++ +||||+++++++......++||||+++|+|.+++.....
T Consensus 73 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 152 (344)
T 1rjb_A 73 GVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 152 (344)
T ss_dssp SCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC-----
T ss_pred CcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhcccccccccc
Confidence 456789999997542 33456889999999999 899999999999999999999999999999999965322
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccc
Q 048243 75 -------------RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEA 141 (303)
Q Consensus 75 -------------~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~ 141 (303)
...+++..++.++.||+.||+|||+.| ++||||||+||+++.++.++|+|||++..........
T Consensus 153 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 229 (344)
T 1rjb_A 153 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229 (344)
T ss_dssp ----------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSE
T ss_pred chhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEEcCCCcEEeCCCccCcccccCccce
Confidence 134789999999999999999999999 9999999999999999999999999998765544333
Q ss_pred cccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCC
Q 048243 142 NTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDD 220 (303)
Q Consensus 142 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (303)
......|++.|+|||.+.+..++.++||||||+++|+|++ |..||......... ......... .
T Consensus 230 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~------~~~~~~~~~---------~ 294 (344)
T 1rjb_A 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF------YKLIQNGFK---------M 294 (344)
T ss_dssp EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH------HHHHHTTCC---------C
T ss_pred eccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHH------HHHHhcCCC---------C
Confidence 4445567889999999998899999999999999999998 99998654432211 111111111 1
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccccC
Q 048243 221 TNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 221 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~~ 260 (303)
..+...+..+.+++.+||..||.+|||+.++++.|+....
T Consensus 295 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 295 DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 1112224578899999999999999999999999987754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=293.36 Aligned_cols=234 Identities=28% Similarity=0.427 Sum_probs=189.1
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
..+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+....++||||+++++|.+++.. ....+++..
T Consensus 31 ~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~ 107 (269)
T 4hcu_A 31 WLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAET 107 (269)
T ss_dssp ETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHT--TTTCCCHHH
T ss_pred ecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHh--cCcccCHHH
Confidence 45788899999975543 447799999999999999999999999999999999999999999999854 345689999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....... ........++..|+|||.+.+..
T Consensus 108 ~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~ 183 (269)
T 4hcu_A 108 LLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSR 183 (269)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc-cccccCcccccccCCHHHhcCCC
Confidence 9999999999999999999 9999999999999999999999999997654332 11222345677899999999899
Q ss_pred CCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
++.++||||||+++|+|++ |..||....... . ........ ....+...+..+.+++.+||+.|
T Consensus 184 ~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~------~-~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~ 247 (269)
T 4hcu_A 184 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------V-VEDISTGF---------RLYKPRLASTHVYQIMNHCWRER 247 (269)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------H-HHHHHTTC---------CCCCCTTSCHHHHHHHHHHTCSS
T ss_pred CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH------H-HHHHhcCc---------cCCCCCcCCHHHHHHHHHHccCC
Confidence 9999999999999999999 899986432211 1 11111111 11111122457889999999999
Q ss_pred CCCCCCHHHHHHHhcccc
Q 048243 242 PNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 242 p~~Rpt~~el~~~L~~~~ 259 (303)
|.+|||+.++++.|++..
T Consensus 248 p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 248 PEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp GGGSCCHHHHHHHHHHHH
T ss_pred cccCcCHHHHHHHHHHHH
Confidence 999999999999998764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=310.20 Aligned_cols=239 Identities=28% Similarity=0.420 Sum_probs=189.7
Q ss_pred CCCcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc----ccccC
Q 048243 4 PCGKVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI----RRLIL 78 (303)
Q Consensus 4 ~~~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~l 78 (303)
.+++.||||+++.. .......+.+|+.++++++||||+++++++.+....++||||+++|+|.+++.... ....+
T Consensus 99 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 178 (367)
T 3l9p_A 99 PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 178 (367)
T ss_dssp -CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCC
T ss_pred CcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccc
Confidence 46789999999654 33445578899999999999999999999999999999999999999999986422 22458
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCC---ceEEcccccccccccCCccccccccccccCCCCh
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM---KPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~---~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aP 155 (303)
++..++.++.||+.||+|||+.| |+||||||+|||++.++ .++|+|||+++...............|++.|+||
T Consensus 179 ~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP 255 (367)
T 3l9p_A 179 AMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255 (367)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCH
T ss_pred cHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECH
Confidence 99999999999999999999999 99999999999999555 5999999999765444333334445678999999
Q ss_pred hhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHH
Q 048243 156 EYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIA 234 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
|.+.+..++.++|||||||++|+|++ |..||....... ........... ..+...+..+.+|+
T Consensus 256 E~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~-------~~~~i~~~~~~---------~~~~~~~~~l~~li 319 (367)
T 3l9p_A 256 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------VLEFVTSGGRM---------DPPKNCPGPVYRIM 319 (367)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHHHTTCCC---------CCCTTCCHHHHHHH
T ss_pred HHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCC---------CCCccCCHHHHHHH
Confidence 99999999999999999999999998 889986433211 11111111111 11112234788999
Q ss_pred HHcccCCCCCCCCHHHHHHHhccccCC
Q 048243 235 LLCVQENPNDRPSMLQVSSMLKNETTN 261 (303)
Q Consensus 235 ~~~l~~dp~~Rpt~~el~~~L~~~~~~ 261 (303)
.+||+.||.+|||+.++++.|+.....
T Consensus 320 ~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 320 TQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 999999999999999999998766543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=298.59 Aligned_cols=229 Identities=23% Similarity=0.299 Sum_probs=184.2
Q ss_pred CCCcEEEEEEecCCCc------ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcccccc
Q 048243 4 PCGKVIAVKKLSKTST------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~~~~valK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
.+|+.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++. ....
T Consensus 34 ~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~ 110 (326)
T 2y0a_A 34 STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKES 110 (326)
T ss_dssp TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHT---TSSC
T ss_pred CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHH---hcCC
Confidence 4789999999975432 246789999999999999999999999999999999999999999999984 3456
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCC----ceEEcccccccccccCCccccccccccccCCC
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM----KPKISDFGLARIFAKESLEANTEQVVGTIGYI 153 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~----~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~ 153 (303)
+++..++.++.||+.||+|||+.+ ++||||||+||+++.++ .++|+|||++....... ......||+.|+
T Consensus 111 ~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~ 184 (326)
T 2y0a_A 111 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFV 184 (326)
T ss_dssp CBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTS---CCCCCCSCTTTC
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCC---ccccccCCcCcC
Confidence 899999999999999999999999 99999999999999887 79999999998764332 123356899999
Q ss_pred ChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHH
Q 048243 154 PPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEI 233 (303)
Q Consensus 154 aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 233 (303)
|||++.+..++.++|||||||++|+|++|..||....... ... ........ .... .....+..+.+|
T Consensus 185 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~---~~~~~~~~--~~~~-----~~~~~~~~~~~l 251 (326)
T 2y0a_A 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLA---NVSAVNYE--FEDE-----YFSNTSALAKDF 251 (326)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHH---HHHHTCCC--CCHH-----HHTTSCHHHHHH
T ss_pred CceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHH---HHHhcCCC--cCcc-----ccccCCHHHHHH
Confidence 9999998899999999999999999999999985432211 111 11111000 0000 001123478899
Q ss_pred HHHcccCCCCCCCCHHHHHHH
Q 048243 234 ALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 234 i~~~l~~dp~~Rpt~~el~~~ 254 (303)
|.+||..||.+|||+.|+++.
T Consensus 252 i~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 252 IRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHccCChhhCCCHHHHhcC
Confidence 999999999999999999874
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=303.65 Aligned_cols=240 Identities=27% Similarity=0.422 Sum_probs=191.2
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccc--------
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR-------- 74 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------- 74 (303)
.+++.||+|.++... ....+.+.+|+.++++++||||+++++++.+....++||||+++++|.+++.....
T Consensus 75 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 154 (343)
T 1luf_A 75 EPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 154 (343)
T ss_dssp SSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC--------
T ss_pred CCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCccccccccc
Confidence 456899999997653 33456789999999999999999999999999999999999999999999864211
Q ss_pred -------------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccc
Q 048243 75 -------------RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEA 141 (303)
Q Consensus 75 -------------~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~ 141 (303)
...+++..++.++.||+.||+|||+.| ++||||||+||+++.++.++|+|||++..........
T Consensus 155 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 231 (343)
T 1luf_A 155 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231 (343)
T ss_dssp --------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC
T ss_pred ccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEECCCCeEEEeecCCCcccccCcccc
Confidence 256899999999999999999999999 9999999999999999999999999997765443333
Q ss_pred cccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCC
Q 048243 142 NTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDD 220 (303)
Q Consensus 142 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (303)
......+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... ............
T Consensus 232 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~-------- 296 (343)
T 1luf_A 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE-------VIYYVRDGNILA-------- 296 (343)
T ss_dssp ----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHHTTCCCC--------
T ss_pred ccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHH-------HHHHHhCCCcCC--------
Confidence 3344567889999999998889999999999999999999 999986432111 111111111111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccccCCC
Q 048243 221 TNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSMLKNETTNR 262 (303)
Q Consensus 221 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~~~~ 262 (303)
.+...+..+.+++.+||..||.+|||+.++++.|++.....
T Consensus 297 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 297 -CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred -CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 11123347889999999999999999999999999886543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=305.30 Aligned_cols=239 Identities=27% Similarity=0.399 Sum_probs=189.8
Q ss_pred cCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCC-eeEEEEeecCCCChhhhhcCccc-----
Q 048243 3 LPCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSE-ERMLVYEYMPNKSLDCYLFDPIR----- 74 (303)
Q Consensus 3 ~~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~----- 74 (303)
..+++.||||+++... ....+.+.+|+.++.++ +||||+++++++.... ..++||||+++|+|.+++.....
T Consensus 49 ~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~ 128 (359)
T 3vhe_A 49 TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128 (359)
T ss_dssp TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSC
T ss_pred cccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhcccccccc
Confidence 3567899999997653 33456799999999999 7999999999998765 48999999999999999965321
Q ss_pred ----------------------------------------------------------cccCCHHHHHHHHHHHHHHHHH
Q 048243 75 ----------------------------------------------------------RLILDWKKRVHIIEGITQGLLY 96 (303)
Q Consensus 75 ----------------------------------------------------------~~~l~~~~~~~~~~~i~~~l~~ 96 (303)
...+++..++.++.|++.||+|
T Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~ 208 (359)
T 3vhe_A 129 KTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 208 (359)
T ss_dssp C------------------------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHH
T ss_pred ccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHH
Confidence 1228899999999999999999
Q ss_pred HHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCCCccchhhHHHHH
Q 048243 97 LQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176 (303)
Q Consensus 97 Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~ 176 (303)
||+.+ |+||||||+||+++.++.++|+|||++................||+.|+|||++.+..++.++||||||+++
T Consensus 209 LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 285 (359)
T 3vhe_A 209 LASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 285 (359)
T ss_dssp HHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHH
Confidence 99999 999999999999999999999999999876544433444456788999999999999999999999999999
Q ss_pred HHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHh
Q 048243 177 LQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSML 255 (303)
Q Consensus 177 ~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~L 255 (303)
|+|++ |..||......... .......... ..+...+..+.+++.+||+.||.+|||+.|+++.|
T Consensus 286 ~ellt~g~~p~~~~~~~~~~------~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 350 (359)
T 3vhe_A 286 WEIFSLGASPYPGVKIDEEF------CRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 350 (359)
T ss_dssp HHHTTTSCCSSTTCCCSHHH------HHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhcCCCCCCccchhHHH------HHHHHcCCCC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 99998 99998654432211 1111111111 11112234788999999999999999999999999
Q ss_pred cccc
Q 048243 256 KNET 259 (303)
Q Consensus 256 ~~~~ 259 (303)
++..
T Consensus 351 ~~~~ 354 (359)
T 3vhe_A 351 GNLL 354 (359)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=291.53 Aligned_cols=245 Identities=16% Similarity=0.133 Sum_probs=193.8
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.||+|++..... .+.+.+|+..++.+ +|+|++++++++......++||||+ +++|.+++.. .+..+++..
T Consensus 33 ~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~--~~~~~~~~~ 107 (298)
T 1csn_A 33 LNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL--CGRKFSVKT 107 (298)
T ss_dssp TTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCHHH
T ss_pred CCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHH--hccCCCHHH
Confidence 6799999999865432 24578899999999 8999999999999999999999999 9999999853 234589999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCc-----eEEcccccccccccCCcc-----ccccccccccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK-----PKISDFGLARIFAKESLE-----ANTEQVVGTIGY 152 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~-----v~l~Df~~~~~~~~~~~~-----~~~~~~~g~~~y 152 (303)
++.++.||+.||+|||+.| ++||||||+||+++.++. ++|+|||++......... .......||+.|
T Consensus 108 ~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y 184 (298)
T 1csn_A 108 VAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184 (298)
T ss_dssp HHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTT
T ss_pred HHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCccc
Confidence 9999999999999999999 999999999999987766 999999999876544221 123345789999
Q ss_pred CChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHH
Q 048243 153 IPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLE 232 (303)
Q Consensus 153 ~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 232 (303)
+|||.+.+..++.++||||||+++|+|++|..||........................... .. ..+..+.+
T Consensus 185 ~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~----~~~~~l~~ 255 (298)
T 1csn_A 185 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL-----CA----GFPEEFYK 255 (298)
T ss_dssp CCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH-----TT----TSCHHHHH
T ss_pred CCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHH-----Hh----hCcHHHHH
Confidence 9999999999999999999999999999999999765544333322222111111110000 01 12347889
Q ss_pred HHHHcccCCCCCCCCHHHHHHHhccccCCCCCC
Q 048243 233 IALLCVQENPNDRPSMLQVSSMLKNETTNRNTP 265 (303)
Q Consensus 233 li~~~l~~dp~~Rpt~~el~~~L~~~~~~~~~~ 265 (303)
++.+||..||.+|||+.+|++.|++........
T Consensus 256 li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~ 288 (298)
T 1csn_A 256 YMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 288 (298)
T ss_dssp HHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence 999999999999999999999998877654433
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=305.34 Aligned_cols=251 Identities=18% Similarity=0.210 Sum_probs=185.6
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+|+.||||+++... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++... ....+++.
T Consensus 50 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~ 128 (389)
T 3gni_B 50 PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH-FMDGMNEL 128 (389)
T ss_dssp TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHT-CTTCCCHH
T ss_pred CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhh-cccCCCHH
Confidence 479999999997543 334567888999999999999999999999999999999999999999998542 23568999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCc-----cccccccccccCCCChh
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL-----EANTEQVVGTIGYIPPE 156 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~-----~~~~~~~~g~~~y~aPE 156 (303)
.++.++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||.+........ ........|++.|+|||
T Consensus 129 ~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 205 (389)
T 3gni_B 129 AIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205 (389)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHH
T ss_pred HHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHH
Confidence 99999999999999999999 99999999999999999999999998865433211 11223346889999999
Q ss_pred hhcc--CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHH-HHHHHHhCCC------------------------
Q 048243 157 YARQ--GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILE-HAYELWKGGK------------------------ 209 (303)
Q Consensus 157 ~~~~--~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~------------------------ 209 (303)
++.+ ..++.++|||||||++|+|++|..||............. ..........
T Consensus 206 ~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (389)
T 3gni_B 206 VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSL 285 (389)
T ss_dssp HHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------------------------------
T ss_pred HHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccccccccccccccccccccccc
Confidence 9987 578999999999999999999999996544332111000 0000000000
Q ss_pred ----cceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccc
Q 048243 210 ----GVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM--LKNE 258 (303)
Q Consensus 210 ----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~--L~~~ 258 (303)
.................+..+.+||.+||+.||.+|||+.|+++. +++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 286 TTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp --------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred ccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 000000000001112234578999999999999999999999864 5443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=308.59 Aligned_cols=230 Identities=20% Similarity=0.297 Sum_probs=185.3
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+.+|+|.+++. ....+++.
T Consensus 34 ~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~---~~~~~~e~ 110 (444)
T 3soa_A 34 LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV---AREYYSEA 110 (444)
T ss_dssp TTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHH---HCSCCCHH
T ss_pred CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHH---HcCCCCHH
Confidence 578999999997654 2345678899999999999999999999999999999999999999999884 34569999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEEC---CCCceEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG---EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~---~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
.+..++.||+.||+|||+.| |+||||||+||+++ .++.++|+|||++....... .......||+.|+|||++
T Consensus 111 ~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l 185 (444)
T 3soa_A 111 DASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVL 185 (444)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC--CBCCCSCSCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC--ceeecccCCcccCCHHHh
Confidence 99999999999999999999 99999999999998 46789999999997665432 222335789999999999
Q ss_pred ccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcc
Q 048243 159 RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238 (303)
Q Consensus 159 ~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 238 (303)
.+..++.++|||||||++|+|++|..||....... ... ....+... .........+..+.+||.+||
T Consensus 186 ~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~---~~~---~i~~~~~~-------~~~~~~~~~s~~~~~li~~~L 252 (444)
T 3soa_A 186 RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR---LYQ---QIKAGAYD-------FPSPEWDTVTPEAKDLINKML 252 (444)
T ss_dssp TTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH---HHHHTCCC-------CCTTTTTTSCHHHHHHHHHHS
T ss_pred cCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH---HHH---HHHhCCCC-------CCccccccCCHHHHHHHHHHc
Confidence 99899999999999999999999999995432111 111 11111110 001111123457889999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 048243 239 QENPNDRPSMLQVSSM 254 (303)
Q Consensus 239 ~~dp~~Rpt~~el~~~ 254 (303)
+.||.+|||+.|+++.
T Consensus 253 ~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 253 TINPSKRITAAEALKH 268 (444)
T ss_dssp CSSTTTSCCHHHHHHS
T ss_pred CCChhHCCCHHHHhcC
Confidence 9999999999999874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=296.43 Aligned_cols=240 Identities=23% Similarity=0.309 Sum_probs=181.4
Q ss_pred cCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 3 LPCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 3 ~~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||||+++ +|.+++.. ....+++
T Consensus 42 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~ 118 (311)
T 3niz_A 42 DSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDE--NKTGLQD 118 (311)
T ss_dssp ETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHT--CTTCCCH
T ss_pred ECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHh--ccCCCCH
Confidence 3578999999996543 23346788999999999999999999999999999999999975 77777743 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.|++.||+|||+.| |+||||||+||+++.++.++|+|||++....... .......|++.|+|||++.+
T Consensus 119 ~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~ 193 (311)
T 3niz_A 119 SQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV--RSYTHEVVTLWYRAPDVLMG 193 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC--C---CCCCCCTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc--ccccCCcccCCcCCHHHhcC
Confidence 999999999999999999999 9999999999999999999999999998764332 22233568999999999876
Q ss_pred -CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceecc------------ccCCCC----CC
Q 048243 161 -GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVD------------SSLDDT----NS 223 (303)
Q Consensus 161 -~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~----~~ 223 (303)
..++.++|||||||++|+|++|..||...........+ ...........+.. ...... ..
T Consensus 194 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (311)
T 3niz_A 194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI---FSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSII 270 (311)
T ss_dssp CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHH---HHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHS
T ss_pred CCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhC
Confidence 46899999999999999999999999765544332222 12111111000000 000000 00
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 224 PCKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 224 ~~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
+..+.++.+||.+||+.||.+|||+.|+++
T Consensus 271 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 271 PGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 112347889999999999999999999987
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=305.85 Aligned_cols=243 Identities=27% Similarity=0.375 Sum_probs=194.9
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccc-------
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR------- 74 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------- 74 (303)
..++.||+|+++... ....+.+.+|+.+++.+ +||||+++++++......++||||+++|+|.+++.....
T Consensus 99 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 178 (382)
T 3tt0_A 99 NRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 178 (382)
T ss_dssp TCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCC
T ss_pred ccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhccccccccc
Confidence 345689999997653 34456789999999999 999999999999999999999999999999999864321
Q ss_pred ------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcccccccccc
Q 048243 75 ------RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVG 148 (303)
Q Consensus 75 ------~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g 148 (303)
...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++................+
T Consensus 179 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~ 255 (382)
T 3tt0_A 179 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 255 (382)
T ss_dssp CCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCC
T ss_pred ccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCC
Confidence 245899999999999999999999999 99999999999999999999999999987655443333444567
Q ss_pred ccCCCChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHH
Q 048243 149 TIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKL 227 (303)
Q Consensus 149 ~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
++.|+|||.+.+..++.++|||||||++|+|++ |..||....... ............ .+...+
T Consensus 256 t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~~~~~---------~~~~~~ 319 (382)
T 3tt0_A 256 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------LFKLLKEGHRMD---------KPSNCT 319 (382)
T ss_dssp GGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHHHTTCCCC---------CCSSCC
T ss_pred CcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCC---------CCccCC
Confidence 889999999999999999999999999999999 999986433211 112222221111 111223
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhccccCCCCCC
Q 048243 228 MRCLEIALLCVQENPNDRPSMLQVSSMLKNETTNRNTP 265 (303)
Q Consensus 228 ~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~~~~~~~ 265 (303)
..+.+++.+||+.||.+|||+.|+++.|++.....+..
T Consensus 320 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 320 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 47889999999999999999999999998876544333
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=301.67 Aligned_cols=229 Identities=22% Similarity=0.323 Sum_probs=183.3
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++||||+.+|+|.+++. ....+++.
T Consensus 52 ~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~---~~~~~~~~ 128 (362)
T 2bdw_A 52 TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV---AREFYSEA 128 (362)
T ss_dssp TTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHT---TCSCCCHH
T ss_pred CCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHH---HcCCCCHH
Confidence 478999999997553 3345678899999999999999999999999999999999999999999884 34568999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCC---ceEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM---KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~---~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
.++.++.||+.||+|||+.| |+||||||+||+++.++ .++|+|||++....... ......||+.|+|||++
T Consensus 129 ~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~ 202 (362)
T 2bdw_A 129 DASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVL 202 (362)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC---SCCCSCSCTTTCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc---ccccCCCCccccCHHHH
Confidence 99999999999999999999 99999999999998654 59999999997665332 22335789999999999
Q ss_pred ccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcc
Q 048243 159 RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238 (303)
Q Consensus 159 ~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 238 (303)
.+..++.++|||||||++|+|++|..||....... ... ....+.... ........+..+.+||.+||
T Consensus 203 ~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~~~---~i~~~~~~~-------~~~~~~~~~~~~~~li~~~L 269 (362)
T 2bdw_A 203 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYA---QIKAGAYDY-------PSPEWDTVTPEAKSLIDSML 269 (362)
T ss_dssp TTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHHTCCCC-------CTTGGGGSCHHHHHHHHHHS
T ss_pred ccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHH---HHHhCCCCC-------CcccccCCCHHHHHHHHHHc
Confidence 99899999999999999999999999986432111 111 111111000 00001123457889999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 048243 239 QENPNDRPSMLQVSSM 254 (303)
Q Consensus 239 ~~dp~~Rpt~~el~~~ 254 (303)
..||.+|||+.|+++.
T Consensus 270 ~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 270 TVNPKKRITADQALKV 285 (362)
T ss_dssp CSSGGGSCCHHHHTTS
T ss_pred CCChhhCcCHHHHhcC
Confidence 9999999999999763
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=303.35 Aligned_cols=229 Identities=24% Similarity=0.284 Sum_probs=186.4
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+|+.||+|+++.......+.+.+|+.++++++||||+++++++......++||||+++++|.+++.. ....+++..+
T Consensus 112 ~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~--~~~~l~~~~~ 189 (373)
T 2x4f_A 112 ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID--ESYNLTELDT 189 (373)
T ss_dssp TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHH--TGGGCCHHHH
T ss_pred CCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHh--cCCCCCHHHH
Confidence 57899999999877656667899999999999999999999999999999999999999999888853 3456899999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEE--CCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL--GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~--~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
+.++.||+.||+|||+.+ |+||||||+||++ +.++.++|+|||++........ .....||+.|+|||++.+.
T Consensus 190 ~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~ 263 (373)
T 2x4f_A 190 ILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKVNFGTPEFLAPEVVNYD 263 (373)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCCCCSSCTTCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cccccCCCcEeChhhccCC
Confidence 999999999999999999 9999999999999 6678899999999987654322 2234689999999999988
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
.++.++|||||||++|+|++|..||....... .. .......... ........+..+.+||.+||+.|
T Consensus 264 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~---~~i~~~~~~~-------~~~~~~~~~~~~~~li~~~L~~d 330 (373)
T 2x4f_A 264 FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE---TL---NNILACRWDL-------EDEEFQDISEEAKEFISKLLIKE 330 (373)
T ss_dssp BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HHHHHTCCCS-------CSGGGTTSCHHHHHHHHTTSCSS
T ss_pred CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HH---HHHHhccCCC-------ChhhhccCCHHHHHHHHHHcCCC
Confidence 89999999999999999999999996443211 11 1111111100 00001122457889999999999
Q ss_pred CCCCCCHHHHHH
Q 048243 242 PNDRPSMLQVSS 253 (303)
Q Consensus 242 p~~Rpt~~el~~ 253 (303)
|.+|||+.|+++
T Consensus 331 p~~Rps~~e~l~ 342 (373)
T 2x4f_A 331 KSWRISASEALK 342 (373)
T ss_dssp GGGSCCHHHHHH
T ss_pred hhhCCCHHHHhc
Confidence 999999999987
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=298.83 Aligned_cols=229 Identities=17% Similarity=0.232 Sum_probs=184.3
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+|+.||+|.+.... .....+.+|+.+++.++||||+++++++.+....++||||+++++|.+++.. ....+++..+
T Consensus 28 ~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~ 104 (321)
T 1tki_A 28 SSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREI 104 (321)
T ss_dssp TTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTS--SSCCCCHHHH
T ss_pred CCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHh--cCCCCCHHHH
Confidence 478999999997543 3446788999999999999999999999999999999999999999999843 3346899999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC--CCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE--DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~--~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
+.++.|++.||+|||+.| ++||||||+||+++. ++.++|+|||++....... ......|++.|+|||++.+.
T Consensus 105 ~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~ 178 (321)
T 1tki_A 105 VSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHD 178 (321)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC---ccccccCChhhcCcHHhcCC
Confidence 999999999999999999 999999999999987 7899999999998765432 22345689999999999988
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
.++.++||||||+++|+|++|..||....... .. ........... .. ..+..+..+.+|+.+||..|
T Consensus 179 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~---~~i~~~~~~~~--~~-----~~~~~s~~~~~li~~~L~~d 245 (321)
T 1tki_A 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---II---ENIMNAEYTFD--EE-----AFKEISIEAMDFVDRLLVKE 245 (321)
T ss_dssp EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HHHHHTCCCCC--HH-----HHTTSCHHHHHHHHTTSCSS
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH---HH---HHHHcCCCCCC--hh-----hhccCCHHHHHHHHHHcCCC
Confidence 88999999999999999999999996433211 11 11111111000 00 00112457889999999999
Q ss_pred CCCCCCHHHHHHH
Q 048243 242 PNDRPSMLQVSSM 254 (303)
Q Consensus 242 p~~Rpt~~el~~~ 254 (303)
|.+|||+.|+++.
T Consensus 246 p~~Rpt~~e~l~h 258 (321)
T 1tki_A 246 RKSRMTASEALQH 258 (321)
T ss_dssp GGGSCCHHHHHHS
T ss_pred hhHCcCHHHHhcC
Confidence 9999999999883
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=297.04 Aligned_cols=239 Identities=25% Similarity=0.383 Sum_probs=192.9
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccc-------
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR------- 74 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------- 74 (303)
.+++.||+|+++... ....+.+.+|+.+++++ +||||+++++++......++||||+++|+|.+++.....
T Consensus 51 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 130 (313)
T 1t46_A 51 DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130 (313)
T ss_dssp TCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC-----
T ss_pred chhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccc
Confidence 567899999997553 33457889999999999 999999999999999999999999999999999864221
Q ss_pred --------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcccccccc
Q 048243 75 --------RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQV 146 (303)
Q Consensus 75 --------~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~ 146 (303)
...+++..++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||.+...............
T Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 207 (313)
T 1t46_A 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207 (313)
T ss_dssp ---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSS
T ss_pred cccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEcCCCCEEEccccccccccccccceeccCC
Confidence 225899999999999999999999999 999999999999999999999999999876655433334445
Q ss_pred ccccCCCChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHH
Q 048243 147 VGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPC 225 (303)
Q Consensus 147 ~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (303)
.+++.|+|||.+.+..++.++||||||+++|+|++ |..||......... . ....... .......
T Consensus 208 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~---~~~~~~~---------~~~~~~~ 272 (313)
T 1t46_A 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF---Y---KMIKEGF---------RMLSPEH 272 (313)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH---H---HHHHHTC---------CCCCCTT
T ss_pred CCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH---H---HHhccCC---------CCCCccc
Confidence 67889999999999899999999999999999998 99998654332211 1 1111110 0111122
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhccccC
Q 048243 226 KLMRCLEIALLCVQENPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 226 ~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~~ 260 (303)
.+..+.+++.+||..||.+|||+.|+++.|++...
T Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 273 APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 34578899999999999999999999999987653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=302.47 Aligned_cols=230 Identities=20% Similarity=0.253 Sum_probs=186.3
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+|+.||+|++..........+.+|+.+++.++||||+++++++.+....++||||+.+++|.+++.. ....+++..+
T Consensus 74 ~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~l~~~~~ 151 (387)
T 1kob_A 74 ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEV 151 (387)
T ss_dssp TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTC--TTCCBCHHHH
T ss_pred CCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHh--hcCCCCHHHH
Confidence 47899999999876655667899999999999999999999999999999999999999999998853 2346899999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC--CCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE--DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~--~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
+.++.||+.||+|||+.| |+||||||+||+++. ++.++|+|||++........ .....||+.|+|||++.+.
T Consensus 152 ~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~ 225 (387)
T 1kob_A 152 INYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDRE 225 (387)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCcc---eeeeccCCCccCchhccCC
Confidence 999999999999999999 999999999999974 47799999999987654321 2234689999999999998
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
.++.++|||||||++|+|++|..||....... ... ....... ..........+..+.+||.+||..|
T Consensus 226 ~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~---~i~~~~~-------~~~~~~~~~~s~~~~~li~~~L~~d 292 (387)
T 1kob_A 226 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQ---NVKRCDW-------EFDEDAFSSVSPEAKDFIKNLLQKE 292 (387)
T ss_dssp CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHH---HHHHCCC-------CCCSSTTTTSCHHHHHHHHTTSCSS
T ss_pred CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH---HHH---HHHhCCC-------CCCccccccCCHHHHHHHHHHcCCC
Confidence 89999999999999999999999996432211 111 1111110 0111111223457889999999999
Q ss_pred CCCCCCHHHHHHH
Q 048243 242 PNDRPSMLQVSSM 254 (303)
Q Consensus 242 p~~Rpt~~el~~~ 254 (303)
|.+|||+.|+++.
T Consensus 293 P~~Rpt~~ell~h 305 (387)
T 1kob_A 293 PRKRLTVHDALEH 305 (387)
T ss_dssp GGGSCCHHHHHTS
T ss_pred hhHCcCHHHHhhC
Confidence 9999999999874
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=293.98 Aligned_cols=239 Identities=15% Similarity=0.134 Sum_probs=191.0
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.||||++...... +.+.+|+.+++.+ +||||+++++++......++||||+ +++|.+++.. ....+++..
T Consensus 32 ~~~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~ 106 (330)
T 2izr_A 32 YTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDL--CDRTFSLKT 106 (330)
T ss_dssp TTTEEEEEEEEETTCSS--CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCHHH
T ss_pred CCCcEEEEEEeccccch--HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHH--cCCCCCHHH
Confidence 67899999999755322 3578999999999 9999999999999999999999999 8999999854 245799999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCc-----eEEcccccccccccCCccc-----cccccccccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK-----PKISDFGLARIFAKESLEA-----NTEQVVGTIGY 152 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~-----v~l~Df~~~~~~~~~~~~~-----~~~~~~g~~~y 152 (303)
++.++.|++.||+|||+.| |+||||||+||+++.++. ++|+|||++.......... ......||+.|
T Consensus 107 ~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y 183 (330)
T 2izr_A 107 VLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183 (330)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTT
T ss_pred HHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccc
Confidence 9999999999999999999 999999999999999887 9999999998765432211 12346789999
Q ss_pred CChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHH
Q 048243 153 IPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLE 232 (303)
Q Consensus 153 ~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 232 (303)
+|||.+.+..++.++||||||+++|+|++|..||........................ . .+ ... .+ .+.+
T Consensus 184 ~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~----~-~~-~~~---~p-~~~~ 253 (330)
T 2izr_A 184 MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI----E-VL-CEN---FP-EMAT 253 (330)
T ss_dssp CCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH----H-HH-TTT---CH-HHHH
T ss_pred cChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH----H-HH-hcc---Ch-HHHH
Confidence 9999999999999999999999999999999999766544433322222111110000 0 00 001 12 7889
Q ss_pred HHHHcccCCCCCCCCHHHHHHHhccccC
Q 048243 233 IALLCVQENPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 233 li~~~l~~dp~~Rpt~~el~~~L~~~~~ 260 (303)
++.+||..||.+||++.+|.+.|++...
T Consensus 254 li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 254 YLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp HHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 9999999999999999999999876553
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=294.97 Aligned_cols=234 Identities=25% Similarity=0.377 Sum_probs=189.0
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
..+++.||+|+++.... ..+.+.+|+.++++++||||+++++++.+....++||||+++++|.+++.. ....+++..
T Consensus 45 ~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~ 121 (283)
T 3gen_A 45 WRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQ 121 (283)
T ss_dssp ETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHC--GGGCCCHHH
T ss_pred EcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHH--hccCCCHHH
Confidence 46778899999975543 347789999999999999999999999999999999999999999999854 245699999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||.+........ .......+++.|+|||.+.+..
T Consensus 122 ~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~ 197 (283)
T 3gen_A 122 LLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSK 197 (283)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-HSTTSTTSCGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc-ccccCCccCcccCCHHHhccCC
Confidence 9999999999999999999 99999999999999999999999999976543321 1122334677899999999889
Q ss_pred CCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
++.++||||||+++|+|++ |..||....... . ........ ....+...+..+.+++.+||+.|
T Consensus 198 ~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~------~-~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~~ 261 (283)
T 3gen_A 198 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------T-AEHIAQGL---------RLYRPHLASEKVYTIMYSCWHEK 261 (283)
T ss_dssp CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------H-HHHHHTTC---------CCCCCTTCCHHHHHHHHHTTCSS
T ss_pred CCchhhHHHHHHHHHHHHhCCCCCccccChhH------H-HHHHhccc---------CCCCCCcCCHHHHHHHHHHccCC
Confidence 9999999999999999998 999986443211 1 11111111 01111122347889999999999
Q ss_pred CCCCCCHHHHHHHhcccc
Q 048243 242 PNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 242 p~~Rpt~~el~~~L~~~~ 259 (303)
|.+|||+.++++.|++..
T Consensus 262 p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 262 ADERPTFKILLSNILDVM 279 (283)
T ss_dssp GGGSCCHHHHHHHHHHHH
T ss_pred hhHCcCHHHHHHHHHHHh
Confidence 999999999999998764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=290.90 Aligned_cols=241 Identities=21% Similarity=0.247 Sum_probs=182.0
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.++...++||||+++ ++.+++.. ....+++.
T Consensus 25 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~l~~~ 101 (292)
T 3o0g_A 25 ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDS--CNGDLDPE 101 (292)
T ss_dssp TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHH--TTTCCCHH
T ss_pred CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHh--CCCCCCHH
Confidence 578999999997553 23346788999999999999999999999999999999999986 45555432 34569999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
.++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||.+....... .......||+.|+|||++.+.
T Consensus 102 ~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~ 176 (292)
T 3o0g_A 102 IVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGA 176 (292)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--SCCCSCCSCGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc--ccccCCccccCCcChHHHcCC
Confidence 99999999999999999999 9999999999999999999999999998764332 222335689999999999776
Q ss_pred C-CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceec---------------cccCCCCCCHH
Q 048243 162 V-YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV---------------DSSLDDTNSPC 225 (303)
Q Consensus 162 ~-~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~ 225 (303)
. ++.++|||||||++|+|++|..||..... ...................+. .........+.
T Consensus 177 ~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (292)
T 3o0g_A 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPK 254 (292)
T ss_dssp SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTT
T ss_pred CCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccc
Confidence 5 79999999999999999998888643322 112222222221111100000 00000111123
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 226 KLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 226 ~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
.+..+.+|+.+||+.||++|||++|+++.
T Consensus 255 ~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 255 LNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 44578899999999999999999999863
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=310.45 Aligned_cols=238 Identities=27% Similarity=0.402 Sum_probs=190.2
Q ss_pred ccCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 2 VLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 2 ~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+++++.||||+++... ...+.+.+|+.++++++||||+++++++. ....++||||+.+|+|.+++... ....+++.
T Consensus 208 ~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~ 284 (454)
T 1qcf_A 208 TYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSD-EGSKQPLP 284 (454)
T ss_dssp EETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSH-HHHTCCHH
T ss_pred EECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhc-cCCCCCHH
Confidence 45678899999997654 45688999999999999999999999986 56789999999999999999542 23468899
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
.++.++.||+.||+|||+++ ++||||||+|||++.++.+||+|||+++....... .......++..|+|||.+...
T Consensus 285 ~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 360 (454)
T 1qcf_A 285 KLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFG 360 (454)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce-eccCCCcccccccCHHHhccC
Confidence 99999999999999999999 99999999999999999999999999986543221 112223457789999999988
Q ss_pred CCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 162 VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
.++.++||||||+++|+|++ |..||....... ... ....+ .. ...+...+..+.++|.+||..
T Consensus 361 ~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~~~---~i~~~-~~---------~~~~~~~~~~l~~li~~cl~~ 424 (454)
T 1qcf_A 361 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIR---ALERG-YR---------MPRPENCPEELYNIMMRCWKN 424 (454)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHH---HHHHT-CC---------CCCCTTSCHHHHHHHHHHTCS
T ss_pred CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---HHH---HHHcC-CC---------CCCCCCCCHHHHHHHHHHccC
Confidence 99999999999999999999 999986433211 111 11111 11 111112345788999999999
Q ss_pred CCCCCCCHHHHHHHhccccCCC
Q 048243 241 NPNDRPSMLQVSSMLKNETTNR 262 (303)
Q Consensus 241 dp~~Rpt~~el~~~L~~~~~~~ 262 (303)
||.+|||+.+|++.|+......
T Consensus 425 dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 425 RPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp SGGGSCCHHHHHHHHHTSSSSS
T ss_pred ChhHCcCHHHHHHHHHHHHhcc
Confidence 9999999999999999887544
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=291.90 Aligned_cols=226 Identities=24% Similarity=0.303 Sum_probs=177.1
Q ss_pred CCCcEEEEEEecCCCc--------------------------ccHHHHHHHHHHHhcCCCCccccEEEEEEe--CCeeEE
Q 048243 4 PCGKVIAVKKLSKTST--------------------------QGFEEFKNEVMLTAKLQHVNLIRVLGFCID--SEERML 55 (303)
Q Consensus 4 ~~~~~valK~~~~~~~--------------------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 55 (303)
.+|+.||||++..... ...+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 36 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 115 (298)
T 2zv2_A 36 NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYM 115 (298)
T ss_dssp TTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEE
T ss_pred CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEE
Confidence 5789999999965431 123568899999999999999999999987 568899
Q ss_pred EEeecCCCChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccc
Q 048243 56 VYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFA 135 (303)
Q Consensus 56 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~ 135 (303)
||||+++++|.+++ ....+++..++.++.||+.||+|||+.| ++||||||+||+++.++.++|+|||++....
T Consensus 116 v~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 188 (298)
T 2zv2_A 116 VFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188 (298)
T ss_dssp EEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCCEEEecCCCccccc
Confidence 99999999998765 3456999999999999999999999999 9999999999999999999999999997765
Q ss_pred cCCccccccccccccCCCChhhhccCC---CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcce
Q 048243 136 KESLEANTEQVVGTIGYIPPEYARQGV---YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVE 212 (303)
Q Consensus 136 ~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (303)
... .......|++.|+|||.+.+.. ++.++||||||+++|+|++|..||...... ...........
T Consensus 189 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~--- 257 (298)
T 2zv2_A 189 GSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM------CLHSKIKSQAL--- 257 (298)
T ss_dssp SSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCC---
T ss_pred ccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH------HHHHHHhcccC---
Confidence 432 1223357899999999987765 367899999999999999999998643211 11111111110
Q ss_pred eccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 213 FVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 213 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
.....+..+..+.++|.+||+.||++|||+.|+++
T Consensus 258 ------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 258 ------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp ------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 00011122347889999999999999999999875
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=295.50 Aligned_cols=230 Identities=22% Similarity=0.272 Sum_probs=180.9
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCC-------------------------------
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE------------------------------- 51 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------------------------------- 51 (303)
.+|+.||||+++... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 29 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 108 (332)
T 3qd2_B 29 VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAP 108 (332)
T ss_dssp TTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---------------------
T ss_pred CCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCccccc
Confidence 479999999997543 345578999999999999999999999986543
Q ss_pred --------------------------eeEEEEeecCCCChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 048243 52 --------------------------ERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTI 105 (303)
Q Consensus 52 --------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i 105 (303)
..++|||||++++|.+++.........++..++.++.||+.||+|||+.| +
T Consensus 109 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i 185 (332)
T 3qd2_B 109 SVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---L 185 (332)
T ss_dssp -----------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred ccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCC---e
Confidence 37999999999999999976555566777889999999999999999999 9
Q ss_pred EecCCCCCceEECCCCceEEcccccccccccCCcc----------ccccccccccCCCChhhhccCCCCCccchhhHHHH
Q 048243 106 IHRDLKASNILLGEDMKPKISDFGLARIFAKESLE----------ANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVL 175 (303)
Q Consensus 106 ~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~----------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~ 175 (303)
+||||||+||+++.++.++|+|||++......... .......||+.|+|||.+.+..++.++||||||++
T Consensus 186 vH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 265 (332)
T 3qd2_B 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLI 265 (332)
T ss_dssp ECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHH
T ss_pred eecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHH
Confidence 99999999999999999999999999876544211 12233568999999999999999999999999999
Q ss_pred HHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 176 LLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 176 ~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
+|+|++|..|+... .. .......... .......+..+.+++.+||+.||.+|||+.|+++.
T Consensus 266 l~el~~~~~~~~~~--------~~-~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 266 LFELLYSFSTQMER--------VR-IITDVRNLKF---------PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHSCCCCHHHH--------HH-HHHHHHTTCC---------CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHcCCChhHH--------HH-HHHHhhccCC---------CcccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 99999987664210 00 0111111100 01112334567899999999999999999999874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=294.34 Aligned_cols=243 Identities=27% Similarity=0.350 Sum_probs=189.8
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeC--CeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||||+++... ....+.+.+|+.++++++||||+++++++.+. ...++||||+++++|.+++. ...+++
T Consensus 58 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~ 133 (318)
T 3lxp_A 58 GTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP----RHSIGL 133 (318)
T ss_dssp -CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGG----GSCCCH
T ss_pred CCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHh----hCCCCH
Confidence 478999999997653 34456789999999999999999999999884 67899999999999999984 334899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-ccccccccccCCCChhhhc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~ 159 (303)
..++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++......... .......++..|+|||.+.
T Consensus 134 ~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 210 (318)
T 3lxp_A 134 AQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 210 (318)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhc
Confidence 999999999999999999999 999999999999999999999999999876544322 2233455788899999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCC--------ccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHH
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGIN--------ENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL 231 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
+..++.++||||||+++|+|++|..||...... ................ .....+...+..+.
T Consensus 211 ~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~ 281 (318)
T 3lxp_A 211 EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG---------ERLPRPDKCPAEVY 281 (318)
T ss_dssp HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT---------CCCCCCTTCCHHHH
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc---------cCCCCCccccHHHH
Confidence 888899999999999999999999998542211 0000111111111111 11112223345789
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhccccCCC
Q 048243 232 EIALLCVQENPNDRPSMLQVSSMLKNETTNR 262 (303)
Q Consensus 232 ~li~~~l~~dp~~Rpt~~el~~~L~~~~~~~ 262 (303)
+|+.+||+.||.+|||+.|+++.|+......
T Consensus 282 ~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 282 HLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 9999999999999999999999998775433
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=301.18 Aligned_cols=225 Identities=21% Similarity=0.268 Sum_probs=180.0
Q ss_pred CCCcEEEEEEecCC---CcccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+|+.||||+++.. .....+.+..|..++..+ +||||+++++++.+....|+||||+++|+|..++. ....++
T Consensus 46 ~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~~~ 122 (353)
T 3txo_A 46 ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQ---KSRRFD 122 (353)
T ss_dssp TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH---HHSSCC
T ss_pred CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHH---HcCCCC
Confidence 57899999999754 234556788999999998 79999999999999999999999999999999884 345699
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..++.++.||+.||+|||+.| |+||||||+|||++.+|.++|+|||+++...... .......||+.|+|||++.
T Consensus 123 ~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~ 197 (353)
T 3txo_A 123 EARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG--VTTATFCGTPDYIAPEILQ 197 (353)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccCC--ccccccCCCcCeEChhhcC
Confidence 9999999999999999999999 9999999999999999999999999987533221 2233457899999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++|||||||++|+|++|..||....... .......... ..+...+..+.++|.+||+
T Consensus 198 ~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~~~~-----------~~p~~~~~~~~~li~~lL~ 260 (353)
T 3txo_A 198 EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD------LFEAILNDEV-----------VYPTWLHEDATGILKSFMT 260 (353)
T ss_dssp HHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCC-----------CCCTTSCHHHHHHHHHHTC
T ss_pred CCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH------HHHHHHcCCC-----------CCCCCCCHHHHHHHHHHhh
Confidence 9889999999999999999999999996443221 1111111111 0111234478899999999
Q ss_pred CCCCCCCCH------HHHHH
Q 048243 240 ENPNDRPSM------LQVSS 253 (303)
Q Consensus 240 ~dp~~Rpt~------~el~~ 253 (303)
.||.+||++ .|+++
T Consensus 261 ~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 261 KNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp SSGGGSTTSGGGTCTHHHHT
T ss_pred hCHHHccCCcccCCHHHHhh
Confidence 999999998 77765
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=288.35 Aligned_cols=230 Identities=29% Similarity=0.404 Sum_probs=175.5
Q ss_pred CCcEEEEEEecCCC----cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 5 CGKVIAVKKLSKTS----TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 5 ~~~~valK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
+|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++ ....+++
T Consensus 29 ~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~----~~~~~~~ 104 (271)
T 3dtc_A 29 IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPP 104 (271)
T ss_dssp TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHH----TSSCCCH
T ss_pred cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHh----hcCCCCH
Confidence 58899999986543 233567899999999999999999999999999999999999999999988 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC--------CCceEEcccccccccccCCccccccccccccCC
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE--------DMKPKISDFGLARIFAKESLEANTEQVVGTIGY 152 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~--------~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y 152 (303)
..++.++.|++.||+|||+.+..+++||||||+||+++. ++.++|+|||.+........ ....|++.|
T Consensus 105 ~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y 180 (271)
T 3dtc_A 105 DILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAW 180 (271)
T ss_dssp HHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----------------CCGGG
T ss_pred HHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccccc----cCCCCccce
Confidence 999999999999999999987555889999999999986 67899999999876543321 234689999
Q ss_pred CChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHH
Q 048243 153 IPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLE 232 (303)
Q Consensus 153 ~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 232 (303)
+|||.+.+..++.++||||||+++|+|++|..||...... ............ ...+...+..+.+
T Consensus 181 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~---------~~~~~~~~~~~~~ 245 (271)
T 3dtc_A 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL------AVAYGVAMNKLA---------LPIPSTCPEPFAK 245 (271)
T ss_dssp SCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHTSCCC---------CCCCTTCCHHHHH
T ss_pred eCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHhhhcCCCC---------CCCCcccCHHHHH
Confidence 9999999999999999999999999999999998643211 111111111111 1111223357889
Q ss_pred HHHHcccCCCCCCCCHHHHHHHhcc
Q 048243 233 IALLCVQENPNDRPSMLQVSSMLKN 257 (303)
Q Consensus 233 li~~~l~~dp~~Rpt~~el~~~L~~ 257 (303)
++.+||+.||.+|||+.|+++.|++
T Consensus 246 li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 246 LMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHHHhcCCcccCcCHHHHHHHHhc
Confidence 9999999999999999999999975
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=297.43 Aligned_cols=236 Identities=25% Similarity=0.402 Sum_probs=175.8
Q ss_pred EEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCee------EEEEeecCCCChhhhhcCcc---ccc
Q 048243 8 VIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER------MLVYEYMPNKSLDCYLFDPI---RRL 76 (303)
Q Consensus 8 ~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~---~~~ 76 (303)
.||||+++.. .....+.+.+|+.++++++||||+++++++...... ++||||+.+++|.+++.... ...
T Consensus 53 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~ 132 (323)
T 3qup_A 53 KVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF 132 (323)
T ss_dssp EEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CC
T ss_pred eEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhcccccc
Confidence 7999999765 334567899999999999999999999999877655 99999999999999885422 122
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChh
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE 156 (303)
.+++..++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++................+++.|+|||
T Consensus 133 ~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE 209 (323)
T 3qup_A 133 NLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALE 209 (323)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHH
T ss_pred ccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCch
Confidence 5899999999999999999999999 9999999999999999999999999998765443333333445678899999
Q ss_pred hhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHH
Q 048243 157 YARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
.+.+..++.++|||||||++|+|++ |..||......... . ....... ...++..+..+.+++.
T Consensus 210 ~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---~----~~~~~~~---------~~~~~~~~~~l~~li~ 273 (323)
T 3qup_A 210 SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY---N----YLIGGNR---------LKQPPECMEEVYDLMY 273 (323)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---H----HHHTTCC---------CCCCTTCCHHHHHHHH
T ss_pred hhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH---H----HHhcCCC---------CCCCCccCHHHHHHHH
Confidence 9999999999999999999999999 88998654332211 1 1111111 1111223357889999
Q ss_pred HcccCCCCCCCCHHHHHHHhccccCCC
Q 048243 236 LCVQENPNDRPSMLQVSSMLKNETTNR 262 (303)
Q Consensus 236 ~~l~~dp~~Rpt~~el~~~L~~~~~~~ 262 (303)
+||+.||.+|||+.++++.|++....+
T Consensus 274 ~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 274 QCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp HTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 999999999999999999998776443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=310.00 Aligned_cols=244 Identities=27% Similarity=0.403 Sum_probs=188.2
Q ss_pred ccCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 2 VLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 2 ~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.++++..||||+++... ...+.+.+|+.++++++||||+++++++.. ...++||||+++|+|.+++.. ..+..+++.
T Consensus 204 ~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~-~~~~~~~~~ 280 (452)
T 1fmk_A 204 TWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKG-ETGKYLRLP 280 (452)
T ss_dssp EETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSH-HHHTTCCHH
T ss_pred EECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHh-cCCCCCCHH
Confidence 34567789999997654 345789999999999999999999999876 678999999999999999953 123458999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
.++.++.||+.||+|||+++ ++||||||+|||++.++.+||+|||+++....... .......++..|+|||.+.+.
T Consensus 281 ~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 356 (452)
T 1fmk_A 281 QLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYG 356 (452)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce-ecccCCcccccccCHhHHhcC
Confidence 99999999999999999999 99999999999999999999999999976543321 122234567889999999988
Q ss_pred CCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 162 VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
.++.++||||||+++|+|++ |..||....... .......+.. ...+...+..+.++|.+||+.
T Consensus 357 ~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~~---------~~~~~~~~~~l~~li~~cl~~ 420 (452)
T 1fmk_A 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYR---------MPCPPECPESLHDLMCQCWRK 420 (452)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCC---------CCCCTTSCHHHHHHHHHHTCS
T ss_pred CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC---------CCCCCCCCHHHHHHHHHHccC
Confidence 99999999999999999999 899986433211 1111111111 111122345788999999999
Q ss_pred CCCCCCCHHHHHHHhccccCCCCCCCCC
Q 048243 241 NPNDRPSMLQVSSMLKNETTNRNTPKKP 268 (303)
Q Consensus 241 dp~~Rpt~~el~~~L~~~~~~~~~~~~~ 268 (303)
||.+|||+.++++.|+...........|
T Consensus 421 dP~~Rpt~~~l~~~L~~~~~~~~~~~~~ 448 (452)
T 1fmk_A 421 EPEERPTFEYLQAFLEDYFTSTEPQYQP 448 (452)
T ss_dssp SGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred ChhhCcCHHHHHHHHHHHhccCCccccc
Confidence 9999999999999999987655544433
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=297.19 Aligned_cols=224 Identities=20% Similarity=0.291 Sum_probs=181.8
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|++.... ......+.+|+.+++.++||||+++++++......++||||+ +|+|.+++. ....+++
T Consensus 32 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~---~~~~l~~ 107 (336)
T 3h4j_B 32 KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIV---EKKRMTE 107 (336)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHH---HHCSCCH
T ss_pred CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHH---HcCCCCH
Confidence 578999999986431 223457889999999999999999999999999999999999 678888884 3456999
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++....... ......|++.|+|||++.+
T Consensus 108 ~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~---~~~~~~gt~~y~aPE~~~~ 181 (336)
T 3h4j_B 108 DEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVING 181 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB---TTCCCTTSTTTSCGGGSCC
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCc---ccccccCCcCcCCHHHHcC
Confidence 999999999999999999999 9999999999999999999999999997654432 2233568999999999988
Q ss_pred CCC-CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 161 GVY-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 161 ~~~-~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
..+ +.++||||||+++|+|++|..||............ ... ....+...+..+.+||.+||.
T Consensus 182 ~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i---------------~~~--~~~~p~~~s~~~~~li~~~L~ 244 (336)
T 3h4j_B 182 KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV---------------NSC--VYVMPDFLSPGAQSLIRRMIV 244 (336)
T ss_dssp SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC---------------CSS--CCCCCTTSCHHHHHHHHTTSC
T ss_pred CCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH---------------HcC--CCCCcccCCHHHHHHHHHHcC
Confidence 776 67999999999999999999999654332211100 000 011112234578899999999
Q ss_pred CCCCCCCCHHHHHHH
Q 048243 240 ENPNDRPSMLQVSSM 254 (303)
Q Consensus 240 ~dp~~Rpt~~el~~~ 254 (303)
.||.+|||+.|+++.
T Consensus 245 ~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 245 ADPMQRITIQEIRRD 259 (336)
T ss_dssp SSGGGSCCHHHHTTC
T ss_pred CChhHCcCHHHHHhC
Confidence 999999999999763
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=292.97 Aligned_cols=223 Identities=23% Similarity=0.308 Sum_probs=184.2
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.+....++||||+++|+|.+++. ....+++
T Consensus 29 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~---~~~~~~~ 105 (318)
T 1fot_A 29 HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFPN 105 (318)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---HTSSCCH
T ss_pred CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHH---HcCCCCH
Confidence 579999999996542 2455778899999999999999999999999999999999999999999984 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.||+.||+|||++| |+||||||+||+++.+|.++|+|||++...... .....||+.|+|||++.+
T Consensus 106 ~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~ 177 (318)
T 1fot_A 106 PVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVST 177 (318)
T ss_dssp HHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc-----cccccCCccccCHhHhcC
Confidence 999999999999999999999 999999999999999999999999999765432 223578999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|||||||++|+|++|..||....... .......... ..+...+..+.++|.+||..
T Consensus 178 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~~~-----------~~p~~~~~~~~~li~~lL~~ 240 (318)
T 1fot_A 178 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYEKILNAEL-----------RFPPFFNEDVKDLLSRLITR 240 (318)
T ss_dssp CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHCCC-----------CCCTTSCHHHHHHHHHHTCS
T ss_pred CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC-----------CCCCCCCHHHHHHHHHHhcc
Confidence 999999999999999999999999996433211 1111222110 01112345788999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 048243 241 NPNDRP-----SMLQVSSM 254 (303)
Q Consensus 241 dp~~Rp-----t~~el~~~ 254 (303)
||.+|| +++|+++.
T Consensus 241 dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 241 DLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp CTTTCTTSSTTTTHHHHTS
T ss_pred CHHHcCCCcCCCHHHHhcC
Confidence 999999 88999853
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=306.45 Aligned_cols=236 Identities=28% Similarity=0.418 Sum_probs=178.4
Q ss_pred CCCcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+++.||||.++.. .....+.+.+|+.++++++||||+++++++......++||||+++++|.+++.. ....+++..
T Consensus 71 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~--~~~~~~~~~ 148 (373)
T 2qol_A 71 KKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQ 148 (373)
T ss_dssp SCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHT--TTTCSCHHH
T ss_pred CCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHh--CCCCCCHHH
Confidence 35778999999765 344556899999999999999999999999999999999999999999999954 345689999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-ccccccccccCCCChhhhccC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~ 161 (303)
++.++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++......... .......++..|+|||.+.+.
T Consensus 149 ~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 225 (373)
T 2qol_A 149 LVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225 (373)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccC
Confidence 9999999999999999999 999999999999999999999999999876543211 111223457789999999999
Q ss_pred CCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 162 VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
.++.++||||||+++|+|++ |..||....... .......... ...+...+..+.+++.+||+.
T Consensus 226 ~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-------~~~~i~~~~~---------~~~~~~~~~~l~~li~~cl~~ 289 (373)
T 2qol_A 226 KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-------VIKAVDEGYR---------LPPPMDCPAALYQLMLDCWQK 289 (373)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-------HHHHHHTTEE---------CCCCTTCBHHHHHHHHHHTCS
T ss_pred CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC---------CCCCccccHHHHHHHHHHhCc
Confidence 99999999999999999998 999985432211 1111111111 011112345788999999999
Q ss_pred CCCCCCCHHHHHHHhccccC
Q 048243 241 NPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 241 dp~~Rpt~~el~~~L~~~~~ 260 (303)
||.+||++.++++.|++...
T Consensus 290 dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 290 DRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp SGGGSCCHHHHHHHHHHHHH
T ss_pred ChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999887653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=297.33 Aligned_cols=230 Identities=21% Similarity=0.264 Sum_probs=173.6
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+|+.||||++...... .+.+.+|+.+++.++||||+++++++......++||||+.+|+|.+++. ....+++..+
T Consensus 43 ~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~ 118 (361)
T 3uc3_A 43 LTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERIC---NAGRFSEDEA 118 (361)
T ss_dssp TTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH---HHSSCCHHHH
T ss_pred CCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHH---hcCCCCHHHH
Confidence 47899999999765433 3678899999999999999999999999999999999999999999884 3456999999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCc--eEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK--PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~--v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
+.++.|++.||+|||+.| |+||||||+||+++.++. ++|+|||+++..... .......||+.|+|||++.+.
T Consensus 119 ~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~ 192 (361)
T 3uc3_A 119 RFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRQ 192 (361)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------------------CTTSCHHHHHCS
T ss_pred HHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc---CCCCCCcCCCCcCChhhhcCC
Confidence 999999999999999999 999999999999987765 999999998743222 122335689999999999888
Q ss_pred CCCCc-cchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 162 VYSTK-SDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~-~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
.++.+ +|||||||++|+|++|..||............ .......... .......+..+.+||.+||..
T Consensus 193 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~--~~~~~~~~~~---------~~~~~~~s~~~~~li~~~L~~ 261 (361)
T 3uc3_A 193 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT--IQRILSVKYS---------IPDDIRISPECCHLISRIFVA 261 (361)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH--HHHHHTTCCC---------CCTTSCCCHHHHHHHHHHSCS
T ss_pred CCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH--HHHHhcCCCC---------CCCcCCCCHHHHHHHHHHccC
Confidence 77655 89999999999999999999754433222111 1111111100 000011234788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 048243 241 NPNDRPSMLQVSSM 254 (303)
Q Consensus 241 dp~~Rpt~~el~~~ 254 (303)
||.+|||+.|+++.
T Consensus 262 dP~~Rps~~ell~h 275 (361)
T 3uc3_A 262 DPATRISIPEIKTH 275 (361)
T ss_dssp CTTTSCCHHHHHTS
T ss_pred ChhHCcCHHHHHhC
Confidence 99999999999874
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=298.31 Aligned_cols=227 Identities=24% Similarity=0.316 Sum_probs=184.2
Q ss_pred CCCcEEEEEEecCC---CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+....++||||+.+|+|..++. ....+++
T Consensus 38 ~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~---~~~~l~~ 114 (384)
T 4fr4_A 38 DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ---QNVHFKE 114 (384)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH---TTCCCCH
T ss_pred CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHH---hcCCCCH
Confidence 57899999999643 23455788899999999999999999999999999999999999999999984 3456999
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.||+.||+|||+.| |+||||||+||+++.+|.++|+|||++....... ......||+.|+|||++.+
T Consensus 115 ~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~ 188 (384)
T 4fr4_A 115 ETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET---QITTMAGTKPYMAPEMFSS 188 (384)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTC---CBCCCCSCGGGCCGGGTCC
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCC---ceeccCCCccccCCeeecc
Confidence 999999999999999999999 9999999999999999999999999998654332 2234578999999999874
Q ss_pred ---CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHc
Q 048243 161 ---GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237 (303)
Q Consensus 161 ---~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 237 (303)
..++.++|||||||++|+|++|..||................ ... ...+...+..+.+||.+|
T Consensus 189 ~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~---~~~-----------~~~p~~~s~~~~~li~~l 254 (384)
T 4fr4_A 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE---TTV-----------VTYPSAWSQEMVSLLKKL 254 (384)
T ss_dssp CSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH---HCC-----------CCCCTTSCHHHHHHHHHH
T ss_pred CCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh---hcc-----------cCCCCcCCHHHHHHHHHH
Confidence 458899999999999999999999997554433222222111 110 011122345788999999
Q ss_pred ccCCCCCCCC-HHHHHH
Q 048243 238 VQENPNDRPS-MLQVSS 253 (303)
Q Consensus 238 l~~dp~~Rpt-~~el~~ 253 (303)
|..||.+||+ +.++++
T Consensus 255 L~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 255 LEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp SCSSGGGSCCSHHHHHT
T ss_pred hcCCHhHhcccHHHHHc
Confidence 9999999998 777765
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=298.53 Aligned_cols=238 Identities=27% Similarity=0.389 Sum_probs=189.0
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccc-------
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR------- 74 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------- 74 (303)
.+++.||+|+++... ....+.+.+|+.+++.+ +||||+++++++...+..++||||+++++|.+++.....
T Consensus 65 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 144 (334)
T 2pvf_A 65 KEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144 (334)
T ss_dssp ---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC
T ss_pred ccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccc
Confidence 467899999997553 34456789999999999 899999999999999999999999999999999965321
Q ss_pred ------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcccccccccc
Q 048243 75 ------RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVG 148 (303)
Q Consensus 75 ------~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g 148 (303)
...+++..++.++.||+.||+|||+.| ++||||||+||+++.++.++|+|||++................+
T Consensus 145 ~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~ 221 (334)
T 2pvf_A 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221 (334)
T ss_dssp --------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCC
T ss_pred cccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCc
Confidence 234889999999999999999999999 99999999999999999999999999987655433333334456
Q ss_pred ccCCCChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHH
Q 048243 149 TIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKL 227 (303)
Q Consensus 149 ~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
++.|+|||.+.+..++.++||||||+++|+|++ |..||....... ........... ..+...+
T Consensus 222 ~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~ 285 (334)
T 2pvf_A 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-------LFKLLKEGHRM---------DKPANCT 285 (334)
T ss_dssp CGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHHHHTCCC---------CCCTTCC
T ss_pred ccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH-------HHHHHhcCCCC---------CCCccCC
Confidence 888999999988889999999999999999999 999986433211 11111111111 1111223
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhccccC
Q 048243 228 MRCLEIALLCVQENPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 228 ~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~~ 260 (303)
..+.+++.+||..||.+|||+.|+++.|++...
T Consensus 286 ~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 286 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 478899999999999999999999999987764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=289.59 Aligned_cols=242 Identities=23% Similarity=0.347 Sum_probs=188.5
Q ss_pred cCCCcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCccccEEEEEEeC--CeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 3 LPCGKVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 3 ~~~~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
..+|+.||+|++... .....+.+.+|+.+++.++||||+++++++... ...++||||+++++|.+++.. ....++
T Consensus 47 ~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~ 124 (302)
T 4e5w_A 47 DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK--NKNKIN 124 (302)
T ss_dssp SSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHH--HTTTCC
T ss_pred CccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHh--ccccCC
Confidence 357899999999754 344567899999999999999999999999876 668999999999999999843 335689
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-ccccccccccCCCChhhh
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~ 158 (303)
+..++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++......... .......|+..|+|||.+
T Consensus 125 ~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 201 (302)
T 4e5w_A 125 LKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECL 201 (302)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeee
Confidence 9999999999999999999999 999999999999999999999999999876544322 223345678889999999
Q ss_pred ccCCCCCccchhhHHHHHHHHHhCCCCCccCC--------CCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHH
Q 048243 159 RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG--------INENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRC 230 (303)
Q Consensus 159 ~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 230 (303)
.+..++.++||||||+++|+|++|..|+.... .................... ...+...+..+
T Consensus 202 ~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~l 272 (302)
T 4e5w_A 202 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKR---------LPCPPNCPDEV 272 (302)
T ss_dssp HHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCC---------CCCCTTCCHHH
T ss_pred cCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCC---------CCCCCCCCHHH
Confidence 98888999999999999999999998864221 11111111112222222111 11122334578
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHhccc
Q 048243 231 LEIALLCVQENPNDRPSMLQVSSMLKNE 258 (303)
Q Consensus 231 ~~li~~~l~~dp~~Rpt~~el~~~L~~~ 258 (303)
.+++.+||+.||.+|||+.++++.|++.
T Consensus 273 ~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 273 YQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 8999999999999999999999999764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=295.31 Aligned_cols=247 Identities=27% Similarity=0.400 Sum_probs=192.8
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEE--eCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCI--DSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
..+|+.||+|++........+.+.+|+.++++++||||+++++++. +....++||||+++++|.+++.. ....+++
T Consensus 49 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~ 126 (327)
T 3lxl_A 49 DNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDA 126 (327)
T ss_dssp SSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHH--HGGGCCH
T ss_pred CCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHh--cccCCCH
Confidence 3578999999998777666778999999999999999999999987 45678999999999999999853 2346899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-ccccccccccCCCChhhhc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~ 159 (303)
..++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||.+......... .......|+..|+|||.+.
T Consensus 127 ~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 203 (327)
T 3lxl_A 127 SRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 203 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhc
Confidence 999999999999999999999 999999999999999999999999999876543322 2223345788899999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCC--------ccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHH
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGIN--------ENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL 231 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
+..++.++||||||+++|+|++|..||...... ................. ....+...+..+.
T Consensus 204 ~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~l~ 274 (327)
T 3lxl_A 204 DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ---------RLPAPPACPAEVH 274 (327)
T ss_dssp HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTC---------CCCCCTTCCHHHH
T ss_pred cCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhccc---------CCCCCCcccHHHH
Confidence 888899999999999999999999998532211 01111111112222111 1112223345788
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhccccCCCC
Q 048243 232 EIALLCVQENPNDRPSMLQVSSMLKNETTNRN 263 (303)
Q Consensus 232 ~li~~~l~~dp~~Rpt~~el~~~L~~~~~~~~ 263 (303)
+++.+||+.||.+|||+.|+++.|+.......
T Consensus 275 ~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 275 ELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 99999999999999999999999998875443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=300.19 Aligned_cols=231 Identities=20% Similarity=0.300 Sum_probs=182.8
Q ss_pred CCCcEEEEEEecCC-----CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc-cccc
Q 048243 4 PCGKVIAVKKLSKT-----STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-RRLI 77 (303)
Q Consensus 4 ~~~~~valK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~ 77 (303)
.+|+.||||++... .....+.+.+|+.+++.++||||+++++++.+....++|||||++++|.+++.... ....
T Consensus 47 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~ 126 (351)
T 3c0i_A 47 ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFV 126 (351)
T ss_dssp TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCC
T ss_pred CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCC
Confidence 57899999998543 12246789999999999999999999999999999999999999999988775422 2345
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCc---eEEcccccccccccCCccccccccccccCCCC
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK---PKISDFGLARIFAKESLEANTEQVVGTIGYIP 154 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~---v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~a 154 (303)
+++..++.++.||+.||+|||+++ |+||||||+||+++.++. ++|+|||++....... .......||+.|+|
T Consensus 127 ~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~a 201 (351)
T 3c0i_A 127 YSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LVAGGRVGTPHFMA 201 (351)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTS--CBCCCCCSCGGGCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcceeEecCCC--eeecCCcCCcCccC
Confidence 899999999999999999999999 999999999999987654 9999999998765432 12234578999999
Q ss_pred hhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHH
Q 048243 155 PEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIA 234 (303)
Q Consensus 155 PE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
||++.+..++.++|||||||++|+|++|..||.... .... ........... ... ....+..+.+||
T Consensus 202 PE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~---~~i~~~~~~~~--~~~-----~~~~s~~~~~li 267 (351)
T 3c0i_A 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLF---EGIIKGKYKMN--PRQ-----WSHISESAKDLV 267 (351)
T ss_dssp HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHH---HHHHHTCCCCC--HHH-----HTTSCHHHHHHH
T ss_pred HHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHH---HHHHcCCCCCC--ccc-----cccCCHHHHHHH
Confidence 999999899999999999999999999999996421 1111 11111110000 000 001235788999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 048243 235 LLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 235 ~~~l~~dp~~Rpt~~el~~ 253 (303)
.+||..||.+|||+.|+++
T Consensus 268 ~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 268 RRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHTCSSTTTSCCHHHHHT
T ss_pred HHHCCCChhHCcCHHHHhc
Confidence 9999999999999999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=296.07 Aligned_cols=233 Identities=20% Similarity=0.257 Sum_probs=165.1
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.||||++... ....+.+|+.+++.+. ||||+++++++.+....++||||+++++|.+++. ....+++..
T Consensus 34 ~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~ 107 (325)
T 3kn6_A 34 KSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIK---KKKHFSETE 107 (325)
T ss_dssp TTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---HCSCCCHHH
T ss_pred CCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHH---hcCCCCHHH
Confidence 57899999999653 3467788999999996 9999999999999999999999999999999984 345699999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCC---ceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM---KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~---~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
++.++.|++.||+|||+.| |+||||||+||+++.++ .++|+|||++....... .......||+.|+|||++.
T Consensus 108 ~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~ 182 (325)
T 3kn6_A 108 ASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPCFTLHYAAPELLN 182 (325)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----------------------
T ss_pred HHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--CcccccCCCcCccCHHHhc
Confidence 9999999999999999999 99999999999997765 79999999997654332 2223356799999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++||||||+++|+|++|..||.....................+... .........+..+.+||.+||+
T Consensus 183 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~~~~~~~~~s~~~~~li~~~L~ 256 (325)
T 3kn6_A 183 QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------FEGEAWKNVSQEAKDLIQGLLT 256 (325)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------CCSHHHHTSCHHHHHHHHHHHC
T ss_pred CCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------CCcccccCCCHHHHHHHHHHCC
Confidence 9999999999999999999999999997654332222222222222221110 0000001234578999999999
Q ss_pred CCCCCCCCHHHHHH
Q 048243 240 ENPNDRPSMLQVSS 253 (303)
Q Consensus 240 ~dp~~Rpt~~el~~ 253 (303)
.||.+|||+.|+++
T Consensus 257 ~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 257 VDPNKRLKMSGLRY 270 (325)
T ss_dssp CCTTTCCCTTTSTT
T ss_pred CChhHCCCHHHHhc
Confidence 99999999999874
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=292.18 Aligned_cols=242 Identities=25% Similarity=0.309 Sum_probs=182.8
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc---ccccCC
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI---RRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~l~ 79 (303)
.+|+.||+|+++... ....+.+.+|+.++++++||||+++++++...+..++||||++ ++|.+++.... ....++
T Consensus 28 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~ 106 (317)
T 2pmi_A 28 TTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLE 106 (317)
T ss_dssp SSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCC
T ss_pred CCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCC
Confidence 478999999997543 3344678899999999999999999999999999999999998 58988875421 124589
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..+..++.||+.||+|||+.| |+||||||+||+++.++.++|+|||++....... .......||+.|+|||++.
T Consensus 107 ~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~ 181 (317)
T 2pmi_A 107 LNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV--NTFSSEVVTLWYRAPDVLM 181 (317)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTSCC--CCCCCCCSCCTTCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCCCc--ccCCCCcccccccCchHhh
Confidence 9999999999999999999999 9999999999999999999999999997654322 1223356899999999987
Q ss_pred cC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCC---ccee-----ccccCCC----------
Q 048243 160 QG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK---GVEF-----VDSSLDD---------- 220 (303)
Q Consensus 160 ~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-----~~~~~~~---------- 220 (303)
+. .++.++|||||||++|+|++|..||......... ........... .... .......
T Consensus 182 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (317)
T 2pmi_A 182 GSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL---KLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVL 258 (317)
T ss_dssp TCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHH
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhh
Confidence 64 6899999999999999999999999654332211 11111111000 0000 0000000
Q ss_pred --CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 221 --TNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 221 --~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
......+..+.+||.+||+.||++|||+.|+++.
T Consensus 259 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 259 QPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0001123478899999999999999999999863
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=298.55 Aligned_cols=237 Identities=28% Similarity=0.404 Sum_probs=189.4
Q ss_pred CCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc---------
Q 048243 5 CGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI--------- 73 (303)
Q Consensus 5 ~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------- 73 (303)
.++.||+|.++... ....+.+.+|+.+++.+ +||||+++++++......++||||+++|+|.+++....
T Consensus 75 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 154 (333)
T 2i1m_A 75 AVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAF 154 (333)
T ss_dssp CCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC---
T ss_pred chhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccc
Confidence 45689999997653 34456789999999999 89999999999999999999999999999999986421
Q ss_pred --ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccC
Q 048243 74 --RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIG 151 (303)
Q Consensus 74 --~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~ 151 (303)
....+++..++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++................+++.
T Consensus 155 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 231 (333)
T 2i1m_A 155 AIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 231 (333)
T ss_dssp ----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGG
T ss_pred cccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCcc
Confidence 1345789999999999999999999999 99999999999999999999999999987654433333444567889
Q ss_pred CCChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHH
Q 048243 152 YIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRC 230 (303)
Q Consensus 152 y~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 230 (303)
|+|||.+.+..++.++||||||+++|+|++ |..||......... ......... ...+...+..+
T Consensus 232 y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~------~~~~~~~~~---------~~~~~~~~~~l 296 (333)
T 2i1m_A 232 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF------YKLVKDGYQ---------MAQPAFAPKNI 296 (333)
T ss_dssp GSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH------HHHHHHTCC---------CCCCTTCCHHH
T ss_pred ccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH------HHHHhcCCC---------CCCCCCCCHHH
Confidence 999999998899999999999999999998 88898654332211 111111110 11111123478
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHhcccc
Q 048243 231 LEIALLCVQENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 231 ~~li~~~l~~dp~~Rpt~~el~~~L~~~~ 259 (303)
.+++.+||+.||.+|||+.|+++.|++..
T Consensus 297 ~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 297 YSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 89999999999999999999999998654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=300.53 Aligned_cols=227 Identities=20% Similarity=0.304 Sum_probs=178.3
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+|+.||+|++++.. ....+.+..|..++.++ +||||+++++++.+....++||||+++|+|..++. ....++
T Consensus 75 ~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~---~~~~l~ 151 (396)
T 4dc2_A 75 KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLP 151 (396)
T ss_dssp TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHSSCC
T ss_pred CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHH---HcCCCC
Confidence 578999999997542 22334678899999887 89999999999999999999999999999998884 345699
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..++.++.||+.||+|||+.| |+||||||+|||++.+|.++|+|||+++...... .......||+.|+|||++.
T Consensus 152 ~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~ 226 (396)
T 4dc2_A 152 EEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILR 226 (396)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccCC--CccccccCCcccCCchhhc
Confidence 9999999999999999999999 9999999999999999999999999997532221 2234467999999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCcc--ccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINEN--LSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 237 (303)
+..++.++|||||||++|+|++|..||........ ............... ...+...+..+.+||.+|
T Consensus 227 ~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~~~p~~~s~~~~~li~~l 296 (396)
T 4dc2_A 227 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------IRIPRSLSVKAASVLKSF 296 (396)
T ss_dssp TCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC----------CCCCTTSCHHHHHHHHHH
T ss_pred CCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc----------cCCCCcCCHHHHHHHHHH
Confidence 99999999999999999999999999965432221 111111111111110 011112345788999999
Q ss_pred ccCCCCCCCCH
Q 048243 238 VQENPNDRPSM 248 (303)
Q Consensus 238 l~~dp~~Rpt~ 248 (303)
|+.||.+||++
T Consensus 297 L~~dP~~R~~~ 307 (396)
T 4dc2_A 297 LNKDPKERLGC 307 (396)
T ss_dssp TCSCTTTSTTC
T ss_pred hcCCHhHcCCC
Confidence 99999999996
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=295.43 Aligned_cols=239 Identities=22% Similarity=0.267 Sum_probs=180.1
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++||||+++++|.+++. ....+++..
T Consensus 36 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~ 112 (316)
T 2ac3_A 36 ITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH---KRRHFNELE 112 (316)
T ss_dssp SSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHH---HHSSCCHHH
T ss_pred CCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHh---ccCCCCHHH
Confidence 57899999999876666678899999999995 79999999999999999999999999999999984 345689999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCc---eEEcccccccccccCCc-----cccccccccccCCCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK---PKISDFGLARIFAKESL-----EANTEQVVGTIGYIP 154 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~---v~l~Df~~~~~~~~~~~-----~~~~~~~~g~~~y~a 154 (303)
++.++.||+.||+|||+.+ ++||||||+||+++.++. ++|+|||++........ ........|++.|+|
T Consensus 113 ~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 189 (316)
T 2ac3_A 113 ASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189 (316)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCC
T ss_pred HHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccC
Confidence 9999999999999999999 999999999999998776 99999999876542211 111223458999999
Q ss_pred hhhhcc-----CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccc-c-------HHHHHHHHHhCCCcceeccccCCCC
Q 048243 155 PEYARQ-----GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL-S-------ILEHAYELWKGGKGVEFVDSSLDDT 221 (303)
Q Consensus 155 PE~~~~-----~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~-~-------~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (303)
||++.+ ..++.++|||||||++|+|++|..||......... . .............. ......
T Consensus 190 PE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~---- 264 (316)
T 2ac3_A 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKY-EFPDKD---- 264 (316)
T ss_dssp HHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCC-CCCHHH----
T ss_pred hHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCc-ccCchh----
Confidence 999875 45788999999999999999999999754432200 0 00111111111100 000000
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 222 NSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 222 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
....+..+.+||.+||..||.+|||+.|+++.
T Consensus 265 -~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 265 -WAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp -HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -cccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00123478899999999999999999999874
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=290.00 Aligned_cols=241 Identities=20% Similarity=0.288 Sum_probs=179.8
Q ss_pred cCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 3 LPCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 3 ~~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++......++||||+.+ +|.+++.. ....+++
T Consensus 23 ~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~ 99 (288)
T 1ob3_A 23 NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDV--CEGGLES 99 (288)
T ss_dssp ETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHT--STTCCCH
T ss_pred cCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHh--cccCCCH
Confidence 3578999999996543 23346788999999999999999999999999999999999975 88888753 2356899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||.+....... .......||+.|+|||.+.+
T Consensus 100 ~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~ 174 (288)
T 1ob3_A 100 VTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKYTHEIVTLWYRAPDVLMG 174 (288)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc--cccccccccccccCchheeC
Confidence 999999999999999999999 9999999999999999999999999987654321 11223467999999999876
Q ss_pred C-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCccee--------ccccCC-------CCCCH
Q 048243 161 G-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF--------VDSSLD-------DTNSP 224 (303)
Q Consensus 161 ~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~-------~~~~~ 224 (303)
. .++.++|||||||++|+|++|..||....... ................+ .++... .....
T Consensus 175 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (288)
T 1ob3_A 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLK 251 (288)
T ss_dssp CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCC
T ss_pred CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhh
Confidence 4 58999999999999999999999996543222 11111121111100000 000000 00011
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 225 CKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 225 ~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
..+..+.+||.+||+.||++|||+.|+++.
T Consensus 252 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 252 GLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp SCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 234578899999999999999999999863
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=309.81 Aligned_cols=234 Identities=27% Similarity=0.408 Sum_probs=190.5
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHH
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~ 84 (303)
+++.||||.++... ...+.+.+|+.++++++||||+++++++......++||||+.+|+|.+++... ....+++..++
T Consensus 244 ~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~ 321 (495)
T 1opk_A 244 YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLL 321 (495)
T ss_dssp GTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHS-CTTTSCHHHHH
T ss_pred CCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhc-CcCCCCHHHHH
Confidence 47899999997554 34678999999999999999999999999999999999999999999999542 34568999999
Q ss_pred HHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCC
Q 048243 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYS 164 (303)
Q Consensus 85 ~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 164 (303)
.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....... .......++..|+|||.+.+..++
T Consensus 322 ~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~ 397 (495)
T 1opk_A 322 YMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFS 397 (495)
T ss_dssp HHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE-ECCTTCCCCGGGCCHHHHHHCEEC
T ss_pred HHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce-eecCCCcCCcceeCHhHHhcCCCC
Confidence 99999999999999999 99999999999999999999999999987644321 222234457789999999988899
Q ss_pred CccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCC
Q 048243 165 TKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 165 ~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 243 (303)
.++|||||||++|+|++ |..||......... ....... ....+...+..+.+||.+||+.||.
T Consensus 398 ~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~-------~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~ 461 (495)
T 1opk_A 398 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-------ELLEKDY---------RMERPEGCPEKVYELMRACWQWNPS 461 (495)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-------HHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred cHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHcCC---------CCCCCCCCCHHHHHHHHHHcCcChh
Confidence 99999999999999999 88898654332211 1111111 1111222345788999999999999
Q ss_pred CCCCHHHHHHHhccccC
Q 048243 244 DRPSMLQVSSMLKNETT 260 (303)
Q Consensus 244 ~Rpt~~el~~~L~~~~~ 260 (303)
+|||+.+|++.|+....
T Consensus 462 ~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 462 DRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp GSCCHHHHHHHHHTSCS
T ss_pred HCcCHHHHHHHHHHHHh
Confidence 99999999999988753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=295.81 Aligned_cols=223 Identities=19% Similarity=0.188 Sum_probs=184.0
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.+....|+||||+++|+|.+++. ....+++
T Consensus 64 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~---~~~~~~~ 140 (350)
T 1rdq_E 64 ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSE 140 (350)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHCCCCH
T ss_pred CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHH---HcCCCCH
Confidence 579999999996542 2455788899999999999999999999999999999999999999999984 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.||+.||+|||++| |+||||||+||+++.+|.++|+|||++...... .....||+.|+|||++.+
T Consensus 141 ~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~ 212 (350)
T 1rdq_E 141 PHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILS 212 (350)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC-----cccccCCccccCHHHhcC
Confidence 999999999999999999999 999999999999999999999999999865432 223578999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|||||||++|+|++|..||....... .......+.. . .+...+..+.++|.+||+.
T Consensus 213 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~~~~-------~----~p~~~~~~~~~li~~lL~~ 275 (350)
T 1rdq_E 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSGKV-------R----FPSHFSSDLKDLLRNLLQV 275 (350)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCC-------C----CCTTCCHHHHHHHHHHSCS
T ss_pred CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH------HHHHHHcCCC-------C----CCCCCCHHHHHHHHHHhhc
Confidence 999999999999999999999999996432211 1111111110 0 1112345788999999999
Q ss_pred CCCCCCC-----HHHHHHH
Q 048243 241 NPNDRPS-----MLQVSSM 254 (303)
Q Consensus 241 dp~~Rpt-----~~el~~~ 254 (303)
||.+||+ ++|+++.
T Consensus 276 dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 276 DLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CTTTCTTSSTTTTHHHHTS
T ss_pred CHHhccCCccCCHHHHHhC
Confidence 9999998 8888763
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=297.87 Aligned_cols=231 Identities=24% Similarity=0.388 Sum_probs=180.6
Q ss_pred EEEEEEecCC-CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHH
Q 048243 8 VIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86 (303)
Q Consensus 8 ~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~ 86 (303)
.||+|.+... .....+.+.+|+.++++++||||+++++++.... .++|++++.+|+|.+++.. ....+++..++.+
T Consensus 46 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~ 122 (327)
T 3poz_A 46 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNW 122 (327)
T ss_dssp EEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHH--STTSCCHHHHHHH
T ss_pred EEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHh--cCCCCCHHHHHHH
Confidence 3588888544 3345678999999999999999999999998754 7899999999999999854 3456899999999
Q ss_pred HHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCCCc
Q 048243 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTK 166 (303)
Q Consensus 87 ~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 166 (303)
+.||+.||+|||+.+ |+||||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.+
T Consensus 123 ~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 199 (327)
T 3poz_A 123 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 199 (327)
T ss_dssp HHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCch
Confidence 999999999999999 99999999999999999999999999987655443333344566889999999999999999
Q ss_pred cchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 048243 167 SDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDR 245 (303)
Q Consensus 167 ~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 245 (303)
+||||||+++|+|++ |..||......... ....... ....+...+..+.+++.+||+.||.+|
T Consensus 200 ~Di~slG~il~ellt~g~~p~~~~~~~~~~-------~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~R 263 (327)
T 3poz_A 200 SDVWSYGVTVWELMTFGSKPYDGIPASEIS-------SILEKGE---------RLPQPPICTIDVYMIMVKCWMIDADSR 263 (327)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-------HHHHTTC---------CCCCCTTBCHHHHHHHHHHTCSCGGGS
T ss_pred hhhhhhHHHHHHHHhcCCCCccCCCHHHHH-------HHHHcCC---------CCCCCccCCHHHHHHHHHHcCCChhhC
Confidence 999999999999999 99998654332211 1111111 111122234478899999999999999
Q ss_pred CCHHHHHHHhccccC
Q 048243 246 PSMLQVSSMLKNETT 260 (303)
Q Consensus 246 pt~~el~~~L~~~~~ 260 (303)
||+.|+++.|+....
T Consensus 264 ps~~ell~~l~~~~~ 278 (327)
T 3poz_A 264 PKFRELIIEFSKMAR 278 (327)
T ss_dssp CCHHHHHHHHHHHHT
T ss_pred CCHHHHHHHHHHHHh
Confidence 999999999876653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=294.79 Aligned_cols=237 Identities=25% Similarity=0.395 Sum_probs=189.9
Q ss_pred CCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccc-------cc
Q 048243 5 CGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR-------RL 76 (303)
Q Consensus 5 ~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~ 76 (303)
+++.||+|.+.... ......+.+|+.+++.++||||+++++++.+....++||||+++++|.+++..... ..
T Consensus 54 ~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 133 (322)
T 1p4o_A 54 PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133 (322)
T ss_dssp EEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCC
T ss_pred CceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCC
Confidence 57889999997543 33455788999999999999999999999999999999999999999999854211 14
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChh
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE 156 (303)
.+++..++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++................+++.|+|||
T Consensus 134 ~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 210 (322)
T 1p4o_A 134 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 210 (322)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHH
T ss_pred CcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChh
Confidence 5689999999999999999999999 9999999999999999999999999997665443333334456788999999
Q ss_pred hhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHH
Q 048243 157 YARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
.+.+..++.++||||||+++|+|++ |..||....... ............ .+...+..+.+++.
T Consensus 211 ~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~l~~li~ 274 (322)
T 1p4o_A 211 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------VLRFVMEGGLLD---------KPDNCPDMLFELMR 274 (322)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-------HHHHHHTTCCCC---------CCTTCCHHHHHHHH
T ss_pred hhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH-------HHHHHHcCCcCC---------CCCCCCHHHHHHHH
Confidence 9999889999999999999999999 888885432111 111111111111 11123347889999
Q ss_pred HcccCCCCCCCCHHHHHHHhccccC
Q 048243 236 LCVQENPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 236 ~~l~~dp~~Rpt~~el~~~L~~~~~ 260 (303)
+||..||.+|||+.|+++.|++...
T Consensus 275 ~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 275 MCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHcCCCcccCcCHHHHHHHHHHhhc
Confidence 9999999999999999999988754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=294.02 Aligned_cols=227 Identities=21% Similarity=0.303 Sum_probs=179.4
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+|+.||+|+++... ....+.+.+|+.++.++ +||||+++++++.+....|+||||+++|+|..++. ....++
T Consensus 32 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~---~~~~l~ 108 (345)
T 3a8x_A 32 KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLP 108 (345)
T ss_dssp TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---HHSSCC
T ss_pred CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHH---HcCCCC
Confidence 578999999997542 23445688999999988 89999999999999999999999999999999884 345699
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..++.++.||+.||+|||+.| |+||||||+||+++.+|.++|+|||+++...... .......||+.|+|||++.
T Consensus 109 ~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~ 183 (345)
T 3a8x_A 109 EEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILR 183 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCC--CcccccCCCccccCccccC
Confidence 9999999999999999999999 9999999999999999999999999987533221 2233457899999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccc--cHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL--SILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 237 (303)
+..++.++|||||||++|+|++|..||...+..... .............. ...+...+..+.++|.+|
T Consensus 184 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~~~p~~~s~~~~~li~~l 253 (345)
T 3a8x_A 184 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------IRIPRSLSVKAASVLKSF 253 (345)
T ss_dssp TCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC----------CCCCTTSCHHHHHHHHHH
T ss_pred CCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC----------CCCCCCCCHHHHHHHHHH
Confidence 999999999999999999999999999654322111 11111111111110 001112345788999999
Q ss_pred ccCCCCCCCCH
Q 048243 238 VQENPNDRPSM 248 (303)
Q Consensus 238 l~~dp~~Rpt~ 248 (303)
|+.||.+||++
T Consensus 254 L~~dP~~R~~~ 264 (345)
T 3a8x_A 254 LNKDPKERLGC 264 (345)
T ss_dssp TCSSTTTSTTC
T ss_pred hcCCHhHCCCC
Confidence 99999999996
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=304.49 Aligned_cols=228 Identities=28% Similarity=0.405 Sum_probs=184.3
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCC-eeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE-ERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.|+.||||.++... ..+.+.+|+.++++++||||+++++++.... ..++||||+++|+|.+++... ....+++..+
T Consensus 215 ~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~-~~~~~~~~~~ 291 (450)
T 1k9a_A 215 RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCL 291 (450)
T ss_dssp TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHH-CTTTCCHHHH
T ss_pred cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhc-CCCCCCHHHH
Confidence 47899999997654 4468999999999999999999999987765 789999999999999999542 2334789999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
+.++.||+.||+|||+++ ++||||||+|||++.++.+||+|||+++..... .....++..|+|||.+.+..+
T Consensus 292 ~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~ 363 (450)
T 1k9a_A 292 LKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKF 363 (450)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCC
T ss_pred HHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-----ccCCCCCcceeCHHHhcCCCC
Confidence 999999999999999999 999999999999999999999999998754322 112356889999999999999
Q ss_pred CCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC
Q 048243 164 STKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 242 (303)
+.++||||||+++|+|++ |..||.......... ....+.. ...+...+..+.++|.+||+.||
T Consensus 364 ~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~-------~i~~~~~---------~~~p~~~~~~l~~li~~cl~~dp 427 (450)
T 1k9a_A 364 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-------RVEKGYK---------MDAPDGCPPAVYDVMKNCWHLDA 427 (450)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH-------HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSG
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHHcCCC---------CCCCCcCCHHHHHHHHHHcCCCh
Confidence 999999999999999998 999987554333211 1111111 11112234578899999999999
Q ss_pred CCCCCHHHHHHHhcccc
Q 048243 243 NDRPSMLQVSSMLKNET 259 (303)
Q Consensus 243 ~~Rpt~~el~~~L~~~~ 259 (303)
.+|||+.++++.|+...
T Consensus 428 ~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 428 ATRPTFLQLREQLEHIR 444 (450)
T ss_dssp GGSCCHHHHHHHHHHHH
T ss_pred hHCcCHHHHHHHHHHHH
Confidence 99999999999998765
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=302.77 Aligned_cols=229 Identities=22% Similarity=0.345 Sum_probs=186.0
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||||++.... ....+.+.+|+.+++.++||||+++++++......++||||+++|+|.+++. ....+++
T Consensus 39 ~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~l~~ 115 (476)
T 2y94_A 39 LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYIC---KNGRLDE 115 (476)
T ss_dssp TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTT---SSSSCCH
T ss_pred CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHH---hcCCCCH
Confidence 479999999996542 2345678999999999999999999999999999999999999999999984 3556999
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.||+.||+|||+.| |+||||||+||+++.++.++|+|||++....... ......|++.|+|||++.+
T Consensus 116 ~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~ 189 (476)
T 2y94_A 116 KESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISG 189 (476)
T ss_dssp HHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTC---CBCCCCSCSTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccccc---cccccCCCcCeEChhhccC
Confidence 999999999999999999999 9999999999999999999999999998764432 2233578999999999988
Q ss_pred CCC-CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 161 GVY-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 161 ~~~-~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
..+ +.++|||||||++|+|++|..||........ . .....+. . ..+...+..+.+||.+||.
T Consensus 190 ~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~---~---~~i~~~~-~----------~~p~~~s~~~~~Li~~~L~ 252 (476)
T 2y94_A 190 RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL---F---KKICDGI-F----------YTPQYLNPSVISLLKHMLQ 252 (476)
T ss_dssp CCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH---H---HHHHTTC-C----------CCCTTCCHHHHHHHHHHTC
T ss_pred CCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH---H---HHHhcCC-c----------CCCccCCHHHHHHHHHHcC
Confidence 765 6799999999999999999999964432211 1 1111111 0 0011123478899999999
Q ss_pred CCCCCCCCHHHHHH--Hhccc
Q 048243 240 ENPNDRPSMLQVSS--MLKNE 258 (303)
Q Consensus 240 ~dp~~Rpt~~el~~--~L~~~ 258 (303)
.||.+|||+.|+++ ++.+.
T Consensus 253 ~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 253 VDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp SSTTTSCCHHHHHTCHHHHTT
T ss_pred CCchhCcCHHHHHhCHHhhhc
Confidence 99999999999987 45443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=292.52 Aligned_cols=241 Identities=24% Similarity=0.353 Sum_probs=191.8
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
++++.||+|+++... ....+.+.+|+.++++++||||+++++++ .....++|||++++++|.+++.. ....+++..
T Consensus 35 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~ 111 (287)
T 1u59_A 35 KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSN 111 (287)
T ss_dssp -CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTT--CTTTSCHHH
T ss_pred CCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHh--CCccCCHHH
Confidence 368889999997653 34567899999999999999999999999 55678999999999999999853 345689999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-ccccccccccCCCChhhhccC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~ 161 (303)
++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++......... .......+++.|+|||.+.+.
T Consensus 112 ~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 188 (287)
T 1u59_A 112 VAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188 (287)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccC
Confidence 9999999999999999999 999999999999999999999999999876543221 222234568899999999888
Q ss_pred CCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 162 VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
.++.++||||||+++|+|++ |..||........ .......... ..+...+..+.+++.+||..
T Consensus 189 ~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------~~~i~~~~~~---------~~~~~~~~~l~~li~~~l~~ 252 (287)
T 1u59_A 189 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-------MAFIEQGKRM---------ECPPECPPELYALMSDCWIY 252 (287)
T ss_dssp EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH-------HHHHHTTCCC---------CCCTTCCHHHHHHHHHTTCS
T ss_pred CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH-------HHHHhcCCcC---------CCCCCcCHHHHHHHHHHcCC
Confidence 89999999999999999998 9999865432211 1111111111 11122345788999999999
Q ss_pred CCCCCCCHHHHHHHhccccCCCCCCC
Q 048243 241 NPNDRPSMLQVSSMLKNETTNRNTPK 266 (303)
Q Consensus 241 dp~~Rpt~~el~~~L~~~~~~~~~~~ 266 (303)
||.+|||+.++++.|++......++.
T Consensus 253 ~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 253 KWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp SGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred ChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 99999999999999988765544443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=291.69 Aligned_cols=231 Identities=20% Similarity=0.286 Sum_probs=181.8
Q ss_pred CCCcEEEEEEecCC--CcccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|+++.. .......+.+|+.++..+ .||||+++++++.+....++||||+.+++|.+++.. .....+++
T Consensus 52 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~ 130 (327)
T 3lm5_A 52 STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLP-ELAEMVSE 130 (327)
T ss_dssp TTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSS-CC-CCCCH
T ss_pred CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHH-hcccCCCH
Confidence 47999999999754 234467899999999999 579999999999999999999999999999998854 23456899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC---CCceEEcccccccccccCCccccccccccccCCCChhh
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE---DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~---~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 157 (303)
..++.++.|++.||+|||+.| ++||||||+||+++. ++.++|+|||++....... ......|++.|+|||+
T Consensus 131 ~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~ 204 (327)
T 3lm5_A 131 NDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEI 204 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHH
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc---ccccccCCcCccCCee
Confidence 999999999999999999999 999999999999998 7899999999998764332 1233568999999999
Q ss_pred hccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHc
Q 048243 158 ARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237 (303)
Q Consensus 158 ~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 237 (303)
+.+..++.++||||||+++|+|++|..||......... ....... ...........+..+.++|.+|
T Consensus 205 ~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~i~~~~-------~~~~~~~~~~~~~~~~~li~~~ 271 (327)
T 3lm5_A 205 LNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY------LNISQVN-------VDYSEETFSSVSQLATDFIQSL 271 (327)
T ss_dssp HTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHTC-------CCCCTTTTTTSCHHHHHHHHHH
T ss_pred ecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH------HHHHhcc-------cccCchhhcccCHHHHHHHHHH
Confidence 99999999999999999999999999999643321111 1111110 0011111122345788999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 048243 238 VQENPNDRPSMLQVSSM 254 (303)
Q Consensus 238 l~~dp~~Rpt~~el~~~ 254 (303)
|+.||.+|||+.++++.
T Consensus 272 L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 272 LVKNPEKRPTAEICLSH 288 (327)
T ss_dssp SCSSGGGSCCHHHHTTC
T ss_pred cCCChhhCcCHHHHhCC
Confidence 99999999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=292.80 Aligned_cols=226 Identities=22% Similarity=0.272 Sum_probs=174.2
Q ss_pred CCCcEEEEEEecCCC----cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTS----TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+|+.||+|+++... ......+.+|+.+++.++||||+++++++...+..++||||+++++|.+++. ....++
T Consensus 43 ~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~ 119 (327)
T 3a62_A 43 NTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLE---REGIFM 119 (327)
T ss_dssp TTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHH---HHSSCC
T ss_pred CCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHH---hCCCCC
Confidence 589999999997642 2334567889999999999999999999999999999999999999999884 345689
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..++.++.||+.||+|||+.| |+||||||+||+++.++.++|+|||++....... .......|++.|+|||++.
T Consensus 120 ~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~ 194 (327)
T 3a62_A 120 EDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILM 194 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccccCC--ccccccCCCcCccCHhhCc
Confidence 9999999999999999999999 9999999999999999999999999987543222 1223457899999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++||||||+++|+|++|..||....... .. ........ ..++..+..+.++|.+||+
T Consensus 195 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~---~~i~~~~~-----------~~p~~~~~~~~~li~~~L~ 257 (327)
T 3a62_A 195 RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK---TI---DKILKCKL-----------NLPPYLTQEARDLLKKLLK 257 (327)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH---HHHHHTCC-----------CCCTTSCHHHHHHHHHHSC
T ss_pred CCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH---HH---HHHHhCCC-----------CCCCCCCHHHHHHHHHHHh
Confidence 9899999999999999999999999996433211 11 11111110 1111234578899999999
Q ss_pred CCCCCCC-----CHHHHHHH
Q 048243 240 ENPNDRP-----SMLQVSSM 254 (303)
Q Consensus 240 ~dp~~Rp-----t~~el~~~ 254 (303)
.||.+|| ++.|+++.
T Consensus 258 ~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 258 RNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp SCGGGSTTSSTTTHHHHHHS
T ss_pred cCHhhccCCCCCCHHHHHcC
Confidence 9999999 77788763
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=296.91 Aligned_cols=248 Identities=19% Similarity=0.265 Sum_probs=193.2
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCC--eeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE--ERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||||+++... ....+.+.+|+.++++++||||+++++++.... ..++||||+++++|.+++........+++
T Consensus 32 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~ 111 (396)
T 4eut_A 32 KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPE 111 (396)
T ss_dssp TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCH
T ss_pred CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCH
Confidence 468999999997543 345677889999999999999999999998765 77999999999999999966444445999
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEE----CCCCceEEcccccccccccCCccccccccccccCCCChh
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL----GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE 156 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~----~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE 156 (303)
..++.++.||+.||+|||+.| |+||||||+||++ +.++.++|+|||++....... ......|++.|+|||
T Consensus 112 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE 185 (396)
T 4eut_A 112 SEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPD 185 (396)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG---GSSCSSSCCTTCCHH
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC---ccccccCCccccCHH
Confidence 999999999999999999999 9999999999999 778889999999997754432 222356899999999
Q ss_pred hhcc--------CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcc-------------eec-
Q 048243 157 YARQ--------GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV-------------EFV- 214 (303)
Q Consensus 157 ~~~~--------~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~- 214 (303)
++.+ ..++.++|||||||++|+|++|..||............ ......+.... .+.
T Consensus 186 ~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~--~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 263 (396)
T 4eut_A 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV--MYKIITGKPSGAISGVQKAENGPIDWSG 263 (396)
T ss_dssp HHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH--HHHHHHSCCTTCCEEEECSTTCCEEEES
T ss_pred HhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH--HHHHhcCCCcccchhheeccCCCcccCc
Confidence 9875 45678999999999999999999999755433222111 12222211110 000
Q ss_pred cccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcccc
Q 048243 215 DSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 215 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~ 259 (303)
...............+.+++.+||+.||++|||+.++++.++...
T Consensus 264 ~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 264 DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred cCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 011122344677788999999999999999999999988876554
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=284.50 Aligned_cols=230 Identities=24% Similarity=0.339 Sum_probs=185.3
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++. ....+++..
T Consensus 30 ~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~ 106 (276)
T 2yex_A 30 VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPD 106 (276)
T ss_dssp TTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSB---TTTBCCHHH
T ss_pred CCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHh---hccCCCHHH
Confidence 478999999996543 3445788999999999999999999999999999999999999999999884 345689999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
++.++.|++.||+|||+.| ++||||+|+||+++.++.++|+|||.+................|+..|+|||.+.+..
T Consensus 107 ~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 183 (276)
T 2yex_A 107 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183 (276)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSS
T ss_pred HHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCC
Confidence 9999999999999999999 9999999999999999999999999997665433333334467899999999998776
Q ss_pred C-CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 163 Y-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~-~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
+ +.++||||||+++|+|++|..||......... ...+...... .......+..+.+++.+||..|
T Consensus 184 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~ 249 (276)
T 2yex_A 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEKKTY--------LNPWKKIDSAPLALLHKILVEN 249 (276)
T ss_dssp BCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH------HHHHHTTCTT--------STTGGGSCHHHHHHHHHHSCSS
T ss_pred CCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH------HHHhhhcccc--------cCchhhcCHHHHHHHHHHCCCC
Confidence 5 67899999999999999999999654432211 1111111100 0011123447889999999999
Q ss_pred CCCCCCHHHHHH
Q 048243 242 PNDRPSMLQVSS 253 (303)
Q Consensus 242 p~~Rpt~~el~~ 253 (303)
|.+|||+.|+++
T Consensus 250 p~~Rps~~~il~ 261 (276)
T 2yex_A 250 PSARITIPDIKK 261 (276)
T ss_dssp TTTSCCHHHHTT
T ss_pred chhCCCHHHHhc
Confidence 999999999976
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=292.39 Aligned_cols=240 Identities=21% Similarity=0.287 Sum_probs=187.4
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEe----CCeeEEEEeecCCCChhhhhcCcc-ccccC
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCID----SEERMLVYEYMPNKSLDCYLFDPI-RRLIL 78 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~-~~~~l 78 (303)
.+|+.||||++........+.+.+|+.+++.++||||+++++++.. ....++||||+.+++|.+++.... .+..+
T Consensus 52 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 131 (317)
T 2buj_A 52 HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFL 131 (317)
T ss_dssp TTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCC
T ss_pred CCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCC
Confidence 5789999999977666667789999999999999999999999873 347899999999999999885421 24668
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-------ccccccccccC
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-------ANTEQVVGTIG 151 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-------~~~~~~~g~~~ 151 (303)
++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||.+......... .......|++.
T Consensus 132 ~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 208 (317)
T 2buj_A 132 TEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208 (317)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGG
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcc
Confidence 99999999999999999999999 999999999999999999999999988764322111 01123457999
Q ss_pred CCChhhhccCC---CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHH
Q 048243 152 YIPPEYARQGV---YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLM 228 (303)
Q Consensus 152 y~aPE~~~~~~---~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
|+|||.+.+.. ++.++||||||+++|+|++|..||......... .. ...... ......+..+.
T Consensus 209 y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~---~~~~~~---------~~~~~~~~~~~ 274 (317)
T 2buj_A 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS--VA---LAVQNQ---------LSIPQSPRHSS 274 (317)
T ss_dssp GCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC--HH---HHHHCC-----------CCCCTTSCH
T ss_pred cCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch--hh---HHhhcc---------CCCCccccCCH
Confidence 99999987654 688999999999999999999998532111100 00 001110 00111122345
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHhccccC
Q 048243 229 RCLEIALLCVQENPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 229 ~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~~ 260 (303)
.+.++|.+||+.||.+|||+.++++.|+....
T Consensus 275 ~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 275 ALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred HHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 78899999999999999999999999998764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=286.22 Aligned_cols=234 Identities=28% Similarity=0.416 Sum_probs=188.6
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++.. ....+++..
T Consensus 29 ~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~ 105 (267)
T 3t9t_A 29 WLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRT--QRGLFAAET 105 (267)
T ss_dssp ETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHH--TTTCCCHHH
T ss_pred ecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhh--CcccCCHHH
Confidence 45788999999976543 447899999999999999999999999999999999999999999999853 235689999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||.+....... ........++..|+|||.+.+..
T Consensus 106 ~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~ 181 (267)
T 3t9t_A 106 LLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSR 181 (267)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc-ccccccccccccccChhhhcCCC
Confidence 9999999999999999999 9999999999999999999999999987654321 11222345678899999999888
Q ss_pred CCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
++.++||||||+++|+|++ |..||....... . ......... ...+...+..+.+++.+||..|
T Consensus 182 ~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~-~~~i~~~~~---------~~~~~~~~~~l~~li~~~l~~~ 245 (267)
T 3t9t_A 182 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------V-VEDISTGFR---------LYKPRLASTHVYQIMNHCWRER 245 (267)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------H-HHHHHTTCC---------CCCCTTSCHHHHHHHHHHTCSS
T ss_pred ccchhchhhhHHHHHHHhccCCCCCCCCCHHH------H-HHHHhcCCc---------CCCCccCcHHHHHHHHHHccCC
Confidence 9999999999999999999 888886432111 1 111111111 1111123457889999999999
Q ss_pred CCCCCCHHHHHHHhcccc
Q 048243 242 PNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 242 p~~Rpt~~el~~~L~~~~ 259 (303)
|.+|||+.++++.|++..
T Consensus 246 p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 246 PEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp GGGSCCHHHHHHHHHHHH
T ss_pred hhhCcCHHHHHHHHHHHH
Confidence 999999999999998764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=297.22 Aligned_cols=225 Identities=24% Similarity=0.293 Sum_probs=182.4
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+|+.||+|+++... ....+.+..|..++..+ +||||+++++++.+....|+||||+++|+|.+++. ....++
T Consensus 40 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~~~ 116 (345)
T 1xjd_A 40 KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFD 116 (345)
T ss_dssp TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHSSCC
T ss_pred CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHH---HcCCCC
Confidence 578999999997542 33556788899999887 99999999999999999999999999999999984 345689
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..++.++.||+.||+|||+.| |+||||||+||+++.+|.++|+|||+++...... .......||+.|+|||++.
T Consensus 117 ~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~ 191 (345)
T 1xjd_A 117 LSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILL 191 (345)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcccCC--CcccCCCCCcccCChhhhc
Confidence 9999999999999999999999 9999999999999999999999999987543221 1233467899999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++|+|||||++|+|++|..||....... ... ....... .. +...+..+.++|.+||.
T Consensus 192 ~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~---~i~~~~~-------~~----p~~~s~~~~~li~~lL~ 254 (345)
T 1xjd_A 192 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFH---SIRMDNP-------FY----PRWLEKEAKDLLVKLFV 254 (345)
T ss_dssp TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHHCCC-------CC----CTTSCHHHHHHHHHHSC
T ss_pred CCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH---HHH---HHHhCCC-------CC----CcccCHHHHHHHHHHhc
Confidence 9999999999999999999999999996433211 111 1111110 01 11234578899999999
Q ss_pred CCCCCCCCHH-HHHH
Q 048243 240 ENPNDRPSML-QVSS 253 (303)
Q Consensus 240 ~dp~~Rpt~~-el~~ 253 (303)
.||.+||++. ++++
T Consensus 255 ~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 255 REPEKRLGVRGDIRQ 269 (345)
T ss_dssp SSGGGSBTTBSCGGG
T ss_pred CCHhHcCCChHHHHc
Confidence 9999999998 6653
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=287.74 Aligned_cols=234 Identities=27% Similarity=0.406 Sum_probs=190.3
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+++.||+|.+.... ...+.+.+|+.++++++||||+++++++.+....++||||+++++|.+++... ....+++..+
T Consensus 36 ~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~ 113 (288)
T 3kfa_A 36 KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVL 113 (288)
T ss_dssp GGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHC-CTTTSCHHHH
T ss_pred CCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhc-ccCCccHhHH
Confidence 358899999996543 34578899999999999999999999999999999999999999999998542 3456899999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
+.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||.+........ .......+++.|+|||.+.+..+
T Consensus 114 ~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~ 189 (288)
T 3kfa_A 114 LYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKF 189 (288)
T ss_dssp HHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCcc-ccccCCccccCcCChhhhccCCC
Confidence 999999999999999999 99999999999999999999999999987654332 22333456889999999998899
Q ss_pred CCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC
Q 048243 164 STKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 242 (303)
+.++||||||+++|+|++ |..||.......... ...... ....+...+..+.+++.+||..||
T Consensus 190 ~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~-------~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp 253 (288)
T 3kfa_A 190 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-------LLEKDY---------RMERPEGCPEKVYELMRACWQWNP 253 (288)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-------HHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHhccC---------CCCCCCCCCHHHHHHHHHHhCCCh
Confidence 999999999999999999 888886543322111 111111 111112233578899999999999
Q ss_pred CCCCCHHHHHHHhcccc
Q 048243 243 NDRPSMLQVSSMLKNET 259 (303)
Q Consensus 243 ~~Rpt~~el~~~L~~~~ 259 (303)
.+|||+.++++.|+...
T Consensus 254 ~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 254 SDRPSFAEIHQAFETMF 270 (288)
T ss_dssp GGSCCHHHHHHHHHHHH
T ss_pred hhCcCHHHHHHHHHHHH
Confidence 99999999999987765
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=290.38 Aligned_cols=243 Identities=15% Similarity=0.126 Sum_probs=185.4
Q ss_pred CCcEEEEEEecCCCcc-----------cHHHHHHHHHHHhcCCCCccccEEEEEEe----CCeeEEEEeecCCCChhhhh
Q 048243 5 CGKVIAVKKLSKTSTQ-----------GFEEFKNEVMLTAKLQHVNLIRVLGFCID----SEERMLVYEYMPNKSLDCYL 69 (303)
Q Consensus 5 ~~~~valK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l 69 (303)
+++.||+|++...... ....+.+|+..++.++||||+++++++.. ....++||||+ +++|.+++
T Consensus 64 ~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l 142 (345)
T 2v62_A 64 KDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKIS 142 (345)
T ss_dssp GGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHC
T ss_pred ccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHH
Confidence 6788999998765321 11235678889999999999999999988 67899999999 99999998
Q ss_pred cCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCC--ceEEcccccccccccCCcc-----cc
Q 048243 70 FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM--KPKISDFGLARIFAKESLE-----AN 142 (303)
Q Consensus 70 ~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~--~v~l~Df~~~~~~~~~~~~-----~~ 142 (303)
.. ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++ .++|+|||++..+...... ..
T Consensus 143 ~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~ 216 (345)
T 2v62_A 143 GQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENP 216 (345)
T ss_dssp BG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCG
T ss_pred Hh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhcc
Confidence 43 347999999999999999999999999 99999999999998877 9999999999876433211 11
Q ss_pred ccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCC
Q 048243 143 TEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTN 222 (303)
Q Consensus 143 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (303)
.....|+..|+|||.+.+..++.++|||||||++|+|++|..||......... ............... .......
T Consensus 217 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~-- 291 (345)
T 2v62_A 217 RKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA--VQTAKTNLLDELPQS-VLKWAPS-- 291 (345)
T ss_dssp GGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH--HHHHHHHHHHTTTHH-HHHHSCT--
T ss_pred ccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH--HHHHHHhhcccccHH-HHhhccc--
Confidence 23457899999999999999999999999999999999999999643222111 111111111110000 0000000
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccccC
Q 048243 223 SPCKLMRCLEIALLCVQENPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 223 ~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~~ 260 (303)
...+..+.+++.+||..||.+|||+.++++.|++...
T Consensus 292 -~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 292 -GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp -TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred -cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 0123478899999999999999999999999998765
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=288.18 Aligned_cols=238 Identities=25% Similarity=0.302 Sum_probs=179.2
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhc--CCCCccccEEEEEEeC----CeeEEEEeecCCCChhhhhcCccccccC
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAK--LQHVNLIRVLGFCIDS----EERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
+|+.||||++... ....+..|.+++.. ++||||+++++++... ...++||||+++|+|.+++. ...+
T Consensus 30 ~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~----~~~~ 102 (301)
T 3q4u_A 30 QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LTTL 102 (301)
T ss_dssp TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHT----TCCB
T ss_pred CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHh----hccc
Confidence 6889999999654 23455666666666 7999999999997653 45799999999999999993 3469
Q ss_pred CHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccc--ccccccc
Q 048243 79 DWKKRVHIIEGITQGLLYLQ--------EYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEA--NTEQVVG 148 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh--------~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~--~~~~~~g 148 (303)
++..++.++.|++.||+||| +.+ ++||||||+||+++.++.++|+|||++.......... ......|
T Consensus 103 ~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g 179 (301)
T 3q4u_A 103 DTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179 (301)
T ss_dssp CHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCC
T ss_pred CHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCCCeeeccccccccccccccccc
Confidence 99999999999999999999 777 9999999999999999999999999997654432221 1233478
Q ss_pred ccCCCChhhhccC------CCCCccchhhHHHHHHHHHhC----------CCCCccCCCCccccHHHHHHHHHh-CCCcc
Q 048243 149 TIGYIPPEYARQG------VYSTKSDVFSFGVLLLQIISG----------KRLSMLCGINENLSILEHAYELWK-GGKGV 211 (303)
Q Consensus 149 ~~~y~aPE~~~~~------~~~~~~DiwslG~~~~~l~~g----------~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 211 (303)
|+.|+|||.+.+. .++.++||||||+++|+|++| ..||......... ......... .....
T Consensus 180 t~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~--~~~~~~~~~~~~~~~ 257 (301)
T 3q4u_A 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS--FEDMRKVVCVDQQRP 257 (301)
T ss_dssp CGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC--HHHHHHHHTTSCCCC
T ss_pred ccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcc--hhhhhHHHhccCCCC
Confidence 9999999999876 345689999999999999999 7776543332211 111111111 11111
Q ss_pred eeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccc
Q 048243 212 EFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSMLKNE 258 (303)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~ 258 (303)
.... .......+..+.+++.+||+.||.+|||+.|+++.|++.
T Consensus 258 ~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 258 NIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 1100 011224567899999999999999999999999999764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=288.87 Aligned_cols=241 Identities=24% Similarity=0.352 Sum_probs=182.3
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHH
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~ 84 (303)
.++.||+|.+.... ..+.+.+|+.++++++||||+++++++. +..++||||+++++|.+++........++...++
T Consensus 30 ~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 105 (307)
T 2eva_A 30 RAKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAM 105 (307)
T ss_dssp TTEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHH
T ss_pred CCeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHH
Confidence 47889999996543 4567899999999999999999999886 3589999999999999999754444457889999
Q ss_pred HHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCc-eEEcccccccccccCCccccccccccccCCCChhhhccCCC
Q 048243 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK-PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 85 ~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~-v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
.++.|++.||+|||+.+..+++||||||+||+++.++. ++|+|||.+...... .....|++.|+|||.+.+..+
T Consensus 106 ~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~ 180 (307)
T 2eva_A 106 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNY 180 (307)
T ss_dssp HHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSCHHHHTCCCC
T ss_pred HHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-----cccCCCCCceEChhhhCCCCC
Confidence 99999999999999932233999999999999988886 799999998654332 123458999999999999899
Q ss_pred CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCC
Q 048243 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 243 (303)
+.++||||||+++|+|++|..||....... ......... ...... ....+..+.+++.+||+.||.
T Consensus 181 ~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~-~~~~~~---------~~~~~~~l~~li~~~l~~dp~ 246 (307)
T 2eva_A 181 SEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWAVHN-GTRPPL---------IKNLPKPIESLMTRCWSKDPS 246 (307)
T ss_dssp CTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHHHHT-TCCCCC---------BTTCCHHHHHHHHHHTCSSGG
T ss_pred CcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHHHhc-CCCCCc---------ccccCHHHHHHHHHHhcCChh
Confidence 999999999999999999999996443221 111111111 111111 112234788999999999999
Q ss_pred CCCCHHHHHHHhccccCCCCCCCCC
Q 048243 244 DRPSMLQVSSMLKNETTNRNTPKKP 268 (303)
Q Consensus 244 ~Rpt~~el~~~L~~~~~~~~~~~~~ 268 (303)
+|||+.++++.|+...........|
T Consensus 247 ~Rps~~ell~~L~~~~~~~~~~~~~ 271 (307)
T 2eva_A 247 QRPSMEEIVKIMTHLMRYFPGADEP 271 (307)
T ss_dssp GSCCHHHHHHHHHHHGGGCCCTTSC
T ss_pred hCcCHHHHHHHHHHHHHhccCCCCc
Confidence 9999999999998776555444433
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=285.38 Aligned_cols=230 Identities=23% Similarity=0.361 Sum_probs=181.7
Q ss_pred cEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHH
Q 048243 7 KVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86 (303)
Q Consensus 7 ~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~ 86 (303)
+.||+|++........+.+.+|+.++++++||||+++++++.+....++||||+++++|.+++.. ....+++..++.+
T Consensus 41 ~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i 118 (289)
T 4fvq_A 41 TEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINILWKLEV 118 (289)
T ss_dssp EEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHH
T ss_pred hhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHH
Confidence 57999999776666778899999999999999999999999999999999999999999999954 2344899999999
Q ss_pred HHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCc--------eEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK--------PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 87 ~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~--------v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
+.|++.||+|||+.+ ++||||||+||+++.++. ++|+|||.+...... ....|+..|+|||.+
T Consensus 119 ~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~ 189 (289)
T 4fvq_A 119 AKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK------DILQERIPWVPPECI 189 (289)
T ss_dssp HHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHH
T ss_pred HHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeeccCcccccccCc------cccCCcCcccCHHHh
Confidence 999999999999999 999999999999998877 999999998654322 224578899999999
Q ss_pred cc-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHc
Q 048243 159 RQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237 (303)
Q Consensus 159 ~~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 237 (303)
.+ ..++.++||||||+++|+|++|..|+....... .. ......... ... ..+..+.+++.+|
T Consensus 190 ~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-----~~-~~~~~~~~~-------~~~----~~~~~l~~li~~~ 252 (289)
T 4fvq_A 190 ENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-----RK-LQFYEDRHQ-------LPA----PKAAELANLINNC 252 (289)
T ss_dssp HCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HH-HHHHHTTCC-------CCC----CSSCTTHHHHHHH
T ss_pred CCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH-----HH-HHHhhccCC-------CCC----CCCHHHHHHHHHH
Confidence 87 668999999999999999999655543221111 11 111111100 000 0123577999999
Q ss_pred ccCCCCCCCCHHHHHHHhccccCCCCC
Q 048243 238 VQENPNDRPSMLQVSSMLKNETTNRNT 264 (303)
Q Consensus 238 l~~dp~~Rpt~~el~~~L~~~~~~~~~ 264 (303)
|+.||.+|||+.|+++.|++...+..+
T Consensus 253 l~~dp~~Rps~~~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 253 MDYEPDHRPSFRAIIRDLNSLFTPDLV 279 (289)
T ss_dssp SCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred cCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence 999999999999999999988764443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=291.37 Aligned_cols=237 Identities=26% Similarity=0.396 Sum_probs=178.1
Q ss_pred CCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCC-----eeEEEEeecCCCChhhhhcCc---cc
Q 048243 5 CGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE-----ERMLVYEYMPNKSLDCYLFDP---IR 74 (303)
Q Consensus 5 ~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~---~~ 74 (303)
+++.||+|.++... ....+.+.+|+.++++++||||+++++++.... ..++||||+.+++|.+++... ..
T Consensus 61 ~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~ 140 (313)
T 3brb_A 61 TSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETG 140 (313)
T ss_dssp CEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTS
T ss_pred ceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcC
Confidence 45689999997553 334567899999999999999999999998754 359999999999999988432 23
Q ss_pred cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCC
Q 048243 75 RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIP 154 (303)
Q Consensus 75 ~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~a 154 (303)
...+++..++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++................+++.|+|
T Consensus 141 ~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a 217 (313)
T 3brb_A 141 PKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217 (313)
T ss_dssp CCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSC
T ss_pred CccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccC
Confidence 456899999999999999999999999 99999999999999999999999999977654433333334557889999
Q ss_pred hhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHH
Q 048243 155 PEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEI 233 (303)
Q Consensus 155 PE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 233 (303)
||.+.+..++.++||||||+++|+|++ |..||......... . ........ ..+...+..+.++
T Consensus 218 PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~----~~~~~~~~---------~~~~~~~~~l~~l 281 (313)
T 3brb_A 218 IESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY---D----YLLHGHRL---------KQPEDCLDELYEI 281 (313)
T ss_dssp HHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---H----HHHTTCCC---------CCBTTCCHHHHHH
T ss_pred chhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH---H----HHHcCCCC---------CCCccccHHHHHH
Confidence 999999999999999999999999999 88888654332211 1 11111111 1111233478899
Q ss_pred HHHcccCCCCCCCCHHHHHHHhccccC
Q 048243 234 ALLCVQENPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 234 i~~~l~~dp~~Rpt~~el~~~L~~~~~ 260 (303)
+.+||..||.+|||+.++++.|++...
T Consensus 282 i~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 282 MYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 999999999999999999999987654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=297.41 Aligned_cols=231 Identities=24% Similarity=0.391 Sum_probs=177.8
Q ss_pred EEEEEecCC-CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHHH
Q 048243 9 IAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHII 87 (303)
Q Consensus 9 valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~ 87 (303)
||+|.+... .....+.+.+|+.+++.++||||+++++++.... .++|++++.+|+|.+++.. ....+++..++.++
T Consensus 47 v~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~ 123 (327)
T 3lzb_A 47 VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWC 123 (327)
T ss_dssp EEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHH--TTTCCCHHHHHHHH
T ss_pred EEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHh--cCCCCCHHHHHHHH
Confidence 577777543 3456678999999999999999999999998764 7899999999999999854 24568999999999
Q ss_pred HHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCCCcc
Q 048243 88 EGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKS 167 (303)
Q Consensus 88 ~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~ 167 (303)
.|++.||+|||+.| ++||||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++
T Consensus 124 ~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 200 (327)
T 3lzb_A 124 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS 200 (327)
T ss_dssp HHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHH
Confidence 99999999999999 999999999999999999999999999876554433333445568899999999999999999
Q ss_pred chhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 048243 168 DVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRP 246 (303)
Q Consensus 168 DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 246 (303)
||||||+++|+|++ |..||.......... ...... ....+...+..+.+++.+||..||.+||
T Consensus 201 Di~slG~il~ell~~g~~p~~~~~~~~~~~-------~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rp 264 (327)
T 3lzb_A 201 DVWSYGVTVWELMTFGSKPYDGIPASEISS-------ILEKGE---------RLPQPPICTIDVYMIMRKCWMIDADSRP 264 (327)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-------HHHTTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-------HHHcCC---------CCCCCccCCHHHHHHHHHHcCCChhHCc
Confidence 99999999999999 999986543332111 111111 1111222344788999999999999999
Q ss_pred CHHHHHHHhccccCC
Q 048243 247 SMLQVSSMLKNETTN 261 (303)
Q Consensus 247 t~~el~~~L~~~~~~ 261 (303)
|+.|+++.|++....
T Consensus 265 s~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 265 KFRELIIEFSKMARD 279 (327)
T ss_dssp CHHHHHHHHHHHHTS
T ss_pred CHHHHHHHHHHHHhC
Confidence 999999999877643
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=286.50 Aligned_cols=242 Identities=30% Similarity=0.435 Sum_probs=188.6
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
..+++.||+|.++... ...+.+.+|+.+++.++||||+++++++. .+..++||||+.+++|.+++... ....+++..
T Consensus 34 ~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~ 110 (279)
T 1qpc_A 34 YNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTP-SGIKLTINK 110 (279)
T ss_dssp ETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSH-HHHTCCHHH
T ss_pred EcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcC-CCCCCCHHH
Confidence 4567899999997543 34578999999999999999999999986 45689999999999999998531 233689999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||.+........ .......++..|+|||.+.+..
T Consensus 111 ~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~ 186 (279)
T 1qpc_A 111 LLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGT 186 (279)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc-ccccCCCCccCccChhhhccCC
Confidence 9999999999999999999 99999999999999999999999999987654322 2222345678899999998888
Q ss_pred CCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
++.++||||||+++|+|++ |..||....... . ......... ...+...+..+.+++.+||..|
T Consensus 187 ~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~----~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~ 250 (279)
T 1qpc_A 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---V----IQNLERGYR---------MVRPDNCPEELYQLMRLCWKER 250 (279)
T ss_dssp ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---H----HHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSS
T ss_pred CCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---H----HHHHhcccC---------CCCcccccHHHHHHHHHHhccC
Confidence 8999999999999999999 888886432211 1 111111111 1111123357889999999999
Q ss_pred CCCCCCHHHHHHHhccccCCCCCCCC
Q 048243 242 PNDRPSMLQVSSMLKNETTNRNTPKK 267 (303)
Q Consensus 242 p~~Rpt~~el~~~L~~~~~~~~~~~~ 267 (303)
|++|||+.++++.|++.........+
T Consensus 251 p~~Rps~~~l~~~l~~~~~~~~~~~~ 276 (279)
T 1qpc_A 251 PEDRPTFDYLRSVLEDFFTATEGQYQ 276 (279)
T ss_dssp GGGSCCHHHHHHHHHHHHHHC-----
T ss_pred hhhCCCHHHHHHHHHHHHHhccCCCC
Confidence 99999999999999988765444433
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=291.93 Aligned_cols=238 Identities=27% Similarity=0.401 Sum_probs=189.5
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCC-eeEEEEeecCCCChhhhhcCccc------
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSE-ERMLVYEYMPNKSLDCYLFDPIR------ 74 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~------ 74 (303)
.+++.||||+++... ....+.+.+|+.++.++ +||||+++++++...+ ..++||||+++++|.+++.....
T Consensus 55 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 134 (316)
T 2xir_A 55 ATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134 (316)
T ss_dssp TCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-
T ss_pred ccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhccccccccc
Confidence 567899999997653 33456789999999999 7999999999988754 58999999999999999965322
Q ss_pred -------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccc
Q 048243 75 -------RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVV 147 (303)
Q Consensus 75 -------~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~ 147 (303)
...+++..++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++................
T Consensus 135 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 211 (316)
T 2xir_A 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211 (316)
T ss_dssp ------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEE
T ss_pred ccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEECCCccccccccCccceeccCCC
Confidence 123789999999999999999999999 9999999999999999999999999998765443333344456
Q ss_pred cccCCCChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHH
Q 048243 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCK 226 (303)
Q Consensus 148 g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
|++.|+|||.+.+..++.++||||||+++|+|++ |..||......... . ......... ..+...
T Consensus 212 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~--~----~~~~~~~~~---------~~~~~~ 276 (316)
T 2xir_A 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--C----RRLKEGTRM---------RAPDYT 276 (316)
T ss_dssp ECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH--H----HHHHHTCCC---------CCCTTC
T ss_pred cceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH--H----HHhccCccC---------CCCCCC
Confidence 7889999999999999999999999999999998 99998654432211 1 111111111 111122
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhcccc
Q 048243 227 LMRCLEIALLCVQENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 227 ~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~ 259 (303)
+..+.+++.+||+.||.+|||+.|+++.|++..
T Consensus 277 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 277 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 347889999999999999999999999998764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=284.71 Aligned_cols=227 Identities=22% Similarity=0.293 Sum_probs=183.0
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+++.||+|++........+.+.+|+.++++++||||+++++++.+....++||||+++++|.+++. ....+++..+
T Consensus 32 ~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~ 108 (277)
T 3f3z_A 32 GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVV---HKRVFRESDA 108 (277)
T ss_dssp TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH---HHCSCCHHHH
T ss_pred CCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHH---HcCCCCHHHH
Confidence 4678999999987666667889999999999999999999999999999999999999999998884 3456899999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEE---CCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~---~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
+.++.|++.||+|||+.| ++||||||+||++ +.++.++|+|||.+....... ......|++.|+|||.+.+
T Consensus 109 ~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~ 182 (277)
T 3f3z_A 109 ARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEG 182 (277)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc---chhccCCCCCccChHHhcc
Confidence 999999999999999999 9999999999999 788899999999987654332 2233568999999999876
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
. ++.++||||||+++|+|++|..||....... ............. .... ...+..+.+++.+||+.
T Consensus 183 ~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~--~~~~-----~~~~~~~~~li~~~l~~ 248 (277)
T 3f3z_A 183 L-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE------VMLKIREGTFTFP--EKDW-----LNVSPQAESLIRRLLTK 248 (277)
T ss_dssp C-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCCCC--HHHH-----TTSCHHHHHHHHHHTCS
T ss_pred c-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhCCCCCC--chhh-----hcCCHHHHHHHHHHccC
Confidence 5 8999999999999999999999996433211 1111111110000 0000 01235788999999999
Q ss_pred CCCCCCCHHHHHH
Q 048243 241 NPNDRPSMLQVSS 253 (303)
Q Consensus 241 dp~~Rpt~~el~~ 253 (303)
||.+|||+.++++
T Consensus 249 dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 249 SPKQRITSLQALE 261 (277)
T ss_dssp STTTSCCHHHHTT
T ss_pred ChhhCcCHHHHhc
Confidence 9999999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=283.72 Aligned_cols=228 Identities=23% Similarity=0.316 Sum_probs=182.7
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+|+.||+|++.... ....+.+.+|+.++++++||||+++++++......++||||+.+++|.+++. ....+++.
T Consensus 29 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~---~~~~~~~~ 105 (284)
T 3kk8_A 29 TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV---AREFYSEA 105 (284)
T ss_dssp TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---HHSSCCHH
T ss_pred CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHH---hcCCCCHH
Confidence 568999999996543 3345678899999999999999999999999999999999999999988884 34568999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCc---eEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK---PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~---v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
.++.++.|++.||+|||+.| ++||||||+||+++.++. ++|+|||.+........ .....|++.|+|||.+
T Consensus 106 ~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~ 179 (284)
T 3kk8_A 106 DASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVL 179 (284)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB---CCCSCSCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc---ccCCCCCcCCcCchhh
Confidence 99999999999999999999 999999999999986655 99999999976544322 2335689999999999
Q ss_pred ccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcc
Q 048243 159 RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238 (303)
Q Consensus 159 ~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 238 (303)
.+..++.++||||||+++|+|++|..||........ . ......... .........+..+.+++.+||
T Consensus 180 ~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~---~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l 246 (284)
T 3kk8_A 180 KKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL---Y---AQIKAGAYD-------YPSPEWDTVTPEAKSLIDSML 246 (284)
T ss_dssp TTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H---HHHHHTCCC-------CCTTTTTTSCHHHHHHHHHHS
T ss_pred cCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH---H---HHHHhcccc-------CCchhhcccCHHHHHHHHHHc
Confidence 999999999999999999999999999854322111 1 111111100 001111122347889999999
Q ss_pred cCCCCCCCCHHHHHH
Q 048243 239 QENPNDRPSMLQVSS 253 (303)
Q Consensus 239 ~~dp~~Rpt~~el~~ 253 (303)
+.||.+|||+.|+++
T Consensus 247 ~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 247 TVNPKKRITADQALK 261 (284)
T ss_dssp CSSTTTSCCHHHHTT
T ss_pred ccChhhCCCHHHHhc
Confidence 999999999999987
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=286.08 Aligned_cols=238 Identities=30% Similarity=0.429 Sum_probs=174.3
Q ss_pred CcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 6 GKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 6 ~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
+..||+|+++... ....+.+.+|+.++++++||||++++++. .....++||||+.+++|.+++.. ....+++..+
T Consensus 46 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~ 122 (289)
T 3og7_A 46 HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHA--SETKFEMKKL 122 (289)
T ss_dssp SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTT--C---CCHHHH
T ss_pred cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhh--ccCCCCHHHH
Confidence 3469999997553 34456789999999999999999999965 55678999999999999998853 3456899999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc---c
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR---Q 160 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~ 160 (303)
+.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++................|++.|+|||.+. +
T Consensus 123 ~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 199 (289)
T 3og7_A 123 IDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199 (289)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----
T ss_pred HHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCC
Confidence 999999999999999999 9999999999999999999999999987654433233334457899999999986 5
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++||||||+++|+|++|..||........ .............. ... ....+..+.+++.+||+.
T Consensus 200 ~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~-~~~----~~~~~~~l~~li~~~l~~ 268 (289)
T 3og7_A 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIEMVGRGSLSPDL-SKV----RSNCPKRMKRLMAECLKK 268 (289)
T ss_dssp CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH------HHHHHHHTSCCCCT-TSS----CTTSCHHHHHHHHHHTCS
T ss_pred CCCCcccchHHHHHHHHHHHHCCCCccccchHHH------HHHHhcccccCcch-hhc----cccCCHHHHHHHHHHccC
Confidence 5678899999999999999999999965432211 11111111111000 011 112235788999999999
Q ss_pred CCCCCCCHHHHHHHhccccC
Q 048243 241 NPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 241 dp~~Rpt~~el~~~L~~~~~ 260 (303)
||.+|||+.++++.|++...
T Consensus 269 ~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 269 KRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SGGGSCCHHHHHHHHHHTTC
T ss_pred ChhhCCCHHHHHHHHHHHhh
Confidence 99999999999999987653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=293.86 Aligned_cols=235 Identities=24% Similarity=0.262 Sum_probs=179.5
Q ss_pred CCCcEEEEEEecCC-----CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc-----
Q 048243 4 PCGKVIAVKKLSKT-----STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI----- 73 (303)
Q Consensus 4 ~~~~~valK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----- 73 (303)
.+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+....++||||+++|+|.+++....
T Consensus 49 ~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~ 128 (345)
T 3hko_A 49 QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTG 128 (345)
T ss_dssp TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTT
T ss_pred CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccc
Confidence 57889999998643 33456789999999999999999999999999999999999999999999884210
Q ss_pred --------------------------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCC
Q 048243 74 --------------------------------RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121 (303)
Q Consensus 74 --------------------------------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~ 121 (303)
....+++..++.++.||+.||+|||+.+ ++||||||+||+++.++
T Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~ 205 (345)
T 3hko_A 129 KCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNK 205 (345)
T ss_dssp EEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSS
T ss_pred ccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEecCC
Confidence 0223467788999999999999999999 99999999999998776
Q ss_pred --ceEEcccccccccccCCcc--ccccccccccCCCChhhhcc--CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccc
Q 048243 122 --KPKISDFGLARIFAKESLE--ANTEQVVGTIGYIPPEYARQ--GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL 195 (303)
Q Consensus 122 --~v~l~Df~~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~ 195 (303)
.++|+|||++..+...... .......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||.......
T Consensus 206 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-- 283 (345)
T 3hko_A 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD-- 283 (345)
T ss_dssp SCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--
T ss_pred CceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHH--
Confidence 8999999999765432211 12334568999999999875 568899999999999999999999996443221
Q ss_pred cHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 196 SILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
............. .......+..+.+||.+||..||.+|||+.++++.
T Consensus 284 ----~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 284 ----TISQVLNKKLCFE-------NPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp ----HHHHHHHCCCCTT-------SGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred ----HHHHHHhcccccC-------CcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1112222111110 00111234578899999999999999999999873
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=286.47 Aligned_cols=232 Identities=20% Similarity=0.333 Sum_probs=174.8
Q ss_pred CCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 5 CGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+..||+|.++... ....+.+.+|+.++++++||||+++++++. ++..++||||+++++|.+++.. ....+++..+
T Consensus 42 ~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~ 118 (281)
T 1mp8_A 42 PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV--RKYSLDLASL 118 (281)
T ss_dssp CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHH--TTTTSCHHHH
T ss_pred CceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHh--cCCCCCHHHH
Confidence 35679999987543 344567899999999999999999999984 5678999999999999999853 2446899999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
+.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++......... ......+++.|+|||.+.+..+
T Consensus 119 ~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 194 (281)
T 1mp8_A 119 ILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRF 194 (281)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCccccc-ccccCCCcccccChhhcccCCC
Confidence 999999999999999999 999999999999999999999999999776543221 1223456788999999998899
Q ss_pred CCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC
Q 048243 164 STKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 242 (303)
+.++||||||+++|+|++ |..||........ .. ........ ..+...+..+.+++.+||..||
T Consensus 195 ~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~----~i~~~~~~---------~~~~~~~~~l~~li~~~l~~~p 258 (281)
T 1mp8_A 195 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IG----RIENGERL---------PMPPNCPPTLYSLMTKCWAYDP 258 (281)
T ss_dssp SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH----HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSG
T ss_pred CCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HH----HHHcCCCC---------CCCCCCCHHHHHHHHHHccCCh
Confidence 999999999999999996 8889865433221 11 11111111 1112234578899999999999
Q ss_pred CCCCCHHHHHHHhcccc
Q 048243 243 NDRPSMLQVSSMLKNET 259 (303)
Q Consensus 243 ~~Rpt~~el~~~L~~~~ 259 (303)
.+|||+.|+++.|++..
T Consensus 259 ~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 259 SRRPRFTELKAQLSTIL 275 (281)
T ss_dssp GGSCCHHHHHHHHHHHH
T ss_pred hhCcCHHHHHHHHHHHH
Confidence 99999999999998654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=288.32 Aligned_cols=242 Identities=20% Similarity=0.283 Sum_probs=182.5
Q ss_pred CCCcEEEEEEecCC---CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc-ccccCC
Q 048243 4 PCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-RRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~l~ 79 (303)
.+|+.||+|++... .....+.+.+|+.+++.++||||+++++++...+..++||||+++++|.+++.... ....++
T Consensus 55 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 134 (310)
T 2wqm_A 55 LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP 134 (310)
T ss_dssp TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCC
T ss_pred CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCC
Confidence 57899999999753 23445678899999999999999999999999999999999999999999885421 245689
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++....... .......|+..|+|||.+.
T Consensus 135 ~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~ 209 (310)
T 2wqm_A 135 ERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIH 209 (310)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------------------CCSSCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC--ccccccCCCeeEeChHHhC
Confidence 9999999999999999999999 9999999999999999999999999987654332 1222356899999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++||||||+++|+|++|..||....... ... ............ .....+..+.+++.+||.
T Consensus 210 ~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~-~~~~~~~~~~~~--------~~~~~~~~l~~li~~~l~ 276 (310)
T 2wqm_A 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSL-CKKIEQCDYPPL--------PSDHYSEELRQLVNMCIN 276 (310)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH----HHH-HHHHHTTCSCCC--------CTTTSCHHHHHHHHHHTC
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH----HHH-HHHhhcccCCCC--------cccccCHHHHHHHHHHcC
Confidence 9899999999999999999999999986432211 111 111111111111 111233478899999999
Q ss_pred CCCCCCCCHHHHHHHhccccCCCC
Q 048243 240 ENPNDRPSMLQVSSMLKNETTNRN 263 (303)
Q Consensus 240 ~dp~~Rpt~~el~~~L~~~~~~~~ 263 (303)
.||.+|||+.++++.|++......
T Consensus 277 ~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 277 PDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred CChhhCCCHHHHHHHHHHHHHhhh
Confidence 999999999999999988764433
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=291.93 Aligned_cols=248 Identities=22% Similarity=0.316 Sum_probs=178.0
Q ss_pred CCCcEEEEEEecCCCccc-HHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTSTQG-FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.||+|+++...... ...+.+|+.+++.++||||+++++++......++||||++ ++|.+++.. .+..+++..
T Consensus 25 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~ 101 (324)
T 3mtl_A 25 LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDD--CGNIINMHN 101 (324)
T ss_dssp TTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHH--TTTCCCHHH
T ss_pred CCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHh--cCCCCCHHH
Confidence 478999999996543221 1245579999999999999999999999999999999997 588888753 345689999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc-C
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ-G 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~ 161 (303)
++.++.|++.||+|||+.| |+||||||+||+++.++.++|+|||++....... .......|++.|+|||++.+ .
T Consensus 102 ~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~ 176 (324)
T 3mtl_A 102 VKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTYDNEVVTLWYRPPDILLGST 176 (324)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--------------CGGGCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc--cccccccCcccccChhhhcCCC
Confidence 9999999999999999999 9999999999999999999999999987544322 22233567999999999876 5
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCc---ceecc---------ccCCCC----CCHH
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG---VEFVD---------SSLDDT----NSPC 225 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~---------~~~~~~----~~~~ 225 (303)
.++.++|||||||++|+|++|..||.......... ........... ..... +..... ..+.
T Consensus 177 ~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (324)
T 3mtl_A 177 DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLH---FIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPR 253 (324)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTT
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCC
Confidence 68999999999999999999999996544322211 11111111100 00000 000000 0012
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccccCCC
Q 048243 226 KLMRCLEIALLCVQENPNDRPSMLQVSS--MLKNETTNR 262 (303)
Q Consensus 226 ~~~~l~~li~~~l~~dp~~Rpt~~el~~--~L~~~~~~~ 262 (303)
.+..+.+||.+||+.||.+|||+.|+++ ++.+.....
T Consensus 254 ~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 292 (324)
T 3mtl_A 254 LDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERI 292 (324)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTT
T ss_pred CCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccc
Confidence 2347889999999999999999999987 455554433
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=291.12 Aligned_cols=250 Identities=29% Similarity=0.394 Sum_probs=190.8
Q ss_pred CCcE--EEEEEecCC-CcccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc-------
Q 048243 5 CGKV--IAVKKLSKT-STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI------- 73 (303)
Q Consensus 5 ~~~~--valK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------- 73 (303)
+|+. ||+|.++.. .....+.+.+|+.+++++ +||||+++++++.+.+..++||||+++++|.+++....
T Consensus 49 ~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 128 (327)
T 1fvr_A 49 DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA 128 (327)
T ss_dssp TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHH
T ss_pred CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhccccccccc
Confidence 4554 499998754 233456789999999999 89999999999999999999999999999999986532
Q ss_pred ------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccc
Q 048243 74 ------RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVV 147 (303)
Q Consensus 74 ------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~ 147 (303)
....+++..++.++.||+.||+|||+.| ++||||||+||+++.++.++|+|||++...... .......
T Consensus 129 ~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~ 202 (327)
T 1fvr_A 129 FAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGR 202 (327)
T ss_dssp HHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEE---CCC----
T ss_pred ccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeEEEcccCcCcccccc---ccccCCC
Confidence 2346899999999999999999999999 999999999999999999999999998643221 1122345
Q ss_pred cccCCCChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHH
Q 048243 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCK 226 (303)
Q Consensus 148 g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ......... ....+...
T Consensus 203 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~~---------~~~~~~~~ 266 (327)
T 1fvr_A 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEKLPQGY---------RLEKPLNC 266 (327)
T ss_dssp CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHGGGTC---------CCCCCTTB
T ss_pred CCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-------HHHHhhcCC---------CCCCCCCC
Confidence 6789999999988888999999999999999998 999985432111 111111111 11111223
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhccccCCCCCCCCCCCcccccc
Q 048243 227 LMRCLEIALLCVQENPNDRPSMLQVSSMLKNETTNRNTPKKPAFSKQVDE 276 (303)
Q Consensus 227 ~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~~~~~~~~~~~~~~~~~~ 276 (303)
+..+.+++.+||..||.+|||+.++++.|++...................
T Consensus 267 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~~~~ 316 (327)
T 1fvr_A 267 DDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTY 316 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBCCBCTTCCCC
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCccccchhccCCc
Confidence 45788999999999999999999999999887766655555444434333
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=290.35 Aligned_cols=243 Identities=21% Similarity=0.267 Sum_probs=178.8
Q ss_pred CCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+|+.||+|++..... ...+.+.+|+.++++++||||+++++++......++||||+++++|..++. ....+++.
T Consensus 26 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~ 102 (311)
T 4agu_A 26 DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR---YQRGVPEH 102 (311)
T ss_dssp TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH---TSSCCCHH
T ss_pred CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHh---hhcCCCHH
Confidence 4689999999865532 234678899999999999999999999999999999999999999988874 34568999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc-
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ- 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~- 160 (303)
.+..++.|++.||+|||+.| ++||||||+||+++.++.++|+|||.+....... .......|+..|+|||.+.+
T Consensus 103 ~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~ 177 (311)
T 4agu_A 103 LVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS--DYYDDEVATRWYRSPELLVGD 177 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--------------GGGCCHHHHHTC
T ss_pred HHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc--cccCCCcCCccccChHHHhcC
Confidence 99999999999999999999 9999999999999999999999999997655332 12233568999999999876
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHH--------HHHHhCCCcce-eccccCCCCC-----CHHH
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA--------YELWKGGKGVE-FVDSSLDDTN-----SPCK 226 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~-~~~~~~~~~~-----~~~~ 226 (303)
..++.++||||||+++|+|++|..||............... ...+....... ...+...... .+..
T Consensus 178 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (311)
T 4agu_A 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNI 257 (311)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTC
T ss_pred CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccc
Confidence 56899999999999999999999999654432221111110 00000000000 0000000000 0123
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 227 LMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 227 ~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
+..+.+|+.+||+.||.+|||++|+++.
T Consensus 258 ~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 258 SYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 4468899999999999999999999864
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=293.62 Aligned_cols=225 Identities=23% Similarity=0.269 Sum_probs=182.0
Q ss_pred CCCcEEEEEEecCC---CcccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+|+.||+|+++.. .....+.+..|..++..+ +||||+++++++.+....|+||||+++|+|.+++. ....++
T Consensus 43 ~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~~~ 119 (353)
T 2i0e_A 43 GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ---QVGRFK 119 (353)
T ss_dssp TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH---HHSSCC
T ss_pred CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHH---hcCCCC
Confidence 45789999999754 234557788999999998 89999999999999999999999999999999984 345699
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..++.++.||+.||+|||+.| |+||||||+||+++.+|.++|+|||++....... .......||+.|+|||++.
T Consensus 120 ~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~ 194 (353)
T 2i0e_A 120 EPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIA 194 (353)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccCC--cccccccCCccccChhhhc
Confidence 9999999999999999999999 9999999999999999999999999987543221 2233467899999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++|||||||++|+|++|..||....... .. ........ ..+...+..+.+||.+||.
T Consensus 195 ~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~---~~i~~~~~-----------~~p~~~s~~~~~li~~lL~ 257 (353)
T 2i0e_A 195 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LF---QSIMEHNV-----------AYPKSMSKEAVAICKGLMT 257 (353)
T ss_dssp TCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHHCCC-----------CCCTTSCHHHHHHHHHHTC
T ss_pred CCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH---HH---HHHHhCCC-----------CCCCCCCHHHHHHHHHHhh
Confidence 9999999999999999999999999996432211 11 11111110 0111234578899999999
Q ss_pred CCCCCCCC-----HHHHHH
Q 048243 240 ENPNDRPS-----MLQVSS 253 (303)
Q Consensus 240 ~dp~~Rpt-----~~el~~ 253 (303)
.||.+||+ +.++++
T Consensus 258 ~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 258 KHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp SCTTSCTTCSTTHHHHHHT
T ss_pred cCHHHcCCCCCCCHHHHhc
Confidence 99999995 577765
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=293.09 Aligned_cols=228 Identities=23% Similarity=0.298 Sum_probs=168.4
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+++.||||+++... ..+.+.+|+.++++++||||+++++++......++||||+++++|.+++. ....+++..+
T Consensus 76 ~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~ 150 (349)
T 2w4o_A 76 GTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV---EKGYYSERDA 150 (349)
T ss_dssp TTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHT---TCSSCCHHHH
T ss_pred CCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHH---hcCCCCHHHH
Confidence 468899999997553 33568899999999999999999999999999999999999999999984 3456899999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC---CCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE---DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~---~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
+.++.|++.||+|||+.| ++||||||+||+++. ++.++|+|||++....... ......|++.|+|||++.+
T Consensus 151 ~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~ 224 (349)
T 2w4o_A 151 ADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRG 224 (349)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------------------CGGGSCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCccc---ccccccCCCCccCHHHhcC
Confidence 999999999999999999 999999999999975 8899999999987654322 2233568999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|||||||++|+|++|..||....... ............ . ........+..+.+||.+||..
T Consensus 225 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~i~~~~~~-~-----~~~~~~~~~~~~~~li~~~L~~ 292 (349)
T 2w4o_A 225 CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ------FMFRRILNCEYY-F-----ISPWWDEVSLNAKDLVRKLIVL 292 (349)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH------HHHHHHHTTCCC-C-----CTTTTTTSCHHHHHHHHTTSCS
T ss_pred CCCCcccchHHHHHHHHHHHhCCCCCCCCcccH------HHHHHHHhCCCc-c-----CCchhhhCCHHHHHHHHHHccC
Confidence 899999999999999999999999985433211 011111111110 0 0111122345788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 048243 241 NPNDRPSMLQVSSM 254 (303)
Q Consensus 241 dp~~Rpt~~el~~~ 254 (303)
||++|||+.|+++.
T Consensus 293 dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 293 DPKKRLTTFQALQH 306 (349)
T ss_dssp SGGGSCCHHHHHHS
T ss_pred ChhhCcCHHHHhcC
Confidence 99999999999874
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=296.07 Aligned_cols=230 Identities=23% Similarity=0.392 Sum_probs=180.7
Q ss_pred EEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHHH
Q 048243 9 IAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHII 87 (303)
Q Consensus 9 valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~ 87 (303)
||+|.+.... ......+.+|+.+++.++||||+++++++. +...++||||+.+|+|.+++.. ....+++..++.++
T Consensus 45 v~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ 121 (325)
T 3kex_A 45 VCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWG 121 (325)
T ss_dssp EEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHS--SGGGSCTTHHHHHH
T ss_pred EEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHH--ccccCCHHHHHHHH
Confidence 7888875442 233356778999999999999999999986 4568999999999999999854 24568899999999
Q ss_pred HHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCCCcc
Q 048243 88 EGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKS 167 (303)
Q Consensus 88 ~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~ 167 (303)
.|++.||+|||+.| |+||||||+||+++.++.++|+|||++................|+..|+|||.+.+..++.++
T Consensus 122 ~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 198 (325)
T 3kex_A 122 VQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQS 198 (325)
T ss_dssp HHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhh
Confidence 99999999999999 999999999999999999999999999877555444444456678899999999988999999
Q ss_pred chhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCC
Q 048243 168 DVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRP 246 (303)
Q Consensus 168 DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 246 (303)
||||||+++|+|++ |..||......... ........... +...+..+.+++.+||..||.+||
T Consensus 199 Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rp 262 (325)
T 3kex_A 199 DVWSYGVTVWELMTFGAEPYAGLRLAEVP-------DLLEKGERLAQ---------PQICTIDVYMVMVKCWMIDENIRP 262 (325)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTSCTTHHH-------HHHHTTCBCCC---------CTTBCTTTTHHHHHHTCSCTTTSC
T ss_pred HhHHhHHHHHHHHhCCCCCccccCHHHHH-------HHHHcCCCCCC---------CCcCcHHHHHHHHHHcCCChhhCc
Confidence 99999999999999 99999754432211 11111111111 111222567899999999999999
Q ss_pred CHHHHHHHhccccC
Q 048243 247 SMLQVSSMLKNETT 260 (303)
Q Consensus 247 t~~el~~~L~~~~~ 260 (303)
|+.|+++.|+....
T Consensus 263 s~~el~~~l~~~~~ 276 (325)
T 3kex_A 263 TFKELANEFTRMAR 276 (325)
T ss_dssp CHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHHHHh
Confidence 99999999987653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=293.57 Aligned_cols=252 Identities=15% Similarity=0.140 Sum_probs=188.2
Q ss_pred CCcEEEEEEecCCCccc-----------HHHHHHHHHHHhcCCCCccccEEEEEEeC----CeeEEEEeecCCCChhhhh
Q 048243 5 CGKVIAVKKLSKTSTQG-----------FEEFKNEVMLTAKLQHVNLIRVLGFCIDS----EERMLVYEYMPNKSLDCYL 69 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l 69 (303)
.++.||||++....... ......|+..+..++||||+++++++... ...++||||+ +++|.+++
T Consensus 64 ~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~ 142 (364)
T 3op5_A 64 SDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIY 142 (364)
T ss_dssp TTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHH
T ss_pred cccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHH
Confidence 46899999987654211 11233456667778899999999998864 4589999999 99999998
Q ss_pred cCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEEC--CCCceEEcccccccccccCCccc-----c
Q 048243 70 FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG--EDMKPKISDFGLARIFAKESLEA-----N 142 (303)
Q Consensus 70 ~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~--~~~~v~l~Df~~~~~~~~~~~~~-----~ 142 (303)
.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++ .++.++|+|||+++.+....... .
T Consensus 143 ~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 217 (364)
T 3op5_A 143 EA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADP 217 (364)
T ss_dssp HH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCS
T ss_pred Hh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCc
Confidence 54 3456999999999999999999999999 99999999999999 88999999999997765432211 1
Q ss_pred ccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCC
Q 048243 143 TEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTN 222 (303)
Q Consensus 143 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (303)
.....||+.|+|||.+.+..++.++|||||||++|+|++|..||.......... ........ .....+.+..+....
T Consensus 218 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~ 294 (364)
T 3op5_A 218 KRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV--RDSKIRYR-ENIASLMDKCFPAAN 294 (364)
T ss_dssp SCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH--HHHHHHHH-HCHHHHHHHHSCTTC
T ss_pred ccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH--HHHHHHhh-hhHHHHHHHhccccc
Confidence 123458999999999999999999999999999999999999997543322111 11111111 111122222221111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccccCCCCCCCCC
Q 048243 223 SPCKLMRCLEIALLCVQENPNDRPSMLQVSSMLKNETTNRNTPKKP 268 (303)
Q Consensus 223 ~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~~~~~~~~~~ 268 (303)
.+..+.+++.+||..||.+||++.+|++.|++.......+...
T Consensus 295 ---~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~ 337 (364)
T 3op5_A 295 ---APGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDG 337 (364)
T ss_dssp ---CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCC
T ss_pred ---CHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCC
Confidence 1347889999999999999999999999998877665555444
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=289.94 Aligned_cols=229 Identities=21% Similarity=0.277 Sum_probs=183.8
Q ss_pred CCCcEEEEEEecCCCc------ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcccccc
Q 048243 4 PCGKVIAVKKLSKTST------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~~~~valK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
.+|+.||+|+++.... ...+.+.+|+.++++++||||+++++++.+....++||||+++++|.+++.. ...
T Consensus 35 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~ 111 (321)
T 2a2a_A 35 STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ---KES 111 (321)
T ss_dssp TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT---CSC
T ss_pred CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHh---cCC
Confidence 4789999999975432 1467899999999999999999999999999999999999999999999843 456
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCC----ceEEcccccccccccCCccccccccccccCCC
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM----KPKISDFGLARIFAKESLEANTEQVVGTIGYI 153 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~----~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~ 153 (303)
+++..++.++.|++.||+|||+.| ++||||||+||+++.++ .++|+|||++....... ......|++.|+
T Consensus 112 ~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~ 185 (321)
T 2a2a_A 112 LSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFV 185 (321)
T ss_dssp EEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTC---CCCCCCSCGGGC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccceecCccc---cccccCCCCCcc
Confidence 899999999999999999999999 99999999999999888 79999999997665432 123356899999
Q ss_pred ChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHH
Q 048243 154 PPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEI 233 (303)
Q Consensus 154 aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 233 (303)
|||.+.+..++.++||||||+++|+|++|..||....... .......... .. .... ....+..+.++
T Consensus 186 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~i~~~~~--~~-~~~~----~~~~~~~~~~l 252 (321)
T 2a2a_A 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANITSVSY--DF-DEEF----FSHTSELAKDF 252 (321)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHTTCC--CC-CHHH----HTTCCHHHHHH
T ss_pred CcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhccc--cc-Chhh----hcccCHHHHHH
Confidence 9999999899999999999999999999999986432111 1111111100 00 0000 01123468899
Q ss_pred HHHcccCCCCCCCCHHHHHHH
Q 048243 234 ALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 234 i~~~l~~dp~~Rpt~~el~~~ 254 (303)
|.+||..||.+|||+.|+++.
T Consensus 253 i~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 253 IRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHTTSCSSTTTSCCHHHHHHS
T ss_pred HHHHcCCChhhCcCHHHHhcC
Confidence 999999999999999999874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=288.84 Aligned_cols=238 Identities=23% Similarity=0.310 Sum_probs=186.1
Q ss_pred CcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCee-EEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 6 GKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER-MLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 6 ~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
+..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.... ++||||+.+++|.+++.. ....+++..+
T Consensus 49 ~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~ 126 (298)
T 3pls_A 49 RIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS--PQRNPTVKDL 126 (298)
T ss_dssp EEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHC--TTCCCBHHHH
T ss_pred eeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhc--cccCCCHHHH
Confidence 3479999997543 34457889999999999999999999999876655 999999999999999854 3456889999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc--ccccccccccCCCChhhhccC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE--ANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~ 161 (303)
+.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++......... .......++..|+|||.+.+.
T Consensus 127 ~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 203 (298)
T 3pls_A 127 ISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY 203 (298)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccC
Confidence 999999999999999999 999999999999999999999999999765443211 222334678899999999999
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
.++.++||||||+++|+|++|..|+....... .... ........ ..+...+..+.+++.+||+.|
T Consensus 204 ~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~--~~~~----~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~ 268 (298)
T 3pls_A 204 RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF--DLTH----FLAQGRRL---------PQPEYCPDSLYQVMQQCWEAD 268 (298)
T ss_dssp CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG--GHHH----HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSS
T ss_pred CCChhhchhhHHHHHHHHhhCCCCCCccCCHH--HHHH----HhhcCCCC---------CCCccchHHHHHHHHHHccCC
Confidence 99999999999999999999665543222111 1111 11111111 111122347889999999999
Q ss_pred CCCCCCHHHHHHHhccccCCCC
Q 048243 242 PNDRPSMLQVSSMLKNETTNRN 263 (303)
Q Consensus 242 p~~Rpt~~el~~~L~~~~~~~~ 263 (303)
|.+|||+.++++.|++......
T Consensus 269 p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 269 PAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp GGGSCCHHHHHHHHHHHHHHCC
T ss_pred hhhCcCHHHHHHHHHHHHHHHh
Confidence 9999999999999988765443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=294.63 Aligned_cols=230 Identities=18% Similarity=0.235 Sum_probs=173.4
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCccccEEEEEEe----CCeeEEEEeecCCCChhhhhcCccccccC
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCID----SEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
.+|+.||||+++.. ..+.+|+.++.++ +||||+++++++.. ....|+||||+++|+|.+++... ....+
T Consensus 85 ~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~l 158 (400)
T 1nxk_A 85 RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR-GDQAF 158 (400)
T ss_dssp TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC----CC
T ss_pred CCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHh-CCCCC
Confidence 57899999999632 4567888887554 89999999999876 56789999999999999999642 23468
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC---CCceEEcccccccccccCCccccccccccccCCCCh
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE---DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~---~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aP 155 (303)
++..++.++.||+.||+|||+.| |+||||||+|||++. ++.+||+|||++....... ......||+.|+||
T Consensus 159 ~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aP 232 (400)
T 1nxk_A 159 TEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAP 232 (400)
T ss_dssp BHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCG
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCCCC---ccccCCCCCCccCH
Confidence 99999999999999999999999 999999999999997 7889999999997654321 22345789999999
Q ss_pred hhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHH
Q 048243 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
|++.+..++.++|||||||++|+|++|..||............... ...+... .........+..+.+||.
T Consensus 233 E~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--i~~~~~~-------~~~~~~~~~s~~~~~li~ 303 (400)
T 1nxk_A 233 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR--IRMGQYE-------FPNPEWSEVSEEVKMLIR 303 (400)
T ss_dssp GGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH--HHHTCCC-------CCTTTTTTSCHHHHHHHH
T ss_pred hhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH--HHcCccc-------CCCcccccCCHHHHHHHH
Confidence 9999989999999999999999999999999654433221111111 1111100 000011123457889999
Q ss_pred HcccCCCCCCCCHHHHHHH
Q 048243 236 LCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 236 ~~l~~dp~~Rpt~~el~~~ 254 (303)
+||+.||.+|||+.|+++.
T Consensus 304 ~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 304 NLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTSCSSGGGSCCHHHHHHS
T ss_pred HHCCCChhHCcCHHHHhcC
Confidence 9999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=284.11 Aligned_cols=231 Identities=24% Similarity=0.374 Sum_probs=182.2
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+++.||+|.+........+.+.+|+.+++.++||||+++++++......++||||+++++|.+++........+++..+
T Consensus 45 ~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 124 (295)
T 2clq_A 45 SNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI 124 (295)
T ss_dssp TTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHH
T ss_pred CCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHH
Confidence 57899999999877666667899999999999999999999999999999999999999999999865434446778999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC-CCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
+.++.|++.||+|||+.| ++||||||+||+++. ++.++|+|||.+....... .......|++.|+|||.+.+..
T Consensus 125 ~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~ 199 (295)
T 2clq_A 125 GFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEIIDKGP 199 (295)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGG
T ss_pred HHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC--CcccccCCCccccChhhhcCCC
Confidence 999999999999999999 999999999999987 8999999999987654322 1223456899999999987653
Q ss_pred --CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 163 --YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 163 --~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
++.++||||||+++|+|++|..||......... ... ..... .....+...+..+.+++.+||+.
T Consensus 200 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~-~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~ 265 (295)
T 2clq_A 200 RGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA--MFK-VGMFK-----------VHPEIPESMSAEAKAFILKCFEP 265 (295)
T ss_dssp GGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH--HHH-HHHHC-----------CCCCCCTTSCHHHHHHHHHTTCS
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH--HHh-hcccc-----------ccccccccCCHHHHHHHHHHccC
Confidence 788999999999999999999998643321110 000 00100 01111122345788999999999
Q ss_pred CCCCCCCHHHHHH
Q 048243 241 NPNDRPSMLQVSS 253 (303)
Q Consensus 241 dp~~Rpt~~el~~ 253 (303)
||++|||+.++++
T Consensus 266 dp~~Rps~~~ll~ 278 (295)
T 2clq_A 266 DPDKRACANDLLV 278 (295)
T ss_dssp STTTSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=282.70 Aligned_cols=226 Identities=27% Similarity=0.409 Sum_probs=163.6
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||||+++++|.+++.. ....+++
T Consensus 34 ~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~ 111 (278)
T 3cok_A 34 HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN--RVKPFSE 111 (278)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHT--CSSCCCH
T ss_pred cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhh--ccCCCCH
Confidence 578999999996442 23357789999999999999999999999999999999999999999999854 2356899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||.+........ ......|++.|+|||.+.+
T Consensus 112 ~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~ 186 (278)
T 3cok_A 112 NEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE--KHYTLCGTPNYISPEIATR 186 (278)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-------------------------
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC--cceeccCCCCcCCcchhcC
Confidence 999999999999999999999 99999999999999999999999999876543321 1223568999999999998
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++||||||+++|+|++|..||.......... ... .. . ...+...+..+.+++.+||+.
T Consensus 187 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~----~~---~----~~~~~~~~~~~~~li~~~l~~ 249 (278)
T 3cok_A 187 SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN------KVV----LA---D----YEMPSFLSIEAKDLIHQLLRR 249 (278)
T ss_dssp -----CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CC----SS---C----CCCCTTSCHHHHHHHHHHSCS
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH------HHh----hc---c----cCCccccCHHHHHHHHHHccc
Confidence 889999999999999999999999996544322110 000 00 0 011122345788999999999
Q ss_pred CCCCCCCHHHHHH
Q 048243 241 NPNDRPSMLQVSS 253 (303)
Q Consensus 241 dp~~Rpt~~el~~ 253 (303)
||.+|||+.++++
T Consensus 250 dp~~Rps~~~~l~ 262 (278)
T 3cok_A 250 NPADRLSLSSVLD 262 (278)
T ss_dssp SGGGSCCHHHHTT
T ss_pred CHhhCCCHHHHhc
Confidence 9999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=282.97 Aligned_cols=240 Identities=19% Similarity=0.219 Sum_probs=179.2
Q ss_pred CCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTST---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|++..... ...+.+.+|+.++++++||||+++++++..++..++||||+++++|.+++. ....+++
T Consensus 57 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~ 133 (309)
T 2h34_A 57 VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLR---RQGPLAP 133 (309)
T ss_dssp TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHH---HHCSCCH
T ss_pred CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHH---hcCCCCH
Confidence 4789999999975532 234678899999999999999999999999999999999999999999984 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++........ .......|++.|+|||.+.+
T Consensus 134 ~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~ 209 (309)
T 2h34_A 134 PRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-TQLGNTVGTLYYMAPERFSE 209 (309)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----------------CCGGGCCGGGTCC
T ss_pred HHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccccc-ccccccCCCcCccCHHHHcC
Confidence 999999999999999999999 99999999999999999999999999876543321 12233568999999999998
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++||||||+++|+|++|..||...... ............ .... .+..+..+.+++.+||..
T Consensus 210 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~---~~~~----~~~~~~~l~~li~~~l~~ 275 (309)
T 2h34_A 210 SHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIPR---PSTV----RPGIPVAFDAVIARGMAK 275 (309)
T ss_dssp ----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCCC---GGGT----STTCCTHHHHHHHHHTCS
T ss_pred CCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCCC---cccc----CCCCCHHHHHHHHHhccC
Confidence 88999999999999999999999998643211 111111111100 0011 112233788999999999
Q ss_pred CCCCCC-CHHHHHHHhccccCCCCC
Q 048243 241 NPNDRP-SMLQVSSMLKNETTNRNT 264 (303)
Q Consensus 241 dp~~Rp-t~~el~~~L~~~~~~~~~ 264 (303)
||.+|| +++++++.|++.......
T Consensus 276 dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 276 NPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp SGGGSCSSHHHHHHHHHHTCC----
T ss_pred CHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 999999 999999999887654433
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=290.44 Aligned_cols=230 Identities=23% Similarity=0.336 Sum_probs=175.5
Q ss_pred cCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCC--CccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccC
Q 048243 3 LPCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQH--VNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 3 ~~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
..+++.||||++.... ....+.+.+|+.++..++| +||+++++++......++||| +.+++|.+++. ....+
T Consensus 30 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~---~~~~~ 105 (343)
T 3dbq_A 30 NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLK---KKKSI 105 (343)
T ss_dssp CTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHH---HSCCC
T ss_pred eCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCCCCHHHHHH---hcCCC
Confidence 4678999999997543 3344678999999999976 999999999999999999999 56789999984 34568
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
++..+..++.||+.||+|||+.+ |+||||||+||+++ ++.++|+|||++................||+.|+|||++
T Consensus 106 ~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~ 181 (343)
T 3dbq_A 106 DPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181 (343)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHH
Confidence 99999999999999999999999 99999999999997 578999999999876544333334456799999999998
Q ss_pred cc-----------CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHH
Q 048243 159 RQ-----------GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKL 227 (303)
Q Consensus 159 ~~-----------~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
.+ ..++.++|||||||++|+|++|..||..... .............. ...+...+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~~~~~~---------~~~~~~~~ 247 (343)
T 3dbq_A 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIIDPNHE---------IEFPDIPE 247 (343)
T ss_dssp HHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHCTTSC---------CCCCCCSC
T ss_pred hhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHHHhcCCcc---------cCCcccCC
Confidence 65 5678899999999999999999999953221 11111122211111 11111123
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 228 MRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 228 ~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
..+.+|+.+||+.||.+|||+.|+++.
T Consensus 248 ~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 248 KDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 478899999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=282.27 Aligned_cols=231 Identities=25% Similarity=0.463 Sum_probs=180.6
Q ss_pred CCCcEEEEEEecCCCccc-------HHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccc
Q 048243 4 PCGKVIAVKKLSKTSTQG-------FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 76 (303)
.+++.||+|++....... .+.+.+|+.++++++||||+++++++.+.. ++||||+++++|.+++.. ...
T Consensus 42 ~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~--~~~ 117 (287)
T 4f0f_A 42 KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD--KAH 117 (287)
T ss_dssp TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHC--TTS
T ss_pred CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhc--ccC
Confidence 578999999986543211 167889999999999999999999986554 799999999999888854 345
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCc-----eEEcccccccccccCCccccccccccccC
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK-----PKISDFGLARIFAKESLEANTEQVVGTIG 151 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~-----v~l~Df~~~~~~~~~~~~~~~~~~~g~~~ 151 (303)
.+++..++.++.|++.||+|||+.+ .+++||||||+||+++.++. ++|+|||++..... ......|++.
T Consensus 118 ~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~ 191 (287)
T 4f0f_A 118 PIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQ 191 (287)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS-----CEECCCCCCT
T ss_pred CccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc-----cccccCCCcc
Confidence 6899999999999999999999874 34999999999999988776 99999999875332 2233568999
Q ss_pred CCChhhhc--cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHH
Q 048243 152 YIPPEYAR--QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMR 229 (303)
Q Consensus 152 y~aPE~~~--~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (303)
|+|||.+. ...++.++||||||+++|+|++|..||........ ............ ...+...+..
T Consensus 192 y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~---------~~~~~~~~~~ 258 (287)
T 4f0f_A 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----KFINMIREEGLR---------PTIPEDCPPR 258 (287)
T ss_dssp TSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----HHHHHHHHSCCC---------CCCCTTSCHH
T ss_pred ccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----HHHHHHhccCCC---------CCCCcccCHH
Confidence 99999984 44578899999999999999999999965443321 111111111111 1111223457
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHhcc
Q 048243 230 CLEIALLCVQENPNDRPSMLQVSSMLKN 257 (303)
Q Consensus 230 l~~li~~~l~~dp~~Rpt~~el~~~L~~ 257 (303)
+.+++.+||+.||.+|||+.|+++.|++
T Consensus 259 l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 259 LRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 8899999999999999999999999975
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=287.39 Aligned_cols=227 Identities=24% Similarity=0.336 Sum_probs=180.6
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+|+.||+|+++.......+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++. ....+++..+
T Consensus 32 ~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~ 108 (304)
T 2jam_A 32 LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL---ERGVYTEKDA 108 (304)
T ss_dssp TTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---HHSCCCHHHH
T ss_pred CCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHH---HcCCCCHHHH
Confidence 4789999999986654455678899999999999999999999999999999999999999999884 3456899999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEE---CCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~---~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
+.++.|++.||+|||+.| ++||||||+||++ +.++.++|+|||.+...... ......|++.|+|||.+.+
T Consensus 109 ~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~ 181 (304)
T 2jam_A 109 SLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQ 181 (304)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB----TTHHHHSCCCBCCTTTBSS
T ss_pred HHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC----ccccccCCCCccChHHhcc
Confidence 999999999999999999 9999999999999 77889999999998654322 1233468999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++||||||+++|+|++|..||....... ... ........ .........+..+.++|.+||..
T Consensus 182 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~---~i~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~ 248 (304)
T 2jam_A 182 KPYSKAVDCWSIGVITYILLCGYPPFYEETESK---LFE---KIKEGYYE-------FESPFWDDISESAKDFICHLLEK 248 (304)
T ss_dssp CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHH---HHHHCCCC-------CCTTTTTTSCHHHHHHHHHHHCS
T ss_pred CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHH---HHHcCCCC-------CCccccccCCHHHHHHHHHHcCC
Confidence 889999999999999999999999986432211 111 11111100 01111122345788999999999
Q ss_pred CCCCCCCHHHHHH
Q 048243 241 NPNDRPSMLQVSS 253 (303)
Q Consensus 241 dp~~Rpt~~el~~ 253 (303)
||.+|||+.|+++
T Consensus 249 dp~~Rps~~~~l~ 261 (304)
T 2jam_A 249 DPNERYTCEKALS 261 (304)
T ss_dssp STTTSCCHHHHHT
T ss_pred ChhHCcCHHHHhc
Confidence 9999999999986
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=300.16 Aligned_cols=230 Identities=21% Similarity=0.250 Sum_probs=182.0
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.+....|+||||+++|+|.+++. ...+++
T Consensus 92 ~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~----~~~~~e 167 (410)
T 3v8s_A 92 STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS----NYDVPE 167 (410)
T ss_dssp TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH----HCCCCH
T ss_pred CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHH----cCCCCH
Confidence 478999999996531 1223457889999999999999999999999999999999999999999883 345899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.||+.||+|||+.| |+||||||+|||++.+|.++|+|||++........ .......||+.|+|||++.+
T Consensus 168 ~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~ 243 (410)
T 3v8s_A 168 KWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKS 243 (410)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCCc-ccccCCcCCccccCHHHhhc
Confidence 999999999999999999999 99999999999999999999999999977654321 12234679999999999987
Q ss_pred CC----CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 161 GV----YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 161 ~~----~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
.. ++.++|||||||++|+|++|..||.......... .......... .......+..+.+||.+
T Consensus 244 ~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~------~i~~~~~~~~-------~p~~~~~s~~~~~li~~ 310 (410)
T 3v8s_A 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS------KIMNHKNSLT-------FPDDNDISKEAKNLICA 310 (410)
T ss_dssp TTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHTHHHHCC-------CCTTCCCCHHHHHHHHH
T ss_pred cCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHH------HHHhcccccc-------CCCcccccHHHHHHHHH
Confidence 65 7889999999999999999999996443222111 1111000000 00011123478899999
Q ss_pred cccCCCCC--CCCHHHHHHH
Q 048243 237 CVQENPND--RPSMLQVSSM 254 (303)
Q Consensus 237 ~l~~dp~~--Rpt~~el~~~ 254 (303)
||..+|.+ ||++.|+++.
T Consensus 311 lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 311 FLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HSSCGGGCTTSSCHHHHHTS
T ss_pred HccChhhhCCCCCHHHHhcC
Confidence 99999988 9999999874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=280.86 Aligned_cols=245 Identities=18% Similarity=0.195 Sum_probs=190.0
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEE-EeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFC-IDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.||+|++...... +.+.+|+.+++.++|++++..+..+ ......++||||+ +++|.+++.. ....+++..
T Consensus 32 ~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~ 106 (296)
T 3uzp_A 32 AAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF--CSRKFSLKT 106 (296)
T ss_dssp TTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCHHH
T ss_pred CCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHh--hccCCCHHH
Confidence 67999999998765432 4688999999999888765555544 5677889999999 8999999853 245699999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEEC---CCCceEEcccccccccccCCcc-----ccccccccccCCCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG---EDMKPKISDFGLARIFAKESLE-----ANTEQVVGTIGYIP 154 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~---~~~~v~l~Df~~~~~~~~~~~~-----~~~~~~~g~~~y~a 154 (303)
++.++.|++.||+|||+++ ++||||||+||+++ .++.++|+|||.+......... .......|++.|+|
T Consensus 107 ~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 183 (296)
T 3uzp_A 107 VLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183 (296)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCC
T ss_pred HHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCC
Confidence 9999999999999999999 99999999999995 7889999999999876544321 11234578999999
Q ss_pred hhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHH
Q 048243 155 PEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIA 234 (303)
Q Consensus 155 PE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
||.+.+..++.++||||||+++|+|++|..||......................... .... ..+..+.+++
T Consensus 184 PE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~----~~~~~l~~li 254 (296)
T 3uzp_A 184 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-----VLCK----GYPSEFATYL 254 (296)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH-----HHTT----TSCHHHHHHH
T ss_pred hhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH-----HHHh----hCCHHHHHHH
Confidence 999999999999999999999999999999998655444333333222211110000 0001 1224788999
Q ss_pred HHcccCCCCCCCCHHHHHHHhccccCCCCCC
Q 048243 235 LLCVQENPNDRPSMLQVSSMLKNETTNRNTP 265 (303)
Q Consensus 235 ~~~l~~dp~~Rpt~~el~~~L~~~~~~~~~~ 265 (303)
.+||+.||.+|||+.++++.|++.......+
T Consensus 255 ~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 255 NFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp HHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 9999999999999999999999877655544
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=291.28 Aligned_cols=228 Identities=23% Similarity=0.293 Sum_probs=178.8
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.||+|++...... ..+|++++.++ +||||+++++++.+....|+||||+.+|+|.+++. ....+++..
T Consensus 45 ~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~---~~~~~~~~~ 117 (342)
T 2qr7_A 45 ATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL---RQKFFSERE 117 (342)
T ss_dssp TTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---TCTTCCHHH
T ss_pred CCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHH---HcCCCCHHH
Confidence 47899999999765432 34688888888 79999999999999999999999999999999884 345689999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCC----CceEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED----MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~----~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
+..++.||+.||+|||+.| |+||||||+||++... +.++|+|||++....... .......||+.|+|||++
T Consensus 118 ~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~ 192 (342)
T 2qr7_A 118 ASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVL 192 (342)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT--CCBCCSSCCSSCCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC--CceeccCCCccccCHHHh
Confidence 9999999999999999999 9999999999998543 359999999998654432 122335689999999999
Q ss_pred ccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcc
Q 048243 159 RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238 (303)
Q Consensus 159 ~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 238 (303)
.+..++.++|||||||++|+|++|..||.............. ...+.. ..........+..+.+||.+||
T Consensus 193 ~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~---i~~~~~-------~~~~~~~~~~s~~~~~li~~~L 262 (342)
T 2qr7_A 193 ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR---IGSGKF-------SLSGGYWNSVSDTAKDLVSKML 262 (342)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH---HHHCCC-------CCCSTTTTTSCHHHHHHHHHHT
T ss_pred cCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH---HccCCc-------ccCccccccCCHHHHHHHHHHC
Confidence 888888999999999999999999999965432222221211 111110 0111111223457889999999
Q ss_pred cCCCCCCCCHHHHHH
Q 048243 239 QENPNDRPSMLQVSS 253 (303)
Q Consensus 239 ~~dp~~Rpt~~el~~ 253 (303)
..||++|||+.++++
T Consensus 263 ~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 263 HVDPHQRLTAALVLR 277 (342)
T ss_dssp CSSTTTSCCHHHHTT
T ss_pred CCChhHCcCHHHHhc
Confidence 999999999999976
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=311.49 Aligned_cols=241 Identities=27% Similarity=0.401 Sum_probs=191.0
Q ss_pred ccCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 2 VLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 2 ~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+.+++.||||+++... ...+.+.+|+.+|++++|+||+++++++.+ ...++||||+.+|+|.+++.. .....+++.
T Consensus 287 ~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~-~~~~~l~~~ 363 (535)
T 2h8h_A 287 TWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKG-ETGKYLRLP 363 (535)
T ss_dssp EETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSH-HHHTTCCHH
T ss_pred EECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhh-cCCCCCCHH
Confidence 35567789999997654 345789999999999999999999999866 678999999999999999953 123458999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
.++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ........++..|+|||.+.+.
T Consensus 364 ~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~ 439 (535)
T 2h8h_A 364 QLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYG 439 (535)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-eecccCCcCcccccCHHHhccC
Confidence 99999999999999999999 9999999999999999999999999997654321 1112223467889999999988
Q ss_pred CCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 162 VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
.++.++||||||+++|+|++ |..||....... .......+... ..+...+..+.+||.+||+.
T Consensus 440 ~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~~~---------~~~~~~~~~l~~li~~cl~~ 503 (535)
T 2h8h_A 440 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRM---------PCPPECPESLHDLMCQCWRK 503 (535)
T ss_dssp CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-------HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCS
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCC
Confidence 99999999999999999999 899986432211 11111111111 11122345788999999999
Q ss_pred CCCCCCCHHHHHHHhccccCCCCCC
Q 048243 241 NPNDRPSMLQVSSMLKNETTNRNTP 265 (303)
Q Consensus 241 dp~~Rpt~~el~~~L~~~~~~~~~~ 265 (303)
||++|||+.+|++.|+.........
T Consensus 504 dP~~RPt~~~l~~~L~~~~~~~~~~ 528 (535)
T 2h8h_A 504 EPEERPTFEYLQAFLEDYFTSTEPQ 528 (535)
T ss_dssp SGGGSCCHHHHHHHHHTSSCCCSCS
T ss_pred ChhHCcCHHHHHHHHHHHhhccCcc
Confidence 9999999999999999887654433
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=283.17 Aligned_cols=224 Identities=25% Similarity=0.377 Sum_probs=179.8
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++||||+++++|.+++. ....+++
T Consensus 32 ~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~---~~~~~~~ 108 (279)
T 3fdn_A 32 QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDE 108 (279)
T ss_dssp TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH---HHSSCCH
T ss_pred cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHH---hcCCCCH
Confidence 567899999986432 2345678899999999999999999999999999999999999999999884 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++....... .....|++.|+|||.+.+
T Consensus 109 ~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~ 181 (279)
T 3fdn_A 109 QRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEG 181 (279)
T ss_dssp HHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCccc----ccccCCCCCccCHhHhcc
Confidence 999999999999999999998 9999999999999999999999999885433221 233568999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++||||||+++|+|++|..||......... . ...... ...+...+..+.+|+.+||+.
T Consensus 182 ~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~---~~~~~~-----------~~~~~~~~~~~~~li~~~l~~ 244 (279)
T 3fdn_A 182 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY---K---RISRVE-----------FTFPDFVTEGARDLISRLLKH 244 (279)
T ss_dssp CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---H---HHHHTC-----------CCCCTTSCHHHHHHHHHHCCS
T ss_pred CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH---H---HHHhCC-----------CCCCCcCCHHHHHHHHHHhcc
Confidence 99999999999999999999999998643321111 1 111100 011112334788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 048243 241 NPNDRPSMLQVSSM 254 (303)
Q Consensus 241 dp~~Rpt~~el~~~ 254 (303)
||.+|||+.|+++.
T Consensus 245 ~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 245 NPSQRPMLREVLEH 258 (279)
T ss_dssp SGGGSCCHHHHHHC
T ss_pred ChhhCCCHHHHhhC
Confidence 99999999999874
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=294.27 Aligned_cols=238 Identities=29% Similarity=0.421 Sum_probs=185.6
Q ss_pred CCCcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccc----cccC
Q 048243 4 PCGKVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR----RLIL 78 (303)
Q Consensus 4 ~~~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~l 78 (303)
.+++.||||.+... .......+.+|+.++++++||||+++++++......++||||+++++|.+++..... ...+
T Consensus 58 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 137 (327)
T 2yfx_A 58 PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSL 137 (327)
T ss_dssp --CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSC
T ss_pred CccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccc
Confidence 46789999999654 334456788999999999999999999999999999999999999999999965321 2458
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC---CCceEEcccccccccccCCccccccccccccCCCCh
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE---DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~---~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aP 155 (303)
++..++.++.|++.||+|||+.| ++||||||+||+++. +..++|+|||++................|++.|+||
T Consensus 138 ~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 214 (327)
T 2yfx_A 138 AMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214 (327)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCH
T ss_pred cHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCH
Confidence 89999999999999999999999 999999999999994 446999999998765444333333445678899999
Q ss_pred hhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHH
Q 048243 156 EYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIA 234 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
|.+.+..++.++||||||+++|+|++ |..||....... ........... ......+..+.+++
T Consensus 215 E~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~l~~li 278 (327)
T 2yfx_A 215 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------VLEFVTSGGRM---------DPPKNCPGPVYRIM 278 (327)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHHHTTCCC---------CCCTTCCHHHHHHH
T ss_pred hHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH-------HHHHHhcCCCC---------CCCCCCCHHHHHHH
Confidence 99998899999999999999999998 888885432111 11111111111 11112334788999
Q ss_pred HHcccCCCCCCCCHHHHHHHhccccC
Q 048243 235 LLCVQENPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 235 ~~~l~~dp~~Rpt~~el~~~L~~~~~ 260 (303)
.+||..||.+|||+.++++.|+....
T Consensus 279 ~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 279 TQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 99999999999999999999876653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=294.11 Aligned_cols=220 Identities=23% Similarity=0.291 Sum_probs=180.0
Q ss_pred cCCCcEEEEEEecCCCc--------ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCC-ChhhhhcCcc
Q 048243 3 LPCGKVIAVKKLSKTST--------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK-SLDCYLFDPI 73 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~ 73 (303)
..+|+.||||+++.... ...+.+.+|+.+++.++||||+++++++.+....++|||++.+| +|.+++.
T Consensus 46 ~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~--- 122 (335)
T 3dls_A 46 KEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFID--- 122 (335)
T ss_dssp TTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHH---
T ss_pred CCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHH---
Confidence 35789999999976531 12345778999999999999999999999999999999998766 9988884
Q ss_pred ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCC
Q 048243 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYI 153 (303)
Q Consensus 74 ~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~ 153 (303)
....+++..++.++.||+.||+|||+.| |+||||||+||+++.++.++|+|||++........ .....||+.|+
T Consensus 123 ~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~ 196 (335)
T 3dls_A 123 RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYC 196 (335)
T ss_dssp TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTCC---BCEECSCGGGC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceECCCCCc---eeccCCCcccc
Confidence 3456999999999999999999999999 99999999999999999999999999977654321 22356899999
Q ss_pred ChhhhccCCC-CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHH
Q 048243 154 PPEYARQGVY-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLE 232 (303)
Q Consensus 154 aPE~~~~~~~-~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 232 (303)
|||++.+..+ +.++||||||+++|+|++|..||....... . ... ..+...+..+.+
T Consensus 197 aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------------~---------~~~--~~~~~~~~~l~~ 253 (335)
T 3dls_A 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------------E---------AAI--HPPYLVSKELMS 253 (335)
T ss_dssp CHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------------T---------TCC--CCSSCCCHHHHH
T ss_pred ChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH------------h---------hcc--CCCcccCHHHHH
Confidence 9999988876 779999999999999999999985321100 0 000 001112347889
Q ss_pred HHHHcccCCCCCCCCHHHHHHH
Q 048243 233 IALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 233 li~~~l~~dp~~Rpt~~el~~~ 254 (303)
||.+||+.||.+|||+.++++.
T Consensus 254 li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 254 LVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHC
T ss_pred HHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999875
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=304.39 Aligned_cols=225 Identities=20% Similarity=0.239 Sum_probs=173.8
Q ss_pred CCCcEEEEEEecCC---CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||||+++.. .......+.+|+.+++.++||||+++++++......++||||+++++|.+++. ....+++
T Consensus 171 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~ 247 (446)
T 4ejn_A 171 ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS---RERVFSE 247 (446)
T ss_dssp TTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHH---HHSCCCH
T ss_pred CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHH---hcCCCCH
Confidence 57899999999753 23344567889999999999999999999999999999999999999998884 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 81 KKRVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
..+..++.||+.||+|||+ .| |+||||||+|||++.++.++|+|||++....... .......||+.|+|||++.
T Consensus 248 ~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~ 322 (446)
T 4ejn_A 248 DRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLE 322 (446)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCCC--cccccccCCccccCHhhcC
Confidence 9999999999999999998 88 9999999999999999999999999987533221 2233467899999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++|||||||++|+|++|..||....... .. ........ . .+...+..+.+||.+||+
T Consensus 323 ~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~---~~i~~~~~-------~----~p~~~~~~~~~li~~~L~ 385 (446)
T 4ejn_A 323 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LF---ELILMEEI-------R----FPRTLGPEAKSLLSGLLK 385 (446)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHHCCC-------C----CCTTSCHHHHHHHHHHTC
T ss_pred CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HH---HHHHhCCC-------C----CCccCCHHHHHHHHHHcc
Confidence 9999999999999999999999999996433211 11 11111110 0 111223578899999999
Q ss_pred CCCCCCC-----CHHHHHH
Q 048243 240 ENPNDRP-----SMLQVSS 253 (303)
Q Consensus 240 ~dp~~Rp-----t~~el~~ 253 (303)
.||.+|| ++.|+++
T Consensus 386 ~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 386 KDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp SSTTTSTTCSTTTHHHHHT
T ss_pred cCHHHhCCCCCCCHHHHHh
Confidence 9999999 9999987
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=282.74 Aligned_cols=246 Identities=17% Similarity=0.164 Sum_probs=189.1
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEE-EEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGF-CIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.||+|++...... +.+.+|+.+++.++|++++..+.. +......++||||+ +++|.+++.. ....+++..
T Consensus 32 ~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~ 106 (296)
T 4hgt_A 32 AAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF--CSRKFSLKT 106 (296)
T ss_dssp TTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTSCCCHHH
T ss_pred CCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHH--hcCCCCHHH
Confidence 67899999987654332 357889999999987776655555 46677889999999 8999999853 245689999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEE---CCCCceEEcccccccccccCCcc-----ccccccccccCCCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GEDMKPKISDFGLARIFAKESLE-----ANTEQVVGTIGYIP 154 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~---~~~~~v~l~Df~~~~~~~~~~~~-----~~~~~~~g~~~y~a 154 (303)
++.++.|++.||+|||+.+ ++||||||+||++ +.++.++|+|||++......... .......|++.|+|
T Consensus 107 ~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~a 183 (296)
T 4hgt_A 107 VLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183 (296)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCC
T ss_pred HHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccc
Confidence 9999999999999999999 9999999999999 78899999999999876544321 12234578999999
Q ss_pred hhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHH
Q 048243 155 PEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIA 234 (303)
Q Consensus 155 PE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
||.+.+..++.++|||||||++|+|++|..||......................... ..... .+..+.+++
T Consensus 184 PE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~----~~~~l~~li 254 (296)
T 4hgt_A 184 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-----VLCKG----YPSEFATYL 254 (296)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH-----HHTTT----SCHHHHHHH
T ss_pred hHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh-----hhhcc----CCHHHHHHH
Confidence 999999999999999999999999999999998765544444333322211111000 00011 124788999
Q ss_pred HHcccCCCCCCCCHHHHHHHhccccCCCCCCC
Q 048243 235 LLCVQENPNDRPSMLQVSSMLKNETTNRNTPK 266 (303)
Q Consensus 235 ~~~l~~dp~~Rpt~~el~~~L~~~~~~~~~~~ 266 (303)
.+||+.||++|||+.++++.|++.......+.
T Consensus 255 ~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~ 286 (296)
T 4hgt_A 255 NFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 286 (296)
T ss_dssp HHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCT
T ss_pred HHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCc
Confidence 99999999999999999999988776554433
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=292.32 Aligned_cols=239 Identities=21% Similarity=0.255 Sum_probs=172.5
Q ss_pred cCCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 3 LPCGKVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
..+|+.||||+++.... ...+.+.+|+.++++++||||+++++++.+....++||||+. ++|.+++. ....+++
T Consensus 56 ~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~~~~~ 131 (329)
T 3gbz_A 56 TVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMD---KNPDVSM 131 (329)
T ss_dssp TTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHH---HCTTCCH
T ss_pred CCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHh---hcCCCCH
Confidence 35789999999975532 234567899999999999999999999999999999999997 48988884 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEE-----CCCCceEEcccccccccccCCccccccccccccCCCCh
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL-----GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~-----~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aP 155 (303)
..++.++.||+.||+|||+.+ |+||||||+||++ +.++.++|+|||++....... .......|++.|+||
T Consensus 132 ~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aP 206 (329)
T 3gbz_A 132 RVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI--RQFTHEIITLWYRPP 206 (329)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-------------CCTTCCH
T ss_pred HHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc--cccCCCcCCccccCH
Confidence 999999999999999999999 9999999999999 455569999999997654332 122335679999999
Q ss_pred hhhccC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCccee---------cc--ccCCCCCC
Q 048243 156 EYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF---------VD--SSLDDTNS 223 (303)
Q Consensus 156 E~~~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~--~~~~~~~~ 223 (303)
|++.+. .++.++|||||||++|+|++|..||....... ................. .. +.......
T Consensus 207 E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (329)
T 3gbz_A 207 EILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID---QLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTL 283 (329)
T ss_dssp HHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCH
T ss_pred HHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH---HHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccH
Confidence 999875 48999999999999999999999996543222 11111111111000000 00 00000000
Q ss_pred H-----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 224 P-----CKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 224 ~-----~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
. ..+..+.+||.+||+.||.+|||+.|+++
T Consensus 284 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 284 KRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0 12357889999999999999999999987
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=304.14 Aligned_cols=231 Identities=24% Similarity=0.276 Sum_probs=186.6
Q ss_pred CCCcEEEEEEecCC---CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|++... .......+.+|+.+++.++||||+++++++.+....|+||||+++|+|.+++... ....+++
T Consensus 207 ~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~-~~~~l~e 285 (576)
T 2acx_A 207 ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM-GQAGFPE 285 (576)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSS-SSCCCCH
T ss_pred CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhc-CCCCCCH
Confidence 57999999999653 2334567889999999999999999999999999999999999999999988542 2345899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.||+.||+|||+.| |+||||||+||+++.+|.++|+|||++....... ......||+.|+|||++.+
T Consensus 286 ~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~ 359 (576)
T 2acx_A 286 ARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKN 359 (576)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTC---CEECCCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccCc---cccccCCCccccCHHHHcC
Confidence 999999999999999999999 9999999999999999999999999997764332 1223578999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|||||||++|+|++|..||...........+..... ... ...+...+..+.+||.+||+.
T Consensus 360 ~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~--~~~-----------~~~p~~~s~~~~dLI~~lL~~ 426 (576)
T 2acx_A 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK--EVP-----------EEYSERFSPQARSLCSQLLCK 426 (576)
T ss_dssp CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH--HCC-----------CCCCTTSCHHHHHHHHHHTCS
T ss_pred CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh--ccc-----------ccCCccCCHHHHHHHHHhccC
Confidence 8899999999999999999999999976543322221211111 110 011122345788999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 048243 241 NPNDRP-----SMLQVSSM 254 (303)
Q Consensus 241 dp~~Rp-----t~~el~~~ 254 (303)
||.+|| ++.|+++.
T Consensus 427 dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 427 DPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp SGGGSTTCSSSHHHHHHTS
T ss_pred CHHHcCCCCCCCHHHHHhC
Confidence 999999 78888763
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=311.20 Aligned_cols=237 Identities=24% Similarity=0.355 Sum_probs=186.5
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.++..||||+++... ....+.+.+|+.++++++||||+++++++.. +..++||||+.+|+|.+++.. ....+++..
T Consensus 361 ~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~--~~~~l~~~~ 437 (613)
T 2ozo_A 361 KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG--KREEIPVSN 437 (613)
T ss_dssp SCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTT--CTTTSCHHH
T ss_pred CCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhh--ccCCCCHHH
Confidence 356789999997653 3456889999999999999999999999976 568999999999999999854 345689999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-ccccccccccCCCChhhhccC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~ 161 (303)
++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........ .......++..|+|||++.+.
T Consensus 438 ~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~ 514 (613)
T 2ozo_A 438 VAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 514 (613)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCC
Confidence 9999999999999999999 999999999999999999999999999876433211 112223456899999999988
Q ss_pred CCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 162 VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
.++.++|||||||++|+|++ |..||......... .....+... ..+...+..+.+||.+||..
T Consensus 515 ~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-------~~i~~~~~~---------~~p~~~~~~l~~li~~cl~~ 578 (613)
T 2ozo_A 515 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-------AFIEQGKRM---------ECPPECPPELYALMSDCWIY 578 (613)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH-------HHHHTTCCC---------CCCTTCCHHHHHHHHHTTCS
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-------HHHHcCCCC---------CCCCcCCHHHHHHHHHHcCC
Confidence 99999999999999999998 99999654432211 112111111 11122345788999999999
Q ss_pred CCCCCCCHHHHHHHhccccCCC
Q 048243 241 NPNDRPSMLQVSSMLKNETTNR 262 (303)
Q Consensus 241 dp~~Rpt~~el~~~L~~~~~~~ 262 (303)
||.+||++.++++.|+......
T Consensus 579 dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 579 KWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp STTTSCCHHHHHHHHHHHHHHH
T ss_pred ChhHCcCHHHHHHHHHHHHHHh
Confidence 9999999999999998876444
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=288.67 Aligned_cols=235 Identities=26% Similarity=0.380 Sum_probs=185.0
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+++.||||+++... ....+.+.+|+.+++.++||||+++++++ .....++||||+.+++|.+++.. ...+++.
T Consensus 42 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~ 117 (291)
T 1xbb_A 42 KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ---NRHVKDK 117 (291)
T ss_dssp SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHH---CTTCCHH
T ss_pred CceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHh---CcCCCHH
Confidence 457899999997553 23356899999999999999999999999 56678999999999999999843 4568999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-ccccccccccCCCChhhhcc
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~ 160 (303)
.++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++......... .......++..|+|||.+.+
T Consensus 118 ~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 194 (291)
T 1xbb_A 118 NIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194 (291)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhcc
Confidence 99999999999999999999 999999999999999999999999999776443221 11222345788999999988
Q ss_pred CCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 161 GVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
..++.++||||||+++|+|++ |..||....... ........... ..+...+..+.+++.+||.
T Consensus 195 ~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~ 258 (291)
T 1xbb_A 195 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERM---------GCPAGCPREMYDLMNLCWT 258 (291)
T ss_dssp CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTC
T ss_pred CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcC
Confidence 888999999999999999999 999986433211 11112111111 1112234578899999999
Q ss_pred CCCCCCCCHHHHHHHhccccCC
Q 048243 240 ENPNDRPSMLQVSSMLKNETTN 261 (303)
Q Consensus 240 ~dp~~Rpt~~el~~~L~~~~~~ 261 (303)
.||.+|||+.++++.|++....
T Consensus 259 ~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 259 YDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp SSTTTSCCHHHHHHHHHHHHHH
T ss_pred CChhhCcCHHHHHHHHHHHHHH
Confidence 9999999999999999887643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=298.94 Aligned_cols=240 Identities=25% Similarity=0.324 Sum_probs=177.5
Q ss_pred CCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCC-CCccccEEEEEEeCC--eeEEEEeecCCCChhhhhcCccccccC
Q 048243 4 PCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSE--ERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 4 ~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
.+|+.||||++... .....+.+.+|+.+++.+. ||||+++++++...+ ..|+|||||+ ++|..++. ...+
T Consensus 32 ~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~ 106 (388)
T 3oz6_A 32 RTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIR----ANIL 106 (388)
T ss_dssp TTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHH----HTCC
T ss_pred CCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHH----cCCC
Confidence 57899999999644 3344567889999999996 999999999998654 6899999997 58888873 3468
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCC-------------------c
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKES-------------------L 139 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~-------------------~ 139 (303)
++..+..++.||+.||+|||+.| |+||||||+||+++.++.++|+|||+++.+.... .
T Consensus 107 ~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (388)
T 3oz6_A 107 EPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183 (388)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccc
Confidence 99999999999999999999999 9999999999999999999999999997654311 0
Q ss_pred cccccccccccCCCChhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceec----
Q 048243 140 EANTEQVVGTIGYIPPEYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV---- 214 (303)
Q Consensus 140 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 214 (303)
........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||......... ..............+.
T Consensus 184 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~---~~i~~~~~~p~~~~~~~~~~ 260 (388)
T 3oz6_A 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL---ERIIGVIDFPSNEDVESIQS 260 (388)
T ss_dssp ------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCHHHHHTSCC
T ss_pred cccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCCHHHHHhccC
Confidence 112233578999999999886 56899999999999999999999999654322211 1111111100000000
Q ss_pred -------c---------ccCCCCCCH-------------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 215 -------D---------SSLDDTNSP-------------CKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 215 -------~---------~~~~~~~~~-------------~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
. ........+ ..+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 261 PFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp SSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 0 000000000 123478899999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=289.80 Aligned_cols=233 Identities=25% Similarity=0.404 Sum_probs=180.3
Q ss_pred CcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHH
Q 048243 6 GKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 6 ~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~ 84 (303)
+..||+|.++... ......+.+|+.++++++||||+++++++......++||||+++++|.+++.. ....+++..++
T Consensus 73 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~ 150 (333)
T 1mqb_A 73 EVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLV 150 (333)
T ss_dssp EEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH--TTTCSCHHHHH
T ss_pred cccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHh--CCCCCCHHHHH
Confidence 3469999997553 33456788999999999999999999999999999999999999999999853 34568999999
Q ss_pred HHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-ccccccccccCCCChhhhccCCC
Q 048243 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 85 ~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++......... .......++..|+|||.+.+..+
T Consensus 151 ~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 227 (333)
T 1mqb_A 151 GMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227 (333)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCC
T ss_pred HHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCC
Confidence 99999999999999999 999999999999999999999999999776543221 11222345778999999998899
Q ss_pred CCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC
Q 048243 164 STKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 242 (303)
+.++||||||+++|+|++ |..||....... ........... ..+...+..+.+++.+||+.||
T Consensus 228 ~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p 291 (333)
T 1mqb_A 228 TSASDVWSFGIVMWEVMTYGERPYWELSNHE-------VMKAINDGFRL---------PTPMDCPSAIYQLMMQCWQQER 291 (333)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTCCC---------CCCTTCBHHHHHHHHHHTCSST
T ss_pred CchhhhHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHCCCcC---------CCcccCCHHHHHHHHHHcCCCh
Confidence 999999999999999998 999985432211 11111111111 1111234578899999999999
Q ss_pred CCCCCHHHHHHHhcccc
Q 048243 243 NDRPSMLQVSSMLKNET 259 (303)
Q Consensus 243 ~~Rpt~~el~~~L~~~~ 259 (303)
.+||++.++++.|++..
T Consensus 292 ~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 292 ARRPKFADIVSILDKLI 308 (333)
T ss_dssp TTSCCHHHHHHHHHHHH
T ss_pred hhCcCHHHHHHHHHHHH
Confidence 99999999999988765
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=285.53 Aligned_cols=228 Identities=23% Similarity=0.361 Sum_probs=183.3
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEe----------------CCeeEEEEeecCCCChhh
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCID----------------SEERMLVYEYMPNKSLDC 67 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~~~L~~ 67 (303)
.+|+.||+|+++... +.+.+|+.++++++||||+++++++.. ....++||||+++++|.+
T Consensus 34 ~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~ 109 (284)
T 2a19_B 34 IDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQ 109 (284)
T ss_dssp TTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHH
T ss_pred CCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHH
Confidence 479999999997654 356789999999999999999999864 345799999999999999
Q ss_pred hhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccc
Q 048243 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVV 147 (303)
Q Consensus 68 ~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~ 147 (303)
++... ....+++..++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||.+........ .....
T Consensus 110 ~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~ 182 (284)
T 2a19_B 110 WIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSK 182 (284)
T ss_dssp HHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC---CCCCC
T ss_pred HHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECcchhheecccccc---ccccC
Confidence 98542 3456899999999999999999999999 99999999999999999999999999877654321 22346
Q ss_pred cccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHH
Q 048243 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKL 227 (303)
Q Consensus 148 g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
|++.|+|||.+.+..++.++||||||+++|+|++|..|+... .......... ... ...+
T Consensus 183 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~~~~~~~~~--------~~~----~~~~ 241 (284)
T 2a19_B 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SKFFTDLRDG--------IIS----DIFD 241 (284)
T ss_dssp SCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HHHHHHHHTT--------CCC----TTSC
T ss_pred CcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HHHHHHhhcc--------ccc----ccCC
Confidence 899999999999999999999999999999999999886311 0111111111 111 1123
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhccccCCCC
Q 048243 228 MRCLEIALLCVQENPNDRPSMLQVSSMLKNETTNRN 263 (303)
Q Consensus 228 ~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~~~~~ 263 (303)
..+.+++.+||+.||.+|||+.|+++.|........
T Consensus 242 ~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 242 KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 468899999999999999999999999988765443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=287.94 Aligned_cols=242 Identities=29% Similarity=0.412 Sum_probs=188.9
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCC--eeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE--ERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+|+.||+|++........+.+.+|+.++++++||||+++++++.... ..++||||+++++|.+++.. ....+++.
T Consensus 68 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~ 145 (326)
T 2w1i_A 68 NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHI 145 (326)
T ss_dssp SCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHH--STTSSCHH
T ss_pred CCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHh--cccCCCHH
Confidence 578999999998776666678999999999999999999999987654 78999999999999999854 23458999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-ccccccccccCCCChhhhcc
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~ 160 (303)
.++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++......... .......++..|+|||.+.+
T Consensus 146 ~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 222 (326)
T 2w1i_A 146 KLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 222 (326)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcC
Confidence 99999999999999999999 999999999999999999999999999876544321 11223456778999999998
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCC--------CC-ccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHH
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCG--------IN-ENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL 231 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~--------~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
..++.++||||||+++|+|++|..|+.... .. .................. ...+...+..+.
T Consensus 223 ~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~l~ 293 (326)
T 2w1i_A 223 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR---------LPRPDGCPDEIY 293 (326)
T ss_dssp CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCC---------CCCCTTCCHHHH
T ss_pred CCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCC---------CCCCCcccHHHH
Confidence 888999999999999999999998875321 00 000011111111211111 111122345788
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhcccc
Q 048243 232 EIALLCVQENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 232 ~li~~~l~~dp~~Rpt~~el~~~L~~~~ 259 (303)
++|.+||..||.+|||+.|+++.|++..
T Consensus 294 ~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 294 MIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999999998764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=284.50 Aligned_cols=235 Identities=24% Similarity=0.347 Sum_probs=182.9
Q ss_pred cEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEE-eCCeeEEEEeecCCCChhhhhcCccccccCCHHHHH
Q 048243 7 KVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCI-DSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 7 ~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~ 84 (303)
..||+|.++... ....+.+.+|+.++++++||||+++++++. .+...++||||+++++|.+++.. ....+++..++
T Consensus 54 ~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~ 131 (298)
T 3f66_A 54 IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLI 131 (298)
T ss_dssp EEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHC--TTCCCCHHHHH
T ss_pred eEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHh--cccCCCHHHHH
Confidence 368999997643 344567899999999999999999999865 45678999999999999999954 34568899999
Q ss_pred HHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc--ccccccccccCCCChhhhccCC
Q 048243 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE--ANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 85 ~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++......... .......+++.|+|||.+.+..
T Consensus 132 ~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 208 (298)
T 3f66_A 132 GFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 208 (298)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCC
Confidence 99999999999999999 999999999999999999999999999866543321 1223345778999999999999
Q ss_pred CCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
++.++||||||+++|+|++ |.+||......... . ...... . ...+...+..+.+++.+||+.|
T Consensus 209 ~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~---~---~~~~~~-~---------~~~~~~~~~~l~~li~~~l~~~ 272 (298)
T 3f66_A 209 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---V---YLLQGR-R---------LLQPEYCPDPLYEVMLKCWHPK 272 (298)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH---H---HHHTTC-C---------CCCCTTCCHHHHHHHHHHTCSS
T ss_pred CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH---H---HHhcCC-C---------CCCCccCCHHHHHHHHHHcCCC
Confidence 9999999999999999999 45555433322211 1 111111 0 0011112347889999999999
Q ss_pred CCCCCCHHHHHHHhccccCCC
Q 048243 242 PNDRPSMLQVSSMLKNETTNR 262 (303)
Q Consensus 242 p~~Rpt~~el~~~L~~~~~~~ 262 (303)
|.+|||+.|+++.|+......
T Consensus 273 p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 273 AEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp GGGSCCHHHHHHHHHHHHHTS
T ss_pred hhhCcCHHHHHHHHHHHHHhh
Confidence 999999999999998876544
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=292.52 Aligned_cols=230 Identities=23% Similarity=0.343 Sum_probs=176.4
Q ss_pred cCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCC--CCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccC
Q 048243 3 LPCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQ--HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 3 ~~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
..+|+.||||++.... ....+.+.+|+.+++.++ ||||+++++++......++||| +.+++|.+++.. ...+
T Consensus 77 ~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~---~~~~ 152 (390)
T 2zmd_A 77 NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK---KKSI 152 (390)
T ss_dssp CTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHH---CSSC
T ss_pred cCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHh---cCCC
Confidence 4568999999997543 334567899999999996 5999999999999999999999 568899999853 4468
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
++..++.++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||++..+.............||+.|+|||++
T Consensus 153 ~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~ 228 (390)
T 2zmd_A 153 DPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228 (390)
T ss_dssp CHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHh
Confidence 89999999999999999999999 99999999999995 578999999999876544333333446799999999998
Q ss_pred cc-----------CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHH
Q 048243 159 RQ-----------GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKL 227 (303)
Q Consensus 159 ~~-----------~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
.+ ..++.++|||||||++|+|++|..||..... ................ .+...+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~~~~~~~~~---------~~~~~~ 294 (390)
T 2zmd_A 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIIDPNHEIE---------FPDIPE 294 (390)
T ss_dssp HCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHHCTTSCCC---------CCCCSC
T ss_pred hhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHHhCccccCC---------CCccch
Confidence 75 3578899999999999999999999953321 1111122222111111 111113
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 228 MRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 228 ~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
..+.+||.+||..||.+|||+.|+++.
T Consensus 295 ~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 295 KDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 478899999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=293.66 Aligned_cols=236 Identities=24% Similarity=0.300 Sum_probs=175.1
Q ss_pred CCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCe----eEEEEeecCCCChhhhhcCccccc
Q 048243 4 PCGKVIAVKKLSKTST---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE----RMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~~~~valK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~ 76 (303)
.+|+.||||+++.... .....+.+|+.++++++||||+++++++..... .++||||+++++|.+++. ...
T Consensus 35 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~---~~~ 111 (311)
T 3ork_A 35 RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEG 111 (311)
T ss_dssp TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHH---HHC
T ss_pred CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHH---hcC
Confidence 6789999999976532 234578899999999999999999999876543 499999999999999984 345
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-ccccccccccCCCCh
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPP 155 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-~~~~~~~g~~~y~aP 155 (303)
.+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++......... .......|++.|+||
T Consensus 112 ~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aP 188 (311)
T 3ork_A 112 PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188 (311)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCH
Confidence 6899999999999999999999999 999999999999999999999999999766543221 222335689999999
Q ss_pred hhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHH
Q 048243 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
|.+.+..++.++||||||+++|+|++|..||....... .............. ... ...+..+.+++.
T Consensus 189 E~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~~~---~~~----~~~~~~l~~li~ 255 (311)
T 3ork_A 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPIPPS---ARH----EGLSADLDAVVL 255 (311)
T ss_dssp HHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCCCHH---HHS----TTCCHHHHHHHH
T ss_pred HHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCCCcc---ccc----CCCCHHHHHHHH
Confidence 99999999999999999999999999999995433211 11111211111100 000 112347889999
Q ss_pred HcccCCCCCCCCHHHHH-HHhccc
Q 048243 236 LCVQENPNDRPSMLQVS-SMLKNE 258 (303)
Q Consensus 236 ~~l~~dp~~Rpt~~el~-~~L~~~ 258 (303)
+||+.||.+||++.+++ ..|...
T Consensus 256 ~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 256 KALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp HHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHhcCHhhChhhHHHHHHHHHHH
Confidence 99999999999766654 445443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=292.20 Aligned_cols=243 Identities=24% Similarity=0.344 Sum_probs=178.8
Q ss_pred CCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+....++||||+++++|..++. ....+++.
T Consensus 48 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~ 124 (331)
T 4aaa_A 48 DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL---FPNGLDYQ 124 (331)
T ss_dssp TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH---STTCCCHH
T ss_pred CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHh---hccCCCHH
Confidence 4689999999865432 234567899999999999999999999999999999999999998888763 34568999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
.++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||.+....... .......|+..|+|||.+.+.
T Consensus 125 ~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~ 199 (331)
T 4aaa_A 125 VVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYDDEVATRWYRAPELLVGD 199 (331)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC--------------CCCCCTTCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc--cccCCCcCCccccCcccccCC
Confidence 99999999999999999999 9999999999999999999999999997654332 222335689999999998875
Q ss_pred -CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHH--------HHHHHhCCC-cceeccccCCCCCC-----HHH
Q 048243 162 -VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH--------AYELWKGGK-GVEFVDSSLDDTNS-----PCK 226 (303)
Q Consensus 162 -~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~-~~~~~~~~~~~~~~-----~~~ 226 (303)
.++.++|||||||++|+|++|..||.............. ....+.... ......+....... +..
T Consensus 200 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (331)
T 4aaa_A 200 VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKL 279 (331)
T ss_dssp TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTS
T ss_pred CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccch
Confidence 689999999999999999999999865432221111100 000000000 00000000111111 123
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 227 LMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 227 ~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 280 ~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 280 SEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 4578999999999999999999999863
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=287.79 Aligned_cols=225 Identities=26% Similarity=0.346 Sum_probs=183.9
Q ss_pred CCCcEEEEEEecCC---CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||||+.+++|.+++. ....+++
T Consensus 64 ~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~l~~ 140 (335)
T 2owb_A 64 DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK---RRKALTE 140 (335)
T ss_dssp TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHH---HHCSCCH
T ss_pred CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHh---ccCCCCH
Confidence 46889999998654 23445678899999999999999999999999999999999999999999884 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.||+.||+|||++| ++||||||+||+++.++.++|+|||++........ ......|+..|+|||.+.+
T Consensus 141 ~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~ 215 (335)
T 2owb_A 141 PEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSK 215 (335)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCcc--cccccCCCccccCHHHhcc
Confidence 999999999999999999999 99999999999999999999999999977643321 2233568999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++||||||+++|+|++|..||........ ......... .. +...+..+.++|.+||+.
T Consensus 216 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~~~-------~~----~~~~~~~~~~li~~~l~~ 278 (335)
T 2owb_A 216 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLRIKKNEY-------SI----PKHINPVAASLIQKMLQT 278 (335)
T ss_dssp SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHTCC-------CC----CTTSCHHHHHHHHHHTCS
T ss_pred CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH------HHHHhcCCC-------CC----CccCCHHHHHHHHHHccC
Confidence 8899999999999999999999999864332111 111111110 01 112234788999999999
Q ss_pred CCCCCCCHHHHHH
Q 048243 241 NPNDRPSMLQVSS 253 (303)
Q Consensus 241 dp~~Rpt~~el~~ 253 (303)
||.+|||+.|+++
T Consensus 279 dp~~Rps~~ell~ 291 (335)
T 2owb_A 279 DPTARPTINELLN 291 (335)
T ss_dssp SGGGSCCGGGGGG
T ss_pred ChhHCcCHHHHhc
Confidence 9999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=291.37 Aligned_cols=224 Identities=29% Similarity=0.375 Sum_probs=179.4
Q ss_pred CCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTST---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||||++..... ...+.+.+|+.++++++||||+++++++......++||||+. |+|.+++.. ....+++
T Consensus 77 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~--~~~~l~~ 153 (348)
T 1u5q_A 77 RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV--HKKPLQE 153 (348)
T ss_dssp TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHH--HTSCCCH
T ss_pred cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHH--hcCCCCH
Confidence 6799999999975432 234578899999999999999999999999999999999997 577777642 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc-
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR- 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~- 159 (303)
..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++...... ....|++.|+|||++.
T Consensus 154 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~------~~~~gt~~y~aPE~~~~ 224 (348)
T 1u5q_A 154 VEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILA 224 (348)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB------CCCCSCGGGCCHHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC------CcccCCcceeCHhhhcc
Confidence 999999999999999999999 999999999999999999999999998765432 2356899999999985
Q ss_pred --cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHc
Q 048243 160 --QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237 (303)
Q Consensus 160 --~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 237 (303)
+..++.++|||||||++|+|++|..||...... ........... .. ......+..+.+||.+|
T Consensus 225 ~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~~~~~~~~-~~--------~~~~~~~~~l~~li~~~ 289 (348)
T 1u5q_A 225 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNES-PA--------LQSGHWSEYFRNFVDSC 289 (348)
T ss_dssp TSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCC-CC--------CCCTTSCHHHHHHHHHH
T ss_pred ccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhcCC-CC--------CCCCCCCHHHHHHHHHH
Confidence 456889999999999999999999998543321 11112222111 00 01112234788999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 048243 238 VQENPNDRPSMLQVSSM 254 (303)
Q Consensus 238 l~~dp~~Rpt~~el~~~ 254 (303)
|+.||++|||+.++++.
T Consensus 290 l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 290 LQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp TCSSGGGSCCHHHHTTC
T ss_pred cccChhhCcCHHHHhhC
Confidence 99999999999999764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=294.61 Aligned_cols=236 Identities=24% Similarity=0.358 Sum_probs=176.9
Q ss_pred cEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEe-CCeeEEEEeecCCCChhhhhcCccccccCCHHHHH
Q 048243 7 KVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCID-SEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 7 ~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~ 84 (303)
..||+|.++... ....+.+.+|+.++++++||||+++++++.. ++..++||||+++++|.+++.. ....+++..++
T Consensus 118 ~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~ 195 (373)
T 3c1x_A 118 IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLI 195 (373)
T ss_dssp EEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHC--TTCCCBHHHHH
T ss_pred EEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhh--cccCCCHHHHH
Confidence 468999997543 3456789999999999999999999998754 4578999999999999999954 34457889999
Q ss_pred HHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccc--cccccccccCCCChhhhccCC
Q 048243 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEA--NTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 85 ~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~ 162 (303)
.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++......... ......+++.|+|||.+.+..
T Consensus 196 ~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 272 (373)
T 3c1x_A 196 GFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 272 (373)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCC
Confidence 99999999999999999 9999999999999999999999999997654432211 122345678899999999999
Q ss_pred CCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
++.++||||||+++|+|++ |.+||......... . ....+. .. ..+...+..+.+++.+||..|
T Consensus 273 ~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~---~---~~~~~~-~~---------~~p~~~~~~l~~li~~cl~~d 336 (373)
T 3c1x_A 273 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---V---YLLQGR-RL---------LQPEYCPDPLYEVMLKCWHPK 336 (373)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH---H---HHHTTC-CC---------CCCTTCCHHHHHHHHHHTCSS
T ss_pred CCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH---H---HHHcCC-CC---------CCCCCCCHHHHHHHHHHcCCC
Confidence 9999999999999999999 66677544333211 1 111111 10 011122347889999999999
Q ss_pred CCCCCCHHHHHHHhccccCCCC
Q 048243 242 PNDRPSMLQVSSMLKNETTNRN 263 (303)
Q Consensus 242 p~~Rpt~~el~~~L~~~~~~~~ 263 (303)
|.+|||+.|+++.|+.......
T Consensus 337 p~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 337 AEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp GGGSCCHHHHHHHHHHHHHTCC
T ss_pred hhhCcCHHHHHHHHHHHHHhcc
Confidence 9999999999999988775544
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=280.66 Aligned_cols=223 Identities=22% Similarity=0.317 Sum_probs=182.3
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++. ....+++
T Consensus 37 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~ 113 (284)
T 2vgo_A 37 QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ---KHGRFDE 113 (284)
T ss_dssp TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH---HHSSCCH
T ss_pred CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHH---hcCCCCH
Confidence 468899999986432 2345678999999999999999999999999999999999999999999884 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.|++.||+|||+.| ++||||+|+||+++.++.++|+|||.+....... .....|++.|+|||.+.+
T Consensus 114 ~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~ 186 (284)
T 2vgo_A 114 QRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEG 186 (284)
T ss_dssp HHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSC----BCCCCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcccc----cccccCCCCcCCHHHhcc
Confidence 999999999999999999999 9999999999999999999999999986544321 223568999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++||||||+++|+|++|..||....... ......... ...+...+..+.++|.+||..
T Consensus 187 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~-----------~~~~~~~~~~~~~li~~~l~~ 249 (284)
T 2vgo_A 187 KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE------THRRIVNVD-----------LKFPPFLSDGSKDLISKLLRY 249 (284)
T ss_dssp CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTTC-----------CCCCTTSCHHHHHHHHHHSCS
T ss_pred CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH------HHHHHhccc-----------cCCCCcCCHHHHHHHHHHhhc
Confidence 889999999999999999999999986433211 111111110 011122345788999999999
Q ss_pred CCCCCCCHHHHHH
Q 048243 241 NPNDRPSMLQVSS 253 (303)
Q Consensus 241 dp~~Rpt~~el~~ 253 (303)
||.+|||+.++++
T Consensus 250 ~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 250 HPPQRLPLKGVME 262 (284)
T ss_dssp SGGGSCCHHHHHT
T ss_pred CHhhCCCHHHHhh
Confidence 9999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=299.83 Aligned_cols=232 Identities=23% Similarity=0.279 Sum_probs=186.1
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc-ccccCC
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-RRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~l~ 79 (303)
.+|+.||+|++.... ....+.+..|+.+++.++||||+++++++.+....|+||||++||+|..++.... ....++
T Consensus 208 ~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~ 287 (543)
T 3c4z_A 208 ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ 287 (543)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCC
T ss_pred CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhccccccc
Confidence 579999999996542 2345678899999999999999999999999999999999999999999886532 245699
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..++.++.||+.||+|||+.| |+||||||+||+++.+|.++|+|||++........ ......||+.|+|||++.
T Consensus 288 e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~ 362 (543)
T 3c4z_A 288 EPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLL 362 (543)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC--CBCCCCSCTTTSCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccCCCc--ccccccCCccccChhhhc
Confidence 9999999999999999999999 99999999999999999999999999987644321 123357899999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++|||||||++|+|++|..||............. ........ ..+...+..+.+||.+||+
T Consensus 363 ~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~--~~i~~~~~-----------~~p~~~s~~~~~li~~lL~ 429 (543)
T 3c4z_A 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK--QRVLEQAV-----------TYPDKFSPASKDFCEALLQ 429 (543)
T ss_dssp TCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHH--HHHHHCCC-----------CCCTTSCHHHHHHHHHHSC
T ss_pred CCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHH--HHHhhccc-----------CCCcccCHHHHHHHHHhcc
Confidence 9999999999999999999999999997554322211111 11111110 1112234578899999999
Q ss_pred CCCCCCCCH-----HHHHH
Q 048243 240 ENPNDRPSM-----LQVSS 253 (303)
Q Consensus 240 ~dp~~Rpt~-----~el~~ 253 (303)
.||.+||++ .++++
T Consensus 430 ~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 430 KDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp SSGGGSCCCBTTBSHHHHT
T ss_pred CCHhHCCCCcccCHHHHHc
Confidence 999999975 66654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=282.94 Aligned_cols=231 Identities=24% Similarity=0.351 Sum_probs=181.2
Q ss_pred CcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHH
Q 048243 6 GKVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 6 ~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~ 84 (303)
++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+ ...++||||+.+++|.+++.. ....+++..++
T Consensus 40 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~ 116 (281)
T 3cc6_A 40 KINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLER--NKNSLKVLTLV 116 (281)
T ss_dssp EEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHH--HTTTCCHHHHH
T ss_pred cceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHh--ccccCCHHHHH
Confidence 456999999765 34456789999999999999999999999865 457899999999999999853 23458999999
Q ss_pred HHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCC
Q 048243 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYS 164 (303)
Q Consensus 85 ~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 164 (303)
.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||.+......... ......++..|+|||.+.+..++
T Consensus 117 ~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~ 192 (281)
T 3cc6_A 117 LYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFT 192 (281)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccccccccc-ccccCCCCcceeCchhhccCCCC
Confidence 99999999999999999 999999999999999999999999998765443221 12234567889999999988899
Q ss_pred CccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCC
Q 048243 165 TKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 165 ~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 243 (303)
.++||||||+++|+|++ |..||......... ... .... .. ..+...+..+.+++.+||..||.
T Consensus 193 ~~~Di~slG~il~~llt~g~~p~~~~~~~~~~---~~~---~~~~-~~---------~~~~~~~~~l~~li~~~l~~~p~ 256 (281)
T 3cc6_A 193 TASDVWMFAVCMWEILSFGKQPFFWLENKDVI---GVL---EKGD-RL---------PKPDLCPPVLYTLMTRCWDYDPS 256 (281)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH---HHH---HHTC-CC---------CCCTTCCHHHHHHHHHHTCSSGG
T ss_pred chhccHHHHHHHHHHHhCCCCCcccCChHHHH---HHH---hcCC-CC---------CCCCCCCHHHHHHHHHHccCCch
Confidence 99999999999999998 99998644333211 111 1111 00 01112234788999999999999
Q ss_pred CCCCHHHHHHHhcccc
Q 048243 244 DRPSMLQVSSMLKNET 259 (303)
Q Consensus 244 ~Rpt~~el~~~L~~~~ 259 (303)
+|||+.|+++.|++..
T Consensus 257 ~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 257 DRPRFTELVCSLSDVY 272 (281)
T ss_dssp GSCCHHHHHHHHHHHH
T ss_pred hCcCHHHHHHHHHHHH
Confidence 9999999999987653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=283.54 Aligned_cols=240 Identities=25% Similarity=0.343 Sum_probs=179.3
Q ss_pred CCCcEEEEEEecCCC-----cccHHHHHHHHHHHhcC---CCCccccEEEEEEeCC-----eeEEEEeecCCCChhhhhc
Q 048243 4 PCGKVIAVKKLSKTS-----TQGFEEFKNEVMLTAKL---QHVNLIRVLGFCIDSE-----ERMLVYEYMPNKSLDCYLF 70 (303)
Q Consensus 4 ~~~~~valK~~~~~~-----~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~ 70 (303)
.+|+.||||++.... ......+.+|+.+++.+ +||||+++++++.... ..++|||++. ++|.+++.
T Consensus 32 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~ 110 (308)
T 3g33_A 32 HSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLD 110 (308)
T ss_dssp TTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHH
T ss_pred CCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHh
Confidence 578999999986432 11234566788777776 4999999999998765 5799999997 59999885
Q ss_pred CccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcccccccccccc
Q 048243 71 DPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTI 150 (303)
Q Consensus 71 ~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~ 150 (303)
.. ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||.+....... ......||+
T Consensus 111 ~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~ 183 (308)
T 3g33_A 111 KA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM---ALTPVVVTL 183 (308)
T ss_dssp TC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCC---CSGGGGCCC
T ss_pred hc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeCccccccCCCc---ccCCccccc
Confidence 42 2344899999999999999999999999 9999999999999999999999999997654332 223457899
Q ss_pred CCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCccee------ccccCCC--CC
Q 048243 151 GYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF------VDSSLDD--TN 222 (303)
Q Consensus 151 ~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~--~~ 222 (303)
.|+|||.+.+..++.++|||||||++|+|++|..||........ ...............+ ....... ..
T Consensus 184 ~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (308)
T 3g33_A 184 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPR 260 (308)
T ss_dssp SSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCC
T ss_pred cccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChhhccchhhccccccCCCCCC
Confidence 99999999999999999999999999999999999965432221 1111121111100000 0000000 00
Q ss_pred -----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 223 -----SPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 223 -----~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
.+..+..+.+||.+||+.||.+|||+.|+++.
T Consensus 261 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 261 PVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 01233578899999999999999999999863
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=293.46 Aligned_cols=239 Identities=23% Similarity=0.274 Sum_probs=182.4
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCC------eeEEEEeecCCCChhhhhcCcccc
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE------ERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~ 75 (303)
.+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.... ..|+||||+ +++|.+++. .
T Consensus 48 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~----~ 122 (367)
T 1cm8_A 48 RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK----H 122 (367)
T ss_dssp TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHH----H
T ss_pred CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHh----c
Confidence 579999999996542 333567889999999999999999999998653 459999999 789998884 3
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCCh
Q 048243 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aP 155 (303)
..+++..+..++.||+.||+|||+.| ++||||||+||+++.++.++|+|||+++..... .....||+.|+||
T Consensus 123 ~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aP 194 (367)
T 1cm8_A 123 EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAP 194 (367)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCT
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecccccccc-----cCcCcCCCCcCCH
Confidence 46899999999999999999999999 999999999999999999999999999865432 2335679999999
Q ss_pred hhhcc-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCc------------------ceeccc
Q 048243 156 EYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG------------------VEFVDS 216 (303)
Q Consensus 156 E~~~~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~ 216 (303)
|++.+ ..++.++||||+||++|+|++|..||......... ............ ......
T Consensus 195 E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l---~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (367)
T 1cm8_A 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL---KEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKK 271 (367)
T ss_dssp HHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCC
T ss_pred HHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCC
Confidence 99887 67899999999999999999999999654322211 111111100000 000000
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hcccc
Q 048243 217 SLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM--LKNET 259 (303)
Q Consensus 217 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~--L~~~~ 259 (303)
.+ ....+..+..+.+|+.+||..||.+|||+.|+++. +++..
T Consensus 272 ~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 272 DF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp CG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 00 00111234578899999999999999999999883 55544
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=304.00 Aligned_cols=228 Identities=28% Similarity=0.330 Sum_probs=183.6
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+....++||||+.+++|.+++. ....+++
T Consensus 49 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~ 125 (484)
T 3nyv_A 49 ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII---SRKRFSE 125 (484)
T ss_dssp TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---TCSCCBH
T ss_pred CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHH---hcCCCCH
Confidence 478999999996542 3456789999999999999999999999999999999999999999999884 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEE---CCCCceEEcccccccccccCCccccccccccccCCCChhh
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~---~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 157 (303)
..++.++.||+.||+|||++| |+||||||+||++ +.++.++|+|||++....... ......||+.|+|||+
T Consensus 126 ~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~ 199 (484)
T 3nyv_A 126 VDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEV 199 (484)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC---SHHHHTTGGGTCCHHH
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc---ccccCCCCccccCcee
Confidence 999999999999999999999 9999999999999 567889999999997664432 2233568999999999
Q ss_pred hccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHc
Q 048243 158 ARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237 (303)
Q Consensus 158 ~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 237 (303)
+.+ .++.++|||||||++|+|++|.+||....... .. ........... .......+..+.+||.+|
T Consensus 200 ~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~---~~i~~~~~~~~-------~~~~~~~s~~~~~li~~~ 265 (484)
T 3nyv_A 200 LHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD---IL---KKVEKGKYTFE-------LPQWKKVSESAKDLIRKM 265 (484)
T ss_dssp HHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHHCCCCCC-------SGGGGGSCHHHHHHHHHH
T ss_pred ecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH---HH---HHHHcCCCCCC-------CcccccCCHHHHHHHHHH
Confidence 876 68999999999999999999999996543221 11 11111111110 001112345788999999
Q ss_pred ccCCCCCCCCHHHHHHH
Q 048243 238 VQENPNDRPSMLQVSSM 254 (303)
Q Consensus 238 l~~dp~~Rpt~~el~~~ 254 (303)
|+.||.+|||+.|+++.
T Consensus 266 L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 266 LTYVPSMRISARDALDH 282 (484)
T ss_dssp TCSSGGGSCCHHHHHTS
T ss_pred CCCChhHCcCHHHHhhC
Confidence 99999999999999863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=285.01 Aligned_cols=226 Identities=23% Similarity=0.358 Sum_probs=185.0
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++......++||||+++++|.+++. ...+++..
T Consensus 45 ~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~ 120 (303)
T 3a7i_A 45 RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE----PGPLDETQ 120 (303)
T ss_dssp TTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHT----TSCCCHHH
T ss_pred CCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHh----cCCCCHHH
Confidence 578999999997553 4456789999999999999999999999999999999999999999999983 35689999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
++.++.|++.||+|||+.| ++||||+|+||+++.++.++|+|||.+........ ......|++.|+|||.+.+..
T Consensus 121 ~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~ 195 (303)
T 3a7i_A 121 IATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSA 195 (303)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--CBCCCCSCGGGCCHHHHTTCC
T ss_pred HHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccc--ccCccCCCcCccCHHHHhcCC
Confidence 9999999999999999999 99999999999999999999999999976554321 223356899999999999989
Q ss_pred CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC
Q 048243 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 242 (303)
++.++||||||+++|+|++|..||....... ......... . ..... ..+..+.+++.+||..||
T Consensus 196 ~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~-~-----~~~~~----~~~~~l~~li~~~l~~dp 259 (303)
T 3a7i_A 196 YDSKADIWSLGITAIELARGEPPHSELHPMK------VLFLIPKNN-P-----PTLEG----NYSKPLKEFVEACLNKEP 259 (303)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSC-C-----CCCCS----SCCHHHHHHHHHHCCSSG
T ss_pred CCchhhhHHHHHHHHHHccCCCCCCCcCHHH------HHHHhhcCC-C-----CCCcc----ccCHHHHHHHHHHcCCCh
Confidence 9999999999999999999999986432211 111111111 0 11111 123478899999999999
Q ss_pred CCCCCHHHHHHH
Q 048243 243 NDRPSMLQVSSM 254 (303)
Q Consensus 243 ~~Rpt~~el~~~ 254 (303)
.+|||+.++++.
T Consensus 260 ~~Rps~~~ll~~ 271 (303)
T 3a7i_A 260 SFRPTAKELLKH 271 (303)
T ss_dssp GGSCCHHHHTTC
T ss_pred hhCcCHHHHhhC
Confidence 999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=296.16 Aligned_cols=176 Identities=26% Similarity=0.369 Sum_probs=145.6
Q ss_pred CCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEeC-----CeeEEEEeecCCCChhhhhcCccccc
Q 048243 4 PCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-----EERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~ 76 (303)
.+|+.||||+++.. .....+.+.+|+.+++.++||||+++++++... ...|+||||+. ++|.+++. ...
T Consensus 49 ~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~ 124 (432)
T 3n9x_A 49 NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFK---TPI 124 (432)
T ss_dssp TTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHH---SSC
T ss_pred CCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHh---ccC
Confidence 57899999999754 233456889999999999999999999999876 57899999986 58998884 345
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc----------------
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE---------------- 140 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~---------------- 140 (303)
.+++..++.++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+++........
T Consensus 125 ~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (432)
T 3n9x_A 125 FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201 (432)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC----------------------
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccc
Confidence 6999999999999999999999999 999999999999999999999999999876543211
Q ss_pred ----ccccccccccCCCChhhh-ccCCCCCccchhhHHHHHHHHHhCCCCC
Q 048243 141 ----ANTEQVVGTIGYIPPEYA-RQGVYSTKSDVFSFGVLLLQIISGKRLS 186 (303)
Q Consensus 141 ----~~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~~~~~l~~g~~p~ 186 (303)
.......||+.|+|||++ .+..++.++|||||||++|+|++|..||
T Consensus 202 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp ---------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 122446789999999986 5566999999999999999999865444
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=289.46 Aligned_cols=240 Identities=24% Similarity=0.265 Sum_probs=178.6
Q ss_pred CCCcEEEEEEecCCCcc-----cHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccC
Q 048243 4 PCGKVIAVKKLSKTSTQ-----GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
.+|+.||+|+++..... ....+.+|+.+++.++||||+++++++.+....++||||+++ +|..++.. ....+
T Consensus 33 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~ 109 (346)
T 1ua2_A 33 NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKD--NSLVL 109 (346)
T ss_dssp SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTT--CCSSC
T ss_pred CCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHh--cCcCC
Confidence 46899999999754221 124678999999999999999999999999999999999986 78877743 34468
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
++..++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++....... .......||+.|+|||.+
T Consensus 110 ~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~ 184 (346)
T 1ua2_A 110 TPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELL 184 (346)
T ss_dssp CSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccCCc--ccCCcccccccccCchHh
Confidence 88899999999999999999999 9999999999999999999999999997664332 222335689999999998
Q ss_pred ccC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceecc------c---cCCCCCC-----
Q 048243 159 RQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVD------S---SLDDTNS----- 223 (303)
Q Consensus 159 ~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~---~~~~~~~----- 223 (303)
.+. .++.++|||||||++|+|++|.+||....... ................+.+ . ......+
T Consensus 185 ~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (346)
T 1ua2_A 185 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIF 261 (346)
T ss_dssp TTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHC
T ss_pred hCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhh
Confidence 764 57889999999999999999999886543222 1222222111111000000 0 0000000
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 224 PCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 224 ~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
...+..+.+||.+||..||.+|||+.|+++.
T Consensus 262 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 262 SAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 1223578999999999999999999999874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=276.78 Aligned_cols=229 Identities=22% Similarity=0.315 Sum_probs=177.6
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc-ccccCCHH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-RRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~l~~~ 81 (303)
.+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||||+++++|.+++.... ....+++.
T Consensus 45 ~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 124 (285)
T 3is5_A 45 SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEG 124 (285)
T ss_dssp TTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHH
T ss_pred cCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHH
Confidence 578999999997553 4456789999999999999999999999999999999999999999998885422 24679999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEE---CCCCceEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~---~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
.++.++.|++.||+|||+.| ++||||||+||++ +.++.++|+|||++....... ......|++.|+|||.+
T Consensus 125 ~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~ 198 (285)
T 3is5_A 125 YVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYMAPEVF 198 (285)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc---cCcCcccccCcCChHHh
Confidence 99999999999999999999 9999999999999 456789999999997654332 22335689999999988
Q ss_pred ccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcc
Q 048243 159 RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238 (303)
Q Consensus 159 ~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 238 (303)
. ..++.++||||||+++|+|++|..||....... .............. .. ...+..+.+++.+||
T Consensus 199 ~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~~~-----~~---~~~~~~~~~li~~~L 263 (285)
T 3is5_A 199 K-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE------VQQKATYKEPNYAV-----EC---RPLTPQAVDLLKQML 263 (285)
T ss_dssp T-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCCCCC----------CCCCHHHHHHHHHHT
T ss_pred c-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH------HHhhhccCCccccc-----cc---CcCCHHHHHHHHHHc
Confidence 6 467889999999999999999999996433211 11111111111000 00 012347889999999
Q ss_pred cCCCCCCCCHHHHHH
Q 048243 239 QENPNDRPSMLQVSS 253 (303)
Q Consensus 239 ~~dp~~Rpt~~el~~ 253 (303)
+.||++|||+.|+++
T Consensus 264 ~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 264 TKDPERRPSAAQVLH 278 (285)
T ss_dssp CSCTTTSCCHHHHHT
T ss_pred cCChhhCcCHHHHhc
Confidence 999999999999985
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=281.54 Aligned_cols=226 Identities=26% Similarity=0.319 Sum_probs=184.0
Q ss_pred CCCcEEEEEEecCC---CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++. ....+++
T Consensus 38 ~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~ 114 (294)
T 2rku_A 38 DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK---RRKALTE 114 (294)
T ss_dssp TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHCSCCH
T ss_pred CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHH---hcCCCCH
Confidence 46889999998654 23345678899999999999999999999999999999999999999999884 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||.+........ ......|++.|+|||.+.+
T Consensus 115 ~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~ 189 (294)
T 2rku_A 115 PEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSK 189 (294)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCcc--ccccccCCCCcCCcchhcc
Confidence 999999999999999999999 99999999999999999999999999976543321 2233568999999999998
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++||||||+++|+|++|..||....... .. ........ ..+...+..+.+++.+||+.
T Consensus 190 ~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~-~~~~~~~~----------~~~~~~~~~~~~li~~~l~~ 252 (294)
T 2rku_A 190 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TY-LRIKKNEY----------SIPKHINPVAASLIQKMLQT 252 (294)
T ss_dssp SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH-HHHHTTCC----------CCCTTSCHHHHHHHHHHTCS
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHhhccC----------CCccccCHHHHHHHHHHccc
Confidence 889999999999999999999999986433211 11 11111110 01112234788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 048243 241 NPNDRPSMLQVSSM 254 (303)
Q Consensus 241 dp~~Rpt~~el~~~ 254 (303)
||++|||+.|+++.
T Consensus 253 ~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 253 DPTARPTINELLND 266 (294)
T ss_dssp SGGGSCCGGGGGGS
T ss_pred ChhhCcCHHHHhhC
Confidence 99999999999863
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=293.52 Aligned_cols=241 Identities=23% Similarity=0.283 Sum_probs=182.6
Q ss_pred CCCcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.||+|++... .....+.+.+|+.+++.++||||+++++++......++||||+++++|.+++. ....+++..
T Consensus 56 ~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~ 132 (360)
T 3eqc_A 56 PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQI 132 (360)
T ss_dssp TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHH---HHSSCCHHH
T ss_pred CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHH---HcCCCCHHH
Confidence 47899999999765 33445678999999999999999999999999999999999999999999984 345689999
Q ss_pred HHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 83 RVHIIEGITQGLLYLQEY-SRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~-~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
+..++.|++.||+|||+. | ++||||||+||+++.++.++|+|||++...... ......|++.|+|||.+.+.
T Consensus 133 ~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~ 205 (360)
T 3eqc_A 133 LGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGT 205 (360)
T ss_dssp HHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----C----CCCCTTCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc----cccCCCCCCCeECHHHHcCC
Confidence 999999999999999985 8 999999999999999999999999998654322 12335789999999999999
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHH-----------------------HHhCCCcce----ec
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE-----------------------LWKGGKGVE----FV 214 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~----~~ 214 (303)
.++.++||||||+++|+|++|..||................. ........+ ..
T Consensus 206 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (360)
T 3eqc_A 206 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIV 285 (360)
T ss_dssp CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHH
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHh
Confidence 999999999999999999999999965332111000000000 000000000 00
Q ss_pred cccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 215 DSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 215 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
............+..+.+||.+||+.||.+|||+.|+++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 286 NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp HSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000011111234578899999999999999999999863
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=298.69 Aligned_cols=236 Identities=24% Similarity=0.259 Sum_probs=174.6
Q ss_pred CCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEeC------CeeEEEEeecCCCChhhhhcCcccc
Q 048243 4 PCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------EERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~ 75 (303)
.+|+.||||++... .....+.+.+|+.+++.++||||+++++++... ...|+||||++++ |.+.+.
T Consensus 85 ~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~-l~~~~~----- 158 (464)
T 3ttj_A 85 VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQ----- 158 (464)
T ss_dssp TTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-HHHHHT-----
T ss_pred CCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCC-HHHHHh-----
Confidence 57899999999754 334456788999999999999999999999754 3579999999765 555552
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCCh
Q 048243 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aP 155 (303)
..+++..++.++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+++...... ......||+.|+||
T Consensus 159 ~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aP 232 (464)
T 3ttj_A 159 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAP 232 (464)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-----CC---CC----CCCTTCCH
T ss_pred hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc---ccCCCcccccccCH
Confidence 23889999999999999999999999 9999999999999999999999999997654331 22345789999999
Q ss_pred hhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCc-------------------------
Q 048243 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG------------------------- 210 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------------------- 210 (303)
|++.+..++.++|||||||++|+|++|..||........ .............
T Consensus 233 E~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~---~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (464)
T 3ttj_A 233 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ---WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTF 309 (464)
T ss_dssp HHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCH
T ss_pred HHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCCh
Confidence 999999999999999999999999999999965432221 1111111110000
Q ss_pred ceeccccC-CCC--CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 211 VEFVDSSL-DDT--NSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 211 ~~~~~~~~-~~~--~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
........ ... .....+..+.+||.+||+.||.+|||+.|+++.
T Consensus 310 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 310 PKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 000 011225678999999999999999999999874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=293.58 Aligned_cols=221 Identities=21% Similarity=0.230 Sum_probs=170.0
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHH-HhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVML-TAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+|+.||+|+++... ......+..|..+ ++.++||||+++++++.+....|+||||+++|+|.+++. ....++
T Consensus 61 ~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~---~~~~~~ 137 (373)
T 2r5t_A 61 AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ---RERCFL 137 (373)
T ss_dssp TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH---HHSSCC
T ss_pred CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHH---hcCCCC
Confidence 468999999997553 2233456667766 466799999999999999999999999999999999884 345689
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..++.++.||+.||+|||++| |+||||||+||+++.+|.++|+|||+++...... .......||+.|+|||++.
T Consensus 138 ~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~ 212 (373)
T 2r5t_A 138 EPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--STTSTFCGTPEYLAPEVLH 212 (373)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccCC--CccccccCCccccCHHHhC
Confidence 9999999999999999999999 9999999999999999999999999987533221 2233467899999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++|+|||||++|+|++|..||....... .......... .+ ++..+..+.+||.+||+
T Consensus 213 ~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~~~~-------~~----~~~~~~~~~~li~~lL~ 275 (373)
T 2r5t_A 213 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYDNILNKPL-------QL----KPNITNSARHLLEGLLQ 275 (373)
T ss_dssp TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH------HHHHHHHSCC-------CC----CSSSCHHHHHHHHHHTC
T ss_pred CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHhccc-------CC----CCCCCHHHHHHHHHHcc
Confidence 9999999999999999999999999996432211 1111111110 01 11223478899999999
Q ss_pred CCCCCCCCHH
Q 048243 240 ENPNDRPSML 249 (303)
Q Consensus 240 ~dp~~Rpt~~ 249 (303)
.||.+||++.
T Consensus 276 ~dp~~R~~~~ 285 (373)
T 2r5t_A 276 KDRTKRLGAK 285 (373)
T ss_dssp SSGGGSTTTT
T ss_pred cCHHhCCCCC
Confidence 9999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=301.45 Aligned_cols=228 Identities=28% Similarity=0.337 Sum_probs=180.3
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+....++|||||.+|+|.+++. ....+++.
T Consensus 60 ~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~---~~~~~~~~ 136 (494)
T 3lij_A 60 VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII---HRMKFNEV 136 (494)
T ss_dssp TTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH---HHSSCCHH
T ss_pred CCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHH---HcCCCCHH
Confidence 478999999997553 3345778999999999999999999999999999999999999999988884 44568999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCC---CceEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED---MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~---~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
.++.++.||+.||+|||+.| |+||||||+||+++.. +.++|+|||++....... ......||+.|+|||++
T Consensus 137 ~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l 210 (494)
T 3lij_A 137 DAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVL 210 (494)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB---CBCCCCSCTTTCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc---cccccCCCcCeeCHHHH
Confidence 99999999999999999999 9999999999999764 459999999997765432 22335789999999998
Q ss_pred ccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcc
Q 048243 159 RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238 (303)
Q Consensus 159 ~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 238 (303)
. ..++.++|||||||++|+|++|..||........ .. ......... ..+.+ ...+..+.+||.+||
T Consensus 211 ~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~---~i~~~~~~~--~~~~~-----~~~s~~~~~li~~~L 276 (494)
T 3lij_A 211 R-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI---LR---KVEKGKYTF--DSPEW-----KNVSEGAKDLIKQML 276 (494)
T ss_dssp T-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH---HHHHTCCCC--CSGGG-----TTSCHHHHHHHHHHT
T ss_pred c-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH---HHHhCCCCC--Cchhc-----ccCCHHHHHHHHHHC
Confidence 6 4689999999999999999999999965432211 11 111111100 00000 122347889999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 048243 239 QENPNDRPSMLQVSSM 254 (303)
Q Consensus 239 ~~dp~~Rpt~~el~~~ 254 (303)
+.||.+|||+.|+++.
T Consensus 277 ~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 277 QFDSQRRISAQQALEH 292 (494)
T ss_dssp CSSTTTSCCHHHHHTC
T ss_pred CCChhhCccHHHHhcC
Confidence 9999999999999863
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=302.01 Aligned_cols=228 Identities=27% Similarity=0.346 Sum_probs=180.9
Q ss_pred CCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+|+.||||++... .......+.+|+.++++++||||+++++++.+....++|||||.+++|.+++. ....+++.
T Consensus 45 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~ 121 (486)
T 3mwu_A 45 ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII---KRKRFSEH 121 (486)
T ss_dssp TTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---HHSSCCHH
T ss_pred CCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHH---hcCCCCHH
Confidence 47899999998643 23456788999999999999999999999999999999999999999998884 34569999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEEC---CCCceEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG---EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~---~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
.++.++.||+.||+|||+.| |+||||||+||+++ .++.++|+|||++....... ......||+.|+|||++
T Consensus 122 ~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~ 195 (486)
T 3mwu_A 122 DAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVL 195 (486)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGG
T ss_pred HHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC---ccCCCcCCCCCCCHHHh
Confidence 99999999999999999999 99999999999995 45679999999997654332 22335789999999998
Q ss_pred ccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcc
Q 048243 159 RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238 (303)
Q Consensus 159 ~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 238 (303)
.+ .++.++|||||||++|+|++|..||....... ... .......... .......+..+.+||.+||
T Consensus 196 ~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~---~i~~~~~~~~-------~~~~~~~s~~~~~li~~~L 261 (486)
T 3mwu_A 196 RG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---ILK---RVETGKYAFD-------LPQWRTISDDAKDLIRKML 261 (486)
T ss_dssp GS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHHTCCCSC-------SGGGGGSCHHHHHHHHHHT
T ss_pred CC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---HHHhCCCCCC-------CcccCCCCHHHHHHHHHHc
Confidence 76 48999999999999999999999996433211 111 1111111100 0011123457889999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 048243 239 QENPNDRPSMLQVSSM 254 (303)
Q Consensus 239 ~~dp~~Rpt~~el~~~ 254 (303)
+.||.+|||+.++++.
T Consensus 262 ~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 262 TFHPSLRITATQCLEH 277 (486)
T ss_dssp CSSTTTSCCHHHHHHC
T ss_pred CCChhhCcCHHHHhcC
Confidence 9999999999999874
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=280.93 Aligned_cols=228 Identities=21% Similarity=0.282 Sum_probs=180.2
Q ss_pred CCCcEEEEEEecCCCc------ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcccccc
Q 048243 4 PCGKVIAVKKLSKTST------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~~~~valK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
.+|+.||+|+++.... ...+.+.+|+.++++++||||+++++++.+....++||||+++++|.+++. ....
T Consensus 28 ~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~ 104 (283)
T 3bhy_A 28 GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA---EKES 104 (283)
T ss_dssp TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH---HHSS
T ss_pred CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHH---hcCC
Confidence 4789999999875421 246789999999999999999999999999999999999999999999984 3456
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCC----ceEEcccccccccccCCccccccccccccCCC
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM----KPKISDFGLARIFAKESLEANTEQVVGTIGYI 153 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~----~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~ 153 (303)
+++..++.++.|++.||+|||+.| ++||||||+||+++.++ .++|+|||.+....... ......|++.|+
T Consensus 105 ~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~ 178 (283)
T 3bhy_A 105 LTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFV 178 (283)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-----------CCCGGGC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC---cccccCCCcCcc
Confidence 899999999999999999999999 99999999999998877 79999999987654332 122346899999
Q ss_pred ChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHH
Q 048243 154 PPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEI 233 (303)
Q Consensus 154 aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 233 (303)
|||.+.+..++.++||||||+++|+|++|..||....... . .......... .........+..+.++
T Consensus 179 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~-~~~~~~~~~~------~~~~~~~~~~~~~~~l 245 (283)
T 3bhy_A 179 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE------T-LTNISAVNYD------FDEEYFSNTSELAKDF 245 (283)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------H-HHHHHTTCCC------CCHHHHTTCCHHHHHH
T ss_pred CcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH------H-HHHhHhcccC------CcchhcccCCHHHHHH
Confidence 9999998899999999999999999999999986433211 1 1111111000 0000001123468899
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 048243 234 ALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 234 i~~~l~~dp~~Rpt~~el~~ 253 (303)
+.+||..||.+|||+.|+++
T Consensus 246 i~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 246 IRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHccCCHhHCcCHHHHHh
Confidence 99999999999999999987
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=280.51 Aligned_cols=231 Identities=22% Similarity=0.329 Sum_probs=183.0
Q ss_pred CCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeC--CeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 5 CGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 5 ~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
+|+.||+|+++... ....+.+.+|+.++++++||||+++++++.+. ...++||||+++++|.+++... ....+++
T Consensus 32 ~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~ 110 (271)
T 3kmu_A 32 QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQ 110 (271)
T ss_dssp TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSC-SSCCCCH
T ss_pred CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhc-ccCCCCH
Confidence 48899999997653 33456789999999999999999999999887 7789999999999999999642 2335899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.|++.||+|||+.+ ..++||||||+||+++.++.++++|||.+..... ....|++.|+|||.+.+
T Consensus 111 ~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~ 182 (271)
T 3kmu_A 111 SQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPEALQK 182 (271)
T ss_dssp HHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHS
T ss_pred HHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-------cCccCCccccChhhhcc
Confidence 999999999999999999863 3499999999999999999999999887644222 22467999999999987
Q ss_pred CCCCC---ccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHc
Q 048243 161 GVYST---KSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237 (303)
Q Consensus 161 ~~~~~---~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 237 (303)
..++. ++||||||+++|+|++|..||....... ............ ..+...+..+.+++.+|
T Consensus 183 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~ 247 (271)
T 3kmu_A 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME------IGMKVALEGLRP---------TIPPGISPHVSKLMKIC 247 (271)
T ss_dssp CGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH------HHHHHHHSCCCC---------CCCTTCCHHHHHHHHHH
T ss_pred CCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH------HHHHHHhcCCCC---------CCCCCCCHHHHHHHHHH
Confidence 65444 7999999999999999999986433211 111222221111 11122344788999999
Q ss_pred ccCCCCCCCCHHHHHHHhcccc
Q 048243 238 VQENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 238 l~~dp~~Rpt~~el~~~L~~~~ 259 (303)
|+.||.+|||+.++++.|++..
T Consensus 248 l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 248 MNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHC
T ss_pred cCCChhhCcCHHHHHHHHHHhh
Confidence 9999999999999999998764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=312.92 Aligned_cols=233 Identities=27% Similarity=0.375 Sum_probs=184.0
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+++.||||+++... ....+.+.+|+.++++++||||+++++++.. ...++||||+.+|+|.+++. ....+++.
T Consensus 394 ~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~---~~~~l~~~ 469 (635)
T 4fl3_A 394 KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQ---QNRHVKDK 469 (635)
T ss_dssp SCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHH---HCTTCCHH
T ss_pred CcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHh---hCCCCCHH
Confidence 457889999997543 3446789999999999999999999999964 56889999999999999994 34568999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCc-cccccccccccCCCChhhhcc
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL-EANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~ 160 (303)
.++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..... ........++..|+|||++.+
T Consensus 470 ~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~ 546 (635)
T 4fl3_A 470 NIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 546 (635)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcC
Confidence 99999999999999999999 99999999999999999999999999987654322 122223456788999999999
Q ss_pred CCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 161 GVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
..++.++|||||||++|+|++ |..||....... ............ .+...+..+.+||.+||+
T Consensus 547 ~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~~---------~p~~~~~~l~~li~~cl~ 610 (635)
T 4fl3_A 547 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMG---------CPAGCPREMYDLMNLCWT 610 (635)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTC
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCC---------CCCCCCHHHHHHHHHHcC
Confidence 999999999999999999998 999986443221 111122111111 112234578899999999
Q ss_pred CCCCCCCCHHHHHHHhcccc
Q 048243 240 ENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 240 ~dp~~Rpt~~el~~~L~~~~ 259 (303)
.||++|||+.+|++.|++..
T Consensus 611 ~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 611 YDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp SSTTTSCCHHHHHHHHHHHH
T ss_pred CCHhHCcCHHHHHHHHHHHH
Confidence 99999999999999998764
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=291.93 Aligned_cols=244 Identities=21% Similarity=0.207 Sum_probs=173.4
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCccccEEEEEEe--------CCeeEEEEeecCCCChhhhhcCccc
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCID--------SEERMLVYEYMPNKSLDCYLFDPIR 74 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~ 74 (303)
.+|+.||+|++........+.+.+|+.++.++. ||||+++++++.. ....++||||+. |+|.+++.....
T Consensus 51 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~ 129 (337)
T 3ll6_A 51 GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMES 129 (337)
T ss_dssp TTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHT
T ss_pred CCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhc
Confidence 478999999997666666678899999999995 9999999999953 345799999996 688888865344
Q ss_pred cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccc----------ccc
Q 048243 75 RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEA----------NTE 144 (303)
Q Consensus 75 ~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~----------~~~ 144 (303)
...+++..++.++.||+.||+|||+.+ .+++||||||+||+++.++.++|+|||++.......... ...
T Consensus 130 ~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (337)
T 3ll6_A 130 RGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208 (337)
T ss_dssp TCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC----------------
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhc
Confidence 567999999999999999999999864 349999999999999999999999999998765432211 111
Q ss_pred ccccccCCCChhhh---ccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCC
Q 048243 145 QVVGTIGYIPPEYA---RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDT 221 (303)
Q Consensus 145 ~~~g~~~y~aPE~~---~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (303)
...|++.|+|||++ .+..++.++||||||+++|+|++|..||........ ... .....
T Consensus 209 ~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~----------~~~---------~~~~~ 269 (337)
T 3ll6_A 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI----------VNG---------KYSIP 269 (337)
T ss_dssp ---------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------------------------------CCCC
T ss_pred cccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh----------hcC---------cccCC
Confidence 34589999999998 556688899999999999999999999854322110 000 00000
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccccCCCCCCCCC
Q 048243 222 NSPCKLMRCLEIALLCVQENPNDRPSMLQVSSMLKNETTNRNTPKKP 268 (303)
Q Consensus 222 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~~~~~~~~~~ 268 (303)
.....+..+.+|+.+||+.||.+|||+.|+++.|+............
T Consensus 270 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~ 316 (337)
T 3ll6_A 270 PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKS 316 (337)
T ss_dssp TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCc
Confidence 11111235779999999999999999999999998887655444433
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=281.68 Aligned_cols=227 Identities=22% Similarity=0.328 Sum_probs=184.1
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+|+.||+|.+.... ..+.+.+|+.+++.++||||+++++++......++||||+++++|.+++.. ....+++..+
T Consensus 52 ~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~ 127 (314)
T 3com_A 52 ETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL--RNKTLTEDEI 127 (314)
T ss_dssp TTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH--HTCCCCHHHH
T ss_pred CCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHh--cCCCCCHHHH
Confidence 468999999997643 346788999999999999999999999999999999999999999999842 3456899999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
+.++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||.+....... .......|+..|+|||.+.+..+
T Consensus 128 ~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~ 202 (314)
T 3com_A 128 ATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGY 202 (314)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--SCBCCCCSCGGGCCHHHHSSSCB
T ss_pred HHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--cccCccCCCCCccChhhcCCCCC
Confidence 999999999999999999 9999999999999999999999999997654332 12233568999999999999889
Q ss_pred CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCC
Q 048243 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 243 (303)
+.++||||||+++|+|++|..||....... .......... . ....+...+..+.+++.+||..||.
T Consensus 203 ~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~-~-------~~~~~~~~~~~l~~li~~~l~~dp~ 268 (314)
T 3com_A 203 NCVADIWSLGITAIEMAEGKPPYADIHPMR------AIFMIPTNPP-P-------TFRKPELWSDNFTDFVKQCLVKSPE 268 (314)
T ss_dssp CTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSCC-C-------CCSSGGGSCHHHHHHHHHHTCSCTT
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCC-c-------ccCCcccCCHHHHHHHHHHccCChh
Confidence 999999999999999999999986432111 1111111110 0 0011122345788999999999999
Q ss_pred CCCCHHHHHH
Q 048243 244 DRPSMLQVSS 253 (303)
Q Consensus 244 ~Rpt~~el~~ 253 (303)
+|||+.++++
T Consensus 269 ~Rpt~~~ll~ 278 (314)
T 3com_A 269 QRATATQLLQ 278 (314)
T ss_dssp TSCCHHHHTT
T ss_pred hCcCHHHHHh
Confidence 9999999976
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=282.64 Aligned_cols=240 Identities=26% Similarity=0.318 Sum_probs=178.8
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcC--CCCccccEEEEEEeC----CeeEEEEeecCCCChhhhhcCccccccC
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKL--QHVNLIRVLGFCIDS----EERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
.|+.||||++.... ......|.+++..+ +||||+++++++... ...++||||+++|+|.+++. ...+
T Consensus 59 ~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~----~~~~ 131 (337)
T 3mdy_A 59 RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK----STTL 131 (337)
T ss_dssp TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHH----HCCB
T ss_pred CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhh----ccCC
Confidence 48899999996442 24455566666655 899999999999987 78899999999999999983 3468
Q ss_pred CHHHHHHHHHHHHHHHHHHHhC--------CCCCeEecCCCCCceEECCCCceEEcccccccccccCCccc--ccccccc
Q 048243 79 DWKKRVHIIEGITQGLLYLQEY--------SRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEA--NTEQVVG 148 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~--------~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~--~~~~~~g 148 (303)
++..++.++.|++.||+|||+. + ++||||||+||+++.++.++|+|||++.......... ......|
T Consensus 132 ~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g 208 (337)
T 3mdy_A 132 DAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208 (337)
T ss_dssp CHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCS
T ss_pred CHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCcc
Confidence 9999999999999999999988 7 9999999999999999999999999997664432221 1224578
Q ss_pred ccCCCChhhhccCCCCCc------cchhhHHHHHHHHHhC----------CCCCccCCCCccccHHHHHHHHHhCCCcce
Q 048243 149 TIGYIPPEYARQGVYSTK------SDVFSFGVLLLQIISG----------KRLSMLCGINENLSILEHAYELWKGGKGVE 212 (303)
Q Consensus 149 ~~~y~aPE~~~~~~~~~~------~DiwslG~~~~~l~~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (303)
|+.|+|||.+.+...+.. +|||||||++|+|++| ..||......... .............
T Consensus 209 t~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~-- 284 (337)
T 3mdy_A 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS--YEDMREIVCIKKL-- 284 (337)
T ss_dssp CGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC--HHHHHHHHTTSCC--
T ss_pred CcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCc--hhhhHHHHhhhcc--
Confidence 999999999988776655 9999999999999999 5555433222211 1111111111110
Q ss_pred eccccCCC-CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccccC
Q 048243 213 FVDSSLDD-TNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 213 ~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~~ 260 (303)
.+.... ......+..+.+++.+||+.||.+|||+.|+++.|++...
T Consensus 285 --~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 285 --RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp --CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 011110 0112556789999999999999999999999999987654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=286.52 Aligned_cols=239 Identities=23% Similarity=0.255 Sum_probs=179.8
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-----CCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccC
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-----HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
.+|+.||||+++.. ......+..|+.+++.++ ||||+++++++......++|||++ +++|.+++... ....+
T Consensus 58 ~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~ 134 (360)
T 3llt_A 58 DNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGF 134 (360)
T ss_dssp TTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCC
T ss_pred CCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCC
Confidence 57899999999643 334456788999999986 999999999999999999999999 89999998542 23458
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC-------------------------CCceEEcccccccc
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-------------------------DMKPKISDFGLARI 133 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-------------------------~~~v~l~Df~~~~~ 133 (303)
++..++.++.||+.||+|||+.| |+||||||+|||++. ++.++|+|||++..
T Consensus 135 ~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~ 211 (360)
T 3llt_A 135 HIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF 211 (360)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEE
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCcee
Confidence 99999999999999999999999 999999999999975 78899999999976
Q ss_pred cccCCccccccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHH--------HHH
Q 048243 134 FAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAY--------ELW 205 (303)
Q Consensus 134 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~ 205 (303)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.... ...
T Consensus 212 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 286 (360)
T 3llt_A 212 KSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEA 286 (360)
T ss_dssp TTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHH
T ss_pred cCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhh
Confidence 4332 233568999999999999999999999999999999999999996543222111111100 000
Q ss_pred hCCCcceecc-----ccCCCCCC-H---------------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 206 KGGKGVEFVD-----SSLDDTNS-P---------------CKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 206 ~~~~~~~~~~-----~~~~~~~~-~---------------~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
.......... ........ . .....+.+||.+||+.||.+|||+.|+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 287 TKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp TTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 00000000 0 01146779999999999999999999975
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=289.02 Aligned_cols=245 Identities=15% Similarity=0.175 Sum_probs=186.5
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCcccc---------------EEEEEEe-CCeeEEEEeecCCCChhhh
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIR---------------VLGFCID-SEERMLVYEYMPNKSLDCY 68 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~---------------~~~~~~~-~~~~~lv~e~~~~~~L~~~ 68 (303)
+++.||+|.+... +.+.+|+.++++++||||++ +++++.. +...++||||+ +++|.++
T Consensus 74 ~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~ 147 (352)
T 2jii_A 74 QKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSA 147 (352)
T ss_dssp ---CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHH
T ss_pred cCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHH
Confidence 5899999999754 35788999999999999887 6777776 67889999999 9999999
Q ss_pred hcCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCC--ceEEcccccccccccCCcc-----c
Q 048243 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM--KPKISDFGLARIFAKESLE-----A 141 (303)
Q Consensus 69 l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~--~v~l~Df~~~~~~~~~~~~-----~ 141 (303)
+... ....+++..++.++.||+.||+|||+.| ++||||||+||+++.++ .++|+|||++..+...... .
T Consensus 148 l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 223 (352)
T 2jii_A 148 LDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEG 223 (352)
T ss_dssp HHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTT
T ss_pred HHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCcccccccc
Confidence 9542 2467999999999999999999999999 99999999999999998 8999999999776543221 1
Q ss_pred cccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCC
Q 048243 142 NTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDT 221 (303)
Q Consensus 142 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (303)
......|++.|+|||.+.+..++.++||||||+++|+|++|..||........ ........+... ...+.......
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~- 299 (352)
T 2jii_A 224 SRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTE--DIMKQKQKFVDK-PGPFVGPCGHW- 299 (352)
T ss_dssp SSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH--HHHHHHHHHHHS-CCCEECTTSCE-
T ss_pred ccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHH--HHHHHHHhccCC-hhhhhhhcccc-
Confidence 12334789999999999998999999999999999999999999975542221 111111111111 11111111100
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccccCCCCCC
Q 048243 222 NSPCKLMRCLEIALLCVQENPNDRPSMLQVSSMLKNETTNRNTP 265 (303)
Q Consensus 222 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~~~~~~~ 265 (303)
...+..+.+++.+||..||.+|||+.++++.|++........
T Consensus 300 --~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 300 --IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp --ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred --CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 011347889999999999999999999999998877655443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=286.26 Aligned_cols=223 Identities=21% Similarity=0.217 Sum_probs=171.6
Q ss_pred CCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTST--QGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||||++..... ........|+..+..+ +||||+++++++.+....++||||+ +++|.+++.. .+..+++
T Consensus 80 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~l~~ 156 (311)
T 3p1a_A 80 EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEA--WGASLPE 156 (311)
T ss_dssp TTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--HCSCCCH
T ss_pred CCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHh--cCCCCCH
Confidence 4799999999865432 2333455566666665 8999999999999999999999999 6788888753 2456999
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++....... ......||+.|+|||++.+
T Consensus 157 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~ 230 (311)
T 3p1a_A 157 AQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG---AGEVQEGDPRYMAPELLQG 230 (311)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccCC---CCcccCCCccccCHhHhcC
Confidence 999999999999999999999 9999999999999999999999999987654332 2233468999999999876
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
.++.++|||||||++|+|++|..|+.... .............. ....+..+.+++.+||+.
T Consensus 231 -~~~~~~DiwslG~il~el~~g~~~~~~~~----------~~~~~~~~~~~~~~--------~~~~~~~l~~li~~~L~~ 291 (311)
T 3p1a_A 231 -SYGTAADVFSLGLTILEVACNMELPHGGE----------GWQQLRQGYLPPEF--------TAGLSSELRSVLVMMLEP 291 (311)
T ss_dssp -CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------HHHHHTTTCCCHHH--------HTTSCHHHHHHHHHHSCS
T ss_pred -CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------HHHHHhccCCCccc--------ccCCCHHHHHHHHHHcCC
Confidence 68999999999999999999976653211 11111111110000 011235788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 048243 241 NPNDRPSMLQVSSM 254 (303)
Q Consensus 241 dp~~Rpt~~el~~~ 254 (303)
||++|||+.|+++.
T Consensus 292 dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 292 DPKLRATAEALLAL 305 (311)
T ss_dssp STTTSCCHHHHHTS
T ss_pred ChhhCcCHHHHHhC
Confidence 99999999999863
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=288.75 Aligned_cols=231 Identities=21% Similarity=0.289 Sum_probs=182.6
Q ss_pred CCCcEEEEEEecCCC----cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccC
Q 048243 4 PCGKVIAVKKLSKTS----TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 4 ~~~~~valK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
.+|+.||||+++... ....+.+.+|+.+++.+ +||||+++++++......++||||+++++|.+++. ....+
T Consensus 80 ~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~ 156 (355)
T 1vzo_A 80 DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS---QRERF 156 (355)
T ss_dssp TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHH---HHSCC
T ss_pred CCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHH---HcCCC
Confidence 589999999986532 23345677899999999 79999999999999999999999999999999984 34568
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
++..++.++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++..+..... .......||+.|+|||++
T Consensus 157 ~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~ 232 (355)
T 1vzo_A 157 TEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIV 232 (355)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecccCCC-CcccCcccCcCccChhhh
Confidence 99999999999999999999999 99999999999999999999999999976543322 222335789999999999
Q ss_pred ccC--CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 159 RQG--VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 159 ~~~--~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
.+. .++.++|||||||++|+|++|..||...........+.. ...... ...+...+..+.+||.+
T Consensus 233 ~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~--~~~~~~-----------~~~~~~~~~~~~~li~~ 299 (355)
T 1vzo_A 233 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--RILKSE-----------PPYPQEMSALAKDLIQR 299 (355)
T ss_dssp TTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH--HHHHCC-----------CCCCTTSCHHHHHHHHH
T ss_pred cCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH--HHhccC-----------CCCCcccCHHHHHHHHH
Confidence 863 478899999999999999999999975543332221111 111111 01112233478899999
Q ss_pred cccCCCCCCC-----CHHHHHHH
Q 048243 237 CVQENPNDRP-----SMLQVSSM 254 (303)
Q Consensus 237 ~l~~dp~~Rp-----t~~el~~~ 254 (303)
||..||.+|| |+.|+++.
T Consensus 300 ~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 300 LLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp HTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HhhhCHHHhcCCCCCCHHHHHcC
Confidence 9999999999 99999875
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=287.74 Aligned_cols=245 Identities=19% Similarity=0.253 Sum_probs=179.3
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEe--------CCeeEEEEeecCCCChhhhhcCcc
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCID--------SEERMLVYEYMPNKSLDCYLFDPI 73 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~ 73 (303)
.+|+.||+|++.... ......+.+|+.+++.++||||+++++++.. .+..++||||+++ +|...+..
T Consensus 40 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~-- 116 (351)
T 3mi9_A 40 KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN-- 116 (351)
T ss_dssp TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHC--
T ss_pred CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhh--
Confidence 578999999986543 2234577899999999999999999999987 3468999999975 66666643
Q ss_pred ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCc--cccccccccccC
Q 048243 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL--EANTEQVVGTIG 151 (303)
Q Consensus 74 ~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~--~~~~~~~~g~~~ 151 (303)
....+++..++.++.||+.||+|||+.| |+||||||+||+++.++.++|+|||++........ ........||+.
T Consensus 117 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~ 193 (351)
T 3mi9_A 117 VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 193 (351)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGG
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccC
Confidence 3346899999999999999999999999 99999999999999999999999999987653221 122234568999
Q ss_pred CCChhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceecc--------ccCCCCC
Q 048243 152 YIPPEYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVD--------SSLDDTN 222 (303)
Q Consensus 152 y~aPE~~~~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~ 222 (303)
|+|||++.+ ..++.++|||||||++|+|++|..||...........+................. .......
T Consensus 194 y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (351)
T 3mi9_A 194 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKR 273 (351)
T ss_dssp GCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCC
T ss_pred ccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhccccccccccc
Confidence 999999876 4579999999999999999999999875432222211111111000000000000 0000000
Q ss_pred C-HH------HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 223 S-PC------KLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 223 ~-~~------~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
. .. .+..+.+||.+||+.||.+|||+.|+++.
T Consensus 274 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 274 KVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0 00 13458899999999999999999999874
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=282.72 Aligned_cols=228 Identities=29% Similarity=0.399 Sum_probs=177.0
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeC-CeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-EERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
+|+.||+|+++... ..+.+.+|+.++++++||||+++++++... ...++||||+++++|.+++... ....+++..+
T Consensus 43 ~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~ 119 (278)
T 1byg_A 43 RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCL 119 (278)
T ss_dssp TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHH-HHHHCCHHHH
T ss_pred cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhc-ccccCCHHHH
Confidence 58899999997543 457789999999999999999999997654 4789999999999999998531 2234889999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
+.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++....... ....++..|+|||.+.+..+
T Consensus 120 ~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~ 191 (278)
T 1byg_A 120 LKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKF 191 (278)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-----cCCCccccccCHHHhCCCCC
Confidence 999999999999999999 9999999999999999999999999987543321 22356889999999998889
Q ss_pred CCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC
Q 048243 164 STKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 242 (303)
+.++||||||+++|+|++ |..||........ . ........ ...+...+..+.+++.+||+.||
T Consensus 192 ~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~----~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p 255 (278)
T 1byg_A 192 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V----PRVEKGYK---------MDAPDGCPPAVYEVMKNCWHLDA 255 (278)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---H----HHHTTTCC---------CCCCTTCCHHHHHHHHHHTCSSG
T ss_pred CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---H----HHHhcCCC---------CCCcccCCHHHHHHHHHHhcCCh
Confidence 999999999999999998 9999865432221 1 11111111 11112234578899999999999
Q ss_pred CCCCCHHHHHHHhcccc
Q 048243 243 NDRPSMLQVSSMLKNET 259 (303)
Q Consensus 243 ~~Rpt~~el~~~L~~~~ 259 (303)
.+|||+.|+++.|++..
T Consensus 256 ~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 256 AMRPSFLQLREQLEHIK 272 (278)
T ss_dssp GGSCCHHHHHHHHHHHH
T ss_pred hhCCCHHHHHHHHHHHH
Confidence 99999999999998764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=293.92 Aligned_cols=244 Identities=21% Similarity=0.281 Sum_probs=172.4
Q ss_pred CCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEeC-----CeeEEEEeecCCCChhhhhcCccccc
Q 048243 4 PCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-----EERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~ 76 (303)
.+|+.||||++... .....+.+.+|+.+|+.++||||+++++++... ...|+|||++. ++|..++. ...
T Consensus 76 ~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~ 151 (458)
T 3rp9_A 76 LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFR---TPV 151 (458)
T ss_dssp C--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EEHHHHHH---SSC
T ss_pred CCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccc-cchhhhcc---cCC
Confidence 57899999999654 233456788999999999999999999998543 56899999984 68888884 345
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc----------------
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE---------------- 140 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~---------------- 140 (303)
.+++..++.++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+++........
T Consensus 152 ~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (458)
T 3rp9_A 152 YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228 (458)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC-----------
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccc
Confidence 6999999999999999999999999 999999999999999999999999999876432111
Q ss_pred ---------ccccccccccCCCChhhh-ccCCCCCccchhhHHHHHHHHHh-----------CCCCCccCCCCc------
Q 048243 141 ---------ANTEQVVGTIGYIPPEYA-RQGVYSTKSDVFSFGVLLLQIIS-----------GKRLSMLCGINE------ 193 (303)
Q Consensus 141 ---------~~~~~~~g~~~y~aPE~~-~~~~~~~~~DiwslG~~~~~l~~-----------g~~p~~~~~~~~------ 193 (303)
.......||+.|+|||++ .+..++.++|||||||++|+|++ |.++|.......
T Consensus 229 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~ 308 (458)
T 3rp9_A 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQK 308 (458)
T ss_dssp ----------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC------------
T ss_pred cccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCcccccccccc
Confidence 122345789999999976 55679999999999999999998 555554322100
Q ss_pred -----------cccHHHHHHHHHhCCCcce-----------eccc---cC---CCCCCHHHHHHHHHHHHHcccCCCCCC
Q 048243 194 -----------NLSILEHAYELWKGGKGVE-----------FVDS---SL---DDTNSPCKLMRCLEIALLCVQENPNDR 245 (303)
Q Consensus 194 -----------~~~~~~~~~~~~~~~~~~~-----------~~~~---~~---~~~~~~~~~~~l~~li~~~l~~dp~~R 245 (303)
....+.............. .... .. .....+..+..+.+||.+||..||.+|
T Consensus 309 ~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R 388 (458)
T 3rp9_A 309 AGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKR 388 (458)
T ss_dssp --------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTS
T ss_pred ccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCcccc
Confidence 0011111111111100000 0000 00 000011224578899999999999999
Q ss_pred CCHHHHHHH
Q 048243 246 PSMLQVSSM 254 (303)
Q Consensus 246 pt~~el~~~ 254 (303)
||+.|+++.
T Consensus 389 ~t~~e~L~H 397 (458)
T 3rp9_A 389 ITINECLAH 397 (458)
T ss_dssp CCHHHHHHS
T ss_pred CCHHHHhcC
Confidence 999999984
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=280.06 Aligned_cols=229 Identities=21% Similarity=0.319 Sum_probs=177.9
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+|+.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||+++++|.+++.. ....+++..+
T Consensus 42 ~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~ 119 (302)
T 2j7t_A 42 ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLE--LDRGLTEPQI 119 (302)
T ss_dssp TTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHH--HTSCCCHHHH
T ss_pred CCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHh--hccCCCHHHH
Confidence 46899999999877667778899999999999999999999999999999999999999999988743 2456899999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc----
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR---- 159 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---- 159 (303)
+.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++....... .......|+..|+|||.+.
T Consensus 120 ~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~ 194 (302)
T 2j7t_A 120 QVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETM 194 (302)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--HC-----CCGGGCCHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc--cccccccCChhhcCCeeeccccC
Confidence 999999999999999999 9999999999999999999999999875432211 1122346899999999883
Q ss_pred -cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcc
Q 048243 160 -QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238 (303)
Q Consensus 160 -~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 238 (303)
+..++.++||||||+++|+|++|..||....... ........... . .......+..+.+++.+||
T Consensus 195 ~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~-~-------~~~~~~~~~~l~~li~~~l 260 (302)
T 2j7t_A 195 KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKSDPP-T-------LLTPSKWSVEFRDFLKIAL 260 (302)
T ss_dssp TSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSCCC-C-------CSSGGGSCHHHHHHHHHHS
T ss_pred CCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HHHHHhccCCc-c-------cCCccccCHHHHHHHHHHc
Confidence 5678899999999999999999999986443211 11111111110 0 0111223457889999999
Q ss_pred cCCCCCCCCHHHHHH
Q 048243 239 QENPNDRPSMLQVSS 253 (303)
Q Consensus 239 ~~dp~~Rpt~~el~~ 253 (303)
..||.+|||+.++++
T Consensus 261 ~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 261 DKNPETRPSAAQLLE 275 (302)
T ss_dssp CSCTTTSCCHHHHTT
T ss_pred ccChhhCCCHHHHhc
Confidence 999999999999976
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=295.94 Aligned_cols=233 Identities=18% Similarity=0.218 Sum_probs=182.1
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|+++... ......+.+|+.++..++||||+++++++.+....|+||||+.+|+|.+++.. ....+++
T Consensus 97 ~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e 174 (437)
T 4aw2_A 97 NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSK--FEDRLPE 174 (437)
T ss_dssp TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHT--TTTCCCH
T ss_pred CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHH--ccCCCCH
Confidence 468999999996431 12223478899999999999999999999999999999999999999999954 2456999
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc-
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR- 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~- 159 (303)
..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .......||+.|+|||++.
T Consensus 175 ~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~ 250 (437)
T 4aw2_A 175 EMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQA 250 (437)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhh
Confidence 999999999999999999999 99999999999999999999999999976544322 1223357999999999987
Q ss_pred ----cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHH
Q 048243 160 ----QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235 (303)
Q Consensus 160 ----~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
...++.++|||||||++|+|++|..||...+.......+ ........+ +.. ....+..+.+||.
T Consensus 251 ~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i------~~~~~~~~~--p~~----~~~~s~~~~dLi~ 318 (437)
T 4aw2_A 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI------MNHKERFQF--PTQ----VTDVSENAKDLIR 318 (437)
T ss_dssp HHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HTHHHHCCC--CSS----CCCSCHHHHHHHH
T ss_pred cccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh------hhccccccC--Ccc----cccCCHHHHHHHH
Confidence 456899999999999999999999999654322211111 110000000 000 0112347889999
Q ss_pred HcccCCCCC--CCCHHHHHHH
Q 048243 236 LCVQENPND--RPSMLQVSSM 254 (303)
Q Consensus 236 ~~l~~dp~~--Rpt~~el~~~ 254 (303)
+||..+|++ ||+++|+++.
T Consensus 319 ~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 319 RLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp TTSSCGGGCTTTTTTHHHHTS
T ss_pred HHhcccccccCCCCHHHHhCC
Confidence 999988888 9999999874
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=285.16 Aligned_cols=241 Identities=24% Similarity=0.340 Sum_probs=168.7
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCc-----ccccc
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDP-----IRRLI 77 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~ 77 (303)
.+|+.||||.+.... ....+.+.+|+.++++++||||+++++++......++||||+++++|.+++... .....
T Consensus 38 ~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 117 (303)
T 2vwi_A 38 PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV 117 (303)
T ss_dssp ---CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCS
T ss_pred CCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCC
Confidence 478999999986543 334567889999999999999999999999999999999999999999988531 12456
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCc---cccccccccccCCCC
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL---EANTEQVVGTIGYIP 154 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~---~~~~~~~~g~~~y~a 154 (303)
+++..++.++.||+.||+|||+.| ++||||||+||+++.++.++|+|||.+........ ........|++.|+|
T Consensus 118 ~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~a 194 (303)
T 2vwi_A 118 LDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194 (303)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccC
Confidence 899999999999999999999999 99999999999999999999999999876543321 112234568999999
Q ss_pred hhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHH
Q 048243 155 PEYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEI 233 (303)
Q Consensus 155 PE~~~~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 233 (303)
||.+.+ ..++.++||||||+++|+|++|..||......... . ...... .................+..+.++
T Consensus 195 PE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~---~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l 267 (303)
T 2vwi_A 195 PEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL---M---LTLQND-PPSLETGVQDKEMLKKYGKSFRKM 267 (303)
T ss_dssp HHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH---H---HHHTSS-CCCTTC-----CCCCCCCHHHHHH
T ss_pred HHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH---H---HHhccC-CCccccccccchhhhhhhHHHHHH
Confidence 999876 56899999999999999999999998654332211 1 111111 000000000011111223478899
Q ss_pred HHHcccCCCCCCCCHHHHHHH
Q 048243 234 ALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 234 i~~~l~~dp~~Rpt~~el~~~ 254 (303)
+.+||+.||.+|||+.|+++.
T Consensus 268 i~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 268 ISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp HHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHccCChhhCcCHHHHhhC
Confidence 999999999999999999863
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=289.13 Aligned_cols=229 Identities=23% Similarity=0.358 Sum_probs=180.6
Q ss_pred CCCcEEEEEEecCCCc--------ccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccc
Q 048243 4 PCGKVIAVKKLSKTST--------QGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR 74 (303)
Q Consensus 4 ~~~~~valK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 74 (303)
.+|+.||||++..... ...+.+.+|+.+++++ +||||+++++++......++||||+++++|.+++. .
T Consensus 117 ~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~---~ 193 (365)
T 2y7j_A 117 ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLT---E 193 (365)
T ss_dssp TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHH---H
T ss_pred CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHH---h
Confidence 4799999999975431 1145678899999999 89999999999999999999999999999999984 3
Q ss_pred cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCC
Q 048243 75 RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIP 154 (303)
Q Consensus 75 ~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~a 154 (303)
...+++..+..++.||+.||+|||+.| ++|+||||+||+++.++.++|+|||++....... ......|++.|+|
T Consensus 194 ~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~a 267 (365)
T 2y7j_A 194 KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLA 267 (365)
T ss_dssp HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCC
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcccccCCCc---ccccCCCCCCccC
Confidence 456899999999999999999999999 9999999999999999999999999987655332 2233578999999
Q ss_pred hhhhccC------CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHH
Q 048243 155 PEYARQG------VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLM 228 (303)
Q Consensus 155 PE~~~~~------~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (303)
||++.+. .++.++|||||||++|+|++|..||....... ... .......... .+.. ...+.
T Consensus 268 PE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~---~i~~~~~~~~--~~~~-----~~~~~ 334 (365)
T 2y7j_A 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL---MLR---MIMEGQYQFS--SPEW-----DDRSS 334 (365)
T ss_dssp HHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHHTCCCCC--HHHH-----SSSCH
T ss_pred hhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH---HHH---HHHhCCCCCC--Cccc-----ccCCH
Confidence 9998643 57889999999999999999999985432111 111 1111110000 0000 01134
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 229 RCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 229 ~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
.+.++|.+||..||.+|||+.|+++.
T Consensus 335 ~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 335 TVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 68899999999999999999999873
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=294.05 Aligned_cols=232 Identities=19% Similarity=0.198 Sum_probs=180.3
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|++++.. ....+.+.+|..++..++||||+++++++.+....|+||||+++|+|.+++.. .+..+++
T Consensus 84 ~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~--~~~~l~~ 161 (412)
T 2vd5_A 84 QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSK--FGERIPA 161 (412)
T ss_dssp TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH--HSSCCCH
T ss_pred CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHh--cCCCCCH
Confidence 579999999996532 22334578899999999999999999999999999999999999999999853 2346899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc-
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR- 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~- 159 (303)
..++.++.||+.||+|||+.| |+||||||+|||++.+|.+||+|||++........ .......||+.|+|||++.
T Consensus 162 ~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~ 237 (412)
T 2vd5_A 162 EMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQA 237 (412)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCCCc-cccceeccccCcCCHHHHhh
Confidence 999999999999999999999 99999999999999999999999999977644322 1122357899999999987
Q ss_pred ------cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHH
Q 048243 160 ------QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEI 233 (303)
Q Consensus 160 ------~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 233 (303)
...++.++|||||||++|+|++|..||...........+......+ . .+.. ....+.++.+|
T Consensus 238 ~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~------~--~p~~----~~~~s~~~~dl 305 (412)
T 2vd5_A 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL------S--LPLV----DEGVPEEARDF 305 (412)
T ss_dssp HHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC------C--CC--------CCCHHHHHH
T ss_pred cccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc------C--CCcc----ccCCCHHHHHH
Confidence 3468999999999999999999999996543222111111000000 0 0000 11234578899
Q ss_pred HHHcccCCCCCC---CCHHHHHHH
Q 048243 234 ALLCVQENPNDR---PSMLQVSSM 254 (303)
Q Consensus 234 i~~~l~~dp~~R---pt~~el~~~ 254 (303)
|.+||. +|.+| |+++|+++.
T Consensus 306 i~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 306 IQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHHcC-ChhhcCCCCCHHHHhcC
Confidence 999999 99998 589999764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=286.04 Aligned_cols=231 Identities=14% Similarity=0.076 Sum_probs=185.3
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC---CCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc--cccc
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ---HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI--RRLI 77 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~ 77 (303)
..+++.||+|+++... ...+..|+.++..++ |+||+++++++...+..++||||+++|+|.+++.... ....
T Consensus 92 ~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 168 (365)
T 3e7e_A 92 AKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKV 168 (365)
T ss_dssp --CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCS
T ss_pred cccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccC
Confidence 4578999999997653 356778888888886 9999999999999999999999999999999985321 3456
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC-----------CCceEEcccccccccccCCcccccccc
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-----------DMKPKISDFGLARIFAKESLEANTEQV 146 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-----------~~~v~l~Df~~~~~~~~~~~~~~~~~~ 146 (303)
+++..++.++.||+.||+|||+.| |+||||||+|||++. ++.++|+|||++..+............
T Consensus 169 l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 245 (365)
T 3e7e_A 169 MPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245 (365)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCS
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeee
Confidence 999999999999999999999999 999999999999998 899999999999765533333344456
Q ss_pred ccccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHH
Q 048243 147 VGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCK 226 (303)
Q Consensus 147 ~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
.||+.|+|||++.+..++.++|||||||++|+|++|..||........ .....+.... .
T Consensus 246 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------------------~~~~~~~~~~---~ 304 (365)
T 3e7e_A 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC------------------KPEGLFRRLP---H 304 (365)
T ss_dssp SCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE------------------EECSCCTTCS---S
T ss_pred cCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce------------------eechhccccC---c
Confidence 799999999999999999999999999999999999999853322110 0111111111 2
Q ss_pred HHHHHHHHHHcccCCCCCC-CCHHHHHHHhccccC
Q 048243 227 LMRCLEIALLCVQENPNDR-PSMLQVSSMLKNETT 260 (303)
Q Consensus 227 ~~~l~~li~~~l~~dp~~R-pt~~el~~~L~~~~~ 260 (303)
...+.+++..||..+|.+| |++.++.+.|++...
T Consensus 305 ~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 305 LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 3467789999999999998 577888887776553
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=287.87 Aligned_cols=244 Identities=24% Similarity=0.292 Sum_probs=176.2
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHH--HhcCCCCccccEEEEEEe-----CCeeEEEEeecCCCChhhhhcCcccccc
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVML--TAKLQHVNLIRVLGFCID-----SEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~--l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
+|+.||||++.... ...+..|.++ +..++||||+++++.+.. ....++||||+++|+|.+++. ...
T Consensus 35 ~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~----~~~ 107 (336)
T 3g2f_A 35 DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS----LHT 107 (336)
T ss_dssp TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHH----HCC
T ss_pred CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHh----hcc
Confidence 68899999996543 2344444444 445799999999986653 235689999999999999983 334
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhC---------CCCCeEecCCCCCceEECCCCceEEcccccccccccCCc------ccc
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEY---------SRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL------EAN 142 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~---------~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~------~~~ 142 (303)
.++..++.++.||+.||+|||+. + |+||||||+||+++.++.++|+|||++..+..... ...
T Consensus 108 ~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~ 184 (336)
T 3g2f_A 108 SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184 (336)
T ss_dssp BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC--------
T ss_pred cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEeeccceeecccccccCccccccc
Confidence 58899999999999999999998 8 99999999999999999999999999987654321 111
Q ss_pred ccccccccCCCChhhhcc-------CCCCCccchhhHHHHHHHHHhCCCCCccCCCCcccc-HH----------HHHHHH
Q 048243 143 TEQVVGTIGYIPPEYARQ-------GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLS-IL----------EHAYEL 204 (303)
Q Consensus 143 ~~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~-~~----------~~~~~~ 204 (303)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......... .. ......
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (336)
T 3g2f_A 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVL 264 (336)
T ss_dssp -CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHH
T ss_pred cccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhh
Confidence 223468999999999986 345678999999999999999987764433222111 10 111111
Q ss_pred HhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccccC
Q 048243 205 WKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~~ 260 (303)
.........+.. ........+..+.+||.+||+.||.+|||+.|+++.|++...
T Consensus 265 ~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 265 VSREKQRPKFPE--AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp HTTSCCCCCCCT--TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcccccCCCCCc--ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 111111111110 111223456689999999999999999999999999887653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=300.14 Aligned_cols=228 Identities=27% Similarity=0.344 Sum_probs=181.0
Q ss_pred CCCcEEEEEEecCCCc-------------ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhc
Q 048243 4 PCGKVIAVKKLSKTST-------------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLF 70 (303)
Q Consensus 4 ~~~~~valK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 70 (303)
.+|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+....++|||||++|+|.+++.
T Consensus 59 ~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~ 138 (504)
T 3q5i_A 59 NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII 138 (504)
T ss_dssp TTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH
T ss_pred CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHH
Confidence 5789999999975431 335678999999999999999999999999999999999999999998884
Q ss_pred CccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCC---ceEEcccccccccccCCccccccccc
Q 048243 71 DPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM---KPKISDFGLARIFAKESLEANTEQVV 147 (303)
Q Consensus 71 ~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~---~v~l~Df~~~~~~~~~~~~~~~~~~~ 147 (303)
....+++..++.++.||+.||+|||+.| |+||||||+||+++.++ .++|+|||++....... ......
T Consensus 139 ---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~ 209 (504)
T 3q5i_A 139 ---NRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRL 209 (504)
T ss_dssp ---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTS---CBCCCC
T ss_pred ---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCC---cccccc
Confidence 3456999999999999999999999999 99999999999999876 69999999998765432 223356
Q ss_pred cccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHH
Q 048243 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKL 227 (303)
Q Consensus 148 g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
||+.|+|||++.+ .++.++||||+||++|+|++|..||........ .. ............ . ....+
T Consensus 210 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~---~i~~~~~~~~~~--~-----~~~~s 275 (504)
T 3q5i_A 210 GTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI---IK---KVEKGKYYFDFN--D-----WKNIS 275 (504)
T ss_dssp SCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH---HHHHCCCCCCHH--H-----HTTSC
T ss_pred CCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HH---HHHcCCCCCCcc--c-----cCCCC
Confidence 8999999999874 589999999999999999999999965432211 11 111111100000 0 00123
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 228 MRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 228 ~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
..+.+||.+||+.||.+|||+.|+++.
T Consensus 276 ~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 276 DEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 578899999999999999999999863
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=282.47 Aligned_cols=242 Identities=22% Similarity=0.245 Sum_probs=184.1
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhc--CCCCccccEEEEEEeCC----eeEEEEeecCCCChhhhhcCccccccC
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAK--LQHVNLIRVLGFCIDSE----ERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
+|+.||||++... ....+..|++++.. ++||||+++++++.... ..++||||+++|+|.+++. ...+
T Consensus 64 ~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~----~~~~ 136 (342)
T 1b6c_B 64 RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTV 136 (342)
T ss_dssp TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHH----HCCB
T ss_pred cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHh----ccCc
Confidence 5889999999643 34567788888887 68999999999998876 7899999999999999984 3468
Q ss_pred CHHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccc--ccccccc
Q 048243 79 DWKKRVHIIEGITQGLLYLQ--------EYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEA--NTEQVVG 148 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh--------~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~--~~~~~~g 148 (303)
++..++.++.|++.||+||| +.+ ++||||||+||+++.++.++|+|||++.......... ......|
T Consensus 137 ~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~g 213 (342)
T 1b6c_B 137 TVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 213 (342)
T ss_dssp CHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCC
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCc
Confidence 99999999999999999999 777 9999999999999999999999999997665433211 2334578
Q ss_pred ccCCCChhhhccCC------CCCccchhhHHHHHHHHHhC----------CCCCccCCCCccccHHHHHHHHHhCCCcce
Q 048243 149 TIGYIPPEYARQGV------YSTKSDVFSFGVLLLQIISG----------KRLSMLCGINENLSILEHAYELWKGGKGVE 212 (303)
Q Consensus 149 ~~~y~aPE~~~~~~------~~~~~DiwslG~~~~~l~~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (303)
++.|+|||.+.+.. ++.++||||||+++|+|++| ..||......... ...............
T Consensus 214 t~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~ 291 (342)
T 1b6c_B 214 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS--VEEMRKVVCEQKLRP 291 (342)
T ss_dssp CGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC--HHHHHHHHTTSCCCC
T ss_pred CcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCccc--HHHHHHHHHHHHhCC
Confidence 99999999988763 23689999999999999999 6666543322211 111112111111100
Q ss_pred eccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhccccCC
Q 048243 213 FVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSMLKNETTN 261 (303)
Q Consensus 213 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~~~ 261 (303)
.+... .........+.+++.+||+.||.+|||+.++++.|++....
T Consensus 292 ~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 292 NIPNR---WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp CCCGG---GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCccc---ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 00000 01234566889999999999999999999999999877643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=278.43 Aligned_cols=223 Identities=19% Similarity=0.280 Sum_probs=176.8
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccc-cccCC
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR-RLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~l~ 79 (303)
.+|+.||+|+++... ......+.+|+..+..+ +||||+++++++.+....++||||+++++|.+++..... ...++
T Consensus 34 ~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 113 (289)
T 1x8b_A 34 LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFK 113 (289)
T ss_dssp TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCC
T ss_pred CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCC
Confidence 479999999997643 33456788999999999 999999999999999999999999999999999854221 25689
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCC-------------------CceEEcccccccccccCCcc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED-------------------MKPKISDFGLARIFAKESLE 140 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~-------------------~~v~l~Df~~~~~~~~~~~~ 140 (303)
+..++.++.||+.||+|||+++ ++||||||+||+++.+ ..++|+|||.+.......
T Consensus 114 ~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-- 188 (289)
T 1x8b_A 114 EAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ-- 188 (289)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC--
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc--
Confidence 9999999999999999999999 9999999999999844 479999999987654432
Q ss_pred ccccccccccCCCChhhhccC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCC
Q 048243 141 ANTEQVVGTIGYIPPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLD 219 (303)
Q Consensus 141 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (303)
...|++.|+|||.+.+. .++.++||||||+++|+|++|.+++.... . ........... .
T Consensus 189 ----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------~----~~~~~~~~~~~-----~- 248 (289)
T 1x8b_A 189 ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------Q----WHEIRQGRLPR-----I- 248 (289)
T ss_dssp ----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------H----HHHHHTTCCCC-----C-
T ss_pred ----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------H----HHHHHcCCCCC-----C-
Confidence 23589999999999876 56679999999999999999987753211 0 11111111111 1
Q ss_pred CCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 220 DTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 220 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
+...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 249 ---~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 249 ---PQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ---SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---CcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 11223478899999999999999999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=277.89 Aligned_cols=233 Identities=23% Similarity=0.269 Sum_probs=179.7
Q ss_pred CCCcEEEEEEecCCC----cccHHHHHHHHHHHhcCCCCccccEEEEEE--eCCeeEEEEeecCCCChhhhhcCcccccc
Q 048243 4 PCGKVIAVKKLSKTS----TQGFEEFKNEVMLTAKLQHVNLIRVLGFCI--DSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~~~~valK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
.+|+.||+|+++... ....+.+.+|+.++++++||||+++++++. .....++||||+.++ |.+++.. .....
T Consensus 28 ~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~-~~~~~ 105 (305)
T 2wtk_C 28 ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDS-VPEKR 105 (305)
T ss_dssp TTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHH-STTCS
T ss_pred CCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHh-Ccccc
Confidence 578999999996542 234578999999999999999999999984 445789999999876 6666643 23456
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhh
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 157 (303)
+++..++.++.||+.||+|||++| ++||||||+||+++.++.++|+|||.+................|+..|+|||.
T Consensus 106 ~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 182 (305)
T 2wtk_C 106 FPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182 (305)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHH
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhh
Confidence 899999999999999999999999 99999999999999999999999999987654333333344568999999999
Q ss_pred hccCC--CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHH
Q 048243 158 ARQGV--YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235 (303)
Q Consensus 158 ~~~~~--~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
+.+.. ++.++||||||+++|+|++|..||....... ... ....... ... ...+..+.+++.
T Consensus 183 ~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~---~i~~~~~-------~~~----~~~~~~l~~li~ 245 (305)
T 2wtk_C 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK---LFE---NIGKGSY-------AIP----GDCGPPLSDLLK 245 (305)
T ss_dssp HTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH---HHHHCCC-------CCC----SSSCHHHHHHHH
T ss_pred ccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH---HHH---HHhcCCC-------CCC----CccCHHHHHHHH
Confidence 88654 3779999999999999999999986432111 111 1111110 011 112347889999
Q ss_pred HcccCCCCCCCCHHHHHHH--hccc
Q 048243 236 LCVQENPNDRPSMLQVSSM--LKNE 258 (303)
Q Consensus 236 ~~l~~dp~~Rpt~~el~~~--L~~~ 258 (303)
+||..||.+|||+.|+++. +.+.
T Consensus 246 ~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 246 GMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp HHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred HHccCChhhCCCHHHHhcCcccccC
Confidence 9999999999999999864 5444
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=296.19 Aligned_cols=219 Identities=16% Similarity=0.187 Sum_probs=167.9
Q ss_pred CCCcEEEEEEecCC---CcccHHHHHHHHH---HHhcCCCCccccEE-------EEEEeCCe-----------------e
Q 048243 4 PCGKVIAVKKLSKT---STQGFEEFKNEVM---LTAKLQHVNLIRVL-------GFCIDSEE-----------------R 53 (303)
Q Consensus 4 ~~~~~valK~~~~~---~~~~~~~~~~e~~---~l~~l~h~~i~~~~-------~~~~~~~~-----------------~ 53 (303)
.+|+.||||++... .....+.+.+|+. .++.++||||++++ +++...+. .
T Consensus 96 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 175 (377)
T 3byv_A 96 ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR 175 (377)
T ss_dssp CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESE
T ss_pred CCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEE
Confidence 57999999999743 3345678899994 55555899999998 77665532 7
Q ss_pred EEEEeecCCCChhhhhcCccc----cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccc
Q 048243 54 MLVYEYMPNKSLDCYLFDPIR----RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFG 129 (303)
Q Consensus 54 ~lv~e~~~~~~L~~~l~~~~~----~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~ 129 (303)
++||||+ +|+|.+++..... ...+++..++.++.||+.||+|||+.| |+||||||+|||++.++.+||+|||
T Consensus 176 ~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG 251 (377)
T 3byv_A 176 FFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE 251 (377)
T ss_dssp EEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGG
T ss_pred EEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEech
Confidence 8999999 6799999854211 122335888899999999999999999 9999999999999999999999999
Q ss_pred cccccccCCccccccccccccCCCChhhhccC-----------CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHH
Q 048243 130 LARIFAKESLEANTEQVVGTIGYIPPEYARQG-----------VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSIL 198 (303)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~ 198 (303)
++..... ......| +.|+|||++.+. .++.++|||||||++|+|++|..||...........
T Consensus 252 ~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~- 324 (377)
T 3byv_A 252 HLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEW- 324 (377)
T ss_dssp GCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGG-
T ss_pred hheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhh-
Confidence 9875332 2233467 999999999887 789999999999999999999999864332221110
Q ss_pred HHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 199 EHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
... .. . ..+..+.+||.+||+.||.+|||+.|+++
T Consensus 325 --------------~~~-~~-~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 325 --------------IFR-SC-K----NIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp --------------GGS-SC-C----CCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred --------------hhh-hc-c----CCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 000 00 1 12347889999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=278.68 Aligned_cols=235 Identities=26% Similarity=0.312 Sum_probs=181.9
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEe--CCeeEEEEeecCCCChhhhhcCcc-ccccC
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCID--SEERMLVYEYMPNKSLDCYLFDPI-RRLIL 78 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~l 78 (303)
.+|+.||+|.+.... ....+.+.+|+.++++++||||+++++++.. ....++||||+++++|.+++.... ....+
T Consensus 29 ~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 108 (279)
T 2w5a_A 29 SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108 (279)
T ss_dssp TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCC
T ss_pred CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCC
Confidence 478999999997543 3445678999999999999999999998854 568899999999999999986422 23458
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChh
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYS--RLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE 156 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~--~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE 156 (303)
++..++.++.|++.||+|||+.+ ..+++||||||+||+++.++.++|+|||.+....... .......|+..|+|||
T Consensus 109 ~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE 186 (279)
T 2w5a_A 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKTFVGTPYYMSPE 186 (279)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---C--HHHHHHHSCCTTCCHH
T ss_pred CHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccc--ccccccCCCccccChH
Confidence 99999999999999999999876 2349999999999999999999999999987654332 1122356899999999
Q ss_pred hhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 157 YARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
.+.+..++.++||||||+++|+|++|..||....... . ........... .+...+..+.+++.+
T Consensus 187 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~----~~~i~~~~~~~---------~~~~~~~~l~~li~~ 250 (279)
T 2w5a_A 187 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---L----AGKIREGKFRR---------IPYRYSDELNEIITR 250 (279)
T ss_dssp HHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H----HHHHHHTCCCC---------CCTTSCHHHHHHHHH
T ss_pred HhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---H----HHHHhhccccc---------CCcccCHHHHHHHHH
Confidence 9999889999999999999999999999986543211 1 11111111111 111234578899999
Q ss_pred cccCCCCCCCCHHHHHHHhc
Q 048243 237 CVQENPNDRPSMLQVSSMLK 256 (303)
Q Consensus 237 ~l~~dp~~Rpt~~el~~~L~ 256 (303)
||+.||.+|||+.|+++.+.
T Consensus 251 ~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 251 MLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HTCSSGGGSCCHHHHHTSTT
T ss_pred HcCCCcccCCCHHHHHhChh
Confidence 99999999999999998754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=281.58 Aligned_cols=231 Identities=25% Similarity=0.347 Sum_probs=179.1
Q ss_pred EEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHH
Q 048243 8 VIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 8 ~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~ 84 (303)
.||+|+++... ....+.+.+|+.++++++||||+++++++.... .++|||++.+++|.+++.. ....+++..++
T Consensus 48 ~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~ 124 (291)
T 1u46_A 48 SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRK--HQGHFLLGTLS 124 (291)
T ss_dssp EEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHH--HGGGSCHHHHH
T ss_pred EEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHh--ccCCcCHHHHH
Confidence 68999987542 334578899999999999999999999998765 8999999999999999853 23568999999
Q ss_pred HHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-ccccccccccCCCChhhhccCCC
Q 048243 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 85 ~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++......... .......++..|+|||.+.+..+
T Consensus 125 ~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 201 (291)
T 1u46_A 125 RYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 201 (291)
T ss_dssp HHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCC
Confidence 99999999999999999 999999999999999999999999999776543322 12233456788999999988888
Q ss_pred CCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC
Q 048243 164 STKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 242 (303)
+.++||||||+++|+|++ |..||...... ............. ......+..+.+++.+||..||
T Consensus 202 ~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p 266 (291)
T 1u46_A 202 SHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGERL---------PRPEDCPQDIYNVMVQCWAHKP 266 (291)
T ss_dssp EHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCCCC---------CCCTTCCHHHHHHHHHHTCSSG
T ss_pred CchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHHccCCCC---------CCCcCcCHHHHHHHHHHccCCc
Confidence 999999999999999999 99998644321 1111111111111 1112234578899999999999
Q ss_pred CCCCCHHHHHHHhcccc
Q 048243 243 NDRPSMLQVSSMLKNET 259 (303)
Q Consensus 243 ~~Rpt~~el~~~L~~~~ 259 (303)
.+|||+.++++.|++..
T Consensus 267 ~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 267 EDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp GGSCCHHHHHHHHHHHC
T ss_pred ccCcCHHHHHHHHHHhC
Confidence 99999999999998765
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=279.90 Aligned_cols=235 Identities=19% Similarity=0.231 Sum_probs=180.1
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCccccEEEEEEe--CCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCID--SEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
..+|+.||+|+++.. ..+.+.+|+.++++++ ||||+++++++.+ ....++||||+.+++|.+++. .++
T Consensus 58 ~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~------~~~ 128 (330)
T 3nsz_A 58 ITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLT 128 (330)
T ss_dssp TTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG------GCC
T ss_pred CCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH------hCC
Confidence 367899999999754 3467899999999996 9999999999998 567899999999999988873 388
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCC-ceEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM-KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~-~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
+..++.++.||+.||+|||+.| ++||||||+||+++.++ .++|+|||++........ .....|+..|+|||.+
T Consensus 129 ~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~ 202 (330)
T 3nsz_A 129 DYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELL 202 (330)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc---cccccccccccChhhh
Confidence 8999999999999999999999 99999999999999776 899999999976544322 2335688999999998
Q ss_pred cc-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHH---------h--------------CCCcceec
Q 048243 159 RQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELW---------K--------------GGKGVEFV 214 (303)
Q Consensus 159 ~~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------~--------------~~~~~~~~ 214 (303)
.+ ..++.++|||||||++|+|++|..||....... .......... . ........
T Consensus 203 ~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (330)
T 3nsz_A 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRW 280 (330)
T ss_dssp TTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCG
T ss_pred cCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH--HHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccch
Confidence 87 568999999999999999999999985433211 1111100000 0 00000001
Q ss_pred cccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 215 DSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 215 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
............+..+.+||.+||+.||.+|||++|+++.
T Consensus 281 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 281 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp GGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1111112222245688999999999999999999999873
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=277.92 Aligned_cols=228 Identities=24% Similarity=0.304 Sum_probs=181.0
Q ss_pred CCCcEEEEEEecCCC---------cccHHHHHHHHHHHhcCC-CCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc
Q 048243 4 PCGKVIAVKKLSKTS---------TQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI 73 (303)
Q Consensus 4 ~~~~~valK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 73 (303)
.+|+.||||++.... ....+.+.+|+.+++++. ||||+++++++......++||||+++++|.+++.
T Consensus 40 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--- 116 (298)
T 1phk_A 40 PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT--- 116 (298)
T ss_dssp TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---
T ss_pred CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHh---
Confidence 478999999997543 122456789999999995 9999999999999999999999999999999984
Q ss_pred ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCC
Q 048243 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYI 153 (303)
Q Consensus 74 ~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~ 153 (303)
....+++..++.++.|++.||+|||+.| ++||||+|+||+++.++.++|+|||.+....... ......|++.|+
T Consensus 117 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~ 190 (298)
T 1phk_A 117 EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYL 190 (298)
T ss_dssp HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGC
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhhcCCCc---ccccccCCcccc
Confidence 3456899999999999999999999999 9999999999999999999999999987654332 223356899999
Q ss_pred Chhhhc------cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHH
Q 048243 154 PPEYAR------QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKL 227 (303)
Q Consensus 154 aPE~~~------~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
|||.+. ...++.++||||||+++|+|++|..||....... ........... .........+
T Consensus 191 aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~~-------~~~~~~~~~~ 257 (298)
T 1phk_A 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------MLRMIMSGNYQ-------FGSPEWDDYS 257 (298)
T ss_dssp CHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCCC-------CCTTTGGGSC
T ss_pred CHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH------HHHHHhcCCcc-------cCcccccccC
Confidence 999885 3457889999999999999999999985432111 11111111100 0011112234
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 228 MRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 228 ~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
..+.+++.+||..||.+|||+.|+++
T Consensus 258 ~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 258 DTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHccCCcccCCCHHHHHh
Confidence 57889999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=284.50 Aligned_cols=241 Identities=25% Similarity=0.284 Sum_probs=169.8
Q ss_pred cCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeC------CeeEEEEeecCCCChhhhhcCccc
Q 048243 3 LPCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------EERMLVYEYMPNKSLDCYLFDPIR 74 (303)
Q Consensus 3 ~~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~ 74 (303)
..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++... ...++|++++ +++|.+++.
T Consensus 51 ~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~---- 125 (367)
T 2fst_X 51 TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK---- 125 (367)
T ss_dssp TTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC--------
T ss_pred CCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHh----
Confidence 3578999999996542 33456788999999999999999999999754 5679999999 688888873
Q ss_pred cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCC
Q 048243 75 RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIP 154 (303)
Q Consensus 75 ~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~a 154 (303)
...+++..++.++.||+.||+|||+.| |+||||||+||+++.++.++|+|||+++..... .....||..|+|
T Consensus 126 ~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~a 197 (367)
T 2fst_X 126 CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRA 197 (367)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--------------------CCCTTCC
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccccccccc-----CCCcCcCcCccC
Confidence 356999999999999999999999999 999999999999999999999999998764432 233578999999
Q ss_pred hhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCc-----------ceeccccC--CC
Q 048243 155 PEYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG-----------VEFVDSSL--DD 220 (303)
Q Consensus 155 PE~~~~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~--~~ 220 (303)
||++.+ ..++.++|||||||++|+|++|..||......... ............ ..+..... ..
T Consensus 198 PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l---~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (367)
T 2fst_X 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL---KLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 274 (367)
T ss_dssp HHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCC
T ss_pred hHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCC
Confidence 999887 57899999999999999999999999654322211 111111110000 00000000 00
Q ss_pred CCC----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hcccc
Q 048243 221 TNS----PCKLMRCLEIALLCVQENPNDRPSMLQVSSM--LKNET 259 (303)
Q Consensus 221 ~~~----~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~--L~~~~ 259 (303)
... +..+..+.+||.+||..||.+|||+.|+++. +.+..
T Consensus 275 ~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 275 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp CCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 000 1123468899999999999999999999874 44443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=276.10 Aligned_cols=225 Identities=21% Similarity=0.341 Sum_probs=174.6
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||||++.... ....+.+.+|+..++.++||||+++++++......++||||+++++|.+++. ....+++
T Consensus 34 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~ 110 (276)
T 2h6d_A 34 LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYIC---KHGRVEE 110 (276)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH---HHCSCCH
T ss_pred CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHh---ccCCCCH
Confidence 478999999996542 2345688999999999999999999999999999999999999999999984 3456899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||.+....... ......|++.|+|||.+.+
T Consensus 111 ~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~ 184 (276)
T 2h6d_A 111 MEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISG 184 (276)
T ss_dssp HHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----------------CCTGGGTT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCc---ceecccCCccccCHHHHcC
Confidence 999999999999999999999 9999999999999999999999999987654332 1223468999999999988
Q ss_pred CCC-CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 161 GVY-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 161 ~~~-~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
..+ +.++||||||+++|+|++|..||....... .......... .. +...+..+.+++.+||+
T Consensus 185 ~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~------~~----~~~~~~~l~~li~~~l~ 247 (276)
T 2h6d_A 185 RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-------LFKKIRGGVF------YI----PEYLNRSVATLLMHMLQ 247 (276)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC------CC----CTTSCHHHHHHHHHHTC
T ss_pred CCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-------HHHHhhcCcc------cC----chhcCHHHHHHHHHHcc
Confidence 765 579999999999999999999986432111 1111111100 01 11123478899999999
Q ss_pred CCCCCCCCHHHHHHH
Q 048243 240 ENPNDRPSMLQVSSM 254 (303)
Q Consensus 240 ~dp~~Rpt~~el~~~ 254 (303)
.||.+|||+.|+++.
T Consensus 248 ~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 248 VDPLKRATIKDIREH 262 (276)
T ss_dssp SSGGGSCCHHHHHHS
T ss_pred CChhhCCCHHHHHhC
Confidence 999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=291.60 Aligned_cols=239 Identities=17% Similarity=0.191 Sum_probs=187.6
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCC-CccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQH-VNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.||||++...... ..+..|+.+++.++| ++|..+..++......++||||+ +++|.+++.. ....+++..
T Consensus 30 ~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~--~~~~l~~~~ 104 (483)
T 3sv0_A 30 QTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNF--CSRKLSLKT 104 (483)
T ss_dssp TTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCHHH
T ss_pred CCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHh--hcCCCCHHH
Confidence 67999999998755432 357889999999976 56677777777888999999999 8999999853 245699999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEE---CCCCceEEcccccccccccCCcc-----ccccccccccCCCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GEDMKPKISDFGLARIFAKESLE-----ANTEQVVGTIGYIP 154 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~---~~~~~v~l~Df~~~~~~~~~~~~-----~~~~~~~g~~~y~a 154 (303)
++.++.||+.||+|||+++ |+||||||+|||+ +.++.++|+|||++..+...... .......|+..|+|
T Consensus 105 ~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~a 181 (483)
T 3sv0_A 105 VLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181 (483)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCC
T ss_pred HHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccC
Confidence 9999999999999999999 9999999999999 57889999999999876544321 12234678999999
Q ss_pred hhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHH
Q 048243 155 PEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIA 234 (303)
Q Consensus 155 PE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
||.+.+..++.++|||||||++|+|++|..||...........+..............+.. ..+.++.+|+
T Consensus 182 PE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~---------~~p~~l~~li 252 (483)
T 3sv0_A 182 VNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCR---------GYPTEFASYF 252 (483)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHT---------TSCHHHHHHH
T ss_pred HHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhc---------CCcHHHHHHH
Confidence 9999999999999999999999999999999977655443333332222111111111100 1134788999
Q ss_pred HHcccCCCCCCCCHHHHHHHhcccc
Q 048243 235 LLCVQENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 235 ~~~l~~dp~~Rpt~~el~~~L~~~~ 259 (303)
.+||..||.+||++.+|++.|++..
T Consensus 253 ~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 253 HYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp HHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HHHhcCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999887654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=281.27 Aligned_cols=228 Identities=23% Similarity=0.331 Sum_probs=174.4
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCccccEEEEEEe------CCeeEEEEeecCCCChhhhhcCccccc
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCID------SEERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~ 76 (303)
.+|+.||||++..... ..+.+.+|+.+++++ +||||+++++++.. ....++||||+++++|.+++... ...
T Consensus 47 ~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~ 124 (326)
T 2x7f_A 47 KTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGN 124 (326)
T ss_dssp TTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHS-GGG
T ss_pred CCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhc-ccC
Confidence 5789999999965432 346788999999999 89999999999987 46789999999999999998542 345
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChh
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE 156 (303)
.+++..++.++.||+.||+|||+.| ++||||||+||+++.++.++|+|||++....... .......|++.|+|||
T Consensus 125 ~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE 199 (326)
T 2x7f_A 125 TLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPE 199 (326)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc--cccccccCCccccChh
Confidence 6899999999999999999999999 9999999999999999999999999987654321 1223356899999999
Q ss_pred hhc-----cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHH
Q 048243 157 YAR-----QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL 231 (303)
Q Consensus 157 ~~~-----~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
.+. +..++.++||||||+++|+|++|..||...... ........... ... .....+..+.
T Consensus 200 ~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~-~~~--------~~~~~~~~l~ 264 (326)
T 2x7f_A 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RALFLIPRNPA-PRL--------KSKKWSKKFQ 264 (326)
T ss_dssp HHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCC-CCC--------SCSCSCHHHH
T ss_pred hhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHHHHhhcCcc-ccC--------CccccCHHHH
Confidence 987 456889999999999999999999998543211 11111111111 000 0111234788
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 048243 232 EIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 232 ~li~~~l~~dp~~Rpt~~el~~ 253 (303)
++|.+||..||.+|||+.++++
T Consensus 265 ~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 265 SFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHhccChhhCCCHHHHhh
Confidence 9999999999999999999987
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=290.46 Aligned_cols=231 Identities=11% Similarity=0.071 Sum_probs=160.9
Q ss_pred CCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcC--CCCccccEE-------EEEEeC-----------------CeeE
Q 048243 4 PCGKVIAVKKLSKTST---QGFEEFKNEVMLTAKL--QHVNLIRVL-------GFCIDS-----------------EERM 54 (303)
Q Consensus 4 ~~~~~valK~~~~~~~---~~~~~~~~e~~~l~~l--~h~~i~~~~-------~~~~~~-----------------~~~~ 54 (303)
.+|+.||||++..... ...+.+.+|+.+++.+ +||||++++ +++... ...+
T Consensus 85 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (371)
T 3q60_A 85 ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYL 164 (371)
T ss_dssp TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEE
T ss_pred CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEE
Confidence 5789999999987542 3345677785444444 699988755 455433 2379
Q ss_pred EEEeecCCCChhhhhcCccccccCCHHHH------HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEccc
Q 048243 55 LVYEYMPNKSLDCYLFDPIRRLILDWKKR------VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128 (303)
Q Consensus 55 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~------~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df 128 (303)
+||||++ ++|.+++... +..+++..+ +.++.||+.||+|||++| |+||||||+|||++.++.+||+||
T Consensus 165 lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DF 238 (371)
T 3q60_A 165 LLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDV 238 (371)
T ss_dssp EEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEECTTSCEEECCG
T ss_pred EEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---CccCcCCHHHEEECCCCCEEEEec
Confidence 9999998 8999999642 233454555 677899999999999999 999999999999999999999999
Q ss_pred ccccccccCCccccccccccccCCCChhhhcc--CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHh
Q 048243 129 GLARIFAKESLEANTEQVVGTIGYIPPEYARQ--GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWK 206 (303)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 206 (303)
|++....... ....+++.|+|||++.+ ..++.++|||||||++|+|++|..||.......... +.
T Consensus 239 G~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~--------~~ 305 (371)
T 3q60_A 239 SALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS--------WK 305 (371)
T ss_dssp GGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTC--------CC
T ss_pred ceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccc--------hh
Confidence 9998654321 13456799999999987 678999999999999999999999997553221100 00
Q ss_pred CCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 207 GGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
....................+..+.+||.+||+.||++|||+.++++
T Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 306 RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000111111111233457889999999999999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=292.23 Aligned_cols=229 Identities=24% Similarity=0.283 Sum_probs=170.2
Q ss_pred CCCcEEEEEEecCCC--------cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcccc
Q 048243 4 PCGKVIAVKKLSKTS--------TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~~~~valK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 75 (303)
.+|+.||+|++.... ......+.+|+.++++++||||+++++++. ....++||||+.+++|.+++. ..
T Consensus 158 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~---~~ 233 (419)
T 3i6u_A 158 KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVV---GN 233 (419)
T ss_dssp TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEEEECCTTCBGGGGTS---SS
T ss_pred CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEEEEcCCCCcHHHHHh---cc
Confidence 578999999986532 112235789999999999999999999975 456899999999999998884 45
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCC---ceEEcccccccccccCCccccccccccccCC
Q 048243 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM---KPKISDFGLARIFAKESLEANTEQVVGTIGY 152 (303)
Q Consensus 76 ~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~---~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y 152 (303)
..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++ .++|+|||++....... ......||+.|
T Consensus 234 ~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y 307 (419)
T 3i6u_A 234 KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTY 307 (419)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--------------CTT
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeecccceecCCCc---cccccCCCCCc
Confidence 56999999999999999999999999 99999999999997554 59999999998764332 22345789999
Q ss_pred CChhhhcc---CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHH
Q 048243 153 IPPEYARQ---GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMR 229 (303)
Q Consensus 153 ~aPE~~~~---~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (303)
+|||++.+ ..++.++|||||||++|+|++|..||......... .. ......... .... ....+..
T Consensus 308 ~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~--~~----~i~~~~~~~-~~~~-----~~~~~~~ 375 (419)
T 3i6u_A 308 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KD----QITSGKYNF-IPEV-----WAEVSEK 375 (419)
T ss_dssp CCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH--HH----HHHTTCCCC-CHHH-----HTTSCHH
T ss_pred cCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH--HH----HHhcCCCCC-Cchh-----hcccCHH
Confidence 99999864 56788999999999999999999999654332211 11 111111000 0000 0012357
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 230 CLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 230 l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
+.+|+.+||+.||.+|||+.|+++.
T Consensus 376 ~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 376 ALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHccCChhHCcCHHHHhCC
Confidence 8899999999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=280.49 Aligned_cols=244 Identities=22% Similarity=0.263 Sum_probs=182.6
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeC-----CeeEEEEeecCCCChhhhhcCcccccc
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-----EERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
.+|+.||||++.... ....+.+.+|+.++++++||||+++++++... ...++|||++. ++|.+++. ...
T Consensus 50 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~----~~~ 124 (364)
T 3qyz_A 50 LNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLK----TQH 124 (364)
T ss_dssp TTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHH----HCC
T ss_pred CCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHH----hCC
Confidence 478899999997543 33446788999999999999999999999754 36899999997 58888873 345
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-ccccccccccCCCChh
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPPE 156 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-~~~~~~~g~~~y~aPE 156 (303)
+++..+..++.|++.||+|||+.| |+||||||+||+++.++.++|+|||++......... .......||+.|+|||
T Consensus 125 ~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE 201 (364)
T 3qyz_A 125 LSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201 (364)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCH
Confidence 999999999999999999999999 999999999999999999999999999876543221 1223457899999999
Q ss_pred hhcc-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcc-----------eeccccCC-CCC-
Q 048243 157 YARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV-----------EFVDSSLD-DTN- 222 (303)
Q Consensus 157 ~~~~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~-~~~- 222 (303)
++.+ ..++.++|||||||++|+|++|..||...........+. ......... ........ ...
T Consensus 202 ~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (364)
T 3qyz_A 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL---GILGSPSQEDLNCIINLKARNYLLSLPHKNKVP 278 (364)
T ss_dssp HHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH---HHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCC
T ss_pred HhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH---HHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCC
Confidence 8654 458999999999999999999999996554333222111 111110000 00000000 000
Q ss_pred ----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccc
Q 048243 223 ----SPCKLMRCLEIALLCVQENPNDRPSMLQVSSM--LKNE 258 (303)
Q Consensus 223 ----~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~--L~~~ 258 (303)
.+..+..+.+||.+||+.||.+|||+.|+++. +++.
T Consensus 279 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 279 WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 01123478899999999999999999999873 4443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=270.93 Aligned_cols=228 Identities=26% Similarity=0.366 Sum_probs=178.8
Q ss_pred CCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEe----CCeeEEEEeecCCCChhhhhcCcccccc
Q 048243 4 PCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCID----SEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
.+++.||+|++... .....+.+.+|+.+++.++||||+++++++.. ....++||||+++++|.+++. ....
T Consensus 49 ~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~ 125 (290)
T 1t4h_A 49 ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKV 125 (290)
T ss_dssp TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHH---HHSS
T ss_pred CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHH---HccC
Confidence 57889999998654 34455678999999999999999999999875 356899999999999999984 3456
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEEC-CCCceEEcccccccccccCCccccccccccccCCCChh
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG-EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE 156 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~-~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE 156 (303)
+++..++.++.|++.||+|||+.+ .+++||||||+||+++ .++.++|+|||++...... ......|++.|+|||
T Consensus 126 ~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE 200 (290)
T 1t4h_A 126 MKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPE 200 (290)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc----ccccccCCcCcCCHH
Confidence 899999999999999999999874 3499999999999998 7889999999998654332 122356899999999
Q ss_pred hhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 157 YARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
.+.+ .++.++||||||+++|+|++|..||....... ................ . ..+..+.++|.+
T Consensus 201 ~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~----~----~~~~~l~~li~~ 265 (290)
T 1t4h_A 201 MYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVKPASFD----K----VAIPEVKEIIEG 265 (290)
T ss_dssp GGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCCCGGGG----G----CCCHHHHHHHHH
T ss_pred HHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH------HHHHHHhccCCccccC----C----CCCHHHHHHHHH
Confidence 8874 58999999999999999999999986433211 1112222111111111 1 112368899999
Q ss_pred cccCCCCCCCCHHHHHHH
Q 048243 237 CVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 237 ~l~~dp~~Rpt~~el~~~ 254 (303)
||+.||.+|||+.|+++.
T Consensus 266 ~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 266 CIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HSCSSGGGSCCHHHHHTS
T ss_pred HccCChhhCCCHHHHhhC
Confidence 999999999999999863
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=305.28 Aligned_cols=225 Identities=23% Similarity=0.257 Sum_probs=183.3
Q ss_pred CCCcEEEEEEecCC---CcccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+|+.||||+++.. .....+.+..|..++..+ +||+|+.+++++.+....|+||||+++|+|..++. ....++
T Consensus 364 ~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~---~~~~~~ 440 (674)
T 3pfq_A 364 GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ---QVGRFK 440 (674)
T ss_dssp SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHH---HHSSCC
T ss_pred CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHH---hcCCCC
Confidence 57889999999753 233456788899999998 79999999999999999999999999999999984 345699
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..++.++.||+.||+|||+.+ |+||||||+|||++.+|.++|+|||+++...... .......||+.|+|||++.
T Consensus 441 ~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~ 515 (674)
T 3pfq_A 441 EPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIA 515 (674)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCTT--CCBCCCCSCSSSCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccCC--cccccccCCCcccCHhhhc
Confidence 9999999999999999999999 9999999999999999999999999997543222 2234467999999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++||||||+++|+|++|..||....... .......... ..+...+.++.+||.+||+
T Consensus 516 ~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~~-----------~~p~~~s~~~~~li~~lL~ 578 (674)
T 3pfq_A 516 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LFQSIMEHNV-----------AYPKSMSKEAVAICKGLMT 578 (674)
T ss_dssp CCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHSSCC-----------CCCTTSCHHHHHHHHHHSC
T ss_pred CCCCCccceEechHHHHHHHHcCCCCCCCCCHHH------HHHHHHhCCC-----------CCCccCCHHHHHHHHHHcc
Confidence 9999999999999999999999999996433211 1111221110 1112234578999999999
Q ss_pred CCCCCCCCH-----HHHHH
Q 048243 240 ENPNDRPSM-----LQVSS 253 (303)
Q Consensus 240 ~dp~~Rpt~-----~el~~ 253 (303)
.||.+||++ +||++
T Consensus 579 ~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 579 KHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp SSSTTCTTCSTTHHHHHHS
T ss_pred CCHHHCCCCCCCcHHHHhc
Confidence 999999998 67765
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=285.28 Aligned_cols=241 Identities=22% Similarity=0.219 Sum_probs=182.5
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC--------CCccccEEEEEE----eCCeeEEEEeecCCCChhhhhc
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ--------HVNLIRVLGFCI----DSEERMLVYEYMPNKSLDCYLF 70 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~ 70 (303)
..+|+.||||+++.. ....+.+.+|+.+++.++ |+||+++++++. .....++||||+ +++|.+++.
T Consensus 59 ~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~ 136 (397)
T 1wak_A 59 IQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWII 136 (397)
T ss_dssp TTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHH
T ss_pred cCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHH
Confidence 357899999999644 334567889999999985 788999999988 456789999999 556666654
Q ss_pred CccccccCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceEECCCC----------------------------
Q 048243 71 DPIRRLILDWKKRVHIIEGITQGLLYLQEY-SRLTIIHRDLKASNILLGEDM---------------------------- 121 (303)
Q Consensus 71 ~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~-~~~~i~H~dikp~nil~~~~~---------------------------- 121 (303)
.. ....+++..++.++.||+.||+|||++ | |+||||||+|||++.++
T Consensus 137 ~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (397)
T 1wak_A 137 KS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212 (397)
T ss_dssp HT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHHHHHC-----------------
T ss_pred hc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCcccc
Confidence 31 235689999999999999999999998 8 99999999999999775
Q ss_pred ---------------------ceEEcccccccccccCCccccccccccccCCCChhhhccCCCCCccchhhHHHHHHHHH
Q 048243 122 ---------------------KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180 (303)
Q Consensus 122 ---------------------~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~ 180 (303)
.++|+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 287 (397)
T 1wak_A 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELA 287 (397)
T ss_dssp ----CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHH
T ss_pred CCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHh
Confidence 7999999999765432 23346899999999999999999999999999999999
Q ss_pred hCCCCCccCCCCccccH---HHHHHHHHhCCC---------cceecccc-------------------CCCCCCHHHHHH
Q 048243 181 SGKRLSMLCGINENLSI---LEHAYELWKGGK---------GVEFVDSS-------------------LDDTNSPCKLMR 229 (303)
Q Consensus 181 ~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~---------~~~~~~~~-------------------~~~~~~~~~~~~ 229 (303)
+|..||........... ............ ........ .........+..
T Consensus 288 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (397)
T 1wak_A 288 TGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAG 367 (397)
T ss_dssp HSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHH
T ss_pred hCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHH
Confidence 99999976554432221 111111111100 00000000 001234566778
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 230 CLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 230 l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
+.+||.+||+.||++|||+.|+++.
T Consensus 368 ~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 368 FTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp HHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHhccChhhcCCHHHHhhC
Confidence 9999999999999999999999863
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=281.59 Aligned_cols=234 Identities=22% Similarity=0.345 Sum_probs=181.9
Q ss_pred CCcEEEEEEecCCCccc-----------------HHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhh
Q 048243 5 CGKVIAVKKLSKTSTQG-----------------FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 67 (303)
+|+.||||.+....... .+.+.+|+.++++++||||+++++++.+....++||||+++++|.+
T Consensus 53 ~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 132 (348)
T 2pml_X 53 DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILK 132 (348)
T ss_dssp TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSE
T ss_pred CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHH
Confidence 78999999986442111 1789999999999999999999999999999999999999999999
Q ss_pred h------hcCccccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc
Q 048243 68 Y------LFDPIRRLILDWKKRVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE 140 (303)
Q Consensus 68 ~------l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~ 140 (303)
+ +.. .....+++..++.++.|++.||+|||+ .| ++||||+|+||+++.++.++|+|||.+......
T Consensus 133 ~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 205 (348)
T 2pml_X 133 FDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK--- 205 (348)
T ss_dssp ESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECTTSCEEECCCTTCEECBTT---
T ss_pred HHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcCCCcEEEeccccccccccc---
Confidence 8 432 125679999999999999999999999 88 999999999999999999999999999765433
Q ss_pred ccccccccccCCCChhhhccC-CCCC-ccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccc--
Q 048243 141 ANTEQVVGTIGYIPPEYARQG-VYST-KSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS-- 216 (303)
Q Consensus 141 ~~~~~~~g~~~y~aPE~~~~~-~~~~-~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 216 (303)
......|+..|+|||.+.+. .++. ++||||||+++|+|++|..||....... . .......... .....
T Consensus 206 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~----~~~~i~~~~~-~~~~~~~ 277 (348)
T 2pml_X 206 -KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV--E----LFNNIRTKNI-EYPLDRN 277 (348)
T ss_dssp -EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH--H----HHHHHTSCCC-CCCCSSS
T ss_pred -cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH--H----HHHHHhccCc-CCccchh
Confidence 22345689999999999887 5666 9999999999999999999996543311 1 1111111110 00000
Q ss_pred cC--------CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 217 SL--------DDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 217 ~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
.. ........+..+.+|+.+||+.||.+|||+.|+++
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 278 HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp SSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 00001223457889999999999999999999987
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=281.54 Aligned_cols=239 Identities=23% Similarity=0.233 Sum_probs=171.0
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCC------eeEEEEeecCCCChhhhhcCcccc
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE------ERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~ 75 (303)
.+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.... ..++||||+++ +|.+++.
T Consensus 48 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----- 121 (371)
T 2xrw_A 48 ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ----- 121 (371)
T ss_dssp TTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHH-----
T ss_pred CCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHh-----
Confidence 578999999997542 334567889999999999999999999998664 78999999975 6777763
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCCh
Q 048243 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aP 155 (303)
..+++..+..++.||+.||+|||+.| |+||||||+||+++.++.++|+|||++....... ......|++.|+||
T Consensus 122 ~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aP 195 (371)
T 2xrw_A 122 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAP 195 (371)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-------------------CTTCCH
T ss_pred hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccccccccc---ccCCceecCCccCH
Confidence 24889999999999999999999999 9999999999999999999999999997654321 22335789999999
Q ss_pred hhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHH----------------HHHHHHhCCCc------cee
Q 048243 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILE----------------HAYELWKGGKG------VEF 213 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~----------------~~~~~~~~~~~------~~~ 213 (303)
|++.+..++.++|||||||++|+|++|..||...........+. ........... ...
T Consensus 196 E~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (371)
T 2xrw_A 196 EVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKL 275 (371)
T ss_dssp HHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHH
T ss_pred HHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhh
Confidence 99999999999999999999999999999996543211110000 00000000000 000
Q ss_pred ccccCCCC---CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 214 VDSSLDDT---NSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 214 ~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
........ .....+..+.+||.+||..||.+|||+.|+++.
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 276 FPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp SCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000000 012235678999999999999999999999874
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=279.19 Aligned_cols=228 Identities=25% Similarity=0.306 Sum_probs=174.6
Q ss_pred CCCcEEEEEEecCCC--------cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcccc
Q 048243 4 PCGKVIAVKKLSKTS--------TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~~~~valK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 75 (303)
.+|+.||||++.... ......+.+|+.++++++||||+++++++.... .++||||+++++|.+++. ..
T Consensus 33 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~---~~ 108 (322)
T 2ycf_A 33 KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVV---GN 108 (322)
T ss_dssp TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHS---TT
T ss_pred CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHh---cc
Confidence 578999999986542 122345789999999999999999999987655 899999999999999884 45
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCc---eEEcccccccccccCCccccccccccccCC
Q 048243 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK---PKISDFGLARIFAKESLEANTEQVVGTIGY 152 (303)
Q Consensus 76 ~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~---v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y 152 (303)
..+++..++.++.||+.||+|||++| ++||||||+||+++.++. ++|+|||++....... ......|++.|
T Consensus 109 ~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y 182 (322)
T 2ycf_A 109 KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTY 182 (322)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCH---HHHHHHSCCTT
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCccceeccccc---ccccccCCcCc
Confidence 56899999999999999999999999 999999999999987665 9999999997654321 12235689999
Q ss_pred CChhhhc---cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHH
Q 048243 153 IPPEYAR---QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMR 229 (303)
Q Consensus 153 ~aPE~~~---~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (303)
+|||++. ...++.++|||||||++|+|++|..||......... ..... . .... ... .. ....+..
T Consensus 183 ~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~---~-~~~~-~~~-~~----~~~~~~~ 250 (322)
T 2ycf_A 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQIT---S-GKYN-FIP-EV----WAEVSEK 250 (322)
T ss_dssp CCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--HHHHH---H-TCCC-CCH-HH----HTTSCHH
T ss_pred cCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--HHHHH---h-Cccc-cCc-hh----hhhcCHH
Confidence 9999874 456889999999999999999999999654433211 11110 0 0000 000 00 0012347
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 048243 230 CLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 230 l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
+.+++.+||..||.+|||+.++++
T Consensus 251 ~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 251 ALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHcccCHhhCCCHHHHhh
Confidence 889999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=287.14 Aligned_cols=245 Identities=20% Similarity=0.263 Sum_probs=170.9
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEe--CCeeEEEEeecCCCChhhhhcCcc------cc
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCID--SEERMLVYEYMPNKSLDCYLFDPI------RR 75 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~------~~ 75 (303)
.+++.||||++..... ...+.+|+.+++.++||||+++++++.. ....++||||+. ++|.+++.... ..
T Consensus 46 ~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~ 122 (405)
T 3rgf_A 46 KDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKP 122 (405)
T ss_dssp SCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-----
T ss_pred CCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccc
Confidence 3688999999975432 2568899999999999999999999965 678999999996 47777664211 12
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEE----CCCCceEEcccccccccccCCc-ccccccccccc
Q 048243 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL----GEDMKPKISDFGLARIFAKESL-EANTEQVVGTI 150 (303)
Q Consensus 76 ~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~----~~~~~v~l~Df~~~~~~~~~~~-~~~~~~~~g~~ 150 (303)
..+++..++.++.||+.||+|||+.| |+||||||+|||+ +.++.++|+|||++........ ........||+
T Consensus 123 ~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~ 199 (405)
T 3rgf_A 123 VQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199 (405)
T ss_dssp --CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCC
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecC
Confidence 34899999999999999999999999 9999999999999 6778999999999987654321 12233467899
Q ss_pred CCCChhhhccC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCc------cccHHHHHHHHHhCCCcceecc--------
Q 048243 151 GYIPPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINE------NLSILEHAYELWKGGKGVEFVD-------- 215 (303)
Q Consensus 151 ~y~aPE~~~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~-------- 215 (303)
.|+|||++.+. .++.++|||||||++|+|++|..||....... ....+..............+..
T Consensus 200 ~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~ 279 (405)
T 3rgf_A 200 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHS 279 (405)
T ss_dssp TTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHH
T ss_pred cccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchh
Confidence 99999999875 48999999999999999999999996543211 1112222222221111000000
Q ss_pred --------ccCCCCCCH--------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 216 --------SSLDDTNSP--------CKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 216 --------~~~~~~~~~--------~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
......... ..+..+.+||.+||+.||.+|||+.|+++.
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 280 TLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000 003467899999999999999999999874
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=273.38 Aligned_cols=227 Identities=27% Similarity=0.345 Sum_probs=180.0
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+|+.||+|++.... ....+.+.+|+.++++++||||+++++++......++|||++.+++|.+++. ....+++.
T Consensus 45 ~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~ 121 (287)
T 2wei_A 45 ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII---KRKRFSEH 121 (287)
T ss_dssp TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---HHSSCCHH
T ss_pred CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHH---hcCCCCHH
Confidence 478999999986542 3456789999999999999999999999999999999999999999988884 34568999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCC---CceEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED---MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~---~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
.++.++.||+.||+|||+.| ++||||+|+||+++.+ +.++|+|||++....... ......|++.|+|||.+
T Consensus 122 ~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~ 195 (287)
T 2wei_A 122 DAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVL 195 (287)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS---SCSCHHHHHTTCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCCC---ccccccCcccccChHHh
Confidence 99999999999999999999 9999999999999764 469999999987654332 12234578999999998
Q ss_pred ccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcc
Q 048243 159 RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238 (303)
Q Consensus 159 ~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 238 (303)
.+. ++.++||||||+++|+|++|..||....... .. ............. .....+..+.+++.+||
T Consensus 196 ~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~---~~~~~~~~~~~~~-------~~~~~~~~~~~li~~~l 261 (287)
T 2wei_A 196 RGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYD---IL---KRVETGKYAFDLP-------QWRTISDDAKDLIRKML 261 (287)
T ss_dssp TTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHHCCCCCCSG-------GGTTSCHHHHHHHHHHT
T ss_pred cCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHH---HH---HHHHcCCCCCCch-------hhhhcCHHHHHHHHHHc
Confidence 764 8899999999999999999999986433211 11 1111111110000 00112347889999999
Q ss_pred cCCCCCCCCHHHHHH
Q 048243 239 QENPNDRPSMLQVSS 253 (303)
Q Consensus 239 ~~dp~~Rpt~~el~~ 253 (303)
..||.+|||+.|+++
T Consensus 262 ~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 262 TFHPSLRITATQCLE 276 (287)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred ccChhhCcCHHHHhc
Confidence 999999999999987
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=274.50 Aligned_cols=239 Identities=23% Similarity=0.314 Sum_probs=177.5
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEE--------------eCCeeEEEEeecCCCChhhhh
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCI--------------DSEERMLVYEYMPNKSLDCYL 69 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--------------~~~~~~lv~e~~~~~~L~~~l 69 (303)
.+|+.||+|++........+.+.+|+.++++++||||+++++++. .....++||||+. ++|.+++
T Consensus 34 ~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~ 112 (320)
T 2i6l_A 34 DCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVL 112 (320)
T ss_dssp TTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHH
T ss_pred CCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHh
Confidence 468999999998776666778999999999999999999999874 3467899999997 6898888
Q ss_pred cCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEEC-CCCceEEcccccccccccCCc-cccccccc
Q 048243 70 FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG-EDMKPKISDFGLARIFAKESL-EANTEQVV 147 (303)
Q Consensus 70 ~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~-~~~~v~l~Df~~~~~~~~~~~-~~~~~~~~ 147 (303)
. ...+++..++.++.|++.||+|||+.| ++||||||+||+++ .++.++|+|||.+........ ........
T Consensus 113 ~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 185 (320)
T 2i6l_A 113 E----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185 (320)
T ss_dssp T----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGG
T ss_pred h----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCccccccCCCccccccccccc
Confidence 3 356899999999999999999999999 99999999999997 567899999999986543211 12223356
Q ss_pred cccCCCChhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCC----------Ccceeccc
Q 048243 148 GTIGYIPPEYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG----------KGVEFVDS 216 (303)
Q Consensus 148 g~~~y~aPE~~~~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~ 216 (303)
++..|+|||.+.+ ..++.++||||||+++|+|++|..||......... .......... ........
T Consensus 186 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (320)
T 2i6l_A 186 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM---QLILESIPVVHEEDRQELLSVIPVYIRN 262 (320)
T ss_dssp SCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHSCCCCHHHHHHHHTTSCHHHHH
T ss_pred ccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCchhhhhhhhhcCcccccc
Confidence 7899999998865 67899999999999999999999999654322111 1110000000 00000000
Q ss_pred cCC-CCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 217 SLD-DTN-----SPCKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 217 ~~~-~~~-----~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
... ... .+..+..+.++|.+||+.||.+|||+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 263 DMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000 000 0112457889999999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=273.67 Aligned_cols=230 Identities=22% Similarity=0.344 Sum_probs=174.0
Q ss_pred cCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCC--CCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccC
Q 048243 3 LPCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQ--HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 3 ~~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
..+|+.||+|++.... ....+.+.+|+.++++++ |+||+++++++......++||| +.+++|.+++. ....+
T Consensus 49 ~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~---~~~~~ 124 (313)
T 3cek_A 49 NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLK---KKKSI 124 (313)
T ss_dssp CTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHH---HCSSC
T ss_pred cCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHH---hcCCC
Confidence 4568999999997543 334577899999999996 5999999999999999999999 56789999984 34568
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
++..++.++.|++.||+|||+.+ ++||||||+||++++ +.++|+|||++................|++.|+|||.+
T Consensus 125 ~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 200 (313)
T 3cek_A 125 DPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200 (313)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHH
Confidence 99999999999999999999999 999999999999964 89999999999876544333333445789999999998
Q ss_pred cc-----------CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHH
Q 048243 159 RQ-----------GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKL 227 (303)
Q Consensus 159 ~~-----------~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
.+ ..++.++||||||+++|+|++|..||...... .............. ..+...+
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~---------~~~~~~~ 266 (313)
T 3cek_A 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAIIDPNHEI---------EFPDIPE 266 (313)
T ss_dssp TTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHCTTSCC---------CCCCCSC
T ss_pred hhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----HHHHHHHHhccccc---------CCcccch
Confidence 75 46788999999999999999999998543211 11111222111111 1111113
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 228 MRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 228 ~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
..+.+++.+||..||.+|||+.|+++.
T Consensus 267 ~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 267 KDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 478899999999999999999999863
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=287.35 Aligned_cols=242 Identities=17% Similarity=0.234 Sum_probs=174.0
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCC------eeEEEEeecCCCChhhhhcCcccccc
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE------ERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
..+..||+|++...... ..+|+.+++.++||||+++++++.... ..++||||++++.+............
T Consensus 62 ~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~ 137 (394)
T 4e7w_A 62 VESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQT 137 (394)
T ss_dssp TTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSC
T ss_pred CCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCC
Confidence 34556899988654322 236999999999999999999996543 37899999987544333322223567
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEEC-CCCceEEcccccccccccCCccccccccccccCCCChh
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG-EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE 156 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~-~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE 156 (303)
+++..++.++.||+.||+|||+.| |+||||||+||+++ .++.++|+|||+++....... .....|++.|+|||
T Consensus 138 ~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE 211 (394)
T 4e7w_A 138 MPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSYICSRYYRAPE 211 (394)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSSCSCGGGCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC---CcccccCcCccCHH
Confidence 999999999999999999999999 99999999999998 789999999999987543321 22356799999999
Q ss_pred hhccC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCc-------ceeccccCCC---C----
Q 048243 157 YARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG-------VEFVDSSLDD---T---- 221 (303)
Q Consensus 157 ~~~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~---~---- 221 (303)
++.+. .++.++|||||||++|+|++|..||......... ............ .......... .
T Consensus 212 ~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l---~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (394)
T 4e7w_A 212 LIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQL---VEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSK 288 (394)
T ss_dssp HHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHH
T ss_pred HHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHH
Confidence 98765 5899999999999999999999999754422211 111111110000 0000000000 0
Q ss_pred -CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccc
Q 048243 222 -NSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM--LKNE 258 (303)
Q Consensus 222 -~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~--L~~~ 258 (303)
..+..+..+.+||.+||+.||.+|||+.|+++. +++.
T Consensus 289 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 289 VFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred hccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 011133578999999999999999999999874 5443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=278.03 Aligned_cols=233 Identities=25% Similarity=0.325 Sum_probs=174.3
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCee------EEEEeecCCCChhhhhcCcccc
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER------MLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~~~ 75 (303)
.+|+.||||++.... ....+.+.+|+.+++.++||||+++++++...... ++||||+. ++|.+++.
T Consensus 65 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----- 138 (371)
T 4exu_A 65 RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG----- 138 (371)
T ss_dssp TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT-----
T ss_pred CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh-----
Confidence 578999999997643 23356788999999999999999999999877654 99999997 57877762
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCCh
Q 048243 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aP 155 (303)
..+++..+..++.|++.||+|||+.| |+||||||+||+++.++.++|+|||++...... .....|++.|+||
T Consensus 139 ~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aP 210 (371)
T 4exu_A 139 MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAP 210 (371)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCH
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccccccC-----cCCcccCccccCH
Confidence 33899999999999999999999999 999999999999999999999999998764332 2335679999999
Q ss_pred hhhcc-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceec------------cccCCCC-
Q 048243 156 EYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV------------DSSLDDT- 221 (303)
Q Consensus 156 E~~~~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~- 221 (303)
|.+.+ ..++.++|||||||++|+|++|..||......... ........ ....+.. .......
T Consensus 211 E~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (371)
T 4exu_A 211 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL---TQILKVTG-VPGTEFVQKLNDKAAKSYIQSLPQTPR 286 (371)
T ss_dssp HHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHC-CCCHHHHTTCSCHHHHHHHHHSCCCCC
T ss_pred HHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhC-CCcHHHHHHhhhhhhhhhhhccCCCcc
Confidence 99887 67899999999999999999999999654322111 11111100 0000000 0000000
Q ss_pred C-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 222 N-----SPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 222 ~-----~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
. .+..+..+.+||.+||+.||.+|||+.|+++.
T Consensus 287 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 287 KDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0 01124578899999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=278.80 Aligned_cols=240 Identities=18% Similarity=0.252 Sum_probs=181.2
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCC------ccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcccccc
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHV------NLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
.+|+.||+|+++.. ....+.+.+|+.+++.++|+ +++++++++......++||||+ +++|.+++... ....
T Consensus 38 ~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~-~~~~ 114 (339)
T 1z57_A 38 AGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKEN-GFLP 114 (339)
T ss_dssp TTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCC
T ss_pred CCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhc-CCCC
Confidence 47899999999644 33456788999999988655 4999999999999999999999 88999988542 2346
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC-------------------CCceEEcccccccccccCC
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-------------------DMKPKISDFGLARIFAKES 138 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-------------------~~~v~l~Df~~~~~~~~~~ 138 (303)
+++..++.++.||+.||+|||+.| ++||||||+||+++. ++.++|+|||.+......
T Consensus 115 ~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~- 190 (339)
T 1z57_A 115 FRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH- 190 (339)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-
T ss_pred CcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc-
Confidence 889999999999999999999999 999999999999987 668999999998764322
Q ss_pred ccccccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHH-----HHhCCCccee
Q 048243 139 LEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE-----LWKGGKGVEF 213 (303)
Q Consensus 139 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~ 213 (303)
.....||+.|+|||.+.+..++.++|||||||++|+|++|..||................. .+........
T Consensus 191 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 266 (339)
T 1z57_A 191 ----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKY 266 (339)
T ss_dssp ----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGG
T ss_pred ----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhH
Confidence 2335689999999999999999999999999999999999999965433221111111100 0000000000
Q ss_pred c-cc---------------------cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 214 V-DS---------------------SLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 214 ~-~~---------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
. .. ..........+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 267 FHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp EETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 0 00 00011223456788999999999999999999999853
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=281.19 Aligned_cols=244 Identities=21% Similarity=0.279 Sum_probs=178.9
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeC-----CeeEEEEeecCCCChhhhhcCcccccc
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-----EERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
.+|+.||||++.... ......+.+|+.+++.++||||+++++++... ...++|||++. ++|.+++. ...
T Consensus 34 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~----~~~ 108 (353)
T 2b9h_A 34 PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIS----TQM 108 (353)
T ss_dssp TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHH----HCC
T ss_pred CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHh----hcC
Confidence 478999999996543 33456788999999999999999999998754 67899999997 58888873 346
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccc--------cccccccc
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEA--------NTEQVVGT 149 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~--------~~~~~~g~ 149 (303)
+++..++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||++.......... ......|+
T Consensus 109 ~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt 185 (353)
T 2b9h_A 109 LSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185 (353)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCC
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhcccc
Confidence 899999999999999999999999 9999999999999999999999999998765332111 12234689
Q ss_pred cCCCChhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcc------------eeccc
Q 048243 150 IGYIPPEYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV------------EFVDS 216 (303)
Q Consensus 150 ~~y~aPE~~~~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~ 216 (303)
+.|+|||++.+ ..++.++|||||||++|+|++|..||......... ............. +....
T Consensus 186 ~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (353)
T 2b9h_A 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL---LLIFGIIGTPHSDNDLRCIESPRAREYIKS 262 (353)
T ss_dssp GGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCSTTTTTTCCCHHHHHHHHT
T ss_pred ccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH---HHHHHHhCCCchhccccccccchhhHHhhc
Confidence 99999998765 67899999999999999999999999654322111 1111111100000 00000
Q ss_pred cCC-CCC-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--Hhccc
Q 048243 217 SLD-DTN-----SPCKLMRCLEIALLCVQENPNDRPSMLQVSS--MLKNE 258 (303)
Q Consensus 217 ~~~-~~~-----~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~--~L~~~ 258 (303)
... ... .+..+..+.+||.+||+.||.+|||+.|+++ +++..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 263 LPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp SCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred ccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 000 000 0123457889999999999999999999987 35443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=278.03 Aligned_cols=240 Identities=22% Similarity=0.328 Sum_probs=176.7
Q ss_pred cEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHH
Q 048243 7 KVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 7 ~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~ 84 (303)
..||+|+++... ....+.+.+|+.++++++||||+++++++.+....++||||+++++|.+++.. ....+++..++
T Consensus 56 ~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~ 133 (319)
T 2y4i_B 56 GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTR 133 (319)
T ss_dssp SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTS--SCCCCCSHHHH
T ss_pred CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHh--cCCCCCHHHHH
Confidence 358999986542 23345677899999999999999999999999999999999999999999854 23468899999
Q ss_pred HHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCc---cccccccccccCCCChhhhcc-
Q 048243 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL---EANTEQVVGTIGYIPPEYARQ- 160 (303)
Q Consensus 85 ~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~- 160 (303)
.++.|++.||+|||+.| ++||||||+||+++ ++.++|+|||++........ ........|++.|+|||.+.+
T Consensus 134 ~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 209 (319)
T 2y4i_B 134 QIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209 (319)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCB
T ss_pred HHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhc
Confidence 99999999999999999 99999999999998 67999999999865432211 122233458999999999875
Q ss_pred --------CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHH
Q 048243 161 --------GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLE 232 (303)
Q Consensus 161 --------~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 232 (303)
..++.++||||||+++|+|++|..||....... . ............... ..+..+.+
T Consensus 210 ~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~-~~~~~~~~~~~~~~~--------~~~~~l~~ 274 (319)
T 2y4i_B 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA------I-IWQMGTGMKPNLSQI--------GMGKEISD 274 (319)
T ss_dssp SCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH------H-HHHHHTTCCCCCCCS--------SCCTTHHH
T ss_pred cccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------H-HHHhccCCCCCCCcC--------CCCHHHHH
Confidence 346889999999999999999999986432211 1 111111111111110 12236889
Q ss_pred HHHHcccCCCCCCCCHHHHHHHhccccCCCCCCCC
Q 048243 233 IALLCVQENPNDRPSMLQVSSMLKNETTNRNTPKK 267 (303)
Q Consensus 233 li~~~l~~dp~~Rpt~~el~~~L~~~~~~~~~~~~ 267 (303)
++.+||..||.+|||+.++++.|++..........
T Consensus 275 li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~ 309 (319)
T 2y4i_B 275 ILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSH 309 (319)
T ss_dssp HHHHHHCSSTTTSCCHHHHHHHHTTC---------
T ss_pred HHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCC
Confidence 99999999999999999999999988765544333
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=275.47 Aligned_cols=229 Identities=20% Similarity=0.281 Sum_probs=165.5
Q ss_pred CCCcEEEEEEecCCCc--ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCc-cccccCCH
Q 048243 4 PCGKVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDP-IRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~l~~ 80 (303)
.+|+.||+|+++.... ...+.+.++...++.++||||+++++++.+....++||||++ ++|.+++... .....+++
T Consensus 30 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~ 108 (290)
T 3fme_A 30 PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPE 108 (290)
T ss_dssp TTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCH
T ss_pred CCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCH
Confidence 5789999999975532 222334455556788899999999999999999999999997 4787776432 23467999
Q ss_pred HHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhh-
Q 048243 81 KKRVHIIEGITQGLLYLQEY-SRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA- 158 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~-~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~- 158 (303)
..++.++.|++.||+|||+. | ++||||||+||+++.++.++|+|||++........ .....|++.|+|||.+
T Consensus 109 ~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~ 182 (290)
T 3fme_A 109 DILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA---KDIDAGCKPYMAPERIN 182 (290)
T ss_dssp HHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------------------CCCCCCSCHHHHS
T ss_pred HHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccccccc---ccccCCCccccChhhcC
Confidence 99999999999999999998 8 99999999999999999999999999876544321 2224689999999996
Q ss_pred ---ccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHH
Q 048243 159 ---RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235 (303)
Q Consensus 159 ---~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
.+..++.++||||||+++|+|++|..||....... ............ .......+..+.+++.
T Consensus 183 ~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~---------~~~~~~~~~~~~~li~ 248 (290)
T 3fme_A 183 PELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-----QQLKQVVEEPSP---------QLPADKFSAEFVDFTS 248 (290)
T ss_dssp CCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-----HHHHHHHHSCCC---------CCCTTTSCHHHHHHHH
T ss_pred hhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-----HHHHHHhccCCC---------CcccccCCHHHHHHHH
Confidence 45568889999999999999999999986432211 111112221111 0111123447889999
Q ss_pred HcccCCCCCCCCHHHHHH
Q 048243 236 LCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 236 ~~l~~dp~~Rpt~~el~~ 253 (303)
+||+.||.+|||+.|+++
T Consensus 249 ~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 249 QCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHTCSSGGGSCCHHHHTT
T ss_pred HHhhcChhhCcCHHHHHh
Confidence 999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=283.83 Aligned_cols=240 Identities=24% Similarity=0.288 Sum_probs=171.7
Q ss_pred cCCCcEEEEEEecCCCc-----------ccHHHHHHHHHHHhcCCCCccccEEEEEEeC-----CeeEEEEeecCCCChh
Q 048243 3 LPCGKVIAVKKLSKTST-----------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-----EERMLVYEYMPNKSLD 66 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~ 66 (303)
..+|+.||||++..... ...+.+.+|+.++++++||||+++++++... ...++||||+. |+|.
T Consensus 43 ~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~ 121 (362)
T 3pg1_A 43 DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLA 121 (362)
T ss_dssp CTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHH
T ss_pred CCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHH
Confidence 45689999999854321 1236789999999999999999999998543 36799999997 5787
Q ss_pred hhhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcccccccc
Q 048243 67 CYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQV 146 (303)
Q Consensus 67 ~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~ 146 (303)
+++.. ....+++..++.++.||+.||+|||+.| ++||||||+||+++.++.++|+|||++....... .....
T Consensus 122 ~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~ 193 (362)
T 3pg1_A 122 QVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHY 193 (362)
T ss_dssp HHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCTTC----------------
T ss_pred HHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEEecCccccccccc---cccee
Confidence 77753 3456899999999999999999999999 9999999999999999999999999987543322 22335
Q ss_pred ccccCCCChhhhcc-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcc-----------eec
Q 048243 147 VGTIGYIPPEYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGV-----------EFV 214 (303)
Q Consensus 147 ~g~~~y~aPE~~~~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~ 214 (303)
.|++.|+|||.+.+ ..++.++|||||||++|+|++|..||......... ............. ...
T Consensus 194 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~ 270 (362)
T 3pg1_A 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL---NKIVEVVGTPKIEDVVMFSSPSARDYL 270 (362)
T ss_dssp --CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCHHHHHHTSCHHHHHHT
T ss_pred cccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCChHHhhhccchhhhHHH
Confidence 68899999999877 67899999999999999999999999654322211 1111111100000 000
Q ss_pred cccCC---CC----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 215 DSSLD---DT----NSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 215 ~~~~~---~~----~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
..... .. ..+..+..+.+||.+||+.||.+|||+.|+++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 271 RNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp TTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 00000 00 001123468899999999999999999999874
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=285.47 Aligned_cols=237 Identities=19% Similarity=0.254 Sum_probs=174.9
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeC--------------------------------
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-------------------------------- 50 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-------------------------------- 50 (303)
..+|+.||||++...... ..+|+.+++.++||||+++++++...
T Consensus 29 ~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 104 (383)
T 3eb0_A 29 IESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVI 104 (383)
T ss_dssp TTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC--------------------------------
T ss_pred CCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccccccccccccccccccccccccccccc
Confidence 368999999999655322 24699999999999999999998543
Q ss_pred ------CeeEEEEeecCCCChhhhhcCc-cccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEEC-CCCc
Q 048243 51 ------EERMLVYEYMPNKSLDCYLFDP-IRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG-EDMK 122 (303)
Q Consensus 51 ------~~~~lv~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~-~~~~ 122 (303)
...++||||++ ++|.+.+... ..+..+++..++.++.||+.||+|||+.| |+||||||+||+++ .++.
T Consensus 105 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~ 180 (383)
T 3eb0_A 105 VNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNT 180 (383)
T ss_dssp -----CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEEETTTTE
T ss_pred ccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc---CccCccCHHHEEEcCCCCc
Confidence 34889999998 5777666431 23567999999999999999999999999 99999999999997 6889
Q ss_pred eEEcccccccccccCCccccccccccccCCCChhhhccC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHH
Q 048243 123 PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA 201 (303)
Q Consensus 123 v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~ 201 (303)
++|+|||++....... ......|++.|+|||.+.+. .++.++||||+||++|+|++|..||......+.. ...
T Consensus 181 ~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~i 254 (383)
T 3eb0_A 181 LKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQL---VRI 254 (383)
T ss_dssp EEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH
T ss_pred EEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHH---HHH
Confidence 9999999998654332 12234679999999998775 4899999999999999999999999654322211 111
Q ss_pred HHHHhCCCc----------ceeccccCCCC-----CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 202 YELWKGGKG----------VEFVDSSLDDT-----NSPCKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 202 ~~~~~~~~~----------~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
......... .....+..... .+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 255 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 255 IQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111000 00000000000 11123446889999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=279.99 Aligned_cols=233 Identities=24% Similarity=0.280 Sum_probs=174.8
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCe------eEEEEeecCCCChhhhhcCcccc
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE------RMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~~ 75 (303)
.+|+.||||++.... ....+.+.+|+.+++.++||||+++++++..... .++||||+. ++|.+++.
T Consensus 47 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----- 120 (353)
T 3coi_A 47 RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG----- 120 (353)
T ss_dssp TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT-----
T ss_pred CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc-----
Confidence 579999999997543 2335678899999999999999999999987654 499999997 57877762
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCCh
Q 048243 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aP 155 (303)
..+++..++.++.||+.||+|||+.| ++||||||+||+++.++.++|+|||.+...... .....|++.|+||
T Consensus 121 ~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aP 192 (353)
T 3coi_A 121 LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAP 192 (353)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC-------------CCSBCCSCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCCCC-----ccccccCcCcCCH
Confidence 24899999999999999999999999 999999999999999999999999998764322 2235679999999
Q ss_pred hhhcc-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCC------------------cceeccc
Q 048243 156 EYARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGK------------------GVEFVDS 216 (303)
Q Consensus 156 E~~~~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~ 216 (303)
|.+.+ ..++.++||||||+++|+|++|..||........ ............ .......
T Consensus 193 E~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (353)
T 3coi_A 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRK 269 (353)
T ss_dssp HHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH---HHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSC
T ss_pred HHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCc
Confidence 99877 6789999999999999999999999965432211 111111100000 0000000
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 217 SLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 217 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
.+ ....+..+..+.+||.+||..||.+|||+.++++.
T Consensus 270 ~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 270 DF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 01112335578999999999999999999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=284.32 Aligned_cols=176 Identities=21% Similarity=0.234 Sum_probs=149.9
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcC------CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcccccc
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKL------QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
.+|+.||||+++.. ......+.+|+.+++.+ .|+||+++++++......++|||++. ++|.+++... ....
T Consensus 120 ~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~ 196 (429)
T 3kvw_A 120 KVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKN-KFQG 196 (429)
T ss_dssp TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHT-TTCC
T ss_pred CCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhc-cCCC
Confidence 56899999999654 23345677888888877 57799999999999999999999996 6888888542 2345
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCc--eEEcccccccccccCCccccccccccccCCCCh
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK--PKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~--v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aP 155 (303)
+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. ++|+|||++...... .....||+.|+||
T Consensus 197 ~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aP 268 (429)
T 3kvw_A 197 FSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAP 268 (429)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccceecCCc-----ccccCCCCCccCh
Confidence 899999999999999999999999 999999999999999887 999999998654322 2235689999999
Q ss_pred hhhccCCCCCccchhhHHHHHHHHHhCCCCCccCC
Q 048243 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~ 190 (303)
|++.+..++.++|||||||++|+|++|.+||....
T Consensus 269 E~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 269 EVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp HHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999999999999986543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=273.01 Aligned_cols=230 Identities=24% Similarity=0.348 Sum_probs=171.3
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEe-------------CCeeEEEEeecCCCChhhhhc
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCID-------------SEERMLVYEYMPNKSLDCYLF 70 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~l~ 70 (303)
.+|+.||||++... ....+.+.+|+.++++++||||+++++++.+ ....++||||+++++|.+++.
T Consensus 29 ~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 107 (303)
T 1zy4_A 29 LDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH 107 (303)
T ss_dssp TTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHH
T ss_pred CCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhh
Confidence 57899999999643 3345678899999999999999999999865 346799999999999999995
Q ss_pred CccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCc-----------
Q 048243 71 DPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL----------- 139 (303)
Q Consensus 71 ~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~----------- 139 (303)
. ....+++..++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||.+........
T Consensus 108 ~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 182 (303)
T 1zy4_A 108 S--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182 (303)
T ss_dssp H--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC--------------
T ss_pred c--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccc
Confidence 3 3446788999999999999999999999 99999999999999999999999999876543210
Q ss_pred -cccccccccccCCCChhhhccC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceecccc
Q 048243 140 -EANTEQVVGTIGYIPPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSS 217 (303)
Q Consensus 140 -~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (303)
........|++.|+|||.+.+. .++.++||||||+++|+|++ ||... ..... ......... ..
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~-----~~~~~-~~~~~~~~~------~~ 247 (303)
T 1zy4_A 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG-----MERVN-ILKKLRSVS------IE 247 (303)
T ss_dssp -----------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHHHH-HHHHHHSTT------CC
T ss_pred cccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc-----hhHHH-HHHhccccc------cc
Confidence 1122345689999999999865 68999999999999999998 33211 01111 111111111 01
Q ss_pred CCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 218 LDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 218 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
.........+..+.+++.+||+.||.+|||+.++++.
T Consensus 248 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 248 FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1111222334468899999999999999999999974
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=290.60 Aligned_cols=236 Identities=21% Similarity=0.285 Sum_probs=172.0
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeC------CeeEEEEeecCCCChhhhhcC-ccccc
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------EERMLVYEYMPNKSLDCYLFD-PIRRL 76 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~-~~~~~ 76 (303)
.+|+.||||++..... ...+|+++++.++||||+++++++... ...++||||+.+ ++.+.+.. .....
T Consensus 77 ~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~ 151 (420)
T 1j1b_A 77 DSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 151 (420)
T ss_dssp TTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTC
T ss_pred CCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccC
Confidence 4799999999965432 234699999999999999999998642 236799999976 55555432 12346
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCC-CceEEcccccccccccCCccccccccccccCCCCh
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED-MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~-~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aP 155 (303)
.+++..++.++.||+.||+|||+.| |+||||||+|||++.+ +.+||+|||+++....... .....|++.|+||
T Consensus 152 ~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~t~~y~aP 225 (420)
T 1j1b_A 152 TLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAP 225 (420)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCTTSCCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC---ceeeeeCCCcCCH
Confidence 7999999999999999999999999 9999999999999965 5689999999986543321 2235689999999
Q ss_pred hhhccC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCC----------CcceeccccCCCC---
Q 048243 156 EYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGG----------KGVEFVDSSLDDT--- 221 (303)
Q Consensus 156 E~~~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~--- 221 (303)
|++.+. .++.++|||||||++|+|++|..||........ +.......... ....+..+.....
T Consensus 226 E~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~---l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~ 302 (420)
T 1j1b_A 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ---LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWT 302 (420)
T ss_dssp HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHH
T ss_pred HHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHH
Confidence 998765 689999999999999999999999975432221 11111111100 0000000000000
Q ss_pred --CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 222 --NSPCKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 222 --~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
..+..+..+.+||.+||..||.+|||+.|+++
T Consensus 303 ~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 303 KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 01122457899999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=281.40 Aligned_cols=234 Identities=16% Similarity=0.219 Sum_probs=155.1
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEe----CCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCID----SEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+|+.||||++.... ....+....++.++||||+++++++.. ....++||||+++|+|.+++... ....++
T Consensus 52 ~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~l~ 126 (336)
T 3fhr_A 52 RTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQER-GDQAFT 126 (336)
T ss_dssp TTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC--CCCCB
T ss_pred CCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhc-CCCCCC
Confidence 479999999996532 222233344566799999999999986 44589999999999999999642 234699
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCC---CceEEcccccccccccCCccccccccccccCCCChh
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED---MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE 156 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~---~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE 156 (303)
+..++.++.|++.||+|||+.| ++||||||+||+++.+ +.++|+|||++....... .....|++.|+|||
T Consensus 127 ~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE 199 (336)
T 3fhr_A 127 EREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPE 199 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC----------------------
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccceeccccc----cccCCCCcCccChh
Confidence 9999999999999999999999 9999999999999864 459999999987654322 22356799999999
Q ss_pred hhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 157 YARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
.+.+..++.++||||||+++|+|++|..||.............. ..... ............+..+.+|+.+
T Consensus 200 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~~~~------~~~~~~~~~~~~~~~~~~li~~ 270 (336)
T 3fhr_A 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR---RIRLG------QYGFPNPEWSEVSEDAKQLIRL 270 (336)
T ss_dssp ----CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------------CCCTTTSTTCCHHHHHHHHH
T ss_pred hhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH---hhhcc------ccccCchhhccCCHHHHHHHHH
Confidence 99888889999999999999999999999964433221110000 00000 0000111111234578899999
Q ss_pred cccCCCCCCCCHHHHHH--Hhccc
Q 048243 237 CVQENPNDRPSMLQVSS--MLKNE 258 (303)
Q Consensus 237 ~l~~dp~~Rpt~~el~~--~L~~~ 258 (303)
||+.||.+|||+.|+++ ++.+.
T Consensus 271 ~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 271 LLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp HSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred HCCCChhHCcCHHHHhcCcccccc
Confidence 99999999999999998 45543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=277.06 Aligned_cols=239 Identities=24% Similarity=0.313 Sum_probs=177.3
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcC---CCCccccEEEEEE-----eCCeeEEEEeecCCCChhhhhcCcc
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKL---QHVNLIRVLGFCI-----DSEERMLVYEYMPNKSLDCYLFDPI 73 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~ 73 (303)
.+|+.||+|+++... ......+.+|+.+++.+ +||||+++++++. .....++||||+. ++|.+++...
T Consensus 35 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~- 112 (326)
T 1blx_A 35 NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKV- 112 (326)
T ss_dssp TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHS-
T ss_pred CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhc-
Confidence 568999999986432 22223456777777666 8999999999987 4567899999997 6998888542
Q ss_pred ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCC
Q 048243 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYI 153 (303)
Q Consensus 74 ~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~ 153 (303)
....+++..++.++.|++.||+|||+.| ++||||||+||+++.++.++|+|||.+....... ......|+..|+
T Consensus 113 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~ 186 (326)
T 1blx_A 113 PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYR 186 (326)
T ss_dssp CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTC
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCcccccccCCC---Ccccccccccee
Confidence 2345899999999999999999999999 9999999999999999999999999987654322 223456899999
Q ss_pred ChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceec------cccC-------CC
Q 048243 154 PPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV------DSSL-------DD 220 (303)
Q Consensus 154 aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~-------~~ 220 (303)
|||.+.+..++.++||||||+++|+|++|..||........ ...............+. .... ..
T Consensus 187 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (326)
T 1blx_A 187 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIE 263 (326)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGG
T ss_pred CHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcCCCCcccCccccccchhhhcccCcchhh
Confidence 99999998999999999999999999999999865432221 11111111100000000 0000 00
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 221 TNSPCKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 221 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
......+..+.+|+.+||..||.+|||+.|+++
T Consensus 264 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 264 KFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 011123457889999999999999999999985
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=284.80 Aligned_cols=231 Identities=22% Similarity=0.278 Sum_probs=170.0
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccc----cC
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRL----IL 78 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~----~l 78 (303)
.+|+.||||++... ..+.+.+|+.+++++ +||||+++++++.+....++|||||. |+|.+++....... ..
T Consensus 37 ~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~ 112 (434)
T 2rio_A 37 FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQ 112 (434)
T ss_dssp SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC----------
T ss_pred ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhc
Confidence 46899999998653 235678899999987 89999999999999999999999996 69999986432111 11
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCC-------------CceEEcccccccccccCCcc--ccc
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED-------------MKPKISDFGLARIFAKESLE--ANT 143 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~-------------~~v~l~Df~~~~~~~~~~~~--~~~ 143 (303)
.+..++.++.||+.||+|||+.| |+||||||+||+++.+ +.++|+|||++......... ...
T Consensus 113 ~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~ 189 (434)
T 2rio_A 113 KEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189 (434)
T ss_dssp --CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC---------
T ss_pred cchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeee
Confidence 23345789999999999999999 9999999999999654 48999999999876543221 122
Q ss_pred cccccccCCCChhhhcc-------CCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceecc
Q 048243 144 EQVVGTIGYIPPEYARQ-------GVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVD 215 (303)
Q Consensus 144 ~~~~g~~~y~aPE~~~~-------~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (303)
....||+.|+|||++.+ ..++.++|||||||++|+|++ |..||....... ..........
T Consensus 190 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--------~~i~~~~~~~---- 257 (434)
T 2rio_A 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--------SNIIRGIFSL---- 257 (434)
T ss_dssp -----CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--------HHHHHTCCCC----
T ss_pred cCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--------HHHhcCCCCc----
Confidence 34578999999999976 568899999999999999999 899985332111 1111111111
Q ss_pred ccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 216 SSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 216 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
...........+.++.++|.+||+.||.+|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 258 DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11122234566778999999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=277.31 Aligned_cols=239 Identities=17% Similarity=0.200 Sum_probs=178.4
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-----------CCccccEEEEEEeCC----eeEEEEeecCCCChhhh
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-----------HVNLIRVLGFCIDSE----ERMLVYEYMPNKSLDCY 68 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~ 68 (303)
.+|+.||||++... ....+.+.+|+.++++++ |+||+++++++.... ..++|||++ +++|.++
T Consensus 42 ~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~ 119 (373)
T 1q8y_A 42 VNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLAL 119 (373)
T ss_dssp TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHH
T ss_pred CCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHH
Confidence 57899999999643 334467888999999886 889999999998654 789999999 8899998
Q ss_pred hcCccccccCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceEEC------CCCceEEcccccccccccCCccc
Q 048243 69 LFDPIRRLILDWKKRVHIIEGITQGLLYLQEY-SRLTIIHRDLKASNILLG------EDMKPKISDFGLARIFAKESLEA 141 (303)
Q Consensus 69 l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~-~~~~i~H~dikp~nil~~------~~~~v~l~Df~~~~~~~~~~~~~ 141 (303)
+... ....+++..++.++.||+.||+|||++ | |+||||||+||+++ ..+.++|+|||++......
T Consensus 120 ~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~---- 191 (373)
T 1q8y_A 120 IKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH---- 191 (373)
T ss_dssp HHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC----
T ss_pred HHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC----
Confidence 8542 234589999999999999999999998 8 99999999999994 4458999999999765432
Q ss_pred cccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccH---HHHHHHHHhCCCcc-------
Q 048243 142 NTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSI---LEHAYELWKGGKGV------- 211 (303)
Q Consensus 142 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~------- 211 (303)
.....||+.|+|||.+.+..++.++|||||||++|+|++|..||........... ..............
T Consensus 192 -~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 270 (373)
T 1q8y_A 192 -YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKY 270 (373)
T ss_dssp -CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTT
T ss_pred -CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccch
Confidence 2234689999999999999999999999999999999999999975543222111 11111111100000
Q ss_pred --------eeccc-------------cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 212 --------EFVDS-------------SLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 212 --------~~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
..... ......+...+..+.+||.+||+.||.+|||+.|+++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 271 TRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred hhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence 00000 0011234567788999999999999999999999987
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=299.39 Aligned_cols=232 Identities=20% Similarity=0.344 Sum_probs=181.2
Q ss_pred CCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 5 CGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+..||+|.++... ....+.+.+|+.++++++||||+++++++. ++..++||||+++|+|.+++.. ....+++..+
T Consensus 417 ~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~ 493 (656)
T 2j0j_A 417 PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV--RKFSLDLASL 493 (656)
T ss_dssp CCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHH--TTTTCCHHHH
T ss_pred ccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHh--ccCCCCHHHH
Confidence 35679999987543 334567899999999999999999999985 4568999999999999999853 3346899999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
+.++.|++.||+|||+.| |+||||||+||+++.++.++|+|||++......... ......+++.|+|||.+.+..+
T Consensus 494 ~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~ 569 (656)
T 2j0j_A 494 ILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRF 569 (656)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCC
Confidence 999999999999999999 999999999999999999999999999876443221 1223456789999999998899
Q ss_pred CCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC
Q 048243 164 STKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 242 (303)
+.++||||||+++|+|++ |..||....... ... ...... .. ..++..+..+.+++.+||..||
T Consensus 570 ~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~---~i~~~~-~~---------~~~~~~~~~l~~li~~~l~~dP 633 (656)
T 2j0j_A 570 TSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG---RIENGE-RL---------PMPPNCPPTLYSLMTKCWAYDP 633 (656)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH---HHHHTC-CC---------CCCTTCCHHHHHHHHHHTCSSG
T ss_pred CchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHH---HHHcCC-CC---------CCCccccHHHHHHHHHHcCCCh
Confidence 999999999999999997 888986433221 111 111111 11 1112233578899999999999
Q ss_pred CCCCCHHHHHHHhcccc
Q 048243 243 NDRPSMLQVSSMLKNET 259 (303)
Q Consensus 243 ~~Rpt~~el~~~L~~~~ 259 (303)
.+|||+.++++.|++..
T Consensus 634 ~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 634 SRRPRFTELKAQLSTIL 650 (656)
T ss_dssp GGSCCHHHHHHHHHHHH
T ss_pred hHCcCHHHHHHHHHHHH
Confidence 99999999999987653
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=275.96 Aligned_cols=248 Identities=18% Similarity=0.213 Sum_probs=177.1
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCe-------eEEEEeecCCCChhhhhcC-cccc
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE-------RMLVYEYMPNKSLDCYLFD-PIRR 75 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-------~~lv~e~~~~~~L~~~l~~-~~~~ 75 (303)
.+|+.||||++..... ......+++..+..++||||+++++++..... .++||||+.++ |...+.. ....
T Consensus 46 ~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~ 123 (360)
T 3e3p_A 46 STGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQ 123 (360)
T ss_dssp TTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCB-HHHHHHHHHTTT
T ss_pred CCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeeccccc-HHHHHHHHhhcc
Confidence 5789999999865432 22456678888899999999999999976433 78999999864 4433322 1345
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEecCCCCCceEECC-CCceEEcccccccccccCCccccccccccccCC
Q 048243 76 LILDWKKRVHIIEGITQGLLYLQ--EYSRLTIIHRDLKASNILLGE-DMKPKISDFGLARIFAKESLEANTEQVVGTIGY 152 (303)
Q Consensus 76 ~~l~~~~~~~~~~~i~~~l~~Lh--~~~~~~i~H~dikp~nil~~~-~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y 152 (303)
..+++..++.++.|++.||.||| +.| |+||||||+||+++. ++.++|+|||++........ .....|++.|
T Consensus 124 ~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y 197 (360)
T 3e3p_A 124 VAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP---NVAYICSRYY 197 (360)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGG
T ss_pred cCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCC---cccccCCcce
Confidence 66889999999999999999999 888 999999999999996 89999999999986654322 2234679999
Q ss_pred CChhhhccCC-CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHH--------HHHHhC-CCcceeccc------
Q 048243 153 IPPEYARQGV-YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHA--------YELWKG-GKGVEFVDS------ 216 (303)
Q Consensus 153 ~aPE~~~~~~-~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~-~~~~~~~~~------ 216 (303)
+|||++.+.. ++.++|||||||++|+|++|..||............... ...... .........
T Consensus 198 ~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (360)
T 3e3p_A 198 RAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWS 277 (360)
T ss_dssp CCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHH
T ss_pred eCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcc
Confidence 9999986654 899999999999999999999999654322211111110 000000 000000000
Q ss_pred cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hcccc
Q 048243 217 SLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM--LKNET 259 (303)
Q Consensus 217 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~--L~~~~ 259 (303)
..........+..+.+|+.+||+.||.+|||+.|+++. +++..
T Consensus 278 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 278 NVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred cccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 00001111235688999999999999999999999874 44443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=273.68 Aligned_cols=176 Identities=23% Similarity=0.273 Sum_probs=147.8
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CC-----ccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcccccc
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HV-----NLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
.+|+.||||+++.. ......+..|+.+++.++ |+ +|+++++++......++||||+. ++|.+++... ....
T Consensus 77 ~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~ 153 (382)
T 2vx3_A 77 VEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNT-NFRG 153 (382)
T ss_dssp TTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHT-TTSC
T ss_pred CCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhc-CcCC
Confidence 47899999999743 233466778888888884 55 49999999999999999999996 5898888542 2245
Q ss_pred CCHHHHHHHHHHHHHHHHHHHh--CCCCCeEecCCCCCceEEC--CCCceEEcccccccccccCCccccccccccccCCC
Q 048243 78 LDWKKRVHIIEGITQGLLYLQE--YSRLTIIHRDLKASNILLG--EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYI 153 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~--~~~~~i~H~dikp~nil~~--~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~ 153 (303)
+++..++.++.|++.||+|||. .| |+||||||+|||++ .++.++|+|||++...... .....||+.|+
T Consensus 154 ~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~ 225 (382)
T 2vx3_A 154 VSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYR 225 (382)
T ss_dssp CCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGC
T ss_pred CCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEeccCceecccc-----cccccCCcccc
Confidence 8999999999999999999994 56 99999999999995 4778999999999765432 22356899999
Q ss_pred ChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCC
Q 048243 154 PPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCG 190 (303)
Q Consensus 154 aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~ 190 (303)
|||++.+..++.++|||||||++|+|++|..||....
T Consensus 226 aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 226 SPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999999999999999997543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=281.86 Aligned_cols=227 Identities=25% Similarity=0.289 Sum_probs=167.6
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.||||++...... .+.+|+.+++++ +||||+++++++.+....|+|||+|. |+|.+++... ........
T Consensus 46 ~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~--~~~~~~~~ 119 (432)
T 3p23_A 46 FDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQK--DFAHLGLE 119 (432)
T ss_dssp SSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSS--SCCCCSSC
T ss_pred eCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhc--CCCccchh
Confidence 47899999999755432 356799999999 89999999999999999999999996 5999988642 22344456
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC-----CCceEEcccccccccccCCc-cccccccccccCCCChh
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-----DMKPKISDFGLARIFAKESL-EANTEQVVGTIGYIPPE 156 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-----~~~v~l~Df~~~~~~~~~~~-~~~~~~~~g~~~y~aPE 156 (303)
++.++.||+.||+|||+.+ |+||||||+||+++. ...++|+|||++........ ........||+.|+|||
T Consensus 120 ~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE 196 (432)
T 3p23_A 120 PITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196 (432)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGG
T ss_pred HHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChh
Confidence 6789999999999999999 999999999999953 23588999999987653321 12233457899999999
Q ss_pred hhcc---CCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHH
Q 048243 157 YARQ---GVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLE 232 (303)
Q Consensus 157 ~~~~---~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 232 (303)
++.+ ..++.++|||||||++|+|++ |..||....... ........... ........+..+.+
T Consensus 197 ~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~--------~~~~~~~~~~~------~~~~~~~~~~~~~~ 262 (432)
T 3p23_A 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ--------ANILLGACSLD------CLHPEKHEDVIARE 262 (432)
T ss_dssp GTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH--------HHHHTTCCCCT------TSCTTCHHHHHHHH
T ss_pred hhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH--------HHHHhccCCcc------ccCccccccHHHHH
Confidence 9974 557889999999999999999 888884321110 11111111100 01112234556889
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 048243 233 IALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 233 li~~~l~~dp~~Rpt~~el~~ 253 (303)
||.+||+.||.+|||+.|+++
T Consensus 263 li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 263 LIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhCCHhhCCCHHHHHh
Confidence 999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=273.59 Aligned_cols=232 Identities=20% Similarity=0.287 Sum_probs=158.0
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHH-HHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCc--cccccCC
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVM-LTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDP--IRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~l~ 79 (303)
.+|+.||||+++... ......+..|+. +++.++||||+++++++...+..++||||+.+ +|.+++... .....++
T Consensus 45 ~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~ 123 (327)
T 3aln_A 45 PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIP 123 (327)
T ss_dssp TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCC
T ss_pred CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCc
Confidence 478999999997653 233345556665 66777999999999999999999999999975 777776421 1245689
Q ss_pred HHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 80 WKKRVHIIEGITQGLLYLQEY-SRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~-~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
+..+..++.|++.||+|||+. | ++||||||+||+++.++.++|+|||++....... ......|++.|+|||.+
T Consensus 124 ~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~ 197 (327)
T 3aln_A 124 EEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERI 197 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-------------------------
T ss_pred HHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceeccccc---ccccCCCCccccCceee
Confidence 999999999999999999998 8 9999999999999999999999999987654332 12224689999999998
Q ss_pred ----ccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHH
Q 048243 159 ----RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIA 234 (303)
Q Consensus 159 ----~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
.+..++.++||||||+++|+|++|..||....... ....... ......+........+..+.+|+
T Consensus 198 ~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---------~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li 266 (327)
T 3aln_A 198 DPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF---------DQLTQVV--KGDPPQLSNSEEREFSPSFINFV 266 (327)
T ss_dssp --------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------CCCC--CSCCCCCCCCSSCCCCHHHHHHH
T ss_pred ccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH---------HHHHHHh--cCCCCCCCCcccccCCHHHHHHH
Confidence 45568999999999999999999999986432111 0000000 00000111111112345788999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 048243 235 LLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 235 ~~~l~~dp~~Rpt~~el~~ 253 (303)
.+||..||.+|||+.++++
T Consensus 267 ~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 267 NLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp HHHTCSSGGGSCCHHHHTT
T ss_pred HHHhhCChhhCcCHHHHHh
Confidence 9999999999999999976
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=274.60 Aligned_cols=234 Identities=18% Similarity=0.227 Sum_probs=176.9
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCc------cccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccC
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN------LIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
+++.||+|+++.. ....+.+.+|+.+++.++|++ ++.+++++......++||||+ ++++.+++.. .....+
T Consensus 44 ~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~-~~~~~~ 120 (355)
T 2eu9_A 44 GKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKE-NNFQPY 120 (355)
T ss_dssp TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH-TTTCCC
T ss_pred CceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHh-ccCCCC
Confidence 3478999999643 334567888999999987655 899999999999999999999 5666666643 223468
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEE-------------------CCCCceEEcccccccccccCCc
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL-------------------GEDMKPKISDFGLARIFAKESL 139 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~-------------------~~~~~v~l~Df~~~~~~~~~~~ 139 (303)
++..++.++.||+.||+|||+.| |+||||||+||++ +.++.++|+|||++......
T Consensus 121 ~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-- 195 (355)
T 2eu9_A 121 PLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-- 195 (355)
T ss_dssp CHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC--
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc--
Confidence 99999999999999999999998 9999999999999 56788999999998764332
Q ss_pred cccccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCccee------
Q 048243 140 EANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEF------ 213 (303)
Q Consensus 140 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 213 (303)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||............. .... ......
T Consensus 196 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~---~~~~-~~p~~~~~~~~~ 268 (355)
T 2eu9_A 196 ---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMME---KILG-PIPSHMIHRTRK 268 (355)
T ss_dssp ---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHHC-CCCHHHHHHCSC
T ss_pred ---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HHcC-CCcHHHhhhccc
Confidence 223568999999999999999999999999999999999999997544322111111 1110 000000
Q ss_pred ----ccc---------------------cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 214 ----VDS---------------------SLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 214 ----~~~---------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
... ..........+..+.+||.+||+.||.+|||+.|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 269 QKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp GGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 0001122344568899999999999999999999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=267.08 Aligned_cols=228 Identities=20% Similarity=0.317 Sum_probs=164.1
Q ss_pred CCCcEEEEEEecCCCc-cc-HHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTST-QG-FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~~-~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+|+.||||++..... .. .+.+.++..+++.++||||+++++++......++||||+ ++.+..+... ....+++.
T Consensus 48 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~--~~~~~~~~ 124 (318)
T 2dyl_A 48 KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKR--MQGPIPER 124 (318)
T ss_dssp TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHH--HTSCCCHH
T ss_pred cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHH--hccCCCHH
Confidence 4789999999976532 22 233445556678889999999999999999999999999 4555444421 24568999
Q ss_pred HHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc-
Q 048243 82 KRVHIIEGITQGLLYLQEY-SRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR- 159 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~-~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~- 159 (303)
.++.++.|++.||+|||+. | ++||||||+||+++.++.++|+|||.+....... ......|++.|+|||.+.
T Consensus 125 ~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~ 198 (318)
T 2dyl_A 125 ILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK---AKDRSAGCAAYMAPERIDP 198 (318)
T ss_dssp HHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC-
T ss_pred HHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCc---cccccCCCccccChhhccc
Confidence 9999999999999999995 8 9999999999999999999999999987654322 122346899999999985
Q ss_pred ----cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHH
Q 048243 160 ----QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235 (303)
Q Consensus 160 ----~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
...++.++||||||+++|+|++|..||...... . ........... ... .. ....+..+.+++.
T Consensus 199 ~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~---~~~~~~~~~~~-~~~-----~~--~~~~~~~l~~li~ 265 (318)
T 2dyl_A 199 PDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--F---EVLTKVLQEEP-PLL-----PG--HMGFSGDFQSFVK 265 (318)
T ss_dssp -------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--H---HHHHHHHHSCC-CCC-----CS--SSCCCHHHHHHHH
T ss_pred ccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--H---HHHHHHhccCC-CCC-----Cc--cCCCCHHHHHHHH
Confidence 456788999999999999999999998643221 1 11111111111 000 00 0112347889999
Q ss_pred HcccCCCCCCCCHHHHHH
Q 048243 236 LCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 236 ~~l~~dp~~Rpt~~el~~ 253 (303)
+||..||.+|||+.++++
T Consensus 266 ~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 266 DCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHTCSCTTTSCCHHHHTT
T ss_pred HHccCChhHCcCHHHHhh
Confidence 999999999999999976
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=270.83 Aligned_cols=218 Identities=23% Similarity=0.324 Sum_probs=171.5
Q ss_pred CCCcEEEEEEecCCCcc------cHHHHHHHHHHHhcC----CCCccccEEEEEEeCCeeEEEEee-cCCCChhhhhcCc
Q 048243 4 PCGKVIAVKKLSKTSTQ------GFEEFKNEVMLTAKL----QHVNLIRVLGFCIDSEERMLVYEY-MPNKSLDCYLFDP 72 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~------~~~~~~~e~~~l~~l----~h~~i~~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~ 72 (303)
.+|+.||||++...... ....+.+|+.++.++ +|+||+++++++...+..++|||+ +.+++|.+++.
T Consensus 54 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~-- 131 (312)
T 2iwi_A 54 TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYIT-- 131 (312)
T ss_dssp TTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHH--
T ss_pred cCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHH--
Confidence 57899999999755321 223456789999988 899999999999999999999999 78999999984
Q ss_pred cccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEEC-CCCceEEcccccccccccCCccccccccccccC
Q 048243 73 IRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG-EDMKPKISDFGLARIFAKESLEANTEQVVGTIG 151 (303)
Q Consensus 73 ~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~-~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~ 151 (303)
....+++..++.++.||+.||+|||+.| ++||||||+||+++ .++.++|+|||++....... .....|+..
T Consensus 132 -~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~ 203 (312)
T 2iwi_A 132 -EKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRV 203 (312)
T ss_dssp -HHCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTT
T ss_pred -hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCccc
Confidence 3456899999999999999999999999 99999999999999 78999999999987765432 223468999
Q ss_pred CCChhhhccCCCC-CccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHH
Q 048243 152 YIPPEYARQGVYS-TKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRC 230 (303)
Q Consensus 152 y~aPE~~~~~~~~-~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 230 (303)
|+|||.+.+..+. .++||||||+++|+|++|..||.... ....... ......+..+
T Consensus 204 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------~~~~~~~-----------~~~~~~~~~~ 260 (312)
T 2iwi_A 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------EILEAEL-----------HFPAHVSPDC 260 (312)
T ss_dssp TSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHTCC-----------CCCTTSCHHH
T ss_pred ccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------------HHhhhcc-----------CCcccCCHHH
Confidence 9999998877654 48999999999999999999985321 1111100 0111223478
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHH
Q 048243 231 LEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 231 ~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
.++|.+||+.||++|||+.|+++.
T Consensus 261 ~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 261 CALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHccCChhhCcCHHHHhcC
Confidence 899999999999999999999973
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=290.96 Aligned_cols=242 Identities=25% Similarity=0.288 Sum_probs=180.2
Q ss_pred CCCcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCccccEEEEEEe------CCeeEEEEeecCCCChhhhhcCccccc
Q 048243 4 PCGKVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCID------SEERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 4 ~~~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~ 76 (303)
.+|+.||||+++.. .....+.+.+|+.+++.++||||+++++++.. ....++||||+++++|.+++.......
T Consensus 37 ~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~ 116 (676)
T 3qa8_A 37 DTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC 116 (676)
T ss_dssp TTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTT
T ss_pred CCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCC
Confidence 57899999999754 34455678999999999999999999999765 667899999999999999997644445
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCc---eEEcccccccccccCCccccccccccccCCC
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK---PKISDFGLARIFAKESLEANTEQVVGTIGYI 153 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~---v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~ 153 (303)
.+++..++.++.|++.||+|||+.| ++||||||+||+++.++. ++|+|||.+....... ......|++.|+
T Consensus 117 ~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~---~~~~~~gt~~Y~ 190 (676)
T 3qa8_A 117 GLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYL 190 (676)
T ss_dssp CCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC---CCCCCCSCCTTC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccccccccccc---ccccccCCcccC
Confidence 6889999999999999999999999 999999999999997765 9999999998764432 223457899999
Q ss_pred ChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccc-cHH-HHHHH-HHhCCC--c-ceeccc-cCCCCCCHHH
Q 048243 154 PPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENL-SIL-EHAYE-LWKGGK--G-VEFVDS-SLDDTNSPCK 226 (303)
Q Consensus 154 aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~-~~~-~~~~~-~~~~~~--~-~~~~~~-~~~~~~~~~~ 226 (303)
|||.+.+..++.++||||||+++|+|++|..||......... ... ..... ...... . ..+... ..........
T Consensus 191 APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~l 270 (676)
T 3qa8_A 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGIL 270 (676)
T ss_dssp SSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGG
T ss_pred ChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhh
Confidence 999999999999999999999999999999998643110000 000 00000 000000 0 000000 0111233446
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHH
Q 048243 227 LMRCLEIALLCVQENPNDRPSMLQV 251 (303)
Q Consensus 227 ~~~l~~li~~~l~~dp~~Rpt~~el 251 (303)
+..+.+++.+||..||.+|||+.++
T Consensus 271 s~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 271 AGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp HHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hHHHHHHHHHHccCCHhhCcCHHHH
Confidence 7789999999999999999999764
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=272.97 Aligned_cols=219 Identities=22% Similarity=0.340 Sum_probs=176.3
Q ss_pred cCCCcEEEEEEecCCCcc------cHHHHHHHHHHHhcCC--CCccccEEEEEEeCCeeEEEEeecCC-CChhhhhcCcc
Q 048243 3 LPCGKVIAVKKLSKTSTQ------GFEEFKNEVMLTAKLQ--HVNLIRVLGFCIDSEERMLVYEYMPN-KSLDCYLFDPI 73 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~------~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~ 73 (303)
..+|+.||||++...... ..+.+.+|+.++++++ |+||+++++++......++|||++.+ ++|.+++.
T Consensus 65 ~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~--- 141 (320)
T 3a99_A 65 VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT--- 141 (320)
T ss_dssp TTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHH---
T ss_pred CCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHh---
Confidence 357899999999654211 2245678999999995 59999999999999999999999976 89999884
Q ss_pred ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEEC-CCCceEEcccccccccccCCccccccccccccCC
Q 048243 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG-EDMKPKISDFGLARIFAKESLEANTEQVVGTIGY 152 (303)
Q Consensus 74 ~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~-~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y 152 (303)
....+++..++.++.||+.||+|||+.+ ++||||||+||+++ .++.++|+|||++....... .....|++.|
T Consensus 142 ~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y 214 (320)
T 3a99_A 142 ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVY 214 (320)
T ss_dssp HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGG
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc----ccCCCCCccC
Confidence 3456899999999999999999999999 99999999999999 77899999999987765332 2234689999
Q ss_pred CChhhhccCCC-CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHH
Q 048243 153 IPPEYARQGVY-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL 231 (303)
Q Consensus 153 ~aPE~~~~~~~-~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
+|||.+.+..+ +.++||||||+++|+|++|..||.... ....... .... ..+..+.
T Consensus 215 ~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------~~~~~~~-------~~~~----~~~~~~~ 271 (320)
T 3a99_A 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQV-------FFRQ----RVSSECQ 271 (320)
T ss_dssp SCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCCC-------CCSS----CCCHHHH
T ss_pred CChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------------hhhcccc-------cccc----cCCHHHH
Confidence 99999887765 678999999999999999999985321 1111110 0111 1234788
Q ss_pred HHHHHcccCCCCCCCCHHHHHHH
Q 048243 232 EIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 232 ~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
++|.+||..||.+|||+.|+++.
T Consensus 272 ~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 272 HLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999873
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=285.96 Aligned_cols=214 Identities=20% Similarity=0.279 Sum_probs=169.5
Q ss_pred CCcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCe-----eEEEEeecCCCChhhhhcCccccccC
Q 048243 5 CGKVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEE-----RMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 5 ~~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
+|+.||||++... .......+.+|+.++.+++||||+++++++..... .|+||||+++++|.+++.. .+
T Consensus 105 ~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~-----~l 179 (681)
T 2pzi_A 105 NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KL 179 (681)
T ss_dssp TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C-----CC
T ss_pred CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC-----CC
Confidence 6899999998654 33445678899999999999999999999987655 6999999999999877632 68
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
++..++.++.||+.||+|||++| |+||||||+||+++.+ .+||+|||++...... ....||+.|+|||++
T Consensus 180 ~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~ 249 (681)
T 2pzi_A 180 PVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIV 249 (681)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhcccC------CccCCCccccCHHHH
Confidence 99999999999999999999999 9999999999999985 8999999999765432 335689999999998
Q ss_pred ccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcc
Q 048243 159 RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238 (303)
Q Consensus 159 ~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 238 (303)
.+.. +.++|||||||++|+|++|..||....... ..........+..+.++|.+||
T Consensus 250 ~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------------------~~~~~~~~~~~~~l~~li~~~l 305 (681)
T 2pzi_A 250 RTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------------------LPEDDPVLKTYDSYGRLLRRAI 305 (681)
T ss_dssp HHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------------------CCTTCHHHHHCHHHHHHHHHHT
T ss_pred cCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-----------------------ccccccccccCHHHHHHHhhhc
Confidence 7654 889999999999999999988874311110 0001111123357889999999
Q ss_pred cCCCCCCCC-HHHHHHHhcc
Q 048243 239 QENPNDRPS-MLQVSSMLKN 257 (303)
Q Consensus 239 ~~dp~~Rpt-~~el~~~L~~ 257 (303)
+.||.+||+ ++++.+.|..
T Consensus 306 ~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 306 DPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp CSSGGGSCSSHHHHHHHHHH
T ss_pred cCChhhCCCHHHHHHHHHHH
Confidence 999999995 5555555543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=256.27 Aligned_cols=210 Identities=18% Similarity=0.233 Sum_probs=160.2
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHH-hcCCCCccccEEEEEEe----CCeeEEEEeecCCCChhhhhcCccccccC
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLT-AKLQHVNLIRVLGFCID----SEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
.+|+.||+|+++.. ..+.+|+.++ +..+||||+++++++.. ....++||||+++++|.+++... ....+
T Consensus 41 ~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~ 114 (299)
T 3m2w_A 41 RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR-GDQAF 114 (299)
T ss_dssp TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHC-TTCCC
T ss_pred CCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhc-cCCCC
Confidence 57899999999643 4567888888 55599999999999987 66789999999999999998642 23468
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC---CCceEEcccccccccccCCccccccccccccCCCCh
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE---DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~---~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aP 155 (303)
++..++.++.|++.||+|||+.| ++||||||+||+++. ++.++|+|||++....
T Consensus 115 ~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-------------------- 171 (299)
T 3m2w_A 115 TEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-------------------- 171 (299)
T ss_dssp BHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT--------------------
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccccc--------------------
Confidence 99999999999999999999999 999999999999998 7889999999885432
Q ss_pred hhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCC----HHHHHHHH
Q 048243 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNS----PCKLMRCL 231 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~ 231 (303)
+..++.++|||||||++|+|++|..||......... ........... ...+ ...+..+.
T Consensus 172 ----~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 234 (299)
T 3m2w_A 172 ----GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKTRIRMGQ--YEFPNPEWSEVSEEVK 234 (299)
T ss_dssp ----TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCSSCTTC--CSSCHHHHTTSCHHHH
T ss_pred ----cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHHHHHhhcc--ccCCchhcccCCHHHH
Confidence 123577899999999999999999998543221100 00000000000 0011 11245789
Q ss_pred HHHHHcccCCCCCCCCHHHHHH--Hhcccc
Q 048243 232 EIALLCVQENPNDRPSMLQVSS--MLKNET 259 (303)
Q Consensus 232 ~li~~~l~~dp~~Rpt~~el~~--~L~~~~ 259 (303)
+++.+||+.||.+|||+.|+++ ++.+..
T Consensus 235 ~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 235 MLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred HHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 9999999999999999999987 354443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=249.71 Aligned_cols=209 Identities=12% Similarity=0.112 Sum_probs=161.8
Q ss_pred CCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTST---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||||++..... ...+.+.+|+..+.+++||||+++++++.+.+..|+||||+++++|.+++.. . ...
T Consensus 54 ~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~-~~~ 128 (286)
T 3uqc_A 54 ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT----S-PSP 128 (286)
T ss_dssp TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT----C-CCH
T ss_pred CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc----C-CCh
Confidence 4589999999976533 2346789999999999999999999999999999999999999999999832 2 345
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..+..++.|++.||+|||+.| |+||||||+||+++.+|.++|++++. ++
T Consensus 129 ~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~----------------------~~------ 177 (286)
T 3uqc_A 129 VGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPAT----------------------MP------ 177 (286)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCC----------------------CT------
T ss_pred HHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccc----------------------cC------
Confidence 578889999999999999999 99999999999999999999985432 22
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
.++.++|||||||++|+|++|..||............. ...... .. ...... +..+..+.++|.+||+.
T Consensus 178 -~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---~~~~~~-~~--~~~~~~----~~~~~~l~~li~~~l~~ 246 (286)
T 3uqc_A 178 -DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---RDTAGQ-PI--EPADID----RDIPFQISAVAARSVQG 246 (286)
T ss_dssp -TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---BCTTSC-BC--CHHHHC----TTSCHHHHHHHHHHHCT
T ss_pred -CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---HHhccC-CC--Chhhcc----cCCCHHHHHHHHHHccc
Confidence 25889999999999999999999997544322110000 000000 00 000000 12234788999999999
Q ss_pred CCCCCCCHHHHHHHhccccC
Q 048243 241 NPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 241 dp~~Rpt~~el~~~L~~~~~ 260 (303)
||.+| |+.|+++.|+....
T Consensus 247 dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 247 DGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp TSSCC-CHHHHHHHHHHHHC
T ss_pred CCccC-CHHHHHHHHHHHhc
Confidence 99999 99999999987654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=263.21 Aligned_cols=220 Identities=17% Similarity=0.168 Sum_probs=160.1
Q ss_pred cCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCC-Ccc---------ccEE------------EEEEe-----CCe
Q 048243 3 LPCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQH-VNL---------IRVL------------GFCID-----SEE 52 (303)
Q Consensus 3 ~~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h-~~i---------~~~~------------~~~~~-----~~~ 52 (303)
..+|+.||||+++... ....+.+.+|+.+++.++| +|. +... .++.. ...
T Consensus 100 ~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (413)
T 3dzo_A 100 QETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLS 179 (413)
T ss_dssp TTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCS
T ss_pred cCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccc
Confidence 4579999999997432 2235789999999999976 221 1111 11111 124
Q ss_pred eEEEEeecCCCChhhhhcC----ccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEccc
Q 048243 53 RMLVYEYMPNKSLDCYLFD----PIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDF 128 (303)
Q Consensus 53 ~~lv~e~~~~~~L~~~l~~----~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df 128 (303)
.+++|+++ +++|.+++.. ......+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 180 ~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiKp~NILl~~~~~~kL~DF 255 (413)
T 3dzo_A 180 RFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGF 255 (413)
T ss_dssp EEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCG
T ss_pred eEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcccceEEEecCCeEEEEec
Confidence 56777766 5789888841 122456788899999999999999999999 999999999999999999999999
Q ss_pred ccccccccCCccccccccccccCCCChhhh----------ccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHH
Q 048243 129 GLARIFAKESLEANTEQVVGTIGYIPPEYA----------RQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSIL 198 (303)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~ 198 (303)
|++...... .....| +.|+|||++ .+..++.++|||||||++|+|++|..||...........
T Consensus 256 G~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~- 328 (413)
T 3dzo_A 256 EHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEW- 328 (413)
T ss_dssp GGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGG-
T ss_pred cceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHH-
Confidence 998765433 233567 999999998 445578899999999999999999999965432221110
Q ss_pred HHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 199 EHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
..... .. .+..+.+||.+||+.||.+|||+.++++
T Consensus 329 --------------~~~~~--~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 329 --------------IFRSC--KN----IPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp --------------GGSSC--CC----CCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --------------HHhhc--cc----CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00100 01 1257889999999999999999877643
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=257.69 Aligned_cols=218 Identities=14% Similarity=0.072 Sum_probs=164.4
Q ss_pred CCcEEEEEEecCCC--------cccHHHHHHHHHHHhcCC---------CCccccEEEEEE-------------------
Q 048243 5 CGKVIAVKKLSKTS--------TQGFEEFKNEVMLTAKLQ---------HVNLIRVLGFCI------------------- 48 (303)
Q Consensus 5 ~~~~valK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~~i~~~~~~~~------------------- 48 (303)
+|+.||||++.... ....+.+.+|+.+++.++ ||||+++.+.+.
T Consensus 42 ~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~ 121 (336)
T 2vuw_A 42 DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNST 121 (336)
T ss_dssp TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHH
T ss_pred CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhh
Confidence 68999999997542 234478889999999885 888888777653
Q ss_pred -----------eCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCCCCceE
Q 048243 49 -----------DSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQ-EYSRLTIIHRDLKASNIL 116 (303)
Q Consensus 49 -----------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh-~~~~~~i~H~dikp~nil 116 (303)
.....|+||||+++|++.+.+. ...+++..++.++.||+.||+||| +.+ |+||||||+|||
T Consensus 122 ~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivHrDlKp~NIL 194 (336)
T 2vuw_A 122 KGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTASLAVAEASLR---FEHRDLHWGNVL 194 (336)
T ss_dssp TCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHHHHHHHHHHC---CBCSCCCGGGEE
T ss_pred ccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHhCC---EeECCCCHHHEE
Confidence 2678999999999997766662 255899999999999999999999 899 999999999999
Q ss_pred ECCCC--------------------ceEEcccccccccccCCccccccccccccCCCChhhhccCCCCCccchhhHHHH-
Q 048243 117 LGEDM--------------------KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVL- 175 (303)
Q Consensus 117 ~~~~~--------------------~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~- 175 (303)
++.++ .+||+|||+++..... ...||+.|+|||++.+.. +.++||||+|++
T Consensus 195 l~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~ 266 (336)
T 2vuw_A 195 LKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKE 266 (336)
T ss_dssp EEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHH
T ss_pred EeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccChhhhcCCC-ccceehhhhhCCC
Confidence 99887 8999999999865432 347899999999998777 889999998777
Q ss_pred HHHHHhCCCCCccCCCCccccHHHHHH-HHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 048243 176 LLQIISGKRLSMLCGINENLSILEHAY-ELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVS 252 (303)
Q Consensus 176 ~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~ 252 (303)
.++++.|..||.... ...... ........ .........+..+.++.+||.+||+.| |+.|++
T Consensus 267 ~~~~~~g~~p~~~~~------~~~~~~~~~~~~~~~----~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 267 NNNRWGEYHPYSNVL------WLHYLTDKMLKQMTF----KTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HTTCTTSCCTHHHHH------HHHHHHHHHHHTCCC----SSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred CcccccccCCCcchh------hhhHHHHhhhhhhcc----CcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 677888988873210 000001 11111000 000111112356778999999999977 999988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.5e-33 Score=255.16 Aligned_cols=169 Identities=17% Similarity=0.143 Sum_probs=126.5
Q ss_pred CCcEEEEEEecCCC----------cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc
Q 048243 5 CGKVIAVKKLSKTS----------TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI 73 (303)
Q Consensus 5 ~~~~valK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 73 (303)
.|+.+|+|.+.... ....+++.+|+++|+++ .|+||+++++++++++..||||||++|++|.++|.
T Consensus 258 fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~--- 334 (569)
T 4azs_A 258 FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLA--- 334 (569)
T ss_dssp ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHH---
T ss_pred ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHH---
Confidence 47889999996541 12345799999999999 79999999999999999999999999999999995
Q ss_pred ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCC
Q 048243 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYI 153 (303)
Q Consensus 74 ~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~ 153 (303)
.++.++.. .++.||+.||+|+|++| |+||||||+|||++.+|.+||+|||+++....... .....+||+.|+
T Consensus 335 ~~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~--~~~t~vGTp~Ym 406 (569)
T 4azs_A 335 AGEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS--WPTNLVQSFFVF 406 (569)
T ss_dssp TTCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---C--CSHHHHHHHHHH
T ss_pred hCCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCCc--cccCceechhhc
Confidence 34556654 47899999999999999 99999999999999999999999999986654322 233467999999
Q ss_pred ChhhhccCCCCCccchhhHHHHHHHHHhCCCC
Q 048243 154 PPEYARQGVYSTKSDVFSFGVLLLQIISGKRL 185 (303)
Q Consensus 154 aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p 185 (303)
|||++.+. +..++|+||+|++.+++.++..+
T Consensus 407 APE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 407 VNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp HHHHC------------------CCCCTTHHH
T ss_pred cHHHhCCC-CCCcccccccccchhhhccccch
Confidence 99998764 46689999999998877665444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-25 Score=204.21 Aligned_cols=166 Identities=19% Similarity=0.182 Sum_probs=134.4
Q ss_pred CCcEEEEEEecCCCcc--------cHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccc
Q 048243 5 CGKVIAVKKLSKTSTQ--------GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRL 76 (303)
Q Consensus 5 ~~~~valK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 76 (303)
.++.+++|+....... ..+.+.+|+.++++++||||+++..++......|+||||+++++|.+++..
T Consensus 358 ~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~----- 432 (540)
T 3en9_A 358 LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED----- 432 (540)
T ss_dssp SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT-----
T ss_pred CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH-----
Confidence 5788999987543211 134578999999999999999655555577788999999999999999843
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccc-----cccccccccC
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEA-----NTEQVVGTIG 151 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~-----~~~~~~g~~~ 151 (303)
+..++.|++.||+|||+++ |+||||||+|||++. .+||+|||+++......... ......||+.
T Consensus 433 ------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~ 501 (540)
T 3en9_A 433 ------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHH 501 (540)
T ss_dssp ------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCG
T ss_pred ------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCC
Confidence 5689999999999999999 999999999999999 99999999998765432211 1234679999
Q ss_pred CCChhhhcc--CCCCCccchhhHHHHHHHHHhCCCCC
Q 048243 152 YIPPEYARQ--GVYSTKSDVFSFGVLLLQIISGKRLS 186 (303)
Q Consensus 152 y~aPE~~~~--~~~~~~~DiwslG~~~~~l~~g~~p~ 186 (303)
|+|||++.. ..|+..+|+|+..+-..+-+.++.++
T Consensus 502 y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 502 EKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp GGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 999999987 56788899999998888877665443
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.9e-21 Score=164.03 Aligned_cols=125 Identities=19% Similarity=0.073 Sum_probs=98.1
Q ss_pred cCCCcEEEEEEecCCCc------------------ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCC
Q 048243 3 LPCGKVIAVKKLSKTST------------------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 64 (303)
..+|+.||||.++.... .....+.+|+.+++.++| +++++++.. +..++||||+++++
T Consensus 111 ~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~~~~-~~~~lvmE~~~g~~ 186 (282)
T 1zar_A 111 SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKVYAW-EGNAVLMELIDAKE 186 (282)
T ss_dssp ETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCEEEE-ETTEEEEECCCCEE
T ss_pred eCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeEEec-cceEEEEEecCCCc
Confidence 35799999999964321 124568899999999984 555555433 45799999999999
Q ss_pred hhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcccccc
Q 048243 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTE 144 (303)
Q Consensus 65 L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~ 144 (303)
|.+ +.. .....++.|++.||+|||+.| |+||||||+||+++ ++.++|+|||++..
T Consensus 187 L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DFG~a~~----------- 241 (282)
T 1zar_A 187 LYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVE----------- 241 (282)
T ss_dssp GGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCCTTCEE-----------
T ss_pred HHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEECCCCeE-----------
Confidence 987 421 124469999999999999999 99999999999999 99999999999853
Q ss_pred ccccccCCCChhhhcc
Q 048243 145 QVVGTIGYIPPEYARQ 160 (303)
Q Consensus 145 ~~~g~~~y~aPE~~~~ 160 (303)
+..+.|||++..
T Consensus 242 ----~~~~~a~e~l~r 253 (282)
T 1zar_A 242 ----VGEEGWREILER 253 (282)
T ss_dssp ----TTSTTHHHHHHH
T ss_pred ----CCCCCHHHHHHH
Confidence 445678887753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=1.7e-16 Score=132.14 Aligned_cols=116 Identities=20% Similarity=0.208 Sum_probs=87.2
Q ss_pred CCCcE--EEEEEecCCCcc------------------------cHHHHHHHHHHHhcCCCCcc--ccEEEEEEeCCeeEE
Q 048243 4 PCGKV--IAVKKLSKTSTQ------------------------GFEEFKNEVMLTAKLQHVNL--IRVLGFCIDSEERML 55 (303)
Q Consensus 4 ~~~~~--valK~~~~~~~~------------------------~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~~~~~l 55 (303)
.+|+. ||||+++..... ....+.+|+..+..+.|+++ ..+++. ...++
T Consensus 70 ~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~l 145 (258)
T 1zth_A 70 FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSVPQPYTY----MKNVL 145 (258)
T ss_dssp ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTCCCCCEEEE----ETTEE
T ss_pred CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCCCCCeEEEc----CCCEE
Confidence 47888 999997543211 11357889999999987754 445543 25789
Q ss_pred EEeecCC-C----ChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCCCCceEECCCCceEEcccc
Q 048243 56 VYEYMPN-K----SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQ-EYSRLTIIHRDLKASNILLGEDMKPKISDFG 129 (303)
Q Consensus 56 v~e~~~~-~----~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh-~~~~~~i~H~dikp~nil~~~~~~v~l~Df~ 129 (303)
||||+.+ | +|.++... .++..+..++.|++.+|.+|| +.| |+||||||+|||++. .++|+|||
T Consensus 146 VmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlkp~NILl~~--~~~liDFG 214 (258)
T 1zth_A 146 LMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHADLSEYNIMYID--KVYFIDMG 214 (258)
T ss_dssp EEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCSTTSEEESS--SEEECCCT
T ss_pred EEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEEcC--cEEEEECc
Confidence 9999942 3 55554321 224467789999999999999 998 999999999999998 89999999
Q ss_pred ccccc
Q 048243 130 LARIF 134 (303)
Q Consensus 130 ~~~~~ 134 (303)
++...
T Consensus 215 ~a~~~ 219 (258)
T 1zth_A 215 QAVTL 219 (258)
T ss_dssp TCEET
T ss_pred ccccC
Confidence 98654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.48 E-value=4.9e-14 Score=122.43 Aligned_cols=118 Identities=15% Similarity=0.135 Sum_probs=83.0
Q ss_pred ccCCCcEEEEEEecCCCc--------------ccHH--------HHHHHHHHHhcCCCCcc--ccEEEEEEeCCeeEEEE
Q 048243 2 VLPCGKVIAVKKLSKTST--------------QGFE--------EFKNEVMLTAKLQHVNL--IRVLGFCIDSEERMLVY 57 (303)
Q Consensus 2 ~~~~~~~valK~~~~~~~--------------~~~~--------~~~~e~~~l~~l~h~~i--~~~~~~~~~~~~~~lv~ 57 (303)
..++|+.||||+++.... .... ....|...|.++.+.++ ...++.. ..++||
T Consensus 115 ~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~p~~~~----~~~LVM 190 (397)
T 4gyi_A 115 ADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPEPIAQS----RHTIVM 190 (397)
T ss_dssp ECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCCEEEEE----TTEEEE
T ss_pred ECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeecc----CceEEE
Confidence 346899999999754210 0011 12356777777754443 3333322 347999
Q ss_pred eecCCCChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCC----------ceEEcc
Q 048243 58 EYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM----------KPKISD 127 (303)
Q Consensus 58 e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~----------~v~l~D 127 (303)
||++|++|..+.. . .....++.|++.+|.+||+.| |+||||||.|||++.+| .+.|+|
T Consensus 191 E~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID 258 (397)
T 4gyi_A 191 SLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAEDPSSITLTPIIIX 258 (397)
T ss_dssp ECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSSCTTSEEEEEEECC
T ss_pred EecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCcccccccccceEEEE
Confidence 9999988865541 1 123568899999999999999 99999999999998876 389999
Q ss_pred cccccccc
Q 048243 128 FGLARIFA 135 (303)
Q Consensus 128 f~~~~~~~ 135 (303)
|+.+....
T Consensus 259 ~~Q~V~~~ 266 (397)
T 4gyi_A 259 FPQMVSMD 266 (397)
T ss_dssp CTTCEETT
T ss_pred eCCcccCC
Confidence 99876544
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=7.4e-12 Score=104.10 Aligned_cols=120 Identities=17% Similarity=0.100 Sum_probs=92.3
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
+|+.+++|............+..|+.+++.+ .+..+.++++++......++|||+++|.+|.+.+.. ....
T Consensus 36 ~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~--------~~~~ 107 (263)
T 3tm0_A 36 ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED--------EQSP 107 (263)
T ss_dssp SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCT--------TTCH
T ss_pred CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccCC--------cccH
Confidence 4688999998653212234588899999998 467788999999988899999999999998765411 1123
Q ss_pred HHHHHHHHHHHHHHHhCC--------------------------------------------------------CCCeEe
Q 048243 84 VHIIEGITQGLLYLQEYS--------------------------------------------------------RLTIIH 107 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~--------------------------------------------------------~~~i~H 107 (303)
..++.+++.+++.||+.. ...++|
T Consensus 108 ~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~H 187 (263)
T 3tm0_A 108 EKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSH 187 (263)
T ss_dssp HHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEEC
T ss_pred HHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEEC
Confidence 467889999999999811 134899
Q ss_pred cCCCCCceEECCCCceEEccccccc
Q 048243 108 RDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 108 ~dikp~nil~~~~~~v~l~Df~~~~ 132 (303)
||++|.||+++.++.+.|+||+.+.
T Consensus 188 gDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 188 GDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCCcCcEEEECCcEEEEEEchhcc
Confidence 9999999999876556799998763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.07 E-value=1.6e-10 Score=95.60 Aligned_cols=115 Identities=17% Similarity=0.181 Sum_probs=84.9
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCc--cccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN--LIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+|+.+++|...... ...+..|+.+++.+.+.+ +.+++++....+..++|||+++|.++. ... .+
T Consensus 42 ~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~------~~-- 108 (264)
T 1nd4_A 42 QGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH------LA-- 108 (264)
T ss_dssp TTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC------CC--
T ss_pred CCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc------CC--
Confidence 457789999986542 245778999999885434 566888888777889999999998884 211 11
Q ss_pred HHHHHHHHHHHHHHHHHhCC-------------------------------------------------------CCCeE
Q 048243 82 KRVHIIEGITQGLLYLQEYS-------------------------------------------------------RLTII 106 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~-------------------------------------------------------~~~i~ 106 (303)
...++.+++..++.||... ...++
T Consensus 109 -~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 187 (264)
T 1nd4_A 109 -PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVT 187 (264)
T ss_dssp -HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEE
T ss_pred -HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEE
Confidence 1256777778888888643 12399
Q ss_pred ecCCCCCceEECCCCceEEccccccc
Q 048243 107 HRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 107 H~dikp~nil~~~~~~v~l~Df~~~~ 132 (303)
|||++|.||+++.++.+.|+||+.+.
T Consensus 188 HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 188 HGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCCCCCCcEEEECCcEEEEEcchhcc
Confidence 99999999999876666799999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.95 E-value=4e-09 Score=91.67 Aligned_cols=123 Identities=14% Similarity=0.251 Sum_probs=90.6
Q ss_pred CcEEEEEEec--CCC-cccHHHHHHHHHHHhcCC--CCccccEEEEEEeC---CeeEEEEeecCCCChhhhhcCcccccc
Q 048243 6 GKVIAVKKLS--KTS-TQGFEEFKNEVMLTAKLQ--HVNLIRVLGFCIDS---EERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 6 ~~~valK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
+..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..++|||+++|..+.+.. ...
T Consensus 61 ~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~-----~~~ 135 (359)
T 3dxp_A 61 GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS-----LPG 135 (359)
T ss_dssp SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT-----CTT
T ss_pred CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc-----ccc
Confidence 4677888775 322 122356788999999996 45578899988776 3579999999988774322 123
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------------------C
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYS-------------------------------------------------------R 102 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~-------------------------------------------------------~ 102 (303)
++......++.+++..|+.||... .
T Consensus 136 l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 215 (359)
T 3dxp_A 136 MSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADL 215 (359)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSC
T ss_pred CCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCC
Confidence 677888899999999999999731 2
Q ss_pred CCeEecCCCCCceEECCCCc--eEEcccccccc
Q 048243 103 LTIIHRDLKASNILLGEDMK--PKISDFGLARI 133 (303)
Q Consensus 103 ~~i~H~dikp~nil~~~~~~--v~l~Df~~~~~ 133 (303)
..++|||++|.||+++.++. +.|+||+.+..
T Consensus 216 ~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 216 TSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 45999999999999997753 68999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.82 E-value=4.7e-09 Score=89.06 Aligned_cols=167 Identities=17% Similarity=0.162 Sum_probs=106.2
Q ss_pred cEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCc--cccEEEEEEeCC---eeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 7 KVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVN--LIRVLGFCIDSE---ERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 7 ~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~--i~~~~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
+.+++|+.... .....+..|+..++.+ .+.. +.+++....... ..|+||++++|.++..... ..++.
T Consensus 41 ~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~-----~~l~~ 113 (304)
T 3sg8_A 41 RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL-----NNLPK 113 (304)
T ss_dssp TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH-----HTSCH
T ss_pred CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc-----ccCCH
Confidence 45788886433 2346788999999888 4333 345555543333 3589999999988864321 23566
Q ss_pred HHHHHHHHHHHHHHHHHHhCC-------------------------------------------------------CCCe
Q 048243 81 KKRVHIIEGITQGLLYLQEYS-------------------------------------------------------RLTI 105 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~-------------------------------------------------------~~~i 105 (303)
.....++.+++..++.||... ...+
T Consensus 114 ~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~ 193 (304)
T 3sg8_A 114 QSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCL 193 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEE
T ss_pred HHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCcee
Confidence 777788888888888888621 1348
Q ss_pred EecCCCCCceEECC--CCceEEcccccccccccCCccccccccccccCC---CChhhhc----cCCC----------CCc
Q 048243 106 IHRDLKASNILLGE--DMKPKISDFGLARIFAKESLEANTEQVVGTIGY---IPPEYAR----QGVY----------STK 166 (303)
Q Consensus 106 ~H~dikp~nil~~~--~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y---~aPE~~~----~~~~----------~~~ 166 (303)
+|||++|.||+++. .+.+.++||+.+..-... . . ......+ ..|+... .... ..-
T Consensus 194 ~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~--D---l~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~ 267 (304)
T 3sg8_A 194 IHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-N--D---FISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMK 267 (304)
T ss_dssp ECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-H--H---HHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHH
T ss_pred EeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-H--H---HHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHH
Confidence 99999999999998 456889999987542110 0 0 0001111 2222111 0000 112
Q ss_pred cchhhHHHHHHHHHhCCCCC
Q 048243 167 SDVFSFGVLLLQIISGKRLS 186 (303)
Q Consensus 167 ~DiwslG~~~~~l~~g~~p~ 186 (303)
.+.|+++.++|.+.+|..+|
T Consensus 268 ~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 268 EKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHHHHHcCCHHH
Confidence 58899999999999998665
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=5.9e-07 Score=74.59 Aligned_cols=118 Identities=15% Similarity=0.142 Sum_probs=85.8
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
+++.+++|.-... ....+..|...|+.+. +--+.++++++.+.+..++||++++|.++.+.... .....
T Consensus 49 ~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~-------~~~~~ 118 (272)
T 4gkh_A 49 NAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEE-------YPDSG 118 (272)
T ss_dssp TCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHH-------CGGGH
T ss_pred CCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccC-------CHHHH
Confidence 4567888887543 3356788999998884 33477889999999999999999999887655421 11123
Q ss_pred HHHHHHHHHHHHHHHhCC-------------------------------------------------------CCCeEec
Q 048243 84 VHIIEGITQGLLYLQEYS-------------------------------------------------------RLTIIHR 108 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~-------------------------------------------------------~~~i~H~ 108 (303)
..+..++...|+.||... ...++||
T Consensus 119 ~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HG 198 (272)
T 4gkh_A 119 ENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHG 198 (272)
T ss_dssp HHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECS
T ss_pred HHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcC
Confidence 345666777777777431 1237999
Q ss_pred CCCCCceEECCCCceEEccccccc
Q 048243 109 DLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 109 dikp~nil~~~~~~v~l~Df~~~~ 132 (303)
|+.+.||+++.++.+-|+||+.+.
T Consensus 199 Dl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 199 DFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCCCeEEEECCeEEEEEECcccc
Confidence 999999999987777899998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=3.1e-06 Score=71.72 Aligned_cols=121 Identities=18% Similarity=0.180 Sum_probs=79.9
Q ss_pred CcEEEEEEecCCCcccHHHHHHHHHHHhcCCCC---ccccEEEEEE-eCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHV---NLIRVLGFCI-DSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 6 ~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
|+.+++|+... ......+..|..+|+.+.+. .+.+++.+.. ..+..++||++++|.++..... ..++..
T Consensus 39 g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~-----~~l~~~ 111 (306)
T 3tdw_A 39 NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM-----AVLPDD 111 (306)
T ss_dssp TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHH-----TTSCHH
T ss_pred CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhh-----hhCCHH
Confidence 45678887532 23346788999999999642 3566777664 3456789999999988765321 113344
Q ss_pred HHHHHHHHHHHHHHHHHhC---------------------------------------------------------CCCC
Q 048243 82 KRVHIIEGITQGLLYLQEY---------------------------------------------------------SRLT 104 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~---------------------------------------------------------~~~~ 104 (303)
....++.++...|+.||+. ....
T Consensus 112 ~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~ 191 (306)
T 3tdw_A 112 AKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPR 191 (306)
T ss_dssp HHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCE
T ss_pred HHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCe
Confidence 4444555555555555532 2234
Q ss_pred eEecCCCCCceEECC---CCc-eEEcccccccc
Q 048243 105 IIHRDLKASNILLGE---DMK-PKISDFGLARI 133 (303)
Q Consensus 105 i~H~dikp~nil~~~---~~~-v~l~Df~~~~~ 133 (303)
++|||++|.|++++. ++. +.|+||+.+..
T Consensus 192 ~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 192 LIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp EECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred eEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 799999999999997 455 48999997643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=4.6e-06 Score=72.09 Aligned_cols=62 Identities=6% Similarity=0.016 Sum_probs=42.1
Q ss_pred CcEEEEEEecCCC---cccHHHHHHHHHHHhcCC-C--CccccEEEEEEeC---CeeEEEEeecCCCChhh
Q 048243 6 GKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQ-H--VNLIRVLGFCIDS---EERMLVYEYMPNKSLDC 67 (303)
Q Consensus 6 ~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~ 67 (303)
|+.+++|+..... ......+..|+.+++.+. + -.+.+++.+..+. ...++|||+++|..+.+
T Consensus 52 ~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 52 QQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp EEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCCB
T ss_pred CceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChhh
Confidence 6678898875432 101245678888888883 3 3567788887655 35689999999877653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.73 E-value=8.6e-05 Score=58.60 Aligned_cols=99 Identities=12% Similarity=0.054 Sum_probs=63.7
Q ss_pred CChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcccc
Q 048243 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEAN 142 (303)
Q Consensus 63 ~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~ 142 (303)
.+|.+.|. ..+.++++.++|.++.|.+.+|.-+-... . -...=+.|..|++..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~--~~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILR--LYNQPINEEQAWAVCYQCCGSLRAAARRR-Q-PRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHTT-C-CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHH--HcCCCcCHHHHHHHHHHHHHHHHhhhhcc-c-CCceecCCcceEEecCCceeccc-cccc----------
Confidence 46777774 35788999999999999999987762211 0 11223457899999999888864 1110
Q ss_pred ccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHh
Q 048243 143 TEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181 (303)
Q Consensus 143 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~ 181 (303)
.....+.|||... ...+.+.-|||||+++|.-+-
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1133466887653 344677889999999998875
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00013 Score=62.43 Aligned_cols=31 Identities=26% Similarity=0.383 Sum_probs=27.2
Q ss_pred CCCeEecCCCCCceEECCCCceEEccccccc
Q 048243 102 RLTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 102 ~~~i~H~dikp~nil~~~~~~v~l~Df~~~~ 132 (303)
...++|||+++.||+++.++.+.|+||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 3459999999999999888899999998763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00039 Score=58.79 Aligned_cols=58 Identities=19% Similarity=0.134 Sum_probs=45.6
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCC---CCccccEEEEEEeCCeeEEEEeecCCCCh
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ---HVNLIRVLGFCIDSEERMLVYEYMPNKSL 65 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 65 (303)
+++.+++|+.... ....+..|...|+.+. ...+.+++.+.......++|||++++..+
T Consensus 58 ~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 58 EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 4677888887543 3467888999998883 35688899988888889999999998765
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00056 Score=59.43 Aligned_cols=124 Identities=17% Similarity=0.188 Sum_probs=74.5
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCccccEEEEEEeCCeeEEEEeecCCCChhhh-hcC-----------
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCY-LFD----------- 71 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~----------- 71 (303)
+++.+++|+..... .....+.+|..+++.+. +.-..++++++.+ .+||+|++|.+|..- +.+
T Consensus 81 ~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~L 155 (379)
T 3feg_A 81 EPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKM 155 (379)
T ss_dssp CCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHH
T ss_pred CCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHH
Confidence 35789999974332 34466778999998884 3334567766543 399999998665321 110
Q ss_pred -------ccccccCC--HHHHHHHHHHHHH-------------------HHHH----HHhC-CCCCeEecCCCCCceEEC
Q 048243 72 -------PIRRLILD--WKKRVHIIEGITQ-------------------GLLY----LQEY-SRLTIIHRDLKASNILLG 118 (303)
Q Consensus 72 -------~~~~~~l~--~~~~~~~~~~i~~-------------------~l~~----Lh~~-~~~~i~H~dikp~nil~~ 118 (303)
........ +..+.+|+.++-. .+.. |... ....++|+|+.+.||+++
T Consensus 156 a~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~ 235 (379)
T 3feg_A 156 AQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLL 235 (379)
T ss_dssp HHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEE
T ss_pred HHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEc
Confidence 00011111 3445555544322 1222 2222 234599999999999998
Q ss_pred CC----CceEEcccccccc
Q 048243 119 ED----MKPKISDFGLARI 133 (303)
Q Consensus 119 ~~----~~v~l~Df~~~~~ 133 (303)
.+ +.+.++||..+..
T Consensus 236 ~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 236 SEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp SCC---CCEEECCCTTCEE
T ss_pred CCCCccCcEEEEecccCCc
Confidence 76 7899999988743
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.0018 Score=55.15 Aligned_cols=32 Identities=28% Similarity=0.521 Sum_probs=27.1
Q ss_pred CCCeEecCCCCCceEECCC----CceEEcccccccc
Q 048243 102 RLTIIHRDLKASNILLGED----MKPKISDFGLARI 133 (303)
Q Consensus 102 ~~~i~H~dikp~nil~~~~----~~v~l~Df~~~~~ 133 (303)
...++|||+.+.||+++.+ +.+.++||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3459999999999999874 6799999988753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00058 Score=59.78 Aligned_cols=29 Identities=34% Similarity=0.449 Sum_probs=24.8
Q ss_pred CCeEecCCCCCceEECCCCceEEccccccc
Q 048243 103 LTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 103 ~~i~H~dikp~nil~~~~~~v~l~Df~~~~ 132 (303)
..++|||+.|.||+++.+ .++++||..+.
T Consensus 227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~ 255 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAF 255 (397)
T ss_dssp CEEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence 459999999999999876 48999997664
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00083 Score=55.99 Aligned_cols=59 Identities=22% Similarity=0.252 Sum_probs=41.0
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-C--CccccEEEEEEeCCeeEEEEeecCCCCh
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-H--VNLIRVLGFCIDSEERMLVYEYMPNKSL 65 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L 65 (303)
+.+|+.|.+|+...........+..|+..|+.+. . -.+.++++.. ..++|||++.++..
T Consensus 36 l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 36 LADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERPP 97 (288)
T ss_dssp ETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCCC
T ss_pred ECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccCC
Confidence 4689999999876554444456788999998883 2 2355566542 34789999887654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0016 Score=57.38 Aligned_cols=31 Identities=19% Similarity=0.380 Sum_probs=26.7
Q ss_pred CCCeEecCCCCCceEECCCCceEEcccccccc
Q 048243 102 RLTIIHRDLKASNILLGEDMKPKISDFGLARI 133 (303)
Q Consensus 102 ~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~ 133 (303)
...++|||++|.||+++.++ +.++||+.+..
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 34599999999999999876 99999988754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0012 Score=58.45 Aligned_cols=54 Identities=13% Similarity=0.149 Sum_probs=35.7
Q ss_pred CcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCccccEEEEEEeCCeeEEEEeecCCCCh
Q 048243 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSL 65 (303)
Q Consensus 6 ~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 65 (303)
++.+++|+..... ....+..|+.+++.+. +.-..++++.+. + .+|++|++|.++
T Consensus 105 ~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e~l~G~~l 159 (429)
T 1nw1_A 105 PNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEYIPSRPL 159 (429)
T ss_dssp CSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECCCCEEEC
T ss_pred CceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEEEeCCccc
Confidence 5789999985421 1245567999998884 333456776653 2 389999986544
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0017 Score=54.47 Aligned_cols=30 Identities=23% Similarity=0.272 Sum_probs=24.8
Q ss_pred CCeEecCCCCCceEECCCCceEEcccccccc
Q 048243 103 LTIIHRDLKASNILLGEDMKPKISDFGLARI 133 (303)
Q Consensus 103 ~~i~H~dikp~nil~~~~~~v~l~Df~~~~~ 133 (303)
..++|+|+.+.||+ ..++.+.++||..+..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 44899999999999 5566789999987743
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0086 Score=50.64 Aligned_cols=126 Identities=14% Similarity=0.134 Sum_probs=68.7
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCC--ccccEEEE-----EEeCCeeEEEEeecCCCChhh----hhc--
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHV--NLIRVLGF-----CIDSEERMLVYEYMPNKSLDC----YLF-- 70 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~-----~~~~~~~~lv~e~~~~~~L~~----~l~-- 70 (303)
.+|+.+++|...... .....+..|...++.+... .+.+++.. ....+..+++|++++|..+.. .+.
T Consensus 47 ~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~ 125 (328)
T 1zyl_A 47 EDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAV 125 (328)
T ss_dssp TTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHH
T ss_pred CCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHH
Confidence 457789999986432 2345677788888877321 23444432 122456688999998754321 000
Q ss_pred --------C---cc---ccccCCHHHH----------------------HHHHHHHHHHHHHHHh-CCCCCeEecCCCCC
Q 048243 71 --------D---PI---RRLILDWKKR----------------------VHIIEGITQGLLYLQE-YSRLTIIHRDLKAS 113 (303)
Q Consensus 71 --------~---~~---~~~~l~~~~~----------------------~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~ 113 (303)
. .. .....+.... ...+..++..+..+.. .....++|||+++.
T Consensus 126 g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~ 205 (328)
T 1zyl_A 126 GRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAG 205 (328)
T ss_dssp HHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGG
T ss_pred HHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcc
Confidence 0 00 0111221111 1112222222222211 12345899999999
Q ss_pred ceEECCCCceEEccccccc
Q 048243 114 NILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 114 nil~~~~~~v~l~Df~~~~ 132 (303)
||+++ + .+.++||+.+.
T Consensus 206 Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 206 NILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp GEEES-S-SEEECCCTTCC
T ss_pred cEeEc-C-CCEEEECCCCC
Confidence 99999 4 89999998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.005 Score=54.89 Aligned_cols=55 Identities=13% Similarity=0.175 Sum_probs=34.9
Q ss_pred CcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCcc-ccEEEEEEeCCeeEEEEeecCCCCh
Q 048243 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL-IRVLGFCIDSEERMLVYEYMPNKSL 65 (303)
Q Consensus 6 ~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L 65 (303)
++.+++|+......... ....|+.+++.+...++ .++++.+ .+ .+|++|++|.+|
T Consensus 133 ~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 133 QAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYAL 188 (458)
T ss_dssp TEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEEC
T ss_pred CceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCccC
Confidence 47888998854332211 12578888888854444 5677766 22 369999987554
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0023 Score=54.13 Aligned_cols=30 Identities=30% Similarity=0.361 Sum_probs=25.5
Q ss_pred CCeEecCCCCCceEECCCCceEEccccccc
Q 048243 103 LTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 103 ~~i~H~dikp~nil~~~~~~v~l~Df~~~~ 132 (303)
..++|||+.+.||+++.++.+.++||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 459999999999999887666899998763
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.68 E-value=0.006 Score=52.66 Aligned_cols=29 Identities=24% Similarity=0.455 Sum_probs=24.3
Q ss_pred CCeEecCCCCCceEECCCCceEEccccccc
Q 048243 103 LTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 103 ~~i~H~dikp~nil~~~~~~v~l~Df~~~~ 132 (303)
..++|+|+.+.||+++.++ +.++||..+.
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 4599999999999998654 8999998764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.95 E-value=0.094 Score=46.12 Aligned_cols=30 Identities=27% Similarity=0.500 Sum_probs=26.0
Q ss_pred CCeEecCCCCCceEECCCCceEEcccccccc
Q 048243 103 LTIIHRDLKASNILLGEDMKPKISDFGLARI 133 (303)
Q Consensus 103 ~~i~H~dikp~nil~~~~~~v~l~Df~~~~~ 133 (303)
..++|+|+.+.|++ +.++.+.++||..+..
T Consensus 262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 45899999999999 7778899999988753
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.48 E-value=0.023 Score=49.71 Aligned_cols=30 Identities=33% Similarity=0.470 Sum_probs=25.2
Q ss_pred CeEecCCCCCceEE------CCCCceEEcccccccc
Q 048243 104 TIIHRDLKASNILL------GEDMKPKISDFGLARI 133 (303)
Q Consensus 104 ~i~H~dikp~nil~------~~~~~v~l~Df~~~~~ 133 (303)
.++|+|+.+.||++ ++.+.+.++||.++..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36899999999999 4567799999988753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=92.52 E-value=0.1 Score=44.39 Aligned_cols=30 Identities=27% Similarity=0.458 Sum_probs=26.7
Q ss_pred CCeEecCCCCCceEECCCCceEEccccccc
Q 048243 103 LTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 103 ~~i~H~dikp~nil~~~~~~v~l~Df~~~~ 132 (303)
..++|||+.+.|++++.++.+.++||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 459999999999999988889999998764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.68 E-value=1.1 Score=35.38 Aligned_cols=83 Identities=8% Similarity=0.024 Sum_probs=58.2
Q ss_pred CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEecCCCCCc
Q 048243 36 QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLL-YLQEYSRLTIIHRDLKASN 114 (303)
Q Consensus 36 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~-~Lh~~~~~~i~H~dikp~n 114 (303)
.||++ --.+-.+...+.+.++.-+++.-...+ ..++....++++..|+.... +++. -+|--+.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 57777 444445666766666654333222222 34778899999998887766 4433 6888999999
Q ss_pred eEECCCCceEEcccccc
Q 048243 115 ILLGEDMKPKISDFGLA 131 (303)
Q Consensus 115 il~~~~~~v~l~Df~~~ 131 (303)
++++.++.+++.-.|+-
T Consensus 115 L~f~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVK 131 (219)
T ss_dssp EEECTTCCEEESCCEET
T ss_pred EEEeCCCcEEEEEcCCc
Confidence 99999999999877753
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=90.11 E-value=0.94 Score=35.55 Aligned_cols=116 Identities=10% Similarity=0.043 Sum_probs=76.2
Q ss_pred CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCce
Q 048243 36 QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115 (303)
Q Consensus 36 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~ni 115 (303)
.||+++.. .+-.....+.+.++.-+ ....+- .-..++....++++..|+....+++. -+|--+.|+|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHH----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 58888877 45556666666555433 222222 22347888999999999888755543 47889999999
Q ss_pred EECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCc
Q 048243 116 LLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSM 187 (303)
Q Consensus 116 l~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~ 187 (303)
+++.++.+++.-.|+-..+ +|. ..+...=.-.+=|++..+++++..|.
T Consensus 111 ~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999877753221 111 11111122356788888999988773
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 303 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-63 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-56 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-56 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-55 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-54 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-53 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-53 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-52 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-51 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-51 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-50 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-50 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-50 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-50 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-49 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-48 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-48 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-47 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-46 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-45 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-44 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-44 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-41 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-38 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-38 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-36 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-35 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-35 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-34 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-34 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-34 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-33 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-33 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-33 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-31 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-31 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-30 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-29 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-26 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-24 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-23 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-21 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-15 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 7e-63
Identities = 72/269 (26%), Positives = 130/269 (48%), Gaps = 22/269 (8%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G + + ++ + Q + FKNEV + K +HVN++ +G+ + + +V ++
Sbjct: 27 GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWC 85
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
SL +L + K + I QG+ YL S IIHRDLK++NI L ED
Sbjct: 86 EGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHED 140
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR---QGVYSTKSDVFSFGVLLL 177
+ KI DFGLA + ++ S EQ+ G+I ++ PE R + YS +SDV++FG++L
Sbjct: 141 LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLY 200
Query: 178 QIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237
++++G+ N++ + + G ++ L S C + C
Sbjct: 201 ELMTGQLP------YSNINNRDQIIFMVGRG----YLSPDLSKVRSNC-PKAMKRLMAEC 249
Query: 238 VQENPNDRPSMLQVSSMLKNETTNRNTPK 266
+++ ++RP Q+ + + E R+ PK
Sbjct: 250 LKKKRDERPLFPQILASI--ELLARSLPK 276
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 2e-56
Identities = 66/256 (25%), Positives = 113/256 (44%), Gaps = 22/256 (8%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G +A+K + + E+F E + KL H L+++ G C++ LV+E+M
Sbjct: 24 GYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
+ L YL +R + + + + + +G+ YL+E +IHRDL A N L+GE+
Sbjct: 83 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGEN 137
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
K+SDFG+ R + ++ + + PE YS+KSDV+SFGVL+ ++
Sbjct: 138 QVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 196
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240
S ++ N + + G L T +I C +E
Sbjct: 197 SEGKIPYENRSNSEV--------VEDISTGFRLYKPRLAST-------HVYQIMNHCWKE 241
Query: 241 NPNDRPSMLQVSSMLK 256
P DRP+ ++ L
Sbjct: 242 RPEDRPAFSRLLRQLA 257
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 5e-56
Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 22/257 (8%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G +AVK L + S + F E L +LQH L+R+ E ++ EYM
Sbjct: 32 GYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
N SL +L P + L K + + I +G+ +++E + IHRDL+A+NIL+ +
Sbjct: 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDT 145
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
+ KI+DFGLAR+ A I + PE G ++ KSDV+SFG+LL +I+
Sbjct: 146 LSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240
+ R+ Y + ++ ++ ++ LC +E
Sbjct: 205 THGRI---------------PYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKE 249
Query: 241 NPNDRPSMLQVSSMLKN 257
P DRP+ + S+L++
Sbjct: 250 RPEDRPTFDYLRSVLED 266
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 9e-55
Identities = 55/274 (20%), Positives = 113/274 (41%), Gaps = 27/274 (9%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE----ERMLVYEYMP 61
G+ +AVK S + + + E+ T L+H N++ + + LV +Y
Sbjct: 26 GEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQE-----YSRLTIIHRDLKASNIL 116
+ S LFD + R + + + + GL +L + I HRDLK+ NIL
Sbjct: 85 HGS----LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 140
Query: 117 LGEDMKPKISDFGLARIF--AKESLEANTEQVVGTIGYIPPEYARQGV------YSTKSD 168
+ ++ I+D GLA A ++++ VGT Y+ PE + ++D
Sbjct: 141 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRAD 200
Query: 169 VFSFGVLLLQIISGKRLSMLCGINE----NLSILEHAYELWKGGKGVEFVDSSLDDTNSP 224
+++ G++ +I + + + +L + + E + + + ++ +
Sbjct: 201 IYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQS 260
Query: 225 CKLMRCL-EIALLCVQENPNDRPSMLQVSSMLKN 257
C+ +R + +I C N R + L++ L
Sbjct: 261 CEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 8e-54
Identities = 59/257 (22%), Positives = 108/257 (42%), Gaps = 22/257 (8%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G +A+K + + S +EF E + L H L+++ G C ++ EYM
Sbjct: 23 GKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
N L YL + R ++ + + + + + + YL+ +HRDL A N L+ +
Sbjct: 82 ANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQ 136
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
K+SDFGL+R + ++ + + PPE +S+KSD+++FGVL+ +I
Sbjct: 137 GVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 195
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240
S + YE + + E + L + I C E
Sbjct: 196 SLGK---------------MPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHE 240
Query: 241 NPNDRPSMLQVSSMLKN 257
++RP+ + S + +
Sbjct: 241 KADERPTFKILLSNILD 257
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (442), Expect = 2e-53
Identities = 64/274 (23%), Positives = 115/274 (41%), Gaps = 40/274 (14%)
Query: 6 GKVIAVKKLSKTSTQGFE-EFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
++AVK L + ++ + +F+ E L A+ + N++++LG C + L++EYM
Sbjct: 43 FTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGD 102
Query: 65 LDCYLFDPIRRLI---------------------LDWKKRVHIIEGITQGLLYLQEYSRL 103
L+ +L + L +++ I + G+ YL E
Sbjct: 103 LNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-- 160
Query: 104 TIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163
+HRDL N L+GE+M KI+DFGL+R I ++PPE Y
Sbjct: 161 -FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY 219
Query: 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNS 223
+T+SDV+++GV+L +I S +E + + G + ++ +
Sbjct: 220 TTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV------IYYVRDGNILACPENCPLE--- 270
Query: 224 PCKLMRCLEIALLCVQENPNDRPSMLQVSSMLKN 257
+ LC + P DRPS + +L+
Sbjct: 271 ------LYNLMRLCWSKLPADRPSFCSIHRILQR 298
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 4e-53
Identities = 67/269 (24%), Positives = 120/269 (44%), Gaps = 22/269 (8%)
Query: 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
G +A+K L T E F E + KL+H L+++ + E +V EYM
Sbjct: 36 GTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
SL +L + + + V + I G+ Y++ + +HRDL+A+NIL+GE+
Sbjct: 94 SKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGEN 149
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQII 180
+ K++DFGLAR+ A I + PE A G ++ KSDV+SFG+LL ++
Sbjct: 150 LVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 208
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240
+ R+ +N + ++ V+ P ++ C ++
Sbjct: 209 TKGRVPYPGMVNREV---------------LDQVERGYRMPCPPECPESLHDLMCQCWRK 253
Query: 241 NPNDRPSMLQVSSMLKNETTNRNTPKKPA 269
P +RP+ + + L++ T+ +P
Sbjct: 254 EPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 9e-53
Identities = 54/274 (19%), Positives = 103/274 (37%), Gaps = 37/274 (13%)
Query: 6 GKVIAVKKLSKTSTQGF-EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
G V+A K + + E+ + + ++ G E + E+M S
Sbjct: 31 GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 90
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
LD L + + + + + +GL YL + I+HRD+K SNIL+ + K
Sbjct: 91 LDQVLK---KAGRIPEQILGKVSIAVIKGLTYL--REKHKIMHRDVKPSNILVNSRGEIK 145
Query: 125 ISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKR 184
+ DFG++ ++ VGT Y+ PE + YS +SD++S G+ L+++ G+
Sbjct: 146 LCDFGVSGQLI----DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 201
Query: 185 ---------LSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMR------ 229
L ++ G E G+ + + +L+
Sbjct: 202 PIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEP 261
Query: 230 ------------CLEIALLCVQENPNDRPSMLQV 251
+ C+ +NP +R + Q+
Sbjct: 262 PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 1e-52
Identities = 63/276 (22%), Positives = 112/276 (40%), Gaps = 37/276 (13%)
Query: 6 GKVIAVKKLSKTSTQGF-EEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNK 63
+AVK L ++ E +E+ + + L H+N++ +LG C +++ EY
Sbjct: 53 AMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYG 112
Query: 64 SLDCYLFDPIRRLI---------------LDWKKRVHIIEGITQGLLYLQEYSRLTIIHR 108
L +L I LD + + + +G+ +L IHR
Sbjct: 113 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHR 169
Query: 109 DLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSD 168
DL A NILL KI DFGLAR +S + ++ PE VY+ +SD
Sbjct: 170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESD 229
Query: 169 VFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLM 228
V+S+G+ L ++ S + + Y++ K G + + + +
Sbjct: 230 VWSYGIFLWELFSLGSSPY-----PGMPVDSKFYKMIKEGFRMLSPEHAPAE-------- 276
Query: 229 RCLEIALLCVQENPNDRPSMLQVSSMLK---NETTN 261
+I C +P RP+ Q+ +++ +E+TN
Sbjct: 277 -MYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 3e-52
Identities = 67/253 (26%), Positives = 115/253 (45%), Gaps = 27/253 (10%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMPNKS 64
G +AVK + +T + F E + +L+H NL+++LG ++ + + +V EYM S
Sbjct: 30 GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 87
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
L YL R +L + + + + YL+ + +HRDL A N+L+ ED K
Sbjct: 88 LVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAK 143
Query: 125 ISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKR 184
+SDFGL + + + + + PE R+ +STKSDV+SFG+LL +I S R
Sbjct: 144 VSDFGLTKE-----ASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 198
Query: 185 LSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPND 244
+ +++ + G ++ D E+ C +
Sbjct: 199 VPYPRIPLKDV------VPRVEKGYKMDAPDGCPPA---------VYEVMKNCWHLDAAM 243
Query: 245 RPSMLQVSSMLKN 257
RPS LQ+ L++
Sbjct: 244 RPSFLQLREQLEH 256
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-51
Identities = 58/253 (22%), Positives = 104/253 (41%), Gaps = 23/253 (9%)
Query: 6 GKVIAVKKLSKTSTQGF-EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
+A+K L + + + EE E + +L + ++R++G C +E MLV E
Sbjct: 36 QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP 94
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
L +L +R + ++ ++ G+ YL+E + +HRDL A N+LL K
Sbjct: 95 LHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAK 149
Query: 125 ISDFGLARIF-AKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
ISDFGL++ A +S + + PE +S++SDV+S+GV + + +S
Sbjct: 150 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG 209
Query: 184 RLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPN 243
+ + + GK +E + + C
Sbjct: 210 QKPYKKMKGPEV------MAFIEQGKRMECPPECPPE---------LYALMSDCWIYKWE 254
Query: 244 DRPSMLQVSSMLK 256
DRP L V ++
Sbjct: 255 DRPDFLTVEQRMR 267
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 5e-51
Identities = 61/255 (23%), Positives = 104/255 (40%), Gaps = 25/255 (9%)
Query: 6 GKVIAVKKLSKTSTQG--FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
K +AVK L + +E E + +L + ++R++G C ++E MLV E
Sbjct: 34 VKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG 92
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
L+ YL + K + ++ ++ G+ YL+ +HRDL A N+LL
Sbjct: 93 PLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYA 146
Query: 124 KISDFGLARIFAKESLEANTE-QVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
KISDFGL++ + + + + PE +S+KSDV+SFGVL+ + S
Sbjct: 147 KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSY 206
Query: 183 KRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242
+ Y KG + ++ ++ LC +
Sbjct: 207 GQ---------------KPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDV 251
Query: 243 NDRPSMLQVSSMLKN 257
+RP V L+N
Sbjct: 252 ENRPGFAAVELRLRN 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 6e-51
Identities = 63/275 (22%), Positives = 113/275 (41%), Gaps = 39/275 (14%)
Query: 6 GKVIAVKKLSKTSTQGF-EEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNK 63
+AVK L + + E +E+ + +L H N++ +LG C S L++EY
Sbjct: 67 SIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYG 126
Query: 64 SLDCYLFDPIRRL--------------------ILDWKKRVHIIEGITQGLLYLQEYSRL 103
L YL + +L ++ + + +G+ +L+ S
Sbjct: 127 DLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-- 184
Query: 104 TIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163
+HRDL A N+L+ KI DFGLAR +S + ++ PE +G+Y
Sbjct: 185 -CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY 243
Query: 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNS 223
+ KSDV+S+G+LL +I S + + + Y+L + G ++ + ++
Sbjct: 244 TIKSDVWSYGILLWEIFSLGVNPY-----PGIPVDANFYKLIQNGFKMDQPFYATEE--- 295
Query: 224 PCKLMRCLEIALLCVQENPNDRPSMLQVSSMLKNE 258
I C + RPS ++S L +
Sbjct: 296 ------IYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 324
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 167 bits (423), Expect = 9e-51
Identities = 70/252 (27%), Positives = 118/252 (46%), Gaps = 21/252 (8%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
+AVK L + + + EEF E + +++H NL+++LG C ++ E+M +L
Sbjct: 42 SLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 100
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
YL + R + +++ I+ + YL + IHRDL A N L+GE+ K+
Sbjct: 101 LDYLREC-NRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKV 156
Query: 126 SDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRL 185
+DFGL+R+ ++ A+ I + PE +S KSDV++FGVLL +I +
Sbjct: 157 ADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 215
Query: 186 SMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDR 245
GI+ L YEL + +E + + E+ C Q NP+DR
Sbjct: 216 -PYPGID-----LSQVYELLEKDYRMERPEGCPEK---------VYELMRACWQWNPSDR 260
Query: 246 PSMLQVSSMLKN 257
PS ++ +
Sbjct: 261 PSFAEIHQAFET 272
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 166 bits (422), Expect = 2e-50
Identities = 62/265 (23%), Positives = 120/265 (45%), Gaps = 24/265 (9%)
Query: 6 GKVIAVKKLSKTST-QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
+A+K L T + +F +E + + H N+I + G S M++ E+M N S
Sbjct: 54 EIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGS 113
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
LD +L + + V ++ GI G+ YL + + +HRDL A NIL+ ++ K
Sbjct: 114 LDSFLRQNDGQF--TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCK 168
Query: 125 ISDFGLARIFAKESLEANTEQVVG---TIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
+SDFGL+R ++ + +G I + PE + +++ SDV+S+G+++ +++S
Sbjct: 169 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 228
Query: 182 GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241
+++ + + + + +D ++ L C Q++
Sbjct: 229 YGERPY-----WDMTNQDVINAIEQDYRLPPPMDCPSA----------LHQLMLDCWQKD 273
Query: 242 PNDRPSMLQVSSMLKNETTNRNTPK 266
N RP Q+ + L N N+ K
Sbjct: 274 RNHRPKFGQIVNTLDKMIRNPNSLK 298
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 3e-50
Identities = 65/253 (25%), Positives = 105/253 (41%), Gaps = 25/253 (9%)
Query: 6 GKVIAVKKLSKTST--QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERML--VYEYMP 61
GK++ K+L S + +EV L +L+H N++R ID L V EY
Sbjct: 29 GKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 88
Query: 62 NKSLDCYLFDPIR-RLILDWKKRVHIIEGITQGLLYL--QEYSRLTIIHRDLKASNILLG 118
L + + R LD + + ++ +T L + T++HRDLK +N+ L
Sbjct: 89 GGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD 148
Query: 119 EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
K+ DFGLARI ++ A VGT Y+ PE + Y+ KSD++S G LL +
Sbjct: 149 GKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 206
Query: 179 IISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238
+ + S E A ++ +G + D EI +
Sbjct: 207 LCALMPP------FTAFSQKELAGKIREG--KFRRIPYRYSD--------ELNEIITRML 250
Query: 239 QENPNDRPSMLQV 251
RPS+ ++
Sbjct: 251 NLKDYHRPSVEEI 263
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 4e-50
Identities = 61/253 (24%), Positives = 101/253 (39%), Gaps = 30/253 (11%)
Query: 6 GKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER----MLVYEY 59
+A +L + + FK E + LQH N++R + + +LV E
Sbjct: 34 TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 93
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL-G 118
M + +L YL R ++ K I +GL +L + IIHRDLK NI + G
Sbjct: 94 MTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITG 149
Query: 119 EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
KI D GLA + + V+GT ++ PE + Y DV++FG+ +L+
Sbjct: 150 PTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLE 204
Query: 179 IISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238
+ + + I K +S D P EI C+
Sbjct: 205 MATSEYP--YSECQNAAQIYRRVTSGVK--------PASFDKVAIP----EVKEIIEGCI 250
Query: 239 QENPNDRPSMLQV 251
++N ++R S+ +
Sbjct: 251 RQNKDERYSIKDL 263
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 6e-50
Identities = 54/251 (21%), Positives = 104/251 (41%), Gaps = 26/251 (10%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
+ A K + S + E++ E+ + A H N++++L ++ E+ ++
Sbjct: 37 SVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV 96
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
D + + R L + + + L YL + IIHRDLKA NIL D K+
Sbjct: 97 DAVMLELERP--LTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKL 151
Query: 126 SDFGLARIFAKESLEANTEQVVGTIGYIPPEYA-----RQGVYSTKSDVFSFGVLLLQII 180
+DFG++ + ++ +GT ++ PE + Y K+DV+S G+ L+++
Sbjct: 152 ADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 209
Query: 181 SGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240
+ +N +L+ A S+ D L +CL ++
Sbjct: 210 EIEPPHH--ELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF-----LKKCL-------EK 255
Query: 241 NPNDRPSMLQV 251
N + R + Q+
Sbjct: 256 NVDARWTTSQL 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-49
Identities = 59/263 (22%), Positives = 107/263 (40%), Gaps = 25/263 (9%)
Query: 6 GKVIAVKKLSKTSTQGF-EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
+ +AVK + E K E+ + L H N+++ G + + L EY
Sbjct: 30 EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 89
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
L + + + + G++YL + I HRD+K N+LL E K
Sbjct: 90 LFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLK 143
Query: 125 ISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR-QGVYSTKSDVFSFGVLLLQIISGK 183
ISDFGLA +F + E ++ GT+ Y+ PE + + ++ DV+S G++L +++G+
Sbjct: 144 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 203
Query: 184 RLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPN 243
+++ WK K +D L + + ENP+
Sbjct: 204 L--PWDQPSDSCQEYSD----WKEKKTYLNPWKKIDS--------APLALLHKILVENPS 249
Query: 244 DRPSMLQVSSMLKNETTNRNTPK 266
R ++ + K+ N+ K
Sbjct: 250 ARITIPDI---KKDRWYNKPLKK 269
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (417), Expect = 1e-49
Identities = 64/261 (24%), Positives = 111/261 (42%), Gaps = 26/261 (9%)
Query: 6 GKVIAVKKLSKTSTQGF-EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
+A+K +++ ++ EF NE + + +++R+LG + +++ E M
Sbjct: 50 ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD 109
Query: 65 LDCYLFDPIRRLI-------LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
L YL + K + + I G+ YL +HRDL A N ++
Sbjct: 110 LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 166
Query: 118 GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
ED KI DFG+ R + + + + ++ PE + GV++T SDV+SFGV+L
Sbjct: 167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 226
Query: 178 QIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237
+I + NE + G ++ D+ D E+ +C
Sbjct: 227 EIATLAEQPYQGLSNEQV------LRFVMEGGLLDKPDNCPDM---------LFELMRMC 271
Query: 238 VQENPNDRPSMLQVSSMLKNE 258
Q NP RPS L++ S +K E
Sbjct: 272 WQYNPKMRPSFLEIISSIKEE 292
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 2e-49
Identities = 56/255 (21%), Positives = 106/255 (41%), Gaps = 24/255 (9%)
Query: 6 GKVIAVKKLSKTSTQGF-EEFKNEVMLTAKLQHVNLIRVLGFCIDSEER-MLVYEYMPNK 63
AVK L++ + G +F E ++ H N++ +LG C+ SE ++V YM +
Sbjct: 55 KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 114
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
L ++ + + + ++ + +HRDL A N +L E
Sbjct: 115 DLRNFIRNETHNPTVKDLIGFGLQVAK-----GMKFLASKKFVHRDLAARNCMLDEKFTV 169
Query: 124 KISDFGLARIFAKESLEANTEQ--VVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
K++DFGLAR + ++ + + ++ E + ++TKSDV+SFGVLL ++++
Sbjct: 170 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 229
Query: 182 GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241
+++ + L +G + L P E+ L C
Sbjct: 230 RGAP-----PYPDVNTFDITVYLLQGRR-------LLQPEYCP---DPLYEVMLKCWHPK 274
Query: 242 PNDRPSMLQVSSMLK 256
RPS ++ S +
Sbjct: 275 AEMRPSFSELVSRIS 289
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (413), Expect = 5e-49
Identities = 65/252 (25%), Positives = 104/252 (41%), Gaps = 33/252 (13%)
Query: 6 GKVIAVKKLSKTSTQG---FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
+V+A+KK+S + Q +++ EV KL+H N I+ G + LV EY
Sbjct: 40 SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG 99
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
+ D + + L + + G QGL YL ++ +IHRD+KA NILL E
Sbjct: 100 SASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGL 153
Query: 123 PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR---QGVYSTKSDVFSFGVLLLQI 179
K+ DFG A I A VGT ++ PE +G Y K DV+S G+ +++
Sbjct: 154 VKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
Query: 180 ISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239
K N++ + Y + + + C+Q
Sbjct: 208 AERKPP------LFNMNAMSALYHIAQNES-PALQSGHWSE--------YFRNFVDSCLQ 252
Query: 240 ENPNDRPSMLQV 251
+ P DRP+ +
Sbjct: 253 KIPQDRPTSEVL 264
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 9e-49
Identities = 56/253 (22%), Positives = 108/253 (42%), Gaps = 22/253 (8%)
Query: 6 GKVIAVKKLSKTSTQGF-EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
+A+K L T+ +F E + + H N+IR+ G + M++ EYM N +
Sbjct: 36 EVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA 95
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
LD +L + + + V ++ GI G+ Y + + +HRDL A NIL+ ++ K
Sbjct: 96 LDKFLRE--KDGEFSVLQLVGMLRGIAAGMKY---LANMNYVHRDLAARNILVNSNLVCK 150
Query: 125 ISDFGLARIFAKESLEANTEQ-VVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
+SDFGL+R+ + T I + PE +++ SDV+SFG+++ ++++
Sbjct: 151 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG 210
Query: 184 RLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPN 243
N + ++ ++ ++ + C Q+
Sbjct: 211 ERPYWELSNHEV---------------MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERA 255
Query: 244 DRPSMLQVSSMLK 256
RP + S+L
Sbjct: 256 RRPKFADIVSILD 268
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 7e-48
Identities = 53/249 (21%), Positives = 110/249 (44%), Gaps = 22/249 (8%)
Query: 9 IAVKKLSK-TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDC 67
+A+K+L + TS + +E +E + A + + ++ R+LG C+ L+ + MP L
Sbjct: 41 VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLD 99
Query: 68 YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISD 127
Y+ + + + + ++ I +G+ YL++ ++HRDL A N+L+ KI+D
Sbjct: 100 YVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITD 154
Query: 128 FGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSM 187
FGLA++ E E + E I ++ E +Y+ +SDV+S+GV + ++++
Sbjct: 155 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS--- 211
Query: 188 LCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPS 247
Y+ + ++ P + I + C + + RP
Sbjct: 212 ------------KPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPK 259
Query: 248 MLQVSSMLK 256
++
Sbjct: 260 FRELIIEFS 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 7e-48
Identities = 55/246 (22%), Positives = 105/246 (42%), Gaps = 23/246 (9%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+ +A+++++ E NE+++ + ++ N++ L + +E +V EY+ S
Sbjct: 45 GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS- 103
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKI 125
L D + +D + + Q L +L +IHRD+K+ NILLG D K+
Sbjct: 104 ---LTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 157
Query: 126 SDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRL 185
+DFG E + +T +VGT ++ PE + Y K D++S G++ +++I G+
Sbjct: 158 TDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
Query: 186 SMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDR 245
N + L Y + G L + C+ + R
Sbjct: 216 ------YLNENPLRALYLIATNGTPELQNPEKLSA--------IFRDFLNRCLDMDVEKR 261
Query: 246 PSMLQV 251
S ++
Sbjct: 262 GSAKEL 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-47
Identities = 61/250 (24%), Positives = 105/250 (42%), Gaps = 32/250 (12%)
Query: 6 GKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
++A+K L K + + EV + + L+H N++R+ G+ D+ L+ EY P
Sbjct: 31 KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 90
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
++ L + D ++ I + L Y +IHRD+K N+LLG +
Sbjct: 91 GTVYRELQKLSK---FDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGE 144
Query: 123 PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
KI+DFG + + + + GT+ Y+PPE ++ K D++S GVL + + G
Sbjct: 145 LKIADFGWS----VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 200
Query: 183 KRLSMLCGINENLS-ILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241
K E I + +FV D + R L + N
Sbjct: 201 KPPFEANTYQETYKRISRVEFTFP------DFVTEGARDL-----ISRLL-------KHN 242
Query: 242 PNDRPSMLQV 251
P+ RP + +V
Sbjct: 243 PSQRPMLREV 252
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 1e-47
Identities = 76/284 (26%), Positives = 119/284 (41%), Gaps = 40/284 (14%)
Query: 7 KVIAVKKLSKT-STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
A+K++ + S +F E+ + KL H N+I +LG C L EY P+ +
Sbjct: 38 MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN 97
Query: 65 LDCYL-------------FDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLK 111
L +L L ++ +H + +G+ YL + IHRDL
Sbjct: 98 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLA 154
Query: 112 ASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFS 171
A NIL+GE+ KI+DFGL+R + ++ E VY+T SDV+S
Sbjct: 155 ARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWS 211
Query: 172 FGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL 231
+GVLL +I+S CG+ YE G +E + D+
Sbjct: 212 YGVLLWEIVSLGGTPY-CGMTC-----AELYEKLPQGYRLEKPLNCDDE---------VY 256
Query: 232 EIALLCVQENPNDRPSMLQV----SSMLKNETTNRNTPKKPAFS 271
++ C +E P +RPS Q+ + ML+ T NT F+
Sbjct: 257 DLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFT 300
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 1e-46
Identities = 62/255 (24%), Positives = 99/255 (38%), Gaps = 24/255 (9%)
Query: 6 GKVIAVKKLSK---TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
+AVK L + + ++F EV L H NLIR+ G + +M V E P
Sbjct: 36 TVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPL 94
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
SL L +L R + +G+ YL+ IHRDL A N+LL
Sbjct: 95 GSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDL 149
Query: 123 PKISDFGLARIFAK-ESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
KI DFGL R + + E + PE + +S SD + FGV L ++ +
Sbjct: 150 VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209
Query: 182 GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241
+ L+ + +++ K G+ + + D + + C
Sbjct: 210 YGQEPW-----IGLNGSQILHKIDKEGERLPRPEDCPQD---------IYNVMVQCWAHK 255
Query: 242 PNDRPSMLQVSSMLK 256
P DRP+ + + L
Sbjct: 256 PEDRPTFVALRDFLL 270
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-45
Identities = 67/268 (25%), Positives = 108/268 (40%), Gaps = 33/268 (12%)
Query: 6 GKVIAVKKLSKTSTQG-FEEFKNEV-MLTAKLQHVNLIRVLGFCIDSEER-MLVYEYMPN 62
+ +AVK L + +T +E+ +L H+N++ +LG C M++ E+
Sbjct: 43 CRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKF 102
Query: 63 KSLDCYLF-------------DPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRD 109
+L YL + + + L + + + +G+ +L IHRD
Sbjct: 103 GNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 159
Query: 110 LKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDV 169
L A NILL E KI DFGLAR K+ + ++ PE VY+ +SDV
Sbjct: 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 219
Query: 170 FSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMR 229
+SFGVLL +I S + I E K G + D + +
Sbjct: 220 WSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRLKEGTRMRAPDYTTPE--------- 265
Query: 230 CLEIALLCVQENPNDRPSMLQVSSMLKN 257
+ L C P+ RP+ ++ L N
Sbjct: 266 MYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 152 bits (384), Expect = 3e-44
Identities = 53/250 (21%), Positives = 98/250 (39%), Gaps = 27/250 (10%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G A K + E + E+ + L+H L+ + D E +++YE+M L
Sbjct: 51 GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 110
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG--EDMKP 123
+ D + + + V + + +GL ++ E + +H DLK NI+ +
Sbjct: 111 FEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNEL 165
Query: 124 KISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
K+ DFGL + + + GT + PE A +D++S GVL ++SG
Sbjct: 166 KLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 222
Query: 184 RLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCK--LMRCLEIALLCVQEN 241
G N++ ++ W DS+ + K + + L +
Sbjct: 223 SP--FGGENDDETLRNVKSCDWN------MDDSAFSGISEDGKDFIRKLLLA-------D 267
Query: 242 PNDRPSMLQV 251
PN R ++ Q
Sbjct: 268 PNTRMTIHQA 277
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 6e-44
Identities = 65/267 (24%), Positives = 107/267 (40%), Gaps = 33/267 (12%)
Query: 6 GKVIAVKKLSKTSTQ-GFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNK 63
+AVK L +T+ + +E+ + + +H N+I +LG C ++ EY
Sbjct: 45 VTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 104
Query: 64 SLDCYLFDPIRRLI-------------LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDL 110
+L YL + L K V + +G+ YL IHRDL
Sbjct: 105 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDL 161
Query: 111 KASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVF 170
A N+L+ ED KI+DFGLAR T + ++ PE +Y+ +SDV+
Sbjct: 162 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVW 221
Query: 171 SFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRC 230
SFGVLL +I + +E ++L K G ++ + ++
Sbjct: 222 SFGVLLWEIFTLGGSPY------PGVPVEELFKLLKEGHRMDKPSNCTNE---------L 266
Query: 231 LEIALLCVQENPNDRPSMLQVSSMLKN 257
+ C P+ RP+ Q+ L
Sbjct: 267 YMMMRDCWHAVPSQRPTFKQLVEDLDR 293
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 6e-44
Identities = 54/250 (21%), Positives = 92/250 (36%), Gaps = 28/250 (11%)
Query: 6 GKVIAVKKLSK---TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
+ A+K L K E + ++L H +++ D E+ Y N
Sbjct: 33 SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 92
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
L Y+ D + + L+ IIHRDLK NILL EDM
Sbjct: 93 GELLKYIRKIGS---FDETCTRFYTA---EIVSALEYLHGKGIIHRDLKPENILLNEDMH 146
Query: 123 PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
+I+DFG A++ + ES +A VGT Y+ PE + SD+++ G ++ Q+++G
Sbjct: 147 IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206
Query: 183 KRLSMLCGINENLS-ILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241
I++ Y+ E D + + L + +
Sbjct: 207 LPPFRAGNEYLIFQKIIKLEYDFP------EKFFPKARDL-----VEKLLVL-------D 248
Query: 242 PNDRPSMLQV 251
R ++
Sbjct: 249 ATKRLGCEEM 258
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-43
Identities = 45/253 (17%), Positives = 97/253 (38%), Gaps = 23/253 (9%)
Query: 6 GKVIAVKKLSKTSTQGF-EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
+A+K ++ E+F E + + H ++++++G + ++ E
Sbjct: 35 ALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGE 93
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
L +L L D + ++ L YL+ +HRD+ A N+L+ + K
Sbjct: 94 LRSFLQVRKYSL--DLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVK 148
Query: 125 ISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKR 184
+ DFGL+R ++S + I ++ PE +++ SDV+ FGV + +I+
Sbjct: 149 LGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV 207
Query: 185 LSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPND 244
N ++ + G+ + + + C +P+
Sbjct: 208 KPFQGVKNNDV------IGRIENGERLPMPPNCPPT---------LYSLMTKCWAYDPSR 252
Query: 245 RPSMLQVSSMLKN 257
RP ++ + L
Sbjct: 253 RPRFTELKAQLST 265
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 145 bits (366), Expect = 1e-41
Identities = 48/250 (19%), Positives = 95/250 (38%), Gaps = 27/250 (10%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+V K ++ KNE+ + +L H LI + D E +L+ E++ L
Sbjct: 54 GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 113
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL--GEDMKP 123
+ + + ++ + +GL ++ E +I+H D+K NI+ +
Sbjct: 114 FDRIAA--EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSV 168
Query: 124 KISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
KI DFGLA + + + T + PE + +D+++ GVL ++SG
Sbjct: 169 KIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 225
Query: 184 RLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCK--LMRCLEIALLCVQEN 241
G ++ ++ W EF + + + K + L+
Sbjct: 226 SP--FAGEDDLETLQNVKRCDW------EFDEDAFSSVSPEAKDFIKNLLQK-------E 270
Query: 242 PNDRPSMLQV 251
P R ++
Sbjct: 271 PRKRLTVHDA 280
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (352), Expect = 6e-40
Identities = 58/252 (23%), Positives = 105/252 (41%), Gaps = 30/252 (11%)
Query: 6 GKVIAVKKLSKTSTQGFEE-FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
K++A+K ++K + +G E +NE+ + K++H N++ + L+ + +
Sbjct: 34 QKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE 93
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL---GEDM 121
L + + + + +I + + YL + I+HRDLK N+L ED
Sbjct: 94 LFDRI---VEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDS 147
Query: 122 KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
K ISDFGL+++ S+ GT GY+ PE Q YS D +S GV+ ++
Sbjct: 148 KIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC 204
Query: 182 GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCK--LMRCLEIALLCVQ 239
G + + + ++ K EF DD + K + +E
Sbjct: 205 GYPPF------YDENDAKLFEQILKA--EYEFDSPYWDDISDSAKDFIRHLMEK------ 250
Query: 240 ENPNDRPSMLQV 251
+P R + Q
Sbjct: 251 -DPEKRFTCEQA 261
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 134 bits (339), Expect = 2e-38
Identities = 58/250 (23%), Positives = 101/250 (40%), Gaps = 27/250 (10%)
Query: 6 GKVIAVKKLSKTSTQG---FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEER----MLVYE 58
+ +AVK L + + F+ E A L H ++ V +V E
Sbjct: 32 HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 91
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
Y+ +L + + K+ + +I Q L + + IIHRD+K +NI++
Sbjct: 92 YVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMIS 145
Query: 119 EDMKPKISDFGLARIFAKE-SLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
K+ DFG+AR A + T V+GT Y+ PE AR +SDV+S G +L
Sbjct: 146 ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLY 205
Query: 178 QIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237
++++G+ S + AY+ + S+ + S + L
Sbjct: 206 EVLTGEPP------FTGDSPVSVAYQHVREDP---IPPSARHEGLSA----DLDAVVLKA 252
Query: 238 VQENPNDRPS 247
+ +NP +R
Sbjct: 253 LAKNPENRYQ 262
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 3e-38
Identities = 59/306 (19%), Positives = 114/306 (37%), Gaps = 25/306 (8%)
Query: 6 GKVIAVKKLSKTSTQGF-EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKS 64
+A+KK+S Q + + E+ + + +H N+I + + Y+
Sbjct: 33 KVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHL 92
Query: 65 LDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPK 124
+ L+ ++ L + + I +GL Y+ ++HRDLK SN+LL K
Sbjct: 93 MGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLK 149
Query: 125 ISDFGLARIFAKESLEANTE-QVVGTIGYIPPEYARQGVYSTKS-DVFSFGVLLLQIISG 182
I DFGLAR+ + + V T Y PE TKS D++S G +L +++S
Sbjct: 150 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 209
Query: 183 KR--------------LSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLM 228
+ L +L ++ + + + + P
Sbjct: 210 RPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADS 269
Query: 229 RCLEIALLCVQENPNDRPSMLQVSSM-----LKNETTNRNTPKKPAFSKQVDEIGIELLS 283
+ L++ + NP+ R + Q + + + F ++D++ E L
Sbjct: 270 KALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLK 329
Query: 284 TTQLEK 289
E+
Sbjct: 330 ELIFEE 335
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 5e-38
Identities = 43/250 (17%), Positives = 88/250 (35%), Gaps = 28/250 (11%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
K K + T K E+ + +H N++ + EE ++++E++ +
Sbjct: 30 KKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI 88
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG--EDMKP 123
+ L+ ++ V + + + L +L ++ I H D++ NI+
Sbjct: 89 FERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTI 143
Query: 124 KISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
KI +FG AR N + Y PE + V ST +D++S G L+ ++SG
Sbjct: 144 KIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI 200
Query: 184 RLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCK--LMRCLEIALLCVQEN 241
+ E + F + + + + + R L
Sbjct: 201 NP--FLAETN-----QQIIENIMNAEY-TFDEEAFKEISIEAMDFVDRLLVK-------E 245
Query: 242 PNDRPSMLQV 251
R + +
Sbjct: 246 RKSRMTASEA 255
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 134 bits (337), Expect = 9e-38
Identities = 58/251 (23%), Positives = 98/251 (39%), Gaps = 33/251 (13%)
Query: 6 GKVIAVKKLSK---TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
G+ A+K L K + E +E ++ + + H +IR+ G D+++ ++ +Y+
Sbjct: 29 GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG 88
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
L L R K + L L+ II+RDLK NILL ++
Sbjct: 89 GELFSLLRKSQRFPNPVAKFYAAEV------CLALEYLHSKDIIYRDLKPENILLDKNGH 142
Query: 123 PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
KI+DFG A+ + T + GT YI PE Y+ D +SFG+L+ ++++G
Sbjct: 143 IKITDFGFAKY-----VPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 197
Query: 183 KRLSMLCGINENLS-ILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241
+ IL F + + D L R + +
Sbjct: 198 YTPFYDSNTMKTYEKILNAELRFP------PFFNEDVKDL-----LSRLITR-------D 239
Query: 242 PNDRPSMLQVS 252
+ R LQ
Sbjct: 240 LSQRLGNLQNG 250
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 129 bits (326), Expect = 2e-36
Identities = 61/264 (23%), Positives = 102/264 (38%), Gaps = 42/264 (15%)
Query: 6 GKVIAVKKLSKTSTQGF---------EEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERML 55
K AVK + T F E EV + K+ H N+I++ + L
Sbjct: 28 CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 87
Query: 56 VYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
V++ M L YL ++ L K+ I+ + + + L + L I+HRDLK NI
Sbjct: 88 VFDLMKKGELFDYL---TEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENI 141
Query: 116 LLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR------QGVYSTKSDV 169
LL +DM K++DFG + +V GT Y+ PE Y + D+
Sbjct: 142 LLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDM 198
Query: 170 FSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCK--L 227
+S GV++ +++G + + + G +F DD + K +
Sbjct: 199 WSTGVIMYTLLAGSPP------FWHRKQMLMLRMIMSG--NYQFGSPEWDDYSDTVKDLV 250
Query: 228 MRCLEIALLCVQENPNDRPSMLQV 251
R L + P R + +
Sbjct: 251 SRFLVV-------QPQKRYTAEEA 267
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (320), Expect = 2e-35
Identities = 42/260 (16%), Positives = 80/260 (30%), Gaps = 24/260 (9%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
G+ +A+K + + E + +Q I + +C + ++ + SL
Sbjct: 32 GEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSL 89
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNIL---LGEDMK 122
+ R+ K + + + + + Y+ IHRD+K N L +
Sbjct: 90 EDLFNFCSRKF--SLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNL 144
Query: 123 PKISDFGLARIFAKESLEAN-----TEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
I DFGLA+ + + + + GT Y S + D+ S G +L+
Sbjct: 145 VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLM 204
Query: 178 QIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLC 237
G E E K + L C
Sbjct: 205 YFNLGSLPWQGLKAATKRQKYERISE-----KKMSTPIEVLCKGYPSE----FATYLNFC 255
Query: 238 VQENPNDRPSMLQVSSMLKN 257
+D+P + + +N
Sbjct: 256 RSLRFDDKPDYSYLRQLFRN 275
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 3e-35
Identities = 56/249 (22%), Positives = 89/249 (35%), Gaps = 29/249 (11%)
Query: 6 GKVIAVKKLSK---TSTQGFEEFKNEV-MLTAKLQHVNLIRVLGFCIDSEERMLVYEYMP 61
+ A+K L K E E +L+ +H L + E V EY+
Sbjct: 27 NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 86
Query: 62 NKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM 121
L ++ + D + I GL +L I++RDLK NILL +D
Sbjct: 87 GGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDG 140
Query: 122 KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
KI+DFG+ + + NT GT YI PE Y+ D +SFGVLL +++
Sbjct: 141 HIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI 198
Query: 182 GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241
G+ E + + +++ D L++
Sbjct: 199 GQSPFHGQDEEELFHSIRMDNPFYP-----RWLEKEAKDL-----LVKLF-------VRE 241
Query: 242 PNDRPSMLQ 250
P R +
Sbjct: 242 PEKRLGVRG 250
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 126 bits (317), Expect = 5e-35
Identities = 35/270 (12%), Positives = 80/270 (29%), Gaps = 26/270 (9%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSL 65
+ +A+K + S + ++E L I + + ++ + SL
Sbjct: 30 NQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSL 87
Query: 66 DCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP-- 123
+ L R+ K + + + + E S +++RD+K N L+G
Sbjct: 88 EDLLDLCGRKF--SVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNA 142
Query: 124 ---KISDFGLARIFAKESLEAN-----TEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVL 175
+ DFG+ + + + + + + GT Y+ S + D+ + G +
Sbjct: 143 NMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHV 202
Query: 176 LLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235
+ + G + + YE K + +
Sbjct: 203 FMYFLRGSLPWQ----GLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFY-----KYMH 253
Query: 236 LCVQENPNDRPSMLQVSSMLKNETTNRNTP 265
+ P + + NT
Sbjct: 254 YARNLAFDATPDYDYLQGLFSKVLERLNTT 283
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 1e-34
Identities = 56/258 (21%), Positives = 102/258 (39%), Gaps = 36/258 (13%)
Query: 6 GKVIAVKKLSKTSTQGF------EEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEY 59
G A K + K T+ E+ + EV + ++QH N+I + + + +L+ E
Sbjct: 35 GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 94
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
+ L + + L ++ ++ I L + L I H DLK NI+L +
Sbjct: 95 VAGGELFDF---LAEKESLTEEEATEFLKQI---LNGVYYLHSLQIAHFDLKPENIMLLD 148
Query: 120 DMKP----KISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVL 175
P KI DFGLA + + + GT ++ PE ++D++S GV+
Sbjct: 149 RNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 205
Query: 176 LLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCK--LMRCLEI 233
++SG + E L+ + EF D +T++ K + R L
Sbjct: 206 TYILLSGASPFLGDTKQETLANVSA--------VNYEFEDEYFSNTSALAKDFIRRLL-- 255
Query: 234 ALLCVQENPNDRPSMLQV 251
++P R ++
Sbjct: 256 -----VKDPKKRMTIQDS 268
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 126 bits (318), Expect = 1e-34
Identities = 55/254 (21%), Positives = 95/254 (37%), Gaps = 31/254 (12%)
Query: 6 GKVIAVKKLSKTSTQG------FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEY 59
GK+ A+K L K + + + L + ++ + ++ + +
Sbjct: 29 GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 88
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
M L +L + + I GL ++ +++RDLK +NILL E
Sbjct: 89 MNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDE 142
Query: 120 DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV-YSTKSDVFSFGVLLLQ 178
+ISD GLA F+K+ VGT GY+ PE ++GV Y + +D FS G +L +
Sbjct: 143 HGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFK 198
Query: 179 IISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238
++ G + I + L D+ SP + +
Sbjct: 199 LLRGHSPFRQHKTKDKHEIDRMTLTM----------AVELPDSFSP----ELRSLLEGLL 244
Query: 239 QENPNDRPSMLQVS 252
Q + N R L
Sbjct: 245 QRDVNRRLGCLGRG 258
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 8e-34
Identities = 59/266 (22%), Positives = 109/266 (40%), Gaps = 28/266 (10%)
Query: 6 GKVIAVKKLSKTSTQG--FEEFKNEVMLTAKL---QHVNLIRVLGFCIDSEERMLVYEYM 60
G+ +A+K++ + + EV + L +H N++R+ C S +
Sbjct: 33 GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 92
Query: 61 PNKSLDC---YLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
+ +D D + + + ++ + +GL +L + ++HRDLK NIL+
Sbjct: 93 VFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILV 149
Query: 118 GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
+ K++DFGLARI++ + VV T+ Y PE Q Y+T D++S G +
Sbjct: 150 TSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 206
Query: 178 QIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLE----- 232
++ K L G ++ + + + G+ D +L K + +E
Sbjct: 207 EMFRRKPL--FRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD 264
Query: 233 -----IALL--CVQENPNDRPSMLQV 251
LL C+ NP R S
Sbjct: 265 IDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 1e-33
Identities = 54/260 (20%), Positives = 95/260 (36%), Gaps = 20/260 (7%)
Query: 6 GKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
G+V+A+KK+ + E+ L +L H N++++L + LV+E++
Sbjct: 27 GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 86
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
+ + L K Q L L ++HRDLK N+L+ +
Sbjct: 87 LKKFMDASALTGIPLPLIKSYLF-----QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAI 141
Query: 124 KISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
K++DFGLAR F T +VV P YST D++S G + ++++ +
Sbjct: 142 KLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200
Query: 184 RLSMLCGINENL-----SILEHAYELWKGGKGVEFVDSSLDDTNS-------PCKLMRCL 231
L + L ++ +W G + S P
Sbjct: 201 ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGR 260
Query: 232 EIALLCVQENPNDRPSMLQV 251
+ + +PN R S
Sbjct: 261 SLLSQMLHYDPNKRISAKAA 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 3e-33
Identities = 48/256 (18%), Positives = 90/256 (35%), Gaps = 42/256 (16%)
Query: 6 GKVIAVKKLSKTSTQGFEE------FKNEVMLTAKLQ--HVNLIRVLGFCIDSEERMLVY 57
+A+K + K + E EV+L K+ +IR+L + + +L+
Sbjct: 29 NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 88
Query: 58 EYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
E R L + + + + + ++HRD+K NIL+
Sbjct: 89 ERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILI 143
Query: 118 GED-MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKS-DVFSFGVL 175
+ + K+ DFG + + GT Y PPE+ R Y +S V+S G+L
Sbjct: 144 DLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 199
Query: 176 LLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235
L ++ G ++ + + S C +
Sbjct: 200 LYDMVCGDI-------------------PFEHDEEIIRGQVFFRQRVSS----ECQHLIR 236
Query: 236 LCVQENPNDRPSMLQV 251
C+ P+DRP+ ++
Sbjct: 237 WCLALRPSDRPTFEEI 252
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 4e-33
Identities = 58/263 (22%), Positives = 101/263 (38%), Gaps = 25/263 (9%)
Query: 6 GKVIAVKKLSKTSTQGFEE-----FKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYM 60
+++A+KK+ ++ E+ L +L H N+I +L LV+++M
Sbjct: 23 NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
D + L+L + QGL YL ++ I+HRDLK +N+LL E+
Sbjct: 83 ET---DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDEN 136
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ-GVYSTKSDVFSFGVLLLQI 179
K++DFGLA+ F + V T Y PE +Y D+++ G +L ++
Sbjct: 137 GVLKLADFGLAKSFGSPNRAYT--HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAEL 194
Query: 180 ISGKRLSMLCGINENLS-ILEHAY----ELWKGGKGVEFVDSSLDDTNSPCKLM------ 228
+ + L+ I E E W + + P +
Sbjct: 195 LLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGD 254
Query: 229 RCLEIALLCVQENPNDRPSMLQV 251
L++ NP R + Q
Sbjct: 255 DLLDLIQGLFLFNPCARITATQA 277
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 4e-33
Identities = 52/265 (19%), Positives = 96/265 (36%), Gaps = 28/265 (10%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM------LVYEY 59
G+++A+KK+ + E+ + KL H N++R+ F S E+ LV +Y
Sbjct: 45 GELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100
Query: 60 MPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE 119
+P + L + + + L Y+ I HRD+K N+LL
Sbjct: 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDP 157
Query: 120 D-MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
D K+ DFG A+ + E N + P Y++ DV+S G +L +
Sbjct: 158 DTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 215
Query: 179 IISGKRL-------SMLCGINENL-----SILEHAYELWKGGKGVEFVDSSLDDTNSPCK 226
++ G+ + L I + L + + K + P
Sbjct: 216 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRT 275
Query: 227 LMRCLEIALLCVQENPNDRPSMLQV 251
+ + ++ P R + L+
Sbjct: 276 PPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 120 bits (302), Expect = 5e-33
Identities = 51/265 (19%), Positives = 100/265 (37%), Gaps = 21/265 (7%)
Query: 1 GVLPCGKVIAVKKL--SKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYE 58
G+ A+KK+ K E+ + +L+H N++++ + +LV+E
Sbjct: 21 AQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80
Query: 59 YMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG 118
++ L+ + + G+ Y + ++HRDLK N+L+
Sbjct: 81 HLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLIN 134
Query: 119 EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQ 178
+ + KI+DFGLAR F + ++V P YST D++S G + +
Sbjct: 135 REGELKIADFGLARAFGIPVRKYTH-EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAE 193
Query: 179 IISGKRL-------SMLCGINENL-----SILEHAYELWKGGKGVEFVDSSLDDTNSPCK 226
+++G L L I L + EL K + ++
Sbjct: 194 MVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGL 253
Query: 227 LMRCLEIALLCVQENPNDRPSMLQV 251
+++ ++ +PN R + Q
Sbjct: 254 DESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 8e-32
Identities = 51/274 (18%), Positives = 102/274 (37%), Gaps = 34/274 (12%)
Query: 6 GKVIAVKKLSKTSTQG--FEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM--------L 55
G+ +A+KK+ + + E+ + L+H N++ ++ C L
Sbjct: 35 GQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL 94
Query: 56 VYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNI 115
V+++ + ++ + +++ + GL Y+ I+HRD+KA+N+
Sbjct: 95 VFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANV 148
Query: 116 LLGEDMKPKISDFGLARIF--AKESLEANTEQVVGTIGYIPPEYARQG-VYSTKSDVFSF 172
L+ D K++DFGLAR F AK S V T+ Y PPE Y D++
Sbjct: 149 LITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGA 208
Query: 173 GVLLLQIISGKRLSMLCGINENLSILEHAY-----ELWKGGKGVEFVDSSLDDTNSPCKL 227
G ++ ++ + + L+++ E+W E + K+
Sbjct: 209 GCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKV 268
Query: 228 MRCLEIALL----------CVQENPNDRPSMLQV 251
L+ + + +P R
Sbjct: 269 KDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 1e-31
Identities = 47/263 (17%), Positives = 96/263 (36%), Gaps = 26/263 (9%)
Query: 6 GKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63
+++A+K++ E+ L +L+H N++R+ ++ LV+E+
Sbjct: 27 HEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQD 86
Query: 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKP 123
+ + + Q L L ++HRDLK N+L+ + +
Sbjct: 87 LKKYFDSCN------GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGEL 140
Query: 124 KISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK 183
K+++FGLAR F + +VV P +YST D++S G + ++ +
Sbjct: 141 KLANFGLARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 199
Query: 184 RLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMR-------------- 229
R L N+ L+ + L ++ + P +
Sbjct: 200 R--PLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNA 257
Query: 230 -CLEIALLCVQENPNDRPSMLQV 251
++ ++ NP R S +
Sbjct: 258 TGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 6e-31
Identities = 44/247 (17%), Positives = 82/247 (33%), Gaps = 30/247 (12%)
Query: 6 GKVIAVKKLSK---TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
G+ A+K L K + E + +H L + + V EY
Sbjct: 30 GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
L +L R + ++ + + L+ +++RD+K N++L +D
Sbjct: 90 GELFFHL---SRERVFTEERARFYG---AEIVSALEYLHSRDVVYRDIKLENLMLDKDGH 143
Query: 123 PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
KI+DFGL + + A + GT Y+ PE Y D + GV++ +++ G
Sbjct: 144 IKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201
Query: 183 KRLSMLCGINENLS-ILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241
+ IL + + L L +++
Sbjct: 202 RLPFYNQDHERLFELILMEEIRFPRT------LSPEAKSL-----LAGLL-------KKD 243
Query: 242 PNDRPSM 248
P R
Sbjct: 244 PKQRLGG 250
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 1e-30
Identities = 48/256 (18%), Positives = 97/256 (37%), Gaps = 33/256 (12%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEER----MLVYEYM 60
+ A+K L + + EV L + Q +++R++ + ++V E +
Sbjct: 37 QEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 91
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL--- 117
L + D + ++ I++ I + + YL + I HRD+K N+L
Sbjct: 92 DGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK 147
Query: 118 GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
+ K++DFG A+ + + T Y+ PE Y D++S GV++
Sbjct: 148 RPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMY 204
Query: 178 QIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCK--LMRCLEIAL 235
++ G N L+I + G+ EF + + + K + L
Sbjct: 205 ILLCGYPPFY---SNHGLAISPGMKTRIRMGQ-YEFPNPEWSEVSEEVKMLIRNLL---- 256
Query: 236 LCVQENPNDRPSMLQV 251
+ P R ++ +
Sbjct: 257 ---KTEPTQRMTITEF 269
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 5e-29
Identities = 57/291 (19%), Positives = 109/291 (37%), Gaps = 26/291 (8%)
Query: 6 GKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYE-YMPN 62
G +A+KKL + S + E+ L ++H N+I +L E + Y+
Sbjct: 43 GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 102
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
+ L ++ L + ++ + +GL Y+ IIHRDLK N+ + ED +
Sbjct: 103 PFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCE 159
Query: 123 PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
KI DFGLAR E T VV P Y+ D++S G ++ ++I+G
Sbjct: 160 LKILDFGLARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 215
Query: 183 KRL-SMLCGINENLSILEHAY----ELWKGGKGVEFVDSSLDDTNSPCKLMR-------- 229
K L +++ I++ E + + E + K
Sbjct: 216 KTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASP 275
Query: 230 -CLEIALLCVQENPNDRPSMLQV--SSMLKNETTNRNTPKKPAFSKQVDEI 277
+ + + + R + + ++ + P+ + D++
Sbjct: 276 LAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDV 326
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 106 bits (264), Expect = 5e-27
Identities = 41/183 (22%), Positives = 72/183 (39%), Gaps = 14/183 (7%)
Query: 6 GKVIAVKKLSK---TSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPN 62
G A+K L K + E NE + + L+++ D+ +V EY+
Sbjct: 66 GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
+ +L R I YL L +I+RDLK N+L+ +
Sbjct: 126 GEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGY 179
Query: 123 PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
+++DFG A+ + T + GT + PE Y+ D ++ GVL+ ++ +G
Sbjct: 180 IQVTDFGFAKRV-----KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 183 KRL 185
Sbjct: 235 YPP 237
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 1e-26
Identities = 52/252 (20%), Positives = 99/252 (39%), Gaps = 27/252 (10%)
Query: 6 GKVIAVKKLSKTS----TQGFEEFKNEVMLTAKLQHV-NLIRVLGFCIDSEERMLVYEYM 60
GK+ A+K L K + + E + E + ++ L+ + + L+ +Y+
Sbjct: 52 GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYI 111
Query: 61 PNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED 120
L +L R + + + + +L L+ +L II+RD+K NILL +
Sbjct: 112 NGGELFTHLSQRERFTEHEVQIY------VGEIVLALEHLHKLGIIYRDIKLENILLDSN 165
Query: 121 MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV--YSTKSDVFSFGVLLLQ 178
++DFGL++ F + E GTI Y+ P+ R G + D +S GVL+ +
Sbjct: 166 GHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 224
Query: 179 IISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238
+++G E S E + + K + S ++ +
Sbjct: 225 LLTGASP--FTVDGEKNSQAEISRRILKS-------EPPYPQEMSA----LAKDLIQRLL 271
Query: 239 QENPNDRPSMLQ 250
++P R
Sbjct: 272 MKDPKKRLGCGP 283
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 97.2 bits (241), Expect = 5e-24
Identities = 47/271 (17%), Positives = 95/271 (35%), Gaps = 39/271 (14%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERM--LVYEYMPN 62
+ + VK L ++ K E+ + L+ N+I + D R LV+E++ N
Sbjct: 60 NEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 116
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG-EDM 121
+ L + I + L Y + I+HRD+K N+++ E
Sbjct: 117 TDF----KQLYQTL--TDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHR 167
Query: 122 KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS 181
K ++ D+GLA + + +V P +Y D++S G +L +I
Sbjct: 168 KLRLIDWGLAEFYHPG--QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 225
Query: 182 GKR--------LSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLE- 232
K L I + L + + K ++ + + +S + R +
Sbjct: 226 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHS 285
Query: 233 ----------IALL--CVQENPNDRPSMLQV 251
+ L ++ + R + +
Sbjct: 286 ENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.6 bits (234), Expect = 7e-23
Identities = 58/263 (22%), Positives = 99/263 (37%), Gaps = 24/263 (9%)
Query: 6 GKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERM-LVYEYMPN 62
G +AVKKLS+ S + E+ L ++H N+I +L + Y+
Sbjct: 43 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102
Query: 63 KSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMK 122
+ L + ++ L +I I +GL Y+ IHRDLK SN+ + ED +
Sbjct: 103 HLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCE 159
Query: 123 PKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISG 182
KI DFGLAR E T V P Y+ D++S G ++ ++++G
Sbjct: 160 LKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215
Query: 183 KRLSMLCGINENLSILEHA-----YELWKGGKGVEFVDSSLDDTNSPCKLMR-------- 229
+ L + L ++ EL K + T P
Sbjct: 216 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 275
Query: 230 -CLEIALLCVQENPNDRPSMLQV 251
+++ + + + R + Q
Sbjct: 276 LAVDLLEKMLVLDSDKRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.2 bits (225), Expect = 1e-21
Identities = 48/188 (25%), Positives = 81/188 (43%), Gaps = 20/188 (10%)
Query: 6 GKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCI------DSEERMLVY 57
+ +A+KKLS+ + + E++L + H N+I +L + ++ LV
Sbjct: 42 DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 101
Query: 58 EYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILL 117
E M + D ++ +++ + G+ +L IIHRDLK SNI++
Sbjct: 102 ELMDANLCQVIQMEL------DHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVV 152
Query: 118 GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLL 177
D KI DFGLAR + V T Y PE Y D++S G ++
Sbjct: 153 KSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 209
Query: 178 QIISGKRL 185
+++ K L
Sbjct: 210 EMVRHKIL 217
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 89.3 bits (220), Expect = 6e-21
Identities = 50/289 (17%), Positives = 99/289 (34%), Gaps = 31/289 (10%)
Query: 6 GKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVY--EYMPNK 63
+A+K + E ++E+ L ++ + + + ++L + PN
Sbjct: 38 NTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG 96
Query: 64 SLDCYLFDPIRRLILDWKKR-----------VHIIEGITQGLLYLQEYSRLTIIHRDLKA 112
+F+ + +L K+ I + + GL Y+ + R IIH D+K
Sbjct: 97 VHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYM--HRRCGIIHTDIKP 154
Query: 113 SNILL-GEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTKSDVFS 171
N+L+ D + +A + + + + T Y PE + +D++S
Sbjct: 155 ENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWS 214
Query: 172 FGVLLLQIISGKRLSMLCGINENLSILEH------------AYELWKGGKGVEFVDSSLD 219
L+ ++I+G L + +H +Y L G F +S
Sbjct: 215 TACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGL 274
Query: 220 DTNSPCKLMRCLEIALLCVQENPNDRPSMLQ--VSSMLKNETTNRNTPK 266
N LE L + D + +S ML+ + R
Sbjct: 275 LRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 69.4 bits (169), Expect = 7e-15
Identities = 30/185 (16%), Positives = 58/185 (31%), Gaps = 33/185 (17%)
Query: 1 GVLPCGKVIAVKKLSKTST----------QGFEEFKNEVMLTAKLQHVNLIRVLGFCI-- 48
VK T G F + +A+ + L ++ G +
Sbjct: 19 CYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPK 78
Query: 49 --DSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTII 106
E ++ E + K L + +++ I + + I+
Sbjct: 79 VYAWEGNAVLMELIDAKELYRVRVENPDE----------VLDMILEEVAKFYHR---GIV 125
Query: 107 HRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTK 166
H DL N+L+ + I DF + +E E + + I ++R Y T+
Sbjct: 126 HGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWR---EILERDVRNIITYFSRT--YRTE 179
Query: 167 SDVFS 171
D+ S
Sbjct: 180 KDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 303 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.8 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.6 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.11 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.33 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.31 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.13 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.82 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-52 Score=347.02 Aligned_cols=230 Identities=24% Similarity=0.328 Sum_probs=185.2
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.||||+++... ....+.+.+|+.++++++||||+++++++.+++..|+|||||++|+|.+++. ....+++..
T Consensus 28 ~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~---~~~~l~e~~ 104 (271)
T d1nvra_ 28 VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPD 104 (271)
T ss_dssp TTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSB---TTTBCCHHH
T ss_pred CCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHh---cCCCCCHHH
Confidence 579999999997553 2344678999999999999999999999999999999999999999999984 455799999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..
T Consensus 105 ~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~ 181 (271)
T d1nvra_ 105 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181 (271)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSS
T ss_pred HHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCC
Confidence 9999999999999999999 9999999999999999999999999998765544444445568999999999998887
Q ss_pred C-CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 163 Y-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~-~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
+ +.++|||||||++|+|++|..||......... . ......... .......+.++.+|+.+||+.|
T Consensus 182 ~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~--~----~~~~~~~~~--------~~~~~~~s~~~~~li~~~L~~d 247 (271)
T d1nvra_ 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--Y----SDWKEKKTY--------LNPWKKIDSAPLALLHKILVEN 247 (271)
T ss_dssp BCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH--H----HHHHTTCTT--------STTGGGSCHHHHHHHHHHSCSS
T ss_pred CCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH--H----HHHhcCCCC--------CCccccCCHHHHHHHHHHcCCC
Confidence 6 57899999999999999999999654432211 1 111111000 1111223457889999999999
Q ss_pred CCCCCCHHHHHH
Q 048243 242 PNDRPSMLQVSS 253 (303)
Q Consensus 242 p~~Rpt~~el~~ 253 (303)
|++|||++|+++
T Consensus 248 P~~R~t~~eil~ 259 (271)
T d1nvra_ 248 PSARITIPDIKK 259 (271)
T ss_dssp TTTSCCHHHHTT
T ss_pred hhHCcCHHHHhc
Confidence 999999999865
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=347.85 Aligned_cols=228 Identities=22% Similarity=0.350 Sum_probs=188.6
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
..+|+.||||+++.......+.+.+|+.++++++||||+++++++.+++..|+|||||++|+|.+++. ...+++..
T Consensus 42 ~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~----~~~l~~~~ 117 (293)
T d1yhwa1 42 VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQ 117 (293)
T ss_dssp TTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHH----HSCCCHHH
T ss_pred CCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhh----ccCCCHHH
Confidence 36799999999976665667889999999999999999999999999999999999999999998873 34699999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+++.+.... .......||+.|+|||++.+..
T Consensus 118 ~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~ 192 (293)
T d1yhwa1 118 IAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKA 192 (293)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCGGGCCHHHHSSSC
T ss_pred HHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc--ccccccccCCCccChhhhcCCC
Confidence 9999999999999999999 9999999999999999999999999998765432 2233467999999999999999
Q ss_pred CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC
Q 048243 163 YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 242 (303)
++.++|||||||++|+|++|..||....... ........... ....+...+..+.+||.+||+.||
T Consensus 193 ~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~~~~~~~~--------~~~~~~~~s~~~~~li~~~L~~dP 258 (293)
T d1yhwa1 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGTP--------ELQNPEKLSAIFRDFLNRCLDMDV 258 (293)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCSC--------CCSSGGGSCHHHHHHHHHHTCSST
T ss_pred CCchhceehHhHHHHHHhhCCCCCCCCCHHH------HHHHHHhCCCC--------CCCCcccCCHHHHHHHHHHccCCh
Confidence 9999999999999999999999996433211 11111111110 011112234578899999999999
Q ss_pred CCCCCHHHHHH
Q 048243 243 NDRPSMLQVSS 253 (303)
Q Consensus 243 ~~Rpt~~el~~ 253 (303)
.+|||+.|+++
T Consensus 259 ~~R~s~~eil~ 269 (293)
T d1yhwa1 259 EKRGSAKELLQ 269 (293)
T ss_dssp TTSCCHHHHTT
T ss_pred hHCcCHHHHhc
Confidence 99999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=340.99 Aligned_cols=223 Identities=25% Similarity=0.371 Sum_probs=185.6
Q ss_pred CCCcEEEEEEecCC---CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||+|++... .....+.+.+|+.++++++||||+++++++.+++..|+|||||++|+|.+++. ....+++
T Consensus 29 ~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~---~~~~l~e 105 (263)
T d2j4za1 29 QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDE 105 (263)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHSSCCH
T ss_pred CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHh---hcCCCCH
Confidence 57999999998643 23456788999999999999999999999999999999999999999999984 4556999
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++....... .....||+.|+|||++.+
T Consensus 106 ~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~----~~~~~Gt~~Y~APE~~~~ 178 (263)
T d2j4za1 106 QRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEG 178 (263)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC----CEETTEEGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCCc----ccccCCCCcccCHHHHcC
Confidence 999999999999999999999 9999999999999999999999999997654332 233579999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|||||||++|+|++|..||...+... .. ....... . ..+...+.++.+|+.+||+.
T Consensus 179 ~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~---~~i~~~~-~----------~~p~~~s~~~~~li~~~L~~ 241 (263)
T d2j4za1 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TY---KRISRVE-F----------TFPDFVTEGARDLISRLLKH 241 (263)
T ss_dssp CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HHHHTTC-C----------CCCTTSCHHHHHHHHHHTCS
T ss_pred CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH---HH---HHHHcCC-C----------CCCccCCHHHHHHHHHHccC
Confidence 999999999999999999999999996433211 11 1111111 0 11112345788999999999
Q ss_pred CCCCCCCHHHHHH
Q 048243 241 NPNDRPSMLQVSS 253 (303)
Q Consensus 241 dp~~Rpt~~el~~ 253 (303)
||++|||++|+++
T Consensus 242 dp~~R~t~~eil~ 254 (263)
T d2j4za1 242 NPSQRPMLREVLE 254 (263)
T ss_dssp SGGGSCCHHHHHT
T ss_pred CHhHCcCHHHHHc
Confidence 9999999999986
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-51 Score=344.52 Aligned_cols=229 Identities=21% Similarity=0.286 Sum_probs=187.2
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+|+.||+|+++.......+.+.+|++++++++||||+++++++.+++..++|||||++|+|.+++.. ....+++..+
T Consensus 35 ~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~--~~~~l~e~~~ 112 (288)
T d2jfla1 35 ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQI 112 (288)
T ss_dssp TTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH--HTSCCCHHHH
T ss_pred CCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHh--cCCCCCHHHH
Confidence 57999999999877666667899999999999999999999999999999999999999999998743 3456999999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc----
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR---- 159 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---- 159 (303)
..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++....... .......||+.|+|||++.
T Consensus 113 ~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~ 187 (288)
T d2jfla1 113 QVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETS 187 (288)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HHHTCCCSCCTTCCHHHHTTCST
T ss_pred HHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--ccccccccccccCCHHHHhhccc
Confidence 999999999999999999 9999999999999999999999999987643321 1223467999999999984
Q ss_pred -cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcc
Q 048243 160 -QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCV 238 (303)
Q Consensus 160 -~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 238 (303)
+..++.++|||||||++|+|++|..||...+.... .. ....... . ....+...+.++.+||.+||
T Consensus 188 ~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~---~~---~i~~~~~-~-------~~~~~~~~s~~~~~li~~~L 253 (288)
T d2jfla1 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV---LL---KIAKSEP-P-------TLAQPSRWSSNFKDFLKKCL 253 (288)
T ss_dssp TTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HH---HHHHSCC-C-------CCSSGGGSCHHHHHHHHHHS
T ss_pred CCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH---HH---HHHcCCC-C-------CCCccccCCHHHHHHHHHHc
Confidence 44578999999999999999999999965443221 11 1111111 0 11112233458899999999
Q ss_pred cCCCCCCCCHHHHHH
Q 048243 239 QENPNDRPSMLQVSS 253 (303)
Q Consensus 239 ~~dp~~Rpt~~el~~ 253 (303)
+.||++|||+.|+++
T Consensus 254 ~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 254 EKNVDARWTTSQLLQ 268 (288)
T ss_dssp CSSTTTSCCHHHHTT
T ss_pred cCChhHCcCHHHHhc
Confidence 999999999999976
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=342.44 Aligned_cols=236 Identities=27% Similarity=0.444 Sum_probs=180.2
Q ss_pred ccCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 2 VLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 2 ~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
.+.+++.||||+++... ...+.+.+|+.++++++||||+++++++..+...++|||||++|+|.+++.. ....+++.
T Consensus 25 ~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~--~~~~~~~~ 101 (263)
T d1sm2a_ 25 YWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAE 101 (263)
T ss_dssp EETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHT--TTTCCCHH
T ss_pred EECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhc--cccCCCHH
Confidence 45678899999997543 4457899999999999999999999999999999999999999999998854 34568899
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
.++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++....... .......||+.|+|||++.+.
T Consensus 102 ~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~ 177 (263)
T d1sm2a_ 102 TLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFS 177 (263)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-------------------CTTSCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc-eeecceecCcccCChHHhcCC
Confidence 99999999999999999999 99999999999999999999999999987654332 222335689999999999999
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
.++.++|||||||++|||+++..|+.... ........ ...+.. ...+...+.++.+|+.+||+.|
T Consensus 178 ~~~~k~DVwS~Gvil~el~t~~~~~~~~~--~~~~~~~~----i~~~~~---------~~~p~~~~~~l~~li~~cl~~~ 242 (263)
T d1sm2a_ 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENR--SNSEVVED----ISTGFR---------LYKPRLASTHVYQIMNHCWKER 242 (263)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCTTCSC--CHHHHHHH----HHHTCC---------CCCCTTSCHHHHHHHHHHTCSS
T ss_pred CCCchhhhcchHHHHHHHHHCCCCCCCCC--CHHHHHHH----HHhcCC---------CCCccccCHHHHHHHHHHccCC
Confidence 99999999999999999999654442221 11111111 111111 1111122357889999999999
Q ss_pred CCCCCCHHHHHHHhcccc
Q 048243 242 PNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 242 p~~Rpt~~el~~~L~~~~ 259 (303)
|++|||++|+++.|++..
T Consensus 243 p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 243 PEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp GGGSCCHHHHHHHHHHHH
T ss_pred HhHCcCHHHHHHHHHHHH
Confidence 999999999999998764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=344.41 Aligned_cols=227 Identities=23% Similarity=0.288 Sum_probs=183.7
Q ss_pred CCCcEEEEEEecCC---CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||||+++.. .....+.+.+|+.++++++||||+++++++.+++..|+|||||++|+|.+++. ..+.+++
T Consensus 31 ~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~---~~~~l~e 107 (288)
T d1uu3a_ 31 ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDE 107 (288)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH---HHSSCCH
T ss_pred CCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhh---ccCCCCH
Confidence 57999999999643 23455789999999999999999999999999999999999999999999884 4567999
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.|++.||+|||+.| |+||||||+|||++.++.++|+|||+++.+.............||+.|+|||++.+
T Consensus 108 ~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~ 184 (288)
T d1uu3a_ 108 TCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184 (288)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHT
T ss_pred HHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeecc
Confidence 999999999999999999999 99999999999999999999999999987765544444445679999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|||||||++|+|++|..||...+... .......... .+ +...+.++.+||.+||+.
T Consensus 185 ~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~~~~-------~~----p~~~s~~~~~li~~~L~~ 247 (288)
T d1uu3a_ 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL------IFQKIIKLEY-------DF----PEKFFPKARDLVEKLLVL 247 (288)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHTTCC-------CC----CTTCCHHHHHHHHTTSCS
T ss_pred CCCCcccceehhhHHHHHHhhCCCCCCCcCHHH------HHHHHHcCCC-------CC----CccCCHHHHHHHHHHccC
Confidence 999999999999999999999999996432111 1111111110 11 112345788999999999
Q ss_pred CCCCCCCHHHHHH
Q 048243 241 NPNDRPSMLQVSS 253 (303)
Q Consensus 241 dp~~Rpt~~el~~ 253 (303)
||++|||++|+++
T Consensus 248 dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 248 DATKRLGCEEMEG 260 (288)
T ss_dssp SGGGSTTSGGGTC
T ss_pred CHhHCcCHHHHcC
Confidence 9999999999743
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-50 Score=336.29 Aligned_cols=237 Identities=29% Similarity=0.405 Sum_probs=181.4
Q ss_pred cEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHH
Q 048243 7 KVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 7 ~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~ 84 (303)
..||||+++.. .....+.+.+|+.++++++||||+++++++. ....++|||||++|+|.+++.. .+..+++..+.
T Consensus 31 ~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~--~~~~~~~~~~~ 107 (276)
T d1uwha_ 31 GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLI 107 (276)
T ss_dssp SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHHT--SCCCCCHHHHH
T ss_pred CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCCHHHHHhh--ccCCCCHHHHH
Confidence 46999999654 3455678999999999999999999999875 4568999999999999999854 34569999999
Q ss_pred HHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccC---
Q 048243 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG--- 161 (303)
Q Consensus 85 ~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--- 161 (303)
.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+.
T Consensus 108 ~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 184 (276)
T d1uwha_ 108 DIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184 (276)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSC
T ss_pred HHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCC
Confidence 99999999999999998 999999999999999999999999999876544333344456789999999998643
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
.++.++|||||||++|||++|..||........ . ............. .... ...+..+.+|+.+||+.|
T Consensus 185 ~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~---~---~~~~~~~~~~p~~-~~~~----~~~~~~l~~li~~cl~~d 253 (276)
T d1uwha_ 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---I---IFMVGRGYLSPDL-SKVR----SNCPKAMKRLMAECLKKK 253 (276)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---H---HHHHHHTSCCCCG-GGSC----TTCCHHHHHHHHHHTCSS
T ss_pred CCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH---H---HHHHhcCCCCCcc-hhcc----ccchHHHHHHHHHHcCCC
Confidence 478899999999999999999999964432211 1 1111111111100 0111 122347889999999999
Q ss_pred CCCCCCHHHHHHHhccccC
Q 048243 242 PNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 242 p~~Rpt~~el~~~L~~~~~ 260 (303)
|++|||+.|+++.|+....
T Consensus 254 p~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 254 RDERPLFPQILASIELLAR 272 (276)
T ss_dssp GGGSCCHHHHHHHHHHHHH
T ss_pred HhHCcCHHHHHHHHHHHHH
Confidence 9999999999999987653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.8e-50 Score=346.83 Aligned_cols=236 Identities=21% Similarity=0.252 Sum_probs=192.0
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+|+.||||+++.......+.+.+|+.+|++++||||+++++++.++...|+|||||++|+|.+++.. ....+++..+
T Consensus 52 ~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~--~~~~l~e~~~ 129 (352)
T d1koba_ 52 ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEV 129 (352)
T ss_dssp TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTC--TTCCBCHHHH
T ss_pred CCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHh--cCCCCCHHHH
Confidence 57999999999877666667889999999999999999999999999999999999999999887743 3456999999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEEC--CCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG--EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~--~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
+.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||++....... ......|++.|+|||++.+.
T Consensus 130 ~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~ 203 (352)
T d1koba_ 130 INYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDRE 203 (352)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---CEEEECSSGGGCCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC---ceeeccCcccccCHHHHcCC
Confidence 999999999999999999 99999999999998 57899999999998765432 22335789999999999999
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
.++.++|||||||++|+|++|..||....... .. ........ .......+..+.++.+||.+||+.|
T Consensus 204 ~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~---~~i~~~~~-------~~~~~~~~~~s~~~~~li~~~L~~d 270 (352)
T d1koba_ 204 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TL---QNVKRCDW-------EFDEDAFSSVSPEAKDFIKNLLQKE 270 (352)
T ss_dssp CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HH---HHHHHCCC-------CCCSSTTTTSCHHHHHHHHTTSCSS
T ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HH---HHHHhCCC-------CCCcccccCCCHHHHHHHHHHccCC
Confidence 99999999999999999999999996433221 11 11111111 0111111233457889999999999
Q ss_pred CCCCCCHHHHHHH--hccccC
Q 048243 242 PNDRPSMLQVSSM--LKNETT 260 (303)
Q Consensus 242 p~~Rpt~~el~~~--L~~~~~ 260 (303)
|.+|||+.|+++. +++...
T Consensus 271 p~~R~s~~eil~Hp~~~~~~~ 291 (352)
T d1koba_ 271 PRKRLTVHDALEHPWLKGDHS 291 (352)
T ss_dssp GGGSCCHHHHHTSTTTSSCCT
T ss_pred hhHCcCHHHHhcCHhhCCCcc
Confidence 9999999999883 655443
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.7e-51 Score=342.98 Aligned_cols=236 Identities=28% Similarity=0.400 Sum_probs=191.6
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+|+.||||+++... ...+++.+|+.+|++++||||+++++++.++...++|||||++|+|.+++.. .....+++..+
T Consensus 40 ~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~-~~~~~~~~~~~ 117 (287)
T d1opja_ 40 KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVL 117 (287)
T ss_dssp GGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH-SCTTTSCHHHH
T ss_pred CCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhh-ccccchHHHHH
Confidence 468899999997543 4567899999999999999999999999999999999999999999999854 23457899999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
+.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++....... .......|++.|+|||.+.+..+
T Consensus 118 ~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~ 193 (287)
T d1opja_ 118 LYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKF 193 (287)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS-EEETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc-eeeccccccccccChHHHcCCCC
Confidence 999999999999999999 99999999999999999999999999987654332 22233568899999999999999
Q ss_pred CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCC
Q 048243 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 243 (303)
+.++|||||||++|||++|..|+....... ............ ..+...+..+.+|+.+||+.||+
T Consensus 194 ~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~------~~~~~i~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~ 258 (287)
T d1opja_ 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYRM---------ERPEGCPEKVYELMRACWQWNPS 258 (287)
T ss_dssp SHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGG
T ss_pred CchhhhhhHHHHHHHHHhCCCCCCCcchHH------HHHHHHhcCCCC---------CCCccchHHHHHHHHHHcCCCHh
Confidence 999999999999999999777654322111 111222222111 11222345789999999999999
Q ss_pred CCCCHHHHHHHhccccC
Q 048243 244 DRPSMLQVSSMLKNETT 260 (303)
Q Consensus 244 ~Rpt~~el~~~L~~~~~ 260 (303)
+|||+.|+++.|+....
T Consensus 259 ~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 259 DRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp GSCCHHHHHHHHHHTTS
T ss_pred HCcCHHHHHHHHHHHHH
Confidence 99999999999987653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=345.39 Aligned_cols=241 Identities=23% Similarity=0.280 Sum_probs=184.8
Q ss_pred cCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 3 LPCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 3 ~~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
..+|+.||+|+++... ....+.+.+|+.+|++++||||+++++++.+....|+|||||++|+|.+++. ....+++.
T Consensus 28 ~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~---~~~~l~~~ 104 (322)
T d1s9ja_ 28 KPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQ 104 (322)
T ss_dssp TTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHH---HHSSCCHH
T ss_pred CCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHh---hcCCCCHH
Confidence 3679999999997653 3445688999999999999999999999999999999999999999999984 34569999
Q ss_pred HHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 82 KRVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
.++.++.|++.||+|||+ +| |+||||||+|||++.+|.+||+|||+|....... .....||+.|+|||++.+
T Consensus 105 ~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~ 177 (322)
T d1s9ja_ 105 ILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQG 177 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT----C---CCSSCCCCHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCCc----cccccCCccccCchHHcC
Confidence 999999999999999997 48 9999999999999999999999999998654321 234689999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHH-HHHH---------HhC-------------CCccee----
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH-AYEL---------WKG-------------GKGVEF---- 213 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~---------~~~-------------~~~~~~---- 213 (303)
..++.++||||+||++|+|++|+.||.............. .... ... ....+.
T Consensus 178 ~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (322)
T d1s9ja_ 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYI 257 (322)
T ss_dssp SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhh
Confidence 9999999999999999999999999965433211000000 0000 000 000000
Q ss_pred ccccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 214 VDSSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 214 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
.............+.++.+|+.+||+.||.+|||++|+++
T Consensus 258 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 258 VNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp HTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0000000011123457889999999999999999999987
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=338.34 Aligned_cols=233 Identities=27% Similarity=0.322 Sum_probs=175.0
Q ss_pred cCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEe--CCeeEEEEeecCCCChhhhhcCcc-cccc
Q 048243 3 LPCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCID--SEERMLVYEYMPNKSLDCYLFDPI-RRLI 77 (303)
Q Consensus 3 ~~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~ 77 (303)
..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+ ++..|+|||||++|+|.+++.... .+..
T Consensus 26 ~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~ 105 (269)
T d2java1 26 KSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY 105 (269)
T ss_dssp TTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCC
T ss_pred CCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCC
Confidence 3679999999997553 3445678999999999999999999999865 456899999999999999985422 3567
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCCh
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYS--RLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~--~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aP 155 (303)
+++..++.++.||+.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++...... .......||+.|+||
T Consensus 106 l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~Y~AP 183 (269)
T d2java1 106 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTPYYMSP 183 (269)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-------------CCCSCCCH
T ss_pred CCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCC--CccccCCCCcccCCH
Confidence 999999999999999999999865 2359999999999999999999999999998765432 222346789999999
Q ss_pred hhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHH
Q 048243 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
|++.+..++.++|||||||++|+|++|..||...+... .. .......... .+...+.++.+||.
T Consensus 184 E~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~~----~~i~~~~~~~---------~~~~~s~~l~~li~ 247 (269)
T d2java1 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LA----GKIREGKFRR---------IPYRYSDELNEIIT 247 (269)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH----HHHHHTCCCC---------CCTTSCHHHHHHHH
T ss_pred HHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---HH----HHHHcCCCCC---------CCcccCHHHHHHHH
Confidence 99999999999999999999999999999996433211 11 1111111111 11123457899999
Q ss_pred HcccCCCCCCCCHHHHHH
Q 048243 236 LCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 236 ~~l~~dp~~Rpt~~el~~ 253 (303)
+||+.||.+|||+.|+++
T Consensus 248 ~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 248 RMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHTCSSGGGSCCHHHHHT
T ss_pred HHcCCChhHCcCHHHHHh
Confidence 999999999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-50 Score=331.21 Aligned_cols=234 Identities=26% Similarity=0.394 Sum_probs=191.7
Q ss_pred CccCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 1 ~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
|.+++++.||||+++.... ..+.+.+|+.++++++||||+++++++.+++..++||||+++|+|..++.. ....+++
T Consensus 23 ~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~--~~~~~~~ 99 (258)
T d1k2pa_ 23 GKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQT 99 (258)
T ss_dssp EEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHS--GGGCCCH
T ss_pred EEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhc--cccCCcH
Confidence 3457888999999976543 457899999999999999999999999999999999999999999998754 4556889
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.|++.||+|||++| |+||||||+||+++.++.+||+|||+++........ ......||+.|+|||.+.+
T Consensus 100 ~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~ 175 (258)
T d1k2pa_ 100 QQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMY 175 (258)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCCCSCCCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-eecccCCCCCcCCcHHhcC
Confidence 999999999999999999999 999999999999999999999999999766543322 2333568999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 161 GVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
..++.++|||||||++|||++ |..||........ ......+.... .+...+.++.+||.+||+
T Consensus 176 ~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~-------~~~i~~~~~~~---------~p~~~~~~l~~li~~cl~ 239 (258)
T d1k2pa_ 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-------AEHIAQGLRLY---------RPHLASEKVYTIMYSCWH 239 (258)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-------HHHHHTTCCCC---------CCTTCCHHHHHHHHHTTC
T ss_pred CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH-------HHHHHhCCCCC---------CcccccHHHHHHHHHHcc
Confidence 999999999999999999998 7888864432211 11122221111 111223578899999999
Q ss_pred CCCCCCCCHHHHHHHhcc
Q 048243 240 ENPNDRPSMLQVSSMLKN 257 (303)
Q Consensus 240 ~dp~~Rpt~~el~~~L~~ 257 (303)
.||++|||++|+++.|.+
T Consensus 240 ~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 240 EKADERPTFKILLSNILD 257 (258)
T ss_dssp SSGGGSCCHHHHHHHHHC
T ss_pred CCHhHCcCHHHHHHHhhC
Confidence 999999999999999864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=339.24 Aligned_cols=238 Identities=30% Similarity=0.452 Sum_probs=188.6
Q ss_pred CccCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 1 ~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
|.+++++.||||+++... ...+.+.+|+.++++++||||+++++++.+ +..++|||||++|+|.+++.. .....+++
T Consensus 32 ~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~-~~~~~l~~ 108 (272)
T d1qpca_ 32 GYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTI 108 (272)
T ss_dssp EEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTS-HHHHTCCH
T ss_pred EEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhh-cCCCCCCH
Confidence 356788999999997543 455789999999999999999999998754 567999999999999988754 23446899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....... .......|++.|+|||++.+
T Consensus 109 ~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~ 184 (272)
T d1qpca_ 109 NKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINY 184 (272)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc-ccccccCCcccccChHHHhC
Confidence 999999999999999999999 99999999999999999999999999987654322 22334568999999999998
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|||||||++|||++|..|+...... ... .......... ..+...+.++.+|+.+||+.
T Consensus 185 ~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~~----~~~i~~~~~~---------~~p~~~~~~l~~li~~cl~~ 249 (272)
T d1qpca_ 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEV----IQNLERGYRM---------VRPDNCPEELYQLMRLCWKE 249 (272)
T ss_dssp CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHH----HHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCS
T ss_pred CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HHH----HHHHHhcCCC---------CCcccChHHHHHHHHHHcCC
Confidence 88999999999999999999976654322211 111 1111111111 11122344788999999999
Q ss_pred CCCCCCCHHHHHHHhccccC
Q 048243 241 NPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 241 dp~~Rpt~~el~~~L~~~~~ 260 (303)
||++|||++|+++.|++.++
T Consensus 250 ~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 250 RPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp SGGGSCCHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHhhhhhh
Confidence 99999999999999987653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-50 Score=336.48 Aligned_cols=234 Identities=25% Similarity=0.374 Sum_probs=189.7
Q ss_pred CCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 5 CGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
++..||||+++... ....+.+.+|+.+|++++||||+++++++.. +..++|||||++|+|.+++.. .+..+++..+
T Consensus 35 ~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~--~~~~l~~~~~ 111 (285)
T d1u59a_ 35 KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG--KREEIPVSNV 111 (285)
T ss_dssp CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTT--CTTTSCHHHH
T ss_pred CcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhc--cccCCCHHHH
Confidence 45689999997553 4456789999999999999999999999865 468999999999999998743 3456999999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-ccccccccccCCCChhhhccCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~ 162 (303)
..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.+...... .......||+.|+|||++.+..
T Consensus 112 ~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 188 (285)
T d1u59a_ 112 AELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 188 (285)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCC
Confidence 999999999999999999 999999999999999999999999999877554322 2233456899999999999889
Q ss_pred CCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
++.++|||||||++|||++ |..||....... . ......+...+ .++..+.++.+||.+||+.|
T Consensus 189 ~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~----~~~i~~~~~~~---------~p~~~~~~l~~li~~cl~~~ 252 (285)
T d1u59a_ 189 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---V----MAFIEQGKRME---------CPPECPPELYALMSDCWIYK 252 (285)
T ss_dssp ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---H----HHHHHTTCCCC---------CCTTCCHHHHHHHHHTTCSS
T ss_pred CCccchhhcchHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcCCCCC---------CCCcCCHHHHHHHHHHcCCC
Confidence 9999999999999999998 899996543221 1 11222222211 11223457889999999999
Q ss_pred CCCCCCHHHHHHHhccccC
Q 048243 242 PNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 242 p~~Rpt~~el~~~L~~~~~ 260 (303)
|++|||+.++.+.|+....
T Consensus 253 p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 253 WEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp GGGSCCHHHHHHHHHHHHH
T ss_pred HhHCcCHHHHHHHHHHHHH
Confidence 9999999999999886653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.3e-50 Score=339.78 Aligned_cols=232 Identities=25% Similarity=0.400 Sum_probs=178.0
Q ss_pred EEEEEEecCC-CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHH
Q 048243 8 VIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86 (303)
Q Consensus 8 ~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~ 86 (303)
.||||.+... .....+.+.+|+.+|++++||||+++++++..+...++|||||++|+|.+++.. ....+++..+..+
T Consensus 56 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i 133 (299)
T d1jpaa_ 56 FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQFTVIQLVGM 133 (299)
T ss_dssp EEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHT--TTTCSCHHHHHHH
T ss_pred EEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeecc--ccCCCCHHHHHHH
Confidence 5899998654 344567899999999999999999999999999999999999999999998853 3456899999999
Q ss_pred HHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcccc---ccccccccCCCChhhhccCCC
Q 048243 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEAN---TEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 87 ~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~ 163 (303)
+.||+.||+|||+++ ++||||||+|||++.++.+||+|||+++.......... .....||+.|+|||.+.+..+
T Consensus 134 ~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 210 (299)
T d1jpaa_ 134 LRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKF 210 (299)
T ss_dssp HHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCC
T ss_pred HHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCC
Confidence 999999999999999 99999999999999999999999999987654332211 122457899999999999999
Q ss_pred CCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC
Q 048243 164 STKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 242 (303)
+.++|||||||++|||++ |..||....... . ......+.. ...+...+..+.+|+.+||+.||
T Consensus 211 ~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~----~~~i~~~~~---------~~~~~~~~~~l~~li~~cl~~~P 274 (299)
T d1jpaa_ 211 TSASDVWSYGIVMWEVMSYGERPYWDMTNQD---V----INAIEQDYR---------LPPPMDCPSALHQLMLDCWQKDR 274 (299)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H----HHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSST
T ss_pred CcccccccchHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcCCC---------CCCCccchHHHHHHHHHHcCCCH
Confidence 999999999999999998 889986443221 1 111111111 11122234578899999999999
Q ss_pred CCCCCHHHHHHHhccccC
Q 048243 243 NDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 243 ~~Rpt~~el~~~L~~~~~ 260 (303)
++|||+.|+++.|++...
T Consensus 275 ~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 275 NHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp TTSCCHHHHHHHHHHHHH
T ss_pred hHCcCHHHHHHHHHHHhc
Confidence 999999999999987643
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.4e-50 Score=339.42 Aligned_cols=229 Identities=22% Similarity=0.281 Sum_probs=170.7
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+++..|+|||||+||+|.+++. ....+++..
T Consensus 32 ~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~---~~~~l~e~~ 108 (307)
T d1a06a_ 32 RTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERD 108 (307)
T ss_dssp TTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---TCSCCCHHH
T ss_pred CCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhh---cccCCCHHH
Confidence 579999999997553 2334568899999999999999999999999999999999999999999994 355799999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEEC---CCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG---EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~---~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..++.||+.||+|||++| |+||||||+||++. .++.+||+|||+++...... ......||+.|+|||++.
T Consensus 109 ~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~ 182 (307)
T d1a06a_ 109 ASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLA 182 (307)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC---------------------CTTSCHHHHT
T ss_pred HHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCCC---eeeeeeeCccccCcHHHc
Confidence 9999999999999999999 99999999999995 57899999999997654332 223457999999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++|||||||++|+|++|..||....... ........... ......+..+.++.+||.+||+
T Consensus 183 ~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~~~~~-------~~~~~~~~~s~~~~~li~~~L~ 249 (307)
T d1a06a_ 183 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK------LFEQILKAEYE-------FDSPYWDDISDSAKDFIRHLME 249 (307)
T ss_dssp TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHTTCCC-------CCTTTTTTSCHHHHHHHHHHSC
T ss_pred CCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHhccCCC-------CCCccccCCCHHHHHHHHHHcc
Confidence 9999999999999999999999999996432111 11111221111 1111112334578999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 048243 240 ENPNDRPSMLQVSSM 254 (303)
Q Consensus 240 ~dp~~Rpt~~el~~~ 254 (303)
.||++|||+.|+++.
T Consensus 250 ~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 250 KDPEKRFTCEQALQH 264 (307)
T ss_dssp SSGGGSCCHHHHHHS
T ss_pred CCHhHCcCHHHHhcC
Confidence 999999999999873
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-50 Score=337.48 Aligned_cols=232 Identities=27% Similarity=0.377 Sum_probs=184.5
Q ss_pred CCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 5 CGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 5 ~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
+++.||||+++... ....+.+.+|+.+|++++||||+++++++.. +..++|||||++|+|.+++. ....+++..
T Consensus 33 ~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~---~~~~l~~~~ 108 (277)
T d1xbba_ 33 VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQ---QNRHVKDKN 108 (277)
T ss_dssp SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHH---HCTTCCHHH
T ss_pred cCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHh---hccCCCHHH
Confidence 46789999996542 3345689999999999999999999999865 46789999999999999984 455699999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-ccccccccccCCCChhhhccC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~ 161 (303)
++.++.||+.||+|||+++ |+||||||+||+++.++.++|+|||+++........ .......||+.|+|||.+.+.
T Consensus 109 ~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 185 (277)
T d1xbba_ 109 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185 (277)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCC
Confidence 9999999999999999999 999999999999999999999999999876544322 223345689999999999998
Q ss_pred CCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 162 VYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
.++.++|||||||++|||++ |..||....... .......+.... .+...+.++.+|+.+||+.
T Consensus 186 ~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-------~~~~i~~~~~~~---------~p~~~~~~~~~li~~cl~~ 249 (277)
T d1xbba_ 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMG---------CPAGCPREMYDLMNLCWTY 249 (277)
T ss_dssp EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCS
T ss_pred CCCchhhhccchhhhhHHhhCCCCCCCCCCHHH-------HHHHHHcCCCCC---------CCcccCHHHHHHHHHHcCC
Confidence 99999999999999999998 899986433211 112222222111 1122345788999999999
Q ss_pred CCCCCCCHHHHHHHhcccc
Q 048243 241 NPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 241 dp~~Rpt~~el~~~L~~~~ 259 (303)
||++|||+++|.+.|++..
T Consensus 250 dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 250 DVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp STTTSCCHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHhhCHH
Confidence 9999999999999887654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-49 Score=343.40 Aligned_cols=230 Identities=22% Similarity=0.272 Sum_probs=188.7
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+|+.||||++........+.+.+|+.+|++++||||+++++++.+++..|+|||||++|+|.+++.. ....+++..+
T Consensus 49 ~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~--~~~~l~e~~~ 126 (350)
T d1koaa2 49 ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEA 126 (350)
T ss_dssp TTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTC--TTSCBCHHHH
T ss_pred CCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHh--hcCCCCHHHH
Confidence 57999999999877666677899999999999999999999999999999999999999999998853 3456999999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEEC--CCCceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG--EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~--~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
+.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||++..+.... ......||+.|+|||++.+.
T Consensus 127 ~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~ 200 (350)
T d1koaa2 127 VEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGK 200 (350)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS---CEEEECSCTTTCCHHHHHTC
T ss_pred HHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc---ccceecCcccccCHHHHcCC
Confidence 999999999999999999 99999999999996 46789999999998765432 22345789999999999999
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
.++.++|||||||++|+|++|..||...+... ... ........ ......+..+..+.+||.+||..|
T Consensus 201 ~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~---~i~~~~~~-------~~~~~~~~~s~~~~~li~~~L~~d 267 (350)
T d1koaa2 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TLR---NVKSCDWN-------MDDSAFSGISEDGKDFIRKLLLAD 267 (350)
T ss_dssp CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHHTCCC-------SCCGGGGGCCHHHHHHHHHHCCSS
T ss_pred CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH---HHH---HHHhCCCC-------CCcccccCCCHHHHHHHHHHccCC
Confidence 99999999999999999999999996432211 111 11111110 011111223457889999999999
Q ss_pred CCCCCCHHHHHHH
Q 048243 242 PNDRPSMLQVSSM 254 (303)
Q Consensus 242 p~~Rpt~~el~~~ 254 (303)
|++|||++|+++.
T Consensus 268 P~~R~t~~eil~h 280 (350)
T d1koaa2 268 PNTRMTIHQALEH 280 (350)
T ss_dssp GGGSCCHHHHHHS
T ss_pred hhHCcCHHHHhcC
Confidence 9999999999984
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=340.84 Aligned_cols=232 Identities=28% Similarity=0.405 Sum_probs=186.3
Q ss_pred cEEEEEEecCC-CcccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccc----------
Q 048243 7 KVIAVKKLSKT-STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIR---------- 74 (303)
Q Consensus 7 ~~valK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------- 74 (303)
..||+|.+... .......+.+|+.++.++ +||||+++++++.+.+..++|||||++|+|.+++.....
T Consensus 68 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~ 147 (325)
T d1rjba_ 68 IQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 147 (325)
T ss_dssp EEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC--------
T ss_pred eEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhc
Confidence 46999998654 334456789999999998 899999999999999999999999999999999965321
Q ss_pred ----------cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcccccc
Q 048243 75 ----------RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTE 144 (303)
Q Consensus 75 ----------~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~ 144 (303)
...+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++............
T Consensus 148 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 224 (325)
T d1rjba_ 148 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRG 224 (325)
T ss_dssp -------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEET
T ss_pred cccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchhccccccCCeEEEeeccccccccCCCceeeec
Confidence 245889999999999999999999999 9999999999999999999999999998766554444444
Q ss_pred ccccccCCCChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCC
Q 048243 145 QVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNS 223 (303)
Q Consensus 145 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (303)
...||+.|+|||++.+..++.++|||||||++|||++ |..||......... .......... ..+
T Consensus 225 ~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~------~~~~~~~~~~---------~~p 289 (325)
T d1rjba_ 225 NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF------YKLIQNGFKM---------DQP 289 (325)
T ss_dssp TEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH------HHHHHTTCCC---------CCC
T ss_pred cccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHH------HHHHhcCCCC---------CCC
Confidence 5678999999999999999999999999999999998 89998654432211 1222222111 112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhc
Q 048243 224 PCKLMRCLEIALLCVQENPNDRPSMLQVSSMLK 256 (303)
Q Consensus 224 ~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~ 256 (303)
...+.++.+||.+||+.||++|||++||++.|.
T Consensus 290 ~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 290 FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 223457899999999999999999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=324.84 Aligned_cols=227 Identities=26% Similarity=0.369 Sum_probs=179.4
Q ss_pred CCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEe----CCeeEEEEeecCCCChhhhhcCcccccc
Q 048243 4 PCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCID----SEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
.+|+.||+|++... .....+.+.+|+++|++++||||+++++++.+ ....|+|||||++|+|.+++. ....
T Consensus 32 ~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~---~~~~ 108 (270)
T d1t4ha_ 32 ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKV 108 (270)
T ss_dssp TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHH---HHSS
T ss_pred CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHh---cccc
Confidence 57899999998654 34455678999999999999999999999875 346799999999999999984 4567
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEEC-CCCceEEcccccccccccCCccccccccccccCCCChh
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLG-EDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE 156 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~-~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE 156 (303)
+++..++.++.||+.||+|||+++ .+|+||||||+|||++ .++.+||+|||+++..... ......||+.|+|||
T Consensus 109 ~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~----~~~~~~GT~~Y~aPE 183 (270)
T d1t4ha_ 109 MKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPE 183 (270)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGG
T ss_pred ccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC----ccCCcccCccccCHH
Confidence 999999999999999999999864 3499999999999997 5789999999999754332 223457999999999
Q ss_pred hhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 157 YARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
++.+ .++.++|||||||++|+|++|..||....... ............... .. ..+.++.+||.+
T Consensus 184 ~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~------~~~~~i~~~~~~~~~----~~----~~~~~~~~li~~ 248 (270)
T d1t4ha_ 184 MYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVKPASF----DK----VAIPEVKEIIEG 248 (270)
T ss_dssp GGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCCCGGG----GG----CCCHHHHHHHHH
T ss_pred HhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH------HHHHHHHcCCCCccc----Cc----cCCHHHHHHHHH
Confidence 9875 58999999999999999999999996432111 111222211111111 11 123368899999
Q ss_pred cccCCCCCCCCHHHHHH
Q 048243 237 CVQENPNDRPSMLQVSS 253 (303)
Q Consensus 237 ~l~~dp~~Rpt~~el~~ 253 (303)
||+.||++|||+.|+++
T Consensus 249 ~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 249 CIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HSCSSGGGSCCHHHHHT
T ss_pred HccCCHhHCcCHHHHhC
Confidence 99999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-49 Score=336.65 Aligned_cols=224 Identities=29% Similarity=0.390 Sum_probs=181.8
Q ss_pred cCCCcEEEEEEecCCCc---ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 3 LPCGKVIAVKKLSKTST---QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
..+|+.||||++..... ...+.+.+|+.++++++||||+++++++.+++..|+|||||.+|+|..++. .+..++
T Consensus 37 ~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~---~~~~l~ 113 (309)
T d1u5ra_ 37 VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQ 113 (309)
T ss_dssp TTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH---HTSCCC
T ss_pred CCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHH---hCCCCC
Confidence 36799999999975532 334578899999999999999999999999999999999999998876663 456799
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++...... ....||+.|+|||++.
T Consensus 114 e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~------~~~~GT~~Y~APE~~~ 184 (309)
T d1u5ra_ 114 EVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVIL 184 (309)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB------CCCCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC------CccccCccccCHHHHh
Confidence 9999999999999999999999 999999999999999999999999999764332 2357999999999986
Q ss_pred c---CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 160 Q---GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 160 ~---~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
+ ..++.++|||||||++|+|++|..||...... ............ .. .....+..+.+||.+
T Consensus 185 ~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~~~~~~-~~--------~~~~~s~~~~~li~~ 249 (309)
T d1u5ra_ 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNESP-AL--------QSGHWSEYFRNFVDS 249 (309)
T ss_dssp TTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCCC-CC--------SCTTSCHHHHHHHHH
T ss_pred ccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCCC-CC--------CCCCCCHHHHHHHHH
Confidence 4 35889999999999999999999998643211 111122221111 11 111234578899999
Q ss_pred cccCCCCCCCCHHHHHH
Q 048243 237 CVQENPNDRPSMLQVSS 253 (303)
Q Consensus 237 ~l~~dp~~Rpt~~el~~ 253 (303)
||+.||.+|||+.|+++
T Consensus 250 ~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 250 CLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HTCSSGGGSCCHHHHTT
T ss_pred HCcCChhHCcCHHHHHh
Confidence 99999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=334.07 Aligned_cols=246 Identities=27% Similarity=0.426 Sum_probs=188.0
Q ss_pred CccCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 1 GVLPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 1 ~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
|.+.+++.||||+++... ...+.+.+|+.++++++||||+++++++. ++..++|||||++|+|..++... ....+++
T Consensus 36 ~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~~~~~~~-~~~~l~~ 112 (285)
T d1fmka3 36 GTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGE-TGKYLRL 112 (285)
T ss_dssp EEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHSHH-HHTTCCH
T ss_pred EEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCchhhhhhhc-ccccchH
Confidence 346677889999996543 34578999999999999999999999985 45689999999999998888542 3456999
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....... .......||+.|+|||.+.+
T Consensus 113 ~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~ 188 (285)
T d1fmka3 113 PQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALY 188 (285)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-eeeccccccccccChHHHhC
Confidence 999999999999999999999 99999999999999999999999999976543322 22233568999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|||||||++|||++|..|+...... .. ........... ..+...+.++.++|.+||+.
T Consensus 189 ~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~----~~~~i~~~~~~---------~~~~~~~~~l~~li~~cl~~ 253 (285)
T d1fmka3 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--RE----VLDQVERGYRM---------PCPPECPESLHDLMCQCWRK 253 (285)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HH----HHHHHHTTCCC---------CCCTTSCHHHHHHHHHHTCS
T ss_pred CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HH----HHHHHHhcCCC---------CCCcccCHHHHHHHHHHccc
Confidence 99999999999999999999977665432211 11 11112211111 11222345789999999999
Q ss_pred CCCCCCCHHHHHHHhccccCCCCCCCCC
Q 048243 241 NPNDRPSMLQVSSMLKNETTNRNTPKKP 268 (303)
Q Consensus 241 dp~~Rpt~~el~~~L~~~~~~~~~~~~~ 268 (303)
||++|||+.+|+++|++.......+.+|
T Consensus 254 dP~~Rps~~~i~~~L~~~~~~~~p~~~p 281 (285)
T d1fmka3 254 EPEERPTFEYLQAFLEDYFTSTEPQYQP 281 (285)
T ss_dssp SGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred CHhHCcCHHHHHHHHhhhhcCCCCCCCC
Confidence 9999999999999999987665443333
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8e-48 Score=328.47 Aligned_cols=223 Identities=22% Similarity=0.309 Sum_probs=185.3
Q ss_pred CCCcEEEEEEecCC---CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||||+++.. .....+.+.+|+.+++.++||||+++++++.+....|+|||||.||+|..++. ....+++
T Consensus 27 ~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~---~~~~~~~ 103 (316)
T d1fota_ 27 HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFPN 103 (316)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---HTSSCCH
T ss_pred CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCcccccccc---ccccccc
Confidence 67999999999643 23456789999999999999999999999999999999999999999988884 4566889
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+++...... ....||+.|+|||++.+
T Consensus 104 ~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~l~~ 175 (316)
T d1fota_ 104 PVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVST 175 (316)
T ss_dssp HHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-----CCCCSCTTTCCHHHHTT
T ss_pred cHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecccc-----ccccCcccccCHHHHcC
Confidence 999999999999999999999 9999999999999999999999999998764332 23579999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|||||||++|+|++|..||...+... .......... ..++..+.++.+++.+||..
T Consensus 176 ~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~i~~~~~-----------~~p~~~s~~~~~li~~~L~~ 238 (316)
T d1fota_ 176 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYEKILNAEL-----------RFPPFFNEDVKDLLSRLITR 238 (316)
T ss_dssp CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHCCC-----------CCCTTSCHHHHHHHHHHTCS
T ss_pred CCCCchhhccccchhHHHHHhCCCCCCCcCHHH------HHHHHHcCCC-----------CCCCCCCHHHHHHHHHHhhh
Confidence 999999999999999999999999996433211 1111122111 11122345788999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 048243 241 NPNDRP-----SMLQVSSM 254 (303)
Q Consensus 241 dp~~Rp-----t~~el~~~ 254 (303)
||.+|+ |++++++.
T Consensus 239 dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 239 DLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CTTTCTTSSTTTTHHHHTS
T ss_pred CHHhccccchhhHHHHHcC
Confidence 999996 89999873
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=330.18 Aligned_cols=228 Identities=22% Similarity=0.285 Sum_probs=184.4
Q ss_pred CCCcEEEEEEecCCC------cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcccccc
Q 048243 4 PCGKVIAVKKLSKTS------TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~~~~valK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
.+|+.||||+++... ....+.+.+|+.+|++++||||+++++++.+....|+|||||++|+|.+++. ....
T Consensus 33 ~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~---~~~~ 109 (293)
T d1jksa_ 33 STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKES 109 (293)
T ss_dssp TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH---HHSS
T ss_pred CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhc---cccc
Confidence 679999999986432 2246789999999999999999999999999999999999999999999984 3457
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCC----ceEEcccccccccccCCccccccccccccCCC
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM----KPKISDFGLARIFAKESLEANTEQVVGTIGYI 153 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~----~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~ 153 (303)
+++..++.++.|++.||+|||+.+ |+||||||+||+++.++ .+|++|||++....... ......|++.|+
T Consensus 110 l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~ 183 (293)
T d1jksa_ 110 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFV 183 (293)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC---BCSCCCCCGGGC
T ss_pred cchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhhhcCCCc---cccccCCCCccc
Confidence 999999999999999999999999 99999999999998776 49999999998764432 223356899999
Q ss_pred ChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHH
Q 048243 154 PPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEI 233 (303)
Q Consensus 154 aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 233 (303)
|||++.+..++.++|||||||++|+|++|..||....... ............. . ...+..+..+.+|
T Consensus 184 APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~~~~~~~--~-----~~~~~~s~~~~~l 250 (293)
T d1jksa_ 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANVSAVNYEFE--D-----EYFSNTSALAKDF 250 (293)
T ss_dssp CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHTTCCCCC--H-----HHHTTSCHHHHHH
T ss_pred CHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH------HHHHHHhcCCCCC--c-----hhcCCCCHHHHHH
Confidence 9999999999999999999999999999999996433211 1111111110000 0 0001123478899
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 048243 234 ALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 234 i~~~l~~dp~~Rpt~~el~~ 253 (303)
|.+||+.||.+|||++|+++
T Consensus 251 i~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 251 IRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHccCChhHCcCHHHHhc
Confidence 99999999999999999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-49 Score=330.38 Aligned_cols=233 Identities=24% Similarity=0.377 Sum_probs=179.7
Q ss_pred cEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHH
Q 048243 7 KVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVH 85 (303)
Q Consensus 7 ~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~ 85 (303)
..||||+++... ......+.+|+.++++++||||+++++++.+....++|||||.++++.+++.. ....+++..+..
T Consensus 37 ~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~ 114 (283)
T d1mqba_ 37 VPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVG 114 (283)
T ss_dssp EEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH--TTTCSCHHHHHH
T ss_pred EEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhc--ccccccHHHHHH
Confidence 479999997553 34456789999999999999999999999999999999999999999887743 345699999999
Q ss_pred HHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-ccccccccccCCCChhhhccCCCC
Q 048243 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPPEYARQGVYS 164 (303)
Q Consensus 86 ~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~ 164 (303)
++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........ .......||+.|+|||.+.+..++
T Consensus 115 i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~ 191 (283)
T d1mqba_ 115 MLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT 191 (283)
T ss_dssp HHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCC
T ss_pred HHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCC
Confidence 9999999999999999 999999999999999999999999999876543222 222335689999999999999999
Q ss_pred CccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCC
Q 048243 165 TKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPND 244 (303)
Q Consensus 165 ~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 244 (303)
.++|||||||++|||+++..|+...... . ........+... ..+...+..+.+|+.+||+.||++
T Consensus 192 ~~sDI~S~Gvil~el~t~~~~~~~~~~~--~----~~~~~i~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~ 256 (283)
T d1mqba_ 192 SASDVWSFGIVMWEVMTYGERPYWELSN--H----EVMKAINDGFRL---------PTPMDCPSAIYQLMMQCWQQERAR 256 (283)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTCCH--H----HHHHHHHTTCCC---------CCCTTCBHHHHHHHHHHTCSSTTT
T ss_pred CcccccccHHHHHHHHhCCCCccccCCH--H----HHHHHHhccCCC---------CCchhhHHHHHHHHHHHCcCCHhH
Confidence 9999999999999999976665332211 1 111222222111 111223457889999999999999
Q ss_pred CCCHHHHHHHhcccc
Q 048243 245 RPSMLQVSSMLKNET 259 (303)
Q Consensus 245 Rpt~~el~~~L~~~~ 259 (303)
|||+.||++.|+...
T Consensus 257 RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 257 RPKFADIVSILDKLI 271 (283)
T ss_dssp SCCHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHh
Confidence 999999999998664
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-48 Score=331.72 Aligned_cols=225 Identities=20% Similarity=0.260 Sum_probs=186.3
Q ss_pred CCCcEEEEEEecCC---CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||||++++. .....+.+.+|+.+|+.++||||+++++++.+....|+|||||++|+|.+++. ....+++
T Consensus 28 ~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~---~~~~~~e 104 (337)
T d1o6la_ 28 ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTE 104 (337)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHSCCCH
T ss_pred CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhh---cccCCcH
Confidence 68999999999754 23456788999999999999999999999999999999999999999999984 4567899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+++...... .......||+.|+|||++.+
T Consensus 105 ~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~ 179 (337)
T d1o6la_ 105 ERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLED 179 (337)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSS
T ss_pred HHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCC--cccccceeCHHHhhhhhccC
Confidence 999999999999999999999 9999999999999999999999999998654332 22334679999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|||||||++|+|++|.+||...+... ... ...... . ..+...+.++.+||.+||+.
T Consensus 180 ~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~~---~i~~~~--~---------~~p~~~s~~~~dli~~~L~~ 242 (337)
T d1o6la_ 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFE---LILMEE--I---------RFPRTLSPEAKSLLAGLLKK 242 (337)
T ss_dssp SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHHCC--C---------CCCTTSCHHHHHHHHHHTCS
T ss_pred CCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---HHH---HHhcCC--C---------CCCccCCHHHHHHHHhhccC
Confidence 999999999999999999999999996543221 111 111111 0 11112345788999999999
Q ss_pred CCCCCCC-----HHHHHH
Q 048243 241 NPNDRPS-----MLQVSS 253 (303)
Q Consensus 241 dp~~Rpt-----~~el~~ 253 (303)
||.+||+ +.|+++
T Consensus 243 dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 243 DPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp STTTSTTCSTTTHHHHHT
T ss_pred CchhhcccccccHHHHHc
Confidence 9999995 788876
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-48 Score=328.05 Aligned_cols=243 Identities=23% Similarity=0.227 Sum_probs=181.4
Q ss_pred CCCcEEEEEEecCCCcc-----cHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccC
Q 048243 4 PCGKVIAVKKLSKTSTQ-----GFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
.+|+.||||+++..... ..+.+.+|+.++++++||||+++++++.+++..|+||||+.++++..+. ..+..+
T Consensus 21 ~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~---~~~~~l 97 (299)
T d1ua2a_ 21 NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIK---DNSLVL 97 (299)
T ss_dssp SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHT---TCCSSC
T ss_pred CCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhh---hcccCC
Confidence 57999999999654322 1246889999999999999999999999999999999999988776655 345668
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||.+........ ......||+.|+|||++
T Consensus 98 ~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~ 172 (299)
T d1ua2a_ 98 TPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELL 172 (299)
T ss_dssp CSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc--cccceecChhhccHHHH
Confidence 89999999999999999999999 99999999999999999999999999976554322 22335789999999988
Q ss_pred ccC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccc---------cCCCCCC-----
Q 048243 159 RQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDS---------SLDDTNS----- 223 (303)
Q Consensus 159 ~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~----- 223 (303)
.+. .++.++|||||||++|+|++|.+||......+ ......+.........+.+. ......+
T Consensus 173 ~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
T d1ua2a_ 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIF 249 (299)
T ss_dssp TTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHC
T ss_pred ccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhc
Confidence 654 57999999999999999999999986443222 12222222111110000000 0000000
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH--Hhcc
Q 048243 224 PCKLMRCLEIALLCVQENPNDRPSMLQVSS--MLKN 257 (303)
Q Consensus 224 ~~~~~~l~~li~~~l~~dp~~Rpt~~el~~--~L~~ 257 (303)
+..+..+.+|+.+||+.||++||||+|+++ +|.+
T Consensus 250 ~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 250 SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp TTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 122457899999999999999999999987 3543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.1e-47 Score=319.93 Aligned_cols=230 Identities=24% Similarity=0.301 Sum_probs=184.5
Q ss_pred cCCCcEEEEEEecCCCcc---------cHHHHHHHHHHHhcCC-CCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCc
Q 048243 3 LPCGKVIAVKKLSKTSTQ---------GFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDP 72 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~---------~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 72 (303)
.++|+.||||++...... ..+.+.+|+.++++++ ||||+++++++.++...|+|||||++|+|.+++.
T Consensus 25 ~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~-- 102 (277)
T d1phka_ 25 KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-- 102 (277)
T ss_dssp TTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH--
T ss_pred CCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHH--
Confidence 368999999999765321 2346889999999996 9999999999999999999999999999999994
Q ss_pred cccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCC
Q 048243 73 IRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGY 152 (303)
Q Consensus 73 ~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y 152 (303)
....+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||++....... ......||+.|
T Consensus 103 -~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y 175 (277)
T d1phka_ 103 -EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSY 175 (277)
T ss_dssp -HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGG
T ss_pred -hcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeEccCCC---ceeeeeccCCC
Confidence 4567999999999999999999999999 9999999999999999999999999998765432 22335789999
Q ss_pred CChhhhcc------CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHH
Q 048243 153 IPPEYARQ------GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCK 226 (303)
Q Consensus 153 ~aPE~~~~------~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
+|||.+.+ ..++.++||||+||++|+|++|..||....... .. .....+.. .......+..
T Consensus 176 ~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~---~~---~~i~~~~~-------~~~~~~~~~~ 242 (277)
T d1phka_ 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---ML---RMIMSGNY-------QFGSPEWDDY 242 (277)
T ss_dssp CCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHHTCC-------CCCTTTGGGS
T ss_pred CCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH---HH---HHHHhCCC-------CCCCcccccC
Confidence 99998864 246789999999999999999999996433211 11 11111111 0111122234
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 227 LMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 227 ~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
++++.+|+.+||+.||++|||+.|+++.
T Consensus 243 s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 243 SDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 5689999999999999999999999763
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-47 Score=326.43 Aligned_cols=237 Identities=27% Similarity=0.424 Sum_probs=189.0
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc---------
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI--------- 73 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------- 73 (303)
.+++.||||+++... ....+.+.+|+.++++++||||+++++++......+++||++.+|+|.+++....
T Consensus 41 ~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~ 120 (301)
T d1lufa_ 41 EPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120 (301)
T ss_dssp SSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC--------
T ss_pred CCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccc
Confidence 567899999997543 3345679999999999999999999999999999999999999999999985311
Q ss_pred ------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccc
Q 048243 74 ------------RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEA 141 (303)
Q Consensus 74 ------------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~ 141 (303)
....+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++.........
T Consensus 121 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~ 197 (301)
T d1lufa_ 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 197 (301)
T ss_dssp --------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC
T ss_pred cccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcccceEECCCCcEEEccchhheeccCCcccc
Confidence 1234888999999999999999999999 9999999999999999999999999998765544344
Q ss_pred cccccccccCCCChhhhccCCCCCccchhhHHHHHHHHHhCC-CCCccCCCCccccHHHHHHHHHhCCCcceeccccCCC
Q 048243 142 NTEQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK-RLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDD 220 (303)
Q Consensus 142 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (303)
......|++.|+|||.+.+..++.++|||||||++|||++|. +||....... .. .....+.....
T Consensus 198 ~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e---~~----~~v~~~~~~~~------- 263 (301)
T d1lufa_ 198 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE---VI----YYVRDGNILAC------- 263 (301)
T ss_dssp ----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HH----HHHHTTCCCCC-------
T ss_pred ccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH---HH----HHHHcCCCCCC-------
Confidence 444567889999999999999999999999999999999986 5564332211 11 12222222111
Q ss_pred CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcccc
Q 048243 221 TNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 221 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~ 259 (303)
+...+.++.+|+.+||+.||.+|||+.||+++|++..
T Consensus 264 --p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 264 --PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred --CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 1122347889999999999999999999999998764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.2e-47 Score=326.10 Aligned_cols=222 Identities=19% Similarity=0.191 Sum_probs=184.7
Q ss_pred CCCcEEEEEEecCC---CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||||++... .....+.+.+|+.+|+.++||||+++++++.+....++||||+.+|+|..++. ....+++
T Consensus 64 ~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~---~~~~l~e 140 (350)
T d1rdqe_ 64 ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSE 140 (350)
T ss_dssp TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHCCCCH
T ss_pred CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHh---hcCCCCH
Confidence 57999999998643 23456788999999999999999999999999999999999999999999884 4457999
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++..... .....||+.|+|||++.+
T Consensus 141 ~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~ 212 (350)
T d1rdqe_ 141 PHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILS 212 (350)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc-----cccccCccccCCHHHHcC
Confidence 999999999999999999999 999999999999999999999999999876533 223579999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccC
Q 048243 161 GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQE 240 (303)
Q Consensus 161 ~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 240 (303)
..++.++|||||||++|+|++|..||...+.. ........... ..+...+.++.+||.+||..
T Consensus 213 ~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~i~~~~~-----------~~p~~~s~~~~~li~~~L~~ 275 (350)
T d1rdqe_ 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIYEKIVSGKV-----------RFPSHFSSDLKDLLRNLLQV 275 (350)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCC-----------CCCTTCCHHHHHHHHHHSCS
T ss_pred CCCCccccccchhHHHHHHHhCCCCCCCcCHH------HHHHHHhcCCC-----------CCCccCCHHHHHHHHHHhhh
Confidence 99999999999999999999999999643211 11111122111 01112344788999999999
Q ss_pred CCCCCC-----CHHHHHH
Q 048243 241 NPNDRP-----SMLQVSS 253 (303)
Q Consensus 241 dp~~Rp-----t~~el~~ 253 (303)
||.+|+ |++|+++
T Consensus 276 dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 276 DLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CTTTCTTSSTTTTHHHHT
T ss_pred CHHhccccccccHHHHHc
Confidence 999994 8999987
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=325.03 Aligned_cols=233 Identities=18% Similarity=0.236 Sum_probs=185.8
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.+|+.||+|+++.... ....+.+|+.+|+.++||||+++++++.+++..|+|||||+||+|.+++.. .+..+++..+
T Consensus 28 ~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~--~~~~l~e~~~ 104 (321)
T d1tkia_ 28 SSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREI 104 (321)
T ss_dssp TTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTS--SSCCCCHHHH
T ss_pred CCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHh--cCCCCCHHHH
Confidence 5789999999976543 335688999999999999999999999999999999999999999999853 3346999999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCC--CceEEcccccccccccCCccccccccccccCCCChhhhccC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGED--MKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQG 161 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~--~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 161 (303)
+.++.||+.||+|||++| |+||||||+|||++.+ +.++|+|||++....... ......|++.|+|||.+.+.
T Consensus 105 ~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~---~~~~~~~t~~y~ape~~~~~ 178 (321)
T d1tkia_ 105 VSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHD 178 (321)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTC
T ss_pred HHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCC---cccccccccccccchhccCC
Confidence 999999999999999999 9999999999999854 479999999997754332 22335789999999999999
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 162 VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 162 ~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
.++.++|||||||++|+|++|..||........ . ........... ... .+..+.++.+||.+||..|
T Consensus 179 ~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~---~---~~i~~~~~~~~--~~~-----~~~~s~~~~~li~~~L~~d 245 (321)
T d1tkia_ 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQI---I---ENIMNAEYTFD--EEA-----FKEISIEAMDFVDRLLVKE 245 (321)
T ss_dssp EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---H---HHHHHTCCCCC--HHH-----HTTSCHHHHHHHHTTSCSS
T ss_pred CCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH---H---HHHHhCCCCCC--hhh-----ccCCCHHHHHHHHHHccCC
Confidence 999999999999999999999999965432211 1 11111111000 000 0012347889999999999
Q ss_pred CCCCCCHHHHHH--Hhccc
Q 048243 242 PNDRPSMLQVSS--MLKNE 258 (303)
Q Consensus 242 p~~Rpt~~el~~--~L~~~ 258 (303)
|.+|||+.|+++ ++.+.
T Consensus 246 p~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 246 RKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp GGGSCCHHHHHHSHHHHSC
T ss_pred hhHCcCHHHHhcCHhhccC
Confidence 999999999987 35443
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-48 Score=321.88 Aligned_cols=228 Identities=29% Similarity=0.406 Sum_probs=177.1
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEe-CCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCID-SEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
.|+.||||+++... ..+.+.+|+.++++++||||+++++++.+ ++..++||||+++|+|.+++... ....+++..+
T Consensus 29 ~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~l~~~~~ 105 (262)
T d1byga_ 29 RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCL 105 (262)
T ss_dssp TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHH-HHHHCCHHHH
T ss_pred CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhc-CCCCCCHHHH
Confidence 47889999996543 44789999999999999999999999865 45689999999999999998542 2345899999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
+.++.||+.||+|||+.+ ++||||||+||+++.++.++++|||+++..... .....++..|+|||.+.+..+
T Consensus 106 ~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~ 177 (262)
T d1byga_ 106 LKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKF 177 (262)
T ss_dssp HHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCC
T ss_pred HHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC-----CccccccccCCChHHHhCCCC
Confidence 999999999999999998 999999999999999999999999999764332 223457889999999999999
Q ss_pred CCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCC
Q 048243 164 STKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENP 242 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 242 (303)
+.++|||||||++|||++ |.+||........ .. ....+... ..+...+.++.+|+.+||+.||
T Consensus 178 t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~---~~----~i~~~~~~---------~~~~~~~~~~~~li~~cl~~dP 241 (262)
T d1byga_ 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VP----RVEKGYKM---------DAPDGCPPAVYEVMKNCWHLDA 241 (262)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HH----HHTTTCCC---------CCCTTCCHHHHHHHHHHTCSSG
T ss_pred ChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH---HH----HHHcCCCC---------CCCccCCHHHHHHHHHHcccCH
Confidence 999999999999999998 6777654332221 11 11111111 1122233578899999999999
Q ss_pred CCCCCHHHHHHHhcccc
Q 048243 243 NDRPSMLQVSSMLKNET 259 (303)
Q Consensus 243 ~~Rpt~~el~~~L~~~~ 259 (303)
.+|||+.|+++.|++..
T Consensus 242 ~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 242 AMRPSFLQLREQLEHIK 258 (262)
T ss_dssp GGSCCHHHHHHHHHHHH
T ss_pred hHCcCHHHHHHHHHHHH
Confidence 99999999999998764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=323.95 Aligned_cols=237 Identities=27% Similarity=0.388 Sum_probs=178.4
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCccccEEEEEEeC-CeeEEEEeecCCCChhhhhcCcc-------
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDS-EERMLVYEYMPNKSLDCYLFDPI------- 73 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~------- 73 (303)
.+++.||||+++... ....+.+.+|...+.++ +|+||+.+++++... ...++|||||++|+|.+++....
T Consensus 41 ~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~ 120 (299)
T d1ywna1 41 ATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 120 (299)
T ss_dssp SCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC--
T ss_pred cCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccc
Confidence 456899999997543 34456778888888887 689999999998765 46899999999999999986422
Q ss_pred ------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccc
Q 048243 74 ------RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVV 147 (303)
Q Consensus 74 ------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~ 147 (303)
....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...............
T Consensus 121 ~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~ 197 (299)
T d1ywna1 121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 197 (299)
T ss_dssp ---------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCC
T ss_pred cchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECCCCcEEEccCcchhhccccccccccCcee
Confidence 1345889999999999999999999999 9999999999999999999999999998765554444445567
Q ss_pred cccCCCChhhhccCCCCCccchhhHHHHHHHHHhCC-CCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHH
Q 048243 148 GTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK-RLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCK 226 (303)
Q Consensus 148 g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (303)
||+.|+|||++.+..++.++|||||||++|||++|. +||........ . ......+.... .+...
T Consensus 198 gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~---~---~~~~~~~~~~~---------~~~~~ 262 (299)
T d1ywna1 198 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---F---CRRLKEGTRMR---------APDYT 262 (299)
T ss_dssp CGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH---H---HHHHHHTCCCC---------CCTTC
T ss_pred eCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH---H---HHHHhcCCCCC---------CCccC
Confidence 999999999999999999999999999999999875 56654332221 1 11111111111 11122
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHhccc
Q 048243 227 LMRCLEIALLCVQENPNDRPSMLQVSSMLKNE 258 (303)
Q Consensus 227 ~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~ 258 (303)
+.++.+++.+||+.||++|||+.|+++.|++.
T Consensus 263 ~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 263 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 34788999999999999999999999999865
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=319.71 Aligned_cols=230 Identities=20% Similarity=0.342 Sum_probs=175.1
Q ss_pred CcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHH
Q 048243 6 GKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRV 84 (303)
Q Consensus 6 ~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~ 84 (303)
+..||||.++... ....+.+.+|+.++++++||||+++++++. ++..++||||+++|+|.+++.. ....+++..++
T Consensus 35 ~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~--~~~~l~~~~~~ 111 (273)
T d1mp8a_ 35 ALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV--RKYSLDLASLI 111 (273)
T ss_dssp CEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHH--TTTTSCHHHHH
T ss_pred eEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhc--cCCCCCHHHHH
Confidence 4569999986543 444567999999999999999999999985 4678999999999999988743 34568999999
Q ss_pred HHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCC
Q 048243 85 HIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYS 164 (303)
Q Consensus 85 ~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~ 164 (303)
.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||+++....... .......||+.|+|||.+.+..++
T Consensus 112 ~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~ 187 (273)
T d1mp8a_ 112 LYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFT 187 (273)
T ss_dssp HHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCS
T ss_pred HHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCCcc-eeccceecCcccchhhHhccCCCC
Confidence 99999999999999999 99999999999999999999999999987554322 222335679999999999999999
Q ss_pred CccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCC
Q 048243 165 TKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 165 ~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 243 (303)
.++|||||||++|||++ |.+||......... . ....+.... .++..+..+.+||.+||..||+
T Consensus 188 ~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~---~----~i~~~~~~~---------~~~~~~~~~~~li~~cl~~dp~ 251 (273)
T d1mp8a_ 188 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---G----RIENGERLP---------MPPNCPPTLYSLMTKCWAYDPS 251 (273)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---H----HHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGG
T ss_pred CccccccchHHHHHHHhcCCCCCCCCCHHHHH---H----HHHcCCCCC---------CCCCCCHHHHHHHHHHcCCCHh
Confidence 99999999999999998 88888654433211 1 111111111 1122345789999999999999
Q ss_pred CCCCHHHHHHHhccc
Q 048243 244 DRPSMLQVSSMLKNE 258 (303)
Q Consensus 244 ~Rpt~~el~~~L~~~ 258 (303)
+|||+.||++.|++.
T Consensus 252 ~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 252 RRPRFTELKAQLSTI 266 (273)
T ss_dssp GSCCHHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHHH
Confidence 999999999988764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.3e-47 Score=320.68 Aligned_cols=237 Identities=24% Similarity=0.317 Sum_probs=180.9
Q ss_pred cCCCcEEEEEEecCCC---cccHHHHHHHHHHHhcCCCCccccEEEEEEeCC----eeEEEEeecCCCChhhhhcCcccc
Q 048243 3 LPCGKVIAVKKLSKTS---TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE----ERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 3 ~~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~ 75 (303)
..+|+.||||+++... ....+.+.+|+.+++.++||||+++++++.... ..|+|||||+|++|..++. ..
T Consensus 29 ~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~---~~ 105 (277)
T d1o6ya_ 29 LRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TE 105 (277)
T ss_dssp TTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHH---HH
T ss_pred CCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhc---cc
Confidence 3679999999997553 233457899999999999999999999998653 4789999999999998883 45
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCc-cccccccccccCCCC
Q 048243 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESL-EANTEQVVGTIGYIP 154 (303)
Q Consensus 76 ~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~-~~~~~~~~g~~~y~a 154 (303)
..+++..++.++.||+.||+|||++| |+||||||+||+++.++.++++|||.+........ ........||+.|+|
T Consensus 106 ~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~a 182 (277)
T d1o6ya_ 106 GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182 (277)
T ss_dssp CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCC
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccC
Confidence 67999999999999999999999999 99999999999999999999999999876543322 222344679999999
Q ss_pred hhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHH
Q 048243 155 PEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIA 234 (303)
Q Consensus 155 PE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
||++.+..++.++|||||||++|+|++|.+||...... .............. .... +..+..+.++|
T Consensus 183 PE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~~~~~~~---~~~~----~~~s~~l~~li 249 (277)
T d1o6ya_ 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIPP---SARH----EGLSADLDAVV 249 (277)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCCG---GGTS----SSCCHHHHHHH
T ss_pred HHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHhcCCCCC---chhc----cCCCHHHHHHH
Confidence 99999999999999999999999999999999643221 11122222221110 1111 12234788999
Q ss_pred HHcccCCCCCCC-CHHHHHHHhccc
Q 048243 235 LLCVQENPNDRP-SMLQVSSMLKNE 258 (303)
Q Consensus 235 ~~~l~~dp~~Rp-t~~el~~~L~~~ 258 (303)
.+||+.||.+|| |++++++.|.+.
T Consensus 250 ~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 250 LKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp HHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHccCCHhHCHhHHHHHHHHHHHH
Confidence 999999999999 899998887654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-47 Score=325.30 Aligned_cols=230 Identities=17% Similarity=0.216 Sum_probs=180.2
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcC-CCCccccEEEEEEe----CCeeEEEEeecCCCChhhhhcCcccccc
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKL-QHVNLIRVLGFCID----SEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
..+|+.||||+++.. +.+.+|+.++.++ +||||++++++|.+ +...|+|||||+||+|.+++.. .....
T Consensus 34 ~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~-~~~~~ 107 (335)
T d2ozaa1 34 KRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQA 107 (335)
T ss_dssp TTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHS-CSCCC
T ss_pred CCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHh-cCCCC
Confidence 367999999999643 5677899987665 89999999999876 3568999999999999999964 22456
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC---CCceEEcccccccccccCCccccccccccccCCCC
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE---DMKPKISDFGLARIFAKESLEANTEQVVGTIGYIP 154 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~---~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~a 154 (303)
+++..++.++.||+.||+|||+.| |+||||||+|||++. ++.+||+|||+++...... ......||+.|+|
T Consensus 108 l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~---~~~~~~gt~~y~a 181 (335)
T d2ozaa1 108 FTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVA 181 (335)
T ss_dssp EEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC---CCCCCSCCCSSCC
T ss_pred cCHHHHHHHHHHHHHHHHHHHHcC---CccccccccccccccccccccccccccceeeeccCCC---ccccccCCcccCC
Confidence 999999999999999999999999 999999999999985 4679999999998765432 2234579999999
Q ss_pred hhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHH
Q 048243 155 PEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIA 234 (303)
Q Consensus 155 PE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
||++.+..++.++|||||||++|+|++|..||............. ..... ....+........+.++.+||
T Consensus 182 PE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~---~~i~~------~~~~~~~~~~~~~s~~~~~li 252 (335)
T d2ozaa1 182 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---TRIRM------GQYEFPNPEWSEVSEEVKMLI 252 (335)
T ss_dssp CCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCS------CSSSCCTTHHHHSCHHHHHHH
T ss_pred cHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH---HHHhc------CCCCCCCcccccCCHHHHHHH
Confidence 999999999999999999999999999999997554332211110 00000 000111111123456899999
Q ss_pred HHcccCCCCCCCCHHHHHH
Q 048243 235 LLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 235 ~~~l~~dp~~Rpt~~el~~ 253 (303)
.+||+.||++|||+.|+++
T Consensus 253 ~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 253 RNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp HHHSCSSTTTSCCHHHHHH
T ss_pred HHHccCChhHCcCHHHHHc
Confidence 9999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.7e-46 Score=326.05 Aligned_cols=226 Identities=23% Similarity=0.243 Sum_probs=179.2
Q ss_pred CCCcEEEEEEecCCC---cccHHHHHH---HHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcccccc
Q 048243 4 PCGKVIAVKKLSKTS---TQGFEEFKN---EVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~~~~valK~~~~~~---~~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
.+|+.||||++.... ......+.+ ++.+++.++||||+++++++.+.+..|+|||||++|+|.+++. ....
T Consensus 27 ~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~---~~~~ 103 (364)
T d1omwa3 27 DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGV 103 (364)
T ss_dssp TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH---HHCS
T ss_pred CCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHH---hccc
Confidence 579999999986432 122233334 4677778899999999999999999999999999999999984 4566
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhh
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEY 157 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 157 (303)
+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+++.+.... .....||+.|+|||+
T Consensus 104 ~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~----~~~~~GT~~y~APE~ 176 (364)
T d1omwa3 104 FSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEV 176 (364)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSSC----CCSCCSCGGGCCHHH
T ss_pred ccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCCc----ccccccccccchhHH
Confidence 899999999999999999999999 9999999999999999999999999998765432 233579999999999
Q ss_pred hcc-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 158 ARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 158 ~~~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
+.. ..++.++|||||||++|+|++|..||............ ...... . ...+...+.++.+||.+
T Consensus 177 ~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~----~~~~~~-~---------~~~~~~~s~~~~~li~~ 242 (364)
T d1omwa3 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLTM-A---------VELPDSFSPELRSLLEG 242 (364)
T ss_dssp HSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH----HHSSSC-C---------CCCCSSSCHHHHHHHHH
T ss_pred hhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HhcccC-C---------CCCCCCCCHHHHHHHHH
Confidence 864 56899999999999999999999999765443321111 111000 0 01111234578999999
Q ss_pred cccCCCCCCCC-----HHHHHH
Q 048243 237 CVQENPNDRPS-----MLQVSS 253 (303)
Q Consensus 237 ~l~~dp~~Rpt-----~~el~~ 253 (303)
||+.||.+||| ++|+++
T Consensus 243 ~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 243 LLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HTCSSTTTSTTTSSSTHHHHHT
T ss_pred HcccCHHHhCCCcccCHHHHHc
Confidence 99999999999 688876
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-47 Score=325.72 Aligned_cols=230 Identities=24% Similarity=0.392 Sum_probs=180.8
Q ss_pred EEEEEEecCC-CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHHHHH
Q 048243 8 VIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVHI 86 (303)
Q Consensus 8 ~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~~ 86 (303)
.||+|.++.. .....+.+.+|+.++++++||||+++++++.++ ..+++++++.+++|.+++.. ....+++..++.+
T Consensus 40 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i 116 (317)
T d1xkka_ 40 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNW 116 (317)
T ss_dssp EEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHH--TSSSCCHHHHHHH
T ss_pred EEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccc--cccCCCHHHHHHH
Confidence 5899988654 345567899999999999999999999999765 56788899999999888753 3567899999999
Q ss_pred HHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhccCCCCCc
Q 048243 87 IEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQGVYSTK 166 (303)
Q Consensus 87 ~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~ 166 (303)
+.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++...............||+.|+|||.+.+..++.+
T Consensus 117 ~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~ 193 (317)
T d1xkka_ 117 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 193 (317)
T ss_dssp HHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChh
Confidence 999999999999999 99999999999999999999999999987765444433444568999999999999999999
Q ss_pred cchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCCCC
Q 048243 167 SDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPNDR 245 (303)
Q Consensus 167 ~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 245 (303)
+|||||||++|||++ |..||.......... ....+.. ...++..+..+.+|+.+||..||.+|
T Consensus 194 sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~-------~i~~~~~---------~~~p~~~~~~~~~li~~cl~~dP~~R 257 (317)
T d1xkka_ 194 SDVWSYGVTVWELMTFGSKPYDGIPASEISS-------ILEKGER---------LPQPPICTIDVYMIMVKCWMIDADSR 257 (317)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTSCGGGHHH-------HHHHTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGS
T ss_pred hhhhhHHHHHHHHHHCCCCCCCCCCHHHHHH-------HHHcCCC---------CCCCcccCHHHHHHHHHhCCCChhhC
Confidence 999999999999998 778876443322111 1111111 11112234578899999999999999
Q ss_pred CCHHHHHHHhcccc
Q 048243 246 PSMLQVSSMLKNET 259 (303)
Q Consensus 246 pt~~el~~~L~~~~ 259 (303)
||+.|+++.|+...
T Consensus 258 Ps~~eil~~l~~~~ 271 (317)
T d1xkka_ 258 PKFRELIIEFSKMA 271 (317)
T ss_dssp CCHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHH
Confidence 99999999887654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-47 Score=321.82 Aligned_cols=237 Identities=27% Similarity=0.376 Sum_probs=192.7
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc--------
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-------- 73 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------- 73 (303)
.++..||||+++... ......+.+|...+.++ +||||+++++++.++...++|||||++|+|.+++....
T Consensus 43 ~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~ 122 (299)
T d1fgka_ 43 NRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 122 (299)
T ss_dssp CCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------
T ss_pred cCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCcccccc
Confidence 345689999997654 34457788899999888 89999999999999999999999999999999996532
Q ss_pred -----ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcccccccccc
Q 048243 74 -----RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVG 148 (303)
Q Consensus 74 -----~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g 148 (303)
....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.+................|
T Consensus 123 ~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 199 (299)
T d1fgka_ 123 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 199 (299)
T ss_dssp ------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCC
T ss_pred ccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeecCCCCeEeccchhhccccccccccccccCCC
Confidence 1346899999999999999999999999 99999999999999999999999999987766544444455678
Q ss_pred ccCCCChhhhccCCCCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHH
Q 048243 149 TIGYIPPEYARQGVYSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKL 227 (303)
Q Consensus 149 ~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
++.|+|||.+.+..++.++|||||||++|+|++ |.+||...... .....+..+..... +...+
T Consensus 200 ~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~-------~~~~~i~~~~~~~~---------p~~~~ 263 (299)
T d1fgka_ 200 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-------ELFKLLKEGHRMDK---------PSNCT 263 (299)
T ss_dssp GGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------HHHHHHHTTCCCCC---------CSSCC
T ss_pred ChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH-------HHHHHHHcCCCCCC---------Cccch
Confidence 999999999999999999999999999999998 67777533321 12223322222211 11233
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHhcccc
Q 048243 228 MRCLEIALLCVQENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 228 ~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~ 259 (303)
..+.+||.+||+.||++|||+.||++.|++..
T Consensus 264 ~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 264 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 47899999999999999999999999998753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-47 Score=324.33 Aligned_cols=225 Identities=24% Similarity=0.297 Sum_probs=182.4
Q ss_pred CCCcEEEEEEecCC---CcccHHHHHHHHHHHh-cCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 4 PCGKVIAVKKLSKT---STQGFEEFKNEVMLTA-KLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 4 ~~~~~valK~~~~~---~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
.+|+.||||++++. .....+.+..|..++. .++||||+++++++.+++..|+|||||++|+|.+++. ....++
T Consensus 25 ~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~---~~~~~~ 101 (320)
T d1xjda_ 25 KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFD 101 (320)
T ss_dssp TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH---HHSSCC
T ss_pred CCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhh---ccCCCC
Confidence 57999999999643 2344566677777665 6899999999999999999999999999999999984 455689
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..++.++.||+.||+|||+++ ++||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.
T Consensus 102 e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~ 176 (320)
T d1xjda_ 102 LSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILL 176 (320)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccccc--ccccccCCCCCcCCHHHHc
Confidence 9999999999999999999999 9999999999999999999999999998654432 2233467999999999999
Q ss_pred cCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHccc
Q 048243 160 QGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQ 239 (303)
Q Consensus 160 ~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 239 (303)
+..++.++|||||||++|+|++|..||...+... ... ...... ... +...+.++.+||.+||.
T Consensus 177 ~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~---~i~~~~-------~~~----p~~~s~~~~dli~~~L~ 239 (320)
T d1xjda_ 177 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFH---SIRMDN-------PFY----PRWLEKEAKDLLVKLFV 239 (320)
T ss_dssp TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHHCC-------CCC----CTTSCHHHHHHHHHHSC
T ss_pred CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH---HHH---HHHcCC-------CCC----CccCCHHHHHHHHHhcc
Confidence 9999999999999999999999999996443221 111 111111 011 11224578899999999
Q ss_pred CCCCCCCCHH-HHHH
Q 048243 240 ENPNDRPSML-QVSS 253 (303)
Q Consensus 240 ~dp~~Rpt~~-el~~ 253 (303)
.||.+|||+. |+++
T Consensus 240 ~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 240 REPEKRLGVRGDIRQ 254 (320)
T ss_dssp SSGGGSBTTBSCGGG
T ss_pred cCCCCCcCHHHHHHh
Confidence 9999999995 7764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=319.20 Aligned_cols=230 Identities=25% Similarity=0.343 Sum_probs=179.3
Q ss_pred cEEEEEEecCC---CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 7 KVIAVKKLSKT---STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 7 ~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
..||||+++.. .....+.+.+|+.++++++||||+++++++.+ ...++|||||++|++.+++.. ....+++..+
T Consensus 37 ~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~--~~~~l~~~~~ 113 (273)
T d1u46a_ 37 VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRK--HQGHFLLGTL 113 (273)
T ss_dssp EEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHH--HGGGSCHHHH
T ss_pred EEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhc--ccCCCCHHHH
Confidence 36899998754 23345689999999999999999999999965 467899999999999988753 3456999999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccc-cccccccccCCCChhhhccCC
Q 048243 84 VHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEA-NTEQVVGTIGYIPPEYARQGV 162 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~ 162 (303)
+.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++......... ......|+..|+|||.+.+..
T Consensus 114 ~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 190 (273)
T d1u46a_ 114 SRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190 (273)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE
T ss_pred HHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCC
Confidence 999999999999999998 9999999999999999999999999998765543322 223345788999999999999
Q ss_pred CCCccchhhHHHHHHHHHh-CCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCC
Q 048243 163 YSTKSDVFSFGVLLLQIIS-GKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQEN 241 (303)
Q Consensus 163 ~~~~~DiwslG~~~~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 241 (303)
++.++||||||+++|||++ |..||...+... ............ ..+...+..+.+|+.+||+.|
T Consensus 191 ~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~------~~~~i~~~~~~~---------~~~~~~~~~l~~li~~cl~~d 255 (273)
T d1u46a_ 191 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKEGERL---------PRPEDCPQDIYNVMVQCWAHK 255 (273)
T ss_dssp EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTSCCCC---------CCCTTCCHHHHHHHHHHTCSS
T ss_pred CCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH------HHHHHHhCCCCC---------CCcccccHHHHHHHHHHcCCC
Confidence 9999999999999999998 899986433222 112222222111 111223357889999999999
Q ss_pred CCCCCCHHHHHHHhcc
Q 048243 242 PNDRPSMLQVSSMLKN 257 (303)
Q Consensus 242 p~~Rpt~~el~~~L~~ 257 (303)
|++|||+.||.+.|++
T Consensus 256 p~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 256 PEDRPTFVALRDFLLE 271 (273)
T ss_dssp GGGSCCHHHHHHHHHH
T ss_pred hhHCcCHHHHHHHHHh
Confidence 9999999999999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-47 Score=324.38 Aligned_cols=238 Identities=25% Similarity=0.380 Sum_probs=191.7
Q ss_pred CCCcEEEEEEecCCC-cccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc--------
Q 048243 4 PCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-------- 73 (303)
Q Consensus 4 ~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------- 73 (303)
.+++.||||+++... ......+.+|+.++..+ +||||+++++++.+....++|||||++|+|.+++....
T Consensus 51 ~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~ 130 (311)
T d1t46a_ 51 DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130 (311)
T ss_dssp TCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC-----
T ss_pred CCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhcccccccccc
Confidence 577899999997653 44556789999999999 79999999999999999999999999999999986421
Q ss_pred -------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcccccccc
Q 048243 74 -------RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQV 146 (303)
Q Consensus 74 -------~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~ 146 (303)
....+++..+..++.||+.||+|||+++ ++||||||+||+++.++.++++|||.++..............
T Consensus 131 ~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~ 207 (311)
T d1t46a_ 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207 (311)
T ss_dssp ---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSS
T ss_pred ccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccccccCcccccccchheeccCCCcceEeeec
Confidence 2336889999999999999999999999 999999999999999999999999999877655444445557
Q ss_pred ccccCCCChhhhccCCCCCccchhhHHHHHHHHHhCC-CCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHH
Q 048243 147 VGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGK-RLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPC 225 (303)
Q Consensus 147 ~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (303)
.||+.|+|||.+.+..++.++|||||||++|+|++++ +||......... ......+. ....+..
T Consensus 208 ~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~------~~~i~~~~---------~~~~~~~ 272 (311)
T d1t46a_ 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF------YKMIKEGF---------RMLSPEH 272 (311)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH------HHHHHHTC---------CCCCCTT
T ss_pred ccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH------HHHHhcCC---------CCCCccc
Confidence 8899999999999999999999999999999999955 444333322211 11111111 1111122
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHhcccc
Q 048243 226 KLMRCLEIALLCVQENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 226 ~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~ 259 (303)
.+..+.+||.+||+.||++|||++||++.|++.-
T Consensus 273 ~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 273 APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 3457899999999999999999999999998653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=317.86 Aligned_cols=233 Identities=24% Similarity=0.363 Sum_probs=185.4
Q ss_pred EEEEEEecCC-CcccHHHHHHHHHHHhcCCCCccccEEEEEEe-CCeeEEEEeecCCCChhhhhcCccccccCCHHHHHH
Q 048243 8 VIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCID-SEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKRVH 85 (303)
Q Consensus 8 ~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~ 85 (303)
.||||+++.. .....+.+.+|++++++++||||+++++++.. +...++|||||++|+|.+++.. ....+++..++.
T Consensus 57 ~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~--~~~~~~~~~~~~ 134 (311)
T d1r0pa_ 57 HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIG 134 (311)
T ss_dssp EEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHC--TTCCCBHHHHHH
T ss_pred EEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhcc--ccccchHHHHHH
Confidence 5899999754 45556789999999999999999999999876 4588999999999999998854 345677888999
Q ss_pred HHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc--ccccccccccCCCChhhhccCCC
Q 048243 86 IIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE--ANTEQVVGTIGYIPPEYARQGVY 163 (303)
Q Consensus 86 ~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~ 163 (303)
++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++........ .......||+.|+|||.+.+..+
T Consensus 135 i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 211 (311)
T d1r0pa_ 135 FGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 211 (311)
T ss_dssp HHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCC
T ss_pred HHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCC
Confidence 9999999999999999 999999999999999999999999999876544222 22233568999999999999999
Q ss_pred CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHHcccCCCC
Q 048243 164 STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALLCVQENPN 243 (303)
Q Consensus 164 ~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 243 (303)
+.++||||||+++|||++|+.||....... .... .... +.... .+...+.++.+||.+||+.||+
T Consensus 212 ~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~---~i~~-g~~~~---------~p~~~~~~l~~li~~cl~~dP~ 276 (311)
T d1r0pa_ 212 TTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITV---YLLQ-GRRLL---------QPEYCPDPLYEVMLKCWHPKAE 276 (311)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSCC--------CHH---HHHT-TCCCC---------CCTTCCHHHHHHHHHHTCSSGG
T ss_pred CChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHH---HHHc-CCCCC---------CcccCcHHHHHHHHHHcCCCHh
Confidence 999999999999999999888875432211 1111 1111 11111 1112234788999999999999
Q ss_pred CCCCHHHHHHHhccccC
Q 048243 244 DRPSMLQVSSMLKNETT 260 (303)
Q Consensus 244 ~Rpt~~el~~~L~~~~~ 260 (303)
+|||+.|+++.|++...
T Consensus 277 ~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 277 MRPSFSELVSRISAIFS 293 (311)
T ss_dssp GSCCHHHHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHHHHH
Confidence 99999999999988864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-46 Score=315.41 Aligned_cols=246 Identities=21% Similarity=0.251 Sum_probs=182.2
Q ss_pred cCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 3 LPCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 3 ~~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
..+|+.||||+++... ....+.+.+|++++++++||||+++++++.++...|+||||+.++.+ .++.. .....+++
T Consensus 24 ~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~-~~~~~-~~~~~l~e 101 (298)
T d1gz8a_ 24 KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLK-KFMDA-SALTGIPL 101 (298)
T ss_dssp TTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHH-HHHHH-TTTTCCCH
T ss_pred CCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCchh-hhhhh-hcccCCCH
Confidence 3679999999996543 23356889999999999999999999999999999999999976544 44322 23566999
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.||+.||+|||+.| |+||||||+|||++.++.+||+|||.++...... .......||+.|+|||.+..
T Consensus 102 ~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~apE~~~~ 176 (298)
T d1gz8a_ 102 PLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLG 176 (298)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--BCTTCCBCCCTTCCHHHHTT
T ss_pred HHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc--ccceeecccceeeehhhhcc
Confidence 999999999999999999999 9999999999999999999999999997654332 22334578999999998877
Q ss_pred CC-CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCc---ceec---c---ccCC-CCC-----CH
Q 048243 161 GV-YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG---VEFV---D---SSLD-DTN-----SP 224 (303)
Q Consensus 161 ~~-~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~---~---~~~~-~~~-----~~ 224 (303)
.. ++.++||||+||++|+|++|..||...+... .............. .... . .... ... .+
T Consensus 177 ~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (298)
T d1gz8a_ 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVP 253 (298)
T ss_dssp CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHST
T ss_pred ccCCCccccccccchhhhHHhhCCCCCCCCCHHH---HHHHHHHhcCCCchhhccccccccccccccccccccchhhhcc
Confidence 65 5789999999999999999999996443211 11111111111000 0000 0 0000 000 01
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccc
Q 048243 225 CKLMRCLEIALLCVQENPNDRPSMLQVSSM--LKNE 258 (303)
Q Consensus 225 ~~~~~l~~li~~~l~~dp~~Rpt~~el~~~--L~~~ 258 (303)
..+.++.+|+.+||+.||++|||+.|+++. |++.
T Consensus 254 ~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 254 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 223578899999999999999999999874 5443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=319.30 Aligned_cols=231 Identities=29% Similarity=0.396 Sum_probs=181.3
Q ss_pred EEEEEEecCC-CcccHHHHHHHHHHHhcC-CCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCc-------------
Q 048243 8 VIAVKKLSKT-STQGFEEFKNEVMLTAKL-QHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDP------------- 72 (303)
Q Consensus 8 ~valK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------------- 72 (303)
.||||.++.. .....+.+.+|+.+|.++ +||||+++++++.++...++||||+++|+|.+++...
T Consensus 39 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~ 118 (309)
T d1fvra_ 39 DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 118 (309)
T ss_dssp EEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHT
T ss_pred EEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccc
Confidence 4788888644 344556899999999999 7999999999999999999999999999999998643
Q ss_pred cccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCC
Q 048243 73 IRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGY 152 (303)
Q Consensus 73 ~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y 152 (303)
.....+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++...... ......||..|
T Consensus 119 ~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y 192 (309)
T d1fvra_ 119 STASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRW 192 (309)
T ss_dssp TBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTT
T ss_pred cccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCceEEccccccccccccc---cccceecCCcc
Confidence 23467999999999999999999999999 9999999999999999999999999987543322 12234689999
Q ss_pred CChhhhccCCCCCccchhhHHHHHHHHHhCCC-CCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHH
Q 048243 153 IPPEYARQGVYSTKSDVFSFGVLLLQIISGKR-LSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL 231 (303)
Q Consensus 153 ~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
+|||.+.+..++.++|||||||++|||++|.. ||....... .......+.. ...+...+.++.
T Consensus 193 ~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~-------~~~~i~~~~~---------~~~~~~~~~~~~ 256 (309)
T d1fvra_ 193 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEKLPQGYR---------LEKPLNCDDEVY 256 (309)
T ss_dssp CCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHGGGTCC---------CCCCTTBCHHHH
T ss_pred cchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHhcCC---------CCCCccCCHHHH
Confidence 99999999999999999999999999999765 554322111 1111111111 111122345889
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhccccC
Q 048243 232 EIALLCVQENPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 232 ~li~~~l~~dp~~Rpt~~el~~~L~~~~~ 260 (303)
+||.+||+.||++|||++|+++.|++...
T Consensus 257 ~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 257 DLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999887754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-46 Score=315.69 Aligned_cols=237 Identities=26% Similarity=0.383 Sum_probs=190.4
Q ss_pred CCcEEEEEEecCC-CcccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCcc-------ccc
Q 048243 5 CGKVIAVKKLSKT-STQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPI-------RRL 76 (303)
Q Consensus 5 ~~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~ 76 (303)
+++.||||+++.. .......+.+|+.++++++||||+++++++......++|||||.+|+|.+++.... ...
T Consensus 49 ~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~ 128 (308)
T d1p4oa_ 49 PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 128 (308)
T ss_dssp EEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCC
T ss_pred CCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccC
Confidence 4578999999754 33444578999999999999999999999999999999999999999999885421 123
Q ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChh
Q 048243 77 ILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE 156 (303)
Q Consensus 77 ~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE 156 (303)
.+++..+..++.|++.||+|||+++ |+||||||+|||++.++++||+|||+++...............|++.|+|||
T Consensus 129 ~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe 205 (308)
T d1p4oa_ 129 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 205 (308)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHH
Confidence 4688999999999999999999998 9999999999999999999999999998766554444445567899999999
Q ss_pred hhccCCCCCccchhhHHHHHHHHHhCC-CCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHH
Q 048243 157 YARQGVYSTKSDVFSFGVLLLQIISGK-RLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIAL 235 (303)
Q Consensus 157 ~~~~~~~~~~~DiwslG~~~~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 235 (303)
.+.+..++.++||||||+++|||++|. .||...+... . ......+.... .+...+..+.++|.
T Consensus 206 ~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~------~-~~~i~~~~~~~---------~p~~~~~~l~~li~ 269 (308)
T d1p4oa_ 206 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ------V-LRFVMEGGLLD---------KPDNCPDMLFELMR 269 (308)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH------H-HHHHHTTCCCC---------CCTTCCHHHHHHHH
T ss_pred HHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH------H-HHHHHhCCCCC---------CcccchHHHHHHHH
Confidence 999999999999999999999999985 5664332111 1 11111221111 11122357999999
Q ss_pred HcccCCCCCCCCHHHHHHHhccccC
Q 048243 236 LCVQENPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 236 ~~l~~dp~~Rpt~~el~~~L~~~~~ 260 (303)
+||+.||++|||+++|++.|++...
T Consensus 270 ~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 270 MCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHcCCChhHCcCHHHHHHHHHHhcC
Confidence 9999999999999999999988743
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.1e-45 Score=311.91 Aligned_cols=241 Identities=19% Similarity=0.258 Sum_probs=181.6
Q ss_pred ccCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCC
Q 048243 2 VLPCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILD 79 (303)
Q Consensus 2 ~~~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~ 79 (303)
..++|+.||||+++... ....+.+.+|+.+|++++||||+++++++.+++..+++|+++.++.+..+. .....++
T Consensus 22 ~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~---~~~~~l~ 98 (286)
T d1ob3a_ 22 QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD---VCEGGLE 98 (286)
T ss_dssp EETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHH---TSTTCCC
T ss_pred EeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHH---hhcCCcc
Confidence 34688999999996553 333578999999999999999999999999999999999999887766665 3456799
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 80 WKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 80 ~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
+..++.++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||.+........ ......|++.|+|||.+.
T Consensus 99 ~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~y~~pE~~~ 173 (286)
T d1ob3a_ 99 SVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLM 173 (286)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHT
T ss_pred hhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc--ccceecccchhhhHHHHh
Confidence 9999999999999999999999 99999999999999999999999999987654322 223346899999999987
Q ss_pred cC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceec---------------cccCCCCCC
Q 048243 160 QG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV---------------DSSLDDTNS 223 (303)
Q Consensus 160 ~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~ 223 (303)
+. .++.++|||||||++|+|++|+.||...+... .................. .........
T Consensus 174 ~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (286)
T d1ob3a_ 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFL 250 (286)
T ss_dssp TCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTC
T ss_pred CCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH---HHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhc
Confidence 65 56899999999999999999999996543222 112111111111000000 000000111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 224 PCKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 224 ~~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
...+..+.+|+.+||+.||++|||++|+++
T Consensus 251 ~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 251 KGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 223457889999999999999999999985
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-45 Score=310.67 Aligned_cols=246 Identities=22% Similarity=0.244 Sum_probs=178.4
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeCC----eeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE----ERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
+|+.||||+++.... .......|+..+..++||||+++++++.+.+ ..++|||||++|+|.+++. ...+++
T Consensus 25 ~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----~~~l~~ 99 (303)
T d1vjya_ 25 RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTV 99 (303)
T ss_dssp TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHH----HCCBCH
T ss_pred CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHh----cCCCCH
Confidence 588999999964422 1122334555556789999999999998654 5799999999999999994 345899
Q ss_pred HHHHHHHHHHHHHHHHHHhC-----CCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc--ccccccccccCCC
Q 048243 81 KKRVHIIEGITQGLLYLQEY-----SRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE--ANTEQVVGTIGYI 153 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~-----~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~--~~~~~~~g~~~y~ 153 (303)
..++.++.|++.||+|||+. +.++|+||||||+|||++.++.+||+|||+++........ .......||+.|+
T Consensus 100 ~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~ 179 (303)
T d1vjya_ 100 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179 (303)
T ss_dssp HHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGC
T ss_pred HHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcC
Confidence 99999999999999999974 1234999999999999999999999999999876543221 2234467999999
Q ss_pred ChhhhccCC------CCCccchhhHHHHHHHHHhCCCCCccCCCCcc--------ccHHHHHHHHHhCCCcceeccccCC
Q 048243 154 PPEYARQGV------YSTKSDVFSFGVLLLQIISGKRLSMLCGINEN--------LSILEHAYELWKGGKGVEFVDSSLD 219 (303)
Q Consensus 154 aPE~~~~~~------~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (303)
|||++.+.. ++.++|||||||++|||++|..||........ ................ .+.+.
T Consensus 180 aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~p~~~ 255 (303)
T d1vjya_ 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL----RPNIP 255 (303)
T ss_dssp CHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC----CCCCC
T ss_pred ChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhcccc----CCCCC
Confidence 999987653 46689999999999999999888754332111 1111222222211111 11111
Q ss_pred CC-CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHhcccc
Q 048243 220 DT-NSPCKLMRCLEIALLCVQENPNDRPSMLQVSSMLKNET 259 (303)
Q Consensus 220 ~~-~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~L~~~~ 259 (303)
.. ........+.+++.+||+.||++|||+.||++.|++..
T Consensus 256 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 256 NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 11 12234567889999999999999999999999987654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-45 Score=309.32 Aligned_cols=239 Identities=23% Similarity=0.279 Sum_probs=175.9
Q ss_pred CCcEEEEEEecCC--CcccHHHHHHHHHHHhcC---CCCccccEEEEEEe-----CCeeEEEEeecCCCChhhhhcCccc
Q 048243 5 CGKVIAVKKLSKT--STQGFEEFKNEVMLTAKL---QHVNLIRVLGFCID-----SEERMLVYEYMPNKSLDCYLFDPIR 74 (303)
Q Consensus 5 ~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~ 74 (303)
+++.||||+++.. .......+.+|+.+++.+ +||||+++++++.. ....+++||++.++.+..... ..
T Consensus 32 ~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~--~~ 109 (305)
T d1blxa_ 32 GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK--VP 109 (305)
T ss_dssp TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHH--SC
T ss_pred CCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhh--cc
Confidence 4678999998643 222233566777777666 79999999999863 246799999999877654432 24
Q ss_pred cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCC
Q 048243 75 RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIP 154 (303)
Q Consensus 75 ~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~a 154 (303)
...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.++|+|||.+...... .......||+.|+|
T Consensus 110 ~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~A 183 (305)
T d1blxa_ 110 EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRA 183 (305)
T ss_dssp TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG---GGGCCCCCCCTTCC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhhhhhhccc---ccCCCcccChhhcC
Confidence 567899999999999999999999999 999999999999999999999999998754332 23344679999999
Q ss_pred hhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceec------cccC-------CCC
Q 048243 155 PEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFV------DSSL-------DDT 221 (303)
Q Consensus 155 PE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~-------~~~ 221 (303)
||++.+..++.++||||+||++|+|++|..||...+... ................+. .... ...
T Consensus 184 PE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (305)
T d1blxa_ 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEK 260 (305)
T ss_dssp HHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGG
T ss_pred cchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhhCCCchhcccccccchhhhhccccccchhh
Confidence 999999999999999999999999999999996543222 111111111110000000 0000 000
Q ss_pred CCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 222 NSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 222 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
.....+..+.+||.+||+.||++|||+.|+++.
T Consensus 261 ~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 261 FVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp TCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 111234578899999999999999999999863
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=307.98 Aligned_cols=218 Identities=22% Similarity=0.339 Sum_probs=174.7
Q ss_pred cCCCcEEEEEEecCCCc------ccHHHHHHHHHHHhcCC--CCccccEEEEEEeCCeeEEEEeecCC-CChhhhhcCcc
Q 048243 3 LPCGKVIAVKKLSKTST------QGFEEFKNEVMLTAKLQ--HVNLIRVLGFCIDSEERMLVYEYMPN-KSLDCYLFDPI 73 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~------~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~ 73 (303)
..+|+.||||+++.... ....++.+|+.++++++ ||||+++++++.+.+..++|||++.+ +++.+++.
T Consensus 26 ~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~--- 102 (273)
T d1xwsa_ 26 VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT--- 102 (273)
T ss_dssp TTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHH---
T ss_pred CCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHh---
Confidence 35799999999865321 11234668999999986 89999999999999999999999976 56767763
Q ss_pred ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC-CCceEEcccccccccccCCccccccccccccCC
Q 048243 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-DMKPKISDFGLARIFAKESLEANTEQVVGTIGY 152 (303)
Q Consensus 74 ~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y 152 (303)
.+..+++..++.++.||+.||+|||++| |+||||||+|||++. ++.+||+|||++...... ......||+.|
T Consensus 103 ~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~----~~~~~~GT~~y 175 (273)
T d1xwsa_ 103 ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVY 175 (273)
T ss_dssp HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCSS----CBCCCCSCGGG
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccceecccc----cccccccCCCc
Confidence 4567999999999999999999999999 999999999999985 478999999999765432 22346799999
Q ss_pred CChhhhccCCC-CCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHH
Q 048243 153 IPPEYARQGVY-STKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL 231 (303)
Q Consensus 153 ~aPE~~~~~~~-~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
+|||++.+..+ +.++|||||||++|+|++|..||.... ....... ..... .+.++.
T Consensus 176 ~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~~~-------~~~~~----~s~~~~ 232 (273)
T d1xwsa_ 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQV-------FFRQR----VSSECQ 232 (273)
T ss_dssp SCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCCC-------CCSSC----CCHHHH
T ss_pred CCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhhccc-------CCCCC----CCHHHH
Confidence 99999987765 567999999999999999999995321 1111111 01111 235788
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 048243 232 EIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 232 ~li~~~l~~dp~~Rpt~~el~~ 253 (303)
+||.+||+.||++|||++|+++
T Consensus 233 ~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 233 HLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHccCCHhHCcCHHHHhc
Confidence 9999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-44 Score=308.82 Aligned_cols=245 Identities=20% Similarity=0.253 Sum_probs=176.9
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCccccEEEEEEeC------CeeEEEEeecCCCChhhhhcCcccccc
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS------EERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
++|+.||||+++.... ...+|+.+|++++||||+++++++... ...++|||||+++.+..+.........
T Consensus 43 ~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~ 118 (350)
T d1q5ka_ 43 DSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT 118 (350)
T ss_dssp TTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCC
T ss_pred CCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCC
Confidence 5799999999976542 234799999999999999999998643 357899999987644443322234567
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCC-ceEEcccccccccccCCccccccccccccCCCChh
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM-KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPE 156 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~-~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE 156 (303)
+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||++....... ......|+..|+|||
T Consensus 119 l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE 192 (350)
T d1q5ka_ 119 LPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PNVSYICSRYYRAPE 192 (350)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS---CCCSCCSCTTSCCHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhccCCc---ccccccccccccChH
Confidence 999999999999999999999999 99999999999999775 89999999997764432 223357899999999
Q ss_pred hhcc-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHH--------HHHHHhC----CCcceeccccCCCCCC
Q 048243 157 YARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH--------AYELWKG----GKGVEFVDSSLDDTNS 223 (303)
Q Consensus 157 ~~~~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~~~~----~~~~~~~~~~~~~~~~ 223 (303)
.+.+ ..++.++||||+||++|+|++|..||...........+.. ....... ................
T Consensus 193 ~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (350)
T d1q5ka_ 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 272 (350)
T ss_dssp HHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSC
T ss_pred HhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcc
Confidence 8765 4689999999999999999999999965442221111100 0000000 0000000000000111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH--Hhccc
Q 048243 224 PCKLMRCLEIALLCVQENPNDRPSMLQVSS--MLKNE 258 (303)
Q Consensus 224 ~~~~~~l~~li~~~l~~dp~~Rpt~~el~~--~L~~~ 258 (303)
+..+.++.+||.+||+.||++|||+.|+++ +|++.
T Consensus 273 ~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 273 PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 223457889999999999999999999986 35444
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-43 Score=304.24 Aligned_cols=243 Identities=23% Similarity=0.261 Sum_probs=181.5
Q ss_pred cCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCC------eeEEEEeecCCCChhhhhcCccc
Q 048243 3 LPCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE------ERMLVYEYMPNKSLDCYLFDPIR 74 (303)
Q Consensus 3 ~~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~ 74 (303)
..+|+.||||+++... ....+.+.+|+.+|+.++||||+++++++...+ ..|+||||+ +.+|..++ .
T Consensus 40 ~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~----~ 114 (346)
T d1cm8a_ 40 GRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM----K 114 (346)
T ss_dssp TTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHH----H
T ss_pred CCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHH----H
Confidence 3679999999997543 334567889999999999999999999998654 569999999 56676665 3
Q ss_pred cccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCC
Q 048243 75 RLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIP 154 (303)
Q Consensus 75 ~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~a 154 (303)
...+++..++.++.||+.||+|||++| |+||||||+|||++.++.++++|||.+...... .....||+.|+|
T Consensus 115 ~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~a 186 (346)
T d1cm8a_ 115 HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRA 186 (346)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCC
T ss_pred hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccCCc-----cccccccccccC
Confidence 456999999999999999999999999 999999999999999999999999999875443 234578999999
Q ss_pred hhhhccC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHH-----HHhCCC----------cceeccccC
Q 048243 155 PEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE-----LWKGGK----------GVEFVDSSL 218 (303)
Q Consensus 155 PE~~~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~----------~~~~~~~~~ 218 (303)
||.+.+. .++.++||||+||++|+|++|..||................. .+.... ........+
T Consensus 187 PE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (346)
T d1cm8a_ 187 PEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF 266 (346)
T ss_dssp THHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG
T ss_pred HHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccch
Confidence 9998764 578999999999999999999999965432221111110000 000000 000000000
Q ss_pred CCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hcccc
Q 048243 219 DDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM--LKNET 259 (303)
Q Consensus 219 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~--L~~~~ 259 (303)
.......+..+.+||.+||..||.+|||+.|+++. |++..
T Consensus 267 -~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 267 -ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp -GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred -HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 00111223467899999999999999999999984 66554
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=302.75 Aligned_cols=242 Identities=19% Similarity=0.259 Sum_probs=176.3
Q ss_pred CCCcEEEEEEecCC--CcccHHHHHHHHHHHhcCCCCccccEEEEEEe--------CCeeEEEEeecCCCChhhhhcCcc
Q 048243 4 PCGKVIAVKKLSKT--STQGFEEFKNEVMLTAKLQHVNLIRVLGFCID--------SEERMLVYEYMPNKSLDCYLFDPI 73 (303)
Q Consensus 4 ~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~ 73 (303)
.+|+.||||++... .......+.+|+.+|++++||||+++++++.. ....|+|||++.++.+..+. .
T Consensus 33 ~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~---~ 109 (318)
T d3blha1 33 KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---N 109 (318)
T ss_dssp TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHT---C
T ss_pred CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhh---h
Confidence 68999999998644 33445678899999999999999999999865 34679999999877665444 3
Q ss_pred ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc--ccccccccccC
Q 048243 74 RRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE--ANTEQVVGTIG 151 (303)
Q Consensus 74 ~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~--~~~~~~~g~~~ 151 (303)
....+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||++......... .......||+.
T Consensus 110 ~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~ 186 (318)
T d3blha1 110 VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186 (318)
T ss_dssp TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGG
T ss_pred cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHH
Confidence 4556899999999999999999999999 999999999999999999999999999766533221 22233568999
Q ss_pred CCChhhhccC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCc---cee--------ccccCC
Q 048243 152 YIPPEYARQG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKG---VEF--------VDSSLD 219 (303)
Q Consensus 152 y~aPE~~~~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~--------~~~~~~ 219 (303)
|+|||++.+. .++.++||||+||++|+|++|..||...........+ ......... ... ......
T Consensus 187 Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T d3blha1 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI---SQLCGSITPEVWPNVDNYELYEKLELVKG 263 (318)
T ss_dssp GCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCCTTTSTTCCCC-------CCSS
T ss_pred HhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHH---HHhcCCCChhhccccchhhhhhhhccccc
Confidence 9999998765 6899999999999999999999999643322211111 111111000 000 000000
Q ss_pred CCCCH-------HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 220 DTNSP-------CKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 220 ~~~~~-------~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
..... ..+..+.+||.+||+.||++|||++|+++.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 264 QKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 01111 113467899999999999999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-43 Score=302.82 Aligned_cols=246 Identities=21% Similarity=0.251 Sum_probs=180.5
Q ss_pred cCCCcEEEEEEecCCC-cccHHHHHHHHHHHhcCCCCccccEEEEEEeCC----eeEEEEeecCCCChhhhhcCcccccc
Q 048243 3 LPCGKVIAVKKLSKTS-TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSE----ERMLVYEYMPNKSLDCYLFDPIRRLI 77 (303)
Q Consensus 3 ~~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~ 77 (303)
..+|+.||||+++... ....+.+++|+++|+.++||||+++++++.... ..+++++++.+|+|.+++. ...
T Consensus 30 ~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~----~~~ 105 (345)
T d1pmea_ 30 NVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK----TQH 105 (345)
T ss_dssp TTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHH----HCC
T ss_pred CCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhh----cCC
Confidence 3689999999997543 344568899999999999999999999997643 2344555667899999984 346
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCcc-ccccccccccCCCChh
Q 048243 78 LDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLE-ANTEQVVGTIGYIPPE 156 (303)
Q Consensus 78 l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~-~~~~~~~g~~~y~aPE 156 (303)
+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++......... .......|++.|+|||
T Consensus 106 l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE 182 (345)
T d1pmea_ 106 LSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182 (345)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGG
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHH
Confidence 999999999999999999999999 999999999999999999999999999775443222 2234467899999999
Q ss_pred hhcc-CCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcce-----------eccccCCCCC--
Q 048243 157 YARQ-GVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVE-----------FVDSSLDDTN-- 222 (303)
Q Consensus 157 ~~~~-~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~-- 222 (303)
++.. ..++.++||||+||++|+|++|..||............ ........... ..........
T Consensus 183 ~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (345)
T d1pmea_ 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI---LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVP 259 (345)
T ss_dssp GTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCC
T ss_pred HhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHH---hhhccCCChhhhhhhhhhhhhcccccCCccCCCC
Confidence 9854 46788999999999999999999999654322111111 01000000000 0000000000
Q ss_pred ----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--hccc
Q 048243 223 ----SPCKLMRCLEIALLCVQENPNDRPSMLQVSSM--LKNE 258 (303)
Q Consensus 223 ----~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~--L~~~ 258 (303)
.+..+.++.+|+.+||+.||.+|||+.|+++. |+..
T Consensus 260 ~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 260 WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 01123468899999999999999999999974 5433
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-43 Score=299.99 Aligned_cols=230 Identities=21% Similarity=0.296 Sum_probs=183.6
Q ss_pred CCCcEEEEEEecCCC----cccHHHHHHHHHHHhcCCC-CccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccC
Q 048243 4 PCGKVIAVKKLSKTS----TQGFEEFKNEVMLTAKLQH-VNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLIL 78 (303)
Q Consensus 4 ~~~~~valK~~~~~~----~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l 78 (303)
.+|+.||||+++... ....+.+.+|+.++++++| |||+++++++.+....+++|||+.+|+|.+++. ....+
T Consensus 50 ~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~---~~~~~ 126 (322)
T d1vzoa_ 50 DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS---QRERF 126 (322)
T ss_dssp TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHH---HHSCC
T ss_pred CCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHH---hcccc
Confidence 368999999986542 2334678899999999966 899999999999999999999999999999984 45567
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhh
Q 048243 79 DWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYA 158 (303)
Q Consensus 79 ~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 158 (303)
++..++.++.||+.||+|||+.+ ++||||||+||+++.+|.++|+|||+++.+...... ......|++.|+|||.+
T Consensus 127 ~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~ 202 (322)
T d1vzoa_ 127 TEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIV 202 (322)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHH
T ss_pred cHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhcccccc-cccccccccccchhHHh
Confidence 89999999999999999999999 999999999999999999999999999876544322 23345789999999998
Q ss_pred ccC--CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHHHH
Q 048243 159 RQG--VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIALL 236 (303)
Q Consensus 159 ~~~--~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 236 (303)
.+. .++.++|||||||++|+|++|..||...+.......+... ..... ...+...+.++.+|+.+
T Consensus 203 ~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~--~~~~~-----------~~~~~~~s~~~~~li~~ 269 (322)
T d1vzoa_ 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR--ILKSE-----------PPYPQEMSALAKDLIQR 269 (322)
T ss_dssp TTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH--HHHCC-----------CCCCTTSCHHHHHHHHH
T ss_pred hcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh--cccCC-----------CCCcccCCHHHHHHHHH
Confidence 765 4688999999999999999999999766554433332221 11111 01112234588999999
Q ss_pred cccCCCCCCC-----CHHHHHH
Q 048243 237 CVQENPNDRP-----SMLQVSS 253 (303)
Q Consensus 237 ~l~~dp~~Rp-----t~~el~~ 253 (303)
||++||.+|| |++|+++
T Consensus 270 ~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 270 LLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HTCSSGGGSTTSSTTTHHHHHT
T ss_pred HcccCHHHcCCCCcccHHHHHc
Confidence 9999999999 4788876
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=294.61 Aligned_cols=241 Identities=20% Similarity=0.227 Sum_probs=185.5
Q ss_pred cCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 3 LPCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 3 ~~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
..+|+.||||+++... ....+.+.+|+.+++.++||||+++++++.+....++|++++.++++..++. ..+.+++
T Consensus 24 ~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~---~~~~~~~ 100 (292)
T d1unla_ 24 RETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS---CNGDLDP 100 (292)
T ss_dssp TTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHH---TTTCCCH
T ss_pred CCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccccccc---cccccch
Confidence 3689999999996543 3446789999999999999999999999999999999999999998887773 4567899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCChhhhcc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYARQ 160 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 160 (303)
..++.++.|++.||+|||+++ |+||||||+|||++.++.++|+|||.+........ ......++..|.|||.+.+
T Consensus 101 ~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~~~~~~pe~~~~ 175 (292)
T d1unla_ 101 EIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFG 175 (292)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTT
T ss_pred hHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCc--cceeeccccchhhhhHhcc
Confidence 999999999999999999999 99999999999999999999999999987654322 2223456788999999876
Q ss_pred CC-CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcce---------------eccccCCCCCCH
Q 048243 161 GV-YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVE---------------FVDSSLDDTNSP 224 (303)
Q Consensus 161 ~~-~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~ 224 (303)
.. ++.++||||+||++|+|++|+.||..... ................... ............
T Consensus 176 ~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (292)
T d1unla_ 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVP 253 (292)
T ss_dssp CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTST
T ss_pred CCCCCchhhccccchHHHHHhhCCCCCCCCCC--HHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccc
Confidence 65 68999999999999999999999754332 1122222222211110000 000001111122
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 225 CKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 225 ~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
..+..+.+|+.+||+.||.+||||+|+++
T Consensus 254 ~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 254 KLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 33457889999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-42 Score=293.39 Aligned_cols=240 Identities=17% Similarity=0.161 Sum_probs=179.8
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCc-cccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVN-LIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKK 82 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~ 82 (303)
.+|+.||||++...... +.+..|+++++.++|++ |+.+.+++.+....++||||+. +++...+.. ....+++..
T Consensus 30 ~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~l~~~~~~--~~~~~~~~~ 104 (299)
T d1ckia_ 30 AAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNF--CSRKFSLKT 104 (299)
T ss_dssp TTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC-CBHHHHHHH--TTTCCCHHH
T ss_pred CCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC-Cchhhhhhh--ccCCCcHHH
Confidence 57899999998765432 35788999999997665 5566677778888999999995 556555532 345699999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC---CCceEEcccccccccccCCcc-----ccccccccccCCCC
Q 048243 83 RVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE---DMKPKISDFGLARIFAKESLE-----ANTEQVVGTIGYIP 154 (303)
Q Consensus 83 ~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~---~~~v~l~Df~~~~~~~~~~~~-----~~~~~~~g~~~y~a 154 (303)
+..++.|++.||+|||++| |+||||||+||+++. +..++|+|||+++.+...... .......||+.|+|
T Consensus 105 ~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~a 181 (299)
T d1ckia_ 105 VLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181 (299)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCC
T ss_pred HHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccC
Confidence 9999999999999999999 999999999999864 456999999999876543321 22334679999999
Q ss_pred hhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHHHHH
Q 048243 155 PEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCLEIA 234 (303)
Q Consensus 155 PE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 234 (303)
||.+.+..++.++|||||||++|+|++|..||......................... ..... .+.++.+++
T Consensus 182 PE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~----~p~~~~~li 252 (299)
T d1ckia_ 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-----VLCKG----YPSEFATYL 252 (299)
T ss_dssp HHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH-----HHTTT----SCHHHHHHH
T ss_pred HHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh-----HhccC----CCHHHHHHH
Confidence 999999999999999999999999999999997665544333332221111100000 00111 224788999
Q ss_pred HHcccCCCCCCCCHHHHHHHhccccC
Q 048243 235 LLCVQENPNDRPSMLQVSSMLKNETT 260 (303)
Q Consensus 235 ~~~l~~dp~~Rpt~~el~~~L~~~~~ 260 (303)
.+||+.||++||+++++.+.|++...
T Consensus 253 ~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 253 NFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHccCChhHCcCHHHHHHHHHHHHH
Confidence 99999999999999999988877653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.2e-42 Score=289.48 Aligned_cols=244 Identities=16% Similarity=0.142 Sum_probs=189.3
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
..+|+.||||++...... ..+.+|++.++.++ |+|++.+++++..+...++||||+ +++|.+++.. .+..++..
T Consensus 27 ~~~~~~vAvK~~~~~~~~--~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~--~~~~~~~~ 101 (293)
T d1csna_ 27 LLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL--CGRKFSVK 101 (293)
T ss_dssp TTTTEEEEEEEEECCTTS--CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCHH
T ss_pred CCCCCEEEEEEEccccCc--HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHh--hccchhhH
Confidence 357999999998654322 35778999999996 589999999999999999999999 6889888743 34568999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECC-----CCceEEcccccccccccCCcc-----ccccccccccC
Q 048243 82 KRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGE-----DMKPKISDFGLARIFAKESLE-----ANTEQVVGTIG 151 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~-----~~~v~l~Df~~~~~~~~~~~~-----~~~~~~~g~~~ 151 (303)
.+..++.|++.||+|||++| |+||||||+||+++. ++.++|+|||+++........ .......||+.
T Consensus 102 ~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~ 178 (293)
T d1csna_ 102 TVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178 (293)
T ss_dssp HHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTT
T ss_pred HHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchh
Confidence 99999999999999999999 999999999999974 578999999999876543221 12334579999
Q ss_pred CCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHHHhCCCcceeccccCCCCCCHHHHHHHH
Q 048243 152 YIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYELWKGGKGVEFVDSSLDDTNSPCKLMRCL 231 (303)
Q Consensus 152 y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 231 (303)
|+|||.+.+..++.++||||||+++|+|++|..||.........................+ +.... +.++.
T Consensus 179 y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~-----l~~~~----p~~l~ 249 (293)
T d1csna_ 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE-----LCAGF----PEEFY 249 (293)
T ss_dssp TCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH-----HTTTS----CHHHH
T ss_pred hcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHH-----hcCCC----CHHHH
Confidence 9999999999999999999999999999999999976555443333322222111111111 11111 24788
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHhccccCCCC
Q 048243 232 EIALLCVQENPNDRPSMLQVSSMLKNETTNRN 263 (303)
Q Consensus 232 ~li~~~l~~dp~~Rpt~~el~~~L~~~~~~~~ 263 (303)
+++..|+..+|++||+++.+.+.|++......
T Consensus 250 ~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 250 KYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp HHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 99999999999999999999888876654433
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6e-42 Score=294.47 Aligned_cols=233 Identities=19% Similarity=0.226 Sum_probs=176.9
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCccccEEEEEEeC--CeeEEEEeecCCCChhhhhcCccccccCCH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDS--EERMLVYEYMPNKSLDCYLFDPIRRLILDW 80 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~ 80 (303)
.+|+.||||+++.. ..+++.+|+.+|++++ ||||+++++++... ...++|||||.+++|..+. ..+++
T Consensus 58 ~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~------~~l~e 128 (328)
T d3bqca1 58 TNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTD 128 (328)
T ss_dssp TTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT------TSCCH
T ss_pred CCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh------cCCCH
Confidence 67999999999754 3467889999999995 99999999999854 5689999999999986654 34899
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCC-ceEEcccccccccccCCccccccccccccCCCChhhhc
Q 048243 81 KKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDM-KPKISDFGLARIFAKESLEANTEQVVGTIGYIPPEYAR 159 (303)
Q Consensus 81 ~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~-~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 159 (303)
..++.++.||+.||+|||++| |+||||||+|||++.++ .++|+|||++....... ......||+.|+|||.+.
T Consensus 129 ~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~ 202 (328)
T d3bqca1 129 YDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLV 202 (328)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC---CCCSCCSCGGGCCHHHHT
T ss_pred HHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCC---cccccccCccccCccccc
Confidence 999999999999999999999 99999999999998654 69999999998654432 223456899999999987
Q ss_pred cC-CCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHHH---------H---hCCCccee-----------cc
Q 048243 160 QG-VYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYEL---------W---KGGKGVEF-----------VD 215 (303)
Q Consensus 160 ~~-~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------~---~~~~~~~~-----------~~ 215 (303)
+. .++.++||||+||++|+|++|..||......... ....... . ........ ..
T Consensus 203 ~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~--~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (328)
T d3bqca1 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ--LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE 280 (328)
T ss_dssp TCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH--HHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGG
T ss_pred CCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHH--HHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchh
Confidence 65 4799999999999999999999998654432211 1111000 0 00000000 00
Q ss_pred ccCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 048243 216 SSLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSS 253 (303)
Q Consensus 216 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~ 253 (303)
...........+.++.+||.+||+.||++|||++|+++
T Consensus 281 ~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 281 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111122234457899999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-42 Score=295.87 Aligned_cols=246 Identities=23% Similarity=0.262 Sum_probs=177.1
Q ss_pred cCCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEeC-----CeeEEEEeecCCCChhhhhcCcccc
Q 048243 3 LPCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCIDS-----EERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 3 ~~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~ 75 (303)
..+|+.||||+++... ....+.+.+|+.+|++++||||+++++++... ...+++++++.+|+|.+++. .
T Consensus 40 ~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~----~ 115 (348)
T d2gfsa1 40 TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK----C 115 (348)
T ss_dssp TTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHT----T
T ss_pred CCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcc----c
Confidence 4689999999997553 33445788999999999999999999998643 33466677788999999883 3
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCCh
Q 048243 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aP 155 (303)
..+++..++.++.||+.||+|||++| |+||||||+|||++.++.++++|||.+...... .....|++.|+||
T Consensus 116 ~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~-----~~~~~g~~~y~ap 187 (348)
T d2gfsa1 116 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAP 187 (348)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTGG-----GSSSCHHHHTSCH
T ss_pred ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccCcc-----cccccccccccCc
Confidence 46999999999999999999999999 999999999999999999999999998654332 2335689999999
Q ss_pred hhhccCC-CCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHHHHH-----HHhCCCcc---eeccccCC-CCC---
Q 048243 156 EYARQGV-YSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEHAYE-----LWKGGKGV---EFVDSSLD-DTN--- 222 (303)
Q Consensus 156 E~~~~~~-~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~---~~~~~~~~-~~~--- 222 (303)
|.+.+.. ++.++|||||||++|+|++|..||...........+..... ........ ........ ...
T Consensus 188 E~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (348)
T d2gfsa1 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA 267 (348)
T ss_dssp HHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHH
T ss_pred hhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchh
Confidence 9877654 68899999999999999999999965432221111111000 00000000 00000000 000
Q ss_pred --CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HhccccC
Q 048243 223 --SPCKLMRCLEIALLCVQENPNDRPSMLQVSS--MLKNETT 260 (303)
Q Consensus 223 --~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~--~L~~~~~ 260 (303)
....+..+.+||.+||+.||.+|||+.|+++ ++.+...
T Consensus 268 ~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 268 NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 0112346889999999999999999999998 4665543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=294.25 Aligned_cols=239 Identities=23% Similarity=0.235 Sum_probs=172.5
Q ss_pred CCCcEEEEEEecCCC--cccHHHHHHHHHHHhcCCCCccccEEEEEEe------CCeeEEEEeecCCCChhhhhcCcccc
Q 048243 4 PCGKVIAVKKLSKTS--TQGFEEFKNEVMLTAKLQHVNLIRVLGFCID------SEERMLVYEYMPNKSLDCYLFDPIRR 75 (303)
Q Consensus 4 ~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~ 75 (303)
.+|+.||||+++... ....+.+.+|+.++++++||||+++++++.. ....|+|||||.++.+ ..+ .
T Consensus 40 ~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~-~~~-----~ 113 (355)
T d2b1pa1 40 VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC-QVI-----Q 113 (355)
T ss_dssp TTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHH-HHH-----T
T ss_pred CCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHH-Hhh-----h
Confidence 579999999997553 3344578899999999999999999999964 3688999999976654 333 2
Q ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccccccccccCCCCh
Q 048243 76 LILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANTEQVVGTIGYIPP 155 (303)
Q Consensus 76 ~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~~~~~g~~~y~aP 155 (303)
..+++..++.++.||+.||+|||+.| |+||||||+|||++.++.++++|||.++..... .......||+.|+||
T Consensus 114 ~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~---~~~~~~~~t~~y~aP 187 (355)
T d2b1pa1 114 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAP 187 (355)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------------------CCTTCCH
T ss_pred cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhccccc---cccccccccccccCh
Confidence 34889999999999999999999999 999999999999999999999999998765433 223345689999999
Q ss_pred hhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHH----------------HHHHHhCCC------ccee
Q 048243 156 EYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH----------------AYELWKGGK------GVEF 213 (303)
Q Consensus 156 E~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~----------------~~~~~~~~~------~~~~ 213 (303)
|.+.+..++.++||||+||++|+|++|..||...+.......... ......... ....
T Consensus 188 E~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (355)
T d2b1pa1 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL 267 (355)
T ss_dssp HHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHH
T ss_pred hhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccc
Confidence 999999999999999999999999999999964432211111100 000000000 0000
Q ss_pred ccccCCC---CCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 214 VDSSLDD---TNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 214 ~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
....... ......+..+.+||.+||..||++||||+|+++.
T Consensus 268 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 268 FPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0001111 1123456789999999999999999999999864
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-36 Score=264.29 Aligned_cols=242 Identities=17% Similarity=0.145 Sum_probs=172.4
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-----------CCccccEEEEEEe--CCeeEEEEeecCCCChhhhhc
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-----------HVNLIRVLGFCID--SEERMLVYEYMPNKSLDCYLF 70 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~ 70 (303)
.+|+.||||+++... ...+.+.+|+.+++.++ |+||+++++++.. ....++++.++..+.......
T Consensus 36 ~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 114 (362)
T d1q8ya_ 36 VNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALI 114 (362)
T ss_dssp TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHH
T ss_pred CCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeeccccccccccc
Confidence 689999999997542 33467788999888875 5789999988764 356677777765554433333
Q ss_pred CccccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCceEECCCC------ceEEcccccccccccCCccccc
Q 048243 71 DPIRRLILDWKKRVHIIEGITQGLLYLQE-YSRLTIIHRDLKASNILLGEDM------KPKISDFGLARIFAKESLEANT 143 (303)
Q Consensus 71 ~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~-~~~~~i~H~dikp~nil~~~~~------~v~l~Df~~~~~~~~~~~~~~~ 143 (303)
.......+++..++.++.||+.||+|||+ .| |+||||||+|||++.++ .++++|||.+...... .
T Consensus 115 ~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~-----~ 186 (362)
T d1q8ya_ 115 KKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----Y 186 (362)
T ss_dssp HHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----C
T ss_pred ccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccceeeEeecccccccccc-----c
Confidence 33456678999999999999999999997 77 99999999999998665 3999999998754322 2
Q ss_pred cccccccCCCChhhhccCCCCCccchhhHHHHHHHHHhCCCCCccCCCCccccHHHH---HHHHHhCC---------C--
Q 048243 144 EQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLLLQIISGKRLSMLCGINENLSILEH---AYELWKGG---------K-- 209 (303)
Q Consensus 144 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~---------~-- 209 (303)
....|++.|+|||++.+..++.++||||+||++++|++|..||.............. ........ .
T Consensus 187 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~ 266 (362)
T d1q8ya_ 187 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTR 266 (362)
T ss_dssp CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHH
T ss_pred ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccc
Confidence 345789999999999999999999999999999999999999975443322211111 11111100 0
Q ss_pred -------cceeccc----------cCCCCCCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 048243 210 -------GVEFVDS----------SLDDTNSPCKLMRCLEIALLCVQENPNDRPSMLQVSSM 254 (303)
Q Consensus 210 -------~~~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~el~~~ 254 (303)
....... ..........+..+.+|+.+||+.||.+||||+|+++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 267 TFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp HHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred cccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000000 00122345677889999999999999999999999873
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.80 E-value=1.5e-20 Score=147.73 Aligned_cols=152 Identities=20% Similarity=0.159 Sum_probs=104.2
Q ss_pred ccCCCcEEEEEEecCCCc------------------ccHHHHHHHHHHHhcCCCCccccEEEEEEeCCeeEEEEeecCCC
Q 048243 2 VLPCGKVIAVKKLSKTST------------------QGFEEFKNEVMLTAKLQHVNLIRVLGFCIDSEERMLVYEYMPNK 63 (303)
Q Consensus 2 ~~~~~~~valK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 63 (303)
..++|+.||||+++.... ........|...+.++.|.+++..+++. ..+++|||+++.
T Consensus 20 ~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~----~~~lvme~~~~~ 95 (191)
T d1zara2 20 YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAK 95 (191)
T ss_dssp EETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE----TTEEEEECCCCE
T ss_pred ECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec----CCEEEEEeeccc
Confidence 457899999998753211 0122345688899999999999988764 347999999876
Q ss_pred ChhhhhcCccccccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCceEECCCCceEEcccccccccccCCccccc
Q 048243 64 SLDCYLFDPIRRLILDWKKRVHIIEGITQGLLYLQEYSRLTIIHRDLKASNILLGEDMKPKISDFGLARIFAKESLEANT 143 (303)
Q Consensus 64 ~L~~~l~~~~~~~~l~~~~~~~~~~~i~~~l~~Lh~~~~~~i~H~dikp~nil~~~~~~v~l~Df~~~~~~~~~~~~~~~ 143 (303)
.+.. ++......++.|++.+++|||++| |+||||||+|||++++ .++|+|||++............
T Consensus 96 ~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~~l 161 (191)
T d1zara2 96 ELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREIL 161 (191)
T ss_dssp EGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHHHHH
T ss_pred cccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEECCCcccCCCCCcHHHH
Confidence 5533 223345678999999999999999 9999999999999965 5899999998765433211110
Q ss_pred cccccccCCCChhhhccCCCCCccchhhHHHHH
Q 048243 144 EQVVGTIGYIPPEYARQGVYSTKSDVFSFGVLL 176 (303)
Q Consensus 144 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~~ 176 (303)
...... -.+. ....+..++|+||+.--+
T Consensus 162 ~rd~~~----~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 162 ERDVRN----IITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp HHHHHH----HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred HHHHHH----HHHH-HcCCCCCcccHHHHHHHH
Confidence 000000 0111 134567889999986544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.60 E-value=7e-08 Score=77.83 Aligned_cols=120 Identities=17% Similarity=0.118 Sum_probs=83.6
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHHHH
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWKKR 83 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~ 83 (303)
+++.++||+...........+..|...+..+. +--+.+++.+...++..++||++.+|.++....... ...
T Consensus 36 ~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~--------~~~ 107 (263)
T d1j7la_ 36 ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE--------QSP 107 (263)
T ss_dssp SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC--------SCH
T ss_pred CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc--------ccH
Confidence 56678888886554334445677888887773 444677888888888999999999988775544211 112
Q ss_pred HHHHHHHHHHHHHHHhCC--------------------------------------------------------CCCeEe
Q 048243 84 VHIIEGITQGLLYLQEYS--------------------------------------------------------RLTIIH 107 (303)
Q Consensus 84 ~~~~~~i~~~l~~Lh~~~--------------------------------------------------------~~~i~H 107 (303)
..++.+++..++.||+.. ...++|
T Consensus 108 ~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~H 187 (263)
T d1j7la_ 108 EKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSH 187 (263)
T ss_dssp HHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEEC
T ss_pred HHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEE
Confidence 334555566666666421 123799
Q ss_pred cCCCCCceEECCCCceEEccccccc
Q 048243 108 RDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 108 ~dikp~nil~~~~~~v~l~Df~~~~ 132 (303)
||+.|.||++++++.+.|+||+.+.
T Consensus 188 gD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 188 GDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SCCCTTSEEEETTEEEEECCCTTCE
T ss_pred eeccCcceeecCCceEEEeechhcc
Confidence 9999999999987667799998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.11 E-value=7.7e-06 Score=65.08 Aligned_cols=115 Identities=18% Similarity=0.162 Sum_probs=75.7
Q ss_pred CCCcEEEEEEecCCCcccHHHHHHHHHHHhcCC--CCccccEEEEEEeCCeeEEEEeecCCCChhhhhcCccccccCCHH
Q 048243 4 PCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ--HVNLIRVLGFCIDSEERMLVYEYMPNKSLDCYLFDPIRRLILDWK 81 (303)
Q Consensus 4 ~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~ 81 (303)
++|..+++|........ .+..|...++.+. .-.+.+++.+..+.+..++||++++|.++.... ....
T Consensus 33 ~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~~--------~~~~ 101 (255)
T d1nd4a_ 33 QGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSH--------LAPA 101 (255)
T ss_dssp TTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTSC--------CCHH
T ss_pred CCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccccc--------ccHH
Confidence 56777889987655432 4567788777773 233677888888888899999999886653321 1111
Q ss_pred HHHHHHHHHHHHHHHHHhC-------------------------------------------------------CCCCeE
Q 048243 82 KRVHIIEGITQGLLYLQEY-------------------------------------------------------SRLTII 106 (303)
Q Consensus 82 ~~~~~~~~i~~~l~~Lh~~-------------------------------------------------------~~~~i~ 106 (303)
..+.++...|+.||.. ....++
T Consensus 102 ---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~li 178 (255)
T d1nd4a_ 102 ---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVT 178 (255)
T ss_dssp ---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEE
T ss_pred ---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCCceEE
Confidence 1222333444444421 113389
Q ss_pred ecCCCCCceEECCCCceEEccccccc
Q 048243 107 HRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 107 H~dikp~nil~~~~~~v~l~Df~~~~ 132 (303)
|||+.|.||+++.++.+.|+||+.+.
T Consensus 179 HgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 179 HGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred eCCCCCcceEEeCCceEEEEEchhcc
Confidence 99999999999987667899998763
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.33 E-value=0.00044 Score=58.41 Aligned_cols=29 Identities=34% Similarity=0.413 Sum_probs=25.0
Q ss_pred CCeEecCCCCCceEECCCCceEEccccccc
Q 048243 103 LTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 103 ~~i~H~dikp~nil~~~~~~v~l~Df~~~~ 132 (303)
..++|||+.|.|||+++++ ++++||..+.
T Consensus 223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a~ 251 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEHE-TKVIDPEFAF 251 (392)
T ss_dssp CEEECSCCCGGGEEECSSC-EEECCCTTCE
T ss_pred cceeccCCcCCceeEcCCc-eEEechhhcc
Confidence 3599999999999998764 8999998764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.31 E-value=0.00036 Score=57.33 Aligned_cols=127 Identities=14% Similarity=0.119 Sum_probs=70.7
Q ss_pred cCCCcEEEEEEecCCCcccHHHHHHHHHHHhcCCCCcc--ccEEE-----EEEeCCeeEEEEeecCCCChhh----hhc-
Q 048243 3 LPCGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQHVNL--IRVLG-----FCIDSEERMLVYEYMPNKSLDC----YLF- 70 (303)
Q Consensus 3 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~~~~-----~~~~~~~~~lv~e~~~~~~L~~----~l~- 70 (303)
+++|+.+++|+..... ...+++..|...+..|....+ +..+. .+......+.+++++.|..+.. .+.
T Consensus 43 ~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~ 121 (325)
T d1zyla1 43 DEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEA 121 (325)
T ss_dssp CTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHH
T ss_pred cCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHHHH
Confidence 5789999999987653 245678888888888742222 11111 1234566788999987643311 000
Q ss_pred -------------C--ccccccCCHH----------------------HHHHHHHHHHHHHHHHH-hCCCCCeEecCCCC
Q 048243 71 -------------D--PIRRLILDWK----------------------KRVHIIEGITQGLLYLQ-EYSRLTIIHRDLKA 112 (303)
Q Consensus 71 -------------~--~~~~~~l~~~----------------------~~~~~~~~i~~~l~~Lh-~~~~~~i~H~dikp 112 (303)
. ...+...+.. .....+.++...+..+- .....+++|||+.+
T Consensus 122 lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~ 201 (325)
T d1zyla1 122 VGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHA 201 (325)
T ss_dssp HHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSG
T ss_pred HHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceeecCCCCc
Confidence 0 0011111111 12222333333333221 22235589999999
Q ss_pred CceEECCCCceEEccccccc
Q 048243 113 SNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 113 ~nil~~~~~~v~l~Df~~~~ 132 (303)
.|||++++ ..++||+-+.
T Consensus 202 ~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 202 GNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp GGEEESSS--EEECCCTTCC
T ss_pred ccEEEeCC--ceEEechhcc
Confidence 99999743 4589998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.13 E-value=0.00057 Score=57.74 Aligned_cols=55 Identities=13% Similarity=0.132 Sum_probs=36.8
Q ss_pred CCcEEEEEEecCCCcccHHHHHHHHHHHhcCC-CCccccEEEEEEeCCeeEEEEeecCCCCh
Q 048243 5 CGKVIAVKKLSKTSTQGFEEFKNEVMLTAKLQ-HVNLIRVLGFCIDSEERMLVYEYMPNKSL 65 (303)
Q Consensus 5 ~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 65 (303)
..+.|.+++.. ... ......+|..+++.+. +.-..++++++.+ ++|++|++|..+
T Consensus 73 ~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 73 EPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp CCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred CCCcEEEEecC-Ccc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 34567777775 322 3345678999999884 5445578887742 689999987554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.82 E-value=0.0089 Score=48.27 Aligned_cols=31 Identities=29% Similarity=0.340 Sum_probs=27.0
Q ss_pred CCCeEecCCCCCceEECCCCceEEccccccc
Q 048243 102 RLTIIHRDLKASNILLGEDMKPKISDFGLAR 132 (303)
Q Consensus 102 ~~~i~H~dikp~nil~~~~~~v~l~Df~~~~ 132 (303)
..+++|+|+.++|++++++...-++||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4559999999999999988777999999763
|